Citrus Sinensis ID: 018619

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350---
Protein Sequence
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT
Secondary Structure (PSIPRED)
ccEEEEEEEEEEEEEEEEEEccccEEEEEEEEcccccEEEEEcccccccHHHHHHHHHHHcccccEEEEcEEEccccccccEEEEEEEEcccccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEcccccccccccccccEEEEEEccccHHHHHcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHcccccHHHHHHcccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccccccHHHHHHccHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
cEEccccEEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHccHHHHHHccccccccccc
Coil and Loop (DISEMBL)
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVmdhpnvislkhcffsttsKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLayihtvprvchrdlkpqnllvdplthqvkicdfgsakqliAGEANISYICSRfyrapelifgateyttsiDIWSAGCVLAELllgqplfpgenaVDQLVEIIKVLgtptreeircmnpnytdfrfpqikahpwhkvfhkrmppeAIDLASRLlqyspslrctaleacahpffdelrepnarlpngrplpplfnfkqelsgaspelVNKLIPdhvkrqlglnflhpagt
Flexible Loop (DISEMBL)
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCletgetvaikkvlqdrrYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYssanqrmpLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLgtptreeiRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT
Low Complexity Region (SEG)
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT
Disordered region (IsUnstruct)
*YLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL*****************************LVNKLIPDHVKRQLGLNF******
Disordered Region (DISOPRED)
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLG*********
Disordered Region (DISEMBL)
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT
Disordered Region (DISPRO)
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQL**********
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	353	2.2.26 [Sep-21-2011]
Q39011	380	Shaggy-related protein ki	yes	no	0.977	0.907	0.933	0.0
Q39010	412	Shaggy-related protein ki	no	no	0.974	0.834	0.898	0.0
Q39012	407	Shaggy-related protein ki	no	no	0.949	0.823	0.913	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.946	0.814	0.829	1e-170
P43289	409	Shaggy-related protein ki	no	no	0.946	0.816	0.808	1e-167
P43288	405	Shaggy-related protein ki	no	no	0.954	0.832	0.803	1e-166
Q40518	409	Shaggy-related protein ki	N/A	no	0.954	0.823	0.794	1e-165
P51139	411	Glycogen synthase kinase-	N/A	no	0.954	0.819	0.786	1e-164
P51137	411	Glycogen synthase kinase-	N/A	no	0.954	0.819	0.791	1e-163
Q96287	472	Shaggy-related protein ki	no	no	0.940	0.703	0.783	1e-163

>sp|Q39011|KSG7_ARATH Shaggy-related protein kinase eta OS=Arabidopsis thaliana GN=ASK7 PE=1 SV=2

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/345 (93%), Positives = 336/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ 
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVC 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYI
Sbjct: 96  LKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H V  VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 336 NGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380

Negative regulator in brassinosteroid signal transduction pathway important for plant growth. May be also involved in auxin signaling pathway. Phosphorylates and increases the degradation of BZR1 and BZR2/BES1 by the proteasome. Phosphorylates BHLH150, beet curly top virus C4 and tomato golden mosaic virus AC4 on threonine and serine residues.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2

 Score =  660 bits (1704), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/344 (89%), Positives = 332/344 (96%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMR+MDHPNV+S
Sbjct: 68  QTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVS 127

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT+++ELFLNLVMEYVPE++YRVLKHY+S+NQRMP+ YVKLYTYQIFRGLAYI
Sbjct: 128 LKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYI 187

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           HT P VCHRD+KPQNLLVDPLTHQ K+CDFGSAK L+ GEANISYICSR+YRAPELIFGA
Sbjct: 188 HTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 247

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDF
Sbjct: 248 TEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDF 307

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLP
Sbjct: 308 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLP 367

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAG 352
           NGRPLPPLFNFKQELSGASPEL+N+LIP+HV+RQ+   F   AG
Sbjct: 368 NGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1

 Score =  655 bits (1689), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 306/335 (91%), Positives = 326/335 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMR MDHPNVIS
Sbjct: 66  QTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVIS 125

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTTS++ELFLNLVMEYVPE++YRVL+HY+S+NQRMP+ YVKLYTYQIFRGLAYI
Sbjct: 126 LKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYI 185

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           HTVP VCHRD+KPQNLLVDPLTHQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 186 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 245

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDF
Sbjct: 246 TEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDF 305

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLP
Sbjct: 306 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLP 365

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQL 343
           NGRPLPPLFNFKQEL GAS EL+N+LIP+HV+RQ+
Sbjct: 366 NGRPLPPLFNFKQELGGASMELINRLIPEHVRRQM 400

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  597 bits (1539), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 278/335 (82%), Positives = 308/335 (91%), Gaps = 1/335 (0%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAER+VG GSFGIVFQAKCLETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+S
Sbjct: 70  QTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 129

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT K+EL+LNLV+EYVPE++YRV KHYS ANQRMP+IYVKLYTYQI R LAYI
Sbjct: 130 LKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYI 189

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 190 HGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 249

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTT+IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct: 250 TEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 309

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKR PPEA+DL SRLLQYSP+LR TA+EA  HPFFDELR+PN RLP
Sbjct: 310 KFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLP 369

Query: 309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 342
           NGR LPPLFNFK QEL GAS EL++KLIPDH ++Q
Sbjct: 370 NGRALPPLFNFKPQELKGASLELLSKLIPDHARKQ 404

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  587 bits (1514), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 271/335 (80%), Positives = 307/335 (91%), Gaps = 1/335 (0%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MR++DHPNV+S
Sbjct: 69  QTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVS 128

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+  NQRMPL+YVKLYTYQIFR L+YI
Sbjct: 129 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYI 188

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 189 HRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct: 249 TEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRC AL++  HPFFDELR+PNARLP
Sbjct: 309 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLP 368

Query: 309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 342
           NGR LPPLFNFK  EL G   E+V KL+P+H ++Q
Sbjct: 369 NGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQ 403

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  583 bits (1502), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 274/341 (80%), Positives = 308/341 (90%), Gaps = 4/341 (1%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MR++DHPNV+S
Sbjct: 65  QTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVS 124

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+  NQRMPLIYVKLYTYQIFR L+YI
Sbjct: 125 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYI 184

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 185 HRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 244

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct: 245 TEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 304

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR  AL+   HPFFDELR+PNARLP
Sbjct: 305 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLP 364

Query: 309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 345
           NGR LPPLFNFK  EL G   E+V KL+P+H ++Q   LGL
Sbjct: 365 NGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  580 bits (1495), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 271/341 (79%), Positives = 306/341 (89%), Gaps = 4/341 (1%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAER+VG GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+ 
Sbjct: 69  QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVC 128

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT K+E++LNLV+EYVPE+++RV+KHY+  NQRMPLI VKLYTYQIFR L+YI
Sbjct: 129 LKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYI 188

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 189 HHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTT+IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNY +F
Sbjct: 249 TEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYNEF 308

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRCTALEA  H FFDELR+PN RLP
Sbjct: 309 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRDPNTRLP 368

Query: 309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 345
           NGR LPPLFNFK  EL G S E + KL+P+H ++Q   LGL
Sbjct: 369 NGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  576 bits (1485), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 266/338 (78%), Positives = 303/338 (89%), Gaps = 1/338 (0%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+S
Sbjct: 70  QTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 129

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT K+EL+LNLV+EYVPE++ RV++HY+  NQRMP+IYVKLY+YQI R LAYI
Sbjct: 130 LKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYI 189

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H    VCHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 190 HNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 249

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTT+IDIWSAGCVL ELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct: 250 TEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 309

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR TALEA  HPF+D++R+PN RLP
Sbjct: 310 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDDVRDPNTRLP 369

Query: 309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQLGL 345
           NGR LPPLFNFK  EL G   E++ KL+P H ++Q  L
Sbjct: 370 NGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCAL 407

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  575 bits (1483), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 270/341 (79%), Positives = 304/341 (89%), Gaps = 4/341 (1%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+S
Sbjct: 71  QTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 130

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHYS  NQRMP+IYVKLYTYQIFR L+YI
Sbjct: 131 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYTYQIFRALSYI 190

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 191 HRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 250

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTT+ID+WS GCVLAELLLGQPLFPGE  VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct: 251 TEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 310

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKRMP EA+DL SRLLQYSP+LRC AL+   HPFFDELR+PNARLP
Sbjct: 311 KFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCLTHPFFDELRDPNARLP 370

Query: 309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 345
            GR LPPLFNFK  EL G   E + KL+P+H ++Q   LGL
Sbjct: 371 TGRFLPPLFNFKPHELKGVPVETLMKLVPEHARKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  573 bits (1478), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 261/333 (78%), Positives = 299/333 (89%), Gaps = 1/333 (0%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMA+RVVGTGSFG+VFQAKCLETGE VAIKKVLQD+RYKNRELQ+MR+ DHPNV+ 
Sbjct: 134 QTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVR 193

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L+H FFSTT K+EL+LNLV+EYVPE++YR  KHY+  NQ MP+I+V+LYTYQI R L Y+
Sbjct: 194 LRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYL 253

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H V  VCHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct: 254 HRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 313

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYT +ID+WS GCV+AELLLGQPLFPGE+ +DQLVEIIK+LGTPTREEIRCMNPNYT+F
Sbjct: 314 TEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEF 373

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRCTALEACAHPFFD+LR+PN  LP
Sbjct: 374 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLP 433

Query: 309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVK 340
           NGR LPPLFNF  QEL+GAS EL  +LIP H +
Sbjct: 434 NGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	353
224116828	380	predicted protein [Populus trichocarpa]	0.977	0.907	0.953	0.0
359483773	380	PREDICTED: shaggy-related protein kinase	0.977	0.907	0.947	0.0
255562450	380	Glycogen synthase kinase-3 beta, putativ	0.977	0.907	0.947	0.0
224079065	380	predicted protein [Populus trichocarpa]	0.977	0.907	0.942	0.0
297804284	380	hypothetical protein ARALYDRAFT_914806 [	0.977	0.907	0.936	0.0
118487502	380	unknown [Populus trichocarpa]	0.977	0.907	0.939	0.0
356507479	380	PREDICTED: shaggy-related protein kinase	0.977	0.907	0.927	0.0
15233984	380	Shaggy-related protein kinase eta [Arabi	0.977	0.907	0.933	0.0
227204507	374	AT4G18710 [Arabidopsis thaliana]	0.977	0.922	0.933	0.0
1161512	380	shaggy-like kinase etha [Arabidopsis tha	0.977	0.907	0.927	0.0

>gi|224116828|ref|XP_002317404.1| predicted protein [Populus trichocarpa] gi|222860469|gb|EEE98016.1| predicted protein [Populus trichocarpa]

 Score =  692 bits (1785), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/345 (95%), Positives = 335/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT  NELFLNLVMEYVPESMYRVLKHYS+A Q MPLIYVKLYTYQIFRGLAYI
Sbjct: 96  LKHCFFSTTDNNELFLNLVMEYVPESMYRVLKHYSNAKQAMPLIYVKLYTYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           HTVPRVCHRDLKPQNLLVDPLTHQVK+CDFGSAK L+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HTVPRVCHRDLKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLF GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFSGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRPLP LFNFKQEL+GASPELVNKLIPDHVKRQ+GLN +H AGT
Sbjct: 336 NGRPLPALFNFKQELNGASPELVNKLIPDHVKRQMGLNLMHLAGT 380

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483773|ref|XP_003633016.1| PREDICTED: shaggy-related protein kinase eta-like [Vitis vinifera] gi|297740523|emb|CBI30705.3| unnamed protein product [Vitis vinifera]

 Score =  691 bits (1784), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/345 (94%), Positives = 339/345 (98%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR MDHPNVIS
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRTMDHPNVIS 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTTS++ELFLNLVMEYVPE+MYRVLKHYS+A QRMPLIYVKLYTYQIFRGLAYI
Sbjct: 96  LKHCFFSTTSRDELFLNLVMEYVPETMYRVLKHYSNAKQRMPLIYVKLYTYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H+VP VCHRDLKPQNLLVDPLTHQVK+CDFGSAK L+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HSVPGVCHRDLKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPSYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRPLPPLFNFKQELSGASPELVNKLIP+HV+RQ+GL+F HPAGT
Sbjct: 336 NGRPLPPLFNFKQELSGASPELVNKLIPEHVRRQIGLSFFHPAGT 380

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562450|ref|XP_002522231.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223538484|gb|EEF40089.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  691 bits (1782), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/345 (94%), Positives = 337/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD+RYKNRELQLMRVMDHPNVIS
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQLMRVMDHPNVIS 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT+ NELFLNLVMEYVPESMYRVLKHYS+A Q MPL+YVKLY YQIFRGLAYI
Sbjct: 96  LKHCFFSTTNNNELFLNLVMEYVPESMYRVLKHYSNAKQTMPLVYVKLYMYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           HTVP VCHRDLKPQN+LVDPLTHQVK+CDFGSAK L+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HTVPGVCHRDLKPQNILVDPLTHQVKLCDFGSAKVLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRPLPPLFNFKQEL+GASPELVNKLIPDH+KRQ+GLNFLH AGT
Sbjct: 336 NGRPLPPLFNFKQELNGASPELVNKLIPDHMKRQMGLNFLHLAGT 380

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224079065|ref|XP_002305736.1| predicted protein [Populus trichocarpa] gi|222848700|gb|EEE86247.1| predicted protein [Populus trichocarpa]

 Score =  686 bits (1769), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/345 (94%), Positives = 335/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS
Sbjct: 36  QTISYMAERVVGTGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT+ NELFLNLVMEYVPESMYRVLKHYS+A Q MPLIYVKLY YQIFRGLAYI
Sbjct: 96  LKHCFFSTTNNNELFLNLVMEYVPESMYRVLKHYSNAKQTMPLIYVKLYMYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H VP VCHRDLKPQNLLVDPLTHQVK+CDFGSAK L+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HAVPGVCHRDLKPQNLLVDPLTHQVKLCDFGSAKVLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV+IIKVLGTPTREEIRCMNPNYTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVDIIKVLGTPTREEIRCMNPNYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRPLP LFNFKQEL+GASPELVNKLIP+HVKRQ+GLNF+H AGT
Sbjct: 336 NGRPLPSLFNFKQELNGASPELVNKLIPEHVKRQMGLNFMHLAGT 380

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297804284|ref|XP_002870026.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata] gi|297315862|gb|EFH46285.1| hypothetical protein ARALYDRAFT_914806 [Arabidopsis lyrata subsp. lyrata]

 Score =  684 bits (1766), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/345 (93%), Positives = 336/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ 
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVC 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYI
Sbjct: 96  LKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H V  VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRP PPLFNFKQE++GASPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 336 NGRPFPPLFNFKQEVAGASPELVNKLIPDHIKRQLGLSFLNQSGT 380

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|118487502|gb|ABK95578.1| unknown [Populus trichocarpa]

 Score =  684 bits (1765), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/345 (93%), Positives = 335/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS
Sbjct: 36  QTISYMAERVVGTGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT+ NELFLNLVMEYVPESMYRVLKHYS+A Q MPLIYVKLY YQIFRGLAYI
Sbjct: 96  LKHCFFSTTNNNELFLNLVMEYVPESMYRVLKHYSNAKQTMPLIYVKLYMYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H VP VCHRDLKPQNLLVDPLTH+VK+CDFGSAK L+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HAVPGVCHRDLKPQNLLVDPLTHEVKLCDFGSAKVLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV+IIKVLGTPTREEIRCMNPNYTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVDIIKVLGTPTREEIRCMNPNYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRPLP LFNFKQEL+GASPELVNKLIP+HVKRQ+GLNF+H AGT
Sbjct: 336 NGRPLPSLFNFKQELNGASPELVNKLIPEHVKRQMGLNFMHLAGT 380

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356507479|ref|XP_003522493.1| PREDICTED: shaggy-related protein kinase eta-like [Glycine max]

 Score =  684 bits (1765), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/345 (92%), Positives = 334/345 (96%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGE VAIKKVLQDRRYKNRELQLMRVMDHPNVIS
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGEAVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTTS +ELFLNLVMEYVPESMYRVLKHYS+ANQRMP+IYVKLY YQIFRGLAYI
Sbjct: 96  LKHCFFSTTSTDELFLNLVMEYVPESMYRVLKHYSNANQRMPIIYVKLYMYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           HTVP+VCHRDLKPQN+LVDPLTHQVK+CDFGSAK L+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HTVPKVCHRDLKPQNILVDPLTHQVKLCDFGSAKVLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYT+SIDIWSAGCVLAELLLGQPLFPGENAVDQLV IIKVLGTPTREE+RCMNPNY DF
Sbjct: 216 TEYTSSIDIWSAGCVLAELLLGQPLFPGENAVDQLVHIIKVLGTPTREEVRCMNPNYNDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHK+FHK+MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKIFHKKMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRP PPLFNFKQELSGASPELVNKLIPDHVKRQ+GL F+H  G+
Sbjct: 336 NGRPFPPLFNFKQELSGASPELVNKLIPDHVKRQMGLQFMHLGGS 380

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15233984|ref|NP_193606.1| Shaggy-related protein kinase eta [Arabidopsis thaliana] gi|47117893|sp|Q39011.2|KSG7_ARATH RecName: Full=Shaggy-related protein kinase eta; AltName: Full=ASK-eta; AltName: Full=Protein BRASSINOSTEROID INSENSITIVE 2; AltName: Full=Protein ULTRACURVATA 1 gi|4539390|emb|CAB37456.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|7268665|emb|CAB78873.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|21554512|gb|AAM63594.1| shaggy-like protein kinase etha (EC 2.7.1.-) [Arabidopsis thaliana] gi|25140476|gb|AAN71719.1| glycogen synthase kinase 3 beta protein kinase DWARF12 [Arabidopsis thaliana] gi|109946417|gb|ABG48387.1| At4g18710 [Arabidopsis thaliana] gi|332658679|gb|AEE84079.1| Shaggy-related protein kinase eta [Arabidopsis thaliana]

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/345 (93%), Positives = 336/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ 
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVC 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYI
Sbjct: 96  LKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H V  VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSRFYRAPELIFGA
Sbjct: 156 HNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 RFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 336 NGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|227204507|dbj|BAH57105.1| AT4G18710 [Arabidopsis thaliana]

 Score =  683 bits (1762), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/345 (93%), Positives = 336/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ 
Sbjct: 30  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVC 89

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYI
Sbjct: 90  LKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYI 149

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H V  VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSRFYRAPELIFGA
Sbjct: 150 HNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSRFYRAPELIFGA 209

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDF
Sbjct: 210 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDF 269

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           RFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 270 RFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 329

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 330 NGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 374

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1161512|emb|CAA64409.1| shaggy-like kinase etha [Arabidopsis thaliana] gi|1627516|emb|CAA70144.1| shaggy-like kinase etha [Arabidopsis thaliana]

 Score =  683 bits (1762), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/345 (92%), Positives = 338/345 (97%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ 
Sbjct: 36  QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVC 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LKHCFFSTT K+ELFLNLVMEYVPE++YRVLKHYSSANQRMPL+YVKLY+YQIFRGLAYI
Sbjct: 96  LKHCFFSTTEKDELFLNLVMEYVPETLYRVLKHYSSANQRMPLVYVKLYSYQIFRGLAYI 155

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H+ P VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GE NISYICSRFYRAPELIFGA
Sbjct: 156 HSCPGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEPNISYICSRFYRAPELIFGA 215

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF
Sbjct: 216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 275

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FPQIKAHPWHK+FHKRMPPEA+DLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct: 276 KFPQIKAHPWHKIFHKRMPPEAVDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query: 309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           NGRPLPPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct: 336 NGRPLPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	353
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.977	0.907	0.933	2.7e-178
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.974	0.834	0.898	1.4e-172
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.949	0.823	0.913	1.5e-170
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.946	0.814	0.829	1.2e-154
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.946	0.816	0.808	1.7e-153
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.954	0.832	0.803	2e-152
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.934	0.699	0.788	2.7e-148
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.966	0.809	0.745	2.2e-144
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.943	0.760	0.733	3.1e-138
ZFIN|ZDB-GENE-090312-2	419	si:dkeyp-80c12.7 "si:dkeyp-80c	0.940	0.792	0.684	1.4e-126

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1731 (614.4 bits), Expect = 2.7e-178, P = 2.7e-178
 Identities = 322/345 (93%), Positives = 336/345 (97%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV+ 
Sbjct:    36 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVVC 95

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKHCFFSTTSK+ELFLNLVMEYVPES+YRVLKHYSSANQRMPL+YVKLY YQIFRGLAYI
Sbjct:    96 LKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYI 155

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             H V  VCHRDLKPQNLLVDPLTHQVKICDFGSAKQL+ GEANISYICSRFYRAPELIFGA
Sbjct:   156 HNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSRFYRAPELIFGA 215

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP+YTDF
Sbjct:   216 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPHYTDF 275

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             RFPQIKAHPWHK+FHKRMPPEAID ASRLLQYSPSLRCTALEACAHPFFDELREPNARLP
Sbjct:   276 RFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 335

Query:   309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
             NGRP PPLFNFKQE++G+SPELVNKLIPDH+KRQLGL+FL+ +GT
Sbjct:   336 NGRPFPPLFNFKQEVAGSSPELVNKLIPDHIKRQLGLSFLNQSGT 380

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1677 (595.4 bits), Expect = 1.4e-172, P = 1.4e-172
 Identities = 309/344 (89%), Positives = 332/344 (96%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMR+MDHPNV+S
Sbjct:    68 QTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRLMDHPNVVS 127

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKHCFFSTT+++ELFLNLVMEYVPE++YRVLKHY+S+NQRMP+ YVKLYTYQIFRGLAYI
Sbjct:   128 LKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYI 187

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             HT P VCHRD+KPQNLLVDPLTHQ K+CDFGSAK L+ GEANISYICSR+YRAPELIFGA
Sbjct:   188 HTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRYYRAPELIFGA 247

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYT+SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDF
Sbjct:   248 TEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDF 307

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLP
Sbjct:   308 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLP 367

Query:   309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAG 352
             NGRPLPPLFNFKQELSGASPEL+N+LIP+HV+RQ+   F   AG
Sbjct:   368 NGRPLPPLFNFKQELSGASPELINRLIPEHVRRQMNGGFPFQAG 411

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1658 (588.7 bits), Expect = 1.5e-170, P = 1.5e-170
 Identities = 306/335 (91%), Positives = 326/335 (97%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QTISYMAERVVGTGSFGIVFQAKCLETGE+VAIKKVLQDRRYKNRELQLMR MDHPNVIS
Sbjct:    66 QTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVIS 125

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKHCFFSTTS++ELFLNLVMEYVPE++YRVL+HY+S+NQRMP+ YVKLYTYQIFRGLAYI
Sbjct:   126 LKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYI 185

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             HTVP VCHRD+KPQNLLVDPLTHQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct:   186 HTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 245

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYT SIDIWSAGCVLAELLLGQPLFPGEN+VDQLVEIIKVLGTPTREEIRCMNPNYTDF
Sbjct:   246 TEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDF 305

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF+ELREPNARLP
Sbjct:   306 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFNELREPNARLP 365

Query:   309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQL 343
             NGRPLPPLFNFKQEL GAS EL+N+LIP+HV+RQ+
Sbjct:   366 NGRPLPPLFNFKQELGGASMELINRLIPEHVRRQM 400

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1508 (535.9 bits), Expect = 1.2e-154, P = 1.2e-154
 Identities = 278/335 (82%), Positives = 308/335 (91%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QTISYMAER+VG GSFGIVFQAKCLETGETVAIKKVLQD+RYKNRELQ MR++DHPNV+S
Sbjct:    70 QTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 129

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKHCFFSTT K+EL+LNLV+EYVPE++YRV KHYS ANQRMP+IYVKLYTYQI R LAYI
Sbjct:   130 LKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYI 189

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct:   190 HGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 249

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYTT+IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct:   250 TEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 309

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             +FPQIKAHPWHK+FHKR PPEA+DL SRLLQYSP+LR TA+EA  HPFFDELR+PN RLP
Sbjct:   310 KFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLP 369

Query:   309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 342
             NGR LPPLFNFK QEL GAS EL++KLIPDH ++Q
Sbjct:   370 NGRALPPLFNFKPQELKGASLELLSKLIPDHARKQ 404

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1497 (532.0 bits), Expect = 1.7e-153, P = 1.7e-153
 Identities = 271/335 (80%), Positives = 307/335 (91%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MR++DHPNV+S
Sbjct:    69 QTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVS 128

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+  NQRMPL+YVKLYTYQIFR L+YI
Sbjct:   129 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYI 188

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct:   189 HRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct:   249 TEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRC AL++  HPFFDELR+PNARLP
Sbjct:   309 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLP 368

Query:   309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 342
             NGR LPPLFNFK  EL G   E+V KL+P+H ++Q
Sbjct:   369 NGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQ 403

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1487 (528.5 bits), Expect = 2.0e-152, P = 2.0e-152
 Identities = 274/341 (80%), Positives = 308/341 (90%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QTISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDRRYKNRELQ MR++DHPNV+S
Sbjct:    65 QTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVS 124

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKHCFFSTT K+EL+LNLV+EYVPE+++RV+KHY+  NQRMPLIYVKLYTYQIFR L+YI
Sbjct:   125 LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYI 184

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             H    VCHRD+KPQNLLV+P THQVK+CDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct:   185 HRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 244

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYTT+ID+WSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct:   245 TEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 304

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LR  AL+   HPFFDELR+PNARLP
Sbjct:   305 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLP 364

Query:   309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ---LGL 345
             NGR LPPLFNFK  EL G   E+V KL+P+H ++Q   LGL
Sbjct:   365 NGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1448 (514.8 bits), Expect = 2.7e-148, P = 2.7e-148
 Identities = 261/331 (78%), Positives = 298/331 (90%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QTISYMA+RVVGTGSFG+VFQAKCLETGE VAIKKVLQD+RYKNRELQ+MR+ DHPNV+ 
Sbjct:   134 QTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVR 193

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             L+H FFSTT K+EL+LNLV+EYVPE++YR  KHY+  NQ MP+I+V+LYTYQI R L Y+
Sbjct:   194 LRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYL 253

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             H V  VCHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE NISYICSR+YRAPELIFGA
Sbjct:   254 HRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGA 313

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYT +ID+WS GCV+AELLLGQPLFPGE+ +DQLVEIIK+LGTPTREEIRCMNPNYT+F
Sbjct:   314 TEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEF 373

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             +FPQIKAHPWHK+FHKRMPPEA+DL SRLLQYSP+LRCTALEACAHPFFD+LR+PN  LP
Sbjct:   374 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLP 433

Query:   309 NGRPLPPLFNFK-QELSGASPELVNKLIPDH 338
             NGR LPPLFNF  QEL+GAS EL  +LIP H
Sbjct:   434 NGRALPPLFNFTAQELAGASTELRQRLIPAH 464

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1411 (501.8 bits), Expect = 2.2e-144, P = 2.2e-144
 Identities = 255/342 (74%), Positives = 297/342 (86%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             QT+SY++E VVGTGSFG+VFQAKC ETGE VAIKKVLQD+RYKNRELQ+M+++DHPN ++
Sbjct:    79 QTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIMQMLDHPNAVA 138

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKH FFS T   E++LNLV+E+VPE++ RV + YS  NQ MPLIYVKLYTYQI R LAYI
Sbjct:   139 LKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYTYQICRALAYI 198

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             H    +CHRD+KPQNLLV+P THQ+KICDFGSAK L+ GE N+SYICSR+YRAPELIFGA
Sbjct:   199 HNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRYYRAPELIFGA 258

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +EYTT+IDIWS GCV+AELLLGQPLFPGE+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F
Sbjct:   259 SEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 318

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             +FPQIK HPWHKVF KR+PPEA+DL  R  QYSP+LRCTALEAC HP FDELR+PN RLP
Sbjct:   319 KFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLFDELRDPNTRLP 378

Query:   309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQLGLNFLH 349
             NGRPLPPLFNFK QELSG  PE+VN+L+P+H ++Q     LH
Sbjct:   379 NGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMALH 420

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1353 (481.3 bits), Expect = 3.1e-138, P = 3.1e-138
 Identities = 245/334 (73%), Positives = 292/334 (87%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             +TISY AE V+GTGSFG+VFQAKCLET E VAIKKVLQD+RYKNRELQ+MR++DHPNV+ 
Sbjct:   105 KTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVE 164

Query:    69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             LKH FFSTT K+EL+LNLV+EYVPE++YR  + Y+  NQ MPLIY++LYTYQI R + Y+
Sbjct:   165 LKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYL 224

Query:   129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
             H V  VCHRD+KPQNLLV+ +TH+VKICDFGSAK LI GE NISYICSR+YRAPELIFGA
Sbjct:   225 HQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGA 284

Query:   189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             TEYT++ID+WS GCV+AEL LG PLFPGE +VDQLVEIIK+LGTP REEI+ MNP Y DF
Sbjct:   285 TEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDF 344

Query:   249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             +FPQIKA PWHK+F +++ PEA+DLASRLLQYSP+LRCTALEACAHPFFD+LR+P A LP
Sbjct:   345 KFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLP 404

Query:   309 NGRPLPPLFNFK-QELSGASPELVNKLIPDHVKR 341
             NGR LPPLF+F  QEL+GAS EL ++LIP+H ++
Sbjct:   405 NGRALPPLFDFTAQELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

ZFIN|ZDB-GENE-090312-2 si:dkeyp-80c12.7 "si:dkeyp-80c12.7" [Danio rerio (taxid:7955)]

 Score = 1243 (442.6 bits), Expect = 1.4e-126, P = 1.4e-126
 Identities = 230/336 (68%), Positives = 281/336 (83%)

Query:     9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
             Q +SY   +V+G GSFG+V+QAK  +TGE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct:    52 QEVSYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 111

Query:    69 LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
             L++ F+S+   K+E++LNLVM+YVPE++YRV +HYS A Q +P++YVKLY YQ+FR LAY
Sbjct:   112 LRYFFYSSGDKKDEVYLNLVMDYVPENVYRVARHYSKAKQNLPMVYVKLYMYQLFRSLAY 171

Query:   128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
             IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct:   172 IHSYG-ICHRDIKPQNLLLDPETAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230

Query:   188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
             AT+YT+SIDIWSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct:   231 ATDYTSSIDIWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290

Query:   248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
             F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELREPN +L
Sbjct:   291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHTFFDELREPNLKL 350

Query:   308 PNGRPLPPLFNFK-QELSGASPELVNKLIPDHVKRQ 342
             PNGR  P LFNF  QELS  +P L + LIP H + Q
Sbjct:   351 PNGRERPVLFNFTTQELSN-NPSLASVLIPAHAQNQ 385

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.8089	0.9461	0.8166	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.8035	0.9546	0.8320	no	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5552	0.9490	0.8656	yes	no
Q39012	KSG9_ARATH	2, ., 7, ., 1, 1, ., 1	0.9134	0.9490	0.8230	no	no
A8X5H5	GSK3_CAEBR	2, ., 7, ., 1, 1, ., 2, 6	0.6547	0.8640	0.8495	N/A	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.8982	0.9745	0.8349	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.9333	0.9773	0.9078	yes	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7456	0.9660	0.8099	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5202	0.9008	0.8594	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6547	0.8640	0.8425	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7514	0.9660	0.8119	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.7947	0.9546	0.8239	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6656	0.9433	0.7928	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6142	0.9433	0.7130	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7917	0.9546	0.8199	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7781	0.9546	0.8199	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.7869	0.9546	0.8199	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7807	0.9405	0.7094	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6656	0.9433	0.7928	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8298	0.9461	0.8146	no	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6656	0.9433	0.7928	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_LG_XI0770 hypothetical protein (381 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	353
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-137
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-90
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-87
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-85
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-81
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-81
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-77
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-75
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-75
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-74
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-73
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-73
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-71
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-69
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-69
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-68
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-67
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-61
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-60
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-60
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-60
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-60
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-59
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-59
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-59
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-59
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-59
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-58
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-58
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-58
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-58
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-58
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-57
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-56
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-55
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-55
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-54
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-51
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-51
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-50
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-50
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-50
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-49
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-48
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-48
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-47
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-47
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-47
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-45
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-45
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-43
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-41
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-40
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-40
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-39
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-38
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-38
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-37
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-36
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-36
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-34
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-34
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-33
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-32
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-31
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-29
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-29
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-29
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-28
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-28
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-27
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-27
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-26
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-26
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-26
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-25
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-24
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-24
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-24
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-24
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-23
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-23
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-23
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-23
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-23
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-21
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-21
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-21
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-20
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-20
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-20
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-19
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-19
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-18
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-17
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-17
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-16
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	5e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	9e-16
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-15
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-15
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-14
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-14
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-09
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-08
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-06
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-05
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.002

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  397 bits (1020), Expect = e-137
 Identities = 176/333 (52%), Positives = 242/333 (72%), Gaps = 6/333 (1%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH 71
           SY    ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL +M+ ++H N+I LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 72  CFFSTT-SKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
            +++    KNE  +FLN+VME++P+++++ +KHY+  N  +PL  VKLY+YQ+ R LAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H+   +CHRDLKPQNLL+DP TH +K+CDFGSAK L+AG+ ++SYICSRFYRAPEL+ GA
Sbjct: 187 HS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           T YTT ID+WS GC++AE++LG P+F G+++VDQLV II+VLGTPT ++++ MNPNY D 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +FP +K     KVF K  P +AI+  S+ L+Y P  R   +EA A PFFD+LR+P  +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365

Query: 309 NG-RPLPPLFNF-KQELSGASPELVNKLIPDHV 339
                LP LFNF   E+   S     K+IP   
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCT 398

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  273 bits (701), Expect = 3e-90
 Identities = 114/307 (37%), Positives = 177/307 (57%), Gaps = 24/307 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y   + +G+G++G+V  A    TG  VAIKK+      L D +   RE++L+R + H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 67  ISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           I L       S    N++++  V E +   +++V+K      Q +   +++ + YQI RG
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYR 180
           L Y+H+   V HRDLKP N+LV+     +KICDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APEL+  ++ YT +IDIWS GC+ AELL  +PLFPG + +DQL  I++VLGTP+ E+++ 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 241 M-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           + +    ++    P+    P  K+F     PEAIDL  ++L + P  R TA EA AHP+ 
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 298 DELREPN 304
            +L +P 
Sbjct: 293 AQLHDPE 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  262 bits (673), Expect = 8e-87
 Identities = 107/290 (36%), Positives = 169/290 (58%), Gaps = 25/290 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 70
           +G G++G+V++A+  +TGE VA+KK+  D   +         RE+ L++ + HPN++ L 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                  ++ +L+L  V EY    + + L         +    +K   YQ+ RGLAY H+
Sbjct: 65  DVI---HTERKLYL--VFEYCDMDLKKYLDKRPGP---LSPNLIKSIMYQLLRGLAYCHS 116

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 189
             R+ HRDLKPQN+L++     +K+ DFG A+   I        + + +YRAPE++ G+ 
Sbjct: 117 H-RILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMNPNYTD 247
            Y+T++DIWS GC+ AE++ G+PLFPG++ +DQL +I ++LGTPT E        P+Y  
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             FP+       KV   R+ PE IDL S++LQY+P+ R +A EA  HP+F
Sbjct: 235 -TFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  258 bits (661), Expect = 6e-85
 Identities = 117/293 (39%), Positives = 164/293 (55%), Gaps = 25/293 (8%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 70
             +G G+ GIVF+AK  ETGETVA+KKV   R          RE++ ++   HP V+ L 
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             F   +        LVMEY+P  +  VL+      + +P   VK Y   + +G+AY+H 
Sbjct: 66  DVFPHGSG-----FVLVMEYMPSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 187
              + HRDLKP NLL+      +KI DFG A+ L + E    Y   + +R+YRAPEL++G
Sbjct: 118 N-GIMHRDLKPANLLISA-DGVLKIADFGLAR-LFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 244
           A +Y   +D+W+ GC+ AELL G PLFPGEN ++QL  + + LGTP  E    +  + P+
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PD 233

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           Y    FP+ K  P  ++F     PEA+DL   LL Y PS R +A EA  HP+F
Sbjct: 234 YNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  249 bits (638), Expect = 1e-81
 Identities = 109/294 (37%), Positives = 165/294 (56%), Gaps = 20/294 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKN---RELQLMRVMDHPNV 66
           Y     +G G++G+V++A+   TGE VAIKK+              RE++L++ ++HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           I L   F          L LV E++   +Y+++K      + +P   +K Y YQ+ +GLA
Sbjct: 61  IKLLDVFRHKGD-----LYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLA 112

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 185
           + H+   + HRDLKP+NLL++     +K+ DFG A+           Y+ +R+YRAPEL+
Sbjct: 113 FCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN- 244
            G   Y+T +DIWS GC+ AELL  +PLFPG++ +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 245 -YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
               F FP+    P  K+F     P+A+DL S++L Y P  R TA +A AHP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  246 bits (630), Expect = 9e-81
 Identities = 100/291 (34%), Positives = 145/291 (49%), Gaps = 43/291 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 67
           Y     +G GSFG V+ A+  +TG+ VAIK +      +DR    RE+++++ + HPN++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L   F          L LVMEY     ++ +LK       R+     + Y  QI   L 
Sbjct: 61  RLYDVFEDED-----KLYLVMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           Y+H+   + HRDLKP+N+L+D     VK+ DFG A+QL  GE   +++ +  Y APE++ 
Sbjct: 112 YLHSK-GIVHRDLKPENILLDE-DGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G   Y  ++DIWS G +L ELL G+P FPG++   QL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPPFPP------- 218

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                              + PEA DL  +LL   P  R TA EA  HPFF
Sbjct: 219 ---------------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  238 bits (610), Expect = 1e-77
 Identities = 98/289 (33%), Positives = 142/289 (49%), Gaps = 39/289 (13%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 69
            R +G+GSFG V++AK   TG+ VA+K + +            RE++++R + HPN++ L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
              F      +   L LVMEY        L  Y S    +     K    QI RGL Y+H
Sbjct: 64  IDAF--EDKDH---LYLVMEYCEGG---DLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGA 188
           +   + HRDLKP+N+L+D     VKI DFG AK+L+    +  +++ + +Y APE++ G 
Sbjct: 116 SN-GIIHRDLKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y   +D+WS G +L ELL G+P F GEN +DQL  I ++LG P               
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                    + +        EA DL  + L   PS R TA E   HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  233 bits (598), Expect = 2e-75
 Identities = 109/296 (36%), Positives = 171/296 (57%), Gaps = 32/296 (10%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQ-LMRVMDHPNVIS 68
           + +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++ L ++ +HPN++ 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           LK  F      +EL+   V EY+  ++Y+++K      +      ++   YQI +GLA+I
Sbjct: 63  LKEVF---RENDELYF--VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHI 115

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H      HRDLKP+NLLV      VKI DFG A+++ +      Y+ +R+YRAPE++  +
Sbjct: 116 HKHGFF-HRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE-------IRCM 241
           T Y++ +DIW+ GC++AEL   +PLFPG + +DQL +I  VLGTPT+++          +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                 FRFPQ      H++      PEAIDL   +L++ P  R TA +A  HP+F
Sbjct: 234 G-----FRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  234 bits (600), Expect = 2e-75
 Identities = 106/299 (35%), Positives = 161/299 (53%), Gaps = 29/299 (9%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDH 63
           Y   + +G G++ +V++A+  ETG  VAIKK+    R +          RE++L++ + H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN+I L   F     K+   +NLV E++   + +V+K     +  +    +K Y     R
Sbjct: 62  PNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSYMLMTLR 113

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRFYR 180
           GL Y+H    + HRDLKP NLL+      +K+ DFG A+    G  N        +R+YR
Sbjct: 114 GLEYLH-SNWILHRDLKPNNLLIAS-DGVLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APEL+FGA  Y   +D+WS GC+ AELLL  P  PG++ +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 241 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           +   P+Y +F+       P  ++F      +A+DL  RLL  +P+ R TA +A  HP+F
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  231 bits (592), Expect = 2e-74
 Identities = 89/293 (30%), Positives = 156/293 (53%), Gaps = 26/293 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G V++A+  +TGE VA+KK+  +   +       RE++L++ + HPN++ LK  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             S   K  +++  V EY+   +  +L        +     +K Y  Q+  GL Y+H+  
Sbjct: 67  VTSKG-KGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN- 119

Query: 133 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 187
            + HRD+K  N+L++   +   +K+ DFG A+       +  Y   + + +YR PEL+ G
Sbjct: 120 GILHRDIKGSNILIN---NDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPELLLG 175

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPN 244
           AT Y   +D+WS GC+LAEL LG+P+F G   ++QL +I ++ G+PT E    +  + P 
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PW 234

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           + + +  +       + F   + P A+DL  +LL   P  R +A +A  H +F
Sbjct: 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  229 bits (587), Expect = 4e-73
 Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 26/305 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 64
           Y     VG+G++G V  A   +TG  VAIKK+ +         R Y  REL+L++ MDH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI L   F   +S  +   + LV   +   +  ++K      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           GL YIH+   + HRDLKP N+ V+    ++KI DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 244 ----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
               NY     PQ+    + +VF     P AIDL  ++L   P  R TA EA AHP+  E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303

Query: 300 LREPN 304
             +P 
Sbjct: 304 YHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  227 bits (582), Expect = 4e-73
 Identities = 102/291 (35%), Positives = 164/291 (56%), Gaps = 21/291 (7%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 71
           VVG G++G+V + +   TGE VAIKK  +    ++      RE++++R + H N+++LK 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            F     K  L+L  V EYV  ++  +L+        +P   V+ Y +Q+ + +AY H+ 
Sbjct: 68  AF---RRKGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH 119

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYRAPELIFGAT 189
             + HRD+KP+N+LV   +  +K+CDFG A+ L A  A+    Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTD 247
            Y   +D+W+ GC++AELL G+PLFPG++ +DQL  I K LG   P+ +E+   NP +  
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237

Query: 248 FRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             FP+        + +  ++   A+D     L+  P  R T  E   HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  224 bits (572), Expect = 6e-71
 Identities = 114/332 (34%), Positives = 178/332 (53%), Gaps = 36/332 (10%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 65
           Y     +G G++G+V  A    TG  VAIKK+          R    RE++++R   H N
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL--REIKILRRFKHEN 64

Query: 66  VISLKHCFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           +I +       +  S N++++  V E +   +Y+++K    +N      +++ + YQI R
Sbjct: 65  IIGILDIIRPPSFESFNDVYI--VQELMETDLYKLIKTQHLSND-----HIQYFLYQILR 117

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFY 179
           GL YIH+   V HRDLKP NLL++     +KICDFG A+       +      Y+ +R+Y
Sbjct: 118 GLKYIHSA-NVLHRDLKPSNLLLNT-NCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
           RAPE++  +  YT +IDIWS GC+LAE+L  +PLFPG++ + QL  I+ VLGTP++E++ 
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235

Query: 240 CM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           C+ +    ++    P     PW+K+F     P+A+DL  ++L ++P  R T  EA AHP+
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Query: 297 ----FDELREPNARLPNGRPLPPLFNFKQELS 324
                D   EP A      P P  F    +L 
Sbjct: 295 LEQYHDPSDEPVAE----EPFPFDFELFDDLP 322

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  218 bits (559), Expect = 6e-69
 Identities = 105/309 (33%), Positives = 173/309 (55%), Gaps = 31/309 (10%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QD--RRYKNRELQLMRVM-DH 63
           Y   + +G G++GIV++A    T E VA+KK+        D  R +  RE+  ++ + DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF--REIMFLQELGDH 66

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L +      ++N+  + LV EY+   ++ V++    AN     ++ +   YQ+ +
Sbjct: 67  PNIVKLLNVI---KAENDKDIYLVFEYMETDLHAVIR----ANILED-VHKRYIMYQLLK 118

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------YICSR 177
            L YIH+   V HRDLKP N+L++     VK+ DFG A+ L   E N        Y+ +R
Sbjct: 119 ALKYIHS-GNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
           +YRAPE++ G+T YT  +D+WS GC+L E+LLG+PLFPG + ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 238 IRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
           I  +   +        P     P  ++   +   +A+DL  +LL ++P+ R TA EA  H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Query: 295 PFFDELREP 303
           P+  +   P
Sbjct: 296 PYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  218 bits (558), Expect = 9e-69
 Identities = 118/333 (35%), Positives = 186/333 (55%), Gaps = 21/333 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y+  + +G G++GIV  AK  ET E VAIKK+        D +   RE++L+R +DH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           I++K        +    + +V E +   ++++++    ++Q +   + + + YQ+ RGL 
Sbjct: 67  IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLK 122

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 185
           YIH+   V HRDLKP NLL++     +KICDFG A+     G+    Y+ +R+YRAPEL+
Sbjct: 123 YIHSA-NVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-NPN 244
              +EYTT+ID+WS GC+ AELL  +PLFPG++ V QL  I ++LG+P+ E++  + N  
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 245 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
              +    P      + ++F     P AIDL  ++L + PS R T  EA AHP+   L +
Sbjct: 241 ARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299

Query: 303 PNARLPNGRPLPPLFNFKQELSGASPELVNKLI 335
           P+       P    F+F  E    + E + +LI
Sbjct: 300 PSDEPVCQTP----FSFDFEEDALTEEDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  217 bits (554), Expect = 3e-68
 Identities = 118/344 (34%), Positives = 180/344 (52%), Gaps = 32/344 (9%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRVMDHPN 65
            Y     +G+G++G+V  A    +G+ VAIKK      V    +   REL+++R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 66  VISLKHCFFSTTSKNELFLN--LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           +I+++            F +  +VM+     M   L H   ++Q +   +++ + YQ+ R
Sbjct: 66  IIAIRDIL---RPPGADFKDVYVVMDL----MESDLHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRF 178
           GL YIH+   V HRDLKP NLLV+     ++I DFG A+ L +           Y+ +R+
Sbjct: 119 GLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           YRAPEL+    EYTT+ID+WS GC+ AE+L  + LFPG+N V QL  I+ VLG+P+ E +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236

Query: 239 RCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
             +       Y     P+ +  PW K+F K   PEA+DL S++LQ+ P  R T  +A  H
Sbjct: 237 NRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQH 294

Query: 295 PFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDH 338
           PF  +  +P+    +    PP F+F  E    S E + + I   
Sbjct: 295 PFLAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  214 bits (546), Expect = 1e-67
 Identities = 103/291 (35%), Positives = 164/291 (56%), Gaps = 26/291 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  +   +       RE+ L++ ++HPN++ L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             S     E  L LV E++       LK Y  SS    +    +K Y YQ+ +G+AY H+
Sbjct: 67  VHS-----ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 189
             RV HRDLKPQNLL+D     +K+ DFG A+   +        + + +YRAPE++ G+ 
Sbjct: 118 -HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR 175

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 246
           +Y+T +DIWS GC+ AE++  +PLFPG++ +DQL  I + LGTP  +    +  + P+Y 
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDYK 234

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
              FP+       KV    +  + +DL S++L Y P+ R +A  A  HP+F
Sbjct: 235 P-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  198 bits (505), Expect = 6e-61
 Identities = 121/326 (37%), Positives = 181/326 (55%), Gaps = 27/326 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y  + V+G GS+G+V  A    TGE VAIKK+      + D     RE++L+R++ HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + +KH     + +    + +V E +   +++V+K    AN  +   + + + YQ+ R L 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN----ISYICSRFYRAP 182
           YIHT   V HRDLKP+N+L +    ++KICDFG A+              Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 183 ELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-R 239
           EL  G+  ++YT +IDIWS GC+ AE+L G+PLFPG+N V QL  I  +LGTP+ E I R
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPF 296
             N     +     K  P    F ++ P   P A+ L  RLL + P  R TA EA A P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292

Query: 297 FDELREPNARLPNGRPLPPL-FNFKQ 321
           F  L +   R P+ +P+  L F F++
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFER 317

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  196 bits (499), Expect = 1e-60
 Identities = 109/290 (37%), Positives = 171/290 (58%), Gaps = 21/290 (7%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKH 71
           +VG GS+G+V + K  ETG+ VAIKK L+       ++   RE+++++ + H N+++L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            F     K  L+L  V E+V  ++   L+ Y +    +    V+ Y +QI RG+ + H+ 
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHS- 118

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATE 190
             + HRD+KP+N+LV   +  VK+CDFG A+ L A GE    Y+ +R+YRAPEL+ G T+
Sbjct: 119 HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 248
           Y  ++DIW+ GC++ E+L G+PLFPG++ +DQL  IIK LG   P  +EI   NP +   
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 249 RFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           R P++K   P  K F K +    +DLA + L+  P  R ++ +   H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  195 bits (497), Expect = 2e-60
 Identities = 109/303 (35%), Positives = 169/303 (55%), Gaps = 29/303 (9%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G++G+V++A+   T ET+A+KK+  ++  +       RE+ L++ M H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQI 121
           + L+    S     E  L LV EY+   +    KH  S+     N R+    +K Y YQI
Sbjct: 64  VRLQDVVHS-----EKRLYLVFEYLDLDLK---KHMDSSPDFAKNPRL----IKTYLYQI 111

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYR 180
            RG+AY H+  RV HRDLKPQNLL+D  T+ +K+ DFG A+   I        + + +YR
Sbjct: 112 LRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++ G+  Y+T +DIWS GC+ AE++  +PLFPG++ +D+L +I ++LGTP  E    
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 241 MN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
           +   P+Y    FP+        V    + P  +DL S++L+  PS R TA  A  H +F 
Sbjct: 231 VTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Query: 299 ELR 301
           +L 
Sbjct: 289 DLG 291

Length = 294

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  195 bits (496), Expect = 8e-60
 Identities = 115/306 (37%), Positives = 168/306 (54%), Gaps = 29/306 (9%)

Query: 10  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVM 61
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK        VL  R Y  REL+L++ +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHL 66

Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
            H N+ISL   F S        +  V E +   ++R+L       Q     +++ + YQI
Sbjct: 67  RHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTSRPLEKQ-----FIQYFLYQI 117

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 181
            RGL Y+H+   V HRDLKP N+L++     +KICDFG A+  I       Y+ +R+YRA
Sbjct: 118 LRGLKYVHSAG-VVHRDLKPSNILINE-NCDLKICDFGLAR--IQDPQMTGYVSTRYYRA 173

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++    +Y   +DIWSAGC+ AE+L G+PLFPG++ V+Q   I  +LGTP  + I  +
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233

Query: 242 NPNYTDFRF----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
               T  RF    P+ +  P+ + F K   P AIDL  ++L + P  R +A EA AHP+ 
Sbjct: 234 CSENT-LRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Query: 298 DELREP 303
               +P
Sbjct: 292 APYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  193 bits (493), Expect = 9e-60
 Identities = 97/289 (33%), Positives = 152/289 (52%), Gaps = 25/289 (8%)

Query: 20  GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVM-DHPNVISLKH 71
           G G+F  V +A+  +TG+  AIK + +   +K+       RE+Q +R +  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCMKK--HFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIH 129
             F   +     L LV E +  ++Y ++K      ++ PL    VK Y YQ+ + L ++H
Sbjct: 66  VLFDRKTGR---LALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
               + HRD+KP+N+L+      +K+ DFGS + + +      YI +R+YRAPE +    
Sbjct: 118 R-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-NYTDF 248
            Y   +DIW+ GCV  E+L   PLFPG N +DQ+ +I  VLGTP  E ++      + ++
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            FP  K     K+       E +DL  +LL Y P  R TA +A  HP+F
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  193 bits (493), Expect = 1e-59
 Identities = 99/303 (32%), Positives = 153/303 (50%), Gaps = 46/303 (15%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD---HPN 65
           +G G++G V++A+ L TG  VA+KKV    R             RE+ L++ ++   HPN
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           ++ L        +  EL L LV E+V + +   L         +P   +K    Q+ RG+
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRGV 120

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            ++H+  R+ HRDLKPQN+LV     QVKI DFG A+      A  S + + +YRAPE++
Sbjct: 121 DFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
             ++ Y T +D+WS GC+ AEL   +PLF G +  DQL +I  V+G P+ EE        
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE-------- 229

Query: 246 TDFRFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAH 294
               +P+  + P    F              +  E +DL  ++L ++P  R +A EA  H
Sbjct: 230 ----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284

Query: 295 PFF 297
           P+F
Sbjct: 285 PYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  193 bits (492), Expect = 1e-59
 Identities = 108/290 (37%), Positives = 166/290 (57%), Gaps = 24/290 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 73
           +G G++  V++ +   TGE VA+K++  D          RE+ LM+ + H N++ L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR-MPLIYVKLYTYQIFRGLAYIHT 130
             T +K    L LV EY    M + LK Y  +   +  +    VK +TYQ+ +G+A+ H 
Sbjct: 67  IHTENK----LMLVFEY----MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 189
             RV HRDLKPQNLL++    ++K+ DFG A+   I      + + + +YRAP+++ G+ 
Sbjct: 119 -NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTD 247
            Y+TSIDIWS GC++AE++ G+PLFPG N  DQL++I +++GTPT      ++  P Y  
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             FP+       ++F     P  IDL  RLLQ +P LR +A +A  HP+F
Sbjct: 237 -TFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 3e-59
 Identities = 111/317 (35%), Positives = 159/317 (50%), Gaps = 46/317 (14%)

Query: 19  VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           +G G++G V++AK      G+  AIKK   D+           RE+ L+R + H NV+SL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYI 128
              F     K+   + L+ +Y    +++++K +  A +   P   VK   +QI  G+ Y+
Sbjct: 68  VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 129 HTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA-------KQLIAGEANISYICSRF 178
           H+   V HRDLKP N+LV    P    VKI D G A       K L   +  +  I   +
Sbjct: 125 HS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKV 229
           YRAPEL+ GA  YT +IDIW+ GC+ AELL  +P+F G  A          DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 230 LGTPTREE---IRCMNPNY----TDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQY 280
           LGTPT ++   I+ M P Y     DF+     ++   K   K      +  DL  +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 281 SPSLRCTALEACAHPFF 297
            P+ R TA EA  HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  192 bits (489), Expect = 4e-59
 Identities = 100/293 (34%), Positives = 158/293 (53%), Gaps = 19/293 (6%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G V++A+   TG+ VA+KK   +   +       RE+ L++++     I     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 73  FFSTTSKN-ELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                 KN +  L LV EY+   + + +  +     + +P   +K + YQ+ +G+A+ H 
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGAT 189
              V HRDLKPQNLLVD     +KI D G  +   I  ++    I + +YRAPE++ G+T
Sbjct: 129 HG-VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST 187

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y+T +DIWS GC+ AE+   QPLFPG++ + QL+ I K+LGTPT +      P  +  R
Sbjct: 188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLR 243

Query: 250 ----FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
               FPQ K     +     + PE +DL  ++L+Y P+ R +A  A  HP+FD
Sbjct: 244 DWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  191 bits (486), Expect = 9e-59
 Identities = 105/295 (35%), Positives = 172/295 (58%), Gaps = 34/295 (11%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             +   +N+L+L  V E+    +++ LK +  +S    +PL  +K Y +Q+ +GLA+ H+
Sbjct: 68  IHT---ENKLYL--VFEF----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFG 187
             RV HRDLKPQNLL++     +K+ DFG A+    G    +Y   + + +YRAPE++ G
Sbjct: 119 -HRVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT- 246
              Y+T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP       + P  T 
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230

Query: 247 --DFR--FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             D++  FP+     + KV    +  +  DL S++L Y P+ R +A  A AHPFF
Sbjct: 231 LPDYKPSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  190 bits (486), Expect = 1e-58
 Identities = 100/294 (34%), Positives = 165/294 (56%), Gaps = 34/294 (11%)

Query: 22  GSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHCFFS 75
           G++G+V++A+  +TGE VA+KK+  ++  +       RE+ ++  + HPN++++K     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75

Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
           +   +++++  VMEYV   +  +++      Q      VK    Q+  G+A++H    + 
Sbjct: 76  SNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD-NWIL 128

Query: 136 HRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGATE 190
           HRDLK  NLL   L +   +KICDFG A++   G     Y   + + +YRAPEL+ GA E
Sbjct: 129 HRDLKTSNLL---LNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKE 183

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           Y+T+ID+WS GC+ AELL  +PLFPG++ +DQL +I K+LGTPT +      P +++   
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPG 239

Query: 251 PQIKAHPWH------KVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + K    +      K F    +     DL +RLL Y P+ R +A +A  HP+F
Sbjct: 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  191 bits (487), Expect = 3e-58
 Identities = 110/305 (36%), Positives = 165/305 (54%), Gaps = 27/305 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVMDHP 64
           Y + + VG+G++G V  A    TGE VAIKK        +   R Y  REL L++ M H 
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY--RELTLLKHMQHE 74

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI L   F S  S +E     LVM Y+   + +++ H  S ++      V+   YQ+  
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLC 128

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           GL YIH+   + HRDLKP NL V+    ++KI DFG A+   A      Y+ +R+YRAPE
Sbjct: 129 GLKYIHSAG-IIHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 184

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN- 242
           +I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ +  
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244

Query: 243 ---PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
               +Y     P+     +  +F  +  P+A+DL  ++L+     R TA EA  HP+FD 
Sbjct: 245 KAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302

Query: 300 LREPN 304
            R+ +
Sbjct: 303 FRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  191 bits (486), Expect = 3e-58
 Identities = 108/299 (36%), Positives = 164/299 (54%), Gaps = 26/299 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A    TG  VAIKK+           R Y  REL+L++ M H NVI L 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMKHENVIGLL 80

Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S +      LVM ++   + +++KH   +  R     ++   YQ+ +GL YIH
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIH 135

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
               + HRDLKP NL V+    ++KI DFG A+Q         Y+ +R+YRAPE+I    
Sbjct: 136 AAG-IIHRDLKPGNLAVNE-DCELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWM 191

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            YT ++DIWS GC++AE+L G+PLF G + +DQL+EI+KV GTP++E ++ +      NY
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNY 251

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
              + P+ +   +  +      P A+++  ++L      R TA EA AHP+F+E  +P 
Sbjct: 252 VK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  189 bits (482), Expect = 4e-58
 Identities = 101/297 (34%), Positives = 159/297 (53%), Gaps = 22/297 (7%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 66
           +Y     +G GS+  V++ +   TG+ VA+K++ L+          RE  L++ + H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 125
           ++L     +  +     L LV EY    +   LK Y       + +  V+L+ +Q+ RGL
Sbjct: 66  VTLHDIIHTKKT-----LTLVFEY----LDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 184
           AY H   RV HRDLKPQNLL+     ++K+ DFG A+ + +  +   + + + +YR P++
Sbjct: 117 AYCHQ-RRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDV 174

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIR--CM 241
           + G+TEY+TS+D+W  GC+  E+  G+PLFPG  +  DQL +I +VLGTPT E       
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234

Query: 242 NPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           NP +  + FP     P      +    P   +LA + LQY P  R +A EA  HP+F
Sbjct: 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  190 bits (485), Expect = 5e-58
 Identities = 110/306 (35%), Positives = 166/306 (54%), Gaps = 31/306 (10%)

Query: 19  VGTGSFGIVFQAKCLET--GETVAIKKV--------LQDRRYKNRELQLMR-VMDHPNVI 67
           +G G++GIV  A+  ET   ETVAIKK+        L  R    REL+L+R    H N+ 
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHFRGHKNIT 65

Query: 68  SLKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L           NEL+L    E +   ++++++    + Q +   + + + YQI  GL 
Sbjct: 66  CLYDMDIVFPGNFNELYL--YEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLK 119

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----YICSRFYRA 181
           YIH+   V HRDLKP NLLV+    ++KICDFG A+         +     Y+ +R+YRA
Sbjct: 120 YIHSA-NVLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RC 240
           PE++     YT +ID+WS GC+LAELL  +P+F G++ VDQL +I++VLGTP  E + R 
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237

Query: 241 MNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
            +P   ++    P I   P+  +F     P A+DL  +LL + P+ R +  EA  HP+  
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296

Query: 299 ELREPN 304
              +P+
Sbjct: 297 IWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  187 bits (476), Expect = 3e-57
 Identities = 105/290 (36%), Positives = 161/290 (55%), Gaps = 24/290 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             S     +  L LV EY  + +    K++ S N  +    VK + +Q+ +GLA+ H+  
Sbjct: 68  LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-H 118

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
            V HRDLKPQNLL++    ++K+ DFG A+   I      + + + +YR P+++FGA  Y
Sbjct: 119 NVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 177

Query: 192 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDF 248
           +TSID+WSAGC+ AEL   G+PLFPG +  DQL  I ++LGTPT E    ++  P+Y  +
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY 237

Query: 249 -RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             +P   +     V   ++     DL   LL  +P  R +A EA  HP+F
Sbjct: 238 PMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  186 bits (474), Expect = 1e-56
 Identities = 109/304 (35%), Positives = 157/304 (51%), Gaps = 46/304 (15%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++GIV++A+   +GE VA+KKV  D           RE+ L+  + HPN++ LK  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                  + +FL  VMEY  + +  +L +  +         VK    Q+ RGL Y+H   
Sbjct: 75  VVGK-HLDSIFL--VMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHE-N 127

Query: 133 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC--------SRFYRAP 182
            + HRDLK  NLL   LT +  +KI DFG A+                     + +YRAP
Sbjct: 128 FIIHRDLKVSNLL---LTDKGCLKIADFGLAR-------TYGLPAKPMTPKVVTLWYRAP 177

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---- 238
           EL+ G T YTT+ID+W+ GC+LAELL  +PL PG++ ++QL  II++LGTP  E I    
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN-ESIWPGF 236

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMP--PEA-IDLASRLLQYSPSLRCTALEACAHP 295
             + P    F  P+    P++ + HK  P   EA + L + LL Y P  R TA EA    
Sbjct: 237 SDL-PLVGKFTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291

Query: 296 FFDE 299
           +F E
Sbjct: 292 YFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  183 bits (465), Expect = 5e-55
 Identities = 91/310 (29%), Positives = 161/310 (51%), Gaps = 38/310 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QDRRYKN--RELQLMRVMDHPNVIS 68
           YM  R +G GS G+VF A   +  + VA+KK++    +  K+  RE++++R +DH N++ 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 69  LKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
           +      + S     +          +V EY+   +  VL+        +   + +L+ Y
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI----C 175
           Q+ RGL YIH+   V HRDLKP N+ ++     +KI DFG A+ +    ++  Y+     
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180

Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIKVLGT 232
           +++YR+P L+     YT +ID+W+AGC+ AE+L G+PLF G + ++Q+   +E + V+  
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240

Query: 233 PTREEIRCMNPNYTDFRFPQIKAHPW--HKVFHKRMP---PEAIDLASRLLQYSPSLRCT 287
             R E+  + P++       ++       +     +P   PEA+D   ++L ++P  R T
Sbjct: 241 EDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293

Query: 288 ALEACAHPFF 297
           A EA  HP+ 
Sbjct: 294 AEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  181 bits (461), Expect = 6e-55
 Identities = 100/295 (33%), Positives = 165/295 (55%), Gaps = 33/295 (11%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 68
           +G G++G+V++ +  +TG+ VA+KK+    R ++          RE+ L++ + HPN++ 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGL 125
           L+        ++ L+L  + E++  SM   LK Y       Q M    VK Y YQI +G+
Sbjct: 64  LQDVLMQ---ESRLYL--IFEFL--SMD--LKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 184
            + H+  RV HRDLKPQNLL+D     +K+ DFG A+   I        + + +YRAPE+
Sbjct: 115 LFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-- 242
           + G+  Y+T +DIWS G + AE+   +PLF G++ +DQL  I ++LGTPT +    +   
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           P+Y +  FP+ K     +   K +  + +DL  ++L Y P+ R +A +A  HP+F
Sbjct: 233 PDYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  178 bits (453), Expect = 8e-54
 Identities = 95/291 (32%), Positives = 157/291 (53%), Gaps = 25/291 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHC 72
           +G GS+G+VF+ +  ETG+ VAIKK ++       ++   RE+++++ + HPN+++L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           F     + +  L+LV EY   ++   L+      + +P   +K   +Q  + + + H   
Sbjct: 69  F-----RRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHK-H 119

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEY 191
              HRD+KP+N+L+     Q+K+CDFG A+ L     + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG--TPTREEIRCMNPNYTDFR 249
              +D+W+ GCV AELL GQPL+PG++ VDQL  I K LG   P  ++I   N  +  F+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN-QF--FK 235

Query: 250 FPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFF 297
              I      +    + P     A+      LQ  P+ R +  E   HP+F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  175 bits (447), Expect = 3e-53
 Identities = 90/291 (30%), Positives = 134/291 (46%), Gaps = 46/291 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLK 70
            ++G GSFG V+ A   +TGE +A+K V L     +      RE++++  + HPN++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 71  HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             + S   + +  LN+ +EYV   S    L        ++P   ++ YT QI  GLAY+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGS----LSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIF 186
           +   + HRD+K  N+LVD     VK+ DFG AK+L     GE   S   + ++ APE+I 
Sbjct: 119 S-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  EY  + DIWS GC + E+  G+P +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
               P+I  H         +  EA D   + L+  P  R TA E   HPF 
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (428), Expect = 6e-51
 Identities = 70/247 (28%), Positives = 120/247 (48%), Gaps = 40/247 (16%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 73
           +G G FG V+ A+  +TG+ VAIK + ++          RE+++++ ++HPN++ L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                ++E  L LVMEY    S+  +LK       ++    +     QI  GL Y+H+  
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG 112

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGATEY 191
            + HRDLKP+N+L+D    +VK+ DFG +K L + ++ +  I  +  Y APE++ G   Y
Sbjct: 113 -IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRF 250
           +   DIWS G +L EL              +L ++I+          + +  +       
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 251 PQIKAHP 257
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  171 bits (436), Expect = 9e-51
 Identities = 104/315 (33%), Positives = 150/315 (47%), Gaps = 51/315 (16%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV---------LQDRRYKN---------RELQLMRV 60
           +G G++G V +A    TG+ VAIKKV          +DR+            REL++M  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
           + H N++ L   +         F+NLVM+     M   LK       R+    VK    Q
Sbjct: 77  IKHENIMGLVDVYVE-----GDFINLVMDI----MASDLKKVVDRKIRLTESQVKCILLQ 127

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-----LIAGEANISYIC 175
           I  GL  +H      HRDL P N+ ++      KI DFG A++          +    + 
Sbjct: 128 ILNGLNVLHKW-YFMHRDLSPANIFINS-KGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 176 SR----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 225
            R          +YRAPEL+ GA +Y  ++D+WS GC+ AELL G+PLFPGEN +DQL  
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245

Query: 226 IIKVLGTPTRE---EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 282
           I ++LGTP  +   + + + P YT+F   + K     K        +AIDL   LL+ +P
Sbjct: 246 IFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLNP 301

Query: 283 SLRCTALEACAHPFF 297
             R +A EA  H +F
Sbjct: 302 LERISAKEALKHEYF 316

Length = 335

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  171 bits (435), Expect = 2e-50
 Identities = 106/304 (34%), Positives = 165/304 (54%), Gaps = 24/304 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y     VG+G++G V  A      + VA+KK+      L   R   REL+L++ M H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 67  ISLKHCFFSTTSK---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           I L   F   TS    NE++L  V   +   +  ++K      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLR 129

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           GL YIH+   + HRDLKP N+ V+    +++I DFG A+Q  A +    Y+ +R+YRAPE
Sbjct: 130 GLKYIHSAG-IIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 244 NYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
            +        P +      K+F +   P AIDL  ++L      R +A EA AHP+F + 
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Query: 301 REPN 304
            +P 
Sbjct: 305 HDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  171 bits (434), Expect = 4e-50
 Identities = 93/342 (27%), Positives = 141/342 (41%), Gaps = 46/342 (13%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 64
           SY   R +G GSFG V+ A+  +    VA+K + +             RE+Q++  ++HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
             I   + FF    ++E  L LVMEYV       L         +          QI   
Sbjct: 58  PNIVKLYDFF----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-------SYICSR 177
           L Y+H+   + HRD+KP+N+L+D     VK+ DFG AK L    +         + + + 
Sbjct: 114 LEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 178 FYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGT 232
            Y APE++ G +    ++S DIWS G  L ELL G P F GE    A  Q ++II  L T
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232

Query: 233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 292
           P                     A P      + +   A DL  +LL   P  R ++    
Sbjct: 233 P-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Query: 293 AHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKL 334
           +H     L+   + L +          +  L  +   L++ L
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315

Length = 384

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  169 bits (430), Expect = 4e-50
 Identities = 95/311 (30%), Positives = 151/311 (48%), Gaps = 49/311 (15%)

Query: 20  GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVISL 69
           G G+FG V++A+ ++TG  VA+KK+L      N          RE+++++ + HPNV+ L
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKHPNVVPL 72

Query: 70  KHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
                     S   +  +++  V  Y+   +  +L    S       I  K Y  Q+  G
Sbjct: 73  IDMAVERPDKSKRKRGSVYM--VTPYMDHDLSGLL-ENPSVKLTESQI--KCYMLQLLEG 127

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---------QLIAGEANISY-- 173
           + Y+H    + HRD+K  N+L+D     +KI DFG A+         +   G     Y  
Sbjct: 128 INYLHE-NHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185

Query: 174 -ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 232
            + +R+YR PEL+ G   YTT++DIW  GCV AE+   +P+  G++ +DQL  I K+ GT
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245

Query: 233 PTREEIRCMNPNYTDF-RFPQIKAHPWH-----KVFHKRMPPEAIDLASRLLQYSPSLRC 286
           PT E      P +        + +   +     + F  ++ PE +DL S+LL   P  R 
Sbjct: 246 PTEETW----PGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRL 300

Query: 287 TALEACAHPFF 297
           TA +A  HP+F
Sbjct: 301 TASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  167 bits (425), Expect = 9e-50
 Identities = 105/292 (35%), Positives = 163/292 (55%), Gaps = 24/292 (8%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 71
           VVG G++G+V + +  ET E VAIKK       +       REL+++R +   N++ LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            F     + +L+L  V EYV ++M  +L+   +    +P   V+ Y YQ+ + + + H  
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLEEMPNG---VPPEKVRSYIYQLIKAIHWCHK- 118

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANIS-YICSRFYRAPELIFGAT 189
             + HRD+KP+NLL+      +K+CDFG A+ L  G  AN + Y+ +R+YR+PEL+ GA 
Sbjct: 119 NDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NPNYTD 247
            Y  ++D+WS GC+L EL  GQPLFPGE+ +DQL  I KVLG    E+++    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 248 FRFPQIKAHP--WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            RFP +  HP    + +   +    +DL   LL+ +P+ R    +   HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  166 bits (421), Expect = 5e-49
 Identities = 98/307 (31%), Positives = 166/307 (54%), Gaps = 21/307 (6%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
           +Y+    +G G++  V++ +   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 125
           ++L     +  S     L LV EY+ +     LK Y       + +  VKL+ +Q+ RGL
Sbjct: 67  VTLHDIIHTEKS-----LTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGL 117

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 184
            Y H   +V HRDLKPQNLL++    ++K+ DFG A+ + I  +   + + + +YR P++
Sbjct: 118 NYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--N 242
           + G+T+Y+T ID+W  GC+  E+  G+PLFPG    +QL  I ++LGTPT E    +  N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
             +  + +P+ +A   H     R+  +  +L S+LLQ+    R +A EA  HP+F  L E
Sbjct: 236 EEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294

Query: 303 PNARLPN 309
              +LP+
Sbjct: 295 RIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  167 bits (424), Expect = 1e-48
 Identities = 106/326 (32%), Positives = 170/326 (52%), Gaps = 43/326 (13%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A    TG+ VAIKK+   R ++N        REL LM++++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL--SRPFQNVTHAKRAYRELVLMKLVNHK 75

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + LVME +  ++ +V+      ++RM  +      YQ+  
Sbjct: 76  NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-QMDLDHERMSYL-----LYQMLC 129

Query: 124 GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
           G+ ++H+   + HRDLKP N++V    T  +KI DFG A+          Y+ +R+YRAP
Sbjct: 130 GIKHLHSAG-IIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 186

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E+I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  +II+ LGTP+ E +  + 
Sbjct: 187 EVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245

Query: 243 P---NYTDFRFPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCT 287
           P   NY + R P+   + + ++F            +K    +A DL S++L   P  R +
Sbjct: 246 PTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304

Query: 288 ALEACAHPF----FDELREPNARLPN 309
             +A  HP+    +D   E  A  P 
Sbjct: 305 VDDALQHPYINVWYDP-SEVEAPPPA 329

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  166 bits (422), Expect = 1e-48
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 82

Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 137

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 138 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 193

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 253

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 254 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  164 bits (418), Expect = 1e-47
 Identities = 101/307 (32%), Positives = 155/307 (50%), Gaps = 37/307 (12%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKK---VLQD-----RRYKNRELQLMRVMDHPNVI 67
           +R +G G+FG+V+       G+ VA+KK   V Q+     R +  REL+++    H NV+
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--RELKMLCFFKHDNVL 62

Query: 68  S--------LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
           S            F       E+++      V E M   L     + Q +   +VK++ Y
Sbjct: 63  SALDILQPPHIDPF------EEIYV------VTELMQSDLHKIIVSPQPLSSDHVKVFLY 110

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSR 177
           QI RGL Y+H+   + HRD+KP NLLV+     +KICDFG A+     E+      + ++
Sbjct: 111 QILRGLKYLHSA-GILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
           +YRAPE++ G+  YT+++DIWS GC+ AELL  + LF  ++ + QL  I  +LGTP+ E 
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228

Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAH 294
           +R                 P   V +        EA+ L  R+L + P  R +A +A AH
Sbjct: 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Query: 295 PFFDELR 301
           P+ DE R
Sbjct: 289 PYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  160 bits (407), Expect = 4e-47
 Identities = 98/296 (33%), Positives = 158/296 (53%), Gaps = 20/296 (6%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 66
           SY+    +G GS+  V++      G+ VA+K +             RE  L++ + H N+
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     +  +     L  V EY+   + + +  +      +    V+L+ +Q+ RGLA
Sbjct: 66  VLLHDIIHTKET-----LTFVFEYMHTDLAQYMIQHPGG---LHPYNVRLFMFQLLRGLA 117

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 185
           YIH    + HRDLKPQNLL+  L  ++K+ DFG A+ + I  +   S + + +YR P+++
Sbjct: 118 YIHG-QHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVL 175

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVLGTPTREEIRCMN-- 242
            GAT+Y++++DIW AGC+  E+L GQP FPG  +  +QL +I  VLG PT +    ++  
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 243 PNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           PNY    F   K      V+ +   PP+A DLAS++L   P  R +A +A  HP+F
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  160 bits (407), Expect = 8e-47
 Identities = 100/299 (33%), Positives = 164/299 (54%), Gaps = 23/299 (7%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 125
           ++L     +  S     L LV EY+ +     LK Y       M +  VK++ YQI RGL
Sbjct: 67  VTLHDIVHTDKS-----LTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGL 117

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 184
           AY H   +V HRDLKPQNLL++    ++K+ DFG A+ + +  +   + + + +YR P++
Sbjct: 118 AYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           + G++EY+T ID+W  GC+  E+  G+PLFPG    D+L  I ++LGTPT E    ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235

Query: 245 --YTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
             + ++ FP+ K  P   + H  R+  E I+L ++ LQY    R +A EA  H +F  L
Sbjct: 236 DEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  157 bits (397), Expect = 2e-45
 Identities = 98/296 (33%), Positives = 161/296 (54%), Gaps = 23/296 (7%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
           +Y+    +G G++  VF+ +   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 6   TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 125
           ++L H    T    E  L LV EY+       LK Y  +    M +  VK++ +Q+ RGL
Sbjct: 66  VTL-HDIIHT----ERCLTLVFEYLDSD----LKQYLDNCGNLMSMHNVKIFMFQLLRGL 116

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPEL 184
           +Y H   ++ HRDLKPQNLL++    ++K+ DFG A+ + +  +   + + + +YR P++
Sbjct: 117 SYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CMN 242
           + G+TEY+T ID+W  GC+L E+  G+P+FPG    ++L  I ++LGTPT E       N
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234

Query: 243 PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             +  + FPQ +A P   + H  R+  + IDL S LL Y    R +A  A  H +F
Sbjct: 235 EEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  154 bits (391), Expect = 5e-45
 Identities = 83/287 (28%), Positives = 131/287 (45%), Gaps = 46/287 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 72
             +G G FG V++A+   TG+ VAIK + L+ +  K     E+Q+++   HPN++     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           +     K+EL++  VME+    S+  +LK     NQ +    +     ++ +GL Y+H+ 
Sbjct: 66  YLK---KDELWI--VMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 132 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
             + HRD+K  N+L   LT   +VK+ DFG + QL   +A  + + + ++ APE+I G  
Sbjct: 118 -GIIHRDIKAANIL---LTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-K 172

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y    DIWS G    EL  G+P +     +  L +I    G P               R
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG-------------LR 218

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            P      W   F         D   + LQ +P  R TA +   HPF
Sbjct: 219 NP----EKWSDEFK--------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 4e-43
 Identities = 91/292 (31%), Positives = 138/292 (47%), Gaps = 55/292 (18%)

Query: 19  VGTGSFGIVFQAKCLETGETVAI----KKVLQDRR---YKNRELQLMRVMDHPNVISLKH 71
           +G GSFG V   +  +TG+  A+    KK +  R+   +   E  ++  ++HP ++ L H
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 72  CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F T  K    L LV+EY P  E     L  + S   R      + Y  +I   L Y+H
Sbjct: 60  YAFQTEEK----LYLVLEYAPGGE-----LFSHLSKEGRFSEERARFYAAEIVLALEYLH 110

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGA 188
           ++  + +RDLKP+N+L+D   H +K+ DFG AK+L +  +  +  C +  Y APE++ G 
Sbjct: 111 SL-GIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y  ++D WS G +L E+L G+P F  E+   ++ E I                     
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC---AHPFF 297
           RFP            + + PEA DL S LLQ  P+ R  +  A    AHPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  145 bits (368), Expect = 4e-41
 Identities = 89/303 (29%), Positives = 150/303 (49%), Gaps = 39/303 (12%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 71
            +G G++G V++A+  +TGE VA+KKV  D   +       RE++++R ++H N+++LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 72  CFFSTTS-----KNELFLNLVMEYVPESMYRVLK----HYSSANQRMPLIYVKLYTYQIF 122
                       K++    LV EY+   +  +L+    H+S  +       +K +  Q+ 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYICSRFYR 180
            GL Y H      HRD+K  N+L++    Q+K+ DFG A+   + E+    + + + +YR
Sbjct: 127 EGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
            PEL+ G   Y  +ID+WS GC+L EL   +P+F     + QL  I ++ G+P       
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA---- 240

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQYSPSLRCTALEACA 293
           + P+    + P        K + +R       +P  A+DL   +L   PS RCTA EA  
Sbjct: 241 VWPDVI--KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298

Query: 294 HPF 296
            P+
Sbjct: 299 SPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  143 bits (364), Expect = 6e-41
 Identities = 74/293 (25%), Positives = 125/293 (42%), Gaps = 44/293 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y   + +G GSFG V+  +    G+   +K++       ++R     E+++++ ++HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           I     F          L +VMEY     + + +K      +  P   +  +  Q+   L
Sbjct: 62  IKYYESFEEKGK-----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPEL 184
            Y+H+  ++ HRD+KPQN+ +      VK+ DFG +K L    +   + + + +Y +PEL
Sbjct: 117 KYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
                 Y    DIWS GCVL EL   +  F GEN + +L    K+L    + +   +   
Sbjct: 175 CQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KGQYPPIPSQ 226

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           Y                       E  +L S LLQ  P  R +  +    PF 
Sbjct: 227 Y---------------------SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  144 bits (364), Expect = 2e-40
 Identities = 87/300 (29%), Positives = 145/300 (48%), Gaps = 30/300 (10%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH- 71
           +G G+FG VF+A+  +T + VA+KKVL +   +       RE+++++++ H NV++L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 72  CFFSTT--SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           C    T  ++ +    LV E+    +  +L   S+ N +  L  +K     +  GL YIH
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEHDLAGLL---SNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK---QLIAGEAN--ISYICSRFYRAPEL 184
              ++ HRD+K  N+L+      +K+ DFG A+        + N   + + + +YR PEL
Sbjct: 137 R-NKILHRDMKAANILITK-DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           + G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    + P 
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE----VWPG 250

Query: 245 ------YTDFRFPQ-IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                 +     PQ  K     ++      P A+DL  +LL   P+ R  A  A  H FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  142 bits (358), Expect = 9e-40
 Identities = 97/302 (32%), Positives = 157/302 (51%), Gaps = 26/302 (8%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRR----YKNRELQLMRVMDHPNV 66
           SY     +G GS+  V++ K    G+ VA+K + LQ+         RE  L++ + H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     +  +     L LV EYV   + + +  +      +    VKL+ +Q+ RGL+
Sbjct: 66  VLLHDIIHTKET-----LTLVFEYVHTDLCQYMDKHPGG---LHPENVKLFLFQLLRGLS 117

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 185
           YIH    + HRDLKPQNLL+   T ++K+ DFG A+ + +      + + + +YR P+++
Sbjct: 118 YIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMN-- 242
            G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    ++  
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235

Query: 243 PNYTDFRFPQIKA----HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
           P++   RF           W+K+ +      A DLAS+LLQ  P  R +A  A +H +F 
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEYFS 292

Query: 299 EL 300
           +L
Sbjct: 293 DL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  141 bits (357), Expect = 1e-39
 Identities = 87/292 (29%), Positives = 141/292 (48%), Gaps = 24/292 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVM---DHPN 65
           +G G++G V++A+   +G  VA+K V    R +           RE+ L++ +   DHPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVALLKRLEAFDHPN 63

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           ++ L     ++ +  E  + LV E+V + +   L         +P   +K    Q  RGL
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--LPAETIKDLMRQFLRGL 121

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            ++H    + HRDLKP+N+LV     QVK+ DFG A+      A    + + +YRAPE++
Sbjct: 122 DFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
             +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  ++    +   
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTL 237

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
               F      P   V    +      L   +L ++P  R +A  A  HPFF
Sbjct: 238 PRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  140 bits (355), Expect = 1e-38
 Identities = 101/314 (32%), Positives = 163/314 (51%), Gaps = 35/314 (11%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A     G  VA+KK+   R ++N        REL L++ ++H 
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    S  E   + LVME +  ++ +V+ H    ++RM  +      YQ+  
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLC 134

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 135 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 192

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ EL+ G  +F G + +DQ  ++I+ LGTP+ E +  + P
Sbjct: 193 VILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251

Query: 244 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 289
              NY + R PQ     + ++F   + P           +A DL S++L   P  R +  
Sbjct: 252 TVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVD 310

Query: 290 EACAHPFFDELREP 303
           EA  HP+     +P
Sbjct: 311 EALRHPYITVWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  137 bits (348), Expect = 1e-38
 Identities = 88/290 (30%), Positives = 137/290 (47%), Gaps = 48/290 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---------NRELQLMRVMDHPNVI 67
            ++G+GSFG V++   L+ G+  A+K+V      +          +E+ L+  + HPN++
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
                 +  T + E  L + +E VP  S+ ++LK Y S     P   ++LYT QI  GL 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLE 116

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           Y+H      HRD+K  N+LVD     VK+ DFG AKQ++      S+  S ++ APE+I 
Sbjct: 117 YLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y  + DIWS GC + E+  G+P +   + ++ +  + K+  +     I        
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                     P H      +  EA D   + LQ  PSLR TA E   HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  136 bits (345), Expect = 8e-38
 Identities = 88/320 (27%), Positives = 133/320 (41%), Gaps = 77/320 (24%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRE-LQLMRVMDH 63
           +   +++G GSF  V  AK  ET +  AI K+L  R+        Y   E   L R+  H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAI-KILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           P +I L + F     ++E  L  V+EY P   + + ++ Y S +++      + Y  +I 
Sbjct: 62  PGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEIL 112

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRF 178
             L Y+H+   + HRDLKP+N+L+D   H +KI DFG+AK L                  
Sbjct: 113 LALEYLHSK-GIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 179 -----------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 221
                            Y +PEL+        S D+W+ GC++ ++L G+P F G N   
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229

Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 281
              +I+K                  ++ FP               PP+A DL  +LL   
Sbjct: 230 TFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVLD 260

Query: 282 PSLRCTALEAC----AHPFF 297
           P  R    E      AHPFF
Sbjct: 261 PQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  135 bits (341), Expect = 8e-37
 Identities = 101/314 (32%), Positives = 165/314 (52%), Gaps = 35/314 (11%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    S  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 130

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 131 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 244 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 289
              NY + R P+     + K+F   + P           +A DL S++L   P+ R +  
Sbjct: 248 TVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306

Query: 290 EACAHPFFDELREP 303
           EA  HP+ +   +P
Sbjct: 307 EALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  133 bits (336), Expect = 1e-36
 Identities = 86/292 (29%), Positives = 129/292 (44%), Gaps = 54/292 (18%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHC 72
           V+G GS G+V++ +   TG+  A+KK+  D   + R     EL+ +R  + P V+     
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           F+         +++V+EY+   S+  +LK       ++P   +     QI +GL Y+HT 
Sbjct: 68  FYKEGE-----ISIVLEYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIF 186
             + HRD+KP NLL++    +VKI DFG +K L     N    C+ F     Y +PE I 
Sbjct: 119 RHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQ 173

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPN 244
           G + Y+ + DIWS G  L E  LG+ P  P       +L++ I            C  P 
Sbjct: 174 GES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPP 220

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                              +   PE  D  S  LQ  P  R +A E   HPF
Sbjct: 221 P----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  135 bits (341), Expect = 1e-36
 Identities = 101/326 (30%), Positives = 167/326 (51%), Gaps = 41/326 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 137

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254

Query: 244 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F   + P           +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313

Query: 290 EACAHPFFD------ELREPNARLPN 309
           EA  HP+ +      E   P  ++P+
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPD 339

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  133 bits (335), Expect = 2e-36
 Identities = 98/294 (33%), Positives = 157/294 (53%), Gaps = 27/294 (9%)

Query: 19  VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMRVMD---HPNVIS 68
           +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R ++   HPNV+ 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 69  L-KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   C  S T + E  L LV E+V + +   L         +P   +K   +Q+ RGL +
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           +H+  RV HRDLKPQN+LV   + Q+K+ DFG A+      A  S + + +YRAPE++  
Sbjct: 126 LHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 183

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P  E+     P   D
Sbjct: 184 SS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR--D 236

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLL----QYSPSLRCTALEACAHPFF 297
              P+   H       ++   +  +L   LL     ++P+ R +A  A +HP+F
Sbjct: 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 2e-34
 Identities = 79/288 (27%), Positives = 139/288 (48%), Gaps = 48/288 (16%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKH 71
           ++G G+FG+V++   LETG+ VAIK++ L+  + +      +E+ L++ + HPN++    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                  +    L +++EY    S+ +++K +    + +    V +Y YQ+ +GLAY+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 189
              V HRD+K  N+L       VK+ DFG A +L     +  S + + ++ APE+I   +
Sbjct: 118 -QGVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
             +T+ DIWS GC + ELL G P +   N +  L  I++             + +     
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-------------DDHP---P 218

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            P            + + PE  D   +  Q  P+LR TA +   HP+ 
Sbjct: 219 LP------------EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  126 bits (319), Expect = 2e-34
 Identities = 79/292 (27%), Positives = 135/292 (46%), Gaps = 50/292 (17%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN-----RELQLMRVMDHPNVISLKHC 72
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++++ ++ HPN++     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           +     + ++   + MEY    ++  +L+H     + +    +++YT Q+  GLAY+H+ 
Sbjct: 65  YGVEVHREKV--YIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHS- 117

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPELIF 186
             + HRD+KP N+ +D     +K+ DFG A +L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 187 GAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           G     +  + DIWS GCV+ E+  G+  +   +   Q++  +     P           
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPP---------- 226

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                 P             ++ PE  D   R L+  P  R TA E   HPF
Sbjct: 227 -----IPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  127 bits (320), Expect = 4e-34
 Identities = 107/316 (33%), Positives = 156/316 (49%), Gaps = 44/316 (13%)

Query: 19  VGTGSFGIVFQAKCLE--TGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 74
           VG G++G V++AK  +       A+K++          RE+ L+R + HPNVISL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 75  STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 129
           S   +    + L+ +Y    ++ ++K +  S AN++   +P   VK   YQI  G+ Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 130 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 182
               V HRDLKP N+LV    P   +VKI D G A+     +   A++  +   F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 233
           EL+ GA  YT +IDIW+ GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 234 TR---EEIRCMNPNYT---DFR------FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 281
                E+I+ M  + T   DFR         IK    HKV   +   +A  L  +LL   
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKLLTMD 301

Query: 282 PSLRCTALEACAHPFF 297
           P  R T+ +A   P+F
Sbjct: 302 PIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  125 bits (316), Expect = 6e-34
 Identities = 90/296 (30%), Positives = 133/296 (44%), Gaps = 59/296 (19%)

Query: 22  GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISLKHCFF 74
           G++G VF AK   TG+  AIK +   D   KN+      E  ++     P V+ L   ++
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL---YY 60

Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           S   K  L+L  VMEY+P   +  +L++  S ++ +     ++Y  +I   L Y+H+   
Sbjct: 61  SFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHSN-G 113

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAK----QLIAGEANISYICSRF-----YRAPEL 184
           + HRDLKP N+L+D   H +K+ DFG +K    +      +      R      Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           I G   ++ ++D WS GC+L E L+G P F GE                  EEI   N  
Sbjct: 173 ILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETP----------------EEI-FQNIL 214

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFF 297
                +P+             +  EAIDL S+LL   P  R  A    E   HPFF
Sbjct: 215 NGKIEWPEDV----------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  126 bits (317), Expect = 1e-33
 Identities = 105/314 (33%), Positives = 158/314 (50%), Gaps = 40/314 (12%)

Query: 19  VGTGSFGIVFQAKCLETGET--VAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFF 74
           VG G++G V++AK  +  +    A+K++          RE+ L+R + HPNVI+L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 75  STTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR---MPLIYVKLYTYQIFRGLAYIH 129
           S + +    + L+ +Y    ++ ++K +  S AN++   +P   VK   YQI  G+ Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 130 TVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL---IAGEANISYICSRF-YRAP 182
               V HRDLKP N+LV    P   +VKI D G A+     +   A++  +   F YRAP
Sbjct: 126 A-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVLGTP 233
           EL+ GA  YT +IDIW+ GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244

Query: 234 TR---EEIRCMNPNY----TDFRFPQIKAHPWHKVFHK-RMPPEA--IDLASRLLQYSPS 283
                E+IR M P Y     DFR          K   K ++ P++    L  +LL   P+
Sbjct: 245 ADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 284 LRCTALEACAHPFF 297
            R T+ +A   P+F
Sbjct: 304 KRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  121 bits (304), Expect = 3e-32
 Identities = 82/297 (27%), Positives = 139/297 (46%), Gaps = 51/297 (17%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNV 66
           + +GTG+F   +QA+ ++TG  +A+K+V   R   +          +E++LM  ++HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           I       +T   +    NL +E++   S+  +L  Y +  +    + +  YT Q+ RGL
Sbjct: 66  I---RMLGATCEDSHF--NLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-----AGEANISYICSRFYR 180
           +Y+H   ++ HRD+K  NLL+D    +++I DFG+A +L      AGE     + +  + 
Sbjct: 117 SYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++ G  +Y  S D+WS GCV+ E+   +P +  E   + L  I K         I  
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                     P I  H         + P   D+  R L+  P  R  + E   HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  120 bits (304), Expect = 4e-32
 Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 49/292 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKH 71
             +G G+ G+V +     TG+ +A+K +  +     ++   REL ++   + P ++    
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 72  CFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F++     ++ +   MEY+   S+ ++LK       R+P   +      + +GL Y+H 
Sbjct: 67  AFYN---NGDISI--CMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE 118

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
             ++ HRD+KP N+LV+    Q+K+CDFG + QL+   A  +++ +  Y APE I G  +
Sbjct: 119 KHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-ND 175

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIRCMNPNY 245
           Y+   DIWS G  L EL  G+  +P EN       + L  I+               P  
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP-- 221

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                P++ +  +         P+  D  +  L   P  R +  E   HPF 
Sbjct: 222 -----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  119 bits (300), Expect = 1e-31
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 41/284 (14%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 75
            +G GS+G V++A   ETG+ VAIK V  +   +   +E+ +++  D P ++     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF- 68

Query: 76  TTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
                +L+  +VMEY    S+  ++K     N+ +    +    YQ  +GL Y+H+  + 
Sbjct: 69  --KNTDLW--IVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN-KK 120

Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTT 193
            HRD+K  N+L++    Q K+ DFG + QL    A   + I + F+ APE+I     Y  
Sbjct: 121 IHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNN 178

Query: 194 SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 253
             DIWS G    E+  G+P +   + +  +  I                P       P  
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KP-------PPT 218

Query: 254 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + P      ++  PE  D   + L   P  R +A++   HPF 
Sbjct: 219 LSDP------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  118 bits (299), Expect = 4e-31
 Identities = 85/296 (28%), Positives = 139/296 (46%), Gaps = 60/296 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 69
           + +GTGSFG V   +   +G+  A+K     K+++ ++ +    E ++++ + HP +++L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
              F     +++  L LVMEYVP  E     L  +   + R P    + Y  Q+   L Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVARFYAAQVVLALEY 116

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +H++  V +RDLKP+NLL+D   + +KI DFG AK++   +     +C +  Y APE+I 
Sbjct: 117 LHSLDIV-YRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y  ++D W+ G ++ E+L G P F  +N   Q+ E  K+L                
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYE--KILE--------------G 213

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 297
             RFP                P+A DL   LLQ   + R   L+        HP+F
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  117 bits (296), Expect = 5e-31
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 34/231 (14%)

Query: 16  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
            + +G G+FG V++             VA+K + +D   +      RE ++MR +DHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRG 124
           + L       T +  L   +VMEY+P      L  Y   +  + + L  +  +  QI RG
Sbjct: 64  VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----YR 180
           + Y+ +     HRDL  +N LV      VKI DFG ++ L     +  Y   +      R
Sbjct: 116 MEYLESK-NFIHRDLAARNCLVGE-NLVVKISDFGLSRDL----YDDDYYKVKGGKLPIR 169

Query: 181 --APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 228
             APE +    ++T+  D+WS G +L E+  LG+  +PG +   +++E +K
Sbjct: 170 WMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  114 bits (288), Expect = 1e-29
 Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 52/290 (17%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVL---QDRRYKNRELQLMRVMDHPNVISLKHCFF 74
            +G G+ G V++A    TG+ VAIKK+    Q++     E+ +M+   HPN++     + 
Sbjct: 26  KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP---LIYVKLYTYQIFRGLAYIHT 130
                +EL++  VMEY+   S+  ++        RM    + YV     ++ +GL Y+H+
Sbjct: 86  V---GDELWV--VMEYMDGGSLTDIITQNFV---RMNEPQIAYVCR---EVLQGLEYLHS 134

Query: 131 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 187
              + HRD+K  N+L   L+    VK+ DFG A QL   ++   S + + ++ APE+I  
Sbjct: 135 QNVI-HRDIKSDNIL---LSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR 190

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
             +Y   +DIWS G +  E+  G+P +  E  +  L  I    G P  +           
Sbjct: 191 -KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN---------- 238

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                     W   F         D  ++ L   P  R +A E   HPF 
Sbjct: 239 -------PEKWSPEF--------KDFLNKCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  113 bits (286), Expect = 1e-29
 Identities = 81/300 (27%), Positives = 129/300 (43%), Gaps = 61/300 (20%)

Query: 16  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
            + +G G+FG V++ K      +    VA+K + +D   +      RE ++MR +DHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 125
           + L       T +  L+  +VMEY+       L  Y   N+ ++ L  +  +  QI RG+
Sbjct: 64  VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--APE 183
            Y+ +   + HRDL  +N LV      VKI DFG ++ L   +           R  APE
Sbjct: 116 EYLESKNFI-HRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPE 173

Query: 184 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
            +    ++T+  D+WS G +L E+  LG+  +PG +  ++++E +K              
Sbjct: 174 SLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLK-------------- 217

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                +R PQ              PPE  DL  +     P  R T         F EL E
Sbjct: 218 ---NGYRLPQP----------PNCPPELYDLMLQCWAEDPEDRPT---------FSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  113 bits (285), Expect = 2e-29
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 53/303 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------------ELQLM 58
           ++   ++G G++G V+ A  + TGE +A+K+V        R              E++ +
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 59  RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLY 117
           + +DH N++             E +L++ +EYVP  S+   L+ Y    +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ---LIAGEANISYI 174
           T Q+  GLAY+H+   + HRDLK  NLLVD      KI DFG +K+   +   + N+S  
Sbjct: 114 TEQVLEGLAYLHS-KGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 175 CSRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
            S F+ APE+I   ++ Y+  +DIWS GCV+ E+  G+  +  E A+  + ++       
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKL------- 224

Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
                             +  A P        + P A+D  +     +P  R TA E   
Sbjct: 225 ----------------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Query: 294 HPF 296
           HPF
Sbjct: 269 HPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 2e-29
 Identities = 87/291 (29%), Positives = 132/291 (45%), Gaps = 58/291 (19%)

Query: 22  GSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQ---LMRVMDHPNVISLKHCF 73
           G+FG V+ AK   TG+  AIK      ++   +  N + +   +M   + P V  L   +
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL---Y 63

Query: 74  FSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           +S  SK+ L+L  VMEY+      S+ + L         +P  + K Y  ++  G+  +H
Sbjct: 64  YSFQSKDYLYL--VMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVEDLH 114

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
               + HRD+KP+NLL+D   H +K+ DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 Q-RGIIHRDIKPENLLIDQTGH-LKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVG 169

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
           +     D WS GCV+ E L G P F  E   D + + I           R +N       
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNI---------LSRRIN------- 211

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 297
                   W +   +   PEA+DL +RLL   P+ R  A    E  +HPFF
Sbjct: 212 --------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (284), Expect = 2e-29
 Identities = 90/308 (29%), Positives = 143/308 (46%), Gaps = 67/308 (21%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYK-----NRELQLMR 59
           ++   ++G+GSFG V+      +GE +A+K+V         +DR+        RE+ L++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYT 118
            + H N++          S +   LN+ +EYVP  S+  +L +Y +  + +    V+ + 
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI------- 171
            QI +GL Y+H    + HRD+K  N+LVD     +KI DFG +K+L   EAN        
Sbjct: 113 RQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISDFGISKKL---EANSLSTKTNG 167

Query: 172 ---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
              S   S F+ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFK 223

Query: 229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 288
           +    +                P+I ++         +  EAID   +  +   + R TA
Sbjct: 224 IGENAS----------------PEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258

Query: 289 LEACAHPF 296
            E   HPF
Sbjct: 259 AELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 3e-28
 Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 22/240 (9%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLM---RVMDHPNVISL 69
           ++G G++G V++ K + TG  VA+K +  D    +     RE+ L+   R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +          L ++MEY      R L       ++    Y+ +   ++   L YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGA 188
            V  V HRD+K  N+LV   T  VK+CDFG A  L    +   +++ + ++ APE+I   
Sbjct: 119 KVG-VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y T  DIWS G  + E+  G P +   +A   ++ I K    P R E    +    +F
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK--SKPPRLEDNGYSKLLREF 234

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 4e-28
 Identities = 85/289 (29%), Positives = 130/289 (44%), Gaps = 41/289 (14%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG G +G VF AK  +TGE VA+K++       L + R+   E  ++       ++ L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            F        L+L   MEYVP   +R L    +    +   + + Y  ++F  +  +H +
Sbjct: 69  AF---QDDEYLYL--AMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 191
               HRDLKP+N L+D   H +K+ DFG +K ++   AN S + S  Y APE++ G   Y
Sbjct: 121 G-YIHRDLKPENFLIDASGH-IKLTDFGLSKGIVT-YAN-SVVGSPDYMAPEVLRG-KGY 175

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
             ++D WS GC+L E L G P F G    +    +     T  R       P Y D RF 
Sbjct: 176 DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF- 227

Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                         +  EA DL ++L+        +  +   HPFF E+
Sbjct: 228 -------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  108 bits (272), Expect = 1e-27
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 17/216 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR---ELQLMRVMDHPN 65
           +  E+ +G G F +V++A CL  G  VA+KKV    + D + +     E+ L++ +DHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           VI     F      NE  LN+V+E      + R++KH+    + +P   +  Y  Q+   
Sbjct: 64  VIKYLASFI---ENNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPE 183
           L ++H+  R+ HRD+KP N+ +   T  VK+ D G  +   +   A  S + + +Y +PE
Sbjct: 119 LEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 219
            I     Y    DIWS GC+L E+   Q  F G+  
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  108 bits (271), Expect = 4e-27
 Identities = 86/298 (28%), Positives = 133/298 (44%), Gaps = 51/298 (17%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN I  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           K C+    +       LVMEY   S   +L+ +    Q + +  +    +   +GLAY+H
Sbjct: 81  KGCYLREHTA-----WLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLH 132

Query: 130 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           +  R+ HRD+K  N LL +P    VK+ DFGSA   +   AN S++ + ++ APE+I   
Sbjct: 133 SHERI-HRDIKAGNILLTEP--GTVKLADFGSAS--LVSPAN-SFVGTPYWMAPEVILAM 186

Query: 189 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
            E  Y   +D+WS G    EL   +P     NA+  L  I +             N +  
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NDS-- 231

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
               P + ++ W   F        +D     LQ  P  R ++ E   H F    R P 
Sbjct: 232 ----PTLSSNDWSDYFRN-----FVDSC---LQKIPQDRPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (269), Expect = 5e-27
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 22/225 (9%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 71
            +G GSFG V + +    G+ +  K++       ++++    E+ ++R + HPN++    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                +++    L +VMEY     + ++++      + +   ++     Q+   L   H 
Sbjct: 67  RIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 131 V----PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPE 183
                  V HRDLKP N+ +D   + VK+ DFG AK L  G  +    +Y+ + +Y +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
            +   + Y    DIWS GC++ EL    P F   N   QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (265), Expect = 1e-26
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 53/295 (17%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 67
           +++G G+FG V+    ++TG  +A+K+V  D               E+QL++ + H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
               C      +++  L++ MEY+P  S+   LK Y +  + +     + YT QI  G+ 
Sbjct: 68  QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 182
           Y+H+   + HRD+K  N+L D     VK+ DFG++K+L     +G    S   + ++ +P
Sbjct: 119 YLHS-NMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E+I G   Y    D+WS GC + E+L  +P +      + +  I K+   PT        
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                   PQ+ +H         + P+A +   R    +   R +A E   H F 
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 2e-26
 Identities = 85/319 (26%), Positives = 132/319 (41%), Gaps = 77/319 (24%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISLK 70
           V+G G+FG V+  +  +TG+  A+K + +    K  ++  +R    ++   D P ++ L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 71  HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           +  F    ++E  L LVMEY+P   +  +L          P    + Y  ++   L  +H
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH 118

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----------- 178
            +  + HRD+KP N+L+D   H +K+ DFG  K++   +    Y+               
Sbjct: 119 KLGFI-HRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 179 -------------------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 219
                              Y APE++ G T Y    D WS G +L E+L G P F  +  
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234

Query: 220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 279
              L E        T  +I  +N      RFP              + PEAIDL  RLL 
Sbjct: 235 ---LQE--------TYNKI--INWK-ESLRFPP----------DPPVSPEAIDLICRLLC 270

Query: 280 YSPSLR-CTALEACAHPFF 297
             P  R  +  E  +HPFF
Sbjct: 271 -DPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  104 bits (261), Expect = 5e-26
 Identities = 77/294 (26%), Positives = 123/294 (41%), Gaps = 52/294 (17%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHPNVISLKH 71
           +G G FG V   K      T A+K V    + +   +     E +++   +HP ++ L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 72  CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    K++ ++ ++MEY    E     L               + Y   +     Y+H
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGE-----LWTILRDRGLFDEYTARFYIACVVLAFEYLH 110

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
               + +RDLKP+NLL+D     VK+ DFG AK+L +G+   ++  +  Y APE+I    
Sbjct: 111 NR-GIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y  S+D WS G +L ELL G+P F GE+  D +             +I   N       
Sbjct: 169 -YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKLE--- 214

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 298
           FP              +   A DL  +LL+ +P  R   L+        H +F+
Sbjct: 215 FPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  104 bits (261), Expect = 6e-26
 Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 46/293 (15%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHC 72
           V+G G+  +V+ A CL   E VAIK++  ++   +     +E+Q M   +HPNV+   + 
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F     +EL+  LVM Y+   S+  ++K  Y        +I   L   ++ +GL Y+H+
Sbjct: 67  SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120

Query: 131 VPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAG-----EANISYICSRFYRAPEL 184
             ++ HRD+K  N+L+       VKI DFG +  L  G     +   +++ +  + APE+
Sbjct: 121 NGQI-HRDIKAGNILLG--EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     Y    DIWS G    EL  G   +     +  L+  ++             N  
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ-------------ND- 223

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                 P ++    +K + K        + S  LQ  PS R TA E   H FF
Sbjct: 224 -----PPSLETGADYKKYSKSFR----KMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  105 bits (263), Expect = 7e-26
 Identities = 88/302 (29%), Positives = 130/302 (43%), Gaps = 62/302 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRY-----KNRELQLMRVMDHPNV 66
           +V+G GSFG V  A+   T E  A+K      +LQD        + R L L     HP +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
             L H  F T  K+ LF   VMEYV   + M+ + +     + R      + Y  +I  G
Sbjct: 59  TQL-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLG 108

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           L ++H    + +RDLK  N+L+D   H +KI DFG  K+ I G    S  C +  Y APE
Sbjct: 109 LQFLHE-RGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPE 166

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++     Y  ++D W+ G +L E+L GQ  F G++  D+L + I                
Sbjct: 167 ILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSIL--------------- 209

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFD 298
              + R+P            + +  EA  +    L  +P  R   L         HPFF 
Sbjct: 210 -EDEVRYP------------RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256

Query: 299 EL 300
           E+
Sbjct: 257 EI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  101 bits (254), Expect = 6e-25
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 25/214 (11%)

Query: 17  RVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           + +G G+FG V++      GE     VA+K + +    +       E  +M+ + HPN++
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLA 126
            L       T    L+  +V EY+P      L  +     +++ L  +     QI +G+ 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE 183
           Y+ +   V HRDL  +N LV      VKI DFG ++ +   +        +    + APE
Sbjct: 117 YLESKNFV-HRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174

Query: 184 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            +    ++T+  D+WS G +L E+  LG+  +PG
Sbjct: 175 SLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207

Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (252), Expect = 8e-25
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 18/217 (8%)

Query: 20  GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 73
           G GS+G V++ K L   +  A+K+V L     K R     E++++  ++HPN+IS K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 74  FSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                     L +VMEY P   + + +       + +P   +     Q+ RGL  +H   
Sbjct: 69  LDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 133 RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 191
           ++ HRDLK  N LLV      VKI D G +K L    A  + I +  Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAN--DLVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           +   DIWS GC+L E+    P F   +  D   ++ +
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  101 bits (252), Expect = 2e-24
 Identities = 97/335 (28%), Positives = 148/335 (44%), Gaps = 64/335 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 68
           +V+G GSFG V  A+   T E  AIK + +D   ++ +++      RV+    +HP    
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP---F 57

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L H F +  +K  LF   VMEY+       L  +  ++ R      + Y  +I  GL ++
Sbjct: 58  LTHLFCTFQTKEHLFF--VMEYLNGGD---LMFHIQSSGRFDEARARFYAAEIICGLQFL 112

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
           H    + +RDLK  N+L+D   H +KI DFG  K+ + GE   S  C +  Y APE++ G
Sbjct: 113 HK-KGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
             +Y  S+D WS G +L E+L+GQ  F GE+  D+L + I         +          
Sbjct: 171 -QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSI-------LNDR--------- 212

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEACAHPFFDELREPNAR 306
                    P    F + +  EA D  S+L +  P+ R     +   HPFF   R  +  
Sbjct: 213 ---------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGIDWE 257

Query: 307 LPNGRPLPPLF-----------NFKQELSGASPEL 330
               R +PP F           NF +E +     L
Sbjct: 258 RLEKREIPPPFKPKVKSPSDASNFDREFTNEKVRL 292

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 99.9 bits (249), Expect = 3e-24
 Identities = 88/308 (28%), Positives = 136/308 (44%), Gaps = 42/308 (13%)

Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMD 62
           L+TIS +     G G+ G V + K + TG  +A K V        R+   RELQ+M    
Sbjct: 7   LETISDL-----GAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR 61

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQI 121
            P ++S    F      NE  + + ME++   S+ R+ K        +P+  +      +
Sbjct: 62  SPYIVSFYGAFL-----NENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAV 112

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 181
             GL Y++ V R+ HRD+KP N+LV+    Q+K+CDFG + +LI   A+ +++ +  Y +
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIAD-TFVGTSTYMS 170

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           PE I G  +YT   D+WS G  + EL LG+ P        D   + + +L          
Sbjct: 171 PERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-------- 221

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-HPFFDE 299
                      QI   P  ++     P +  D     L   P+ R T  + CA  PF   
Sbjct: 222 ---------LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272

Query: 300 LREPNARL 307
           LR  N  L
Sbjct: 273 LRASNVDL 280

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 6e-24
 Identities = 86/294 (29%), Positives = 138/294 (46%), Gaps = 58/294 (19%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 74
           +G+G++G V++A+ + TGE VAIK +      D     +E+ +++   HPN++     F 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV---AYFG 67

Query: 75  STTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           S   +++L+  +VMEY      + +Y+V +   S  Q   + YV     +  +GLAY+H 
Sbjct: 68  SYLRRDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQ---IAYV---CRETLKGLAYLHE 119

Query: 131 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFG 187
             ++ HRD+K  N+L   LT    VK+ DFG + QL A  A   S+I + ++ APE+   
Sbjct: 120 TGKI-HRDIKGANIL---LTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA-- 173

Query: 188 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           A E    Y    DIW+ G    EL   QP  P  +     +  ++ L   ++        
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP--PMFD-----LHPMRALFLISKS------- 219

Query: 244 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              +F  P++K    W  VFH        D   + L   P  R TA +   HPF
Sbjct: 220 ---NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.4 bits (245), Expect = 8e-24
 Identities = 75/218 (34%), Positives = 109/218 (50%), Gaps = 37/218 (16%)

Query: 16  ERVV-GTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK---NRELQLMRVMDHPNVISLK 70
           ERVV G G++GIV+ A+ L T   +AIK++  +D RY    + E+ L   + H N++   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69

Query: 71  HCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
             +  + S+N  F  + ME VP         S +  LK             +  YT QI 
Sbjct: 70  --YLGSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNEQT--------IIFYTKQIL 118

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
            GL Y+H   ++ HRD+K  N+LV+  +  VKI DFG++K+L    A I+     F    
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGINPCTETFTGTL 173

Query: 179 -YRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
            Y APE+I  G   Y    DIWS GC + E+  G+P F
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 8e-24
 Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 53/294 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 67
           +     +G GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
                F   +      L ++MEY    S   +LK       ++   Y+     ++  GL 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLE 112

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAP 182
           Y+H      HRD+K  N+L+      VK+ DFG + QL    + +S    ++ + F+ AP
Sbjct: 113 YLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL---TSTMSKRNTFVGTPFWMAP 167

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E+I   + Y    DIWS G    EL  G+P     + +  L  I K             N
Sbjct: 168 EVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------NN 214

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           P       P ++ + + K F         D  S  L   P  R +A E   H F
Sbjct: 215 P-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 99.4 bits (248), Expect = 8e-24
 Identities = 83/299 (27%), Positives = 138/299 (46%), Gaps = 35/299 (11%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 72
            +G G+ G+V +     +G  +A K +  +     R    REL+++   + P ++     
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           F+S     E+  ++ ME++   S+ +VLK       R+P   +   +  + RGL Y+   
Sbjct: 68  FYS---DGEI--SICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREK 118

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 191
            ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y
Sbjct: 119 HKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THY 175

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-----TREEIRCMNPNYT 246
           T   DIWS G  L E+ +G+   P  +A     E+  + G P      +E  R ++ +  
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRPVSGHPP 231

Query: 247 DFRFPQ--------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           D   P         I   P  K+       E  D   + L+ +P  R    E   HPF 
Sbjct: 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 97.6 bits (243), Expect = 1e-23
 Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 16/213 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y   RVVG G+FGIV   +     + V IK++        +R     E Q+++++ HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           I     F    +     L +VMEY P  ++   ++     N  +    +  +  QI   L
Sbjct: 62  IEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            ++HT   + HRDLK QN+L+D     VKI DFG +K L +     + + +  Y +PEL 
Sbjct: 115 HHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
            G   Y    DIW+ GCVL EL   +  F   N
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 97/337 (28%), Positives = 153/337 (45%), Gaps = 68/337 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 68
           +V+G GSFG V  A+    GE  A+K + +D    + +++      RV+    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L +C F T  K  LF   VME++   + M+ +         R  L     Y  +I  GL 
Sbjct: 61  L-YCTFQT--KEHLFF--VMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQ 110

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           ++H+   + +RDLK  N+++D   H +KI DFG  K+ + G+   S  C +  Y APE++
Sbjct: 111 FLHS-KGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G  +YT S+D WS G +L E+L+GQ  F G++  D+L E I+V  TP            
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 304
               +P+     W       +  E+ D+  +L +  P+ R   +     HPFF  +   N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255

Query: 305 ARLPNGRPLPPLF-----------NFKQELSGASPEL 330
                 R L P F           NF +E     P L
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRL 292

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 47/301 (15%)

Query: 20  GTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISLK--HCFF 74
           G G++G+V + + + TG  +A+K++   +  +  K    +L+  +D    IS++   C +
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK----RLLMDLD----ISMRSVDCPY 61

Query: 75  STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           + T    LF      + ME +  S+ +  K        +P   +      I + L Y+H+
Sbjct: 62  TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              V HRD+KP N+L++    QVK+CDFG +  L+   A       + Y APE I     
Sbjct: 122 KLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN 180

Query: 191 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              Y    D+WS G  + EL  G+  FP ++      ++ +V+  P+             
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPS------------- 225

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
              PQ+ A        ++  PE  D  ++ L+ +   R    E   HPFF+     N  +
Sbjct: 226 ---PQLPA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDV 274

Query: 308 P 308
            
Sbjct: 275 A 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 96.8 bits (242), Expect = 2e-23
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 50/230 (21%)

Query: 17  RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVIS 68
           + +G G+FG V++ K          VA+K + +D   + R     E ++M+ + HPNV+ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY---------SSANQRMPLIYVKLYTY 119
           L       T +  L+  LV+EY+       L  Y         S     + L  +  +  
Sbjct: 61  LLGV---CTEEEPLY--LVLEYME---GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           QI +G+ Y+ +  +  HRDL  +N LV      VKI DFG ++ +   +         +Y
Sbjct: 113 QIAKGMEYLASK-KFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDD---------YY 161

Query: 180 R------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           R            APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.0 bits (242), Expect = 2e-23
 Identities = 72/290 (24%), Positives = 129/290 (44%), Gaps = 46/290 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           RV+G G+FG V   +  +T +  A+K     K ++    +N   E ++++ ++HP +++L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            + F     ++E  + LV++ +   +   L+++ S   +     VK +  +I   L Y+H
Sbjct: 66  WYSF-----QDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+L+D   H V I DF  A ++       S   +  Y APE++    
Sbjct: 118 S-KGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y+ ++D WS G    E L G+  + G +                R++IR          
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEACAHPFF 297
             Q  A   +         EAID  ++LL+  P  R      +   HP+F
Sbjct: 214 --QETADVLYPATW---STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 98.1 bits (244), Expect = 2e-23
 Identities = 93/336 (27%), Positives = 146/336 (43%), Gaps = 66/336 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM----DHPNVIS 68
           +++G GSFG VF A+   T +  AIK + +D    + +++      RV+    +HP    
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 57

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L H + +  +K  LF   VMEY+   + M+ +      +  +  L     Y  +I  GL 
Sbjct: 58  LTHLYCTFQTKENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQ 110

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           ++H+   + +RDLK  N+L+D   H +KI DFG  K+ + G+A     C +  Y APE++
Sbjct: 111 FLHS-KGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G  +Y TS+D WS G +L E+L+GQ  F G +  +              + IR  NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREPN 304
             +                 +  EA D+  +L    P  R     +   HPFF E+    
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW-- 256

Query: 305 ARLPNGRPLPPL----------FNFKQELSGASPEL 330
           + L      PP            NF +E     P L
Sbjct: 257 SALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRL 292

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.9 bits (243), Expect = 4e-23
 Identities = 99/326 (30%), Positives = 145/326 (44%), Gaps = 61/326 (18%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN I  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           K C+       E    LVMEY   S   +L+ +    Q + +  +   T+   +GLAY+H
Sbjct: 91  KGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142

Query: 130 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           +   + HRD+K  N LL +P   QVK+ DFGSA   IA  AN S++ + ++ APE+I   
Sbjct: 143 S-HNMIHRDIKAGNILLTEP--GQVKLADFGSAS--IASPAN-SFVGTPYWMAPEVILAM 196

Query: 189 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
            E  Y   +D+WS G    EL   +P     NA+  L  I +             N +  
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NES-- 241

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 306
               P ++++ W   F         +     LQ  P  R T+ E   H F   LRE    
Sbjct: 242 ----PTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHMFV--LRE---- 283

Query: 307 LPNGRPLPPLFNFKQELSGASPELVN 332
               RP   L +  Q    A  EL N
Sbjct: 284 ----RPETVLIDLIQRTKDAVRELDN 305

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 97.0 bits (241), Expect = 5e-23
 Identities = 90/324 (27%), Positives = 137/324 (42%), Gaps = 61/324 (18%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKH 71
           +G GSFG V+ A    T E VA+KK+    +  N       +E++ ++ + HPN I  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           C+    +       LVMEY   S   +L+ +    Q + +  +   T+   +GLAY+H+ 
Sbjct: 89  CYLKEHTA-----WLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140

Query: 132 PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
             + HRD+K  N LL +P   QVK+ DFGSA    +  AN S++ + ++ APE+I    E
Sbjct: 141 NMI-HRDIKAGNILLTEP--GQVKLADFGSAS--KSSPAN-SFVGTPYWMAPEVILAMDE 194

Query: 191 --YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y   +D+WS G    EL   +P     NA+  L  I +             N +    
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------NDS---- 237

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             P ++++ W   F               LQ  P  R  + E   H F          + 
Sbjct: 238 --PTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDF----------VR 277

Query: 309 NGRPLPPLFNFKQELSGASPELVN 332
             RP   L +  Q    A  EL N
Sbjct: 278 RDRPARVLIDLIQRTKDAVRELDN 301

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 70/244 (28%), Positives = 113/244 (46%), Gaps = 45/244 (18%)

Query: 17  RVVGTGSFGIVFQAKCLE-----TGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNV 66
           + +G G FG V      +     TGE VA+K        Q R    RE++++R +DH N+
Sbjct: 10  KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 125
           +  K        ++   L L+MEY+P      L+ Y   ++ ++ L  + L++ QI +G+
Sbjct: 69  VKYKGVCEKPGGRS---LRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 178
            Y+ +  R  HRDL  +N+LV+     VKI DFG AK L   +    Y   +       F
Sbjct: 123 DYLGSQ-RYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIF 177

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL---------LGQPL-----FPGENAVDQLV 224
           + APE +  +   + S D+WS G  L EL            + L       G+  V +L+
Sbjct: 178 WYAPECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 225 EIIK 228
           E++K
Sbjct: 237 ELLK 240

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 95.3 bits (237), Expect = 1e-22
 Identities = 75/299 (25%), Positives = 128/299 (42%), Gaps = 48/299 (16%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN--RELQLMRVMDHPNVISLKHCF 73
           +G G++G V++     TG T+A+K++   L + ++     EL ++     P ++     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           F   +     + + MEY+       L     A + +P   ++  TY + +GL ++     
Sbjct: 69  FIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI-----FGA 188
           + HRD+KP N+LV+    QVK+CDFG +  L+A  A  +  C   Y APE I        
Sbjct: 124 IIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASLAKTNIGCQS-YMAPERIKSGGPNQN 181

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIRCMNPNY 245
             YT   D+WS G  + E+ LG+  +P E   N   QL  I+   G P       +   Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
           +                      +A D  ++ L   P+ R T  +   HP+  + +  +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 24/220 (10%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN I  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + C+       E    LVMEY   S   +L+ +    Q + +  V   T+   +GLAY+H
Sbjct: 81  RGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132

Query: 130 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           +   + HRD+K  N LL +P    VK+ DFGSA   I   AN  ++ + ++ APE+I   
Sbjct: 133 S-HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS--IMAPAN-XFVGTPYWMAPEVILAM 186

Query: 189 TE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
            E  Y   +D+WS G    EL   +P     NA+  L  I
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 93.7 bits (233), Expect = 7e-22
 Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 53/300 (17%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVISLKHC 72
           +G GS GIV  A    TG  VA+KK+  D R + R      E+ +MR   HPN++ +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           + S    +EL++  VME++   ++  ++ H      RM    +      + + L+++H  
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA- 133

Query: 132 PRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGA 188
             V HRD+K  ++L   LT   +VK+ DFG   Q+        S + + ++ APE+I   
Sbjct: 134 QGVIHRDIKSDSIL---LTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SR 189

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y T +DIWS G ++ E++ G+P +  E  +  +            + IR   P     
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP----- 232

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
             P++K    HKV      P       R+L   P+ R TA E   HPF  +   P++ +P
Sbjct: 233 --PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 93.7 bits (233), Expect = 1e-21
 Identities = 93/343 (27%), Positives = 144/343 (41%), Gaps = 66/343 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 67
           +V+G GSFG V  AK    G+  A+ KVLQ +    ++ Q         L++ + HP ++
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L H  F T  K    L  V++YV   E  + + +      +  P    + Y  +I   L
Sbjct: 60  GL-HYSFQTADK----LYFVLDYVNGGELFFHLQRE-----RSFPEPRARFYAAEIASAL 109

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            Y+H++  + +RDLKP+N+L+D   H V + DFG  K+ I      S  C +  Y APE+
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     Y  ++D W  G VL E+L G P F   +   ++ +   +L  P R     + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDEL 300
            +                       A  L   LLQ   + R  A    LE   H FF  +
Sbjct: 219 IS---------------------VSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257

Query: 301 REPNARLPNGRPLPPLFNFK----QELSGASPELVNKLIPDHV 339
              N      + + P FN       +L    PE   + +P+ V
Sbjct: 258 ---NWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSV 297

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.3 bits (229), Expect = 1e-21
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 31/213 (14%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYK--NRELQLMRVMDHPNVI 67
           V+G G++G V+       G+ +A+K+V  D        + Y+    E+ L++ + H N++
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
                 +  T  ++  +++ ME+VP  S+  +L  +      +P      YT QI  G+A
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVA 116

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI-------CSRFY 179
           Y+H    V HRD+K  N+++ P    +K+ DFG A++L     + ++         + ++
Sbjct: 117 YLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 212
            APE+I   + Y    DIWS GC + E+  G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 42/279 (15%)

Query: 20  GTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFF 74
           G G+ G V + +   TG   A+K +  D     ++   REL++ +    P ++     F 
Sbjct: 10  GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69

Query: 75  STTSKNELFLNLVMEYVP----ESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             +S +   + + MEY      +S+Y +V K      ++  L  +      + +GL+Y+H
Sbjct: 70  DESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +  ++ HRD+KP N+L+     QVK+CDFG + +L+   A  ++  + FY APE I G  
Sbjct: 123 S-RKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAG-TFTGTSFYMAPERIQGKP 179

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPT----------- 234
            Y+ + D+WS G  L E+   +  FP E        +L+  I  +  P            
Sbjct: 180 -YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238

Query: 235 REEIR-----CMNPNYTDFRFP-QIKAHPWHKVFHKRMP 267
            EE +     C+  + T    P  +  HPW K   K+  
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 85/312 (27%), Positives = 130/312 (41%), Gaps = 52/312 (16%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 70
           +G G FG V   +   TG+  A KK L  +R K R        E +++  +    ++SL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIH 129
           + F +        L LVM  +     +   H  +  +   P      Y  QI  GL ++H
Sbjct: 60  YAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
              R+ +RDLKP+N+L+D   + V+I D G A +L  G+       +  Y APE++ G  
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y  S+D ++ GC L E++ G+  F       Q  E ++      +EE++          
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 304
                       +  +  PEA DL   LLQ  P  R      +A E   HP F +L    
Sbjct: 210 ---TLEMA--VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR- 263

Query: 305 ARLPNGRPLPPL 316
            RL  G   PP 
Sbjct: 264 -RLEAGMLEPPF 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.4 bits (227), Expect = 3e-21
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 20/219 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQ--DRRYKN---RELQLMRVMDHPNVISLKHC 72
           +G GSFG+VF+          A+K++ L   +RR +     E +++  +D   +I     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           F          LN+VMEY     ++++LK      + +P   V  +  QI  GLA++H+ 
Sbjct: 68  FLDKGK-----LNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS- 119

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT 189
            ++ HRD+K  NL +D     VKI D G AK L      AN + + + +Y +PEL     
Sbjct: 120 KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFAN-TIVGTPYYLSPELC-EDK 176

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
            Y    D+W+ G VL E   G+  F   N    +++II+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 3e-21
 Identities = 61/209 (29%), Positives = 109/209 (52%), Gaps = 24/209 (11%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           VGTG+FG V   +   +    A+K +       L+  ++ + E ++++ + HP +I L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                T  ++ FL ++MEYVP   ++  L++    +    L     Y  +I   L Y+H+
Sbjct: 68  ----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL----FYASEIVCALEYLHS 119

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 189
              + +RDLKP+N+L+D   H +K+ DFG AK+L         +C +  Y APE+I  + 
Sbjct: 120 K-EIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVI-QSK 173

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
            +  ++D W+ G ++ E+L+G P F  +N
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 90.1 bits (223), Expect = 8e-21
 Identities = 65/236 (27%), Positives = 116/236 (49%), Gaps = 27/236 (11%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 67
           +++G G+FG V+     +TG  +A+K+V  D               E+QL++ + H  ++
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
               C      +    L++ ME++P  S+   LK Y +  + +     + YT QI  G++
Sbjct: 68  QYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 182
           Y+H+   + HRD+K  N+L D     VK+ DFG++K+L    ++G    S   + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           E+I G   Y    DIWS GC + E+L  +P +      + +  I K+   PT   +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPWA---EFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 99/345 (28%), Positives = 145/345 (42%), Gaps = 78/345 (22%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQD-----RRYKNRELQLMRVMDHPNV 66
           +V+G GSFG V  A+   T E  AIK      +LQD        + R L L     HP +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA--KHPFL 58

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +L HC F T  K+ LF   VMEYV   + M+++ +       R      + Y  ++   
Sbjct: 59  TAL-HCCFQT--KDRLFF--VMEYVNGGDLMFQIQRSRKFDEPR-----SRFYAAEVTLA 108

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           L ++H    V +RDLK  N+L+D   H  K+ DFG  K+ I      +  C +  Y APE
Sbjct: 109 LMFLHR-HGVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            I    EY  S+D W+ G ++ E++ GQP F  +N  D L E I                
Sbjct: 167 -ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESIL--------------- 209

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC-----AHPF 296
            + D  +P      W       +  EA+ +    +  +P+ R  C A +        HPF
Sbjct: 210 -HDDVLYPV-----W-------LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256

Query: 297 FDELREPNARLPNGRPLPPLF-----------NFKQELSGASPEL 330
           F   +E +  L   R + P F           NF Q+ +   P L
Sbjct: 257 F---KEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQDFTKEEPVL 298

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 80/293 (27%), Positives = 122/293 (41%), Gaps = 48/293 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 66
           Y+  RV+G G+FG     +  E    V  K+V L       RR    E+ ++ ++ HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           I+  + F    +     L + MEY    ++Y  +       Q      V  Y +QI   +
Sbjct: 62  IAYYNHFMDDNT-----LLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPE 183
           +YIH    + HRD+K  N+ +      +K+ DFG +K L   E +++     + +Y +PE
Sbjct: 115 SYIHKA-GILHRDIKTLNIFLTK-AGLIKLGDFGISKIL-GSEYSMAETVVGTPYYMSPE 171

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           L  G  +Y    DIW+ GCVL ELL  +  F   N ++ +V+I              +  
Sbjct: 172 LCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--------------VQG 216

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           NYT                      E I L   LLQ  P  R TA E    P 
Sbjct: 217 NYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 88.2 bits (218), Expect = 4e-20
 Identities = 68/242 (28%), Positives = 120/242 (49%), Gaps = 27/242 (11%)

Query: 11  ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVM 61
           I++   +++G G+FG V+    ++TG  +A K+V  D               E+QL++ +
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 120
            H  ++    C      + E  L + MEY+P  S+   LK Y +  + +     + YT Q
Sbjct: 62  QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICS 176
           I  G++Y+H+   + HRD+K  N+L D     VK+ DFG++K+L    ++G    S   +
Sbjct: 115 ILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
            ++ +PE+I G   Y    D+WS GC + E+L  +P +    A   +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTNP 228

Query: 237 EI 238
           ++
Sbjct: 229 QL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 88.7 bits (220), Expect = 4e-20
 Identities = 84/302 (27%), Positives = 138/302 (45%), Gaps = 53/302 (17%)

Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRR---YKNRELQ-LMRVMDHP 64
           RV+GTG++G VF  + +   + G+  A+K      ++Q  +   +   E Q L  V   P
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +++L H  F T +K    L+L+++YV  +   +  H     +      V++Y  +I   
Sbjct: 66  FLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIAEIVLA 117

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 182
           L ++H +  + +RD+K +N+L+D   H V + DFG +K+ +A E   +Y  C    Y AP
Sbjct: 118 LDHLHQL-GIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 183 ELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           E+I G +  +  ++D WS G +  ELL G   F  +   +   EI +          R +
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR----------RIL 225

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFD 298
                       K+ P    F K M  EA D   +LL+  P  R     A E   HPFF 
Sbjct: 226 ------------KSKP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Query: 299 EL 300
            +
Sbjct: 271 GI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 88.2 bits (218), Expect = 4e-20
 Identities = 70/215 (32%), Positives = 110/215 (51%), Gaps = 17/215 (7%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 64
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+ L++ ++HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI     F      NE  LN+V+E      + R++KH+    + +P   V  Y  Q+  
Sbjct: 63  NVIKYYASFI---EDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAP 182
            L ++H+  RV HRD+KP N+ +   T  VK+ D G  +   +   A  S + + +Y +P
Sbjct: 118 ALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 217
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 4e-20
 Identities = 86/312 (27%), Positives = 135/312 (43%), Gaps = 50/312 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 68
           RV+G G FG V   +   TG+  A KK L+ +R K R        E Q++  ++   V+S
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L + +    +K+ L L L +    +  + +   Y+  N          Y  +I  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H   R+ +RDLKP+N+L+D   H ++I D G A ++  GE     + +  Y APE++   
Sbjct: 119 HR-ERIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             YT S D W  GC++ E++ G+  F          E +K      REE+          
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVE--------- 214

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--C---TALEACAHPFFDELREP 303
              ++K     + + ++    A  +  +LL   P  R  C    A E  AHPFF      
Sbjct: 215 --RRVKEDQ--EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF- 269

Query: 304 NARLPNGRPLPP 315
             RL  G   PP
Sbjct: 270 -KRLEAGMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 6e-20
 Identities = 67/213 (31%), Positives = 114/213 (53%), Gaps = 27/213 (12%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNR-ELQLMRVM-DHPNVISLKHCF 73
           V+G G++G V++A+  +TG+ VAIK   +++D   + + E  ++R   +HPN+ +    F
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 74  F---STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                  + ++L+  LVME     S+  ++K      +R+   ++     +  RGLAY+H
Sbjct: 73  IKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 130 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 185
              +V HRD+K QN+L   LT   +VK+ DFG + QL +  G  N ++I + ++ APE+I
Sbjct: 131 E-NKVIHRDIKGQNIL---LTKNAEVKLVDFGVSAQLDSTLGRRN-TFIGTPYWMAPEVI 185

Query: 186 FGATE------YTTSIDIWSAGCVLAELLLGQP 212
             A +      Y    D+WS G    EL  G+P
Sbjct: 186 --ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 88.3 bits (219), Expect = 7e-20
 Identities = 83/311 (26%), Positives = 135/311 (43%), Gaps = 65/311 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNR------ELQLMRVMDHPNVISL 69
           +++  G++G V+  +  ET +  A+KK+  Q+   +N+      E  ++   ++P V+S+
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             C F T       L +VMEYV       +LK+  +    +P+   ++Y  +    L Y+
Sbjct: 67  -FCSFETKR----HLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYL 117

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYICSRF---- 178
           H    V HRDLKP NLL+  + H +K+ DFG +K  +        E +I      F    
Sbjct: 118 HNYGIV-HRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 179 ------YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 232
                 Y APE+I     Y   +D W+ G +L E L+G   F G+   +   ++I     
Sbjct: 176 VCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS---- 230

Query: 233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TAL 289
              ++I    P   +                  +P +A DL SRLL+ +P  R     A 
Sbjct: 231 ---DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGGAF 268

Query: 290 EACAHPFFDEL 300
           E   H FF  L
Sbjct: 269 EVKQHRFFLGL 279

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 88.6 bits (219), Expect = 8e-20
 Identities = 68/221 (30%), Positives = 116/221 (52%), Gaps = 22/221 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+V + +   +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK      +R+P   +   +  + RGLAY+    
Sbjct: 73  YSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH 123

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              DIWS G  L EL +G+   P  +A     E+  + G P
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDA----KELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 85/284 (29%), Positives = 130/284 (45%), Gaps = 47/284 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 67
           +V+G GSFG V  AK    G+  A+K VLQ +   NR+ Q         L++ + HP ++
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L H  F TT K    L  V+++V   E  + + +  S    R      + Y  +I   L
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            Y+H++  + +RDLKP+N+L+D   H V + DFG  K+ IA     +  C +  Y APE+
Sbjct: 110 GYLHSI-NIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII-KVL----GTPTR---- 235
           I     Y  ++D W  G VL E+L G P F   +  +    I+ K L    G        
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSI 226

Query: 236 -----EEIRCMNPNYTDFRFPQIKAHP------WHKVFHKRMPP 268
                E+ R       +  F +I+ HP      W  +  K++PP
Sbjct: 227 LEELLEKDRQRRLGAKE-DFLEIQEHPFFESLSWTDLEQKKIPP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 69/210 (32%), Positives = 104/210 (49%), Gaps = 38/210 (18%)

Query: 19  VGTGSFGIVFQAKCL------ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVIS 68
           +G G+FG V    C        TGE VA+KK+        R   RE+++++ + H N++ 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 127
            K   +S   +N   L LVMEY+P   Y  L+ Y   ++ R+    + LY  QI +G+ Y
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLP---YGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----------AGEANISYICSR 177
           +    R  HRDL  +N+LV+     VKI DFG  K L            GE+ I      
Sbjct: 124 L-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI------ 175

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
           F+ APE +   ++++ + D+WS G VL EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 94/320 (29%), Positives = 137/320 (42%), Gaps = 58/320 (18%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 70
           +G GSFG V Q +  +T    A+K + +       E+         L +V + P ++ LK
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLK 59

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              FS  S  +L+L L      E     L H+     R  L   + YT ++   L  +H 
Sbjct: 60  ---FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAELLCALENLHK 111

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFGAT 189
              V +RDLKP+N+L+D   H + +CDFG  K  +  +   +  C +  Y APEL+ G  
Sbjct: 112 F-NVIYRDLKPENILLDYQGH-IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG 169

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            YT ++D W+ G +L E+L G P F  EN V+++    K+L  P               R
Sbjct: 170 -YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEP--------------LR 211

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREPNAR 306
           FP                 +A DL   LL   P+ R     A E   HPFF +L     +
Sbjct: 212 FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW--KK 257

Query: 307 LPNGRPLPPLFNFKQELSGA 326
           L      PP   FK  +S A
Sbjct: 258 LLMKGIQPP---FKPAVSSA 274

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.5 bits (211), Expect = 4e-19
 Identities = 65/215 (30%), Positives = 110/215 (51%), Gaps = 17/215 (7%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 64
           ++  E+ +G G F  V++A CL   + VA+KKV    + D + +    +E+ L++ ++HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI     F      NE  LN+V+E      + +++K++    + +P   V  Y  Q+  
Sbjct: 63  NVIKYLDSFI---EDNE--LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAP 182
            + ++H+  RV HRD+KP N+ +   T  VK+ D G  +   +   A  S + + +Y +P
Sbjct: 118 AVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 217
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.5 bits (211), Expect = 4e-19
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---------ELQLMRVMDHPNVI 67
           +++G G+FG V+     +TG  +A+K+V  D   +           E+QL++ + H  ++
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
               C      K    L++ +EY+P  S+   LK Y +  + +     + YT QI +G++
Sbjct: 68  QYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL----IAGEANISYICSRFYRAP 182
           Y+H+   + HRD+K  N+L D     VK+ DFG++K++    ++G    S   + ++ +P
Sbjct: 121 YLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           E+I G   Y    D+WS  C + E+L  +P +    A   +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 85.9 bits (213), Expect = 7e-19
 Identities = 92/339 (27%), Positives = 146/339 (43%), Gaps = 69/339 (20%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LM---RV------MDHPNVI 67
           V+G G FG V  A+  +TGE  AIK + +       E++ LM   R+        HP ++
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +L  CF   T  +  F   VMEY    + M  +     S  +         Y   +  GL
Sbjct: 66  NLFACF--QTEDHVCF---VMEYAAGGDLMMHIHTDVFSEPR------AVFYAACVVLGL 114

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            Y+H   ++ +RDLK  NLL+D     VKI DFG  K+ +      S  C +  + APE+
Sbjct: 115 QYLHE-NKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   T YT ++D W  G ++ E+L+G+  FPG++  +    I+        +E+R     
Sbjct: 173 LTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------DEVR----- 219

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF-- 297
                      +P        +  EAI +  RLL+ +P  R  + E  A      PFF  
Sbjct: 220 -----------YPRF------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262

Query: 298 ---DEL---REPNARLPNGRPLPPLFNFKQELSGASPEL 330
              D+L   +     +P  +    + NF +E +  +P L
Sbjct: 263 INWDDLLARKIKPPFVPTIKGPEDVSNFDEEFTSEAPVL 301

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 85.2 bits (211), Expect = 9e-19
 Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 63/299 (21%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMDHPNV 66
           +++G G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +LK+ F +        L  VMEY    E  + + +    +  R      + Y  +I   
Sbjct: 58  TALKYSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           L Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I+  A +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEI     
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEI----- 212

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                RFP            + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 213 -----RFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 73  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 123

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 124 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 180

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENA 219
              DIWS G  L E+ +G+   P  +A
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPPPDA 207

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 98/345 (28%), Positives = 146/345 (42%), Gaps = 70/345 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQD-----RRYKNRELQLMRVMDHPNV 66
           RV+G GSFG V  A+  E+G   A+K      +LQD        + R L L R  +HP +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 58

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
             L  CF +    + LF   VME+V   + M+ + K     ++R      + Y  +I   
Sbjct: 59  TQLYCCFQTP---DRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSA 108

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           L ++H    + +RDLK  N+L+D   H  K+ DFG  K+ I      S  C +  Y APE
Sbjct: 109 LMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE 166

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            I     Y  S+D W+ G +L E+L G   F  EN  D L E I        +E+     
Sbjct: 167 -ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV----- 213

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEA----CAHPFF 297
                            V+   +  +A+D+    +  +P++R     L        HPFF
Sbjct: 214 -----------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256

Query: 298 DELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
            EL   +    N R + P F  + +    S E V+   PD +K  
Sbjct: 257 KEL---DWEKLNRRQIEPPFRPRIK----SREDVSNFDPDFIKED 294

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 1e-18
 Identities = 70/221 (31%), Positives = 108/221 (48%), Gaps = 28/221 (12%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 70
           + +G GSFG ++ AK     E   IK++      ++++    +E+ L+  M HPN+++  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYS---SANQRMPLIYVKLYTYQIFRGL 125
             F S      LF+  VMEY    + M R+ +      S +Q      +  +  QI  GL
Sbjct: 65  --FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQ------ILSWFVQISLGL 114

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPE 183
            +IH   ++ HRD+K QN+ +       K+ DFG A+QL      ++Y C  + +Y +PE
Sbjct: 115 KHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 224
            I     Y    DIWS GCVL EL   +  F G N + QLV
Sbjct: 173 -ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 23/220 (10%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISLK 70
           V+G GSFG V  A+   T E  AIK + +D   ++ +++      RV+     P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           H  F T  +    L  VMEYV   + MY + +       + P  +   Y  +I  GL ++
Sbjct: 67  HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAAEIAIGLFFL 117

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
           H+   + +RDLK  N+++D   H +KI DFG  K+ I G       C +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              Y  S+D W+ G +L E+L GQP F GE+  D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 82.7 bits (204), Expect = 9e-18
 Identities = 92/345 (26%), Positives = 150/345 (43%), Gaps = 74/345 (21%)

Query: 17  RVVGTGSFGIVF--------------QAKCLETGETVAIKKVLQDRRYKNRELQLMRVMD 62
           +V+GTG++G VF                K L+    V   K ++  R +   L+ +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR--Q 63

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL---KHYSSANQRMPLIYVKLYT 118
            P +++L H  F T +K    L+L+++YV    M+  L    ++S          V+ Y+
Sbjct: 64  SPFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYS 111

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSR 177
            +I   L ++H +  + +RD+K +N+L+D   H V + DFG +K+ ++ E   +Y  C  
Sbjct: 112 GEIILALEHLHKLG-IVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGT 169

Query: 178 F-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
             Y APE+I G   +  ++D WS G ++ ELL G   F  E   +   E+       +R 
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRR 222

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--- 293
            ++C  P                  F   + PEA DL  +LL+  P  R  A    A   
Sbjct: 223 ILKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEI 264

Query: 294 --HPFFDEL-------REPNARL-PNGRPLPPLFNFKQELSGASP 328
             HPFF  L       R+ N    P+ R    + NF +E +   P
Sbjct: 265 KEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEFTNLEP 309

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 31/209 (14%)

Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           RV+G G FG V    +      TGE VA+K + ++   +N      E+ +++ + H N++
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVKLYTYQIFRGL 125
             K C    + +    L L+MEYVP    R  + KH  +  Q +      L+  QI  G+
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FY 179
           AY+H+     HRDL  +N+L+D     VKI DFG AK +  G     Y          F+
Sbjct: 121 AYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFW 176

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            A E +        S D+WS G  L ELL
Sbjct: 177 YAVECLKENKFSYAS-DVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 84/297 (28%), Positives = 130/297 (43%), Gaps = 66/297 (22%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYK-----NRELQLMRVMDHPNVISLK 70
           +GTGSFG V  AK   TGE  AI K L+ R   + K      +E  ++  + HP ++++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAI-KCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             F     +N ++   ++E+V      +  H   A  R P    K Y  ++     Y+H+
Sbjct: 85  CSF---QDENRVY--FLLEFVVGG--ELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHS 136

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + +RDLKP+NLL+D   H VK+ DFG AK++   +   +   +  Y APE+I  +  
Sbjct: 137 K-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKG 191

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR--EEI---RCMNPNY 245
           +  ++D W+ G +L E + G P F  +              TP R  E+I   R   PN+
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILAGRLKFPNW 237

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFF 297
            D R                    A DL   LLQ   + R   L+        HP+F
Sbjct: 238 FDGR--------------------ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 16/226 (7%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTT 77
           +G G+FG V +     +G  +A+K++    R    E +  R+ MD   V+    C +   
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 78  SKNELFLN----LVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
               LF      + ME +  S+ +  K+ Y      +P   +        + L Y+    
Sbjct: 68  FYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI--FGATE 190
           ++ HRD+KP N+L+D     +K+CDFG + QL+   A       R Y APE I       
Sbjct: 128 KIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG 186

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR 235
           Y    D+WS G  L E+  G+  +P  N+V DQL +++K  G P  
Sbjct: 187 YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 29/223 (13%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 70
           V+G GSFG V  A+   T E  AIK + +D   ++ +++       ++ + D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLI---YVKLYTYQIFRGL 125
           H  F T  +    L  VMEYV   + MY +        Q++          Y  +I  GL
Sbjct: 67  HSCFQTVDR----LYFVMEYVNGGDLMYHI--------QQVGKFKEPQAVFYAAEISVGL 114

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPEL 184
            ++H    + +RDLK  N+++D   H +KI DFG  K+ ++ G    ++  +  Y APE+
Sbjct: 115 FFLHR-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           I     Y  S+D W+ G +L E+L GQP F GE+  D+L + I
Sbjct: 173 I-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 43/294 (14%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 72
           ++G G+ G V++A  L T   +A+K +  D     ++    EL+++   D P +I     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           FF      E  +++  E++      V +       ++P   +      + +GL Y+ ++ 
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL- 114

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    QVK+CDFG + QL+   A  +Y+ +  Y APE I G  +Y 
Sbjct: 115 KILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPNYTDFRFP 251
              D+WS G    EL LG+  +P         +I K  G+    ++ +C+     D   P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP---------QIQKNQGSLMPLQLLQCI----VDEDPP 218

Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
            +    + + F        +   ++ ++  P  R        HPF  +  + NA
Sbjct: 219 VLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 87/356 (24%), Positives = 133/356 (37%), Gaps = 103/356 (28%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 69
           +V+G G+FG V   +  +TG   A+KK+ + +   K +      E  ++   D+P V+ L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK--LYTYQIFRGLA 126
            + F     ++E +L L+MEY+P   M  +L    +  +     Y+   +        L 
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--------------IAGEANIS 172
           YIH       RD+KP NLL+D   H +K+ DFG    L                    + 
Sbjct: 122 YIH-------RDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173

Query: 173 YICSRF-------------------------YRAPELIFGATEYTTSIDIWSAGCVLAEL 207
           +I                             Y APE +F  T Y    D WS G ++ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEM 232

Query: 208 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 267
           L+G P F  +N  +   +I              +N   T  +FP              + 
Sbjct: 233 LVGYPPFCSDNPQETYRKI--------------INWKET-LQFPD----------EVPLS 267

Query: 268 PEAIDLASRLLQYSPSLRC---TALEACAHPFF-----DELREPNARLPNGRPLPP 315
           PEA DL  RL       R       E  +HPFF     + +RE  A      P+ P
Sbjct: 268 PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPA------PIIP 316

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 83/299 (27%), Positives = 129/299 (43%), Gaps = 59/299 (19%)

Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQ---------DRRYKNRELQLMRVMDHP 64
           +V+G G +G VFQ + +   +TG+  A+K VL+         D  +   E  ++  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            ++ L    F T  K    L L++EY+      +  H       M       Y  +I   
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 183
           L ++H    + +RDLKP+N+L+D   H VK+ DFG  K+ I         C    Y APE
Sbjct: 113 LEHLHQQG-IIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            I   + +  ++D WS G ++ ++L G P F  EN    + +I+K          +   P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
            Y                    + PEA DL  +LL+ +PS R       A E  +HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.3 bits (195), Expect = 8e-17
 Identities = 86/313 (27%), Positives = 134/313 (42%), Gaps = 50/313 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 68
           RV+G G FG V   +   TG+  A KK L+ +R K R        E Q++  ++   V+S
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L + +    +K+ L L L +    +  + +   Y              Y  +I  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H   R+ +RDLKP+N+L+D   H ++I D G A  +  G+     + +  Y APE++   
Sbjct: 119 HQ-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             YT S D W+ GC+L E++ GQ  F       Q  + IK      REE+  +       
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL------- 216

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP 303
               +K     + + ++  P+A  L   LL   P  R       A E   HP F ++   
Sbjct: 217 ----VKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268

Query: 304 NARLPNGRPLPPL 316
             RL  G   PP 
Sbjct: 269 FKRLEAGMLEPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 64/299 (21%)

Query: 20  GTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKHC 72
           G G+FG V++A+  ETG   A K +       L+D      E+ ++    HPN++ L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 73  FFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLI--YVKLYTYQIFRGLA 126
           +F      E  L +++E+      +S+   L+          L    ++    Q+   L 
Sbjct: 71  YF-----YENKLWILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALN 117

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELI 185
           ++H+  +V HRDLK  N+L+  L   VK+ DFG SAK     +   ++I + ++ APE++
Sbjct: 118 FLHS-HKVIHRDLKAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175

Query: 186 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
               F    Y    DIWS G  L EL   +P  P  + ++ +  ++K+L +         
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP------- 225

Query: 242 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                    P +     W   F+        D     L   P  R TA E   HPF  +
Sbjct: 226 ---------PTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVSD 267

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 65/236 (27%), Positives = 120/236 (50%), Gaps = 20/236 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+ +MR   HPN+++    + 
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 87  VG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALEFLHS-NQ 135

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEYT 192
           V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S  + + ++ APE++     Y 
Sbjct: 136 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYG 193

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++  + DF
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 80/285 (28%), Positives = 136/285 (47%), Gaps = 47/285 (16%)

Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIK-------KVLQDRRYKNRELQLMRVMDHPNV 66
           +V+G GSFG VF  + +   + G+  A+K       KV +DR     E  ++  ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFI 60

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           + L H  F T  K    L L+++++   +   R+ K      +      VK Y  ++   
Sbjct: 61  VKL-HYAFQTEGK----LYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALA 110

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 183
           L ++H++  + +RDLKP+N+L+D   H +K+ DFG +K+ I  E      C    Y APE
Sbjct: 111 LDHLHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP------TRE 236
           ++     +T S D WS G ++ E+L G   F G++  + +  I+K  LG P       + 
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227

Query: 237 EIRCM---NPNYTDFRFPQ----IKAHP------WHKVFHKRMPP 268
            +R +   NP       P     IK HP      W+K++ + + P
Sbjct: 228 LLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 61/255 (23%), Positives = 120/255 (47%), Gaps = 38/255 (14%)

Query: 19  VGTGSFGIVFQAKCLETGET-VAIKKVL-------QDRRYKNR-------ELQLMR-VMD 62
           +G+G+FG V++ +    G+  +A+K++        +D+R +++       E+ +++  + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS---ANQRMPLIYVKLYTY 119
           HPN++     ++ T  +N+  L +VM+ +  +     +H++S     QR     +     
Sbjct: 68  HPNIVR----YYKTFLENDR-LYIVMDLIEGAPLG--EHFNSLKEKKQRFTEERIWNIFV 120

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   L Y+H   R+ HRDL P N+++     +V I DFG AKQ        S + +  Y
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI- 238
             PE++     Y    D+W+ GC+L ++   QP F   N +    +I++ +  P  E + 
Sbjct: 180 SCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238

Query: 239 ---------RCMNPN 244
                     C+ P+
Sbjct: 239 SEDVTDVITSCLTPD 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 77/288 (26%), Positives = 130/288 (45%), Gaps = 47/288 (16%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 74
           +G+G++G V++A+ + TGE  AIK +     +D     +E+ +M+   H N+++    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 75  STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
           S   +++L++   ME+      + + H +       + YV   T Q   GL Y+H+  ++
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSKGKM 128

Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 190
            HRD+K  N+L+    H VK+ DFG + Q+ A  A   S+I + ++ APE+   A E   
Sbjct: 129 -HRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 191 -YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y    DIW+ G    EL   QP     + +  L  + K                 ++F+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-----------------SNFQ 227

Query: 250 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            P++K    W   FH              L  +P  R TA +   HPF
Sbjct: 228 PPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 84/299 (28%), Positives = 128/299 (42%), Gaps = 62/299 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +LK+ F     +    L  VMEY    E  + + +    +  R      + Y  +I   
Sbjct: 58  TALKYSF-----QTHDRLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           L Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I   A +   C +  Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.5 bits (190), Expect = 3e-16
 Identities = 68/242 (28%), Positives = 122/242 (50%), Gaps = 20/242 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVIS 68
           Y     +G G+ G VF A  + TG+ VAIK++ LQ +  K     E+ +M+ + +PN+++
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
               F      +ELF+  VMEY+   S+  V+        ++  +       +  + L +
Sbjct: 81  FLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQIAAV-----CRECLQALEF 130

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIF 186
           +H   +V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S  + + ++ APE++ 
Sbjct: 131 LHA-NQVIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV- 187

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y   +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++P + 
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSPIFR 246

Query: 247 DF 248
           DF
Sbjct: 247 DF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 45/217 (20%)

Query: 19  VGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 70
           +G G+FG V +   L        VA+K + Q+          RE  +M  +DHP ++ L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 71  HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   K E  + LVME  P   + + LK      + +P+  +K   +Q+  G+AY+ 
Sbjct: 62  ----IGVCKGEPLM-LVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE 112

Query: 130 TVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 180
           +     HRDL  +N LLV+   HQ KI DFG ++ L AG        S +YR        
Sbjct: 113 SK-HFVHRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 181 ----APELIFGATEYTTSIDIWSAGCVLAELL-LGQP 212
               APE I     +++  D+WS G  L E    G  
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAK 197

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 76/304 (25%), Positives = 139/304 (45%), Gaps = 55/304 (18%)

Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNRELQLMRVMDH----P 64
           +V+GTG++G VF  + +   ++G+  A+K      ++Q  +         +V++H    P
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +++L H  F T +K    L+L+++Y+      +  H S   +R     V++Y+ +I   
Sbjct: 66  FLVTL-HYAFQTDTK----LHLILDYINGG--ELFTHLSQ-RERFKEQEVQIYSGEIVLA 117

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 182
           L ++H +  + +RD+K +N+L+D   H V + DFG +K+    E   +Y  C    Y AP
Sbjct: 118 LEHLHKLG-IIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175

Query: 183 ELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           +++ G    +  ++D WS G ++ ELL G   F  +   +   EI + +           
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI----------- 224

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPF 296
                      +K+ P    + + M   A D+  RLL   P  R       A E   HPF
Sbjct: 225 -----------LKSEP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270

Query: 297 FDEL 300
           F ++
Sbjct: 271 FQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.4 bits (190), Expect = 4e-16
 Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 45/296 (15%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 73
           +G GS GIV  A+   +G  VA+K ++  R+ + REL      +MR   H NV+ +   +
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM---Y 84

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            S     EL++  +ME++       +   +  N+      +      + + L Y+H+   
Sbjct: 85  KSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHS-QG 137

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYT 192
           V HRD+K  ++L+  L  +VK+ DFG   Q+        S + + ++ APE+I   T Y 
Sbjct: 138 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPYG 195

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
           T +DIWS G ++ E++ G+P +  ++ V  +  +        R+              P 
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------PP 234

Query: 253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
            K    HK+      P   D   R+L   P  R TA E   HPF  +   P   +P
Sbjct: 235 PKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 87/352 (24%), Positives = 146/352 (41%), Gaps = 100/352 (28%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 69
           +V+G G+FG V   +  +TG+  A+K +L+   +K  +L  ++         D P V+SL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
            + F     ++  +L L+ME++P   +  +L  Y + ++ +     + Y  +    +  +
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG------------SAKQLIAGEANISYICS 176
           H +  + HRD+KP N+L+D   H +K+ DFG              ++L+ G++N + I +
Sbjct: 118 HKLGFI-HRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175

Query: 177 RF------------------------------------YRAPELIFGATEYTTSIDIWSA 200
           R                                     Y APE IF    Y    D WS 
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234

Query: 201 GCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK 260
           G ++ E L+G P F  EN+ +   +II       RE +           FP    H    
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKIINW-----RETL----------YFPD-DIH---- 274

Query: 261 VFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFF-----DELREPNA 305
                +  EA DL  RL+  + +   R  A E  +HPFF     D +R+  A
Sbjct: 275 -----LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA 321

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 67/253 (26%), Positives = 119/253 (47%), Gaps = 29/253 (11%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 73
           +G G+FG V++AK  ETG  +A  KV++ +  +       E++++   +HP ++ L   F
Sbjct: 20  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           +         L +++E+ P      +          P I  ++   Q+   L Y+H++ +
Sbjct: 79  YWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQI--QVICRQMLEALQYLHSM-K 130

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFGAT--- 189
           + HRDLK  N+L+  L   +K+ DFG SAK +   +   S+I + ++ APE++   T   
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 190 -EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIRCMNPN 244
             Y    DIWS G  L E+   +P     N +  L++I K     L  P++      +  
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK-----WSME 244

Query: 245 YTDFRFPQIKAHP 257
           + DF    +  HP
Sbjct: 245 FRDFLKTALDKHP 257

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.9 bits (189), Expect = 5e-16
 Identities = 87/313 (27%), Positives = 136/313 (43%), Gaps = 50/313 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 68
           RV+G G FG V   +   TG+  A K+ L+ +R K R        E Q++  ++   V++
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L + +    +K+ L L L +    +  + +   Y+  N          Y  +I  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H      +RDLKP+N+L+D   H ++I D G A ++  GE+    + +  Y APE++   
Sbjct: 119 HR-ENTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             YT S D W  GC++ E++ GQ  F G        E +K      REE+        D 
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK------REEV--------DR 215

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFDELREP 303
           R  + +     +V+  +   EA  +   LL   P  R  C    A E   HPFF  +   
Sbjct: 216 RVLETE-----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN-- 268

Query: 304 NARLPNGRPLPPL 316
             RL  G   PP 
Sbjct: 269 FKRLEAGMLDPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 24/222 (10%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 68
           +V+G GSFG V  A+     +  A+K + +    K +E +        L++ + HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L H  F T  K    L  V++Y+   E  Y + +       R      + Y  +I   L 
Sbjct: 61  L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 110

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           Y+H++  + +RDLKP+N+L+D   H V + DFG  K+ I      S  C +  Y APE++
Sbjct: 111 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
                Y  ++D W  G VL E+L G P F   N  +    I+
Sbjct: 169 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 76.6 bits (188), Expect = 5e-16
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 35/211 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           Y   RVVG GSFG     + + + +  A+K++   +         +E  L+  M HPN++
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT--------Y 119
           + K  F     + +  L +VMEY                Q++ L   KL+          
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGG---------DLMQKIKLQRGKLFPEDTILQWFV 107

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA-GEANISYICS 176
           Q+  G+ +IH   RV HRD+K +N+    LT   +VK+ DFGSA+ L + G    +Y+ +
Sbjct: 108 QMCLGVQHIHE-KRVLHRDIKSKNIF---LTQNGKVKLGDFGSARLLTSPGAYACTYVGT 163

Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
            +Y  PE I+    Y    DIWS GC+L EL
Sbjct: 164 PYYVPPE-IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-----RVMDHPN---VIS 68
           RV+G G FG V   +   TG+  A KK L+ +R K R+ + M     R+++  N   V+S
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L + +    +K+ L L L +    +  + +   Y+  N          Y  ++  GL  +
Sbjct: 65  LAYAY---ETKDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
               R+ +RDLKP+N+L+D   H ++I D G A Q+  GE     + +  Y APE+I   
Sbjct: 119 QR-ERIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLF 214
            +YT S D W  GC++ E++ GQ  F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 76.9 bits (189), Expect = 9e-16
 Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 51/286 (17%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 67
           +V+G GSFG V  AK    G   A+K VLQ +    ++ Q         L++ + HP ++
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L H  F T  K    L  V++YV   E  + + +       R      + Y  ++   +
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            Y+H++  + +RDLKP+N+L+D   H V + DFG  K+ +  E   S  C +  Y APE 
Sbjct: 110 GYLHSL-NIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII----------------K 228
           +     Y  ++D W  G VL E+L G P F   + V Q+ + I                 
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225

Query: 229 VLGTPTREEIRCMNPNYTDFRFPQIKAH------PWHKVFHKRMPP 268
           +L     ++ R       DF   +IK H       W  ++HKR+ P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITP 269

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 92/341 (26%), Positives = 148/341 (43%), Gaps = 56/341 (16%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLM---RVMDHPNVISLKH 71
           ++G G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 72  C--FFSTTSKNELFLNLVM-EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              +F   + +   + +VM +Y P  +  ++KH   +++ +  I      +Q    L Y 
Sbjct: 196 IQRYFQNETGH---MCIVMPKYGPCLLDWIMKHGPFSHRHLAQI-----IFQTGVALDYF 247

Query: 129 HTVPRVCHRDLKPQNLL-------VDPLTHQ--------VKICDFGSAKQLIAGEANISY 173
           HT   + H DLKP+N+L       VDP+T++        V+ICD G         +  + 
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD--ERHSRTAI 305

Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT- 232
           + +R YR+PE++ G   +  S D+WS GC++ EL  G+ L+   + ++ L  + K LG  
Sbjct: 306 VSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364

Query: 233 PTREEIRCMNPN----YTDFRFPQIKAHPWH--KVFHKRMPPEAI------DLASRLLQY 280
           P+    RC        Y      +    P H  ++   R   E I      DL   LL Y
Sbjct: 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424

Query: 281 SPSLRCTALEACAHP----FFDELRE-PNARLPNGRP-LPP 315
               R  A +   HP    ++ E R+ PN   P+ R  L P
Sbjct: 425 DRQKRLNARQMTTHPYVLKYYPECRQHPNY--PDNRSMLRP 463

Length = 467

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 77/315 (24%), Positives = 133/315 (42%), Gaps = 59/315 (18%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLK 70
           +VG G FG V   +   TG+  A+K + +          +   E  ++ + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           + F     K+ L+L  VMEY P  + +  + ++    ++ M     + Y  ++   +  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY--ICSRFYRAPELI- 185
           H +  V HRD+KP+N+L+D   H +K+ DFGSA +L A +   S   + +  Y APE++ 
Sbjct: 119 HQMGYV-HRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 186 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
                G   Y    D WS G +  E++ G+  F    +      I+              
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM-------------- 222

Query: 242 NPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
             N+  F +FP+            ++  + +DL   LL      R      C HPFF ++
Sbjct: 223 --NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269

Query: 301 REPNARLPNGRPLPP 315
              N R      LPP
Sbjct: 270 DWNNIR----NSLPP 280

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 25/213 (11%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE----------LQLMRVMDHPNVIS 68
           +G G+FG V+Q +  +T    A+K + +      +E          L    + + P ++ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           LK   FS  + ++L+L  V +Y+   E  + + K    +  R      K Y  ++   L 
Sbjct: 61  LK---FSFQTDSDLYL--VTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           ++H    + +RDLKP+N+L+D   H + +CDFG +K  +      +  C +  Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
                YT  +D WS G ++ E+  G   F  E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 85/350 (24%), Positives = 146/350 (41%), Gaps = 80/350 (22%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 68
           RV+G GS+  V   +  +T    A+K + ++    + ++  ++          +HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  CF  T S+  LF   V+E+V   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 61  LHSCF-QTESR--LFF--VIEFVSGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 110

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           ++H    + +RDLK  N+L+D   H +K+ D+G  K+ I      S  C +  Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII--KVLGTPTR 235
            G  +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I  K +  P  
Sbjct: 169 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP-- 225

Query: 236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-- 293
                        R   +KA    K F  + P E              L C         
Sbjct: 226 -------------RSLSVKASSVLKGFLNKDPKE-------------RLGCHPQTGFRDI 259

Query: 294 --HPFFD----ELREPNARLPNGRPLPP-------LFNFKQELSGASPEL 330
             HPFF     +L E    LP   P  P       L NF  + +    +L
Sbjct: 260 KSHPFFRNIDWDLLEQKQVLP---PYKPNIESDRDLDNFDPQFTDEPVQL 306

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 74.6 bits (183), Expect = 2e-15
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 48/295 (16%)

Query: 13  YMAERVVGTGSFGIVF--QAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDH 63
           Y+ ++ +G GSFG V+  + K     E + + K +        +    N+E QL+  +DH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           P ++     F ++  + + F  ++ EY     +   L+      + +    V  +  Q+ 
Sbjct: 62  PAIVK----FHASFLERDAFC-IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRA 181
            G+ Y+H   R+ HRDLK +N+ +    + +KI DFG ++ L+   +   ++  + +Y +
Sbjct: 117 LGVHYMH-QRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE +     Y +  DIWS GC+L E+      F G+N    L  +++++  PT       
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT------- 222

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            P+  +                     +   +   +L   PSLR +A E   +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 83/299 (27%), Positives = 136/299 (45%), Gaps = 51/299 (17%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 73
           +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR   H NV+ +   +
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEM---Y 83

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            S    +EL++  VME++       +  ++  N+      +      + + L+ +H    
Sbjct: 84  NSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLKALSVLHA-QG 136

Query: 134 VCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT 189
           V HRD+K  ++L   LTH  +VK+ DFG   Q ++ E     S + + ++ APELI    
Sbjct: 137 VIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVGTPYWMAPELI-SRL 191

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y   +DIWS G ++ E++ G+P +  E               P  + ++ +  N     
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP--- 233

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
            P++K    HKV      P       RLL   P+ R TA E   HPF  +   P+  +P
Sbjct: 234 -PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 26/224 (11%)

Query: 17  RVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           +V+G+G+FG V++   +  GE     VAIK + ++   K       E  +M  +DHP+V+
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L     S+       + L+ + +P  +  +L +  +    +   Y+  +  QI +G++Y
Sbjct: 73  RLLGICLSSQ------VQLITQLMP--LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 184
           +    R+ HRDL  +N+LV    H VKI DFG AK L   E        +    + A E 
Sbjct: 125 LEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 185 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 225
           I     YT   D+WS G  + EL+  G   + G  AV+   L+E
Sbjct: 183 IL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 28/228 (12%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 68
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L  CF    +++ LF   V+EYV       L  +    +++P  + + Y+ +I   L Y+
Sbjct: 61  LHSCF---QTESRLFF--VIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEISLALNYL 112

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 187
           H    + +RDLK  N+L+D   H +K+ D+G  K+ L  G+   ++  +  Y APE++ G
Sbjct: 113 HE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 227
             +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 171 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 83/297 (27%), Positives = 137/297 (46%), Gaps = 47/297 (15%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 73
           +G GS GIV  A    TG+ VA+KK +  R+ + REL      +MR   H NV+ +   +
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMRDYHHENVVDM---Y 85

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            S    +EL++  VME++       +  ++  N+      +      + R L+Y+H    
Sbjct: 86  NSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCLSVLRALSYLHN-QG 138

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEY 191
           V HRD+K  ++L+     ++K+ DFG   Q ++ E     S + + ++ APE+I     Y
Sbjct: 139 VIHRDIKSDSILLTS-DGRIKLSDFGFCAQ-VSKEVPKRKSLVGTPYWMAPEVI-SRLPY 195

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
            T +DIWS G ++ E++ G+P +  E               P  + +R +  N      P
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPYFNE---------------PPLQAMRRIRDNLP----P 236

Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           ++K    HKV    +    +DL   +L   PS R TA E   HPF      P+  +P
Sbjct: 237 RVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFLKLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 26/212 (12%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKH------- 71
           +G+G+ G V++ +  +TG  +A+K++   RR  N+E +  R++   +V+   H       
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKE-ENKRILMDLDVVLKSHDCPYIVK 78

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHT 130
           C+    + +++F+   ME +   + ++LK        +P  I  K+ T  I + L Y+  
Sbjct: 79  CYGYFITDSDVFI--CMELMSTCLDKLLKR---IQGPIPEDILGKM-TVAIVKALHYLKE 132

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 189
              V HRD+KP N+L+D  +  VK+CDFG + +L+  +A   S  C+  Y APE I    
Sbjct: 133 KHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA-YMAPERIDPPD 190

Query: 190 ---EYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
              +Y    D+WS G  L EL  GQ  FP +N
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQ--FPYKN 220

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.5 bits (180), Expect = 6e-15
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 21/203 (10%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 74
           VG+G++G V++A+ L TGE  A+K +      D     +E+ +++   H N+++    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 75  STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
           S  S+ +L+  + MEY      + + H +     + + YV   T Q   GLAY+H+  ++
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHSKGKM 128

Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIFGATE--- 190
            HRD+K  N+L+      VK+ DFG A ++ A  A   S+I + ++ APE+   A E   
Sbjct: 129 -HRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 191 -YTTSIDIWSAGCVLAELLLGQP 212
            Y    DIW+ G    EL   QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 73.8 bits (181), Expect = 6e-15
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 46/288 (15%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 66
           ++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+   D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + + + F  T  K    L+L+     +  Y + +H   +   M     + Y  +I  GL 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNG--GDLHYHLSQHGVFSEAEM-----RFYAAEIILGLE 111

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           ++H    V +RDLKP N+L+D   H V+I D G A      + + S + +  Y APE++ 
Sbjct: 112 HMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPG-----ENAVDQLVEIIKV------------ 229
               Y +S D +S GC+L +LL G   F       ++ +D++   + V            
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228

Query: 230 -----LGTPTREEIRCMNPNYTDFR-FPQIKAHPWHKVFHKRMPPEAI 271
                L       + C+     + +  P  ++  W  VF ++ PP  I
Sbjct: 229 LLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLI 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 74.5 bits (183), Expect = 6e-15
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 30/295 (10%)

Query: 22  GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 81
           GS G VF A      + V +K  +  +     E  L++ ++HP+VI +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITC- 133

Query: 82  LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 141
               +V+ +    +Y  L   +  ++ +P+    +   QI  GL Y+H   R+ HRD+K 
Sbjct: 134 ----MVLPHYSSDLYTYL---TKRSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKT 185

Query: 142 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 201
           +N+ ++ +  QV I D G+A+  +   A +    +    APE +    +Y +  DIWSAG
Sbjct: 186 ENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 202 CVLAELLL----------GQPLFPGENAVDQLVEIIKVLGT-----PTREEIRCMNPNYT 246
            VL E+L             P    ++    L++II  L       P     R +   + 
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302

Query: 247 DFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
           ++   + + +  +  F +  +P +   L  ++L +  ++R +A E   +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 75.9 bits (186), Expect = 6e-15
 Identities = 67/252 (26%), Positives = 113/252 (44%), Gaps = 45/252 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNR--ELQLMRVMDHPNV 66
           Y   + +G G FG VF  K   T E    K +    L++R       E+ +MR + H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 67  ISLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           +     F +  ++    L ++ME+     +  ++ +  K +    +      +   T Q+
Sbjct: 75  VRYIDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA----IVDITRQL 127

Query: 122 FRGLAYIHTVP------RVCHRDLKPQNLL-------VDPLTHQV---------KICDFG 159
              LAY H +       RV HRDLKPQN+        +  +T Q          KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 160 SAKQLIAGEANISYIC--SRFYRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 216
            +K +  G  ++++ C  + +Y +PEL+   T+ Y    D+W+ GC++ EL  G+  F  
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 217 ENAVDQLVEIIK 228
            N   QL+  +K
Sbjct: 246 ANNFSQLISELK 257

Length = 1021

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.9 bits (181), Expect = 8e-15
 Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 23/220 (10%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 70
           V+G GSFG V  A+   T E  AIK + +D   ++ +++       ++ +   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           H  F T  +    L  VMEYV   + MY++ +       R    +   Y  +I  GL ++
Sbjct: 67  HSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 117

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
           H+   + +RDLK  N+++D   H +KI DFG  K+ +         C +  Y APE+I  
Sbjct: 118 HS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              Y  S+D W+ G +L E+L GQ  F GE+  D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 32/236 (13%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH--------PNVIS 68
           RV+G GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  CF  TTS+    L LV+EYV   + M+ + +      +++P  + + Y  +I   L 
Sbjct: 61  LHSCF-QTTSR----LFLVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYAAEICIALN 110

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 185
           ++H    + +RDLK  N+L+D   H +K+ D+G  K+ +  G+   ++  +  Y APE++
Sbjct: 111 FLHE-RGIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEIL 168

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF------PGENAVDQLVEIIKVLGTPTR 235
            G  EY  S+D W+ G ++ E++ G+  F      P  N  D L ++I  L  P R
Sbjct: 169 RGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 77/295 (26%), Positives = 138/295 (46%), Gaps = 46/295 (15%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAIK++ LQ +  K     E+ +MR   +PN+++    + 
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 87  V---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALDFLHS-NQ 135

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEYT 192
           V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S  + + ++ APE++     Y 
Sbjct: 136 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYG 193

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +     NP         
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQ-----NP--------- 238

Query: 253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
                      +R+     D  +R L+     R +A E   HPF  +L +P + L
Sbjct: 239 -----------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL-KLAKPLSSL 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 57/296 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F  T  +    L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 61  KYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 110

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C +  Y APE + 
Sbjct: 111 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 167

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 213

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 214 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 63/236 (26%), Positives = 120/236 (50%), Gaps = 20/236 (8%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR   +PN+++    + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 88  V---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALEFLHS-NQ 136

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEYT 192
           V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S  + + ++ APE++     Y 
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAYG 194

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++  + DF
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           ER +G G FG V+      T + VA+K +           +E Q+M+ + H  ++ L   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL--- 66

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHT 130
            ++  S+ E    +V EY+ + S+   LK       R+P L+ +     QI  G+AY+ +
Sbjct: 67  -YAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQIAEGMAYLES 121

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELI-F 186
                HRDL  +N+LV       KI DFG A+ LI  +   +   ++F   + APE   +
Sbjct: 122 R-NYIHRDLAARNILVGE-NLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANY 178

Query: 187 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           G   +T   D+WS G +L E++  G+  +PG
Sbjct: 179 G--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVISLK 70
           +G G FG V   +   TG+  A KK L  +R K +        E +++  ++ P +++L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           + F S T      L LVM  +   +  Y +   Y+   + + +  V  Y+ QI  G+ ++
Sbjct: 60  YAFESKTH-----LCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHL 111

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H++  + +RD+KP+N+L+D      ++ D G A +L  G+       +  Y APE I   
Sbjct: 112 HSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLF 214
             Y+  +D ++ GC + E++ G+  F
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.4 bits (175), Expect = 4e-14
 Identities = 85/317 (26%), Positives = 126/317 (39%), Gaps = 58/317 (18%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVISLK 70
           +G G FG V   +   TG+  A KK+ + R  K +  +        L +V  H   I   
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSRFIVSL 58

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              F T  K +L L + +    +  Y +  +    N   P      YT QI  GL ++H 
Sbjct: 59  AYAFQT--KTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRACFYTAQIISGLEHLHQ 115

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGAT 189
             R+ +RDLKP+N+L+D   + V+I D G A +L  G++    Y  +  + APEL+ G  
Sbjct: 116 -RRIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-E 172

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLF--PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           EY  S+D ++ G  L E++  +  F   GE          KV     ++ I   +  Y D
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDSVTYPD 222

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-------CTALEACAHPFFDEL 300
                            +  P +      LL   P  R       C  L    HP F +L
Sbjct: 223 -----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLR--THPLFRDL 263

Query: 301 REPNARLPNGRPLPPLF 317
              N R      LPP F
Sbjct: 264 ---NWRQLEAGMLPPPF 277

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 61/221 (27%), Positives = 112/221 (50%), Gaps = 24/221 (10%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   +G+  A+K + ++      E+       ++++   HP + SL
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F    +K+ L    VMEYV   E  + + +    +  R      + Y  +I   L Y
Sbjct: 61  KYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +H+  ++ +RDLK +NL++D   H +KI DFG  K+ I   A +   C +  Y APE + 
Sbjct: 111 LHS-GKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCF 73
            VVG G++G V++ + ++TG+  AIK   V +D   +   E+ +++   H   I+  +  
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 74  FSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           F   S   ++  L LVME+        L   +  N  +   ++     +I RGLA++H  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLAHLH-A 139

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF--- 186
            +V HRD+K QN+L+     +VK+ DFG + QL    G  N ++I + ++ APE+I    
Sbjct: 140 HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDE 197

Query: 187 -GATEYTTSIDIWSAGCVLAELLLGQP 212
                Y    DIWS G    E+  G P
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 29/209 (13%)

Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++++R + H N++
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 126
             K      T      + L+ME++P      LK Y   N+ ++ L     Y  QI +G+ 
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPRNKNKINLKQQLKYAVQICKGMD 123

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 179
           Y+ +   V HRDL  +N+LV+   HQVKI DFG  K +   E +  Y   +       F+
Sbjct: 124 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFW 178

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +  +  Y  S D+WS G  L ELL
Sbjct: 179 YAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 39/249 (15%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 73
           +G G+FG V++A+  ETG  +A  KV+  +  +       E+ ++   DHPN++ L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 74  FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +    +N L+  +++E+     V   M  + +  +          +++   Q    L Y+
Sbjct: 72  Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTEPQ-------IRVVCKQTLEALNYL 119

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 187
           H   ++ HRDLK  N+L   L   +K+ DFG SAK     +   S+I + ++ APE++  
Sbjct: 120 HE-NKIIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 188 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 239
            T     Y    D+WS G  L E+   +P     N +  L++I K     L  P+R    
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 233

Query: 240 CMNPNYTDF 248
             +  + DF
Sbjct: 234 -WSSEFKDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.0 bits (171), Expect = 8e-14
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPN 65
           +Y   RVVG GS+G V   +    G+   IKK+       ++R+   +E QL+  + HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           +++ +  +       +  L +VM +     +Y  LK      + +P   V  +  QI   
Sbjct: 61  IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPE 183
           L Y+H    + HRDLK QN+ +   T+ +K+ D G A+ L    +   + I + +Y +PE
Sbjct: 115 LQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172

Query: 184 LIFGATEYTTSIDIWSAGCVLAEL 207
           L F    Y    D+W+ GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 29/219 (13%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVMDHPN---VISL 69
           +V+G G+FG V   +   + +  A+K + +    K  +         +M H N   ++ L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            H  F    +++ +L +VMEY+P      L     +N  +P  + + YT ++   L  IH
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNL----MSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPEL 184
           ++  + HRD+KP N+L+D   H +K+ DFG+  ++   +AN    C        Y +PE+
Sbjct: 160 SMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM---DANGMVRCDTAVGTPDYISPEV 214

Query: 185 IF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
           +    G   Y    D WS G  L E+L+G   F  ++ V
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 28/229 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y+  + +G GSFG     K  E G+   IK++       ++R    +E+ ++  M HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY----VKLYTYQIF 122
           +  +  F    +     L +VM+Y           Y   N +  +++    +  +  QI 
Sbjct: 62  VQYQESFEENGN-----LYIVMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG-EANISYICSRFY 179
             L ++H   ++ HRD+K QN+    LT    +K+ DFG A+ L +  E   + I + +Y
Sbjct: 112 LALKHVHD-RKILHRDIKSQNIF---LTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
            +PE I     Y    DIW+ GCVL E+   +  F   N  + +++II+
Sbjct: 168 LSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPNV 66
           ++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+   D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + + + F  T  K    L+L+     +  Y + +H   + + M     + Y  +I  GL 
Sbjct: 60  VCMTYAF-HTPDKLCFILDLMNG--GDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           ++H    V +RDLKP N+L+D   H V+I D G A      + + S + +  Y APE++ 
Sbjct: 112 HMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
             T Y +S D +S GC+L +LL G   F      D+
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 60/229 (26%), Positives = 112/229 (48%), Gaps = 27/229 (11%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 65
           Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           V+ L + F     +++ +L +VMEY+P   +  ++ +Y      +P  + + YT ++   
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 181
           L  IH++  + HRD+KP N+L+D   H +K+ DFG+  ++   E  +   + + +  Y +
Sbjct: 155 LDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGTPDYIS 211

Query: 182 PELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 61/230 (26%), Positives = 112/230 (48%), Gaps = 29/230 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPN 65
           Y   +V+G G+FG V   +   + +  A+K + +       D  +   E  +M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           V+ L  C F    +++ +L +VMEY+P   +  ++ +Y      +P  + K YT ++   
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 180
           L  IH++  + HRD+KP N+L+D   H +K+ DFG+  ++   E  +    + + +  Y 
Sbjct: 155 LDAIHSMGLI-HRDVKPDNMLLDKHGH-LKLADFGTCMKM--DETGMVRCDTAVGTPDYI 210

Query: 181 APELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 57/248 (22%)

Query: 19  VGTGSFGIVFQAKCLETGE-----TVAIKKVLQDRRYKN-----RELQLMRVM-DHPNVI 67
           +G G+FG V +A+ +         TVA+K +  D   K+      E+++M+++  H N+I
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 68  SLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIYV 114
           +L       T +  L++  V+EY              P   Y          + +    +
Sbjct: 80  NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 115 KLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
             + YQ+ RG+ ++ +  + C HRDL  +N+LV    H +KI DFG A+       +I +
Sbjct: 135 VSFAYQVARGMEFLAS--KKCIHRDLAARNVLVTE-DHVMKIADFGLAR-------DIHH 184

Query: 174 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 220
           I   +YR            APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 185 I--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PV 240

Query: 221 DQLVEIIK 228
           ++L +++K
Sbjct: 241 EELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 74/284 (26%), Positives = 116/284 (40%), Gaps = 46/284 (16%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 73
           +G GSFG VF+     T + VAIK + L++   +     +E+ ++   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
              T      L ++MEY+       L      ++      +K    +I +GL Y+H+  +
Sbjct: 72  LKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 122

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYT 192
           + HRD+K  N+L+      VK+ DFG A QL   +    +++ + F+ APE+I   + Y 
Sbjct: 123 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 179

Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
           +  DIWS G    EL  G+P                    P  +    M+P    F  P+
Sbjct: 180 SKADIWSLGITAIELAKGEP--------------------PNSD----MHPMRVLFLIPK 215

Query: 253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                    F K       +     L   PS R TA E   H F
Sbjct: 216 NNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 23/207 (11%)

Query: 17  RVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYKNR-------ELQLMRVMDHPNVIS 68
           R +GTGSFG V  A    E    VAIK+  + +  K +       E +++  ++HP  ++
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   F     K+E +L LV+E+V    +     +   N+R P      Y  QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
            ++  + +RDLKP+NLL+D     +K+ DFG AK +   +     +C +  Y APE++  
Sbjct: 148 QSL-NIVYRDLKPENLLLDK-DGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF 214
              +  + D W+ G  + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 79/324 (24%), Positives = 130/324 (40%), Gaps = 79/324 (24%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHPNVISL 69
           +++G G  G VF  +   TG+  A+K    K +  R    R   E +++  +DHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F + T     +L LVM+Y P   ++R+L+      + +     + Y  ++   L Y+
Sbjct: 67  YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL------------------------ 164
           H +  V +RDLKP+N+L+    H + + DF  +KQ                         
Sbjct: 120 HLLGIV-YRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177

Query: 165 ------IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
                      + S++ +  Y APE+I G   + +++D W+ G +L E+L G   F G N
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 219 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 278
             +    I+K                  +  FP              +   A DL  +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269

Query: 279 QYSPSLRC----TALEACAHPFFD 298
              PS R      A E   HPFF 
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 1e-12
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 32/215 (14%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKK-----VLQDRRYKNRELQLMRVMDHPNVISLKH 71
             +G G+FG V++   L+    VA+K          +R   +E ++++  DHPN++ L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
                  K  +++  VME VP      L        R+ +  +   +     G+ Y+ + 
Sbjct: 58  -IGVCVQKQPIYI--VMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES- 111

Query: 132 PRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------APE 183
            + C HRDL  +N LV    + +KI DFG +++    E    Y  S   +       APE
Sbjct: 112 -KNCIHRDLAARNCLVG-ENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPE 165

Query: 184 -LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            L +G   YT+  D+WS G +L E   LG   +PG
Sbjct: 166 ALNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)

Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 3   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62

Query: 58  MRVMDHPNVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVK 115
           M  +D+P+V  L   C  ST       + L+ + +P   +  L  Y   ++  +   Y+ 
Sbjct: 63  MASVDNPHVCRLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLL 112

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
            +  QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E       
Sbjct: 113 NWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEG 170

Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
            +    + A E I     YT   D+WS G  + EL+
Sbjct: 171 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 24/203 (11%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 73
           +G GSFG VF+     T + VAIK + L++   +     +E+ ++   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 130
              T      L ++MEY+   S   +L       +  PL   ++ T   +I +GL Y+H+
Sbjct: 72  LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 119

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGAT 189
             ++ HRD+K  N+L+     +VK+ DFG A QL   +   + ++ + F+ APE+I   +
Sbjct: 120 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQS 176

Query: 190 EYTTSIDIWSAGCVLAELLLGQP 212
            Y +  DIWS G    EL  G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.5 bits (159), Expect = 4e-12
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 28/205 (13%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYK----NRELQLMRVMDHPNVISLKHCF 73
           +G GSFG V++     T E VAIK + L++   +     +E+ ++   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 74  FSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPL--IYVKLYTYQIFRGLAYIHT 130
              T      L ++MEY+   S   +LK         PL   Y+     +I +GL Y+H+
Sbjct: 72  LKGTK-----LWIIMEYLGGGSALDLLK-------PGPLEETYIATILREILKGLDYLHS 119

Query: 131 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFG 187
             R  HRD+K  N+L   L+ Q  VK+ DFG A QL   +    +++ + F+ APE+I  
Sbjct: 120 -ERKIHRDIKAANVL---LSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-K 174

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQP 212
            + Y    DIWS G    EL  G+P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 73
           +G G++G VF+    + G   A+K +L      + E++     L  + DHPNV+     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 74  FSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +    KN   L LV+E     S+  ++K +    +RM    +    ++   GL ++H V 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-VN 143

Query: 133 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAG--EANISYICSRFYRAPELIFGA 188
           +  HRD+K  N+L   LT +  VK+ DFG + QL +     N S + + F+ APE+I   
Sbjct: 144 KTIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACE 199

Query: 189 ----TEYTTSIDIWSAGCVLAELLLGQP 212
               + Y    D+WS G    EL  G P
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 31/225 (13%)

Query: 19  VGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLK 70
           +G GSFG+V + +   +G     VA+K +  D+         +E  +M  +DH N+I L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 71  HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
               +          +V E  P  S+   L+    A     +  +  Y  QI  G+ Y+ 
Sbjct: 63  GVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLE 114

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------AP 182
           +  R  HRDL  +N+L+     +VKI DFG  + L   E +  Y+    +        AP
Sbjct: 115 S-KRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YV-MEEHLKVPFAWCAP 169

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 226
           E +   T ++ + D+W  G  L E+   G+  + G +    L +I
Sbjct: 170 ESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 65/326 (19%), Positives = 107/326 (32%), Gaps = 52/326 (15%)

Query: 17  RVVGTGSFG--IVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVIS 68
            ++G       IV  AK   T   VA+KK+  D   K        E+   R + HPN++ 
Sbjct: 4   TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVL--KHYSSANQRMPLIYVKLYTYQIFRGLA 126
               F      +EL++  V   +       L   H+      +P + +      +   L 
Sbjct: 64  YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALD 115

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 185
           YIH+   + HR +K  ++L+     +V +     +  +I  G+               L 
Sbjct: 116 YIHSKGFI-HRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 186 FGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP---- 233
           + + E        Y    DI+S G    EL  G   F    A   L+E  KV GT     
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231

Query: 234 ----------TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 283
                     +  + R  N +                 + +             LQ  P 
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPN-------NRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284

Query: 284 LRCTALEACAHPFFDELREPNARLPN 309
            R +A +   H FF + +  N  L +
Sbjct: 285 SRPSASQLLNHSFFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 19/208 (9%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCFF 74
           +VG G++G V++ + ++TG+  AIK   V  D   +  +E+ +++   H   I+  +  F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 75  STTSKNELFLN----LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
               KN   ++    LVME+        L   +  N  +   ++     +I RGL+++H 
Sbjct: 73  --IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 129

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF-- 186
             +V HRD+K QN+L+     +VK+ DFG + QL    G  N ++I + ++ APE+I   
Sbjct: 130 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 186

Query: 187 --GATEYTTSIDIWSAGCVLAELLLGQP 212
                 Y    D+WS G    E+  G P
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 30/218 (13%)

Query: 17  RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLMRVM-DHPN 65
           + +G G+FG V +A      ++     VA+K +        R     EL++M  + +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 123
           +++L     + T    + +  + EY     Y  L ++    +   L    L  ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152

Query: 124 GLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 179
           G+A++ +  + C HRDL  +N+L+      VKICDFG A+ ++     +    +R    +
Sbjct: 153 GMAFLAS--KNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 210 MAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 20/222 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKHCF 73
           +G G++G V++    + G   A+K +L      + E++     L  + +HPNV+     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +         L LV+E     S+  ++K      QR+    +    Y    GL ++H   
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-N 147

Query: 133 RVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA 188
           R+ HRD+K  N+L   LT +  VK+ DFG + QL +     N S + + F+ APE+I   
Sbjct: 148 RIIHRDVKGNNIL---LTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAPEVIACE 203

Query: 189 TEYTTS----IDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
            +Y  S     D+WS G    EL  G P     + V  L +I
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 18/222 (8%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 76
           +V+G G+FG V   K   T    A+K + +    K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 77  T----SKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           T     ++E +L LVM+Y V   +  +L  +     R+P    + Y  ++   +  IH +
Sbjct: 65  TLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL 121

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSA-KQLIAGEANISY-ICSRFYRAPELIF--- 186
               HRD+KP N+L+D   H +++ DFGS  K    G    S  + +  Y +PE++    
Sbjct: 122 -HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 187 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
            G  +Y    D WS G  + E+L G+  F  E+ V+   +I+
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 32/200 (16%)

Query: 22  GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE 81
           G+ G  F     +T E V IK     R     E  ++R ++HP++I LK  F  T +K  
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK-- 156

Query: 82  LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 141
            F  L++      +Y     Y +A + + +  +      + R + Y+H   R+ HRD+K 
Sbjct: 157 -FTCLILPRYKTDLY----CYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKA 210

Query: 142 QNLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFY--------RAPELIFGATEY 191
           +N+ ++   H   +C  DFG+A   +   AN      ++Y         APEL+     Y
Sbjct: 211 ENIFIN---HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPY 260

Query: 192 TTSIDIWSAGCVLAELLLGQ 211
             ++DIWSAG VL E+    
Sbjct: 261 GPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 33/219 (15%)

Query: 17  RVVGTGSFGIVFQAK-CLETGE--TVAIKKVLQDRRYKNREL-----QLMRVMDHPNVIS 68
           R +G G FG V+Q        E   VA+K          RE       +MR  DHP+++ 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAY 127
           L        ++N ++  +VME  P      L+ Y   N+  + L  + LY+YQ+   LAY
Sbjct: 72  L----IGVITENPVW--IVMELAP---LGELRSYLQVNKYSLDLASLILYSYQLSTALAY 122

Query: 128 IHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 181
           + +  R  HRD+  +N+LV  P    VK+ DFG ++ L   E    Y  S+      + A
Sbjct: 123 LESK-RFVHRDIAARNVLVSSP--DCVKLGDFGLSRYL---EDESYYKASKGKLPIKWMA 176

Query: 182 PELIFGATEYTTSIDIWSAG-CVLAELLLG-QPLFPGEN 218
           PE I     +T++ D+W  G C+   L+LG +P    +N
Sbjct: 177 PESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 32/214 (14%)

Query: 16  ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVIS 68
           ERV  +G+G+ G V++     TG   A+K +  +     RR   RE++++R ++HPNV+ 
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             H  F    + ++ L  +     E  +   + + +   R           QI  G+AY+
Sbjct: 137 C-HDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR-----------QILSGIAYL 184

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELI- 185
           H    + HRD+KP NLL++     VKI DFG ++ L       N S + +  Y +PE I 
Sbjct: 185 HR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCN-SSVGTIAYMSPERIN 241

Query: 186 ----FGATEYTTSIDIWSAGCVLAELLLGQPLFP 215
                GA +     DIWS G  + E  LG+  FP
Sbjct: 242 TDLNHGAYDGYAG-DIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VM---DHPNVISL 69
           +V+G G+FG V   K   TG+  A+K + +    K  E    R    V+   D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 70  KHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
            + F     ++E  L LVM+Y V   +  +L   S    R+P    + Y  ++   +  +
Sbjct: 67  HYAF-----QDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANIS-----YICSRFYR 180
           H +  V HRD+KP N+L+D   H +++ DFGS  +L+A    ++N++     YI     +
Sbjct: 119 HQLGYV-HRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 221
           A E   G   Y    D WS G  + E+L G+  F  E+ V+
Sbjct: 177 AME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 49/238 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNV 66
           + +G G FG V +A            TVA+K + +     + R    E  L++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 116
           I L    +   S++   L L++EY   + Y  L+ +   ++++   Y+            
Sbjct: 66  IKL----YGACSQDGPLL-LIVEY---AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 117 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 162
                         + +QI RG+ Y+  +  V HRDL  +N+LV     ++KI DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLV-HRDLAARNVLVAE-GRKMKISDFGLSR 175

Query: 163 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            +   ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.2 bits (153), Expect = 3e-11
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 25/220 (11%)

Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------L 57
           IL+       +V+G+G+FG V++   +  GETV I    K+L +       ++      +
Sbjct: 3   ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62

Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  MDHP+++ L     S T      + LV + +P        H    N    L+    +
Sbjct: 63  MASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN--W 114

Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG A+ L   E   +    +
Sbjct: 115 CVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGK 172

Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQP 212
               + A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 173 MPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 4e-11
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 18/166 (10%)

Query: 117 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
           Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ +      +    
Sbjct: 184 YSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 240

Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 231
           +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 241 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 292

Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
              +E  R   P+YT     Q     WH    +R  P   +L   L
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 17/169 (10%)

Query: 117 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
           Y++Q+ RG+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ +      +    
Sbjct: 179 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGS 235

Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 231
           +R    + APE IF    YTT  D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 236 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFC 287

Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP-PEAIDLASRLLQ 279
              ++  R   P        +I    W     +R      +++   LLQ
Sbjct: 288 QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 61.7 bits (150), Expect = 7e-11
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR----ELQLMRVMDHPNVISLKH 71
           ER +G+G FG V++         VAIK +  D   K +    E+Q ++ + H ++ISL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 129
             F+  S  E    ++ E + + S+   L+        +  LI +     Q+  G+AY+ 
Sbjct: 68  --FAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDM---ACQVAEGMAYLE 121

Query: 130 TVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQL-----IAGEANISYICSRFYRAPE 183
                 HRDL  +N+LV + L    K+ DFG A+ +     ++ +  I Y     + APE
Sbjct: 122 E-QNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYK----WTAPE 174

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN---AVDQLVE 225
                  ++T  D+WS G +L E+   GQ  +PG N     DQ+  
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 66/235 (28%), Positives = 101/235 (42%), Gaps = 55/235 (23%)

Query: 16  ERVVGTGSFGIVFQ--AKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
            R +G GSFG+V++  AK +  GE    VAIK V     +++R     E  +M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--------SSANQRMPLIYVKLY 117
           V+ L        S  +  L +VME + +     LK Y         +     P    K  
Sbjct: 71  VVRL----LGVVSTGQPTL-VVMELMAKGD---LKSYLRSRRPEAENNPGLGPPTLQKFI 122

Query: 118 TY--QIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYI 174
               +I  G+AY+    +  HRDL  +N +V + LT  VKI DFG  +       +I   
Sbjct: 123 QMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDLT--VKIGDFGMTR-------DIYE- 171

Query: 175 CSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            + +YR            APE +     +TT  D+WS G VL E+  L +  + G
Sbjct: 172 -TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQG 224

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 60.6 bits (148), Expect = 1e-10
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 35/220 (15%)

Query: 56  QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYV 114
           QLM+  D+PN I L   ++S T+     L  +M+Y+ +  ++ +LK       ++    V
Sbjct: 63  QLMK--DNPNFIKL---YYSVTTLKGHVL--IMDYIKDGDLFDLLKK----EGKLSEAEV 111

Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 174
           K    Q+   L  +H    + H D+K +N+L D    ++ +CD+G  K  I G     Y 
Sbjct: 112 KKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIG-TPSCYD 167

Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI-------- 226
            +  Y +PE I G   Y  S D W+ G +  ELL G+   P +   D+ +++        
Sbjct: 168 GTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDEDEELDLESLLKRQQ 224

Query: 227 -----IKVLGTPTREEIRCM---NPNYTDFRFPQIKAHPW 258
                IK +     + ++ M   N NY    + +I  HP+
Sbjct: 225 KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264

Length = 267

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 69/266 (25%), Positives = 100/266 (37%), Gaps = 63/266 (23%)

Query: 8   LQTISYMAERVVGTGSFGIVFQAKC--LETGET---VAIKKVLQD------RRYKNRELQ 56
             TI     R +G G+FG VF  +C  LE       VA+ K L++      R+   RE +
Sbjct: 4   RDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREAE 60

Query: 57  LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-----------MYRVLKHYSSA 105
           L+    H N++                  +V EY+                  LK   S 
Sbjct: 61  LLTNFQHENIVKFYGVCTEGDP-----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115

Query: 106 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQL 164
              + L  +     QI  G+ Y+       HRDL  +N LV   L   VKI DFG ++ +
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYL-ASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDV 172

Query: 165 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELLL--G 210
                   Y    +YR             PE I     +TT  D+WS G VL E+     
Sbjct: 173 --------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222

Query: 211 QPLFPGENAVDQLVEIIK---VLGTP 233
           QP +   N  ++++E I    +L  P
Sbjct: 223 QPWYGLSN--EEVIECITQGRLLQRP 246

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 54/281 (19%)

Query: 19  VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 65
           +G G FG V  A+ L       +   TVA+K +  D   K+      E+++M+++  H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 114
           +I+L     + T    L++  ++EY  +   R            YS    R+P   + + 
Sbjct: 83  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137

Query: 115 KLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            L   TYQ+ RG+ Y+ +  +  HRDL  +N+LV    + +KI DFG A+ +     NI 
Sbjct: 138 DLVSCTYQVARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDV----NNID 191

Query: 173 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 224
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249

Query: 225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 265
           +++K  G    +   C N  Y   R        WH +   R
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHR 283

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 72/278 (25%), Positives = 113/278 (40%), Gaps = 46/278 (16%)

Query: 34  ETGETVAIKKVLQD-----RRYK--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL 86
            TG  VAIK +  D      +     RE  L   + HPN+++L      +       L  
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFA 56

Query: 87  VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 146
           V EYVP    R L+   +A+  +P         Q+   LA  H    + HRDLKPQN++V
Sbjct: 57  VFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHN-QGIVHRDLKPQNIMV 112

Query: 147 DP--LTHQVKICDFGSAKQLI-AGEANIS-------YICSRFYRAPELIFGATEYTTSID 196
               +    K+ DFG    L    +A+++        + +  Y APE + G    T + D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSD 171

Query: 197 IWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ-IKA 255
           +++ G +  E L GQ +  G +    + EI+           + ++P   D   P  I  
Sbjct: 172 LYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--DVSLPPWIAG 215

Query: 256 HPWHKVFHKRM---PPEAIDLASRLLQYSPSLRCTALE 290
           HP  +V  K +   P +    A  L +   +L   AL 
Sbjct: 216 HPLGQVLRKALNKDPRQRAASAPALAERFRALELCALV 253

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 48/148 (32%), Positives = 71/148 (47%), Gaps = 16/148 (10%)

Query: 117 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
           Y++Q+ RG+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ +      +    
Sbjct: 178 YSFQVARGMEFLAS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGD 234

Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 231
           +R    + APE IF    YTT  D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 235 ARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFC 286

Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWH 259
              +E  R   P Y       I    WH
Sbjct: 287 RRLKEGTRMRAPEYATPEIYSIMLDCWH 314

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 27/216 (12%)

Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRY--KNREL----QL 57
           IL+       +V+G+G+FG V++   +  GE V I    KVL++      N+E+     +
Sbjct: 3   ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 62

Query: 58  MRVMDHPNVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVK 115
           M  +  P V  L   C  ST       + LV + +P   Y  L  Y   N+ R+    + 
Sbjct: 63  MAGVGSPYVCRLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLL 112

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
            +  QI +G++Y+  V R+ HRDL  +N+LV    H VKI DFG A+ L   E       
Sbjct: 113 NWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADG 170

Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
            +    + A E I     +T   D+WS G  + EL+
Sbjct: 171 GKVPIKWMALESIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 64/238 (26%), Positives = 97/238 (40%), Gaps = 58/238 (24%)

Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIK--------KVLQDRRYKNR 53
            L  + ++ E  +G G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 54  ELQLMRVMDHPNVISL--------KHC-FFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 104
           E +LM  + HPN++ L          C  F   +  +L   LV    P S   V      
Sbjct: 58  EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHS--DVGAESGD 114

Query: 105 ANQRMPLIYVKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 162
              +  L          QI  G+ Y+ +     HRDL  +N LV      VKI DFG ++
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGE-GLTVKISDFGLSR 172

Query: 163 QLIAGEANISYICSRFYR------------APELI-FGATEYTTSIDIWSAGCVLAEL 207
            + + +         +YR             PE I +G  ++TT  DIWS G VL E+
Sbjct: 173 DIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 29/219 (13%)

Query: 13  YMAERVVGTGSFGIVFQA-KCLETGETVAIKKV-LQDRR---YKNRELQLMRVMDHPNVI 67
           Y+   +VG       F A +  +  E V  K V L D R   Y   EL  +   DH  ++
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 68  SLKHCFFSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPL--IYVKLYTYQ 120
             KH F    S ++L L  +MEY     + + + + LK      + +P     V L  YQ
Sbjct: 129 --KH-FDDFKSDDKLLL--IMEYGSGGDLNKQIKQRLK------EHLPFQEYEVGLLFYQ 177

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSR 177
           I   L  +H+  ++ HRDLK  N+ + P T  +K+ DFG +KQ    ++ +   S+  + 
Sbjct: 178 IVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTP 235

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 216
           +Y APEL +    Y+   D+WS G +L ELL     F G
Sbjct: 236 YYLAPEL-WERKRYSKKADMWSLGVILYELLTLHRPFKG 273

Length = 478

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 58/282 (20%)

Query: 17  RVVGTGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDRRYKNRELQLMRVMDHPN 65
             +G+G+FG V++    +     +G   VA+K        Q+++   +E  LM   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVK---LYTYQI 121
           ++ L                ++ME +    +   L+         PL+ +K        +
Sbjct: 61  IVKLLGVCLLNEP-----QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----VKICDFGSAKQLIAGEANISYICSR 177
            +G  Y+  +    HRDL  +N LV    +     VKI DFG A+ +           S 
Sbjct: 116 AKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------SD 165

Query: 178 FYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQL 223
           +YR            APE L+ G   +TT  D+WS G ++ E+L LGQ  +P  N  + L
Sbjct: 166 YYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223

Query: 224 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 265
             +            R   P     +  Q+  + W +   +R
Sbjct: 224 QHV--------TAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 33/219 (15%)

Query: 8   LQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN------RELQL 57
           LQ I+      +G G FG VF AK      E GET+ + K LQ  + +N      REL +
Sbjct: 7   LQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIY 113
            R + H NV+ L         + E    +++EY      +   R  K      +  PL  
Sbjct: 62  FRKLSHKNVVRL----LGLCREAEPHY-MILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 114 VKLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--- 168
            +      QI  G+ ++    R  HRDL  +N LV     +VK+     +K +   E   
Sbjct: 117 KQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSS-QREVKVSLLSLSKDVYNSEYYK 174

Query: 169 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
              + I  R + APE +    +++T  D+WS G ++ E+
Sbjct: 175 LRNALIPLR-WLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 72/284 (25%), Positives = 125/284 (44%), Gaps = 47/284 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRVMDHPNVIS 68
           RV+G G FG V+    +++       A+K +     L++     +E  +M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFRG 124
           L      +         LV+  +P   +  L+++  +    P    LI   L   Q+ +G
Sbjct: 61  LLGICLPSEG-----SPLVV--LPYMKHGDLRNFIRSETHNPTVKDLIGFGL---QVAKG 110

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y+ +  +  HRDL  +N ++D  +  VK+ DFG A+ +   E    Y     +   +L
Sbjct: 111 MEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKE----YYSVHNHTGAKL 164

Query: 185 --IFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 235
              + A E      +TT  D+WS G +L EL+  G P +P  ++ D  V +++  G    
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLL 222

Query: 236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 279
           +   C +P Y      ++    WH     R  P   +L SR+ Q
Sbjct: 223 QPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 24/225 (10%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 68
           +V+G G+FG V   K L+  + V   K+L       R        E  ++   D+  + +
Sbjct: 7   KVIGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITT 65

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L + F     +N L+L  VM+Y       +L   S    R+P    + Y  ++   +  +
Sbjct: 66  LHYAF---QDENNLYL--VMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIF 186
           H +  V HRD+KP N+L+D +   +++ DFGS  +L+      S +   +  Y +PE++ 
Sbjct: 119 HQLHYV-HRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 187 ----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
               G  +Y    D WS G  + E+L G+  F  E+ V+   +I+
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 31/209 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 67
           E+V+G G FG V + +    G+    VAIK +      + R     E  +M   DHPN+I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L+       +K+   + ++ EY+   S+ + L+      +      V +    I  G+ 
Sbjct: 69  RLE----GVVTKSRPVM-IITEYMENGSLDKFLRENDG--KFTVGQLVGM-LRGIASGMK 120

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQV-KICDFGSAKQLIAGEANISY------ICSRFY 179
           Y+  +  V HRDL  +N+LV+  ++ V K+ DFG +++L   ++  +Y      I  R +
Sbjct: 121 YLSEMNYV-HRDLAARNILVN--SNLVCKVSDFGLSRRL--EDSEATYTTKGGKIPIR-W 174

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE I    ++T++ D+WS G V+ E++
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 36/236 (15%)

Query: 17  RVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           + +G G FG V+            K L+ G T++++  L+       E  LM+ + H  +
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLE-------EANLMKTLQHDKL 63

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           + L    ++  +K E  + ++ EY+ + S+   LK  S    ++ L  +  ++ QI  G+
Sbjct: 64  VRL----YAVVTKEEP-IYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGM 116

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 182
           AYI     + HRDL+  N+LV       KI DFG A+ +I      +   ++F   + AP
Sbjct: 117 AYIERKNYI-HRDLRAANVLVSESL-MCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 173

Query: 183 ELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 236
           E I FG+  +T   D+WS G +L E++  G+  +PG +  D +  + +    P  E
Sbjct: 174 EAINFGS--FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 42/107 (39%), Positives = 58/107 (54%), Gaps = 13/107 (12%)

Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
           +TYQ+ RG+ ++ +     HRDL  +N+L   L     VKICDFG A+  I  ++N    
Sbjct: 242 FTYQVARGMEFLAS-KNCVHRDLAARNVL---LAQGKIVKICDFGLARD-IMHDSNYVSK 296

Query: 175 CSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            S F    + APE IF    YTT  D+WS G +L E+  LG   +PG
Sbjct: 297 GSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 16/219 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y   RV+G+G+ G V  AK +  GE  A+K V        D+     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 67  ISLKHCFFSTTSKNE---LFLNLVMEYVPESMYRV-LKHYSSANQRMPLIYVKLYTYQIF 122
           +     F     +N    L + LV++Y      R  +K  +  N+        L   Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFY 179
             + ++H+   + HRD+K  N+L+      VK+ DFG +K     ++ +   ++  + +Y
Sbjct: 154 LAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
            APE I+    Y+   D++S G +L ELL  +  F GEN
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 70/315 (22%)

Query: 19  VGTGSFGIVFQAKCL-------ETGETVAIKKVLQDRRYKN-----RELQLMRVMD-HPN 65
           +G G FG V +A+         +   TVA+K +  +   K+      E++LM+++  H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 114
           +I+L       T +  L++  ++EY  +   R            Y+    ++P   L + 
Sbjct: 80  IINL---LGVCTQEGPLYV--IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 115 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            L +  YQ+ RG+ Y+ +  R  HRDL  +N+LV    + +KI DFG A+    G  +I 
Sbjct: 135 DLVSCAYQVARGMEYLES-RRCIHRDLAARNVLVTE-DNVMKIADFGLAR----GVHDID 188

Query: 173 YICSRF-------YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 224
           Y            + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L 
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEELF 246

Query: 225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR----------------MPP 268
           +++       RE  R   P+        +    WH V  +R                +  
Sbjct: 247 KLL-------REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299

Query: 269 EAIDLASRLLQYSPS 283
           E +DL+    QYSPS
Sbjct: 300 EYLDLSMPFEQYSPS 314

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 30/219 (13%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
            R +G G+FG VFQA+       E    VA+K +        +    RE  LM   DHPN
Sbjct: 10  VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 66  VISL--------KHC----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY 113
           ++ L          C    + +    NE   +          +            +PL  
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 114 VKLY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--- 168
            +      Q+  G+AY+     V HRDL  +N LV      VKI DFG ++ + + +   
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYK 187

Query: 169 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
           A+ +      +  PE IF    YTT  D+W+ G VL E+
Sbjct: 188 ASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 37/217 (17%)

Query: 16  ERVVGTGSFGIVFQA----------KCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN 65
           E+ +G G FG V+ A          K ++ G +++++  L        E  +M+ + H  
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLA-------EANVMKTLQHDK 62

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++ L     +  +K  +++  + E++ + S+   LK  S    + PL  +  ++ QI  G
Sbjct: 63  LVKLH----AVVTKEPIYI--ITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEG 114

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRA 181
           +A+I     + HRDL+  N+LV       KI DFG A+ +I      +   ++F   + A
Sbjct: 115 MAFIEQRNYI-HRDLRAANILVSASL-VCKIADFGLAR-VIEDNEYTAREGAKFPIKWTA 171

Query: 182 PELI-FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           PE I FG+  +T   D+WS G +L E++  G+  +PG
Sbjct: 172 PEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 84/316 (26%), Positives = 134/316 (42%), Gaps = 71/316 (22%)

Query: 19  VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 65
           +G G FG V  A+ +   +       TVA+K +  D   K+      E+++M+++  H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVL--------KHYSSANQRMP---LIYV 114
           +I+L     + T    L++  ++EY  +   R            YS    ++P   L + 
Sbjct: 80  IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 115 KLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            L +  YQ+ RG+ Y+ +  +  HRDL  +N+LV    + +KI DFG A+ +     NI 
Sbjct: 135 DLVSCAYQVARGMEYLAS-QKCIHRDLAARNVLVTE-DNVMKIADFGLARDV----HNID 188

Query: 173 Y----ICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLV 224
           Y       R    + APE +F    YT   D+WS G +L E+  LG   +PG   V++L 
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELF 246

Query: 225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-----------------MP 267
           +++K       E  R   P         I    WH V  +R                   
Sbjct: 247 KLLK-------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299

Query: 268 PEAIDLASRLLQYSPS 283
            E +DL+    QYSP 
Sbjct: 300 DEYLDLSVPFEQYSPG 315

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 61/240 (25%), Positives = 102/240 (42%), Gaps = 36/240 (15%)

Query: 22  GSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           GS G VF   C + G+      I K +   +   RE+ +++ + H  +I+L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 79  KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD 138
           + +  + +VM      ++     Y   +  +PL        ++   LAY+H    + HRD
Sbjct: 156 RWKSTVCMVMPKYKCDLFT----YVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRD 210

Query: 139 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPELIFGATEYTT 193
           +K +N+ +D   + V + DFG+A +L       +  C  +       +PEL+     Y  
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266

Query: 194 SIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
             DIWSAG VL E+ +    LF  +          K   +  R  IRCM  +     FPQ
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQV---------KSSSSQLRSIIRCMQVH--PLEFPQ 315

Length = 392

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 67
           E V+G G FG V + +    G+    VAIK +      + RR    E  +M   DHPN+I
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 68  SLKHCFFSTTSKNELFLNLVMEY-VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L+     T S+  + +   ME    +S  R        + +  +I +      I  G+ 
Sbjct: 69  HLEGVV--TKSRPVMIITEFMENGALDSFLRQ------NDGQFTVIQLVGMLRGIAAGMK 120

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FYR 180
           Y+  +  V HRDL  +N+LV+      K+ DFG ++ L    ++ +Y  S        + 
Sbjct: 121 YLSEMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELL 208
           APE I    ++T++ D+WS G V+ E++
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 47/151 (31%), Positives = 70/151 (46%), Gaps = 24/151 (15%)

Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
           ++YQ+ +G++++       HRDL  +N+L   LTH    KICDFG A+  I  ++N  Y+
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNIL---LTHGRITKICDFGLARD-IRNDSN--YV 271

Query: 175 CSRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEII 227
                R      APE IF    YT   D+WS G +L E+  LG   +PG     +  ++I
Sbjct: 272 VKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330

Query: 228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPW 258
           K       E  R ++P         I    W
Sbjct: 331 K-------EGYRMLSPECAPSEMYDIMKSCW 354

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHC 72
           ++G G+FG VF+   L+    VA+K   +D  +  K + L   R++   DHPN++ L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
               T +  ++  +VME VP   +  L         +    +  +      G+AY+ +  
Sbjct: 58  IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-K 112

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPE-LIFGA 188
              HRDL  +N LV    + +KI DFG ++Q    I   + +  I  + + APE L +G 
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYG- 169

Query: 189 TEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             Y++  D+WS G +L E   LG   +PG
Sbjct: 170 -RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 26/197 (13%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPNVISLKHCFFS 75
           +G G FG V        G+ VA+K +  D         E  +M  + HPN++ L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQL--LGVV 69

Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                   L +V EY+ +     L  Y  S     + L     +   +  G+ Y+     
Sbjct: 70  LQGNP---LYIVTEYMAKG---SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KN 122

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 190
             HRDL  +N+LV       K+ DFG AK     EA+      +    + APE +    +
Sbjct: 123 FVHRDLAARNVLVSE-DLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKK 175

Query: 191 YTTSIDIWSAGCVLAEL 207
           ++T  D+WS G +L E+
Sbjct: 176 FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 17  RVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           R +G G FG V++   L    T VA+K +            E Q+M+ + HP +I L   
Sbjct: 12  RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66

Query: 73  FFSTTSKNE--LFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIH 129
            ++  +  E    +  +M+Y   S+   L+  +    ++P LI +     Q+  G+AY+ 
Sbjct: 67  -YAVCTLEEPIYIVTELMKY--GSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLE 120

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIF 186
               + HRDL  +N+LV    +  K+ DFG A+ +       +   ++F   + APE   
Sbjct: 121 AQNYI-HRDLAARNVLVGE-NNICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAAL 177

Query: 187 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
               ++   D+WS G +L E++  G+  +PG
Sbjct: 178 -YNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 36/108 (33%), Positives = 58/108 (53%), Gaps = 15/108 (13%)

Query: 117 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
           ++ Q+ +G+ ++ +  + C HRD+  +N+L+       KICDFG A+  I  ++N  Y+ 
Sbjct: 217 FSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDG-RVAKICDFGLARD-IMNDSN--YVV 270

Query: 176 SRFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
               R      APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 271 KGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
            + +G G FG V+          VAIK + Q          E  LM+ + HP ++ L   
Sbjct: 11  VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--- 66

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            ++  ++  +++  + EY+   S+   LK  +    ++ +  +     QI  G+A+I   
Sbjct: 67  -YAVVTQEPIYI--ITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERK 121

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELI-FG 187
             + HRDL+  N+LV       KI DFG A+ LI      +   ++F   + APE I +G
Sbjct: 122 NYI-HRDLRAANILVSETLC-CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              +T   D+WS G +L E++  G+  +PG
Sbjct: 179 T--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 58/246 (23%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 69
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R         D   V+ +
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
              F+S   K  L+L  +ME++P  + M  ++K  + + +       + Y  +    +  
Sbjct: 67  ---FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDA 116

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG---------------------------- 159
           IH +  + HRD+KP NLL+D   H VK+ DFG                            
Sbjct: 117 IHQLGFI-HRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 160 ---SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 211
              S ++    + N      S + +  Y APE +F  T Y    D WS G ++ E+L+G 
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 212 PLFPGE 217
           P F  E
Sbjct: 234 PPFCSE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 52/243 (21%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VMDHPNVISLKHC 72
           +V+G G+FG V   +  +TG   A+K + +    +  ++  +R    ++   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 73  FFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           F+S   K  L+L  +ME++P  + M  ++K  +   +       + Y  +    +  IH 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFG------------------------------- 159
           +  + HRD+KP NLL+D   H VK+ DFG                               
Sbjct: 120 LGFI-HRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 160 SAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 214
           S ++    + N      S + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 215 PGE 217
             E
Sbjct: 237 CSE 239

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 50/206 (24%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 75
           +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 69

Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
             ++   F  ++ E++      +L +    N Q +  + +     QI   + Y+     +
Sbjct: 70  VCTREPPFY-IITEFMTYG--NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126

Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 191
            HRDL  +N LV    H VK+ DFG ++ L+ G+   ++  ++F   + APE +    ++
Sbjct: 127 -HRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNKF 182

Query: 192 TTSIDIWSAGCVLAEL-LLGQPLFPG 216
           +   D+W+ G +L E+   G   +PG
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 27/226 (11%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKN---RELQLMRVMDHPNVI 67
           S    + +G G FG V+       G T VA+K +            E Q+M+ + H  ++
Sbjct: 7   SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L    ++  S+  +++  V EY+ + S+   LK       ++P + V +   Q+  G+A
Sbjct: 65  QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116

Query: 127 YIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 182
           YI  +  + HRDL+  N+LV D L    KI DFG A+ LI      +   ++F   + AP
Sbjct: 117 YIERMNYI-HRDLRSANILVGDGLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAP 172

Query: 183 EL-IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEI 226
           E  ++G   +T   D+WS G +L EL+  G+  +PG N  + L ++
Sbjct: 173 EAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 53/225 (23%), Positives = 100/225 (44%), Gaps = 29/225 (12%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ-------LMRVMDHPNV 66
           +++G G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 67  ISLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           + L    F  +S  ++   +V    M++     + +        +++PL  +  +   I 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
            G+ Y+       HRDL  +N ++      V + DFG +K++ +G+    Y   R  + P
Sbjct: 124 LGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIYSGD---YYRQGRIAKMP 178

Query: 183 ELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLFPG-ENA 219
            + + A E      YT+  D+W+ G  + E+   GQ  +PG EN 
Sbjct: 179 -VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH 222

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 52/169 (30%), Positives = 76/169 (44%), Gaps = 18/169 (10%)

Query: 106 NQRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ 163
           N+   L Y+ L  ++YQ+  G+ ++ +   V HRDL  +N+L+      VKICDFG A+ 
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLICE-GKLVKICDFGLARD 288

Query: 164 LIAGEANISYICSRF----YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGEN 218
           ++     IS   S F    + APE IF    YTT  D+WS G +L E+  LG   +P   
Sbjct: 289 IMRDSNYISK-GSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP 346

Query: 219 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 267
             +Q    IK          R   P +      +I    W + F  R  
Sbjct: 347 MNEQFYNAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 26/207 (12%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 67
           E+V+G G FG V   +    G+    VAIK +      + RR    E  +M   DHPN+I
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L+     T SK  +   +V EY+   S+   L+ +     +  +I +      I  G+ 
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMK 120

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRA 181
           Y+  +  V HRDL  +N+LV+      K+ DFG ++ ++  +   +Y          + A
Sbjct: 121 YLSDMGYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTA 177

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELL 208
           PE I    ++T++ D+WS G V+ E++
Sbjct: 178 PEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 53/235 (22%)

Query: 16  ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRVMDHPNV 66
           +R +G G+FG VF A+C     T     VA+K +    L  R+   RE +L+  + H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIY 113
           +     F+      +  + +V EY+             P++M  V      A   + L  
Sbjct: 70  VK----FYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
           +     QI  G+ Y+ +   V HRDL  +N LV      VKI DFG ++ + +       
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGA-NLLVKIGDFGMSRDVYS------- 175

Query: 174 ICSRFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLF 214
             + +YR             PE I    ++TT  D+WS G +L E+     QP F
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 67/281 (23%), Positives = 118/281 (41%), Gaps = 36/281 (12%)

Query: 17  RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 67
           R++G G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNVI
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 68  SLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
            L      + +K  L + +V    M++     + ++         +PL  +  +   I  
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YR 180
           G+ Y+ +     HRDL  +N +++     V + DFG +K++ +G+       S+    + 
Sbjct: 125 GMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG-ENAVDQLVEIIKVL--GTPTRE 236
           A E +     YTT  D+W+ G  + E++  GQ  + G EN+     EI   L  G   ++
Sbjct: 183 ALESL-ADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNYLIKGNRLKQ 236

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
              C+   Y      ++    W      R  P    L  +L
Sbjct: 237 PPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           E  +G G FG V+      T   VAIK +           +E Q+M+ + H  ++ L   
Sbjct: 11  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 66

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            ++  S+  +++  V EY+ + S+   LK       R+P +       QI  G+AY+  +
Sbjct: 67  -YAVVSEEPIYI--VTEYMSKGSLLDFLKGEMGKYLRLPQLVD--MAAQIASGMAYVERM 121

Query: 132 PRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 186
             V HRDL+  N+LV + L    K+ DFG A+ LI      +   ++F   + APE  ++
Sbjct: 122 NYV-HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 177

Query: 187 GATEYTTSIDIWSAGCVLAELLL-GQPLFPG 216
           G   +T   D+WS G +L EL   G+  +PG
Sbjct: 178 G--RFTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 83/321 (25%), Positives = 129/321 (40%), Gaps = 83/321 (25%)

Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMPLIYVK---LYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   ++       
Sbjct: 72  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +         +Y
Sbjct: 127 EIADGMAYLNA-KKFVHRDLAARNCMVAH-DFTVKIGDFGMTRDIYETD---------YY 175

Query: 180 R------------APELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVE 225
           R            APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLK 232

Query: 226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 285
            +             M+  Y D         P         P    DL     Q++P +R
Sbjct: 233 FV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMR 265

Query: 286 CTALEACA------HPFFDEL 300
            T LE         HP F E+
Sbjct: 266 PTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 50/223 (22%)

Query: 19  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 69
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ V+ H +++  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK------HYSSANQRMPLIYVKL-----Y 117
              F+   ++    L +V EY+    + R L+         +  + +    + L      
Sbjct: 72  ---FYGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI  G+ Y+ ++  V HRDL  +N LV      VKI DFG ++ + + +         
Sbjct: 128 ASQIASGMVYLASLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD--------- 176

Query: 178 FYRA------------PELIFGATEYTTSIDIWSAGCVLAELL 208
           +YR             PE I    ++TT  DIWS G VL E+ 
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 63/268 (23%), Positives = 116/268 (43%), Gaps = 35/268 (13%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVISLKHCFF 74
           +G+G FG+V+    LE  + VAIK +    + +  +   E Q+M  + HP ++ L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 75  STTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
             +      + LV E++    +   L+       +  L+ + L    +  G+AY+ +   
Sbjct: 70  ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL---DVCEGMAYLES-SN 120

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 190
           V HRDL  +N LV      VK+ DFG  +  +  +   S   ++F   + +PE +F  ++
Sbjct: 121 VIHRDLAARNCLVGE-NQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           Y++  D+WS G ++ E +  +   P EN  +   E+++ +        R   P       
Sbjct: 178 YSSKSDVWSFGVLMWE-VFSEGKTPYENRSNS--EVVETINA----GFRLYKPRLASQSV 230

Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLL 278
            ++  H W      +  PE     S LL
Sbjct: 231 YELMQHCW------KERPEDRPSFSLLL 252

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.6 bits (121), Expect = 2e-07
 Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 65/225 (28%)

Query: 93  ESMYRVLKH--------YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL 144
           +S++ VL+H        + S    +P   VK +  ++   L  +H    VC RDL P N+
Sbjct: 58  DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNI 116

Query: 145 LVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAG 201
           L+D   H +++  F    ++     GEA         Y APE + G +E T + D WS G
Sbjct: 117 LLDDRGH-IQLTYFSRWSEVEDSCDGEA-----VENMYCAPE-VGGISEETEACDWWSLG 169

Query: 202 CVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN----YTDFRFPQIKAHP 257
            +L ELL G+ L                        + C +P+    +T    P+     
Sbjct: 170 AILFELLTGKTL------------------------VEC-HPSGINTHTTLNIPEW---- 200

Query: 258 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-----AHPFF 297
                   +  EA  L  +LLQ++P+ R  A  A      +HPFF
Sbjct: 201 --------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 46/277 (16%)

Query: 19  VGTGSFGIVFQAKCLETGE-------TVAIKKVLQDRRYKN-----RELQLMRVM-DHPN 65
           +G G FG V  A+ +   +        VA+K +  D   K+      E+++M+++  H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 112
           +I+L     + T    L++  ++EY              P  M           +++   
Sbjct: 86  IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +    YQ+ RG+ Y+ +  +  HRDL  +N+LV    + +KI DFG A+ +   +    
Sbjct: 141 DLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKK 198

Query: 173 YICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIK 228
               R    + APE +F    YT   D+WS G +L E+  LG   +PG   V++L +++K
Sbjct: 199 TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVEELFKLLK 256

Query: 229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR 265
             G    +   C N  Y   R        WH V  +R
Sbjct: 257 E-GHRMDKPSNCTNELYMMMR------DCWHAVPSQR 286

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 67
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ ++  HPN+I
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVK-- 115
           +L         ++  +L L +EY P           RVL+    ++ AN     +  +  
Sbjct: 72  NLL-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 116 -LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 173
             +   + RG+ Y+ +  +  HRDL  +N+LV    +  KI DFG S  Q +  +  +  
Sbjct: 127 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 184

Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 185 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 34/226 (15%)

Query: 8   LQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQL 57
           L T+ +M E  +G   FG V++         E  + VAIK  L+D+     R + +   +
Sbjct: 4   LSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAM 60

Query: 58  MRV-MDHPNVISL---------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ 107
           MR  + HPN++ L             FS  S ++L   LVM      +       +  + 
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 108 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIA 166
             P  +V + T QI  G+ ++ +   V H+DL  +N+LV D L   VKI D G  +++ A
Sbjct: 121 LEPADFVHIVT-QIAAGMEFLSS-HHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYA 176

Query: 167 GE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
            +       S +  R+     +++G  +++   DIWS G VL E+ 
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 37/221 (16%)

Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQL 57
           IL+       +++G+G FG V +   +  G+++ I    K +QDR  +         +  
Sbjct: 3   ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62

Query: 58  MRVMDHPNVISLKH-CFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYV 114
           M  +DH  ++ L   C  ++       L LV +  P    +  V +H  S + +  L   
Sbjct: 63  MGSLDHAYIVRLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN-- 113

Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA-------KQLIAG 167
             +  QI +G+ Y+    R+ HR+L  +N+L+      V+I DFG A       K+    
Sbjct: 114 --WCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYS 169

Query: 168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           E        ++     ++FG   YT   D+WS G  + E++
Sbjct: 170 EHKTPI---KWMALESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.6 bits (118), Expect = 6e-07
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)

Query: 19  VGTGSFGIVFQA--KCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLK 70
           +G+G+FG V +   K  +    VAIK VL++   K+      RE ++M  +D+P ++ + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
               +        L LVME          K  S     + +  V    +Q+  G+ Y+  
Sbjct: 62  GVCEAEA------LMLVMEMASGGPLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 131 VPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 182
              V HRDL  +N LLV+   H  KI DFG +K L A +   SY  +R        + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL 208
           E I    ++++  D+WS G  + E  
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 58/263 (22%)

Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV-----MEYVPESMYRVLKHYSSANQ 107
            E   M+  DHPNV+ L      T  ++E + + V     M++     + +        Q
Sbjct: 49  SEAVCMKEFDHPNVMRLIGVCLQTV-ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107

Query: 108 RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 167
            +P   +  +   I  G+ Y+ +     HRDL  +N +++     V + DFG +K++  G
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIYNG 165

Query: 168 EANISYICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG-ENA 219
           +    Y   R  + P + + A E      YTT  D+WS G  + E+   GQ  +PG EN+
Sbjct: 166 D---YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221

Query: 220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 279
                EI   L    R                             + PP+ +D       
Sbjct: 222 -----EIYDYLRQGNR----------------------------LKQPPDCLDGL----- 243

Query: 280 YSPSLRCTALEACAHPFFDELRE 302
           YS    C  L     P F+ LR 
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 49.7 bits (119), Expect = 8e-07
 Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 40/189 (21%)

Query: 40  AIKKVLQDRRYKNRELQLMRVMDHPNVISL-------KHCFFSTTSKNELFLN-LVMEYV 91
           A     +D     +E++++  +  PN+  L                     LN  + ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 92  PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH 151
            E+    L   S +     L+Y+     QI  G+ Y+ ++  V HRDL  +N LV    +
Sbjct: 115 AET--SGLACNSKSLSFSTLLYMAT---QIASGMRYLESLNFV-HRDLATRNCLVGKN-Y 167

Query: 152 QVKICDFGSAKQLIAGEANISYICSRFY----RAP--------ELIFGATEYTTSIDIWS 199
            +KI DFG ++ L + +         +Y    RAP        E +    ++TT  D+W+
Sbjct: 168 TIKIADFGMSRNLYSSD---------YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWA 217

Query: 200 AGCVLAELL 208
            G  L E+L
Sbjct: 218 FGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 57/225 (25%), Positives = 81/225 (36%), Gaps = 79/225 (35%)

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF- 178
           QI   L  +H+   V HRD+KPQN++    +   KI D G+A  L  G   I+YI   F 
Sbjct: 263 QILFALDGLHSTGIV-HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 179 ----YRAPELIFGATEYTTS---------------------------IDIWSAGCVLAEL 207
               Y APE      +Y  S                            DI+SAG     L
Sbjct: 319 LDPRYAAPE------QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----L 367

Query: 208 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMP 267
           +  Q  FP   +   L++         R+  R       D+         W K+   R  
Sbjct: 368 IFLQMAFPNLRSDSNLIQF-------NRQLKRN------DYDLVA-----WRKLVEPRAS 409

Query: 268 P------EAIDLASR--------LLQYSPSLRCTALEACAHPFFD 298
           P      E +DL           ++++    R +A  A AHP+FD
Sbjct: 410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 19/161 (11%)

Query: 22  GSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPNVISLK------HCFF 74
           G+FG V+  +     +  A+K V + D   KN   Q   V    + ++L       H ++
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ---VQAERDALALSKSPFIVHLYY 71

Query: 75  STTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           S  S N ++L  VMEY+     + L H Y   ++ M + Y+     ++   L Y+H    
Sbjct: 72  SLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR-HG 124

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 174
           + HRDLKP N+L+    H +K+ DFG +K  +  E N+  I
Sbjct: 125 IIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 11  ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVI 67
           +++M E  +G+G FG+V   K       VAIK + +    +     E ++M  + HP ++
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQ-IFRGL 125
            L   +   T +  L++      V E M    L +Y    Q      + L   Q +  G+
Sbjct: 63  QL---YGVCTQQKPLYI------VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGM 113

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 182
            Y+     + HRDL  +N LV   T  VK+ DFG  + ++  E   S   ++F   +  P
Sbjct: 114 EYLERNSFI-HRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPP 170

Query: 183 ELIFGATEYTTSIDIWSAGCVLAEL 207
           E +F  ++Y++  D+WS G ++ E+
Sbjct: 171 E-VFNFSKYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFFS 75
           ++G G FG V Q +   TG+ VA+K +  D   +    E  +M  + H N++ L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 76  TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
                   L +VME + + ++   L+  +     + +I +  ++  +  G+ Y+ +  ++
Sbjct: 71  NG------LYIVMELMSKGNLVNFLR--TRGRALVSVIQLLQFSLDVAEGMEYLES-KKL 121

Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 191
            HRDL  +N+LV       K+ DFG A+    G  N     S+    + APE +    ++
Sbjct: 122 VHRDLAARNILVSE-DGVAKVSDFGLARVGSMGVDN-----SKLPVKWTAPEAL-KHKKF 174

Query: 192 TTSIDIWSAGCVLAELL-LGQPLFP 215
           ++  D+WS G +L E+   G+  +P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 54/232 (23%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRV---MDHPNVISL 69
           R++G G  G V+ A        VA+KK+ +D       K R L+  ++   + HP ++ +
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--------------ESMYRVLKHYSSANQRMPLIYVK 115
               +S  S  +  +   M Y+               ES+ + L   +S    +  I+ K
Sbjct: 68  ----YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS-IFHK 121

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------QLIAGE 168
                I   + Y+H+   V HRDLKP N+L+  L  +V I D+G+A         L+  +
Sbjct: 122 -----ICATIEYVHS-KGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 169 ANISYICSRF------------YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
            +   IC               Y APE + G    + S DI++ G +L ++L
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 47/195 (24%), Positives = 93/195 (47%), Gaps = 18/195 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 75
           +GTG FG+V   K       VAIK + +    ++    E ++M  + H  ++ L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
            T +  +++  V EY+      +L +     +R     +      +  G+AY+ +  +  
Sbjct: 68  CTKQRPIYI--VTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFI 122

Query: 136 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYT 192
           HRDL  +N LVD     VK+ DFG ++ ++  E   S + S+F   +  PE +   ++++
Sbjct: 123 HRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPE-VLLYSKFS 179

Query: 193 TSIDIWSAGCVLAEL 207
           +  D+W+ G ++ E+
Sbjct: 180 SKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 47.4 bits (112), Expect = 3e-06
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 25/208 (12%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 75
           +G G FG V+      T + VAIK +           +E Q+M+ + H  ++ L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 76  TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
             S+  +++  V E++ + S+   LK       ++P + V +   QI  G+AYI  +  +
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIERMNYI 124

Query: 135 CHRDLKPQNLLV-DPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL-IFGAT 189
            HRDL+  N+LV D L    KI DFG A+ LI      +   ++F   + APE  ++G  
Sbjct: 125 -HRDLRAANILVGDNLV--CKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYG-- 178

Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPG 216
            +T   D+WS G +L EL+  G+  +PG
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 47.3 bits (112), Expect = 4e-06
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           ++V+G G FG VF+      G     VAIK +      K R     E  +M    H N+I
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L+     T  K  + +   ME    ++ + L+ +        L+ +      I  G+ Y
Sbjct: 70  RLEGVV--TKFKPAMIITEYME--NGALDKYLRDHDGEFSSYQLVGM---LRGIAAGMKY 122

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 182
           +  +  V HRDL  +N+LV+    + K+ DFG ++ ++  +   +Y  S       + AP
Sbjct: 123 LSDMNYV-HRDLAARNILVNS-NLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAP 179

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL 208
           E I    ++T++ D+WS G V+ E++
Sbjct: 180 EAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.6 bits (111), Expect = 6e-06
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 39/219 (17%)

Query: 18  VVGTGSFGIVFQAKCLETG----ETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNVIS 68
           ++  G+FG +F    ++      E V +K V             +E  L+  + H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY------SSAN--QRMPLIYVKLYTYQ 120
           + H          +         P   +  LK +        AN  Q +    +     Q
Sbjct: 73  ILHVCIEDGEPPFVLY-------PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----- 175
           I  G++Y+H    V H+D+  +N ++D    QVKI D   ++ L   +    Y C     
Sbjct: 126 IACGMSYLHKR-GVIHKDIAARNCVIDE-ELQVKITDNALSRDLFPMD----YHCLGDNE 179

Query: 176 SRFYR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQ 211
           +R  +  A E +    EY+++ D+WS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 70/341 (20%), Positives = 123/341 (36%), Gaps = 103/341 (30%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 69
           + +G G+FG V   + ++T    A+K + + D   +N+      E  ++   D+  V+ L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
              ++S   K+ L+   VM+Y+P  + M  +++              + Y  ++   +  
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIES 116

Query: 128 IHTVPRVCHRDLK--------------------------------------------PQN 143
           +H +  + HRD+K                                            P  
Sbjct: 117 VHKMGFI-HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 144 LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV 203
              +    ++K  +    +Q     A+ S + +  Y APE++   T YT   D WS G +
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAH-SLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVI 233

Query: 204 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH 263
           L E+L+GQP F  +              TP   +++ +N               W    H
Sbjct: 234 LYEMLVGQPPFLAD--------------TPAETQLKVIN---------------WETTLH 264

Query: 264 ----KRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFF 297
                ++  EA DL  RL       R     A E  AHPFF
Sbjct: 265 IPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 35/236 (14%)

Query: 19  VGTGSFGIVFQA--KCLETGETVAIKKVLQ----DRRYKN---RELQLMRVMDHPNVISL 69
           +G+G+FG V +   K  ++ +TVA+K +L+    D   K+   RE  +M+ +D+P ++ +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                    + E ++ LVME    +    L  +   N+ +    +    +Q+  G+ Y+ 
Sbjct: 62  -----IGICEAESWM-LVMEL---AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------YRAP 182
               V HRDL  +N+L+    H  KI DFG +K L A E   +Y  ++        + AP
Sbjct: 113 ETNFV-HRDLAARNVLL-VTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAP 167

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGE--NAVDQLVEIIKVLGTPTR 235
           E +    ++++  D+WS G ++ E    GQ  + G   N V Q++E  + +  P R
Sbjct: 168 ECM-NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQR 222

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 28/124 (22%)

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           Y APE++     YT   D WS G +L E+L+GQP F              +  TPT  ++
Sbjct: 214 YIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQL 258

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPF 296
           + +N   T    PQ+K           + PEA+DL ++L   +     R  A +  AHPF
Sbjct: 259 KVINWENTLHIPPQVK-----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307

Query: 297 FDEL 300
           F E+
Sbjct: 308 FSEV 311

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 46.6 bits (110), Expect = 9e-06
 Identities = 64/254 (25%), Positives = 113/254 (44%), Gaps = 55/254 (21%)

Query: 16  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNV 66
           +R +G G+FG VF A+C     E  + +   K L+D     R+  +RE +L+  + H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY-------SSANQRMPLIYVKLY- 117
           +     F+    + +  + +V EY+    + + L+ +       +  N+   L   ++  
Sbjct: 70  VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124

Query: 118 -TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 176
              QI  G+ Y+ +     HRDL  +N LV      VKI DFG ++ + + +        
Sbjct: 125 IAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTD-------- 174

Query: 177 RFYRA------------PELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQ 222
            +YR             PE I    ++TT  D+WS G VL E+     QP +   N  ++
Sbjct: 175 -YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NE 230

Query: 223 LVEII---KVLGTP 233
           ++E I   +VL  P
Sbjct: 231 VIECITQGRVLQRP 244

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 21/152 (13%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 68
           + +G G+FG V  A  ++T    A+K  L+ +   NR        E  ++   D+  V+ 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   ++S   K+ L+   VM+Y+P   M  +L       + +   Y+   T  I      
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI----ES 116

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 159
           +H +  + HRD+KP N+L+D L   +K+ DFG
Sbjct: 117 VHKMGFI-HRDIKPDNILID-LDGHIKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 35/217 (16%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 67
           E V+G G+FG V +A   + G     AIK + +     D R    EL+++ ++  HPN+I
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQ 120
           +L         +N  +L + +EY P           RVL+    A  +       L + Q
Sbjct: 67  NL-----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLE-TDPAFAKEHGTASTLTSQQ 120

Query: 121 IFR-------GLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVKICDFG-SAKQLIAGEANI 171
           + +       G+ Y+ +  +  HRDL  +N+LV + L    KI DFG S  + +  +  +
Sbjct: 121 LLQFASDVATGMQYL-SEKQFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVYVKKTM 177

Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
             +  R+     L +    YTT  D+WS G +L E++
Sbjct: 178 GRLPVRWMAIESLNYSV--YTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 54/197 (27%), Positives = 81/197 (41%), Gaps = 45/197 (22%)

Query: 54  ELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 111
           E +L+R + HP V++L         T        LV+      +Y  L    +  + + L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC-------LVLPKYRSDLYTYL---GARLRPLGL 259

Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC--DFGSA-------- 161
             V     Q+   + YIH    + HRD+K +N+LV+       IC  DFG+A        
Sbjct: 260 AQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG---PEDICLGDFGAACFARGSWS 315

Query: 162 ---KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL------LLGQP 212
                 IAG  + +        APE++ G   YT S+DIWSAG V+ E       L    
Sbjct: 316 TPFHYGIAGTVDTN--------APEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSAS 366

Query: 213 LFPGENAVD-QLVEIIK 228
                   D Q++ II+
Sbjct: 367 RGDERRPYDAQILRIIR 383

Length = 461

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 31/123 (25%)

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK---VLGTPTR 235
           Y APE++   T YT   D WS G +L E+L+GQP F  +  ++  +++I     L  P +
Sbjct: 214 YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQ 272

Query: 236 EEIRCMNPNYTDF-----RFP----------QIKAHPWHKVFHKRMPPEAIDLASRLLQY 280
            +   ++P  +D      R P          +IKAHP+ K          ID +S L Q 
Sbjct: 273 AK---LSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFK---------TIDFSSDLRQQ 320

Query: 281 SPS 283
           S  
Sbjct: 321 SAP 323

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 47/199 (23%), Positives = 91/199 (45%), Gaps = 26/199 (13%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 75
           +G+G FG+V   K     + VAIK + +    ++    E ++M  + HPN++ L    + 
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL----YG 66

Query: 76  TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
             +K    + +V EY+    +   L+          L+ +      +   + Y+ +    
Sbjct: 67  VCTKQRP-IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS---DVCEAMEYLES-NGF 121

Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS---RF---YRAPELIFGA 188
            HRDL  +N LV    + VK+ DFG A+ ++  +    Y  S   +F   +  PE +F  
Sbjct: 122 IHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPE-VFDY 175

Query: 189 TEYTTSIDIWSAGCVLAEL 207
           + +++  D+WS G ++ E+
Sbjct: 176 SRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 33/191 (17%)

Query: 39  VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE 93
           VA+K +  D     R     E+++M  + +PN+I L     S        L ++ EY+  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMEN 101

Query: 94  -------SMYRVLKHYSSANQ-----RMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP 141
                  S   +   ++ AN         L+Y+ +   QI  G+ Y+ ++  V HRDL  
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAV---QIASGMKYLASLNFV-HRDLAT 157

Query: 142 QNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDI 197
           +N LV    + +KI DFG ++ L +G+       + +  R+     ++ G  ++TT+ D+
Sbjct: 158 RNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDV 214

Query: 198 WSAGCVLAELL 208
           W+ G  L E+ 
Sbjct: 215 WAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 26/200 (13%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G+FG VF  +       VA+K   +      K + LQ  R++    HPN++ L    
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 59

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP-LIYVKLYTYQIFRGLAYIHTVP 132
              T K  ++  +VME V    +           ++  LI +         G+ Y+ +  
Sbjct: 60  GVCTQKQPIY--IVMELVQGGDFLTFLRTEGPRLKVKELIQM---VENAAAGMEYLES-- 112

Query: 133 RVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQ----LIAGEANISYICSRFYRAPE-LIF 186
           + C HRDL  +N LV    + +KI DFG +++    + A    +  I  + + APE L +
Sbjct: 113 KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYASTGGMKQIPVK-WTAPEALNY 170

Query: 187 GATEYTTSIDIWSAGCVLAE 206
           G   Y++  D+WS G +L E
Sbjct: 171 G--RYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 57/214 (26%), Positives = 91/214 (42%), Gaps = 39/214 (18%)

Query: 19  VGTGSFGIVFQAKCLETGETVA--IKKVLQDRRYKNRELQLM------RVMDHPNVIS-L 69
           +G G FG V   +    G + A  + K L+     + +L  +      R ++HPNV+  L
Sbjct: 3   IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM------PLIYVKLYTYQIFR 123
             C  S          LV+E+ P      LK+Y  +N+ M        +  ++   ++  
Sbjct: 62  GQCIESIP------YLLVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111

Query: 124 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 179
           GL ++H    + H DL  +N  L   L+  VKI D+G A +    +  I+  C      +
Sbjct: 112 GLLWLHQADFI-HSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRW 168

Query: 180 RAPEL--IFGA----TEYTTSIDIWSAGCVLAEL 207
            APEL  I G      + T   +IWS G  + EL
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 23/153 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNR------ELQLMRVMDHPNVISL 69
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E  ++   D+  V+ L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              ++S   K+ L+   VM+Y+P   M  +L        RM +    L  + I      +
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPGGDMMSLLI-------RMGIFPEDLARFYIAELTCAV 114

Query: 129 HTVPRV--CHRDLKPQNLLVDPLTHQVKICDFG 159
            +V ++   HRD+KP N+L+D   H +K+ DFG
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 18  VVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVISL 69
           V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ ++  HPN+I+L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-------MYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                    ++  +L L +EY P           RVL+    A          L + Q+ 
Sbjct: 62  L-----GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE-TDPAFAIANSTASTLSSQQLL 115

Query: 123 R-------GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYI 174
                   G+ Y+ +  +  HRDL  +N+LV    +  KI DFG S  Q +  +  +  +
Sbjct: 116 HFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGRL 173

Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
             R+     L +    YTT+ D+WS G +L E++
Sbjct: 174 PVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 39/121 (32%), Positives = 59/121 (48%), Gaps = 29/121 (23%)

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           QI  G+ Y+ ++  V HRDL  +N LV      +KI DFG ++ L AG+         +Y
Sbjct: 146 QIASGMKYLSSLNFV-HRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 180 R------------APELIFGATEYTTSIDIWSAGCVLAELLL---GQPLFPGENAVDQLV 224
           R            A E I    ++TT+ D+W+ G  L E+L+    QP   GE   +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251

Query: 225 E 225
           E
Sbjct: 252 E 252

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 23/54 (42%), Positives = 33/54 (61%), Gaps = 2/54 (3%)

Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG 167
           +K    Q+  GL  +H +  + HRD+KP+NLLV  +  QVKI DFG+A  +  G
Sbjct: 311 IKGVMRQVLTGLRKLHRIG-IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTG 362

Length = 507

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 32/219 (14%)

Query: 17  RVVGTGSFGIVFQ--AKCL---ETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  AK +   E    VAIK V +    + R     E  +M+  +  +V
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRM---PLIYVKLYTY 119
           + L        S+ +  L ++ME +     +S  R L+     N       L  +     
Sbjct: 72  VRL----LGVVSQGQPTL-VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 175
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +         + 
Sbjct: 127 EIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQP 212
            R+     L  G   +TT  D+WS G VL E+  L  QP
Sbjct: 185 VRWMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 62/311 (19%), Positives = 122/311 (39%), Gaps = 49/311 (15%)

Query: 35  TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM 88
           TGE V ++++  +        +   EL + ++ +HPN++  +  F +    NEL++    
Sbjct: 24  TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---DNELWVVTSF 80

Query: 89  EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP 148
                +   +  H+      + + Y+      + + L YIH +  V HR +K  ++L+  
Sbjct: 81  MAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKALDYIHHMGYV-HRSVKASHILIS- 135

Query: 149 LTHQVKICDFGSAKQLI--AGEANISYICSRF------YRAPELIFGATE-YTTSIDIWS 199
           +  +V +    S   +I       + +   ++      + +PE++    + Y    DI+S
Sbjct: 136 VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 195

Query: 200 AGCVLAELLLGQPLFPGENAVDQLVEIIK-----VLGTPT--REEIR------------C 240
            G    EL  G   F    A   L+E +      +L T T   EE+              
Sbjct: 196 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255

Query: 241 MNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
            +   +  R    +  +HP+++ F     P       + LQ +P  R +A     H FF 
Sbjct: 256 ESTTVSTPRPSNGESSSHPYNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311

Query: 299 EL-REPNARLP 308
           ++ R  +  LP
Sbjct: 312 QIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 42/207 (20%), Positives = 85/207 (41%), Gaps = 32/207 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLE---------------TGETVAIKKVLQDRRY-KNRELQLMR 59
           ++++G G FG V++ +C                   ET+ ++ ++ +  Y  ++      
Sbjct: 17  DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76

Query: 60  V--MDHPNVISLKHCFFSTTSKNELFLNLVM-EYVPESMYRVLKHYSSANQRMPLIYVKL 116
           +  +DH  +     C   +  +  ++   ++ E + E+   + K     N+   LI  K 
Sbjct: 77  IHNIDHLGIPKYYGC--GSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNK--KLI--KN 130

Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 176
               +   L YIH    + H D+KP+N++VD   ++  I D+G A   I    +I Y   
Sbjct: 131 IMKDMLTTLEYIHEHG-ISHGDIKPENIMVDG-NNRGYIIDYGIASHFIIHGKHIEY--- 185

Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCV 203
              +  + +   T Y   +D  +  CV
Sbjct: 186 --SKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 8/93 (8%)

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYIC 175
           QI  G+ Y+ ++  V HRDL  +N LV    + +KI DFG ++ L +G+       + + 
Sbjct: 138 QIASGMKYLSSLNFV-HRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLP 195

Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
            R+     ++ G  ++TT+ D+W+ G  L E+L
Sbjct: 196 IRWMSWESILLG--KFTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	353
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
KOG1243	690	consensus Protein kinase [General function predict	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.1
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.09
COG4248	637	Uncharacterized protein with protein kinase and he	98.94
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
PRK09902	216	hypothetical protein; Provisional	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.78
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.74
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.74
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.6
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.6
PF01636	239	APH: Phosphotransferase enzyme family This family	98.49
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
PLN02876	822	acyl-CoA dehydrogenase	98.13
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.11
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.99
KOG2270	520	consensus Serine/threonine protein kinase involved	97.97
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.86
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.86
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.77
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.77
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.76
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.74
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.71
PRK10593	297	hypothetical protein; Provisional	97.7
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.57
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.53
PRK05231	319	homoserine kinase; Provisional	97.42
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.38
PLN02236	344	choline kinase	97.34
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.22
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.16
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.09
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.04
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.0
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.96
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.93
PRK12396	409	5-methylribose kinase; Reviewed	96.83
PLN02756	418	S-methyl-5-thioribose kinase	96.71
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.49
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.88
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.84
PTZ00384	383	choline kinase; Provisional	95.53
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	95.3
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.13
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.27
COG2334	331	Putative homoserine kinase type II (protein kinase	94.17
PRK10271	188	thiK thiamine kinase; Provisional	93.93
PTZ00296	442	choline kinase; Provisional	93.93
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.93

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-73  Score=485.89  Aligned_cols=342  Identities=71%  Similarity=1.208  Sum_probs=327.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      .-+|+..+++|+|+||.||.|....+++.||||++..+.+...+|+.+|+.++|||||++.-+|+...+.+..++.+|||
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle  102 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE  102 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence            45799999999999999999999999999999999999999999999999999999999999887776665678889999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC
Q 018619           90 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA  169 (353)
Q Consensus        90 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~  169 (353)
                      |++.+|.+.+.++...+.+++...++-+.+||++||+|||+ .||+||||||+|+|+|.+.+.+||||||.|+....++.
T Consensus       103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep  181 (364)
T KOG0658|consen  103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP  181 (364)
T ss_pred             hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence            99999999999988889999999999999999999999999 79999999999999999889999999999999999999


Q ss_pred             cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCc
Q 018619          170 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  249 (353)
Q Consensus       170 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
                      ..++.+|+.|+|||++.|...|+.+.||||.||++.||+.|++.|.+.+..+++..|++.+|.|+.+.+..+++++.++.
T Consensus       182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~  261 (364)
T KOG0658|consen  182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFK  261 (364)
T ss_pred             ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCchhhhccCCHH
Q 018619          250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPE  329 (353)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (353)
                      +|.+...+|...+.+.+++++.||+.++|+++|.+|.++.|++.||||..++.++..++.+.++|++++|+....+..++
T Consensus       262 ~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~e~~~~~~  341 (364)
T KOG0658|consen  262 FPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRAELGISPE  341 (364)
T ss_pred             CcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCcCCCccCchHHHhccchH
Confidence            99999999999899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhccHHHHHhhcCCCCCCCCC
Q 018619          330 LVNKLIPDHVKRQLGLNFLHPAG  352 (353)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
                      ..+.++|.+.+...+....++++
T Consensus       342 ~~~~l~p~~~~~~~~~~~~~~~~  364 (364)
T KOG0658|consen  342 LVNVLIPEHLREQEKDKILCESA  364 (364)
T ss_pred             HHHhhccHhhhhhccccccccCC
Confidence            99999999999998887777653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7e-64  Score=415.40  Aligned_cols=280  Identities=35%  Similarity=0.688  Sum_probs=248.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +.|+....+|+|+||+||+|+++.||+.||||++....      +...||+++|++++|||+|.++++|     .....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            67999999999999999999999999999999996543      3445899999999999999999999     666679


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|+|||+.++++.+..+   ...+++..++.+++|++.|+.|+|+ ++++||||||+|||++. ++.+||||||+|+..
T Consensus        77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQ-NGVVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEec-CCcEEeccchhhHhh
Confidence            999999999988888763   4678999999999999999999999 89999999999999996 899999999999988


Q ss_pred             c-cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh--hc
Q 018619          165 I-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--CM  241 (353)
Q Consensus       165 ~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~  241 (353)
                      . .++..+.++.|+||+|||++.|+..|+.++||||+||++.||++|.+.|++..+.+++..|.+.+|.-.....+  ..
T Consensus       152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            7 55566789999999999999998889999999999999999999999999999999999999999988876544  44


Q ss_pred             CcCCCCCcCCCCCC-CccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          242 NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ++-|....+|.... .+....++ +++.-+.||+.+||+.||++|++.+|+|.||||.++.
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            56677777776543 34444454 4788999999999999999999999999999997654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-63  Score=421.76  Aligned_cols=322  Identities=38%  Similarity=0.635  Sum_probs=271.7

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +.....|...+.||+|+||.|+.|.++.+|+.||||++..      ..++..||+++|+.++|+||+.+.+++.......
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            3445667778999999999999999999999999999863      2345568999999999999999999987644445


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      -..+|+|+|+|+.+|...++.    +..+++..++.+++||+.||+|+|+ .+++||||||+|++++. +..+||||||+
T Consensus        98 f~DvYiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~-~c~lKI~DFGL  171 (359)
T KOG0660|consen   98 FNDVYLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNA-DCDLKICDFGL  171 (359)
T ss_pred             cceeEEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeecc-CCCEEeccccc
Confidence            556999999999888877764    5569999999999999999999999 79999999999999997 88899999999


Q ss_pred             cccccc---CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          161 AKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       161 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+....   ....+.++.|.||+|||++.....|+.+.||||+|||+.||++|++.|.+.+..+++..|++.+|+|+.+.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            998764   34446789999999999998888999999999999999999999999999999999999999999999888


Q ss_pred             HhhcCcCC-CC--CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCC
Q 018619          238 IRCMNPNY-TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP  314 (353)
Q Consensus       238 ~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~  314 (353)
                      +....... ..  ..+|..+..+|...|+ ++++++.||+.+||.+||.+|+|++|+|+|||++.+.++........ .+
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~-~~  329 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQP-IF  329 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCC-CC
Confidence            87655221 11  2467778889999888 79999999999999999999999999999999999988765532221 11


Q ss_pred             CCCCchhhhccCCHHHHhhccHHHHHh
Q 018619          315 PLFNFKQELSGASPELVNKLIPDHVKR  341 (353)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (353)
                      ..    .+.. .+.+.+++++..++..
T Consensus       330 ~~----~~~~-~~~~~~r~~i~~e~~~  351 (359)
T KOG0660|consen  330 DS----FEHE-LTEEELRELIYKEILD  351 (359)
T ss_pred             cc----cccc-ccHHHHHHHHHHHHHh
Confidence            11    2222 6778888888887653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-64  Score=439.35  Aligned_cols=288  Identities=37%  Similarity=0.653  Sum_probs=257.7

Q ss_pred             eeeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHHHcC-CCceeecceeeeecC
Q 018619            4 VCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMRVMD-HPNVISLKHCFFSTT   77 (353)
Q Consensus         4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~~l~-h~~iv~~~~~~~~~~   77 (353)
                      +.+....++|.+++.||.|.||.||+|+.+.+|+.||||++++....     ..||+..|++++ ||||+++.+++.+..
T Consensus         3 ~~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    3 LTQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             ceehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            34566789999999999999999999999999999999988654322     238999999998 999999999985433


Q ss_pred             CCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           78 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .    .+|+|||||+.+|+++++.+   +..|++..++.|+.||+.||+|+|. +|+.|||+||+|||+.. +..|||+|
T Consensus        83 ~----~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~-~~~iKiaD  153 (538)
T KOG0661|consen   83 R----ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISG-NDVIKIAD  153 (538)
T ss_pred             c----eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecc-cceeEecc
Confidence            2    59999999999999999873   7889999999999999999999999 89999999999999996 77899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||+|+...+....+.++.|+||+|||+++....|+.+.|||++|||++|+.+-++.|++.++.|++.+|.+.+|+|....
T Consensus       154 FGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  154 FGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             cccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999876


Q ss_pred             Hhhc--CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          238 IRCM--NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       238 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      +..-  ..+...+.+|.....+....++. .++++.++|.+||++||.+||||+|+|+||||+.-.
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            5431  12234567788777777777776 999999999999999999999999999999997543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.3e-61  Score=392.79  Aligned_cols=277  Identities=39%  Similarity=0.725  Sum_probs=243.3

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+|...+.||+|.||.||+|++..||+.||||++....      ....||++.|+.++|+||+.++++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            57999999999999999999999999999999996432      2345999999999999999999999     444458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      .+|+||++.+|...++.   ....++...++.|+.+++.|++|||+ +.|+||||||.|+|+++ ++.+||+|||+|+.+
T Consensus        77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISS-DGQLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcC-CCcEEeecccchhcc
Confidence            89999999999888875   56789999999999999999999999 89999999999999997 899999999999987


Q ss_pred             ccCCCcc-eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 018619          165 IAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-  242 (353)
Q Consensus       165 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  242 (353)
                      .+..... ..+.|+||+|||++.|...|+..+||||.|||+.||+.|.+.|++.++.+++..|.+.+|+|..+.+..+. 
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            7655443 34789999999999999999999999999999999999999999999999999999999999999887765 


Q ss_pred             -cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          243 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                       ++|..+.  ..+..+....|+ ..++++.||+.+||.+||.+|+|+.|+|+||||+..
T Consensus       232 lpdY~~~~--~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  232 LPDYVKIQ--QFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             cccHHHHh--cCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence             3343332  333344444444 478899999999999999999999999999999973

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-61  Score=416.73  Aligned_cols=257  Identities=32%  Similarity=0.495  Sum_probs=213.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ..+.|.+.+.||+|+||.|.+|..+.||+.||||++.++.           ....+|+++|++|+|||||++++.|    
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f----  245 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF----  245 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee----
Confidence            4678999999999999999999999999999999997542           1225899999999999999999999    


Q ss_pred             CCCceeEEEEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEE
Q 018619           78 SKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVK  154 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vk  154 (353)
                       +...+.|+||||++|+ |.+.    ...++.+.+...+.+++||+.|+.|||+ .||+||||||+|||+..  ++..+|
T Consensus       246 -~~~ds~YmVlE~v~GGeLfd~----vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  246 -EVPDSSYMVLEYVEGGELFDK----VVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             -ecCCceEEEEEEecCccHHHH----HHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEE
Confidence             4444589999999964 4333    3467889999999999999999999999 79999999999999974  236799


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhhCCC--CCCccccchhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhC
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVD-QLVEIIKVLG  231 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  231 (353)
                      |+|||+|+.........+.+|||.|.|||++.+..  .+..++|+||+||+||.+++|.+||.+..... ...+|.+.  
T Consensus       320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G--  397 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG--  397 (475)
T ss_pred             ecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC--
Confidence            99999999888777788899999999999996542  34558899999999999999999998765544 33333331  


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                     .+.+        ....+..+|+++++||.+||..||++|||++|+|+||||+..
T Consensus       398 ---------------~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  398 ---------------RYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ---------------cccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence                           1111        111224589999999999999999999999999999999864

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.9e-60  Score=396.08  Aligned_cols=283  Identities=33%  Similarity=0.575  Sum_probs=246.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+.|+.+..|++|.||.||+|+++.|++.||+|+++.+..      ...||+.+|.+.+|||||.+.++.....-.   .
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d---~  151 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD---K  151 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc---e
Confidence            4689999999999999999999999999999999965432      225999999999999999999988654433   3


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +|+|||||..+|..++..   -.+++...+++.++.|++.|++|||. +.|+||||||+|+|++. .|.+||+|||+|+.
T Consensus       152 iy~VMe~~EhDLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~-~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  152 IYIVMEYVEHDLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSH-KGILKIADFGLARE  226 (419)
T ss_pred             eeeeHHHHHhhHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeecc-CCcEEecccchhhh
Confidence            889999999998888875   34789999999999999999999999 89999999999999995 88999999999998


Q ss_pred             cccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          164 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       164 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      +.+... .+..+-|.||+|||++.|...|+++.|+||+|||+.||+++.+.|.+....+++.+|++.+|.|+...+....
T Consensus       227 ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  227 YGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             hcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            876643 4556789999999999999999999999999999999999999999999999999999999999987665432


Q ss_pred             --cCCCCCcCCCCCCCccccccCCC-CChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          243 --PNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       243 --~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                        +....+.++...-.+....|+.. +++...+|++++|.+||.+|+||.|+|.|+||...
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence              22223455555556666666654 78999999999999999999999999999999974

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-59  Score=423.38  Aligned_cols=248  Identities=33%  Similarity=0.542  Sum_probs=221.9

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+|...+.||+|||++||.+++..+|+.||+|++.+.       +....+|+++.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5799999999999999999999999999999999762       34456899999999999999999999     77777


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|.|+|. ++|.++++    ..++++|.+++.++.||+.||.|||+ ++|+|||||..|+++++ +.+|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~-~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNE-NMNVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecC-cCcEEecccceee
Confidence            999999999 55555554    56889999999999999999999999 79999999999999996 7889999999999


Q ss_pred             ccccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ....+ +...+.+|||.|.|||++.. ...+..+||||+||+||.|+.|++||...+-.+.+.+|..             
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~-------------  232 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL-------------  232 (592)
T ss_pred             eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence            87744 67788999999999999974 4599999999999999999999999999988888887766             


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                          .++.+            |..+|.+++|||.+||+.||.+|||++++|.|+||++
T Consensus       233 ----~~Y~~------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~  274 (592)
T KOG0575|consen  233 ----NEYSM------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS  274 (592)
T ss_pred             ----cCccc------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence                23333            3578999999999999999999999999999999954

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-58  Score=430.81  Aligned_cols=329  Identities=53%  Similarity=0.982  Sum_probs=282.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCC---CCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS---KNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~l   86 (353)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++..+.....+|+.+++.++||||++++++|+....   ....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            468999999999999999999999999999999998777677789999999999999999988754332   23456889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++..++.+||+|||+|+....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            99999999888887766677889999999999999999999999 79999999999999986556899999999987766


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      ........||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+.++++.++.|..+.+..+.+.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55556678899999999987766789999999999999999999999999999999999999999999999888888888


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCC-CCCCCCCCCchh-hhc
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN-GRPLPPLFNFKQ-ELS  324 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~-~~~  324 (353)
                      +..++......+...++...++++++||.+||++||.+|+|+.|+|+||||+.++......+. ...++.+.++.. +..
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK  383 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence            888888777778888888899999999999999999999999999999999998776544443 234566666654 334


Q ss_pred             cCCHHHHhhccHHHH
Q 018619          325 GASPELVNKLIPDHV  339 (353)
Q Consensus       325 ~~~~~~~~~~~~~~~  339 (353)
                      +...+....+++...
T Consensus       384 ~~~~~~~~~~~~~~~  398 (440)
T PTZ00036        384 EMSDACRRKIIPKCT  398 (440)
T ss_pred             hCCHHHHHHHhhHHH
Confidence            666666666665443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-59  Score=413.94  Aligned_cols=282  Identities=35%  Similarity=0.583  Sum_probs=239.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...+.|+.+++||+|.||.||+|++..||+.||+|++..+.      ....||+.||++|+||||+++.+..+..   ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~  190 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LS  190 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CC
Confidence            34578999999999999999999999999999999997554      2335999999999999999999988654   23


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+|+|||+.+|..++..   ..-.|++.++..++.||+.||+|||+ +||+|||||.+|||||. +|++||+|||+|
T Consensus       191 ~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn-~G~LKiaDFGLA  265 (560)
T KOG0600|consen  191 GSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDN-NGVLKIADFGLA  265 (560)
T ss_pred             ceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcC-CCCEEeccccce
Confidence            35999999999988777653   56689999999999999999999999 89999999999999995 899999999999


Q ss_pred             cccccCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          162 KQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       162 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      +.+....  ..+..+.|.||+|||+++|...|+.++|+||+||||.||++|++.|++.+..+++..|.+..|.|....+.
T Consensus       266 r~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  266 RFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            9665544  45677889999999999999999999999999999999999999999999999999999999999988776


Q ss_pred             hcCcC-CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          240 CMNPN-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       240 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                      ..... +..+.-...-.+...+. -+.+++.+.+|+.+||..||.+|.||.++|+|+||.
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence            32211 11111111112233333 356899999999999999999999999999999994

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-59  Score=412.29  Aligned_cols=258  Identities=33%  Similarity=0.574  Sum_probs=227.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHc-CCCceeecceeeeecCCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...+|..++.||+|+|++|++|+++.+++.||||++.+.       .....+|..+|.+| +||.|++++-.|     ++
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD  145 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD  145 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence            346899999999999999999999999999999988654       23445799999999 899999999888     66


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|+||++ |+|++++..+    +.|++..++.++.||+.||+|||+ +|||||||||+|||+|+ ++.+||+|||
T Consensus       146 ~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~-dmhikITDFG  219 (604)
T KOG0592|consen  146 EESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDK-DGHIKITDFG  219 (604)
T ss_pred             ccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcC-CCcEEEeecc
Confidence            666999999999 6777777754    889999999999999999999999 89999999999999996 8999999999


Q ss_pred             cccccccCCC--------------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018619          160 SAKQLIAGEA--------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE  225 (353)
Q Consensus       160 ~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  225 (353)
                      .|+.+.+...              ..+.+||..|.+||++.. ...++.+|+|+||||+|+|+.|.+||.+.++.-..++
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqk  298 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQK  298 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHH
Confidence            9987643211              145899999999999954 5589999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCC
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA  305 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~  305 (353)
                      |++.                 ++.            |+.++++.++|||+++|..||++|+|+.||.+||||..+.|.+.
T Consensus       299 I~~l-----------------~y~------------fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  299 IQAL-----------------DYE------------FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             HHHh-----------------ccc------------CCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            9884                 333            34578999999999999999999999999999999999998875


Q ss_pred             CC
Q 018619          306 RL  307 (353)
Q Consensus       306 ~~  307 (353)
                      +-
T Consensus       350 w~  351 (604)
T KOG0592|consen  350 WQ  351 (604)
T ss_pred             hh
Confidence            53

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-58  Score=394.74  Aligned_cols=259  Identities=31%  Similarity=0.498  Sum_probs=224.2

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .+..+.|++.++||+|+||+||.++.+.|++.||+|++.+..       .....|..+|..++||+||+++-.|     +
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Q   95 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----Q   95 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----c
Confidence            355789999999999999999999999999999999886543       3345799999999999999998888     6


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      +...+|+|+||+.|+   .|..+++..+.+++..++.|+.+|+.||.|||+ +|||||||||+|||+|. +|.++|+|||
T Consensus        96 t~~kLylVld~~~GG---eLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~-~GHi~LtDFg  170 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGG---ELFYHLQREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDE-QGHIKLTDFG  170 (357)
T ss_pred             cCCeEEEEEeccCCc---cHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecC-CCcEEEeccc
Confidence            667799999999975   333344567899999999999999999999999 79999999999999996 8889999999


Q ss_pred             ccccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          160 SAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       160 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +|+.... +....+.+||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+......+|.+.-.       
T Consensus       171 L~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~-------  242 (357)
T KOG0598|consen  171 LCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL-------  242 (357)
T ss_pred             cchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC-------
Confidence            9995444 4455667999999999999876 599999999999999999999999999998888888776310       


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC----CHHHHhcCcccccccCCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELREPN  304 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~~~l~hp~f~~~~~~~  304 (353)
                                           ...+..++.++++||+++|+.||++|.    ++.++-+||||..++|..
T Consensus       243 ---------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~  291 (357)
T KOG0598|consen  243 ---------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEK  291 (357)
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHH
Confidence                                 011234899999999999999999996    688999999999998764

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-58  Score=393.82  Aligned_cols=255  Identities=31%  Similarity=0.567  Sum_probs=215.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .+.+..+.||+|+.|+||+|+|+.|++.+|+|++...     ++.+.+|+++++..+||+||++|++|+....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3677889999999999999999999999999999432     3445689999999999999999999976542    388


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||++ +|...+..    .++++|.....++.++++||.|||+.++||||||||+|||+++ .|.|||||||.++.+
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHh
Confidence            99999995 55555543    4889999999999999999999995379999999999999997 899999999999987


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-----NAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ... ...+++||..|||||.+.+. .|+.++||||||+.++||++|+.||...     +..+.+..|..  +.|+.    
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~--~ppP~----  301 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD--EPPPR----  301 (364)
T ss_pred             hhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc--CCCCC----
Confidence            666 55789999999999999775 4999999999999999999999999875     44455544443  11110    


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCC-CChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                                            ++.. +|+++++||.+||++||.+|+|+.|+++|||+++....+
T Consensus       302 ----------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  302 ----------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             ----------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence                                  2233 799999999999999999999999999999999865543

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-56  Score=379.84  Aligned_cols=290  Identities=34%  Similarity=0.686  Sum_probs=242.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHcCCCc-eeecceeeeecCC-CCc
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPN-VISLKHCFFSTTS-KNE   81 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~-~~~   81 (353)
                      ...|..++.||+|+||+||+|+.+.+|+.||+|++.-+..      ...+|+.+++.++|+| |+.+++++..... ...
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3457788889999999999999999999999999964432      3369999999999999 9999999865442 233


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+++|+||++.+|...+.........++...++.++.||+.||+|||+ ++|+||||||+||||++ ++.+||+|||+|
T Consensus        90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~-~G~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISS-SGVLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECC-CCcEeeeccchH
Confidence            4688999999999988888754433567889999999999999999999 89999999999999997 899999999999


Q ss_pred             cccc-cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +... +.......++|.+|+|||++.|...|+...||||+|||++||+++++.|.+..+.+++..|.+.+|+|....+..
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            9665 334456778999999999999998899999999999999999999999999999999999999999999876654


Q ss_pred             cC--cCCCCCcCCCCC-CCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          241 MN--PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       241 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      ..  +.+.. .++... ...+.... ++.+++..|++.+||++||.+|.|+..+|.||||......
T Consensus       248 v~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  248 VSSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             ccccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            32  22221 222222 22333333 2355799999999999999999999999999999987544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-57  Score=372.41  Aligned_cols=254  Identities=29%  Similarity=0.489  Sum_probs=222.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ..-++|+..+.||.|+||+|.+++++.+|..||+|++.++.       ....+|..+|+.+.||++++++..|     .+
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d  115 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD  115 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence            34568999999999999999999999999999999997653       2334799999999999999999888     56


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...+|+||||++|+   .+..+....+++++..++.++.||+.||+|||+ ++|++|||||+|||+|+ +|.+||+|||+
T Consensus       116 ~~~lymvmeyv~GG---ElFS~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~-~G~iKitDFGF  190 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGG---ELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQ-NGHIKITDFGF  190 (355)
T ss_pred             CCeEEEEEeccCCc---cHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeecc-CCcEEEEeccc
Confidence            66699999999975   333444567899999999999999999999999 79999999999999997 88899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |+.....  ..+.+|||.|+|||++.. .+|+.++|+|||||++|||+.|.+||...+....+.+|.+.           
T Consensus       191 AK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~-----------  256 (355)
T KOG0616|consen  191 AKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG-----------  256 (355)
T ss_pred             eEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC-----------
Confidence            9976554  667899999999999965 45999999999999999999999999999999988888873           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                            +..            ||..++++++|||+++|+.|-++|.     ...++..||||+.+.|.
T Consensus       257 ------~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~  306 (355)
T KOG0616|consen  257 ------KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE  306 (355)
T ss_pred             ------ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence                  222            4467899999999999999999995     56899999999998775

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.6e-56  Score=396.50  Aligned_cols=270  Identities=31%  Similarity=0.498  Sum_probs=224.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|.++++||+||||.||+|+.+.||+.||+|++.+..       .-...|-++|...++|+||+++-.|     ++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD  212 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD  212 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence            46789999999999999999999999999999999997653       2234688899999999999999888     77


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ..++|+||||++| ++..+|.    ..+.|++..++.++.+++.|++.+|+ .|+|||||||+|+|||. .|.+||+|||
T Consensus       213 ~~~LYLiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~-~GHiKLSDFG  286 (550)
T KOG0605|consen  213 KEYLYLIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDA-KGHIKLSDFG  286 (550)
T ss_pred             CCeeEEEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecC-CCCEeecccc
Confidence            7779999999996 4444443    56899999999999999999999999 79999999999999997 8889999999


Q ss_pred             ccccccc------------------------CC-----C-------------------cceeeeeceeeChhhhhCCCCC
Q 018619          160 SAKQLIA------------------------GE-----A-------------------NISYICSRFYRAPELIFGATEY  191 (353)
Q Consensus       160 ~a~~~~~------------------------~~-----~-------------------~~~~~~t~~y~aPE~~~~~~~~  191 (353)
                      +|.....                        ..     .                   ..+.+|||.|+|||++.+.. |
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y  365 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-Y  365 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-C
Confidence            9853211                        00     0                   01358999999999998865 9


Q ss_pred             CccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHH
Q 018619          192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAI  271 (353)
Q Consensus       192 ~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (353)
                      +..+|+||||||+|||+.|.+||.+.+..+...+|+..-..               +.+|.          ...++++++
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~  420 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAK  420 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHH
Confidence            99999999999999999999999999999999998875211               11111          124789999


Q ss_pred             HHHHHhcCcCCCCCCC---HHHHhcCcccccccCCCCCCCCCCCCCC
Q 018619          272 DLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNGRPLPP  315 (353)
Q Consensus       272 ~li~~~L~~dp~~R~t---~~~~l~hp~f~~~~~~~~~~~~~~~~~~  315 (353)
                      |||.+||. ||.+|+.   ++||.+||||+.+.|.........-+|.
T Consensus       421 DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~  466 (550)
T KOG0605|consen  421 DLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQ  466 (550)
T ss_pred             HHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCC
Confidence            99999999 9999985   8999999999999987655433333333

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-56  Score=401.79  Aligned_cols=254  Identities=34%  Similarity=0.550  Sum_probs=226.6

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      +-|.+++.||.|+.|.|.+|+|..||+..|||++.+.       ...+++|+-+|+.+.|||++.++++|     ++...
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence            4589999999999999999999999999999999876       45678999999999999999999999     66677


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|.||++| .|.+++    ...+++++.++++++.||+.|+.|||. .+|+||||||+|+|+|. .++|||+|||+|.
T Consensus        87 lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~-~~nIKIADFGMAs  160 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDV-KNNIKIADFGMAS  160 (786)
T ss_pred             EEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhc-ccCEeeeccceee
Confidence            9999999995 444444    457899999999999999999999999 69999999999999997 5669999999999


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ...++.-..+.+|+|.|.|||++.|.++.+.++||||+|||||.|++|++||.+.+-...+.++.+              
T Consensus       161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~--------------  226 (786)
T KOG0588|consen  161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR--------------  226 (786)
T ss_pred             cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--------------
Confidence            888888888899999999999999998889999999999999999999999998777666666554              


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                         +.|.+|            ..+|+++++||++||..||++|+|.+||+.|||+.+.....
T Consensus       227 ---G~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  227 ---GVFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             ---CcccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence               344444            47999999999999999999999999999999999876543

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.3e-54  Score=392.70  Aligned_cols=280  Identities=35%  Similarity=0.602  Sum_probs=231.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccch---HHHHHHHHHcC-C-----CceeecceeeeecCCCCc
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMD-H-----PNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~   81 (353)
                      .+|.+.++||+|+||.|-+|.+..|++.||||+++......   ..|+.+|..++ |     -|+|+++++|     ...
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr  260 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFR  260 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----ccc
Confidence            39999999999999999999999999999999998776544   36899999986 3     4899999999     555


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC-CCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~-~~~~vkl~Dfg~  160 (353)
                      .++|||+|.++.+|+++++..  .-..++...++.++.||+.||.+||+ .||||+||||+|||+.. ....|||+|||.
T Consensus       261 ~HlciVfELL~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  261 NHLCIVFELLSTNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             cceeeeehhhhhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEeccc
Confidence            669999999999999999864  33559999999999999999999999 79999999999999953 345799999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |....  ....+++.++.|+|||+++|.+ |+.+.||||||||++||++|.++|++.+..+++..|++.+|.|+...+..
T Consensus       338 Sc~~~--q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  338 SCFES--QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             ccccC--CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            98543  3334889999999999999976 99999999999999999999999999999999999999999999887753


Q ss_pred             cCcCCCCCcC----CC-----------------------------C-CCCccccccCCCCChhHHHHHHHhcCcCCCCCC
Q 018619          241 MNPNYTDFRF----PQ-----------------------------I-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  286 (353)
Q Consensus       241 ~~~~~~~~~~----~~-----------------------------~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  286 (353)
                      -......++-    +.                             - ..+.|.......-...+.|||.+||.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence            3222111111    00                             0 112222222222335679999999999999999


Q ss_pred             CHHHHhcCccccccc
Q 018619          287 TALEACAHPFFDELR  301 (353)
Q Consensus       287 t~~~~l~hp~f~~~~  301 (353)
                      |+.++|+||||....
T Consensus       495 tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  495 TPAQALNHPFLTGTS  509 (586)
T ss_pred             CHHHHhcCccccccc
Confidence            999999999998543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-56  Score=369.13  Aligned_cols=254  Identities=28%  Similarity=0.496  Sum_probs=214.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHHcCCCceeecce-eeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKH-CFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~~~~~~   83 (353)
                      ..|.+.++||+|.||.||+|.+..+|+.+|.|.+.-      .+...-+|+.+|++|+|||||++++ .| .   ++...
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f-~---~~~ev   94 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF-I---EDNEV   94 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh-h---ccchh
Confidence            469999999999999999999999999999998852      2334458999999999999999987 33 1   33334


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc--CC-CeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--VP-RVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~--~~-~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ++||||||+ |+|...++++.+....+++..+|.++.|||.||..||+  -+ -|+||||||.||+++. +|.+||+|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccch
Confidence            889999999 79999999999999999999999999999999999998  21 3899999999999996 8999999999


Q ss_pred             cccccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          160 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       160 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +++....... ..+++|||.|||||.+.+. +|+.+|||||+||++|||+.-++||.+.+-.+...+|.+.--+|...  
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~--  250 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD--  250 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--
Confidence            9998766554 3578999999999999765 59999999999999999999999999997777766666531111110  


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                               ...|.++..+|.-|+..||..||+.     +|++.++..
T Consensus       251 -------------------------~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  251 -------------------------EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             -------------------------HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence                                     2478999999999999999999987     566665543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-55  Score=376.83  Aligned_cols=254  Identities=30%  Similarity=0.531  Sum_probs=218.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+.+..      ....+|+.+|+.++|||||.+++++     ....
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            4678999999999999999999999999999999996653      3345899999999999999999998     4555


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--C---CcEEEe
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--T---HQVKIC  156 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~---~~vkl~  156 (353)
                      ++|+|||||+ |+|..++.    ..+.+++..++.++.||+.||++||+ ++||||||||+|||++..  +   ..+||+
T Consensus        83 ~i~lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEec
Confidence            7999999999 56665555    45789999999999999999999999 899999999999999752  1   469999


Q ss_pred             eeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          157 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      |||+|+....+....+.+|+|.|||||++.. +.|+.++|+||+|+|+|+|++|++||...+..+.+..+.+.-.     
T Consensus       158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~-----  231 (429)
T KOG0595|consen  158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE-----  231 (429)
T ss_pred             ccchhhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc-----
Confidence            9999999988887788999999999999965 4599999999999999999999999999999888775444211     


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                           ....++..+++.+.+|+...|+.+|.+|.+..+-+.|+++..
T Consensus       232 ---------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~  273 (429)
T KOG0595|consen  232 ---------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA  273 (429)
T ss_pred             ---------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence                                 111123446788889999999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-54  Score=389.22  Aligned_cols=253  Identities=33%  Similarity=0.503  Sum_probs=218.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHHcC-CCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMD-HPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~   77 (353)
                      ...++|.+.+.||+|+||+|++|.+..+++.||+|++.+.         .....+|+.+++.++ ||||+++++++    
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~----   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF----   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE----
Confidence            4467999999999999999999999999999999976543         123458999999999 99999999998    


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       .....+|+|||||.| .|++.+.    ..+++.+..++.++.||+.|++|||+ +||+||||||+|||++...+++||+
T Consensus        90 -~t~~~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   90 -ATPTKIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             -ecCCeEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEe
Confidence             444449999999996 6665554    36899999999999999999999999 7999999999999999733899999


Q ss_pred             eecccccc-ccCCCcceeeeeceeeChhhhhCCC-CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          157 DFGSAKQL-IAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       157 Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      |||++... .......+.+||+.|+|||++.+.. +-+.++||||+||+||.|++|..||...+.......+.+      
T Consensus       164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------  237 (370)
T KOG0583|consen  164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------  237 (370)
T ss_pred             ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence            99999987 4556677889999999999998766 457899999999999999999999999877777766544      


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCC-ChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRM-PPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                 ..+.            ++..+ |+++++|+++||..||.+|+|+.+++.||||+.
T Consensus       238 -----------~~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  238 -----------GEFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -----------CCcc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence                       1222            23346 999999999999999999999999999999997

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-54  Score=394.98  Aligned_cols=257  Identities=30%  Similarity=0.507  Sum_probs=224.1

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcC-CCceeecceeeeecCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTS   78 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   78 (353)
                      .+.-++|++.++||+|.||+|++|..+.+++.||||.++|+.       .....|.+|+...+ ||++++++.+|     
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----  438 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----  438 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence            455679999999999999999999999999999999998764       33456888887774 99999999999     


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      +...++|+||||+.|+.   +.. ....+.+++..++.|+++++.||+|||+ +||||||||.+|||+|. +|.+||+||
T Consensus       439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~-eGh~kiADF  512 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDT-EGHVKIADF  512 (694)
T ss_pred             ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcc-cCcEEeccc
Confidence            77777999999999873   322 3355889999999999999999999999 89999999999999997 788999999


Q ss_pred             ccccccc-cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          159 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       159 g~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+|+... .+....+.+|||.|+|||++.+. .|+.++|+|||||+||||+.|+.||.+++..+....|+..        
T Consensus       513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--------  583 (694)
T KOG0694|consen  513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--------  583 (694)
T ss_pred             ccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence            9999755 45566788999999999999665 5999999999999999999999999999999999888762        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN  304 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~~  304 (353)
                               +..            +|..+|.++.++++++|.+||++|+.     ++++..||||+.+.|..
T Consensus       584 ---------~~~------------yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~  634 (694)
T KOG0694|consen  584 ---------EVR------------YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD  634 (694)
T ss_pred             ---------CCC------------CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence                     111            34568999999999999999999996     57999999999998753

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-56  Score=361.30  Aligned_cols=258  Identities=30%  Similarity=0.481  Sum_probs=221.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeec------cccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +....++|.+.++||+|+|+.|+++.+..||+.+|+|++..      +.+.+++|+.+-+.|+||||+++.+.+     .
T Consensus         6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~   80 (355)
T KOG0033|consen    6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----Q   80 (355)
T ss_pred             ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----c
Confidence            45668999999999999999999999999999999997742      345667999999999999999999888     6


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEe
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKIC  156 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~  156 (353)
                      ...+.|+|+|++.| +|...+-.    ..-+++..+..++.||++||.|+|. +||+|||+||+|+++-+.  +.-+||+
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeec
Confidence            66779999999996 44333322    2557899999999999999999999 899999999999999542  3469999


Q ss_pred             eeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          157 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      |||+|....++..-...+|||.|+|||++... +|+.++|||+.|||||-|+.|.+||.+.+..+.+.+|++.       
T Consensus       156 ~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g-------  227 (355)
T KOG0033|consen  156 DFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG-------  227 (355)
T ss_pred             ccceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-------
Confidence            99999988866666678999999999999765 4999999999999999999999999999999999888873       


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                ++.++.   +.|     .++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus       228 ----------~yd~~~---~~w-----~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  228 ----------AYDYPS---PEW-----DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             ----------ccCCCC---ccc-----CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence                      333221   223     458999999999999999999999999999999975

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.8e-52  Score=369.92  Aligned_cols=277  Identities=33%  Similarity=0.650  Sum_probs=229.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      -++|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            468999999999999999999999999999999885322     2345899999999999999999988     344468


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++||||++++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~  153 (288)
T cd07871          79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINE-KGELKLADFGLARAK  153 (288)
T ss_pred             EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEECcCcceeec
Confidence            89999999988777653   34568899999999999999999999 79999999999999996 788999999999754


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... ......+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            3322 223457799999999987766689999999999999999999999999999999999999999888877654321


Q ss_pred             --CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                        .+..+.++.....++... ...++++++|||++||++||.+|+|++|+++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             chhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              222233333333333322 23578999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-53  Score=371.82  Aligned_cols=256  Identities=28%  Similarity=0.443  Sum_probs=214.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------------cchHHHHHHHHHcCCCceeecc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------RYKNRELQLMRVMDHPNVISLK   70 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h~~iv~~~   70 (353)
                      +-++|++.+.||+|.||+|.+|++..+++.||||++.+..                  ....+|+.+|+++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4578999999999999999999999999999999996532                  2345899999999999999999


Q ss_pred             eeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC
Q 018619           71 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL  149 (353)
Q Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~-l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~  149 (353)
                      ++.-+   .....+|+|+|||..+   .+.. .....+ +++.+++.|+..++.||+|||. +|||||||||+|+|+++ 
T Consensus       175 EvLDD---P~s~~~YlVley~s~G---~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~-  245 (576)
T KOG0585|consen  175 EVLDD---PESDKLYLVLEYCSKG---EVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSS-  245 (576)
T ss_pred             EeecC---cccCceEEEEEeccCC---cccc-CCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcC-
Confidence            98833   4445599999999954   2221 234455 9999999999999999999999 79999999999999997 


Q ss_pred             CCcEEEeeeccccccccC------CCcceeeeeceeeChhhhhC---CCCCCccccchhHHHHHHHHHhCCCCCCCCChH
Q 018619          150 THQVKICDFGSAKQLIAG------EANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  220 (353)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  220 (353)
                      ++++||+|||.+.....+      ......+|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||-+....
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            799999999999866322      22345789999999999976   234578999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          221 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      +...+|++.                 ...+|..          ..+.++++|||.+||++||++|+++.++..|||..+-
T Consensus       326 ~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  326 ELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            999888873                 1122221          1368899999999999999999999999999999764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-53  Score=368.35  Aligned_cols=259  Identities=32%  Similarity=0.536  Sum_probs=209.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..+|...+.||+|+||.||++.+..+|+.+|+|.+...    .....+|+.+|+.++|||||++++.......   ..++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeE
Confidence            35689999999999999999999999999999998765    3446899999999999999999885322211   4688


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +.|||+++ +|.+.+..+   ++.+++..++.+..|++.||+|||+ +||+||||||+|||++..++.+||+|||+++..
T Consensus        93 i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            99999995 666665542   2279999999999999999999999 899999999999999964578999999999876


Q ss_pred             cc----CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IA----GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ..    ........||+.|||||++........++||||+||++.||+||..||... ...+.+..+...   .      
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C------
Confidence            53    223446789999999999974222345999999999999999999999873 333333222221   0      


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                               ..         ..++..+|+++++||.+||++||.+||||+++|+|||.++...
T Consensus       240 ---------~~---------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  240 ---------SL---------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             ---------CC---------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence                     01         1255679999999999999999999999999999999987543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-52  Score=362.81  Aligned_cols=271  Identities=26%  Similarity=0.431  Sum_probs=225.0

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .+..+.+.|++..+||.|..++||+|++..+++.||||++.-+     -..+.+|+..++.++||||++++.+|....+ 
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~-   98 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE-   98 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-
Confidence            4678899999999999999999999999999999999999533     2445689999999999999999999955444 


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                          +|+||+||. |++.+++..+-..  .+.|..+..+++++++||.|||+ +|.||||||+.||||++ +|.|||+||
T Consensus        99 ----LWvVmpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~-dG~VkLadF  170 (516)
T KOG0582|consen   99 ----LWVVMPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDS-DGTVKLADF  170 (516)
T ss_pred             ----eEEeehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcC-CCcEEEcCc
Confidence                999999999 6888888876544  39999999999999999999999 79999999999999996 899999999


Q ss_pred             ccccccccCCCc-----ceeeeeceeeChhhh-hCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          159 GSAKQLIAGEAN-----ISYICSRFYRAPELI-FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       159 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~-~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |.+..+......     ...+||++|||||++ .....|+.++||||||++.+||.+|+.||....+...+...++  +.
T Consensus       171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~  248 (516)
T KOG0582|consen  171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--ND  248 (516)
T ss_pred             eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CC
Confidence            987765443321     345889999999994 4456799999999999999999999999999988887755544  33


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      |+......                 ....-.+..+..++++|..||++||++|||++++|+|+||++.+..
T Consensus       249 pp~~~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  249 PPTLLTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             CCCccccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            32111100                 0000113467899999999999999999999999999999986654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.7e-53  Score=378.35  Aligned_cols=249  Identities=30%  Similarity=0.543  Sum_probs=219.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|.+.+.||+|+||.||+++.+.+.+.||||.+.+..+.      ..+|+++++.++|||||.+++.|     +....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            6899999999999999999999999999999999765433      45899999999999999999999     666679


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|+|||.|+|..++.    .++.++|+.++.++.+++.||.|||+ ++|+|||+||.|||++. ++.+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEK-GGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecC-CCceeechhhhhhhc
Confidence            9999999998877776    57899999999999999999999999 79999999999999996 889999999999987


Q ss_pred             ccCCCc-ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..+... .+..|||.|||||++.+ ++|+..+|+||+|||+|||++|++||...........|...-..           
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-----------  218 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-----------  218 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-----------
Confidence            765543 45679999999999975 56999999999999999999999999887776666666552111           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                        .+..+|..+++|+..+|.+||.+|+|-.+++.|||.++-
T Consensus       219 ------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  219 ------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             ------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence                              123589999999999999999999999999999998763

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.8e-51  Score=367.45  Aligned_cols=283  Identities=33%  Similarity=0.568  Sum_probs=219.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ..++|.+.+.||+|+||.||+|++..+++.||+|++....     ....+|+.+++.++||||+++++++.     ....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~   77 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKET   77 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCe
Confidence            3578999999999999999999999999999999886432     23458999999999999999999883     3445


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .|+||||+.+++.+.+..   ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        78 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~  152 (303)
T cd07869          78 LTLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISD-TGELKLADFGLARA  152 (303)
T ss_pred             EEEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECCCCccee
Confidence            899999999988777653   34668999999999999999999999 79999999999999996 78899999999875


Q ss_pred             cccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhc
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ..... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+.+..+....+.+....+...
T Consensus       153 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         153 KSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             ccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccch
Confidence            43222 22345678999999998776668999999999999999999999998754 34556666666666655443321


Q ss_pred             Cc--CCCCCcCCCCCCCccccccC-CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          242 NP--NYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       242 ~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ..  .+....+.......+...+. ...++++.+||++||+.||.+|+|+.|+++||||+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            10  00000011111111111111 13567899999999999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-51  Score=371.76  Aligned_cols=318  Identities=37%  Similarity=0.647  Sum_probs=239.8

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..........+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            699999999999999999999999999999988532      12345799999999999999999988655444445688


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +|||||+++|.+.+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANA-DCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEccCccccccc
Confidence            999999988777665    34679999999999999999999999 79999999999999996 8899999999997543


Q ss_pred             cCCC----cceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          166 AGEA----NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       166 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ....    .....+|+.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+....+..+....+.+....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            3221    1245789999999998542 4588999999999999999999999999888888888888888877665543


Q ss_pred             cCcCCCC-C--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCC
Q 018619          241 MNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF  317 (353)
Q Consensus       241 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~  317 (353)
                      ....... +  .+......++...+ ..+++++.++|.+||+.||++|||++++++||||+.+...... +...+.+.. 
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~~-  311 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITKL-  311 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCccccc-
Confidence            2211000 0  00000111112222 2468899999999999999999999999999999987654322 233333332 


Q ss_pred             CchhhhccCCHHHHhhccHHH
Q 018619          318 NFKQELSGASPELVNKLIPDH  338 (353)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~  338 (353)
                      .+.-+....+.+.+.....++
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~  332 (338)
T cd07859         312 EFEFERRRLTKEDVRELIYRE  332 (338)
T ss_pred             cccHHHHhcCHHHHHHHHHHH
Confidence            222233445555555555444

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-52  Score=371.65  Aligned_cols=251  Identities=29%  Similarity=0.496  Sum_probs=216.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ...|...+.||+|+.|.||.|+...+++.||||++...    ++.+..|+.+|+..+|+|||.+++.|...+.     ++
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LW  346 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LW  346 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eE
Confidence            34788899999999999999999999999999999643    3345689999999999999999999865533     99


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||++| +|.+.+.     ...++|.++..+.++++.||+|||. +||+|||||.+|||++. ++.+||+|||+|..+
T Consensus       347 VVMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi  419 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQI  419 (550)
T ss_pred             EEEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEecc-CCcEEEeeeeeeecc
Confidence            99999996 5555544     3569999999999999999999999 79999999999999996 788999999999987


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... ...+.+|||+|||||++.. ..|+++.||||||+++.||+-|++||-..++...++.|... |+|...       
T Consensus       420 ~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~lk-------  490 (550)
T KOG0578|consen  420 SEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKLK-------  490 (550)
T ss_pred             ccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCcC-------
Confidence            7665 4456799999999999954 45999999999999999999999999988888777766653 333221       


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                        .+..+|+.++||+.+||+.|+.+|++|.++|+||||+.
T Consensus       491 ------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  491 ------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             ------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence                              23569999999999999999999999999999999954

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-51  Score=355.62  Aligned_cols=275  Identities=27%  Similarity=0.445  Sum_probs=226.1

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .+.-.++++.+.||.|.-|+||+|+.+.++..+|+|++.+..       .+.+-|.+||..++||.+..+|..|     +
T Consensus        73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----e  147 (459)
T KOG0610|consen   73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----E  147 (459)
T ss_pred             ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----e
Confidence            345567899999999999999999999999999999997653       2334689999999999999999999     7


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+.|++||||+|+-+..+.+ .+.++.+++..++.++.+++.||+|||- -|||+|||||+||||-+ +|.|-|+||.
T Consensus       148 t~~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvre-dGHIMLsDFD  224 (459)
T KOG0610|consen  148 TDKYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVRE-DGHIMLSDFD  224 (459)
T ss_pred             ccceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEec-CCcEEeeecc
Confidence            7788999999999654444433 3467889999999999999999999999 59999999999999996 8889999999


Q ss_pred             ccccccc-----------------------------------C----------------------CCcceeeeeceeeCh
Q 018619          160 SAKQLIA-----------------------------------G----------------------EANISYICSRFYRAP  182 (353)
Q Consensus       160 ~a~~~~~-----------------------------------~----------------------~~~~~~~~t~~y~aP  182 (353)
                      ++.....                                   .                      ....+.+||-.|.||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            8643210                                   0                      011245788899999


Q ss_pred             hhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCcccccc
Q 018619          183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVF  262 (353)
Q Consensus       183 E~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (353)
                      |++.|.. .+.++|+|+||+++|||+.|..||.+.+..+.+..++..                 +..+|..         
T Consensus       305 EvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~---------  357 (459)
T KOG0610|consen  305 EVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE---------  357 (459)
T ss_pred             eeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC---------
Confidence            9998765 899999999999999999999999999999988877662                 1222221         


Q ss_pred             CCCCChhHHHHHHHhcCcCCCCCCC----HHHHhcCcccccccCCCCCCCCCCCCCCCC
Q 018619          263 HKRMPPEAIDLASRLLQYSPSLRCT----ALEACAHPFFDELREPNARLPNGRPLPPLF  317 (353)
Q Consensus       263 ~~~~~~~~~~li~~~L~~dp~~R~t----~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~  317 (353)
                       ..++..++|||+++|.+||++|+.    |.||.+||||+.++|..-+....+.+|...
T Consensus       358 -~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~  415 (459)
T KOG0610|consen  358 -PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV  415 (459)
T ss_pred             -CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence             147889999999999999999998    999999999999999854443333344433

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=319.15  Aligned_cols=279  Identities=34%  Similarity=0.638  Sum_probs=238.3

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+|.-.+.||+|.||+||++++..+++.||+|.+.-+.      ....+|+.+++.++|.|||+++++.     ..+..+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkkl   76 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCcee
Confidence            35667789999999999999999999999999886432      3446999999999999999999987     555568


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      -+|+|||..+|...+..   -++.++.+.++.++.|++.||.|+|+ +++.|||+||.|+|++. ++.+||+|||+++.+
T Consensus        77 tlvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~-ngelkladfglaraf  151 (292)
T KOG0662|consen   77 TLVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINR-NGELKLADFGLARAF  151 (292)
T ss_pred             EEeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEecc-CCcEEecccchhhhc
Confidence            89999999988777765   57889999999999999999999999 89999999999999996 899999999999865


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .-.-. .+..+-|.+|++|.++.|..-|+++.|+||.|||+.|+. .|.+.|++.+-.+++.+|...+|.|..+.+..+.
T Consensus       152 gipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             CCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence            44332 234567999999999999999999999999999999998 5889999999999999999999999988776654


Q ss_pred             cCCCCCcCCCCC-CCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          243 PNYTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       243 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .--..-.+|... ...|.+..+ +++...+||++++|.-+|.+|++++++++||||...
T Consensus       232 ~lpdyk~yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCCCcccCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            221112233332 356777665 478899999999999999999999999999999864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-50  Score=358.11  Aligned_cols=276  Identities=37%  Similarity=0.705  Sum_probs=222.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|.+.+.||+|+||.||+|+++.+++.||+|++....      ....+|+.+++.++||||+++++++     .....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence            47999999999999999999999999999999886432      2345799999999999999999988     344468


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||+.+++...+..   ....+++..++.++.|++.||+|||+ .|++||||||+||+++. ++.+||+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~  150 (287)
T cd07848          76 YLVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISH-NDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccCcccc
Confidence            99999999876665543   34679999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 018619          165 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-  241 (353)
Q Consensus       165 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (353)
                      .....  .....+|+.|+|||++.+. .++.++|+||+||++|+|++|++||.+.+..+....+.+..+..+...+... 
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            43322  2345789999999999664 4899999999999999999999999998888888777777777665544322 


Q ss_pred             -CcCCCCCcCCCC-CCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          242 -NPNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       242 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                       ++.+.....+.. ....+.......+|.++.+||++||++||++|||++++++||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence             122211112211 11222333344578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.1e-53  Score=344.73  Aligned_cols=258  Identities=31%  Similarity=0.541  Sum_probs=222.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------------ccchHHHHHHHHHc-CCCceeecceeeeecC
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------------RRYKNRELQLMRVM-DHPNVISLKHCFFSTT   77 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   77 (353)
                      ..|.-.++||+|..++|-++.++.+|+.+|+|++...            .+...+|+.+|+++ .||+|+++.++|    
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----   92 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----   92 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence            4678889999999999999999999999999988421            12234799999998 699999999999    


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       +...++++|+|.|+ |.|.+++.    ..-.+++...+.++.||+.|++|||. ++|+||||||+|||++. +.++||+
T Consensus        93 -es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILldd-n~~i~is  165 (411)
T KOG0599|consen   93 -ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDD-NMNIKIS  165 (411)
T ss_pred             -cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeecc-ccceEEe
Confidence             77788999999999 66666654    46789999999999999999999999 89999999999999995 8899999


Q ss_pred             eeccccccccCCCcceeeeeceeeChhhhhC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 018619          157 DFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      |||+|..+..++.....+|||.|.|||.+..     .+.|+..+|+|++|||+|.|+.|.+||......-++..|++.  
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG--  243 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG--  243 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc--
Confidence            9999999999999899999999999999833     456899999999999999999999999998888888877773  


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                                     .+.|.   ...|     .++|.+.+|||++||+.||++|+|+.|+|+||||.++-...
T Consensus       244 ---------------kyqF~---speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~  293 (411)
T KOG0599|consen  244 ---------------KYQFR---SPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ  293 (411)
T ss_pred             ---------------ccccC---Ccch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence                           22221   2233     45899999999999999999999999999999998765443

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.6e-50  Score=356.80  Aligned_cols=280  Identities=35%  Similarity=0.592  Sum_probs=220.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECC-CCcEEEEEEeeccc------cchHHHHHHHHHc---CCCceeecceeeeecCCCC
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~   80 (353)
                      .+|++.+.||+|+||.||+|++.. +++.||+|.+....      ....+|+.+++.+   +||||+++++++.......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            479999999999999999999865 46789999885322      2234677777765   6999999999875444344


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...+++||||++++|.+.+...  ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcC-CCCEEEccccc
Confidence            5568899999999888777542  33568999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............+|+.|+|||.+.+. .++.++||||+||++|+|++|.+||.+.+..+.+..+....+.+....+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (290)
T cd07862         157 ARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  235 (290)
T ss_pred             eEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence            9866554444456789999999998654 589999999999999999999999999999999999988877766544322


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      .. ......+......+... +...+++.+++||.+||+.||++|||+.++|+||||
T Consensus       236 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         236 DV-ALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hh-cccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            11 00111111111112222 223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.8e-50  Score=359.90  Aligned_cols=285  Identities=33%  Similarity=0.643  Sum_probs=231.1

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   78 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKS   78 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCe
Confidence            3478999999999999999999999999999999886332     23457999999999999999999883     3345


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .++||||+++++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        79 ~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~  153 (309)
T cd07872          79 LTLVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARA  153 (309)
T ss_pred             EEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcccccee
Confidence            889999999987776653   34568999999999999999999999 79999999999999996 78899999999875


Q ss_pred             cccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          164 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       164 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ...... .....+|+.|+|||.+.+...++.++||||+||++|+|++|++||.+.+..+....+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             cCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            433222 2335678999999998776668999999999999999999999999999999999999999888877655432


Q ss_pred             cC--CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          243 PN--YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       243 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      ..  +..+.++......+.... ..+++++++||.+||+.||.+|+|+.|+++||||+.+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence            21  112222322222222222 35789999999999999999999999999999999875443

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-49  Score=364.56  Aligned_cols=288  Identities=32%  Similarity=0.556  Sum_probs=228.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|.+.+.||+|+||.||++.+..+++.||||++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3579999999999999999999999999999999986431      234579999999999999999988744322 223


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||+++++...+.      ..+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECC-CCcEEEEeCCCc
Confidence            4578999999998777664      347889999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....++...+.+........
T Consensus       174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         174 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             cccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            866544444556789999999999664 4899999999999999999999999999999999999988888776544333


Q ss_pred             CcC----------CCCCcCCCC---CCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCC
Q 018619          242 NPN----------YTDFRFPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA  305 (353)
Q Consensus       242 ~~~----------~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~  305 (353)
                      .+.          +..+.+...   ...++........+.++++||.+||+.||.+|||++++|+||||..+..+..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~  329 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSE  329 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCccc
Confidence            221          111111000   0111222222335678999999999999999999999999999987665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.5e-50  Score=367.44  Aligned_cols=285  Identities=32%  Similarity=0.568  Sum_probs=225.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|++...      .....+|+.+++.++||||+++++++..... ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457999999999999999999999999999999998543      2234579999999999999999998754332 122


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||+++++...+.      ..+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEecCCCc
Confidence            3478999999998766553      348889999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .............+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+.+..+.+........
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            865544444556789999999999664 4899999999999999999999999999988888888888888776543221


Q ss_pred             C----------cCCCCCcCCCCCCCcc----ccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          242 N----------PNYTDFRFPQIKAHPW----HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       242 ~----------~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      .          +.+....+... ...|    ........++++++||.+||+.||++|||+.|+|+||||..+..+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEEL-FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhh-ccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence            1          11111111000 0001    011222357889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=363.67  Aligned_cols=257  Identities=32%  Similarity=0.551  Sum_probs=220.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHcC-CCceeecceeeeecCCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVMD-HPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   80 (353)
                      ....|.+.+.||+|.||.||.+.++.||+.||+|.+.+...       ...+|+.+|+.+. |||||.+++.|     +.
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----ED  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ec
Confidence            45689999999999999999999999999999999976533       5678999999998 99999999999     45


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC---CcEEEe
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKIC  156 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~---~~vkl~  156 (353)
                      ...+++|||+|.| .|.+.+...     .+++..+..++.|++.|++|||+ .|++||||||+|+|+...+   +.+|++
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEe
Confidence            5569999999994 666666543     39999999999999999999999 7999999999999996532   479999


Q ss_pred             eeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          157 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      |||++.....+......+||+.|+|||++.+ ..|+..+||||+||++|.|++|.+||.+.+......++...       
T Consensus       182 DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-------  253 (382)
T KOG0032|consen  182 DFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-------  253 (382)
T ss_pred             eCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC-------
Confidence            9999998877666778899999999999954 45999999999999999999999999999988777766552       


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                ++.   .....|     ..++..+++||++||..||.+|+|+.++|+|||++....
T Consensus       254 ----------~~~---f~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  254 ----------DFD---FTSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             ----------CCC---CCCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence                      111   122333     458999999999999999999999999999999987643

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-49  Score=352.74  Aligned_cols=279  Identities=30%  Similarity=0.548  Sum_probs=222.1

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHc---CCCceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5899999999999999999999999999999886421      1234677777665   799999999988655545556


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++++|||+.+++...+...  ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccCccc
Confidence            68899999999887776542  23458999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ............+|..|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.+.++....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            76544444456789999999999664 48999999999999999999999999998888888888887776654433211


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                       ......+.......+.. +...++.++.+||.+||++||.+|||+.+++.||||
T Consensus       236 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         236 -TLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             -cccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence             00011111111111222 223578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.4e-50  Score=366.54  Aligned_cols=284  Identities=32%  Similarity=0.551  Sum_probs=225.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||+|+||.||++.+..+++.||||++...      .....+|+.+++.++||||+++++++...........|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999999999999999988542      12345799999999999999999988544322233688


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +||||+.+++...+.    ....+++..++.++.||+.||+|||+ +|++||||||+|||++. ++.+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNS-NCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECC-CCCEEeccccceeecc
Confidence            999999988776654    35679999999999999999999999 79999999999999996 7899999999997643


Q ss_pred             cCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          166 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       166 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...  ......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.++...+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  223346789999999997766689999999999999999999999999999999999999999888765543211


Q ss_pred             CCCCCcCCCCC-CCcc--ccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          244 NYTDFRFPQIK-AHPW--HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       244 ~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ........... ...+  ...+....++++.+||.+||+.||.+|||+.++++||||+..+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            10000000000 0000  0112345688999999999999999999999999999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-49  Score=363.49  Aligned_cols=286  Identities=33%  Similarity=0.565  Sum_probs=227.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4679999999999999999999999999999999886431      233479999999999999999998754332 222


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||+++++...+.      ..+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~-~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECC-CCCEEEeeCccc
Confidence            3578999999998776654      348889999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +............+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+++.++.+..+.....
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         167 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             ccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            866554444556789999999999664 4899999999999999999999999999988888888888887766544333


Q ss_pred             CcC----------CCCCcCCCCC---CCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          242 NPN----------YTDFRFPQIK---AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       242 ~~~----------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      .+.          +....++...   ..+.........+.++++||.+||+.||++|||+.|+|+||||..+..+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence            221          1111111110   0111122223456789999999999999999999999999999866443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-50  Score=357.60  Aligned_cols=250  Identities=27%  Similarity=0.420  Sum_probs=209.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     .+...
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence            4799999999999999999999999999999988542       22345799999999999999998877     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+.+ +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~  149 (291)
T cd05612          76 LYMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDK-EGHIKLTDFGFAK  149 (291)
T ss_pred             EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEEecCcch
Confidence            8999999985 6655554    35679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...             
T Consensus       150 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------  213 (291)
T cd05612         150 KLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------  213 (291)
T ss_pred             hccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence            65432  2345689999999998654 4899999999999999999999999988776666555431             


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                          .            ..++..+++.+++||++||+.||.+|++     ++++++||||+.+.+.
T Consensus       214 ----~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         214 ----K------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             ----C------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence                0            0123457889999999999999999995     9999999999887654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.5e-50  Score=361.18  Aligned_cols=253  Identities=28%  Similarity=0.438  Sum_probs=210.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++     ..
T Consensus        15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~   89 (329)
T PTZ00263         15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QD   89 (329)
T ss_pred             CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ec
Confidence            45678999999999999999999999999999999986432       2345799999999999999999988     34


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||+.+ +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~Dfg  163 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDN-KGHVKVTDFG  163 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECC-CCCEEEeecc
Confidence            4458999999985 5555554    35678999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ++......  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...          
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------  230 (329)
T PTZ00263        164 FAKKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------  230 (329)
T ss_pred             CceEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence            99865432  2345789999999999654 4899999999999999999999999887766555444321          


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                             ..            .++..++.++++||.+||+.||.+|++     ++++++||||++..+.
T Consensus       231 -------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~  280 (329)
T PTZ00263        231 -------RL------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD  280 (329)
T ss_pred             -------Cc------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence                   00            122347889999999999999999997     7999999999876443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-51  Score=328.54  Aligned_cols=255  Identities=29%  Similarity=0.467  Sum_probs=223.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ..+.-++|++++.||.|-||.||+|+.+.++-.||+|++.+..       ....+|+++...|+||||++++++|     
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----   91 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----   91 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----
Confidence            3456689999999999999999999999999999999986643       4456899999999999999999999     


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .+...+|+++||.. |.++..|..  ....++++..++.++.|++.||.|+|. ++++||||||+|+|++. .+.+||+|
T Consensus        92 hd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~-~~~lkiAd  167 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGS-AGELKIAD  167 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCC-CCCeeccC
Confidence            55566999999998 677777764  246779999999999999999999999 89999999999999996 88899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||.+.... .....+.+||..|.+||...+. .++..+|+|++|++.||++.|.+||...+..+.+.+|.+.        
T Consensus       168 fGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--------  237 (281)
T KOG0580|consen  168 FGWSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--------  237 (281)
T ss_pred             CCceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--------
Confidence            99998655 4455678999999999999665 4899999999999999999999999999988888777763        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                               ++.            ++..++.++.|||.+||.++|.+|.+..|++.|||+...
T Consensus       238 ---------~~~------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  238 ---------DLK------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             ---------ccc------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence                     222            335789999999999999999999999999999999764

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.2e-51  Score=339.94  Aligned_cols=284  Identities=36%  Similarity=0.629  Sum_probs=228.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCc----EEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ..|++.+.||+|.||.||+|..+.++.    .||||++....      ...-||+.+++.++|||++++..+|...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            368999999999999999997665543    68999986542      2335899999999999999999999653    


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC---CCCcEEEe
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKIC  156 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~---~~~~vkl~  156 (353)
                      +..+++++||.+.+|+.++..+... ...++...++.++.||+.|+.|||+ +-|+||||||.||||..   +.|.|||+
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEee
Confidence            4459999999999999999865543 3568999999999999999999999 89999999999999974   23899999


Q ss_pred             eeccccccccCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC---------hHHHH
Q 018619          157 DFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---------AVDQL  223 (353)
Q Consensus       157 Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---------~~~~~  223 (353)
                      |||+++.+.+.-    .....+-|.||+|||++.|...|+.+.|||+.|||+.||++-++.|.+..         ..+++
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            999999765542    23346779999999999999999999999999999999999999997643         34789


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCCCCC--cCCCCCCCcccc-----ccC--CCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          224 VEIIKVLGTPTREEIRCMNPNYTDF--RFPQIKAHPWHK-----VFH--KRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-----~~~--~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+|++.+|.|+...+..+... .++  .+..+....|..     .+.  +.-++.+.+|+.+||++||.+|+|++++++|
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~-Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKM-PEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHcCCCccccchhhhhC-cchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            999999999998877654321 111  011111111111     111  2235569999999999999999999999999


Q ss_pred             cccccc
Q 018619          295 PFFDEL  300 (353)
Q Consensus       295 p~f~~~  300 (353)
                      +||...
T Consensus       338 ~yF~~d  343 (438)
T KOG0666|consen  338 PYFTED  343 (438)
T ss_pred             cccccC
Confidence            999874

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.8e-50  Score=360.66  Aligned_cols=246  Identities=28%  Similarity=0.447  Sum_probs=203.2

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            47999999999999999999999999986432       2234789999999999999999887     44446899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC-
Q 018619           90 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-  167 (353)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  167 (353)
                      |+.+ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+++..... 
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCC
Confidence            9985 5544443    45679999999999999999999999 79999999999999996 788999999998754322 


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      .......||+.|+|||++.+. .++.++||||+||++|+|++|..||...+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  211 (323)
T ss_pred             CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence            223456789999999998654 5899999999999999999999999887765554443321                 0


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                      .            .++..+++++.+||++||+.||++|+     ++.++++||||+.+.+.
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            0            12346899999999999999999999     89999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-49  Score=351.03  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=207.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+..       ....+|+.+++.++|+||+++.+++     .....+
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence            4789999999999999999999999999999886432       1234799999999999999998887     334458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++||||+.+ +|...+..  .....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        76 ~lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~  151 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDD-RGHIRISDLGLAVQ  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeCCCcEE
Confidence            899999985 55444432  123468999999999999999999999 79999999999999996 78899999999987


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...........||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+.......+.......          
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05631         152 IPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------  220 (285)
T ss_pred             cCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------
Confidence            6544444456789999999999654 58999999999999999999999998766543333322211110          


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                                     ...++..+++++.+||++||+.||.+|+|     ++++++||||..+.+.
T Consensus       221 ---------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         221 ---------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             ---------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence                           11133458999999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.4e-49  Score=350.25  Aligned_cols=283  Identities=32%  Similarity=0.624  Sum_probs=227.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      -++|++.+.||+|+||.||++++..+++.||+|.+....     ....+|+.+++.++||||+++++++     .....+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-----ecCCeE
Confidence            468999999999999999999999999999999885332     2345799999999999999999998     334458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++||||++++|...+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINE-RGELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECC-CCcEEECcCcchhcc
Confidence            89999999988777654   34568999999999999999999999 79999999999999996 788999999998754


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....+++.|+|||.+.+...++.++||||+||++|+|++|++||...+..+....+...++.+....+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            33222 23346788999999987766688999999999999999999999999988888888888888777655443211


Q ss_pred             --CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          244 --NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       244 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                        .+....++....... ......+++++++||.+||+.||.+|||++++++||||+.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence              111122222111111 11234578999999999999999999999999999999887643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-49  Score=358.75  Aligned_cols=285  Identities=36%  Similarity=0.630  Sum_probs=227.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~   82 (353)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... ....
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            578999999999999999999999999999999886432      234479999999999999999988743322 2223


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ..|+++++++++|...+.     ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        94 ~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~  166 (343)
T cd07878          94 EVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNE-DCELRILDFGLAR  166 (343)
T ss_pred             cEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECC-CCCEEEcCCccce
Confidence            478999999888766553     3579999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .....  .....+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+....+....
T Consensus       167 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         167 QADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             ecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            65432  3346789999999999775668999999999999999999999999998888888888888877765544322


Q ss_pred             cCCCCC---cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          243 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       243 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      ......   .++......+...+ ...++.+.+||.+||+.||.+|||+.++++||||.....+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence            111000   11111111222222 34678899999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-50  Score=348.98  Aligned_cols=248  Identities=27%  Similarity=0.471  Sum_probs=221.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..+|++.+.||.|.||+|.+|.+...|+.||||.+.++.       ..+.+|++||..|+||||++++++|     ++..
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkd  126 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKD  126 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCc
Confidence            458999999999999999999999999999999887653       2345899999999999999999999     6666


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+.|||||.. |.|++++..    .+.+++.+++++++||..|+.|||. ++++|||||.+|||+|. ++++||+|||++
T Consensus       127 KIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~-N~NiKIADFGLS  200 (668)
T KOG0611|consen  127 KIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQ-NNNIKIADFGLS  200 (668)
T ss_pred             eEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecC-CCCeeeeccchh
Confidence            6889999998 577777764    5889999999999999999999999 89999999999999996 888999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ..+.......+++|+|.|.+||++.|.++-++.+|.||||++||.|+.|..||.+.+....+.+|-..            
T Consensus       201 Nly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G------------  268 (668)
T KOG0611|consen  201 NLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG------------  268 (668)
T ss_pred             hhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc------------
Confidence            98888888889999999999999999887799999999999999999999999999998888777552            


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                           .+.-             ..-+.++.-||++||-.||++|.|++++-+|=|++
T Consensus       269 -----aYrE-------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  269 -----AYRE-------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             -----cccC-------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence                 2211             12477899999999999999999999999998875

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=354.54  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=230.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+-|.+.+.||+|-|.+|.+|+|..||+.||||++.+..      ..+.+|++.|+.++|||||++|++.     .....
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTK   91 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTK   91 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccce
Confidence            467999999999999999999999999999999997654      2345899999999999999999998     55666


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|+|+-+ |+|++++..   ....+.++.++.|++||+.|+.|+|+ -.+|||||||+|+.+-+.-|-|||+|||++.
T Consensus        92 lyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   92 LYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccc
Confidence            999999988 488887765   45779999999999999999999999 5999999999999987778899999999999


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .+.++....+.+|+..|.|||+++|..+-.+++||||||||||.|++|++||+..++.+.+-+|+.+             
T Consensus       168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-------------  234 (864)
T KOG4717|consen  168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-------------  234 (864)
T ss_pred             cCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-------------
Confidence            9999999999999999999999999987789999999999999999999999999999999888874             


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                          .+.            ++..+|.+++|||..||..||.+|.|.++|.+|+|++......
T Consensus       235 ----KYt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~  280 (864)
T KOG4717|consen  235 ----KYT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL  280 (864)
T ss_pred             ----ccc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence                111            3457899999999999999999999999999999999876543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-49  Score=363.55  Aligned_cols=278  Identities=23%  Similarity=0.347  Sum_probs=213.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      +...+|.+.+.||+|+||.||+|.+..+++.||+|...  .....+|+.+++.++||||++++++|.     .....++|
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~lv  161 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCLI  161 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEEE
Confidence            34568999999999999999999999999999999754  234568999999999999999999883     33458899


Q ss_pred             eccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           88 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      +|++.++|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|......
T Consensus       162 ~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        162 LPRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             EecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcC-CCCEEEEeCCcccccccc
Confidence            99999887766643    4578999999999999999999999 79999999999999996 788999999999753322


Q ss_pred             --CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHHhCCCCHHHH
Q 018619          168 --EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-------NAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       168 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~  238 (353)
                        .......||+.|+|||++.+. .++.++||||+||++|+|++|..||...       +....+..++...+.++....
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             cccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence              222345789999999998654 5899999999999999999999877543       234566667776666543211


Q ss_pred             hhcCcC----C----CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          239 RCMNPN----Y----TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       239 ~~~~~~----~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ......    +    ............|...  ..++.++.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            000000    0    0000000011122221  13677899999999999999999999999999998753

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5e-49  Score=360.14  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=206.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.+..       ....+|+.++..++||||+++++.+     .+...
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence            57999999999999999999999999999999986532       2345799999999999999999888     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||+| +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus        76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~-~~~vkL~DFGla~  149 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDS-KGHVKLSDFGLCT  149 (363)
T ss_pred             EEEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCCEEEeeccCcc
Confidence            8999999985 5555554    35689999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCC------------------------------------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHH
Q 018619          163 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE  206 (353)
Q Consensus       163 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~  206 (353)
                      ......                                    .....+||+.|+|||++.+. .++.++||||+||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~e  228 (363)
T cd05628         150 GLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE  228 (363)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHH
Confidence            543211                                    01235789999999999664 58999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--
Q 018619          207 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--  284 (353)
Q Consensus       207 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--  284 (353)
                      |++|..||.+.+..+....+.......               .++.          ...+++++++||.+|+. +|.+  
T Consensus       229 ll~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~----------~~~~s~~~~~li~~l~~-~~~~r~  282 (363)
T cd05628         229 MLIGYPPFCSETPQETYKKVMNWKETL---------------IFPP----------EVPISEKAKDLILRFCC-EWEHRI  282 (363)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHcCcCcc---------------cCCC----------cCCCCHHHHHHHHHHcC-ChhhcC
Confidence            999999999888777666555421110               0110          01378999999999876 4554  


Q ss_pred             -CCCHHHHhcCcccccccCCC
Q 018619          285 -RCTALEACAHPFFDELREPN  304 (353)
Q Consensus       285 -R~t~~~~l~hp~f~~~~~~~  304 (353)
                       ||+++|+++||||+.+.+..
T Consensus       283 ~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         283 GAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCCHHHHhCCCCCCCCCHHH
Confidence             57999999999999876543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-49  Score=361.76  Aligned_cols=255  Identities=31%  Similarity=0.492  Sum_probs=207.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.+++.++||||+++++++     .....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence            47999999999999999999999999999999996432       2245799999999999999999988     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||.+ +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~  149 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDA-KGHIKLSDFGLCT  149 (364)
T ss_pred             EEEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEeecccce
Confidence            8999999985 5555544    35679999999999999999999999 79999999999999996 8889999999987


Q ss_pred             ccccCCC---------------------------------------cceeeeeceeeChhhhhCCCCCCccccchhHHHH
Q 018619          163 QLIAGEA---------------------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCV  203 (353)
Q Consensus       163 ~~~~~~~---------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i  203 (353)
                      .......                                       ....+||+.|+|||++.+ ..++.++||||+||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~i  228 (364)
T cd05599         150 GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVI  228 (364)
T ss_pred             eccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhH
Confidence            5432110                                       012468999999999855 458999999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCC
Q 018619          204 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS  283 (353)
Q Consensus       204 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  283 (353)
                      +|+|++|..||.+.+..+....+.+....               ..++.          ...+++++++||++||. ||.
T Consensus       229 l~el~~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~~li~~ll~-~p~  282 (364)
T cd05599         229 MYEMLVGYPPFCSDNPQETYRKIINWKET---------------LQFPD----------EVPLSPEAKDLIKRLCC-EAE  282 (364)
T ss_pred             HHHhhcCCCCCCCCCHHHHHHHHHcCCCc---------------cCCCC----------CCCCCHHHHHHHHHHcc-CHh
Confidence            99999999999988876665554431100               00110          01478999999999997 999


Q ss_pred             CCCC---HHHHhcCcccccccCC
Q 018619          284 LRCT---ALEACAHPFFDELREP  303 (353)
Q Consensus       284 ~R~t---~~~~l~hp~f~~~~~~  303 (353)
                      +|++   +.++++||||+...+.
T Consensus       283 ~R~~~~~~~~ll~h~~~~~~~~~  305 (364)
T cd05599         283 RRLGNNGVNEIKSHPFFKGVDWE  305 (364)
T ss_pred             hcCCCCCHHHHhcCCCcCCCCHH
Confidence            9998   9999999999987543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-49  Score=356.77  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=209.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCC-cEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|.+.+.||+|+||.||+|.+..++ ..||+|.+.+..       ....+|+.+++.++||||+++++++     .
T Consensus        27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~  101 (340)
T PTZ00426         27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----K  101 (340)
T ss_pred             CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----E
Confidence            44578999999999999999999876655 689999886432       2334799999999999999999988     3


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+||||+.+ +|.+.+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~ikL~DF  175 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDK-DGFIKMTDF  175 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEecC
Confidence            34458999999975 5655554    35679999999999999999999999 79999999999999996 889999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |++.....  ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+....        
T Consensus       176 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------  244 (340)
T PTZ00426        176 GFAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------  244 (340)
T ss_pred             CCCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC--------
Confidence            99986533  23456789999999999664 48999999999999999999999999887765555544310        


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                               .            .++..+++++.++|++||+.||.+|+     |++++++||||+++.+.
T Consensus       245 ---------~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~  293 (340)
T PTZ00426        245 ---------I------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV  293 (340)
T ss_pred             ---------C------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence                     0            12345789999999999999999996     89999999999987643

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.8e-48  Score=343.63  Aligned_cols=275  Identities=35%  Similarity=0.588  Sum_probs=218.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++     .+...++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            5899999999999999999999999999999886431      2345799999999999999999988     3444588


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +++||+++++.+.+..   ....+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.+||+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINK-NGELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcC-CCcEEECccchhhccC
Confidence            9999999987776653   34679999999999999999999999 79999999999999996 7889999999998654


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... .....+++.|+|||.+.+...++.++||||+||++|+|++|..| |.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            3322 22346688999999987766679999999999999999998877 566666777777777777766554433221


Q ss_pred             CCCCCcCCCCCC-CccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ......++.... ..|.. ....+++++.+||.+||+.||.+|||+++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         231 LPDYKPYPMYPATTSLVN-VVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cccccccCCCCCcchhhh-hcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            101011111111 12222 234589999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-50  Score=332.87  Aligned_cols=263  Identities=29%  Similarity=0.467  Sum_probs=214.3

Q ss_pred             ecceeeEe-eeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEE
Q 018619            9 QTISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus         9 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..++|.+- ++||-|-.|+|-.+.++.||+.+|+|++. +.....+|+++.... .|||||+++++|.. ...+..++.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~rkcLLi  136 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYEN-SYQGRKCLLI  136 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccCceeeEe
Confidence            46677664 58999999999999999999999999774 445556888876555 69999999998733 3356778889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeeeccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQ  163 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Dfg~a~~  163 (353)
                      |||.+.| .|...++.  ..++.++|.++..|+.||+.|+.|||+ .+|.||||||+|+|...  .+..+||+|||+|+.
T Consensus       137 VmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEecccccccc
Confidence            9999996 45555543  245679999999999999999999999 69999999999999953  356799999999998


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~  239 (353)
                      ........+.+.||+|.|||++ |.+.|+..+|+||+||++|-|++|.+||.+.....    +-.+|..           
T Consensus       214 t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~-----------  281 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT-----------  281 (400)
T ss_pred             cCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-----------
Confidence            7776777788899999999998 77779999999999999999999999998765421    1111211           


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                            ..+.||.   ..|     ..+|++++|+|+++|..+|++|+|+.++++|||+.+...
T Consensus       282 ------gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  282 ------GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             ------cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence                  2333432   334     348999999999999999999999999999999998643

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.6e-48  Score=349.25  Aligned_cols=278  Identities=33%  Similarity=0.561  Sum_probs=210.4

Q ss_pred             eeeeecCCCeEEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           16 ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      .+.||+|+||.||+|+++  .+++.||+|.+....  ....+|+.+++.++||||+++++++...   ....+|++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            468999999999999965  467899999886543  3356899999999999999999887542   234588999999


Q ss_pred             cchHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe---CCCCcEEEeeeccccc
Q 018619           92 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ  163 (353)
Q Consensus        92 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~---~~~~~vkl~Dfg~a~~  163 (353)
                      ++++...+.....     ....+++..++.++.||+.||+|||+ +||+||||||+|||++   ..++.+||+|||+|..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9988877654221     12358999999999999999999999 7999999999999994   2356899999999986


Q ss_pred             cccCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 018619          164 LIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL  230 (353)
Q Consensus       164 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~  230 (353)
                      .....    ......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.....         .+.+..+.+.+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            54332    123457799999999997766689999999999999999999999975442         35667777878


Q ss_pred             CCCCHHHHhhcCcCCCC------C---cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          231 GTPTREEIRCMNPNYTD------F---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      +.+....+.........      +   .........+........+.++.+||.+||++||.+|+|++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            87776554432211000      0   0000000001111112346789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-48  Score=359.42  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=203.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .|.+++.||+|+||+||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++.     ....+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            5899999999999999999999999999999986432       23457999999999999999999883     34458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+|||||++ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~-~~~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDL-DGHIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECC-CCCEEEeeCcCCcc
Confidence            999999985 5555554    34679999999999999999999999 79999999999999996 78899999999753


Q ss_pred             cccCC------------------------------------------------CcceeeeeceeeChhhhhCCCCCCccc
Q 018619          164 LIAGE------------------------------------------------ANISYICSRFYRAPELIFGATEYTTSI  195 (353)
Q Consensus       164 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  195 (353)
                      .....                                                ...+..||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence            21000                                                01234689999999998654 589999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHH
Q 018619          196 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS  275 (353)
Q Consensus       196 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  275 (353)
                      ||||+||++|+|++|..||...+..+....+.......               ..+          ....+++++++||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~----------~~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HIP----------PQVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CCC----------CCCCCCHHHHHHHH
Confidence            99999999999999999998877665554444311100               001          01247899999999


Q ss_pred             HhcCc--CCCCCCCHHHHhcCcccccccCC
Q 018619          276 RLLQY--SPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       276 ~~L~~--dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      +||..  ++..|++++++++||||+.+.+.
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~  314 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAHPFFSEVDFS  314 (381)
T ss_pred             HHccCcccccCCCCHHHHhcCcccCCCChh
Confidence            96654  44559999999999999987553

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-49  Score=361.20  Aligned_cols=254  Identities=29%  Similarity=0.470  Sum_probs=204.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||++.+..+++.||||++.+..       ....+|+.+++.++||||++++++|     .+...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence            47999999999999999999999999999999886432       2345799999999999999999988     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+++ +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus        76 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~-~~~~kl~DfGla~  149 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDR-GGHIKLSDFGLST  149 (377)
T ss_pred             eEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEEeeccccc
Confidence            8999999974 6655554    35678999999999999999999999 79999999999999996 7889999999986


Q ss_pred             ccccCCC------------------------------------------------cceeeeeceeeChhhhhCCCCCCcc
Q 018619          163 QLIAGEA------------------------------------------------NISYICSRFYRAPELIFGATEYTTS  194 (353)
Q Consensus       163 ~~~~~~~------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~  194 (353)
                      .......                                                .....||+.|+|||++.+. .++.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  228 (377)
T cd05629         150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQE  228 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCc
Confidence            3211000                                                0124689999999998654 58999


Q ss_pred             ccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHH
Q 018619          195 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLA  274 (353)
Q Consensus       195 ~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  274 (353)
                      +||||+||++|+|++|.+||.+.+..+....+......               ..++.          ...++.++.+||
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~dli  283 (377)
T cd05629         229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------LYFPD----------DIHLSVEAEDLI  283 (377)
T ss_pred             eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------cCCCC----------CCCCCHHHHHHH
Confidence            99999999999999999999888776665555431100               01110          024789999999


Q ss_pred             HHhcCcCCCCC---CCHHHHhcCcccccccC
Q 018619          275 SRLLQYSPSLR---CTALEACAHPFFDELRE  302 (353)
Q Consensus       275 ~~~L~~dp~~R---~t~~~~l~hp~f~~~~~  302 (353)
                      .+||+ +|.+|   +|+.++++||||+...+
T Consensus       284 ~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         284 RRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             HHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99998 77765   59999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-48  Score=353.61  Aligned_cols=257  Identities=29%  Similarity=0.469  Sum_probs=210.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||+|++..+++.||+|++.+..       ....+|+.++..++||||+++++++     .....
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence            47999999999999999999999999999999986432       2345799999999999999999888     44446


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+++ +|.+.+.    ..+.+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~  149 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDA-SGHIKLTDFGLSK  149 (333)
T ss_pred             EEEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEEEeCcCCc
Confidence            8999999985 6655554    35678999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ....  ......||+.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+........        
T Consensus       150 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------  218 (333)
T cd05600         150 GIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------  218 (333)
T ss_pred             cccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc--------
Confidence            6543  23456789999999999665 589999999999999999999999998877766655443211000        


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                             .+.     +.. ....+++++.+||.+||+.+|.+|+|+.++++||||+.+.+
T Consensus       219 -------~~~-----~~~-~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         219 -------RPV-----YDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             -------CCC-----CCc-cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence                   000     000 00247899999999999999999999999999999998654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-48  Score=360.20  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=204.8

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +|++++.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++.+.     +...+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            6899999999999999999999999999999986532       23457999999999999999999883     34458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+|||||++ +|.+.+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus        77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEeECCCCcc
Confidence            999999985 5655554    34678999999999999999999999 79999999999999996 88899999999753


Q ss_pred             cccC------------------------------------------------CCcceeeeeceeeChhhhhCCCCCCccc
Q 018619          164 LIAG------------------------------------------------EANISYICSRFYRAPELIFGATEYTTSI  195 (353)
Q Consensus       164 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  195 (353)
                      ....                                                ....+..||+.|+|||++.+. .++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence            2100                                                001124689999999999654 589999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHH
Q 018619          196 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS  275 (353)
Q Consensus       196 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  275 (353)
                      ||||+||++|+|++|++||.+.+..+....+.......               ..+          ....+++++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------HIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------CCC----------CcccCCHHHHHHHH
Confidence            99999999999999999999887766655544311110               000          01247999999999


Q ss_pred             HhcCcCCCCCCC---HHHHhcCcccccccCC
Q 018619          276 RLLQYSPSLRCT---ALEACAHPFFDELREP  303 (353)
Q Consensus       276 ~~L~~dp~~R~t---~~~~l~hp~f~~~~~~  303 (353)
                      +|+ .||.+|++   ++++++||||+.+.+.
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            987 59999997   9999999999886543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-49  Score=356.93  Aligned_cols=255  Identities=31%  Similarity=0.516  Sum_probs=210.6

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||+|++..+++.||||++.+..       ....+|+.++..++||||+++++++     .....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence            47999999999999999999999999999999986432       2345799999999999999999887     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+.+ +|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~  149 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDA-DGHIKLADFGLCK  149 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEeecCCCCc
Confidence            8999999975 66666543    3679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCC------------------------------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCC
Q 018619          163 QLIAGE------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  212 (353)
Q Consensus       163 ~~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  212 (353)
                      ......                              ......||+.|+|||++.+. .++.++|||||||++|+|++|..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~  228 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFP  228 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCC
Confidence            654433                              22345789999999999665 58999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-HHHH
Q 018619          213 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEA  291 (353)
Q Consensus       213 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~~~  291 (353)
                      ||...+.......+......               ..++.          ...+++++.+||.+||. ||.+|++ ++++
T Consensus       229 Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~l  282 (350)
T cd05573         229 PFYSDTLQETYNKIINWKES---------------LRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEI  282 (350)
T ss_pred             CCCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence            99988866665555431110               00110          11268999999999998 9999999 9999


Q ss_pred             hcCcccccccCC
Q 018619          292 CAHPFFDELREP  303 (353)
Q Consensus       292 l~hp~f~~~~~~  303 (353)
                      ++||||+.+.+.
T Consensus       283 l~hp~~~~~~~~  294 (350)
T cd05573         283 KSHPFFKGIDWE  294 (350)
T ss_pred             hcCCCcCCCCHH
Confidence            999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=349.21  Aligned_cols=242  Identities=31%  Similarity=0.521  Sum_probs=199.7

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++||||+++++++     ......|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999886431       2234799999999999999998887     3344588999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC-C
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-A  169 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~  169 (353)
                      ++ +|.+.+.    ..+.+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||+++...... .
T Consensus        76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCc
Confidence            85 5555554    35679999999999999999999999 79999999999999996 7889999999997543322 2


Q ss_pred             cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCc
Q 018619          170 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  249 (353)
Q Consensus       170 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
                      .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...                    
T Consensus       150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--------------------  208 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--------------------  208 (312)
T ss_pred             cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--------------------
Confidence            3345789999999999664 5899999999999999999999999887766555444321                    


Q ss_pred             CCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC---CHHHHhcCccccccc
Q 018619          250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELR  301 (353)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~~~l~hp~f~~~~  301 (353)
                               ...++..+++++.+||.+||+.||.+|+   ++.++++||||++..
T Consensus       209 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~  254 (312)
T cd05585         209 ---------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS  254 (312)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence                     0012345789999999999999999997   589999999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-48  Score=351.93  Aligned_cols=245  Identities=28%  Similarity=0.448  Sum_probs=200.9

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.||+|+||.||++++..+++.||+|++.+..       ....+|+.+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            47999999999999999999999999986532       2334789999999999999998887     44445899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC-
Q 018619           90 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-  167 (353)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  167 (353)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...... 
T Consensus        76 y~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcc
Confidence            9985 5544443    35679999999999999999999999 79999999999999996 788999999998754322 


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      .......||+.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~  211 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D  211 (328)
T ss_pred             cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence            222345689999999998654 5899999999999999999999999887765544433210                 0


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                      .            .++..+++++.+||++||+.||.+|+     ++.++++||||....+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~  259 (328)
T cd05593         212 I------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW  259 (328)
T ss_pred             c------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            0            12345899999999999999999997     8999999999987654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.9e-48  Score=353.09  Aligned_cols=258  Identities=26%  Similarity=0.435  Sum_probs=209.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...++|++.+.||+|+||.||++++..+++.||+|.+.+.       .....+|+.+++.++||||+++++++     ..
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QD  114 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence            4567999999999999999999999999999999988642       22345799999999999999999988     44


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|||||++ +|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~-~~~~kL~DFG  187 (370)
T cd05621         115 DKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDK-HGHLKLADFG  187 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEEecc
Confidence            4568999999985 66665542     468999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCC--cceeeeeceeeChhhhhCCC---CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          160 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      +|........  .....||+.|+|||++.+..   .++.++|+||+||++|+|++|..||.+.+......++....... 
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-  266 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-  266 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc-
Confidence            9986543322  23457899999999986532   37889999999999999999999999888766665554421110 


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCcccccccC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE  302 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~~  302 (353)
                                    .++.          ...++..++++|.+||+.++.+  |+|+.++++||||+...+
T Consensus       267 --------------~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~  312 (370)
T cd05621         267 --------------NFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW  312 (370)
T ss_pred             --------------CCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence                          0110          1246899999999999866654  889999999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.2e-48  Score=354.40  Aligned_cols=259  Identities=25%  Similarity=0.431  Sum_probs=211.0

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|.+.+..       ....+|+.+++.++||||+++++++     .
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~  113 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----Q  113 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence            355679999999999999999999999999999999986421       2245799999999999999999887     4


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+|||||++ +|.+.+..     ..+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~-~~~~kL~Df  186 (370)
T cd05596         114 DDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADF  186 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcC-CCCEEEEec
Confidence            44568999999985 56655532     468899999999999999999999 79999999999999996 889999999


Q ss_pred             ccccccccCCC--cceeeeeceeeChhhhhCC---CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGEA--NISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |++........  .....||+.|+|||++.+.   ..++.++||||+||++|+|++|..||.+.+.......+...... 
T Consensus       187 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-  265 (370)
T cd05596         187 GTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS-  265 (370)
T ss_pred             cceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc-
Confidence            99986543322  2345789999999998653   24788999999999999999999999988876666555431110 


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCcccccccC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELRE  302 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~~  302 (353)
                                    ..++.          ...+|.++.+||++||+.+|.+  |+|++++++||||+...+
T Consensus       266 --------------~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~  312 (370)
T cd05596         266 --------------LTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQW  312 (370)
T ss_pred             --------------CCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCCh
Confidence                          01110          1247999999999999999998  999999999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.6e-49  Score=360.11  Aligned_cols=254  Identities=27%  Similarity=0.429  Sum_probs=204.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++||||+++++.|     .....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~   75 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN   75 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence            3699999999999999999999999999999988542       23345799999999999999999888     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||++ +|.+.+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|.
T Consensus        76 ~~lv~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~  149 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLCT  149 (376)
T ss_pred             EEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECC-CCCEEEEeCCCCc
Confidence            8999999985 6666554    34678999999999999999999999 79999999999999996 7889999999975


Q ss_pred             ccccC--------------------------------------------CCcceeeeeceeeChhhhhCCCCCCccccch
Q 018619          163 QLIAG--------------------------------------------EANISYICSRFYRAPELIFGATEYTTSIDIW  198 (353)
Q Consensus       163 ~~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  198 (353)
                      .....                                            .......||+.|+|||++.+. .++.++|||
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  228 (376)
T cd05598         150 GFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWW  228 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeee
Confidence            32100                                            001134689999999999654 589999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhc
Q 018619          199 SAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL  278 (353)
Q Consensus       199 SlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  278 (353)
                      |+||++|+|++|+.||.+.+..+....+......               ...+          ....+++++.++|.+|+
T Consensus       229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~l~  283 (376)
T cd05598         229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIP----------SQAKLSREASDLILRLC  283 (376)
T ss_pred             eccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCC----------CCCCCCHHHHHHHHHHh
Confidence            9999999999999999988776655444321000               0000          01247899999999987


Q ss_pred             CcCCCCCC---CHHHHhcCcccccccC
Q 018619          279 QYSPSLRC---TALEACAHPFFDELRE  302 (353)
Q Consensus       279 ~~dp~~R~---t~~~~l~hp~f~~~~~  302 (353)
                       .+|.+|+   |+.++++||||+.+..
T Consensus       284 -~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         284 -CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             -cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence             5999999   9999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2e-48  Score=350.57  Aligned_cols=245  Identities=27%  Similarity=0.446  Sum_probs=201.8

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.||+|+||.||++++..+|+.||+|++.+..       ....+|+.+++.++||||++++++|     .....+|+|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            47999999999999999999999999986532       2234689999999999999999888     33445899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC-
Q 018619           90 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-  167 (353)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  167 (353)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCC
Confidence            9985 5544443    45679999999999999999999999 79999999999999996 788999999998753322 


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      .......||+.|+|||.+.+. .++.++||||+||++|+|++|..||...+.......+...                 .
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~  211 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E  211 (323)
T ss_pred             CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            222345689999999998654 5899999999999999999999999887766555444321                 0


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                      .            .++..+++++.+||.+||+.||.+|+     ++.++++||||.+..+
T Consensus       212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~  259 (323)
T cd05595         212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  259 (323)
T ss_pred             C------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            0            12345799999999999999999998     8999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.5e-48  Score=362.94  Aligned_cols=280  Identities=25%  Similarity=0.381  Sum_probs=212.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCC------ceeecceeeeecCCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFSTTSKN   80 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~~~~~~   80 (353)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....   .....|+.+++.++|.      ++++++++|..    .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            578999999999999999999999999999999985432   2335678888777554      57777776632    2


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC---------
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---------  151 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~---------  151 (353)
                      ...+|+|||+++++|.+.+..    .+.+++..++.++.||+.||+|||+..||+||||||+|||++..+.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            235889999999888776653    4679999999999999999999997139999999999999985321         


Q ss_pred             ------cEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018619          152 ------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE  225 (353)
Q Consensus       152 ------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  225 (353)
                            .+||+|||.+....  .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  59999999886422  223456789999999999765 489999999999999999999999999998888888


Q ss_pred             HHHHhCCCCHHHHhhcCcC-CCCC-----c-CCCCC---------CCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH
Q 018619          226 IIKVLGTPTREEIRCMNPN-YTDF-----R-FPQIK---------AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL  289 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~-~~~~-----~-~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  289 (353)
                      +.+.++.++.......... ..++     . .+...         ...+...   ..++.+.|||.+||++||.+|+|++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~dli~~mL~~dP~~R~ta~  433 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV---IRDDLLCDLIYGLLHYDRQKRLNAR  433 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh---hchHHHHHHHHHhCCcChhhCCCHH
Confidence            8888887765432211000 0000     0 00000         0001110   1246788999999999999999999


Q ss_pred             HHhcCcccccccCC
Q 018619          290 EACAHPFFDELREP  303 (353)
Q Consensus       290 ~~l~hp~f~~~~~~  303 (353)
                      |+|+||||.+....
T Consensus       434 e~L~Hp~~~~~~~~  447 (467)
T PTZ00284        434 QMTTHPYVLKYYPE  447 (467)
T ss_pred             HHhcCccccccCCc
Confidence            99999999876443

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-47  Score=346.46  Aligned_cols=319  Identities=36%  Similarity=0.640  Sum_probs=244.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|.+.+.||+|+||+||++.+..+++.||||.+...      .....+|+.+++.++||||+++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            56899999999999999999999999999999988542      123347999999999999999999875544333345


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +|+++||+.++|.+.+.    ..+.+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.+||+|||++..
T Consensus        84 ~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMDTDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNA-NCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCCCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcCccccc
Confidence            88999999988776664    35679999999999999999999999 79999999999999996 78899999999986


Q ss_pred             cccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+.......+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            54432 22345678899999998654558999999999999999999999999988888888888888877765543211


Q ss_pred             cC-CCCC--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCc
Q 018619          243 PN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF  319 (353)
Q Consensus       243 ~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  319 (353)
                      .. ...+  ..+......+.. ....+++++.+||++||+.||++|||+.++++||||+.++.......  ...+  +.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~--~~~~--~~~  312 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPV--CQTP--FSF  312 (337)
T ss_pred             chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCcc--CCCc--cch
Confidence            11 0000  001111111111 22358999999999999999999999999999999999877654322  1222  244


Q ss_pred             hhhhccCCHHHHhhccHHHH
Q 018619          320 KQELSGASPELVNKLIPDHV  339 (353)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~  339 (353)
                      .-+..+.+.+.+.+++-.+.
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~  332 (337)
T cd07858         313 DFEEDALTEEDIKELIYNEM  332 (337)
T ss_pred             hhhhhhcCHHHHHHHHHHHH
Confidence            44444466667776665554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.6e-48  Score=351.10  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=209.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||+|++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .....
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence            47999999999999999999999999999999986532       2345789999999999999998887     33445


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~  150 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDR-TGHIKLADFGSAA  150 (330)
T ss_pred             EEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECC-CCCEEeccCCCCe
Confidence            889999997 466666543   23679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      ........  ....||+.|+|||++.+     ...++.++||||+||++|+|++|..||...+....+..+......   
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~---  227 (330)
T cd05601         151 RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF---  227 (330)
T ss_pred             ECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc---
Confidence            66543322  23468999999999853     345788999999999999999999999888777666555432100   


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                  ..++.          ...+++++.+||++||+ ||.+|+|++++++||||+.+.+.
T Consensus       228 ------------~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~  272 (330)
T cd05601         228 ------------LKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN  272 (330)
T ss_pred             ------------cCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence                        00110          12478999999999998 99999999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-47  Score=346.02  Aligned_cols=287  Identities=36%  Similarity=0.686  Sum_probs=227.2

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+++|.+.+.||+|++|.||++.+..+|+.||+|.+....     ....+|+.+++.++||||+++++++..........
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3678999999999999999999999999999999885321     22446999999999999999998775444344456


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .|+++||+.+++...+.     ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~  155 (336)
T cd07849          83 VYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-NCDLKICDFGLARI  155 (336)
T ss_pred             EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECC-CCCEEECcccceee
Confidence            88999999998776654     3579999999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .......    ....+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+.......+...++.+..+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            5432221    234678899999998665568999999999999999999999999988888888888877777665544


Q ss_pred             hcCcCCCC-C--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          240 CMNPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       240 ~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      ........ +  ..+.....+|... ....++++.+||.+||+.||.+|||+.++++||||+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence            32211100 0  0111111222221 12468899999999999999999999999999999988654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.8e-48  Score=347.62  Aligned_cols=245  Identities=29%  Similarity=0.505  Sum_probs=200.6

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|+++.+++.||+|++.+..       ....+|..++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986432       2234677777766 699999999988     3444589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+++ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 Ey~~~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcC
Confidence            99985 5544443    45679999999999999999999999 79999999999999996 788999999998754322


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~-----------------  211 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-----------------  211 (320)
T ss_pred             CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence             223345789999999998654 5899999999999999999999999988877666554431                 


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH------HHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~~~l~hp~f~~~~~  302 (353)
                      ..            .++..++.++.+||++||+.||.+|+++      +++++||||+.+.+
T Consensus       212 ~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         212 EV------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            00            1223478999999999999999999998      89999999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-47  Score=339.27  Aligned_cols=276  Identities=34%  Similarity=0.664  Sum_probs=217.6

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||+|++|.||+|.+..+++.||+|++....      ....+|+.+++.++|||++++++++.     ....+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            5899999999999999999999999999999885321      23467999999999999999999884     334588


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +||||+.+++.+.+... ..+..+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSL-PKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcC-CCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcC-CCcEEECcccceeecC
Confidence            99999998877776542 234679999999999999999999999 79999999999999996 8889999999987543


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+.+..+.+....+..... 
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  231 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS-  231 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh-
Confidence            3221 22345688999999987666678999999999999999999999999888887777777776665443321110 


Q ss_pred             CCCC--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          245 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       245 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ..++  ..+....... ......+++++.++|++||+.||.+|||+.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         232 LPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            0000  0111111111 11123579999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.9e-48  Score=347.40  Aligned_cols=250  Identities=30%  Similarity=0.455  Sum_probs=204.3

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCC-ceeecceeeeecCCCCcee
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~   83 (353)
                      +|++.+.||+|+||.||+|++..+++.||+|++.+..       .....|..++..++|+ +|+++++++     .....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence            5899999999999999999999999999999986532       2234688888888765 577887777     33345


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDA-EGHIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcC-CCCEEEeecCcce
Confidence            8899999985 5554443    35678999999999999999999999 79999999999999996 7889999999987


Q ss_pred             cccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .... ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            5322 2233445789999999999664 48999999999999999999999999888776665554310           


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH-----HHHhcCcccccccC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELRE  302 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~f~~~~~  302 (353)
                                        ..++..+++++.++|.+||+.||.+|++.     +++++||||+.+.+
T Consensus       218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                              11234578999999999999999999976     89999999998755

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=378.07  Aligned_cols=270  Identities=27%  Similarity=0.466  Sum_probs=227.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|.++++||+|+||.|.+++++.|++.||+|++.+-       ...++.|-++|-.-+.+-|+.++-.|     ++
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD  146 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QD  146 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cC
Confidence            5678999999999999999999999999999999999762       34567788898888899999998888     77


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      +.++|+||||++| +|..++..+    .++++..+++|+..|+.||.-+|++ |+|||||||+|||+|. .|.+||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDiKPDNvLld~-~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDIKPDNVLLDK-SGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccCCcceeEecc-cCcEeeccch
Confidence            8889999999995 677776653    4899999999999999999999995 9999999999999997 8889999999


Q ss_pred             cccccccCCC--cceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          160 SAKQLIAGEA--NISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       160 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      .|-.+..++.  ....+|||.|.|||++..    ...|+..+|+||+||++|||+.|..||...+-.+.+.+|++.-   
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---  297 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---  297 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh---
Confidence            9988775543  345789999999999843    2468999999999999999999999999999999998888741   


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC---HHHHhcCcccccccCCCCCCCCC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREPNARLPNG  310 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~~~l~hp~f~~~~~~~~~~~~~  310 (353)
                                  ..+.||..          ..+|+++++||++++. +|++|..   ++++.+||||.++.|.+-+-...
T Consensus       298 ------------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~p  354 (1317)
T KOG0612|consen  298 ------------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVP  354 (1317)
T ss_pred             ------------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCC
Confidence                        11222210          2489999999999998 8999998   99999999999999865443333


Q ss_pred             CCCC
Q 018619          311 RPLP  314 (353)
Q Consensus       311 ~~~~  314 (353)
                      +.+|
T Consensus       355 P~vP  358 (1317)
T KOG0612|consen  355 PVVP  358 (1317)
T ss_pred             CCCC
Confidence            3333

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.5e-48  Score=346.79  Aligned_cols=248  Identities=29%  Similarity=0.487  Sum_probs=202.1

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHH---HHcCCCceeecceeeeecCCCCce
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM---RVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |++.+.||+|+||.||+|.+..+++.||||++.+..       ....+|+.++   +.++||||+++++++     ....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            788999999999999999999999999999986432       2233455544   456799999999988     3444


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+||||+.+ +|...+.     .+.+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDT-EGFVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECC-CCcEEeCcccCC
Confidence            58999999996 4433332     3579999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ...... .......|++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+....+....          
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------  217 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------  217 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            754332 223346789999999998654 58999999999999999999999999888776665544310          


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                                         ..++..++.++.++|.+||+.||.+||     ++.++++||||+.+.+
T Consensus       218 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         218 -------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence                               012345789999999999999999999     6999999999988654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.5e-49  Score=349.53  Aligned_cols=254  Identities=28%  Similarity=0.463  Sum_probs=222.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|..++++|+|+||.+++++++..++.|++|++.-.      ++...+|..++++++|||||.+.+.|.    .+...
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~   78 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL   78 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence            57899999999999999999999999999999998533      334568999999999999999999883    33334


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ++|||+||+| ++.+.+....  +..++++.+..|+.|++.|++|||+ ++|+|||||+.||+++. ++.|||+|||+|+
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTK-DKKVKLGDFGLAK  154 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccc-cCceeecchhhhh
Confidence            9999999995 6666666532  5779999999999999999999999 89999999999999997 6668999999999


Q ss_pred             ccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...... ...+.+||+.|++||++.+. +|+.++|||||||++|||++-+++|.+.+....+.+|.+....|.       
T Consensus       155 ~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl-------  226 (426)
T KOG0589|consen  155 ILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL-------  226 (426)
T ss_pred             hcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------
Confidence            887776 56778999999999999654 599999999999999999999999999999999998888643332       


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                           +...+.+++.+|+.||..+|..||++.++|.+|.....
T Consensus       227 ---------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  227 ---------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             ---------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence                                 34579999999999999999999999999999998754

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.9e-48  Score=349.13  Aligned_cols=247  Identities=28%  Similarity=0.438  Sum_probs=200.7

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.||+|+||.||++++..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .....+|+|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            47999999999999999999999999986532       2234688899999999999998887     34446899999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC-
Q 018619           90 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-  167 (353)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  167 (353)
                      |+++ +|...+.    ....+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCC
Confidence            9986 4444333    45679999999999999999999996249999999999999996 788999999998754322 


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...                 .
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~  212 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E  212 (325)
T ss_pred             cccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence            223345689999999998654 5899999999999999999999999887765554433221                 0


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                      .            .++..+++++.+||++||+.||.+|+     ++.++++||||++..+.
T Consensus       213 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         213 I------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             C------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            0            12345799999999999999999997     89999999999986543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.1e-47  Score=345.74  Aligned_cols=287  Identities=33%  Similarity=0.578  Sum_probs=226.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~   80 (353)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||.+.+..      ....+|+.+++.++||||++++++|..... .+
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            34688999999999999999999999999999999885421      233479999999999999999998754332 22


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...+|+||||+.+++.+.+..      .+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus        93 ~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~  164 (353)
T cd07850          93 FQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGL  164 (353)
T ss_pred             cCcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCcc
Confidence            235789999999987776643      28899999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............+++.|+|||.+.+. .++.++||||+||++|+|++|+.||...+..+....+.+.++.+.......
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            9876554444455678899999999664 589999999999999999999999999998888888888888887654433


Q ss_pred             cCcCCCCCc--CCCCCCCcccccc------------CCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          241 MNPNYTDFR--FPQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       241 ~~~~~~~~~--~~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      .......+.  .+.....++...+            ....++.+++||.+||+.||++|||+.|+|.||||+.+-..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence            221111100  0000001111111            22356789999999999999999999999999999876544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-47  Score=345.77  Aligned_cols=246  Identities=29%  Similarity=0.484  Sum_probs=201.4

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|++..+++.||+|++.+..       .....|..++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            46999999999999999999999999986532       1234677888765 799999999988     3444589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus        76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEeecccceecccC
Confidence            99985 5544443    35678999999999999999999999 79999999999999996 788999999998754322


Q ss_pred             C-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      . ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||...+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-----------------  211 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-----------------  211 (321)
T ss_pred             CccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2 2334568999999999865 45899999999999999999999999988877766555431                 


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-------CHHHHhcCcccccccCC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-------TALEACAHPFFDELREP  303 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-------t~~~~l~hp~f~~~~~~  303 (353)
                      ..            .++..+++++.++|.+||+.||.+|+       +++++++||||..+.+.
T Consensus       212 ~~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         212 DV------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             CC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence            00            12234789999999999999999999       89999999999886543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-47  Score=338.10  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=200.9

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ||+|+||+||++.+..+++.||+|++.+..       .....|+.+++.++||||+++.+++     .....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999986432       2234699999999999999998887     3444588999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC-
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-  169 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-  169 (353)
                      ++ +|...+......+..+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCcc
Confidence            85 5555554433455679999999999999999999999 79999999999999996 78899999999976544332 


Q ss_pred             cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCc
Q 018619          170 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  249 (353)
Q Consensus       170 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
                      .....||+.|+|||.+.+. .++.++|+||+||++|+|++|+.||...+................               
T Consensus       154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  217 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS---------------  217 (280)
T ss_pred             ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---------------
Confidence            2345689999999999664 588999999999999999999999987553322222221110000               


Q ss_pred             CCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                                ..++..+++++.+++.+||+.||++|+     |++++++||||+.+.+.
T Consensus       218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~  266 (280)
T cd05608         218 ----------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR  266 (280)
T ss_pred             ----------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence                      012345799999999999999999999     88999999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-47  Score=347.55  Aligned_cols=255  Identities=29%  Similarity=0.468  Sum_probs=201.6

Q ss_pred             eeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619           12 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +|++.+.||+|+||.||++++.   .+++.||+|++.+..        ....+|+.+++.+ +||||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            5899999999999999999864   478999999886431        2234689999999 589999998887     4


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+++||||+.+ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDS-EGHVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECC-CCCEEEeeC
Confidence            44558899999985 5555553    34679999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          159 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       159 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      |++........  .....||+.|+|||++.+...++.++|||||||++|+|++|..||...+.......+......    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            99986533322  234578999999999976556789999999999999999999999754322111111111000    


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                          .                 ...++..+++.+.+||.+||+.||++|+     +++++++||||+...+
T Consensus       226 ----~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  275 (332)
T cd05614         226 ----C-----------------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW  275 (332)
T ss_pred             ----C-----------------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence                0                 0112345789999999999999999999     8899999999997654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-47  Score=337.17  Aligned_cols=257  Identities=27%  Similarity=0.411  Sum_probs=207.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .|++.+.||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++     .....+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            4899999999999999999999999999999886432       2235799999999999999998887     333458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+||||+.+ +|...+..  .....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDD-YGHIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECC-CCCEEEeeCCCcee
Confidence            999999985 55544432  233569999999999999999999999 79999999999999996 78899999999987


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...........|++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...+....         
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ---------  221 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc---------
Confidence            6544443455789999999998654 589999999999999999999999987765444333332211100         


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                                      ..++..++..+.+||.+||+.||.+||     +++++++||||....+.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         222 ----------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             ----------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence                            112245789999999999999999999     89999999999875443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-47  Score=340.99  Aligned_cols=250  Identities=31%  Similarity=0.455  Sum_probs=205.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcE-EEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGET-VAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +.+......+.+.+|+|+||+||.+..  .|.. ||+|++....      ..+.+|+.+|.+++|||||++++++.....
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            455566677788899999999999987  4445 9999996532      356789999999999999999999843331


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-eeeccCCCCcEEEeCCCC-cEEE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKPQNLLVDPLTH-QVKI  155 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-i~H~Dlkp~Nill~~~~~-~vkl  155 (353)
                          .+++||||++ |+|..++...  ....++...+..++.||+.||+|||+ ++ ||||||||+|||++. ++ ++||
T Consensus       114 ----~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~-~~~~~KI  185 (362)
T KOG0192|consen  114 ----SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDL-KGKTLKI  185 (362)
T ss_pred             ----ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcC-CCCEEEE
Confidence                4889999999 5666666542  46889999999999999999999999 79 999999999999997 65 9999


Q ss_pred             eeeccccccccC-CCcceeeeeceeeChhhhhC-CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          156 CDFGSAKQLIAG-EANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       156 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      +|||+++..... .......||+.|||||++.+ ...|+.++||||||+++|||+||..||...........+......|
T Consensus       186 ~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp  265 (362)
T KOG0192|consen  186 ADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP  265 (362)
T ss_pred             CCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC
Confidence            999999876554 33344789999999999974 3469999999999999999999999999998866665555432222


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .                           ++...++.+.+|+.+||..||.+||+..+++
T Consensus       266 ~---------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~  297 (362)
T KOG0192|consen  266 P---------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIV  297 (362)
T ss_pred             C---------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence            2                           2344789999999999999999999998875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-47  Score=344.50  Aligned_cols=251  Identities=29%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHc-CCCceeecceeeeecCCCCcee
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      +|.+.+.||+|+||.||+|++..+++.||+|++.+...       ....|..++..+ +|++|+++++++     .....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            58899999999999999999999999999999875421       223566777666 578899998887     33445


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+++ +|...+.    ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECC-CCcEEEccCCCce
Confidence            8899999985 5554443    34679999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            54322 223345789999999999654 58999999999999999999999999888776666554410           


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH-----HHHhcCcccccccCC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP  303 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~f~~~~~~  303 (353)
                                        ..++..++.++.+++.+||+.||.+|+++     .++++||||+.+.+.
T Consensus       218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~  266 (323)
T cd05616         218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  266 (323)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence                              01234579999999999999999999984     899999999987543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.7e-48  Score=351.35  Aligned_cols=255  Identities=27%  Similarity=0.417  Sum_probs=206.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+..       ....+|+.++..++||+|+++++.+     .....
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            47999999999999999999999999999999986421       2345689999999999999999888     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||+| +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~-~~~vkL~DfG~~~  149 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDA-KGHVKLSDFGLCT  149 (360)
T ss_pred             EEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECC-CCCEEEeeccCCc
Confidence            8999999985 5555554    35679999999999999999999999 79999999999999996 7899999999987


Q ss_pred             ccccCC------------------------------------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHH
Q 018619          163 QLIAGE------------------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAE  206 (353)
Q Consensus       163 ~~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~  206 (353)
                      ......                                    .....+||+.|+|||++.+. .++.++||||+||++|+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilye  228 (360)
T cd05627         150 GLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYE  228 (360)
T ss_pred             ccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeee
Confidence            442210                                    01134689999999999664 58999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC
Q 018619          207 LLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  286 (353)
Q Consensus       207 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  286 (353)
                      |++|..||.+.+.......+......               ..++.          ...+++++++||.+|+. ||.+|+
T Consensus       229 l~tG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~  282 (360)
T cd05627         229 MLIGYPPFCSETPQETYRKVMNWKET---------------LVFPP----------EVPISEKAKDLILRFCT-DSENRI  282 (360)
T ss_pred             cccCCCCCCCCCHHHHHHHHHcCCCc---------------eecCC----------CCCCCHHHHHHHHHhcc-ChhhcC
Confidence            99999999988877666555431100               00110          01368999999999875 999998


Q ss_pred             ---CHHHHhcCcccccccCC
Q 018619          287 ---TALEACAHPFFDELREP  303 (353)
Q Consensus       287 ---t~~~~l~hp~f~~~~~~  303 (353)
                         +++++++||||+.+.+.
T Consensus       283 ~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         283 GSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CCCCHHHHhcCCCCCCCCHH
Confidence               48999999999987654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-49  Score=330.12  Aligned_cols=256  Identities=29%  Similarity=0.438  Sum_probs=217.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchH-------HHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      --++|...++||.|.||+|-+++.+.+++.||||++.++.-..+       .|-++|+.-+||.+..+.-.|     +..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            34678889999999999999999999999999999977654333       467889999999999887777     555


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||.+|+   .+..+......+++..++.+..+|+.||.|||+ ++||+||||.+|+|+|. +|.+||+|||+|
T Consensus       241 drlCFVMeyanGG---eLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDk-DGHIKitDFGLC  315 (516)
T KOG0690|consen  241 DRLCFVMEYANGG---ELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDK-DGHIKITDFGLC  315 (516)
T ss_pred             ceEEEEEEEccCc---eEeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheecc-CCceEeeecccc
Confidence            5699999999975   233334456789999999999999999999999 89999999999999997 888999999999


Q ss_pred             cccc-cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.-. .+....+.+|||.|+|||++. ...|+.++|+|.+||++|||++|++||...+.......|.-.           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            8643 344556789999999999994 567999999999999999999999999998887776665542           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCCC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN  304 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~~  304 (353)
                            +.            .|+..++++++.|+..+|.+||.+|..     +.++.+|+||+.+.|..
T Consensus       384 ------d~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 ------DL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             ------hc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                  22            255689999999999999999999984     78999999999998764

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=9.9e-47  Score=335.54  Aligned_cols=286  Identities=34%  Similarity=0.586  Sum_probs=222.9

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcC-CCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....      ....+|+.+++.+. ||||+++++++......+...
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            57999999999999999999999999999999875432      23457999999995 699999998886554444455


Q ss_pred             EEEEeccccchHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSA-NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~-~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .|+||||+++++.+.+...... ...+++..++.++.||+.||.|||+ +|++||||||+||+++..++.+||+|||++.
T Consensus        81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8899999999888877653322 4568999999999999999999999 7999999999999999657889999999987


Q ss_pred             ccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+.......+....+.+....+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            553322 2223456888999999876556789999999999999999999999998888888888877776665433211


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                      .........+........ .....++.++.+||.+||+.||.+|||+.+++.||||+
T Consensus       240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            111000111111111111 11234789999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-47  Score=349.00  Aligned_cols=280  Identities=25%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      ....+|++.+.||+|+||.||+|++..+++.||+|+..+.  ....|+.+++.++||||+++++++..     ....++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEE
Confidence            3456799999999999999999999999999999975432  34579999999999999999998843     3347899


Q ss_pred             eccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           88 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||++.+++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus       136 ~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        136 LPHYSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EEccCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEecCccccccccC
Confidence            99999988777653   45679999999999999999999999 79999999999999996 788999999999754444


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCCHHH
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENA---------VDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~---------~~~~~~~~~~~~~~~~~~  237 (353)
                      .......||+.|+|||++.+. .++.++||||+||++|+|+++. .+|.....         ...+..++...+..+...
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             cccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence            444456789999999998664 4899999999999999999855 44443221         123334444443322111


Q ss_pred             HhhcCcCC-CC-CcCCCCCCCcc---ccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          238 IRCMNPNY-TD-FRFPQIKAHPW---HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       238 ~~~~~~~~-~~-~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ........ .. .........++   ...-...++.++.+||.+||+.||.+|||+.|+|+||||+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            00000000 00 00000000111   011112568889999999999999999999999999999864

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.6e-47  Score=338.19  Aligned_cols=283  Identities=35%  Similarity=0.566  Sum_probs=224.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|.+....      ....+|+.+++.++|+|++++++++....   ..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~   81 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD   81 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence            4578999999999999999999999999999999885332      12347999999999999999999874322   23


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++||||+.++|.+.+...   ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~  156 (309)
T cd07845          82 SIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTD-KGCLKIADFGLAR  156 (309)
T ss_pred             eEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECccceee
Confidence            47899999998887777642   3678999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+.+..+.+..+.+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             ecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            664432 2223345788999999877666899999999999999999999999999999999989888887765543322


Q ss_pred             Cc--CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          242 NP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       242 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ..  ....+..+......+...+ ...++++.+||++||++||++|||+.++++||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             hcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            11  1111111111111122111 2368899999999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.1e-47  Score=343.24  Aligned_cols=245  Identities=29%  Similarity=0.495  Sum_probs=200.5

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||+||+|.+..+++.||+|++.+..       ....+|..+++.+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999987532       2234678888877 699999999988     3344589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+.+ +|...+.    ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus        76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECC-CCcEEecccCCCeecCcC
Confidence            99985 5544443    35679999999999999999999999 79999999999999996 788999999998753222


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             223345689999999999664 4899999999999999999999999887766555444321                 


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH-----HHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~f~~~~~  302 (353)
                      .            ..++..++.++.+||++||+.||.+|||+     .++++||||+...+
T Consensus       212 ~------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~  260 (318)
T cd05570         212 E------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW  260 (318)
T ss_pred             C------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            0            01234578999999999999999999999     99999999988654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.6e-47  Score=347.52  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=207.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|+++.+++.||+|.+.+..       ....+|+.+++.++||||+++++++     ..
T Consensus        40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~  114 (371)
T cd05622          40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD  114 (371)
T ss_pred             cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence            45689999999999999999999999999999999986421       2345789999999999999999888     44


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|||||++ +|...+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~-~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECC-CCCEEEEeCC
Confidence            4568999999985 56555532     458999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCC--cceeeeeceeeChhhhhCCC---CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          160 SAKQLIAGEA--NISYICSRFYRAPELIFGAT---EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      ++........  .....||+.|+|||++.+..   .++.++||||+||++|+|++|..||.+.+.......+......  
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--  265 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--  265 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc--
Confidence            9986543322  23457899999999986532   3788999999999999999999999988876666555432110  


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCccccccc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELR  301 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~  301 (353)
                                   ..++          ....++.++++||.+||..++.+  |++++++++||||++..
T Consensus       266 -------------~~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         266 -------------LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             -------------ccCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence                         0011          01257999999999999854443  78999999999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.4e-47  Score=343.09  Aligned_cols=277  Identities=27%  Similarity=0.450  Sum_probs=207.4

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +..++|++.+.||+|+||.||++.+..++..||+|.+....     ..+.+|+.+++.++||||+++++++..     ..
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~   76 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG   76 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence            34689999999999999999999999999999999886432     345689999999999999999998843     33


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+++||||+++ +|.+.+.    ....+++..+..++.|++.||.|||+.++|+||||||+||+++. ++.+||+|||++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~  151 (331)
T cd06649          77 EISICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVS  151 (331)
T ss_pred             EEEEEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccc
Confidence            48899999995 6655554    34568999999999999999999998336999999999999996 788999999998


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC-  240 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  240 (353)
                      ...... ......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...+..+... +   ++.+....... 
T Consensus       152 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~---~~~~~~~~~~~~  225 (331)
T cd06649         152 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-I---FGRPVVDGEEGE  225 (331)
T ss_pred             cccccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H---hcccccccccCC
Confidence            765332 23345789999999999654 48999999999999999999999998776544322 1   22111100000 


Q ss_pred             ---cCcC-------CCCCcCCCC------------CCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          241 ---MNPN-------YTDFRFPQI------------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       241 ---~~~~-------~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                         ..+.       .........            ............+++++++||.+||++||++|||+.++++||||+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence               0000       000000000            000000000124688999999999999999999999999999998


Q ss_pred             cc
Q 018619          299 EL  300 (353)
Q Consensus       299 ~~  300 (353)
                      ..
T Consensus       306 ~~  307 (331)
T cd06649         306 RS  307 (331)
T ss_pred             hc
Confidence            64

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-47  Score=342.76  Aligned_cols=245  Identities=29%  Similarity=0.500  Sum_probs=198.1

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHH-cCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|+++.+|+.||+|.+.+..       .....|..++.. ++||||+++++++     .....+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999986532       223456777765 4899999999988     4445689999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc-
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-  166 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  166 (353)
                      ||+.+ +|...+.    ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..... 
T Consensus        76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEeCccCCCeecccC
Confidence            99985 5554443    35679999999999999999999999 79999999999999996 78899999999875322 


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      ........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...  .+             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~-------------  213 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP-------------  213 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence            2223446789999999999654 5899999999999999999999999887766554443221  00             


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH-HHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~~~l~hp~f~~~~~  302 (353)
                                    .++..++.++++||++||+.||++|+++ +++++||||+...+
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         214 --------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             --------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence                          1223478999999999999999999997 58999999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-47  Score=341.94  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=206.9

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+.       .....+|+.++..++|+||+++++++     .....
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence            5799999999999999999999999999999998642       12345788999999999999999888     34456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~  150 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDK-NGHIRLADFGSCL  150 (331)
T ss_pred             EEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECC-CCCEEEEECCcee
Confidence            8999999974 66666543   34679999999999999999999999 79999999999999986 7889999999987


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ........  ....||+.|+|||++.+    ...++.++||||+||++|+|++|+.||.+.+..+....+......    
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~----  226 (331)
T cd05597         151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH----  226 (331)
T ss_pred             ecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence            65443322  23468999999999863    244788999999999999999999999887766665554431100    


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCcccccccCC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP  303 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~~~  303 (353)
                                 +.++.         ....+++++++||++||..++.+  |+++.++++||||....+.
T Consensus       227 -----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~  275 (331)
T cd05597         227 -----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD  275 (331)
T ss_pred             -----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence                       00110         01237899999999999765554  7899999999999887554

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=344.70  Aligned_cols=251  Identities=28%  Similarity=0.458  Sum_probs=209.7

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      -...|+..+.||+|+||.||+|.+..+++.||||++.-+.     ..+++|+.+|..++++||.++|+.|+....     
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----   85 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----   85 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----
Confidence            3557888999999999999999999999999999996443     345689999999999999999999965554     


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ++++||||.| ++.+.+.    .+..+.+..+..++++++.||.|||+ ++.+|||||+.|||+.. ++.+||+|||.+.
T Consensus        86 LwiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~-~g~vkl~DfgVa~  159 (467)
T KOG0201|consen   86 LWIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSE-SGDVKLADFGVAG  159 (467)
T ss_pred             HHHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEec-cCcEEEEecceee
Confidence            9999999996 4444443    45666999999999999999999999 79999999999999997 6899999999998


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ....... ..+.+|||.|||||++.+ ..|+.++||||||++.+||++|.+|+....+...+..|-+             
T Consensus       160 ql~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-------------  225 (467)
T KOG0201|consen  160 QLTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-------------  225 (467)
T ss_pred             eeechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-------------
Confidence            7655433 367899999999999975 4599999999999999999999999988776433222211             


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                 ...+    .+....|+.+++||..||.+||+.||||.++|+|+|++.
T Consensus       226 -----------~~PP----~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  226 -----------SAPP----RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             -----------CCCC----ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence                       1111    112357899999999999999999999999999999986

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.5e-47  Score=339.12  Aligned_cols=278  Identities=32%  Similarity=0.566  Sum_probs=207.3

Q ss_pred             eeeeecCCCeEEEEEEECC--CCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           16 ERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ...||+|+||.||+|+++.  ++..||+|.+....  ....+|+.+++.++||||+++++++...   ....+++||||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            3689999999999999654  56889999886543  2456899999999999999999987543   233578999999


Q ss_pred             cchHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe---CCCCcEEEeeeccccc
Q 018619           92 PESMYRVLKHYSS-----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQ  163 (353)
Q Consensus        92 ~~~l~~~l~~~~~-----~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~---~~~~~vkl~Dfg~a~~  163 (353)
                      ++++...+.....     ....+++..++.++.|++.||+|||+ +||+||||||+||++.   ..++.+||+|||+++.
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            9988877753221     22458999999999999999999999 7999999999999994   2356899999999986


Q ss_pred             cccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHHh
Q 018619          164 LIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIKVL  230 (353)
Q Consensus       164 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~  230 (353)
                      ......    .....+|+.|+|||.+.+...++.++||||+||++|+|++|.+||.....         ...+..+...+
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            543321    23457799999999997766689999999999999999999999975432         24455666666


Q ss_pred             CCCCHHHHhhcCcC--CCCC-------cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          231 GTPTREEIRCMNPN--YTDF-------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       231 ~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      +.+....+......  +...       ..................+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            76665444322110  0000       0000000000111112356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.7e-47  Score=343.20  Aligned_cols=246  Identities=25%  Similarity=0.471  Sum_probs=196.0

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      ++||+|+||.||+|++..+++.||+|++.+..       ....+|..++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            47999999999999999999999999997532       2234788888888 799999999988     3444589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc-c
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-A  166 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~-~  166 (353)
                      |||++ +|...+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||+++... .
T Consensus        76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEECcCccccccccC
Confidence            99985 5544443    35689999999999999999999999 79999999999999996 7889999999987532 2


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~  238 (353)
                      ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.....        .+...+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            2333456789999999999664 589999999999999999999999963221        1111111110         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC------HHHHhcCcccccccC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE  302 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~~~l~hp~f~~~~~  302 (353)
                             .            ...++..++.++.++|++||+.||.+|+|      ++++++||||..+.+
T Consensus       220 -------~------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         220 -------K------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             -------C------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   0            00123457899999999999999999997      789999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-47  Score=342.67  Aligned_cols=246  Identities=29%  Similarity=0.487  Sum_probs=200.4

Q ss_pred             eeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           16 ERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++.||+|+||.||+|++.   .+++.||+|.+.+..        ....+|+.+++.++||||+++++++.     ....+
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~   75 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKL   75 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeE
Confidence            368999999999999864   478899999886431        22347999999999999999998883     34458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+||||+.+ +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++.
T Consensus        76 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~  149 (323)
T cd05584          76 YLILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDA-QGHVKLTDFGLCKE  149 (323)
T ss_pred             EEEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEeeCcCCee
Confidence            899999986 5555443    45678999999999999999999999 79999999999999996 78999999999875


Q ss_pred             cccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..... ......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||...+.......+...             
T Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------  215 (323)
T cd05584         150 SIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------  215 (323)
T ss_pred             cccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------------
Confidence            43322 23345689999999998654 4889999999999999999999999988776655544331             


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                          ..            .++..+++++.+||++||+.||++|+     +++++++||||+...+
T Consensus       216 ----~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         216 ----KL------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             ----CC------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence                00            12345789999999999999999999     8999999999987543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.7e-47  Score=344.74  Aligned_cols=245  Identities=29%  Similarity=0.479  Sum_probs=198.0

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHH-HHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||+||+|.+..+|+.||+|++.+...       ....|.. +++.++||||+++++.+     .....+|+||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence            479999999999999999999999999864321       1123333 56778999999999888     3344588999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+.+ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccC
Confidence            99986 5544443    45679999999999999999999999 79999999999999996 788999999998754322


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       .......||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P-------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence             223345689999999998654 5899999999999999999999999988776655554431   0             


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH----HHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~~~l~hp~f~~~~~  302 (353)
                                   ..++..+++++.++|++||+.||.+|+++    .++++||||....+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence                         00123578999999999999999999997    69999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.5e-47  Score=340.73  Aligned_cols=245  Identities=31%  Similarity=0.512  Sum_probs=197.6

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHH-cCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|++..+++.||+|.+.+..       .....|..++.. .+||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999886532       122345566654 4899999999887     3444689999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||++| +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus        76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCC
Confidence            99985 5544443    35679999999999999999999999 79999999999999996 788999999999754332


Q ss_pred             C-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 E-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      . ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~--------------  212 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R--------------  212 (316)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence            2 23345789999999999664 4899999999999999999999999988876655544321  0              


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH-HHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-LEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~~~l~hp~f~~~~~  302 (353)
                                   ..++..++.++.+||.+||+.||.+|+++ .++++||||+.+.+
T Consensus       213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~  256 (316)
T cd05592         213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW  256 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence                         01224578999999999999999999986 58899999988653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.5e-46  Score=332.73  Aligned_cols=276  Identities=42%  Similarity=0.752  Sum_probs=225.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            5899999999999999999999999999999986432      23458999999999999999999883     345589


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +||||+.++|.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++....
T Consensus        76 ~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISA-DGVLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcC-CCcEEEeeeeeccccc
Confidence            9999997788777654   23679999999999999999999999 79999999999999996 7889999999998665


Q ss_pred             cCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 018619          166 AGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-  242 (353)
Q Consensus       166 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  242 (353)
                      ....  .....++..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..+....+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4432  2345678899999998766667899999999999999999999999988888888888888887765443321 


Q ss_pred             -cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          243 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                       ..+....++......|...+ ...+.++.+||++||+.||++|||++++++||||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence             11222223333333333322 35678999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4e-46  Score=330.07  Aligned_cols=276  Identities=34%  Similarity=0.648  Sum_probs=215.3

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|++|.||++.+..+++.||+|++....      ....+|+.+++.++|||++++++++.     ....+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence            57999999999999999999999999999999885432      23457999999999999999999883     34458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++||||++++++..+..   ....+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.+||+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITK-QGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcC-CCcEEECccccceec
Confidence            89999999875554432   44579999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+.+..+............
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            5443 223446788899999987656688999999999999999999999998888777777666555443322111110


Q ss_pred             C--CCCCcCCCCC-CCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 N--YTDFRFPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~--~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      .  +.....+... ..++.. ....++..+.+||.+||+.||++|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         231 NQFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             ccccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            0  0011111110 111111 123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-48  Score=337.53  Aligned_cols=262  Identities=28%  Similarity=0.404  Sum_probs=218.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..+.|+.-++||+|+||.||-+..+.||+.||+|++.+.+       .....|..+|.+++.++||.+--.|     +.
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eT  256 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ET  256 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cC
Confidence            44567899999999999999999999999999999885443       2234689999999999999987777     44


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcC--CCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~--~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ...+|+|+..|+|+   .|..++...  ..+++..++.++.+|+.||++||+ .+||+|||||+|||+|. .|.++|+|+
T Consensus       257 kd~LClVLtlMNGG---DLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd-~GhvRISDL  331 (591)
T KOG0986|consen  257 KDALCLVLTLMNGG---DLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDD-HGHVRISDL  331 (591)
T ss_pred             CCceEEEEEeecCC---ceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeecc-CCCeEeecc
Confidence            44599999999976   344444443  489999999999999999999999 89999999999999996 888999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |+|..+..+....+.+||..|||||++.... |+.+.|+|||||++|+|+.|+.||........-..+-+.....     
T Consensus       332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~-----  405 (591)
T KOG0986|consen  332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED-----  405 (591)
T ss_pred             ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc-----
Confidence            9999999988888889999999999996654 9999999999999999999999998765443332222221111     


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCCCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPNA  305 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~~~  305 (353)
                                          ...++.++|++++++++.+|++||.+|+.     ++++.+||||+.+++...
T Consensus       406 --------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  406 --------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             --------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence                                12244679999999999999999999984     679999999999988753

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-48  Score=330.79  Aligned_cols=283  Identities=29%  Similarity=0.506  Sum_probs=222.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeec---cccchHHHHHHHHHcCC--C----ceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ---DRRYKNRELQLMRVMDH--P----NVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h--~----~iv~~~~~~~~~~~   78 (353)
                      +..++|.+++.+|+|.||.|-.+.+..++..||||++..   .+....-|+++|.++.+  |    -+|.+.++|     
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----  160 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----  160 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----
Confidence            348899999999999999999999999999999998853   34445568999999832  2    256666666     


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC---------
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---------  149 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~---------  149 (353)
                      +.....|||+|.++-++++.+..  +.-.+++...++.+++||+.++++||+ .+++|.||||+|||+.+.         
T Consensus       161 dyrghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  161 DYRGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             hccCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccC
Confidence            66667999999999888888865  234679999999999999999999999 799999999999998421         


Q ss_pred             ----------CCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh
Q 018619          150 ----------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA  219 (353)
Q Consensus       150 ----------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  219 (353)
                                +..|+++|||.|+...  +.....+.|..|+|||++++.+ ++.++||||+||||+|+++|...|+..++
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCc
Confidence                      2359999999998543  3346778999999999999876 99999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcC------cCCCCCcCCCC---------CCCccccccCC--CCChhHHHHHHHhcCcCC
Q 018619          220 VDQLVEIIKVLGTPTREEIRCMN------PNYTDFRFPQI---------KAHPWHKVFHK--RMPPEAIDLASRLLQYSP  282 (353)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~--~~~~~~~~li~~~L~~dp  282 (353)
                      .+.+..+...+|+.+...+....      ....+|.....         ...+....+..  .--.++.|||++||.+||
T Consensus       315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            99999999999988877665541      11111111000         01111111111  112368999999999999


Q ss_pred             CCCCCHHHHhcCccccccc
Q 018619          283 SLRCTALEACAHPFFDELR  301 (353)
Q Consensus       283 ~~R~t~~~~l~hp~f~~~~  301 (353)
                      .+|+|+.|+|+||||+...
T Consensus       395 ~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  395 ARRITLREALSHPFFARLT  413 (415)
T ss_pred             cccccHHHHhcCHHhhcCC
Confidence            9999999999999999754

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6.8e-47  Score=339.48  Aligned_cols=246  Identities=30%  Similarity=0.523  Sum_probs=198.7

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHH-cCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|.+..+++.||+|.+.+..       .....|..++.. ++||||+++++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            47999999999999999999999999986542       223356777765 58999999998883     334588999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+++ +|...+.    ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCC
Confidence            99985 6655554    34678999999999999999999999 79999999999999996 788999999998754322


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...  .+             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~-------------  213 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP-------------  213 (316)
T ss_pred             CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC-------------
Confidence             223445789999999998654 5899999999999999999999999888766555443221  00             


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH-HHhcCcccccccCC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP  303 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-~~l~hp~f~~~~~~  303 (353)
                                    .++..++.++.+||.+||+.||.+|+++. ++++||||+.+.+.
T Consensus       214 --------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         214 --------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             --------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence                          01234788999999999999999999996 99999999987543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-46  Score=340.09  Aligned_cols=259  Identities=25%  Similarity=0.399  Sum_probs=207.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||+++++.+++.||+|.+.+..       ....+|+.++..++|++|+++++++     .....
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence            47999999999999999999999999999999986421       2245788899999999999999888     34445


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+. |+|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~  150 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFGSCL  150 (332)
T ss_pred             EEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECC-CCCEEEeecchhe
Confidence            899999998 566666643   24578999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ........  ....||+.|+|||++.+    ...++.++||||+||++|+|++|+.||...+..+....+.....     
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~-----  225 (332)
T cd05623         151 KLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE-----  225 (332)
T ss_pred             ecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc-----
Confidence            65433222  23568999999999853    34578999999999999999999999998877666655543110     


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCcccccccCC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP  303 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~~~  303 (353)
                                ...++.         ....+++++++||++||..++.+  |++++++++||||..+.+.
T Consensus       226 ----------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~  275 (332)
T cd05623         226 ----------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD  275 (332)
T ss_pred             ----------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence                      001110         11347999999999999776555  6899999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.8e-46  Score=330.41  Aligned_cols=275  Identities=35%  Similarity=0.631  Sum_probs=219.0

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHHcC-CCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |++.+.||+|+||.||++.+..+++.||+|++.+...     ...+|+.+++.+. |+|++++++++.+..   ...+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence            7889999999999999999999999999998865321     1236888888885 999999999885431   134789


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ||||+++++.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||+|+||+++.  +.+||+|||++.....
T Consensus        78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD--DILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC--CCeEEEeccccccccc
Confidence            999999988777654   23578999999999999999999999 79999999999999995  8899999999987655


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-C
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN-Y  245 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  245 (353)
                      ........++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+..+....+.+........... .
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            544445567899999998766556789999999999999999999999999988888888888777776443322211 1


Q ss_pred             CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ..+.++....... ..+...++.++.++|.+||++||++|||++++++||||
T Consensus       232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1122222111111 11223578999999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.4e-47  Score=344.05  Aligned_cols=245  Identities=30%  Similarity=0.492  Sum_probs=197.3

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHH-HHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|++..+|+.||+|++.+..       ....+|.. +++.++||||+++++.+     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            46999999999999999999999999986432       11223433 56778999999998887     3344588999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc-
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-  166 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  166 (353)
                      ||+.+ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCC
Confidence            99986 4444433    45789999999999999999999999 79999999999999996 78899999999875332 


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      ........||+.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~-----------------  211 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK-----------------  211 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            2233456789999999998654 4899999999999999999999999988776665544331                 


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH----HHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~~~l~hp~f~~~~~  302 (353)
                      .            ..+....+..+.++|++||+.||.+||++    .+++.||||+...+
T Consensus       212 ~------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         212 P------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             C------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            0            00123478899999999999999999976    59999999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-46  Score=332.97  Aligned_cols=280  Identities=35%  Similarity=0.609  Sum_probs=225.5

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++.+.||+|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++....   ...
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~   80 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK   80 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence            357999999999999999999999999999999886432      12357999999999999999999875432   245


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .|+||||++++|.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++..
T Consensus        81 ~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~  155 (293)
T cd07843          81 IYMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNN-RGILKICDFGLARE  155 (293)
T ss_pred             EEEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCcEEEeecCceee
Confidence            889999999888777654   23468999999999999999999999 79999999999999996 78899999999986


Q ss_pred             cccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+...++....+.+....+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         156 YGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             ccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            65442 22345678889999998766557899999999999999999999999999888888888888877765544321


Q ss_pred             c--CCCCCcCCCCCCCccccccCCC-CChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          243 P--NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       243 ~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      .  ..............+...++.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            1  1111111222223344445554 68999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.2e-46  Score=338.93  Aligned_cols=250  Identities=29%  Similarity=0.452  Sum_probs=203.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcC-CCceeecceeeeecCCCCcee
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      +|...+.||+|+||.||+|.++.+|+.||+|++.+..       .....|..++..+. |++|+++++++     .....
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            4788999999999999999999999999999986532       12346778888776 56777888777     33345


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||+++ +|...+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDS-EGHIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEecccccc
Confidence            8999999985 5544443    45679999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            543322 22345689999999998654 58999999999999999999999999888766665554410           


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE  302 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~  302 (353)
                            .            .++..++.++.+++.+||+.||.+|++     ..++++||||+.+.+
T Consensus       218 ------~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         218 ------V------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             ------C------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence                  0            122457899999999999999999997     478999999998754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8e-47  Score=340.93  Aligned_cols=246  Identities=26%  Similarity=0.474  Sum_probs=194.3

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++.     ....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            47999999999999999999999999987532       1234677777766 8999999999883     344589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc-
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-  166 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  166 (353)
                      ||+++ +|...+.    ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..... 
T Consensus        76 E~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCC
Confidence            99995 4544433    45679999999999999999999999 79999999999999996 78899999999875332 


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--------VDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~  238 (353)
                      ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.....        .+.+.+.+..         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            2223346789999999999664 589999999999999999999999953211        1111111110         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC------HHHHhcCcccccccC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELRE  302 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~~~l~hp~f~~~~~  302 (353)
                             .            ...++..++.++.+||++||+.||.+|+|      .+++++||||+.+.+
T Consensus       220 -------~------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         220 -------K------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             -------C------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence                   0            01133467899999999999999999998      579999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-46  Score=354.53  Aligned_cols=263  Identities=24%  Similarity=0.357  Sum_probs=215.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC---
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   78 (353)
                      ...++|++.+.||+|+||+||+|++..+|+.||||.+....      ....+|+.++..++|+|++++++.+.....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34689999999999999999999999999999999885432      234578999999999999998877643322   


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .....+++||||+. |+|.+.+.........+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~-~~~vkL~D  186 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCS-NGLVKLGD  186 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeC-CCCEEEEe
Confidence            12235789999998 57877777655566789999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccC---CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          158 FGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       158 fg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      ||+++.....   .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+.....   
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~---  262 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY---  262 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC---
Confidence            9999765432   122345789999999999664 489999999999999999999999988776655554433100   


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                               ..++..+++++.+++.+||+.||.+|||+.++++|||++...
T Consensus       263 -------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~  304 (496)
T PTZ00283        263 -------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI  304 (496)
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence                                     012345789999999999999999999999999999987643

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.1e-46  Score=338.06  Aligned_cols=288  Identities=35%  Similarity=0.671  Sum_probs=229.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      +++|.+.+.||+|++|.||++.++.+|+.||+|++....      ....+|+.+++.++||||+++++++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            589999999999999999999999999999999886532      23347999999999999999998774433 33456


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +++||||+.+++...+.    ..+.+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        83 ~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~  156 (334)
T cd07855          83 VYVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNE-DCELRIGDFGMARG  156 (334)
T ss_pred             EEEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEeccccccee
Confidence            88999999987666554    35669999999999999999999999 79999999999999996 88999999999876


Q ss_pred             cccCCC-----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ......     .....++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..+....+.++...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            543221     123467889999999866556899999999999999999999999999888888888888888876654


Q ss_pred             hhcCcCCCC---CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCC
Q 018619          239 RCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA  305 (353)
Q Consensus       239 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~  305 (353)
                      .........   -.++.....+|.. +....++++.++|++||+.||.+|||+++++.||||.+...+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence            332211000   0112222223332 22347899999999999999999999999999999998766543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-46  Score=349.11  Aligned_cols=278  Identities=24%  Similarity=0.348  Sum_probs=208.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ......|.+.+.||+|+||.||++.+..+++.||||...  .....+|+.+++.++|+||+++++++..     ....++
T Consensus       165 ~~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~l  237 (461)
T PHA03211        165 VVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCL  237 (461)
T ss_pred             ccccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEE
Confidence            345678999999999999999999999999999999643  2345689999999999999999988743     334789


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |||++.++|...+..   ....+++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||+++....
T Consensus       238 v~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        238 VLPKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNG-PEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECC-CCCEEEcccCCceeccc
Confidence            999999988777653   23579999999999999999999999 79999999999999996 78899999999976543


Q ss_pred             CCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHH
Q 018619          167 GEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-------AVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       167 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~~~~~  236 (353)
                      ...   .....||+.|+|||++.+. .++.++|||||||++|+|++|..|+....       ....+.++++..+.....
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            221   2235689999999999665 48999999999999999999875543211       123444444443322111


Q ss_pred             H--------HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          237 E--------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       237 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      .        .............+......|....  .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYY--KLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhc--cccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            0        0000000000011112223343322  46789999999999999999999999999999964

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-46  Score=347.85  Aligned_cols=280  Identities=23%  Similarity=0.348  Sum_probs=212.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +...+|.+.+.||+|+||.||++...  .+++.||+|.+... ....+|+.+++.++||||+++++.+     .....+|
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~  162 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVC  162 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEE
Confidence            34568999999999999999999754  35678999988654 3456899999999999999999888     3344588


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ++||++.+++...+.    ....+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||++....
T Consensus       163 lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        163 MVMPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDE-PENAVLGDFGAACKLD  236 (392)
T ss_pred             EEehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEccCccccccC
Confidence            999999998877663    35679999999999999999999999 79999999999999996 7889999999997654


Q ss_pred             cCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHh
Q 018619          166 AGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       166 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ....   .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+   ....+..+.+.++..+.....
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             cccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            3322   2345789999999998654 48999999999999999999999997654   345566666665544322111


Q ss_pred             hcCcC----CCCCcCCCCCCCcccccc-CCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          240 CMNPN----YTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       240 ~~~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .....    +..+.........+...+ ...++.++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence            00000    000000000000011111 12467889999999999999999999999999999763

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-47  Score=341.99  Aligned_cols=245  Identities=28%  Similarity=0.472  Sum_probs=201.2

Q ss_pred             eeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           17 RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      +.||+|+||.||++++.   .+|+.||+|++.+..      ....+|+.+++.++||||+++++++     .....+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            67999999999999863   578999999986532      2334799999999999999999888     334458899


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |||+.+ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECC-CCcEEEeeccCCcccCC
Confidence            999984 6555553    35679999999999999999999999 79999999999999996 78899999999886544


Q ss_pred             C-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 G-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      . .......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||...+..+....+.+.                
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~----------------  213 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA----------------  213 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC----------------
Confidence            3 223345789999999998654 4789999999999999999999999988776665554331                


Q ss_pred             CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccC
Q 018619          246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE  302 (353)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~  302 (353)
                       ..            .++..+++++.+||++||+.||.+|||     +.+++.||||+.+.+
T Consensus       214 -~~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~  262 (318)
T cd05582         214 -KL------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW  262 (318)
T ss_pred             -CC------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence             00            122357899999999999999999999     778999999987643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-46  Score=329.49  Aligned_cols=277  Identities=35%  Similarity=0.666  Sum_probs=216.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .++|++.+.||+|++|.||++.+..+++.||||.+....     ....+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            478999999999999999999999899999999885432     2345799999999999999999988     344468


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||+.++|.+.+..   ....+++..++.++.|++.||.|||+ ++|+|+||||+||+++. ++.+||+|||++...
T Consensus        79 ~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~  153 (291)
T cd07844          79 TLVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISE-RGELKLADFGLARAK  153 (291)
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcC-CCCEEECcccccccc
Confidence            89999999988776653   23478999999999999999999999 79999999999999996 788999999998754


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .... ......++..|+|||.+.+...++.++||||+||++|+|++|..||.... ..+.+..+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            3221 11223467889999998765668899999999999999999999997766 566677777777777665543322


Q ss_pred             cC--CCCCcCCCCCCCccccccCCCCC--hhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          243 PN--YTDFRFPQIKAHPWHKVFHKRMP--PEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       243 ~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ..  +.....+..........+ ..++  .++.++|.+||+.||.+|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            11  111111111111111111 1244  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=308.71  Aligned_cols=261  Identities=26%  Similarity=0.374  Sum_probs=208.4

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .++..+|++.+.||+|||+.||++++..+++.||+|++...    .+...+|++..++++|||++++++........+..
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            47889999999999999999999999999999999998543    34456899999999999999999887766666777


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ..|++++|.. |++.+.+......+..+++.++..|+.++++||++||+ ..  ++||||||.|||+.. ++.++|.|||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~-~~~~vl~D~G  174 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSD-SGLPVLMDLG  174 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecC-CCceEEEecc
Confidence            8999999998 78999998887778899999999999999999999999 68  999999999999996 7889999999


Q ss_pred             cccccccCCC----------cceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018619          160 SAKQLIAGEA----------NISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  227 (353)
Q Consensus       160 ~a~~~~~~~~----------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  227 (353)
                      .+....-.-.          -....+|..|+|||++.-.  ...+.++|||||||+||.|+.|..||...         .
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~  245 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------Y  245 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------h
Confidence            9875421111          1123578999999998432  23588999999999999999999999421         1


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +.-+.-.. .+     ....+.+|.          ...+|+.+.+||++||+.||.+||++.+++.+
T Consensus       246 ~~GgSlaL-Av-----~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  246 QQGGSLAL-AV-----QNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             hcCCeEEE-ee-----eccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            10000000 00     000111111          12489999999999999999999999999854

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-47  Score=342.33  Aligned_cols=244  Identities=27%  Similarity=0.494  Sum_probs=195.8

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHc---CCCceeecceeeeecCCCCceeEEEEe
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM---DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      ||+|+||+||+|++..+++.||+|++.+...       ....|..++...   +||||+++++++     .....+|+||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999999999999999864321       112355565554   699999999888     4444589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+.+ +|...+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCC
Confidence            99985 5554443    45779999999999999999999999 79999999999999996 788999999998754332


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       .......||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-----------------  212 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-----------------  212 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             22335678999999999876656899999999999999999999999887766555443321                 


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC----CHHHHhcCccccccc
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC----TALEACAHPFFDELR  301 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~~~l~hp~f~~~~  301 (353)
                      ...++           ...+++++.+||++||+.||.+|+    ++.++++||||....
T Consensus       213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            01111           023688999999999999999998    789999999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.9e-46  Score=337.65  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=206.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||++++..+++.||+|.+.+..       ....+|..++..++|++|+++++++     .....
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence            57999999999999999999999999999999886421       2244688899999999999999888     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .|+||||+.| +|...+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~  150 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDM-NGHIRLADFGSCL  150 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcC-CCCEEEEecccee
Confidence            8999999985 66666543   24678999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhCC----CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ........  ....||+.|+|||++.+.    ..++.++|+||+||++|+|++|+.||...+..+....+......    
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~----  226 (331)
T cd05624         151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER----  226 (331)
T ss_pred             eccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc----
Confidence            65443322  234689999999998542    34788999999999999999999999888776655554431100    


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCcccccccCC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP  303 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~~~  303 (353)
                                 ..++.         ....++++++++|.+||..++.+  |++++++++||||+.+.+.
T Consensus       227 -----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~  275 (331)
T cd05624         227 -----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE  275 (331)
T ss_pred             -----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence                       00110         01247899999999999976655  4689999999999987654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=9.1e-46  Score=329.22  Aligned_cols=281  Identities=36%  Similarity=0.648  Sum_probs=220.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|++|.||++.+..+|+.||+|.+....      ....+|+.+++.++||||+++++++.     .....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            57999999999999999999999999999999885431      23457999999999999999999883     34458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||+++++.+.+...  ....+++..++.++.||+.||+|||+ ++++|+||+|+||+++..++.+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            999999998877766432  23346888999999999999999999 799999999999999865678999999999754


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+...++....+.+....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            3322 223346788999999987655688999999999999999999999999888888888887777766544321100


Q ss_pred             CCCCC--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          244 NYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       244 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                       ..++  ..+..... ........+++++.++|.+||+.||++||++.+++.||||..+.
T Consensus       234 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        234 -LPDYKSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             -chhhhhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence             0000  00000000 00111235788999999999999999999999999999999864

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-45  Score=329.28  Aligned_cols=279  Identities=36%  Similarity=0.645  Sum_probs=219.8

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc---------chHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|.+.+.||+|++|.||+|.+..+++.||+|.+.....         ....|+.+++.++|+||+++++++.     ...
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            58899999999999999999999999999999865432         2346899999999999999999883     344


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ..++||||+.++|.+.+..   ....+++..++.++.||+.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIAS-DGVLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcC-CCCEEEccceeee
Confidence            5889999997777776653   12379999999999999999999999 79999999999999996 8889999999998


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ....... .....+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.++....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            6654322 223456788999999866666889999999999999999999999988888888777777766665443321


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ...............+... .....+.++.+||.+||++||++|||+.+++.||||++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence            1110000111111111111 2234688999999999999999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=6.9e-48  Score=308.58  Aligned_cols=284  Identities=31%  Similarity=0.589  Sum_probs=239.1

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHcC-CCceeecceeeeecCCCCceeEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..++|++.+.+|+|-|+.||.+.+..+++.++||+++.- .+.+.+|+.+|+.|. ||||+++.++.-+..+..   ..+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt---paL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT---PSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC---chh
Confidence            568999999999999999999999999999999988543 456779999999996 999999999986655543   668


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |+||++..-...+-      ..++...++.++.||+.||.|||+ .||+|||+||.|+++|.....++|+|+|+|.....
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            99999975333332      458888999999999999999999 69999999999999998778899999999999888


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHh-----h
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIR-----C  240 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-----~  240 (353)
                      +......+.+..|..||++...+.|..+-|+|||||++..|+..+.|| .+.++.+++.+|.+.+|+......-     .
T Consensus       186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence            888778889999999999988888999999999999999999988665 7889999999999999987664332     1


Q ss_pred             cCcCCCCCcCCCCCCCccccccCC----CCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      +++.+.+. +......+|...+..    -+++++.||+.++|.+|..+|+||.|++.||||..+...
T Consensus       266 Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~  331 (338)
T KOG0668|consen  266 LDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA  331 (338)
T ss_pred             CChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence            23333321 233455677766554    257999999999999999999999999999999887654

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.4e-46  Score=330.31  Aligned_cols=275  Identities=36%  Similarity=0.687  Sum_probs=218.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||.|++|.||+|++..+++.||||.+..+.      ....+|+.+++.++||||+++++++     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence            5899999999999999999999999999999885432      2356799999999999999999987     3344588


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +||||+.+++...+..  .....+++..++.++.|++.||+|||+ ++++|+||+|+||+++. ++.+||+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEeeccchhhcc
Confidence            9999999887766653  234678999999999999999999999 79999999999999996 7889999999987554


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--  242 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  242 (353)
                      .... .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+...++.+..+.+....+....  
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3322 2234567889999988766657889999999999999999999999998888888888888777654322110  


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      +.+. ..++......... ....++++++++|.+||+.||.+|||+.+++.||||
T Consensus       232 ~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         232 PDYK-PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHH-hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0000 0111111111111 123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=316.91  Aligned_cols=287  Identities=29%  Similarity=0.523  Sum_probs=232.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC---
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   78 (353)
                      .....|.-...+|+|.||.||+|+++.+|+.||+|++.-+.      ....+|+++|..++|+|++.+++++-...+   
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            45678888999999999999999999999999998774321      233589999999999999999887744332   


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      .....+|+||.+|..+|..++..   ...+++..++..++.+++.||.|+|+ +.|+|||+||.|+||+. ++.+||+||
T Consensus        94 r~r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~-dgilklADF  168 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITK-DGILKLADF  168 (376)
T ss_pred             cccceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcC-CceEEeecc
Confidence            34456899999999988777754   45789999999999999999999999 79999999999999996 899999999


Q ss_pred             ccccccccCC-----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+++.++..+     ..+..+.|.+|++||.+.|...|+++.|||+.|||+.+|.+|.+.+++++...++..|-...|..
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            9997654332     23345679999999999999999999999999999999999999999999999999999999988


Q ss_pred             CHHHHhhcCcC--CCCCc---CCCCCCCccccccCC-CCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          234 TREEIRCMNPN--YTDFR---FPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       234 ~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      +.+.+...+.-  +...+   +++.+.+........ .-++++.||+.+||..||.+|++++++++|.||.+
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK  320 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence            87766544311  11111   122111111111110 12568999999999999999999999999999975

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-46  Score=327.73  Aligned_cols=252  Identities=35%  Similarity=0.577  Sum_probs=205.7

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY------KNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |++.+.||+|+||+||++++..+++.||+|.+......      ..+|+.+++.++||||+++++++..     ....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            89999999999999999999999999999999765322      1248999999999999999998854     445889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc-
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-  164 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~-  164 (353)
                      +||++.+ +|.+.+.    ....+++..+..++.|++.||++||+ +|++|+||||+||+++. ++.++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEEST-TSEEEESSGTTTEEST
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccccc
Confidence            9999997 7777766    35778999999999999999999999 79999999999999995 889999999999764 


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ..........++..|+|||++.....++.++|+||+|+++|+|++|..||...+..+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            223333456779999999998634568999999999999999999999999885555544444432222111100     


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                       .....++++.++|.+||+.||++|||+.++++||||
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence                             001124799999999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-46  Score=338.38  Aligned_cols=245  Identities=27%  Similarity=0.450  Sum_probs=197.6

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHH-HHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRE-LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|++..+++.||+|++.+...       ...+| ..+++.++||||+++++++     .....+|+||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence            479999999999999999999999999864321       11223 3356778999999999888     3344588999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+.+ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus        76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECC-CCCEEEccCCCCcccccC
Confidence            99996 5554443    35678899999999999999999999 79999999999999996 788999999998754322


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P-------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence             223445789999999999654 5899999999999999999999999988877665554431   0             


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH----HHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL----EACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~----~~l~hp~f~~~~~  302 (353)
                                   ..+...+++.+.++|.+||+.||.+|+++.    ++++|+||....+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence                         001235789999999999999999999876    8999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.8e-46  Score=328.50  Aligned_cols=257  Identities=27%  Similarity=0.424  Sum_probs=203.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .|++.+.||+|+||.||++.+..+++.||+|.+....       ....+|+.+++.++|++++.+.+.+     .....+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence            4788899999999999999999999999999886432       2234699999999999999998887     333458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+||||+.+ +|...+..  .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.++|+|||++..
T Consensus        76 ~lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~  151 (285)
T cd05630          76 CLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDD-HGHIRISDLGLAVH  151 (285)
T ss_pred             EEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECC-CCCEEEeeccceee
Confidence            999999985 56555533  233468999999999999999999999 79999999999999996 77899999999976


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...........|+..|+|||++.+. .++.++|+||+||++|+|++|..||..................           
T Consensus       152 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-----------  219 (285)
T cd05630         152 VPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-----------  219 (285)
T ss_pred             cCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-----------
Confidence            5544433445789999999999654 4899999999999999999999999865432111111110000           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                                    ....++..+++++.+|+++||+.||.+|+|     ++++++||||+.+...
T Consensus       220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05630         220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK  270 (285)
T ss_pred             --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence                          001123457889999999999999999999     9999999999876443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-45  Score=335.51  Aligned_cols=286  Identities=30%  Similarity=0.532  Sum_probs=216.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCC------
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK------   79 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------   79 (353)
                      +.+|.+.+.||.|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++......      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            579999999999999999999999999999999885432    2345799999999999999998876432211      


Q ss_pred             ---CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           80 ---NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        80 ---~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                         .....|+||||+++++.+.+.     ...+++..++.++.|++.||+|||+ +|++||||||+||+++..++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEEC
Confidence               113578999999987766553     3568999999999999999999999 7999999999999998657789999


Q ss_pred             eeccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||.+........    .....++..|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+....+......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999875432211    122356888999998766556889999999999999999999999988887777666655433


Q ss_pred             CCHHHHhhcCcCCCCCcC--CCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          233 PTREEIRCMNPNYTDFRF--PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ..................  ......+... +...++.++++||++||+.||.+|||+.++++||||+.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~  308 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC  308 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence            332211111000000000  0001111111 22357899999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-46  Score=352.02  Aligned_cols=254  Identities=27%  Similarity=0.360  Sum_probs=210.3

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCC-CcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..|.+.+.||+|++|.||+|.+..+ ++.||+|.+....    ....+|+.+++.++||||+++++.+.     ....+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEE
Confidence            3599999999999999999998877 7889999764332    23457999999999999999999884     334589


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||++ |+|.+.+........++++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++...
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECC-CCcEEEEeCcCceec
Confidence            9999998 57777776655566789999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .....   .....||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.+..+......         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            44322   234568999999999865 45899999999999999999999999888776665554431000         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                         .++..++.++.+||.+||+.||++|||+.+++.|||++..
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence                               0123578899999999999999999999999999998753

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.5e-46  Score=341.18  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=198.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .++|...+.||+|+||.||++++..+++.||||++....     ..+.+|+.+++.++|+||+++++++     .....+
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~  147 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGEI  147 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCeE
Confidence            467889999999999999999999999999999985432     3345899999999999999999988     444458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||+.++.+   .    ......+..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus       148 ~lv~e~~~~~~L---~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DfG~~~~~  218 (353)
T PLN00034        148 QVLLEFMDGGSL---E----GTHIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINS-AKNVKIADFGVSRIL  218 (353)
T ss_pred             EEEEecCCCCcc---c----ccccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEcccccceec
Confidence            899999997522   1    12345678888999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCC----CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .... ......||..|+|||.+...    ...+.++|||||||++|+|++|+.||......+....+.......      
T Consensus       219 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------  292 (353)
T PLN00034        219 AQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------  292 (353)
T ss_pred             ccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------
Confidence            4322 22345789999999987431    234568999999999999999999997433222211111100000      


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                         ....+..++.++++||.+||+.||++|||+.|+++||||.+...
T Consensus       293 -------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        293 -------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             -------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence                               00112357899999999999999999999999999999988543

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-46  Score=335.68  Aligned_cols=247  Identities=25%  Similarity=0.444  Sum_probs=196.4

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|++..+++.||+|++.+..       ....+|+.++..+ +||||+++++++     .....+|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            47999999999999999999999999997532       2234788888877 699999999988     3344589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc-
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-  166 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-  166 (353)
                      ||+++ +|...+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeC-CCCEEEeccccceeccCC
Confidence            99985 5544443    34679999999999999999999999 79999999999999996 78899999999875332 


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhh
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ........||+.|+|||++.+. .++.++||||+||++|+|++|..||....      ..+...+.+..  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            2233456789999999999654 58999999999999999999999996422      11222222110  0        


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC------HHHHhcCcccccccCC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP  303 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~~~l~hp~f~~~~~~  303 (353)
                                        ...++..++..+.++|++||+.||.+|++      .+++++||||+.+.+.
T Consensus       219 ------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~  269 (327)
T cd05617         219 ------------------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD  269 (327)
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence                              00123457899999999999999999998      4699999999987643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-45  Score=334.29  Aligned_cols=317  Identities=35%  Similarity=0.615  Sum_probs=240.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|.+.+.||+|++|.||++++..+++.||+|++....      ....+|+.+++.++|||++++.+++..... ...
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4778999999999999999999999999999999875421      223479999999999999999887743322 223


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ...++|+||++++|.+.+..     .++++..++.++.|++.||+|||+ .||+|+||||+||+++. ++.++|+|||++
T Consensus        93 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~-~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNE-DCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEcccccc
Confidence            34889999999888776653     579999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  .....++..|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.+....+...
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            865432  234567889999999866556789999999999999999999999998888888888887776665443322


Q ss_pred             CcCCC-CC--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCC
Q 018619          242 NPNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN  318 (353)
Q Consensus       242 ~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~  318 (353)
                      ..... .+  ..+......+...+ ...++++.+||++||+.||.+|||+.++++||||++......     .+.++..+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~-----~~~~~~~~  317 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPED-----EPVAPPYD  317 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcc-----cccccccC
Confidence            21100 00  01111111222211 246899999999999999999999999999999998755432     22233333


Q ss_pred             chhhhccCCHHHHhhccHHHHH
Q 018619          319 FKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      ..-+-......++..++..+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~  339 (343)
T cd07851         318 QSFESRDLTVDEWKELVYKEIM  339 (343)
T ss_pred             cchhhhhcCHHHHHHHhHHHHH
Confidence            3333345666667777666654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.4e-46  Score=337.03  Aligned_cols=245  Identities=28%  Similarity=0.451  Sum_probs=196.0

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHH-HHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNREL-QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      ++||+|+||.||+|++..+++.||+|.+.+..       ....+|. .+++.++||||+++++.+     .....+|+||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            47999999999999999999999999986432       1122333 467889999999999887     3344588999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      |||++ +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus        76 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCC
Confidence            99986 5544443    35678999999999999999999999 79999999999999996 788999999998753222


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       .......||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P-------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence             223345789999999998654 5899999999999999999999999888765554443321   0             


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH----HHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~~~l~hp~f~~~~~  302 (353)
                                   ..++...+.++.++|.+||+.||.+|+++    .++++||||..+.+
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~  259 (321)
T cd05603         213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW  259 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence                         01223468899999999999999999976    49999999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.3e-46  Score=362.11  Aligned_cols=265  Identities=28%  Similarity=0.417  Sum_probs=213.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...++|.+.+.||+|+||+||+|++..+++.||+|.+...      ...+.+|+.+++.++||||++++++|....   .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---N   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---C
Confidence            3457999999999999999999999999999999988532      233457999999999999999999885432   3


Q ss_pred             eeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC------CCeeeccCCCCcEEEeCC-----
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV------PRVCHRDLKPQNLLVDPL-----  149 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~------~~i~H~Dlkp~Nill~~~-----  149 (353)
                      ..+|+||||+. ++|...+.........+++..++.|+.||+.||.|||+.      ++|+||||||+||||+..     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            35889999998 578877776555567899999999999999999999982      139999999999999631     


Q ss_pred             -----------CCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 018619          150 -----------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGE  217 (353)
Q Consensus       150 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~  217 (353)
                                 ...+||+|||++.............||+.|+|||++.+. ..++.++|||||||+||+|++|..||...
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                       235899999999876544444456789999999998643 35789999999999999999999999876


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      +....+...+...  +.               ++           ....+.++.+||.+||+.||.+|||+.|+|.|||+
T Consensus       247 ~~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~i  298 (1021)
T PTZ00266        247 NNFSQLISELKRG--PD---------------LP-----------IKGKSKELNILIKNLLNLSAKERPSALQCLGYQII  298 (1021)
T ss_pred             CcHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHH
Confidence            6555443333210  00               00           02368899999999999999999999999999999


Q ss_pred             ccccCC
Q 018619          298 DELREP  303 (353)
Q Consensus       298 ~~~~~~  303 (353)
                      +.+..+
T Consensus       299 k~i~~p  304 (1021)
T PTZ00266        299 KNVGPP  304 (1021)
T ss_pred             hhcCCC
Confidence            876543

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=331.63  Aligned_cols=282  Identities=38%  Similarity=0.641  Sum_probs=214.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECC--CCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|.+.+.||+|++|.||+|.+..  +++.||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            58999999999999999999988  89999999987632       2345799999999999999999988432   224


Q ss_pred             eEEEEeccccchHHHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC---CCCcEEEeee
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDF  158 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~-~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~---~~~~vkl~Df  158 (353)
                      .+++||||+++++...+....... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.   .++.+||+||
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            588999999988887776544333 379999999999999999999999 79999999999999984   2578999999


Q ss_pred             ccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 018619          159 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVE  225 (353)
Q Consensus       159 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---------~~~~~  225 (353)
                      |++........    .....+++.|+|||.+.+...++.++|+||+||++|+|++|++||.+.+..         ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886543322    223467889999999877666899999999999999999999999865533         34555


Q ss_pred             HHHHhCCCCHHHHhhcC--cCCCC----CcCCCCCCCccccccC--CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          226 IIKVLGTPTREEIRCMN--PNYTD----FRFPQIKAHPWHKVFH--KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      +...++.+.........  +.+..    ..............+.  ...+.++.++|.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            66666655544332111  11110    0000000000001111  2578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.9e-46  Score=327.13  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=197.3

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ||+|+||.||++.++.+|+.||+|.+....       .....|+.+++.++||||+++++.+     .....+|+||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            699999999999999999999999885422       2234689999999999999998887     4445689999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                      .| +|...+..  .....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++.........
T Consensus        76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCcee
Confidence            85 55544432  233458899999999999999999999 79999999999999996 788999999999876554444


Q ss_pred             ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcC
Q 018619          171 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF  250 (353)
Q Consensus       171 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
                      ....+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||...........+.......             ....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~~~~  217 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------EVKF  217 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------cccc
Confidence            4456889999999986654 8999999999999999999999997654322211221110000             0000


Q ss_pred             CCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH----HHHhcCcccccccCC
Q 018619          251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP  303 (353)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~~~l~hp~f~~~~~~  303 (353)
                                 ....+++++.+||++||+.||.+||++    ++++.||||+.+.++
T Consensus       218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~  263 (277)
T cd05607         218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP  263 (277)
T ss_pred             -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence                       013478999999999999999999999    678899999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-45  Score=333.85  Aligned_cols=288  Identities=38%  Similarity=0.699  Sum_probs=232.6

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||+|.+..+++.||||++....      ....+|+.+++.++||||+++.+++..........+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6899999999999999999999899999999886532      3456799999999999999999988555433334588


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ++|||+++++.+.+.    ....+++..++.++.||+.||++||+ +||+|+||||+||+++. ++.++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNS-NCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcccCceEeec
Confidence            999999987766664    34589999999999999999999999 79999999999999996 7899999999998765


Q ss_pred             cCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          166 AGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       166 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...    ......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+....+....+.+....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    2334567889999999977646899999999999999999999999999999999999988888876655421


Q ss_pred             CcC-CCCC--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCC
Q 018619          242 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  306 (353)
Q Consensus       242 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~  306 (353)
                      ... ..++  ..+.....+|...+ ..++.++.+||++||++||.+|||+++++.||||++++.....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~  301 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDE  301 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccC
Confidence            111 0110  01111222333322 3478999999999999999999999999999999998766444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-45  Score=325.60  Aligned_cols=276  Identities=36%  Similarity=0.665  Sum_probs=221.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      +|++.+.||.|++|.||+|.+..+|+.||||.+....     ....+|+.+++.++||||+++++.+..     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            5899999999999999999999999999999886432     234579999999999999999998843     334889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ||||+++++.+.+.... ....+++..+..++.|++.||+|||+ .|++|+||||+||++++ ++.++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINK-RGELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcC
Confidence            99999998877765422 23568999999999999999999999 79999999999999996 78899999999975433


Q ss_pred             CC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      .. ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.+..+...++.+....+....+.... ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            22 12334568899999998776667899999999999999999999999998888888888887777765554332 11


Q ss_pred             CC--CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          246 TD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       246 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ..  ..++......+.. +....+.++.++|.+||+.||.+||++.++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            11  1122222222211 223468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5e-46  Score=336.31  Aligned_cols=281  Identities=26%  Similarity=0.424  Sum_probs=205.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +..++|++.+.||+|+||.||++.+..++..+|+|.+....     ....+|+.+++.++||||+++++++..     ..
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~   76 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG   76 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CC
Confidence            34689999999999999999999999999999999876432     235689999999999999999998843     34


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+++||||+.+ +|.+.+.    ..+.+++..+..++.|++.||.|||+.++++|+||||+|||++. ++.+||+|||++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~  151 (333)
T cd06650          77 EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS  151 (333)
T ss_pred             EEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcc
Confidence            58899999985 6666654    34678999999999999999999997237999999999999996 788999999998


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHHhh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~  240 (353)
                      ...... ......++..|+|||++.+. .++.++|+||+||++|+|++|..||......+....+... .+.+.......
T Consensus       152 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (333)
T cd06650         152 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP  229 (333)
T ss_pred             hhhhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence            755332 22345688999999998654 4899999999999999999999999876553332211100 00000000000


Q ss_pred             cC-c------CCCCCcCCCCC--------CCcccccc-CCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MN-P------NYTDFRFPQIK--------AHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~-~------~~~~~~~~~~~--------~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .. .      .+.....+...        .......+ ...++.++++||.+||++||++|||+.|++.||||+..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            00 0      00000000000        00000001 12367899999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-47  Score=316.56  Aligned_cols=320  Identities=30%  Similarity=0.509  Sum_probs=247.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCC-
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN-   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~-   80 (353)
                      ....+|.-.+.+|.|+- .|..|.+..++++||+|+....      .+...+|..++..++|+||++++.+|....... 
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            44678999999999998 7888999999999999988543      345568999999999999999999985544321 


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...+|+|||+|..+|-..+.      -.++-..+..++.|++.|++|||+ .||+||||||+||+++. ++.+||.|||+
T Consensus        93 ~~e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~-~~~lKi~dfg~  164 (369)
T KOG0665|consen   93 FQEVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNS-DCTLKILDFGL  164 (369)
T ss_pred             HHhHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecc-hhheeeccchh
Confidence            22488999999998877665      346678899999999999999999 79999999999999996 88999999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |+.....-..+.++.|+.|+|||++.+.+ |...+||||+||++.||++|+..|.+.+..++..++.+.+|.|....+..
T Consensus       165 ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  165 ARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             hcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            98765554566789999999999999877 99999999999999999999999999999999999999999999887766


Q ss_pred             cCcCCCC----------CcCCC-CCCCccccccCC--CCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCC
Q 018619          241 MNPNYTD----------FRFPQ-IKAHPWHKVFHK--RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL  307 (353)
Q Consensus       241 ~~~~~~~----------~~~~~-~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~  307 (353)
                      +.+.-..          +.+.. ++...|......  .-+..++|++.+||-.||++|.|++++|+||||+=+-..+  .
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~--e  321 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPD--E  321 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccc--c
Confidence            5433211          11111 122222222211  1245789999999999999999999999999999432222  1


Q ss_pred             CCCCCCCCCCCchhhhccCCHHHHhhccHHHHH
Q 018619          308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      ...++.+ ......+..+.+.+.+..++..+++
T Consensus       322 v~ap~pe-~~d~~~d~~~~t~~e~ke~If~ev~  353 (369)
T KOG0665|consen  322 VEAPPPE-IYDKQLDEREHTIEEWKELIFKEVQ  353 (369)
T ss_pred             ccCCCCc-hhhhhcccccCCHHHHHHHHHHHHH
Confidence            2222222 1212223444557777766666665

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-45  Score=331.67  Aligned_cols=287  Identities=37%  Similarity=0.631  Sum_probs=226.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCC--CcEEEEEEeeccc------cchHHHHHHHHHc-CCCceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|.+.+.||+|+||.||++.+..+  +..||+|.+....      ....+|+.+++.+ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            589999999999999999999888  8999999886421      2345799999988 5999999988654322 2234


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|+++++++++|...+.    ....+++..++.++.||+.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~-~~~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNA-DCELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcC-CCCEEeCcCCCce
Confidence            478999999988777664    35679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCC-----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          163 QLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       163 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      .......     .....+|+.|+|||.+.+...++.++|+||+||++|+|++|.+||...+....+..++..++.+....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6543221     22346789999999986655689999999999999999999999999999999999999999887765


Q ss_pred             HhhcCcCCCC---CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCC
Q 018619          238 IRCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  306 (353)
Q Consensus       238 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~  306 (353)
                      +.........   ..........+.. .....+..+.+|+.+||+.||.+|||+.+++.||||++++++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~  304 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE  304 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccc
Confidence            5433221100   0011111111111 112468899999999999999999999999999999998776443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.8e-45  Score=327.55  Aligned_cols=283  Identities=29%  Similarity=0.517  Sum_probs=216.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC---CC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN   80 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~   80 (353)
                      .++|.+.+.||+|+||.||+|.+..+++.||||.+....      ....+|+.+++.++||||+++++++.....   ..
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            468999999999999999999999999999999885432      123479999999999999999998754332   22


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ....++||||+.+++...+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||+
T Consensus        91 ~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~  165 (310)
T cd07865          91 KGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITK-DGILKLADFGL  165 (310)
T ss_pred             CceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECC-CCcEEECcCCC
Confidence            345789999999987776653   34578999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCc-----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          161 AKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       161 a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +.........     ....++..|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+.......+....+..+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9765433221     23456788999999876655788999999999999999999999988887777766666665554


Q ss_pred             HHHhhcC--cCCCCCcCCCCCCCccccccC-CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          236 EEIRCMN--PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       236 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ..+....  ..+....++..........+. ...+..+.+||.+||+.||.+|||++++++||||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            4322110  000111111111111111111 1236788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.8e-45  Score=324.12  Aligned_cols=278  Identities=35%  Similarity=0.615  Sum_probs=212.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+....     ....+|+.+++.++|+||+++++++.     .....
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~   78 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence            478999999999999999999999999999999885432     23457999999999999999999873     33458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||+.+++...+..   ....+++..++.++.|++.||+|||+ +||+|+||||+||+++. ++.+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~  153 (291)
T cd07870          79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISY-LGELKLADFGLARAK  153 (291)
T ss_pred             EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcC-CCcEEEecccccccc
Confidence            89999999887766543   34567888999999999999999999 79999999999999996 788999999998754


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||...+ ..+.+.++...++.|.........
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            3322 12334568899999998665567889999999999999999999997654 345566666666766554332211


Q ss_pred             --cCCCCCcCCCCCCCccccccC-CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          243 --PNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       243 --~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                        +.+....++............ -..+.++.+++.+||+.||++|||+.|++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              111111111111111000000 0136789999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.2e-45  Score=324.87  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=204.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|+||.||++.++.+|+.||||.+.....     ....|+. .++.++|||++++++.+..     ...+
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcE
Confidence            479999999999999999999999999999998865421     2223444 4667799999999998843     3348


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |++|||++++|.+.+.........+++..++.++.|++.||+|||+ + +++||||||+||+++. ++.+||+|||++..
T Consensus        76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~  153 (283)
T cd06617          76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINR-NGQVKLCDFGISGY  153 (283)
T ss_pred             EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecccccc
Confidence            8999999998888887655556789999999999999999999999 6 9999999999999996 78899999999986


Q ss_pred             cccCCCcceeeeeceeeChhhhhCC---CCCCccccchhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ...........++..|+|||.+.+.   ..++.++|+||+||++|+|++|+.||.... ..+.+......  ...     
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-----  226 (283)
T cd06617         154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE--PSP-----  226 (283)
T ss_pred             cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc--CCC-----
Confidence            5443333345678899999988542   346889999999999999999999996532 22333222211  000     


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                               .+           ....+|.++.++|.+||+.||.+|||++++++||||....
T Consensus       227 ---------~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         227 ---------QL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             ---------CC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence                     00           0123688999999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=321.38  Aligned_cols=248  Identities=28%  Similarity=0.502  Sum_probs=202.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ++|.+.+.||+|++|.||.+.+..+++.||+|.+....         ....+|+.+++.++||||+++++++     ...
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence            57999999999999999999999999999999875331         2345799999999999999999988     333


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+++++||+++ +|.+.+.    ....+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||+
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~-~~~~~l~dfg~  150 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA  150 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeccc
Confidence            468999999985 5555554    34568999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          161 AKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       161 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +.........    ....++..|+|||.+.+.. ++.++||||+||++|+|++|+.||...+.......+.....     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-----  224 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-----  224 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC-----
Confidence            8755332211    2345678899999996654 89999999999999999999999987665544433322100     


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                            ...++..++.++.++|.+||..||.+|||+.++++||||
T Consensus       225 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         225 ----------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             ----------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence                                  111334578999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.8e-45  Score=323.75  Aligned_cols=257  Identities=27%  Similarity=0.416  Sum_probs=207.3

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .|+..+.||+|+||+||++.+..+++.||+|.+....       ....+|+.+++.++|+|++.+.+.+     ......
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~   75 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence            4788899999999999999999999999999885432       2245799999999999999998887     334458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |++|||+.+ +|...+..  .....+++..+..++.|++.||.|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~  151 (285)
T cd05632          76 CLVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDD-YGHIRISDLGLAVK  151 (285)
T ss_pred             EEEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECC-CCCEEEecCCccee
Confidence            899999996 45444432  234579999999999999999999999 79999999999999996 77899999999976


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...........|+..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+........         
T Consensus       152 ~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------  221 (285)
T cd05632         152 IPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------  221 (285)
T ss_pred             cCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc---------
Confidence            5444433455789999999998654 589999999999999999999999987766544443333211110         


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                                      ..+...++.++.+|+.+||+.||.+|||     +++++.||||+.....
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05632         222 ----------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK  270 (285)
T ss_pred             ----------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence                            0122457889999999999999999999     8899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.2e-45  Score=323.55  Aligned_cols=277  Identities=35%  Similarity=0.667  Sum_probs=215.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+.+..      ....+|+.+++.++||||+++++++     ......
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence            57999999999999999999999899999999875432      2345799999999999999999988     444568


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||+.+++...+..   ....+++..+..++.|++.||+|||+ .|++|+||+|+||++++ ++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~  150 (286)
T cd07846          76 YLVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCcEEEEeeeeeeec
Confidence            99999999865544432   34568999999999999999999999 79999999999999996 788999999998865


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN-  242 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  242 (353)
                      ..... .....++..|+|||.+.+...++.++||||+||++|+|++|.+||...+..+....+....+........... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07846         151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK  230 (286)
T ss_pred             cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence            44332 2345678899999998765567889999999999999999999999888777777777665554322111111 


Q ss_pred             -cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          243 -PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                       +.......+......-.......++..+.+|+.+||+.||++|||+.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence             0001111111111100111123578999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.5e-45  Score=325.10  Aligned_cols=281  Identities=32%  Similarity=0.613  Sum_probs=220.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC---CC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN   80 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~   80 (353)
                      .++|++.+.||+|++|.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++.+.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            689999999999999999999999999999999885321      234579999999999999999988754332   22


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...+++||||+.+++...+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||++++ ++.++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDN-QGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEECcCcc
Confidence            346789999999887666543   34579999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCC------------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 018619          161 AKQLIAGEA------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       161 a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  228 (353)
                      +........            .....+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            975543221            12235688899999987665688999999999999999999999999988888888888


Q ss_pred             HhCCCCHHHHhhcC--cCCCC-CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          229 VLGTPTREEIRCMN--PNYTD-FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       229 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ..+.+....+....  +.... ...... .......+ ..+++++.+||.+||+.||.+|||+.++++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCC-CccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            77766554332211  11110 000110 11111111 2356889999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-47  Score=335.66  Aligned_cols=249  Identities=30%  Similarity=0.548  Sum_probs=212.1

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      .++||+|.||+||.++++.+|+.||||++.+-      ......|+.||+.+.||.||.+.-.|     +....+++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEeh
Confidence            47899999999999999999999999988543      34556899999999999999998777     44555889999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC--CcEEEeeeccccccccC
Q 018619           90 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAG  167 (353)
Q Consensus        90 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~--~~vkl~Dfg~a~~~~~~  167 (353)
                      -+.|++++.+..  ...+++++.....++.||+.||+|||. ++|+|+||||+|||+.+.+  .++||||||+|+.+.+.
T Consensus       644 Kl~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KLHGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hhcchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            999998887764  456899999999999999999999999 7999999999999997533  37999999999999888


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      ....+.+|||.|+|||++... .|+..-|+||.|||+|.-+.|..||....+...  +|.+.                 .
T Consensus       721 sFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNA-----------------a  780 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNA-----------------A  780 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhH--Hhhcc-----------------c
Confidence            888889999999999999654 599999999999999999999999966543322  22221                 1


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      |-+   +..+|.+     +++++.|||+.+|+..-.+|.|++..|+|||+++.
T Consensus       781 FMy---Pp~PW~e-----is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  781 FMY---PPNPWSE-----ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ccc---CCCchhh-----cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            111   2356644     89999999999999999999999999999999864

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-45  Score=322.67  Aligned_cols=277  Identities=35%  Similarity=0.678  Sum_probs=221.5

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||+++++++..     ....
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence            4799999999999999999999999999999987532      2345689999999999999999999844     3358


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++|||+++++...+..   ....+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 ~iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~  150 (288)
T cd07833          76 YLVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSE-SGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCCEEEEeeeccccc
Confidence            89999999876665443   34568999999999999999999999 79999999999999996 888999999998876


Q ss_pred             ccCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ....  ......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+..+.+..+....+...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            5543  23345678899999999776468999999999999999999999999888888777777766655544332221


Q ss_pred             --cCCCCCcCCCC-CCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          243 --PNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       243 --~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                        ..+....++.. ....+...++..++.++.+||++||..||++|||+++++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence              11111111111 11222333445568999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7e-46  Score=330.32  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=199.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcC-CCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   80 (353)
                      +.+..|++.+.||+||.+.||++... ..+.||+|++....      .-...|+.+|.+|+ |.+|++++++=     -+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~  431 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VT  431 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----cc
Confidence            55678999999999999999999854 44577777664322      22357999999995 89999998865     34


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      +.++|+||||-+.+|-..|...   ...++...++.+..|++.|++++|+ +||||.||||.|+|+-  .|.+||+|||+
T Consensus       432 d~~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLlV--kG~LKLIDFGI  505 (677)
T KOG0596|consen  432 DGYLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLLV--KGRLKLIDFGI  505 (677)
T ss_pred             CceEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEEE--eeeEEeeeech
Confidence            6679999999888998888763   3344545899999999999999999 8999999999999998  58899999999


Q ss_pred             ccccccCCCc---ceeeeeceeeChhhhhCCC----------CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018619          161 AKQLIAGEAN---ISYICSRFYRAPELIFGAT----------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  227 (353)
Q Consensus       161 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  227 (353)
                      |..+......   .+.+||+.|||||.+....          ..+.+|||||||||||+|+.|++||.....   ....+
T Consensus       506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl  582 (677)
T KOG0596|consen  506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKL  582 (677)
T ss_pred             hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHH
Confidence            9877665443   3568999999999984422          146799999999999999999999965432   22222


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      ..+..|.           .+++||.+.           -..++.++++.||+.||.+|||+.++|+|||++-
T Consensus       583 ~aI~~P~-----------~~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  583 HAITDPN-----------HEIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             HhhcCCC-----------ccccccCCC-----------CchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            2233332           122333321           1234999999999999999999999999999975

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-44  Score=327.68  Aligned_cols=286  Identities=35%  Similarity=0.588  Sum_probs=223.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            4689999999999999999999999999999999886432      234579999999999999999988743322 222


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ...|++++++++++.+.+.     ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus        95 ~~~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~-~~~~kl~dfg~~  167 (345)
T cd07877          95 NDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLA  167 (345)
T ss_pred             ccEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcC-CCCEEEeccccc
Confidence            3478999999888766554     2468999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .....  ......++..|+|||.+.+...++.++|+||+||++|+|++|..||...+....+..+....+.+........
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T cd07877         168 RHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  245 (345)
T ss_pred             ccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            75432  2234567889999999866556889999999999999999999999988888888888777777665554333


Q ss_pred             CcCCCCC---cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          242 NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      .......   ..+......+... ....++++++||.+||+.||.+|+|+.++++||||+++..+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         246 SSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             ccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence            2111000   0011111111111 124688999999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-44  Score=327.13  Aligned_cols=284  Identities=37%  Similarity=0.645  Sum_probs=222.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCC-Cce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~   82 (353)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++.+..      ....+|+.+++.++||||+++++++...... ...
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            568999999999999999999999999999999886421      2245799999999999999999987543321 223


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|+|+||+..++....      ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNE-DCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCCCCc
Confidence            46899999987654432      2468999999999999999999999 79999999999999996 7899999999987


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ....  ......+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+....+..++...+.+.........
T Consensus       166 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         166 HADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            5432  22345678899999998665558899999999999999999999999988888888888877766654433221


Q ss_pred             cCCC-CC--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          243 PNYT-DF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       243 ~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      .... .+  ..+......+...+ ...+.++.+||++||+.||.+|||+++++.||||..++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~  307 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD  307 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccc
Confidence            1100 00  01111122222212 24688999999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-45  Score=322.80  Aligned_cols=274  Identities=39%  Similarity=0.731  Sum_probs=222.0

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |.+.+.||+|++|.||++.+..+++.+++|.+....      ....+|+.+++.++|+||+++++.+..     ....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence            678899999999999999999999999999886442      234579999999999999999998733     345889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ++||+++++...+..   ....+++..+..++.|++.||.|||+ ++++|+||||+||+++. ++.++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINT-EGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCC
Confidence            999999987777654   34679999999999999999999999 79999999999999996 78899999999986654


Q ss_pred             CC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 018619          167 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP--  243 (353)
Q Consensus       167 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  243 (353)
                      .. ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||...+..+....+....+.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            43 223345788899999987664689999999999999999999999999999888888888888776655443332  


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ......++....... ......++.++.+||.+||+.||.+||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            111222222222221 11223578999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.9e-45  Score=329.94  Aligned_cols=280  Identities=36%  Similarity=0.578  Sum_probs=220.1

Q ss_pred             ecceeeE-eeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------------------chHHHHHHHHHcCCCceeec
Q 018619            9 QTISYMA-ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------YKNRELQLMRVMDHPNVISL   69 (353)
Q Consensus         9 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~~iv~~   69 (353)
                      ..++|.. .+.||+|+||.||+|.+..+++.||+|++.....                  ...+|+.+++.++||||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3567864 5789999999999999999999999998854321                  24579999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC
Q 018619           70 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL  149 (353)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~  149 (353)
                      ++++.     .....+++|||+.+++.+.+.    ....+++..+..++.|++.||+|||+ +|++|+||+|+||+++. 
T Consensus        86 ~~~~~-----~~~~~~lv~e~~~~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~-  154 (335)
T PTZ00024         86 VDVYV-----EGDFINLVMDIMASDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINS-  154 (335)
T ss_pred             eEEEe-----cCCcEEEEEeccccCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECC-
Confidence            99883     334588999999998777664    34678999999999999999999999 79999999999999996 


Q ss_pred             CCcEEEeeeccccccccC---------------CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCC
Q 018619          150 THQVKICDFGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF  214 (353)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  214 (353)
                      ++.++|+|||.+......               .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            788999999998765411               11122345788999999877666799999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcC--cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          215 PGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .+.+..+.+..+....+.+....+....  +.+..  +.......... .....+.++.++|.+||+.||++|||+++++
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l  311 (335)
T PTZ00024        235 PGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTE--FTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEAL  311 (335)
T ss_pred             CCCCHHHHHHHHHHHhCCCchhhCcchhhcccccc--cCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence            9999988888888887777654332111  00000  00000111111 1234688999999999999999999999999


Q ss_pred             cCcccccccC
Q 018619          293 AHPFFDELRE  302 (353)
Q Consensus       293 ~hp~f~~~~~  302 (353)
                      .||||+....
T Consensus       312 ~~~~~~~~~~  321 (335)
T PTZ00024        312 KHEYFKSDPL  321 (335)
T ss_pred             cCcccCCCCC
Confidence            9999987543

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.2e-44  Score=321.66  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=208.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|.+.+.||+|+||.||++.+..+++.+|+|.+....   ....+|+.+++.+ +|||++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            578999999999999999999999999999999886432   3345788999988 899999999988665444445688


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+.........+++..++.++.|++.||+|||+ ++++|+||||+||+++. ++.+||+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEeecccchhc
Confidence            99999985 6766665544456789999999999999999999999 79999999999999996 778999999998865


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCC----CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ..... .....++..|+|||.+....    .++.++|+||+||++|+|++|+.||...+....+..+.+.   +.     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~-----  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP-----  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC-----
Confidence            43322 23346788899999975432    2578999999999999999999999877655444333221   00     


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                                 +       ....+...+..+.+||.+||+.||++||++.++++||||+
T Consensus       251 -----------~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 -----------P-------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             -----------C-------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence                       0       0001124577899999999999999999999999999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=323.40  Aligned_cols=257  Identities=30%  Similarity=0.456  Sum_probs=217.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +...+|..+.+||.|+||+|.+|..+.|.+.||||++.++..       ....|.++|... +-|.+++++.+|     +
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----Q  420 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----Q  420 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----h
Confidence            445678899999999999999999999999999999877642       233577777665 467889998888     4


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      .-..+|+||||+.|+   .|..++.+-+++.+..+..++.+|+.||-+||+ +||++||||.+||++|. ++.+||+|||
T Consensus       421 TmDRLyFVMEyvnGG---DLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~-eGHiKi~DFG  495 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGG---DLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDS-EGHIKIADFG  495 (683)
T ss_pred             hhhheeeEEEEecCc---hhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEecc-CCceEeeecc
Confidence            444499999999975   233334456889999999999999999999999 89999999999999997 7889999999


Q ss_pred             cccccc-cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          160 SAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       160 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +++... .+....+.+|||.|+|||++ ..++|+.++|+||+||+||||+.|++||.+.+..+..+.|++.         
T Consensus       496 mcKEni~~~~TTkTFCGTPdYiAPEIi-~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh---------  565 (683)
T KOG0696|consen  496 MCKENIFDGVTTKTFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH---------  565 (683)
T ss_pred             cccccccCCcceeeecCCCcccccceE-EecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------
Confidence            998644 34445678999999999998 4567999999999999999999999999999999999988873         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH-----HHHhcCcccccccCCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREPN  304 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~f~~~~~~~  304 (353)
                                          ...+++.+|.++.+++..+|.+.|.+|+.+     .++..||||+.+.|..
T Consensus       566 --------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  566 --------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             --------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence                                122457899999999999999999999864     5899999999998753

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.6e-45  Score=330.32  Aligned_cols=287  Identities=35%  Similarity=0.681  Sum_probs=226.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHc-CCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++|.+.+.||+|+||.||++.+..+++.+|+|++.+.      .....+|+.+++.+ +||||+++++++..   .+.
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            357899999999999999999999989999999988542      22345799999999 99999999988733   223


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ...|+||||+.++|...+..     ..+++..++.++.|++.||+|||+ +||+|+||||+||+++. ++.+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~-~~~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNS-DCRVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCcEEEeeccch
Confidence            45789999999887766543     378889999999999999999999 79999999999999996 889999999999


Q ss_pred             cccccCC------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          162 KQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       162 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      .......      ......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+....+....+....+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            8654332      1223567889999998866566889999999999999999999999998888888888888777765


Q ss_pred             HHHhhcCcCCCCCcC---CCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCC
Q 018619          236 EEIRCMNPNYTDFRF---PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  306 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~  306 (353)
                      ..+..+........+   +......... ....++.++.++|.+||+.||++|||+.++++||||+++..+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~  307 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDE  307 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCC
Confidence            544433221111101   1111111112 223478999999999999999999999999999999998765444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=320.65  Aligned_cols=274  Identities=35%  Similarity=0.669  Sum_probs=216.6

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |++.+.||.|++|.||++.+..+|+.||+|++....      ....+|+.+++.++|||++++++.+.     .....|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            678899999999999999999999999999886432      23457999999999999999999883     3355889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      +|||+++++.+.+...  ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCcEEEeecccccccCC
Confidence            9999988877776542  12468999999999999999999999 79999999999999997 88999999999975433


Q ss_pred             CCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--c
Q 018619          167 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P  243 (353)
Q Consensus       167 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  243 (353)
                      ... .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+....+.+..+.+....+....  +
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            221 2233568889999988665557899999999999999999999999988888888888877777655432211  0


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      .+. ..++........ .....++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       232 ~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         232 DYK-PTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hhh-hhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            000 011111111111 1224578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=325.09  Aligned_cols=260  Identities=29%  Similarity=0.503  Sum_probs=210.9

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|++|.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++.+     .....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence            47999999999999999999999999999999886542       2345799999999999999999887     44456


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .|+||||+.+ +|.+.+..  .....+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~  151 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHE-SGHIMLSDFDLSK  151 (316)
T ss_pred             EEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcC-CCCEEEeecchhh
Confidence            8999999985 66665542  234679999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCC------------------------------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCC
Q 018619          163 QLIAGEA------------------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  212 (353)
Q Consensus       163 ~~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  212 (353)
                      .......                              .....||..|+|||.+.+. .++.++||||+||++|+|++|..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~  230 (316)
T cd05574         152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTT  230 (316)
T ss_pred             cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCC
Confidence            5432211                              1123578889999999654 47899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC----H
Q 018619          213 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT----A  288 (353)
Q Consensus       213 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~  288 (353)
                      ||.+.+.......+...                 ...++.          ...++.++.++|.+||+.||.+|||    +
T Consensus       231 pf~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~  283 (316)
T cd05574         231 PFKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGA  283 (316)
T ss_pred             CCCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence            99888766555444321                 000000          0126899999999999999999999    9


Q ss_pred             HHHhcCcccccccCCCCCC
Q 018619          289 LEACAHPFFDELREPNARL  307 (353)
Q Consensus       289 ~~~l~hp~f~~~~~~~~~~  307 (353)
                      +++++||||++.+++.-..
T Consensus       284 ~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         284 AEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             HHHHcCchhhcCChhhccc
Confidence            9999999999987766555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.3e-45  Score=322.42  Aligned_cols=250  Identities=30%  Similarity=0.501  Sum_probs=207.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.+..       ....+|+.+++.++||||+++++++.     ....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence            47999999999999999999999999999999886432       23457999999999999999999883     3445


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||||++ ++|.+.+..    ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++.
T Consensus        76 ~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~dfg~~~  149 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDS-DGYIKITDFGFAK  149 (290)
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEeeCCCcc
Confidence            889999996 566666543    4679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .....  .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+...  .          
T Consensus       150 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------  214 (290)
T cd05580         150 RVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K----------  214 (290)
T ss_pred             ccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C----------
Confidence            66444  3344678899999998654 4789999999999999999999999887755444433320  0          


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                                       ..++..++..+.++|++||+.||.+|+     +++++++||||+.+.+.
T Consensus       215 -----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  263 (290)
T cd05580         215 -----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI  263 (290)
T ss_pred             -----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence                             012345689999999999999999999     99999999999887643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.4e-45  Score=330.59  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=195.6

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      |.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.++..+ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            4566789999999999999999999753     345789999886432     2345799999999 8999999998774


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh-------------------------------------------------
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------------------------  104 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------------------------------------  104 (353)
                      ..    ...++++|||++ |+|.+.+.....                                                 
T Consensus        82 ~~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (338)
T cd05102          82 KP----NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST  157 (338)
T ss_pred             CC----CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence            22    224789999998 577666653211                                                 


Q ss_pred             ---------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc---ce
Q 018619          105 ---------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---IS  172 (353)
Q Consensus       105 ---------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~  172 (353)
                               ...++++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++........   ..
T Consensus       158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~  235 (338)
T cd05102         158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGS  235 (338)
T ss_pred             ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccC
Confidence                     02358888999999999999999999 79999999999999996 788999999999865332221   12


Q ss_pred             eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCC
Q 018619          173 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP  251 (353)
Q Consensus       173 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (353)
                      ..+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+....+...........                   
T Consensus       236 ~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------------------  295 (338)
T cd05102         236 ARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-------------------  295 (338)
T ss_pred             CCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-------------------
Confidence            3346789999998654 48999999999999999997 99999876544333322221000                   


Q ss_pred             CCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                              ...+...++++.+++.+||+.||.+|||+.++++
T Consensus       296 --------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 --------MRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                    0012357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-44  Score=319.97  Aligned_cols=261  Identities=25%  Similarity=0.369  Sum_probs=208.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ..++|++.+.||+|+||.||++.+..+++.||+|.+....   ....+|+.+++.+ +||||+++++++..........+
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            5689999999999999999999999999999999875432   3345789999998 69999999998865544455678


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++||||+++ +|.+.+.........+++..++.++.|++.||.|||+ ++++||||||+||+++. ++.+||+|||++..
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~  173 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTT-EGGVKLVDFGVSAQ  173 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECC-CCCEEEccCCceee
Confidence            899999985 6766666544556779999999999999999999999 79999999999999996 77899999999876


Q ss_pred             cccCC-CcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ..... ......+++.|+|||.+..    ...++.++|+||+||++|+|++|..||...+....+......  .+.    
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~~----  247 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PPP----  247 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CCC----
Confidence            54332 2234568899999998743    234788999999999999999999999876554333221110  000    


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                          ....+...+.++.+||.+||+.||++|||+.++++||||
T Consensus       248 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 --------------------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             --------------------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence                                000122357889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-44  Score=326.83  Aligned_cols=285  Identities=36%  Similarity=0.654  Sum_probs=221.2

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCC-Cc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~   81 (353)
                      ..++|.+.+.||+|++|.||++.+..+++.||+|++....      ....+|+.+++.++||||+++++++...... ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999999999999999885421      2345799999999999999999987443221 12


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+++||||+++++...+.     ...+++..++.++.|++.||+|||+ .||+||||||+||+++. ++.+||+|||++
T Consensus        93 ~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~-~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccc
Confidence            3468999999877765553     3578999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.+.......+.+..+.+........
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            865332  223466889999999866455889999999999999999999999988887777777776655544332222


Q ss_pred             CcCCCC-C--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          242 NPNYTD-F--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       242 ~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      ...... +  ..+......+ ..+...+++++.++|.+||+.||.+|||+.+++.||||+..+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             cchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            111000 0  0111111111 11224578899999999999999999999999999999988654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-44  Score=317.94  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=203.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc-CCCceeecceeeeecCCC-CceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-NELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~~   84 (353)
                      .+.|++.+.||+|+||.||++.+..+++.||+|.+....   ....+|+.+++.+ +|||++++++.+...... ....+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            467999999999999999999999999999999886442   3345788889888 799999999988654332 23468


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |++|||+++ +|.+.+..  .....+++..+..++.|++.||+|||+ ++|+|+||||+||+++. ++.++|+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECC-CCCEEEccCCCcee
Confidence            899999985 66665543  124568999999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCC-CcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ..... ......+++.|+|||++.+    ...++.++|+||+||++|+|++|..||...............   +     
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~-----  232 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-----  232 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence            54322 2234567889999999853    234788999999999999999999999766544333222110   0     


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                         ........++.++.+|+.+||..||.+|||+.+++.||||
T Consensus       233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence                               0000113468899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-44  Score=320.81  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=207.4

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ++...+.|++.+.||.|+||.||++++..+++.|++|.+....    ....+|+.+++.++|||++++++++..     .
T Consensus         7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   81 (292)
T cd06644           7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----D   81 (292)
T ss_pred             ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----C
Confidence            4455678999999999999999999999999999999986443    234578999999999999999998843     3


Q ss_pred             eeEEEEeccccchHH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~-~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+||||++++.+ ..+..   ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus        82 ~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~dfg~  156 (292)
T cd06644          82 GKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTL-DGDIKLADFGV  156 (292)
T ss_pred             CeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcC-CCCEEEccCcc
Confidence            358899999997543 33322   34568999999999999999999999 79999999999999986 78899999999


Q ss_pred             ccccccCC-CcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          161 AKQLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       161 a~~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +....... ......+++.|+|||.+.+    ...++.++|+||+||++|+|++|..||...+......++...  .++ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~-  233 (292)
T cd06644         157 SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-  233 (292)
T ss_pred             ceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc-
Confidence            87543322 2234567889999999843    234678999999999999999999999877654444333221  000 


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                             ....+..++.++.++|.+||+.||++||+++++++||||..+...
T Consensus       234 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         234 -----------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             -----------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence                                   000123468899999999999999999999999999999876543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=319.66  Aligned_cols=277  Identities=31%  Similarity=0.605  Sum_probs=217.6

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |.+.+.||+|++|.||++.+..+++.+|+|.+....      ....+|+.+++.++|||++++++++....   ....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence            788999999999999999999999999999997542      23457999999999999999999884331   245889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ||||+++++.+.+..   ....+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.+||+|||++.....
T Consensus        78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINN-DGVLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcC-CCCEEEccccceeeccC
Confidence            999999887766653   23579999999999999999999999 79999999999999996 88999999999986654


Q ss_pred             CCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          167 GEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       167 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ...  .....++..|+|||.+.+...++.++||||+||++|+|++|..||...+.......+.+..+.+....+......
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            431  233456788999998766556889999999999999999999999999988888888877776665443321110


Q ss_pred             --CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          245 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                        .................+....++++.++|++||+.||.+|||+.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence              00000000000011112222248899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-44  Score=326.38  Aligned_cols=277  Identities=21%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             EeeeeecC--CCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           15 AERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        15 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      +.++||+|  ++++||++.++.+|+.||+|++....      ....+|+.+++.++||||+++++++..     ....|+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            56789999  67899999999999999999986432      234579999999999999999998843     334889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ||||+++ ++.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEec-CCcEEEcccchhhccc
Confidence            9999984 666665432  23458999999999999999999999 79999999999999996 7889999998754332


Q ss_pred             cCCC--------cceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC----
Q 018619          166 AGEA--------NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT----  232 (353)
Q Consensus       166 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----  232 (353)
                      ....        .....++..|+|||++.+. ..++.++||||+||++|+|++|..||..................    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            2111        1123457779999998653 35889999999999999999999999876554433332221000    


Q ss_pred             ---CCHHHHhhcCcCCCCC--cCCC---------CCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          233 ---PTREEIRCMNPNYTDF--RFPQ---------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       233 ---~~~~~~~~~~~~~~~~--~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                         .+.+.+. +.+.....  ....         .........+...+++++.+||++||+.||++|||++++++||||+
T Consensus       233 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         233 TTTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             ccchhhhhcc-cCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence               0000000 00000000  0000         0000000112234678999999999999999999999999999998


Q ss_pred             ccc
Q 018619          299 ELR  301 (353)
Q Consensus       299 ~~~  301 (353)
                      ++.
T Consensus       312 ~~~  314 (327)
T cd08227         312 QIK  314 (327)
T ss_pred             hcc
Confidence            764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.3e-44  Score=319.02  Aligned_cols=283  Identities=30%  Similarity=0.526  Sum_probs=220.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC----
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS----   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----   78 (353)
                      ..++|.+.+.||+|++|.||++.++.+|+.||+|.+....      ....+|+.+++.++|||++++++++....+    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4578999999999999999999999999999999885432      233579999999999999999988754331    


Q ss_pred             -CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 -KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 -~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       .+...+++|+||+++++...+..   ....+++..++.++.|++.||+|||+ +||+|+||||+||+++. ++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~-~~~~kl~d  159 (302)
T cd07864          85 KKDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNN-KGQIKLAD  159 (302)
T ss_pred             cccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCcEEeCc
Confidence             12236889999999987766553   24578999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          158 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       158 fg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      ||++........  .....++..|+|||.+.+...++.++||||+||++|+|++|++||...+..+.+..+.+..+.+..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            999986544331  122345778999999866555789999999999999999999999988888888888887776665


Q ss_pred             HHHhhcCc--CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          236 EEIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       236 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ..+.....  .+............+...+ ..++..+.++|.+||+.||++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            44322110  0100000011111122222 3478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-44  Score=320.37  Aligned_cols=260  Identities=26%  Similarity=0.441  Sum_probs=204.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....     ....+|+.+++.++||||+++++.+.     .....|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVY   75 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEE
Confidence            47899999999999999999999999999999886431     23457999999999999999999873     344588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|...+.. ......+++..+..++.|++.||.|||+..+++|+||||+||+++. ++.+||+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~  153 (286)
T cd06622          76 MCMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccc
Confidence            99999996 55444432 1123479999999999999999999996249999999999999996 788999999998755


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCC-----CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGEANISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ... ......+++.|+|||.+.+..     .++.++|+||+||++|+|++|..||...+.......+........     
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----  227 (286)
T cd06622         154 VAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP-----  227 (286)
T ss_pred             cCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-----
Confidence            332 223345788899999985432     257899999999999999999999977654443333222111100     


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                          ..++..+++++.+||.+||+.||.+||+++++++||||...+..
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         228 --------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             --------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence                                01223478999999999999999999999999999999886544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-45  Score=333.25  Aligned_cols=257  Identities=30%  Similarity=0.428  Sum_probs=221.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...+.|.+.+.||+|.|++|.++++..|+..||||.+.+..      ....+|+++|+.++|||||+++.+.     ...
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~  127 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETE  127 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eec
Confidence            45678999999999999999999999999999999997653      2245899999999999999999998     444


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||+.++   .+..|...++++.+..++.++.|++.|++|||+ ++|+|||||++|||++. +.++||+|||++
T Consensus       128 ~~lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~-~mnikIaDfgfS  202 (596)
T KOG0586|consen  128 ATLYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDE-NMNIKIADFGFS  202 (596)
T ss_pred             ceeEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhccccc-ccceeeeccccc
Confidence            4499999999964   444555678999999999999999999999999 89999999999999996 778999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ..+..+....+++|++.|.|||++.|..+.++.+|+||+|+++|.|+.|.+||.+.+-.+.-...+.             
T Consensus       203 ~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~-------------  269 (596)
T KOG0586|consen  203 TFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR-------------  269 (596)
T ss_pred             eeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-------------
Confidence            9998888888999999999999999988789999999999999999999999988764433222111             


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                          ..+            .++-.++.++.++|+++|-.+|.+|++++++..|.|.......
T Consensus       270 ----gk~------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  270 ----GKY------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             ----eee------------cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence                001            1223589999999999999999999999999999999876554

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-44  Score=315.80  Aligned_cols=260  Identities=28%  Similarity=0.424  Sum_probs=208.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc-CCCceeecceeeeecCC-CCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~   84 (353)
                      .++|++.+.||+|++|.||+|.++.+++.|++|.+....   ..+.+|+.+++.+ +|+||+++++++..... .....+
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            589999999999999999999999999999999886543   3456799999998 79999999998865443 345568


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+||||+++ +|.+.+......+..+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++..
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~-~~~~~l~d~~~~~~  162 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTK-NAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEcc-CCeEEECCCcccee
Confidence            899999995 6666665544446789999999999999999999999 79999999999999996 78899999999876


Q ss_pred             cccCCC-cceeeeeceeeChhhhhCC----CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAGEA-NISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~~~-~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ...... .....++..|+|||.+...    ..++.++||||+||++|+|++|..||...+......++....   .    
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~----  235 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---P----  235 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---C----
Confidence            543222 2345678899999987432    346788999999999999999999998765554444332210   0    


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                  +..       ..+...+.++.+||++||..||++|||+.++++|||+
T Consensus       236 ------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         236 ------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             ------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence                        000       0012367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.6e-44  Score=322.25  Aligned_cols=283  Identities=38%  Similarity=0.710  Sum_probs=222.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...++|.+.+.||.|+||.||+|.+..+++.||+|++.+.      .....+|+.+++.++||||+++.++|...    .
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~   82 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----L   82 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----C
Confidence            4578999999999999999999999999999999987532      23445799999999999999999887432    2


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ...|+++||+++++...+.     ..++++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||.+
T Consensus        83 ~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~-~~~~~l~dfg~~  155 (328)
T cd07856          83 EDIYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINE-NCDLKICDFGLA  155 (328)
T ss_pred             CcEEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECC-CCCEEeCccccc
Confidence            2478999999888766654     3568889999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .....  ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||...+.......+.+.++.++.+.....
T Consensus       156 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         156 RIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            75432  2234567888999998766456899999999999999999999999998887777777887787765544321


Q ss_pred             CcC-CCCC--cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          242 NPN-YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       242 ~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      ... ..++  ..+.....++...+ ..++.++.++|++||+.||++|||+++++.||||...+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence            110 0000  01111111111212 34788999999999999999999999999999998876553

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=343.64  Aligned_cols=252  Identities=26%  Similarity=0.413  Sum_probs=202.5

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcC-CCceeeccee-eeecCCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKHC-FFSTTSKN   80 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~-~~~~~~~~   80 (353)
                      .+...+++|.++|.+|||+.||+|.+...|..||+|++....    ....+|+++|+.|+ |+|||.+++. .......+
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            356678899999999999999999999888999999885332    34468999999996 9999999994 33332333


Q ss_pred             -ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEe
Q 018619           81 -ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        81 -~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       ...+.|+||||. |+|.+.|..+..  .+|++.++.+|++++++|+.+||. ..  |||||||-+||||+. ++..|||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~-~g~~KLC  188 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSA-DGNYKLC  188 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcC-CCCEEeC
Confidence             355789999999 699999987654  349999999999999999999999 47  999999999999996 7889999


Q ss_pred             eeccccccccCCCc----------ceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018619          157 DFGSAKQLIAGEAN----------ISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV  224 (353)
Q Consensus       157 Dfg~a~~~~~~~~~----------~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  224 (353)
                      |||.|.........          .....|+.|+|||++.-  ....+.++|||+|||+||.|+....||.......++.
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln  268 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN  268 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe
Confidence            99998744332211          12356999999999732  3457999999999999999999999998765432221


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                           ..|.+|..          .+.+..+++||+.||+.||.+||++.|++.
T Consensus       269 ---------------------g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  269 ---------------------GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             ---------------------ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence                                 22333321          257899999999999999999999999873

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-43  Score=309.44  Aligned_cols=249  Identities=27%  Similarity=0.448  Sum_probs=202.3

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .|++.+.||.|++|.||++.+..+++.||+|.+..+.      ....+|+.+++.++|+|++++++.+.    .....+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            5899999999999999999999999999999985432      23457899999999999999887662    1233578


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|||+++ ++.+.+..  .....+++.+++.++.|++.|+++||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTR-TNIIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEec-CCcEEEecccceEEe
Confidence            99999985 66666553  134568999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....+++.|+|||++.+. .++.++|+||+||++++|++|+.||...+.......+.....            
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            43322 2334678899999998654 588999999999999999999999987776555444333100            


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                             +         ..+..+++++.+++.+||+.||.+|||+.+++.||||
T Consensus       220 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         220 -------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             -------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   0         0123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-44  Score=316.53  Aligned_cols=275  Identities=40%  Similarity=0.699  Sum_probs=220.6

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHHcC-CCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |.+.+.||+|++|.||+|....+++.|+||.+.....     ...+|+..++.++ |||++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            7889999999999999999988999999998865322     2346889999999 9999999998843     445889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ||||+++++.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCCEEEeecccceeccC
Confidence            9999988887777542  13578999999999999999999999 79999999999999996 88899999999987655


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC--
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN--  244 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  244 (353)
                      ........++..|+|||.+.+...++.++|+||+|+++++|++|.+||...+..+.+.++...++.+....+......  
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            544455677889999998866556889999999999999999999999999988889888888888776543321111  


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      .....++..........+ ...+.++.++|++||+.||++|||+.|++.||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            111111211111111112 2347899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=337.51  Aligned_cols=256  Identities=23%  Similarity=0.386  Sum_probs=211.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .+.|.|+..||.|+||+||+|.++.++-.-|.|.+....    ....-|+.||...+||+||++++.||....     ++
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lw  105 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LW  105 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eE
Confidence            356789999999999999999999888888888774332    223368999999999999999999865544     89


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      |+.|||+|+--+.+.-  .-+..+++.+++.+.+|+|.||.|||+ ++|||||||..|||+.. +|.++|+|||.+....
T Consensus       106 iliEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNK  181 (1187)
T ss_pred             EEEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEe-cCcEeeecccccccch
Confidence            9999999764443332  346789999999999999999999999 79999999999999996 8889999999876433


Q ss_pred             c-CCCcceeeeeceeeChhhhh----CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          166 A-GEANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       166 ~-~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      . .....+++|||+|||||+..    ...+|.+++||||||++|.+|..+.+|-...+....+.++.+.  .|+.     
T Consensus       182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS--ePPT-----  254 (1187)
T KOG0579|consen  182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPPT-----  254 (1187)
T ss_pred             hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc--CCCc-----
Confidence            2 23345789999999999973    3567999999999999999999999999999988888777662  1110     


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                 ..+        +...+..+.||+.+||.+||..||+++++|.||||.+.
T Consensus       255 -----------Llq--------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  255 -----------LLQ--------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             -----------ccC--------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence                       011        23457789999999999999999999999999999864

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=307.52  Aligned_cols=253  Identities=26%  Similarity=0.428  Sum_probs=201.3

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEecc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVMEY   90 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   90 (353)
                      .+.||+|+|+.|--+....||..||||++.+..    ....+|++++..- .|+||+++++.|     +++..+|+|||-
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYLVfEK  157 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYLVFEK  157 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEEEEec
Confidence            358999999999999999999999999997753    4455899988877 599999999999     666779999999


Q ss_pred             ccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC--cEEEeeeccccccccC
Q 018619           91 VPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAG  167 (353)
Q Consensus        91 ~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~--~vkl~Dfg~a~~~~~~  167 (353)
                      +.|+ ++.-    +.....+++.++.++...|+.||.|||. +||.||||||+|||-...+.  -||||||.+...+...
T Consensus       158 m~GGplLsh----I~~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  158 MRGGPLLSH----IQKRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             ccCchHHHH----HHHhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            9964 4433    3456789999999999999999999999 89999999999999864332  4999999987643221


Q ss_pred             --------CCcceeeeeceeeChhhhh----CCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---------------H
Q 018619          168 --------EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------------V  220 (353)
Q Consensus       168 --------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------------~  220 (353)
                              ....+.+|+..|||||+..    ....|..++|.||||||+|-|++|.+||.+.=.               .
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN  312 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence                    1234567888999999962    234689999999999999999999999976311               1


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          221 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .....|.+                 +.++||   ...|     ..+|.+++|+|+.+|..|+.+|.++.++++|||++..
T Consensus       313 ~LFesIQE-----------------GkYeFP---dkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  313 KLFESIQE-----------------GKYEFP---DKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHhc-----------------cCCcCC---hhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            12222222                 223333   2344     3489999999999999999999999999999999987


Q ss_pred             cCC
Q 018619          301 REP  303 (353)
Q Consensus       301 ~~~  303 (353)
                      ...
T Consensus       368 ~~e  370 (463)
T KOG0607|consen  368 APE  370 (463)
T ss_pred             chh
Confidence            544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=332.17  Aligned_cols=246  Identities=30%  Similarity=0.452  Sum_probs=203.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHH-cCCCceeecceeeeecCCCCceeEEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-MDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      ..+.|.+...+|.|+|+.|..+.+..+++.+++|++.+......+|+.++.. -+||||+++.+++     .+....|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            4678999999999999999999999999999999998887777788865554 4799999999998     666779999


Q ss_pred             eccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           88 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||.+.|..  .+.. +.....+. ..+..|++||+.|+.|||+ +|++||||||+|||++.+.+.++|+|||.++.....
T Consensus       395 ~e~l~g~e--ll~r-i~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  395 MELLDGGE--LLRR-IRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             ehhccccH--HHHH-HHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999752  2221 22223333 7888899999999999999 799999999999999534788999999999866544


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                        ..+.+-|..|.|||++. ...|+.++|+||||++||+|++|+.||......   ..+...++.+.             
T Consensus       470 --~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~-------------  530 (612)
T KOG0603|consen  470 --CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK-------------  530 (612)
T ss_pred             --hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc-------------
Confidence              33445688899999996 566999999999999999999999999877766   33334333332             


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                    +...+|.+++|||++||+.||.+|+++++++.||||
T Consensus       531 --------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  531 --------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             --------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                          114589999999999999999999999999999999

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-45  Score=331.39  Aligned_cols=248  Identities=30%  Similarity=0.462  Sum_probs=211.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .|.-.+.||.|+||.||.|++..+.+.||||++.-..       ..+.+|+..|+.++|||++.+.+||....+     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            3556788999999999999999999999999995332       233489999999999999999999954443     8


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+|||||-|+-.+++.-+   ..++.+.++..|..+.+.||+|||+ .+.||||||..|||++. .+.|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSE-PGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecC-CCeeeeccccchhhc
Confidence            899999999777776653   4679999999999999999999999 79999999999999995 899999999999765


Q ss_pred             ccCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .+   ..+++|||+|||||++..  .+.|+-++||||||++..||...++|.-..+....++.|.+.-            
T Consensus       177 ~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------------  241 (948)
T KOG0577|consen  177 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------  241 (948)
T ss_pred             Cc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC------------
Confidence            43   346899999999999843  3458999999999999999999999999999998888887631            


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                             -|.++...        .|..++.||..||++-|.+|||.+++|.|+|+..
T Consensus       242 -------sPtLqs~e--------WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  242 -------SPTLQSNE--------WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             -------CCCCCCch--------hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence                   12233333        4778999999999999999999999999999865

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=317.08  Aligned_cols=250  Identities=27%  Similarity=0.413  Sum_probs=205.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||.|++|.||++.+..+++.||+|.+....     ....+|+.+++.++|+|++++++.+..     ...+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLW   75 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEE
Confidence            47999999999999999999999999999999886432     234579999999999999999998743     34589


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +|+||+.+ +|.+.+..     .++++..++.++.|++.||.|||+ ++++|+||+|+||++++ ++.++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~  148 (274)
T cd06609          76 IIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSE-EGDVKLADFGVSGQL  148 (274)
T ss_pred             EEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEcccccceee
Confidence            99999985 56555542     378999999999999999999999 79999999999999996 888999999999876


Q ss_pred             ccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ... .......+++.|+|||.+.+.. ++.++||||+||++|+|++|..||...+.......+....             
T Consensus       149 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------  214 (274)
T cd06609         149 TSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------  214 (274)
T ss_pred             cccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------
Confidence            544 2233456788899999986654 8999999999999999999999998766544433322210             


Q ss_pred             CCCCCcCCCCCCCccccccCCC-CChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                     ...+... +++++.+++.+||..||++|||++++++||||++..
T Consensus       215 ---------------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         215 ---------------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             ---------------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence                           0001122 688999999999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-44  Score=318.69  Aligned_cols=252  Identities=25%  Similarity=0.461  Sum_probs=198.5

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+..+.     ..+.+|+.+++.++||||+++++.+..     ....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   75 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRIS   75 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEE
Confidence            46889999999999999999999999999999886442     234579999999999999999998843     33478


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +||||++++.+...       ..+++..+..++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++....
T Consensus        76 lv~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~  146 (279)
T cd06619          76 ICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLV  146 (279)
T ss_pred             EEEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECC-CCCEEEeeCCcceecc
Confidence            99999997543322       357888999999999999999999 79999999999999996 7889999999997654


Q ss_pred             cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHhhcC
Q 018619          166 AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ---LVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       166 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .. ......+|..|+|||.+.+. .++.++|+||+||++|+|++|..||........   .....+....+..       
T Consensus       147 ~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------  217 (279)
T cd06619         147 NS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-------  217 (279)
T ss_pred             cc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-------
Confidence            32 22345788999999998654 489999999999999999999999965332111   0011111000000       


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                              +        .......++++.++|.+||+.||.+||+++++++||||....
T Consensus       218 --------~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         218 --------P--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             --------C--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence                    0        001124688999999999999999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-44  Score=317.46  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=205.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|.+.+.||.|++|.||++.+..+++.||+|.+....    ....+|+.+++.++|||++++++.+.     .....|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLW   78 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEE
Confidence            468999999999999999999998899999999885432    23457999999999999999999884     334588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~  153 (280)
T cd06611          79 ILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTL-DGDVKLADFGVSAKN  153 (280)
T ss_pred             EEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECC-CCCEEEccCccchhh
Confidence            99999996 55554433   34579999999999999999999999 79999999999999996 788999999998754


Q ss_pred             ccCC-CcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .... ......+++.|+|||.+..    ...++.++|+||+||++|+|++|..||...+.......+...  .+      
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------  225 (280)
T cd06611         154 KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP------  225 (280)
T ss_pred             cccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC------
Confidence            3322 2234567899999999742    234678999999999999999999999887665544333221  00      


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                 +.       ...+..++.++.++|.+||+.||.+|||+.++++||||.+.
T Consensus       226 -----------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         226 -----------PT-------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             -----------CC-------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence                       00       00123478899999999999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=313.56  Aligned_cols=278  Identities=36%  Similarity=0.627  Sum_probs=216.5

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHc---CCCceeecceeeeecCCCCcee
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      |.+.+.||+|++|.||++++..+++.||+|.+....      ....+|+.+++.+   +|||++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            788999999999999999998889999999886321      1234677777665   5999999999987655444556


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++++|||+++++.+.+...  ....+++..++.++.|++.||+|||+ ++++|+||+|+||+++. ++.+||+|||++..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTS-DGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEcc-CCCEEEeccCccee
Confidence            8899999998877766542  22468999999999999999999999 79999999999999997 68999999999987


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...........++..|+|||.+.+. .++.++|+||+||++|+|++|.+||......+.+.++....+.+....+.... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  234 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV-  234 (287)
T ss_pred             ccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence            6555444445678889999998664 48899999999999999999999999998888888887766554433221110 


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      ......++......+ ......+++.+.++|.+||+.||.+||++.++++||||
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            000001111111112 11223467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-44  Score=314.81  Aligned_cols=274  Identities=39%  Similarity=0.706  Sum_probs=223.0

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |++.+.||+|++|.||++++..+++.||+|.+....      ....+|+.+++.++|+|++++++++.     .....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            678899999999999999999999999999886532      23347999999999999999999883     3345889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ||||++++|.+.+...   ...+++..+..++.|++.||++||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINR-DGVLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcC-CCCEEEecCCcccccCC
Confidence            9999999888777642   2579999999999999999999999 79999999999999996 78899999999986544


Q ss_pred             CC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      .. ......++..|+|||.+.+...++.++|+||+||++|+|++|.+||...+..+.+..+.+..+.+....+.......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            33 22234557789999998766568999999999999999999999999999888888888888888776654332221


Q ss_pred             -CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          246 -TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                       ....++......+...++ .++.++.++|++||+.||++||++.++++||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence             122233333333333333 358899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-44  Score=319.74  Aligned_cols=266  Identities=24%  Similarity=0.364  Sum_probs=205.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcC-CCceeecceeeeecCCCCce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..++|...+.||+|+||.||++.+..+++.||+|.+....     ....+|+.++.++. ||||+++++++..     ..
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~   76 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EG   76 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CC
Confidence            3457788899999999999999999999999999886432     23457888888886 9999999998743     23


Q ss_pred             eEEEEeccccchHHHHHHh-hhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~-~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+++|||+..++...... .......+++..+..++.|++.||+|||+..+++||||||+||+++. ++.+||+|||++
T Consensus        77 ~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~  155 (288)
T cd06616          77 DCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGIS  155 (288)
T ss_pred             cEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchh
Confidence            4779999998765544332 12234679999999999999999999997249999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .............+++.|+|||.+.+.  ..++.++||||+||++|+|++|+.||.....  ....+.+......     
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~-----  228 (288)
T cd06616         156 GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP-----  228 (288)
T ss_pred             HHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC-----
Confidence            765544444445678899999998665  3588999999999999999999999976542  2222222111000     


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                 +..     .......++.++.+||.+||+.||++|||+++++.||||+.....
T Consensus       229 -----------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         229 -----------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             -----------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence                       000     001113478999999999999999999999999999999875543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.7e-44  Score=312.95  Aligned_cols=256  Identities=28%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||.|++|+||++.+..++..+|+|++....     ....+|+.+++.++|+|++++++.+.     .....+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence            47999999999999999999998899999999886432     33457999999999999999998873     334588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++||++.+ ++.+.+... .....+++..++.++.|++.||++||+ +|++|+||+|+||++++ ++.++|+|||++...
T Consensus        76 iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSS-YPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGE-DGSVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccchHHHh
Confidence            99999985 555555431 123568999999999999999999999 79999999999999996 788999999998766


Q ss_pred             ccCCCc-----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGEAN-----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ......     ....++..|+|||.+.....++.++|+||+||++|+|++|+.||...+......+....   ...    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~----  225 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPP----  225 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCC----
Confidence            544322     33467889999999866546899999999999999999999999877665544443321   000    


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                          .     ++.       ......+++++.+++.+||+.||++|||+.+++.||||
T Consensus       226 ----~-----~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         226 ----S-----LET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ----C-----cCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence                0     000       00013578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=315.97  Aligned_cols=252  Identities=29%  Similarity=0.459  Sum_probs=209.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +-|.++..||+|+||.||+|.|+.+|..+|||+++-+.  ..+.+|+.++++.+.|++|++|+.|+...+     +++||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVM  107 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVM  107 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeeh
Confidence            35678899999999999999999999999999997543  455689999999999999999999965554     99999


Q ss_pred             cccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      |||+ |+..+.+..   .+.++++.++..++..-+.||+|||.+ .-+|||||..|||++. +|..||+|||.|..+.+.
T Consensus       108 EYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  108 EYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcc-cchhhhhhccccchhhhh
Confidence            9999 677777664   568899999999999999999999995 7889999999999997 888999999999865443


Q ss_pred             -CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 -EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                       ....+..|||.|||||++..- .|...+||||||++..||..|++||.+-.+...+..|      |+.           
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------PT~-----------  244 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------PTK-----------  244 (502)
T ss_pred             HHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------cCC-----------
Confidence             334567899999999999654 4999999999999999999999999876654332211      110           


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                             +...+..  +...|.++.|||++||-+.|++|.|+.++++|||+++
T Consensus       245 -------PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn  288 (502)
T KOG0574|consen  245 -------PPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN  288 (502)
T ss_pred             -------CCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence                   0000100  1235889999999999999999999999999999976

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7e-44  Score=319.11  Aligned_cols=277  Identities=25%  Similarity=0.399  Sum_probs=203.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||+|+||.||++.+..++..||+|.+....     ....+|+++++.++||||+++++++.     ....+|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence            47999999999999999999999999999999885431     23457999999999999999999884     334588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+.    ....+++..+..++.|++.||.|||+..+++|+||||+||+++. ++.+||+|||++...
T Consensus        76 lv~ey~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~  150 (308)
T cd06615          76 ICMEHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL  150 (308)
T ss_pred             EEeeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCcccc
Confidence            99999985 6655554    34678999999999999999999997248999999999999996 788999999998755


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+..... ....................
T Consensus       151 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         151 IDSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             cccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCccccc
Confidence            3322 2345678999999998654 4889999999999999999999999776543322 21111000000000000000


Q ss_pred             CCCCcCCC----------CCCCccccccC-CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          245 YTDFRFPQ----------IKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       245 ~~~~~~~~----------~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ......+.          ...... ..++ ..++.++.+|+.+||+.||++|||+.++++||||.+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPP-PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCC-ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            00000000          000000 0011 13678899999999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=333.64  Aligned_cols=248  Identities=29%  Similarity=0.496  Sum_probs=204.6

Q ss_pred             eeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccc
Q 018619           18 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE   93 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~   93 (353)
                      +||.|.||+||-+++..|....|||.++...    .-...|+.+.+.|+|.|||++.+++     ..+.++-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            8999999999999999999999999886432    3346899999999999999999887     444567799999996


Q ss_pred             -hHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619           94 -SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus        94 -~l~~~l~~~~~~~~~l--~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                       +|..++..   .=+++  .+..+..+..||++||+|||+ +.|||||||-+|+||+...|.+||+|||.++....-...
T Consensus       657 GSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~  732 (1226)
T KOG4279|consen  657 GSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC  732 (1226)
T ss_pred             CcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence             55555543   23556  889999999999999999999 799999999999999998999999999999987665443


Q ss_pred             -ceeeeeceeeChhhhhC-CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCC
Q 018619          171 -ISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF  248 (353)
Q Consensus       171 -~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
                       .+..||..|||||++.. ...|+.++|||||||++.||.||++||.........  +.+. |..               
T Consensus       733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-Gmy---------------  794 (1226)
T KOG4279|consen  733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-GMY---------------  794 (1226)
T ss_pred             ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-cce---------------
Confidence             45789999999999954 356999999999999999999999999765543222  2221 000               


Q ss_pred             cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                              .-+..++..+|.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus       795 --------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  795 --------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             --------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence                    01223456789999999999999999999999999999999864

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.3e-44  Score=313.28  Aligned_cols=250  Identities=30%  Similarity=0.501  Sum_probs=199.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .+|.+.+.||+|+||.||+|.+..++..||+|++....         ....+|+.+++.++||||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            57999999999999999999999999999999885321         2345799999999999999998877432   23


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+++++||+++ +|.+.+.    ....+++..++.++.|++.||+|||+ ++++|+||||+||+++. ++.+||+|||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~-~~~~~l~dfg~  152 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA  152 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEccCCC
Confidence            357899999985 6665554    34568999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          161 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       161 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +.......    ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+.......+...   +.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~--  226 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT--  226 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC--
Confidence            87543211    11224578889999998654 4889999999999999999999999876554444332211   00  


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                                            ...++..+++.++++| +||..||++|||++++++||||+
T Consensus       227 ----------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         227 ----------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             ----------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence                                  1112345788999999 67778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.1e-44  Score=315.59  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=203.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .+-|++.+.||+|+||.||++.+..++..+++|.+....    ....+|+.+++.++|||++++++.+..     ....+
T Consensus         4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~   78 (282)
T cd06643           4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLW   78 (282)
T ss_pred             HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEE
Confidence            345789999999999999999999999999999885432    234579999999999999999998843     34588


Q ss_pred             EEeccccchHH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~~l~-~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +|+||++++.+ ..+..   ...++++..+..++.|++.||+|||+ .|++|+||||+||+++. ++.+||+|||++...
T Consensus        79 ~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~  153 (282)
T cd06643          79 ILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcc-CCCEEEccccccccc
Confidence            99999996533 33322   34679999999999999999999999 79999999999999996 788999999998754


Q ss_pred             ccCC-CcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .... ......+++.|+|||++..    ...++.++|+||+||++|+|++|.+||...+..+....+.......      
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------  227 (282)
T cd06643         154 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------  227 (282)
T ss_pred             cccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC------
Confidence            3322 1233567889999999742    2346789999999999999999999998877665555443311000      


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                          ...+..++.++.+||.+||+.||.+|||++++++||||+..
T Consensus       228 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         228 --------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             --------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence                                00123478899999999999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-43  Score=316.32  Aligned_cols=252  Identities=26%  Similarity=0.426  Sum_probs=204.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..+|++.+.||+|++|.||++.+..+++.||+|.+....    ....+|+.+++.++|||++++++.+..     ....|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            358999999999999999999999999999999886432    234579999999999999999998843     33588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+.+ +|.+.+.     ...+++.++..++.|++.||.|||+ .||+|+||||+||+++. ++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~~  166 (296)
T cd06654          94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI  166 (296)
T ss_pred             EeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEEECccccchhc
Confidence            99999985 5655543     2468899999999999999999999 79999999999999986 788999999998765


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+... +.+.         
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---------  235 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE---------  235 (296)
T ss_pred             cccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC---------
Confidence            43322 223467889999999865 44789999999999999999999999877654443322210 1000         


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                      ...+..++..+.++|.+||..||.+|||+.++++||||...
T Consensus       236 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         236 ----------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             ----------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence                            00123478899999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.2e-44  Score=313.06  Aligned_cols=252  Identities=29%  Similarity=0.524  Sum_probs=200.8

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      +|+..+.||+|++|.||++.+..+++.||+|.+....          ....+|+.+++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            5888999999999999999999999999999886432          2345799999999999999999988     344


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++|+||+.+ +|.+.+.    ...++++..++.++.|++.||+|||+ +|++|+||+|+||+++..+..+||+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            458899999995 5555554    34578999999999999999999999 79999999999999986455799999999


Q ss_pred             ccccccCCC-----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          161 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       161 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +........     .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+.+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--  227 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC--
Confidence            876543321     123457889999999865 458899999999999999999999997654333222222110000  


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                                            ....++..+++++.+++.+||+.||++|||+.++++||||+
T Consensus       228 ----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         228 ----------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             ----------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence                                  00112345789999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.4e-44  Score=313.34  Aligned_cols=246  Identities=32%  Similarity=0.534  Sum_probs=199.5

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+....             ....+|+.+++.++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            5788999999999999999999899999999885321             234578999999999999999998733   


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                        ....+++|||+++ +|...+.    ..+.+++..++.++.|++.||+|||+ +|++|+||+|+||++++ ++.++|+|
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~-~~~~~l~d  149 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDN-KGGIKISD  149 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcC-CCCEEecc
Confidence              3458899999985 5555554    34678999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCCC-------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 018619          158 FGSAKQLIAGEA-------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL  230 (353)
Q Consensus       158 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  230 (353)
                      ||.+........       .....++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+....+..+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999886643211       1123467889999998654 47889999999999999999999998776554443322200


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                                  ...++..++.++.++|++||+.||.+||++.++++||||
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence                                        001223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-43  Score=315.93  Aligned_cols=252  Identities=28%  Similarity=0.467  Sum_probs=204.9

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      .+|++.+.||.|++|.||++.+..+++.|++|.+....    ....+|+.+++.++|||++++++.+.     ....+|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            47999999999999999999999999999999885432    23457999999999999999999883     3345889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      |+||+.+ +|...+.     ...+++.++..++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++....
T Consensus        94 v~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~~  166 (296)
T cd06655          94 VMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccchhcc
Confidence            9999986 4444433     2468999999999999999999999 79999999999999996 7889999999987654


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..+....+... ..+.          
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------  234 (296)
T cd06655         167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------  234 (296)
T ss_pred             cccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------
Confidence            4332 223467889999999855 44889999999999999999999999887766554433221 1000          


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                     ...+..+++.+.+||++||..||.+|||+.+++.||||+..+
T Consensus       235 ---------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         235 ---------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ---------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence                           001235788999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1e-43  Score=309.52  Aligned_cols=249  Identities=31%  Similarity=0.456  Sum_probs=206.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            5899999999999999999999999999999886432      23457999999999999999998873     344588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+...  ....+++..+..++.|++.||+|||+ +|++|+||+|+||+++.+++.+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999985 676666542  24558999999999999999999999 799999999999999865667899999999876


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ..........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            655544456788899999998654 478899999999999999999999988776555444332100             


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                     ..++..++.++.+++.+||+.||++|||+.++++||||
T Consensus       219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence                           01223478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.4e-44  Score=314.68  Aligned_cols=257  Identities=27%  Similarity=0.412  Sum_probs=203.5

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc-CCCceeecceeeeecCC-CCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTS-KNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~   84 (353)
                      .+.|++.+.||.|+||.||++.+..+++.||+|.+....   .....|+.+++.+ +|||++++++++..... .....+
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            478999999999999999999999999999999886542   2345788888888 79999999998864332 234568


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |++|||+++ +|.+.+...  ....+++..++.++.|++.||+|||+ +||+|+||+|+||+++. ++.++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~-~~~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEeeCcchhh
Confidence            899999985 666665432  24568899999999999999999999 79999999999999996 78899999999875


Q ss_pred             cccC-CCcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAG-EANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      .... .......+++.|+|||.+..    ...++.++|+||+||++|+|++|..||...........+...   ..    
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP----  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence            4322 22234568899999999753    234788999999999999999999999776544333322110   00    


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                          .......++.++.+||++||+.||.+|||+.+++.||||
T Consensus       244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence                                000113478899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-43  Score=309.20  Aligned_cols=252  Identities=25%  Similarity=0.432  Sum_probs=207.3

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||.|++|.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++.+..   .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            5899999999999999999999999999999885432      234468999999999999999887643   2334578


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH-----cCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-----TVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH-----~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ++|||++ ++|.+.+.........+++..++.++.||+.||.|||     + .+++|+||||+||+++. ++.+||+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~-~~~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDA-NNNVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEec-CCCEEEeccc
Confidence            9999998 4777777765555678999999999999999999999     8 79999999999999996 7899999999


Q ss_pred             cccccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          160 SAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       160 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ++........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+... .       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~-------  226 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG-K-------  226 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC-C-------
Confidence            9987655443 3345789999999998654 4889999999999999999999999887744433322210 0       


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                 .         ..++...+.++.+++.+||+.||++|||+.++++|||+
T Consensus       227 -----------~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         227 -----------F---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             -----------C---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence                       0         01234578899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=322.33  Aligned_cols=248  Identities=27%  Similarity=0.360  Sum_probs=205.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |.+....+.+.+.||+|.||.||.+....+ ..||+|.+...   ...+.+|+.+|++|+|++||++++++..     ..
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-----~~  274 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-----QE  274 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEec-----CC
Confidence            556677788899999999999999997433 37899988643   3455689999999999999999999943     33


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|||||||. |+|.+.|..  ..+..+...+...++.|||+|++||++ +++|||||-..||||+. +..+||+|||+|
T Consensus       275 piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~-~~~vKIsDFGLA  350 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDE-DLVVKISDFGLA  350 (468)
T ss_pred             ceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeecc-CceEEEcccccc
Confidence            5899999999 788888875  356789999999999999999999999 79999999999999996 889999999999


Q ss_pred             cccccCCCcce--eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEANIS--YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +...++.....  .....-|.|||.+.. ..++.+|||||||++||||+| |+.||.+.+..+.+..+.+...-|-    
T Consensus       351 r~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~----  425 (468)
T KOG0197|consen  351 RLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR----  425 (468)
T ss_pred             cccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC----
Confidence            95433332211  122456999999955 459999999999999999997 8999999999999888776432222    


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                              |..+|+++-+++..||..+|++|||.+.+.
T Consensus       426 ------------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 ------------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             ------------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence                                    246899999999999999999999998653

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.3e-44  Score=317.77  Aligned_cols=252  Identities=27%  Similarity=0.442  Sum_probs=203.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      .+|++.+.||+|++|.||++.+..+++.||+|.+....    ....+|+.+++.++|||++++++.+.     .....|+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence            68999999999999999999999999999999886432    23457899999999999999999883     3445889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ||||+++ +|.+.+.     ...+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.++|+|||++....
T Consensus        94 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          94 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT  166 (297)
T ss_pred             eecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEECcCccceEcc
Confidence            9999985 5555443     2468899999999999999999999 79999999999999996 7889999999987654


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+.......+.. .+.+           
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~-----------  233 (297)
T cd06656         167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP-----------  233 (297)
T ss_pred             CCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC-----------
Confidence            3332 223467889999999865 4588999999999999999999999977654333221111 0000           


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                    ....+..++..+.+||.+||+.||++|||+.++++||||+..+
T Consensus       234 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         234 --------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             --------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence                          0011234788999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=298.61  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=207.6

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc-----hHHHHHHHH-HcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-----KNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +..++..||+|..|+|++++.+.+|...|||.+.+....     +...++++. ..+.|+||+.+++|....+     ++
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-----V~  167 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-----VF  167 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----HH
Confidence            346678899999999999999999999999999654322     223333332 3358999999999966554     78


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +.||.|..-...++..   -.++++|..+-.+...++.||.||.+.+||+|||+||+|||+|. .|++||||||++..+.
T Consensus       168 IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  168 ICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEeecccccceee
Confidence            9999998655555543   34679999999999999999999999789999999999999996 8999999999999988


Q ss_pred             cCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          166 AGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       166 ~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      +....+...|.+.|||||.+.-  ...|..++||||||+.++||.||+.||.+.+ +.+.+.++.+.  .|+.       
T Consensus       244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP~-------  314 (391)
T KOG0983|consen  244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPPL-------  314 (391)
T ss_pred             cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCCC-------
Confidence            8888888899999999999843  3468899999999999999999999998855 45566555552  1111       


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                             ++          ....+|+++.+|+..||++|+.+||.-.++|+|||+....
T Consensus       315 -------L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  315 -------LP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             -------CC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence                   00          1134899999999999999999999999999999998754

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.8e-44  Score=314.33  Aligned_cols=253  Identities=25%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+.     ....+
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~   81 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKL   81 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEE
Confidence            3568999999999999999999999999999999886432    23457999999999999999999873     33458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |++|||+++ +|.+.+.    ..+.+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++..
T Consensus        82 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~  155 (267)
T cd06645          82 WICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTD-NGHVKLADFGVSAQ  155 (267)
T ss_pred             EEEEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEECcceeeeE
Confidence            899999985 6655554    35679999999999999999999999 79999999999999996 78899999999875


Q ss_pred             cccCC-CcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ..... ......|++.|+|||.+..  ...++.++|+||+||++|+|++|..||................          
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~----------  225 (267)
T cd06645         156 ITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN----------  225 (267)
T ss_pred             ccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC----------
Confidence            54322 1234568899999999742  3347889999999999999999999997655443332221110          


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                             ...+     .+..  ...++..+.++|.+||+.||++|||++++++|||
T Consensus       226 -------~~~~-----~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         226 -------FQPP-----KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             -------CCCC-----cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence                   0000     0000  1136788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-43  Score=310.52  Aligned_cols=247  Identities=28%  Similarity=0.471  Sum_probs=198.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      +|.+.+.||.|+||.||++.+ .+++.+|+|.+....          ....+|+.+++.++|+||+++++++.     ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence            588999999999999999986 588899999875321          23457999999999999999999883     33


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++++||+.+ +|.+.+.    ....+++..++.++.|++.||+|||+ .+++|+||+|+||++++ ++.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMP-NGIIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECC-CCeEEeccchh
Confidence            568899999986 5555553    34578999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccC-------CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          161 AKQLIAG-------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       161 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      +......       .......++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+....+. 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8754321       111234578899999998654 4889999999999999999999999876655443332221000 


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                               ...++..++.++.++|++||+.||.+|||+.++++||||
T Consensus       227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                                     011234578999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.6e-44  Score=310.84  Aligned_cols=246  Identities=27%  Similarity=0.450  Sum_probs=202.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +|.+.+.||.|+||.||+|.+..+++.||+|.+.+..       ....+|+.+++.++||||+++++.+     .+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            5899999999999999999999999999999886432       2345799999999999999999887     445568


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++|+||+.+ +|...+..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||++++ ++.++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDE-QGHVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcC-CCCEEEeecccccc
Confidence            999999986 55555442    3689999999999999999999999 79999999999999996 78899999999987


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..  +.+.....   .         
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~---------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE---T---------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc---c---------
Confidence            6554444456678899999998554 4899999999999999999999999877642  22211111   0         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH--HHHhcCccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA--LEACAHPFF  297 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--~~~l~hp~f  297 (353)
                                      ....++..++.++.++|++||+.||.+|+++  .|+++||||
T Consensus       217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence                            0111234578999999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-43  Score=308.67  Aligned_cols=248  Identities=33%  Similarity=0.541  Sum_probs=202.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|+..+.||+|++|.||+|.+..+++.|++|.+....         ....+|+.+++.++|+||+++++.+     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            5888999999999999999998899999999885432         2345799999999999999999877     3334


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+++++||+++ +|.+.+.    ....+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.+||+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDT-NGVVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccCccc
Confidence            58899999985 5655554    34568999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .............++..|+|||.+.....++.++|+||+||++|+|++|..||......+....+......         
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  220 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL---------  220 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC---------
Confidence            86554443445667889999999854334789999999999999999999999876644444332221000         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                        ..++..+++++.+++++||+.||++|||+.+++.|||+
T Consensus       221 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         221 ------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             ------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence                              01234578999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.3e-43  Score=306.27  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=203.3

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+...      .....+|+.+++.++|||++++++.+.     .....|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            488999999999999999999999999999988532      233457899999999999999999883     334588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+.+ +|.+.+...  ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeC-CCCEEEcccccceec
Confidence            99999974 666666542  24678999999999999999999999 79999999999999996 788999999998865


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....+++.|+|||++.+. .++.++|+|||||++++|++|..||...+.......+.....            
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------  218 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            44332 2234678899999998654 488999999999999999999999988876555444332100            


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                      ..++..++.++.++|.+||+.+|++||++.++++|||+
T Consensus       219 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         219 ----------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence                            00122468899999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.5e-44  Score=313.86  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=199.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ..++|++.+.||+|+||.||++++..+++.||+|++....    ....+|+.+++.++||||+++++.+..     ...+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~   81 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKL   81 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEE
Confidence            3567999999999999999999999999999999886432    234579999999999999999988843     3458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++||||+++ +|.+.+.    ....+++..+..++.|++.||+|||+ +||+|+||||+||+++. ++.+||+|||++..
T Consensus        82 ~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~  155 (267)
T cd06646          82 WICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTD-NGDVKLADFGVAAK  155 (267)
T ss_pred             EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECC-CCCEEECcCcccee
Confidence            899999995 5555553    34678999999999999999999999 79999999999999986 77899999999986


Q ss_pred             cccCC-CcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ..... ......+++.|+|||.+.+  ...++.++|+||+||++|+|++|..||...+..+....+...           
T Consensus       156 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-----------  224 (267)
T cd06646         156 ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-----------  224 (267)
T ss_pred             ecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-----------
Confidence            54322 2234567889999998743  334678999999999999999999999655433222111110           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                            .+..+     .+.  ....++..+.+||++||+.||++|||++++++|+|
T Consensus       225 ------~~~~~-----~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         225 ------NFQPP-----KLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             ------CCCCC-----CCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence                  00000     000  11246889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.4e-43  Score=308.72  Aligned_cols=251  Identities=29%  Similarity=0.464  Sum_probs=203.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .++|++.+.||+|++|.||++.+..+++.|++|.+....  ....+|+.+++.++||||+++++.+..     ...+|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEE
Confidence            478999999999999999999999889999999886543  445689999999999999999998843     3458899


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      +||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++. ++.++|+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          77 MEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECC-CCcEEEcccccchhccc
Confidence            999995 55555532   34678999999999999999999999 79999999999999996 78899999999986654


Q ss_pred             CC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      .. ......++..|+|||.+.+. .++.++||||+||++|+|++|..||...+.......+...  .             
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-------------  215 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--P-------------  215 (256)
T ss_pred             CccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--C-------------
Confidence            43 22334578899999998654 5889999999999999999999999876554332221110  0             


Q ss_pred             CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                          .+       ....+..++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       216 ----~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         216 ----PP-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ----CC-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence                00       000123467899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-43  Score=309.28  Aligned_cols=246  Identities=29%  Similarity=0.487  Sum_probs=199.7

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ||.|++|.||++.+..+++.||+|.+.+..       ....+|+.+++.++||||+++++.+.     ....+|++|||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            699999999999999999999999886432       23457999999999999999999873     334588999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                      ++ +|.+.+..    ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccccc
Confidence            84 66655543    4568999999999999999999999 89999999999999996 788999999999876554433


Q ss_pred             ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCcCCCCC
Q 018619          171 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDF  248 (353)
Q Consensus       171 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
                      ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+  ..+....+.....                 
T Consensus       150 ~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------  211 (262)
T cd05572         150 WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG-----------------  211 (262)
T ss_pred             ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence            44567889999999855 448899999999999999999999998766  3333333221000                 


Q ss_pred             cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                                ...++...++++.++|.+||+.||++|+|     +.|+++||||+...+.
T Consensus       212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence                      01122345889999999999999999999     9999999999987543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-43  Score=308.78  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=203.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|++.+.||+|++|.||+|.+..+++.+++|.+....    ....+|+.+++.++||||+++++.+..     ...+|
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   76 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLW   76 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEE
Confidence            468999999999999999999999999999999886542    345689999999999999999988733     34588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus        77 l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~  151 (262)
T cd06613          77 IVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTE-DGDVKLADFGVSAQL  151 (262)
T ss_pred             EEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECC-CCCEEECccccchhh
Confidence            99999996 55444432   23679999999999999999999999 79999999999999996 788999999998765


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .... ......++..|+|||.+.+.  ..++.++|+||+||++|+|++|.+||...+.......+....-.+.       
T Consensus       152 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~-------  224 (262)
T cd06613         152 TATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP-------  224 (262)
T ss_pred             hhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------
Confidence            4432 22334678889999998553  2578899999999999999999999988776555443332100000       


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                                .       .......+.++.+|+++||+.||.+|||+.+++.|||
T Consensus       225 ----------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         225 ----------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             ----------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence                      0       0011235788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-44  Score=340.01  Aligned_cols=283  Identities=19%  Similarity=0.287  Sum_probs=197.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCc-EEEEE------------------Eeecc---ccchHHHHHHHHHcCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGE-TVAIK------------------KVLQD---RRYKNRELQLMRVMDHPNVI   67 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK------------------~~~~~---~~~~~~E~~~l~~l~h~~iv   67 (353)
                      .++|++.+.||+|+||+||++..+.... ..+.|                  .+...   ...+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3689999999999999999987643322 11211                  11111   12345899999999999999


Q ss_pred             ecceeeeecCCCCceeEEEEeccccchHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           68 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                      ++++++..     ....|++++++.+++...+.... ..........++.++.||+.||+|||+ +||+||||||+|||+
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEE
Confidence            99998843     33478999999988777664321 112334567788999999999999999 799999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCC-CCC--CChHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPG--ENAVD  221 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p-f~~--~~~~~  221 (353)
                      +. ++.+||+|||++........  .....||+.|+|||++.+. .++.++|||||||++|+|++|..+ |..  .+...
T Consensus       301 ~~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NC-DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CC-CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            96 78899999999986654332  2345789999999999664 489999999999999999998854 432  23345


Q ss_pred             HHHHHHHHhCCCCHHHHh---hcCcCCCCCcCCCCCCCcccccc-CCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          222 QLVEIIKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                      .+.+++..++....+...   ..........+.... ......+ ...++.++.++|.+||++||.+|||+.|+|+||||
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            555555544432211000   000000000000000 0000001 12467889999999999999999999999999999


Q ss_pred             cccc
Q 018619          298 DELR  301 (353)
Q Consensus       298 ~~~~  301 (353)
                      ....
T Consensus       458 ~~~~  461 (501)
T PHA03210        458 SAEE  461 (501)
T ss_pred             hcCC
Confidence            8743

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.4e-43  Score=308.01  Aligned_cols=250  Identities=29%  Similarity=0.490  Sum_probs=199.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .+|++.+.||+|+||.||.+.+..+++.||||.+..+.         ....+|+.+++.++||||+++++++...   ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence            57999999999999999999999999999999875321         2345799999999999999998876322   23


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..++++|||+++ +|.+.+.    ....+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~Dfg~  152 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDS-VGNVKLGDFGA  152 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecC-CCCEEECcCcc
Confidence            457899999985 5655554    33568899999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          161 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       161 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +.......    ......++..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...+......++..   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--  226 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--  226 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC--
Confidence            87543211    1223457889999999865 4588999999999999999999999987655444332221   110  


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                                            ...++..++..+.++|++||. +|.+||+++++++|||+.
T Consensus       227 ----------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         227 ----------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             ----------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence                                  011233568889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-43  Score=311.65  Aligned_cols=250  Identities=27%  Similarity=0.387  Sum_probs=191.5

Q ss_pred             eeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHHHHH---HcCCCceeecceeeeecCCCCceeEEEE
Q 018619           18 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQLMR---VMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .||+|+||.||++.+..+++.||+|.+.+...       ...+|..+++   ..+|||++.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            48999999999999999999999998854321       1223443333   3479999999888733     3358899


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |||+.+ +|...+.    ..+.+++..+..++.|++.||+|||+ ++|+|+||||+||+++. ++.++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECC-CCCEEEccCCcceeccc
Confidence            999995 5544443    45679999999999999999999999 79999999999999996 78899999999875433


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      .. .....++..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------  212 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------  212 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence            22 223468999999999864455889999999999999999999999764322111 1111000               


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCCCC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPNA  305 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~~~  305 (353)
                                .+...++..++.++.++|++||..||.+|+     |+.++++||||+.+.+...
T Consensus       213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~  266 (279)
T cd05633         213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV  266 (279)
T ss_pred             ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHH
Confidence                      001112345789999999999999999999     6999999999999765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.1e-43  Score=304.74  Aligned_cols=248  Identities=31%  Similarity=0.477  Sum_probs=205.1

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||.|+||.||.+++..+++.+++|.+....      ....+|+.+++.++|+||+++++++..     ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            6999999999999999999999999999999875432      234579999999999999999999843     34588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|||+++ +|.+.+...  ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTK-AGLIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeC-CCCEEECcCcceEEc
Confidence            99999984 777666532  24578999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... ......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||...+..+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            4433 233456789999999986644 788999999999999999999999887766655554331  000         


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                       .....++.++.++|.+||+.||.+|||+.++++|||+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence                             0113468899999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.2e-43  Score=314.51  Aligned_cols=254  Identities=29%  Similarity=0.465  Sum_probs=203.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||++.+..+++.|++|.+....       ....+|+.+++.++||||+++++.+     .....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence            47999999999999999999999999999999886432       2334789999999999999999887     34446


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +++||||++| +|.+.+.    ..+.+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||+++
T Consensus        76 ~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~  149 (305)
T cd05609          76 LCMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSK  149 (305)
T ss_pred             EEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECC-CCCEEEeeCCCcc
Confidence            8999999986 5555554    34678999999999999999999999 79999999999999996 8889999999986


Q ss_pred             ccccCC----------------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 018619          163 QLIAGE----------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI  226 (353)
Q Consensus       163 ~~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~  226 (353)
                      ......                ......++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+..+....+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~  228 (305)
T cd05609         150 IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  228 (305)
T ss_pred             ccCcCccccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            321100                0012346778999999865 45899999999999999999999999887766555444


Q ss_pred             HHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC---HHHHhcCcccccccC
Q 018619          227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE  302 (353)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~~~l~hp~f~~~~~  302 (353)
                      ......                 .+.         ....++.++.++|.+||+.||++||+   +.++++||||....+
T Consensus       229 ~~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         229 ISDDIE-----------------WPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             HhcccC-----------------CCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            331000                 000         01246889999999999999999998   799999999977544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-43  Score=314.83  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=203.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      +.|.....||+|+||.||++.+..+++.||||.+....    ....+|+.+++.++|||++++++.+.     .....|+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~l   96 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWV   96 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEE
Confidence            45666788999999999999999999999999885432    23457999999999999999999874     3345889


Q ss_pred             Eeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ||||++++ +.+.+.     .+.+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.++|+|||++....
T Consensus        97 v~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~~  169 (292)
T cd06658          97 VMEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVS  169 (292)
T ss_pred             EEeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcC-CCCEEEccCcchhhcc
Confidence            99999864 444332     3568999999999999999999999 79999999999999996 7889999999987543


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+........          
T Consensus       170 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------  238 (292)
T cd06658         170 KEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV----------  238 (292)
T ss_pred             cccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------
Confidence            3222 234567899999999855 4488999999999999999999999987776554443322111000          


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                      ......+..+.+++.+||..||.+|||++++++||||+....+
T Consensus       239 ----------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         239 ----------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             ----------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence                            0012468899999999999999999999999999999976544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.2e-43  Score=307.47  Aligned_cols=252  Identities=32%  Similarity=0.540  Sum_probs=199.1

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +|.+.+.||+|++|.||++.+..+|+.||+|.+....              ..+.+|+.+++.++|||++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            6899999999999999999999999999999874311              1245789999999999999999887    


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       ......++||||+.+ +|.+.+..    .+.+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~  150 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDA-DGICKIS  150 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcC-CCeEEEe
Confidence             333458899999985 56555543    3678999999999999999999999 79999999999999996 8899999


Q ss_pred             eeccccccccCC---CcceeeeeceeeChhhhhCCC-CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||++.......   ......++..|+|||.+.+.. .++.++|+||+|+++|+|++|..||...+.......+..... 
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  229 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-  229 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcccc-
Confidence            999987543321   122345788899999986543 478899999999999999999999976554433322211000 


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                            ...+...+...++.++.++|.+||+.||++|||++++++||||
T Consensus       230 ----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         230 ----------------------APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ----------------------CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence                                  0001111223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-43  Score=311.58  Aligned_cols=251  Identities=29%  Similarity=0.428  Sum_probs=199.1

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ||+|+||+||+|.+..+|+.||+|.+.+..       ....+|+.+++.++|||++++++++     ......|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            689999999999999999999999885421       2234799999999999999998887     3344588999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                      ++ +|.+.+...  ....+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECC-CCCEEEccCcchhhhccCCcc
Confidence            85 665555432  22468999999999999999999999 79999999999999996 788999999998765544333


Q ss_pred             ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcC
Q 018619          171 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF  250 (353)
Q Consensus       171 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (353)
                      ....++..|+|||.+.+.. ++.++|+||+||++|+|++|+.||...+.......+.+....                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            4456788899999986654 889999999999999999999999776542221111111000                  


Q ss_pred             CCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCCC
Q 018619          251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN  304 (353)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~~  304 (353)
                             ....++..+++++.++|++||+.||.+||     ++.++++||||+.+.+..
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~  264 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR  264 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence                   01112345789999999999999999999     899999999999876643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6e-43  Score=304.77  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=203.5

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...      .....+|+.+++.++||||+++.+++     ......+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            589999999999999999999999999999988532      12455799999999999999999887     4445688


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+.+ +|.+.+..  .....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus        76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEEeeccceeec
Confidence            99999985 66665543  123468899999999999999999999 79999999999999996 778999999999765


Q ss_pred             ccCCCc-ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...... ....+++.|+|||.+.+. .++.++|+||+||++++|++|..||...+..+....+.....            
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~------------  218 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY------------  218 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC------------
Confidence            443221 234578889999998654 478899999999999999999999988776665554433100            


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                      ...+..++.++.++|.+||+.||++||++.++++||||
T Consensus       219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         219 ----------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ----------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence                            00123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.6e-43  Score=322.11  Aligned_cols=253  Identities=22%  Similarity=0.356  Sum_probs=195.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCC-----cEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      |.+..++|.+.+.||+|+||.||+|.+..++     +.||+|.+....     ....+|+.+++.+ +||||+++++++ 
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-  111 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-  111 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-
Confidence            3455678999999999999999999865443     579999886432     2345799999999 899999999988 


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh-------------------------------------------------
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------------------------  104 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------------------------------------  104 (353)
                          .....+++|||||. |+|.+.+.....                                                 
T Consensus       112 ----~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         112 ----THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             ----cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence                33345889999998 567666643210                                                 


Q ss_pred             -----------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619          105 -----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus       105 -----------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                                       ...++++..++.++.|++.||.|||+ +||+||||||+|||++. ++.+||+|||++......
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~  265 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMND  265 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeC-CCeEEEeeceeeeeccCC
Confidence                             12357889999999999999999999 79999999999999995 788999999999765433


Q ss_pred             CCcc---eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          168 EANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       168 ~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ....   ...++..|+|||++.+ ..++.++||||+||++|+|++ |..||..................           
T Consensus       266 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-----------  333 (374)
T cd05106         266 SNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-----------  333 (374)
T ss_pred             cceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-----------
Confidence            2211   1223567999999865 458999999999999999997 99999876554433333321000           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                      ...+..+++++.+++.+||+.||.+|||+.++++
T Consensus       334 ----------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         334 ----------------MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             ----------------ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                            0012346889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.8e-43  Score=310.40  Aligned_cols=249  Identities=16%  Similarity=0.181  Sum_probs=197.3

Q ss_pred             eecceeeEe--eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAE--RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~--~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +..+++...  ..+|+|++|.||++..  +|+.||||.+....       ..+.+|+.+++.++||||+++++++.+.. 
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-   91 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-   91 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-
Confidence            334445444  6899999999999987  78999999886532       23358999999999999999999885422 


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .+...+++||||+++ +|.+.+.    ....+++.....++.|++.||.|||+..+++||||||+||+++. ++.+||+|
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~d  166 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIIC  166 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcc
Confidence            223457899999996 5655554    34678999999999999999999997238999999999999996 78999999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ||++.......  ....++..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+.  
T Consensus       167 fg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--  242 (283)
T PHA02988        167 HGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK--  242 (283)
T ss_pred             cchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence            99998654322  345678899999998652 4589999999999999999999999998876666555443211110  


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                               ++...++++.+|+.+||+.||++|||++++++
T Consensus       243 -------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        243 -------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             -------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                                     12347889999999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=302.14  Aligned_cols=282  Identities=33%  Similarity=0.575  Sum_probs=224.3

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      +-.+-||-|+||.||.+.+..+|+.||+|++..-      .+..-+|+++|..++|.|+++..++.-...-..-..+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4457899999999999999999999999998643      2344589999999999999998877632222212236788


Q ss_pred             eccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           88 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      +|++..+|-.++    ...+.++...+.-+++||++||+|||+ .+|.||||||.|+|+++ +..+||||||+++....+
T Consensus       136 TELmQSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNS-NCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  136 TELMQSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNS-NCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHHhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEecc-CceEEecccccccccchh
Confidence            998887665554    357889999999999999999999999 79999999999999997 899999999999865544


Q ss_pred             CC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          168 EA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       168 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      +.  .+..+-|-+|+|||++.|...|+.+.||||.|||+.|++..+..|+..++.+++..|.+.+|+|..+.++.-...-
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            33  2345668899999999999999999999999999999999999999999999999999999999999887543332


Q ss_pred             CCCcCCCCCCCc-----cccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          246 TDFRFPQIKAHP-----WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       246 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ..-.+..-...+     +.-.-+..-..+..+++.++|.+||++|++.++++.|++..+.+
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence            211111100000     00001113345789999999999999999999999999987654

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-42  Score=308.29  Aligned_cols=262  Identities=26%  Similarity=0.439  Sum_probs=203.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|+..+.||.|++|.||++.+..+++.||+|.+....     ....+|+.+++.++||||+++++++...   ....+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence            57899999999999999999999999999999886432     2345899999999999999999887442   233578


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~  155 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTR-KGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEec-CCeEEEeeccccccc
Confidence            99999985 6766665544556778999999999999999999999 79999999999999996 778999999998754


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-----VDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ..... ....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.....     .+....+..    .....+ 
T Consensus       156 ~~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~-  228 (287)
T cd06621         156 VNSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPEL-  228 (287)
T ss_pred             ccccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhh-
Confidence            33222 23456788999999855 4589999999999999999999999976522     121111111    000000 


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                 +.   .   .......++.+.+||.+||+.||++|||+.|++.||||++..
T Consensus       229 -----------~~---~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         229 -----------KD---E---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             -----------cc---C---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence                       00   0   000012467899999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-43  Score=306.61  Aligned_cols=246  Identities=32%  Similarity=0.516  Sum_probs=194.0

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHHH-HHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQL-MRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|++|.||+|.+..+++.||+|.+.+...       ....|..+ ....+|+|++++++++     .....+|+|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence            578999999999999999999999998864321       11234333 3445899999999988     3344589999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+++ +|...+.    ..+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++. ++.+||+|||++..... 
T Consensus        77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECC-CCcEEEeecccceeccc-
Confidence            99985 5555543    34678999999999999999999999 79999999999999996 78899999999875433 


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                        .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+.......+.....                
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------  210 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI----------------  210 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc----------------
Confidence              22345788899999986654 89999999999999999999999988776655444332100                


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC---HHHHhcCcccccccC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELRE  302 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~~~l~hp~f~~~~~  302 (353)
                               .|.......+++++.++|.+||+.||++|||   ++|+++||||+++++
T Consensus       211 ---------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~  259 (260)
T cd05611         211 ---------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW  259 (260)
T ss_pred             ---------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence                     0111122357899999999999999999995   579999999988764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.5e-43  Score=308.80  Aligned_cols=249  Identities=28%  Similarity=0.399  Sum_probs=192.4

Q ss_pred             eeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHH---HHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           18 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNREL---QLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .||+|+||.||+|.+..+++.||+|.+.+...       ....|.   .+++...||+|+.+.+.+     .....+|+|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            48999999999999999999999998865321       112233   344456799999998888     334458899


Q ss_pred             eccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |||+.|+ |...+    ...+.+++..++.++.|++.||+|||+ ++++||||||+||+++. ++.+||+|||++.....
T Consensus        76 ~e~~~g~~L~~~l----~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECC-CCCEEEccCcCccccCc
Confidence            9999864 44333    245679999999999999999999999 79999999999999996 78899999999875543


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      .. .....|+..|+|||.+.+...++.++|+||+||++|+|++|..||.......... .......              
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~--------------  213 (278)
T cd05606         150 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLT--------------  213 (278)
T ss_pred             cC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-HHHHhhc--------------
Confidence            32 2345689999999998655458899999999999999999999997763221111 0000000              


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCCC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN  304 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~~  304 (353)
                                 ....++...+.++.+++.+||..||.+|+     ++.++++||||+...+..
T Consensus       214 -----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~  265 (278)
T cd05606         214 -----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM  265 (278)
T ss_pred             -----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence                       00112334689999999999999999999     999999999999876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.6e-43  Score=313.18  Aligned_cols=252  Identities=29%  Similarity=0.443  Sum_probs=204.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...+|.+.+.||+|++|.||++.+..+++.||+|.+....       ....+|+.+++.++|||++++.+++..     .
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----~   87 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----E   87 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----C
Confidence            3567999999999999999999999999999999885321       234579999999999999999998843     3


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ...|+||||+.|++.+.+..   ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++
T Consensus        88 ~~~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~  162 (307)
T cd06607          88 HTAWLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTE-PGTVKLADFGSA  162 (307)
T ss_pred             CeEEEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECC-CCCEEEeecCcc
Confidence            34889999999987776653   23568999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ......   ....+++.|+|||++.+  ...++.++||||+|+++|+|++|..||...+.......+...  .+      
T Consensus       163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~------  231 (307)
T cd06607         163 SLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS------  231 (307)
T ss_pred             eecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC------
Confidence            754332   23467888999998742  345788999999999999999999999877665544333221  00      


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                 +..        .....+.++.++|.+||+.||.+|||+.+++.||||..-
T Consensus       232 -----------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         232 -----------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             -----------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence                       000        012357889999999999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.1e-44  Score=317.50  Aligned_cols=283  Identities=32%  Similarity=0.531  Sum_probs=230.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcC------CCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD------HPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~   78 (353)
                      +.-.+|.+....|.|-|++|..|.+..-|..||||++....   +...+|+.+|++|+      --|.+.++..|     
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----  503 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----  503 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----
Confidence            33579999999999999999999999999999999997664   34458999999995      34788888888     


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      .....+|+|+|-+.-+|.++|..+. .+-.|....++.|+.||..||..|.. .||+|.||||+||||++....+|||||
T Consensus       504 ~hknHLClVFE~LslNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDf  581 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLSLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDF  581 (752)
T ss_pred             hhcceeEEEehhhhchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccC
Confidence            5566699999999999999998865 35568899999999999999999999 799999999999999988889999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |.|.....++ .+.+..+..|+|||+++|.+ |+...|+||+||.||||.||+..|++.++..++.-.+..-|..+...+
T Consensus       582 GSA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  582 GSASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            9998765544 34567788999999999876 999999999999999999999999999999999999999999988777


Q ss_pred             hhc-------Cc--CCCCCcCCCCCCC-------------ccccccCC--CCC-------hhHHHHHHHhcCcCCCCCCC
Q 018619          239 RCM-------NP--NYTDFRFPQIKAH-------------PWHKVFHK--RMP-------PEAIDLASRLLQYSPSLRCT  287 (353)
Q Consensus       239 ~~~-------~~--~~~~~~~~~~~~~-------------~~~~~~~~--~~~-------~~~~~li~~~L~~dp~~R~t  287 (353)
                      ++-       +.  ++...+.......             .+...+..  .++       ..+++|+.+||..||++|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence            632       11  1111111111110             11111110  122       35889999999999999999


Q ss_pred             HHHHhcCccccc
Q 018619          288 ALEACAHPFFDE  299 (353)
Q Consensus       288 ~~~~l~hp~f~~  299 (353)
                      +.|+|.||||..
T Consensus       740 ~nqAL~HpFi~~  751 (752)
T KOG0670|consen  740 VNQALKHPFITE  751 (752)
T ss_pred             HHHHhcCCcccC
Confidence            999999999974

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=320.53  Aligned_cols=240  Identities=28%  Similarity=0.444  Sum_probs=203.4

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEecccc-
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-   92 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-   92 (353)
                      .-++-||+|+.|.||+++.  .++.||||++..   ..+.+++-|++|+||||+.+.+++     ....++|||||||. 
T Consensus       127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~e---lkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRE---LKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQ  196 (904)
T ss_pred             hhhhhhccCcccceeeeec--cCceehhHHHhh---hhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccc
Confidence            3456799999999999875  788999998743   334679999999999999999999     56667999999999 


Q ss_pred             chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcce
Q 018619           93 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS  172 (353)
Q Consensus        93 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (353)
                      |-|+++|+    ....++......|..+|+.|+.|||. +.|||||||.-||||.. +..|||+|||.++.........+
T Consensus       197 GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMS  270 (904)
T KOG4721|consen  197 GQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMS  270 (904)
T ss_pred             ccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhh
Confidence            67777776    57889999999999999999999999 89999999999999996 77899999999998888877888


Q ss_pred             eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCC
Q 018619          173 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ  252 (353)
Q Consensus       173 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
                      +.||..|||||++.. ++.+.++|||||||+||||+||..||..-+...++      +|.                    
T Consensus       271 FaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------wGV--------------------  323 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------WGV--------------------  323 (904)
T ss_pred             hhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeE------Eec--------------------
Confidence            999999999999965 56999999999999999999999999876543222      111                    


Q ss_pred             CCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                       ..+..+-.++..+++-++=||++||+-.|..||+..++|.|==+
T Consensus       324 -GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  324 -GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             -cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence             11223334556788899999999999999999999999988433

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.3e-43  Score=305.52  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=191.9

Q ss_pred             ceeeEeeee--ecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEE
Q 018619           11 ISYMAERVV--GTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        11 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      ++|.+.+.+  |+|+||.||++.++.+++.+|+|.+...... ..|+.....+ +|||++++++.|..     ...+|+|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-AIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-hhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEE
Confidence            456666666  9999999999999999999999988654322 1234333333 79999999998843     3358999


Q ss_pred             ecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |||++ ++|.+.+..    ...+++..++.++.|++.||+|||+ .|++||||||+||+++..++.++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  162 (267)
T PHA03390         88 MDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT  162 (267)
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence            99998 577666643    3489999999999999999999999 79999999999999997443899999999875533


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      .   ....++..|+|||++.+. .++.++|+||+||++|+|++|..||......... .........             
T Consensus       163 ~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------  225 (267)
T PHA03390        163 P---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------------  225 (267)
T ss_pred             C---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-------------
Confidence            2   234578899999999654 4889999999999999999999999865433221 111111000             


Q ss_pred             CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-HHHHhcCccccc
Q 018619          246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDE  299 (353)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~~~l~hp~f~~  299 (353)
                                   .....+.+++.+.+||.+||+.||.+|++ .+++|+||||.+
T Consensus       226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence                         00112357999999999999999999996 599999999973

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.5e-43  Score=306.51  Aligned_cols=251  Identities=29%  Similarity=0.526  Sum_probs=201.5

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||+|++|.||++.++.+++.+|+|.+....     ....+|+.+++.++||||+++++.+..     ...++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~   75 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDIS   75 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEE
Confidence            46889999999999999999999999999999886542     234579999999999999999998833     35588


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++||++ ++|.+.+...   ...+++..+..++.|++.||+|||+..|++|+||||+||+++. ++.++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~  151 (265)
T cd06605          76 ICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQL  151 (265)
T ss_pred             EEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhh
Confidence            9999999 5666665532   2678999999999999999999999339999999999999996 788999999998765


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-----AVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ...... ...++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+     ..+....+..   .+.     
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~-----  221 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP-----  221 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC-----
Confidence            433222 26678899999998664 58999999999999999999999997652     1122211111   000     


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCC-CCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                 +         .++. .++.++.++|.+||..||.+|||+.+++.||||+++
T Consensus       222 -----------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         222 -----------P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             -----------C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence                       0         0111 268899999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.4e-42  Score=310.26  Aligned_cols=255  Identities=20%  Similarity=0.258  Sum_probs=193.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVI   67 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv   67 (353)
                      ..++|++.+.||+|+||.||+|.+..                ++..||+|.+....     ..+.+|+.++..++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            46789999999999999999997532                34579999886432     2345799999999999999


Q ss_pred             ecceeeeecCCCCceeEEEEecccc-chHHHHHHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHhHcC
Q 018619           68 SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS---------------ANQRMPLIYVKLYTYQIFRGLAYIHTV  131 (353)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------~~~~l~~~~~~~i~~qll~al~~LH~~  131 (353)
                      ++++++...     ...++||||+. ++|.+.+.....               ....+++..++.++.||+.||+|||+ 
T Consensus        83 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-  156 (304)
T cd05096          83 RLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-  156 (304)
T ss_pred             EEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-
Confidence            999988432     34889999998 477766644211               12347888899999999999999999 


Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHH
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL  208 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~  208 (353)
                      +||+||||||+|||++. ++.+||+|||++.........   ....++..|+|||++.+. .++.++|||||||++|+|+
T Consensus       157 ~~ivH~dlkp~Nill~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~  234 (304)
T cd05096         157 LNFVHRDLATRNCLVGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEIL  234 (304)
T ss_pred             CCccccCcchhheEEcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHH
Confidence            79999999999999996 788999999999865433221   122346789999998654 4899999999999999998


Q ss_pred             h--CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC
Q 018619          209 L--GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  286 (353)
Q Consensus       209 ~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  286 (353)
                      +  +..||...+..+...............                     .....+..++..+.+|+.+||+.||.+||
T Consensus       235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP  293 (304)
T cd05096         235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERP  293 (304)
T ss_pred             HccCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCc
Confidence            6  568888776655554433321110000                     00001234688999999999999999999


Q ss_pred             CHHHHh
Q 018619          287 TALEAC  292 (353)
Q Consensus       287 t~~~~l  292 (353)
                      |+.++.
T Consensus       294 s~~~i~  299 (304)
T cd05096         294 SFSDIH  299 (304)
T ss_pred             CHHHHH
Confidence            999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2e-42  Score=301.54  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||++.++.+|..||+|.+...      .....+|+.+++.++|+|++++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            589999999999999999999999999999988543      23445899999999999999999987     3444588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++||+.+ +|.+.+..  .....+++..+..++.|++.||.|||+ ++++|+||||+||++++++..+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 66665543  123458999999999999999999999 799999999999999874456899999998765


Q ss_pred             ccCCCc-ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...... ....+++.|+|||.+.+. .++.++|+||+||++++|++|..||...+..+....+.....            
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  219 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF------------  219 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC------------
Confidence            443322 234578889999988554 488999999999999999999999987766554443322100            


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                      ..+...++.++.++|.+||+.+|++|||+.++++||||
T Consensus       220 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         220 ----------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence                            00123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.8e-43  Score=310.59  Aligned_cols=250  Identities=28%  Similarity=0.414  Sum_probs=201.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +.|...+.||+|++|.||++.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     ....+|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLW   78 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceE
Confidence            46788899999999999999999999999999886332     23468999999999999999999883     344588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ ++.+.+.     .+.+++..++.++.|++.|+.|||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~  151 (277)
T cd06642          79 IIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSE-QGDVKLADFGVAGQL  151 (277)
T ss_pred             EEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeC-CCCEEEccccccccc
Confidence            99999996 5544442     3578999999999999999999999 79999999999999996 788999999998765


Q ss_pred             ccCCCc-ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...... ....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...........+...              
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------  216 (277)
T cd06642         152 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------  216 (277)
T ss_pred             cCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--------------
Confidence            443221 234578889999998654 5889999999999999999999999765544332211110              


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                    ....+...++.++.++|.+||+.||++|||+.++++||||....
T Consensus       217 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         217 --------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             --------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence                          00012234688999999999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.1e-42  Score=302.44  Aligned_cols=252  Identities=28%  Similarity=0.463  Sum_probs=196.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ++......||+|+||.||++.+..++..||+|.+....    ....+|+.+++.++|+||+++++++.     .....++
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   82 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKI   82 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEE
Confidence            34445568999999999999999999999999886432    34568999999999999999998873     3345889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRM--PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l--~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++||+.+ +|...+..   ....+  ++..+..++.|++.||+|||+ +||+||||||+||+++..++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          83 FMEQVPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEecCCCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999985 66666543   12344  788889999999999999999 79999999999999986567899999999876


Q ss_pred             cccCCC-cceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          164 LIAGEA-NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       164 ~~~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...... .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..||...+.............          
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  228 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK----------  228 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc----------
Confidence            543222 2234578899999998543 3478899999999999999999999976443221111000000          


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                      ....++..+++++.+|+++||+.+|.+|||+.+++.||||
T Consensus       229 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         229 ----------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             ----------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence                            0111234578899999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.7e-42  Score=301.84  Aligned_cols=251  Identities=32%  Similarity=0.511  Sum_probs=205.6

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||+|++|.||+|.+..+++.|++|++....     ....+|+..+..++|+|++++++.+.     ....++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence            47899999999999999999999999999999886542     34568999999999999999999883     335588


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-CCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~-~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +||||++ ++|.+.+..    ...+++..++.++.|++.|++|||+ . +++|+||+|+||+++. ++.++|+|||.+..
T Consensus        76 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~  149 (264)
T cd06623          76 IVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINS-KGEVKIADFGISKV  149 (264)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECC-CCCEEEccCcccee
Confidence            9999999 566666543    3779999999999999999999998 6 9999999999999996 78899999999987


Q ss_pred             cccCCCcc-eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........ ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+   ..+....+..   ...     
T Consensus       150 ~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~-----  220 (264)
T cd06623         150 LENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP-----  220 (264)
T ss_pred             cccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC-----
Confidence            65444332 45678899999998554 58899999999999999999999997774   2222222211   000     


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCC-CChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKR-MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                          ..+... ++..+.++|++||..+|++|||+.++++||||+..+
T Consensus       221 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         221 --------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             --------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence                                001123 788999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-42  Score=318.32  Aligned_cols=253  Identities=23%  Similarity=0.350  Sum_probs=194.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeeee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS   75 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~   75 (353)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||+|++....     ....+|+.+++.+ +||||+++++++  
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~--  108 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC--  108 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee--
Confidence            34456899999999999999999974     3467789999885432     2345799999999 899999999988  


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhh--------------------------------------------------
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSS--------------------------------------------------  104 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------------------------------------  104 (353)
                         ......++|||||+ |+|.+.+.....                                                  
T Consensus       109 ---~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         109 ---TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             ---ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence               33344889999998 577666643210                                                  


Q ss_pred             ---------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619          105 ---------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus       105 ---------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                                           ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~  263 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARD  263 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEEC-CCcEEEecCcccee
Confidence                                 12357889999999999999999999 79999999999999996 77899999999986


Q ss_pred             cccCCCcc---eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........   ...++..|+|||++.+. .++.++|||||||++|+|++ |..||..........+.+.....       
T Consensus       264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------  335 (375)
T cd05104         264 IRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR-------  335 (375)
T ss_pred             ccCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc-------
Confidence            54332211   12235679999999654 58999999999999999997 89999876554444333321000       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                          ...+...+.++.+||.+||+.||++|||+.++++.
T Consensus       336 --------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         336 --------------------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                00112357899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.4e-43  Score=315.24  Aligned_cols=279  Identities=20%  Similarity=0.305  Sum_probs=199.0

Q ss_pred             eeeeecC--CCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           16 ERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        16 ~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      ...||.|  +||+||+|++..+|+.||+|++....      ....+|+.+++.++||||++++++|.     .....++|
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v   77 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVI   77 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEE
Confidence            3466776  99999999999999999999886432      33457888999999999999999983     34458899


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      +||+.+ ++.+.+...  ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++++||+.+.....
T Consensus        78 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~  153 (328)
T cd08226          78 SPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVR  153 (328)
T ss_pred             EecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhc
Confidence            999995 666666543  23458999999999999999999999 79999999999999996 78899999986543322


Q ss_pred             CCCcc--------eeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-
Q 018619          167 GEANI--------SYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE-  236 (353)
Q Consensus       167 ~~~~~--------~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  236 (353)
                      .....        ...++..|+|||++.+. ..++.++||||+||++|+|++|..||...................+.. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         154 NGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             cCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccc
Confidence            11110        11235569999998653 347899999999999999999999998876655443333211110000 


Q ss_pred             --------HHhhcCcCCC----CCcC-----CCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          237 --------EIRCMNPNYT----DFRF-----PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       237 --------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                              ..........    +...     .......+........++.+.+||++||+.||++|||++++++||||+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                    0000000000    0000     0001111122223346788999999999999999999999999999998


Q ss_pred             ccCC
Q 018619          300 LREP  303 (353)
Q Consensus       300 ~~~~  303 (353)
                      .+..
T Consensus       314 ~~~~  317 (328)
T cd08226         314 VKEQ  317 (328)
T ss_pred             HHHh
Confidence            7654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-42  Score=306.50  Aligned_cols=249  Identities=27%  Similarity=0.410  Sum_probs=202.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..|...+.||.|+||.||.|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++.     +...+|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLW   78 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEE
Confidence            46888999999999999999999999999999886432     23457999999999999999999883     344589


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+.     .+++++..+..++.|++.||+|||+ ++++|+||+|+||+++. ++.++|+|||++...
T Consensus        79 lv~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~  151 (277)
T cd06640          79 IIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSE-QGDVKLADFGVAGQL  151 (277)
T ss_pred             EEEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcC-CCCEEEcccccceec
Confidence            99999986 5555543     2568999999999999999999999 79999999999999996 788999999999765


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....++..|+|||.+.+. ..+.++|+||+||++|+|++|..||...+.......+... ..           
T Consensus       152 ~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~-----------  218 (277)
T cd06640         152 TDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN-NP-----------  218 (277)
T ss_pred             cCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC-CC-----------
Confidence            44332 2234578889999998654 4889999999999999999999999876654433221110 00           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                      ..+...++..+.++|.+||+.||.+||++.++++||||...
T Consensus       219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         219 ----------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             ----------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence                            01223467889999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.4e-42  Score=299.84  Aligned_cols=250  Identities=28%  Similarity=0.458  Sum_probs=206.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||++.+..+++.|++|++....      ....+|+++++.++|||++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            5899999999999999999999999999999986432      234579999999999999999998843     34588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++|++++ +|.+.+.........+++..+..++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTS-NGLVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcC-CCcEEECCccceeec
Confidence            99999985 7777776544445789999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+..........            
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  220 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY------------  220 (258)
T ss_pred             ccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC------------
Confidence            5443 22345678899999998654 488999999999999999999999987775544443322100            


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                      ..++...+.++.+++++||..||++|||+.++++||||
T Consensus       221 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         221 ----------------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence                            00123478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-42  Score=307.36  Aligned_cols=256  Identities=29%  Similarity=0.475  Sum_probs=200.7

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++....     ....+|+.+++.++||||+++++.+..     ...
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~   77 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENN   77 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCE
Confidence            4578999999999999999999999999999999875432     234579999999999999999998843     345


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +++||||+++ +|...+.    ..+.+++..++.++.|++.||.|||+.++++|+||||+||+++. ++.++|+|||++.
T Consensus        78 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~  152 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSG  152 (284)
T ss_pred             EEEEEecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCccc
Confidence            8899999996 4444443    34678999999999999999999996348999999999999996 7889999999987


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHH-------HHHHHHHhCCCCH
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-------LVEIIKVLGTPTR  235 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~  235 (353)
                      ...... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||......+.       +........... 
T Consensus       153 ~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  229 (284)
T cd06620         153 ELINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-  229 (284)
T ss_pred             chhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-
Confidence            543222 2245688999999998654 588999999999999999999999986554211       001111000000 


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccC-CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                    .+         .++ ..++.++.+|+.+||+.||.+|||++++++||||.+-
T Consensus       230 --------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         230 --------------PP---------RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             --------------CC---------CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence                          00         001 1267889999999999999999999999999999663

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.5e-42  Score=300.72  Aligned_cols=245  Identities=27%  Similarity=0.455  Sum_probs=199.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      +|++.+.||+|+||.||++.+..+++.||+|.+....     ....+|+.+++.++|||++++++.+     .....+|+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            5899999999999999999999999999999885322     2345789999999999999999988     34446899


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +|||+++ ++.+.+..  .....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECC-CCcEEEcccCcceeec
Confidence            9999985 66655543  234568999999999999999999999 79999999999999996 7889999999987654


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....+++.|+|||++.+. .++.++|+||+|+++|+|++|..||...+.......+.....             
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------  217 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-------------  217 (255)
T ss_pred             ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-------------
Confidence            3322 2345678899999998554 489999999999999999999999988776555443332100             


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                     ..++..++..+.+||.+||+.||.+|||+.++++-
T Consensus       218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                           00123468899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-42  Score=308.00  Aligned_cols=253  Identities=26%  Similarity=0.425  Sum_probs=201.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..|.....||+|+||.||++.+..+++.||+|.+...    .....+|+.+++.++|||++++++.+..     ....|+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~i   95 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWV   95 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEE
Confidence            3455667899999999999999999999999988532    2234578999999999999999998843     345889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ++||+++ ++...+.     ...+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++....
T Consensus        96 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~  168 (297)
T cd06659          96 LMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQIS  168 (297)
T ss_pred             EEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEcc-CCcEEEeechhHhhcc
Confidence            9999996 4444332     3568999999999999999999999 79999999999999996 7889999999987554


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+..+....+...   +. .        
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~--------  235 (297)
T cd06659         169 KDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-P--------  235 (297)
T ss_pred             cccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-C--------
Confidence            3322 2345688999999998654 4899999999999999999999999877665554332210   00 0        


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                  .+  .....++.++.++|++||+.||.+||++.++++||||.+...
T Consensus       236 ------------~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         236 ------------KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             ------------Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence                        00  011347889999999999999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-42  Score=308.26  Aligned_cols=262  Identities=24%  Similarity=0.381  Sum_probs=203.1

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +.+..++|.+.+.||+|++|.||++.+..+++.||+|.+.+..     ....+|+.++... +||||+++++++.     
T Consensus        10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----   84 (296)
T cd06618          10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----   84 (296)
T ss_pred             ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----
Confidence            4567789999999999999999999999899999999986432     1223466555555 5999999999883     


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      .....|++|||+++.+...+..   ....+++..+..++.|++.||+|||+..||+||||+|+||+++. ++.+||+|||
T Consensus        85 ~~~~~~~v~e~~~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg  160 (296)
T cd06618          85 TDSDVFICMELMSTCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFG  160 (296)
T ss_pred             cCCeEEEEeeccCcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccc
Confidence            3345889999998876665543   24578999999999999999999997249999999999999996 7899999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCC---CCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCH
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGA---TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTR  235 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~  235 (353)
                      ++.............++..|+|||.+.+.   ..++.++|+||+|+++|+|++|+.||...... +.+..+...   .. 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~-  236 (296)
T cd06618         161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP-  236 (296)
T ss_pred             cchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC-
Confidence            98765544333344577889999998543   24788999999999999999999999764332 222222211   00 


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                .  ..+          ....++.++.+|+.+||+.||.+|||+++++.||||...+.
T Consensus       237 ----------~--~~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         237 ----------P--SLP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             ----------C--CCC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence                      0  000          01136889999999999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-42  Score=303.39  Aligned_cols=247  Identities=19%  Similarity=0.225  Sum_probs=193.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|.+.+.||+|+||.||++..+   ..+..||+|.+....     ..+.+|+.+++.++||||+++++++..    
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----   77 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----   77 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec----
Confidence            35678999999999999999999765   346789999886432     234579999999999999999998743    


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                       ....++||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+|++||
T Consensus        78 -~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~-~~~~~l~df  151 (266)
T cd05064          78 -GNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNS-DLVCKISGF  151 (266)
T ss_pred             -CCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcC-CCcEEECCC
Confidence             3348899999996 45444432   24578999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCCcc--eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          159 GSAKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       159 g~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      |.+..........  ...++..|+|||.+.+ ..++.++||||+||++|++++ |..||...+..+.+..+.+....   
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---  227 (266)
T cd05064         152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---  227 (266)
T ss_pred             cccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC---
Confidence            9876432221111  1234578999999865 458999999999999999774 99999887766655444221000   


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                               ..+..++..+.+++.+||+.||.+|||++++++
T Consensus       228 -------------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         228 -------------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence                                     012357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.5e-42  Score=308.08  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=204.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .+.|...+.||+|+||.||++++..+++.|++|++....       ....+|+.+++.++|||++++++++..     ..
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~   94 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EH   94 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence            345777888999999999999999999999999886421       234578999999999999999998843     34


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ..|+||||+.+++.+.+..   ....+++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++.
T Consensus        95 ~~~lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~-~~~~kL~dfg~~~  169 (313)
T cd06633          95 TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSAS  169 (313)
T ss_pred             EEEEEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECC-CCCEEEeecCCCc
Confidence            5889999999987776653   34678999999999999999999999 79999999999999986 7889999999986


Q ss_pred             ccccCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          163 QLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ....   .....++..|+|||.+..  ...++.++|+||+||++|+|++|..||...+.......+... ..+       
T Consensus       170 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~-------  238 (313)
T cd06633         170 KSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP-------  238 (313)
T ss_pred             ccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCC-------
Confidence            4322   234567889999999742  244788999999999999999999999887766555544321 000       


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                 .        .....++..+++|+.+||+.||.+||++.++++||||+..
T Consensus       239 -----------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         239 -----------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             -----------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                       0        0112357789999999999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.8e-42  Score=304.37  Aligned_cols=260  Identities=25%  Similarity=0.327  Sum_probs=201.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFS   75 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (353)
                      |-+..++|.+.+.||+|+||.||++.++.     .+..||+|.+....     ....+|+.+++.++||||+++++++. 
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence            34667899999999999999999987652     34579999875432     12346889999999999999999873 


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                          .....|+||||+. |+|.+.+......      ...++...+..++.|++.||.|||+ ++++||||||+||+++.
T Consensus        80 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~  154 (288)
T cd05061          80 ----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAH  154 (288)
T ss_pred             ----CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcC
Confidence                3334789999998 5777777543211      2345677889999999999999999 89999999999999996


Q ss_pred             CCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 018619          149 LTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  224 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  224 (353)
                       ++.++|+|||+++........   ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.+..+...
T Consensus       155 -~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~  232 (288)
T cd05061         155 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK  232 (288)
T ss_pred             -CCcEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             788999999998754332211   122346679999998654 48999999999999999998 789998877655443


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc------Ccccc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFD  298 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~------hp~f~  298 (353)
                      .+... +.+                           .++...++.+.+++.+||+.||.+|||+.++++      ||||+
T Consensus       233 ~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~  284 (288)
T cd05061         233 FVMDG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP  284 (288)
T ss_pred             HHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence            33221 000                           012346789999999999999999999999986      99998


Q ss_pred             ccc
Q 018619          299 ELR  301 (353)
Q Consensus       299 ~~~  301 (353)
                      .+.
T Consensus       285 ~~~  287 (288)
T cd05061         285 EVS  287 (288)
T ss_pred             CCC
Confidence            764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-42  Score=300.14  Aligned_cols=249  Identities=28%  Similarity=0.494  Sum_probs=200.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .+|++.+.||+|++|.||++.+..+++.||+|.+...         ...+.+|+.+++.++|+||+++++++...   ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            5899999999999999999999999999999987432         12345799999999999999999877332   22


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+++++||+++ +|.+.+.    ..+.+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||+
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~  152 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDS-AGNVKLGDFGA  152 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcC-CCCEEECcccc
Confidence            347799999985 5555554    34568999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccC----CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          161 AKQLIAG----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       161 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +......    .......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||..........++..   .+.  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--  226 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--  226 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC--
Confidence            9865321    112234678899999998654 478999999999999999999999987665544433321   111  


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                            ...++..+++++.++|++||+ +|.+|||+.+++.|||.
T Consensus       227 ----------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         227 ----------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             ----------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence                                  112345688999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.8e-42  Score=300.31  Aligned_cols=250  Identities=29%  Similarity=0.520  Sum_probs=198.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+.....      .+.+|+.+++.++|+||+++++.+     .....++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            68999999999999999999988999999998865432      345799999999999999998876     3344588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +|+||+.+ +|.+.+.    ....+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEccccccccc
Confidence            99999985 5555543    34568899999999999999999999 79999999999999996 888999999998865


Q ss_pred             ccCCCcc-----eeeeeceeeChhhhhCCC--CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          165 IAGEANI-----SYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       165 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      .......     ...+++.|+|||.+.+..  .++.++||||+|+++|+|++|..||...+........... +...   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence            4433221     245678899999985532  3788999999999999999999999765433222211111 1000   


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                 .++.          ...++..+.++|.+||+.||.+|||+.+++.|||+
T Consensus       226 -----------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         226 -----------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             -----------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                       0000          12358899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=304.07  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=200.8

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcC---CCceeecceeeeecCCCCcee
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .|.+.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.++   |||++++++++.     ....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            588899999999999999999999999999988543     123457889999986   999999999874     3345


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .|++|||+.+ +|.+.+.     ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTN-TGNVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcC-CCCEEEccCCcee
Confidence            8899999986 5554443     2478999999999999999999999 79999999999999996 8889999999998


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ....... .....++..|+|||.+.+...++.++|+||+||++|+|++|..||...+.......+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            6654432 233467889999999866555789999999999999999999999776543322111100            


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                             ..+..        .....+.++.+++.+||+.||++|||+.+++.||||++..
T Consensus       218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence                   00000        0012678999999999999999999999999999997743

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3e-42  Score=306.39  Aligned_cols=253  Identities=27%  Similarity=0.442  Sum_probs=202.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|.+.+.||+|+||.||++.+..+++.||+|.+....    ....+|+.+++.++|||++++++.+..     ....|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            468999999999999999999998899999999885432    234578999999999999999998843     33488


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +|+||+.+ +|.+.+..     ..+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcC-CCCEEEccCcceecc
Confidence            99999985 55555432     457899999999999999999999 79999999999999996 788999999988755


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||...+..+....+.. .+.+.         
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~~---------  234 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------  234 (293)
T ss_pred             cccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCCC---------
Confidence            43332 223457888999999855 4588999999999999999999999987665443322111 00000         


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                      ...+..++..+.++|++||+.||++||++.+++.||||+..+
T Consensus       235 ----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         235 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence                            001234688999999999999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.8e-42  Score=309.65  Aligned_cols=272  Identities=20%  Similarity=0.263  Sum_probs=193.7

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccc-hH
Q 018619           23 SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SM   95 (353)
Q Consensus        23 ~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l   95 (353)
                      ++|.||.+++..+++.||+|++....      ....+|+.+++.++||||+++++++.     .....+++|||+++ ++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l   86 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSC   86 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCH
Confidence            45667777778899999999986441      24568999999999999999999884     33448899999994 56


Q ss_pred             HHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC------
Q 018619           96 YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------  169 (353)
Q Consensus        96 ~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~------  169 (353)
                      .+.+...  ....+++..++.++.|++.||+|||+ ++|+|+||||+||+++. ++.+||+|||.+........      
T Consensus        87 ~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          87 EDLLKTH--FPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             HHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEec-CCceEEecCccceeeccccccccccc
Confidence            5555532  23468999999999999999999999 79999999999999995 78899999998875432221      


Q ss_pred             --cceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--HHhhcCcC
Q 018619          170 --NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPN  244 (353)
Q Consensus       170 --~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  244 (353)
                        .....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||......................  ........
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS  242 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence              1223467789999998653 347899999999999999999999998766554433222210000000  00000000


Q ss_pred             CCCC---cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          245 YTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       245 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      ....   .................++.++.+|+.+||+.||++|||++++|+||||+.++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhccc
Confidence            0000   0000011111222233456789999999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.8e-42  Score=299.42  Aligned_cols=248  Identities=22%  Similarity=0.350  Sum_probs=198.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +....|.+.+.||+|++|.||+|.+..+++.||+|.+..+..   ...+|+.+++.++||||+++++++.     ....+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   77 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCc
Confidence            445679999999999999999999999999999998865432   3457999999999999999998873     33347


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +++|||++ ++|.+.+...  ....+++..++.++.|++.||+|||+ +|++||||||+||++++ ++.+||+|||++..
T Consensus        78 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~  153 (263)
T cd05052          78 YIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLSRL  153 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCcEEeCCCccccc
Confidence            89999997 4666665431  23568999999999999999999999 79999999999999986 78899999999986


Q ss_pred             cccCCCcc--eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ........  ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....          
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------  222 (263)
T cd05052         154 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY----------  222 (263)
T ss_pred             cccceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------
Confidence            54332211  12235679999988554 58899999999999999998 999998877655443332210          


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                        ...++..++.++.++|.+||+.||++|||+.++++
T Consensus       223 ------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         223 ------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                              01123457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=315.86  Aligned_cols=254  Identities=24%  Similarity=0.412  Sum_probs=223.1

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +..++..||-|+||.|-+++.+.....+|+|++++.+       +-...|..+|...+.|.||++|..|     .+..++
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~kyv  495 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKYV  495 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchhh
Confidence            4567778999999999999876665568999886532       2334789999999999999999999     788889


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |++||-|-| .++..+.    ..+.+.+..++.++..+++|++|||+ +|||+|||||+|++++. +|-+||.|||+|+.
T Consensus       496 YmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~-~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDN-RGYLKLVDFGFAKK  569 (732)
T ss_pred             hhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeecc-CCceEEeehhhHHH
Confidence            999999975 6666665    46889999999999999999999999 89999999999999996 88899999999999


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      +..+....+.+|||.|.|||++.... ...++|.||||+++|||++|.+||.+.++...+..|.+.+..           
T Consensus       570 i~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----------  637 (732)
T KOG0614|consen  570 IGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----------  637 (732)
T ss_pred             hccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence            99999999999999999999997654 899999999999999999999999999999999888874321           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCCC
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREPN  304 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~~  304 (353)
                                      -.||+.++..+.+||+++...+|.+|..     +.+|..|-||....|..
T Consensus       638 ----------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  638 ----------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             ----------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence                            1245678999999999999999999986     88999999999988764

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.8e-42  Score=300.45  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=197.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||.||+|++..+++.||||.+....       ....+|+.+++.++||||+++++.+...     ..
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence            58999999999999999999999999999999775321       2345799999999999999999988432     34


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++++||+++ +|...+.........+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcC-CCCEEECccccce
Confidence            7899999995 6766666554455678999999999999999999999 79999999999999996 7889999999988


Q ss_pred             ccccCCCc-ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 018619          163 QLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       163 ~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ........ ....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...... ......+...+.++.     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----  228 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-----  228 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-----
Confidence            65433221 234578889999998654 4789999999999999999999999654321 122222221111110     


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                           .....+..+.+++.+||+.||++|||+.++++
T Consensus       229 ---------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         229 ---------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             ---------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence                                 11236788999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.3e-42  Score=304.58  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=198.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCC-----cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETG-----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ..++|++.+.||+|+||.||++.+...+     ..||+|.+....     ..+.+|+.+++.++||||+++++++.    
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~----   78 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT----   78 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc----
Confidence            3468999999999999999999976655     679999885432     23457999999999999999998873    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL  145 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nil  145 (353)
                       .....|++|||++ ++|.+.+.....            ....+++..+..++.|++.||+|||+ +|++|+||||+||+
T Consensus        79 -~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil  156 (283)
T cd05048          79 -KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCL  156 (283)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEE
Confidence             3344889999998 577666654211            11568899999999999999999999 79999999999999


Q ss_pred             EeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHH
Q 018619          146 VDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD  221 (353)
Q Consensus       146 l~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~  221 (353)
                      ++. ++.+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+
T Consensus       157 ~~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~  234 (283)
T cd05048         157 VGE-GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE  234 (283)
T ss_pred             EcC-CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            996 78899999999976543321   2234557889999998654 48999999999999999998 999998877766


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ....+.+....                            ..+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus       235 ~~~~i~~~~~~----------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         235 VIEMIRSRQLL----------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHcCCcC----------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            55443321000                            0124578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8.3e-42  Score=302.39  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=202.6

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .|...+.||+|++|.||++.+..+++.+++|++....    ....+|+.+++.++|||++++++.+..     ....+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            5667789999999999999999999999999875322    234579999999999999999998743     3347899


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      +||+.+ +|.+.+..     .++++..+..++.|++.||+|||+ +|++||||+|+||+++. ++.++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcC-CCcEEEcccccchhhcc
Confidence            999975 65555432     568999999999999999999999 79999999999999996 78999999998875443


Q ss_pred             CCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      ... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+... ..+.           
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~-----------  234 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK-----------  234 (285)
T ss_pred             CCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC-----------
Confidence            222 2234678899999998654 4889999999999999999999999877665554433321 0000           


Q ss_pred             CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                    ......++..+.+||++||+.||++|||+.++++||||++.+.
T Consensus       235 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         235 --------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             --------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence                          0001236889999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-41  Score=296.55  Aligned_cols=249  Identities=28%  Similarity=0.446  Sum_probs=204.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|++.+.||+|++|.||++.+..+++.+++|.+....      ....+|+.+++.++|+||+++++++..     ....|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            5899999999999999999999999999999886432      233478899999999999999988843     34588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+.........+++..++.++.|++.||+|||+ .|++|+||+|+||+++. ++.+||+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVA-NDLVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEec-CCcEEEeeccchhhh
Confidence            99999975 6777776554556779999999999999999999999 79999999999999996 788999999999866


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ... ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+..+....+....              
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------------  217 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK--------------  217 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Confidence            544 3334567889999999865 458889999999999999999999998877654443332210              


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                           ++         .++...+.++++++.+||+.||.+|||+.++++||++
T Consensus       218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         218 -----YP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             -----CC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence                 00         0112468899999999999999999999999999984

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=3.8e-42  Score=300.87  Aligned_cols=245  Identities=33%  Similarity=0.549  Sum_probs=198.0

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ||.|++|.||++++..+|+.|++|.+....       ....+|+.+++.++||||+++++.+     ......|+++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999999999999886442       2345789999999999999998877     3445588999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC--
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--  168 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~--  168 (353)
                      .+ +|.+.+..    .+.+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCccc
Confidence            85 66666543    3478999999999999999999999 79999999999999996 7889999999987544332  


Q ss_pred             -------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          169 -------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       169 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                             ......++..|+|||.+.+.. .+.++|+||+|+++|+|++|..||...+..+....+...  .         
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~---------  217 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K---------  217 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence                   112345678899999986544 889999999999999999999999887766555443320  0         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH---HHHhcCcccccccC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFFDELRE  302 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~~~l~hp~f~~~~~  302 (353)
                            ...+.          ...++..+.+++.+||+.||.+|||+   .++++||||+++.+
T Consensus       218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~  265 (265)
T cd05579         218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW  265 (265)
T ss_pred             ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence                  00010          01258899999999999999999999   99999999997653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.5e-42  Score=301.84  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=196.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFS   75 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (353)
                      |.+..++|++.+.||+|++|.||++.+..     ++..||+|++....     ....+|+.+++.++||||+++++++  
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--   78 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--   78 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--
Confidence            34578899999999999999999998642     35679999885432     2245789999999999999999887  


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                         ......++||||++ ++|.+.+......      ...+++..+..++.|++.||.|||+ +|++|+||||+||++++
T Consensus        79 ---~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~  154 (277)
T cd05062          79 ---SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE  154 (277)
T ss_pred             ---cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcC
Confidence               33345889999998 4676666542211      2346778889999999999999999 79999999999999996


Q ss_pred             CCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 018619          149 LTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  224 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  224 (353)
                       ++.++|+|||++.........   ....+++.|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus       155 -~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~  232 (277)
T cd05062         155 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR  232 (277)
T ss_pred             -CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence             788999999998754332221   122446789999998654 48999999999999999998 789998877655544


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+... +.                           ..++...+..+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         233 FVMEG-GL---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHcC-Cc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33321 00                           00123468899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.2e-42  Score=311.78  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=195.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      |.+-.++|++.+.||+|+||.||+|.+..     +++.||+|++....     ....+|+.++..+ +|+||+++++++.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            44556799999999999999999997543     45789999885432     2334799999999 8999999998774


Q ss_pred             ecCCCCceeEEEEeccccc-hHHHHHHhhhh-------------------------------------------------
Q 018619           75 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS-------------------------------------------------  104 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-------------------------------------------------  104 (353)
                      ..    ...++++|||+++ +|.+.+.....                                                 
T Consensus        82 ~~----~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (337)
T cd05054          82 KP----GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE  157 (337)
T ss_pred             cC----CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence            32    2347899999985 66666543211                                                 


Q ss_pred             --------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC---ccee
Q 018619          105 --------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISY  173 (353)
Q Consensus       105 --------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~  173 (353)
                              ...++++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++........   ....
T Consensus       158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~  235 (337)
T cd05054         158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDA  235 (337)
T ss_pred             cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCC
Confidence                    12368999999999999999999999 79999999999999996 78899999999986543322   1223


Q ss_pred             eeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCC
Q 018619          174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ  252 (353)
Q Consensus       174 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
                      .++..|+|||++.+. .++.++||||+||++|+|++ |..||.+....+.....+.....                    
T Consensus       236 ~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------  294 (337)
T cd05054         236 RLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--------------------  294 (337)
T ss_pred             CCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC--------------------
Confidence            446779999998664 58999999999999999997 99999775543333322221000                    


Q ss_pred             CCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                             ...+...++++.+++.+||+.+|++||++.++++|
T Consensus       295 -------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         295 -------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   00123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.3e-42  Score=306.81  Aligned_cols=251  Identities=24%  Similarity=0.331  Sum_probs=194.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcE--EEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      ++-++|.+.+.||+|+||.||+|.+..++..  +++|.+....     ..+.+|+.++..+ +||||+++++++     .
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~   78 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----E   78 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----C
Confidence            4567899999999999999999998877764  5777664321     2345799999999 899999999987     3


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                      ....+|+||||++ ++|.+.+.....            ....+++..++.++.|++.||+|||+ +|++||||||+|||+
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili  157 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV  157 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEe
Confidence            3445889999998 577766654221            12468999999999999999999999 799999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE  225 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~  225 (353)
                      +. ++.+||+|||++..............+..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+....
T Consensus       158 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  235 (303)
T cd05088         158 GE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  235 (303)
T ss_pred             cC-CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            96 78899999999864322111112233567999998855 448899999999999999998 9999987765544332


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +...                  .          ....+..+++++.+||.+||+.||++|||+++++++
T Consensus       236 ~~~~------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         236 LPQG------------------Y----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HhcC------------------C----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2110                  0          000122468899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-43  Score=318.59  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=205.7

Q ss_pred             cee-eEeeeeecCCCeEEEEEEECCCCcEEEEEEe-----ecc---ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           11 ISY-MAERVVGTGSFGIVFQAKCLETGETVAIKKV-----LQD---RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        11 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-----~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ++| +...+||+|+|-+||+|.|..+|..||--.+     .+.   ...+..|+.+|+.|+||||++++..|.+...   
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---  115 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---  115 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---
Confidence            344 6677999999999999999999999884322     222   2456689999999999999999999866544   


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+.+|+|++.++   .|..|++..+++....++.|++||+.||.|||++ .-|+|||||-+||+|+...|.|||+|+|+
T Consensus       116 ~~in~iTEL~TSG---tLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  116 KTINFITELFTSG---TLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             ceeeeeeecccCC---cHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence            4577999999843   3344445678889999999999999999999993 35999999999999998889999999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |......... ..+|||.|||||+..  ..|+..+||||||+.+.||+|+..||.......++++.+.--..|  ..   
T Consensus       193 Atl~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP--~s---  264 (632)
T KOG0584|consen  193 ATLLRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP--AA---  264 (632)
T ss_pred             HHHhhccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH--HH---
Confidence            9876544433 479999999999985  469999999999999999999999998877666655544321111  11   


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                           |.+--.+++++||.+||.. .++|+|+.|+|.||||..-
T Consensus       265 ---------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 ---------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ---------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                                 1122378999999999999 9999999999999999874

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.1e-42  Score=303.32  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +...+|.+.+.||+|+||.||++.+.     .++..+|+|.+....    ....+|+.+++.++||||+++++++.    
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   77 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV----   77 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence            46789999999999999999999863     345679999886432    23567999999999999999999873    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                       ....+++||||++ ++|.+.+....         .....+++..+..++.|++.||+|||+ +|++||||||+||+++.
T Consensus        78 -~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~  155 (288)
T cd05093          78 -EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE  155 (288)
T ss_pred             -cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEcc
Confidence             3345889999998 56666665321         122358999999999999999999999 89999999999999996


Q ss_pred             CCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 018619          149 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  224 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  224 (353)
                       ++.+||+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+...
T Consensus       156 -~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~  233 (288)
T cd05093         156 -NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE  233 (288)
T ss_pred             -CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             78899999999986543221   112334678999999865 458999999999999999998 999998877665554


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .+......                            ..+...+.++.+|+.+||+.||.+|||+.+++
T Consensus       234 ~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         234 CITQGRVL----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             HHHcCCcC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            44331000                            01134688999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-43  Score=317.62  Aligned_cols=267  Identities=26%  Similarity=0.427  Sum_probs=210.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..-|..++.||-|+||.|.+++...|...||+|.+.+..       .-.+.|.+||..-+++-||+++-.|     ++..
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkd  702 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKD  702 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCC
Confidence            345788899999999999999999999999999886542       2234688999999999999998887     5555


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+||+|++| ++..+|.    ..+-|.|..++.++.+|..|+++.|. -|+|||||||+|||||. +|.|||+|||+|
T Consensus       703 nLYFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDr-dGHIKLTDFGLC  776 (1034)
T KOG0608|consen  703 NLYFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDR-DGHIKLTDFGLC  776 (1034)
T ss_pred             ceEEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEcc-CCceeeeecccc
Confidence            69999999995 5554444    45889999999999999999999999 49999999999999996 888999999998


Q ss_pred             ccccc---------C-----------------C-----------------CcceeeeeceeeChhhhhCCCCCCccccch
Q 018619          162 KQLIA---------G-----------------E-----------------ANISYICSRFYRAPELIFGATEYTTSIDIW  198 (353)
Q Consensus       162 ~~~~~---------~-----------------~-----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  198 (353)
                      .-+..         +                 .                 .....+||+.|+|||++.. ..|+..+|+|
T Consensus       777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdww  855 (1034)
T KOG0608|consen  777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWW  855 (1034)
T ss_pred             ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhh
Confidence            63210         0                 0                 0013478999999999965 4599999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhc
Q 018619          199 SAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL  278 (353)
Q Consensus       199 SlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  278 (353)
                      |.|||||+|+.|++||...+..+...+++++..             +..+            ....++|.++.++|.++.
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-------------~l~~------------~~~~~ls~e~~~li~kLc  910 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRN-------------FLHI------------PYQGNLSKEALDLIQKLC  910 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-------------cccc------------ccccccCHHHHHHHHHHh
Confidence            999999999999999988887666555544211             1111            112468999999999876


Q ss_pred             CcCCCCCCC---HHHHhcCcccccccCCCCCCCCCCCCC
Q 018619          279 QYSPSLRCT---ALEACAHPFFDELREPNARLPNGRPLP  314 (353)
Q Consensus       279 ~~dp~~R~t---~~~~l~hp~f~~~~~~~~~~~~~~~~~  314 (353)
                      . +++.|+.   ++|+..||||+.+.+.+.+......+|
T Consensus       911 ~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP  948 (1034)
T KOG0608|consen  911 C-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIP  948 (1034)
T ss_pred             c-ChhhhhcccchhhhhcCccccccchHhhhhccCCcCc
Confidence            5 7899984   678999999999887654443333343

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.6e-42  Score=303.79  Aligned_cols=256  Identities=26%  Similarity=0.462  Sum_probs=201.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619           12 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +|++.+.||.|+||.||+|.+.   .+|+.||+|.+....        ....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            5899999999999999999875   478999999886421        2345799999999 589999998887     4


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+||||+++ +|.+.+.    ....+++..+..++.|++.||.|||+ .|++||||+|+||+++. ++.+||+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECC-CCCEEEeeC
Confidence            44568899999995 5555554    34678999999999999999999999 79999999999999996 789999999


Q ss_pred             ccccccccCCC--cceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          159 GSAKQLIAGEA--NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       159 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      |++........  .....++..|+|||.+.+. ..++.++||||+|+++|+|++|..||...+.......+.+.....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            99976544322  2235678899999998543 346789999999999999999999997543322222222211000  


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                                             ...++..+++.+.+++++||+.||.+|+     ++++++.||||+..++.
T Consensus       228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~  277 (290)
T cd05613         228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD  277 (290)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence                                   0012235788999999999999999997     88999999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.8e-42  Score=300.72  Aligned_cols=249  Identities=27%  Similarity=0.420  Sum_probs=200.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +-|.+.+.||+|+||.||++.+..+++.||+|.+....     ....+|+.+++.++||||+++++.+.     .....|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~   78 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW   78 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEE
Confidence            45788899999999999999999999999999875322     23457999999999999999999883     344588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ ++.+.+.     ...+++..+..++.|++.|+.+||+ +|++|+||+|+||+++. ++.++|+|||++...
T Consensus        79 lv~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~  151 (277)
T cd06641          79 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAGQL  151 (277)
T ss_pred             EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECC-CCCEEEeecccceec
Confidence            99999986 5554443     3568999999999999999999999 89999999999999996 788999999998765


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....++..|+|||.+.+ ...+.++|+||+||++|+|++|..||...+.......+... ..           
T Consensus       152 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~-----------  218 (277)
T cd06641         152 TDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP-----------  218 (277)
T ss_pred             ccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC-----------
Confidence            43322 223457888999999854 34788999999999999999999999876654433322110 00           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                      ..+...++.++.++|.+||+.||.+||++.++++||||.+.
T Consensus       219 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         219 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             ----------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence                            00223478899999999999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.5e-42  Score=303.22  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=198.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +..++|.+.+.||+|+||.||+|.+..     +++.||+|.+....     ....+|+++++.++||||+++++++... 
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-   80 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-   80 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-
Confidence            346789999999999999999998743     46789999886532     3456799999999999999999988443 


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhh----------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYS----------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~----------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                          ...++||||+. ++|.+.+....          .....+++..+..++.|++.|+++||+ +|++||||||+||++
T Consensus        81 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili  155 (280)
T cd05049          81 ----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLV  155 (280)
T ss_pred             ----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEE
Confidence                44889999998 46666665421          123558899999999999999999999 799999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  222 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  222 (353)
                      +. ++.+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+.
T Consensus       156 ~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~  233 (280)
T cd05049         156 GY-DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV  233 (280)
T ss_pred             cC-CCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            96 78999999999875433221   1233457789999998654 48999999999999999998 9999988776655


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ...+...  ..                          ...+..++..+.+++++||+.||++|||+.|+++
T Consensus       234 ~~~~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         234 IECITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            5443321  00                          0012347889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.5e-41  Score=305.20  Aligned_cols=249  Identities=30%  Similarity=0.437  Sum_probs=203.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ..|...+.||+|+||.||++++..++..||+|.+....       ....+|+.+++.++|||++++++++..     ...
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~   99 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHT   99 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCe
Confidence            45888999999999999999999999999999886432       134578999999999999999998843     334


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .++||||+.|++.+.+..   ...++++..+..++.|++.||.|||+ +|++|+||+|+||+++. ++.+||+|||++..
T Consensus       100 ~~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~  174 (317)
T cd06635         100 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTE-PGQVKLADFGSASI  174 (317)
T ss_pred             EEEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECC-CCCEEEecCCCccc
Confidence            889999999987766643   34568999999999999999999999 79999999999999986 78899999999875


Q ss_pred             cccCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          164 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...   .....+++.|+|||.+..  ...++.++|+||+||++|+|++|..||...+.......+......+.       
T Consensus       175 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-------  244 (317)
T cd06635         175 ASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL-------  244 (317)
T ss_pred             cCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-------
Confidence            432   223467888999999742  23478899999999999999999999988776665555443211000       


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                          .....++.++++|.+||+.||.+||++.++++|||+..
T Consensus       245 --------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         245 --------------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             --------------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                                01236788999999999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.4e-42  Score=305.36  Aligned_cols=251  Identities=28%  Similarity=0.430  Sum_probs=203.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ...|...+.||+|++|.||++++..+++.+|+|.+....       ....+|+.+++.++|+|++++.+++..     ..
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   88 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH   88 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CC
Confidence            456888899999999999999999999999999885321       123479999999999999999998843     34


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ..++||||+.+++...+..   ....+++..++.++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||++.
T Consensus        89 ~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~  163 (308)
T cd06634          89 TAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSAS  163 (308)
T ss_pred             eeEEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECC-CCcEEECCcccce
Confidence            5889999999887766643   34568999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          163 QLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .....   ....+++.|+|||.+.+  ...++.++||||+||++|+|++|..||...+..+....+..... +.      
T Consensus       164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~------  233 (308)
T cd06634         164 IMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PA------  233 (308)
T ss_pred             eecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-CC------
Confidence            54332   23467889999999753  23478899999999999999999999977665554443332100 00      


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                          ......+..+.+||++||+.+|.+||+++++++|||+...
T Consensus       234 --------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         234 --------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             --------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence                                0012468899999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.4e-42  Score=301.67  Aligned_cols=246  Identities=33%  Similarity=0.584  Sum_probs=202.6

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcC-CCceeecceeeeecCCCCce
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ++|.+.+.||+|++|.||++.+..+++.||+|++.+..       ....+|..+++.++ ||||+++++++     .+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence            47999999999999999999999999999999886421       23457889999998 99999999987     4444


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+++||++. ++|.+.+..    .+.+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~-~~~~~l~df~~~  149 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDK-DMHIKITDFGTA  149 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECC-CCCEEecCCccc
Confidence            5889999995 677666653    4579999999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCC---------------------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH
Q 018619          162 KQLIAGEA---------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  220 (353)
Q Consensus       162 ~~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  220 (353)
                      ........                     .....++..|+|||.+.+. .++.++|+||+|++++++++|..||...+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  228 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY  228 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            76543221                     1223567889999998554 4888999999999999999999999887755


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH----HHHhcCcc
Q 018619          221 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPF  296 (353)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~~~l~hp~  296 (353)
                      .....+...                 .            ..++..+++.+.+||.+||+.||.+|||+    .++++|||
T Consensus       229 ~~~~~~~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         229 LTFQKILKL-----------------E------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             HHHHHHHhc-----------------C------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence            544443321                 0            01223568899999999999999999999    99999999


Q ss_pred             c
Q 018619          297 F  297 (353)
Q Consensus       297 f  297 (353)
                      |
T Consensus       280 ~  280 (280)
T cd05581         280 F  280 (280)
T ss_pred             C
Confidence            8

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.9e-42  Score=333.42  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=193.6

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..+.       ....+|+.+++.++||||+++++++.     ....
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            68999999999999999999999999999999986431       23457999999999999999998873     3345


Q ss_pred             EEEEeccccc-hHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~-------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                      .|++|||++| +|.+.+.....       ....++...+..++.|++.||+|||+ +||+||||||+||+++. ++.+||
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~-dg~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGL-FGEVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcC-CCCEEE
Confidence            8899999985 66666653211       12345677788999999999999999 79999999999999996 788999


Q ss_pred             eeeccccccccCC-------------------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCC
Q 018619          156 CDFGSAKQLIAGE-------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG  216 (353)
Q Consensus       156 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~  216 (353)
                      +|||++.......                   ......||+.|+|||.+.+. .++.++||||+||++|+|++|..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999998652110                   01124689999999998664 489999999999999999999999977


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          217 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+.......  .....+..                   ..+     ...+++.+.+++.+||+.||++|++..+.+.+
T Consensus       234 ~~~~ki~~~--~~i~~P~~-------------------~~p-----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        234 KKGRKISYR--DVILSPIE-------------------VAP-----YREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             cchhhhhhh--hhccChhh-------------------ccc-----cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            554332211  11111000                   000     12478899999999999999999987766644

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.7e-41  Score=292.23  Aligned_cols=248  Identities=30%  Similarity=0.497  Sum_probs=202.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .|++.+.||+|++|.||++.+..+++.+++|++....    ....+|+.+++.++|+|++++++.+..     ....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence            4889999999999999999998899999999986554    345689999999999999999998833     3458899


Q ss_pred             ecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      +||++ ++|.+.+..   ....+++..++.++.|++.||++||+ +|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEcc-CCeEEEeeccccccccc
Confidence            99999 566555543   22578999999999999999999999 79999999999999996 78899999999987655


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      ........++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+........... ..+.            
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------  216 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------  216 (253)
T ss_pred             cccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC------------
Confidence            4433456678899999998654 4789999999999999999999999877654444332220 0000            


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                         .+          ....++..+.++|.+||+.||++|||+.+++.|||
T Consensus       217 ---~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         217 ---LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ---cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence               00          00124789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.3e-42  Score=298.33  Aligned_cols=249  Identities=25%  Similarity=0.459  Sum_probs=198.8

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|.+.+.||+|+||.||++++..++..+++|.+...         .....+|+.+++.++||||+++++.+..     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence            689999999999999999999888777777665321         1123468899999999999999988743     33


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..++||||+.+ ++...+.........+++..++.++.|++.||.|||+ +|++|+||+|+||+++.  +.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~~--~~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLKN--NLLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEeec--CCEeecccCce
Confidence            48899999985 7766666555566789999999999999999999999 79999999999999974  56999999998


Q ss_pred             cccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+...  ..       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~-------  222 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT-------  222 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-------
Confidence            76544322 223457888999999854 44788999999999999999999999776654444333220  00       


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                         ..++..++.++.++|.+||+.||++||++.++++||||
T Consensus       223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence                               00123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-41  Score=296.41  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=197.4

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |.+..++|++.+.||+|++|.||+|... ++..||+|.+....   ....+|+.+++.++|+||+++++++     ....
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   74 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEE   74 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCC
Confidence            3466789999999999999999999864 56779999876432   3445799999999999999998887     3334


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+++|||+. ++|.+.+..  .....+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~  150 (261)
T cd05072          75 PIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSE-SLMCKIADFGLA  150 (261)
T ss_pred             CcEEEEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecC-CCcEEECCCccc
Confidence            4889999997 577666643  234568889999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      .........  ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||...+..+....+.+....      
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------  223 (261)
T cd05072         151 RVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------  223 (261)
T ss_pred             eecCCCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            865432211  123346679999998654 48889999999999999998 99999887766655444321100      


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                            .....++.++.+++.+||+.||++|||++++.
T Consensus       224 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  255 (261)
T cd05072         224 ----------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQ  255 (261)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence                                  01134788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-41  Score=298.19  Aligned_cols=251  Identities=25%  Similarity=0.321  Sum_probs=198.1

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeec
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFST   76 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (353)
                      .+..++|++.+.||+|+||.||++.+...     +..||+|.+....     ....+|+.+++.++||||+++++++.  
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--   79 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--   79 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc--
Confidence            45678999999999999999999987644     3789999885442     23457899999999999999999883  


Q ss_pred             CCCCceeEEEEecccc-chHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC
Q 018619           77 TSKNELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL  149 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~  149 (353)
                         .....++||||++ ++|.+.+.....      ....+++..+..++.|++.||.|||+ ++++||||||+||+++. 
T Consensus        80 ---~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~-  154 (277)
T cd05032          80 ---TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAE-  154 (277)
T ss_pred             ---CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcC-
Confidence               3345889999997 577777654322      12347888999999999999999999 79999999999999996 


Q ss_pred             CCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 018619          150 THQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE  225 (353)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~  225 (353)
                      ++.+||+|||+++.......   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  233 (277)
T cd05032         155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF  233 (277)
T ss_pred             CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence            78899999999875543321   1223457789999998554 48999999999999999998 9999988776555443


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +... ..                           ..++...+.++.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         234 VIDG-GH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HhcC-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3210 00                           0012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.7e-41  Score=300.60  Aligned_cols=256  Identities=29%  Similarity=0.460  Sum_probs=207.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..+.|++.+.||+|++|.||++.+..+++.|++|.+....   ....+|+.+++.++|+|++++++.+...     ...|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEE
Confidence            3567999999999999999999999899999999987543   3456799999999999999999988443     4588


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++||++ ++|.+.+...   ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++. ++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcC-CCCEEECccchhhhh
Confidence            9999999 5777766542   1379999999999999999999999 79999999999999996 788999999998755


Q ss_pred             ccCCCc-ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...... ....++..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+... +.+..        
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~--------  236 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPPL--------  236 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCCC--------
Confidence            433221 233567889999998654 5899999999999999999999999877665544433221 00000        


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                       .....++.++.++|.+||+.||.+|||+.+++.||||++..
T Consensus       237 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         237 -----------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             -----------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence                             00123688999999999999999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-41  Score=295.48  Aligned_cols=246  Identities=20%  Similarity=0.290  Sum_probs=194.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ...+|.+.+.||+|++|.||++.+.. +..+|+|.+....   ....+|+.+++.++||||+++++++.     ....++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIY   75 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcE
Confidence            45789999999999999999998653 4569999886442   23467999999999999999999873     233478


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||.+...
T Consensus        76 lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~  150 (256)
T cd05113          76 IVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYV  150 (256)
T ss_pred             EEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCCEEECCCccceec
Confidence            99999985 56655543   23468999999999999999999999 79999999999999996 788999999998765


Q ss_pred             ccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+....+.+....         
T Consensus       151 ~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------  220 (256)
T cd05113         151 LDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------  220 (256)
T ss_pred             CCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC---------
Confidence            433221  122345679999998654 48899999999999999998 99999877765554444331110         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                         ..+...+..+.+++.+||+.||.+|||+.+++.+
T Consensus       221 -------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         221 -------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence                               0112357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.2e-41  Score=322.66  Aligned_cols=281  Identities=20%  Similarity=0.262  Sum_probs=185.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCC----CcEEEEEEeeccccchHHHHHHHHH---cCCCceeecceeeeecCC-C
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLET----GETVAIKKVLQDRRYKNRELQLMRV---MDHPNVISLKHCFFSTTS-K   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l~~---l~h~~iv~~~~~~~~~~~-~   79 (353)
                      +..++|.+.+.||+|+||.||+|.+..+    +..||+|++.....   .|..+...   ..+.++..+...+..... .
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence            3567999999999999999999999988    89999998754322   22222222   223334433333322221 3


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhh----------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCC
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSS----------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ  142 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~----------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~  142 (353)
                      ....+++|+||+++ +|.+.+.....                .........++.++.||+.||+|||+ ++|+||||||+
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHRDLKP~  284 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHRDVKPQ  284 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeCcCCHH
Confidence            44458899999985 66666643110                01112345577899999999999999 79999999999


Q ss_pred             cEEEeCCCCcEEEeeeccccccccCC--CcceeeeeceeeChhhhhCCC---------------------CCCccccchh
Q 018619          143 NLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGAT---------------------EYTTSIDIWS  199 (353)
Q Consensus       143 Nill~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwS  199 (353)
                      |||++.+++.+||+|||+|+......  ......+|+.|+|||.+....                     .+..++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            99999656789999999998654322  223567899999999763321                     1334569999


Q ss_pred             HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCcccc--ccCCCCChhHHHHHHHh
Q 018619          200 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK--VFHKRMPPEAIDLASRL  277 (353)
Q Consensus       200 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  277 (353)
                      +||++|+|+++..++  .+....+..++...+... ..+.......        .......  .+....+..+.|||.+|
T Consensus       365 lGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        365 AGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDL-VAWRKLVEPR--------ASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             HHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcH-HHHHHhhccc--------cchhhhhhhhhccccchHHHHHHHHH
Confidence            999999999876553  333334444444333221 1111111000        0000000  01112345677999999


Q ss_pred             cCcCCCCCCCHHHHhcCcccccccCC
Q 018619          278 LQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       278 L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      |++||.+|||+.++|+||||+.....
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            99999999999999999999875443

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-41  Score=292.97  Aligned_cols=246  Identities=33%  Similarity=0.572  Sum_probs=202.8

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+.....      ...+|+++++.++|||++++++++.     .....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            58999999999999999999999999999998865432      3458999999999999999988873     334588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|||+++ +|.+.+.    ....+++..++.++.|++.||.+||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTK-DGVVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECC-CCCEEEeccccceec
Confidence            99999986 5555544    34679999999999999999999999 79999999999999996 788999999999866


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+........... .            
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~------------  215 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-D------------  215 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-C------------
Confidence            54433 23356788899999986544 889999999999999999999999876654443332210 0            


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                     ...++..++..+.+++.+||..||++|||+.++++||||
T Consensus       216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         216 ---------------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence                           011234578999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-41  Score=302.27  Aligned_cols=251  Identities=27%  Similarity=0.416  Sum_probs=199.7

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      |.....||+|+||.||++.+..+++.||+|++....    ....+|+.+++.++|+|++++++.+..     ....+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence            344568999999999999999999999999874322    234579999999999999999998843     34588999


Q ss_pred             ccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+++ ++.+.+.     ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||++......
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCCEEEcccccceecccc
Confidence            99986 4444332     3568999999999999999999999 79999999999999996 788999999998755433


Q ss_pred             CC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 EA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      .. .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+.......             
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  235 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-------------  235 (292)
T ss_pred             cccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-------------
Confidence            22 233567889999998854 457899999999999999999999998776655543332211000             


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                   ......++.++.+++.+||+.||.+||++.+++.||||.....
T Consensus       236 -------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         236 -------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             -------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence                         0011246889999999999999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.5e-41  Score=305.17  Aligned_cols=248  Identities=26%  Similarity=0.377  Sum_probs=194.4

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcE----EEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ++...+|++.+.||+|+||.||+|.+..+++.    ||+|.+....     ....+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-   81 (316)
T cd05108           3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   81 (316)
T ss_pred             ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence            46678899999999999999999998766654    8999885332     2345789999999999999999887431 


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                           ..++++||+. |+|.+.+..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus        82 -----~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~-~~~~kl~  151 (316)
T cd05108          82 -----TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKT-PQHVKIT  151 (316)
T ss_pred             -----CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecC-CCcEEEc
Confidence                 2568999998 566666653   23568899999999999999999999 79999999999999996 7889999


Q ss_pred             eeccccccccCCCcc---eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||+++.........   ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.. .+......
T Consensus       152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~  229 (316)
T cd05108         152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGER  229 (316)
T ss_pred             cccccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCC
Confidence            999998665433322   12335679999998654 58999999999999999997 99999876654432 22221000


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +                 +          .+...+.++.+++.+||+.||++|||+.+++.+
T Consensus       230 ~-----------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         230 L-----------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             C-----------------C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0                 0          112367889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.6e-41  Score=294.54  Aligned_cols=245  Identities=21%  Similarity=0.295  Sum_probs=194.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..++|++.+.||+|+||.||++..+ .+..+|+|.+....   ....+|+.+++.++||||+++++++.     ....++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLY   75 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEE
Confidence            3467999999999999999999864 45689999876432   34567999999999999999998873     334488


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||++ ++|.+.+..   ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||.+...
T Consensus        76 iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~  150 (256)
T cd05114          76 IVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYV  150 (256)
T ss_pred             EEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcC-CCeEEECCCCCcccc
Confidence            9999998 566665543   23468999999999999999999999 79999999999999996 788999999998765


Q ss_pred             ccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.||...+..+....+.+....         
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------  220 (256)
T cd05114         151 LDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------  220 (256)
T ss_pred             CCCceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC---------
Confidence            332221  122345679999998654 58999999999999999999 89999888776665554331000         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                         ..+...+.++.+++.+||+.||++|||++++++
T Consensus       221 -------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         221 -------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             -------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                               011235778999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-41  Score=302.61  Aligned_cols=248  Identities=23%  Similarity=0.310  Sum_probs=192.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeeeecCCCCce
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ++|++.+.||+|+||.||+|....++.  .+++|.+....     ....+|+.++.++ +||||+++++++     ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            579999999999999999999877765  46888775321     2345799999888 799999999987     3334


Q ss_pred             eEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL  149 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~  149 (353)
                      .+|++|||++ ++|.+.+.....            ....+++..++.++.|++.||+|||+ +|++||||||+||+++. 
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~-  154 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGE-  154 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECC-
Confidence            5889999998 577777654221            12358899999999999999999999 89999999999999996 


Q ss_pred             CCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 018619          150 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  228 (353)
                      ++.+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+..
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         155 NLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             CCeEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            788999999998643221111112224569999998554 48999999999999999997 9999988776655544322


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ...                            ...+..++.++.+|+.+||+.||.+|||++++++.
T Consensus       234 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            100                            01123478899999999999999999999999755

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4e-41  Score=293.18  Aligned_cols=250  Identities=33%  Similarity=0.516  Sum_probs=201.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+....      ....+|+.+++.++||||+++++.+....   ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            5889999999999999999999999999999886543      24567999999999999999988874321   24588


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++||++ ++|.+.+..    ...+++..++.++.|++.||+|||+ +|++|+||+|+||+++. ++.++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDS-DGVVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcC-CCCEEEcccccEEec
Confidence            9999996 566555543    3489999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .....   .....++..|+|||.+.+. ..+.++|+||+|+++|+|++|..||...+....  .......          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence            65543   3445678899999998554 489999999999999999999999987662211  1111000          


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                    ......++..++..+.++|.+||+.||++||++.++++||||
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence                          000111334568999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.9e-41  Score=295.30  Aligned_cols=246  Identities=26%  Similarity=0.314  Sum_probs=194.4

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+..++|++.+.||+|+||.||+|.+..+ ..||+|.+....   ....+|+.+++.++||||+++++.+.     . ..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~   74 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EP   74 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CC
Confidence            45678999999999999999999998655 469999886533   23568999999999999999987651     1 22


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++||||+++ +|.+.+...  ....+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.+||+|||.+.
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~  150 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLAR  150 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcC-CCcEEeccCCcee
Confidence            6799999985 776666532  23467899999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........  ....++..|+|||...+. .++.++|+||+||++|+|++ |..||.+....+....+......       
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------  222 (262)
T cd05071         151 LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------  222 (262)
T ss_pred             eccccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-------
Confidence            65433221  123456789999988554 48999999999999999999 88999877765554433221000       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                           .....++..+.+++.+||+.||++|||+.+++
T Consensus       223 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~  254 (262)
T cd05071         223 ---------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQ  254 (262)
T ss_pred             ---------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence                                 01134788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-41  Score=296.73  Aligned_cols=251  Identities=22%  Similarity=0.280  Sum_probs=194.7

Q ss_pred             eeEeeeeecCCCeEEEEEEECC---CCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCce
Q 018619           13 YMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL   82 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~   82 (353)
                      |.+.+.||+|+||.||.|....   ++..||+|.+..+.      ....+|+.+++.++||||+++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5788999999999999998765   34789999886432      234578999999999999999987754433 3334


Q ss_pred             eEEEEecccc-chHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~--~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ..+++|||+. ++|...+.....  ....+++..++.++.|++.||.|||+ ++++||||||+||++++ ++.+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLRE-DMTVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECC-CCeEEECCcc
Confidence            5789999998 466666543221  23468999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          160 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       160 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +++........   ....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+.+..+....+.....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----  233 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR----  233 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            99865433221   11234567999999854 458999999999999999999 8999988776555433322100    


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                              ...+..++.++.+++.+||+.||++|||+.+++.+
T Consensus       234 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         234 ------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             ------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                    00123578899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=342.35  Aligned_cols=254  Identities=28%  Similarity=0.477  Sum_probs=204.9

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      -+|.-...||.|.||.||.|.+..+|+..|+|.+.-+      .....+|..++..++|||+|+++++=.     ++..+
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-----HRekv 1309 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-----HREKV 1309 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----cHHHH
Confidence            3566677999999999999999999999999977422      233458999999999999999988753     33348


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +|.||||.+ +|.+.+.+    ++..++...+.+..|++.|+.|||+ +|||||||||.||+++. +|.+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~-~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDF-NGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeec-CCcEEeecccceeE
Confidence            899999995 55555543    4557788888899999999999999 79999999999999996 88999999999987


Q ss_pred             cccCC-----CcceeeeeceeeChhhhhCCC--CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          164 LIAGE-----ANISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       164 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +....     ......||+.|||||++.+..  ....+.||||+||++.||+||+.||...+..=.+--.+.....|.  
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq-- 1461 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ-- 1461 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC--
Confidence            76543     234678999999999997753  356799999999999999999999987665433322222222221  


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                               +|.++|++.+|||.+||+.||.+|.++.|++.|-|-+.-.+
T Consensus      1462 -------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1462 -------------------------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             -------------------------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence                                     44569999999999999999999999999999998776443

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.2e-41  Score=297.46  Aligned_cols=252  Identities=20%  Similarity=0.278  Sum_probs=196.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +..++|.+.+.||+|++|.||+|.+..     ++..||+|.+....     ..+.+|+.+++.++|+||+++++++... 
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-   81 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-   81 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence            356889999999999999999999987     77889999875432     2345789999999999999999887432 


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CC
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--TH  151 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~  151 (353)
                          ...++||||+. ++|.+.+.....   ....+++..+..++.||+.||+|||+ ++++|+||||+||+++..  +.
T Consensus        82 ----~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          82 ----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             ----CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCc
Confidence                34789999997 577776654321   12358999999999999999999999 799999999999999852  23


Q ss_pred             cEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018619          152 QVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  227 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  227 (353)
                      .+||+|||+++........   .....+..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~  235 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT  235 (277)
T ss_pred             ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            6999999999865322211   112234679999998654 48999999999999999996 999998877665443322


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .. ..                           ..++..++..+.+++.+||+.||++|||+.++++|
T Consensus       236 ~~-~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         236 GG-GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cC-Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            21 00                           01123578899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.6e-41  Score=292.46  Aligned_cols=247  Identities=22%  Similarity=0.315  Sum_probs=196.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      |.+...+|.+.+.||+|++|.||++..  .|..||+|.+..+..  ...+|+.+++.++|+|+++++++++..    ...
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~   74 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG   74 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCc
Confidence            456778999999999999999999976  478899998865432  345899999999999999998876432    224


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||+++ +|.+.+...  ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~  150 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTK  150 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcC-CCcEEecCCccce
Confidence            7899999984 776666531  23458899999999999999999999 79999999999999996 8889999999987


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  ....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+....+.+..           
T Consensus       151 ~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------  216 (256)
T cd05082         151 EASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY-----------  216 (256)
T ss_pred             eccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-----------
Confidence            543322  22334567999999855 458899999999999999997 999998776555443332210           


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                       ....+..+++.+.+++.+||+.||++|||+.++++
T Consensus       217 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         217 -----------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                             01122357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.8e-41  Score=293.16  Aligned_cols=248  Identities=30%  Similarity=0.490  Sum_probs=197.5

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|++|.||+|.+..+|+.||+|.+...       .....+|+.+++.++|+|++++++.+..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            6899999999999999999999999999999987531       2345589999999999999999998843     345


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||+++ +|...+.........+++..+..++.|++.||.|||+ .|++|+||+|+||+++. ++.++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITA-TGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECC-CCcEEEeccceee
Confidence            8899999984 7777776554556678999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--DQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  239 (353)
                      ....... .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||......  +....+...          
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----------  223 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence            6543322 2345678899999998654 4889999999999999999999999654321  111111110          


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                               ..+.        .....++.++.++|.+||..+|++|||+.++++
T Consensus       224 ---------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         224 ---------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             ---------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                     0000        001246789999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.5e-41  Score=309.69  Aligned_cols=253  Identities=25%  Similarity=0.373  Sum_probs=194.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHHcC-CCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~   74 (353)
                      +....++|++.+.||+|+||.||+|.+...     +..||||++....     ....+|+.++..++ ||||+++++++ 
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~-  110 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC-  110 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-
Confidence            445578899999999999999999987433     3469999886432     23457999999996 99999999988 


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh-------------------------------------------------
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------------------------  104 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------------------------------------  104 (353)
                          .....+|+|||||+ |+|.+.+.....                                                 
T Consensus       111 ----~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         111 ----TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             ----ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence                33445899999998 567666543210                                                 


Q ss_pred             -------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCC
Q 018619          105 -------------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP  141 (353)
Q Consensus       105 -------------------------------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp  141 (353)
                                                                 ....+++..+..++.|++.||+|||+ ++|+||||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp  265 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAA  265 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCh
Confidence                                                       12357888899999999999999999 7999999999


Q ss_pred             CcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 018619          142 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE  217 (353)
Q Consensus       142 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~  217 (353)
                      +|||++. ++.+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||...
T Consensus       266 ~Nill~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         266 RNVLLAQ-GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             HhEEEeC-CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999996 78899999999986543322   1223456789999998654 48999999999999999997 99999876


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ...+.....+.....                           ...+..++.++.+++.+||+.||++|||+.++.+
T Consensus       344 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         344 IVDSTFYNKIKSGYR---------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             chhHHHHHHHhcCCC---------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            544333332221000                           0012347889999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.7e-41  Score=328.64  Aligned_cols=142  Identities=23%  Similarity=0.381  Sum_probs=122.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .++|.+.+.||.|+||.||+|.+..+++.||||++.+..       ....+|+.++..++||||++++.++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            468999999999999999999999999999999986532       3456789999999999999998877     3344


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+||||+.+ +|...+..    .+.+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~-~g~vkL~DFGls  151 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISN-EGHIKLTDFGLS  151 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcC-CCCEEEEeCCCC
Confidence            58999999974 66665543    4568999999999999999999999 79999999999999996 788999999987


Q ss_pred             c
Q 018619          162 K  162 (353)
Q Consensus       162 ~  162 (353)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-41  Score=297.36  Aligned_cols=248  Identities=29%  Similarity=0.473  Sum_probs=195.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|++|.||++.+..+++.||+|.+...       .....+|+.+++.++||||+++++++..     ...
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            5789999999999999999999999999999987532       1234579999999999999999998843     334


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~-~~~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEECcchhhh
Confidence            8899999985 6776666544455678999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ....... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.... ....+......         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------  224 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD---------  224 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC---------
Confidence            6543322 2234678899999998654 4889999999999999999999999754432 11111111000         


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                               .+        .......++++.++|.+||+.||++|||+.+++
T Consensus       225 ---------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~  259 (267)
T cd08229         225 ---------YP--------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVY  259 (267)
T ss_pred             ---------CC--------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHH
Confidence                     00        001124788999999999999999999999775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.8e-41  Score=293.63  Aligned_cols=238  Identities=22%  Similarity=0.321  Sum_probs=186.2

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      +.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ...+++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCCeEEEEeec
Confidence            46899999999999999999999999875432     335679999999999999999998833     34488999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                      .+ +|.+.+..   ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++.........
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcC-CCcEEECccccCccccccccc
Confidence            85 55555532   34568999999999999999999999 79999999999999996 788999999998754322111


Q ss_pred             c---eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          171 I---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       171 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      .   ....+..|+|||.+.+. .++.++|+||+||++|+|++ |..||...........+.....               
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~---------------  214 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR---------------  214 (252)
T ss_pred             ccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------------
Confidence            1   11224569999998554 48899999999999999997 8999977665443332221100               


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                   ..++...+..+.+|+.+||+.||++|||+.++++
T Consensus       215 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         215 -------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             -------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                         0112346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.9e-41  Score=298.62  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=197.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeeee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFS   75 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~   75 (353)
                      -+..++|.+.+.||+|+||.||++.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++++. 
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-   86 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-   86 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-
Confidence            45678999999999999999999987644     3789999886432     2245799999999 8999999999873 


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCC
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQ  142 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~  142 (353)
                          ....++++|||+. ++|...+....            .....+++..+..++.|++.||+|||+ ++|+||||||+
T Consensus        87 ----~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~  161 (293)
T cd05053          87 ----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAAR  161 (293)
T ss_pred             ----CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCcccccccee
Confidence                3344889999998 57766665421            234678999999999999999999999 79999999999


Q ss_pred             cEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCC
Q 018619          143 NLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGEN  218 (353)
Q Consensus       143 Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~  218 (353)
                      ||+++. ++.+||+|||+++........   ....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+..
T Consensus       162 Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~  239 (293)
T cd05053         162 NVLVTE-DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP  239 (293)
T ss_pred             eEEEcC-CCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence            999996 889999999999865433211   11223567999999855 458999999999999999997 999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          219 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ..+....+.....                            ...+...+.++.+|+.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         240 VEELFKLLKEGYR----------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6555443322100                            00123468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.5e-41  Score=298.07  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=194.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEEC----CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      -..|++.+.||+|+||+||+|...    .+++.||+|.+....     ..+.+|+.+++.++||||+++++++.     .
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~   78 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----Q   78 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----c
Confidence            367899999999999999999853    456789999886422     34567999999999999999998873     3


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhh-------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSS-------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~-------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                      ....|++|||+++ +|.+.+.....             ....+++..+..++.|++.||+|||+ +|++|+||||+||++
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili  157 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILI  157 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEE
Confidence            3348899999984 66666542110             12357889999999999999999999 799999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  222 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  222 (353)
                      +. ++.+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+.
T Consensus       158 ~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~  235 (283)
T cd05090         158 GE-QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV  235 (283)
T ss_pred             cC-CCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            96 78899999999986543321   1223446679999998654 48999999999999999998 9999987765544


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ...+... ..+                           ..+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       236 ~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         236 IEMVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            4333221 000                           0123478899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-41  Score=293.24  Aligned_cols=246  Identities=24%  Similarity=0.317  Sum_probs=195.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +..++|++.+.||+|++|.||++.+. +++.||+|.+....   ....+|+.+++.++||||+++++++.     .....
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPI   76 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCe
Confidence            45788999999999999999999864 45789999886532   34567999999999999999998773     33347


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |++|||+. ++|.+.+...  ....+++..+..++.|++.||.+||+ +|++|+||||+||+++. ++.+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~  152 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGE-NNICKVADFGLARV  152 (261)
T ss_pred             eeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcC-CCCEEECCcceEEE
Confidence            89999995 6777666542  23568999999999999999999999 79999999999999996 78899999999986


Q ss_pred             cccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .......  .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |+.||.+.+.......+.+....        
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------  223 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM--------  223 (261)
T ss_pred             ccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence            6532211  11122457999998855 458999999999999999999 99999887766555444321100        


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                          ..+...+..+.+++.+||+.||.+||++.+++
T Consensus       224 --------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~  255 (261)
T cd05068         224 --------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQ  255 (261)
T ss_pred             --------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence                                01234688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-41  Score=300.26  Aligned_cols=250  Identities=22%  Similarity=0.279  Sum_probs=195.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ...+|++.+.||+|+||.||++.+..+     ++.||+|++....     ..+.+|+.++..++||||+++++++.    
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~----   78 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT----   78 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc----
Confidence            345789999999999999999987543     5789999986443     23457889999999999999999873    


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEE
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL  145 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nil  145 (353)
                       .....++++||+.+ +|...+....            .....+++..+..++.|++.||+|||+ +|++||||||+||+
T Consensus        79 -~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil  156 (283)
T cd05091          79 -KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVL  156 (283)
T ss_pred             -CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheE
Confidence             33347899999984 5655553211            112458889999999999999999999 79999999999999


Q ss_pred             EeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHH
Q 018619          146 VDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVD  221 (353)
Q Consensus       146 l~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~  221 (353)
                      ++. ++.+||+|||+++........   ....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||.+....+
T Consensus       157 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  234 (283)
T cd05091         157 VFD-KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  234 (283)
T ss_pred             ecC-CCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            995 778999999998765432221   123346789999998654 48999999999999999998 889998877666


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ....+......                            .++..++..+.+|+.+||+.||.+||+++++++.
T Consensus       235 ~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         235 VIEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            55544431100                            1224578899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-41  Score=291.85  Aligned_cols=242  Identities=27%  Similarity=0.402  Sum_probs=196.4

Q ss_pred             eeeecCCCeEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|.+...   +..|++|.+....     ....+|+.+++.++|+|++++++++..     ...++++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4789999999999998866   8899999886543     344579999999999999999988843     44588999


Q ss_pred             cccc-chHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           89 EYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        89 e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ||+. ++|.+.+......     ...+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~-~~~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGE-DLVVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECC-CCcEEEccccccc
Confidence            9995 6777776653211     4779999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          163 QLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       163 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ......   ......++..|+|||.+.+. .++.++||||+||++|+|++ |..||...+..+....+...         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------  223 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------  223 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence            765442   12334568889999998654 58999999999999999998 69999888765555443321         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                         +....+..+++++.+++.+||+.||++|||+.++++|
T Consensus       224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                               0011223568999999999999999999999999865

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=292.50  Aligned_cols=247  Identities=24%  Similarity=0.310  Sum_probs=195.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ..++|.+.+.||+|+||.||+|....+   ...||+|.+....     ....+|+.+++.++||||+++++.+.     .
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   76 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----K   76 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----c
Confidence            467899999999999999999998654   4579999875432     23346999999999999999999873     3


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....+++|||+.+ +|.+.+..   ..+.+++..+..++.|++.||+|||+ ++|+|+||||+||+++. ++.++|+|||
T Consensus        77 ~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~-~~~~~l~dfg  151 (266)
T cd05033          77 SRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFG  151 (266)
T ss_pred             CCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCCEEECccc
Confidence            3448899999985 66655543   23578999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCc-c--eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          160 SAKQLIAGEAN-I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       160 ~a~~~~~~~~~-~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      ++......... .  ...++..|+|||.+.+ ..++.++||||+|+++|+|++ |..||......+....+.+....+  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~--  228 (266)
T cd05033         152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP--  228 (266)
T ss_pred             hhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence            99876422221 1  1223567999999855 458999999999999999997 999998776655544333210000  


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                                .+...++.+.+++.+||+.||++||++.+++++
T Consensus       229 --------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         229 --------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             --------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                      113468899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-44  Score=290.72  Aligned_cols=267  Identities=24%  Similarity=0.353  Sum_probs=210.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHH-HHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQ-LMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      +..++.+-...||.|+||+|++..++.+|+..|+|++....     .++..|.+ +++.-+.||||++++..+...+   
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd---  137 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD---  137 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc---
Confidence            44556667789999999999999999999999999986432     23334555 3444579999999999865544   


Q ss_pred             eeEEEEeccccchHHHHHH-hhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPESMYRVLK-HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~-~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                        .|+.||+|+-++..... -+......++|..+-.+....+.||.||.....|||||+||+|||++. .|.+||||||+
T Consensus       138 --cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFGI  214 (361)
T KOG1006|consen  138 --CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFGI  214 (361)
T ss_pred             --eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecccc
Confidence              88999999976655443 244556789999999999999999999998668999999999999996 88899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCC-CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCHHHH
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPTREEI  238 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  238 (353)
                      |....+.-..+...|...|||||.+.... .|..+||+||||++|||+.||..||.+.++  ...++... .|.|+.-..
T Consensus       215 cGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  215 CGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             hHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC
Confidence            98877766666778999999999985543 389999999999999999999999987665  33333322 122221100


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                           +..                --..+..+..||.-||.+|-+.||.-.+++.+||++.....
T Consensus       293 -----~~~----------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  293 -----DKE----------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             -----ccc----------------ccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence                 000                01378899999999999999999999999999999876544

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=292.17  Aligned_cols=246  Identities=19%  Similarity=0.283  Sum_probs=194.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ...+|++.+.||+|++|.||++.+. ++..+|+|.+.+..   ....+|+.+++.++||||+++++++     ......|
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIF   75 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceE
Confidence            3467899999999999999999875 56789999886432   2345799999999999999998887     3334588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||+++..
T Consensus        76 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~  150 (256)
T cd05059          76 IVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGE-DNVVKVSDFGLARYV  150 (256)
T ss_pred             EEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECC-CCcEEECCcccceec
Confidence            99999975 66665543   23478999999999999999999999 79999999999999996 788999999998765


Q ss_pred             ccCCCcc--eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .......  ...++..|+|||.+.+. .++.++|+||+||++|+|++ |..||...+..+....+.....          
T Consensus       151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  219 (256)
T cd05059         151 LDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR----------  219 (256)
T ss_pred             ccccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc----------
Confidence            4322111  12234579999998654 48999999999999999998 8999987776555443322100          


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                        ...+...+.++.+++.+||+.+|++|||+.++++.
T Consensus       220 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         220 ------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                              01123468899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8e-41  Score=299.26  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=195.4

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECC-------CCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeeccee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHC   72 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~   72 (353)
                      +.+..++|.+.+.||+|+||.||++++..       +...+|+|.+..+.     ....+|+.+++.+ +||||++++++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            44567899999999999999999998653       23569999886532     2344689999999 79999999998


Q ss_pred             eeecCCCCceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           73 FFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      +.     .....|+||||++ ++|.+.+.....            ....+++..+..++.|++.||+|||+ +|++||||
T Consensus        93 ~~-----~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dl  166 (307)
T cd05098          93 CT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDL  166 (307)
T ss_pred             Ee-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccc
Confidence            73     3345889999998 577777754321            12358899999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+||+++. ++.+||+|||.+.........   ....+++.|+|||.+.+. .++.++|+||+||++|+|++ |..||.
T Consensus       167 kp~Nill~~-~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         167 AARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             cHHheEEcC-CCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999996 788999999998765432211   112234679999998654 48999999999999999998 889997


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +.+..+....+... .                           ...++..++.++.+|+.+||..+|++|||+.+++++
T Consensus       245 ~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         245 GVPVEELFKLLKEG-H---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             cCCHHHHHHHHHcC-C---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            76654433322210 0                           001223578899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1e-40  Score=295.09  Aligned_cols=258  Identities=28%  Similarity=0.366  Sum_probs=189.7

Q ss_pred             cee-eEeeeeecCCCeEEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619           11 ISY-MAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        11 ~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ++| .+.+.||+|+||+||++.    ...+++.||+|.+....     ....+|+.+++.++||||+++++++..   ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~   79 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QG   79 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence            455 999999999999998865    33568899999886432     234579999999999999999887643   22


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...++++|||+++ +|.+.+..     ..+++..++.++.|++.||+|||+ +|++|+||||+||++++ ++.+||+|||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~~l~dfg  152 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDN-DRLVKIGDFG  152 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcC-CCcEEEeecc
Confidence            3457899999995 55555532     469999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCC
Q 018619          160 SAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~  234 (353)
                      ++.........    ....++..|+|||.+.+. .++.++|||||||++|+|++|..||......  ....... .+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~  229 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMT  229 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccc
Confidence            99865443221    122346679999998654 4899999999999999999999998654421  1111110 00000


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ...+..            ..........+...+.++.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         230 VVRLIE------------LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhhh------------hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000            00001111123457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.1e-40  Score=296.23  Aligned_cols=248  Identities=24%  Similarity=0.345  Sum_probs=194.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      ...+|.+.+.||+|+||.||++++..     ++..+++|.+....    ....+|+.+++.++||||+++++++.     
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   77 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----   77 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----
Confidence            35679999999999999999998643     45678999885442    34568999999999999999999873     


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                      .....++||||++ ++|.+.+.....            ....+++..++.++.||+.||+|||+ +|++||||||+||++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~  156 (291)
T cd05094          78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLV  156 (291)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEE
Confidence            3345889999997 577666654221            22458999999999999999999999 899999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  222 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  222 (353)
                      +. ++.++|+|||++........   .....++..|+|||.+.+. .++.++||||+||++|+|++ |..||...+..+.
T Consensus       157 ~~-~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  234 (291)
T cd05094         157 GA-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV  234 (291)
T ss_pred             cc-CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            96 78899999999976543321   1233457789999998654 48899999999999999998 9999988776554


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      ...+...  ..                 +         ..+...+..+.+++.+||+.||++|||+.+++
T Consensus       235 ~~~~~~~--~~-----------------~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~  276 (291)
T cd05094         235 IECITQG--RV-----------------L---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIY  276 (291)
T ss_pred             HHHHhCC--CC-----------------C---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence            4332210  00                 0         01124688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.4e-41  Score=294.61  Aligned_cols=251  Identities=21%  Similarity=0.263  Sum_probs=192.0

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCc--EEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCC-CCcee
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF   83 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~   83 (353)
                      +.+.+.||+|+||.||++....++.  .||+|.+...      .....+|+.+++.++||||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3578899999999999999877765  6899987543      2234578999999999999999987654322 22234


Q ss_pred             EEEEecccc-chHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      .+++|||+. ++|...+....  .....+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNE-NMNVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcC-CCCEEECCCCc
Confidence            679999998 56665553221  123458999999999999999999999 89999999999999996 78899999999


Q ss_pred             ccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          161 AKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       161 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +........   .....+++.|+|||.+.+ ..++.++||||+||++|+|++ |..||.+....+....+.+...     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR-----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            986543322   112234677999999855 458999999999999999999 8999988766554433322100     


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                             ...+..++..+.++|.+||+.||.+|||+++++++
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                                   00123467889999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.5e-41  Score=294.47  Aligned_cols=245  Identities=24%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..+|.+.+.||.|++|.||+|.+.. ++.+|+|.+....    ....+|+.+++.++||||+++++.+.     .....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            4679999999999999999999877 8899999886543    23457999999999999999988873     334488


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+++ +|.+.+...  ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGE-DLVCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcC-CceEEEccccchhhc
Confidence            99999985 777766542  34568999999999999999999999 79999999999999996 788999999999765


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+.+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------  223 (261)
T ss_pred             CCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence            43221 112334678999999855 458899999999999999998 89999887766665554431110          


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                        ..+...++.+.+++.+||+.||.+|||+.++++
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                              012347889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-41  Score=290.38  Aligned_cols=238  Identities=34%  Similarity=0.578  Sum_probs=196.1

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ||+|++|.||++.+..+++.||+|.+.+..       ....+|+.+++.++|||++++++.+     ......|++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            699999999999999899999999886532       2445789999999999999999887     4455689999999


Q ss_pred             c-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC-C
Q 018619           92 P-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-A  169 (353)
Q Consensus        92 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~  169 (353)
                      . ++|.+.+..    ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++. ++.++|+|||.+....... .
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCc
Confidence            5 566666543    4578999999999999999999999 79999999999999996 7889999999998654432 2


Q ss_pred             cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCc
Q 018619          170 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR  249 (353)
Q Consensus       170 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
                      .....++..|+|||...+. ..+.++|+||+|+++|+|++|..||...+.......+..  .               .  
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~---------------~--  209 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D---------------P--  209 (250)
T ss_pred             ccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C---------------C--
Confidence            3345678889999998654 478899999999999999999999987766444333322  0               0  


Q ss_pred             CCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH---HHHhcCccc
Q 018619          250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF  297 (353)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~~~l~hp~f  297 (353)
                                ..++..++.++.++|++||..||++|||+   .++++||||
T Consensus       210 ----------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         210 ----------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence                      01234468899999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.8e-41  Score=291.86  Aligned_cols=246  Identities=25%  Similarity=0.324  Sum_probs=194.5

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+..++|++.+.||+|++|.||+|.+. .+..+|+|.+....   ....+|+.+++.++|+|++++++.+.     . ..
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~   74 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EP   74 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CC
Confidence            355788999999999999999999865 56679999886532   34568999999999999999988652     1 12


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||+.+ +|.+.+..  .....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||++.
T Consensus        75 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~-~~~~~l~dfg~~~  150 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGD-GLVCKIADFGLAR  150 (260)
T ss_pred             cEEEEEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeC-CceEEeCCceeee
Confidence            6799999985 66666643  234568999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+......       
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------  222 (260)
T cd05070         151 LIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM-------  222 (260)
T ss_pred             eccCcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence            65433211  122345679999998554 48899999999999999999 89999887766555444321000       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                           ..+...+..+.+|+.+||+.||++|||+++++
T Consensus       223 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         223 ---------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                                 01234688999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=290.55  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=196.7

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+..++|++.+.||+|++|.||++..  .|+.||+|.+.....   ...+|+.+++.++|+||+++++.+..     ...
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   74 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNP   74 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCC
Confidence            35678999999999999999999986  488999999976543   45579999999999999999998743     334


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++||||++ ++|.+.+...  ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.+.
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~-~~~~~l~d~g~~~  150 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSE-DLVAKVSDFGLAK  150 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeC-CCCEEEccccccc
Confidence            889999998 5777666532  22368999999999999999999999 89999999999999996 8889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .......  ....+..|+|||.+.+. .++.++|+||+|+++|+|++ |..||...+..+....+...            
T Consensus       151 ~~~~~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------------  215 (256)
T cd05039         151 EASQGQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG------------  215 (256)
T ss_pred             ccccccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC------------
Confidence            6633222  23345679999998554 48889999999999999997 99999877655543332221            


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                      +....+...++++.++|.+||..+|++|||+.+++.
T Consensus       216 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         216 ----------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             ----------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                            000112346899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-40  Score=296.79  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=196.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      +.+..++|.+.+.||+|+||.||++.+.     .++..||+|.+....     ....+|+.+++.+ +||||+++++.+.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            4566789999999999999999999753     345689999886432     2345799999999 7999999999873


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                           ....++++|||+. ++|.+.+..  .....+++..+..++.|++.||+|||+ ++|+|+||||+||+++. ++.+
T Consensus       110 -----~~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~  180 (302)
T cd05055         110 -----IGGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTH-GKIV  180 (302)
T ss_pred             -----cCCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcC-CCeE
Confidence                 3334889999998 566666643  122348999999999999999999999 79999999999999985 7889


Q ss_pred             EEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 018619          154 KICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV  229 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  229 (353)
                      +|+|||++.........   ....++..|+|||.+.+. .++.++||||+||++|+|++ |..||......+........
T Consensus       181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~  259 (302)
T cd05055         181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE  259 (302)
T ss_pred             EECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence            99999999865433221   122346789999998654 48999999999999999998 99999877655544333321


Q ss_pred             hCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..                           ....+...++++.+++.+||..||++|||+.++++
T Consensus       260 ~~---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         260 GY---------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CC---------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            00                           00012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.4e-40  Score=289.19  Aligned_cols=245  Identities=25%  Similarity=0.314  Sum_probs=193.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +..++|++.+.||+|++|.||++.+..+ ..+|+|.+....   ....+|+.+++.++|||++++++++.     . ...
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~   75 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPI   75 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCc
Confidence            4568899999999999999999987655 469999876443   23457999999999999999987762     1 236


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +++|||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||||+||++++ ++.++|+|||++..
T Consensus        76 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~  151 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGD-NLVCKIADFGLARL  151 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcC-CCeEEECCCccceE
Confidence            799999985 777776542  23458899999999999999999999 79999999999999996 78899999999976


Q ss_pred             cccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .......  ....++..|+|||...+. .++.++|+||+||++|+|++ |..||.+....+....+.....         
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---------  221 (260)
T cd05069         152 IEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---------  221 (260)
T ss_pred             ccCCcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence            5332211  123456779999988554 48999999999999999999 9999988776655544332100         


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                         ...+...+..+.+++++||+.||.+||++++++
T Consensus       222 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  254 (260)
T cd05069         222 -------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQ  254 (260)
T ss_pred             -------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHH
Confidence                               011234688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.1e-40  Score=294.34  Aligned_cols=247  Identities=24%  Similarity=0.328  Sum_probs=193.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ++...+|++.+.||+|+||+||+|.+..+++    .||+|.+....     ....+|+.+++.++||||+++++.+..  
T Consensus         3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   80 (279)
T cd05109           3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--   80 (279)
T ss_pred             ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--
Confidence            5677899999999999999999999877776    48999875332     234578899999999999999887732  


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                          ...++++||++ |++.+.+..   ....+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.+||+
T Consensus        81 ----~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~-~~~~kL~  151 (279)
T cd05109          81 ----STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKS-PNHVKIT  151 (279)
T ss_pred             ----CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcC-CCcEEEC
Confidence                12568999998 576666543   24578999999999999999999999 79999999999999985 7789999


Q ss_pred             eeccccccccCCCcc---eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||+++.........   ...+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.......... .+.....
T Consensus       152 dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~  229 (279)
T cd05109         152 DFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGER  229 (279)
T ss_pred             CCCceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCc
Confidence            999998664333221   12346679999998654 48999999999999999998 999997766544332 2221110


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ++                           .+...+.++.++|.+||+.||++|||+.++++
T Consensus       230 ~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         230 LP---------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CC---------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00                           11246889999999999999999999999983

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-40  Score=296.22  Aligned_cols=256  Identities=20%  Similarity=0.242  Sum_probs=195.7

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCC----------------cEEEEEEeeccc-----cchHHHHHHHHHcCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETG----------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVI   67 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv   67 (353)
                      ...+|++.+.||+|+||.||+|.+..++                ..||+|.+....     ....+|+.+++.++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            4578999999999999999999876544                558999886542     2345799999999999999


Q ss_pred             ecceeeeecCCCCceeEEEEecccc-chHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           68 SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      ++++++..     ....+++||++. ++|...+.....       ....+++..++.++.|++.||+|||+ +|++|+||
T Consensus        83 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dl  156 (296)
T cd05051          83 RLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDL  156 (296)
T ss_pred             EEEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCcccccc
Confidence            99988733     345889999998 467666654321       12368999999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh--CCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLF  214 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~--g~~pf  214 (353)
                      ||+||+++. ++.++|+|||++........   .....+++.|+|||.+.+. .++.++||||+||++|+|++  |..||
T Consensus       157 kp~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~  234 (296)
T cd05051         157 ATRNCLVGK-NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPY  234 (296)
T ss_pred             chhceeecC-CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCC
Confidence            999999996 78899999999876533321   1223456789999998654 48999999999999999998  77888


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          215 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ...+..+.+............                     ......+...+.++.+++.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         235 EHLTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCcChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            776665554444332111000                     0000012346789999999999999999999999953

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-40  Score=290.40  Aligned_cols=247  Identities=25%  Similarity=0.324  Sum_probs=196.1

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      -+..++|++.+.||+|+||.||+|.. .+++.||+|.+....   ....+|+.+++.++|+|++++++.+.     . ..
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~   74 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EP   74 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CC
Confidence            35678999999999999999999985 467889999886543   34467999999999999999988652     1 23


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||+. ++|.+.+..  ..+..+++..+..++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||++.
T Consensus        75 ~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~  150 (260)
T cd05067          75 IYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSE-TLCCKIADFGLAR  150 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcC-CCCEEEccCccee
Confidence            789999997 466666543  234578999999999999999999999 79999999999999996 7889999999997


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........  ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |.+||.+.+..+....+......       
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------  222 (260)
T cd05067         151 LIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------  222 (260)
T ss_pred             ecCCCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-------
Confidence            65422211  123346789999998554 48899999999999999998 99999887765554443221110       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                           ..+...+.++.++|.+||+.||++|||++++++
T Consensus       223 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         223 ---------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                                 012346889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-40  Score=291.76  Aligned_cols=246  Identities=24%  Similarity=0.311  Sum_probs=193.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...+|.+.+.||+|+||.||+|.++.++.   .+|+|.+....     ....+|+.+++.++||||+++++++.     .
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   76 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----K   76 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----c
Confidence            45789999999999999999999875543   79999885432     34467999999999999999998873     3


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||+++ +|.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~-~~~~~l~dfg  151 (267)
T cd05066          77 SKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNS-NLVCKVSDFG  151 (267)
T ss_pred             CCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECC-CCeEEeCCCC
Confidence            3458899999985 56655543   23568999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCcc----eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          160 SAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      ++..........    ...++..|+|||.+.+. .++.++|+||+||++|++++ |..||...+..+....+.+....  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~--  228 (267)
T cd05066         152 LSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL--  228 (267)
T ss_pred             cccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC--
Confidence            998654432211    11224679999998654 48999999999999999886 99999887765554444321100  


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                                ..+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       229 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         229 --------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence                                      011246889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-40  Score=295.63  Aligned_cols=256  Identities=29%  Similarity=0.467  Sum_probs=197.5

Q ss_pred             eeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619           12 SYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +|.+.+.||+|++|.||++.+.   .+++.||+|.+.+..        ....+|+.++..+ +||||+++++.+     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4889999999999999999864   467889999886421        2345789999999 599999999887     3


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+||||+.+ +|.+.+.    ....+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~-~~~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDS-EGHVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECC-CCCEEEEEC
Confidence            44458899999985 5555543    34578999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCC--cceeeeeceeeChhhhhCCC-CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          159 GSAKQLIAGEA--NISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       159 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+.......+.+.....  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  227 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence            99876543322  12345788999999985532 36789999999999999999999996543322222221110000  


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC---HHHHhcCcccccccCC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPFFDELREP  303 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~~~l~hp~f~~~~~~  303 (353)
                                             ....+..++.++.++|.+||+.||++|||   +.++|+||||+.+.+.
T Consensus       228 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         228 -----------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             -----------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence                                   00122347889999999999999999998   5678999999987653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5e-42  Score=309.04  Aligned_cols=251  Identities=22%  Similarity=0.297  Sum_probs=197.5

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      .|.+-.+...+...||+|.||+||++++-   ..||||++..+      .+.+++|+.++++-+|.||+-+.+++     
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----  457 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----  457 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----
Confidence            35566677889999999999999999863   36999999643      34567899999999999999998887     


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .... +.||+.+|.| +|+..+..   ....|.....+.|+.|++.|+.|||. ++|||||||..||++.+ +++|||+|
T Consensus       458 ~~p~-~AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~-~~kVkIgD  531 (678)
T KOG0193|consen  458 MNPP-LAIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHE-DLKVKIGD  531 (678)
T ss_pred             cCCc-eeeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEcc-CCcEEEec
Confidence            3333 3799999997 66666654   34679999999999999999999999 89999999999999996 79999999


Q ss_pred             eccccccc---cCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          158 FGSAKQLI---AGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       158 fg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      ||++..-.   .........|...|||||+++.  ..+|++.||||||||++|||++|..||...+....+.++-+....
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~  611 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM  611 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC
Confidence            99987432   2222334556788999999853  346899999999999999999999999955444333332221112


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      |....                        ...+.+.++++|+..||.+++++||+..++|.
T Consensus       612 pd~s~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  612 PDLSK------------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             ccchh------------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            22111                        22456789999999999999999999998874

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-40  Score=293.85  Aligned_cols=249  Identities=25%  Similarity=0.356  Sum_probs=194.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      ...+|.+.+.||+|+||.||++...     .++..+|+|.+....    ....+|+.+++.++|+||+++++.+.     
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   77 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----   77 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----
Confidence            4578999999999999999999753     356789999875432    34567999999999999999988773     


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD  147 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~  147 (353)
                      .....+++|||+. ++|.+.+.....           ....+++..+..++.|++.||+|||+ +|++|+||||+||+++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~  156 (280)
T cd05092          78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVG  156 (280)
T ss_pred             cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEc
Confidence            3334889999998 467666654211           11358899999999999999999999 7999999999999999


Q ss_pred             CCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHH
Q 018619          148 PLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQL  223 (353)
Q Consensus       148 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~  223 (353)
                      . ++.+||+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |.+||......+..
T Consensus       157 ~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  234 (280)
T cd05092         157 Q-GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI  234 (280)
T ss_pred             C-CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            6 78899999999875533221   1123346789999998654 48999999999999999998 99999877766555


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          224 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..+.....                            ...+..+++.+.++|.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         235 ECITQGRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            44332100                            0112347889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.3e-40  Score=296.15  Aligned_cols=251  Identities=24%  Similarity=0.343  Sum_probs=195.0

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECC-------CCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCF   73 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~   73 (353)
                      .+..++|.+.+.||+|+||.||+|.+..       ....+|+|.+....     ....+|+.+++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            4556899999999999999999998642       34579999876432     2345799999999 699999999987


Q ss_pred             eecCCCCceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCC
Q 018619           74 FSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK  140 (353)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlk  140 (353)
                      .     ....+|++|||+. ++|.+.+.....            ....+++..+..++.|++.||.|||+ +|++|||||
T Consensus        88 ~-----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlk  161 (314)
T cd05099          88 T-----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLA  161 (314)
T ss_pred             c-----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecccc
Confidence            3     3345889999998 577777754321            23468999999999999999999999 899999999


Q ss_pred             CCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 018619          141 PQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG  216 (353)
Q Consensus       141 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  216 (353)
                      |+||+++. ++.+||+|||+++........   ....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+
T Consensus       162 p~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         162 ARNVLVTE-DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             ceeEEEcC-CCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence            99999996 788999999999865432211   11223457999999865 458999999999999999998 8999988


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          217 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .+..+....+....                            ...++..++.++.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         240 IPVEELFKLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCHHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            77655554332210                            00112356889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=289.96  Aligned_cols=247  Identities=26%  Similarity=0.349  Sum_probs=197.2

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      -+..++|++.+.||+|++|.||+|.+. .++.||+|.+....   ....+|+.+++.++|+||+++++++.     ....
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   75 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEP   75 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCc
Confidence            356789999999999999999999975 55789999886542   34568999999999999999998873     3334


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||+.+ +|.+.+..  .....+++..+..++.|++.|+.|||+ +|++|+||||+||+++. ++.+||+|||++.
T Consensus        76 ~~~v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~  151 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGE-NLVCKIADFGLAR  151 (261)
T ss_pred             eEEEEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcC-CCCEEECccccce
Confidence            8899999985 66666643  223568999999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........  .....+..|+|||.+.+. .++.++|+||+||++|+|++ |+.||.+.+.......+......+      
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------  224 (261)
T cd05034         152 LIEDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------  224 (261)
T ss_pred             eccchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            65432111  122335679999998654 48999999999999999998 999998877666555543311100      


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                            .+...+.++.+++.+||+.||.+||++++++
T Consensus       225 ----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         225 ----------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             ----------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence                                  1123578999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-40  Score=290.56  Aligned_cols=247  Identities=22%  Similarity=0.307  Sum_probs=194.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|+..+.||+|++|.||+|.+..+++   .+|+|.+....     .....|+.+++.++|||++++.+++.     
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   76 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----   76 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----
Confidence            346789999999999999999999876654   79999885432     23457899999999999999998883     


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      .....++||||+++ +|...+..   ....+++..+..++.|++.|++|||+ +|++|+||||+||+++. ++.+||+||
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~df  151 (268)
T cd05063          77 KFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNS-NLECKVSDF  151 (268)
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcC-CCcEEECCC
Confidence            33347899999995 55555432   34678999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCCcc----eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |++..........    ....+..|+|||.+.+. .++.++|+||+||++|+|++ |..||...+..+....+......+
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~  230 (268)
T cd05063         152 GLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP  230 (268)
T ss_pred             ccceecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence            9987654332211    11224569999998654 48899999999999999997 999998877665554443211110


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                                  .....+.++.+++.+||+.||++||++.++++
T Consensus       231 ----------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         231 ----------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             ----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                                        01246889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-40  Score=295.91  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=197.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeeccee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHC   72 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~   72 (353)
                      +.+..++|.+.+.||+|+||.||+|++.       ..+..||+|.+....     ....+|+.+++.+ +||||+++++.
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            4577889999999999999999999753       234579999885432     2355799999999 89999999998


Q ss_pred             eeecCCCCceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           73 FFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      +.     .....|++|||+. ++|.+.+.....            ....+++..+..++.|++.||+|||+ +|++||||
T Consensus        90 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dl  163 (304)
T cd05101          90 CT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDL  163 (304)
T ss_pred             Ee-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeeccc
Confidence            73     3345889999998 477777654321            12457888999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+||+++. ++.+||+|||+++........   ....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.
T Consensus       164 kp~Nili~~-~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         164 AARNVLVTE-NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             ccceEEEcC-CCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            999999996 788999999999865433221   122346789999998654 58999999999999999998 889998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +.+..+....+.....                            ...+..++.++.+|+.+||+.+|.+|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         242 GIPVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             cCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            7776555443322100                            00123578899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-40  Score=302.21  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=193.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      |.+..++|++.+.||+|+||.||+|.+     ..+++.||||.+....     ....+|+.++..+ +||||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            455678999999999999999999984     3467899999886432     2345799999999 6899999998774


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh-------------------------------------------------
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------------------------  104 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------------------------------------  104 (353)
                      ..    ...++++||||+ |+|.+.+.....                                                 
T Consensus        82 ~~----~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (343)
T cd05103          82 KP----GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS  157 (343)
T ss_pred             cC----CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence            32    234789999998 466666543210                                                 


Q ss_pred             --------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619          105 --------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus       105 --------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                                    ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~  235 (343)
T cd05103         158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDY  235 (343)
T ss_pred             cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcC-CCcEEEEecccccccccCcch
Confidence                          01347888889999999999999999 79999999999999996 788999999998765332211


Q ss_pred             ---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          171 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       171 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                         ....++..|+|||.+.+. .++.++||||+||++|+|++ |..||..................              
T Consensus       236 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------------  300 (343)
T cd05103         236 VRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--------------  300 (343)
T ss_pred             hhcCCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC--------------
Confidence               112345679999998654 48999999999999999996 99999775443322222211000              


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                   ...+...++++.+++.+||+.||.+|||+.++++|
T Consensus       301 -------------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         301 -------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                         00112367889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=286.08  Aligned_cols=258  Identities=25%  Similarity=0.426  Sum_probs=209.1

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTS   78 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   78 (353)
                      .+.-.+|.+.++||+|+|.+|-+++.+.|.+.||+|++++.-       ...+.|..+..+- +||.+|.++.+|     
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----  320 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----  320 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----
Confidence            345578999999999999999999999999999999886532       2234566666554 799999999998     


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      +.+..+++|.||++|+   .+..+......++++.++.+..+|+.||.|||+ +||++||||.+|+|+|. .+.+||+|+
T Consensus       321 qtesrlffvieyv~gg---dlmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvllda-eghikltdy  395 (593)
T KOG0695|consen  321 QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDA-EGHIKLTDY  395 (593)
T ss_pred             cccceEEEEEEEecCc---ceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEcc-CCceeeccc
Confidence            6666699999999975   222233456789999999999999999999999 89999999999999997 778999999


Q ss_pred             ccccccc-cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHHh
Q 018619          159 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-------ENAVDQLVEIIKVL  230 (353)
Q Consensus       159 g~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-------~~~~~~~~~~~~~~  230 (353)
                      |.|+.-. ++...++.+|||.|.|||++.|.. |+.++|+|+|||+++||+.|+.||.-       .+..+.+.+++-. 
T Consensus       396 gmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile-  473 (593)
T KOG0695|consen  396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE-  473 (593)
T ss_pred             chhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-
Confidence            9998643 445566789999999999998764 99999999999999999999999952       2223333332210 


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC------HHHHhcCcccccccCC
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPFFDELREP  303 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~~~l~hp~f~~~~~~  303 (353)
                                               +  ...++..+|-.+..+++..|.+||.+|..      ..++..||||+.+.|.
T Consensus       474 -------------------------k--qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd  525 (593)
T KOG0695|consen  474 -------------------------K--QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWD  525 (593)
T ss_pred             -------------------------h--cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHH
Confidence                                     0  11134567888899999999999999985      5799999999988775

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.9e-41  Score=323.61  Aligned_cols=256  Identities=30%  Similarity=0.448  Sum_probs=193.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeec---------
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFST---------   76 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------   76 (353)
                      .+|+..+.||+||||.||+|+++-+|+.||||+++-.     ...+.+|+.+|.+|+|||||+++..|...         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            3567889999999999999999999999999999654     23345899999999999999987544100         


Q ss_pred             ---------------------------------------------C---------C----------------------C-
Q 018619           77 ---------------------------------------------T---------S----------------------K-   79 (353)
Q Consensus        77 ---------------------------------------------~---------~----------------------~-   79 (353)
                                                                   .         +                      + 
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                         0         0                      0 


Q ss_pred             ----------------------------CceeEEEEeccccchHHHHHHhhhhcCCCC-CHHHHHHHHHHHHHHHHHhHc
Q 018619           80 ----------------------------NELFLNLVMEYVPESMYRVLKHYSSANQRM-PLIYVKLYTYQIFRGLAYIHT  130 (353)
Q Consensus        80 ----------------------------~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l-~~~~~~~i~~qll~al~~LH~  130 (353)
                                                  ....+||=||||+.+++..+..   .+... ....+|++++||++||.|+|+
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~---~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIR---RNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHH---hcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                        0056899999999876665543   22222 578899999999999999999


Q ss_pred             CCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc-------------------cCCCcceeeeeceeeChhhhhCCC--
Q 018619          131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------------AGEANISYICSRFYRAPELIFGAT--  189 (353)
Q Consensus       131 ~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~--  189 (353)
                       .|||||||||.||++++ ++.|||+|||+|....                   +....++.+||..|+|||++.+..  
T Consensus       716 -~giIHRDLKP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  716 -QGIIHRDLKPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             -CceeeccCCcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence             69999999999999996 7789999999998611                   011235678999999999996655  


Q ss_pred             CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChh
Q 018619          190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPE  269 (353)
Q Consensus       190 ~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (353)
                      .|+.++|+||||+|++||+.   ||..  ..+.... +..+..+..               |..      ..|..+--+.
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~i-L~~LR~g~i---------------P~~------~~f~~~~~~~  846 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERASI-LTNLRKGSI---------------PEP------ADFFDPEHPE  846 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCc--hHHHHHH-HHhcccCCC---------------CCC------cccccccchH
Confidence            69999999999999999994   4543  2333322 222222211               110      1122223446


Q ss_pred             HHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          270 AIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       270 ~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                      -..+|++||+.||++||||.|+|++.||-
T Consensus       847 e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  847 EASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            67899999999999999999999999996

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.6e-40  Score=290.41  Aligned_cols=246  Identities=24%  Similarity=0.357  Sum_probs=193.2

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +...|.+.+.||+|+||.||+|.++.+++   .||+|.+...     ...+..|+.+++.++||||+++.+++     ..
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~   76 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK   76 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CC
Confidence            34679999999999999999999887665   5999988643     12345799999999999999999887     33


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....++||||+++ +|.+.+..   ..+.+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~-~~~~kl~dfg  151 (269)
T cd05065          77 SRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNS-NLVCKVSDFG  151 (269)
T ss_pred             CCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcC-CCcEEECCCc
Confidence            4458899999985 55555543   24568999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCccee---e---eeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          160 SAKQLIAGEANISY---I---CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       160 ~a~~~~~~~~~~~~---~---~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      ++............   .   .+..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+....+..... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~-  229 (269)
T cd05065         152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR-  229 (269)
T ss_pred             cccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence            98755433221111   1   1357999999855 458999999999999999886 9999988776655444322100 


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                       .+          .+..++..+.+++.+||+.||++||++.+++.
T Consensus       230 -----------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         230 -----------------LP----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             -----------------CC----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                             00          11246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-40  Score=299.20  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=196.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCC-------CcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeeccee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHC   72 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~   72 (353)
                      |.+...+|.+.+.||+|+||.||+|.+...       +..||+|.+....     ....+|+.+++.+ +||||+++++.
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            445667899999999999999999986432       2368999876432     2345799999999 79999999998


Q ss_pred             eeecCCCCceeEEEEeccccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           73 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      +.     ....+++++||+++ +|.+.+.....            ....++...+..++.|++.||+|||+ +|++||||
T Consensus        87 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dl  160 (334)
T cd05100          87 CT-----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDL  160 (334)
T ss_pred             Ec-----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeecccc
Confidence            83     33448899999984 77777654321            23457888899999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+||+++. ++.+||+|||+++........   ....++..|+|||++.+. .++.++||||+||++|+|++ |..||.
T Consensus       161 kp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         161 AARNVLVTE-DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             ccceEEEcC-CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence            999999996 788999999999765432211   112335679999998654 48899999999999999998 889998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +.+..+....+.....                            ...+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         239 GIPVEELFKLLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            8776655444322100                            01123468899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.5e-40  Score=292.21  Aligned_cols=250  Identities=20%  Similarity=0.274  Sum_probs=196.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +.+++|.+.+.||+|+||.||++.+..    ++..|++|.+....     ....+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC--
Confidence            567899999999999999999999875    35789999886432     2345799999999999999999876432  


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSA----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~----~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                        ....+++++|++ ++|...+......    ...+++..++.++.|++.||+|||+ ++++|+||||+||+++. ++.+
T Consensus        81 --~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~  156 (280)
T cd05043          81 --GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDE-ELQV  156 (280)
T ss_pred             --CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcC-CCcE
Confidence              234779999998 5777766543222    1568999999999999999999999 79999999999999996 7889


Q ss_pred             EEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 018619          154 KICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV  229 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  229 (353)
                      ||+|||+++........   ....++..|+|||.+.+. .++.++||||+||++|++++ |..||...+..+....+...
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  235 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG  235 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence            99999999865433221   122346679999998654 48999999999999999998 99999887665543322211


Q ss_pred             hCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .                  ..+          ....+++++.+++.+||+.||++|||+.+++
T Consensus       236 ~------------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~  270 (280)
T cd05043         236 Y------------------RLA----------QPINCPDELFAVMACCWALDPEERPSFSQLV  270 (280)
T ss_pred             C------------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            0                  000          1124688999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.7e-41  Score=290.16  Aligned_cols=228  Identities=25%  Similarity=0.321  Sum_probs=180.7

Q ss_pred             CCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccc-hHHHHHH
Q 018619           22 GSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK  100 (353)
Q Consensus        22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~  100 (353)
                      |.+|.||+|++..+++.||+|.+.+... ..+|...+....||||+++++.+.     ....++++|||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8899999999999999999999976543 334555556667999999999883     33458899999995 6666654


Q ss_pred             hhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceee
Q 018619          101 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR  180 (353)
Q Consensus       101 ~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~  180 (353)
                      .    ...+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++++|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcC-CCCEEEecccchhccccc--cccCCcCcccc
Confidence            3    3468999999999999999999999 79999999999999996 778999999987654332  22334567799


Q ss_pred             ChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCcccc
Q 018619          181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHK  260 (353)
Q Consensus       181 aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (353)
                      |||.+.+ ..++.++|+||+||++|+|++|..||.......      .               ...            ..
T Consensus       150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~---------------~~~------------~~  195 (237)
T cd05576         150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI------N---------------THT------------TL  195 (237)
T ss_pred             CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------c---------------ccc------------cc
Confidence            9998854 457899999999999999999998874322100      0               000            00


Q ss_pred             ccCCCCChhHHHHHHHhcCcCCCCCCCH-----HHHhcCccc
Q 018619          261 VFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFF  297 (353)
Q Consensus       261 ~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~f  297 (353)
                      .++..+++.+.++|.+||+.||++|+|+     +++++||||
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            1234578999999999999999999985     999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.7e-40  Score=288.33  Aligned_cols=234  Identities=26%  Similarity=0.340  Sum_probs=184.3

Q ss_pred             eeecCCCeEEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           18 VVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      .||+|+||.||+|..  ..+++.+|+|++....      ....+|+.+++.++||||+++++.+     .+. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence            689999999999854  4678899999885432      2345789999999999999998865     222 3679999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC
Q 018619           90 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE  168 (353)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  168 (353)
                      |+++ +|.+.+.    ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcC-CCeEEECCCccccccCCCC
Confidence            9995 5655554    34578999999999999999999999 79999999999999996 7889999999998654433


Q ss_pred             Cc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          169 AN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       169 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..    ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||...+..+....+.+..             
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------  215 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------  215 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            21    11223578999998854 458889999999999999998 999998877655544432210             


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                     ...++..+++++.++|.+||+.||++||+++++.
T Consensus       216 ---------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~  249 (257)
T cd05116         216 ---------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE  249 (257)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHH
Confidence                           0012235789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.8e-40  Score=293.35  Aligned_cols=246  Identities=25%  Similarity=0.373  Sum_probs=190.1

Q ss_pred             eeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            47899999999999999998753     23568888875432     23457999999999999999998873     33


Q ss_pred             eeEEEEecccc-chHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCC
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK  140 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlk  140 (353)
                      ...++++||+. ++|.+.+....                    .....+++..++.++.|++.||+|||+ ++++|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhh
Confidence            44789999999 56666654321                    122458899999999999999999999 799999999


Q ss_pred             CCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 018619          141 PQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG  216 (353)
Q Consensus       141 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  216 (353)
                      |+||+++. ++.+||+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus       155 p~nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAE-GRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcC-CCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            99999996 78899999999975533222   112234667999999855 458999999999999999998 9999987


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          217 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ....+.........                            ....+..++.++.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         233 IAPERLFNLLKTGY----------------------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCHHHHHHHHhCCC----------------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            76554433221100                            00112357889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-40  Score=290.89  Aligned_cols=263  Identities=27%  Similarity=0.357  Sum_probs=191.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEE----CCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..+|++.+.||+|+||.||.+..    ..+++.||+|.+....    ..+.+|+.+++.++||||+++++++....   
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   78 (284)
T cd05081           2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---   78 (284)
T ss_pred             ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---
Confidence            456899999999999999999873    4578899999886432    24468999999999999999988764432   


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+++||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~-~~~~~l~dfg  153 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVES-ENRVKIGDFG  153 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECC-CCeEEECCCc
Confidence            234789999997 577666643   23568999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCcc----eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC-CCC
Q 018619          160 SAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG-TPT  234 (353)
Q Consensus       160 ~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~  234 (353)
                      ++..........    ...++..|+|||.+.+. .++.++|+||+||++|+|++|..++...... ....+..... ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~  231 (284)
T cd05081         154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMI  231 (284)
T ss_pred             ccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccc
Confidence            998654432211    11234569999998654 4899999999999999999998776543321 1110000000 000


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ...+......            ......+..++.++.+||.+||+.||++|||+.+++.
T Consensus       232 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         232 VYHLIELLKN------------NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hHHHHHHHhc------------CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            0000000000            0000112357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4e-40  Score=303.26  Aligned_cols=254  Identities=23%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHcC-CCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMD-HPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~~iv~~~~~~~   74 (353)
                      +.+..++|.+.+.||+|+||.||+|++.     .+++.||+|++....     ....+|+.++..+. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4556678999999999999999999854     355789999996542     23457999999997 999999999883


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh-------------------------------------------------
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------------------------------------  104 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------------------------------------  104 (353)
                      .     ...+++|||||. |+|.+.+.....                                                 
T Consensus       112 ~-----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         112 K-----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             c-----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            3     334889999999 577777653211                                                 


Q ss_pred             ---------------------------------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619          105 ---------------------------------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus       105 ---------------------------------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                                                                   ....+++..++.++.|++.||+|||+ ++++||||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdl  265 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDL  265 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccC
Confidence                                                         11246778889999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+|||++. ++.+||+|||+++.......   .....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||.
T Consensus       266 kp~NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         266 AARNVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             CcceEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            999999996 78899999999986433221   1233567889999998654 58999999999999999998 899998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .....+.....+..-.                           ....+..++.++.+|+.+||+.||.+||+++++++.
T Consensus       344 ~~~~~~~~~~~~~~~~---------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         344 ELPMNEQFYNAIKRGY---------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCchHHHHHHHHcCC---------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            7665554433332100                           001223478999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=294.69  Aligned_cols=256  Identities=21%  Similarity=0.258  Sum_probs=192.7

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCC--------------cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeec
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETG--------------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISL   69 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~   69 (353)
                      ..++|++.+.||+|+||.||+|.+..++              ..||+|.+....     ....+|+++++.++|||++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            3578999999999999999999875432              358999886532     234579999999999999999


Q ss_pred             ceeeeecCCCCceeEEEEeccccc-hHHHHHHhhhh--------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCC
Q 018619           70 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK  140 (353)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlk  140 (353)
                      ++++.     .....++||||+.+ +|.+.+.....        ....+++..+..++.|++.||+|||+ +|++|+|||
T Consensus        83 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlk  156 (295)
T cd05097          83 LGVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLA  156 (295)
T ss_pred             EEEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccC
Confidence            99883     33448899999985 66666543210        11247888999999999999999999 799999999


Q ss_pred             CCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh--CCCCCC
Q 018619          141 PQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP  215 (353)
Q Consensus       141 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~--g~~pf~  215 (353)
                      |+||+++. ++.+||+|||++.........   ....++..|+|||.+.+. .++.++|+|||||++|+|++  |..||.
T Consensus       157 p~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~~~~~p~~  234 (295)
T cd05097         157 TRNCLVGN-HYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTLCKEQPYS  234 (295)
T ss_pred             hhhEEEcC-CCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence            99999996 778999999999765333211   122346789999998654 48999999999999999998  678888


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..+..+.+..+.+........       .              ....+...++.+.+|+.+||+.||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         235 LLSDEQVIENTGEFFRNQGRQ-------I--------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             ccChHHHHHHHHHhhhhcccc-------c--------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            777665554433311100000       0              00011246889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.6e-40  Score=290.38  Aligned_cols=257  Identities=17%  Similarity=0.201  Sum_probs=186.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCC---CcEEEEEEeeccccchH---------------HHHHHHHHcCCCceeec
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN---------------RELQLMRVMDHPNVISL   69 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~~iv~~   69 (353)
                      +..++|.+.+.||+|+||.||+|.+..+   +..+|+|..........               .+...+..++|++++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            5578999999999999999999998877   66778775433222211               12233445689999999


Q ss_pred             ceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC
Q 018619           70 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL  149 (353)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~  149 (353)
                      +++..... ....+.+++++++..++.+.+..    ....++..++.++.|++.||+|||+ ++|+||||||+|||++. 
T Consensus        89 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~-  161 (294)
T PHA02882         89 YGCGSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDG-  161 (294)
T ss_pred             EEeeeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-
Confidence            88654332 22334678899887766655543    2345788899999999999999999 79999999999999996 


Q ss_pred             CCcEEEeeeccccccccCC--------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHH
Q 018619          150 THQVKICDFGSAKQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD  221 (353)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  221 (353)
                      ++.++|+|||+|+......        ......||+.|+|||+..+. .++.++||||+||++|+|++|..||.+.+...
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            7889999999998653221        11234689999999998654 58999999999999999999999998774332


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ......+.      ..+..+...  ..             .....++++.++++.|++.+|.+||+.+++++
T Consensus       241 ~~~~~~~~------~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        241 NLIHAAKC------DFIKRLHEG--KI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhHH------HHHHHhhhh--hh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22221110      000000000  00             01246889999999999999999999999863

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.8e-40  Score=288.60  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=196.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +..++|++.+.||+|+||.||+|+.+.     +.+.|++|.+.....     ...+|+.+++.++|+||+++++.+    
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----   77 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC----   77 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE----
Confidence            345789999999999999999999754     346799998854332     356899999999999999999877    


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH  151 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~  151 (353)
                       ......++||||++ ++|.+.+......     ...+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~-~~  154 (275)
T cd05046          78 -REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSS-QR  154 (275)
T ss_pred             -CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeC-CC
Confidence             33445889999998 5776666543211     1268999999999999999999999 79999999999999996 78


Q ss_pred             cEEEeeeccccccccCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 018619          152 QVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  228 (353)
                      .++++|||++.......  ......++..|+|||.+.+. .++.++||||+|+++|+|++ |..||...........+..
T Consensus       155 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~  233 (275)
T cd05046         155 EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA  233 (275)
T ss_pred             cEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence            89999999987543221  12234567789999998654 47899999999999999998 8899977665544433221


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .                 .          +....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus       234 ~-----------------~----------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         234 G-----------------K----------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             C-----------------C----------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            0                 0          0001123578899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=290.44  Aligned_cols=292  Identities=28%  Similarity=0.420  Sum_probs=217.2

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHcC-----C---Cceeecceee
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMD-----H---PNVISLKHCF   73 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~-----h---~~iv~~~~~~   73 (353)
                      +-.+..++|.+.++||=|-|++||+|.+..+.+.||+|+++....   ....|+++|++++     |   .+||++++.|
T Consensus        72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            445667999999999999999999999999999999999876543   3457999999883     2   4799999988


Q ss_pred             eecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC---
Q 018619           74 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---  150 (353)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~---  150 (353)
                      -... .+...+|+|+|+++.+|+..+...  .-..++...++.|++|++.||.|||...||||.||||+|||+...+   
T Consensus       152 khsG-pNG~HVCMVfEvLGdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  152 KHSG-PNGQHVCMVFEVLGDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             eecC-CCCcEEEEEehhhhhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence            5443 556679999999999999998864  4466999999999999999999999977999999999999983100   


Q ss_pred             --------------------------------------------------------------------------------
Q 018619          151 --------------------------------------------------------------------------------  150 (353)
Q Consensus       151 --------------------------------------------------------------------------------  150 (353)
                                                                                                      
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 018619          151 --------------------------------------------------------------------------------  150 (353)
Q Consensus       151 --------------------------------------------------------------------------------  150 (353)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             --CcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCC------CChHHH
Q 018619          151 --HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG------ENAVDQ  222 (353)
Q Consensus       151 --~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~------~~~~~~  222 (353)
                        -+|||+|||.|....  ...+..+.|+.|+|||++.|.. |++.+||||++|+++||+||..+|..      ..+.+.
T Consensus       389 ~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH  465 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH  465 (590)
T ss_pred             cceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence              012223333222111  1111223477799999999876 99999999999999999999999954      346788


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCC----cC---CCCCCCccccccC------CCCChhHHHHHHHhcCcCCCCCCCHH
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDF----RF---PQIKAHPWHKVFH------KRMPPEAIDLASRLLQYSPSLRCTAL  289 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~dp~~R~t~~  289 (353)
                      +..|++.+|..+......-.....-|    .+   ..++..+....+.      ..-..++.||+.-||+++|.+|+||.
T Consensus       466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~  545 (590)
T KOG1290|consen  466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA  545 (590)
T ss_pred             HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence            99999999988876543221111111    11   1112222111111      11234678999999999999999999


Q ss_pred             HHhcCcccccccC
Q 018619          290 EACAHPFFDELRE  302 (353)
Q Consensus       290 ~~l~hp~f~~~~~  302 (353)
                      ++|+|||+..+-.
T Consensus       546 ~cl~hPwLn~~~~  558 (590)
T KOG1290|consen  546 QCLKHPWLNPVAG  558 (590)
T ss_pred             HHhcCccccCCCC
Confidence            9999999987643

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3e-40  Score=292.91  Aligned_cols=250  Identities=26%  Similarity=0.318  Sum_probs=195.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +..++|++.+.||+|+||.||+|.+..     ++..||+|.+....     ....+|+.+++.++||||+++++++.   
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~---   78 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA---   78 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc---
Confidence            346789999999999999999998753     67889999886432     33557999999999999999998873   


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhh------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecc
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYS------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD  138 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~D  138 (353)
                        .....+++|||+++ +|.+.+....                  .....+++..+..++.|++.||.|||+ ++++|||
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~d  155 (288)
T cd05050          79 --VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRD  155 (288)
T ss_pred             --CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeeccc
Confidence              33347899999984 7777765321                  112347888999999999999999999 7999999


Q ss_pred             CCCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCC
Q 018619          139 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF  214 (353)
Q Consensus       139 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf  214 (353)
                      |||+||+++. ++.++|+|||++........   ......+..|+|||.+.+. .++.++|||||||++|+|++ |..||
T Consensus       156 l~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~  233 (288)
T cd05050         156 LATRNCLVGE-NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPY  233 (288)
T ss_pred             ccHhheEecC-CCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            9999999996 78899999999875433221   1122345679999998654 48999999999999999997 88899


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          215 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .+.+..+....+.....                   .         ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         234 YGMAHEEVIYYVRDGNV-------------------L---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCHHHHHHHHhcCCC-------------------C---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            87776655443322100                   0         012346889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-40  Score=289.30  Aligned_cols=241  Identities=24%  Similarity=0.335  Sum_probs=184.7

Q ss_pred             eeeecCCCeEEEEEEECCCCc--EEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||++....++.  .+++|.+....     ....+|+.++..+ +||||+++++++.     ....++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            468999999999999888776  46888775321     2345799999999 7999999999883     334588999


Q ss_pred             cccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           89 EYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        89 e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                      ||++ ++|.+.+.....            ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~-~~~~kl  153 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKI  153 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcC-CCeEEE
Confidence            9998 577777654221            12358899999999999999999999 89999999999999996 788999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      +|||++..............+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+.+..+....+....    
T Consensus       154 ~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~----  228 (270)
T cd05047         154 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----  228 (270)
T ss_pred             CCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC----
Confidence            99999863322111111223567999999854 458999999999999999997 999998766554443321100    


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                              ....+..++.++.+++.+||..||.+|||++++++
T Consensus       229 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         229 ------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             ------------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence                                    00012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.5e-40  Score=286.01  Aligned_cols=246  Identities=24%  Similarity=0.337  Sum_probs=194.7

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      -+..++|++.+.||+|+||.||++... .+..+|+|.+....   ....+|+.+++.++|+||+++++.+..      ..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   74 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP   74 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence            456789999999999999999999854 55679999886533   334579999999999999999887732      23


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||++ ++|.+.+...  ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||.+.
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~  150 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLAR  150 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCCccee
Confidence            789999998 5777666542  34567888999999999999999999 79999999999999996 7899999999987


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........  ....++..|+|||.+.+ ..++.++|+||+||++|++++ |..||.+.+..+....+......       
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------  222 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM-------  222 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence            65432221  12234567999999865 458899999999999999998 99999887765554433221000       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                           ..+...+.++.+++.+||+.||++||++.+++
T Consensus       223 ---------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  254 (260)
T cd05073         223 ---------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQ  254 (260)
T ss_pred             ---------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence                                 01134788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.5e-40  Score=292.34  Aligned_cols=255  Identities=20%  Similarity=0.266  Sum_probs=191.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECC----------------CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLE----------------TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVIS   68 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~   68 (353)
                      .++|++.+.||+|+||.||++.+..                ++..||+|.+....     ....+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4679999999999999999986432                34578999886432     23457999999999999999


Q ss_pred             cceeeeecCCCCceeEEEEecccc-chHHHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCC
Q 018619           69 LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK  140 (353)
Q Consensus        69 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlk  140 (353)
                      +++++..     ...++++|||+. ++|.+.+......       ...+++..+..++.|++.||+|||+ +|++|+|||
T Consensus        84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlk  157 (296)
T cd05095          84 LLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLA  157 (296)
T ss_pred             EEEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCC
Confidence            9998733     334789999998 5776666542211       1347788999999999999999999 799999999


Q ss_pred             CCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh--CCCCCC
Q 018619          141 PQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFP  215 (353)
Q Consensus       141 p~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~--g~~pf~  215 (353)
                      |+||+++. ++.++|+|||++.........   ....++..|++||...+. .++.++|+||+||++|+|++  |..||.
T Consensus       158 p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         158 TRNCLVGK-NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             hheEEEcC-CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence            99999996 788999999999765433211   112335679999987654 48999999999999999998  779998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..+..+.............           .....          ..+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-----------~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         236 QLSDEQVIENTGEFFRDQG-----------RQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             ccChHHHHHHHHHHHhhcc-----------ccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            7666554433222110000           00000          011346789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-40  Score=288.76  Aligned_cols=242  Identities=26%  Similarity=0.391  Sum_probs=188.9

Q ss_pred             eEeeeeecCCCeEEEEEEEC----CCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           14 MAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+.+.||.|+||.||+|...    ..+..|+||.+...     ...+.+|+..++.++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            57889999999999999987    44678999999542     2345579999999999999999999863222     7


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++|||||+ |+|.+.+...  ....+++..+..++.|++.||+|||+ ++++|+||+++||++++ ++.+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDS-NGQVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEET-TTEEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--cccccccccccccccccccccccccc-ccccccccccccccccc-cccccccccccccc
Confidence            89999998 6788887752  34679999999999999999999999 79999999999999996 88999999999987


Q ss_pred             cccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ......   .........|+|||.+.+.. ++.++||||||+++||+++ |..||...+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            632222   12234577899999986654 8999999999999999999 7899988877766655532100        


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                          ..++..++..+.++|.+||+.||.+|||+.++++
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                                1123457899999999999999999999999864

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.2e-40  Score=284.85  Aligned_cols=239  Identities=26%  Similarity=0.351  Sum_probs=190.0

Q ss_pred             eeeecCCCeEEEEEEECC-CC--cEEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLE-TG--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|++|.||++.+.. ++  ..||||.+.....     .+.+|+.+++.++||||+++++.+..      ..++++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            468999999999999865 33  3699998875543     44579999999999999999988743      4588999


Q ss_pred             cccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||++ ++|.+.+.....  ..+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEec-CCEEEecccccccccccc
Confidence            9997 577776654221  568999999999999999999999 79999999999999996 788999999999866443


Q ss_pred             CCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          168 EAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       168 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ...    ....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||...+..+....+.....           
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-----------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            221    12345678999999854 458999999999999999998 9999988777665554433100           


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                      ....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       219 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         219 ----------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             ----------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence                            00011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-40  Score=284.98  Aligned_cols=235  Identities=28%  Similarity=0.386  Sum_probs=185.3

Q ss_pred             eeeecCCCeEEEEEEECCCC---cEEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|....++   ..||+|.+.....     ...+|+.+++.++|||++++++++.     .. ..++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence            47999999999999876555   7899998865433     3457899999999999999988652     11 367999


Q ss_pred             cccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+. ++|.+.+..    ...+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++.+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcC-CCcEEeccccccceeecC
Confidence            9998 466666543    4478999999999999999999999 79999999999999996 788999999999865443


Q ss_pred             CCcc----eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          168 EANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       168 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ....    ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... .           
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-~-----------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-E-----------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C-----------
Confidence            3211    11224579999998554 48999999999999999998 99999887765544333221 0           


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                      ....+..++..+.++|.+||+.||++|||+.+++
T Consensus       216 ----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~  249 (257)
T cd05060         216 ----------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELE  249 (257)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence                            0011234788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=8.9e-40  Score=286.92  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=196.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECC-CCcEEEEEEeeccc--------------cchHHHHHHHHH-cCCCceeecceeeee
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR--------------RYKNRELQLMRV-MDHPNVISLKHCFFS   75 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~~-l~h~~iv~~~~~~~~   75 (353)
                      .|.+.+.||+|+||.||++.+.. +++.+|+|.+....              ....+|+.++.. ++||||+++++.+  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            48889999999999999999987 68899999874221              112357776654 7999999999988  


Q ss_pred             cCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           76 TTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                         ......+++|||+.+ +|.+.+.........+++..++.++.|++.||.|||+..+++|+||+|+||+++. ++.+|
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~  154 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVT  154 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEE
Confidence               334458899999985 6766665544556789999999999999999999995258999999999999996 78899


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      |+|||.+.............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+.......+......+.
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  233 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL  233 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence            9999999876554444456678899999999654 489999999999999999999999987765554443332111000


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                                 .....++++.++|.+||+.||++||++.|+..+
T Consensus       234 ---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 ---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             ---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence                                       012468899999999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.1e-39  Score=284.15  Aligned_cols=246  Identities=20%  Similarity=0.316  Sum_probs=193.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ...+|++.+.||+|+||.||++.+. ++..+|+|.+....   ....+|+.+++.++|||++++++++     ......+
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPIC   75 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceE
Confidence            3568999999999999999999874 47789999886542   3456899999999999999999887     3334588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++|||+.+ +|.+.+..   ....+++..++.++.|++.|+++||+ ++++|+||||+||+++. ++.+||+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~  150 (256)
T cd05112          76 LVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFV  150 (256)
T ss_pred             EEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcC-CCeEEECCCcceeec
Confidence            99999985 55444432   23568899999999999999999999 79999999999999995 788999999998755


Q ss_pred             ccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||......+....+.+..           
T Consensus       151 ~~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------  218 (256)
T cd05112         151 LDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-----------  218 (256)
T ss_pred             ccCcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-----------
Confidence            332211  122345679999998654 48899999999999999998 999998777655554432210           


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                       ....+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       219 -----------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         219 -----------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence                             000122357899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-39  Score=283.73  Aligned_cols=236  Identities=24%  Similarity=0.302  Sum_probs=183.5

Q ss_pred             eeecCCCeEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEecc
Q 018619           18 VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEY   90 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   90 (353)
                      .||+|+||.||++.+.  .++..||+|.+....     ....+|+.+++.++||||+++++++     .. ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-----~~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EA-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----cC-CCeEEEEEe
Confidence            4899999999998765  345679999885442     2345799999999999999998876     21 237899999


Q ss_pred             ccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC
Q 018619           91 VPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA  169 (353)
Q Consensus        91 ~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~  169 (353)
                      +++ +|.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcC-CCcEEeccCCccccccCCcc
Confidence            985 66555542   34578999999999999999999999 79999999999999996 78899999999975543322


Q ss_pred             cc----eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          170 NI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       170 ~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ..    ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.+. ..            
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~------------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KR------------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CC------------
Confidence            11    1122567999999855 448899999999999999996 99999887766544333221 00            


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                     ..++...++++.++|.+||+.||++||+..++.+
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                           0122346899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-40  Score=289.65  Aligned_cols=236  Identities=17%  Similarity=0.213  Sum_probs=181.1

Q ss_pred             eeeecCCCeEEEEEEECCCCc-------EEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           17 RVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +.||+|+||.||++.+..++.       .+|+|.+....    ....+|..+++.++|||++++++.+...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            468999999999999865544       48888775433    2345788999999999999999988543     2377


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC-------cEEEee
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKICD  157 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~-------~vkl~D  157 (353)
                      +||||+++ +|...+..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.       .++++|
T Consensus        76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 55555543   23468999999999999999999999 79999999999999986332       279999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ||.+......   ....++..|+|||++.+...++.++||||+||++|+|++|. .||...+....... ...       
T Consensus       152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~-------  220 (258)
T cd05078         152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED-------  220 (258)
T ss_pred             cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc-------
Confidence            9998754322   23456788999999976556899999999999999999984 67665554433221 110       


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                            ...++...+.++.+||.+||+.||++|||++++++.
T Consensus       221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence                                  001223456789999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=287.56  Aligned_cols=246  Identities=27%  Similarity=0.365  Sum_probs=194.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ++...+|++.+.||+|+||.||+|.++.+|+    .+|+|......     ....+|+.+++.++||||+++++++..  
T Consensus         3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--   80 (279)
T cd05057           3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--   80 (279)
T ss_pred             ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--
Confidence            3557899999999999999999999877665    58999876543     234579999999999999999998743  


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                          ...++||||+. ++|.+.+..   ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.+||+
T Consensus        81 ----~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~-~~~~kL~  151 (279)
T cd05057          81 ----SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKT-PQHVKIT  151 (279)
T ss_pred             ----CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcC-CCeEEEC
Confidence                23789999998 566666543   34568999999999999999999999 89999999999999986 7889999


Q ss_pred             eeccccccccCCCcce---eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEANIS---YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||++...........   ..++..|+|||.+.. ..++.++|+||+||++|++++ |..||.+.+..+....+... ..
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~  229 (279)
T cd05057         152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ER  229 (279)
T ss_pred             CCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CC
Confidence            9999986543332211   122567999998854 458899999999999999998 99999887765544433321 00


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .                           ..+...+.++.+++.+||..||.+|||+.+++
T Consensus       230 ~---------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         230 L---------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            0                           01123678899999999999999999999885

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=309.44  Aligned_cols=206  Identities=27%  Similarity=0.402  Sum_probs=171.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCC-CCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~   84 (353)
                      ..|...+.||+||||.||+++++.+|+.||||.+.+.     ...--+|+++|++++|||||+++++=-.... --....
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            4567888999999999999999999999999988653     2333489999999999999999765311110 002235


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC---CCcEEEeeecc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKICDFGS  160 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~---~~~vkl~Dfg~  160 (353)
                      .++||||. |+|...+.. .+....+++.++..++..+..||.|||+ +||+||||||.||++...   ...-||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            59999999 467666654 3445679999999999999999999999 899999999999998421   33689999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN  218 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  218 (353)
                      |+..+++....+.+||+.|.+||++.....|+..+|.||+||++|+++||..||....
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            9999999988999999999999999655679999999999999999999999996543

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.6e-39  Score=284.18  Aligned_cols=246  Identities=28%  Similarity=0.384  Sum_probs=193.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|.+.+.||+|+||.||+|.+...   ...||||......     ....+|+.+++.++||||+++++++..    
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----   78 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE----   78 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC----
Confidence            3467899999999999999999987544   3568999875432     234579999999999999999987632    


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                       . ..|+||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+||
T Consensus        79 -~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~  151 (270)
T cd05056          79 -N-PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSS-PDCVKLGDF  151 (270)
T ss_pred             -C-CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEec-CCCeEEccC
Confidence             1 2579999998 466666643   23468999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCCcc--eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          159 GSAKQLIAGEANI--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       159 g~a~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      |++..........  ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.+...    
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~----  226 (270)
T cd05056         152 GLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER----  226 (270)
T ss_pred             ceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc----
Confidence            9987654432211  1223467999998854 458999999999999999986 9999988776655544322100    


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                              ...+..++.++.++|.+||..+|++|||+.+++.
T Consensus       227 ------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         227 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                    0122357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-39  Score=283.56  Aligned_cols=245  Identities=22%  Similarity=0.348  Sum_probs=193.8

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      |.+...+|++.+.||+|+||.||.+.  .+++.||+|.+..+.  ....+|+.+++.++|||++++.+++..     . .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~   72 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-G   72 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-C
Confidence            34566889999999999999999886  478899999886442  345689999999999999999887732     1 2


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|||+. ++|.+.+...  ....+++..+..++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        73 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~  148 (254)
T cd05083          73 LYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSE-DGVAKVSDFGLAR  148 (254)
T ss_pred             cEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcC-CCcEEECCCccce
Confidence            679999998 5777776542  23468899999999999999999999 79999999999999996 7889999999987


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  .....+..|+|||.+.+. .++.++|+||+||++|+|++ |..||...+..+....+.+...          
T Consensus       149 ~~~~~~--~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------  215 (254)
T cd05083         149 VGSMGV--DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR----------  215 (254)
T ss_pred             eccccC--CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC----------
Confidence            543221  122335679999988544 58899999999999999997 9999988776554433322100          


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                        ...+..++..+.+++++||+.+|.+||++++++.
T Consensus       216 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         216 ------------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                              0012347889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2e-39  Score=286.34  Aligned_cols=247  Identities=21%  Similarity=0.321  Sum_probs=190.7

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCc----EEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ++..++|++.+.||+|+||.||++....+++    .+++|.+....     .....|+..+..++||||+++++++.   
T Consensus         3 ~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---   79 (279)
T cd05111           3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---   79 (279)
T ss_pred             cCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---
Confidence            4566889999999999999999999887776    47777764321     22345677888899999999998762   


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                        +. ..++++||+. |+|.+.+..   ....+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.+||+
T Consensus        80 --~~-~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~-~~~~kl~  151 (279)
T cd05111          80 --GA-SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKS-DSIVQIA  151 (279)
T ss_pred             --CC-ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEEc
Confidence              11 2568899988 677666653   34578999999999999999999999 79999999999999996 7889999


Q ss_pred             eeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||+++........   ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....... .++.....
T Consensus       152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~  229 (279)
T cd05111         152 DFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGER  229 (279)
T ss_pred             CCccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCc
Confidence            99999865433221   223456789999998654 48999999999999999998 99999877654432 22221000


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +.                           .+...+.++.+++.+||..||++|||+.++++
T Consensus       230 ~~---------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         230 LA---------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            00                           01235678899999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-39  Score=284.69  Aligned_cols=236  Identities=16%  Similarity=0.199  Sum_probs=177.5

Q ss_pred             eeeecCCCeEEEEEEECC------------CCcEEEEEEeecccc----chHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619           17 RVVGTGSFGIVFQAKCLE------------TGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +.||+|+||.||+++...            ....+++|.+.....    ...+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            468999999999998432            223588887754322    33467889999999999999998743     


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC-------cE
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QV  153 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~-------~v  153 (353)
                      ....+++|||++++.+..+..  .....+++..++.++.|++.||+|||+ ++|+||||||+|||++. ++       .+
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAR-EGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEec-CCccCCCCcee
Confidence            233679999999653333322  234568999999999999999999999 79999999999999975 33       38


Q ss_pred             EEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCC
Q 018619          154 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      +++|||++......   ....++..|+|||.+.....++.++||||+||++|+|+ +|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            99999998754322   23456788999999865566899999999999999997 588888765533221 11110   


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                    ...            .....+.++.+||.+||+.||.+||+..+++++
T Consensus       225 --------------~~~------------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         225 --------------QCM------------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             --------------Ccc------------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence                          000            011246789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.3e-39  Score=284.31  Aligned_cols=246  Identities=21%  Similarity=0.298  Sum_probs=183.2

Q ss_pred             eeeecCCCeEEEEEEECC--CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLE--TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.||+|+||.||++....  ....+++|.+....     ....+|+.+++.++||||+++++.+.     ....+|+|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            368999999999996432  34578888775332     23457899999999999999999873     3344889999


Q ss_pred             ccc-chHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           90 YVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        90 ~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      |++ ++|.+.+..... .....++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecC-CCcEEEeccccccccccc
Confidence            998 477766654322 12345678889999999999999999 79999999999999996 788999999998754332


Q ss_pred             CC---cceeeeeceeeChhhhhC------CCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          168 EA---NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       168 ~~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ..   .....++..|+|||++..      ...++.++||||+||++|+|++ |..||......+.+..........    
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----  229 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK----  229 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc----
Confidence            21   122334667999999743      2346789999999999999998 789998877666555444321110    


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                  .+       ...+...++....+++..|+ .||++|||++++++
T Consensus       230 ------------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         230 ------------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ------------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence                        00       01123457888999999998 59999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-39  Score=282.89  Aligned_cols=242  Identities=28%  Similarity=0.403  Sum_probs=192.9

Q ss_pred             eEeeeeecCCCeEEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           14 MAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+.+.||+|+||.||++.+..++    ..||+|.+....     ....+|+.+++.++|+||+++++.+..     ....
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~   76 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEPL   76 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCee
Confidence            57789999999999999998766    899999986543     244579999999999999999998843     3458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +++|||+++ +|.+.+...  ....+++..+..++.|++.||++||+ +|++|+||||+||+++. ++.++|+|||++..
T Consensus        77 ~~i~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~~  152 (258)
T smart00219       77 MIVMEYMEGGDLLDYLRKN--RPKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGE-NLVVKISDFGLSRD  152 (258)
T ss_pred             EEEEeccCCCCHHHHHHhh--hhccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEcc-CCeEEEcccCCcee
Confidence            899999985 666665531  11228999999999999999999999 79999999999999996 77899999999986


Q ss_pred             cccCCCcce--eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGEANIS--YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~~~~~--~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .........  ..+++.|+|||.+.+ ..++.++|+||+||++|+|++ |.+||...+..+....+.....         
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------  222 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR---------  222 (258)
T ss_pred             cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence            654422211  235678999999844 458999999999999999998 8899988766555544332100         


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                         ...+...+.++.+++.+||..||++|||+.++++
T Consensus       223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence                               0112347889999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.3e-39  Score=280.22  Aligned_cols=237  Identities=25%  Similarity=0.377  Sum_probs=185.0

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      +.||+|+||.||++.. .++..||+|.+....     ....+|+.+++.++||||+++++.+.     .....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECC
Confidence            4789999999999985 468899999875432     23457999999999999999999873     333488999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                      ++ +|.+.+..   ....+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcC-CCeEEECCCccceeccccccc
Confidence            84 55555432   23568899999999999999999999 79999999999999996 788999999998754332211


Q ss_pred             c--eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          171 I--SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       171 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      .  ...++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||...........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            1  1233567999999855 448899999999999999998 999998776654443332210                 


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                 ...++..++.++.+++.+||+.||++|||+.++++
T Consensus       212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                       00112347899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=281.33  Aligned_cols=237  Identities=25%  Similarity=0.368  Sum_probs=186.3

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      +.||+|++|.||++.+.. ++.||+|.+....     ....+|+.+++.++|+||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            478999999999999877 9999999876432     23457999999999999999998873     334488999999


Q ss_pred             cc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc
Q 018619           92 PE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN  170 (353)
Q Consensus        92 ~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~  170 (353)
                      .+ +|.+.+..   ....+++..+..++.|++.||+|||+ ++++||||||+||+++. ++.+||+|||.+.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcce
Confidence            75 55555533   34568899999999999999999999 79999999999999996 788999999998755422211


Q ss_pred             ---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          171 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       171 ---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                         .....+..|+|||.+.+. .++.++|+||+||++|+|++ |..||...........+.....               
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~---------------  213 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR---------------  213 (251)
T ss_pred             eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC---------------
Confidence               112235669999998654 58999999999999999998 8899987765544433221100               


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                   ...+..++.++.+++.+||+.+|.+|||+.++++
T Consensus       214 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         214 -------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             -------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence                         0012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-41  Score=293.66  Aligned_cols=260  Identities=24%  Similarity=0.395  Sum_probs=205.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      .++|-++..||+|+|+.||+|.+...++.||+|+-.-..           +-.-+|.+|.+.|+||.||++|++|.-.  
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD--  539 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD--  539 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec--
Confidence            578999999999999999999999999999999653211           1223799999999999999999988432  


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CCeeeccCCCCcEEEeCC--CCcEEE
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PRVCHRDLKPQNLLVDPL--THQVKI  155 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-~~i~H~Dlkp~Nill~~~--~~~vkl  155 (353)
                        ...+|-|+|||+|+   .|..|.+.+..+++.+++.|+.||+.||.||.+. ..|||-||||.|||+...  .|.+||
T Consensus       540 --tdsFCTVLEYceGN---DLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  540 --TDSFCTVLEYCEGN---DLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             --cccceeeeeecCCC---chhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence              22388999999986   4444556788899999999999999999999983 369999999999999532  367999


Q ss_pred             eeeccccccccCCCc--------ceeeeeceeeChhhhhC---CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018619          156 CDFGSAKQLIAGEAN--------ISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV  224 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  224 (353)
                      +|||+++.+.+....        ....||.||++||.+.-   .+..+.++||||+|||+|.++.|+.||..+.....+.
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL  694 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL  694 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence            999999987654332        34678999999998743   2457889999999999999999999997765443322


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      +.-..+             .-.+..||.-          ..+++++++||++||++--++|..+.++-.||||.-
T Consensus       695 qeNTIl-------------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  695 QENTIL-------------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhhchh-------------cceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            111100             1122233321          248999999999999999999999999999999964

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=4.8e-39  Score=282.33  Aligned_cols=245  Identities=20%  Similarity=0.234  Sum_probs=182.4

Q ss_pred             eeeecCCCeEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.||+|+||.||++...  .++..+|+|.+....     ....+|+.+++.++||||+++++.+.     ....+++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            46899999999999754  356789999885432     23457999999999999999998873     3334789999


Q ss_pred             ccc-chHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           90 YVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        90 ~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      |++ ++|.+.+..... .....++..++.++.|++.||+|||+ ++++|+||||+||+++. ++.+||+|||++......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcC-CCcEEECCccccccccCc
Confidence            998 567666654322 22356777888999999999999999 79999999999999996 788999999998754332


Q ss_pred             CC---cceeeeeceeeChhhhhCCC------CCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          168 EA---NISYICSRFYRAPELIFGAT------EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       168 ~~---~~~~~~t~~y~aPE~~~~~~------~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ..   .....++..|+|||++.+..      .++.++|+||+||++|+|++ |..||...+..+...........     
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-----  228 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-----  228 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence            21   11234577899999985321      35789999999999999996 99999877665544332221000     


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                 ..+       ...+....++.+.+++++|+ .||++|||+++++
T Consensus       229 -----------~~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~  264 (269)
T cd05087         229 -----------KLP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVH  264 (269)
T ss_pred             -----------CCC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHH
Confidence                       000       01112246788999999999 6899999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-39  Score=289.66  Aligned_cols=248  Identities=25%  Similarity=0.355  Sum_probs=192.9

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCc----EEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ++..++|+..+.||+|+||.||++.+..+++    .||+|.+.....     ...+|+.+++.++||||+++++.+... 
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            4667889999999999999999999887776    468887764422     345789999999999999999877321 


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                           ..++++||++ |++.+.+..   ....+++..+..++.|++.||+|||+ +||+|+||||+||+++. ++.+||+
T Consensus        82 -----~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~-~~~~kL~  151 (303)
T cd05110          82 -----TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKS-PNHVKIT  151 (303)
T ss_pred             -----CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecC-CCceEEc
Confidence                 1458999998 566666543   23468899999999999999999999 79999999999999985 7789999


Q ss_pred             eeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||++.........   ....++..|+|||.+.+. .++.++||||+||++|+|++ |..||.+....+.. ........
T Consensus       152 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~  229 (303)
T cd05110         152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-DLLEKGER  229 (303)
T ss_pred             cccccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHCCCC
Confidence            99999865433221   123346789999998654 48999999999999999997 99999776544332 22221000


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +                 +          .+...+.++.+++.+||..||++||++.++++.
T Consensus       230 ~-----------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         230 L-----------------P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             C-----------------C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                 0          112357789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-39  Score=285.58  Aligned_cols=259  Identities=26%  Similarity=0.384  Sum_probs=189.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEE----CCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKC----LETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..-|.+.+.||+|+||.||+|+.    ..+++.||+|.+....     ....+|+.+++.++|||++++.+++...   
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   78 (284)
T cd05079           2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---   78 (284)
T ss_pred             chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---
Confidence            345678999999999999999974    4578899999885332     3456899999999999999998877432   


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      +....++||||++| +|.+.+..   ....+++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+||
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~-~~~~~l~df  153 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIGDF  153 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcC-CCCEEECCC
Confidence            22347899999974 66555543   23468999999999999999999999 89999999999999996 788999999


Q ss_pred             ccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          159 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       159 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      |++.........    ....++..|+|||.+.+. .++.++||||+||++|+|+++..|+.....  ..   .+..+...
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~  227 (284)
T cd05079         154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTH  227 (284)
T ss_pred             ccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhccccc
Confidence            999865443221    123456679999998654 588999999999999999998776533211  00   11111000


Q ss_pred             ----HH-HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          235 ----RE-EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       235 ----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                          .. .+.....             ......+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         228 GQMTVTRLVRVLEE-------------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ccccHHHHHHHHHc-------------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                00 0000000             00011224578999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=304.61  Aligned_cols=261  Identities=28%  Similarity=0.418  Sum_probs=216.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      -.+.+++.+++|.|.+|.||+++++.+++..|+|+...+.   ..++.|.++++.. .|||++.++++|+-........+
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL   96 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL   96 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence            3567899999999999999999999999999999886443   3455678888887 59999999999987666666779


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+|||||+ |+..++++...  +.++.|+.+..|++.++.||.+||. +.++|||||-.|||++. ++.|||+|||.+..
T Consensus        97 WLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~-e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   97 WLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQ  172 (953)
T ss_pred             EEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEec-cCcEEEeeeeeeee
Confidence            99999999 46666666654  8899999999999999999999999 89999999999999996 78899999999887


Q ss_pred             cccCC-CcceeeeeceeeChhhhhCCC----CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ..... ...+.+|||.|||||++...+    .|+..+|+||||++..||.-|.+|+.+..+...+..|-.   -|+... 
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPkL-  248 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPKL-  248 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCccc-
Confidence            65443 345678999999999985533    367799999999999999999999988776655433322   111110 


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                       .     =+++.+.++.|||..||.+|-.+||+..++|.|||++.
T Consensus       249 -----------------k-----rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  249 -----------------K-----RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             -----------------c-----chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence                             0     12346889999999999999999999999999999974

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-39  Score=285.46  Aligned_cols=235  Identities=18%  Similarity=0.216  Sum_probs=178.2

Q ss_pred             eeecCCCeEEEEEEECCC------------------------CcEEEEEEeeccc----cchHHHHHHHHHcCCCceeec
Q 018619           18 VVGTGSFGIVFQAKCLET------------------------GETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISL   69 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~   69 (353)
                      .||+|+||.||++....+                        ...|++|.+....    ....+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            689999999999874321                        2358888875432    234468889999999999999


Q ss_pred             ceeeeecCCCCceeEEEEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           70 KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                      ++++...     ...++||||++++ |...+.   ...+.+++..+..++.|++.||+|||+ +||+||||||+||+++.
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEec
Confidence            9988433     3478999999965 433332   234678999999999999999999999 79999999999999974


Q ss_pred             C------CCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHH-hCCCCCCCCChHH
Q 018619          149 L------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD  221 (353)
Q Consensus       149 ~------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~  221 (353)
                      .      ...+|++|||++......   ....++..|+|||.+.+...++.++|+|||||++|+|+ +|..||......+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            2      224899999988644322   22356778999998866556899999999999999985 7999998765543


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ........                              ..++...++++.++|.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         230 KERFYEKK------------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHHHhc------------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            32211110                              00112346789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3e-39  Score=283.54  Aligned_cols=241  Identities=24%  Similarity=0.350  Sum_probs=186.7

Q ss_pred             eeeecCCCeEEEEEEECCCC------cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           17 RVVGTGSFGIVFQAKCLETG------ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +.||+|+||.||++++....      +.+|+|.+.+..     ....+|+.+++.++||||+++++++..     ....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence            46899999999999976544      689999875432     234579999999999999999988733     33488


Q ss_pred             EEecccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC-----cEEEe
Q 018619           86 LVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKIC  156 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~-----~vkl~  156 (353)
                      ++|||++ ++|.+.+.....   ....+++..+..++.|++.||+|||+ ++++|+||||+||+++. ++     .++|+
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~-~~~~~~~~~~l~  153 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSE-KGYDADRVVKIG  153 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEec-CCCCCCcceEEC
Confidence            9999998 577777654322   23457889999999999999999999 79999999999999986 44     79999


Q ss_pred             eeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||++........   .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... ..
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~  231 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-GR  231 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-Cc
Confidence            9999875533221   1122346789999998654 48999999999999999998 99999877765544332210 00


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                                 ...+..++..+.++|.+||+.+|.+||+++++++
T Consensus       232 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 ---------------------------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             ---------------------------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                                       0112347889999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=296.11  Aligned_cols=249  Identities=26%  Similarity=0.349  Sum_probs=198.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCc---E-EEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGE---T-VAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (353)
                      |.+..++-.+.+.||+|+||.||+++.+..+.   . ||+|......       ..+.+|+++++.++|||||+++++. 
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa-  230 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA-  230 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            66777788888999999999999999765432   3 8999886421       2344799999999999999999988 


Q ss_pred             ecCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           75 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                          .....+++|||+|.| +|.+.|..   ....++..+...++.+.+.||+|||+ ++++||||-..|+|++. ++.+
T Consensus       231 ----~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~-~~~v  301 (474)
T KOG0194|consen  231 ----VLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSK-KGVV  301 (474)
T ss_pred             ----cCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecC-CCeE
Confidence                344448999999995 66666654   23369999999999999999999999 79999999999999996 6778


Q ss_pred             EEeeeccccccccCCCcc-eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 018619          154 KICDFGSAKQLIAGEANI-SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      ||+|||+++......... ...-...|+|||.+... .|+.++||||+||++||+++ |..||.+....+...++...  
T Consensus       302 KISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~--  378 (474)
T KOG0194|consen  302 KISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKN--  378 (474)
T ss_pred             EeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhc--
Confidence            999999987543111111 11224679999999654 69999999999999999998 88899999988887777442  


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                     .+          ...++...+.++..++.+|+..||++|+|..++.
T Consensus       379 ---------------~~----------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  379 ---------------GY----------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             ---------------Cc----------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence                           11          1112345788999999999999999999998875

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=290.70  Aligned_cols=260  Identities=25%  Similarity=0.345  Sum_probs=190.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +++|.-...||+|+||.||++.- ..|..||||++....    ..+.+|+.++..++|||+|+++++|.+...    ..+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~  148 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRL  148 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEE
Confidence            46777788999999999999985 455899999886433    347799999999999999999999854332    367


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--CeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--RVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~--~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+||+. |+|.+.+......  .++|.....|+.+++.||+|||+..  .|+||||||+|||+|+ +.+.||+|||+|+
T Consensus       149 LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsDFGLa~  225 (361)
T KOG1187|consen  149 LVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSDFGLAK  225 (361)
T ss_pred             EEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccCccCcc
Confidence            9999999 6777777642211  8899999999999999999999943  3999999999999995 8999999999997


Q ss_pred             cccc-CCCccee-eeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHH
Q 018619          163 QLIA-GEANISY-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       163 ~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~  237 (353)
                      .... ....... .||..|++||.+.. ...+.++||||||++|.|+++|+.+.....   ......-....+....   
T Consensus       226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~---  301 (361)
T KOG1187|consen  226 LGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK---  301 (361)
T ss_pred             cCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc---
Confidence            6544 3333333 78999999999855 458999999999999999999998876432   1111111111111111   


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCC-CCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                             ..++--+.+....    +.. ..-..+..+..+|++.+|.+||+..|++
T Consensus       302 -------~~eiiD~~l~~~~----~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv  346 (361)
T KOG1187|consen  302 -------LREIVDPRLKEGE----YPDEKEVKKLAELALRCLRPDPKERPTMSQVV  346 (361)
T ss_pred             -------hhheeCCCccCCC----CChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence                   1111111111000    000 0122366788999999999999999874

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.5e-39  Score=280.32  Aligned_cols=239  Identities=24%  Similarity=0.381  Sum_probs=180.8

Q ss_pred             eeeecCCCeEEEEEEECC---CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619           17 RVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      +.||+|+||.||+|.+..   .+..||||.+....     ....+|+.+++.++||||+++++.+...    +...+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            468999999999998653   34579999875321     2345788999999999999998865322    22367999


Q ss_pred             cccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           89 EYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        89 e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||+. ++|.+.+..   .....++..+..++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||++......
T Consensus        77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcC-CCcEEECCccccccccCC
Confidence            9998 566666543   23456777888899999999999999 79999999999999996 788999999999754332


Q ss_pred             CC-----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          168 EA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       168 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ..     .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||...+..+....+...  .+        
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------  220 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------  220 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence            11     1123346789999998654 58999999999999999999 56778776655444332211  00        


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                        ...+..++..+.+++.+||+.||++||++.++++
T Consensus       221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                              0011246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.6e-39  Score=281.59  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=190.5

Q ss_pred             eeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc-e
Q 018619           13 YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE-L   82 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~-~   82 (353)
                      |.+.+.||+|+||.||+|...   .+++.||||.+..+.      ....+|+.+++.++||||+++++++......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999854   457899999886532      234579999999999999999998755433222 2


Q ss_pred             eEEEEecccc-chHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~--~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ..++++||+. +++...+....  .....++...++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~-~~~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNE-NMTVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcC-CCCEEECccc
Confidence            3568889998 45555443211  122357899999999999999999999 89999999999999986 7889999999


Q ss_pred             cccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          160 SAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       160 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      ++........   .....+++.|++||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.+...    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR----  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc----
Confidence            9886543321   1223345679999998554 48899999999999999999 8999987776554443332100    


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                  .            ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       234 ------------~------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         234 ------------L------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             ------------C------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                        0            011236789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-38  Score=278.58  Aligned_cols=246  Identities=20%  Similarity=0.256  Sum_probs=182.1

Q ss_pred             eeeecCCCeEEEEEEECCC--CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.||+|+||.||++.....  ...+++|.+....     ....+|+.+++.++||||+++++.+.     .....|+|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence            3689999999999875433  3456777665332     23457888999999999999999883     3345889999


Q ss_pred             ccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC
Q 018619           90 YVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE  168 (353)
Q Consensus        90 ~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  168 (353)
                      |+. ++|.+.+..........++..++.++.|++.||+|||+ ++++||||||+|||++. ++.+||+|||++.......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcC-CccEEecccccccccCcch
Confidence            999 47776665433233457778888999999999999999 79999999999999996 7889999999986432211


Q ss_pred             ---CcceeeeeceeeChhhhhCC------CCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          169 ---ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       169 ---~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                         ......++..|+|||++...      ..++.++||||+||++|+|++ |..||...+..+.+..+.......     
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-----  228 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK-----  228 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc-----
Confidence               12234567889999987431      235778999999999999996 577888777666555544321100     


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                        .+...+...+++.+.+++..|| .||++|||++++++
T Consensus       229 ------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         229 ------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             ------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence                              0111122346889999999999 68999999999863

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.2e-40  Score=306.02  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=202.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      ..+-...+.||+|+||+||+|+.-.     ....||||.+++.     +..++||++++..++|||||++++++.     
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----  559 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----  559 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----
Confidence            4456788999999999999998643     3357999998654     345679999999999999999999994     


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhc------C----CCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSA------N----QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~------~----~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                      ....+|+|+|||. |+|-+.|......      +    .+++..+...++.||+.|+.||-+ +.+|||||-..|+||.+
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGE  638 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceecc
Confidence            3444999999999 8888888653321      2    238899999999999999999999 79999999999999996


Q ss_pred             CCCcEEEeeeccccccccCCCcc---eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 018619          149 LTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  224 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  224 (353)
                       +..|||+|||+++...+.+...   ...-...|||||.+.-. .++++|||||+||+|||+++ |..||.+..+.+.+.
T Consensus       639 -~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe  716 (774)
T KOG1026|consen  639 -NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE  716 (774)
T ss_pred             -ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHH
Confidence             8899999999999765543321   22335679999999654 59999999999999999995 899999999998887


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                      .+.+..-                  +          .-+.+.|.++.+|+..||+..|.+||+..||
T Consensus       717 ~i~~g~l------------------L----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  717 CIRAGQL------------------L----------SCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHcCCc------------------c----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            7765210                  0          0134689999999999999999999999987

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.8e-39  Score=279.23  Aligned_cols=233  Identities=18%  Similarity=0.206  Sum_probs=179.4

Q ss_pred             eeeecCCCeEEEEEEECCCC----------cEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           17 RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      +.||+|+||.||++.+..++          ..+++|.+....   ..+.+|+.+++.++||||+++++.+..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            46899999999999998776          357888765433   345678999999999999999998744      22


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC-------cEEE
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-------QVKI  155 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~-------~vkl  155 (353)
                      .++||||+.+ +|.+.+..   ....+++..+..++.||+.||+|||+ +||+||||||+||+++. ++       .+||
T Consensus        75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl  149 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVAR-YGLNEGYVPFIKL  149 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEec-CccccCCceeEEe
Confidence            6799999995 55555443   22378999999999999999999999 79999999999999986 44       6999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      +|||++.....   .....++..|+|||.+.+. ..++.++|+||+||++|+|++ |..||...+..+.......    .
T Consensus       150 ~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~  222 (259)
T cd05037         150 SDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q  222 (259)
T ss_pred             CCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C
Confidence            99999986543   2234456779999998665 358999999999999999999 5788876653322111110    0


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                                ...+......+.++|.+||+.||++|||+.++++
T Consensus       223 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         223 --------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                      0001112378999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.9e-39  Score=281.45  Aligned_cols=280  Identities=28%  Similarity=0.493  Sum_probs=214.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECC---CCcEEEEEEee--ccccchHHHHHHHHHc-CCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVL--QDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~--~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+.|.++..||+|.|++||++.+..   .++.||+|.+.  .....+..|+++|..+ .+.||+++.+++     ..+..
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCCe
Confidence            5679999999999999999999887   78899999884  3445677899999988 588999999888     55556


Q ss_pred             EEEEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +.+|+||++.. -.++.       ..++..+++.+++.++.||+++|+ +|||||||||+|+|.+...++-.|+|||+|.
T Consensus       110 v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHH
Confidence            88999999953 22232       236788999999999999999999 7999999999999999888889999999986


Q ss_pred             ccc-----------------c--C--------------------------CCcceeeeeceeeChhhhhCCCCCCccccc
Q 018619          163 QLI-----------------A--G--------------------------EANISYICSRFYRAPELIFGATEYTTSIDI  197 (353)
Q Consensus       163 ~~~-----------------~--~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  197 (353)
                      ...                 .  +                          .......||++|+|||++...+..++++||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            210                 0  0                          000124689999999999988888999999


Q ss_pred             hhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcCcC------------------CCCCcCCCC----C
Q 018619          198 WSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNPN------------------YTDFRFPQI----K  254 (353)
Q Consensus       198 wSlG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~----~  254 (353)
                      ||.|+|+..++++..|| ...++.+.+.+++..+|.-.......+...                  |........    +
T Consensus       262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q  341 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ  341 (418)
T ss_pred             eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence            99999999999999887 556666777777776665444332211111                  110100000    0


Q ss_pred             CCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          255 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ...+........+..+.||+.+||+.||.+|+|++++|.||||.....
T Consensus       342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence            012333344456779999999999999999999999999999996543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.1e-38  Score=277.78  Aligned_cols=261  Identities=26%  Similarity=0.354  Sum_probs=190.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEEC----CCCcEEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...|.+.+.||+|+||.||++...    .+++.||+|.+.....     .+.+|+.+++.++||||+++++++..   .+
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CC
Confidence            467889999999999999999864    3488999998865433     45689999999999999999887633   22


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....+++|||++ ++|.+.+..   ....+++..+..++.|++.||+|||+ +|++|+||||+||+++. ++.++|+|||
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~-~~~~~l~dfg  154 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVES-EDLVKISDFG  154 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcC-CCCEEEcccc
Confidence            345889999997 477666653   23368999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCcc----eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCC
Q 018619          160 SAKQLIAGEANI----SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~  234 (353)
                      .+..........    ...++..|+|||.+.+. .++.++|+||+||++|+|++|..||.........  +... .+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~  231 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMI  231 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--cccccccccc
Confidence            998765332211    12335569999998654 5889999999999999999999998654322100  0000 00000


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ...+........            ....+...+.++.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         232 VTRLLELLKEGE------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HHHHHHHHHcCC------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000000000000            00011246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=289.63  Aligned_cols=274  Identities=22%  Similarity=0.286  Sum_probs=183.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC----------------CCCcEEEEEEeecccc------------------chHH
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL----------------ETGETVAIKKVLQDRR------------------YKNR   53 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~   53 (353)
                      +..++|.+.++||+|+||+||++...                ..++.||||++..+..                  ....
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            56789999999999999999998642                3456799999854321                  1123


Q ss_pred             HHHHHHHcCCCce-----eecceeeeecCC---CCceeEEEEeccccc-hHHHHHHhhh-----------h---------
Q 018619           54 ELQLMRVMDHPNV-----ISLKHCFFSTTS---KNELFLNLVMEYVPE-SMYRVLKHYS-----------S---------  104 (353)
Q Consensus        54 E~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~l~~~~-----------~---------  104 (353)
                      |+.++..++|.++     ++++++|.....   ......++||||+++ +|.+.+....           .         
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6666777766654     455555432211   112347899999984 6666654311           0         


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcce--eeeeceeeCh
Q 018619          105 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAP  182 (353)
Q Consensus       105 ~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~t~~y~aP  182 (353)
                      ....+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++...........  ..+|+.|+||
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11235677889999999999999999 79999999999999996 78899999999976543322222  2347899999


Q ss_pred             hhhhCCCC-------------------CC--ccccchhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          183 ELIFGATE-------------------YT--TSIDIWSAGCVLAELLLGQP-LFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       183 E~~~~~~~-------------------~~--~~~DiwSlG~il~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |.+.....                   ++  ...|+||+||++|+|++|.. ||.............   . .....++.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~---~-~~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY---D-NDLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc---c-chHHHHHh
Confidence            99753211                   11  24799999999999999985 775432211110000   0 00000100


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCC---CCCCCHHHHhcCccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP---SLRCTALEACAHPFFDE  299 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp---~~R~t~~~~l~hp~f~~  299 (353)
                      ..            ...+.-......++.++||+.+||..+|   .+|+|++|+|+||||..
T Consensus       456 ~~------------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        456 YK------------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             hc------------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            00            0001111224578999999999999876   68999999999999963

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=301.21  Aligned_cols=249  Identities=22%  Similarity=0.373  Sum_probs=201.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCc-----EEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ...+-.+.+.||+|+||.||.+.......     .||||.+.+..     ..+.+|..+|+.++|||||+++++.++...
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            35677889999999999999998765433     49999886542     345589999999999999999999976333


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                           .+|++|||. |+|...++....   ....++......++.++++|++||++ +++|||||-..|+|++. ...+|
T Consensus       770 -----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~-~r~VK  842 (1025)
T KOG1095|consen  770 -----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDE-RRVVK  842 (1025)
T ss_pred             -----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecc-cCcEE
Confidence                 779999999 577777765211   15668999999999999999999999 79999999999999997 78999


Q ss_pred             EeeeccccccccCCCcce--e-eeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 018619          155 ICDFGSAKQLIAGEANIS--Y-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL  230 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~--~-~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  230 (353)
                      |+|||+|+.+...+....  . .-...|||||.+.. ..++.++|||||||++||+++ |..||.+.++.+.+....+.-
T Consensus       843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg  921 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG  921 (1025)
T ss_pred             EcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC
Confidence            999999996544332211  1 12356999999965 459999999999999999996 889999999988876555421


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                        .++          .+..++..+-+++.+||+-+|++||+...+++
T Consensus       922 ------------------RL~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 ------------------RLD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ------------------ccC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence                              011          23468999999999999999999999998875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=295.19  Aligned_cols=250  Identities=31%  Similarity=0.467  Sum_probs=191.0

Q ss_pred             eeEeeeeecCCCeE-EEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEEec
Q 018619           13 YMAERVVGTGSFGI-VFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        13 y~~~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.-.+++|.|+.|+ ||++..  .|+.||||.+..... ...+|+.+|+.- +|||||+++..     ..++.+.||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceEEEEeh
Confidence            34457889998876 687765  788999998876554 678999999887 59999997543     367788999999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC----CCCcEEEeeeccccccc
Q 018619           90 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLI  165 (353)
Q Consensus        90 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~----~~~~vkl~Dfg~a~~~~  165 (353)
                      .|..+|.+++...............+.++.|++.||++||+ .+||||||||.||||+.    ...+++|+|||+|+...
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99999999887631111222225567889999999999999 69999999999999975    23579999999999887


Q ss_pred             cCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          166 AGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       166 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .+...    .+..||-.|+|||++.+.. -..++||+|+||++|+.++| ..||...-..  ...|..            
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~------------  727 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILT------------  727 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHh--hhhhhc------------
Confidence            76543    3457899999999997654 57799999999999999986 8999654322  112222            


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                           ..+.+..+         ...-..++.|||.+||.+||..||+|.++|.||+|-.
T Consensus       728 -----~~~~L~~L---------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  728 -----GNYTLVHL---------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             -----Cccceeee---------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence                 01111110         0111228999999999999999999999999999954

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2e-36  Score=260.72  Aligned_cols=238  Identities=38%  Similarity=0.644  Sum_probs=191.3

Q ss_pred             CCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccc-hHH
Q 018619           23 SFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMY   96 (353)
Q Consensus        23 ~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~   96 (353)
                      +||.||++.+..+++.+|+|.+....     ....+|+..++.++|+|++++++.+..     ....++++|++++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            58999999999899999999986542     455689999999999999999988743     3458899999997 776


Q ss_pred             HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcceeeee
Q 018619           97 RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS  176 (353)
Q Consensus        97 ~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t  176 (353)
                      +.+..    ...++...++.++.+++.++.+||+ .+++|+||+|+||+++. ++.++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECC-CCcEEEccccceeeeccccccccccCC
Confidence            66543    2338999999999999999999999 79999999999999996 688999999999876655444556678


Q ss_pred             ceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCC
Q 018619          177 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH  256 (353)
Q Consensus       177 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (353)
                      ..|+|||.+.+ ..++.++|+||+|+++++|++|..||..........+.........                      
T Consensus       150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------  206 (244)
T smart00220      150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF----------------------  206 (244)
T ss_pred             cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence            89999999864 4478899999999999999999999987443333333222100000                      


Q ss_pred             ccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          257 PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       257 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                         ......++.++.+++.+||..||++||++.++++||||
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence               00001167899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=289.69  Aligned_cols=247  Identities=26%  Similarity=0.373  Sum_probs=209.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEee-----ccccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVL-----QDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +....-.|.++||.|.||.|+.++-+..|+   .||||.++     +++..+..|+.||-+++||||+++.++.     .
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----T  700 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----T  700 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----e
Confidence            455566899999999999999999887764   59999996     3455667899999999999999999998     4


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+-||+|||+ |+|...|..   .++.++..++.-+++.|+.|++||-+ .|+|||||-..|||||+ +..+|++||
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNs-nLvCKVsDF  775 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNS-NLVCKVSDF  775 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeecc-ceEEEeccc
Confidence            4445889999999 677767664   45779999999999999999999999 59999999999999997 899999999


Q ss_pred             ccccccccCC-Ccceeee---eceeeChhhhhCCCCCCccccchhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGE-ANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~-~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+++...++. ...+..|   ...|.|||.+. ...++.+|||||+|++|||.+ .|..||....+.+.+..+.+..+.|
T Consensus       776 GLSRvledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP  854 (996)
T KOG0196|consen  776 GLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP  854 (996)
T ss_pred             cceeecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC
Confidence            9999775544 2222232   46799999994 456999999999999999976 6999999999999999998866655


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +.                            -+.+..+-.|+..||++|-.+||+.+||++
T Consensus       855 pP----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  855 PP----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             CC----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            53                            247899999999999999999999999874

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=279.50  Aligned_cols=244  Identities=31%  Similarity=0.460  Sum_probs=196.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCC--C--cEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLET--G--ETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +.++...+.+.||+|-||.||.+.....  |  -.||||..+.+     .+.+..|..+|+.++||||+++++++..   
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e---  462 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---  462 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec---
Confidence            4455556778999999999999886432  3  35899988654     3445679999999999999999999832   


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                         ...+||||+++ |.|..+++.   ....++......+..||+.||.|||+ ..+|||||-..||||.+ ..-|||+|
T Consensus       463 ---~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsS-p~CVKLaD  534 (974)
T KOG4257|consen  463 ---QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSS-PQCVKLAD  534 (974)
T ss_pred             ---cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecC-cceeeecc
Confidence               22889999999 777777765   45678999999999999999999999 79999999999999997 56699999


Q ss_pred             eccccccccCCCcceeee--eceeeChhhhhCCCCCCccccchhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          158 FGSAKQLIAGEANISYIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      ||+++.+.+........|  ..-|||||.+. ...++.+||||-|||.+||++ .|..||.+-.+.+.+..+.+.-..| 
T Consensus       535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP-  612 (974)
T KOG4257|consen  535 FGLSRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP-  612 (974)
T ss_pred             cchhhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC-
Confidence            999998766554333333  44599999984 445899999999999999988 5999999988777765544421111 


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                                                 .+.++++.+-.|+.+||++||.+||+..++
T Consensus       613 ---------------------------~P~nCPp~LYslmskcWayeP~kRPrftei  642 (974)
T KOG4257|consen  613 ---------------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEI  642 (974)
T ss_pred             ---------------------------CCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence                                       245789999999999999999999987654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=244.80  Aligned_cols=213  Identities=23%  Similarity=0.423  Sum_probs=176.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHH-HHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+...-+..||+|+||.|-+.++..+|...|+|.+....     ....+|+++. +...+|++|.+++.++...+     
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-----  119 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-----  119 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc-----
Confidence            344556678999999999999999999999999885332     2223455543 33479999999998865554     


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +++.||.|..++.....+....++.++|..+-+++..++.||.|||+.-.++|||+||+|||+|. .|++|+||||++..
T Consensus       120 vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  120 VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGY  198 (282)
T ss_pred             EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEccccccee
Confidence            99999999999888888888889999999999999999999999999668999999999999996 89999999999987


Q ss_pred             cccCCCcceeeeeceeeChhhhhC---CCCCCccccchhHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 018619          164 LIAGEANISYICSRFYRAPELIFG---ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIK  228 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~~~~  228 (353)
                      ..+.-..+-..|...|+|||.+..   ...|+.+|||||||+.+.||.+++.||.. .++.+++.++++
T Consensus       199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            766555555677888999999843   23589999999999999999999999965 455666666654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=273.94  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |-+++.+......||.|.||.||.+.++.-.-.||||.++.+.   ..+.+|+.+|+.++|||+|++.++|     ..+.
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~Ep  336 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEP  336 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCC
Confidence            4566667788899999999999999999999999999997664   4456899999999999999999999     4445


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|||+|||. |+|+++|....  ...++.....+++.||..|++||.. +++|||||-..|+||.+ ++.||++|||++
T Consensus       337 PFYIiTEfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgE-nhiVKvADFGLs  412 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHIVKVADFGLS  412 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccc-cceEEeeccchh
Confidence            5899999998 89999987643  3457778888999999999999999 89999999999999996 899999999999


Q ss_pred             cccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +.+..+...  -......-|.|||.+ ..+.++.++|||+|||+|||+.| |-.||.+-+....+..+.+.         
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsL-AyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg---------  482 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG---------  482 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccc-cccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc---------
Confidence            987554321  112225569999998 44568999999999999999996 88999998866555443331         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                               +.+.          -+..+++.+-+|++.||+++|.+||+..|+
T Consensus       483 ---------yRM~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  483 ---------YRMD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             ---------cccc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence                     1111          135689999999999999999999998876

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=275.89  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCC-C--cEEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      |+|-.++..+.+.||+|.||.|+++.+... |  ..||||.+..+..     .+.+|+.+|..|+|||++++|++..+. 
T Consensus       105 clIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q-  183 (1039)
T KOG0199|consen  105 CLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ-  183 (1039)
T ss_pred             eeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc-
Confidence            677778888999999999999999987643 3  3589999876543     356899999999999999999998542 


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                           ..-+|||++. |+|++.|..  .....|.......|+.||+.|+.||.+ +++|||||-..|+|+-+ ...|||+
T Consensus       184 -----p~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllas-prtVKI~  254 (1039)
T KOG0199|consen  184 -----PAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLAS-PRTVKIC  254 (1039)
T ss_pred             -----hhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecc-cceeeee
Confidence                 1459999999 788888775  345678899999999999999999999 89999999999999987 6789999


Q ss_pred             eeccccccccCCCcceeee----eceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 018619          157 DFGSAKQLIAGEANISYIC----SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~----t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      |||+.+.+..++......+    ...|.|||.+.. ..++.+||+|++||++|||++ |+.||.+......+..+-+...
T Consensus       255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er  333 (1039)
T KOG0199|consen  255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER  333 (1039)
T ss_pred             cccceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc
Confidence            9999998776665543222    445999999955 459999999999999999996 7899999998877766543110


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                      .                  +          -++.+++++-+++..||+.+|.+|||...|...-+
T Consensus       334 L------------------p----------RPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  334 L------------------P----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             C------------------C----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            0                  0          12458999999999999999999999988754333

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5e-36  Score=268.91  Aligned_cols=251  Identities=22%  Similarity=0.291  Sum_probs=197.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +....+++.||+|-||.|.++. ...+..||+|++..+     +..+.+|+++|.+++||||+.+.+++...+     .+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCe-veg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pi  610 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCE-VEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PL  610 (807)
T ss_pred             hhheehhhhhcCcccceeEEEE-ecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----ch
Confidence            4567899999999999999998 445789999999643     245678999999999999999999995443     38


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++|+||+. |+|.+.+......  .+.......++.||+.|++||.+ .++|||||.+.|+|++. +.++||+|||.++.
T Consensus       611 cmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDG-EFTIKIADFGMSRN  686 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecC-cccEEecCcccccc
Confidence            89999999 6776666653222  24555666799999999999999 69999999999999996 88999999999997


Q ss_pred             cccCCCcc---eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHH--hCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAGEANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL--LGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ..+++...   ..+-...|||||.+.-. +++++||+|++|+++||++  +...||....+.+.....-..+..+....+
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            66554322   23346789999998654 5999999999999999986  578999888877666554443333222111


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                           ..-+.-++..+.+++.+||..|..+|||.+++-
T Consensus       766 ---------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  766 ---------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             ---------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence                                 011234788899999999999999999999983

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.9e-36  Score=304.53  Aligned_cols=252  Identities=22%  Similarity=0.312  Sum_probs=181.4

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccc
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      .|...++||+|+||.||+|++..+++.||+|++........+|+..++.++|||||++++++...     ...|+||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            45667789999999999999999999999999876655556789999999999999999998433     3478999999


Q ss_pred             c-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH---cCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           92 P-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH---TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        92 ~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH---~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      + |+|.+.+.       .+++..+..++.|++.||+|||   + .+|+||||||+||+++. ++..++. ||.+..... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~-~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCS-PAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCC-CCeecCCCCHHhEEECC-CCceEEE-ecccccccc-
Confidence            8 46666553       3788999999999999999999   6 69999999999999996 6666664 665543221 


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                        .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..+.+..+......  ..       .
T Consensus       835 --~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~-------~  902 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC--HL-------D  902 (968)
T ss_pred             --CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc--ch-------h
Confidence              1234678999999998654 5899999999999999999999998532111 11111111000000  00       0


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+.-+.... .  .........++.+++.+||+.||++|||+.|+++.
T Consensus       903 ~~~~~~~~~-~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        903 MWIDPSIRG-D--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             heeCccccC-C--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            000000000 0  00001123367889999999999999999999754

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-35  Score=261.67  Aligned_cols=195  Identities=27%  Similarity=0.408  Sum_probs=170.1

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccch------------HHHHHHHHHcC---CCceeecceeeee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK------------NRELQLMRVMD---HPNVISLKHCFFS   75 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~E~~~l~~l~---h~~iv~~~~~~~~   75 (353)
                      -.|...+.+|+|+||.|++|.++.+...|+||.+.+.+-..            -.|+.||..++   |+||+++.+.|  
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF--  638 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF--  638 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee--
Confidence            36999999999999999999999999999999887664322            26999999997   99999999999  


Q ss_pred             cCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           76 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                         +++.++|++||--+.++  .|..++....+++|.++..|+.|++.|+++||+ .||+|||||=+|+.+++ +|-+||
T Consensus       639 ---Eddd~yyl~te~hg~gI--DLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~-~g~~kl  711 (772)
T KOG1152|consen  639 ---EDDDYYYLETEVHGEGI--DLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDS-NGFVKL  711 (772)
T ss_pred             ---ecCCeeEEEecCCCCCc--chhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEec-CCeEEE
Confidence               77778999999887432  233445567889999999999999999999999 69999999999999997 888999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCC
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP  215 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~  215 (353)
                      +|||.|....+ ......+||..|.|||++.|..+.+.+.|||++|++||.++....||.
T Consensus       712 idfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999875543 445578999999999999888877999999999999999999998885

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=267.41  Aligned_cols=256  Identities=26%  Similarity=0.402  Sum_probs=205.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|.++..+|+|.||.||+|+++.+++..|+|.++-.    ....+.|+-+++.-+||||+.+++.+...+     .++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw   88 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW   88 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence            46899999999999999999999999999999988643    455678999999999999999999884433     389


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +.||||+|+-++.+-+   ..+++++.++.++.++.+.||+|||+ .|=+|||||-.||+++. .+.+|++|||.+..+.
T Consensus        89 icMEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd-~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTD-EGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecc-cCceeecccCchhhhh
Confidence            9999999653333332   57899999999999999999999999 69999999999999995 7889999999987654


Q ss_pred             cC-CCcceeeeeceeeChhhhh--CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          166 AG-EANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       166 ~~-~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .. ....+..||+.|||||+..  ....|+..+|+|++|+...|+-.-++|-........+..+-+-             
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-------------  230 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-------------  230 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-------------
Confidence            43 2345689999999999962  2346899999999999999999888776555544444333221             


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                          .+.-|.+..       ..+.++.+.+|++.+|.++|.+|||++.+|+|||...
T Consensus       231 ----~~qpp~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  231 ----GFQPPTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             ----CCCCCcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence                111111111       1234778889999999999999999999999999865

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-35  Score=238.78  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=191.5

Q ss_pred             CceeeeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc-CCCceeecceeeeec
Q 018619            1 MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM-DHPNVISLKHCFFST   76 (353)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   76 (353)
                      |+.+...-..+.|.|.+.||+|-||.+.+|+|+.++..+++|.++...   +.+.+|..---.| .|.||+..|++-+..
T Consensus        14 ~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   14 MEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             cccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            344455556789999999999999999999999999999999987653   3344555433333 589999998876544


Q ss_pred             CCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE-eCCCCcEE
Q 018619           77 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-DPLTHQVK  154 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill-~~~~~~vk  154 (353)
                      .+    ++++++||++ |+|.+.+.     ...+.|.....++.|++.|+.|||+ +++||||||.+|||| +++..+||
T Consensus        94 ~d----~YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvK  163 (378)
T KOG1345|consen   94 SD----AYVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVK  163 (378)
T ss_pred             Cc----eEEEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEE
Confidence            33    5779999999 66655443     3568889999999999999999999 899999999999998 44456899


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhhCCC----CCCccccchhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHH
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKV  229 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-~~~~~~  229 (353)
                      |||||..+....--..  .-.+..|.+||++....    ...+.+|+|.||+++|.++||.+||+.....+.- ..-++.
T Consensus       164 lcDFG~t~k~g~tV~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w  241 (378)
T KOG1345|consen  164 LCDFGLTRKVGTTVKY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW  241 (378)
T ss_pred             eeecccccccCceehh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH
Confidence            9999998754321111  12255699999874322    2467899999999999999999999854333221 222222


Q ss_pred             hCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCC---CCHHHHhcCccccc
Q 018619          230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDE  299 (353)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~~~l~hp~f~~  299 (353)
                      .+....             ..|.         .-+.+++.+..+.++-|..++.+|   .++......-|...
T Consensus       242 ~~rk~~-------------~~P~---------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  242 LKRKNP-------------ALPK---------KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             hcccCc-------------cCch---------hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            111110             0000         113479999999999999999999   45555566667654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=247.19  Aligned_cols=259  Identities=27%  Similarity=0.337  Sum_probs=185.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHH--cCCCceeecceeeeecCCCCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      -....+.+++|+|.||.||+|.-  +++.||||+++.. ......|.+|.+.  ++|+||++++..=-... .....+++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywL  285 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWL  285 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeE
Confidence            34556788999999999999975  6799999999754 3445567666664  58999999876432222 22445889


Q ss_pred             Eecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--------CCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           87 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------PRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        87 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--------~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      |++|.+ |+|.++|..     ..+++....+++..+++||+|||+-        ..|+|||||..||||.+ +.+..|+|
T Consensus       286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaD  359 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIAD  359 (534)
T ss_pred             EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeec
Confidence            999998 888888875     6799999999999999999999983        36999999999999996 89999999


Q ss_pred             eccccccccCCCc---ceeeeeceeeChhhhhCCCCCC-----ccccchhHHHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 018619          158 FGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYT-----TSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIK  228 (353)
Q Consensus       158 fg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwSlG~il~~l~~g~~pf~-~~~~~~~~~~~~~  228 (353)
                      ||+|..+..+...   ...+||..|||||++.|.-++.     .+.||||+|.+||||++.-..+. +..+.-++---.+
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999887654332   3468999999999998765554     46899999999999998654332 1111101000111


Q ss_pred             HhCCCCHHHHhhcC------cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH
Q 018619          229 VLGTPTREEIRCMN------PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL  289 (353)
Q Consensus       229 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  289 (353)
                      .-..|..+.++...      |.+.+         .|..-   .-...+.+.+.-||.-||+-|+|+.
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~---------~W~~h---~~~~~l~et~EeCWDhDaeARLTA~  494 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPD---------AWRKH---AGMAVLCETIEECWDHDAEARLTAG  494 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChh---------hhhcC---ccHHHHHHHHHHHcCCchhhhhhhH
Confidence            11222333332211      11111         12111   1345688999999999999999985

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-32  Score=260.48  Aligned_cols=251  Identities=25%  Similarity=0.375  Sum_probs=193.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECC-------CCcEEEEEEeecc-----ccchHHHHHHHHHc-CCCceeeccee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHC   72 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~   72 (353)
                      |.+..++..+.+.||+|+||.|+++.-..       ....||+|.+...     ...+..|+++|+.+ +||||+.+.++
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            33445556778899999999999987431       1456999988643     34456899999988 59999999998


Q ss_pred             eeecCCCCceeEEEEecccc-chHHHHHHhhh---h-------cC--CCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           73 FFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS---S-------AN--QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~-------~~--~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      +..     ...+++|+|||. |+|...+....   .       ..  ..++......++.||+.|++||++ ..++||||
T Consensus       371 ~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDL  444 (609)
T KOG0200|consen  371 CTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDL  444 (609)
T ss_pred             ecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhh
Confidence            844     445889999999 78888887654   0       11  138999999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCCcce--eee--eceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YIC--SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLF  214 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~--~~~--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf  214 (353)
                      -..|||+.. +..+||+|||+|+..........  ..+  ...|||||.+.. ..|+.+|||||+|++|||+++ |..||
T Consensus       445 AaRNVLi~~-~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  445 AARNVLITK-NKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hhhhEEecC-CCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCC
Confidence            999999996 78999999999986544333221  111  234999999966 569999999999999999996 78999


Q ss_pred             CCCC-hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          215 PGEN-AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       215 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .+.. ..+... ..+....                           -.-|...++++-++++.||+.+|.+||+..++.
T Consensus       523 p~~~~~~~l~~-~l~~G~r---------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  523 PGIPPTEELLE-FLKEGNR---------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             CCCCcHHHHHH-HHhcCCC---------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence            8855 333332 2221000                           012345799999999999999999999998875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=9.2e-31  Score=220.24  Aligned_cols=208  Identities=37%  Similarity=0.589  Sum_probs=174.6

Q ss_pred             eecCCCeEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEecccc-
Q 018619           19 VGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-   92 (353)
Q Consensus        19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-   92 (353)
                      ||+|++|.||++....+++.+++|++.....     ...+|+..++.++|++++++++.+..     ....++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            6899999999999988899999999976643     46789999999999999999988733     345889999999 


Q ss_pred             chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC-Ccc
Q 018619           93 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANI  171 (353)
Q Consensus        93 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-~~~  171 (353)
                      ++|.+.+...   ...++...++.++.+++.++++||+ .|++|+||+|.||+++..++.++|+|||.+....... ...
T Consensus        76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~  151 (215)
T cd00180          76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK  151 (215)
T ss_pred             CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence            5766665531   1468999999999999999999999 7999999999999999535789999999998654432 123


Q ss_pred             eeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCC
Q 018619          172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP  251 (353)
Q Consensus       172 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (353)
                      ...+...|++||.+......+.++|+||+|+++++|                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            355678899999986543578999999999999999                                            


Q ss_pred             CCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCc
Q 018619          252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  295 (353)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp  295 (353)
                                      ..+.+++.+|++.||++||++.++++|+
T Consensus       188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                            1456899999999999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-31  Score=233.05  Aligned_cols=256  Identities=24%  Similarity=0.304  Sum_probs=182.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHH--cCCCceeecceeeeecCCCCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      +.+..+.+.||+|.||.||+++.  -|+.||||++....+ .-.+|.++.+.  |+|+||+.+++.=.... ..-..+++
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwL  286 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWL  286 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEE
Confidence            45678999999999999999986  788999999975443 34477777764  59999999876532211 23346999


Q ss_pred             Eecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           87 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        87 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-------~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      |++|-+ |+|+++|..     ..++.+...+++..++.||++||..       ..|+|||||..||||.+ ++.+.|+|+
T Consensus       287 vTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk-n~~C~IADL  360 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL  360 (513)
T ss_pred             eeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc-CCcEEEeec
Confidence            999999 899998875     6789999999999999999999972       36999999999999996 899999999


Q ss_pred             ccccccccCC-----CcceeeeeceeeChhhhhCCCCC-----CccccchhHHHHHHHHHhC----------CCCCCCCC
Q 018619          159 GSAKQLIAGE-----ANISYICSRFYRAPELIFGATEY-----TTSIDIWSAGCVLAELLLG----------QPLFPGEN  218 (353)
Q Consensus       159 g~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~~l~~g----------~~pf~~~~  218 (353)
                      |+|.......     .....+||..|||||++...-..     -..+||||||.++||++..          ++||.+--
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998765542     23467899999999999543211     1368999999999999742          46775432


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          219 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                      +.+.           ..+.+.+.   ...-.+.......|..   ...-..+..+++.||..+|.-|.|+--+
T Consensus       441 p~DP-----------s~eeMrkV---VCv~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  441 PSDP-----------SFEEMRKV---VCVQKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             CCCC-----------CHHHHhcc---eeecccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            2111           11111100   0000011111122322   0111245678999999999999998665

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=2.1e-32  Score=273.36  Aligned_cols=207  Identities=17%  Similarity=0.177  Sum_probs=145.8

Q ss_pred             HcCC-CceeecceeeeecCC--CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeee
Q 018619           60 VMDH-PNVISLKHCFFSTTS--KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH  136 (353)
Q Consensus        60 ~l~h-~~iv~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H  136 (353)
                      .++| +||+++++.|-....  .....++.++|+++++|.+.+..   ....+++.+++.++.||+.||.|||+ +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHS-QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHh-CCeee
Confidence            3345 577777776522221  11234668899999998888753   34669999999999999999999999 79999


Q ss_pred             ccCCCCcEEEeC------------------CCCcEEEeeeccccccccCC-----------------CcceeeeeceeeC
Q 018619          137 RDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIAGE-----------------ANISYICSRFYRA  181 (353)
Q Consensus       137 ~Dlkp~Nill~~------------------~~~~vkl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a  181 (353)
                      |||||+||||+.                  .++.+|++|||+++......                 ......+|++|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999963                  13456666666665321100                 0012357889999


Q ss_pred             hhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccc
Q 018619          182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV  261 (353)
Q Consensus       182 PE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (353)
                      ||++.+.. ++.++|||||||+||||++|.+|+....  .....+.... .++.                          
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~--------------------------  233 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ--------------------------  233 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh--------------------------
Confidence            99987654 8999999999999999999988875322  1111111110 0000                          


Q ss_pred             cCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          262 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       262 ~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      . ..-.+...+++.+||+.||.+|||+.|+++||||...+
T Consensus       234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            0 01144567899999999999999999999999998753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-31  Score=247.93  Aligned_cols=241  Identities=28%  Similarity=0.377  Sum_probs=190.6

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCc----EEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..+..++||+|+||+||++.....|+    +||||++...     ...+.+|+-+|..++|||++++.+++....     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            34556799999999999999877765    5788877543     233457999999999999999999873322     


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                       +-||++|++ |.|++.++.   ...++-......|..||++|++|||. ++++||||-..|+||.+ ...+|+.|||++
T Consensus       772 -~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVks-P~hvkitdfgla  845 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKS-PNHVKITDFGLA  845 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecC-CCeEEEEecchh
Confidence             558999999 677777765   45678888999999999999999999 79999999999999997 667999999999


Q ss_pred             cccccCCCcceeee---eceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          162 KQLIAGEANISYIC---SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       162 ~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      +....+.......+   .+-|+|-|.+.. ..|+.+|||||+||++||++| |..|+.+....+.-..+..    +.+  
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~----geR--  918 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK----GER--  918 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc----ccc--
Confidence            98776665544333   456999999854 569999999999999999996 8899988765544332222    110  


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                  ++          -+...+-++--++.+||..|+..||++.++.
T Consensus       919 ------------Ls----------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  919 ------------LS----------QPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             ------------CC----------CCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence                        00          1234778899999999999999999998764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3e-30  Score=219.87  Aligned_cols=201  Identities=34%  Similarity=0.577  Sum_probs=166.7

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      |.+.+.||+|++|.||++.+..+++.+++|.+...     .....+|+..++.++|+|++++++.+.     .....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            67889999999999999999988999999998654     345567999999999999999988773     23448899


Q ss_pred             eccccc-hHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~-l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +|++++ +|.+.+..    ... +++..++.++.+++.++.+||+ ++++|+||+|+||+++. ++.++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGM-DGLVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeeCceeeEec
Confidence            999997 77666653    223 8899999999999999999999 79999999999999996 6889999999998765


Q ss_pred             cCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCC-CChHHHHH
Q 018619          166 AGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLV  224 (353)
Q Consensus       166 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~  224 (353)
                      ...  ......++..|++||.+.+...++.++|+||+|+++++|++|+.||.. .+....+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~  211 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLS  211 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence            543  334556788899999974444578899999999999999999999977 44443333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=5.7e-30  Score=210.22  Aligned_cols=167  Identities=20%  Similarity=0.174  Sum_probs=125.1

Q ss_pred             chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcce
Q 018619           93 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS  172 (353)
Q Consensus        93 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (353)
                      |+|.+.+..   .+..+++..++.++.|++.||+|||+ ++      ||+|||++. ++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTW-DGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcC-ccceee--ccceEeecccc----
Confidence            456666653   24579999999999999999999999 67      999999996 788998  99987654322    


Q ss_pred             eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCCCCCcCC
Q 018619          173 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ-LVEIIKVLGTPTREEIRCMNPNYTDFRFP  251 (353)
Q Consensus       173 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (353)
                      ..||+.|+|||++.+. .++.++||||+||++|+|++|+.||........ +..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            2678999999999664 589999999999999999999999976544322 22222211100000               


Q ss_pred             CCCCCccccccCCCCCh--hHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          252 QIKAHPWHKVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       252 ~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                             .......++.  ++.++|.+||+.||.+|||+.+++.|+|+..
T Consensus       128 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 -------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence                   0000012333  6999999999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=217.15  Aligned_cols=250  Identities=19%  Similarity=0.241  Sum_probs=194.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCC-----CcEEEEEEeeccccch-----HHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-----~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +...+.++...+-+|.||.||.+..+..     .+.|.+|.+......+     ..|..++..+.|||++++.++...  
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie--  358 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE--  358 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee--
Confidence            5567888999999999999999965432     2446677776554433     367778888899999999887653  


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCc
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ  152 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~  152 (353)
                        +....++++.+.+ |+|...+...+.    ..+.++-.+...++.|++.|++|||+ +|++|.||-..|++||. .-+
T Consensus       359 --~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd-~Lq  434 (563)
T KOG1024|consen  359 --DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDD-QLQ  434 (563)
T ss_pred             --ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehh-hee
Confidence              2334667888888 777777763321    23457888889999999999999999 89999999999999995 789


Q ss_pred             EEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 018619          153 VKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       153 vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  228 (353)
                      +||+|=.+++...+.+..   ...-...-|||||.+.. ..|+.++|+||||++||||+| |+.|+..-++.++...+.+
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd  513 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD  513 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence            999999999876544321   11122456999999955 459999999999999999996 8999999999888766654


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .                  +.+.          -+-++++++..++.-||+.+|++||+.+|+.
T Consensus       514 G------------------yRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  514 G------------------YRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             c------------------ceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            2                  1111          1246899999999999999999999999885

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.9e-30  Score=245.76  Aligned_cols=257  Identities=24%  Similarity=0.356  Sum_probs=191.4

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeec----cc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ....++|.|++|.|+.+......+.++.|.+..    ..      .....|..+-..+.|||++.....++....     
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-----  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-----
Confidence            567799999999999988877777666665431    11      012245666677899999887766643332     


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .+-+||||+++|...+..    ...++...+..++.||+.|++|||+ .||.|||+||+|+++.. ++.+||+|||.+..
T Consensus       396 ~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~-~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTE-NGILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEec-CCceEEeecCccee
Confidence            223499999977776653    3578999999999999999999999 69999999999999996 88999999999886


Q ss_pred             cccCC-----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          164 LIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       164 ~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ..-..     .....+|+..|+|||++.+...-....||||.|++++.|.+|+.||......+....-...         
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---------  540 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---------  540 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---------
Confidence            54322     2345788999999999988775567899999999999999999999765544332100000         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                            .......   ..+  ..+...++...+.+|.+||+.||.+|.|+++|++.+||+.+.
T Consensus       541 ------~~~~~~~---~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  541 ------SDQRNIF---EGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             ------ccccccc---cCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence                  0000000   000  111234788999999999999999999999999999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5e-28  Score=196.01  Aligned_cols=211  Identities=22%  Similarity=0.326  Sum_probs=171.4

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHcCC-CceeecceeeeecCCCCc
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH-PNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++.+++|.+++.||+|+||.+|++.+..+|+.||||.-.+..+  ....|..+.+.|++ ..|..+..+.     ...
T Consensus         9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~   83 (341)
T KOG1163|consen    9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEK   83 (341)
T ss_pred             hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----ccc
Confidence            356889999999999999999999999999999999998866543  44579999999975 3455554444     334


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe--CCCCcEEEeeec
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFG  159 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~--~~~~~vkl~Dfg  159 (353)
                      .+-.+||++++.+|.+++..   .+.+++...+..++-|++.-++|+|. ++++||||||+|+|..  ....++.|+|||
T Consensus        84 ~ynvlVMdLLGPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   84 DYNVLVMDLLGPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ccceeeeeccCccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEecc
Confidence            44669999999998887765   45779999999999999999999999 8999999999999984  334579999999


Q ss_pred             cccccccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018619          160 SAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE  225 (353)
Q Consensus       160 ~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  225 (353)
                      +|+...+...        .....||..|.|--...+.. .+.+.|+-|+|.+|..+--|.+||++.......++
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK  232 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK  232 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence            9997655432        23567899999987766543 68889999999999999999999998765544443

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-26  Score=203.47  Aligned_cols=251  Identities=19%  Similarity=0.197  Sum_probs=188.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCC-cEEEEEEeeccc----cchHHHHHHHHHcCC----CceeecceeeeecCCCCce
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR----RYKNRELQLMRVMDH----PNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|.+.+.||+|+||.||.+.+..++ +.+|+|......    .....|..++..+..    +++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            8999999999999999999987774 678999776532    256789999998873    46677665542    2445


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC----CcEEEeee
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT----HQVKICDF  158 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~----~~vkl~Df  158 (353)
                      +.|+||+.++.+|.++.....  .+.++...+..++.|++.+|++||+ .|++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999988775533  6889999999999999999999999 7999999999999997533    57999999


Q ss_pred             cccc--ccccCC--------C-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 018619          159 GSAK--QLIAGE--------A-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII  227 (353)
Q Consensus       159 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~  227 (353)
                      |+|+  ......        . .....||..|.|+.+..+. ..+.+.|+||++.++.+++.|..||..........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  322111        1 1234589999999988665 48999999999999999999999997766433333222


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +........               .         +....+.++..+...+-..+...+|....+...
T Consensus       251 ~~~~~~~~~---------------~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  251 KDPRKLLTD---------------R---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             HHhhhhccc---------------c---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            211000000               0         112245677777777777888999987766433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=224.68  Aligned_cols=237  Identities=26%  Similarity=0.387  Sum_probs=191.4

Q ss_pred             eeecCCCeEEEEEEEC---CCCcEEEEEEeeccc------cchHHHHHHHHHcC-CCceeecceeeeecCCCCceeEEEE
Q 018619           18 VVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      ++|+|+||.|++++..   ..|..||+|...+..      .....|..++...+ ||.+|++.-.|     +....++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence            4799999999987632   456789999775431      22335777888886 99999998887     555558899


Q ss_pred             eccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           88 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      +++..|+   .+.........+.+...+.+...++.|++++|+ .+|+|||+|++||+++. +|.+++.|||+++.....
T Consensus        76 ld~~rgg---~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGG---DLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccc---hhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecc-cCccccCCchhhhHhHhh
Confidence            9999975   333334456778889999999999999999999 69999999999999997 888999999999876655


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      +..   +||..|||||++.   ....++|.||+|+++++|++|..||..    +....|.+.                  
T Consensus       151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~------------------  202 (612)
T KOG0603|consen  151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA------------------  202 (612)
T ss_pred             hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh------------------
Confidence            544   8899999999986   367899999999999999999999988    444444441                  


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                                 ...++..++..+++++..++..+|..|..     +.++++|+||+.+.+.
T Consensus       203 -----------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  203 -----------ELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             -----------ccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                       01123457899999999999999999985     4799999999998776

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6.3e-26  Score=191.83  Aligned_cols=203  Identities=22%  Similarity=0.356  Sum_probs=168.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcC-CCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .++.+-+|++.+.||+|+||..+.+++..+++.||||.-+..  ......|....+.|. .+.|...+  ++.   +...
T Consensus        23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vY--YFG---qeG~   97 (449)
T KOG1165|consen   23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVY--YFG---QEGK   97 (449)
T ss_pred             ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCcee--eec---cccc
Confidence            357788999999999999999999999999999999977543  345567888888885 57777653  222   2233


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC----CCCcEEEeee
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDF  158 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~----~~~~vkl~Df  158 (353)
                      +-.+|+|+++.+|.+++.-   .+.+|+...+..++.|++.-++++|+ +++|+|||||+|+||..    +.+.|.++||
T Consensus        98 ~NiLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   98 YNILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             hhhhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEec
Confidence            4558999999999888765   57889999999999999999999999 89999999999999952    2457999999


Q ss_pred             ccccccccCCCc--------ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 018619          159 GSAKQLIAGEAN--------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN  218 (353)
Q Consensus       159 g~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  218 (353)
                      |+|+.+.+....        .+..||..|||--..+|.+ -+.+.|+-|||-+++..+-|.+||++..
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            999987665442        3467899999988877765 7899999999999999999999998754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.3e-26  Score=207.73  Aligned_cols=170  Identities=19%  Similarity=0.269  Sum_probs=126.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC-CCcEEEEEEeecc---------ccchHHHHHHHHHcCCCceee-cceeeeec
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVIS-LKHCFFST   76 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~   76 (353)
                      ...++|.+.+.||+|+||+||+|.+.. +++.||||+....         ...+.+|+.+|+.++|+|++. +++ +   
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~---   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T---   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c---
Confidence            346789999999999999999999876 6778899986422         233578999999999999985 322 1   


Q ss_pred             CCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC-CCCcEEEeCCCCcEEE
Q 018619           77 TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQVKI  155 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl-kp~Nill~~~~~~vkl  155 (353)
                      .     ..|+|||||.|..+....    ...      ...++.|++.||.|||+ +||+|||| ||+|||++. ++.+||
T Consensus        91 ~-----~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~-~~~ikL  153 (365)
T PRK09188         91 G-----KDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGP-DGEAAV  153 (365)
T ss_pred             C-----CcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcC-CCCEEE
Confidence            1     267999999975333211    111      14678899999999999 79999999 999999985 778999


Q ss_pred             eeeccccccccCCCc---------ceeeeeceeeChhhhhCCC-----CCCccccch
Q 018619          156 CDFGSAKQLIAGEAN---------ISYICSRFYRAPELIFGAT-----EYTTSIDIW  198 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~~~~~~-----~~~~~~Diw  198 (353)
                      +|||+|+........         ....+++.|.|||.+...+     ..+..+|-|
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999866443321         2345677899999873321     123446666

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.94  E-value=7.5e-25  Score=197.08  Aligned_cols=257  Identities=33%  Similarity=0.474  Sum_probs=194.9

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCC-ceeecceeeeecCCCCceeE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHP-NVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~   84 (353)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+....       ....+|+.++..+.|+ +++++.+.+.     .....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence            789999999999999999986   788999885432       2345788999999988 7999998882     22227


Q ss_pred             EEEeccccch-HHHHHHhhhhcC---CCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           85 NLVMEYVPES-MYRVLKHYSSAN---QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        85 ~lv~e~~~~~-l~~~l~~~~~~~---~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      +++++++.+. +...+.    ..   ..++...+..++.|++.+++++|+ .+++|||+||+||+++..+..++++|||.
T Consensus        74 ~~~~~~~~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~  148 (384)
T COG0515          74 YLVMEYVDGGSLEDLLK----KIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGL  148 (384)
T ss_pred             EEEEecCCCCcHHHHHH----hcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence            8999999964 332222    22   379999999999999999999999 79999999999999997333799999999


Q ss_pred             ccccccCC-------CcceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHH
Q 018619          161 AKQLIAGE-------ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIK  228 (353)
Q Consensus       161 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~~~~  228 (353)
                      +.......       ......+|..|++||.+.+.  ..++...|+||+|++++++++|..||.....   .......+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  228 (384)
T COG0515         149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL  228 (384)
T ss_pred             ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH
Confidence            98554433       23567889999999999763  4688999999999999999999999877764   333333333


Q ss_pred             HhCCC-CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          229 VLGTP-TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       229 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ....+ .....            .        ..........+.+++.+++..+|..|.+..+...+++......
T Consensus       229 ~~~~~~~~~~~------------~--------~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         229 ELPTPSLASPL------------S--------PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             hcCCccccccc------------C--------ccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence            22222 00000            0        0000112367899999999999999999999998877765443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=1e-26  Score=222.38  Aligned_cols=225  Identities=28%  Similarity=0.482  Sum_probs=170.2

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEe
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      ....|..++.+..|+||.||+++|+.+.+++|+ ++.++....+.   ++....+|.+|                     
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn---ilt~a~npfvv---------------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN---ILTFAGNPFVV---------------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc---cccccCCccee---------------------
Confidence            456889999999999999999999999999999 46555433322   22222222222                     


Q ss_pred             ccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC-
Q 018619           89 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-  167 (353)
Q Consensus        89 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-  167 (353)
                          |+-...++    .-++++..        ++.+++|||+ -||+|||+||+|.+|.. -|.+|++|||+++..... 
T Consensus       136 ----gDc~tllk----~~g~lPvd--------mvla~Eylh~-ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLLK----NIGPLPVD--------MVLAVEYLHS-YGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhcc----cCCCCcch--------hhHHhHhhcc-CCeecCCCCCCcceeee-cccccccchhhhhhhhhhc
Confidence                22112222    22344443        3788999999 79999999999999997 788999999998743211 


Q ss_pred             -------C--------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          168 -------E--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       168 -------~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                             .        .....+|||.|+|||++.. +.|+..+|+|++|+|+|+.+.|..||.+.+.++.+.+.+.....
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence                   0        1124578999999999965 45999999999999999999999999999999998888773221


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC---CHHHHhcCcccccccCC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC---TALEACAHPFFDELREP  303 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~~~l~hp~f~~~~~~  303 (353)
                                               |.+. ...++++++++|.++|+.+|..|.   .+.++.+|+||+.+.+.
T Consensus       277 -------------------------wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 -------------------------WPEE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             -------------------------cccc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence                                     1111 134789999999999999999997   46788999999998876

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=2.1e-24  Score=185.62  Aligned_cols=237  Identities=24%  Similarity=0.315  Sum_probs=143.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchH-------HHHHHHHHcC----------CCceeecceee-
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMD----------HPNVISLKHCF-   73 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~E~~~l~~l~----------h~~iv~~~~~~-   73 (353)
                      .+...+.||.|+++.||.+.+..||+.+|+|++........       +|.-....+.          |-.++...+.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            56778899999999999999999999999998854332221       2221111111          11111111211 


Q ss_pred             -------eecCCC-Cce---eEEEEeccccchHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           74 -------FSTTSK-NEL---FLNLVMEYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        74 -------~~~~~~-~~~---~~~lv~e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                             ...... ...   ..+++|+-+.++|...+.........   +.......+..|++..+++||+ .|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEeccc
Confidence                   111110 111   24678898888887776542222222   3333334455899999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCC-------CCCCccccchhHHHHHHHHHhCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQP  212 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~l~~g~~  212 (353)
                      +|+|++++. +|.+.|+||+...........  ...+..|.+||.....       -.++.+.|.|+||+++|.|.+|..
T Consensus       172 ~~~nfll~~-~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQ-DGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-T-TS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcC-CCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999997 889999999987654332211  2335679999987432       236889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCC
Q 018619          213 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR  285 (353)
Q Consensus       213 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  285 (353)
                      ||.........                       +.        .|.. = .++|+.+++||+++|+.||.+|
T Consensus       249 Pf~~~~~~~~~-----------------------~~--------~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADP-----------------------EW--------DFSR-C-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTS-----------------------GG--------GGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccc-----------------------cc--------cchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence            99765432110                       00        0000 0 2589999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.9e-24  Score=185.09  Aligned_cols=195  Identities=23%  Similarity=0.328  Sum_probs=142.7

Q ss_pred             CCCceeecceeeeecC----------------------CCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHH
Q 018619           62 DHPNVISLKHCFFSTT----------------------SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY  119 (353)
Q Consensus        62 ~h~~iv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~  119 (353)
                      +|||||.+...|.+..                      -.....+|+||.....+|.+++..     ...+....+-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            5999999987774321                      122456899999999998888764     5567778888999


Q ss_pred             HHHHHHHHhHcCCCeeeccCCCCcEEEeCC---CCcEEEeeeccccccccC-------CCcceeeeeceeeChhhhhCCC
Q 018619          120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQLIAG-------EANISYICSRFYRAPELIFGAT  189 (353)
Q Consensus       120 qll~al~~LH~~~~i~H~Dlkp~Nill~~~---~~~vkl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~  189 (353)
                      |+++|+.|||+ +||.|||+|.+|||+.-+   -..+.++|||+|--...-       ......-|.-.-||||+....+
T Consensus       349 QlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999999 799999999999999422   236899999998532211       1112234566689999974432


Q ss_pred             CC-----CccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCC
Q 018619          190 EY-----TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK  264 (353)
Q Consensus       190 ~~-----~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (353)
                      ..     -.++|.|+.|.+.||++....||.+....-.-.                  .+|.+..+|.         ++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------------r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------------RTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------------hhhhhhhCCC---------Ccc
Confidence            21     237899999999999999999998854321110                  1122223333         345


Q ss_pred             CCChhHHHHHHHhcCcCCCCCCCHH
Q 018619          265 RMPPEAIDLASRLLQYSPSLRCTAL  289 (353)
Q Consensus       265 ~~~~~~~~li~~~L~~dp~~R~t~~  289 (353)
                      .+++.+++++..+|+.||++|+++.
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCcc
Confidence            6899999999999999999999964

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=4.8e-24  Score=176.09  Aligned_cols=135  Identities=18%  Similarity=0.222  Sum_probs=103.5

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------------c-----------------hHHHHHHHHHcCCCc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------------Y-----------------KNRELQLMRVMDHPN   65 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~-----------------~~~E~~~l~~l~h~~   65 (353)
                      ...||+|++|.||+|.+. +|+.||+|++.....             .                 ..+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 899999999864321             1                 124889999998777


Q ss_pred             eeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-HcCCCeeeccCCCCcE
Q 018619           66 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRVCHRDLKPQNL  144 (353)
Q Consensus        66 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~L-H~~~~i~H~Dlkp~Ni  144 (353)
                      +.......  ..   .  .++||||++|+.+...   ......+++..+..++.|++.+|.++ |+ .||+||||||+||
T Consensus        81 v~~p~~~~--~~---~--~~iVmE~i~g~~l~~~---~~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK---S--HVLVMEFIGDDGWAAP---RLKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec---C--CEEEEEEeCCCCCcch---hhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHE
Confidence            64332211  11   1  3699999997532211   11346789999999999999999999 68 7999999999999


Q ss_pred             EEeCCCCcEEEeeecccccc
Q 018619          145 LVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus       145 ll~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++  ++.++|+|||+|...
T Consensus       150 li~--~~~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYH--DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEE--CCcEEEEEccccccC
Confidence            998  367999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=2.8e-24  Score=206.26  Aligned_cols=241  Identities=28%  Similarity=0.412  Sum_probs=172.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      +|...+.||++.|=+|.+|++. .| .|+||++.+...        ...+|++ ....++||.+.+..+.     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            6888999999999999999863 44 489998865431        1123444 5567899999876554     44445


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .|+|-+|+..+|++.+..    ..-+...+.+.|+.||+.||.-+|. .||+|||||.+||||.+ -+=+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTS-WNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITS-WNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEee-echhhhhcccccCC
Confidence            779999999999888864    3557788888999999999999999 79999999999999997 44489999988765


Q ss_pred             cccCCC---cceee-----eeceeeChhhhhCCC---------C-CCccccchhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 018619          164 LIAGEA---NISYI-----CSRFYRAPELIFGAT---------E-YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  224 (353)
Q Consensus       164 ~~~~~~---~~~~~-----~t~~y~aPE~~~~~~---------~-~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  224 (353)
                      ..-.+.   ..++.     .-.+|.|||.+....         . .+++-||||+||+++|+++ |++||.-.    ++-
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHH
Confidence            432221   11211     134699999874411         1 5678999999999999986 68998421    111


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ..... +....+.+-                       .+--+..++.+|..|++.||++|.+|++.|+-
T Consensus       246 aYr~~-~~~~~e~~L-----------------------e~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  246 AYRSG-NADDPEQLL-----------------------EKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hHhcc-CccCHHHHH-----------------------HhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11110 011111000                       00114478999999999999999999999865

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.3e-23  Score=175.61  Aligned_cols=172  Identities=12%  Similarity=0.110  Sum_probs=126.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cc---------hHHHHHHHHHcCCCceeecceeee
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RY---------KNRELQLMRVMDHPNVISLKHCFF   74 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~---------~~~E~~~l~~l~h~~iv~~~~~~~   74 (353)
                      +..++|++.++||.|+||.||++..  ++..+|+|.+....    ..         .++|+..+.++.||+|..+.+.+.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3478999999999999999999765  57789999885321    11         457888999999999999988765


Q ss_pred             ecCCC---CceeEEEEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC
Q 018619           75 STTSK---NELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT  150 (353)
Q Consensus        75 ~~~~~---~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~  150 (353)
                      .....   .....+++|||++|. |.+.        ..+++.    ...+++.++..+|+ .|++|||+||+||++++ +
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~--------~~~~~~----~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~-~  171 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDM--------PEISED----VKAKIKASIESLHQ-HGMVSGDPHKGNFIVSK-N  171 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHh--------hhccHH----HHHHHHHHHHHHHH-cCCccCCCChHHEEEeC-C
Confidence            43211   123478999999984 3322        122332    45699999999999 79999999999999996 6


Q ss_pred             CcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHH
Q 018619          151 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL  208 (353)
Q Consensus       151 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~  208 (353)
                      + ++|+|||.+...........           .... ..|+.++|+||||+++..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            6 99999998875432222111           2223 34678999999999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=2.1e-22  Score=164.73  Aligned_cols=182  Identities=16%  Similarity=0.096  Sum_probs=133.9

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc--------chHHHHHHHHHcC-CCceeecceeeeecCCCCceeE
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+...|++|+||+|+++..  .+.+++.+.+.....        .+.+|+++|+.++ ++++.++++..     .    .
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----~   73 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----R   73 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----E
Confidence            4678999999999997764  778888777754432        3568999999995 47788876631     1    5


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC-CCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL-KPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl-kp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +++|||+.|..+...   ..      .. ...++.|++.+|+++|+ +||+|||| ||+|||++. ++.++|+|||+|..
T Consensus        74 ~lvmeyI~G~~L~~~---~~------~~-~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~  141 (218)
T PRK12274         74 HLDRSYLAGAAMYQR---PP------RG-DLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEeeecCccHHhh---hh------hh-hHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcC-CCCEEEEECCCcee
Confidence            799999998532211   10      01 13477899999999999 79999999 799999986 77899999999985


Q ss_pred             cccCCCc--------------ceeeeeceeeChhhhhCCCCCC-ccccchhHHHHHHHHHhCCCCCCCCC
Q 018619          164 LIAGEAN--------------ISYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGEN  218 (353)
Q Consensus       164 ~~~~~~~--------------~~~~~t~~y~aPE~~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~  218 (353)
                      .......              .-...++.|++|+...-....+ ...++++.|+-+|.++|+..++.+.+
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            5443311              0112477888888653332233 56788999999999999999886654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3e-22  Score=166.06  Aligned_cols=138  Identities=18%  Similarity=0.191  Sum_probs=105.9

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------------------------------chHHHHHHHHHcCCC
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------YKNRELQLMRVMDHP   64 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~   64 (353)
                      +.+.||+|++|.||+|.+. +|+.||||++.....                              ...+|...+..+.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999998864321                              113678889999888


Q ss_pred             ceeecceeeeecCCCCceeEEEEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCc
Q 018619           65 NVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN  143 (353)
Q Consensus        65 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~N  143 (353)
                      ++........  . .    .++||||++|. +.....    ...+++...+..++.|++.++.++|+.+||+||||||+|
T Consensus        80 ~i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~N  148 (190)
T cd05145          80 GVPVPEPILL--K-K----NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYN  148 (190)
T ss_pred             CCCCceEEEe--c-C----CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhh
Confidence            8754433221  1 1    36999999975 222111    235678889999999999999999982399999999999


Q ss_pred             EEEeCCCCcEEEeeecccccccc
Q 018619          144 LLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus       144 ill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |+++  ++.++|+|||+|.....
T Consensus       149 Ill~--~~~~~liDFG~a~~~~~  169 (190)
T cd05145         149 ILYH--DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEEE--CCCEEEEEcccceecCC
Confidence            9998  57799999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=7.3e-21  Score=185.53  Aligned_cols=195  Identities=22%  Similarity=0.369  Sum_probs=148.3

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHcC---CCceeecceeeeecCCCCc
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-KNRELQLMRVMD---HPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~   81 (353)
                      +-+.++.|.|.+.+|+|+||+||+|.+.. |+.||+|+-...... +.-=..++.+|+   -+.|..+..++...+.   
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~---  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA---  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc---
Confidence            34668899999999999999999999876 999999976443211 001122333444   2344444444322222   


Q ss_pred             eeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe------CCCCcEE
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD------PLTHQVK  154 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~------~~~~~vk  154 (353)
                        -++|+||.+ |+|++++.    .++.+++..+..+..|++.-++.||. .+|||+||||+|+||.      .+..-++
T Consensus       769 --S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  769 --SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             --ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceE
Confidence              448999999 78777765    67889999999999999999999999 7999999999999993      2234599


Q ss_pred             Eeeecccccccc---CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCC
Q 018619          155 ICDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  212 (353)
Q Consensus       155 l~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  212 (353)
                      |+|||.+..+.-   +.......+|-.+-.+|...|. .+++.+|.|+++.+++.|+.|+.
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhhhHHHHHHHHHHHHHHH
Confidence            999999976543   3334556778899999999775 49999999999999999999973

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=2e-20  Score=155.88  Aligned_cols=136  Identities=18%  Similarity=0.240  Sum_probs=102.0

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHc-----CCCceeecceeeeecCCCCceeE
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVM-----DHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .-.+.||+|++|.||.  +..++.. +||++...    .....+|+.+++.+     +||||+++++++.+... ....+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-~g~v~   80 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-TGYVY   80 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-CeEEE
Confidence            3457899999999995  7777666 69987643    34567899999999     67999999998854321 12224


Q ss_pred             EEEecccc---chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH-HHhHcCCCeeeccCCCCcEEEeC---CCCcEEEee
Q 018619           85 NLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL-AYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICD  157 (353)
Q Consensus        85 ~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al-~~LH~~~~i~H~Dlkp~Nill~~---~~~~vkl~D  157 (353)
                      .+|+||++   ++|.+.+..     ..+++.  ..++.|++.++ +|||+ ++|+||||||+|||++.   .+..++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            47899955   577777753     345555  35678888888 99999 79999999999999974   234799999


Q ss_pred             eccc
Q 018619          158 FGSA  161 (353)
Q Consensus       158 fg~a  161 (353)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5444

>smart00090 RIO RIO-like kinase

Probab=99.84  E-value=1.1e-20  Score=161.36  Aligned_cols=139  Identities=16%  Similarity=0.113  Sum_probs=105.8

Q ss_pred             eeeEeeeeecCCCeEEEEEE-ECCCCcEEEEEEeeccc----------------------------cchHHHHHHHHHcC
Q 018619           12 SYMAERVVGTGSFGIVFQAK-CLETGETVAIKKVLQDR----------------------------RYKNRELQLMRVMD   62 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~   62 (353)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|++....                            ....+|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999998 77899999999886431                            11347899999887


Q ss_pred             CCceeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-eeeccCCC
Q 018619           63 HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-VCHRDLKP  141 (353)
Q Consensus        63 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-i~H~Dlkp  141 (353)
                      +. .+.+..++.. .     ..++||||++|......   ......+....+..++.|++.++++||+ +| ++||||||
T Consensus       109 ~~-~i~~p~~~~~-~-----~~~lV~E~~~g~~L~~~---~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp  177 (237)
T smart00090      109 EA-GVPVPKPIAW-R-----RNVLVMEFIGGDGLPAP---RLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSE  177 (237)
T ss_pred             hc-CCCCCeeeEe-c-----CceEEEEEecCCccccc---ccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCCh
Confidence            53 2333333311 1     14699999998532211   1123456677778999999999999999 79 99999999


Q ss_pred             CcEEEeCCCCcEEEeeeccccc
Q 018619          142 QNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus       142 ~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +||+++  ++.++|+|||.|..
T Consensus       178 ~NIli~--~~~i~LiDFg~a~~  197 (237)
T smart00090      178 YNILVH--DGKVVIIDVSQSVE  197 (237)
T ss_pred             hhEEEE--CCCEEEEEChhhhc
Confidence            999998  56799999999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=4.8e-21  Score=158.32  Aligned_cols=238  Identities=18%  Similarity=0.253  Sum_probs=173.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +..+..+|.+...|..|+++..  |..++.|++.-.      .+.+..|.-.|+.+.||||+.+.+.+-     ....+.
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv  263 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLV  263 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCce
Confidence            4456678888999999999874  444555655322      345567888899999999999998883     334477


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec-cCCCCcEEEeCCCCcEEE--eeeccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR-DLKPQNLLVDPLTHQVKI--CDFGSA  161 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~-Dlkp~Nill~~~~~~vkl--~Dfg~a  161 (353)
                      ++..||+ |+|+..+...  .+-..+-.++.+++..+++|++|||+...++-| -|....+++|+ +.+.+|  +|--++
T Consensus       264 ~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kfs  340 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKFS  340 (448)
T ss_pred             EeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccceee
Confidence            9999999 7888888752  334467788999999999999999996555544 57888899985 655554  333222


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCC--CccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .      ........|.|+|||.+...+.-  -.++|+|||++++||+.|...||....+.+.--++.-           
T Consensus       341 f------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----------  403 (448)
T KOG0195|consen  341 F------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----------  403 (448)
T ss_pred             e------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----------
Confidence            2      11223447889999999654322  3579999999999999999999988777655433221           


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                      +-....++..++.....|++-|+..||.+||..+.++
T Consensus       404 ----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  404 ----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence                            1112234567899999999999999999999887764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.4e-20  Score=167.61  Aligned_cols=179  Identities=28%  Similarity=0.443  Sum_probs=131.4

Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ..++||.|++|.. +|.+.+.. .......+......++.|+..|++|    ++.+|+|+||.||+... +..+||+|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~r-r~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~-d~q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRR-RRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSD-DDQLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhC-CCcccccchhHHHHHHHhhccchhh----ccchhhhcccccccccc-chhhhhhhhh
Confidence            3468899999994 55555543 3445667888899999999999999    49999999999999985 6789999999


Q ss_pred             cccccccCC-------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhC
Q 018619          160 SAKQLIAGE-------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       160 ~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      +........       ..+..+||.+||+||.+.+.. |+.++||||||+||+|++.- ...|..      .....    
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~----  470 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFER------IATLT----  470 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHH------HHhhh----
Confidence            998776655       456678999999999998765 99999999999999999962 222211      10000    


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                          .+....|...+..+ -++-.+|+.+||...|.+||++.+.--|+|.
T Consensus       471 --------------------d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  471 --------------------DIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             --------------------hhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                                00111111111111 2345689999999999999988877777764

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=2.3e-19  Score=164.11  Aligned_cols=203  Identities=27%  Similarity=0.409  Sum_probs=149.3

Q ss_pred             HHHcCCCceeecceeeeecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCe-e
Q 018619           58 MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-C  135 (353)
Q Consensus        58 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i-~  135 (353)
                      |+.+.|.|+.++++..+..     ...++|.+||. |+|.+.+..   ....+++.....+++.++.||+|+|. ..| .
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~-s~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHN-SPIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhc-Cccee
Confidence            3567899999999998665     33779999999 777777764   56778899999999999999999999 455 9


Q ss_pred             eccCCCCcEEEeCCCCcEEEeeeccccccccC---CCcceeeeeceeeChhhhhCCCC------CCccccchhHHHHHHH
Q 018619          136 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATE------YTTSIDIWSAGCVLAE  206 (353)
Q Consensus       136 H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwSlG~il~~  206 (353)
                      |+.++..|+++|. ...+||+|||+.......   ...........|.|||++.+...      .+.+.|+||+|++++|
T Consensus        72 hg~l~s~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   72 HGALKSSNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeccccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            9999999999996 899999999998755321   11111223456999999966311      3667999999999999


Q ss_pred             HHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCC
Q 018619          207 LLLGQPLFPGENAV----DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP  282 (353)
Q Consensus       207 l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  282 (353)
                      +++.+.||......    +.+..+.+....+....+..                     . ..+.+++..++++||..+|
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~---------------------~-~e~~~~l~~l~~~cw~e~P  208 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIEL---------------------L-NELPPELLLLVARCWEEIP  208 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhh---------------------h-hhcchHHHHHHHHhcccCh
Confidence            99999999763322    23333222011111111100                     0 1245689999999999999


Q ss_pred             CCCCCHHHHh
Q 018619          283 SLRCTALEAC  292 (353)
Q Consensus       283 ~~R~t~~~~l  292 (353)
                      .+||+++++-
T Consensus       209 ~~rPs~~~i~  218 (484)
T KOG1023|consen  209 EKRPSIEQIR  218 (484)
T ss_pred             hhCccHHHHH
Confidence            9999998873

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=3.3e-21  Score=183.97  Aligned_cols=256  Identities=24%  Similarity=0.326  Sum_probs=192.5

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCC-CcEEEEEEeeccc------cchHHHHHHHHHcC-CCceeecceeeeecCCCCc
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...|.+.+.||+|+++.|-++....+ ...+|.|.+....      .....|..+-+.+. |+|+++.++..     ...
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~   93 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP   93 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence            45788999999999999988876443 3456666554322      12234777777776 99999998877     455


Q ss_pred             eeEEEEeccccch-HHHHHHhhhhcCC-CCCHHHHHHHHHHHHHHHHHhH-cCCCeeeccCCCCcEEEeCCCC-cEEEee
Q 018619           82 LFLNLVMEYVPES-MYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTH-QVKICD  157 (353)
Q Consensus        82 ~~~~lv~e~~~~~-l~~~l~~~~~~~~-~l~~~~~~~i~~qll~al~~LH-~~~~i~H~Dlkp~Nill~~~~~-~vkl~D  157 (353)
                      .+.+++++|..|+ +.....   ..+. ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++. .+ .++++|
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~---~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~-s~~~l~~~d  168 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKIS---HPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDE-SGSALKIAD  168 (601)
T ss_pred             cccccccCcccccccccccc---cCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhcc-CCCcccCCC
Confidence            5588999997764 222221   2333 6777888999999999999999 8 89999999999999996 66 899999


Q ss_pred             ecccccccc-CCCc---ceeee-eceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          158 FGSAKQLIA-GEAN---ISYIC-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       158 fg~a~~~~~-~~~~---~~~~~-t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      ||+|..... .+..   ...+| ++.|.|||...+....+...|+||+|+++..|++|..|+......+....       
T Consensus       169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-------  241 (601)
T KOG0590|consen  169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-------  241 (601)
T ss_pred             chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-------
Confidence            999987765 3322   34567 99999999997766678899999999999999999999976554331100       


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                      .+.... ........+.++..+.+++.++|..+|..|.+..++-.+||+..
T Consensus       242 ----------------~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  242 ----------------SWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ----------------eecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                            000000 11112233568999999999999999999999999999999988

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=2.6e-18  Score=143.50  Aligned_cols=134  Identities=19%  Similarity=0.142  Sum_probs=100.5

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--------------------------cchHHHHHHHHHcCCCc
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------RYKNRELQLMRVMDHPN   65 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~~   65 (353)
                      .|.+.+.||+|++|.||++.. .+|+.||||++....                          ....+|..++..+.+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            488999999999999999986 489999999865321                          11346788888887764


Q ss_pred             e--eecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCc
Q 018619           66 V--ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN  143 (353)
Q Consensus        66 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~N  143 (353)
                      +  ...++    .     ...++||||++|.....+..         ......++.+++.++.++|+ .|++|+||||+|
T Consensus        95 i~v~~~~~----~-----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~N  155 (198)
T cd05144          95 FPVPKPID----W-----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYK-HGIIHGDLSEFN  155 (198)
T ss_pred             CCCCceee----c-----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHH-CCCCcCCCCccc
Confidence            3  22221    1     12479999999753222211         03356788999999999999 799999999999


Q ss_pred             EEEeCCCCcEEEeeecccccccc
Q 018619          144 LLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus       144 ill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |+++. ++.++|+|||.+.....
T Consensus       156 ill~~-~~~~~liDfg~~~~~~~  177 (198)
T cd05144         156 ILVDD-DEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEcC-CCcEEEEECCccccCCC
Confidence            99996 78999999999965433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=8.3e-18  Score=142.04  Aligned_cols=129  Identities=20%  Similarity=0.314  Sum_probs=100.7

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +.||+|++|.||++..  .|..+++|+.....            ....+|+.++..+.|+++.....++....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5799999999999986  77889999764221            12347899999999988876655553322     26


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +++|||++| +|.+.+..    ..   . ....++.+++.+|.++|+ .|++|+|++|.||+++  ++.++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS--GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence            799999986 55555432    11   1 678899999999999999 7999999999999998  56799999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=3.3e-17  Score=137.04  Aligned_cols=125  Identities=20%  Similarity=0.307  Sum_probs=93.5

Q ss_pred             eeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           18 VVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .||+|++|.||++..  ++..+++|......            ....+|+.+++.+.|+++......+....     ..+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence            479999999999984  67889999864321            22346999999998877554433332221     256


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++|||++| ++.+.+..    ...       .++.|++.+|.+||+ .|++|+|++|.||+++  ++.++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR--DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence            99999986 44443322    110       678899999999999 7999999999999998  57799999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1.1e-16  Score=153.41  Aligned_cols=130  Identities=20%  Similarity=0.282  Sum_probs=97.5

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEee-cc-----------ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .|...+.||+|+||+||++...  +..+++|+.. +.           .....+|+.+++.++|++++..........  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--  409 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--  409 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence            4456889999999999998864  3344444321 11           123457999999999999887655443221  


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                         ..++||||++| +|.+.+.            ....++.|++.+|.+||+ .|++||||||+||+++  ++.++|+||
T Consensus       410 ---~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl~--~~~~~liDF  471 (535)
T PRK09605        410 ---EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIVR--DDRLYLIDF  471 (535)
T ss_pred             ---CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEEE--CCcEEEEeC
Confidence               25699999986 4444432            246688999999999999 7999999999999995  567999999


Q ss_pred             ccccc
Q 018619          159 GSAKQ  163 (353)
Q Consensus       159 g~a~~  163 (353)
                      |+++.
T Consensus       472 Gla~~  476 (535)
T PRK09605        472 GLGKY  476 (535)
T ss_pred             ccccc
Confidence            99974

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.5e-16  Score=131.79  Aligned_cols=133  Identities=24%  Similarity=0.186  Sum_probs=91.3

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeeccccch----------------------------HHHHHHHHHcCCCc--
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK----------------------------NRELQLMRVMDHPN--   65 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~~--   65 (353)
                      .+.||+|+||+||+|.+. +++.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            568999999999999976 89999999876432111                            13444444443322  


Q ss_pred             eeecceeeeecCCCCceeEEEEeccccchH-H-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCc
Q 018619           66 VISLKHCFFSTTSKNELFLNLVMEYVPESM-Y-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN  143 (353)
Q Consensus        66 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~-~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~N  143 (353)
                      +.+.+.+    .     ..++||||++++. . ..+....     .. ..++.++.+++.++.++|+..||+|+||||+|
T Consensus        81 ~~~~~~~----~-----~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDL----N-----RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEec----C-----CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            2222111    1     1579999999721 1 1121110     11 56788999999999999983499999999999


Q ss_pred             EEEeCCCCcEEEeeecccccccc
Q 018619          144 LLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus       144 ill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |+++  ++.++|+|||.+.....
T Consensus       146 ili~--~~~~~liDfg~a~~~~~  166 (187)
T cd05119         146 ILVD--DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEEE--CCcEEEEECcccccccC
Confidence            9999  67799999999975433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=3.2e-17  Score=150.23  Aligned_cols=250  Identities=25%  Similarity=0.278  Sum_probs=190.5

Q ss_pred             cceeeEeeeeec--CCCeEEEEEEE--CCCCcEEEEEEee------ccccchHHHHHHHHHcC-CCceeecceeeeecCC
Q 018619           10 TISYMAERVVGT--GSFGIVFQAKC--LETGETVAIKKVL------QDRRYKNRELQLMRVMD-HPNVISLKHCFFSTTS   78 (353)
Q Consensus        10 ~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~------~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   78 (353)
                      ...+.+.+.+|.  |.+|.||.+.+  ..++..+|+|.-.      .+.....+|+.-.+.++ |++.++.+..+     
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----  187 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----  187 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----
Confidence            345567788999  99999999999  8899999999642      22333346777666664 88999866666     


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHH----HHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR----GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~----al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                      .+....++-+|+|+.++......   ....++...++..+.+...    ||.++|+ ++++|-|+||.||+..++....+
T Consensus       188 e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCC-Ccccccccchhheecccccceee
Confidence            55556889999999765554432   4455888999999999999    9999999 89999999999999987337899


Q ss_pred             EeeeccccccccCCCcce------eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC--ChHHHHHHH
Q 018619          155 ICDFGSAKQLIAGEANIS------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--NAVDQLVEI  226 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--~~~~~~~~~  226 (353)
                      ++|||+...+.+......      ..+...|++||+..+  -++..+|++|+|.++.+-.+|..++...  +.+..+...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            999999998877653322      145667999999855  4799999999999999999887665443  322221110


Q ss_pred             HHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .                              ...++-...+.++...+..|++.||..|++++.+.+|+++...
T Consensus       342 ~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  342 Y------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             c------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            0                              1112223567778889999999999999999999999999754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=1e-15  Score=131.08  Aligned_cols=133  Identities=18%  Similarity=0.228  Sum_probs=95.6

Q ss_pred             eeee-cCCCeEEEEEEECCCCcEEEEEEeecc-----------------ccchHHHHHHHHHcCCCce--eecceeeeec
Q 018619           17 RVVG-TGSFGIVFQAKCLETGETVAIKKVLQD-----------------RRYKNRELQLMRVMDHPNV--ISLKHCFFST   76 (353)
Q Consensus        17 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~   76 (353)
                      ..|| .|+.|+||.+..  .+..+++|.+...                 .....+|+.++..++|+++  +..++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 788889998876  4778999977421                 1224579999999998775  4444433221


Q ss_pred             CCCCceeEEEEeccccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           77 TSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                       .......++|||+++|  +|.+.+..     .++++..    +.|++.+|.+||+ +||+|+||||+|||++. ++.++
T Consensus       115 -~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~-~~~v~  182 (239)
T PRK01723        115 -HGLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDP-DGKFW  182 (239)
T ss_pred             -cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcC-CCCEE
Confidence             1111123599999996  55555432     3455543    5689999999999 79999999999999996 66899


Q ss_pred             Eeeeccccc
Q 018619          155 ICDFGSAKQ  163 (353)
Q Consensus       155 l~Dfg~a~~  163 (353)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=7.5e-17  Score=155.45  Aligned_cols=268  Identities=25%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeec-------cccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .+.+.+.+-+.+|+++.++.++-..+|-..++|....       +.+...++-.++....+|.++...-.+     .-..
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rs  877 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRS  877 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCC
Confidence            4566777889999999999998877886666664432       222223344444444567666543332     2223


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+++++|.++ ++...+.    ..+..+.+-++.++..+..++++||+ ..+.|+|++|.|++... ++..++.|||..
T Consensus       878 P~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~-~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAY-DGHRPLTDFGTL  951 (1205)
T ss_pred             CcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcc-cCCcccCccccc
Confidence            37799999975 5544443    34567778888899999999999999 57999999999999985 788999999843


Q ss_pred             ccccc------C--------------------------CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh
Q 018619          162 KQLIA------G--------------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL  209 (353)
Q Consensus       162 ~~~~~------~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~  209 (353)
                      .....      .                          .......+|+.|.+||...+.. .+.++|+|+.|+.+++.++
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhc
Confidence            32110      0                          0012346799999999997765 7889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH
Q 018619          210 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL  289 (353)
Q Consensus       210 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  289 (353)
                      |.+||...........+.+...                         +|.. -+...+.++++++.++|..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~~f~ni~~~~~-------------------------~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENILNRDI-------------------------PWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhhhhccccCCC-------------------------CCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence            9999999888777655544211                         1111 1234788999999999999999999887


Q ss_pred             ---HHhcCcccccccCCCCCCCCCCCCCC
Q 018619          290 ---EACAHPFFDELREPNARLPNGRPLPP  315 (353)
Q Consensus       290 ---~~l~hp~f~~~~~~~~~~~~~~~~~~  315 (353)
                         ++-.||||+...+.+........+|.
T Consensus      1085 ~~~e~k~~~~~~~~~~~~l~~q~~~~~p~ 1113 (1205)
T KOG0606|consen 1085 GAAEVKGHPFFQDVDWENLALQKAEFVPQ 1113 (1205)
T ss_pred             cccccccCCccCCCCccccccccCccCCC
Confidence               89999999998887665544444443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.5e-15  Score=119.56  Aligned_cols=131  Identities=20%  Similarity=0.247  Sum_probs=101.8

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHcCC--CceeecceeeeecCCCCceeEEEEecc
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--YKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFLNLVMEY   90 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~lv~e~   90 (353)
                      +++.||+|.++.||++...  +..+++|.......  ...+|+.+++.+++  .++.+++..+     ......+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence            4678999999999999974  37899998866543  56789999999976  4777776554     222347899999


Q ss_pred             ccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--CCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           91 VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        91 ~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +.|.....          ++......++.+++.+++.+|..  .+++|+|++|+||++++ .+.++++|||.+..
T Consensus        75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY  138 (155)
T ss_pred             cCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence            98752211          14455677889999999999983  26999999999999996 78899999999863

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.52  E-value=3.2e-13  Score=125.54  Aligned_cols=165  Identities=23%  Similarity=0.308  Sum_probs=121.6

Q ss_pred             EEECCCCcEEEEEEeecccc----chHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhc
Q 018619           30 AKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA  105 (353)
Q Consensus        30 ~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~  105 (353)
                      +..+.++.+|.+........    ...+-++-|+.++||||+++++.+     +.....|+|+|.+.. |...+..    
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~P-l~~~lk~----  100 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVTERVRP-LETVLKE----  100 (690)
T ss_pred             cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEeecccc-HHHHHHH----
Confidence            45567888888887754433    245677889999999999999887     444468999999873 2234443    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC-cceeeeeceeeChhh
Q 018619          106 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPEL  184 (353)
Q Consensus       106 ~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~  184 (353)
                         +....+..-+.||+.||.|||.-.+++|++|..+.|+|+. .|..||++|.++........ .....---.|..|+.
T Consensus       101 ---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  101 ---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE  176 (690)
T ss_pred             ---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence               3367778889999999999985379999999999999996 88999999999865443322 111111223677776


Q ss_pred             hhCCCCCCccccchhHHHHHHHHHhCC
Q 018619          185 IFGATEYTTSIDIWSAGCVLAELLLGQ  211 (353)
Q Consensus       185 ~~~~~~~~~~~DiwSlG~il~~l~~g~  211 (353)
                      +..   -.-..|.|.|||++++++.|.
T Consensus       177 ~~~---s~~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  177 IDP---SEWSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cCc---cccchhhhhHHHHHHHHhCcc
Confidence            521   224679999999999999993

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=2.8e-14  Score=121.58  Aligned_cols=211  Identities=18%  Similarity=0.194  Sum_probs=145.3

Q ss_pred             HHHHHcCCCceeecceeeeecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-CC
Q 018619           56 QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-PR  133 (353)
Q Consensus        56 ~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-~~  133 (353)
                      .-+-.+-|.|+|+++.++.+....+.....+++||+. |++...|+.-......+....-.+|+.||+.||.|||+. .-
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3445567999999999886655555666789999998 788888877777778888888899999999999999994 35


Q ss_pred             eeeccCCCCcEEEeCCCCcEEEeeeccccccccC-----CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHH
Q 018619          134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL  208 (353)
Q Consensus       134 i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~  208 (353)
                      |+|+++..+-|++.. ++-+|++--.-......-     .......+-+.|.+||.=. ....+.++|||++|.-..+|.
T Consensus       199 iihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             cccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHHH
Confidence            999999999999995 776776432211111000     0111234567789998632 223577899999999999999


Q ss_pred             hCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC
Q 018619          209 LGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT  287 (353)
Q Consensus       209 ~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  287 (353)
                      .|..- -.+......-..+.+.                                +...-...-++++++||+-.|+.||+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~--------------------------------i~~len~lqr~~i~kcl~~eP~~rp~  324 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANV--------------------------------IIGLENGLQRGSITKCLEGEPNGRPD  324 (458)
T ss_pred             HheeccCCCcceeehhhhhhhh--------------------------------eeeccCccccCcCcccccCCCCCCcc
Confidence            87643 2222111111111110                                00001223357899999999999999


Q ss_pred             HHHHhcCcccccc
Q 018619          288 ALEACAHPFFDEL  300 (353)
Q Consensus       288 ~~~~l~hp~f~~~  300 (353)
                      +.+++.||..-++
T Consensus       325 ar~llfHpllfeV  337 (458)
T KOG1266|consen  325 ARLLLFHPLLFEV  337 (458)
T ss_pred             hhhhhcCceeeec
Confidence            9999999997543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=2e-13  Score=128.43  Aligned_cols=141  Identities=18%  Similarity=0.226  Sum_probs=90.9

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------------------------------------------
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------------------------------------------   49 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------------------   49 (353)
                      .|.. +.||+|++|.||.|+.+.+|+.||||+......                                          
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3444 689999999999999988899999998853310                                          


Q ss_pred             --chHHHHHHHHHc----CCCceeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcC---CCCCHHHHHHHHHH
Q 018619           50 --YKNRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN---QRMPLIYVKLYTYQ  120 (353)
Q Consensus        50 --~~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~---~~l~~~~~~~i~~q  120 (353)
                        ...+|+..+.++    .+.+.+.+-.++.+.++    .-++||||+.|.-...+......+   ..+.+..+..++.|
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence              001233333332    23344444444433222    255999999974222222111111   13555566666666


Q ss_pred             HHHHHHHhHcCCCeeeccCCCCcEEEeCCCC----cEEEeeecccccccc
Q 018619          121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIA  166 (353)
Q Consensus       121 ll~al~~LH~~~~i~H~Dlkp~Nill~~~~~----~vkl~Dfg~a~~~~~  166 (353)
                      ++       . .|++|+|+||.||+++. ++    +++++|||++...+.
T Consensus       276 if-------~-~GffHaDpHPGNIlv~~-~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 VF-------R-DGFFHADMHPGNIFVSY-DPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------h-CCeeeCCCChHHeEEec-CCCCCCeEEEEecceEEECCH
Confidence            65       4 69999999999999986 55    899999999986644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.45  E-value=9.2e-13  Score=108.00  Aligned_cols=134  Identities=19%  Similarity=0.223  Sum_probs=93.7

Q ss_pred             eeeeecCCCeEEEEEEECC------CCcEEEEEEeecc--------------cc------------c----hHHHHHHHH
Q 018619           16 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQD--------------RR------------Y----KNRELQLMR   59 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~--------------~~------------~----~~~E~~~l~   59 (353)
                      ...||.|-=+.||.|....      .+..+|||+....              .+            .    .++|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998543      3578999977311              00            1    126888888


Q ss_pred             HcCCC--ceeecceeeeecCCCCceeEEEEeccccch-HH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHh-HcCCCe
Q 018619           60 VMDHP--NVISLKHCFFSTTSKNELFLNLVMEYVPES-MY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI-HTVPRV  134 (353)
Q Consensus        60 ~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~l~~~~~~~~~l~~~~~~~i~~qll~al~~L-H~~~~i  134 (353)
                      ++...  ++...+.+    . .    -++||||++++ +. ..+.     +..++......+..+++.+|..| |+ .|+
T Consensus        82 rl~~~Gv~vP~pi~~----~-~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~-~gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVL----K-K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKE-CNL  146 (197)
T ss_pred             HHHHcCCCCCeEEEe----c-C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHh-CCe
Confidence            87432  33333322    1 1    45999999863 11 1121     23455566777889999999999 88 799


Q ss_pred             eeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619          135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus       135 ~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      +|+||++.||+++  ++.+.|+|||.|.....
T Consensus       147 VHGDLs~~NIL~~--~~~v~iIDF~qav~~~h  176 (197)
T cd05146         147 VHADLSEYNMLWH--DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             ecCCCCHHHEEEE--CCcEEEEECCCceeCCC
Confidence            9999999999997  45699999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=7.1e-13  Score=123.20  Aligned_cols=137  Identities=20%  Similarity=0.252  Sum_probs=88.3

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-cc-------------------------------------------h
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RY-------------------------------------------K   51 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~-------------------------------------------~   51 (353)
                      .+.||+|++|.||+|+. .+|+.||||+..... ..                                           .
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            35799999999999985 589999999874321 00                                           1


Q ss_pred             HHHHHHHHHc----CCCceeecceeeeecCCCCceeEEEEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHH-HH
Q 018619           52 NRELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFR-GL  125 (353)
Q Consensus        52 ~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~-al  125 (353)
                      .+|+..+..+    ++.+-+.+-.++...++    ..++||||++|. +.+.... ..  ....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~-~~--~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAAL-DE--AGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHH-Hh--cCCC---HHHHHHHHHHHHH
Confidence            1244433333    23333444444432222    256999999974 3333221 11  1112   2335555555 46


Q ss_pred             HHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619          126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus       126 ~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ..+|. .|++|+|+||.||+++. +++++++|||++....
T Consensus       271 ~ql~~-~g~~H~D~hPgNilv~~-~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLR-DGFFHADLHPGNIFVLK-DGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHh-CCceeCCCCcccEEECC-CCcEEEEeCCCeeECC
Confidence            78899 79999999999999985 7889999999997654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.43  E-value=1.1e-11  Score=112.13  Aligned_cols=215  Identities=18%  Similarity=0.231  Sum_probs=156.7

Q ss_pred             CeEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccc--hHHH
Q 018619           24 FGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE--SMYR   97 (353)
Q Consensus        24 ~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~   97 (353)
                      ..+.|++....+|..|++|++..++.    ....-++.++++.|+|+|.+.++|. ....++..+++|++|.++  +|++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~-t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFL-TYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhh-hhccCcceEEEEEecCCCCchHHH
Confidence            35789999999999999999943332    2235688999999999999999986 344566678999999984  6666


Q ss_pred             HHHhh-----------hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           98 VLKHY-----------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        98 ~l~~~-----------~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      .....           ...+...++..+|.++.||..||.++|+ .|..-+-|.|.+|+++. +.+++|...|.......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeC-cceEEEecccceeeecC
Confidence            54321           2234568999999999999999999999 79999999999999996 55899998888765544


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      +..             |.+.+    ..+-|.=.||.++..|.||..-- ............                   
T Consensus       446 d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------------------  489 (655)
T KOG3741|consen  446 DPT-------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------------------  489 (655)
T ss_pred             CCC-------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------------------
Confidence            330             11212    23468899999999999996431 111111111111                   


Q ss_pred             CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                      +....|.+++++|.-+...++++ -++.+++.|
T Consensus       490 ----------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 ----------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ----------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                            11346888999999888888886 577776644

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=1.2e-12  Score=106.44  Aligned_cols=124  Identities=15%  Similarity=0.164  Sum_probs=89.4

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCcee-ecceeeeecCCCCceeEEEEeccc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      .+.|+.|..+.||++..  .++.|++|......   ....+|+.+++.+.+.+++ +++...     ...  .++|||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            46789999999999986  47889999875543   3456899999988655443 332221     111  35899999


Q ss_pred             cchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCe-----eeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           92 PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV-----CHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        92 ~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i-----~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|....   ..     .   .....++.+++.+|+.||+ .++     +|+|++|+||+++  ++.++++|||.+.
T Consensus        74 ~G~~l~---~~-----~---~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~  135 (170)
T cd05151          74 EGSELL---TE-----D---FSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG  135 (170)
T ss_pred             CCCccc---cc-----c---ccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence            984211   10     0   1123456799999999999 574     9999999999998  4569999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=1.7e-13  Score=127.72  Aligned_cols=155  Identities=19%  Similarity=0.331  Sum_probs=115.9

Q ss_pred             HHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC--------cce--eeeeceeeChhhhhCCC
Q 018619          120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--------NIS--YICSRFYRAPELIFGAT  189 (353)
Q Consensus       120 qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--------~~~--~~~t~~y~aPE~~~~~~  189 (353)
                      +...|+.|+|...++||++|.|++|.++. ++.+||++|+.+....++..        ...  ......|.|||.+.+ .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            34489999999779999999999999996 88899999999875544211        011  122556999999966 4


Q ss_pred             CCCccccchhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCCh
Q 018619          190 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP  268 (353)
Q Consensus       190 ~~~~~~DiwSlG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
                      ..+.++|++|+||++|.+. .|+..+...+............+..                         ...+.+++++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcH
Confidence            4789999999999999999 6777776655443322221110000                         0112257899


Q ss_pred             hHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          269 EAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       269 ~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ++++=+.++|..|+..||++.+++..|||....
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~  272 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG  272 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence            999999999999999999999999999998743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=8.8e-13  Score=121.35  Aligned_cols=247  Identities=19%  Similarity=0.166  Sum_probs=171.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEEC-CCCcEEEEEEeeccccch------HHHHHHHHHc-CCCceeecceeeeecCCCCc
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDRRYK------NRELQLMRVM-DHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++..+..||.|.|+.|+.+... .++..|++|...+.....      ..|+.+...+ .|.+++.....|...+.   
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~---  340 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ---  340 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc---
Confidence            346788999999999999987755 678899999776543222      2455555555 58888887777744433   


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                        .|+-.|||.+.....-.   .....+.+...+.+..|++.++.++|+ ..++|+|+||+||++...++..+++|||+.
T Consensus       341 --~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 --GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             --ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhccccccc
Confidence              55888999753222211   233557788889999999999999999 799999999999999853478999999998


Q ss_pred             cccccCCCcceeeeeceee-ChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAGEANISYICSRFYR-APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ....-..  ........+. .+|.+.....+..+.|++|||..+.+.++|.+.-........   +..            
T Consensus       415 t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~------------  477 (524)
T KOG0601|consen  415 TRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IRS------------  477 (524)
T ss_pred             cccceec--ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---eec------------
Confidence            6421111  1112222333 355555656688999999999999999998754322221111   000            


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                             ...+          .....+.++..+...++..|+..|+.+.++..|+=|..
T Consensus       478 -------~~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  478 -------GDTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -------cccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                   0000          01123467888999999999999999999988877754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=5e-11  Score=94.22  Aligned_cols=139  Identities=17%  Similarity=0.231  Sum_probs=95.4

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEee-cc-----------ccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVL-QD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ....+.+|+-+.|+++..  .|+.+.||.-. +.           +....+|+++|.+..--.|.-..-+|.+...    
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~----   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG----   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence            567889999999998765  88898888442 21           2333468888887643222222222323222    


Q ss_pred             eEEEEeccccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE--EEeee
Q 018619           83 FLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDF  158 (353)
Q Consensus        83 ~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v--kl~Df  158 (353)
                       -.++|||++|  ++.+.+.....  ..........++.++=..+.-||. ++|+|+||..+||++.+++..+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEee
Confidence             4489999998  55555544222  222233336788889999999999 8999999999999998755544  89999


Q ss_pred             ccccc
Q 018619          159 GSAKQ  163 (353)
Q Consensus       159 g~a~~  163 (353)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=2.8e-10  Score=90.46  Aligned_cols=126  Identities=17%  Similarity=0.272  Sum_probs=83.1

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEe-ecc-----------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~-----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ..+++|+-+.++.+..  -|..+++|.- +|.           .....+|+.++..+.--.|....-++++...     .
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G   74 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence            4578899999998854  4445667743 221           1233478888888753332222212222222     3


Q ss_pred             EEEeccccchHHH-HHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPESMYR-VLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~~l~~-~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .|+|||++|.+.. .+..    .   .    -.++..+=.-+.-||. +||+|+||.++||++..  +.+.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~----~---~----~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~--~~i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEE----A---R----PDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG--GRIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHh----c---c----hHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC--CcEEEEECCcccc
Confidence            4999999996544 3332    2   1    2345566666788999 79999999999999984  4599999999874

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=7.7e-10  Score=90.48  Aligned_cols=122  Identities=26%  Similarity=0.308  Sum_probs=76.6

Q ss_pred             EEEEEEECCCCcEEEEEEeeccc------------------------------cchHHHHHHHHHcCCCc--eeecceee
Q 018619           26 IVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQLMRVMDHPN--VISLKHCF   73 (353)
Q Consensus        26 ~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~~l~h~~--iv~~~~~~   73 (353)
                      .||.|.. ..|+.+|+|......                              ....+|...|..+..-+  +.+.+.+-
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4888885 578899999774210                              11236999999997553  44443321


Q ss_pred             eecCCCCceeEEEEecccc--chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH-hHcCCCeeeccCCCCcEEEeCCC
Q 018619           74 FSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY-IHTVPRVCHRDLKPQNLLVDPLT  150 (353)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~-LH~~~~i~H~Dlkp~Nill~~~~  150 (353)
                           .    -++||||++  |.....+..     ..++......++.+++..+.. +|+ .||+|+||.+.||+++. +
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~-~  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDD-G  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEET-T
T ss_pred             -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeec-c
Confidence                 1    349999999  643233332     112234456677888886555 578 79999999999999995 4


Q ss_pred             CcEEEeeeccccccc
Q 018619          151 HQVKICDFGSAKQLI  165 (353)
Q Consensus       151 ~~vkl~Dfg~a~~~~  165 (353)
                       .+.++|||.+....
T Consensus       144 -~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 -KVYIIDFGQAVDSS  157 (188)
T ss_dssp             -CEEE--GTTEEETT
T ss_pred             -eEEEEecCcceecC
Confidence             79999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.10  E-value=3.1e-09  Score=92.11  Aligned_cols=133  Identities=11%  Similarity=0.062  Sum_probs=89.3

Q ss_pred             eEEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHHcCCCceeec--ceeeeecCCCCceeEEEE
Q 018619           25 GIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISL--KHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~--~~~~~~~~~~~~~~~~lv   87 (353)
                      ..|..+.  ..|+.|.||......               ....+|...+..+..-+|...  +.+...........-++|
T Consensus        36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            3455544  367788888663211               125588888877754333332  222211111112335699


Q ss_pred             eccccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC------CCCcEEEeeec
Q 018619           88 MEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP------LTHQVKICDFG  159 (353)
Q Consensus        88 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~------~~~~vkl~Dfg  159 (353)
                      ||++++  ++.+.+....  ..+.+......++.+++..+.-||. +||+|+|+++.|||++.      ++..+.|+||+
T Consensus       114 te~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999997  5666654322  2445667788999999999999999 79999999999999974      24689999999


Q ss_pred             ccc
Q 018619          160 SAK  162 (353)
Q Consensus       160 ~a~  162 (353)
                      .+.
T Consensus       191 r~~  193 (268)
T PRK15123        191 RAQ  193 (268)
T ss_pred             ccc
Confidence            885

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.09  E-value=2e-09  Score=91.44  Aligned_cols=139  Identities=18%  Similarity=0.186  Sum_probs=92.5

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCc--eeecceeeeecCCCCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      +.|+.|..+.||++... +|+.|++|.....     .....+|..+++.+.+.+  +.+++....  ........++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~--~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCE--DPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECC--CCCccCCceEEEE
Confidence            57899999999999863 3689999987643     235578999999987533  344443321  1111123579999


Q ss_pred             cccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--------------------------------------
Q 018619           90 YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--------------------------------------  131 (353)
Q Consensus        90 ~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--------------------------------------  131 (353)
                      |++|......   .. ...+++.....++.+++.+|..||+.                                      
T Consensus        81 ~i~G~~l~~~---~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          81 RVDGRVLRDR---LL-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             EeCCEecCCC---CC-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            9997421111   00 02355555666666666666666641                                      


Q ss_pred             -----------------CCeeeccCCCCcEEEeCC-CCcEEEeeecccc
Q 018619          132 -----------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAK  162 (353)
Q Consensus       132 -----------------~~i~H~Dlkp~Nill~~~-~~~vkl~Dfg~a~  162 (353)
                                       ..++|+|++|.||+++.+ ++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                             246999999999999853 3568999999886

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.94  E-value=1.9e-08  Score=89.52  Aligned_cols=198  Identities=14%  Similarity=0.160  Sum_probs=129.3

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchH-HHHHHHHH-cCCCceeecceee----eecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-RELQLMRV-MDHPNVISLKHCF----FSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~E~~~l~~-l~h~~iv~~~~~~----~~~~~~~~~~~~l   86 (353)
                      ....+.||+|+-+.+|-.-..  + -.+.|++........ +.+..|-. -.||-+.. .-.+    ....+. .....+
T Consensus        13 i~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~-rvaWPqa~L~G~~~-~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNY-RVAWPQATLHGGRR-GKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHHhccCCCCcchhh-hhcccHHHhhCCCc-cceeEE
Confidence            356678999999999865432  2 234477755433221 22222222 24543322 1111    111112 223668


Q ss_pred             Eeccccch--HHHHHH--hhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           87 VMEYVPES--MYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        87 v~e~~~~~--l~~~l~--~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .|+.+.|-  ...++.  .....-....+..+.+.++.|+.+.+.||. +|.+-+|++++|+|++. ++.|.|.|=..-.
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfq  165 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQ  165 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeec-CceEEEEccccee
Confidence            88888862  211211  122233457899999999999999999999 79999999999999995 8889998866544


Q ss_pred             ccccCCCcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhC-CCCCCCC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLG-QPLFPGE  217 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~  217 (353)
                      ....+......+|...|.+||.-.-    ...-+..+|.|.||+++++++.| +.||.+-
T Consensus       166 i~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         166 INANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            4444444455678899999998531    12246789999999999999987 8999763

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.7e-08  Score=84.02  Aligned_cols=132  Identities=20%  Similarity=0.178  Sum_probs=92.2

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--------------------------ccchHHHHHHHHHcCCC--
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------------------RRYKNRELQLMRVMDHP--   64 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~E~~~l~~l~h~--   64 (353)
                      +.+...||.|--|.||.|.+ ..|.++|||.=.-.                          +...++|.++|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            46778999999999999985 48999999933110                          12234799999988644  


Q ss_pred             ceeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcE
Q 018619           65 NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL  144 (353)
Q Consensus        65 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Ni  144 (353)
                      .+.+.++         .....+|||+++|-.   +..     -+++.+....++..|+.-+..+-. .|++|+|+++-||
T Consensus       172 ~VP~P~~---------~nRHaVvMe~ieG~e---L~~-----~r~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNI  233 (304)
T COG0478         172 KVPKPIA---------WNRHAVVMEYIEGVE---LYR-----LRLDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNI  233 (304)
T ss_pred             CCCCccc---------cccceeeeehcccce---eec-----ccCcccCHHHHHHHHHHHHHHHHH-cCccccCCchheE
Confidence            4444322         122569999999842   211     112344455556666666665556 6999999999999


Q ss_pred             EEeCCCCcEEEeeecccccc
Q 018619          145 LVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus       145 ll~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++++ ++.+.++||--+...
T Consensus       234 lV~~-dg~~~vIDwPQ~v~~  252 (304)
T COG0478         234 LVTE-DGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEec-CCCEEEEeCcccccC
Confidence            9996 778999999877643

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1.9e-07  Score=76.95  Aligned_cols=137  Identities=12%  Similarity=0.082  Sum_probs=96.2

Q ss_pred             ecCCCeEEEEEEECCCCcEEEEEEeec----------cccchHHHHHHHHHcCCCce--eecceeeeecCCCCceeEEEE
Q 018619           20 GTGSFGIVFQAKCLETGETVAIKKVLQ----------DRRYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        20 g~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv   87 (353)
                      |+||.+.|+....  .|+.|-+|....          ....+.+|+..+..+..-++  .+.. .+-.........-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5688999998764  444788886642          23455689999988854333  3332 1111222334456799


Q ss_pred             eccccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCc--EEEeeeccccc
Q 018619           88 MEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQ  163 (353)
Q Consensus        88 ~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~--vkl~Dfg~a~~  163 (353)
                      +|-++|  +|.+.+...  .-.+.+......++.++..++.-||+ .|+.|+|+-+.||+++. ++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence            998884  666555431  12355777778899999999999999 79999999999999984 345  99999987764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.80  E-value=4.7e-08  Score=81.94  Aligned_cols=108  Identities=18%  Similarity=0.216  Sum_probs=75.2

Q ss_pred             chHHHHHHHHHcCCCcee--ecceeeeecCCCCceeEEEEeccccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 018619           50 YKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL  125 (353)
Q Consensus        50 ~~~~E~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al  125 (353)
                      ...+|...+..+..-.|.  +.+.+..... ......++|+|++++  +|.+.+..    ....+......++.++...+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHH
Confidence            345788877777533332  2222222211 222446799999986  45555543    22266677888999999999


Q ss_pred             HHhHcCCCeeeccCCCCcEEEeCCC--CcEEEeeeccccc
Q 018619          126 AYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQ  163 (353)
Q Consensus       126 ~~LH~~~~i~H~Dlkp~Nill~~~~--~~vkl~Dfg~a~~  163 (353)
                      .-||. +||+|+|++|.|||++..+  ..+.++||+-++.
T Consensus       132 ~~lH~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHD-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHH-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999 7999999999999998633  2799999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.78  E-value=1.4e-07  Score=78.13  Aligned_cols=139  Identities=15%  Similarity=0.166  Sum_probs=86.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchH-------------HHHHHHHHcCCCcee---ecce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RELQLMRVMDHPNVI---SLKH   71 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------~E~~~l~~l~h~~iv---~~~~   71 (353)
                      +..++|.+.+++-......|.+..  ..|+.+++|.........+             +++.....+....+.   .++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            346789999999998888887766  4778999997754332222             233333333322222   2211


Q ss_pred             eeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC
Q 018619           72 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH  151 (353)
Q Consensus        72 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~  151 (353)
                      +..-....-....+++|||++|--...+       ..+++    .+...+..++.-+|+ .|+.|+|.+|.|++++.  +
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~-------~~i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~--~  171 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDI-------EDIDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN--N  171 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccc-------hhcCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC--C
Confidence            1111111222335689999998411111       11222    244567788999999 79999999999999984  4


Q ss_pred             cEEEeeecccc
Q 018619          152 QVKICDFGSAK  162 (353)
Q Consensus       152 ~vkl~Dfg~a~  162 (353)
                      .++++||+..+
T Consensus       172 ~i~iID~~~k~  182 (229)
T PF06176_consen  172 GIRIIDTQGKR  182 (229)
T ss_pred             cEEEEECcccc
Confidence            49999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.74  E-value=3.4e-08  Score=92.78  Aligned_cols=136  Identities=21%  Similarity=0.310  Sum_probs=83.4

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc--------------------------------------------cchH
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------------------------------RYKN   52 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------------------------~~~~   52 (353)
                      +-|+.++-|.||.|+- .+|+.||||+...+-                                            -...
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5678999999999995 569999999874221                                            0001


Q ss_pred             HHHHHHHHc----CCCceeecceeeeecCCCCceeEEEEeccccch-HHHH--HHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 018619           53 RELQLMRVM----DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRV--LKHYSSANQRMPLIYVKLYTYQIFRGL  125 (353)
Q Consensus        53 ~E~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~--l~~~~~~~~~l~~~~~~~i~~qll~al  125 (353)
                      +|...+.++    +...-+.+-.++.+.++.    -.++|||++|. +.+.  +.........+...-+..++.|++.  
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~--  283 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLR--  283 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHh--
Confidence            355544444    233334444555333322    34999999983 2222  2211001112233333334444333  


Q ss_pred             HHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619          126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus       126 ~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                            .|++|+|.+|.||+++. ++++.+.|||+.....+
T Consensus       284 ------dgffHaDpHpGNi~v~~-~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 ------DGFFHADPHPGNILVRS-DGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ------cCccccCCCccceEEec-CCcEEEEcCcceecCCH
Confidence                  59999999999999997 78999999999876544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.74  E-value=2.2e-09  Score=99.84  Aligned_cols=245  Identities=20%  Similarity=0.175  Sum_probs=162.8

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCc-eeecceeeeecCCCCceeEEEEecccc
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPN-VISLKHCFFSTTSKNELFLNLVMEYVP   92 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv~e~~~   92 (353)
                      ....-+++|+++++++.+...+...+ .+.+... ....-++++|.+.+||| .+..++     +.+.+.+.++.+++++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~-----d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLE-----DYDGEDYLWIPMRICS  317 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccc-----cCCcccccchhhhhhc
Confidence            44556788999999988865554444 5555433 44446899999999999 333332     3366667889999998


Q ss_pred             chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcce
Q 018619           93 ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS  172 (353)
Q Consensus        93 ~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (353)
                      ++-. ...........+...+...+.+.-+++++++|+ ..=+|+|    ||+..+  +..|..||+....+.......+
T Consensus       318 ~~rs-~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  318 TGRS-SALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILGSE--EEVKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             CCcc-ccccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----cccccc--cccccccccCCcccCccccccc
Confidence            5400 000000112234444555666777889999998 4557888    888874  5689999999887766555667


Q ss_pred             eeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCC
Q 018619          173 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ  252 (353)
Q Consensus       173 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (353)
                      ..+++.++|||+.... .+....|.||+|+-..+|.-|.+|-......  .    ...|..+             -....
T Consensus       390 ~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~----~~~g~~p-------------~s~~L  449 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--L----PMIGNGP-------------NSPML  449 (829)
T ss_pred             CCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCccc--c----CCCCCCC-------------Ccccc
Confidence            7889999999998554 4888999999999888888887775441100  0    0000000             00111


Q ss_pred             CCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .....|...++.       ++...|+..-|..|+....++-|.+|...
T Consensus       450 ~~~~aw~~~~~~-------~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  450 TDKSAWSPVFHR-------DFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             chhhhcCccccc-------CCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            112344443332       67889999999999999999999999864

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.60  E-value=7.1e-07  Score=74.77  Aligned_cols=133  Identities=19%  Similarity=0.176  Sum_probs=88.3

Q ss_pred             eeecCCCeEEEEEEECCCCcEEEEEEeecccc----------------------------chHHHHHHHHHcCCCc--ee
Q 018619           18 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----------------------------YKNRELQLMRVMDHPN--VI   67 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~E~~~l~~l~h~~--iv   67 (353)
                      .|++|--+.||+|.. ..+..+|+|++.....                            ...+|..-|+++....  +.
T Consensus        55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            566677778999874 6788999998843210                            1125777777764322  22


Q ss_pred             ecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe
Q 018619           68 SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD  147 (353)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~  147 (353)
                      +.+.+.     .    ..+||||++...   ...-....-++...++..+..+++..+.-|-...++||+||+.-|||+.
T Consensus       134 ~Pi~~~-----~----nVLvMEfIg~~g---~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFR-----N----NVLVMEFIGDDG---LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             Cceeec-----C----CeEEEEeccCCC---CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            222222     1    349999998531   1110111233444467888889999988877635999999999999998


Q ss_pred             CCCCcEEEeeeccccccc
Q 018619          148 PLTHQVKICDFGSAKQLI  165 (353)
Q Consensus       148 ~~~~~vkl~Dfg~a~~~~  165 (353)
                        ++.+.++|||-|....
T Consensus       202 --~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 --DGEPYIIDVSQAVTID  217 (268)
T ss_pred             --CCeEEEEECccccccC
Confidence              5679999999887554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.60  E-value=1.6e-07  Score=93.30  Aligned_cols=203  Identities=23%  Similarity=0.313  Sum_probs=134.8

Q ss_pred             HHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc
Q 018619           52 NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT  130 (353)
Q Consensus        52 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~  130 (353)
                      +.|+..+....|+|++.++.+-+.....+ ....+..++|.. ++...+.    .-+..+...++.+..+++.||.++|+
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHH
Confidence            35777888889999999876543322222 123344566664 3333333    35778999999999999999999999


Q ss_pred             CCCeeeccCCCC---cEEEeCCCCcEEEe--eeccccccccCCCcceeeeeceeeChhhhhCCCCCC--ccccchhHHHH
Q 018619          131 VPRVCHRDLKPQ---NLLVDPLTHQVKIC--DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT--TSIDIWSAGCV  203 (353)
Q Consensus       131 ~~~i~H~Dlkp~---Nill~~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~~DiwSlG~i  203 (353)
                       ....|.-+..+   +--.+. .+.+..+  ||+.+..............+..+.+||..... .+.  ...|+|++|..
T Consensus       305 -~~l~~v~L~~s~~~~~~~~~-e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~-~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  305 -LSLEHVVLSASSSKESTVDG-EGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKEN-TAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             -hccceeEEecccccccccCc-cceeecchhhhcccccCCCcccchhhcCccccccccccccc-cchhhhhhHHHHHHHH
Confidence             55555444444   222232 3456666  88888877666666666667778888887432 233  34699999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCC
Q 018619          204 LAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS  283 (353)
Q Consensus       204 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  283 (353)
                      ...+..|..+-.....   ....                                   .......+..+++.+|+.-|++
T Consensus       382 ~~~~~~~~~i~~~~~~---~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~~  423 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV---PVSL-----------------------------------LDVLSTSELLDALPKCLDEDSE  423 (1351)
T ss_pred             HhhhhhcCcccccccc---hhhh-----------------------------------hccccchhhhhhhhhhcchhhh
Confidence            9999987644211100   0000                                   0011122778999999999999


Q ss_pred             CCCCHHHHhcCcccccc
Q 018619          284 LRCTALEACAHPFFDEL  300 (353)
Q Consensus       284 ~R~t~~~~l~hp~f~~~  300 (353)
                      +|+++.+++.|||.+--
T Consensus       424 ~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  424 ERLSALELLTHPFLRFP  440 (1351)
T ss_pred             hccchhhhhhchhcccc
Confidence            99999999999998753

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.49  E-value=1.2e-06  Score=74.78  Aligned_cols=75  Identities=20%  Similarity=0.207  Sum_probs=49.2

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCc--eeecceeeeecCCCCceeEEEEeccc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      ++.|+.|..+.||.+....  ..+++|.....  .....+|..+++.+....  +.+++...  .........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~--~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFD--TSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEE--EETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeec--ccccccccceEEEEEe
Confidence            5789999999999998643  59999987655  344567888888875332  33443322  1112233477999999


Q ss_pred             cch
Q 018619           92 PES   94 (353)
Q Consensus        92 ~~~   94 (353)
                      +|.
T Consensus        78 ~g~   80 (239)
T PF01636_consen   78 PGR   80 (239)
T ss_dssp             SSE
T ss_pred             ccc
Confidence            863

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=1.1e-06  Score=82.40  Aligned_cols=138  Identities=19%  Similarity=0.229  Sum_probs=82.0

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-----------------------------------------chHHH
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----------------------------------------YKNRE   54 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------------~~~~E   54 (353)
                      .+-||..+.|.||+|+-+ +|+.||||+...+-+                                         .+.+|
T Consensus       166 ~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            357889999999999965 599999997743210                                         00123


Q ss_pred             HHHHH----HcCCCc---eeecceeeeecCCCCceeEEEEeccccch---HHHHHHhhhhcCCCCCHHHHHHHHHHHHHH
Q 018619           55 LQLMR----VMDHPN---VISLKHCFFSTTSKNELFLNLVMEYVPES---MYRVLKHYSSANQRMPLIYVKLYTYQIFRG  124 (353)
Q Consensus        55 ~~~l~----~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~---l~~~l~~~~~~~~~l~~~~~~~i~~qll~a  124 (353)
                      ++-..    .+.|-+   -|.+-.++.+..+.    -.++||||+|.   -.+.+..     ..++...+..-+.+...-
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~----RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTK----RVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLE  315 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCcc----eEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHH
Confidence            33222    223444   22333444332222    44999999972   1223332     334444443333222211


Q ss_pred             HHHhHcCCCeeeccCCCCcEEEeC---CCCcEEEeeecccccccc
Q 018619          125 LAYIHTVPRVCHRDLKPQNLLVDP---LTHQVKICDFGSAKQLIA  166 (353)
Q Consensus       125 l~~LH~~~~i~H~Dlkp~Nill~~---~~~~vkl~Dfg~a~~~~~  166 (353)
                        -+-. .|++|+|-+|.||++.+   .++.+.+-|||+......
T Consensus       316 --qIf~-~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  316 --QIFK-TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             --HHHh-cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence              1122 59999999999999984   367899999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=6.4e-06  Score=69.96  Aligned_cols=69  Identities=14%  Similarity=0.077  Sum_probs=44.4

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCce--eecceeeeecCCCCceeEEEEecccc
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNV--ISLKHCFFSTTSKNELFLNLVMEYVP   92 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~   92 (353)
                      ..||+|..+.||+.    .+..+++|......  ....+|.++++.+..-.+  .+.+.+.     ......++|||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            57899999999973    25568889775432  335689999988753322  2333322     12222568999999


Q ss_pred             ch
Q 018619           93 ES   94 (353)
Q Consensus        93 ~~   94 (353)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            83

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.13  E-value=3.2e-05  Score=78.32  Aligned_cols=78  Identities=18%  Similarity=0.190  Sum_probs=50.6

Q ss_pred             EeeeeecCCCeEEEEEEECCCC--cEEEEEEeecc-----ccchHHHHHHHHHcC-CCce--eecceeeeecCCCCceeE
Q 018619           15 AERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQD-----RRYKNRELQLMRVMD-HPNV--ISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~   84 (353)
                      -.+.++.|.++.+|++.....+  ..+++|+.+..     .....+|+.+++.+. |.++  .+++..+.+.  ......
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCc
Confidence            3577899999999998764332  46888876432     234678999999995 6654  4433333111  111236


Q ss_pred             EEEeccccch
Q 018619           85 NLVMEYVPES   94 (353)
Q Consensus        85 ~lv~e~~~~~   94 (353)
                      |+||||++|.
T Consensus       120 flVME~v~G~  129 (822)
T PLN02876        120 FYIMEYLEGR  129 (822)
T ss_pred             eEEEEecCCc
Confidence            6999999874

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.11  E-value=2.1e-05  Score=62.51  Aligned_cols=127  Identities=22%  Similarity=0.329  Sum_probs=83.6

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      .-++.+.|+.|..|.||++..  .|..+|+|+-..+  +..++.|+++|..++-.++..-. +++..       -++.||
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~v-y~yg~-------~~i~me   92 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEV-YFYGE-------DFIRME   92 (201)
T ss_pred             hhhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceE-EEech-------hhhhhh
Confidence            346778999999999999886  6678999977554  45567999999998765543311 12111       226699


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCC-CC-cEEEeCCCCcEEEeeecccc
Q 018619           90 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK-PQ-NLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlk-p~-Nill~~~~~~vkl~Dfg~a~  162 (353)
                      |..| .|.+....       .+..    -+..++++---|-. .||-|..|. |. ||+++  +..+.|+||..|+
T Consensus        93 ~i~G~~L~~~~~~-------~~rk----~l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~--~~~~~iIDFd~At  154 (201)
T COG2112          93 YIDGRPLGKLEIG-------GDRK----HLLRVLEKAYKLDR-LGIEHGELSRPWKNVLVN--DRDVYIIDFDSAT  154 (201)
T ss_pred             hhcCcchhhhhhc-------ccHH----HHHHHHHHHHHHHH-hccchhhhcCCceeEEec--CCcEEEEEccchh
Confidence            9998 43322210       0222    23345566555666 699999986 44 55554  4479999999987

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.99  E-value=9.6e-05  Score=63.70  Aligned_cols=69  Identities=16%  Similarity=0.074  Sum_probs=41.8

Q ss_pred             eecCCC-eEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHcCC-CceeecceeeeecCCCCceeEEEEeccccch
Q 018619           19 VGTGSF-GIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPES   94 (353)
Q Consensus        19 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~   94 (353)
                      |..|.+ ..||++..  .+..+.+|..... .....+|+.+++.+.. -.+.+++....     .....++|||+++|.
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G~   77 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPGV   77 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCCc
Confidence            444555 78998864  3467888877543 1345689999888842 22333433331     112356899999873

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.97  E-value=6.5e-05  Score=66.64  Aligned_cols=139  Identities=19%  Similarity=0.217  Sum_probs=96.5

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------c------------------------cchHHHHHHHHHcCC
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------R------------------------RYKNRELQLMRVMDH   63 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~------------------------~~~~~E~~~l~~l~h   63 (353)
                      .+...|..|--+.||.|. ..+|..+|||++...      +                        ...++|.+-|++++.
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            456678888889999988 568889999987421      1                        112367888888764


Q ss_pred             CceeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCc
Q 018619           64 PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN  143 (353)
Q Consensus        64 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~N  143 (353)
                      ..|.-.--+..    .   ...+||++++.+   ....-...+..++...++.+-.|++.-+.-|-+.+++||.||.=-|
T Consensus       226 aGIP~PePIlL----k---~hVLVM~FlGrd---gw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILL----K---NHVLVMEFLGRD---GWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceee----e---cceEeeeeccCC---CCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            44322111111    0   134999999843   1111112346678888888888888888888765799999999999


Q ss_pred             EEEeCCCCcEEEeeeccccccc
Q 018619          144 LLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus       144 ill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +|+-  +|.+.++|.+-+....
T Consensus       296 ~Lyh--dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  296 LLYH--DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             heEE--CCEEEEEEccccccCC
Confidence            9997  6789999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.86  E-value=0.00025  Score=58.60  Aligned_cols=128  Identities=20%  Similarity=0.291  Sum_probs=80.8

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--------------------cchHHHHHHHHHcC------CCceeec
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------------RYKNRELQLMRVMD------HPNVISL   69 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~~iv~~   69 (353)
                      ...||+|+.-.||.  | ..+....||+.....                    ....+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35789999999985  3 344456778775544                    33446777666655      7788888


Q ss_pred             ceeeeecCCCCceeEEEEecccc---chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           70 KHCFFSTTSKNELFLNLVMEYVP---ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~---~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                      ++...     .+.-..+|+|.+.   |+....+..+. ..+.+++ .+...   +-.-.++|-+ ++|+.+|++|.||++
T Consensus        83 ~G~ve-----T~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~~---L~~f~~~l~~-~~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVE-----TNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQA---LDEFKRYLLD-HHIVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEe-----cCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHHH---HHHHHHHHHH-cCCeecCCCcccEEE
Confidence            88763     3333667777774   33333343333 2345665 33333   3344567778 799999999999999


Q ss_pred             eCCC--C-cEEEee
Q 018619          147 DPLT--H-QVKICD  157 (353)
Q Consensus       147 ~~~~--~-~vkl~D  157 (353)
                      ...+  . .+.|+|
T Consensus       152 ~~~~~~~~~lvlID  165 (199)
T PF10707_consen  152 QRRDSGEFRLVLID  165 (199)
T ss_pred             EecCCCceEEEEEe
Confidence            5322  2 566666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.86  E-value=0.00019  Score=61.55  Aligned_cols=30  Identities=40%  Similarity=0.579  Sum_probs=25.0

Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|+|+.|.||+++. +...-|+||+.|.
T Consensus       164 ~~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~  193 (235)
T cd05155         164 PVWFHGDLAPGNLLVQD-GRLSAVIDFGCLG  193 (235)
T ss_pred             ceEEeCCCCCCcEEEEC-CCEEEEEeCcccC
Confidence            35899999999999984 5545799999875

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.84  E-value=0.00025  Score=58.25  Aligned_cols=127  Identities=22%  Similarity=0.310  Sum_probs=85.9

Q ss_pred             cceeeEeeeeecCCC-eEEEEEEECCCCcEEEEEEeec--------------ccc-----------chHHHHHHHHHc--
Q 018619           10 TISYMAERVVGTGSF-GIVFQAKCLETGETVAIKKVLQ--------------DRR-----------YKNRELQLMRVM--   61 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~--------------~~~-----------~~~~E~~~l~~l--   61 (353)
                      +..++..+.||.|.- |.||+++-  .|+.||+|.+..              ...           .+..|-+..-+|  
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            468899999999999 99999985  788999998311              000           112455544444  


Q ss_pred             -CCCce--eecceeeeecCC-------------CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH
Q 018619           62 -DHPNV--ISLKHCFFSTTS-------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL  125 (353)
Q Consensus        62 -~h~~i--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al  125 (353)
                       .+.++  |++++++.-...             .......||.||+...-            .++...    +.+|++-+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl  177 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDL  177 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHH
Confidence             45566  888877643310             12223567888777531            223333    34777888


Q ss_pred             HHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619          126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus       126 ~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|. .||+-+|+++.|..    +  -||+|||.+
T Consensus       178 ~~~~k-~gI~~~Dv~~~ny~----~--G~lvDfs~~  206 (207)
T PF13095_consen  178 KILHK-LGIVPRDVKPRNYR----G--GKLVDFSSS  206 (207)
T ss_pred             HHHHH-CCeeeccCcccccc----C--CEEEecccC
Confidence            99999 79999999999985    2  389999865

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.77  E-value=0.00019  Score=62.34  Aligned_cols=133  Identities=17%  Similarity=0.215  Sum_probs=73.1

Q ss_pred             eeecCCCeEEEEEEECCCCcEEEEEEeecccc----chHHHHHHHHHcCCCcee-ecceeeeecCCCCceeEEEEecccc
Q 018619           18 VVGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVI-SLKHCFFSTTSKNELFLNLVMEYVP   92 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~~~~~~lv~e~~~   92 (353)
                      .+..|..+.+|++.  .+++.+++|.......    ...+|..+++.+....++ +++...     .    -++||||++
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~   71 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLE   71 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEecc
Confidence            35668888999887  3567899997654322    246799999988643332 222111     1    248899998


Q ss_pred             chHHH-----------HH----Hhhh---hcCCCCCH-HHHHHHHHHH---------HHHHHHhHc-------CCCeeec
Q 018619           93 ESMYR-----------VL----KHYS---SANQRMPL-IYVKLYTYQI---------FRGLAYIHT-------VPRVCHR  137 (353)
Q Consensus        93 ~~l~~-----------~l----~~~~---~~~~~l~~-~~~~~i~~ql---------l~al~~LH~-------~~~i~H~  137 (353)
                      |....           .+    ...-   ....+++. ..+..+..++         ...+..+-.       ...++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            73211           11    1100   01111221 1112222111         111121211       0258999


Q ss_pred             cCCCCcEEEeCCCCcEEEeeeccccc
Q 018619          138 DLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus       138 Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+.|.||+++. ++ +.|+||..|..
T Consensus       152 Dl~~~Nil~~~-~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTP-QG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeC-CC-CEEEeccccCc
Confidence            99999999986 45 78999998863

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.77  E-value=0.00062  Score=58.25  Aligned_cols=69  Identities=17%  Similarity=0.319  Sum_probs=43.8

Q ss_pred             eeeeecCCCeEEEEEEECC-CCcEEEEEEeecccc---chHHHHHHHHHcCCCce-eecceeeeecCCCCceeEEEEecc
Q 018619           16 ERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEY   90 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~   90 (353)
                      .+.|..|-...+|++.... .++.|++|+......   ..++|..+++.+....+ .+++..+     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            4567888889999987432 367899997754322   23478989988854333 2332211     11    279999


Q ss_pred             ccc
Q 018619           91 VPE   93 (353)
Q Consensus        91 ~~~   93 (353)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.76  E-value=7.6e-06  Score=83.83  Aligned_cols=213  Identities=16%  Similarity=0.022  Sum_probs=138.2

Q ss_pred             HHHHHHHcCCCceeecceeeeecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 018619           54 ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP  132 (353)
Q Consensus        54 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~  132 (353)
                      |.+.++...|+++.....-....   .....|..++||. |.+...+..-......+....+.....+.+.+..-+|+..
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            44555667899888765444222   2223568889998 5666666654555555666655555555577777777743


Q ss_pred             C----eeeccCCCCcEEEeCCCCcEEEeeecccccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHH
Q 018619          133 R----VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL  207 (353)
Q Consensus       133 ~----i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l  207 (353)
                      +    -+|+++|+-|.++.. +.++|++++|+.+.... .......++++.|++|+.... -.++.++|+|+.|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVt-ny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVT-NYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceec-CCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence            3    479999999999996 88899999999983222 222334677889999998744 3477789999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC
Q 018619          208 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT  287 (353)
Q Consensus       208 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  287 (353)
                      ..|..+|...     .+...+           +...+-..+..+            .-.|.++-.....+|-+.-..||.
T Consensus      1434 s~~n~~fi~f-----lq~~Lk-----------giidn~tf~sIe------------~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFIFF-----LQPALK-----------GIIDNHTFFSIE------------KLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred             hcccHHHHHH-----HHHHHc-----------Cccccccccccc------------ccCCCcccHHHHHHHHHHhhhcch
Confidence            9988777321     111111           111111111111            122445555555566666778999


Q ss_pred             HHHHhcCccccc
Q 018619          288 ALEACAHPFFDE  299 (353)
Q Consensus       288 ~~~~l~hp~f~~  299 (353)
                      -...+.-|.|.-
T Consensus      1486 q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1486 QYISLSRDHFAV 1497 (2724)
T ss_pred             hhhhcccccccc
Confidence            988888888754

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.74  E-value=6.8e-05  Score=69.22  Aligned_cols=170  Identities=21%  Similarity=0.263  Sum_probs=108.6

Q ss_pred             HHHHHHHHcCCCceeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC
Q 018619           53 RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP  132 (353)
Q Consensus        53 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~  132 (353)
                      -...+++.+.|+|.....++-    ........+|||+++-++++.+....     +-..       +++       . +
T Consensus        31 gr~~~lktl~~~~l~~yl~~~----r~~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~-~   86 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFS----RGKHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------A-H   86 (725)
T ss_pred             hhhHHHHhhcCccceeeEeee----cCccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------c-c
Confidence            456788889999998875543    22333477999999999888876421     1111       111       1 3


Q ss_pred             CeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCC
Q 018619          133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  212 (353)
Q Consensus       133 ~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  212 (353)
                      ++.|-     |+        ++.+| -++.   .            |  |      ...++++||||+|.++.++..|..
T Consensus        87 ~~~~~-----~~--------~~~td-~~~t---~------------~--~------~~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   87 GVLHL-----NI--------IYITD-HFLT---K------------Y--P------SPIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             cccee-----hh--------hhccc-cccc---c------------C--C------CCCCcchhhhhHHHHHHHHHHhhH
Confidence            44331     22        33333 0000   0            0  1      112359999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          213 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       213 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .+......+....+.+....+..-....+                 ...+...++.....+..+|+...|..||...++.
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            98887777777666665433332211100                 0012224677888999999999999999999999


Q ss_pred             cCcccccc
Q 018619          293 AHPFFDEL  300 (353)
Q Consensus       293 ~hp~f~~~  300 (353)
                      .|+-|..+
T Consensus       193 k~~i~~ev  200 (725)
T KOG1093|consen  193 KRCSFTEV  200 (725)
T ss_pred             cCccHHHH
Confidence            99999876

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.71  E-value=0.00088  Score=61.49  Aligned_cols=72  Identities=22%  Similarity=0.320  Sum_probs=46.3

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHHcC---CCceeecceeeeecCCCC
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~   80 (353)
                      -.+.||.|....||++.....++.++||.-..           .......|.+.|+.+.   ..++.+++.+-     . 
T Consensus        30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~-  103 (401)
T PRK09550         30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----E-  103 (401)
T ss_pred             eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----C-
Confidence            35689999999999999754336899997431           1122346788887763   23455554431     1 


Q ss_pred             ceeEEEEeccccc
Q 018619           81 ELFLNLVMEYVPE   93 (353)
Q Consensus        81 ~~~~~lv~e~~~~   93 (353)
                       ...++|||++++
T Consensus       104 -~~~~lVME~L~~  115 (401)
T PRK09550        104 -ELAVTVMEDLSD  115 (401)
T ss_pred             -CCCEEEEecCCC
Confidence             114599999874

>PRK10593 hypothetical protein; Provisional

Probab=97.70  E-value=0.00092  Score=59.37  Aligned_cols=76  Identities=5%  Similarity=-0.050  Sum_probs=49.3

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCC---ceeecceeeeecCCCCceeEEEEe
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHP---NVISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      .-.+.||.|..+.||....  .+..+++|.....  ......|...|+.+...   .+.++++++.....  ....++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~--~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS--PGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc--CCCeEEEE
Confidence            4466899999999999863  2335777765432  24667899999988532   45555544322111  22367999


Q ss_pred             ccccc
Q 018619           89 EYVPE   93 (353)
Q Consensus        89 e~~~~   93 (353)
                      |+++|
T Consensus        93 E~i~G   97 (297)
T PRK10593         93 ERLRG   97 (297)
T ss_pred             eccCC
Confidence            99886

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.57  E-value=0.0003  Score=57.80  Aligned_cols=101  Identities=19%  Similarity=0.156  Sum_probs=74.8

Q ss_pred             HHHHHHHHcCC-CceeecceeeeecCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc
Q 018619           53 RELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT  130 (353)
Q Consensus        53 ~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~  130 (353)
                      .|.-+++.+++ +++.++++.+     .    -.+++||.+. +++.. ......-...++.....++.+++..+.+++.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~-~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGI-YRPLSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccc-ccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            58888888876 6889988877     2    2368899884 33211 0000111346889999999999999999997


Q ss_pred             C--CCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619          131 V--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus       131 ~--~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      .  ..+.-+|++|+|+-++. ++++|++|.+.+...
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~-~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVND-DGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCCcEEEeecchHHeEEeC-CCcEEEEechhcchh
Confidence            2  24778899999999995 788999999987644

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.53  E-value=0.00082  Score=59.68  Aligned_cols=143  Identities=14%  Similarity=0.036  Sum_probs=76.3

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeec-cccchHHHHHHHHHcCCCc--eeecceeeeecC--CCCceeEEEEecc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQLMRVMDHPN--VISLKHCFFSTT--SKNELFLNLVMEY   90 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~--~~~~~~~~lv~e~   90 (353)
                      .+.+..|....+|++..  .+..+++|+... .......|+.++..+.+..  +.+++... ...  .......++|+++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~-~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADR-DGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCC-CCcEeeeeCCceEEEEEe
Confidence            55777788889998864  445789998764 2334557888888874332  33332210 000  0111235689999


Q ss_pred             ccchHH------------HHH---Hhhhhc-CCC----CCHHHHH------------HHHHHHHHHHHHhHc------CC
Q 018619           91 VPESMY------------RVL---KHYSSA-NQR----MPLIYVK------------LYTYQIFRGLAYIHT------VP  132 (353)
Q Consensus        91 ~~~~l~------------~~l---~~~~~~-~~~----l~~~~~~------------~i~~qll~al~~LH~------~~  132 (353)
                      ++|...            ..+   ...... ...    .......            .....+..++.++.+      ..
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            976211            111   110000 000    0000000            011112233333332      14


Q ss_pred             CeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       133 ~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDG-DELSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence            7999999999999995 5656899999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.42  E-value=0.0021  Score=57.81  Aligned_cols=30  Identities=30%  Similarity=0.261  Sum_probs=25.6

Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|+|++|+||+++. +...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEG-DRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEEC-CceEEEEeccccc
Confidence            48999999999999984 5545899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.38  E-value=0.0022  Score=57.37  Aligned_cols=145  Identities=16%  Similarity=0.055  Sum_probs=76.1

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCc--eeecceeeeec-CCCCceeEEEEec
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN--VISLKHCFFST-TSKNELFLNLVME   89 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~-~~~~~~~~~lv~e   89 (353)
                      -.+.++.|....+|++..  ++..+++|+....  ......|..+++.|....  +.+++...-.. ........+++++
T Consensus        26 ~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        26 SLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             eccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            356677787789998864  3446888977543  233446777777774322  23332211000 0011234678999


Q ss_pred             cccchH------------HHHHHhhhhcCCCCC-------HHHHH----------------HHHHHHHHHHHHhHc----
Q 018619           90 YVPESM------------YRVLKHYSSANQRMP-------LIYVK----------------LYTYQIFRGLAYIHT----  130 (353)
Q Consensus        90 ~~~~~l------------~~~l~~~~~~~~~l~-------~~~~~----------------~i~~qll~al~~LH~----  130 (353)
                      |++|..            ...+...-.....++       ....+                .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            987621            011111000000000       00000                001112234444432    


Q ss_pred             --CCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          131 --VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       131 --~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                        ..+++|+|+++.||+++. ++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence              158999999999999986 5656899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.34  E-value=0.0048  Score=56.02  Aligned_cols=30  Identities=33%  Similarity=0.617  Sum_probs=26.4

Q ss_pred             CeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       133 ~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++|+|+++.||+++..++.+.++||..|.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            689999999999998645679999999885

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.22  E-value=0.00036  Score=61.06  Aligned_cols=135  Identities=16%  Similarity=0.150  Sum_probs=88.3

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--------------------------ccchHHHHHHHHHcC-CC
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------------------------RRYKNRELQLMRVMD-HP   64 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~E~~~l~~l~-h~   64 (353)
                      -|.++..||-|--+.||.+-+ ..|++.++|.-.-.                          +....+|...|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            578889999999999999885 57888888833100                          111236888888874 32


Q ss_pred             c-eeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCc
Q 018619           65 N-VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN  143 (353)
Q Consensus        65 ~-iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~N  143 (353)
                      . +.+.++         ....++|||++.|--+..+.+      ...   +..+...++.-+.-|-. +|+||+|..--|
T Consensus       172 fpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la~-~GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPKPID---------HNRHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLAN-HGLIHGDFNEFN  232 (465)
T ss_pred             CCCCCccc---------ccceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHHH-cCceecccchhe
Confidence            2 222222         223679999998732111111      111   23344455555667777 799999999999


Q ss_pred             EEEeCCCCcEEEeeeccccccccC
Q 018619          144 LLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus       144 ill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      |+++. ++.++++||--+...+..
T Consensus       233 imv~d-d~~i~vIDFPQmvS~sh~  255 (465)
T KOG2268|consen  233 IMVKD-DDKIVVIDFPQMVSTSHP  255 (465)
T ss_pred             eEEec-CCCEEEeechHhhccCCC
Confidence            99995 778999999866544433

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.16  E-value=0.0078  Score=54.25  Aligned_cols=69  Identities=25%  Similarity=0.268  Sum_probs=42.3

Q ss_pred             eeecCCCeEEEEEEECCCCcEEEEEEeecc-----------ccchHHHHHHHHHcC--CC-ceeecceeeeecCCCCcee
Q 018619           18 VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+|.|....||++.....++.++||.-...           ..+..-|...|+...  -| .+.+++.  ++..     .
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e-----~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE-----M   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc-----c
Confidence            579999999999997543468999955311           122235777777653  23 3444432  1211     1


Q ss_pred             EEEEeccccc
Q 018619           84 LNLVMEYVPE   93 (353)
Q Consensus        84 ~~lv~e~~~~   93 (353)
                      ..+|||+++.
T Consensus        75 ~~~vMEdL~~   84 (370)
T TIGR01767        75 AVTVMEDLSH   84 (370)
T ss_pred             ceehHhhCcc
Confidence            4489999963

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.09  E-value=0.014  Score=51.89  Aligned_cols=48  Identities=15%  Similarity=0.167  Sum_probs=33.4

Q ss_pred             eeeeecCCCeEEEEEEECC------CCcEEEEEEeeccc---cchHHHHHHHHHcCC
Q 018619           16 ERVVGTGSFGIVFQAKCLE------TGETVAIKKVLQDR---RYKNRELQLMRVMDH   63 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h   63 (353)
                      ++.+..|-...+|++....      +++.|++|+.....   ....+|..+++.+..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~   59 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSE   59 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHh
Confidence            3556677778999887533      26789999876542   234678888888854

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.04  E-value=0.0095  Score=53.79  Aligned_cols=29  Identities=24%  Similarity=0.371  Sum_probs=25.6

Q ss_pred             eeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          134 VCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       134 i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|.|+.+.||++++.++.++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            68999999999998545789999999885

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.00  E-value=0.012  Score=52.29  Aligned_cols=29  Identities=31%  Similarity=0.609  Sum_probs=25.7

Q ss_pred             eeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619          134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus       134 i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++|+|+++.|++++. +.-+-+.||+.+..
T Consensus       200 lvHGD~~~gNlii~~-~~~~gVlDwe~~~l  228 (321)
T COG3173         200 LVHGDYRPGNLIIDP-GRPTGVLDWELATL  228 (321)
T ss_pred             eeeCCcccCCEEEeC-CCeeEEEecccccc
Confidence            899999999999997 44599999999874

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.96  E-value=0.017  Score=51.56  Aligned_cols=29  Identities=28%  Similarity=0.558  Sum_probs=25.1

Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|+|+.+.||+++.  +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence            48899999999999985  458999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.93  E-value=0.009  Score=52.43  Aligned_cols=30  Identities=30%  Similarity=0.504  Sum_probs=24.5

Q ss_pred             CeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       133 ~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++|+|++|.||+++.++...-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            589999999999998522335699999886

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.83  E-value=0.011  Score=53.90  Aligned_cols=71  Identities=17%  Similarity=0.212  Sum_probs=44.7

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeecc----------ccchHHHHHHHHHcC--CC-ceeecceeeeecCCCCce
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMD--HP-NVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~--h~-~iv~~~~~~~~~~~~~~~   82 (353)
                      .+.||.|.-..||++.+...++.++||.-...          ..+..-|...|+...  .| .+.+++.+  +..     
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e-----  106 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSV-----  106 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcH-----
Confidence            67889999999999997434568999955211          122345788887663  23 44444331  211     


Q ss_pred             eEEEEeccccc
Q 018619           83 FLNLVMEYVPE   93 (353)
Q Consensus        83 ~~~lv~e~~~~   93 (353)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            14488999863

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.71  E-value=0.025  Score=52.06  Aligned_cols=70  Identities=19%  Similarity=0.247  Sum_probs=44.5

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeec-----------cccchHHHHHHHHHcC---CCceeecceeeeecCCCC
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-----------DRRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~   80 (353)
                      ..+.||.|....||++.+  .+..|+||.-..           ...+...|...|+.+.   ..++.+++.+.     ++
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            467889999999999986  345789996641           2222345677776653   23555555433     21


Q ss_pred             ceeEEEEeccccc
Q 018619           81 ELFLNLVMEYVPE   93 (353)
Q Consensus        81 ~~~~~lv~e~~~~   93 (353)
                      .  .+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            1  4478999975

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.49  E-value=0.044  Score=49.00  Aligned_cols=30  Identities=23%  Similarity=0.283  Sum_probs=26.6

Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++|+|+.++|++++. ++.+.++||..+.
T Consensus       196 ~~lcHgD~~~~Nvl~~~-~~~~~iIDfd~~~  225 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDE-TRGGYFINFEKAS  225 (309)
T ss_pred             eeeeCCCCcHHhEEEcC-CCCEEEEEhhhcc
Confidence            47999999999999986 6679999999886

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.88  E-value=0.068  Score=47.08  Aligned_cols=72  Identities=13%  Similarity=0.140  Sum_probs=42.3

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHcC---CCceeecceeeeecCCCCceeEEEEec
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD---HPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      .-.+.++.|....+|.+.  .+++.|.+|+-... ...+..|..-|+.|.   --.+.+++.+...   .+.  -++|||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~---~~~--~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY---DDD--AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE----SSC--CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee---cCC--ceEEEE
Confidence            445678889999999887  67889999977643 345678999888884   2234444443311   111  369999


Q ss_pred             ccc
Q 018619           90 YVP   92 (353)
Q Consensus        90 ~~~   92 (353)
                      |++
T Consensus        93 ~l~   95 (288)
T PF03881_consen   93 FLE   95 (288)
T ss_dssp             ---
T ss_pred             eec
Confidence            986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.84  E-value=0.033  Score=49.94  Aligned_cols=76  Identities=17%  Similarity=0.188  Sum_probs=56.9

Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+.|++|++-.+.+.. +       ..-..+++..++.+.+.-+.-+...-..-|||+..+|||++  .|+|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~-i-------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId--~GnvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISI-I-------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID--EGNVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee--cCceEEEEe
Confidence            4456788999987765321 1       22345677788888777777777633578999999999999  578999999


Q ss_pred             cccccc
Q 018619          159 GSAKQL  164 (353)
Q Consensus       159 g~a~~~  164 (353)
                      -+|+..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999843

>PTZ00384 choline kinase; Provisional

Probab=95.53  E-value=0.31  Score=44.93  Aligned_cols=28  Identities=32%  Similarity=0.370  Sum_probs=23.7

Q ss_pred             CeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       133 ~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ..+|.|+-+.||+.+.  +.+.++||..|.
T Consensus       228 VfCHNDL~~gNIL~~~--~~l~lID~EYA~  255 (383)
T PTZ00384        228 LFCHNDLFFTNILDFN--QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeccCCcccEEecC--CCEEEEEecccc
Confidence            5789999999999863  459999998874

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=95.30  E-value=0.053  Score=50.38  Aligned_cols=30  Identities=27%  Similarity=0.350  Sum_probs=23.9

Q ss_pred             eeeccCCCCcEEEeCCCC----cEEEeeeccccc
Q 018619          134 VCHRDLKPQNLLVDPLTH----QVKICDFGSAKQ  163 (353)
Q Consensus       134 i~H~Dlkp~Nill~~~~~----~vkl~Dfg~a~~  163 (353)
                      ++|+||...|||.+.+++    -..|+||-.+..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            799999999999987443    467788887653

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.13  E-value=0.057  Score=49.20  Aligned_cols=60  Identities=30%  Similarity=0.328  Sum_probs=38.2

Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                      ..++-+|..| ++...+..     ...++...+.++.-...|+--|--..+.+|.|++|.||++--
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            4466667766 44444432     344555566666666666554443369999999999999953

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.27  E-value=0.062  Score=47.79  Aligned_cols=78  Identities=21%  Similarity=0.216  Sum_probs=45.1

Q ss_pred             EEeccccchHHHHHHhh-hhcCCCCCHHHHHHHHHHHHHHHH---HhHcCCCeeeccCCCCcEEEeCCC-----------
Q 018619           86 LVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLA---YIHTVPRVCHRDLKPQNLLVDPLT-----------  150 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~-~~~~~~l~~~~~~~i~~qll~al~---~LH~~~~i~H~Dlkp~Nill~~~~-----------  150 (353)
                      +|+++..++-.+.-... ..-+-..-.+.++.++.|++.-.-   .|-...+.+|-||||+|||+-+.+           
T Consensus       248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~  327 (434)
T PF05445_consen  248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRN  327 (434)
T ss_pred             EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeE
Confidence            78887765432221111 111222334556778888765431   122225789999999999994322           


Q ss_pred             ------CcEEEeeeccccc
Q 018619          151 ------HQVKICDFGSAKQ  163 (353)
Q Consensus       151 ------~~vkl~Dfg~a~~  163 (353)
                            -.++|.||.+|..
T Consensus       328 ~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  328 YVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             EEecccceeeecccCHHHh
Confidence                  2467778887764

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.17  E-value=0.087  Score=47.31  Aligned_cols=29  Identities=38%  Similarity=0.544  Sum_probs=24.9

Q ss_pred             eeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          134 VCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       134 i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +||+|+.|+||+++.++..+.++||+-|.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999633358999999875

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.93  E-value=0.052  Score=44.30  Aligned_cols=29  Identities=21%  Similarity=0.338  Sum_probs=24.7

Q ss_pred             CeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619          133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus       133 ~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      -.+|+|+.|+|++++. ++ ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~-~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSA-SG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEEC-CC-EEEEeCCcccC
Confidence            3589999999999985 55 99999999863

>PTZ00296 choline kinase; Provisional

Probab=93.93  E-value=1.1  Score=42.12  Aligned_cols=49  Identities=14%  Similarity=0.135  Sum_probs=33.3

Q ss_pred             EeeeeecCCCeEEEEEEECC--------CCcEEEEEEeeccccc---hHHHHHHHHHcCC
Q 018619           15 AERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRRY---KNRELQLMRVMDH   63 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h   63 (353)
                      -++.|..|-.-.+|++....        .++.|.+|+.......   ...|..+++.+..
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~  168 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSK  168 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHH
Confidence            56677778888899987542        1568999987554322   3468888877754

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.93  E-value=0.12  Score=45.20  Aligned_cols=50  Identities=24%  Similarity=0.335  Sum_probs=37.7

Q ss_pred             HHHHHHHHHHHHHHHHhHcCC--CeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619          112 IYVKLYTYQIFRGLAYIHTVP--RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus       112 ~~~~~i~~qll~al~~LH~~~--~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ...+..+..+-.++.-.+. .  -++|+|+.|+|++.++ .+.++|+||..|..
T Consensus       132 ~~~~~~~~~l~~~l~~~~~-~~~v~cH~Dl~~~N~l~t~-~~~l~LIDWEyAg~  183 (269)
T COG0510         132 HLLRKKLKELRRALEEVPK-DDLVPCHNDLNPGNLLLTD-KGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCC-CceeeecCCCCccceEEcC-CCcEEEEecccCCC
Confidence            3344455566666666665 3  4899999999999995 67899999998864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	353
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-137
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-137
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-137
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-137
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-137
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-137
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-137
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-136
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-136
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-136
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-136
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-136
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-136
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-135
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-135
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-135
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-135
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-135
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-134
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-134
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-133
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-128
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		7e-91
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-81
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-46
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-45
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-45
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-45
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-45
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-45
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-45
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-44
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-44
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-44
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-44
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-44
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-44
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-44
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-44
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-44
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-44
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-44
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-44
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-44
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-44
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-44
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-44
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-44
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-44
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-44
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-44
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-44
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-44
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-44
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-44
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-44
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-44
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-44
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-44
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-44
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-44
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-44
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-44
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-44
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-44
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-44
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-44
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-44
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-44
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-44
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-44
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-44
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-44
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-44
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-44
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-44
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-44
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-44
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-44
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-44
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-44
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-44
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-44
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-44
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-44
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-43
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-43
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-43
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-43
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-43
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-43
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-42
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-42
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-42
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-41
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-41
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-41
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-41
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-41
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-41
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-41
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-41
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-41
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-40
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-40
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-40
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-40
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-40
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-40
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-40
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-40
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-40
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-39
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-39
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-39
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-39
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-39
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-39
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-39
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-39
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-39
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-39
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-39
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-39
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-39
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-39
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-39
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-39
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-39
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-39
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-39
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-39
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-39
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-39
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-39
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-39
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-39
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-39
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-39
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-39
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-39
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-39
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-39
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-39
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-39
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-39
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-39
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-39
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-39
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-39
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-39
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-39
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-39
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-39
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-39
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-39
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		9e-39
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-38
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-38
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-38
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-38
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-38
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-38
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-38
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-38
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-38
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-36
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-35
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-35
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-35
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-35
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-35
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-35
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-34
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-34
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-34
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-34
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-34
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-34
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-34
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-34
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-34
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-33
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-33
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-33
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-33
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-33
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-33
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-33
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-33
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-33
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		5e-33
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-33
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-33
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-33
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		6e-33
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-33
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-33
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-33
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-33
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-32
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		5e-32
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-32
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-32
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-31
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-30
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-30
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-30
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-30
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-30
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-30
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-30
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		5e-30
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		6e-30
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-30
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-29
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-29
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-29
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-29
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-29
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-29
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-29
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-29
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-29
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-29
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-29
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-29
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-28
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-28
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-28
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-28
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-28
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-28
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-27
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-27
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-27
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-27
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-26
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-26
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-26
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-26
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-26
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-26
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-26
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-26
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-25
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-25
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-24
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-24
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-23
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-22
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-21
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-21
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-21
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-21
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-21
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-21
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-20
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-20
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-20
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-20
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-19
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-19
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-19
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-19
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-19
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-19
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-19
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-19
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-19
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-19
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-19
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-19
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-18
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-18
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-18
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-18
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-18
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-18
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-18
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-18
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-17
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-17
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-17
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-17
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-17
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-17
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-17
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-17
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-17
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-17
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-17
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-17
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-17
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-17
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-17
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-17
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-17
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-17
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-17
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-17
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-17
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-17
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-17
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-17
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-17
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-17
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-17
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-17
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-16
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-16
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-16
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-16
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-16
3soa_A	444	Full-Length Human Camkii Length = 444		1e-16
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-16
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-16
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-16
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-16
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-16
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-16
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-16
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-16
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-16
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-16
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-16
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-16
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-16
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-16
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-16
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-16
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-16
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-16
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-16
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-16
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-15
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-15
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-15
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-15
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-15
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-15
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-15
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-15
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-15
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-15
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-15
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-15
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-15
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-15
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-15
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-15
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-15
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-15
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-15
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-15
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-15
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-15
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-15
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-15
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-15
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-15
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-15
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-15
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-15
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-15
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-15
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-15
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-15
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-15
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-15
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-15
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-15
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		9e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-14
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-14
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-14
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-14
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-14
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-14
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		4e-14
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-14
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-14
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-14
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-14
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-14
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-14
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-13
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-13
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-13
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-13
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-13
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-12
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-11
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-11
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		6e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-10
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		6e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		8e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-08
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-08
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-07
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-07
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		9e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-05
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		7e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-04
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		7e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-04
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  485 bits (1248), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/335 (66%), Positives = 278/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 46  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 105
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 166 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 224
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 225 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 284
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 285 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 344
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 345 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 379

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/335 (66%), Positives = 278/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 97  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 156
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 217 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 275
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 276 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 335
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 336 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 395
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 396 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 430

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/335 (66%), Positives = 278/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 54  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 113
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 174 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 232
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 233 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 292
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 293 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 352
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 353 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 387

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/335 (66%), Positives = 278/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 111
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 172 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 351 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 385

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  484 bits (1247), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/335 (66%), Positives = 278/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 23  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 82
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 143 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 201
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 202 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 261
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 262 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 321
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 322 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 356

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  484 bits (1246), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/335 (66%), Positives = 278/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 56  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 115
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 176 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 234
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 235 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 294
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 295 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 354
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 355 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 389

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  483 bits (1244), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/335 (66%), Positives = 278/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 31  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 90
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 151 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 209
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 210 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 269
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 270 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 329
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 330 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 364

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  482 bits (1240), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 222/335 (66%), Positives = 277/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 111
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 172 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 230
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 351 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 385

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  481 bits (1239), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 222/333 (66%), Positives = 277/333 (83%), Gaps = 2/333 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  481 bits (1238), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 222/335 (66%), Positives = 277/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 37  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 96
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 157 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 215
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 216 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 275
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 276 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 335
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 336 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 370

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  481 bits (1238), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 222/335 (66%), Positives = 277/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 89
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 150 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 268
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 269 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 328
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 329 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 363

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  481 bits (1238), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 222/335 (66%), Positives = 277/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 30  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 89
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 150 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 208
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 268
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 269 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 328
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 329 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 363

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  481 bits (1237), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 222/335 (66%), Positives = 277/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 26  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 85
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 146 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 204
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 205 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 264
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 265 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 324
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 325 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 359

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  479 bits (1233), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 222/335 (66%), Positives = 277/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 351

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  479 bits (1232), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 221/333 (66%), Positives = 276/333 (82%), Gaps = 2/333 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 19  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 78
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 139 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 197
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 198 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 257
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 258 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 317
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 318 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 350

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  479 bits (1232), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 221/333 (66%), Positives = 276/333 (82%), Gaps = 2/333 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  478 bits (1230), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 221/333 (66%), Positives = 276/333 (82%), Gaps = 2/333 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 22  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 81
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 142 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 200
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 201 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 260
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 261 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 320
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 321 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 353

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  476 bits (1226), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 220/333 (66%), Positives = 275/333 (82%), Gaps = 2/333 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 77
Query: 69  LKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+  K ++ +LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  476 bits (1224), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 220/333 (66%), Positives = 275/333 (82%), Gaps = 2/333 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ + +KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVR 77
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  476 bits (1224), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 221/335 (65%), Positives = 275/335 (82%), Gaps = 2/335 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ + +KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVR 77
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           PNGR  P LFNF  +   ++P L   LIP H + Q
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQ 351

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  470 bits (1209), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 218/333 (65%), Positives = 272/333 (81%), Gaps = 2/333 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQ + +KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVR 77
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVP ++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+S ICSR+YRAPELIFG
Sbjct: 138 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  454 bits (1168), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 210/336 (62%), Positives = 271/336 (80%), Gaps = 3/336 (0%)
Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           + I+Y   +V+G GSFG+VFQAK +E+ E VAIKKVLQD+R+KNRELQ+MR++ HPNV+ 
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVD 96
Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           LK  F+S    K+E+FLNLV+EYVPE++YR  +HY+   Q MP++ +KLY YQ+ R LAY
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH++  +CHRD+KPQNLL+DP +  +K+ DFGSAK LIAGE N+S ICSR+YRAPELIFG
Sbjct: 157 IHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFG 215
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT YTT+IDIWS GCV+AEL+ GQPLFPGE+ +DQLVEIIKVLGTP+RE+I+ MNPNY +
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
            +FPQI+ HP+ KVF  R PP+AIDL SRLL+Y+PS R TA+EA  HPFFDELR   AR+
Sbjct: 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARM 335
Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQL 343
           PNGR LPPLFN+ +E     P+L+++L+P H + +L
Sbjct: 336 PNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAEL 371

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  330 bits (846), Expect = 7e-91,   Method: Compositional matrix adjust.
 Identities = 166/367 (45%), Positives = 240/367 (65%), Gaps = 44/367 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHC 72
           Y   + +GTGSFGIV +   +E+G+  A+KKVLQD RYKNREL +M+V+DH N+I L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 73  FFSTTSK-----------NEL----------------------FLNLVMEYVPESMYRVL 99
           F++T  +           N+L                      +LN++MEYVP+++++VL
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 100 KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG 159
           K +  + + +P+  + +Y YQ+FR + +IH++  +CHRD+KPQNLLV+   + +K+CDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 219
           SAK+LI  E +++ ICSRFYRAPEL+ GATEYT SID+WS GCV  EL+LG+PLF GE +
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 279
           +DQLV II+++GTPT+E++  MNP+YT+ RFP +KA  W K+  +  P  AIDL  ++L+
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 280 YSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPLPPLFNFK-QELSGASPE 329
           Y P LR    EA AHPFFD LR         N+  P+G  + +P LFNF   ELS     
Sbjct: 308 YEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGN 367
Query: 330 LVNKLIP 336
           ++N+++P
Sbjct: 368 VLNRILP 374

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  299 bits (766), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 147/317 (46%), Positives = 211/317 (66%), Gaps = 10/317 (3%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR---VMDHPNVISL 69
           +  ER+ G G+FG V   K   TG +VAIKKV+QD R++NRELQ+M+   V+ HPN++ L
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 70  KHCFFSTTSKN--ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           +  F++   ++  +++LN+VMEYVP++++R  ++Y       P I +K++ +Q+ R +  
Sbjct: 85  QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 128 IHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           +H     VCHRD+KP N+LV+     +K+CDFGSAK+L   E N++YICSR+YRAPELIF
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF 204
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G   YTT++DIWS GC+ AE++LG+P+F G+N+  QL EI++VLG P+RE +R +NP++T
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHT 264
Query: 247 DFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           D      K  PW  VF     +   EA DL S LLQY P  R    EA  HP+FDEL +P
Sbjct: 265 DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324
Query: 304 NARLPNGRPLP-PLFNF 319
             +LPN + LP  LF F
Sbjct: 325 ATKLPNNKDLPEDLFRF 341

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 115/342 (33%), Positives = 183/342 (53%), Gaps = 26/342 (7%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNR---ELQLMRVMDHPNVI 67
           Y   + +G G++G+V  A        VAIKK+   + + Y  R   E+Q++    H NVI
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            ++    ++T +    + +V + +   +Y++LK    +N      ++  + YQI RGL Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSND-----HICYFLYQILRGLKY 159
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICSRFYRAPE 183
           IH+   V HRDLKP NLL++  T  +KICDFG A+       +  +    + +R+YRAPE
Sbjct: 160 IHSA-NVLHRDLKPSNLLIN-TTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 241
           ++  +  YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 242 --NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
               NY     P      W K+F K    +A+DL  R+L ++P+ R T  EA AHP+ ++
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAHPYLEQ 335
Query: 300 LREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
             +P        P    F F  EL     E + +LI     R
Sbjct: 336 YYDPTDEPVAEEP----FTFAMELDDLPKERLKELIFQETAR 373

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  178 bits (451), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 148
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 107/307 (34%), Positives = 179/307 (58%), Gaps = 28/307 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 75  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 126
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 127 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 244
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P  
Sbjct: 245 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 299
Query: 306 RLPNGRP 312
            L   RP
Sbjct: 300 HLRLERP 306

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  177 bits (450), Expect = 6e-45,   Method: Compositional matrix adjust.
 Identities = 105/298 (35%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E+V + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 78  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 129
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 130 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 247
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 248 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  177 bits (449), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  177 bits (448), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 144
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 148
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 110/336 (32%), Positives = 180/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + LV   +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 164
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 284 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 341
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 342 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 373

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 78  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 129
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 130 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 247
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 248 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 300

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 152
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 212 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 271
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 272 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 329
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 330 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 361

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 144
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 75  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 126
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 127 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 244
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 245 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 297

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 105/298 (35%), Positives = 175/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E+V + +   +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHT---ENKLYL--VFEHVHQDLKTFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 144
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 111/339 (32%), Positives = 182/339 (53%), Gaps = 32/339 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA-N 146
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC-MNPNYTDF 248
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C +N    ++
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNY 265
Query: 249 --RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP----FFDELRE 302
               P     PW+++F      +A+DL  ++L ++P  R    +A AHP    ++D   E
Sbjct: 266 LLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSDE 324
Query: 303 PNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
           P A  P        F F  EL     E + +LI +   R
Sbjct: 325 PIAEAP--------FKFDMELDDLPKEKLKELIFEETAR 355

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 164
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 224 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 284 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 341
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 342 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 373

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 142
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 261
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 262 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 319
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 320 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 351

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 146
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 266 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 323
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 324 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 355

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 149
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 269 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 327 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 358

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 150
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 210 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 269
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 270 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 327
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 328 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 359

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 141
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 201 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 260
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 261 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 318
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 319 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 350

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  176 bits (445), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 148
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 112/340 (32%), Positives = 180/340 (52%), Gaps = 34/340 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNR---ELQLMRVMDHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R   E++++    H N+I +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 146
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 206 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP----FFDELR 301
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP    ++D   
Sbjct: 266 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDPSD 323
Query: 302 EPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
           EP A  P        F F  EL     E + +LI +   R
Sbjct: 324 EPIAEAP--------FKFDMELDDLPKEKLKELIFEETAR 355

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GL++ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLSFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 109/314 (34%), Positives = 166/314 (52%), Gaps = 25/314 (7%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVMDH 63
           +Y++   VG+G++G V  A    +GE VAIKK        +   R Y  REL L++ M H
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQH 100
Query: 64  PNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
            NVI L   F   +S +N     LVM ++   + +++    S  +      ++   YQ+ 
Sbjct: 101 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK------IQYLVYQML 154
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
           +GL YIH+   V HRDLKP NL V+    ++KI DFG A+   A      Y+ +R+YRAP
Sbjct: 155 KGLKYIHSAG-VVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAP 210
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E+I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ +N
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270
Query: 243 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                      PQ     + ++F  R  P+A DL  ++L+     R TA +A  HPFF+ 
Sbjct: 271 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 329
Query: 300 LREPNARLPNGRPL 313
            R+P       +P 
Sbjct: 330 FRDPEEETEAQQPF 343

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 108/349 (30%), Positives = 189/349 (54%), Gaps = 30/349 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 66
            +  + ++G G++G+V  A    TGE VAIKK+    +        RE+++++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           I++ +     + +N   + ++ E +   ++RV+     + Q +   +++ + YQ  R + 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSDDHIQYFIYQTLRAVK 126
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----------YIC 175
            +H    V HRDLKP NLL++     +K+CDFG A+ +    A+ S           Y+ 
Sbjct: 127 VLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-T 234
           +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 235 REEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
             ++RC+ +P   ++    P   A P  K+F  R+ P+ IDL  R+L + P+ R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 292 CAHPFFDELREPNARLPNGRPLPP-LFNFKQELSGASPELVNKLIPDHV 339
             HP+     +PN   P G P+PP  F F       + + + KLI + +
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 175/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + +   +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLHQDLKTFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 104/297 (35%), Positives = 165/297 (55%), Gaps = 21/297 (7%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     VG G++G+V++AK  + G  VA+K++  D   +       RE+ L++ + HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +SL     S     E  L LV E++ + + +VL    +  Q      +K+Y YQ+ RG+A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVA 133
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 185
           + H   R+ HRDLKPQNLL++     +K+ DFG A+   I   +    + + +YRAP+++
Sbjct: 134 HCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 243
            G+ +Y+TS+DIWS GC+ AE++ G+PLFPG    DQL +I  +LGTP   E   +   P
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
            +    F   +  PW  +       E IDL S +L + P+ R +A +A  HP+F +L
Sbjct: 252 LWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSND-----HICYFLYQILRGLKYIHSA-N 148
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 109/314 (34%), Positives = 166/314 (52%), Gaps = 25/314 (7%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKK--------VLQDRRYKNRELQLMRVMDH 63
           +Y++   VG+G++G V  A    +GE VAIKK        +   R Y  REL L++ M H
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQH 82
Query: 64  PNVISLKHCFFSTTS-KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
            NVI L   F   +S +N     LVM ++   + +++    S  +      ++   YQ+ 
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK------IQYLVYQML 136
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
           +GL YIH+   V HRDLKP NL V+    ++KI DFG A+   A      Y+ +R+YRAP
Sbjct: 137 KGLKYIHSAG-VVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAP 192
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E+I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ +N
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 243 PNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                      PQ     + ++F  R  P+A DL  ++L+     R TA +A  HPFF+ 
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311
Query: 300 LREPNARLPNGRPL 313
            R+P       +P 
Sbjct: 312 FRDPEEETEAQQPF 325

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKP+NLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 180/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 142
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P +E++ C+      NY
Sbjct: 202 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNY 261
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 262 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 319
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 320 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 351

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 176/298 (59%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKP+NLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 104/297 (35%), Positives = 165/297 (55%), Gaps = 21/297 (7%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     VG G++G+V++AK  + G  VA+K++  D   +       RE+ L++ + HPN+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +SL     S     E  L LV E++ + + +VL    +  Q      +K+Y YQ+ RG+A
Sbjct: 82  VSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDS---QIKIYLYQLLRGVA 133
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 185
           + H   R+ HRDLKPQNLL++     +K+ DFG A+   I   +    + + +YRAP+++
Sbjct: 134 HCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--P 243
            G+ +Y+TS+DIWS GC+ AE++ G+PLFPG    DQL +I  +LGTP   E   +   P
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
            +    F   +  PW  +       E IDL S +L + P+ R +A +A  HP+F +L
Sbjct: 252 LWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAI+K+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 148
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 175/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+ K+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 175/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+ K+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 70  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 121
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 122 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 239
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 240 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 174/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++   +   +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 148
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 268 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 325
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 326 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 357

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 181/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 149
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM----NPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 269 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 326
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 327 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 358

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 174/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++   +   +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 73  IHT---ENKLYL--VFEFLSMDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 125 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 242
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 243 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 295

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 175/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++   + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 123
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKP+NLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 124 RVLHRDLKPENLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 241
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 242 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 294

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 106/349 (30%), Positives = 189/349 (54%), Gaps = 30/349 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 66
            +  + ++G G++G+V  A    TGE VAIKK+    +        RE+++++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           I++ +     + +N   + ++ E +   ++RV+     + Q +   +++ + YQ  R + 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSDDHIQYFIYQTLRAVK 126
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----------ISYIC 175
            +H    V HRDLKP NLL++     +K+CDFG A+ +    A+           + ++ 
Sbjct: 127 VLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-T 234
           +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 235 REEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
             ++RC+ +P   ++    P   A P  K+F  R+ P+ IDL  R+L + P+ R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 292 CAHPFFDELREPNARLPNGRPLPP-LFNFKQELSGASPELVNKLIPDHV 339
             HP+     +PN   P G P+PP  F F       + + + KLI + +
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  174 bits (441), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 175/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++   + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 125
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKP+NLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 126 RVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 243
Query: 250 FPQIKAHPWHKV-FHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W +  F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 244 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 109/336 (32%), Positives = 179/336 (53%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 144
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE----IRCMNPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E+    I     NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 175/298 (58%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + +   +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKDFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKP+NLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF ++ +P
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 293

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 103/294 (35%), Positives = 173/294 (58%), Gaps = 28/294 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN++ L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +   +N+L+L  V E++ + + + +   +SA   +PL  +K Y +Q+ +GLA+ H+  
Sbjct: 71  IHT---ENKLYL--VFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHS-H 122
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
           RV HRDLKPQNLL++     +K+ DFG A+   +        + + +YRAPE++ G   Y
Sbjct: 123 RVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR-- 249
           +T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP  E +     +  D++  
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVWPGVTSMPDYKPS 240
Query: 250 FPQIKAHPW-HKVFHKRMPP---EAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
           FP+     W  + F K +PP   +   L S++L Y P+ R +A  A AHPFF +
Sbjct: 241 FPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 289

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 109/320 (34%), Positives = 176/320 (55%), Gaps = 24/320 (7%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
            +G G++G+V  A+   TG+ VAIKK      V+ + +   REL++++   H N+I++K 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 72  CFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
               T    E   + +V++ +   +++++     ++Q + L +V+ + YQ+ RGL Y+H+
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELI 185
             +V HRDLKP NLLV+    ++KI DFG A+ L    A        Y+ +R+YRAPEL+
Sbjct: 177 A-QVIHRDLKPSNLLVNE-NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
               EYT +ID+WS GC+  E+L  + LFPG+N V QL  I+ VLGTP+   I+ +    
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 294
Query: 246 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                   P  +  PW  V+      +A+ L  R+L++ PS R +A  A  HPF  +  +
Sbjct: 295 VRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353
Query: 303 PNARLPNGRPLPPLFNFKQE 322
           P+   P+  P P  F F +E
Sbjct: 354 PDDE-PDCAP-PFDFAFDRE 371

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 109/320 (34%), Positives = 176/320 (55%), Gaps = 24/320 (7%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKK------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
            +G G++G+V  A+   TG+ VAIKK      V+ + +   REL++++   H N+I++K 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 72  CFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
               T    E   + +V++ +   +++++     ++Q + L +V+ + YQ+ RGL Y+H+
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPELI 185
             +V HRDLKP NLLV+    ++KI DFG A+ L    A        Y+ +R+YRAPEL+
Sbjct: 178 A-QVIHRDLKPSNLLVNE-NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
               EYT +ID+WS GC+  E+L  + LFPG+N V QL  I+ VLGTP+   I+ +    
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAER 295
Query: 246 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                   P  +  PW  V+      +A+ L  R+L++ PS R +A  A  HPF  +  +
Sbjct: 296 VRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354
Query: 303 PNARLPNGRPLPPLFNFKQE 322
           P+   P+  P P  F F +E
Sbjct: 355 PDDE-PDCAP-PFDFAFDRE 372

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 107/349 (30%), Positives = 188/349 (53%), Gaps = 30/349 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNV 66
            +  + ++G G++G+V  A    TGE VAIKK+    +        RE+++++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           I++ +     + +N   + ++ E +   ++RV+     + Q +   +++ + YQ  R + 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-----STQMLSDDHIQYFIYQTLRAVK 126
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----------YIC 175
            +H    V HRDLKP NLL++     +K+CDFG A+ +    A+ S            + 
Sbjct: 127 VLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP-T 234
           +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 235 REEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
             ++RC+ +P   ++    P   A P  K+F  R+ P+ IDL  R+L + P+ R TA EA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 292 CAHPFFDELREPNARLPNGRPLPP-LFNFKQELSGASPELVNKLIPDHV 339
             HP+     +PN   P G P+PP  F F       + + + KLI + +
Sbjct: 304 LEHPYLQTYHDPNDE-PEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEI 351

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 178/336 (52%), Gaps = 26/336 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKNRELQLMRVM---DHPNVISLKHCF 73
           +G G++G+V  A        VAIKK+   + + Y  R L+ ++++    H N+I +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            + T +    + +V + +   +Y++LK    +N      ++  + YQI RGL YIH+   
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND-----HICYFLYQILRGLKYIHSA-N 144
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRAPELIFGAT 189
           V HRDLKP NLL++  T  +KI DFG A+       +      Y+ +R+YRAPE++  + 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE----IRCMNPNY 245
            YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E+    I     NY
Sbjct: 204 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++  +P+ 
Sbjct: 264 L-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSD 321
Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
                 P    F F  EL     E + +LI +   R
Sbjct: 322 EPIAEAP----FKFDMELDDLPKEKLKELIFEETAR 353

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  167 bits (424), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 109/315 (34%), Positives = 168/315 (53%), Gaps = 25/315 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  +  +++G  +A+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   TS  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 172
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 173 AD-IIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 306
           +   PQ+    +  VF     P A+DL  ++L      R TA EA AHP+F +  +P+  
Sbjct: 289 N-SLPQMPKRNFADVF-IGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDPDDE 346
Query: 307 LPNGRPLPPLFNFKQ 321
            P   P    F  +Q
Sbjct: 347 -PESEPYDQSFESRQ 360

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  167 bits (423), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 103/305 (33%), Positives = 162/305 (53%), Gaps = 19/305 (6%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 70
           R VG+G++G V  A      + VA+KK+      L   R   REL+L++ + H NVI L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F   TS  +   + LV   +   +  ++K  + +++     +V+   YQ+ RGL YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDE-----HVQFLVYQLLRGLKYIH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N+ V+    +++I DFG A+Q  A E    Y+ +R+YRAPE++    
Sbjct: 149 SAG-IIHRDLKPSNVAVNE-DSELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 250 FPQIKAHPWHKV--FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
              +   P   +    +   P AIDL  R+L      R +A EA AH +F +  +P    
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE- 323
Query: 308 PNGRP 312
           P   P
Sbjct: 324 PEAEP 328

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 98/289 (33%), Positives = 161/289 (55%), Gaps = 19/289 (6%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQ---DRRYKN---RELQLMRVMDHPNVISLKH 71
           +VG GS+G+V + +  +TG  VAIKK L+   D+  K    RE++L++ + H N+++L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
                  K +    LV E+V  ++   L+ + +    +    V+ Y +QI  G+ + H+ 
Sbjct: 90  ---LEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHS- 142
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGATE 190
             + HRD+KP+N+LV   +  VK+CDFG A+ L A GE     + +R+YRAPEL+ G  +
Sbjct: 143 HNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 248
           Y  ++D+W+ GC++ E+ +G+PLFPG++ +DQL  I+  LG   P  +E+   NP +   
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261
Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           R P+IK     +  + ++    IDLA + L   P  R    E   H FF
Sbjct: 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 105/297 (35%), Positives = 160/297 (53%), Gaps = 26/297 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A    TG  VAIKK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHENVIGLL 90
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    + ++     LVM ++   + +++KH      R     ++   YQ+ +GL YIH
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQMLKGLRYIH 145
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
               + HRDLKP NL V+    ++KI DFG A+Q  A       + +R+YRAPE+I    
Sbjct: 146 AAG-IIHRDLKPGNLAVNE-DCELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWM 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP  E ++ +      NY
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                P+++   +  +      P A++L  ++L      R TA EA AHP+F+ L +
Sbjct: 262 MK-GLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 103/305 (33%), Positives = 162/305 (53%), Gaps = 19/305 (6%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 70
           R VG+G++G V  A      + VA+KK+      L   R   REL+L++ + H NVI L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F   TS  +   + LV   +   +  ++K  + +++     +V+   YQ+ RGL YIH
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDE-----HVQFLVYQLLRGLKYIH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N+ V+    +++I DFG A+Q  A E    Y+ +R+YRAPE++    
Sbjct: 149 SAG-IIHRDLKPSNVAVNE-DSELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 204
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 250 FPQIKAHPWHKV--FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
              +   P   +    +   P AIDL  R+L      R +A EA AH +F +  +P    
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE- 323
Query: 308 PNGRP 312
           P   P
Sbjct: 324 PEAEP 328

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 114/342 (33%), Positives = 174/342 (50%), Gaps = 34/342 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 69
           +G G F  V++A+   T + VAIKK+    R +          RE++L++ + HPN+I L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
              F   ++     ++LV +++   +  ++K  S     +   ++K Y     +GL Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH 129
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIF 186
               + HRDLKP NLL+D     +K+ DFG AK    G  N +Y   + +R+YRAPEL+F
Sbjct: 130 Q-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELLF 185
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI--RCMNPN 244
           GA  Y   +D+W+ GC+LAELLL  P  PG++ +DQL  I + LGTPT E+    C  P+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245
Query: 245 YTDFR-FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           Y  F+ FP I   P H +F      + +DL   L  ++P  R TA +A    +F     P
Sbjct: 246 YVTFKSFPGI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301
Query: 304 NARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGL 345
                  RP  P+   K++   ++P L  K        Q GL
Sbjct: 302 TPGCQLPRPNCPVETLKEQ---SNPALAIKRKRTEALEQGGL 340

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 164/300 (54%), Gaps = 30/300 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     +        L LV E++ + + ++L         +  +  K +  Q+  G+A
Sbjct: 63  VKLYDVIHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 185
           Y H   RV HRDLKPQNLL++    ++KI DFG A+   I        I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------EIR 239
            G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +      E+ 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
             +PN+T +     +  PW   F K +    IDL S++L+  P+ R TA +A  H +F E
Sbjct: 233 KYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 103/305 (33%), Positives = 162/305 (53%), Gaps = 19/305 (6%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLK 70
           R VG+G++G V  A      + VA+KK+      L   R   REL+L++ + H NVI L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F   TS  +   + LV   +   +  ++K  + +++     +V+   YQ+ RGL YIH
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDE-----HVQFLVYQLLRGLKYIH 140
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N+ V+    +++I DFG A+Q  A E    Y+ +R+YRAPE++    
Sbjct: 141 SAG-IIHRDLKPSNVAVNE-DCELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLNWM 196
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++V+GTP+ E +  ++  +    
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 250 FPQIKAHPWHKV--FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
              +   P   +    +   P AIDL  R+L      R +A EA AH +F +  +P    
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPEDE- 315
Query: 308 PNGRP 312
           P   P
Sbjct: 316 PEAEP 320

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 98/300 (32%), Positives = 164/300 (54%), Gaps = 30/300 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     +        L LV E++ + + ++L         +  +  K +  Q+  G+A
Sbjct: 63  VKLYDVIHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 185
           Y H   RV HRDLKPQNLL++    ++KI DFG A+   I        + + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------EIR 239
            G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +      E+ 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
             +PN+T +     +  PW   F K +    IDL S++L+  P+ R TA +A  H +F E
Sbjct: 233 KYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 168/307 (54%), Gaps = 21/307 (6%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
           +Y+    +G G++  V++ K   T   VA+K++  +          RE+ L++ + H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           ++L     +  S     L LV EY+ + + + L         + +  VKL+ +Q+ RGLA
Sbjct: 63  VTLHDIIHTEKS-----LTLVFEYLDKDLKQYL---DDCGNIINMHNVKLFLFQLLRGLA 114
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-QLIAGEANISYICSRFYRAPELI 185
           Y H   +V HRDLKPQNLL++    ++K+ DFG A+ + I  +   + + + +YR P+++
Sbjct: 115 YCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDIL 172
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM--NP 243
            G+T+Y+T ID+W  GC+  E+  G+PLFPG    +QL  I ++LGTPT E    +  N 
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 244 NYTDFRFPQIKAHPWHKVFHK-RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
            +  + +P+ +A     + H  R+  +  DL ++LLQ+    R +A +A  HPFF  L E
Sbjct: 233 EFKTYNYPKYRAEAL--LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290
Query: 303 PNARLPN 309
              +LP+
Sbjct: 291 RIHKLPD 297

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 98/300 (32%), Positives = 164/300 (54%), Gaps = 30/300 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     +        L LV E++ + + ++L         +  +  K +  Q+  G+A
Sbjct: 63  VKLYDVIHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIA 114
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 185
           Y H   RV HRDLKPQNLL++    ++KI DFG A+   I        + + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE------EIR 239
            G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +      E+ 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
             +PN+T +     +  PW   F K +    IDL S++L+  P+ R TA +A  H +F E
Sbjct: 233 KYDPNFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/299 (34%), Positives = 160/299 (53%), Gaps = 30/299 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             S        L LV E+  + +    K++ S N  +    VK + +Q+ +GL + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
            V HRDLKPQNLL++    ++K+ +FG A+   I      + + + +YR P+++FGA  Y
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 192 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           +TSID+WSAGC+ AEL   G+PLFPG +  DQL  I ++LGTPT E+   M       + 
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KL 233
Query: 251 PQIKAHPWHKVFHK------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           P  K +P +           ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 103/299 (34%), Positives = 159/299 (53%), Gaps = 30/299 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             S        L LV E+  + +    K++ S N  +    VK + +Q+ +GL + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
            V HRDLKPQNLL++    ++K+ DFG A+   I      + + + +YR P+++FGA  Y
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 192 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           +TSID+WSAGC+ AEL    +PLFPG +  DQL  I ++LGTPT E+   M       + 
Sbjct: 180 STSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------KL 233
Query: 251 PQIKAHPWHKVFHK------RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           P  K +P +           ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 106/299 (35%), Positives = 162/299 (54%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++  A 
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 89
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 144
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 145 SAD-IIHRDLKPSNLAVNE-DSELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 200
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 261 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 93
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 149 SAD-IIHRDLKPSNLAVNE-DSELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 204
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 264
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 265 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 AD-IIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 266 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 98
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 153
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 154 SAD-IIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 209
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 269
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 270 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 92
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 147
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 148 SAD-IIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 264 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 106
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 161
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 162 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 217
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 277
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 278 IQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 107
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 162
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 163 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 218
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 279 IQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 256 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K     +Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG  +     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DSELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 153
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 270 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 325

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           +G+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 92
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 147
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 148 SAD-IIHRDLKPSNLAVNE-DXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 264 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 149
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 150 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWM 205
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 266 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 149
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 150 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWM 205
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 266 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 99
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 154
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 155 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 210
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 270
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 271 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 149
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 150 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWM 205
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 266 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 148
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 265 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 99
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 154
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 155 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 210
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 270
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 271 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 99
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 154
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 155 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 210
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 270
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 271 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 327

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 110
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 165
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 166 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 221
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 281
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 282 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 145
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 146 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 262 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 110
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 165
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 166 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWM 221
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 281
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 282 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 338

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 98
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 153
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 154 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 209
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 269
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 270 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 326

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 257 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 AD-IIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 266 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 149
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 266 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 321

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 144 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 141
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 258 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 313

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 107
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 162
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 163 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 218
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 279 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 109/318 (34%), Positives = 166/318 (52%), Gaps = 27/318 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+ 
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 316
Query: 306 RLPNGRPLPPLFNFKQEL 323
             P   P    F  +  L
Sbjct: 317 E-PVADPFDQSFESRDLL 333

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 256 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 106
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 161
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 162 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 217
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 277
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 278 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 334

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 89
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 144
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 145 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 200
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 261 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 149
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 150 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 205
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 265
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 266 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 92
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 147
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 148 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 203
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 263
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 264 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 320

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 140
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 257 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 312

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 86
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 141
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 142 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 197
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 257
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 258 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 314

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 105/299 (35%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 89
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 144
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++    
Sbjct: 145 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 200
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 260
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 261 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 317

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 161/298 (54%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 139
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    ++ +R+YRAPE++     
Sbjct: 140 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 256 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    ++ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +    ++ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 159/298 (53%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K     +      +V+   YQI RGL YIH+
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDD-----HVQFLIYQILRGLKYIHS 139
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 AD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 256 Q-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI D+G A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 107
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 162
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +     + +R+YRAPE++    
Sbjct: 163 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWM 218
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 278
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 279 IQ-SLAQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 335

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 103/298 (34%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK-------VLQDRRYKNRELQLMRVMDHPNVISLKH 71
           VG+G++G V  A   +TG  VA+KK       ++  +R   REL+L++ M H NVI L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 72  CFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH+
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 143
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NL V+    ++KI DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 144 AD-IIHRDLKPSNLAVNE-DCELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NYT 246
           Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 260 Q-SLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI  FG A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI DFG A+     +     + +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 98/339 (28%), Positives = 172/339 (50%), Gaps = 57/339 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLM-RVMDHPN 65
           Y   + +G G++GIV+++    TGE VA+KK+        D +   RE+ ++  +  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +++L +      + N+  + LV +Y+   ++ V++    AN   P ++ +   YQ+ + +
Sbjct: 71  IVNLLNVL---RADNDRDVYLVFDYMETDLHAVIR----ANILEP-VHKQYVVYQLIKVI 122
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANI----------- 171
            Y+H+   + HRD+KP N+L++   H VK+ DFG ++  +       NI           
Sbjct: 123 KYLHS-GGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 172 --------SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 223
                    Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG + ++QL
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240
Query: 224 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAH-------------PWHKVFHKRMPP-- 268
             II V+  P+ E++  +   +       +K                W  +  K  P   
Sbjct: 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300
Query: 269 ---EAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
              EA+DL  +LLQ++P+ R +A +A  HPF      PN
Sbjct: 301 CNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI D G A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 98/298 (32%), Positives = 157/298 (52%), Gaps = 28/298 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVISLKHCF 73
           +G G++  V++     TG  VA+K+V  D          RE+ LM+ + H N++ L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTYQIFRGLAYIHTV 131
            +        L LV E++   + + +   +  N  + + L  VK + +Q+ +GLA+ H  
Sbjct: 73  HTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE- 126
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATE 190
            ++ HRDLKPQNLL++    Q+K+ DFG A+   I      S + + +YRAP+++ G+  
Sbjct: 127 NKILHRDLKPQNLLINK-RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNYTDF 248
           Y+TSIDIWS GC+LAE++ G+PLFPG N  +QL  I  ++GTP       +   P Y   
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYN-- 243
Query: 249 RFPQIKAHPWHKVF-----HKRMPPEA--IDLASRLLQYSPSLRCTALEACAHPFFDE 299
             P I+  P   +      H + P +   +D    LLQ +P +R +A +A  HP+F E
Sbjct: 244 --PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI D G A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 160/299 (53%), Gaps = 26/299 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHPNVISLK 70
           VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H NVI L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 71  HCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             F    S  E   + LV   +   +  ++K      Q++   +V+   YQI RGL YIH
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP NL V+    ++KI D G A+     +    Y+ +R+YRAPE++    
Sbjct: 143 SAD-IIHRDLKPSNLAVNE-DCELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWM 198
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP----NY 245
            Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++     NY
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 258
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                 Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P+
Sbjct: 259 IQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 315

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 94/294 (31%), Positives = 162/294 (55%), Gaps = 21/294 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHC 72
           +G GS+G+VF+ +  +TG+ VAIKK L+       ++   RE+++++ + HPN+++L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           F     + +  L+LV EY   ++   L  Y      +P   VK  T+Q  + + + H   
Sbjct: 71  F-----RRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHK-H 121
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI--SYICSRFYRAPELIFGATE 190
              HRD+KP+N+L+   +  +K+CDFG A+ L+ G ++     + +R+YR+PEL+ G T+
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFAR-LLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT--PTREEIRCMNPNYTDF 248
           Y   +D+W+ GCV AELL G PL+PG++ VDQL  I K LG   P  +++   N  ++  
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239
Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
           + P  +     ++    +   A+ L    L   P+ R T  +   HP+F+ +RE
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 101/314 (32%), Positives = 168/314 (53%), Gaps = 46/314 (14%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 68
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++++R +DH N++ 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 69  -----------LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI--YVK 115
                      L     S T  N +++  V EY+   +  VL       ++ PL+  + +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVL-------EQGPLLEEHAR 123
Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANIS 172
           L+ YQ+ RGL YIH+   V HRDLKP NL ++     +KI DFG A+ +    + + ++S
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 173 Y-ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL---VEIIK 228
             + +++YR+P L+     YT +ID+W+AGC+ AE+L G+ LF G + ++Q+   +E I 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 229 VLGTPTREEIRCMNPNY--TDFRFPQIKAHPWHKVFHKRMPP---EAIDLASRLLQYSPS 283
           V+    R+E+  + P Y   D   P       HK   + +P    EA+D   ++L +SP 
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEP-------HKPLTQLLPGISREAVDFLEQILTFSPM 295
Query: 284 LRCTALEACAHPFF 297
            R TA EA +HP+ 
Sbjct: 296 DRLTAEEALSHPYM 309

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 102/335 (30%), Positives = 172/335 (51%), Gaps = 37/335 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN------------RELQL 57
           Y  +R + +GS+G V  A     G  VAIK+V   + D R  N            RE++L
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 58  MRVMDHPNVISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI--Y 113
           +    HPN++ L+  F  F   + ++L+L  V E +   + +V+      +QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135
Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
           ++ + Y I  GL  +H    V HRDL P N+L+    + + ICDF  A++  A      Y
Sbjct: 136 IQYFMYHILLGLHVLHEAG-VVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHY 193
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G    +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 234 TREEIRCM-NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 289
             E++    +P+  D+       + A  W  V      P A+DL +++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTE 312
Query: 290 EACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 324
           +A  HP+F+ L +P   L     L   F+F + ++
Sbjct: 313 QALRHPYFESLFDP---LDLTEGLSERFHFDESVT 344

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 102/335 (30%), Positives = 172/335 (51%), Gaps = 37/335 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKN------------RELQL 57
           Y  +R + +GS+G V  A     G  VAIK+V   + D R  N            RE++L
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 58  MRVMDHPNVISLKHCF--FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI--Y 113
           +    HPN++ L+  F  F   + ++L+L  V E +   + +V+      +QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135
Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
           ++ + Y I  GL  +H    V HRDL P N+L+    + + ICDF  A++  A      Y
Sbjct: 136 IQYFMYHILLGLHVLHEAG-VVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHY 193
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G    +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 234 TREEIRCM-NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 289
             E++    +P+  D+       + A  W  V      P A+DL +++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTE 312
Query: 290 EACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 324
           +A  HP+F+ L +P   L     L   F+F + ++
Sbjct: 313 QALRHPYFESLFDP---LDLTEGLSERFHFDESVT 344

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 97/292 (33%), Positives = 152/292 (52%), Gaps = 24/292 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G V++A    T ETVAIK++  +   +       RE+ L++ + H N+I LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                      L+L+ EY        LK Y   N  + +  +K + YQ+  G+ + H+  
Sbjct: 102 IHHNHR-----LHLIFEYAEND----LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151
Query: 133 RVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFG 187
           R  HRDLKPQNLL+       T  +KI DFG A+   I        I + +YR PE++ G
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN--PNY 245
           +  Y+TS+DIWS  C+ AE+L+  PLFPG++ +DQL +I +VLG P       +   P++
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
               FP+ +     +V    +  E +DL + +L+  P  R +A  A  HP+F
Sbjct: 272 KQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 108/336 (32%), Positives = 171/336 (50%), Gaps = 43/336 (12%)
Query: 4   VCCILQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQ 56
           +C   Q    +AE  +G G++G VF+A+ L+ G   VA+K+V      +       RE+ 
Sbjct: 6   LCRADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 57  LMR---VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY 113
           ++R     +HPNV+ L      + +  E  L LV E+V + +   L         +P   
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTET 121
Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
           +K   +Q+ RGL ++H+  RV HRDLKPQN+LV   + Q+K+ DFG A+      A  S 
Sbjct: 122 IKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSV 179
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR--MPPEAI---------DLASRLLQYSP 282
             E+            +P+  A P  + FH +   P E           DL  + L ++P
Sbjct: 239 GEED------------WPRDVALP-RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285
Query: 283 SLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN 318
           + R +A  A +HP+F +L      L +   LPP  N
Sbjct: 286 AKRISAYSALSHPYFQDLERCKENLDSH--LPPSQN 319

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 102/309 (33%), Positives = 161/309 (52%), Gaps = 23/309 (7%)
Query: 4   VCCILQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQ 56
           +C   Q    +AE  +G G++G VF+A+ L+ G   VA+K+V      +       RE+ 
Sbjct: 6   LCRADQQYECVAE--IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 57  LMR---VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY 113
           ++R     +HPNV+ L      + +  E  L LV E+V + +   L         +P   
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTET 121
Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
           +K   +Q+ RGL ++H+  RV HRDLKPQN+LV   + Q+K+ DFG A+      A  S 
Sbjct: 122 IKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSV 179
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           + + +YRAPE++  ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 234 TREEI--RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
             E+       P      F    A P  K F   +     DL  + L ++P+ R +A  A
Sbjct: 239 GEEDWPRDVALPRQA---FHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 292 CAHPFFDEL 300
            +HP+F +L
Sbjct: 295 LSHPYFQDL 303

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 164/309 (53%), Gaps = 35/309 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 70
           +G+G+ GIV  A        VAIKK+   R ++N        REL LM+V++H N+I L 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 71  HCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  G+ ++H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGIKHLH 143
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE+I G  
Sbjct: 144 SAG-IIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP---NYT 246
            Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P    Y 
Sbjct: 202 -YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 247 DFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
           + R P+   + + K+F           +K    +A DL S++L    S R +  EA  HP
Sbjct: 261 ENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 296 FFDELREPN 304
           + +   +P+
Sbjct: 320 YINVWYDPS 328

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 100/315 (31%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+V++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/291 (33%), Positives = 153/291 (52%), Gaps = 21/291 (7%)
Query: 19  VGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN------RELQLMR---VMDHPNVIS 68
           +G G++G VF+A+ L+ G   VA+K+V      +       RE+ ++R     +HPNV+ 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L      + +  E  L LV E+V + +   L         +P   +K   +Q+ RGL ++
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLDFL 136
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H+  RV HRDLKPQN+LV   + Q+K+ DFG A+      A  S + + +YRAPE++  +
Sbjct: 137 HS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 194
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI--RCMNPNYT 246
           + Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P  E+       P   
Sbjct: 195 S-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 253
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
              F    A P  K F   +     DL  + L ++P+ R +A  A +HP+F
Sbjct: 254 ---FHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 163/309 (52%), Gaps = 35/309 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 70
           +G+G+ GIV  A        VAIKK+   R ++N        REL LM+V++H N+I L 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 71  HCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  G+ ++H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGIKHLH 143
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE+I G  
Sbjct: 144 SAG-IIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP---NYT 246
            Y  ++DIWS G ++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P    Y 
Sbjct: 202 -YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 247 DFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
           + R P+   + + K+F           +K    +A DL S++L    S R +  EA  HP
Sbjct: 261 ENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 296 FFDELREPN 304
           + +   +P+
Sbjct: 320 YINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLX 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLX 130
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 131 GIKHLHSAG-IIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 308 ALQHPYINVWYDP 320

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLX 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 98/309 (31%), Positives = 163/309 (52%), Gaps = 35/309 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 70
           +G+G+ GIV  A        VAIKK+   R ++N        REL LM+V++H N+I L 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKVVNHKNIIGLL 89
Query: 71  HCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  G+ ++H
Sbjct: 90  NVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGIKHLH 143
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE+I G  
Sbjct: 144 SAG-IIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP---NYT 246
            Y  ++DIWS G ++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P    Y 
Sbjct: 202 -YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 247 DFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
           + R P+   + + K+F           +K    +A DL S++L    S R +  EA  HP
Sbjct: 261 ENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 296 FFDELREPN 304
           + +   +P+
Sbjct: 320 YINVWYDPS 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DATLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 98/307 (31%), Positives = 162/307 (52%), Gaps = 33/307 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 70
           +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H N+ISL 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 71  HCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  G+ ++H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLCGIKHLH 143
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE+I G  
Sbjct: 144 SAG-IIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP---NYT 246
            Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P   NY 
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 247 DFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           + R       FP++      P     +K    +A DL S++L   P+ R +  +A  HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 297 FDELREP 303
            +   +P
Sbjct: 321 INVWYDP 327

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 101/313 (32%), Positives = 161/313 (51%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A     G  VA+KK+   R ++N        REL L++ ++H 
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V+ H    ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTACTNFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ EL+ G  +F G + +DQ  ++I+ LGTP+ E +  + P
Sbjct: 196 VILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP 254
Query: 244 ---NYTDFR--FPQIKAH--------PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R  +P IK          P      K    +A DL S++L   P  R +  E
Sbjct: 255 TVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDE 314
Query: 291 ACAHPFFDELREP 303
           A  HP+     +P
Sbjct: 315 ALRHPYITVWYDP 327

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP+ E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 97/302 (32%), Positives = 160/302 (52%), Gaps = 33/302 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVISLK 70
           +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H N+ISL 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKXVNHKNIISLL 89
Query: 71  HCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  G+ ++H
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGIKHLH 143
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE+I G  
Sbjct: 144 SAG-IIHRDLKPSNIVVKS-DXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP---NYT 246
            Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P   NY 
Sbjct: 202 -YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 247 DFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           + R       FP++      P     +K    +A DL S++L   P+ R +  +A  HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 297 FD 298
            +
Sbjct: 321 IN 322

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 136
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 137 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 194
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 195 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 253
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 254 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 313
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 314 ALQHPYINVWYDP 326

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 130
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 131 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 189 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 308 ALQHPYINVWYDP 320

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 255 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 314
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 315 ALQHPYINVWYDP 327

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 131
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 132 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 189
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 190 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 248
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 249 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 308
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 309 ALQHPYINVWYDP 321

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 138
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 139 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 197 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 256 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 315
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 316 ALQHPYINVWYDP 328

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 175
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 176 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 234 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 353 ALQHPYINVWYDP 365

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 138
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 139 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 197 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 256 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 315
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 316 ALQHPYINVWYDP 328

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 131
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 132 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 189
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 190 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 248
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 249 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 308
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 309 ALQHPYINVWYDP 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 99/313 (31%), Positives = 164/313 (52%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 175
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 176 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 234 VILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 244 ---NYTDFR-------FPQI---KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R       FP++      P     +K    +A DL S++L   P+ R +  +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 291 ACAHPFFDELREP 303
           A  HP+ +   +P
Sbjct: 353 ALQHPYINVWYDP 365

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 100/313 (31%), Positives = 160/313 (51%), Gaps = 33/313 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A     G  VA+KK+   R ++N        REL L++ ++H 
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL--SRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V+ H    ++RM  +      YQ+  
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL-----LYQMLC 135
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 136 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTASTNFMMTPYVVTRYYRAPE 193
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ EL+ G  +F G + +DQ  ++I+ LGTP+ E +  + P
Sbjct: 194 VILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP 252
Query: 244 ---NYTDFR--FPQIKAH--------PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
              NY + R  +P I           P      K    +A DL S++L   P  R +  E
Sbjct: 253 TVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDE 312
Query: 291 ACAHPFFDELREP 303
           A  HP+     +P
Sbjct: 313 ALRHPYITVWYDP 325

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 164/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 138
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 139 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 197 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 256 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 315 EALQHPYINVWYDPS 329

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 99/315 (31%), Positives = 164/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 98/315 (31%), Positives = 165/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 139
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+        + ++ +R+YRAPE
Sbjct: 140 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPE 197
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 198 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 256
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 257 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 315
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 316 EALQHPYINVWYDPS 330

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 108/360 (30%), Positives = 179/360 (49%), Gaps = 36/360 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+           + +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVFHKRMPP-----------EAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F   + P           +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN-ARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFL 348
           EA  HP+ +   +P+ A  P  +      + ++       EL+ K + D  KR   LN  
Sbjct: 314 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLPKRPTTLNLF 373

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 150/300 (50%), Gaps = 27/300 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMR-VMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K  RE++++  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 164/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 131
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 132 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 189
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++D+WS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 190 VILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 248
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 249 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 307
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 308 EALQHPYINVWYDPS 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 164/315 (52%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 142
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 143 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 200
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++D+WS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 201 VILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 259
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 260 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 318
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 319 EALQHPYINVWYDPS 333

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 163/315 (51%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+           + +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP    ++ + P
Sbjct: 196 VILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
              NY + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +M  PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGGPNIVKL 91
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +         ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKY 255
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 96/315 (30%), Positives = 163/315 (51%), Gaps = 35/315 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+   R ++N        REL LM+ ++H 
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++     ++RM  +      YQ+  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLC 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+           + +R+YRAPE
Sbjct: 138 GIKHLHSAG-IIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPE 195
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++D+WS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 196 VILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 254
Query: 244 ---NYTDFRFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTAL 289
               Y + R P+   + + K+F           +K    +A DL S++L    S R +  
Sbjct: 255 TVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 290 EACAHPFFDELREPN 304
           EA  HP+ +   +P+
Sbjct: 314 EALQHPYINVWYDPS 328

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/310 (30%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E VA+K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+L+D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/325 (28%), Positives = 161/325 (49%), Gaps = 51/325 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH------PNV 66
           Y   +V+G GSFG V +A   +  + VA+K V  ++R+  +  + +R+++H       N 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +++ H   + T +N + +    E +  ++Y ++K        +PL  V+ + + I + L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF--ELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCLD 214
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQ-VKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            +H   R+ H DLKP+N+L+       +K+ DFGS+      +   + I SRFYRAPE+I
Sbjct: 215 ALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVI 271
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P++   + ++ + 
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASK 327
Query: 246 TDFRFPQIKAHPWH------------------KVFHKRMPPEA---------------ID 272
               F   K +P +                  +    R PPE+               +D
Sbjct: 328 RAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 273 LASRLLQYSPSLRCTALEACAHPFF 297
              + L++ P++R T  +A  HP+ 
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 94/325 (28%), Positives = 161/325 (49%), Gaps = 51/325 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH------PNV 66
           Y   +V+G GSFG V +A   +  + VA+K V  ++R+  +  + +R+++H       N 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +++ H   + T +N + +    E +  ++Y ++K        +PL  V+ + + I + L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF--ELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCLD 214
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQ-VKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            +H   R+ H DLKP+N+L+       +K+ DFGS+      +   + I SRFYRAPE+I
Sbjct: 215 ALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVI 271
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P++   + ++ + 
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ---KLLDASK 327
Query: 246 TDFRFPQIKAHPWH------------------KVFHKRMPPEA---------------ID 272
               F   K +P +                  +    R PPE+               +D
Sbjct: 328 RAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 273 LASRLLQYSPSLRCTALEACAHPFF 297
              + L++ P++R T  +A  HP+ 
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 53  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 112
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +    +    ++ Y Y++ + L Y H
Sbjct: 113 LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPT----LTDYDIRYYIYELLKALDYCH 163
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 164 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 223 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNAYLNKY 276
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 277 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 336
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 337 PYFQQVR 343

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 92
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +    +    ++ Y Y++ + L Y H
Sbjct: 93  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPT----LTDYDIRYYIYELLKALDYCH 143
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 144 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKY 256
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 257 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 317 PYFQQVR 323

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 152/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 91
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +         ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKY 255
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 91
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +    +    ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPT----LTDYDIRYYIYELLKALDYCH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKY 255
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGGPNIVKL 91
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +    +    ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPT----LTDYDIRYYIYELLKALDYCH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKY 255
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 34  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 93
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +    +    ++ Y Y++ + L Y H
Sbjct: 94  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPT----LTDYDIRYYIYELLKALDYCH 144
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 145 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 204 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 257
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 258 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 317
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 318 PYFQQVR 324

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 152/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 91
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +         ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPTLTDYD----IRYYIYELLKALDYCH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 33  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 92
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +    +    ++ Y Y++ + L Y H
Sbjct: 93  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPT----LTDYDIRYYIYELLKALDYCH 143
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 144 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 203 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 256
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 257 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 316
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 317 PYFQQVR 323

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 153/307 (49%), Gaps = 33/307 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R VG G +  VF+   +   E   + I K ++ ++ K     L  +   PN++ L
Sbjct: 32  DYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKL 91
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK     +L+ EYV  + ++VL  Y +    +    ++ Y Y++ + L Y H
Sbjct: 92  LDIVRDQHSKTP---SLIFEYVNNTDFKVL--YPT----LTDYDIRYYIYELLKALDYCH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 143 S-QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
           +Y  S+D+WS GC+ A ++   +P F G +  DQLV+I KVLGT        +N     +
Sbjct: 202 DYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKY 255
Query: 249 RF---PQIKA-------HPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAH 294
           R    PQ++A        PW K  +      + PEAID   +LL+Y    R TALEA  H
Sbjct: 256 RIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTH 315
Query: 295 PFFDELR 301
           P+F ++R
Sbjct: 316 PYFQQVR 322

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 152/310 (49%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L+      Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLR------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 102/295 (34%), Positives = 146/295 (49%), Gaps = 40/295 (13%)
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQR-- 108
           RE+ L+R + HPNVISL+  F S   +    + L+ +Y    ++ ++K +  S AN++  
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 109 -MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQL 164
            +P   VK   YQI  G+ Y+H    V HRDLKP N+LV    P   +VKI D G A+  
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 165 ---IAGEANISYICSRF-YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
              +   A++  +   F YRAPEL+ GA  YT +IDIW+ GC+ AELL  +P+F      
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 221 ---------DQLVEIIKVLGTPTR---EEIRCMNPNYT---DFRFPQ------IKAHPWH 259
                    DQL  I  V+G P     E+I+ M  + T   DFR         IK    H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 260 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP 314
           KV   +   +A  L  +LL   P  R T+ +A   P+F E   P + +  G  +P
Sbjct: 303 KV---KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIP 354

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/325 (28%), Positives = 158/325 (48%), Gaps = 51/325 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH------PNV 66
           Y   +V+G G FG V +A   +  + VA+K V  ++R+  +  + +R+++H       N 
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +++ H   + T +N + +    E +  ++Y ++K        +PL  V+ + + I + L 
Sbjct: 159 MNVIHMLENFTFRNHICMTF--ELLSMNLYELIKKNKFQGFSLPL--VRKFAHSILQCLD 214
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQ-VKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            +H   R+ H DLKP+N+L+       +K+ DFGS+      +     I SRFYRAPE+I
Sbjct: 215 ALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVI 271
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P +   + ++ + 
Sbjct: 272 LGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ---KLLDASK 327
Query: 246 TDFRFPQIKAHPWH------------------KVFHKRMPPEA---------------ID 272
               F   K +P +                  +    R PPE+               +D
Sbjct: 328 RAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 273 LASRLLQYSPSLRCTALEACAHPFF 297
              + L++ P++R T  +A  HP+ 
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 96
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 97  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 147
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 148 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 263
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 324 YTVVKDQARM 333

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 102
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 103 ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 153
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 154 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 269
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 270 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 330 YTVVKDQARM 339

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 151/310 (48%), Gaps = 27/310 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNARL 307
             + +  AR+
Sbjct: 325 YTVVKDQARM 334

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 92/309 (29%), Positives = 150/309 (48%), Gaps = 27/309 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324
Query: 298 DELREPNAR 306
             + +  AR
Sbjct: 325 YTVVKDQAR 333

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 146/300 (48%), Gaps = 27/300 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 146/300 (48%), Gaps = 27/300 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 96
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 97  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 147
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 148 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 263
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 146/300 (48%), Gaps = 27/300 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 96  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 146
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 147 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 262
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 146/300 (48%), Gaps = 27/300 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--LMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E V +K +   ++ K +     L  +   PN+I+L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITL 97
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH 148
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+    
Sbjct: 149 SMG-IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 190 EYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT-- 246
            Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT   E++      Y   
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT---EDLYDYIDKYNIE 264
Query: 247 -DFRFPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            D RF  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F
Sbjct: 265 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 143/299 (47%), Gaps = 16/299 (5%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMR-- 59
           + T  Y     +G G++G V++A+   +G  VA+K V      +       RE+ L+R  
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 60  -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 118
              +HPNV+ L     ++ +  E+ + LV E+V + +   L         +P   +K   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLM 118
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            Q  RGL ++H    + HRDLKP+N+LV      VK+ DFG A+      A    + + +
Sbjct: 119 RQFLRGLDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALFPVVVTLW 176
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  E+ 
Sbjct: 177 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDD 234
Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
              + +     FP     P   V  + M      L   +L ++P  R +A  A  H + 
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 143/299 (47%), Gaps = 16/299 (5%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMR-- 59
           + T  Y     +G G++G V++A+   +G  VA+K V      +       RE+ L+R  
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 60  -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 118
              +HPNV+ L     ++ +  E+ + LV E+V + +   L         +P   +K   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLM 118
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            Q  RGL ++H    + HRDLKP+N+LV      VK+ DFG A+      A    + + +
Sbjct: 119 RQFLRGLDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALAPVVVTLW 176
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  E+ 
Sbjct: 177 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDD 234
Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
              + +     FP     P   V  + M      L   +L ++P  R +A  A  H + 
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 143/299 (47%), Gaps = 16/299 (5%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMR-- 59
           + T  Y     +G G++G V++A+   +G  VA+K V      +       RE+ L+R  
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 60  -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 118
              +HPNV+ L     ++ +  E+ + LV E+V + +   L         +P   +K   
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLM 118
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            Q  RGL ++H    + HRDLKP+N+LV      VK+ DFG A+      A    + + +
Sbjct: 119 RQFLRGLDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALDPVVVTLW 176
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  E+ 
Sbjct: 177 YRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP-EDD 234
Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
              + +     FP     P   V  + M      L   +L ++P  R +A  A  H + 
Sbjct: 235 WPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 90/306 (29%), Positives = 144/306 (47%), Gaps = 27/306 (8%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------------RE 54
           + T  Y     +G G++G V++A+   +G  VA+K V    R  N             RE
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVRE 61
Query: 55  LQLMR---VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 111
           + L+R     +HPNV+ L     ++ +  E+ + LV E+V + +   L         +P 
Sbjct: 62  VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPA 119
Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 171
             +K    Q  RGL ++H    + HRDLKP+N+LV      VK+ DFG A+      A  
Sbjct: 120 ETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLARIYSYQMALT 177
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 231
             + + +YRAPE++  +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G
Sbjct: 178 PVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
            P  E+    + +     FP     P   V  + M      L   +L ++P  R +A  A
Sbjct: 237 LPP-EDDWPRDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 292 CAHPFF 297
             H + 
Sbjct: 295 LQHSYL 300

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 92/302 (30%), Positives = 148/302 (49%), Gaps = 31/302 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E   V I K ++ ++ K     L  +    N+I L
Sbjct: 39  DYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKL 98
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK      LV EY+  + ++ L       Q +    ++ Y Y++ + L Y H
Sbjct: 99  IDTVKDPVSKTPA---LVFEYINNTDFKQLY------QILTDFDIRFYMYELLKALDYCH 149
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPELIFGA 188
           +   + HRD+KP N+++D    ++++ D+G A+    A E N+  + SR+++ PEL+   
Sbjct: 150 S-KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELLVDY 207
Query: 189 TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC------- 240
             Y  S+D+WS GC+LA ++   +P F G++  DQLV I KVLGT   EE+         
Sbjct: 208 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHI 264
Query: 241 -MNPNYTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHP 295
            ++P++ D    Q     W    H      + PEA+DL  +LL+Y    R TA EA  HP
Sbjct: 265 DLDPHFNDI-LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHP 323
Query: 296 FF 297
           +F
Sbjct: 324 YF 325

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 108/376 (28%), Positives = 162/376 (43%), Gaps = 91/376 (24%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ------DRRYKNRELQLMRVMDHPNV 66
           Y    ++GTGS+G V +A        VAIKK+L+      D +   RE+ ++  ++H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL----IYVKLYTYQIF 122
           + +         +    L +V+E       ++         R P+    +++K   Y + 
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF--------RTPVYLTELHIKTLLYNLL 166
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS---------- 172
            G+ Y+H+   + HRDLKP N LV+     VK+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVHSAG-ILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 173 ------------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL------ 208
                             ++ +R+YRAPELI     YT +ID+WS GC+ AELL      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 209 -----LGQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCMNP 243
                   PLFPG +                      DQL  I  +LGTP+ E+I  +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMP---PEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                R+ +I          +R P    +AI L  R+L ++P+ R T  E  AHPFF E+
Sbjct: 345 EDAK-RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
Query: 301 R----EPNA----RLP 308
           R    E NA    RLP
Sbjct: 404 RIAEVETNATEKVRLP 419

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  120 bits (302), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/302 (30%), Positives = 148/302 (49%), Gaps = 31/302 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKNRELQLMRVMDHPNVISL 69
            Y   R +G G +  VF+A  +   E   V I K ++ ++ K     L  +    N+I L
Sbjct: 44  DYQLVRKLGRGKYSEVFEAINITNNERVVVKILKPVKKKKIKREVKILENLRGGTNIIKL 103
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   SK      LV EY+  + ++ L       Q +    ++ Y Y++ + L Y H
Sbjct: 104 IDTVKDPVSKTPA---LVFEYINNTDFKQLY------QILTDFDIRFYMYELLKALDYCH 154
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-AGEANISYICSRFYRAPELIFGA 188
           +   + HRD+KP N+++D    ++++ D+G A+    A E N+  + SR+++ PEL+   
Sbjct: 155 S-KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVR-VASRYFKGPELLVDY 212
Query: 189 TEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC------- 240
             Y  S+D+WS GC+LA ++   +P F G++  DQLV I KVLGT   EE+         
Sbjct: 213 QMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHI 269
Query: 241 -MNPNYTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHP 295
            ++P++ D    Q     W    H      + PEA+DL  +LL+Y    R TA EA  HP
Sbjct: 270 DLDPHFNDI-LGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHP 328
Query: 296 FF 297
           +F
Sbjct: 329 YF 330

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 140/295 (47%), Gaps = 49/295 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 65  NVISLKHCFFSTTSKNELFLNLVME-YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N++ L   F     +++ +  LV E Y    ++  +     + +R   +       Q+  
Sbjct: 87  NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRA 181
           G+ Y+H   ++ HRDLKP+NLL++  +    ++I DFG +    A +     I + +Y A
Sbjct: 138 GITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 242 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 284

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 140/295 (47%), Gaps = 49/295 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 65  NVISLKHCFFSTTSKNELFLNLVME-YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N++ L   F     +++ +  LV E Y    ++  +     + +R   +       Q+  
Sbjct: 110 NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 160
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRA 181
           G+ Y+H   ++ HRDLKP+NLL++  +    ++I DFG +    A +     I + +Y A
Sbjct: 161 GITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 265 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 307

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 140/295 (47%), Gaps = 49/295 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 65  NVISLKHCFFSTTSKNELFLNLVME-YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N++ L   F     +++ +  LV E Y    ++  +     + +R   +       Q+  
Sbjct: 111 NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 161
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRA 181
           G+ Y+H   ++ HRDLKP+NLL++  +    ++I DFG +    A +     I + +Y A
Sbjct: 162 GITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 266 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 308

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 140/295 (47%), Gaps = 49/295 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 65  NVISLKHCFFSTTSKNELFLNLVME-YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N++ L   F     +++ +  LV E Y    ++  +     + +R   +       Q+  
Sbjct: 93  NIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 143
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRA 181
           G+ Y+H   ++ HRDLKP+NLL++  +    ++I DFG +    A +     I + +Y A
Sbjct: 144 GITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              YT F  PQ     W KV        A DL  ++L Y PS+R +A +A  H +
Sbjct: 248 -GKYT-FELPQ-----WKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEW 290

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 104/375 (27%), Positives = 162/375 (43%), Gaps = 82/375 (21%)
Query: 1   MYLVCCILQTI----SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRY 50
           +Y    I++ +    +Y  + ++G GS+G V+ A      + VAIKKV      L D + 
Sbjct: 14  LYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKR 73
Query: 51  KNRELQLMRVMDHPNVISLKHCFF--STTSKNELFLNLVMEYVPESMYRVLKHYSSANQR 108
             RE+ ++  +    +I L            +EL++  V+E     + ++ K      ++
Sbjct: 74  ILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ 131
Query: 109 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 168
               +VK   Y +  G  +IH    + HRDLKP N L++     VKICDFG A+  I  +
Sbjct: 132 ----HVKTILYNLLLGEKFIHE-SGIIHRDLKPANCLLNQ-DCSVKICDFGLART-INSD 184
Query: 169 ANI---------------------------SYICSRFYRAPELIFGATEYTTSIDIWSAG 201
            +I                           S++ +R+YRAPELI     YT SIDIWS G
Sbjct: 185 KDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTG 244
Query: 202 CVLAELLLGQ-----------PLFPGENAV-----------------DQLVEIIKVLGTP 233
           C+ AELL              PLFPG +                   DQL  I  V+GTP
Sbjct: 245 CIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTP 304
Query: 234 TREEIRCMNP----NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 289
             E+++C+       Y    FP        K +   +  E IDL   +L+++   R T  
Sbjct: 305 PEEDLKCITKQEVIKYIKL-FPTRDGIDLSKKY-SSISKEGIDLLESMLRFNAQKRITID 362
Query: 290 EACAHPFFDELREPN 304
           +A +HP+  ++R+ N
Sbjct: 363 KALSHPYLKDVRKEN 377

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 99/354 (27%), Positives = 161/354 (45%), Gaps = 73/354 (20%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPN 65
           +Y+ + ++G GS+G V+ A    T + VAIKKV      L D +   RE+ ++  +    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +I L              L +V+E     + ++ K      +     ++K   Y +  G 
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLLGE 142
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANI------------- 171
            +IH    + HRDLKP N L++     VK+CDFG A+ + +  + NI             
Sbjct: 143 NFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 172 ---------SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQ---------- 211
                    S++ +R+YRAPELI     YT SIDIWS GC+ AELL + Q          
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 212 PLFPGENAV-----------------DQLVEIIKVLGTPTREEIRCMN-PNYTDFRFPQI 253
           PLFPG +                   DQL  I  ++GTPT ++++ +N P    +    I
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY----I 316
Query: 254 KAHPWHKVFHKR-----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
           K  P  K  + +     +  + I+L   +L+++P+ R T  +A  HP+  ++R+
Sbjct: 317 KLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 136/295 (46%), Gaps = 49/295 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y  +RV+G GSFG V   K   TG+  A+K V+  R+ K         RE+QL++ +DHP
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 65  NVISLKHCFFSTTSKNELFLNLVME-YVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+  L   F     +++ +  LV E Y    ++  +     + +R   +       Q+  
Sbjct: 87  NIXKLYEFF-----EDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQVLS 137
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRA 181
           G+ Y H   ++ HRDLKP+NLL++  +    ++I DFG +    A +     I + +Y A
Sbjct: 138 GITYXHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              YT F  PQ     W KV        A DL  + L Y PS R +A +A  H +
Sbjct: 242 -GKYT-FELPQ-----WKKV-----SESAKDLIRKXLTYVPSXRISARDALDHEW 284

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 127/232 (54%), Gaps = 21/232 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPN---- 65
           Y  + ++G GSFG V +A      E VAIK +   + + N+   E++L+ +M+  +    
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 66  --VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
             ++ LK  F          L LV E +  ++Y +L++ +     + L   + +  Q+  
Sbjct: 97  YYIVHLKRHFMFRNH-----LCLVFEMLSYNLYDLLRNTNFRGVSLNL--TRKFAQQMCT 149
Query: 124 GLAYIHTVP-RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 181
            L ++ T    + H DLKP+N LL +P    +KI DFGS+ QL  G+     I SRFYR+
Sbjct: 150 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 207
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG P
Sbjct: 208 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 258

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 127/232 (54%), Gaps = 21/232 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPN---- 65
           Y  + ++G GSFG V +A      E VAIK +   + + N+   E++L+ +M+  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 66  --VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
             ++ LK  F          L LV E +  ++Y +L++ +     + L   + +  Q+  
Sbjct: 116 YYIVHLKRHFMFRNH-----LCLVFEMLSYNLYDLLRNTNFRGVSLNL--TRKFAQQMCT 168
Query: 124 GLAYIHTVP-RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 181
            L ++ T    + H DLKP+N LL +P    +KI DFGS+ QL  G+     I SRFYR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 226
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG P
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 80/232 (34%), Positives = 127/232 (54%), Gaps = 21/232 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPN---- 65
           Y  + ++G GSFG V +A      E VAIK +   + + N+   E++L+ +M+  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 66  --VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
             ++ LK  F          L LV E +  ++Y +L++ +     + L   + +  Q+  
Sbjct: 116 YYIVHLKRHFMFRNH-----LCLVFEMLSYNLYDLLRNTNFRGVSLNL--TRKFAQQMCT 168
Query: 124 GLAYIHTVP-RVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 181
            L ++ T    + H DLKP+N LL +P    +KI DFGS+ QL  G+     I SRFYR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRS 226
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG P
Sbjct: 227 PEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++++ H NV++L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 73  FFSTTS-----KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
             +  S     K  ++L  V ++    +  +L   S+   +  L  +K     +  GL Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAP 182
           IH   ++ HRD+K  N+L+      +K+ DFG A+     + +      + + + +YR P
Sbjct: 141 IHR-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           EL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            NY  +   ++      KV  +       P A+DL  +LL   P+ R  + +A  H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  114 bits (284), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++++ H NV++L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 73  FFSTTS-----KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
             +  S     K  ++L  V ++    +  +L   S+   +  L  +K     +  GL Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAP 182
           IH   ++ HRD+K  N+L+      +K+ DFG A+     + +      + + + +YR P
Sbjct: 140 IHR-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           EL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            NY  +   ++      KV  +       P A+DL  +LL   P+ R  + +A  H FF
Sbjct: 258 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 148/297 (49%), Gaps = 24/297 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++++ H NV++L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 73  FFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             +  S   + +  + LV ++    +  +L   S+   +  L  +K     +  GL YIH
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAPEL 184
              ++ HRD+K  N+L+      +K+ DFG A+     + +      + + + +YR PEL
Sbjct: 143 R-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           + G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    ++ N
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-N 259
Query: 245 YTDFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           Y  +   ++      KV  +       P A+DL  +LL   P+ R  + +A  H FF
Sbjct: 260 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 148/299 (49%), Gaps = 28/299 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++++ H NV++L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 73  FFSTTS-----KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
             +  S     K  ++L  V ++    +  +L   S+   +  L  +K     +  GL Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCEHDLAGLL---SNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-----ISYICSRFYRAP 182
           IH   ++ HRD+K  N+L+      +K+ DFG A+     + +      + + + +YR P
Sbjct: 141 IHR-NKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           EL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            NY  +   ++      KV  +       P A+DL  +LL   P+ R  + +A  H FF
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 104/351 (29%), Positives = 161/351 (45%), Gaps = 53/351 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLM-RVMDHPNV-- 66
           Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L+ RV D  N   
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 67  --ISLKHCF-----FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             +   H       F+    N + + +V E + E++  ++K Y   ++ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIAGEANISYI 174
           Q+  GL Y+H    + H D+KP+N+L++ +       Q+KI D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAV-----DQLVEIIK 228
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF P E        D + +II+
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 229 VLGTPTREEIRCMNPNYTDFRF---------PQIKAHPWHKV------FHKRMPPEAIDL 273
           +LG      +R  N  YT   F          ++K  P   V      F K    E  D 
Sbjct: 256 LLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 274 ASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPLPPLF 317
            S +LQ  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 104/351 (29%), Positives = 161/351 (45%), Gaps = 53/351 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY---KNRELQLM-RVMDHPNV-- 66
           Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L+ RV D  N   
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 67  --ISLKHCF-----FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             +   H       F+    N + + +V E + E++  ++K Y   ++ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIAGEANISYI 174
           Q+  GL Y+H    + H D+KP+N+L++ +       Q+KI D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAV-----DQLVEIIK 228
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF P E        D + +II+
Sbjct: 197 QTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 229 VLGTPTREEIRCMNPNYTDFRF---------PQIKAHPWHKV------FHKRMPPEAIDL 273
           +LG      +R  N  YT   F          ++K  P   V      F K    E  D 
Sbjct: 256 LLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 274 ASRLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPLPPLF 317
            S +LQ  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 90/319 (28%), Positives = 140/319 (43%), Gaps = 71/319 (22%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLK 70
           ++G GSFG V + K   T +  A+K V+     KN       RE++L++ +DHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 71  HCFFSTTS---------KNELFLNLVME--YVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
                ++S           ELF  ++    +      R++K                   
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK------------------- 128
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSR 177
           Q+F G+ Y+H    + HRDLKP+N+L++       +KI DFG +            I + 
Sbjct: 129 QVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
           +Y APE++ G   Y    D+WSAG +L  LL G P F G+N  D    I+K         
Sbjct: 188 YYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK--------- 232
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            R     Y  F  PQ     W  +       +A DL  ++L + PSLR TA +   HP+ 
Sbjct: 233 -RVETGKYA-FDLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPW- 279
Query: 298 DELREPNARLPNGRPLPPL 316
             +++ ++  P    LP L
Sbjct: 280 --IQKYSSETPTISDLPSL 296

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLK 70
           ++G GSFG V + K   T +  A+K V+     KN       RE++L++ +DHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              F     +  F  +   Y    ++  +      ++      +K    Q+F G+ Y+H 
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 131 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
              + HRDLKP+N+L++       +KI DFG +            I + +Y APE++ G 
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y    D+WSAG +L  LL G P F G+N  D    I+K          R     Y  F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK----------RVETGKYA-F 241
Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
             PQ     W     + +  +A DL  ++L + PSLR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 46/288 (15%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISLK 70
           ++G GSFG V + K   T +  A+K V+     KN       RE++L++ +DHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              F     +  F  +   Y    ++  +      ++      +K    Q+F G+ Y+H 
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK----QVFSGITYMHK 139
Query: 131 VPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
              + HRDLKP+N+L++       +KI DFG +            I + +Y APE++ G 
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y    D+WSAG +L  LL G P F G+N  D    I+K          R     Y  F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILK----------RVETGKYA-F 241
Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
             PQ     W     + +  +A DL  ++L + PSLR TA +   HP+
Sbjct: 242 DLPQ-----W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPW 279

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 95/346 (27%), Positives = 148/346 (42%), Gaps = 68/346 (19%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMR 59
           L+   ++  +++G GSFG VF A+  +T +  AIK + +D    + +++        L  
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLY 117
             +HP    L H F +  +K  LF   VMEY+   + MY +      +  +  L     Y
Sbjct: 74  AWEHP---FLTHMFCTFQTKENLFF--VMEYLNGGDLMYHI-----QSCHKFDLSRATFY 123
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             +I  GL ++H+   + +RDLK  N+L+D   H +KI DFG  K+ + G+A  +  C  
Sbjct: 124 AAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGT 181
Query: 178 -FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
             Y APE++ G  +Y  S+D WS G +L E+L+GQ  F G++  +               
Sbjct: 182 PDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------H 228
Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHP 295
            IR  NP Y                  + +  EA DL  +L    P  R     +   HP
Sbjct: 229 SIRMDNPFYP-----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 271
Query: 296 FFDELREPNARLPNGRPLPPLF-----------NFKQELSGASPEL 330
            F   RE N      + + P F           NF +E     P L
Sbjct: 272 LF---REINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 314

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 15  AERVV-GTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYK---NRELQLMRVMDHPNVISL 69
            +RVV G G++GIV+  + L     +AIK++ + D RY    + E+ L + + H N++  
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ- 83
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +  + S+N  F+ + ME VP      L        +     +  YT QI  GL Y+H
Sbjct: 84  ---YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIF-G 187
              ++ HRD+K  N+L++  +  +KI DFG++K+L        ++  +  Y APE+I  G
Sbjct: 140 D-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF 214
              Y  + DIWS GC + E+  G+P F
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 15  AERVV-GTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYK---NRELQLMRVMDHPNVISL 69
            +RVV G G++GIV+  + L     +AIK++ + D RY    + E+ L + + H N++  
Sbjct: 11  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ- 69
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +  + S+N  F+ + ME VP      L        +     +  YT QI  GL Y+H
Sbjct: 70  ---YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIF-G 187
              ++ HRD+K  N+L++  +  +KI DFG++K+L        ++  +  Y APE+I  G
Sbjct: 126 D-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF 214
              Y  + DIWS GC + E+  G+P F
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 161/354 (45%), Gaps = 70/354 (19%)
Query: 1   MYLVCCILQTISYMAERV--VGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKNREL 55
           M+L+C     +S   E V  +G G+FG V +  C++    G  VA+K V    RY     
Sbjct: 2   MHLICQSGDVLSARYEIVDTLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAAR 59
Query: 56  QLMRVMDHPNVISLKHCFFSTTSKNELF-----LNLVMEYVPESMYRVLKHYSSANQRMP 110
             ++V++H N     +  F      E F     + +V E +  S Y  +K     N  +P
Sbjct: 60  SEIQVLEHLNTTD-PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIK----ENGFLP 114
Query: 111 --LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL---------------------VD 147
             L +++   YQI + + ++H+  ++ H DLKP+N+L                     ++
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 148 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
           P    +K+ DFGSA      E + + + +R YRAPE+I  A  ++   D+WS GC+L E 
Sbjct: 174 P---DIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEY 227
Query: 208 LLGQPLFPGENAVDQLVEIIKVLGTPTREEI------RCMNPNYTDF-------RFPQIK 254
            LG  +FP  ++ + L  + ++LG   +  I      +  + +  D+       R+    
Sbjct: 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA 287
Query: 255 AHPW------HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
             P         V H+R+     DL  ++L+Y P+ R T  EA  HPFFD L++
Sbjct: 288 CKPLKEFMLSQDVEHERL----FDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVIS 68
           M ER+ GTG FG V +    +TGE VAIK+  Q+   KNR     E+Q+M+ ++HPNV+S
Sbjct: 19  MKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 77
Query: 69  LKHC--FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            +         + N+L L L MEY      R   +       +    ++     I   L 
Sbjct: 78  AREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           Y+H   R+ HRDLKP+N+++ P   ++  KI D G AK+L  GE    ++ +  Y APEL
Sbjct: 137 YLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 195
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLG-QPLFP 215
           +    +YT ++D WS G +  E + G +P  P
Sbjct: 196 L-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 97.8 bits (242), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/212 (34%), Positives = 110/212 (51%), Gaps = 14/212 (6%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVIS 68
           M ER+ GTG FG V +    +TGE VAIK+  Q+   KNR     E+Q+M+ ++HPNV+S
Sbjct: 18  MKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 69  LKHC--FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            +         + N+L L L MEY      R   +       +    ++     I   L 
Sbjct: 77  AREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQV--KICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           Y+H   R+ HRDLKP+N+++ P   ++  KI D G AK+L  GE    ++ +  Y APEL
Sbjct: 136 YLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLG-QPLFP 215
           +    +YT ++D WS G +  E + G +P  P
Sbjct: 195 L-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 95/346 (27%), Positives = 147/346 (42%), Gaps = 68/346 (19%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMR 59
           L+   +   +++G GSFG VF A+  +T +  AIK + +D    + +++        L  
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLY 117
             +HP    L H F +  +K  LF   VMEY+   + MY +      +  +  L     Y
Sbjct: 75  AWEHP---FLTHMFCTFQTKENLFF--VMEYLNGGDLMYHI-----QSCHKFDLSRATFY 124
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             +I  GL ++H+   + +RDLK  N+L+D   H +KI DFG  K+ + G+A  +  C  
Sbjct: 125 AAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGT 182
Query: 178 -FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
             Y APE++ G  +Y  S+D WS G +L E+L+GQ  F G++  +               
Sbjct: 183 PDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------H 229
Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHP 295
            IR  NP Y                  + +  EA DL  +L    P  R     +   HP
Sbjct: 230 SIRMDNPFYP-----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 272
Query: 296 FFDELREPNARLPNGRPLPPLF-----------NFKQELSGASPEL 330
            F   RE N      + + P F           NF +E     P L
Sbjct: 273 LF---REINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 315

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 96/354 (27%), Positives = 160/354 (45%), Gaps = 70/354 (19%)
Query: 1   MYLVCCILQTISYMAERV--VGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKNREL 55
           M+L+C     +S   E V  +G G+FG V +  C++    G  VA+K V    RY     
Sbjct: 2   MHLICQSGDVLSARYEIVDTLGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAAR 59
Query: 56  QLMRVMDHPNVISLKHCFFSTTSKNELF-----LNLVMEYVPESMYRVLKHYSSANQRMP 110
             ++V++H N     +  F      E F     + +V E +  S Y  +K     N  +P
Sbjct: 60  SEIQVLEHLNTTD-PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIK----ENGFLP 114
Query: 111 --LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL---------------------VD 147
             L +++   YQI + + ++H+  ++ H DLKP+N+L                     ++
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 148 PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
           P    +K+ DFGSA      E + + +  R YRAPE+I  A  ++   D+WS GC+L E 
Sbjct: 174 P---DIKVVDFGSAT--YDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEY 227
Query: 208 LLGQPLFPGENAVDQLVEIIKVLGTPTREEI------RCMNPNYTDF-------RFPQIK 254
            LG  +FP  ++ + L  + ++LG   +  I      +  + +  D+       R+    
Sbjct: 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA 287
Query: 255 AHPW------HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
             P         V H+R+     DL  ++L+Y P+ R T  EA  HPFFD L++
Sbjct: 288 CKPLKEFMLSQDVEHERL----FDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 145
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN S++ +  Y +PEL
Sbjct: 146 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-SFVGTAQYVSPEL 202
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 203 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 246
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+            +  P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 247 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 299 ELREPN 304
            +   N
Sbjct: 293 SVTWEN 298

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 24/227 (10%)
Query: 16  ERV--VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVIS 68
           ER+  +G G+ G+V + +   +G  +A K +  +     R    RELQ++   + P ++ 
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 78
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
               F+S        +++ ME++   S+ +VLK      +R+P   +   +  + RGLAY
Sbjct: 79  FYGAFYSDGE-----ISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAY 129
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           +    ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y APE + G
Sbjct: 130 LREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERLQG 187
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            T Y+   DIWS G  L EL +G+   P  +A     E+  + G P 
Sbjct: 188 -THYSVQSDIWSMGLSLVELAVGRYPIPPPDA----KELEAIFGRPV 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 141/306 (46%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 149
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN S++ +  Y +PEL
Sbjct: 150 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-SFVGTAQYVSPEL 206
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 207 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 250
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 251 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296
Query: 299 ELREPN 304
            +   N
Sbjct: 297 SVTWEN 302

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG  VAIK +  D+   N        RE+++M++++H
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 70
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L L+MEY        +  Y  A+ RM     +    QI  
Sbjct: 71  PNIVKLFEVI-----ETEKTLYLIMEYASGGE---VFDYLVAHGRMKEKEARSKFRQIVS 122
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H   R+ HRDLK +NLL+D     +KI DFG + +   G    ++  S  Y APE
Sbjct: 123 AVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPE 180
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 141/307 (45%), Gaps = 62/307 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   +F+     +L+  L   Y     + + ++   S ++       + YT +I   L Y
Sbjct: 97  L---YFTFQDDEKLYFGL--SYAKNGCLLKYIRKIGSFDETC----TRFYTAEIVSALEY 147
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPE 183
           +H    + HRDLKP+N+L++   H ++I DFG+AK L        AN S++ +  Y +PE
Sbjct: 148 LHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-SFVGTAQYVSPE 204
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           L+   +   +S D+W+ GC++ +L+ G P F   N      +IIK+              
Sbjct: 205 LLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------------- 249
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 297
              ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF
Sbjct: 250 ---EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294
Query: 298 DELREPN 304
           + +   N
Sbjct: 295 ESVTWEN 301

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------------- 249
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 299 ELREPN 304
            +   N
Sbjct: 296 SVTWEN 301

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 87/306 (28%), Positives = 139/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 101
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L  CF       +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 102 LYFCF---QDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 153
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 154 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 210
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 211 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 254
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 255 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 300
Query: 299 ELREPN 304
            +   N
Sbjct: 301 SVTWEN 306

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y  ++ +G G+F  V  A+ + TG  VA+K +  D+   N        RE+++M++++H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L LVMEY        +  Y  A+ RM     +    QI  
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLVMEYASGGE---VFDYLVAHGRMKEKEARAKFRQIVS 125
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H    + HRDLK +NLL+D     +KI DFG + +   G    ++  S  Y APE
Sbjct: 126 AVQYCHQ-KYIVHRDLKAENLLLDG-DMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 141/306 (46%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN +++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-AFVGTAQYVSPEL 203
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 299 ELREPN 304
            +   N
Sbjct: 294 SVTWEN 299

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 151 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 206
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 207 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 248
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 249 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 111/215 (51%), Gaps = 17/215 (7%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN---RELQLMRVMDHP 64
           ++  E+ +G G F  V++A CL  G  VA+KKV    L D + +    +E+ L++ ++HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI     + S    NE  LN+V+E      + R++KH+    + +P   V  Y  Q+  
Sbjct: 93  NVIKY---YASFIEDNE--LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAP 182
            L ++H+  RV HRD+KP N+ +   T  VK+ D G  +   +   A  S + + +Y +P
Sbjct: 148 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 217
           E I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 142 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 197
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 198 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 239
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 240 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+   +   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F  +T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  +V HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 125 HS-KKVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      D    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 124 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 179
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 180 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 221
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 222 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 184 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 225
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 186 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 227
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 228 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------------- 249
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 299 ELREPN 304
            +   N
Sbjct: 296 SVTWEN 301

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 184 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 225
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG  VAIK +  D+   N        RE+++M++++H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L L+MEY        +  Y  A+ RM     +    QI  
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLIMEYASGGE---VFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H   R+ HRDLK +NLL+D     +KI DFG + +   G    ++  +  Y APE
Sbjct: 126 AVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG 181
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 182 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 129 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 185 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 226
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +    +C    Y  PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEG 181
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 182 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 224 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 203
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 299 ELREPN 304
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 139/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 78
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 79  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 130
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 131 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 187
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 188 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 231
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+            +  P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 232 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 277
Query: 299 ELREPN 304
            +   N
Sbjct: 278 SVTWEN 283

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 139/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 93
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 94  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 145
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 146 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 202
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 203 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 246
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+            +  P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 247 --EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 292
Query: 299 ELREPN 304
            +   N
Sbjct: 293 SVTWEN 298

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 203
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 299 ELREPN 304
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 135/277 (48%), Gaps = 31/277 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 93  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 143
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 144 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 200
Query: 193 TSIDIWSAGCVLAELLLGQ-PLFPGEN--AVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
              DIWS G  L E+ +G+ P+  G    A+ +L++ I V   P +      +  + DF 
Sbjct: 201 VQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI-VNEPPPKLPSGVFSLEFQDFV 259
Query: 250 FPQIKAHPWHK---------VFHKRMPPEAIDLASRL 277
              +  +P  +          F KR   E +D A  L
Sbjct: 260 NKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 296

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEMIEG 183
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 184 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 225
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 249
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 299 ELREPN 304
            +   N
Sbjct: 296 SVTWEN 301

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG 185
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 186 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 227
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 228 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 97
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 98  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 149
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 150 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 206
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 207 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 250
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 251 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 296
Query: 299 ELREPN 304
            +   N
Sbjct: 297 SVTWEN 302

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 136 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 186
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 187 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 243
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENA 219
              DIWS G  L E+ +G+   P  +A
Sbjct: 244 VQSDIWSMGLSLVEMAVGRYPIPPPDA 270

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 249
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 299 ELREPN 304
            +   N
Sbjct: 296 SVTWEN 301

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 72  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 123
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 124 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 180
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 181 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 224
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 225 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 270
Query: 299 ELREPN 304
            +   N
Sbjct: 271 SVTWEN 276

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +    +C    Y  PE+I G
Sbjct: 127 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG 182
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 183 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 224
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 225 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 74  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 125
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 126 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 182
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 183 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 226
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 227 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 272
Query: 299 ELREPN 304
            +   N
Sbjct: 273 SVTWEN 278

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 73  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 125 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 181
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 182 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 225
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 226 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271
Query: 299 ELREPN 304
            +   N
Sbjct: 272 SVTWEN 277

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 96
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 97  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 148
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 149 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 205
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 206 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 249
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 250 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295
Query: 299 ELREPN 304
            +   N
Sbjct: 296 SVTWEN 301

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +    +C    Y  PE+I G
Sbjct: 125 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 181 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 222
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +    +C    Y  PE+I G
Sbjct: 151 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEG 206
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 207 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 248
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 249 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 132/302 (43%), Gaps = 60/302 (19%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 68
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E+++M+ +DHPN+I 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 69  LKHCFFSTT---------SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
           L   F   T         +  ELF  +V +       RV +   +A              
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHK-------RVFRESDAAR----------IMK 113
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLL--VDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
            +   +AY H +  V HRDLKP+N L   D     +K+ DFG A +   G+   + + + 
Sbjct: 114 DVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
           +Y +P+++ G   Y    D WSAG ++  LL G P F      + +++I +  GT     
Sbjct: 173 YYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT----- 223
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                     F FP+     W  V      P+A  L  RLL  SP  R T+L+A  H +F
Sbjct: 224 ----------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 298 DE 299
           ++
Sbjct: 266 EK 267

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +    +C    Y  PE+I G
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIEG 183
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 184 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 225
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 140/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 75  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 126
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 127 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 183
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 184 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 227
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 228 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 273
Query: 299 ELREPN 304
            +   N
Sbjct: 274 SVTWEN 279

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENA 219
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 129 HS-KRVIHRDIKPENLLLGS-NGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G P F      +    I +V                 +
Sbjct: 185 RM-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------E 226
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++ S R T  E   HP+
Sbjct: 227 FTFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 132/302 (43%), Gaps = 60/302 (19%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 68
           Y  E  +G GS+G V  A    T    A KK+    ++D     +E+++M+ +DHPN+I 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 69  LKHCFFSTT---------SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
           L   F   T         +  ELF  +V +       RV +   +A              
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHK-------RVFRESDAAR----------IMK 130
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLL--VDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
            +   +AY H +  V HRDLKP+N L   D     +K+ DFG A +   G+   + + + 
Sbjct: 131 DVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 189
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
           +Y +P+++ G   Y    D WSAG ++  LL G P F      + +++I +  GT     
Sbjct: 190 YYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT----- 240
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                     F FP+     W  V      P+A  L  RLL  SP  R T+L+A  H +F
Sbjct: 241 ----------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWF 282
Query: 298 DE 299
           ++
Sbjct: 283 EK 284

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 106/199 (53%), Gaps = 18/199 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 101 YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 151
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 152 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 208
Query: 193 TSIDIWSAGCVLAELLLGQ 211
              DIWS G  L E+ +G+
Sbjct: 209 VQSDIWSMGLSLVEMAVGR 227

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +    +C    Y  PE+I G
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIEG 183
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 184 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 225
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE I G
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIEG 185
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 186 RX-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 227
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 228 FTFPDF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENA 219
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  +    +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 122 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 177
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 178 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 219
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 220 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P   +Y+ L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +  + +C    Y  PE+I G
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 185
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 186 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 227
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 228 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENA 219
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENA 219
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 74  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G T Y+
Sbjct: 125 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYS 181
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENA 219
              DIWS G  L E+ +G+   P  +A
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 132/289 (45%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +  + A  +    +C    Y  PE+I G
Sbjct: 129 HS-KRVIHRDIKPENLLLGS-NGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIEG 184
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G P F      +    I +V                 +
Sbjct: 185 RM-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------E 226
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++ S R T  E   HP+
Sbjct: 227 FTFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M+V++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L LVMEY        +  Y  A+ RM     +    QI  
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGE---VFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H    + HRDLK +NLL+D     +KI DFG + +   G    ++  S  Y APE
Sbjct: 125 AVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M+V++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L LVMEY        +  Y  A+ RM     +    QI  
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGE---VFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H    + HRDLK +NLL+D     +KI DFG + +   G    ++  S  Y APE
Sbjct: 125 AVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 22/221 (9%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN I  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + C+       E    LVMEY   S   +L+ +    Q + +  V   T+   +GLAY+H
Sbjct: 120 RGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 171
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+K  N+L+      VK+ DFGSA   I   AN  ++ + ++ APE+I    
Sbjct: 172 S-HNMIHRDVKAGNILLSE-PGLVKLGDFGSAS--IMAPAN-XFVGTPYWMAPEVILAMD 226
Query: 190 E--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           E  Y   +D+WS G    EL   +P     NA+  L  I +
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI +FG +  + A  +  + +C    Y  PE+I G
Sbjct: 128 HS-KRVIHRDIKPENLLLGS-AGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 183
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 184 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 225
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 226 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 109/221 (49%), Gaps = 22/221 (9%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN I  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + C+       E    LVMEY   S   +L+ +    Q + +  V   T+   +GLAY+H
Sbjct: 81  RGCYL-----REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   + HRD+K  N+L+      VK+ DFGSA   I   AN  ++ + ++ APE+I    
Sbjct: 133 S-HNMIHRDVKAGNILLSE-PGLVKLGDFGSAS--IMAPAN-XFVGTPYWMAPEVILAMD 187
Query: 190 E--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           E  Y   +D+WS G    EL   +P     NA+  L  I +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 89/319 (27%), Positives = 150/319 (47%), Gaps = 51/319 (15%)
Query: 11  ISYMAERV--VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMD 62
           +S M +RV  +G+G++G V   +   T    AIK + +     +       E+ +++++D
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 63  HPNVISLKHCFFSTTSKNELFLNLVME-YVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           HPN++ L + FF    K   +L  VME Y    ++  + H    N+    + +K    Q+
Sbjct: 95  HPNIMKL-YDFFE--DKRNYYL--VMECYKGGELFDEIIHRMKFNEVDAAVIIK----QV 145
Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 179
             G+ Y+H    + HRDLKP+NLL++       +KI DFG +      +     + + +Y
Sbjct: 146 LSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYY 204
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APE++    +Y    D+WS G +L  LL G P F G+   DQ  EI++          +
Sbjct: 205 IAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQ--TDQ--EILR----------K 248
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                YT F  P+     W     K +   A DL  ++LQ+    R +A +A  HP+   
Sbjct: 249 VEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW--- 294
Query: 300 LREPNARLPNGRPLPPLFN 318
           ++E  ++  +G  LP L N
Sbjct: 295 IKEMCSKKESGIELPSLAN 313

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 139/306 (45%), Gaps = 60/306 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF     A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 95  L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 146
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 147 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 203
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +   +   +S D+W+ GC++ +L+ G P F   N      +IIK+               
Sbjct: 204 LTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------------- 247
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFFD 298
             ++ FP+       K F     P+A DL  +LL    + R  C  +E      AHPFF+
Sbjct: 248 --EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293
Query: 299 ELREPN 304
            +   N
Sbjct: 294 SVTWEN 299

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 37/286 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           +G G++G+V + + + +G+ +A+K++   R   N + Q   +MD    +    C F+ T 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 115
Query: 79  KNELF----LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
              LF    + + ME +  S+ +  K      Q +P   +      I + L ++H+   V
Sbjct: 116 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 175
Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI---FGATEY 191
            HRD+KP N+L++ L  QVK+CDFG +  L+   A       + Y APE I        Y
Sbjct: 176 IHRDVKPSNVLINALG-QVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
           +   DIWS G  + EL + +  FP ++            GTP ++               
Sbjct: 235 SVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------LK 268
Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           Q+   P  ++   +   E +D  S+ L+ +   R T  E   HPFF
Sbjct: 269 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 52/289 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI +FG +  + A  +  + +C    Y  PE+I G
Sbjct: 127 HS-KRVIHRDIKPENLLLGS-AGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 182
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 183 RM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 224
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 225 FTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 64/295 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P  ++YR L+  S  +++    Y+     ++   L+Y 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-------SAKQLIAGEANISYICSRFYRA 181
           H+  RV HRD+KP+NLL+     ++KI DFG       S +  ++G  +        Y  
Sbjct: 126 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE+I G   +   +D+WS G +  E L+G+P F      +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                +F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG+ VA++ +  D+   N        RE+++M+V++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L LVMEY        +  Y  A+ RM     +    QI  
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGE---VFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H    + HRDLK +NLL+D     +KI DFG + +   G    ++  S  Y APE
Sbjct: 125 AVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 137/297 (46%), Gaps = 46/297 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVI 67
           ++ +R +G+G+FG V   +   +G    IK + +DR          E+++++ +DHPN+I
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI---YVKLYTYQIFRG 124
            +   F     ++   + +VME        +L+   SA  R   +   YV     Q+   
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGG--ELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 125 LAYIHTVPRVCHRDLKPQNLLV-DPLTHQ-VKICDFGSAKQLIAGEANISYICSRFYRAP 182
           LAY H+   V H+DLKP+N+L  D   H  +KI DFG A+   + E + +   +  Y AP
Sbjct: 137 LAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E+     + T   DIWSAG V+  LL G   F G +    L E+        +++     
Sbjct: 196 EVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKE 241
Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
           PNY       ++  P        + P+A+DL  ++L   P  R +A +   H +F +
Sbjct: 242 PNYA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M+V++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L LVMEY        +  Y  A+ RM     +    QI  
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGE---VFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H    + HRDLK +NLL+D     +KI DFG + +   G    ++  +  Y APE
Sbjct: 125 AVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 37/286 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           +G G++G+V + + + +G+ +A+K++   R   N + Q   +MD    +    C F+ T 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI---RATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 79  KNELF----LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
              LF    + + ME +  S+ +  K      Q +P   +      I + L ++H+   V
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI---FGATEY 191
            HRD+KP N+L++ L  QVK+CDFG +  L+   A       + Y APE I        Y
Sbjct: 132 IHRDVKPSNVLINALG-QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
           +   DIWS G  + EL + +  FP ++            GTP ++               
Sbjct: 191 SVKSDIWSLGITMIELAILR--FPYDS-----------WGTPFQQ-------------LK 224
Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           Q+   P  ++   +   E +D  S+ L+ +   R T  E   HPFF
Sbjct: 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 138/308 (44%), Gaps = 64/308 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR--------YKNRELQLMRVMDHPNVIS 68
           +++G GSF  V  A+ L T    AIK +L+ R         Y  RE  +M  +DHP  + 
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 99
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   +F+     +L+  L      E + + ++   S ++       + YT +I   L Y+
Sbjct: 100 L---YFTFQDDEKLYFGLSYAKNGE-LLKYIRKIGSFDETC----TRFYTAEIVSALEYL 151
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI----AGEANISYICSRFYRAPEL 184
           H    + HRDLKP+N+L++   H ++I DFG+AK L        AN  ++ +  Y +PEL
Sbjct: 152 HG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARAN-XFVGTAQYVSPEL 208
Query: 185 IFGATEYTT--SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           +   TE +   S D+W+ GC++ +L+ G P F   N      +IIK+             
Sbjct: 209 L---TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 252
Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPF 296
               ++ FP                P+A DL  +LL    + R  C  +E      AHPF
Sbjct: 253 ----EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 296
Query: 297 FDELREPN 304
           F+ +   N
Sbjct: 297 FESVTWEN 304

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++I L   +   ++ +++F+  VMEYV       L  Y   N R+     +    QI  G
Sbjct: 77  HIIKL---YQVISTPSDIFM--VMEYVSGGE---LFDYICKNGRLDEKESRRLFQQILSG 128
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y H    V HRDLKP+N+L+D   +  KI DFG +  +  GE       S  Y APE+
Sbjct: 129 VDYCHR-HMVVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCGSPNYAAPEV 186
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           I G       +DIWS+G +L  LL G   F  ++              PT  +  C    
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKICDGIF 233
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
           YT    PQ             + P  I L   +LQ  P  R T  +   H +F +
Sbjct: 234 YT----PQY------------LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG+ VA++ +  D+   N        RE+++M+V++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L LVMEY        +  Y  A+ RM     +    QI  
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGE---VFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H    + HRDLK +NLL+D     +KI DFG + +   G     +  S  Y APE
Sbjct: 125 AVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 18/199 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCF 73
           +G G+ G+VF+     +G  +A K +  +     R    RELQ++   + P ++     F
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           +S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+    
Sbjct: 77  YSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH 127
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYT 192
           ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN  ++ +R Y +PE + G T Y+
Sbjct: 128 KIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-THYS 184
Query: 193 TSIDIWSAGCVLAELLLGQ 211
              DIWS G  L E+ +G+
Sbjct: 185 VQSDIWSMGLSLVEMAVGR 203

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 136/302 (45%), Gaps = 51/302 (16%)
Query: 8   LQTISYMAERV--VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-------ELQLM 58
            Q +S   +RV  +G+G++G V   K   TG   AIK + +              E+ ++
Sbjct: 16  FQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 59  RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA--NQRMPLIYVKL 116
           + +DHPN++ L   F     +++    LVME     +YR  + +      Q+   +   +
Sbjct: 76  KQLDHPNIMKLYEFF-----EDKRNYYLVME-----VYRGGELFDEIILRQKFSEVDAAV 125
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
              Q+  G  Y+H    + HRDLKP+NLL++  +    +KI DFG +     G      +
Sbjct: 126 IMKQVLSGTTYLHK-HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 184
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            + +Y APE++    +Y    D+WS G +L  LL G P F G+   DQ  EI+K +    
Sbjct: 185 GTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV---E 235
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
           + +     P++T                  ++  EA  L   +L Y PS R +A EA  H
Sbjct: 236 KGKFSFDPPDWT------------------QVSDEAKQLVKLMLTYEPSKRISAEEALNH 277
Query: 295 PF 296
           P+
Sbjct: 278 PW 279

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 131/295 (44%), Gaps = 64/295 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K + + +  K        RE+++   + HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   T      + L++EY P   +Y+ L+  S  +++    Y+     ++   L+Y 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-------SAKQLIAGEANISYICSRFYRA 181
           H+  RV HRD+KP+NLL+     ++KI DFG       S +  + G  +        Y  
Sbjct: 130 HS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRXXLXGTLD--------YLP 179
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE+I G   +   +D+WS G +  E L+G+P F      +    I +V            
Sbjct: 180 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 226
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                +F FP              +   A DL SRLL+++PS R    E   HP+
Sbjct: 227 -----EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMR 59
           L   +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++M+
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMK 61
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
           V++HPN++ L         + E  L LVMEY        +  Y  A+  M     +    
Sbjct: 62  VLNHPNIVKLFEVI-----ETEKTLYLVMEYASGGE---VFDYLVAHGWMKEKEARAKFR 113
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           QI   + Y H    + HRDLK +NLL+D     +KI DFG + +   G    ++  S  Y
Sbjct: 114 QIVSAVQYCHQ-KFIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTFGNKLDTFCGSPPY 171
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
            APEL  G       +D+WS G +L  L+ G   F G+N
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 129/282 (45%), Gaps = 41/282 (14%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKK--VLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 76
           +G GS+G V++A   ETG+ VAIK+  V  D +   +E+ +M+  D P+V+     +F  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 77  TSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
           T      L +VMEY    S+  +++     N+ +    +        +GL Y+H + R  
Sbjct: 97  TD-----LWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLHFM-RKI 147
Query: 136 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEYTTS 194
           HRD+K  N+L++   H  K+ DFG A QL    A  +  I + F+ APE+I     Y   
Sbjct: 148 HRDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI-QEIGYNCV 205
Query: 195 IDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIK 254
            DIWS G    E+  G+P +   + +  +  I      PT       NP  T FR P++ 
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI------PT-------NPPPT-FRKPEL- 250
Query: 255 AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              W   F         D   + L  SP  R TA +   HPF
Sbjct: 251 ---WSDNF--------TDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 131/295 (44%), Gaps = 49/295 (16%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-------ELQLMRVMDHPN 65
           Y   + +G+G++G V   K   TG   AIK + +              E+ +++ +DHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSA--NQRMPLIYVKLYTYQIFR 123
           ++ L   F     +++    LVME     +YR  + +      Q+   +   +   Q+  
Sbjct: 66  IMKLYEFF-----EDKRNYYLVME-----VYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRA 181
           G  Y+H    + HRDLKP+NLL++  +    +KI DFG +     G      + + +Y A
Sbjct: 116 GTTYLHK-HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 174
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++    +Y    D+WS G +L  LL G P F G+   DQ  EI+K          R  
Sbjct: 175 PEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQ--TDQ--EILK----------RVE 218
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
              ++ F  P      W +V       EA  L   +L Y PS R +A EA  HP+
Sbjct: 219 KGKFS-FDPP-----DWTQV-----SDEAKQLVKLMLTYEPSKRISAEEALNHPW 262

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 153/314 (48%), Gaps = 66/314 (21%)
Query: 14  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM----DHPNVIS 68
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++++    DHPNVI 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 69  LKHCFFSTTSKNELFL-----NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY-QIF 122
               + S T+   L++     NL ++ + ES     K+ S  N ++   Y  +    QI 
Sbjct: 91  --RYYCSETTDRFLYIALELCNLNLQDLVES-----KNVSDENLKLQKEYNPISLLRQIA 143
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH------------QVKICDFGSAKQLIAGEAN 170
            G+A++H++ ++ HRDLKPQN+LV   +             ++ I DFG  K+L +G+  
Sbjct: 144 SGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 171 ISY-----ICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 223
                     +  +RAPEL+  +T+   T SIDI+S GCV    +L +   P  +   + 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRE 261
Query: 224 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 283
             II+  G  + +E++C++                     + +  EA DL S+++ + P 
Sbjct: 262 SNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPL 299
Query: 284 LRCTALEACAHPFF 297
            R TA++   HP F
Sbjct: 300 KRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 88/314 (28%), Positives = 153/314 (48%), Gaps = 66/314 (21%)
Query: 14  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM----DHPNVIS 68
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++++    DHPNVI 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 69  LKHCFFSTTSKNELFL-----NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY-QIF 122
               + S T+   L++     NL ++ + ES     K+ S  N ++   Y  +    QI 
Sbjct: 91  --RYYCSETTDRFLYIALELCNLNLQDLVES-----KNVSDENLKLQKEYNPISLLRQIA 143
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH------------QVKICDFGSAKQLIAGEAN 170
            G+A++H++ ++ HRDLKPQN+LV   +             ++ I DFG  K+L +G+  
Sbjct: 144 SGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 202
Query: 171 ISY-----ICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL 223
                     +  +RAPEL+  +T+   T SIDI+S GCV    +L +   P  +   + 
Sbjct: 203 FRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRE 261
Query: 224 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 283
             II+  G  + +E++C++                     + +  EA DL S+++ + P 
Sbjct: 262 SNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPL 299
Query: 284 LRCTALEACAHPFF 297
            R TA++   HP F
Sbjct: 300 KRPTAMKVLRHPLF 313

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSFKDNSN-----LYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 56/306 (18%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 59
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
            ++HP +I +K+ F       + ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 121
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI-SYICS 176
           Q+   + Y+H    + HRDLKP+N+L+        +KI DFG +K  I GE ++   +C 
Sbjct: 122 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCG 178
Query: 177 R-FYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 294 HPFFDE 299
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 56/306 (18%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 59
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
            ++HP +I +K+ F       + ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 121
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI-SYICS 176
           Q+   + Y+H    + HRDLKP+N+L+        +KI DFG +K  I GE ++   +C 
Sbjct: 122 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCG 178
Query: 177 R-FYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 294 HPFFDE 299
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 56/306 (18%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 59
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
            ++HP +I +K+ F       + ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 127
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI-SYICS 176
           Q+   + Y+H    + HRDLKP+N+L+        +KI DFG +K  I GE ++   +C 
Sbjct: 128 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCG 184
Query: 177 R-FYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 234
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 235 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 280
Query: 294 HPFFDE 299
           HP+  +
Sbjct: 281 HPWLQD 286

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 56/306 (18%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 59
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
            ++HP +I +K+ F       + ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 121
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI-SYICS 176
           Q+   + Y+H    + HRDLKP+N+L+        +KI DFG +K  I GE ++   +C 
Sbjct: 122 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCG 178
Query: 177 R-FYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 274
Query: 294 HPFFDE 299
           HP+  +
Sbjct: 275 HPWLQD 280

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 109/209 (52%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y  A+ +R+  I +  YT QI +G+ Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 135 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 186
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 187 YAPESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 56/306 (18%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 59
           Y+  + +G+G+ G V  A   +T + VAIK ++  R++                E+++++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
            ++HP +I +K+ F       + ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 120
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI-SYICS 176
           Q+   + Y+H    + HRDLKP+N+L+        +KI DFG +K  I GE ++   +C 
Sbjct: 121 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCG 177
Query: 177 R-FYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 273
Query: 294 HPFFDE 299
           HP+  +
Sbjct: 274 HPWLQD 279

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 45/290 (15%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           ++G G FG V + +   TG  +A K +    ++D+     E+ +M  +DH N+I L   F
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 74  FSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
               SKN++ L  VMEYV   E   R++    +  +   ++++K    QI  G+ ++H +
Sbjct: 156 ---ESKNDIVL--VMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMHQM 206
Query: 132 PRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI-FGAT 189
             + H DLKP+N+L V+    Q+KI DFG A++    E       +  + APE++ +   
Sbjct: 207 -YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            + T  D+WS G +   LL G   F G+N  + L  I+        EE +          
Sbjct: 266 SFPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ---------- 313
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                           +  EA +  S+LL    S R +A EA  HP+  +
Sbjct: 314 ---------------DISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 137/306 (44%), Gaps = 52/306 (16%)
Query: 3   LVCCILQTI-SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRE 54
           L  CI + I  +    ++G GSF  V++A+ + TG  VAIK + +   YK         E
Sbjct: 2   LATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY- 113
           +++   + HP+++ L + F      N ++L L M +  E M R LK     N+  P    
Sbjct: 62  VKIHCQLKHPSILELYNYF---EDSNYVYLVLEMCHNGE-MNRYLK-----NRVKPFSEN 112
Query: 114 -VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANI 171
             + + +QI  G+ Y+H+   + HRDL   NLL+      +KI DFG A QL +  E + 
Sbjct: 113 EARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFGLATQLKMPHEKHY 170
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 231
           +   +  Y +PE I   + +    D+WS GC+   LL+G+P F  +   + L +++    
Sbjct: 171 TLCGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV---- 225
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
                          D+  P              +  EA DL  +LL+ +P+ R +    
Sbjct: 226 -------------LADYEMPSF------------LSIEAKDLIHQLLRRNPADRLSLSSV 260
Query: 292 CAHPFF 297
             HPF 
Sbjct: 261 LDHPFM 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 18/214 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHP 64
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +R++ HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++I L   +    SK+E+ +  V+EY    ++     Y     +M     + +  QI   
Sbjct: 65  HIIKL---YDVIKSKDEIIM--VIEYAGNELF----DYIVQRDKMSEQEARRFFQQIISA 115
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y H   ++ HRDLKP+NLL+D   + VKI DFG +  +  G    +   S  Y APE+
Sbjct: 116 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           I G       +D+WS G +L  +L  +  F  E+
Sbjct: 174 ISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHP 64
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +R++ HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++I L   +    SK+E+ +  V+EY    ++     Y     +M     + +  QI   
Sbjct: 69  HIIKL---YDVIKSKDEIIM--VIEYAGNELF----DYIVQRDKMSEQEARRFFQQIISA 119
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y H   ++ HRDLKP+NLL+D   + VKI DFG +  +  G    +   S  Y APE+
Sbjct: 120 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 185 IFGATEYTTSIDIWSAGCVLAELL 208
           I G       +D+WS G +L  +L
Sbjct: 178 ISGKLYAGPEVDVWSCGVILYVML 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHP 64
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +R++ HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++I L   +    SK+E+ +  V+EY    ++     Y     +M     + +  QI   
Sbjct: 75  HIIKL---YDVIKSKDEIIM--VIEYAGNELF----DYIVQRDKMSEQEARRFFQQIISA 125
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y H   ++ HRDLKP+NLL+D   + VKI DFG +  +  G    +   S  Y APE+
Sbjct: 126 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 185 IFGATEYTTSIDIWSAGCVLAELL 208
           I G       +D+WS G +L  +L
Sbjct: 184 ISGKLYAGPEVDVWSCGVILYVML 207

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +VMEY+P   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSFKDNSN-----LYMVMEYMPGGDMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +VMEY+P   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSFKDNSN-----LYMVMEYMPGGDMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNR---ELQLMRVMDHP 64
           +Y   + +G GSFG V  A    TG+ VA+K    KVL     + R   E+  +R++ HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++I L   +    SK+E+ +  V+EY    ++     Y     +M     + +  QI   
Sbjct: 74  HIIKL---YDVIKSKDEIIM--VIEYAGNELF----DYIVQRDKMSEQEARRFFQQIISA 124
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y H   ++ HRDLKP+NLL+D   + VKI DFG +  +  G    +   S  Y APE+
Sbjct: 125 VEYCHR-HKIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 185 IFGATEYTTSIDIWSAGCVLAELL 208
           I G       +D+WS G +L  +L
Sbjct: 183 ISGKLYAGPEVDVWSCGVILYVML 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 108/211 (51%), Gaps = 34/211 (16%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVIS 68
           R +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++ 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAY 127
            K   +S   +N   L L+ME++P   Y  L+ Y     +R+  I +  YT QI +G+ Y
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLP---YGSLREYLQKHKERIDHIKLLQYTSQICKGMEY 132
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSR 177
           + T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      
Sbjct: 133 LGT-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------ 184
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           F+ APE +   ++++ + D+WS G VL EL 
Sbjct: 185 FWYAPESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 78  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 132 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI------FW 183
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 184 YAPESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 109 GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 163 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 214
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 215 YAPESL-TESKFSVASDVWSFGVVLYELF 242

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFS-- 75
           ++G+G FG VF+AK    G+T  IK+V  +     RE++ +  +DH N++    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 76  ----TTSKNE-------LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
               T+SKN        LF+   ME+  +             +   ++ ++L+  QI +G
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQ--MEFCDKGTLEQWIEKRRGEKLDKVLALELFE-QITKG 134
Query: 125 LAYIHTVPRVCHRDLKPQNL-LVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           + YIH+  ++ +RDLKP N+ LVD  T QVKI DFG    L           +  Y +PE
Sbjct: 135 VDYIHS-KKLINRDLKPSNIFLVD--TKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPE 191
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            I  + +Y   +D+++ G +LAELL
Sbjct: 192 QI-SSQDYGKEVDLYALGLILAELL 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 82  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 136 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 187
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 188 YAPESL-TESKFSVASDVWSFGVVLYELF 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 85  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 139 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 190
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 191 YAPESL-TESKFSVASDVWSFGVVLYELF 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 83  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 137 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 188
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 189 YAPESL-TESKFSVASDVWSFGVVLYELF 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 81  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 135 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 186
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 187 YAPESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 78  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 132 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 183
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 184 YAPESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 77  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 131 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 182
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 183 YAPESL-TESKFSVASDVWSFGVVLYELF 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 76  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 130 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 181
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 182 YAPESL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 78  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 132 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 183
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 184 YAPESL-TESKFSVASDVWSFGVVLYELF 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 84  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 138 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 189
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 190 YAPESL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 96  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 150 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 201
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 202 YAPESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 96  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HRDL  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 150 T-KRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI------FW 201
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 202 YAPESL-TESKFSVASDVWSFGVVLYELF 229

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 153/318 (48%), Gaps = 70/318 (22%)
Query: 14  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM----DHPNVIS 68
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++++    DHPNVI 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 69  LKHCFFSTTSKNELFL-----NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY-QIF 122
               + S T+   L++     NL ++ + ES     K+ S  N ++   Y  +    QI 
Sbjct: 73  --RYYCSETTDRFLYIALELCNLNLQDLVES-----KNVSDENLKLQKEYNPISLLRQIA 125
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH------------QVKICDFGSAKQLIAGEAN 170
            G+A++H++ ++ HRDLKPQN+LV   +             ++ I DFG  K+L +G+++
Sbjct: 126 SGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 171 ISY-----ICSRFYRAPELIFGATEYTT------SIDIWSAGCVLAELLLGQPLFPGENA 219
                     +  +RAPEL+  +    T      SIDI+S GCV    +L +   P  + 
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDK 243
Query: 220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 279
             +   II+  G  + +E++C++                     + +  EA DL S+++ 
Sbjct: 244 YSRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMID 281
Query: 280 YSPSLRCTALEACAHPFF 297
           + P  R TA++   HP F
Sbjct: 282 HDPLKRPTAMKVLRHPLF 299

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 139/306 (45%), Gaps = 56/306 (18%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 59
           Y+  + +G+G+ G V  A   +T + VAI+ ++  R++                E+++++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
            ++HP +I +K+ F       + ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 260
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI-SYICS 176
           Q+   + Y+H    + HRDLKP+N+L+        +KI DFG +K  I GE ++   +C 
Sbjct: 261 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCG 317
Query: 177 R-FYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 318 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 367
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 368 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 413
Query: 294 HPFFDE 299
           HP+  +
Sbjct: 414 HPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 139/306 (45%), Gaps = 56/306 (18%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------------NRELQLMR 59
           Y+  + +G+G+ G V  A   +T + VAI+ ++  R++                E+++++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
            ++HP +I +K+ F       + ++ L +    E   +V+      N+R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVV-----GNKRLKEATCKLYFY 246
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI-SYICS 176
           Q+   + Y+H    + HRDLKP+N+L+        +KI DFG +K  I GE ++   +C 
Sbjct: 247 QMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLCG 303
Query: 177 R-FYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
              Y APE++   G   Y  ++D WS G +L   L G P F        L          
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 353
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
            +++I     N+     P++    W +V  K     A+DL  +LL   P  R T  EA  
Sbjct: 354 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEALR 399
Query: 294 HPFFDE 299
           HP+  +
Sbjct: 400 HPWLQD 405

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K + + +  K +E++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSFKDNSN-----LYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLMIDQQGY-IKVTDFGLAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 127/272 (46%), Gaps = 31/272 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           +G G++G V +     +G+ +A+K++   R   + + Q   +MD   V+    C +    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI---RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 79  KNELFLN----LVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
              LF      + ME +  S  +  K+ YS  +  +P   +   T    + L ++    +
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE--- 190
           + HRD+KP N+L+D  +  +K+CDFG + QL+   A       R Y APE I  +     
Sbjct: 147 IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTP---TREEIRCMNPNYT 246
           Y    D+WS G  L EL  G+  +P  N+V DQL +++K  G P   +  E R  +P++ 
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSNSEEREFSPSFI 263
Query: 247 DF-------------RFPQIKAHPWHKVFHKR 265
           +F             ++ ++  HP+  ++ +R
Sbjct: 264 NFVNLCLTKDESKRPKYKELLKHPFILMYEER 295

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 116/228 (50%), Gaps = 22/228 (9%)
Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVI 67
           +V+G GSFG VF  + +   ++G   A+K +      ++DR     E  ++  ++HP V+
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L + F    ++ +L+L L      +   R+ K      +      VK Y  ++  GL +
Sbjct: 94  KLHYAF---QTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALGLDH 145
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIF 186
           +H++  + +RDLKP+N+L+D   H +K+ DFG +K+ I  E      C    Y APE++ 
Sbjct: 146 LHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV- 202
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP 233
               ++ S D WS G ++ E+L G   F G++  + +  I+K  LG P
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSFKDNSN-----LYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           ++ F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EYSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSFKDNSN-----LYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           ++ F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EYSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           ++ F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EYSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 65
           Y+    +G GSFG V  A   +T + VA+K + +    K+       RE+  ++++ HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +I L     + T      + +V+EY    ++     Y    +RM     + +  QI   +
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            Y H   ++ HRDLKP+NLL+D     VKI DFG +  +  G    +   S  Y APE+I
Sbjct: 122 EYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVI 179
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGE 217
            G       +D+WS G VL  +L+G+  F  E
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 117/220 (53%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 93  EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 143
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 144 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEYLAPEIIL- 197
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 236

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 132/299 (44%), Gaps = 60/299 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISL 69
           R +GTGSFG V   +    G   A+K +       L+   + N E  ++ ++ HP +I +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F       ++F+  +M+Y+    ++ +L+     +QR P    K Y  ++   L Y+
Sbjct: 72  WGTF---QDAQQIFM--IMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYL 122
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSR-FYRAPELIF 186
           H+   + +RDLKP+N+L+D   H +KI DFG AK +     +++Y +C    Y APE++ 
Sbjct: 123 HS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV- 175
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y  SID WS G ++ E+L G   F   N +    +I+                   
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA----------------- 218
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA-----HPFFDEL 300
           + RFP                 +  DL SRL+    S R   L+        HP+F E+
Sbjct: 219 ELRFPPF------------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 147/337 (43%), Gaps = 64/337 (18%)
Query: 10  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDH 63
           T  Y     +G G+F +V +   + TG+  A K +       +D +   RE ++ R++ H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 64  PNVISLK---------HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
           PN++ L          +  F   +  ELF ++V            ++YS A+    +   
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----------EYYSEADASHCI--- 109
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGE-ANI 171
                QI   + + H +  + HRDLKP+NLL+   +    VK+ DFG A ++   + A  
Sbjct: 110 ----QQILESVNHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF 164
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 231
            +  +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E+   +L + IK   
Sbjct: 165 GFAGTPGYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA-- 220
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
                          DF  P+     W  V      PEA DL +++L  +P+ R TA EA
Sbjct: 221 ------------GAYDFPSPE-----WDTV-----TPEAKDLINKMLTINPAKRITASEA 258
Query: 292 CAHPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 326
             HP+  +     + +     +  L  FN +++L GA
Sbjct: 259 LKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGA 295

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 136/315 (43%), Gaps = 50/315 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPN 65
           YM  R +G G F   ++   ++T E  A K V +    K       + E+ + + +D+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           V+   H FF    +++ F+ +V+E       R L       + +     + +  Q  +G+
Sbjct: 104 VVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQTIQGV 155
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 184
            Y+H   RV HRDLK  NL ++     VKI DFG A ++   GE   +   +  Y APE 
Sbjct: 156 QYLHN-NRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPE- 212
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     ++  +DIWS GC+L  LL+G+P F                      E  C+   
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKET 250
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
           Y      +IK + +    H  + P A  L  R+L   P+LR +  E     FF     P 
Sbjct: 251 YI-----RIKKNEYSVPRH--INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP- 302
Query: 305 ARLPNG-RPLPPLFN 318
            RLP     +PP F+
Sbjct: 303 MRLPTSCLTVPPRFS 317

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 87/318 (27%), Positives = 151/318 (47%), Gaps = 70/318 (22%)
Query: 14  MAERVVGTGSFG-IVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM----DHPNVIS 68
           ++E+++G GS G +VFQ      G  VA+K++L D  + +  L  ++++    DHPNVI 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 69  LKHCFFSTTSKNELFL-----NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY-QIF 122
               + S T+   L++     NL ++ + ES     K+ S  N ++   Y  +    QI 
Sbjct: 73  --RYYCSETTDRFLYIALELCNLNLQDLVES-----KNVSDENLKLQKEYNPISLLRQIA 125
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH------------QVKICDFGSAKQLIAGEAN 170
            G+A++H++ ++ HRDLKPQN+LV   +             ++ I DFG  K+L +G+  
Sbjct: 126 SGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXX 184
Query: 171 ISY-----ICSRFYRAPELIFGATEYTT------SIDIWSAGCVLAELLLGQPLFPGENA 219
                     +  +RAPEL+  +    T      SIDI+S GCV    +L +   P  + 
Sbjct: 185 FRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDK 243
Query: 220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 279
             +   II+  G  + +E++C++                     + +  EA DL S+++ 
Sbjct: 244 YSRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMID 281
Query: 280 YSPSLRCTALEACAHPFF 297
           + P  R TA++   HP F
Sbjct: 282 HDPLKRPTAMKVLRHPLF 299

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 84/324 (25%), Positives = 141/324 (43%), Gaps = 41/324 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFS 75
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
            T      L +VMEY   S   + +   +A  R      + +  Q+  G++Y H + +VC
Sbjct: 87  PT-----HLAIVMEYA--SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAM-QVC 137
Query: 136 HRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTS 194
           HRDLK +N L+D     ++KICDFG +K  +      S + +  Y APE++    EY   
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYDGK 196
Query: 195 I-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 253
           + D+WS G  L  +L+G   F          + I           R +N  Y    +  I
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYVHI 246
Query: 254 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPL 313
                         PE   L SR+    P+ R +  E   H +F  L+   A L N   +
Sbjct: 247 S-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTM 291
Query: 314 PPLFNFKQELSGASPELVNKLIPD 337
              F+ + +  G S E + ++I +
Sbjct: 292 TTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K + + +  K +E++       +++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLMIDQQGY-IQVTDFGLAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 135/315 (42%), Gaps = 50/315 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPN 65
           YM  R +G G F   ++   ++T E  A K V +    K       + E+ + + +D+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           V+   H FF    +++ F+ +V+E       R L       + +     + +  Q  +G+
Sbjct: 104 VVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQTIQGV 155
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 184
            Y+H   RV HRDLK  NL ++     VKI DFG A ++   GE       +  Y APE 
Sbjct: 156 QYLHN-NRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE- 212
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     ++  +DIWS GC+L  LL+G+P F                      E  C+   
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKET 250
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
           Y      +IK + +    H  + P A  L  R+L   P+LR +  E     FF     P 
Sbjct: 251 YI-----RIKKNEYSVPRH--INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP- 302
Query: 305 ARLPNG-RPLPPLFN 318
            RLP     +PP F+
Sbjct: 303 MRLPTSCLTVPPRFS 317

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 59/301 (19%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----------------E 54
           SY   R +G+G++G V   K        AIK + + +  K R                 E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLI 112
           + L++ +DHPN+I L   F     +++ +  LV E+    E   +++  +         I
Sbjct: 97  ISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEAN 170
                  QI  G+ Y+H    + HRD+KP+N+L++       +KI DFG +         
Sbjct: 152 -----MKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 171 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 230
              + + +Y APE++    +Y    D+WS G ++  LL G P F G+N  D + ++ K  
Sbjct: 206 RDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK-- 261
Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
                         Y DF       + W     K +  EA +L   +L Y  + RCTA E
Sbjct: 262 -----------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEE 298
Query: 291 A 291
           A
Sbjct: 299 A 299

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 135/315 (42%), Gaps = 50/315 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPN 65
           YM  R +G G F   ++   ++T E  A K V +    K       + E+ + + +D+P+
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 87
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           V+   H FF    +++ F+ +V+E       R L       + +     + +  Q  +G+
Sbjct: 88  VVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQTIQGV 139
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 184
            Y+H   RV HRDLK  NL ++     VKI DFG A ++   GE       +  Y APE 
Sbjct: 140 QYLHN-NRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPE- 196
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     ++  +DIWS GC+L  LL+G+P F                      E  C+   
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKET 234
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
           Y      +IK + +    H  + P A  L  R+L   P+LR +  E     FF     P 
Sbjct: 235 YI-----RIKKNEYSVPRH--INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP- 286
Query: 305 ARLPNG-RPLPPLFN 318
            RLP     +PP F+
Sbjct: 287 MRLPTSCLTVPPRFS 301

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 34/209 (16%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TGE VA+KK+        R   RE+++++ + H N++  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGLAYIH 129
              +S   +N   L L+MEY+P   Y  L+ Y     +R+  I +  YT QI +G+ Y+ 
Sbjct: 79  GVCYSAGRRN---LKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA----------GEANISYICSRFY 179
           T  R  HR+L  +N+LV+   ++VKI DFG  K L            GE+ I      F+
Sbjct: 133 T-KRYIHRNLATRNILVEN-ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI------FW 184
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 185 YAPESL-TESKFSVASDVWSFGVVLYELF 212

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 147/337 (43%), Gaps = 64/337 (18%)
Query: 10  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDH 63
           T  Y     +G G+F +V +   + TG+  A K +       +D +   RE ++ R++ H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 64  PNVISLK---------HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
           PN++ L          +  F   +  ELF ++V            ++YS A+    +   
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----------EYYSEADASHCI--- 109
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGE-ANI 171
                QI   + + H +  + HRDLKP+NLL+   +    VK+ DFG A ++   + A  
Sbjct: 110 ----QQILESVNHCH-LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWF 164
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 231
            +  +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E+   +L + IK   
Sbjct: 165 GFAGTPGYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA-- 220
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
                          DF  P+     W  V      PEA DL +++L  +P+ R TA EA
Sbjct: 221 ------------GAYDFPSPE-----WDTV-----TPEAKDLINKMLTINPAKRITASEA 258
Query: 292 CAHPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 326
             HP+  +     + +     +  L  FN +++L GA
Sbjct: 259 LKHPWICQRSTVASMMHRQETVDCLKKFNARRKLKGA 295

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 90/322 (27%), Positives = 145/322 (45%), Gaps = 52/322 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKHC 72
           +G G+F +V +   +  G+  A K +       +D +   RE ++ R++ HPN++ L H 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 88
Query: 73  FFSTTSKNELFLNLVM--EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             S    + L  +LV   E   + + R  ++YS A+    +        QI   + + H 
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 139
Query: 131 VPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIF 186
           +  V HRDLKP+NLL+        VK+ DFG A + + GE  A   +  +  Y +PE + 
Sbjct: 140 MG-VVHRDLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFAGTPGYLSPE-VL 196
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y   +D+W+ G +L  LL+G P F  E+   +L + IK                  
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA--------------GAY 241
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 306
           DF  P+     W  V      PEA DL +++L  +PS R TA EA  HP+        + 
Sbjct: 242 DFPSPE-----WDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 291
Query: 307 LPNGRPLPPL--FNFKQELSGA 326
           +     +  L  FN +++L GA
Sbjct: 292 MHRQETVDCLKKFNARRKLKGA 313

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 95/340 (27%), Positives = 150/340 (44%), Gaps = 52/340 (15%)
Query: 1   MYLVCCILQTISYMAERVVGTGSFGIVFQ-AKCLETGETVAI-----KKVLQDRRYKNRE 54
           M  + C   T  Y     +G G+F +V +  K L   E  A+     K   +D +   RE
Sbjct: 1   MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVM--EYVPESMYRVLKHYSSANQRMPLI 112
            ++ R++ HPN++ L H   S    + L  +LV   E   + + R  ++YS A+    + 
Sbjct: 61  ARICRLLKHPNIVRL-HDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI- 116
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGE-- 168
                  QI   + + H +  V HR+LKP+NLL+        VK+ DFG A + + GE  
Sbjct: 117 ------QQILEAVLHCHQMG-VVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQ 168
Query: 169 ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           A   +  +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E+   +L + IK
Sbjct: 169 AWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIK 226
Query: 229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 288
                             DF  P+     W  V      PEA DL +++L  +PS R TA
Sbjct: 227 A--------------GAYDFPSPE-----WDTV-----TPEAKDLINKMLTINPSKRITA 262
Query: 289 LEACAHPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 326
            EA  HP+        + +     +  L  FN +++L GA
Sbjct: 263 AEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGA 302

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 128 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 178
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 179 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 232
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 135/315 (42%), Gaps = 50/315 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHPN 65
           YM  R +G G F   ++   ++T E  A K V +    K       + E+ + + +D+P+
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPH 103
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           V+   H FF    +++ F+ +V+E       R L       + +     + +  Q  +G+
Sbjct: 104 VVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQTIQGV 155
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPEL 184
            Y+H   RV HRDLK  NL ++     VKI DFG A ++   GE       +  Y APE 
Sbjct: 156 QYLHN-NRVIHRDLKLGNLFLND-DMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPE- 212
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     ++  +DIWS GC+L  LL+G+P F                      E  C+   
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETSCLKET 250
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
           Y      +IK + +    H  + P A  L  R+L   P+LR +  E     FF     P 
Sbjct: 251 YI-----RIKKNEYSVPRH--INPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYAP- 302
Query: 305 ARLPNG-RPLPPLFN 318
            RLP     +PP F+
Sbjct: 303 MRLPTSCLTVPPRFS 317

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 100 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 150
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 151 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 204
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFS 75
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
            T      L +VMEY   S   + +   +A  R      + +  Q+  G++Y H + +VC
Sbjct: 86  PT-----HLAIVMEYA--SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAM-QVC 136
Query: 136 HRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTS 194
           HRDLK +N L+D     ++KICDFG +K  +      S + +  Y APE++    EY   
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYDGK 195
Query: 195 I-DIWSAGCVLAELLLG 210
           + D+WS G  L  +L+G
Sbjct: 196 VADVWSCGVTLYVMLVG 212

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 35/283 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFS 75
           +G+G+FG+    +   T E VA+K + +         RE+   R + HPN++  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
            T      L ++MEY   S   + +   +A  R      + +  Q+  G++Y H++ ++C
Sbjct: 88  PT-----HLAIIMEYA--SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSM-QIC 138
Query: 136 HRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTS 194
           HRDLK +N L+D     ++KICDFG +K  +      S + +  Y APE++    EY   
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYDGK 197
Query: 195 I-DIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTR--EEIRCMNPN------ 244
           I D+WS G  L  +L+G  P    E   D    I ++L       ++IR ++P       
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR-ISPECCHLIS 256
Query: 245 -------YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 280
                   T    P+IK H W   F K +P + ++ ++   Q+
Sbjct: 257 RIFVADPATRISIPEIKTHSW---FLKNLPADLMNESNTGSQF 296

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P +  L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P +  L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDH 63
           +Y   + +G G+F  V  A+ + TG+ VA+K +  D+   N        RE+++ +V++H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PN++ L         + E  L LV EY        +  Y  A+ R      +    QI  
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVXEYASGGE---VFDYLVAHGRXKEKEARAKFRQIVS 124
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            + Y H    + HRDLK +NLL+D     +KI DFG + +   G    ++  +  Y APE
Sbjct: 125 AVQYCHQ-KFIVHRDLKAENLLLDA-DXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           L  G       +D+WS G +L  L+ G   F G+N
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYVP   M+  L+       R    + + Y  QI     Y+
Sbjct: 100 EFSF-----KDNSNLYMVMEYVPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 150
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 151 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 204
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLMIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 91/343 (26%), Positives = 148/343 (43%), Gaps = 66/343 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 68
           RV+G GSFG V  A+  ETG+  A+K + +D   ++ +++        L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 69  LKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  CF    + + LF   VME+V   + M+ + K     ++R      + Y  +I   L 
Sbjct: 89  LFCCF---QTPDRLF--FVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALM 138
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELI 185
           ++H    + +RDLK  N+L+D   H  K+ DFG  K+ I      +  C    Y APE I
Sbjct: 139 FLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE-I 195
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                Y  ++D W+ G +L E+L G   F  EN  D L E I        +E+       
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV------- 241
Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFDE 299
                          V+   +  +A  +    +  +P++R  +L          HPFF E
Sbjct: 242 ---------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
Query: 300 LREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQ 342
           +    A+L + +  PP   F+  +   S E V+   PD +K +
Sbjct: 287 IDW--AQLNHRQIEPP---FRPRIK--SREDVSNFDPDFIKEE 322

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P +  L
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYAPGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLMIDQQGY-IKVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 136/300 (45%), Gaps = 43/300 (14%)
Query: 6   CILQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDRRYKNRELQLMR-VMDH 63
            I + +S +  R V   + G  F  K +E T E ++ +++ + R    RE  ++R V  H
Sbjct: 101 VIGRGVSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           P++I+L   + S++     F+ LV + + +     L  Y +    +     +     +  
Sbjct: 160 PHIITLIDSYESSS-----FMFLVFDLMRKGE---LFDYLTEKVALSEKETRSIMRSLLE 211
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            ++++H    + HRDLKP+N+L+D    Q+++ DFG +  L  GE       +  Y APE
Sbjct: 212 AVSFLH-ANNIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 184 LIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           ++  + +     Y   +D+W+ G +L  LL G P F     +  L  I++        + 
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG-------QY 322
Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
           +  +P + D R   +K                 DL SRLLQ  P  R TA +A  HPFF+
Sbjct: 323 QFSSPEWDD-RSSTVK-----------------DLISRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           R +GTGSFG V   K  ETG   A+K     KV++ ++ ++   E ++ + ++ P ++ L
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +V+EY P   M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSFKDNSN-----LYMVLEYAPGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +K+ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IKVADFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 19/215 (8%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++I L     + T        +VMEYV       L  Y   + R+  +  +    QI   
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGE---LFDYICKHGRVEEMEARRLFQQILSA 123
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y H    V HRDLKP+N+L+D      KI DFG +  +  GE   +   S  Y APE+
Sbjct: 124 VDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 219
           I G       +DIWS G +L  LL G   F  E+ 
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 134/323 (41%), Gaps = 60/323 (18%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 74
           +GTG+FG+V +     TG   A K V+     D+    +E+Q M V+ HP +++L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 75  STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
                NE    +VM Y   S   + +  +  + +M       Y  Q+ +GL ++H    V
Sbjct: 224 --EDDNE----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 277
Query: 135 CHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYT 192
            H DLKP+N++     ++++K+ DFG    L   ++      +  + APE+  G    Y 
Sbjct: 278 -HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
           T  D+WS G +   LL G   F GEN  + L              ++  + N  D  F  
Sbjct: 337 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 382
Query: 253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NARLPNG 310
           I               +  D   +LL   P+ R T  +A  HP+      P  ++++P+ 
Sbjct: 383 ISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 429
Query: 311 R-----------------PLPPL 316
           R                 PLPPL
Sbjct: 430 RYTKIRDSIKTKYDAWPEPLPPL 452

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 22/228 (9%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAI--KKVLQ-------DRRYKNRELQLMRVMDHPNVI 67
           +V+G GSFG VF  K +   +   +   KVL+       DR     E  ++  ++HP ++
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L + F    ++ +L+L L      +   R+ K      +      VK Y  ++   L +
Sbjct: 90  KLHYAF---QTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALDH 141
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIF 186
           +H++  + +RDLKP+N+L+D   H +K+ DFG +K+ I  E      C    Y APE++ 
Sbjct: 142 LHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV- 198
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP 233
               +T S D WS G ++ E+L G   F G++  + +  I+K  LG P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/323 (25%), Positives = 134/323 (41%), Gaps = 60/323 (18%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCFF 74
           +GTG+FG+V +     TG   A K V+     D+    +E+Q M V+ HP +++L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 75  STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
                NE    +VM Y   S   + +  +  + +M       Y  Q+ +GL ++H    V
Sbjct: 118 --EDDNE----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 171
Query: 135 CHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYT 192
            H DLKP+N++     ++++K+ DFG    L   ++      +  + APE+  G    Y 
Sbjct: 172 -HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 230
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
           T  D+WS G +   LL G   F GEN  + L              ++  + N  D  F  
Sbjct: 231 T--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAFSG 276
Query: 253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NARLPNG 310
           I               +  D   +LL   P+ R T  +A  HP+      P  ++++P+ 
Sbjct: 277 ISE-------------DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 323
Query: 311 R-----------------PLPPL 316
           R                 PLPPL
Sbjct: 324 RYTKIRDSIKTKYDAWPEPLPPL 346

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 62/299 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +LK+ F +        L  VMEY    E  + + +    +  R      + Y  +I   
Sbjct: 73  TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 122
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPE 183
           L Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I   A +   C    Y APE
Sbjct: 123 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 182 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 229
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 230 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 62/299 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +LK+ F +        L  VMEY    E  + + +    +  R      + Y  +I   
Sbjct: 71  TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 120
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPE 183
           L Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I   A +   C    Y APE
Sbjct: 121 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 180 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 227
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 228 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 62/299 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +LK+ F +        L  VMEY    E  + + +    +  R      + Y  +I   
Sbjct: 72  TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 121
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPE 183
           L Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I   A +   C    Y APE
Sbjct: 122 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 228
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 229 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 22/228 (9%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAI--KKVLQ-------DRRYKNRELQLMRVMDHPNVI 67
           +V+G GSFG VF  K +   +   +   KVL+       DR     E  ++  ++HP ++
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L + F    ++ +L+L L      +   R+ K      +      VK Y  ++   L +
Sbjct: 90  KLHYAF---QTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALDH 141
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIF 186
           +H++  + +RDLKP+N+L+D   H +K+ DFG +K+ I  E      C    Y APE++ 
Sbjct: 142 LHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV- 198
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP 233
               +T S D WS G ++ E+L G   F G++  + +  I+K  LG P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 116/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K +ETG   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 19/215 (8%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHP 64
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q +++  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++I L     + T        +VMEYV       L  Y   + R+  +  +    QI   
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGE---LFDYICKHGRVEEMEARRLFQQILSA 123
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           + Y H    V HRDLKP+N+L+D      KI DFG +  +  GE       S  Y APE+
Sbjct: 124 VDYCHR-HMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEV 181
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 219
           I G       +DIWS G +L  LL G   F  E+ 
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 112/228 (49%), Gaps = 22/228 (9%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAI--KKVLQ-------DRRYKNRELQLMRVMDHPNVI 67
           +V+G GSFG VF  K +   +   +   KVL+       DR     E  ++  ++HP ++
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L + F    ++ +L+L L      +   R+ K      +      VK Y  ++   L +
Sbjct: 91  KLHYAF---QTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-----VKFYLAELALALDH 142
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIF 186
           +H++  + +RDLKP+N+L+D   H +K+ DFG +K+ I  E      C    Y APE++ 
Sbjct: 143 LHSLG-IIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV- 199
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-LGTP 233
               +T S D WS G ++ E+L G   F G++  + +  I+K  LG P
Sbjct: 200 NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 110/219 (50%), Gaps = 32/219 (14%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKN--RELQLMRVMDHPNVI 67
           E ++G G FG V++A  +  G+ VA+K    D      +  +N  +E +L  ++ HPN+I
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L+          E  L LVME+     + RVL     + +R+P   +  +  QI RG+ 
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMN 119
Query: 127 YIH--TVPRVCHRDLKPQNLLV-------DPLTHQVKICDFGSAKQLIAGEANISYICSR 177
           Y+H   +  + HRDLK  N+L+       D     +KI DFG A++       +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAAGAY 178
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 216
            + APE+I  A+ ++   D+WS G +L ELL G+  F G
Sbjct: 179 AWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 70
           V+G GSFG V  A    T E  AIK + +D   ++ +++       ++ ++D P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           H  F T  +    L  VMEYV   + MY + +       + P      Y  +I  GL ++
Sbjct: 86  HSCFQTVDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--QAVFYAAEISIGLFFL 136
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 187
           H    + +RDLK  N+++D   H +KI DFG  K+ ++ G     +  +  Y APE+I  
Sbjct: 137 HK-RGIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-A 193
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              Y  S+D W+ G +L E+L GQP F GE+  D+L + I
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 62/299 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +LK+ F +        L  VMEY    E  + + +    +  R      + Y  +I   
Sbjct: 211 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 260
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPE 183
           L Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I   A +   C    Y APE
Sbjct: 261 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 367
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 368 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 127/299 (42%), Gaps = 62/299 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETG----------ETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           +++G G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 213
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +LK+ F +        L  VMEY    E  + + +    +  R      + Y  +I   
Sbjct: 214 TALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 263
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPE 183
           L Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I   A +   C    Y APE
Sbjct: 264 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 322
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            +    +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR    
Sbjct: 323 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 370
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                             F + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 371 ------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 138/314 (43%), Gaps = 60/314 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  +    +A+K + + +  K        RE+++   + HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
            + F          + L++E+ P   +Y+ L+ +   +++    +++    ++   L Y 
Sbjct: 80  YNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H   +V HRD+KP+NLL+     ++KI DFG +  + A       +C    Y  PE+I G
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
            T +   +D+W AG +  E L+G P F   +  +    I+ V                 D
Sbjct: 187 KT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
            +FP              +   + DL S+LL+Y P  R        HP+     + N+R 
Sbjct: 229 LKFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR- 271
Query: 308 PNGRPLPPLFNFKQ 321
              R LPP++   Q
Sbjct: 272 ---RVLPPVYQSTQ 282

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 138/314 (43%), Gaps = 60/314 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  +    +A+K + + +  K        RE+++   + HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
            + F          + L++E+ P   +Y+ L+ +   +++    +++    ++   L Y 
Sbjct: 81  YNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIFG 187
           H   +V HRD+KP+NLL+     ++KI DFG +  + A       +C    Y  PE+I G
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
            T +   +D+W AG +  E L+G P F   +  +    I+ V                 D
Sbjct: 188 KT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 229
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
            +FP              +   + DL S+LL+Y P  R        HP+     + N+R 
Sbjct: 230 LKFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV----KANSR- 272
Query: 308 PNGRPLPPLFNFKQ 321
              R LPP++   Q
Sbjct: 273 ---RVLPPVYQSTQ 283

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 140/324 (43%), Gaps = 41/324 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFS 75
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
            T      L +VMEY   S   + +   +A  R      + +  Q+  G++Y H + +VC
Sbjct: 87  PT-----HLAIVMEYA--SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAM-QVC 137
Query: 136 HRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTS 194
           HRDLK +N L+D     ++KIC FG +K  +      S + +  Y APE++    EY   
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYDGK 196
Query: 195 I-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 253
           + D+WS G  L  +L+G   F          + I           R +N  Y    +  I
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYVHI 246
Query: 254 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPL 313
                         PE   L SR+    P+ R +  E   H +F  L+   A L N   +
Sbjct: 247 S-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTM 291
Query: 314 PPLFNFKQELSGASPELVNKLIPD 337
              F+ + +  G S E + ++I +
Sbjct: 292 TTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 73
           E VVG G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN++ L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV- 131
            +          LVMEY    S+Y VL H +         +   +  Q  +G+AY+H++ 
Sbjct: 71  LNPVC-------LVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 132 PR-VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
           P+ + HRDLKP NLL+      +KICDFG+A  +     N     S  + APE +F  + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSN 179
Query: 191 YTTSIDIWSAGCVLAELL--------LGQPLF 214
           Y+   D++S G +L E++        +G P F
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 120/286 (41%), Gaps = 37/286 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           +G G++G+V + + + +G+  A+K++   R   N + Q   + D         C F+ T 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI---RATVNSQEQKRLLXDLDISXRTVDCPFTVTF 98
Query: 79  KNELF----LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
              LF    + +  E    S+ +  K      Q +P   +      I + L ++H+   V
Sbjct: 99  YGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 158
Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI---FGATEY 191
            HRD+KP N+L++ L  QVK CDFG +  L+   A       + Y APE I        Y
Sbjct: 159 IHRDVKPSNVLINALG-QVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
           +   DIWS G    EL + +  FP ++            GTP ++               
Sbjct: 218 SVKSDIWSLGITXIELAILR--FPYDS-----------WGTPFQQ-------------LK 251
Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           Q+   P  ++   +   E +D  S+ L+ +   R T  E   HPFF
Sbjct: 252 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 132/301 (43%), Gaps = 50/301 (16%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----RELQLMRVMD 62
           I +T  +M   V+G+G+F  VF  K   TG+  A+K + +   +++     E+ +++ + 
Sbjct: 7   IRKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
           H N+++L+  + STT        LVM+ V   E   R+L+      +   L+       Q
Sbjct: 65  HENIVTLEDIYESTTH-----YYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQ 114
Query: 121 IFRGLAYIHTVPRVCHRDLKPQNL--LVDPLTHQVKICDFGSAKQLIAGEANISYICSR- 177
           +   + Y+H    + HRDLKP+NL  L      ++ I DFG +K    G   +S  C   
Sbjct: 115 VLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTP 171
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APE +     Y+ ++D WS G +   LL G P F  E    +L E IK         
Sbjct: 172 GYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFY-EETESKLFEKIK--------- 220
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                  Y +F  P          F   +   A D    LL+  P+ R T  +A +HP+ 
Sbjct: 221 -----EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265
Query: 298 D 298
           D
Sbjct: 266 D 266

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 73
           E VVG G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN++ L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV- 131
            +          LVMEY    S+Y VL H +         +   +  Q  +G+AY+H++ 
Sbjct: 72  LNPVC-------LVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 123
Query: 132 PR-VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
           P+ + HRDLKP NLL+      +KICDFG+A  +     N     S  + APE +F  + 
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VFEGSN 180
Query: 191 YTTSIDIWSAGCVLAELL--------LGQPLF 214
           Y+   D++S G +L E++        +G P F
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 212

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS------LKHC 72
           +G+G+ G V++ +  +TG  +A+K++   RR  N+E     +MD   V+       +  C
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQM---RRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           F +  +  ++F+   ME +     ++ K        +P   +   T  I + L Y+    
Sbjct: 90  FGTFITNTDVFI--AMELMGTCAEKLKKRMQGP---IPERILGKMTVAIVKALYYLKEKH 144
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF----GA 188
            V HRD+KP N+L+D    Q+K+CDFG + +L+  +A         Y APE I       
Sbjct: 145 GVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 230
            +Y    D+WS G  L EL  GQ  FP +N       + KVL
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ--FPYKNCKTDFEVLTKVL 243

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 144/337 (42%), Gaps = 64/337 (18%)
Query: 10  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDH 63
           T  Y     +G G+F +V +   L TG   A K +       +D +   RE ++ R++ H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 64  PNVISLK---------HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            N++ L          +  F   +  ELF ++V            ++YS A+    +   
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----------EYYSEADASHCI--- 109
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGE-ANI 171
                QI   + + H +  V HRDLKP+NLL+        VK+ DFG A ++   + A  
Sbjct: 110 ----QQILEAVLHCHQMG-VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWF 164
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 231
            +  +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E+   +L + IK   
Sbjct: 165 GFAGTPGYLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA-- 220
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
                          DF  P+     W  V      PEA +L +++L  +P+ R TA EA
Sbjct: 221 ------------GAYDFPSPE-----WDTV-----TPEAKNLINQMLTINPAKRITAHEA 258
Query: 292 CAHPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 326
             HP+  +     + +     +  L  FN +++L GA
Sbjct: 259 LKHPWVCQRSTVASMMHRQETVECLKKFNARRKLKGA 295

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 120/275 (43%), Gaps = 51/275 (18%)
Query: 36  GETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES 94
           G + + ++V + R    +E+ ++R V  HPN+I LK  + + T     F  LV + + + 
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG 109
Query: 95  -MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI----HTVPRVCHRDLKPQNLLVDPL 149
            ++  L    + +++         T +I R L  +    H +  + HRDLKP+N+L+D  
Sbjct: 110 ELFDYLTEKVTLSEKE--------TRKIMRALLEVICALHKL-NIVHRDLKPENILLDD- 159
Query: 150 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVL 204
              +K+ DFG + QL  GE   S   +  Y APE+I  +       Y   +D+WS G ++
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 205 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 264
             LL G P F     +  L  I              M+ NY      Q  +  W      
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMI--------------MSGNY------QFGSPEWDD---- 255
Query: 265 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                  DL SR L   P  R TA EA AHPFF +
Sbjct: 256 -YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 123/293 (41%), Gaps = 44/293 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYK-NRELQLMRVMDHPNVI 67
           Y    V+GTG+F  V  A+   T + VAIK    K L+ +      E+ ++  + HPN++
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +    S   L+L + +    E   R++ K + +      LI+      Q+   + 
Sbjct: 80  ALDDIY---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKI--CDFGSAKQLIAGEANISYICSRFYRAPEL 184
           Y+H +  + HRDLKP+NLL   L    KI   DFG +K    G    +   +  Y APE 
Sbjct: 131 YLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     Y+ ++D WS G +   LL G P F  EN      +I+K        E    +P 
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDSPY 241
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
           + D                  +   A D    L++  P  R T  +A  HP+ 
Sbjct: 242 WDD------------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 115/219 (52%), Gaps = 23/219 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 128 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 178
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H++  + +RDLKP+NLL+D   + +++ DFG AK++    A  +   +  Y APE+I  +
Sbjct: 179 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--ATWTLCGTPEYLAPEIIL-S 233
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 150/337 (44%), Gaps = 48/337 (14%)
Query: 2   YLVCCILQTISYMAERV--VGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKNR---EL 55
           +LVC I   +    E V  +G G+FG V +      G++ VA+K +    +Y+     E+
Sbjct: 8   HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI 67
Query: 56  QLMRVMDHPNVISLKHCFFSTTSKN-ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            +++ +   +  +   C   +   N    + +  E + ++ +  LK   +  Q  PL +V
Sbjct: 68  NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHV 125
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-----DPLTHQVKIC------------- 156
           +   YQ+   L ++H   ++ H DLKP+N+L      + L ++ K C             
Sbjct: 126 RHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 157 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 216
           DFGSA      E + + + +R YR PE+I     +    D+WS GC+L E   G  LF  
Sbjct: 185 DFGSAT--FDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 217 ENAVDQLVEIIKVLG-------TPTREEIR------CMNPNYTDFRFPQIKAHPWHKVFH 263
               + LV + K+LG         TR++          + N +D R+ +    P  K + 
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYM 300
Query: 264 KRMPPEAI---DLASRLLQYSPSLRCTALEACAHPFF 297
            +   E +   DL  R+L++ P+ R T  EA  HPFF
Sbjct: 301 LQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 17  RVVGTGSFGIVFQAK--------CLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           +V+G GSFG V  A+         ++  +  AI K  +++   +    L++ + HP ++ 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 69  LKHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L H  F T  K    L  V++Y+   E  Y + +       R      + Y  +I   L 
Sbjct: 104 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 153
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELI 185
           Y+H++  + +RDLKP+N+L+D   H V + DFG  K+ I   +  S  C    Y APE++
Sbjct: 154 YLHSL-NIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
                Y  ++D W  G VL E+L G P F   N  +    I+
Sbjct: 212 H-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 138/301 (45%), Gaps = 54/301 (17%)
Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNRELQLMRVMDH----P 64
           +V+GTG++G VF  + +   +TG+  A+K      ++Q  +         +V++H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +++L + F + T      L+L+++Y+      +  H S   +R     V++Y  +I   
Sbjct: 120 FLVTLHYAFQTETK-----LHLILDYINGG--ELFTHLSQ-RERFTEHEVQIYVGEIVLA 171
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-ICSRF-YRAP 182
           L ++H +  + +RD+K +N+L+D   H V + DFG +K+ +A E   +Y  C    Y AP
Sbjct: 172 LEHLHKLG-IIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 183 ELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           +++ G  + +  ++D WS G ++ ELL G   F  +   +   EI       +R  ++  
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSE 282
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 301
            P      +PQ             M   A DL  RLL   P  R      C     DE++
Sbjct: 283 PP------YPQ------------EMSALAKDLIQRLLMKDPKKRL----GCGPRDADEIK 320
Query: 302 E 302
           E
Sbjct: 321 E 321

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 150/337 (44%), Gaps = 48/337 (14%)
Query: 2   YLVCCILQTISYMAERV--VGTGSFGIVFQAKCLETGET-VAIKKVLQDRRYKNR---EL 55
           +LVC I   +    E V  +G G+FG V +      G++ VA+K +    +Y+     E+
Sbjct: 17  HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI 76
Query: 56  QLMRVMDHPNVISLKHCFFSTTSKN-ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            +++ +   +  +   C   +   N    + +  E + ++ +  LK   +  Q  PL +V
Sbjct: 77  NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLPHV 134
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-----DPLTHQVKIC------------- 156
           +   YQ+   L ++H   ++ H DLKP+N+L      + L ++ K C             
Sbjct: 135 RHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 193
Query: 157 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 216
           DFGSA      E + + + +R YR PE+I     +    D+WS GC+L E   G  LF  
Sbjct: 194 DFGSAT--FDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQT 250
Query: 217 ENAVDQLVEIIKVLG-------TPTREEIR------CMNPNYTDFRFPQIKAHPWHKVFH 263
               + LV + K+LG         TR++          + N +D R+ +    P  K + 
Sbjct: 251 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KSYM 309
Query: 264 KRMPPEAI---DLASRLLQYSPSLRCTALEACAHPFF 297
            +   E +   DL  R+L++ P+ R T  EA  HPFF
Sbjct: 310 LQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 346

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFS-- 75
           ++G+G FG VF+AK    G+T  I++V  +     RE++ +  +DH N++    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 78
Query: 76  -----------------TTSKNE-------LFLNLVMEYVPESMYRVLKHYSSANQRMPL 111
                              SKN        LF+   ME+  +             +   +
Sbjct: 79  YDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQ--MEFCDKGTLEQWIEKRRGEKLDKV 136
Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL-LVDPLTHQVKICDFGSAKQLIAGEAN 170
           + ++L+  QI +G+ YIH+  ++ HRDLKP N+ LVD  T QVKI DFG    L      
Sbjct: 137 LALELFE-QITKGVDYIHS-KKLIHRDLKPSNIFLVD--TKQVKIGDFGLVTSLKNDGKR 192
Query: 171 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
                +  Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 193 TRSKGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 89/339 (26%), Positives = 150/339 (44%), Gaps = 52/339 (15%)
Query: 2   YLVCCILQTISYMAERV--VGTGSFGIVFQAKCLETG---ETVAIKKVLQDRRYKNR--- 53
           +LVC I   +    E V  +G G+FG V   +CL+       VA+K +    +Y+     
Sbjct: 40  HLVCRIGDWLQERYEIVGNLGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARL 97
Query: 54  ELQLMRVMDHPNVISLKHCFFSTTSKN-ELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           E+ +++ +   +  +   C   +   N    + +  E + ++ +  LK   +  Q  PL 
Sbjct: 98  EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLK--ENNFQPYPLP 155
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV-----DPLTHQVKIC----------- 156
           +V+   YQ+   L ++H   ++ H DLKP+N+L      + L ++ K C           
Sbjct: 156 HVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 214
Query: 157 --DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 214
             DFGSA      E + + + +R YR PE+I     +    D+WS GC+L E   G  LF
Sbjct: 215 VADFGSAT--FDHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLF 271
Query: 215 PGENAVDQLVEIIKVLG-------TPTREEIR------CMNPNYTDFRFPQIKAHPWHKV 261
                 + LV + K+LG         TR++          + N +D R+ +    P  K 
Sbjct: 272 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPL-KS 330
Query: 262 FHKRMPPEAI---DLASRLLQYSPSLRCTALEACAHPFF 297
           +  +   E +   DL  R+L++ P+ R T  EA  HPFF
Sbjct: 331 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 369

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 90/350 (25%), Positives = 149/350 (42%), Gaps = 76/350 (21%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIV-----------FQAKCLETGETVAIKKVLQDRRYK 51
           +  C   T  Y     +G G+F +V           + AK + T +  A     +D +  
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKL 77
Query: 52  NRELQLMRVMDHPNVISLK---------HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY 102
            RE ++ R++ HPN++ L          +  F   +  ELF ++V            ++Y
Sbjct: 78  EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR----------EYY 127
Query: 103 SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGS 160
           S A+    +       +QI   + +IH    + HRDLKP+NLL+        VK+ DFG 
Sbjct: 128 SEADASHCI-------HQILESVNHIHQ-HDIVHRDLKPENLLLASKCKGAAVKLADFGL 179
Query: 161 AKQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
           A + + GE  A   +  +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E+
Sbjct: 180 AIE-VQGEQQAWFGFAGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDED 237
Query: 219 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL 278
              +L + IK                  DF  P+     W  V      PEA +L +++L
Sbjct: 238 Q-HKLYQQIKA--------------GAYDFPSPE-----WDTV-----TPEAKNLINQML 272
Query: 279 QYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 326
             +P+ R TA +A  HP+  +     + +     +  L  FN +++L GA
Sbjct: 273 TINPAKRITADQALKHPWVCQRSTVASMMHRQETVECLRKFNARRKLKGA 322

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 139/324 (42%), Gaps = 41/324 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFS 75
           +G+G+FG+    +  ++ E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
            T      L +VMEY   S   + +   +A  R      + +  Q+  G++Y H + +VC
Sbjct: 87  PT-----HLAIVMEYA--SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAM-QVC 137
Query: 136 HRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTS 194
           HRDLK +N L+D     ++KIC FG +K  +        + +  Y APE++    EY   
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL-KKEYDGK 196
Query: 195 I-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 253
           + D+WS G  L  +L+G   F          + I           R +N  Y    +  I
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYVHI 246
Query: 254 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPL 313
                         PE   L SR+    P+ R +  E   H +F  L+   A L N   +
Sbjct: 247 S-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTM 291
Query: 314 PPLFNFKQELSGASPELVNKLIPD 337
              F+ + +  G S E + ++I +
Sbjct: 292 TTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 139/309 (44%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   VA+K + + +  K        RE+++   + HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGLAY 127
            + F+         + L++EY P   +Y+ L+   + + QR   I  +L        L Y
Sbjct: 89  YNYFYDRRR-----IYLILEYAPRGELYKELQKSCTFDEQRTATIMEELAD-----ALMY 138
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPELIF 186
            H   +V HRD+KP+NLL+  L  ++KI DFG +  + A       +C    Y  PE+I 
Sbjct: 139 CHG-KKVIHRDIKPENLLLG-LKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G   +   +D+W  G +  ELL+G P F   +  +    I+KV                 
Sbjct: 195 GRM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV----------------- 236
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 306
           D +FP              +P  A DL S+LL+++PS R    +  AHP+         R
Sbjct: 237 DLKFPA------------SVPTGAQDLISKLLRHNPSERLPLAQVSAHPW--------VR 276
Query: 307 LPNGRPLPP 315
             + R LPP
Sbjct: 277 ANSRRVLPP 285

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 92/343 (26%), Positives = 147/343 (42%), Gaps = 84/343 (24%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ----DRRYKNRELQLMRVMDH 63
           Y  +  +G GS+G+V  A   +T    AIK     K+ Q    D      E++LM+ + H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 64  PNVISLKHCFFSTTSKNELFLNLVME-------------YVPESMYR----VLK------ 100
           PN+  L   +     ++E ++ LVME             ++ +S  +    V+K      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 101 --------HYSSANQRMPLIYV---KLYTY---QIFRGLAYIHTVPRVCHRDLKPQNLLV 146
                   + S    R  L +V   KL +    QIF  L Y+H    +CHRD+KP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201
Query: 147 DP-LTHQVKICDFGSAKQ---LIAGE--ANISYICSRFYRAPELIFGATE-YTTSIDIWS 199
               + ++K+ DFG +K+   L  GE     +   + ++ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 200 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
           AG +L  LL+G   FPG N  D + +++        +++   NPNY              
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-------KKLCFENPNYN------------- 301
Query: 260 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                 + P A DL S LL  +   R  A+ A  HP+  +  +
Sbjct: 302 -----VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 108 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 158
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 159 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 212
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFAEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 119/275 (43%), Gaps = 51/275 (18%)
Query: 36  GETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES 94
           G + + ++V + R    +E+ ++R V  HPN+I LK  + + T     F  LV + + + 
Sbjct: 42  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG 96
Query: 95  -MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI----HTVPRVCHRDLKPQNLLVDPL 149
            ++  L    + +++         T +I R L  +    H +  + HRDLKP+N+L+D  
Sbjct: 97  ELFDYLTEKVTLSEKE--------TRKIMRALLEVICALHKL-NIVHRDLKPENILLDD- 146
Query: 150 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVL 204
              +K+ DFG + QL  GE       +  Y APE+I  +       Y   +D+WS G ++
Sbjct: 147 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206
Query: 205 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 264
             LL G P F     +  L  I              M+ NY      Q  +  W      
Sbjct: 207 YTLLAGSPPFWHRKQMLMLRMI--------------MSGNY------QFGSPEWDD---- 242
Query: 265 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                  DL SR L   P  R TA EA AHPFF +
Sbjct: 243 -YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPI-QIYEKI 250

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 131/306 (42%), Gaps = 58/306 (18%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F IV + +   TG+  A  K ++ RR  +           RE+ ++R + HPN+I
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   F     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 72  TLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 122
Query: 127 YIHTVPRVCHRDLKPQNLLV------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 180
           Y+H+  R+ H DLKP+N+++      +P   ++K+ DFG A ++ AG    +   +  + 
Sbjct: 123 YLHS-KRIAHFDLKPENIMLLDKNVPNP---RIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++          D+WS G +   LL G   F GE   + L  I  V           
Sbjct: 179 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----------- 226
Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
              NY DF           + +       A D   RLL   P  R T  ++  H +   +
Sbjct: 227 ---NY-DF----------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
Query: 301 REPNAR 306
           R  N R
Sbjct: 273 RRRNVR 278

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 119/275 (43%), Gaps = 51/275 (18%)
Query: 36  GETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPES 94
           G + + ++V + R    +E+ ++R V  HPN+I LK  + + T     F  LV + + + 
Sbjct: 55  GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG 109
Query: 95  -MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI----HTVPRVCHRDLKPQNLLVDPL 149
            ++  L    + +++         T +I R L  +    H +  + HRDLKP+N+L+D  
Sbjct: 110 ELFDYLTEKVTLSEKE--------TRKIMRALLEVICALHKL-NIVHRDLKPENILLDD- 159
Query: 150 THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVL 204
              +K+ DFG + QL  GE       +  Y APE+I  +       Y   +D+WS G ++
Sbjct: 160 DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
Query: 205 AELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHK 264
             LL G P F     +  L  I              M+ NY      Q  +  W      
Sbjct: 220 YTLLAGSPPFWHRKQMLMLRMI--------------MSGNY------QFGSPEWDD---- 255
Query: 265 RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                  DL SR L   P  R TA EA AHPFF +
Sbjct: 256 -YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 94  EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 144
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 145 HSLD-LIYRDLKPENLLIDEQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 198
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 128 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 178
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 179 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 232
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 72
           V+GTG+F  V  A+   T + VAIK + ++           E+ ++  + HPN+++L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           +    S   L+L + +    E   R++ K + +      LI+      Q+   + Y+H +
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLHDL 135
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKI--CDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
             + HRDLKP+NLL   L    KI   DFG +K    G    +   +  Y APE +    
Sbjct: 136 G-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQK 193
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y+ ++D WS G +   LL G P F  EN      +I+K        E    +P + D  
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDSPYWDD-- 244
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                           +   A D    L++  P  R T  +A  HP+
Sbjct: 245 ----------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 121/287 (42%), Gaps = 44/287 (15%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 72
           V+GTG+F  V  A+   T + VAIK + ++           E+ ++  + HPN+++L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           +    S   L+L + +    E   R++ K + +      LI+      Q+   + Y+H +
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLHDL 135
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKI--CDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
             + HRDLKP+NLL   L    KI   DFG +K    G    +   +  Y APE +    
Sbjct: 136 G-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQK 193
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y+ ++D WS G +   LL G P F  EN      +I+K        E    +P + D  
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDSPYWDD-- 244
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                           +   A D    L++  P  R T  +A  HP+
Sbjct: 245 ----------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F   ++     L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 102 EFSFKDNSN-----LYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 152
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 153 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 206
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 245

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 121/288 (42%), Gaps = 44/288 (15%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC 72
           V+GTG+F  V  A+   T + VAIK + ++           E+ ++  + HPN+++L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           +    S   L+L + +    E   R++ K + +      LI+      Q+   + Y+H +
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVKYLHDL 135
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKI--CDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
             + HRDLKP+NLL   L    KI   DFG +K    G    +   +  Y APE +    
Sbjct: 136 G-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE-VLAQK 193
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y+ ++D WS G +   LL G P F  EN      +I+K        E    +P + D  
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-------EYEFDSPYWDD-- 244
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                           +   A D    L++  P  R T  +A  HP+ 
Sbjct: 245 ----------------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 59/299 (19%)
Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIK--------KVLQDRRYKNRELQLMRVMDHPN 65
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E  ++  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++ L + F  T  K    L L++EY+    ++  L+      +     Y+     +I   
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLEREGIFMEDTACFYLA----EISMA 133
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 183
           L ++H    + +RDLKP+N++++   H VK+ DFG  K+ I         C    Y APE
Sbjct: 134 LGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++   + +  ++D WS G ++ ++L G P F GEN    + +I+K               
Sbjct: 192 ILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------------- 236
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                   ++   P+       +  EA DL  +LL+ + + R       A E  AHPFF
Sbjct: 237 --------KLNLPPY-------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 114/219 (52%), Gaps = 23/219 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H++  + +RDLKP+NLL+D   + +++ DFG AK++      ++      Y APE+I  +
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLAGTPE--YLAPEIIL-S 212
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFXEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 59/299 (19%)
Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIK--------KVLQDRRYKNRELQLMRVMDHPN 65
           RV+G G +G VFQ + +    TG+  A+K        +  +D  +   E  ++  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++ L + F  T  K    L L++EY+    ++  L+      +     Y+     +I   
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLEREGIFMEDTACFYLA----EISMA 133
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YRAPE 183
           L ++H    + +RDLKP+N++++   H VK+ DFG  K+ I         C    Y APE
Sbjct: 134 LGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++   + +  ++D WS G ++ ++L G P F GEN    + +I+K               
Sbjct: 192 ILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-------------- 236
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFF 297
                   ++   P+       +  EA DL  +LL+ + + R       A E  AHPFF
Sbjct: 237 --------KLNLPPY-------LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 133/299 (44%), Gaps = 51/299 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR   H NV+ + + +
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                 +EL++  VME++       +  ++  N+      +      + + L+ +H    
Sbjct: 87  LVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHA-QG 136
Query: 134 VCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT 189
           V HRD+K  ++L   LTH  +VK+ DFG   Q ++ E       + + ++ APELI    
Sbjct: 137 VIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKXLVGTPYWMAPELI-SRL 191
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y   +DIWS G ++ E++ G+P +  E               P  + ++ +  N     
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP--- 233
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
                  P  K  HK + P       RLL   P+ R TA E   HPF  +   P + +P
Sbjct: 234 -------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 284

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 133/299 (44%), Gaps = 51/299 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR   H NV+ + + +
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                 +EL++  VME++       +  ++  N+      +      + + L+ +H    
Sbjct: 91  LVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHA-QG 140
Query: 134 VCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT 189
           V HRD+K  ++L   LTH  +VK+ DFG   Q ++ E       + + ++ APELI    
Sbjct: 141 VIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKXLVGTPYWMAPELI-SRL 195
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y   +DIWS G ++ E++ G+P +  E               P  + ++ +  N     
Sbjct: 196 PYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP--- 237
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
                  P  K  HK + P       RLL   P+ R TA E   HPF  +   P + +P
Sbjct: 238 -------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 288

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 133/299 (44%), Gaps = 51/299 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR   H NV+ + + +
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                 +EL++  VME++       +  ++  N+      +      + + L+ +H    
Sbjct: 98  LVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHA-QG 147
Query: 134 VCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT 189
           V HRD+K  ++L   LTH  +VK+ DFG   Q ++ E       + + ++ APELI    
Sbjct: 148 VIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKXLVGTPYWMAPELI-SRL 202
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y   +DIWS G ++ E++ G+P +  E               P  + ++ +  N     
Sbjct: 203 PYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP--- 244
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
                  P  K  HK + P       RLL   P+ R TA E   HPF  +   P + +P
Sbjct: 245 -------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 295

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 133/299 (44%), Gaps = 51/299 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR   H NV+ + + +
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                 +EL++  VME++       +  ++  N+      +      + + L+ +H    
Sbjct: 96  LVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHA-QG 145
Query: 134 VCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT 189
           V HRD+K  ++L   LTH  +VK+ DFG   Q ++ E       + + ++ APELI    
Sbjct: 146 VIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKXLVGTPYWMAPELI-SRL 200
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y   +DIWS G ++ E++ G+P +  E               P  + ++ +  N     
Sbjct: 201 PYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP--- 242
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
                  P  K  HK + P       RLL   P+ R TA E   HPF  +   P + +P
Sbjct: 243 -------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 293

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 44/289 (15%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYK-NRELQLMRVMDHPNVISLK 70
           +  +GTG+F  V  A+   TG+  A+K    K L+ +      E+ ++R + H N+++L+
Sbjct: 27  KETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             +    S N L+L + +    E   R++ K + +      LI       Q+   + Y+H
Sbjct: 87  DIY---ESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR------QVLDAVYYLH 137
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKI--CDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
            +  + HRDLKP+NLL      + KI   DFG +K    G+   +   +  Y APE +  
Sbjct: 138 RMG-IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPE-VLA 195
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              Y+ ++D WS G +   LL G P F  EN      +I+K        E    +P + D
Sbjct: 196 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKA-------EYEFDSPYWDD 248
Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                             +   A D    L++  P+ R T  +A  HP+
Sbjct: 249 ------------------ISDSAKDFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ ++  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPI-QIYEKI 250

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 115/220 (52%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NL++D   + +++ DFG AK++   +     +C    Y APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLIIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPEIII- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 38/220 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL-- 69
           +G G    V+ A+       VAIK +    R K        RE+     + H N++S+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 70  ----KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
                 C++           LVMEY+       L  Y  ++  + +     +T QI  G+
Sbjct: 79  VDEEDDCYY-----------LVMEYIEGP---TLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRA 181
            + H + R+ HRD+KPQN+L+D     +KI DFG AK L   E +++     + +  Y +
Sbjct: 125 KHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFS 180
Query: 182 PELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
           PE   G AT+  T  DI+S G VL E+L+G+P F GE AV
Sbjct: 181 PEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 96/352 (27%), Positives = 149/352 (42%), Gaps = 79/352 (22%)
Query: 13  YMAERVVGTGSFGIVFQAKC-LETG--ETVAIKKVLQDRR--YKNRELQLMRVMD-HPNV 66
           +  E  +G G+F  V+ A   L+ G  E +A+K ++          ELQ + V     NV
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNV 82
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           + +K+CF     KN+  + + M Y+  ES   +L   S          V+ Y   +F+ L
Sbjct: 83  MGVKYCF----RKNDHVV-IAMPYLEHESFLDILNSLSFQE-------VREYMLNLFKAL 130
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK----------QLIAGEA------ 169
             IH    + HRD+KP N L +    +  + DFG A+          + +  EA      
Sbjct: 131 KRIHQFG-IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCS 189
Query: 170 -NISYIC-SR-----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFP 215
            N   IC SR            +RAPE++      TT+ID+WSAG +   LL G+ P + 
Sbjct: 190 QNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249
Query: 216 GENAVDQLVEIIKVLGTPTREEIR-----------------------CMNPNYTDFRFPQ 252
             + +  L +I+ + G  +RE I+                       C      D   P+
Sbjct: 250 ASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPK 307
Query: 253 ----IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
               I+ H  +      +P EA DL  +LL  +P+ R TA EA  HPFF ++
Sbjct: 308 LTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 113/219 (51%), Gaps = 23/219 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           H++  + +RDLKP+NLL+D   + +++ DFG AK++      +       Y APE+I  +
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWXLXGTPE--YLAPEIIL-S 212
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 133/299 (44%), Gaps = 51/299 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR   H NV+ + + +
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                 +EL++  VME++       +  ++  N+      +      + + L+ +H    
Sbjct: 141 LVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHA-QG 190
Query: 134 VCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT 189
           V HRD+K  ++L   LTH  +VK+ DFG   Q ++ E       + + ++ APELI    
Sbjct: 191 VIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKXLVGTPYWMAPELI-SRL 245
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y   +DIWS G ++ E++ G+P +  E               P  + ++ +  N     
Sbjct: 246 PYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP--- 287
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
                  P  K  HK + P       RLL   P+ R TA E   HPF  +   P + +P
Sbjct: 288 -------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 338

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 128/293 (43%), Gaps = 37/293 (12%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRVMDHPNVISLK 70
            Y+ +  +G GS+    +     T    A+K + + +R  + E++ L+R   HPN+I+LK
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             +        ++L   +    E + ++L+    + +    +      + I + + Y+H+
Sbjct: 88  DVY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVL-----HTIGKTVEYLHS 139
Query: 131 VPRVCHRDLKPQNLL-VDPLTHQ--VKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
              V HRDLKP N+L VD   +   ++ICDFG AKQL A    +   C +  + APE + 
Sbjct: 140 -QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VL 197
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y    DIWS G +L  +L G   F      D   EI+  +G+              
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSG------------- 243
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
             +F  +    W+ V        A DL S++L   P  R TA +   HP+  +
Sbjct: 244 --KF-TLSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 129/290 (44%), Gaps = 37/290 (12%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRVMDHPNVISLK 70
            Y+ +  +G GS+    +     T    A+K + + +R  + E++ L+R   HPN+I+LK
Sbjct: 28  GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLK 87
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             +        ++L   +    E + ++L+    + +    +   L+T  I + + Y+H+
Sbjct: 88  DVY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV---LHT--IGKTVEYLHS 139
Query: 131 VPRVCHRDLKPQNLL-VDPLTHQ--VKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
              V HRDLKP N+L VD   +   ++ICDFG AKQL A    +   C +  + APE + 
Sbjct: 140 -QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VL 197
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y    DIWS G +L  +L G   F      D   EI+  +G+              
Sbjct: 198 KRQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSG------------- 243
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
             +F  +    W+ V        A DL S++L   P  R TA +   HP+
Sbjct: 244 --KFT-LSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 24/231 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 73
           +G G+FG V++AK  ETG  +A  KV++ +  +       E++++   DHP ++ L   +
Sbjct: 19  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           +         L +++E+ P      +          P I V     Q+   L ++H+  R
Sbjct: 78  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHS-KR 129
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELI----FGA 188
           + HRDLK  N+L+  L   +++ DFG SAK L   +   S+I + ++ APE++       
Sbjct: 130 IIHRDLKAGNVLM-TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTR 235
           T Y    DIWS G  L E+   +P     N +  L++I K     L TP++
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 239

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 24/231 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLKHCF 73
           +G G+FG V++AK  ETG  +A  KV++ +  +       E++++   DHP ++ L   +
Sbjct: 27  LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           +         L +++E+ P      +          P I V     Q+   L ++H+  R
Sbjct: 86  YHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHS-KR 137
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELI----FGA 188
           + HRDLK  N+L+  L   +++ DFG SAK L   +   S+I + ++ APE++       
Sbjct: 138 IIHRDLKAGNVLM-TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196
Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTR 235
           T Y    DIWS G  L E+   +P     N +  L++I K     L TP++
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSK 247

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 137/302 (45%), Gaps = 46/302 (15%)
Query: 10  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRVMDHPNVIS 68
           T  Y  +  +G GS+ +  +     T    A+K + + +R    E++ L+R   HPN+I+
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           LK  +      +  ++ +V E +   E + ++L+    + +    +   L+T  I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV---LFT--ITKTVE 130
Query: 127 YIHTVPRVCHRDLKPQNLL-VDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAP 182
           Y+H    V HRDLKP N+L VD   +   ++ICDFG AKQL A    +   C +  + AP
Sbjct: 131 YLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           E +     Y  + DIWS G +L  +L G  P   G +  D   EI+  +G+         
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILARIGSG-------- 238
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF---FD 298
                  +F  +    W+ V        A DL S++L   P  R TA     HP+   +D
Sbjct: 239 -------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285
Query: 299 EL 300
           +L
Sbjct: 286 QL 287

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 132/299 (44%), Gaps = 51/299 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A    +G+ VA+KK +  R+ + REL      +MR   H NV+ + + +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKK-MDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                 +EL++  VME++       +  ++  N+      +      + + L+ +H    
Sbjct: 218 LVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLQALSVLHAQ-G 267
Query: 134 VCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT 189
           V HRD+K  ++L   LTH  +VK+ DFG   Q ++ E       + + ++ APELI    
Sbjct: 268 VIHRDIKSDSIL---LTHDGRVKLSDFGFCAQ-VSKEVPRRKXLVGTPYWMAPELI-SRL 322
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y   +DIWS G ++ E++ G+P +                  P  + ++ +  N     
Sbjct: 323 PYGPEVDIWSLGIMVIEMVDGEPPY---------------FNEPPLKAMKMIRDNLP--- 364
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
                  P  K  HK + P       RLL   P+ R TA E   HPF  +   P + +P
Sbjct: 365 -------PRLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 110/228 (48%), Gaps = 28/228 (12%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 68
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L  CF     + E  L  V+EYV       L  +    +++P  + + Y+ +I   L Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 187
           H    + +RDLK  N+L+D   H +K+ D+G  K+ L  G+    +  +  Y APE++ G
Sbjct: 138 HERG-IIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 227
             +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 242

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 128/309 (41%), Gaps = 50/309 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKH 71
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            FF        F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 84  GFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 135
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATE 190
            RV HRDLK  NL ++    +VKI DFG A ++   GE   +   +  Y APE +     
Sbjct: 136 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 309
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 310 GRPLPPLFN 318
              +PP F+
Sbjct: 284 CLTIPPXFS 292

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 92/357 (25%), Positives = 148/357 (41%), Gaps = 66/357 (18%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPN 65
           +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R + HPN
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 66  VI---------SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 116
           ++         S  +  F   +  ELF ++V            + YS A+    +     
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCI----- 134
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 174
              QI   +AY H+   + HR+LKP+NLL+        VK+ DFG A ++   EA   + 
Sbjct: 135 --QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 191
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+   +L   IK      
Sbjct: 192 GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA----- 244
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                       D+  P+     W  V      PEA  L   +L  +P  R TA +A   
Sbjct: 245 ---------GAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 295 PFFDELREPNARLPNGRPLPPL--FNFKQELSGASPELVNKLIPDHVKRQLGLNFLH 349
           P+        + +     +  L  FN +++L GA   ++  +I       LG N L+
Sbjct: 286 PWICNRERVASAIHRQDTVDCLKKFNARRKLKGA---ILTTMIATRNLSNLGRNLLN 339

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 110/228 (48%), Gaps = 28/228 (12%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 68
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L  CF     + E  L  V+EYV       L  +    +++P  + + Y+ +I   L Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 187
           H    + +RDLK  N+L+D   H +K+ D+G  K+ L  G+    +  +  Y APE++ G
Sbjct: 127 HERG-IIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 227
             +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 91/327 (27%), Positives = 143/327 (43%), Gaps = 46/327 (14%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMRVMDHPNVISLK 70
           +  E  +G G+  IV++ K   T +  A+K  K   D++    E+ ++  + HPN+I LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVL-KHYSSANQRMPLIYVKLYTYQIFRGLAY 127
             F + T      ++LV+E V   E   R++ K Y S  +R     VK    QI   +AY
Sbjct: 115 EIFETPTE-----ISLVLELVTGGELFDRIVEKGYYS--ERDAADAVK----QILEAVAY 163
Query: 128 IHTVPRVCHRDLKPQNLL-VDPLTHQ-VKICDFGSAKQLIAGEANISYICSR-FYRAPEL 184
           +H    + HRDLKP+NLL   P     +KI DFG +K ++  +  +  +C    Y APE+
Sbjct: 164 LHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVCGTPGYCAPEI 221
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           + G   Y   +D+WS G +   LL G   F  E   DQ +          R  + C    
Sbjct: 222 LRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FRRILNC---- 266
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
             ++ F      PW       +   A DL  +L+   P  R T  +A  HP+        
Sbjct: 267 --EYYF----ISPW----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316
Query: 305 ARLPNGRPLPPLFNFKQELSGASPELV 331
             +   +     FN +++L  A   +V
Sbjct: 317 VHMDTAQKKLQEFNARRKLKAAVKAVV 343

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C    Y AP +I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEYLAPAIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 138/312 (44%), Gaps = 48/312 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           RV+G G FG V   +   TG+  A KK+ + R  K         E Q++  ++   V+SL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            + +    +K+ L L L +    +  + +   Y       P      Y  +I  GL  +H
Sbjct: 250 AYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
              R+ +RDLKP+N+L+D   H ++I D G A  +  G+     + +  Y APE++    
Sbjct: 304 R-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNE 360
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            YT S D W+ GC+L E++ GQ  F       Q  + IK      REE+  +        
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL-------- 400
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 304
              +K  P  + + +R  P+A  L S+LL   P+ R      +A E   HP F +L    
Sbjct: 401 ---VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN--F 453
Query: 305 ARLPNGRPLPPL 316
            RL  G   PP 
Sbjct: 454 KRLGAGMLEPPF 465

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 110/228 (48%), Gaps = 28/228 (12%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 68
           RV+G GS+  V   +  +T    A+K V ++    + ++  ++          +HP ++ 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L  CF     + E  L  V+EYV       L  +    +++P  + + Y+ +I   L Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 187
           H    + +RDLK  N+L+D   H +K+ D+G  K+ L  G+    +  +  Y APE++ G
Sbjct: 123 HERG-IIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 227
             +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 127/305 (41%), Gaps = 56/305 (18%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F IV + +   TG+  A  K ++ RR  +           RE+ ++R + HPN+I
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           +L H  F   +   L L LV       ++  L    S  +     ++K    QI  G+ Y
Sbjct: 93  TL-HDIFENKTDVVLILELVS---GGELFDFLAEKESLTEDEATQFLK----QILDGVHY 144
Query: 128 IHTVPRVCHRDLKPQNLLV------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 181
           +H+  R+ H DLKP+N+++      +P   ++K+ DFG A ++ AG    +   +  + A
Sbjct: 145 LHS-KRIAHFDLKPENIMLLDKNVPNP---RIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++          D+WS G +   LL G   F GE   + L  I  V            
Sbjct: 201 PEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV------------ 247
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 301
             NY DF           + +       A D   RLL   P  R    ++  H +   +R
Sbjct: 248 --NY-DF----------DEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIR 294
Query: 302 EPNAR 306
             N R
Sbjct: 295 RRNVR 299

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 138/312 (44%), Gaps = 48/312 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           RV+G G FG V   +   TG+  A KK+ + R  K         E Q++  ++   V+SL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            + +    +K+ L L L +    +  + +   Y       P      Y  +I  GL  +H
Sbjct: 250 AYAY---ETKDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
              R+ +RDLKP+N+L+D   H ++I D G A  +  G+     + +  Y APE++    
Sbjct: 304 R-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KNE 360
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            YT S D W+ GC+L E++ GQ  F       Q  + IK      REE+  +        
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERL-------- 400
Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREPN 304
              +K  P  + + +R  P+A  L S+LL   P+ R      +A E   HP F +L    
Sbjct: 401 ---VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN--F 453
Query: 305 ARLPNGRPLPPL 316
            RL  G   PP 
Sbjct: 454 KRLGAGMLEPPF 465

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVA-----IKKVLQDRRYKNRELQLMRVMDHPNVI 67
           YM    +G G FGIV   +C+ET          +K    D+    +E+ ++ +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L   F S        L ++ E++   +   R+       N+R  + YV    +Q+   L
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
            ++H+   + H D++P+N++     +  +KI +FG A+QL  G+       +  Y APE 
Sbjct: 116 QFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +      +T+ D+WS G ++  LL G   F  E    Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
           YT           + +   K +  EA+D   RLL      R TA EA  HP+  +
Sbjct: 220 YT-----------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 128/309 (41%), Gaps = 50/309 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKH 71
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 87
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            FF        F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 88  GFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 139
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATE 190
            RV HRDLK  NL ++    +VKI DFG A ++   GE   +   +  Y APE +     
Sbjct: 140 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 197
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 231
Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 309
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 232 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 287
Query: 310 GRPLPPLFN 318
              +PP F+
Sbjct: 288 CLTIPPRFS 296

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--------MDHPNVIS 68
           RV+G GS+  V   +  +T    A++ V ++    + ++  ++          +HP ++ 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L  CF     + E  L  V+EYV       L  +    +++P  + + Y+ +I   L Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ-LIAGEANISYICSRFYRAPELIFG 187
           H    + +RDLK  N+L+D   H +K+ D+G  K+ L  G+   ++  +  Y APE++ G
Sbjct: 170 HERG-IIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLF--------PGENAVDQLVEII 227
             +Y  S+D W+ G ++ E++ G+  F        P +N  D L ++I
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 137/324 (42%), Gaps = 41/324 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVMDHPNVISLKHCFFS 75
           +G G+FG+    +  +  E VA+K + +  +      RE+   R + HPN++  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC 135
            T      L +VMEY   S   + +   +A  R      + +  Q+  G++Y H + +V 
Sbjct: 87  PT-----HLAIVMEYA--SGGELFERICNAG-RFSEDEARFFFQQLISGVSYAHAM-QVA 137
Query: 136 HRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTS 194
           HRDLK +N L+D     ++KI DFG +K  +      S + +  Y APE++    EY   
Sbjct: 138 HRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLL-KKEYDGK 196
Query: 195 I-DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQI 253
           + D+WS G  L  +L+G   F          + I           R +N  Y    +  I
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH----------RILNVQYAIPDYVHI 246
Query: 254 KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPL 313
                         PE   L SR+    P+ R +  E   H +F  L+   A L N   +
Sbjct: 247 S-------------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLMNDNTM 291
Query: 314 PPLFNFKQELSGASPELVNKLIPD 337
              F+ + +  G S E + ++I +
Sbjct: 292 TTQFD-ESDQPGQSIEEIMQIIAE 314

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 128/309 (41%), Gaps = 50/309 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKH 71
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 83
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            FF        F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 84  GFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 135
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATE 190
            RV HRDLK  NL ++    +VKI DFG A ++   GE   +   +  Y APE +     
Sbjct: 136 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKKG 193
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 227
Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 309
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 228 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 283
Query: 310 GRPLPPLFN 318
              +PP F+
Sbjct: 284 CLTIPPRFS 292

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVISLKHC 72
           +G GSFG V +A+    G  VA+K +++   +  R      E+ +M+ + HPN++     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            F         L++V EY+   S+YR+L H S A +++         Y + +G+ Y+H  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 132 -PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--YRAPELIFGA 188
            P + HRDLK  NLLVD   + VK+CDFG ++ L A     S   +    + APE++   
Sbjct: 157 NPPIVHRDLKSPNLLVDK-KYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 189 TEYTTSIDIWSAGCVLAEL-LLGQP 212
                S D++S G +L EL  L QP
Sbjct: 215 PSNEKS-DVYSFGVILWELATLQQP 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 114/220 (51%), Gaps = 25/220 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ ++ ++   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +  F     K+   L +VMEYV    M+  L+       R    + + Y  QI     Y+
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYL 157
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
           H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C      APE+I  
Sbjct: 158 HSLD-LIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWXLCGTPEALAPEIIL- 211
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y  ++D W+ G ++ E+  G P F  +  + Q+ E I
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 42/291 (14%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPNVISL 69
           R +G GSFG V   +  +T +  A+K     K ++    +N  +ELQ+M+ ++HP +++L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
              ++S   + ++F+      V   +   L+++   N       VKL+  ++   L Y+ 
Sbjct: 81  ---WYSFQDEEDMFM-----VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-- 187
              R+ HRD+KP N+L+D   H V I DF  A  L       +   ++ Y APE+     
Sbjct: 133 N-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP--------TREEI- 238
              Y+ ++D WS G    ELL G+  +   ++     EI+    T         ++E + 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEMVS 249
Query: 239 ---RCMNPNYTDFRFPQ---IKAHP------WHKVFHKRMPPEAIDLASRL 277
              + + PN  D RF Q   ++  P      W  VF KR+ P  I    RL
Sbjct: 250 LLKKLLEPN-PDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRL 299

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++++R + H N++
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
             K      T      + L+ME++P      LK Y   N+    +  +L Y  QI +G+ 
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----FYRAP 182
           Y+ +   V HRDL  +N+LV+   HQVKI DFG  K +   +   +    R    F+ AP
Sbjct: 141 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL 208
           E +  +  Y  S D+WS G  L ELL
Sbjct: 199 ECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------ELQLMRVMDHPNVISLKHC 72
           +G GSFG V +A+    G  VA+K +++   +  R      E+ +M+ + HPN++     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            F         L++V EY+   S+YR+L H S A +++         Y + +G+ Y+H  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 132 -PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGA 188
            P + HR+LK  NLLVD   + VK+CDFG ++ L A    ++ S   +  + APE++   
Sbjct: 157 NPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 189 TEYTTSIDIWSAGCVLAEL-LLGQP 212
                S D++S G +L EL  L QP
Sbjct: 215 PSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           R +G G FG V    +  +   TGE VA+K +  +    +     +E++++R + H N++
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
             K      T      + L+ME++P      LK Y   N+    +  +L Y  QI +G+ 
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGS---LKEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----FYRAP 182
           Y+ +   V HRDL  +N+LV+   HQVKI DFG  K +   +   +    R    F+ AP
Sbjct: 129 YLGSRQYV-HRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL 208
           E +  +  Y  S D+WS G  L ELL
Sbjct: 187 ECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISLKHCF 73
           V+G G FG   +    ETGE + +K+++    + +R   +E+++MR ++HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                K++  LN + EY+     R +    S + + P      +   I  G+AY+H++  
Sbjct: 73  IGVLYKDKR-LNFITEYIKGGTLRGI--IKSMDSQYPWSQRVSFAKDIASGMAYLHSM-N 128
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---------------ISYICSRF 178
           + HRDL   N LV      V + DFG A+ ++  +                  + + + +
Sbjct: 129 IIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           + APE+I G + Y   +D++S G VL E++
Sbjct: 188 WMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A    TG+ VA+KK +  R+ + REL      +MR   H NV+ +   +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKK-MDLRKQQRRELLFNEVVIMRDYHHDNVVDM---Y 108
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            S    +EL++  VME++       +  ++  N+      +      + R L+Y+H    
Sbjct: 109 SSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVCLSVLRALSYLHN-QG 161
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEY 191
           V HRD+K  ++L+     ++K+ DFG   Q ++ E       + + ++ APE+I     Y
Sbjct: 162 VIHRDIKSDSILLTS-DGRIKLSDFGFCAQ-VSKEVPKRKXLVGTPYWMAPEVI-SRLPY 218
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
            T +DIWS G ++ E++ G+P +  E  +  +              IR   P       P
Sbjct: 219 GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM------------RRIRDSLP-------P 259
Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           ++K    HKV    +    +DL   +L   PS R TA E   HPF      P+  +P
Sbjct: 260 RVK--DLHKV--SSVLRGFLDL---MLVREPSQRATAQELLGHPFLKLAGPPSCIVP 309

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 127/309 (41%), Gaps = 50/309 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKH 71
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 105
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            FF        F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 106 GFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 157
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATE 190
            RV HRDLK  NL ++    +VKI DFG A ++   GE       +  Y APE +     
Sbjct: 158 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 215
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 249
Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 309
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 250 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 305
Query: 310 GRPLPPLFN 318
              +PP F+
Sbjct: 306 CLTIPPRFS 314

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 61/302 (20%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPN 65
           +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R + HPN
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 66  VI---------SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 116
           ++         S  +  F   +  ELF ++V            + YS A+    +     
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCI----- 111
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 174
              QI   +AY H+   + HR+LKP+NLL+        VK+ DFG A ++   EA   + 
Sbjct: 112 --QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 168
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I        
Sbjct: 169 GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------- 219
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                       D+  P+     W  V      PEA  L   +L  +P  R TA +A   
Sbjct: 220 -------KAGAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 262
Query: 295 PF 296
           P+
Sbjct: 263 PW 264

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 22/223 (9%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMD 62
           I+    Y+  + +G G F  V   + L  G   A+K++L    QDR    RE  + R+ +
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN 84
Query: 63  HPNVISL-KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           HPN++ L  +C     +K+E +L L+  +   +++  ++        +    +      I
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWL-LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS----------AKQLIAGEANI 171
            RGL  IH      HRDLKP N+L+      V + D GS          ++Q +  +   
Sbjct: 144 CRGLEAIHA-KGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 172 SYICSRFYRAPELIFGATEY---TTSIDIWSAGCVLAELLLGQ 211
           +  C+  YRAPEL F    +       D+WS GCVL  ++ G+
Sbjct: 202 AQRCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 134/302 (44%), Gaps = 46/302 (15%)
Query: 10  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-LMRVMDHPNVIS 68
           T  Y  +  +G GS+ +  +     T    A+K + + +R    E++ L+R   HPN+I+
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           LK  +      +  ++ +V E     E + ++L+    + +    +   L+T  I + + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV---LFT--ITKTVE 130
Query: 127 YIHTVPRVCHRDLKPQNLL-VDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAP 182
           Y+H    V HRDLKP N+L VD   +   ++ICDFG AKQL A    +   C +  + AP
Sbjct: 131 YLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAP 189
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           E +     Y  + DIWS G +L   L G  P   G +  D   EI+  +G+         
Sbjct: 190 E-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD--DTPEEILARIGSG-------- 238
Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF---FD 298
                  +F  +    W+ V        A DL S+ L   P  R TA     HP+   +D
Sbjct: 239 -------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWD 285
Query: 299 EL 300
           +L
Sbjct: 286 QL 287

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 61/303 (20%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPN 65
           +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R + HPN
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 66  VI---------SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 116
           ++         S  +  F   +  ELF ++V            + YS A+    +     
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCI----- 110
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 174
              QI   +AY H+   + HR+LKP+NLL+        VK+ DFG A ++   EA   + 
Sbjct: 111 --QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 167
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I        
Sbjct: 168 GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------- 218
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                       D+  P+     W  V      PEA  L   +L  +P  R TA +A   
Sbjct: 219 -------KAGAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 261
Query: 295 PFF 297
           P+ 
Sbjct: 262 PWI 264

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 127/309 (41%), Gaps = 50/309 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKH 71
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 81
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            FF        F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 82  GFFEDND----FVFVVLELCRR---RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 133
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATE 190
            RV HRDLK  NL ++    +VKI DFG A ++   GE       +  Y APE +     
Sbjct: 134 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 191
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 225
Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 309
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 226 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 281
Query: 310 GRPLPPLFN 318
              +PP F+
Sbjct: 282 CLTIPPRFS 290

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 61/303 (20%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPN 65
           +Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R + HPN
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 66  VI---------SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 116
           ++         S  +  F   +  ELF ++V            + YS A+    +     
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR----------EFYSEADASHCI----- 111
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 174
              QI   +AY H+   + HR+LKP+NLL+        VK+ DFG A ++   EA   + 
Sbjct: 112 --QQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA 168
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I        
Sbjct: 169 GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------- 219
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                       D+  P+     W  V      PEA  L   +L  +P  R TA +A   
Sbjct: 220 -------KAGAYDYPSPE-----WDTV-----TPEAKSLIDSMLTVNPKKRITADQALKV 262
Query: 295 PFF 297
           P+ 
Sbjct: 263 PWI 265

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRVMDHP 64
           Y+   ++G GS+G V +    ET    A+K +                +E+QL+R + H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           NVI L    ++   +    + +VMEY    M  +L   S   +R P+     Y  Q+  G
Sbjct: 67  NVIQLVDVLYNEEKQK---MYMVMEYCVCGMQEMLD--SVPEKRFPVCQAHGYFCQLIDG 121
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL---IAGEANISYICSRFYRA 181
           L Y+H+   + H+D+KP NLL+      +KI   G A+ L    A +   +   S  ++ 
Sbjct: 122 LEYLHS-QGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 182 PELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV-------LGTP 233
           PE+  G   ++   +DIWSAG  L  +  G   F G+N       I K         G P
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP 239
Query: 234 TREEIRCMNPNYTDFRFP--QIKAHPWHKVFHKRMPP 268
             + ++ M       RF   QI+ H W   F K+ PP
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSW---FRKKHPP 273

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 70  KHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C    Y APE + 
Sbjct: 121 LHSRD-VVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VL 177
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 127/309 (41%), Gaps = 50/309 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKH 71
           +G G F   F+    +T E  A K V +        R   + E+ + R + H +V+   H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF-H 107
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            FF        F+ +V+E       R L       + +     + Y  QI  G  Y+H  
Sbjct: 108 GFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR- 159
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATE 190
            RV HRDLK  NL ++    +VKI DFG A ++   GE       +  Y APE +     
Sbjct: 160 NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKKG 217
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++  +D+WS GC++  LL+G+P F                      E  C+   Y     
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL---- 251
Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP-N 309
            +IK + +     K + P A  L  ++LQ  P+ R T  E     FF     P ARLP  
Sbjct: 252 -RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP-ARLPIT 307
Query: 310 GRPLPPLFN 318
              +PP F+
Sbjct: 308 CLTIPPRFS 316

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVI 67
           R +G G FG V    +      TGE VA+K +  D     R    +E+ ++R + H ++I
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
             K C      + E  L LVMEYVP  S+   L  +S     + L  + L+  QI  G+A
Sbjct: 80  KYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMA 131
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------EANISYICSRFY 179
           Y+H+   + HR+L  +N+L+D     VKI DFG AK +  G       E   S +   F+
Sbjct: 132 YLHSQHYI-HRNLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FW 186
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +     Y  S D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 70  KHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C    Y APE + 
Sbjct: 121 LHSRD-VVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VL 177
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 70  KHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C    Y APE + 
Sbjct: 121 LHSRD-VVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VL 177
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVI 67
           R +G G FG V    +      TGE VA+K +  D     R    +E+ ++R + H ++I
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
             K C     + +   L LVMEYVP  S+   L  +S     + L  + L+  QI  G+A
Sbjct: 97  KYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMA 148
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------EANISYICSRFY 179
           Y+H    + HRDL  +N+L+D     VKI DFG AK +  G       E   S +   F+
Sbjct: 149 YLHAQHYI-HRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV---FW 203
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +     Y  S D+WS G  L ELL
Sbjct: 204 YAPECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 45/296 (15%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-----QLMRVMDHPNVISLKHCF 73
           +G GS GIV  A+   +G  VA+K ++  R+ + REL      +MR   H NV+ +   +
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHFNVVEM---Y 108
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
            S     EL++  +ME++       +      N+      +      + + LAY+H    
Sbjct: 109 KSYLVGEELWV--LMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLHA-QG 161
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRAPELIFGATEYT 192
           V HRD+K  ++L+  L  +VK+ DFG   Q+          + + ++ APE+I   + Y 
Sbjct: 162 VIHRDIKSDSILL-TLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLYA 219
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
           T +DIWS G ++ E++ G+P +  ++ V  +            + +R   P       P+
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------KRLRDSPP-------PK 260
Query: 253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
           +K    HKV      P   D   R+L   P  R TA E   HPF  +   P   +P
Sbjct: 261 LKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVP 309

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 70  KHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 76  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 125
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C    Y APE + 
Sbjct: 126 LHSRD-VVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE-VL 182
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 228
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 229 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 119/236 (50%), Gaps = 20/236 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR   +PN+++    + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 88  VG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALEFLHS-NQ 136
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFGATEYT 192
           V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S +    ++ APE++     Y 
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YG 194
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++  + DF
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 70  KHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C    Y APE + 
Sbjct: 121 LHSRD-VVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 177
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 70  KHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 71  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 120
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C    Y APE + 
Sbjct: 121 LHSRD-VVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 177
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 223
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 120/236 (50%), Gaps = 20/236 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR   +PN+++    + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 88  VG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALEFLHS-NQ 136
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEYT 192
           V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S  + + ++ APE++     Y 
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA-YG 194
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++  + DF
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 19  VGTGSFGIVFQAKCLE--TGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKHC 72
           +G+G+FG+V   +C+E  TG     K +      D+     E+ +M  + HP +I+L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           F     +++  + L++E++  S   +    ++ + +M    V  Y  Q   GL ++H   
Sbjct: 117 F-----EDKYEMVLILEFL--SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-H 168
Query: 133 RVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 191
            + H D+KP+N++ +      VKI DFG A +L   E       +  + APE++      
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREPV 227
Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
               D+W+ G +   LL G   F GE+ ++ L  +            RC      D+ F 
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-----------RC------DWEFD 270
Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD-ELREPNARLPNG 310
           +         F   + PEA D    LLQ  P  R T  +A  HP+   +     +R+P+ 
Sbjct: 271 E-------DAF-SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322
Query: 311 R 311
           R
Sbjct: 323 R 323

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 84/351 (23%), Positives = 145/351 (41%), Gaps = 62/351 (17%)
Query: 7   ILQTISYMAER-----VVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRYKNRELQLM 58
           I     ++ ER      +G G+FG V Q  C++    G  VA+K +    +YK      +
Sbjct: 24  IYHVGDWLQERYEIVSTLGEGTFGRVVQ--CVDHRRGGARVALKIIKNVEKYKEAARLEI 81
Query: 59  RVM--------DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP 110
            V+        D+ N+      +F         + +  E +  S +  LK   +     P
Sbjct: 82  NVLEKINEKDPDNKNLCVQMFDWFDYHGH----MCISFELLGLSTFDFLK--DNNYLPYP 135
Query: 111 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ------------------ 152
           +  V+   +Q+ + + ++H   ++ H DLKP+N+L     ++                  
Sbjct: 136 IHQVRHMAFQLCQAVKFLHD-NKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTA 194
Query: 153 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP 212
           V++ DFGSA      E + + + +R YRAPE+I     ++   D+WS GC++ E  +G  
Sbjct: 195 VRVVDFGSAT--FDHEHHSTIVSTRHYRAPEVIL-ELGWSQPCDVWSIGCIIFEYYVGFT 251
Query: 213 LFPGENAVDQLVEIIKVLGTPTREEIR-------------CMNPNYTDFRFPQIKAHPWH 259
           LF   +  + L  + ++LG      IR               + N +  R+ +    P  
Sbjct: 252 LFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLR 311
Query: 260 KVFHKRMPP--EAIDLASRLLQYSPSLRCTALEACAHPFFDELR-EPNARL 307
           +          +  DL   +L+Y P+ R T  EA  HPFF  LR EP  +L
Sbjct: 312 RYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKL 362

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 119/236 (50%), Gaps = 20/236 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR   +PN+++    + 
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 88  VG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALEFLHS-NQ 136
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFGATEYT 192
           V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S +    ++ APE++     Y 
Sbjct: 137 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YG 194
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++  + DF
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 119/236 (50%), Gaps = 20/236 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR   +PN+++    + 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 89  VG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALEFLHS-NQ 137
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFGATEYT 192
           V HRD+K  N+L+  +   VK+ DFG   Q+   ++  S +    ++ APE++     Y 
Sbjct: 138 VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YG 195
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++  + DF
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 250

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRV 60
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKH--YSSANQRMPLIYVKLYT 118
            D P ++ + + F  T  K    L+L+     +  Y + +H  +S A+ R        Y 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            +I  GL ++H    V +RDLKP N+L+D   H V+I D G A      + + S + +  
Sbjct: 299 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRV 60
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKH--YSSANQRMPLIYVKLYT 118
            D P ++ + + F  T  K    L+L+     +  Y + +H  +S A+ R        Y 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            +I  GL ++H    V +RDLKP N+L+D   H V+I D G A      + + S + +  
Sbjct: 299 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 130/296 (43%), Gaps = 57/296 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL-------QLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++      E+       ++++   HP + +L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 70  KHCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           K+ F +        L  VMEY    E  + + +      +R      + Y  +I   L Y
Sbjct: 74  KYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALEY 123
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIF 186
           +H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C    Y APE + 
Sbjct: 124 LHSRD-VVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE-VL 180
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I +      EEIR       
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR------- 226
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                          F + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 227 ---------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 267

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRV 60
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKH--YSSANQRMPLIYVKLYT 118
            D P ++ + + F  T  K    L+L+     +  Y + +H  +S A+ R        Y 
Sbjct: 249 GDCPFIVCMSYAF-HTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            +I  GL ++H    V +RDLKP N+L+D   H V+I D G A      + + S + +  
Sbjct: 299 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVI 67
           R +G G FG V    +      TGE VA+K +  D     R    +E+ ++R + H ++I
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
             K C      + E  L LVMEYVP  S+   L  +S     + L  + L+  QI  G+A
Sbjct: 80  KYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMA 131
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------EANISYICSRFY 179
           Y+H    + HR+L  +N+L+D     VKI DFG AK +  G       E   S +   F+
Sbjct: 132 YLHAQHYI-HRNLAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---FW 186
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +     Y  S D+WS G  L ELL
Sbjct: 187 YAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRV 60
            +   R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+  
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKH--YSSANQRMPLIYVKLYT 118
            D P ++ + + F  T  K    L+L+     +  Y + +H  +S A+ R        Y 
Sbjct: 248 GDCPFIVCMSYAF-HTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 297
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            +I  GL ++H    V +RDLKP N+L+D   H V+I D G A      + + S + +  
Sbjct: 298 AEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 354
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
           Y APE++     Y +S D +S GC+L +LL G   F      D+
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 133/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 113
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 114 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 215
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 216 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 266 PLKKGAKRP 274

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D   + +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGI-GITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 19/218 (8%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-------LMRVMDHPNVISLK 70
           V+G GSFG V  ++   T E  A+K + +D   ++ +++       ++ +   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           H  F T  +    L  VMEYV       L ++     R    +   Y  +I  GL ++ +
Sbjct: 87  HSCFQTMDR----LYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFGAT 189
              + +RDLK  N+++D   H +KI DFG  K+ I         C    Y APE+I    
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 196
Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
            Y  S+D W+ G +L E+L GQ  F GE+  D+L + I
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 233

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 134/309 (43%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D   + +KI DFG A   +    E  ++ +C    Y
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 268 PLKKGAKRP 276

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/303 (25%), Positives = 139/303 (45%), Gaps = 47/303 (15%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HP 64
           I+  IS+  + V+G G+ G +      +  + VA+K++L +   + +RE+QL+R  D HP
Sbjct: 20  IVGKISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHP 78
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           NVI      +  T K+  F  + +E    ++   ++    A+  +  I +     Q   G
Sbjct: 79  NVIR-----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL---LQQTTSG 130
Query: 125 LAYIHTVPRVCHRDLKPQNLLVD-PLTH---QVKICDFGSAKQLIAGEANISYIC----S 176
           LA++H++  + HRDLKP N+L+  P  H   +  I DFG  K+L  G  + S       +
Sbjct: 131 LAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 177 RFYRAPELIFGATEY--TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
             + APE++    +   T ++DI+SAGCV    ++ +   P   ++ +   I+  LG  +
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LGACS 246
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
              + C++P                    K     A +L  +++   P  R +A     H
Sbjct: 247 ---LDCLHPE-------------------KHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284
Query: 295 PFF 297
           PFF
Sbjct: 285 PFF 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRV 60
           ++   Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M  
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 119
            + P V+ L + F     +++ +L +VMEY+P   +  ++ +Y      +P  + + YT 
Sbjct: 131 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA 180
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICS 176
           ++   L  IH++  + HRD+KP N+L+D   H +K+ DFG+  ++   E  +   + + +
Sbjct: 181 EVVLALDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGT 237
Query: 177 RFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             Y +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 62/288 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 255

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 62/288 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 62/288 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRV 60
           ++   Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M  
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 119
            + P V+ L + F     +++ +L +VMEY+P   +  ++ +Y      +P  + + YT 
Sbjct: 126 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA 175
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICS 176
           ++   L  IH++  + HRD+KP N+L+D   H +K+ DFG+  ++   E  +   + + +
Sbjct: 176 EVVLALDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGT 232
Query: 177 RFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             Y +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 62/288 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 114/234 (48%), Gaps = 27/234 (11%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRV 60
           ++   Y   +V+G G+FG V   +   T +  A+K + +       D  +   E  +M  
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 119
            + P V+ L + F     +++ +L +VMEY+P   +  ++ +Y      +P  + + YT 
Sbjct: 131 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA 180
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICS 176
           ++   L  IH++  + HRD+KP N+L+D   H +K+ DFG+  ++   E  +   + + +
Sbjct: 181 EVVLALDAIHSMGFI-HRDVKPDNMLLDKSGH-LKLADFGTCMKM-NKEGMVRCDTAVGT 237
Query: 177 RFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             Y +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 238 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F IV + +   TG+  A  K ++ RR  +           RE+ ++R + HPN+I
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   F     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 79  TLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK----QILDGVH 129
Query: 127 YIHTVPRVCHRDLKPQNLLV------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 180
           Y+H+  R+ H DLKP+N+++      +P   ++K+ DFG A ++ AG    +   +  + 
Sbjct: 130 YLHS-KRIAHFDLKPENIMLLDKNVPNP---RIKLIDFGIAHKIEAGNEFKNIFGTPEFV 185
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 229
           APE++          D+WS G +   LL G   F GE   + L  I  V
Sbjct: 186 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 62/288 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDH-------PNVISLK 70
           V+G GSFG V  ++   T E  A+K + +D   ++ +++   V          P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           H  F T  +    L  VMEYV   + MY + +       R    +   Y  +I  GL ++
Sbjct: 408 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 458
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFG 187
            +   + +RDLK  N+++D   H +KI DFG  K+ I         C    Y APE+I  
Sbjct: 459 QS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-A 515
Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              Y  S+D W+ G +L E+L GQ  F GE+  D+L + I
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 554

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 42/220 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISLKH 71
           RV+  G F  V++A+ + +G   A+K++L +   KNR +      + ++  HPN++    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF-- 91
Query: 72  CFFSTTSKNEL------FLNLVMEYVPESMYRVLKHYSSANQRMPL---IYVKLYTYQIF 122
           C  ++  K E       FL L+ E     +   LK   S   R PL     +K++ YQ  
Sbjct: 92  CSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKMES---RGPLSCDTVLKIF-YQTC 146
Query: 123 RGLAYIH-TVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQL-------------IA 166
           R + ++H   P + HRDLK +NLL   L++Q  +K+CDFGSA  +               
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLL---LSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 167 GEANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVL 204
            E  I+   +  YR PE+I  +         DIW+ GC+L
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVM 61
           Y     +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQ 120
            HPNVI+L   +     +N+  + L++E V    ++  L    S  +     ++K    Q
Sbjct: 71  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----Q 121
Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSR 177
           I  G+ Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   + 
Sbjct: 122 ILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            + APE++          D+WS G +   LL G   F G+   + L              
Sbjct: 181 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------N 227
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           +  +N  + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 228 VSAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVM 61
           Y     +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ +
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQ 120
            HPNVI+L   +     +N+  + L++E V    ++  L    S  +     ++K    Q
Sbjct: 71  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----Q 121
Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSR 177
           I  G+ Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   + 
Sbjct: 122 ILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 180
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            + APE++          D+WS G +   LL G   F G+   + L              
Sbjct: 181 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------N 227
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           +  +N  + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 228 VSAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 75  S--------TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
                    T  K +  L + MEY        L H  + NQ+    Y +L+  QI   L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRLFR-QILEALS 130
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------------QLIAGEAN--I 171
           YIH+   + HRDLKP N+ +D  +  VKI DFG AK             Q + G ++   
Sbjct: 131 YIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           S I +  Y A E++ G   Y   ID++S G +  E++
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A K  ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAK-FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 66/311 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    N   + ++     
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLAT--VFRYNNRERLLNKMXGTL 171
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APEL+     +   +D+WS G VL  +L G+   P +   D   E            
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------ 217
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                  Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++
Sbjct: 218 -------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265
Query: 298 DELREPNARLP 308
           ++  +  A+ P
Sbjct: 266 NKPLKKGAKRP 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 119/236 (50%), Gaps = 20/236 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           +G G+ G V+ A  + TG+ VAI+++ LQ +  K     E+ +MR   +PN+++    + 
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                +EL++  VMEY+   S+  V+        ++  +       +  + L ++H+  +
Sbjct: 89  VG---DELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CRECLQALEFLHS-NQ 137
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-FYRAPELIFGATEYT 192
           V HR++K  N+L+  +   VK+ DFG   Q+   ++  S +    ++ APE++     Y 
Sbjct: 138 VIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YG 195
Query: 193 TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             +DIWS G +  E++ G+P +  EN +  L  +I   GTP  +    ++  + DF
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNPEKLSAIFRDF 250

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 66/311 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    N   + ++     
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLA--TVFRYNNRERLLNKMXGTL 170
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APEL+     +   +D+WS G VL  +L G+   P +   D   E            
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------ 216
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                  Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++
Sbjct: 217 -------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWY 264
Query: 298 DELREPNARLP 308
           ++  +  A+ P
Sbjct: 265 NKPLKKGAKRP 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 75  S--------TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
                    T  K +  L + MEY        L H  + NQ+    Y +L+  QI   L+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QILEALS 130
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------------QLIAGEAN--I 171
           YIH+   + HRDLKP N+ +D  +  VKI DFG AK             Q + G ++   
Sbjct: 131 YIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           S I +  Y A E++ G   Y   ID++S G +  E++
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/329 (27%), Positives = 139/329 (42%), Gaps = 58/329 (17%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV----------LQDRRYKNRELQLMRVMDHPNVI 67
           V+G G+F +V +    ETG+  A+K V          L     K RE  +  ++ HP+++
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIV 89
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L   + S        L +V E++  +   + ++K  + A           Y  QI   L
Sbjct: 90  ELLETYSSDG-----MLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQILEAL 143
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI---SYICSRFYR 180
            Y H    + HRD+KP+N+L+    +   VK+ DFG A QL  GE+ +     + +  + 
Sbjct: 144 RYCHD-NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTPHFM 200
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++     Y   +D+W  G +L  LL G   F G    ++L E I + G         
Sbjct: 201 APEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI-IKGKYK------ 250
Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
           MNP              W  +        A DL  R+L   P+ R T  EA  HP+  E 
Sbjct: 251 MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE- 292
Query: 301 REPNA---RLPNGRPLPPLFNFKQELSGA 326
           R+  A    LP        FN +++L GA
Sbjct: 293 RDRYAYKIHLPETVEQLRKFNARRKLKGA 321

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/309 (23%), Positives = 132/309 (42%), Gaps = 62/309 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G+ G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 216
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++++
Sbjct: 217 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 266
Query: 300 LREPNARLP 308
             +  A+ P
Sbjct: 267 PLKKGAKRP 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 62/288 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ +  +++H NV+    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 115
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYICSRF-Y 179
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    E  ++ +C    Y
Sbjct: 116 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APEL+     +   +D+WS G VL  +L G+   P +   D   E              
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------- 217
Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
                Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 218 -----YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 255

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 52/299 (17%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVM 61
           Y     +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQ 120
            HPNVI+L   +     +N+  + L++E V    ++  L    S  +     ++K    Q
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----Q 122
Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSR 177
           I  G+ Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   + 
Sbjct: 123 ILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            + APE++          D+WS G +   LL G   F G+   + L              
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------N 228
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           +  +N  + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 229 VSAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/319 (25%), Positives = 135/319 (42%), Gaps = 53/319 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRVMDHPNVIS 68
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + HPN+I+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   +     +N   + L++E V    ++  L    S ++     ++K    QI  G+ Y
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 128 IHTVPRVCHRDLKPQN-LLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           +HT  ++ H DLKP+N +L+D   P+ H +K+ DFG A ++  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------- 233
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
                      ++ + + F  +    A D   +LL      R T  EA  HP+   +   
Sbjct: 234 -----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282
Query: 304 NARLPNGRPLPPLFNFKQE 322
            A +     +  L NFK++
Sbjct: 283 QA-MVRRESVVNLENFKKQ 300

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
            Y  + V+G+G+  +V  A C    E VAIK++  ++   +     +E+Q M    HPN+
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR-- 123
           +S    + S   K+EL+  LVM+ +   S+  ++KH  +  +    +  +     I R  
Sbjct: 71  VSY---YTSFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 124 --GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYIC 175
             GL Y+H   ++ HRD+K  N+L+      V+I DFG +  L  G      +   +++ 
Sbjct: 126 LEGLEYLHKNGQI-HRDVKAGNILLGE-DGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 210
           +  + APE++     Y    DIWS G    EL  G
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
            Y  + V+G+G+  +V  A C    E VAIK++  ++   +     +E+Q M    HPN+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR-- 123
           +S    + S   K+EL+  LVM+ +   S+  ++KH  +  +    +  +     I R  
Sbjct: 76  VSY---YTSFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 124 --GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG------EANISYIC 175
             GL Y+H   ++ HRD+K  N+L+      V+I DFG +  L  G      +   +++ 
Sbjct: 131 LEGLEYLHKNGQI-HRDVKAGNILLGE-DGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 210
           +  + APE++     Y    DIWS G    EL  G
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 130
              T      L ++MEY+   S   +L       +  PL   ++ T   +I +GL Y+H+
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 122
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGAT 189
             ++ HRD+K  N+L+     +VK+ DFG A QL   +    +++ + F+ APE+I   +
Sbjct: 123 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQS 179
Query: 190 EYTTSIDIWSAGCVLAELLLGQP 212
            Y +  DIWS G    EL  G+P
Sbjct: 180 AYDSKADIWSLGITAIELARGEP 202

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 126/293 (43%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHPNVI 67
           +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ + HPNVI
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L   +     +N+  + L++E V    ++  L    S  +     ++K    QI  G+ 
Sbjct: 78  TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 127 YIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   +  + APE
Sbjct: 129 YLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L              +  +N 
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------NVSAVNY 234
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 235 EFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 114/235 (48%), Gaps = 29/235 (12%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ-------DRRYKNRELQLMRV 60
           ++   Y   +V+G G+FG V   +   + +  A+K + +       D  +   E  +M  
Sbjct: 72  MKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 131
Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY 119
            + P V+ L  C F    +++ +L +VMEY+P   +  ++ +Y      +P  + K YT 
Sbjct: 132 ANSPWVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTA 181
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYIC 175
           ++   L  IH++  + HRD+KP N+L+D   H +K+ DFG+  ++   E  +    + + 
Sbjct: 182 EVVLALDAIHSMG-LIHRDVKPDNMLLDKHGH-LKLADFGTCMKM--DETGMVHCDTAVG 237
Query: 176 SRFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           +  Y +PE++    G   Y    D WS G  L E+L+G   F  ++ V    +I+
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              +    ++   L LVMEY+P    R       A  R+    + LY+ QI +G+ Y+ +
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 133
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-------IAGEANISYICSRFYRAPE 183
             R  HRDL  +N+LV+   H VKI DFG AK L       +  E   S I   F+ APE
Sbjct: 134 R-RCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            +     ++   D+WS G VL EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 66/311 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    N   + ++     
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLA--TVFRYNNRERLLNKMXGTL 170
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APEL+     +   +D+WS G VL  +L G+   P +   D   E            
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE------------ 216
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                  Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++
Sbjct: 217 -------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWY 264
Query: 298 DELREPNARLP 308
           ++  +  A+ P
Sbjct: 265 NKPLKKGAKRP 275

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 130
              T      L ++MEY+   S   +L       +  PL   ++ T   +I +GL Y+H+
Sbjct: 90  LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 137
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGAT 189
             ++ HRD+K  N+L+     +VK+ DFG A QL   +   + ++ + F+ APE+I   +
Sbjct: 138 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQS 194
Query: 190 EYTTSIDIWSAGCVLAELLLGQP 212
            Y +  DIWS G    EL  G+P
Sbjct: 195 AYDSKADIWSLGITAIELARGEP 217

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHTV 131
              T      L ++MEY+       L       +  PL   ++ T   +I +GL Y+H+ 
Sbjct: 95  LKDTK-----LWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHSE 143
Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATE 190
            ++ HRD+K  N+L+     +VK+ DFG A QL   +    +++ + F+ APE+I   + 
Sbjct: 144 KKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 200
Query: 191 YTTSIDIWSAGCVLAELLLGQP 212
           Y +  DIWS G    EL  G+P
Sbjct: 201 YDSKADIWSLGITAIELARGEP 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 67
           R +G G FG V    +      TGE VA+K +      Q R    RE++++R + H +++
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVKLYTYQIFRGL 125
             K C      + E  + LVMEYVP    R  + +H     Q +      L+  QI  G+
Sbjct: 74  KYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEGM 124
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------EANISYICSRF 178
           AY+H    + HR L  +N+L+D     VKI DFG AK +  G       E   S +   F
Sbjct: 125 AYLHAQHYI-HRALAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---F 179
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           + APE +     Y  S D+WS G  L ELL
Sbjct: 180 WYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              +    ++   L LVMEY+P    R       A  R+    + LY+ QI +G+ Y+ +
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 132
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-------IAGEANISYICSRFYRAPE 183
             R  HRDL  +N+LV+   H VKI DFG AK L       +  E   S I   F+ APE
Sbjct: 133 R-RCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            +     ++   D+WS G VL EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              +    ++   L LVMEY+P    R       A  R+    + LY+ QI +G+ Y+ +
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 145
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-------IAGEANISYICSRFYRAPE 183
             R  HRDL  +N+LV+   H VKI DFG AK L       +  E   S I   F+ APE
Sbjct: 146 R-RCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            +     ++   D+WS G VL EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTY--QIFRGLAYIHT 130
              T      L ++MEY+   S   +L       +  PL   ++ T   +I +GL Y+H+
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLL-------EPGPLDETQIATILREILKGLDYLHS 122
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGAT 189
             ++ HRD+K  N+L+     +VK+ DFG A QL   +   + ++ + F+ APE+I   +
Sbjct: 123 EKKI-HRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQS 179
Query: 190 EYTTSIDIWSAGCVLAELLLGQP 212
            Y +  DIWS G    EL  G+P
Sbjct: 180 AYDSKADIWSLGITAIELARGEP 202

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK-NRELQLMRVMDHPNVISLKHCFF 74
           +VG G++G V++ + ++TG+  AIK   V  D   +  +E+ +++   H   I+  +  F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 75  STTSKN----ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
               KN    +  L LVME+        L   +  N  +   ++     +I RGL+++H 
Sbjct: 91  --IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSHLHQ 147
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL--IAGEANISYICSRFYRAPELIF-- 186
             +V HRD+K QN+L+     +VK+ DFG + QL    G  N ++I + ++ APE+I   
Sbjct: 148 -HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACD 204
Query: 187 ---GATEYTTSIDIWSAGCVLAELLLGQP 212
               AT Y    D+WS G    E+  G P
Sbjct: 205 ENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 17  RVVGTGSFGIV----FQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 67
           R +G G FG V    +      TGE VA+K +      Q R    RE++++R + H +++
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYR--VLKHYSSANQRMPLIYVKLYTYQIFRGL 125
             K C      + E  + LVMEYVP    R  + +H     Q +      L+  QI  G+
Sbjct: 75  KYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEGM 125
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------EANISYICSRF 178
           AY+H    + HR L  +N+L+D     VKI DFG AK +  G       E   S +   F
Sbjct: 126 AYLHAQHYI-HRALAARNVLLDN-DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV---F 180
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           + APE +     Y  S D+WS G  L ELL
Sbjct: 181 WYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 52/299 (17%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVM 61
           Y     +G+G F +V + +   TG   A  K ++ RR K+           RE+ +++ +
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQ 120
            HPNVI+L   +     +N+  + L+ E V    ++  L    S  +     ++K    Q
Sbjct: 72  QHPNVITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLK----Q 122
Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSR 177
           I  G+ Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G    +   + 
Sbjct: 123 ILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTP 181
Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            + APE++          D+WS G +   LL G   F G+   + L              
Sbjct: 182 EFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------------N 228
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           +  +N  + D  F    A              A D   RLL   P  R T  ++  HP+
Sbjct: 229 VSAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 20/201 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           +G GSFG V++     T E VAIK +       +     +E+ ++   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 74  FSTTSKNELFLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +T      L ++MEY+   S   +LK        +   Y+     +I +GL Y+H+  
Sbjct: 87  LKSTK-----LWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHS-E 135
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELIFGATEY 191
           R  HRD+K  N+L+      VK+ DFG A QL   +   + ++ + F+ APE+I   + Y
Sbjct: 136 RKIHRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAY 193
Query: 192 TTSIDIWSAGCVLAELLLGQP 212
               DIWS G    EL  G+P
Sbjct: 194 DFKADIWSLGITAIELAKGEP 214

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 66/311 (21%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    N   + ++     
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLA--TVFRYNNRERLLNKMXGTL 170
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APEL+     +   +D+WS G VL  +L G+   P +   D   E            
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------ 216
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                  Y+D++  +   +PW     K++    + L  ++L  +PS R T  +     ++
Sbjct: 217 -------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARITIPDIKKDRWY 264
Query: 298 DELREPNARLP 308
           ++  +  A+ P
Sbjct: 265 NKPLKKGAKRP 275

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 60/277 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE      + Y PE +Y+         
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-----VPYKPEDLYKDF------- 144
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 166
             + L ++  Y++Q+ +G+ ++ +  +  HRDL  +N+L+    + VKICDFG A+ +  
Sbjct: 145 --LTLEHLIXYSFQVAKGMEFLASR-KXIHRDLAARNILLSE-KNVVKICDFGLARDIXK 200
Query: 167 GEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 222
               +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG      
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG------ 253
Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
            V+I +      +E  R   P+YT     Q     WH
Sbjct: 254 -VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/290 (24%), Positives = 123/290 (42%), Gaps = 66/290 (22%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNVI---- 67
           + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 68  -----SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                ++++ F    S  ELF  +                   +  MP    + + +Q+ 
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDRI-----------------EPDIGMPEPDAQRFFHQLM 114
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
            G+ Y+H +  + HRD+KP+NLL+D     +KI DFG A   +    N   + ++     
Sbjct: 115 AGVVYLHGIG-ITHRDIKPENLLLDE-RDNLKISDFGLAT--VFRYNNRERLLNKMXGTL 170
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APEL+     +   +D+WS G VL  +L G+   P +   D   E            
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------ 216
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
                  Y+D++  +   +PW     K++    + L  ++L  +PS R T
Sbjct: 217 -------YSDWKEKKTYLNPW-----KKIDSAPLALLHKILVENPSARIT 254

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 19  VGTGSFGIV----FQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLK 70
           +G G+FG V    +      TG  VA+K++       +R   RE+Q+++ +    ++  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
              +         L LVMEY+P    R       A  R+    + LY+ QI +G+ Y+ +
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGS 129
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-------IAGEANISYICSRFYRAPE 183
             R  HRDL  +N+LV+   H VKI DFG AK L       +  E   S I   F+ APE
Sbjct: 130 R-RCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            +     ++   D+WS G VL EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 116/249 (46%), Gaps = 39/249 (15%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----LQLMRVMDHPNVISLKHCF 73
           +G G+FG V++A+  ET   +A  KV+  +  +  E     + ++   DHPN++ L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 74  FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +    +N L+  +++E+     V   M  + +  + +        +++   Q    L Y+
Sbjct: 104 Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYL 151
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 187
           H   ++ HRDLK  N+L   L   +K+ DFG SAK     +   S+I + ++ APE++  
Sbjct: 152 HD-NKIIHRDLKAGNILF-TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 209
Query: 188 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 239
            T     Y    D+WS G  L E+   +P     N +  L++I K     L  P+R    
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 265
Query: 240 CMNPNYTDF 248
             + N+ DF
Sbjct: 266 -WSSNFKDF 273

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 116/249 (46%), Gaps = 39/249 (15%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----LQLMRVMDHPNVISLKHCF 73
           +G G+FG V++A+  ET   +A  KV+  +  +  E     + ++   DHPN++ L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 74  FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +    +N L+  +++E+     V   M  + +  + +        +++   Q    L Y+
Sbjct: 104 Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYL 151
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 187
           H   ++ HRDLK  N+L   L   +K+ DFG SAK     +   S+I + ++ APE++  
Sbjct: 152 HD-NKIIHRDLKAGNILF-TLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMC 209
Query: 188 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 239
            T     Y    D+WS G  L E+   +P     N +  L++I K     L  P+R    
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 265
Query: 240 CMNPNYTDF 248
             + N+ DF
Sbjct: 266 -WSSNFKDF 273

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 45/283 (15%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMD-HPNVISLK 70
           + ++ +G GSF I  +    ++ +  A+K ++  R   N  +E+  +++ + HPN++ L 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVK-IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
             F      ++L   LVME +   E   R+ K    +      I  KL +      ++++
Sbjct: 73  EVFH-----DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS-----AVSHM 122
Query: 129 HTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           H V  V HRDLKP+NLL        ++KI DFG A+        +   C +  Y APEL+
Sbjct: 123 HDVG-VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEIIKVLGTPTREEIRCMN 242
                Y  S D+WS G +L  +L GQ  F   +        VEI+K +            
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI------------ 228
Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 285
               DF F   +   W     K +  EA DL   LL   P+ R
Sbjct: 229 -KKGDFSF---EGEAW-----KNVSQEAKDLIQGLLTVDPNKR 262

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 8   LQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRE 54
           + T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-RE 62
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            Q    ++HP ++++     + T    L   +VMEYV     R + H          I V
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---- 170
                Q    L + H    + HRD+KP N+L+   T+ VK+ DFG A+  IA   N    
Sbjct: 122 IADACQ---ALNFSHQ-NGIIHRDVKPANILIS-ATNAVKVVDFGIARA-IADSGNSVXQ 175
Query: 171 -ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
             + I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRVMDHPNVIS 68
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   +     +N   + L++E V    ++  L    S ++     ++K    QI  G+ Y
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 128 IHTVPRVCHRDLKPQN-LLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           +HT  ++ H DLKP+N +L+D   P+ H +K+ DFG A ++  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------- 233
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                      ++ + + F  +    A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRVMDHPNVIS 68
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   + + T      + L++E V    ++  L    S ++     ++K    QI  G+ Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 128 IHTVPRVCHRDLKPQN-LLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           +HT  ++ H DLKP+N +L+D   P+ H +K+ DFG A ++  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV-------------- 233
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                      ++ + + F  +    A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 131/305 (42%), Gaps = 52/305 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRVMDHPNV 66
           +G+G+FG V+ A   E  + V +K     KVL+D   ++        E+ ++  ++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-----QRMPLIYVKLYTY-- 119
           I +   F     +N+ F  LVME          KH S  +      R P +   L +Y  
Sbjct: 92  IKVLDIF-----ENQGFFQLVME----------KHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 120 -QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            Q+   + Y+  +  + HRD+K +N+++      +K+ DFGSA  L  G+   ++  +  
Sbjct: 137 RQLVSAVGYLR-LKDIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGKLFYTFCGTIE 194
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVD-----------QLVEI 226
           Y APE++ G       +++WS G  L  L+  + P    E  V+           +L+ +
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254
Query: 227 IKVLGTPTREEIRCMNPNYTDFRFPQ---IKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 283
           +  L  P  E    +    TD    Q   +  + W +VF    P   +  A+ L   + S
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRS 314
Query: 284 LRCTA 288
           L   A
Sbjct: 315 LSDVA 319

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRVMDHPNVIS 68
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   +     +N   + L++E V    ++  L    S ++     ++K    QI  G+ Y
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 128 IHTVPRVCHRDLKPQN-LLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           +HT  ++ H DLKP+N +L+D   P+ H +K+ DFG A ++  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------- 233
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                      ++ + + F       A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRVMDHPNVIS 68
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   +     +N   + L++E V    ++  L    S ++     ++K    QI  G+ Y
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 128 IHTVPRVCHRDLKPQN-LLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           +HT  ++ H DLKP+N +L+D   P+ H +K+ DFG A ++  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------- 233
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                      ++ + + F       A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y+  + +G GSFG     K  E G    IK++       ++R    RE+ ++  M HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY----VKLYTYQIF 122
           +  +  F    S     L +VM+Y           +   N +  +++    +  +  QI 
Sbjct: 86  VQYRESFEENGS-----LYIVMDYCEGG-----DLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRFYRA 181
             L ++H   ++ HRD+K QN+ +      V++ DFG A+ L +  E   + I + +Y +
Sbjct: 136 LALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
           PE I     Y    DIW+ GCVL EL   +  F   +  + +++II
Sbjct: 194 PE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 52/293 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYK--------NRELQLMRVMDHPNVIS 68
           +G+G F IV + +   TG   A K  K  Q R  +         RE+ ++R + H NVI+
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L   +     +N   + L++E V    ++  L    S ++     ++K    QI  G+ Y
Sbjct: 80  LHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 128 IHTVPRVCHRDLKPQN-LLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           +HT  ++ H DLKP+N +L+D   P+ H +K+ DFG A ++  G    +   +  + APE
Sbjct: 131 LHT-KKIAHFDLKPENIMLLDKNIPIPH-IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++          D+WS G +   LL G   F G+   + L  I  V              
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV-------------- 233
Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                      ++ + + F       A D   +LL      R T  EA  HP+
Sbjct: 234 -----------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 18/166 (10%)
Query: 117 YTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
           Y++Q+ RG+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ +      +    
Sbjct: 204 YSFQVARGMEFLSS--RKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKNPDYVRKGD 260
Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 231
           +R    + APE IF    Y+T  D+WS G +L E+  LG   +PG       V++ +   
Sbjct: 261 TRLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFC 312
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
           +  RE +R   P Y+     QI    WH+   +R  P   +L  +L
Sbjct: 313 SRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 144
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 145 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIX 199
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 253
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 254 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 135
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 136 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIX 190
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 244
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 245 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 135
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 136 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIX 190
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 244
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 245 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 61/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE     V    PE +Y+         
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF----VPYKTPEDLYKDF------- 144
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 145 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIX 199
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 253
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 254 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 8   LQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRE 54
           + T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-RE 62
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            Q    ++HP ++++     + T    L   +VMEYV     R + H          I V
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---- 170
                Q    L + H    + HRD+KP N+++   T+ VK+ DFG A+  IA   N    
Sbjct: 122 IADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARA-IADSGNSVTQ 175
Query: 171 -ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
             + I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 39/249 (15%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----LQLMRVMDHPNVISLKHCF 73
           +G G+FG V++A+  ET   +A  KV+  +  +  E     + ++   DHPN++ L   F
Sbjct: 45  LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 74  FSTTSKNELFLNLVMEY-----VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           +    +N L+  +++E+     V   M  + +  + +        +++   Q    L Y+
Sbjct: 104 Y---YENNLW--ILIEFCAGGAVDAVMLELERPLTESQ-------IQVVCKQTLDALNYL 151
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYICSRFYRAPELIFG 187
           H   ++ HRDLK  N+L   L   +K+ DFG SAK     +    +I + ++ APE++  
Sbjct: 152 HD-NKIIHRDLKAGNILF-TLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMC 209
Query: 188 ATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK----VLGTPTREEIR 239
            T     Y    D+WS G  L E+   +P     N +  L++I K     L  P+R    
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR---- 265
Query: 240 CMNPNYTDF 248
             + N+ DF
Sbjct: 266 -WSSNFKDF 273

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 144
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 145 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY 199
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 253
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 254 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 73  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 124
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 125 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 183 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 73  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 124
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 125 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 183 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 72  MASVDNPHVCRLLGICLTST------VQLIMQLMP--FGXLLDYVREHKDNIGSQYLLNW 123
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 124 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 182 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 75  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 126
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 127 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGK 184
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 185 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 8   LQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRE 54
           + T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-RE 62
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            Q    ++HP ++++     + T    L   +VMEYV     R + H          I V
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---- 170
                Q    L + H    + HRD+KP N+++   T+ VK+ DFG A+  IA   N    
Sbjct: 122 IADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARA-IADSGNSVTQ 175
Query: 171 -ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
             + I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 135
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 136 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY 190
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 244
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 245 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------L 57
           IL+       +V+G+G+FG V++   +  GETV I    K+L +       ++      +
Sbjct: 11  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 70
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  MDHP+++ L     S T      + LV + +P        H    N    L+    +
Sbjct: 71  MASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--W 122
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG A+ L   E   +    +
Sbjct: 123 CVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGK 180
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQP 212
               + A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 181 MPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 144
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 145 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY 199
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 253
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 254 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 289

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNRELQ------L 57
           IL+       +V+G+G+FG V++   +  GETV I    K+L +       ++      +
Sbjct: 34  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 93
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  MDHP+++ L     S T      + LV + +P        H    N    L+    +
Sbjct: 94  MASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--W 145
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG A+ L   E   +    +
Sbjct: 146 CVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGK 203
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQP 212
               + A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 204 MPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 77/333 (23%), Positives = 140/333 (42%), Gaps = 54/333 (16%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR---ELQLMRVMDHPNVIS 68
           +++  R +G G+FG V   + ++  +  A+K V   ++Y      E  +++ + + ++ +
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
                +         + L+ E +  S+Y ++   +     +  I  KLY  +I + L Y+
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI--KLYCIEILKALNYL 153
Query: 129 HTVPRVCHRDLKPQNLLVDP------------------------LTHQVKICDFGSAKQL 164
             +  + H DLKP+N+L+D                          +  +K+ DFG A   
Sbjct: 154 RKMS-LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT-- 210
Query: 165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 224
              + + S I +R YRAPE+I     +  S D+WS GCVLAEL  G  LF     ++ L 
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLA 269
Query: 225 EIIKVL----------GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAI- 271
            +  ++           T T    + +N +     +P+  A   + + H  K +P   I 
Sbjct: 270 MMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPE-NASSINSIKHVKKCLPLYKII 327
Query: 272 ------DLASRLLQYSPSLRCTALEACAHPFFD 298
                 D    +LQ  P+LR +  E   H F +
Sbjct: 328 KHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 135
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 136 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY 190
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 244
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 245 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 280

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 29/223 (13%)
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYV---PESMYRVLKHYSSANQRM 109
           +E+ +++ +DHPNV+ L          NE  L +V E V   P      LK  S    R 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR- 140
Query: 110 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 169
                  Y   + +G+ Y+H   ++ HRD+KP NLLV    H +KI DFG + +    +A
Sbjct: 141 ------FYFQDLIKGIEYLH-YQKIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDA 192
Query: 170 NIS-YICSRFYRAPELIFGATEYTT--SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
            +S  + +  + APE +    +  +  ++D+W+ G  L   + GQ  F  E  +    +I
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252
Query: 227 -IKVLGTPTREEI---------RCMNPN-YTDFRFPQIKAHPW 258
             + L  P + +I         R ++ N  +    P+IK HPW
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 8   LQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRE 54
           + T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-RE 62
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            Q    ++HP ++++     + T    L   +VMEYV     R + H          I V
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---- 170
                Q    L + H    + HRD+KP N+++   T+ VK+ DFG A+  IA   N    
Sbjct: 122 IADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARA-IADSGNSVTQ 175
Query: 171 -ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN 218
             + I +  Y +PE   G +    S D++S GCVL E+L G+P F G++
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKEAPEDLYKDF------- 146
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 147 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY 201
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 202 KDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 255
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 256 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 291

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 121/278 (43%), Gaps = 60/278 (21%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 68  SL---------------KHCFFSTTS------KNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +L               + C F   S      +NE    +  +  PE +Y+         
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF---VPYKVAPEDLYKDF------- 181
Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
             + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 182 --LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY 236
Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG     
Sbjct: 237 KDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG----- 290
Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
             V+I +      +E  R   P+YT     Q     WH
Sbjct: 291 --VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 326

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 8   LQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRE 54
           + T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE
Sbjct: 4   MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-RE 62
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            Q    ++HP ++++     + T    L   +VMEYV     R + H          I V
Sbjct: 63  AQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---- 170
                Q    L + H    + HRD+KP N+++   T+ VK+ DFG A+  IA   N    
Sbjct: 122 IADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARA-IADSGNSVTQ 175
Query: 171 -ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
             + I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 8   LQTISYMAER-----VVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRE 54
           + T S++++R     ++G G    V  A+ L     VA+K +  D         R++ RE
Sbjct: 21  MTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-RE 79
Query: 55  LQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV 114
            Q    ++HP ++++     + T    L   +VMEYV     R + H          I V
Sbjct: 80  AQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV 138
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---- 170
                Q    L + H    + HRD+KP N+++   T+ VK+ DFG A+  IA   N    
Sbjct: 139 IADACQ---ALNFSHQ-NGIIHRDVKPANIMIS-ATNAVKVMDFGIARA-IADSGNSVTQ 192
Query: 171 -ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
             + I +  Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 74
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 75  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 126
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 127 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 184
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 185 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           +G GSFG VF+     T + VAIK +       +     +E+ ++   D   V      +
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
              +      L ++MEY+       L      ++      +K    +I +GL Y+H+  +
Sbjct: 91  LKGSK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHSEKK 141
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYT 192
           + HRD+K  N+L+      VK+ DFG A QL   +    +++ + F+ APE+I   + Y 
Sbjct: 142 I-HRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSAYD 198
Query: 193 TSIDIWSAGCVLAELLLGQP 212
           +  DIWS G    EL  G+P
Sbjct: 199 SKADIWSLGITAIELAKGEP 218

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 73  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 124
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 125 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 183 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 71  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 122
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 123 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 71
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 72  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 123
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 124 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 181
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 182 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 74  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 125
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 126 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 184 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 90/366 (24%), Positives = 140/366 (38%), Gaps = 88/366 (24%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM--------DHP 64
           Y   R +G G F  V+ +  ++  + VA+K V     Y    L  +R++        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 65  N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           N   V+ L   F   +  N   + +V E +   + + +    S  Q +PL  VK    Q+
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKIIQQV 139
Query: 122 FRGLAYIHTVPRVCHRDLKPQNL------------------------------------- 144
            +GL Y+HT  R+ H D+KP+N+                                     
Sbjct: 140 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 199
Query: 145 -----LVDPL------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 193
                LV+PL        +VKI D G+A      +     I +R YR+ E++ G+  Y T
Sbjct: 200 TAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGSG-YNT 256
Query: 194 SIDIWSAGCVLAELLLGQPLF---PGENAV---DQLVEIIKVLGTPTREEIRCMNPNYTD 247
             DIWS  C+  EL  G  LF    GE      D +  II++LG   R+ I  +   Y+ 
Sbjct: 257 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSK 314
Query: 248 FRFPQ-------IKAHPW--------HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 292
             F +        K  PW           + +       D    +L+  P  R TA E  
Sbjct: 315 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 374
Query: 293 AHPFFD 298
            HP+ +
Sbjct: 375 RHPWLN 380

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 90/366 (24%), Positives = 140/366 (38%), Gaps = 88/366 (24%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM--------DHP 64
           Y   R +G G F  V+ +  ++  + VA+K V     Y    L  +R++        + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 65  N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           N   V+ L   F   +  N   + +V E +   + + +    S  Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWI--IKSNYQGLPLPCVKKIIQQV 155
Query: 122 FRGLAYIHTVPRVCHRDLKPQNL------------------------------------- 144
            +GL Y+HT  R+ H D+KP+N+                                     
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 145 -----LVDPL------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 193
                LV+PL        +VKI D G+A      +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGSG-YNT 272
Query: 194 SIDIWSAGCVLAELLLGQPLF---PGENAV---DQLVEIIKVLGTPTREEIRCMNPNYTD 247
             DIWS  C+  EL  G  LF    GE      D +  II++LG   R+ I  +   Y+ 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI--VAGKYSK 330
Query: 248 FRFPQ-------IKAHPW--------HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 292
             F +        K  PW           + +       D    +L+  P  R TA E  
Sbjct: 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
Query: 293 AHPFFD 298
            HP+ +
Sbjct: 391 RHPWLN 396

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 26/209 (12%)
Query: 15  AERVVGTGSFGIVFQAKCLETGET---VAIKKV-----LQDRRYKNRELQLMRVMDHPNV 66
           ++RV+G G FG+V+  + ++  +     AIK +     +Q      RE  LMR ++HPNV
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGL 125
           ++L            + L       P   +  L  +  + QR P +   + +  Q+ RG+
Sbjct: 85  LALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            Y+    +  HRDL  +N ++D  +  VK+ DFG A+ ++  E   S    R  R P + 
Sbjct: 138 EYL-AEQKFVHRDLAARNCMLDE-SFTVKVADFGLARDILDRE-YYSVQQHRHARLP-VK 193
Query: 186 FGATE------YTTSIDIWSAGCVLAELL 208
           + A E      +TT  D+WS G +L ELL
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 121/268 (45%), Gaps = 44/268 (16%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMP----------LIYVK 115
           +L        +K    L +++E+     +  L  Y  S  N+ +P          L ++ 
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCK---FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
            Y++Q+ +G+ ++ +   + HRDL  +N+L+    + VKICDFG A+ +      +    
Sbjct: 148 CYSFQVAKGMEFLASRKXI-HRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGD 205
Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 231
           +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 206 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFC 257
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWH 259
              +E  R   P+YT     Q     WH
Sbjct: 258 RRLKEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 26  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 84
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 85  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 138
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 139 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 196
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 197 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 243
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 244 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 27  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 85
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 86  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 139
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 140 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 197
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 198 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 244
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 245 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 25  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 83
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 84  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 137
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 138 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 195
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 196 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 242
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 243 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 20  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 78
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 79  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 132
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 133 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 190
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 191 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 237
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 238 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           VG GSFG V + K  +TG   A+KKV  +  ++  EL     +  P ++ L         
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFRVEELVACAGLSSPRIVPLYGAV----- 119
Query: 79  KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 137
           +   ++N+ ME +   S+ +++K      +   L Y+     Q   GL Y+HT  R+ H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHG 174
Query: 138 DLKPQNLLVDPLTHQVKICDFGSA---------KQLIAGEANISYI-CSRFYRAPELIFG 187
           D+K  N+L+     +  +CDFG A         K L+ G+    YI  +  + APE++ G
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD----YIPGTETHMAPEVVMG 230
Query: 188 ATEYTTSIDIWSAGCVLAELLLG 210
                  +DIWS+ C++  +L G
Sbjct: 231 KP-CDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           VG GSFG V + K  +TG   A+KKV  +  ++  EL     +  P ++ L         
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE-VFRVEELVACAGLSSPRIVPLYGAV----- 135
Query: 79  KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 137
           +   ++N+ ME +   S+ +++K      +   L Y+     Q   GL Y+HT  R+ H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHG 190
Query: 138 DLKPQNLLVDPLTHQVKICDFGSA---------KQLIAGEANISYI-CSRFYRAPELIFG 187
           D+K  N+L+     +  +CDFG A         K L+ G+    YI  +  + APE++ G
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD----YIPGTETHMAPEVVMG 246
Query: 188 ATEYTTSIDIWSAGCVLAELLLG 210
                  +DIWS+ C++  +L G
Sbjct: 247 KP-CDAKVDIWSSCCMMLHMLNG 268

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 78  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 132 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 189
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 236
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 134 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 191
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 238
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 239 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 71  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 129
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 130 YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 183
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 184 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 241
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 242 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 288
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 289 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 331

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 35  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 93
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 94  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 147
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 148 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 205
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 206 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 252
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 253 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 124 YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 178 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 236 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 282
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 283 QYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWI 325

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 134 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 191
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 192 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 238
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 239 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 281

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKK-VLQDRRYK----------NRELQLMRVMDHP 64
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY-VKL-YTYQ 120
           N++ L     +          +VME+VP  +  +R+L      ++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLL------DKAHPIKWSVKLRLMLD 130
Query: 121 IFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKIC----DFGSAKQLIAGEANISYIC 175
           I  G+ Y+    P + HRDL+  N+ +  L     +C    DFG+++Q +    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV---HSVSGLL 187
Query: 176 SRF-YRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLF 214
             F + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 125/291 (42%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 19  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 77
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 78  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 131
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +      + +Y APE + 
Sbjct: 132 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE-VL 189
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 190 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIRM-----G 236
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 237 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 78  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 129
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 130 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGK 187
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 188 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 71  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 122
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 123 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGK 180
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  +   LI +     Q  RG+ Y+H 
Sbjct: 72  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLH- 125
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF- 186
              + HRDLK  N+ +    + VKI DFG A  K   +G      +  S  + APE+I  
Sbjct: 126 AKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 187 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 73  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 124
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 125 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGK 182
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 183 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 71  MASVDNPHVCRLLGICLTST------VQLITQLMP--FGXLLDYVREHKDNIGSQYLLNW 122
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 123 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 110/222 (49%), Gaps = 28/222 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  +   LI +     Q  RG+ Y+H 
Sbjct: 84  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLH- 137
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF- 186
              + HRDLK  N+ +    + VKI DFG A  K   +G      +  S  + APE+I  
Sbjct: 138 AKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 187 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 32/238 (13%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFF 74
           V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+     + 
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 75  S--------TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
                    T  K +  L +  EY        L H  + NQ+    Y +L+  QI   L+
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QILEALS 130
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK-------------QLIAGEAN--I 171
           YIH+   + HR+LKP N+ +D  +  VKI DFG AK             Q + G ++   
Sbjct: 131 YIHS-QGIIHRNLKPXNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 172 SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 229
           S I +  Y A E++ G   Y   ID +S G +  E +   P   G   V+ L ++  V
Sbjct: 189 SAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY--PFSTGXERVNILKKLRSV 244

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 82/344 (23%), Positives = 138/344 (40%), Gaps = 51/344 (14%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VMDH 63
           LQ   +   +V+G G+F  V   K  +TG+  A+K + +    K  E+   R    V+ +
Sbjct: 58  LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
            +   +    F+   +N  +L LVMEY       +L   S   +R+P    + Y  +I  
Sbjct: 118 GDRRWITQLHFAFQDEN--YLYLVMEYYVGG--DLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--NISYICSRFYRA 181
            +  +H +  V HRD+KP N+L+D   H +++ DFGS  +L A     ++  + +  Y +
Sbjct: 174 AIDSVHRLGYV-HRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 182 PELIFGATEYTTSI------DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 235
           PE++        +       D W+ G    E+  GQ  F  ++  +   +I+        
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-------- 283
Query: 236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLL--QYSPSLRCTALEACA 293
                             K H    +  + +P EA D   RLL    +   R  A +   
Sbjct: 284 ----------------HYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRT 327
Query: 294 HPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPD 337
           HPFF  L     R      +PP   F  +  GA+      L+ D
Sbjct: 328 HPFFFGLDWDGLR----DSVPP---FTPDFEGATDTCNFDLVED 364

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 74  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 125
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 126 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 184 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 72
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 73  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 124
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 125 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 182
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 183 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVA-----IKKVLQDRRYKNR--ELQLMRVMDHPNVISL 69
           RV+G G FG VF  +   TG+  A      K++ + + Y+    E +++  +    ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY---VKLYTYQIFRGLA 126
            + F + T      L LVM  +     R   H  + ++  P         YT QI  GL 
Sbjct: 251 AYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELI 185
           ++H    + +RDLKP+N+L+D     V+I D G A +L AG+     Y  +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
            G  EY  S+D ++ G  L E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 71  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 122
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 123 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           +G GSFG V + K  +TG   A+KKV  +  ++  EL     +  P ++ L         
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAV----- 133
Query: 79  KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 137
           +   ++N+ ME +   S+ +++K      +   L Y+     Q   GL Y+HT  R+ H 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLHT-RRILHG 188
Query: 138 DLKPQNLLVDPLTHQVKICDFGSA---------KQLIAGEANISYI-CSRFYRAPELIFG 187
           D+K  N+L+     +  +CDFG A         K L+ G+    YI  +  + APE++ G
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD----YIPGTETHMAPEVVMG 244
Query: 188 ATEYTTSIDIWSAGCVLAELLLG 210
                  +DIWS+ C++  +L G
Sbjct: 245 KP-CDAKVDIWSSCCMMLHMLNG 266

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 74  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 125
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 126 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 184 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 73
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 74  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 125
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 126 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 183
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 184 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 78  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 129
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 130 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 188 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 76
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 77  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 128
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 129 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 186
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 187 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVA-----IKKVLQDRRYKNR--ELQLMRVMDHPNVISL 69
           RV+G G FG VF  +   TG+  A      K++ + + Y+    E +++  +    ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY---VKLYTYQIFRGLA 126
            + F + T      L LVM  +     R   H  + ++  P         YT QI  GL 
Sbjct: 251 AYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELI 185
           ++H    + +RDLKP+N+L+D     V+I D G A +L AG+     Y  +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
            G  EY  S+D ++ G  L E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 95
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 96  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 147
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 148 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 205
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 206 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 80
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 81  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 132
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 133 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 190
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 191 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVA-----IKKVLQDRRYKNR--ELQLMRVMDHPNVISL 69
           RV+G G FG VF  +   TG+  A      K++ + + Y+    E +++  +    ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY---VKLYTYQIFRGLA 126
            + F + T      L LVM  +     R   H  + ++  P         YT QI  GL 
Sbjct: 251 AYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELI 185
           ++H    + +RDLKP+N+L+D     V+I D G A +L AG+     Y  +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
            G  EY  S+D ++ G  L E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNR--ELQLMRVMDHPNVISL 69
           RV+G G FG VF  +   TG+  A KK+ + R      Y+    E +++  +    ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY---VKLYTYQIFRGLA 126
            + F + T      L LVM  +     R   H  + ++  P         YT QI  GL 
Sbjct: 251 AYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELI 185
           ++H    + +RDLKP+N+L+D     V+I D G A +L AG+     Y  +  + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
            G  EY  S+D ++ G  L E++  +  F
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 71  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 122
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 123 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+ +G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+M+ +P     +L +       +   Y+  +
Sbjct: 78  MASVDNPHVCRLLGICLTST------VQLIMQLMPFGC--LLDYVREHKDNIGSQYLLNW 129
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 130 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 188 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 117/286 (40%), Gaps = 69/286 (24%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM--------DHP 64
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++++          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 65  N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           N   V+ L    F  +  N + + +V E +   + + +    S  Q +P+  VK    Q+
Sbjct: 93  NKDMVVQLID-DFKISGMNGIHVCMVFEVLGHHLLKWI--IKSNYQGLPVRCVKSIIRQV 149
Query: 122 FRGLAYIHTVPRVCHRDLKPQN-------------------------------------- 143
            +GL Y+H+  ++ H D+KP+N                                      
Sbjct: 150 LQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPA 209
Query: 144 --LLVDPLTH------QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSI 195
             LLV+PL        +VKI D G+A      +     I +R YR+ E++ GA  Y+T  
Sbjct: 210 ADLLVNPLDPRNADKIRVKIADLGNA--CWVHKHFTEDIQTRQYRSIEVLIGAG-YSTPA 266
Query: 196 DIWSAGCVLAELLLGQPLF---PGEN---AVDQLVEIIKVLGTPTR 235
           DIWS  C+  EL  G  LF    GE+     D +  II++LG+  R
Sbjct: 267 DIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPR 312

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 65  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 116
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 117 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 175 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQ-------LMRVMDHPNVISLK 70
           +G GSF  V+  K L+T  TV +    LQDR+    E Q        ++ + HPN++   
Sbjct: 34  IGRGSFKTVY--KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             + ST  K +  + LV E         LK Y    +   +  ++ +  QI +GL ++HT
Sbjct: 92  DSWESTV-KGKKCIVLVTELXTSG---TLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHT 147
Query: 131 -VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
             P + HRDLK  N+ +   T  VKI D G A    A  A  + I +  + APE      
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFXAPEXY--EE 204
Query: 190 EYTTSIDIWSAG-CVLAELLLGQPLFPGENAV 220
           +Y  S+D+++ G C L       P    +NA 
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYPYSECQNAA 236

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 89  EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVD 147
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+ 
Sbjct: 184 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLS 232
Query: 148 PLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVL 204
              + VKICDFG A+ +      +    +R    + APE IF    YT   D+WS G +L
Sbjct: 233 E-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLL 290
Query: 205 AELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
            E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 291 WEIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 339

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   + + R       N+E+     +
Sbjct: 45  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYV 104
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 105 MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 156
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 157 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 214
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 215 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 88/329 (26%), Positives = 135/329 (41%), Gaps = 58/329 (17%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV----------LQDRRYKNRELQLMRVMDHPNVI 67
           V+G G F +V +    ETG+  A+K V          L     K RE  +  ++ HP+++
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIV 89
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L   + S        L +V E++  +   + ++K  + A           Y  QI   L
Sbjct: 90  ELLETYSSDG-----MLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQILEAL 143
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI---SYICSRFYR 180
            Y H    + HRD+KP  +L+    +   VK+  FG A QL  GE+ +     + +  + 
Sbjct: 144 RYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFM 200
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++     Y   +D+W  G +L  LL G   F G    ++L E I + G         
Sbjct: 201 APEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI-IKGKYK------ 250
Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
           MNP              W  +        A DL  R+L   P+ R T  EA  HP+  E 
Sbjct: 251 MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE- 292
Query: 301 REPNA---RLPNGRPLPPLFNFKQELSGA 326
           R+  A    LP        FN +++L GA
Sbjct: 293 RDRYAYKIHLPETVEQLRKFNARRKLKGA 321

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           +G GSFG V + +  +TG   A+KKV  +  ++  EL     +  P ++ L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-FRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 79  KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 137
           +   ++N+ ME +   S+ +++K      +   L Y+     Q   GL Y+H+  R+ H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSR-RILHG 209
Query: 138 DLKPQNLLVDPLTHQVKICDFGSA---------KQLIAGEANISYI-CSRFYRAPELIFG 187
           D+K  N+L+        +CDFG A         K L+ G+    YI  +  + APE++ G
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGD----YIPGTETHMAPEVVLG 265
Query: 188 ATEYTTSIDIWSAGCVLAELLLG 210
            +     +D+WS+ C++  +L G
Sbjct: 266 RS-CDAKVDVWSSCCMMLHMLNG 287

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 89  EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVD 147
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+ 
Sbjct: 186 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLS 234
Query: 148 PLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVL 204
              + VKICDFG A+ +      +    +R    + APE IF    YT   D+WS G +L
Sbjct: 235 E-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLL 292
Query: 205 AELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
            E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 293 WEIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 341

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKK-VLQDRRYK----------NRELQLMRVMDHP 64
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY-VKL-YTYQ 120
           N++ L     +          +VME+VP  +  +R+L      ++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLL------DKAHPIKWSVKLRLMLD 130
Query: 121 IFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKIC----DFGSAKQLIAGEANISYIC 175
           I  G+ Y+    P + HRDL+  N+ +  L     +C    DFG ++Q +    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV---HSVSGLL 187
Query: 176 SRF-YRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLF 214
             F + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 89  EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVD 147
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+ 
Sbjct: 177 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLS 225
Query: 148 PLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVL 204
              + VKICDFG A+ +      +    +R    + APE IF    YT   D+WS G +L
Sbjct: 226 E-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLL 283
Query: 205 AELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
            E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 284 WEIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 332

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 25/176 (14%)
Query: 89  EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC-HRDLKPQNLLVD 147
           E  PE +Y+           + L ++  Y++Q+ +G+ ++ +  R C HRDL  +N+L+ 
Sbjct: 179 EEAPEDLYKDF---------LTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLS 227
Query: 148 PLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVL 204
              + VKICDFG A+ +      +    +R    + APE IF    YT   D+WS G +L
Sbjct: 228 E-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLL 285
Query: 205 AELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
            E+  LG   +PG       V+I +      +E  R   P+YT     Q     WH
Sbjct: 286 WEIFSLGASPYPG-------VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L      TT+++++   L+ME+ P  S+Y VL+  S+A   +P     +    +  G+ 
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMN 126
Query: 127 YIHTVPRVCHRDLKPQNLL--VDPLTHQV-KICDFGSAKQLIAGEANISYICSRFYRAPE 183
           ++     + HR++KP N++  +      V K+ DFG+A++L   E  +S   +  Y  P+
Sbjct: 127 HLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185
Query: 184 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQ-PLFPGEN 218
           +   A        +Y  ++D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+G+G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 8   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 67
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 68  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 119
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI  G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 120 CVQIAEGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 178 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 109 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 168
           +P+  +K     +    +YIH    +CHRD+KP N+L+D    +VK+ DFG ++ ++  +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKK 206
Query: 169 ANISYICSRFYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              S     F   PE     + Y    +DIWS G  L  +      F  + +   LVE+ 
Sbjct: 207 IKGSRGTYEF-MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELF 262
Query: 228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKR-------MPPEAIDLASRLLQY 280
             + T   E             +P  + H  + + +K+       +  E ID     L+ 
Sbjct: 263 NNIRTKNIE-------------YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 281 SPSLRCTALEACAHPFF-----DELREPNARLPNGRP 312
           +P+ R T+ +A  H +      ++LRE +  L   R 
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKELYKKRK 346

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 88/329 (26%), Positives = 135/329 (41%), Gaps = 58/329 (17%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV----------LQDRRYKNRELQLMRVMDHPNVI 67
           V+G G F +V +    ETG+  A+K V          L     K RE  +  ++ HP+++
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIV 91
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES--MYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L   + S        L +V E++  +   + ++K  + A           Y  QI   L
Sbjct: 92  ELLETYSSDG-----MLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQILEAL 145
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANI---SYICSRFYR 180
            Y H    + HRD+KP  +L+    +   VK+  FG A QL  GE+ +     + +  + 
Sbjct: 146 RYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFM 202
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++     Y   +D+W  G +L  LL G   F G    ++L E I + G         
Sbjct: 203 APEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI-IKGKYK------ 252
Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
           MNP              W  +        A DL  R+L   P+ R T  EA  HP+  E 
Sbjct: 253 MNPR------------QWSHI-----SESAKDLVRRMLMLDPAERITVYEALNHPWLKE- 294
Query: 301 REPNA---RLPNGRPLPPLFNFKQELSGA 326
           R+  A    LP        FN +++L GA
Sbjct: 295 RDRYAYKIHLPETVEQLRKFNARRKLKGA 323

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 27/203 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS 78
           +G GSFG V + +  +TG   A+KKV  +  ++  EL     +  P ++ L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRLEV-FRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 79  KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR 137
           +   ++N+ ME +   S+ +++K      +   L Y+     Q   GL Y+H+  R+ H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLHSR-RILHG 190
Query: 138 DLKPQNLLVDPLTHQVKICDFGSA---------KQLIAGEANISYI-CSRFYRAPELIFG 187
           D+K  N+L+        +CDFG A         K L+ G+    YI  +  + APE++ G
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGD----YIPGTETHMAPEVVLG 246
Query: 188 ATEYTTSIDIWSAGCVLAELLLG 210
            +     +D+WS+ C++  +L G
Sbjct: 247 RS-CDAKVDVWSSCCMMLHMLNG 268

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 127/305 (41%), Gaps = 44/305 (14%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----RELQ-LMRVMDHPNVIS 68
           +   ++G G++  V  A  L+ G+  A+K + +   +      RE++ L +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   FF   ++  L    +      +  +  KH+   N+R     V+     +   L ++
Sbjct: 76  LIE-FFEDDTRFYLVFEKLQGGSILAHIQKQKHF---NEREASRVVR----DVAAALDFL 127
Query: 129 HTVPRVCHRDLKPQNLLVDP--LTHQVKICDF--GSAKQL------IAGEANISYICSRF 178
           HT   + HRDLKP+N+L +       VKICDF  GS  +L      I      +   S  
Sbjct: 128 HT-KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAE 186
Query: 179 YRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD---QLVEIIKVLG 231
           Y APE++      AT Y    D+WS G VL  +L G P F G    D      E+ +V  
Sbjct: 187 YMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 246
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
               E I+     + D  +  I +             EA DL S+LL      R +A + 
Sbjct: 247 NKLFESIQEGKYEFPDKDWAHISS-------------EAKDLISKLLVRDAKQRLSAAQV 293
Query: 292 CAHPF 296
             HP+
Sbjct: 294 LQHPW 298

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             +ST  +    L +V ++    S+Y  L    +  +   LI +     Q  RG+ Y+H 
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGSSLYHHLHASETKFEMKKLIDI---ARQTARGMDYLH- 137
Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF- 186
              + HRDLK  N+ +    + VKI DFG A  K   +G      +  S  + APE+I  
Sbjct: 138 AKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 187 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
             +  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 33/251 (13%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV--MDHPNVISLKHCFFS 75
           ++G G +G V++    E    V +      + + N E  + RV  M+H N+         
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGDER 78
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT----- 130
            T+   +   LVMEY P      L  Y S +    +   +L  + + RGLAY+HT     
Sbjct: 79  VTADGRMEYLLVMEYYPNG---SLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTELPRG 134
Query: 131 ---VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA------GE---ANISYICSRF 178
               P + HRDL  +N+LV      V I DFG + +L        GE   A IS + +  
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCV-ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 179 YRAPELIFGATEYTT------SIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVEIIKVL 230
           Y APE++ GA            +D+++ G +  E+ +    LFPGE+  + Q+    +V 
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253
Query: 231 GTPTREEIRCM 241
             PT E+++ +
Sbjct: 254 NHPTFEDMQVL 264

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 44/268 (16%)
Query: 19  VGTGSFGIVFQAKCL-----ETGETVAIKKVLQ-----DRRYKNRELQ-LMRVMDHPNVI 67
           +G G+FG V +A         T  TVA+K + +     + R    EL+ L+ +  H NV+
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY--SSANQRMP----------LIYVK 115
           +L        +K    L +++E+     +  L  Y  S  N+ +P          L ++ 
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCK---FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
            Y++Q+ +G+ ++ +  +  HRDL  +N+L+    + VKI DFG A+ +      +    
Sbjct: 148 XYSFQVAKGMEFLAS-RKXIHRDLAARNILLSE-KNVVKIXDFGLARDIYKDPDYVRKGD 205
Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 231
           +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +   
Sbjct: 206 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFX 257
Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWH 259
              +E  R   P+YT     Q     WH
Sbjct: 258 RRLKEGTRMRAPDYTTPEMYQTMLDCWH 285

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 113/254 (44%), Gaps = 37/254 (14%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDH-PNV 66
           +  + +G G F +V Q     TG+  A K + + RR ++       E+ ++ +    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 67  ISLKHCFFSTTSKNELFLNLVMEY----------VPESMYRVLKHYSSANQRMPLIYVKL 116
           I+L H  +  TS+    + L++EY          +PE     L    S N  + LI    
Sbjct: 92  INL-HEVYENTSE----IILILEYAAGGEIFSLCLPE-----LAEMVSENDVIRLIK--- 138
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQLIAGEANISYI 174
              QI  G+ Y+H    + H DLKPQN+L+  +     +KI DFG ++++         +
Sbjct: 139 ---QILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194
Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  Y APE I      TT+ D+W+ G +   LL     F GE+  +  + I +V    +
Sbjct: 195 GTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253
Query: 235 REEIRCMNPNYTDF 248
            E    ++   TDF
Sbjct: 254 EETFSSVSQLATDF 267

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 16/222 (7%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----VMDHPNVISLKHC 72
           +V+G G+FG V   K     +  A+K + +    K  E    R    V+ + +   +   
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
            ++    N L+L  VM+Y       +L   S    R+P    + Y  ++   +  +H + 
Sbjct: 140 HYAFQDDNNLYL--VMDYYVGG--DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELI----F 186
            V HRD+KP N+L+D   H +++ DFGS  +L+      S +   +  Y +PE++     
Sbjct: 196 YV-HRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           G   Y    D WS G  + E+L G+  F  E+ V+   +I+ 
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 71
            +GTGS+G   + +    G+ +  K++        +++    E+ L+R + HPN++    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                T+     L +VMEY     +  V+   +   Q +   +V     Q+   L   H 
Sbjct: 73  RIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 131 VPR----VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELI 185
                  V HRDLKP N+ +D     VK+ DFG A+ L   E     ++ + +Y +PE +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQM 188
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
                Y    DIWS GC+L EL    P F
Sbjct: 189 -NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 107/223 (47%), Gaps = 22/223 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L      TT+++++   L+ME+ P  S+Y VL+  S+A   +P     +    +  G+ 
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMN 126
Query: 127 YIHTVPRVCHRDLKPQNLL--VDPLTHQV-KICDFGSAKQLIAGEANISYICSRFYRAPE 183
           ++     + HR++KP N++  +      V K+ DFG+A++L   E  +    +  Y  P+
Sbjct: 127 HLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPD 185
Query: 184 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQ-PLFPGEN 218
           +   A        +Y  ++D+WS G        G  P  P E 
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+ +G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 70
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 71  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 122
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 123 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 180
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 181 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNREL----QL 57
           IL+   +   +V+ +G+FG V++   +  GE V I   +++ R       N+E+     +
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 77
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 78  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 129
Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 130 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 187
Query: 178 F---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
               + A E I     YT   D+WS G  + EL+
Sbjct: 188 VPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 25/215 (11%)
Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV 66
           IL+       +V+G+G+FG V++   +  GE V I   ++  R          ++D   V
Sbjct: 13  ILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYV 72
Query: 67  IS----------LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 116
           ++          L  C  ST       + LV + +P     +L H      R+    +  
Sbjct: 73  MAGVGSPYVSRLLGICLTST-------VQLVTQLMPYGC--LLDHVRENRGRLGSQDLLN 123
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 176
           +  QI +G++Y+  V R+ HRDL  +N+LV    H VKI DFG A+ L   E        
Sbjct: 124 WCMQIAKGMSYLEDV-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGG 181
Query: 177 RF---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           +    + A E I     +T   D+WS G  + EL+
Sbjct: 182 KVPIKWMALESIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 49/238 (20%)
Query: 17  RVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNRE-----LQLM-RVMDHPN 65
           +V+G+G+FG V  A      +T     VA+K + +      RE     L++M ++  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 66  VISL--------------KHCFFST-----TSKNELFLNLVMEYVPESMYRVLKHYSSAN 106
           +++L              ++C +        SK E F    +EY  +      K      
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ------KRLEEEE 164
Query: 107 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAK 162
               L +  L  + YQ+ +G+ ++       HRDL  +N+LV   TH   VKICDFG A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLV---THGKVVKICDFGLAR 220
Query: 163 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            +++    +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 11/208 (5%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDHPNVISLKHCF-FST 76
           +G GS+G VF+ +  E G   A+K+ +   R  K+R  +L  V  H  V     C     
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 77  TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH 136
             +    L L  E    S+    +H  +    +P   V  Y       LA++H+   V H
Sbjct: 125 AWEEGGILYLQTELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV-H 180
Query: 137 RDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEYTTSI 195
            D+KP N+ + P   + K+ DFG   +L  AG   +     R Y APEL+ G+  Y T+ 
Sbjct: 181 LDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQGS--YGTAA 236
Query: 196 DIWSAGCVLAELLLGQPLFPGENAVDQL 223
           D++S G  + E+     L  G     QL
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 32/233 (13%)
Query: 17  RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRRYKNRE-----LQLMRVMDHPNVIS 68
           R++G G FG V++       GE   VA+K   +D    N+E       +M+ +DHP+++ 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAY 127
           L        +       ++ME  P   Y  L HY   N+  + ++ + LY+ QI + +AY
Sbjct: 74  LIGIIEEEPTW------IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 124
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 184
           + ++  V HRD+  +N+LV      VK+ DFG ++  I  E       +R    + +PE 
Sbjct: 125 LESINCV-HRDIAVRNILVAS-PECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 181
Query: 185 IFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTR 235
           I     +TT+ D+W     + E+L    QP F  EN      ++I VL    R
Sbjct: 182 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDR 228

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKK-VLQDRRYK----------NRELQLMRVMDHP 64
           E+ +G G FG+V + + ++    VAIK  +L D   +           RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY-VKL-YTYQ 120
           N++ L     +          +VME+VP  +  +R+L      ++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRLL------DKAHPIKWSVKLRLMLD 130
Query: 121 IFRGLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKIC----DFGSAKQLIAGEANISYIC 175
           I  G+ Y+    P + HRDL+  N+ +  L     +C    DF  ++Q +    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV---HSVSGLL 187
Query: 176 SRF-YRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLF 214
             F + APE I GA E  YT   D +S   +L  +L G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 76
           +V+G G+FG V   K   T    A+K + +    K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 77  T----SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                 ++E  L LVM+Y       +L   S    ++P    + Y  ++   +  IH + 
Sbjct: 138 ALHYAFQDENHLYLVMDYYVGG--DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELI----F 186
            V HRD+KP N+L+D   H +++ DFGS  ++       S +   +  Y +PE++     
Sbjct: 196 YV-HRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           G  +Y    D WS G  + E+L G+  F  E+ V+   +I+ 
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 71
            +GTGS+G   + +    G+ +  K++        +++    E+ L+R + HPN++    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                T+     L +VMEY     +  V+   +   Q +   +V     Q+   L   H 
Sbjct: 73  RIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 131 VPR----VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELI 185
                  V HRDLKP N+ +D     VK+ DFG A+ L    +   +++ + +Y +PE +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
                Y    DIWS GC+L EL    P F
Sbjct: 189 -NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 76
           +V+G G+FG V   K   T    A+K + +    K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 77  T----SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                 ++E  L LVM+Y       +L   S    ++P    + Y  ++   +  IH + 
Sbjct: 154 ALHYAFQDENHLYLVMDYYVGG--DLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELI----F 186
            V HRD+KP N+L+D   H +++ DFGS  ++       S +   +  Y +PE++     
Sbjct: 212 YV-HRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           G  +Y    D WS G  + E+L G+  F  E+ V+   +I+ 
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISLKH 71
            +GTGS+G   + +    G+ +  K++        +++    E+ L+R + HPN++    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                T+     L +VMEY     +  V+   +   Q +   +V     Q+   L   H 
Sbjct: 73  RIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 131 VPR----VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELI 185
                  V HRDLKP N+ +D     VK+ DFG A+ L    +   +++ + +Y +PE +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 188
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLF 214
                Y    DIWS GC+L EL    P F
Sbjct: 189 -NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 32/233 (13%)
Query: 17  RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRRYKNRE-----LQLMRVMDHPNVIS 68
           R++G G FG V++       GE   VA+K   +D    N+E       +M+ +DHP+++ 
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAY 127
           L        +       ++ME  P   Y  L HY   N+  + ++ + LY+ QI + +AY
Sbjct: 90  LIGIIEEEPTW------IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 140
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 184
           + ++  V HRD+  +N+LV      VK+ DFG ++  I  E       +R    + +PE 
Sbjct: 141 LESINCV-HRDIAVRNILVAS-PECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 197
Query: 185 IFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTR 235
           I     +TT+ D+W     + E+L    QP F  EN      ++I VL    R
Sbjct: 198 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDR 244

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 38/220 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM---------DHPNVISL 69
           +G G FG+VF+AK        AIK++    R  NREL   +VM         +HP ++  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 70  KHCFFSTTSKNEL-------FLNLVMEYV-PESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
            + +    +  +L       +L + M+    E++   +    +  +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF-LQI 127
Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------------ 169
              + ++H+   + HRDLKP N+    +   VK+ DFG    +   E             
Sbjct: 128 AEAVEFLHS-KGLMHRDLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 170 -NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
            +   + ++ Y +PE I G + Y+  +DI+S G +L ELL
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 109/233 (46%), Gaps = 32/233 (13%)
Query: 17  RVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQDRRYKNRE-----LQLMRVMDHPNVIS 68
           R++G G FG V++       GE   VA+K   +D    N+E       +M+ +DHP+++ 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAY 127
           L        +       ++ME  P   Y  L HY   N+  + ++ + LY+ QI + +AY
Sbjct: 78  LIGIIEEEPTW------IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPEL 184
           + ++  V HRD+  +N+LV      VK+ DFG ++  I  E       +R    + +PE 
Sbjct: 129 LESINCV-HRDIAVRNILVAS-PECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 185
Query: 185 IFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEIIKVLGTPTR 235
           I     +TT+ D+W     + E+L    QP F  EN      ++I VL    R
Sbjct: 186 I-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDR 232

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 37/291 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K  LQD     RE++L  R    P+++ +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +V E +          +S    R    + +    +I + +     Y+
Sbjct: 124 YENLYAGRKCLL-IVXECLDGGEL-----FSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE + 
Sbjct: 178 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D WS G +   LL G P F   + +         +    +  IR       
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL--------AISPGXKTRIR-----XG 282
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 283 QYEFPNPE---WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLH- 141
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 142 AKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLH- 148
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 149 AKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 26/221 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVISLKHCF 73
           +G+GSFG V++ K       V I KV+     Q + ++N E+ ++R   H N++     F
Sbjct: 44  IGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----LF 97
Query: 74  FSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
               +K+ L   +V ++    S+Y+ L    +  Q   LI +   T Q   G+ Y+H   
Sbjct: 98  MGYMTKDNL--AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ---GMDYLHA-K 151
Query: 133 RVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISY-ICSRFYRAPELIF-- 186
            + HRD+K  N+ + + LT  VKI DFG A  K   +G   +     S  + APE+I   
Sbjct: 152 NIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
               ++   D++S G VL EL+ G+  +   N  DQ++ ++
Sbjct: 210 DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLH- 149
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLH- 149
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 124
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 125 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 122
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 122
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 127
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 128 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 112/223 (50%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            F   ++K +L   +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 127
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 128 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 122/294 (41%), Gaps = 29/294 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 62
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 123 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 180
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 240
Query: 239 R-CMNPNYTDF-RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
           R C+    +D   F +I+ HPW +     +P E  ++    L   PS +  ALE
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAALE 291

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 61
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFW 121
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 122 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 179
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 239
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPW 261

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 89
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 150 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 207
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLI 267
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 90
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 151 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 208
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLI 268
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 90
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 151 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 208
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLI 268
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 89
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 150 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 207
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLI 267
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 89
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 150 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 207
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 267
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 77
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 138 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 195
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 255
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPW 277

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 96
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 97  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 157 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 214
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 275 RWCLALRPSDRPTFEEIQNHPW 296

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 104
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 105 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 164
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 165 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 222
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 282
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPW 304

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 57
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 118 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 175
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLI 235
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPW 257

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 76
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 136
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 137 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 194
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 254
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPW 276

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 57
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 118 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 175
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 235
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPW 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 62
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 123 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 180
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 240
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPW 262

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 61
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 62  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 121
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 122 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 179
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 239
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPW 261

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 62
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 63  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 122
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 123 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 180
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 181 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 240
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPW 262

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 90
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 151 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 208
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLI 268
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 38  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 89
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 90  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 149
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 150 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 207
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 208 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLI 267
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 60
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 61  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 120
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 121 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 178
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +  I
Sbjct: 179 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 238
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 239 RWCLALRPSDRPTFEEIQNHPW 260

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 39  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 90
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 91  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 150
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 151 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 208
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 209 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLI 268
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
           ++YQ+ +G+A++ +     HRDL  +N+L   LTH    KICDFG A+ +      +   
Sbjct: 166 FSYQVAKGMAFLAS-KNCIHRDLAARNIL---LTHGRITKICDFGLARDIKNDSNYVVKG 221
Query: 175 CSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 230
            +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK  
Sbjct: 222 NARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-- 278
Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPW 258
                E  R ++P +       I    W
Sbjct: 279 -----EGFRMLSPEHAPAEMYDIMKTCW 301

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
           ++YQ+ +G+A++ +     HRDL  +N+L   LTH    KICDFG A+ +      +   
Sbjct: 150 FSYQVAKGMAFLAS-KNCIHRDLAARNIL---LTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 175 CSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 230
            +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK  
Sbjct: 206 NARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-- 262
Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPW 258
                E  R ++P +       I    W
Sbjct: 263 -----EGFRMLSPEHAPAEMYDIMKTCW 285

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 58  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 109
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 110 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 169
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 170 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 227
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 228 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLI 287
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 288 RWCLALRPSDRPTFEEIQNHPW 309

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
           ++YQ+ +G+A++ +     HRDL  +N+L   LTH    KICDFG A+ +      +   
Sbjct: 173 FSYQVAKGMAFLAS-KNCIHRDLAARNIL---LTHGRITKICDFGLARDIKNDSNYVVKG 228
Query: 175 CSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 230
            +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK  
Sbjct: 229 NARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-- 285
Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPW 258
                E  R ++P +       I    W
Sbjct: 286 -----EGFRMLSPEHAPAEMYDIMKTCW 308

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
           ++YQ+ +G+A++ +     HRDL  +N+L   LTH    KICDFG A+ +      +   
Sbjct: 168 FSYQVAKGMAFLAS-KNCIHRDLAARNIL---LTHGRITKICDFGLARDIKNDSNYVVKG 223
Query: 175 CSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 230
            +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK  
Sbjct: 224 NARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-- 280
Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPW 258
                E  R ++P +       I    W
Sbjct: 281 -----EGFRMLSPEHAPAEMYDIMKTCW 303

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 69/148 (46%), Gaps = 18/148 (12%)
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYI 174
           ++YQ+ +G+A++ +     HRDL  +N+L   LTH    KICDFG A+ +      +   
Sbjct: 173 FSYQVAKGMAFLAS-KNCIHRDLAARNIL---LTHGRITKICDFGLARHIKNDSNYVVKG 228
Query: 175 CSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVL 230
            +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK  
Sbjct: 229 NARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK-- 285
Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPW 258
                E  R ++P +       I    W
Sbjct: 286 -----EGFRMLSPEHAPAEMYDIMKTCW 308

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 111/223 (49%), Gaps = 30/223 (13%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISLKH 71
           +G+GSFG V++ K    G+ VA+K +        Q + +KN E+ ++R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 72  CFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             +ST  +    L +V ++    S+Y  L    +  + + LI +   T Q   G+ Y+H 
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ---GMDYLHA 122
Query: 131 VPRVCHRDLKPQNLLV-DPLTHQVKICDFGSA--KQLIAGEANISYIC-SRFYRAPELIF 186
              + HRDLK  N+ + + LT  VKI DFG A  K   +G      +  S  + APE+I 
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 187 GATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
              +  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 53  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 104
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 105 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 164
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 165 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 222
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 223 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLI 282
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPW 304

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCFFS 75
           +G G FG V++    +   TVA+K + +D        +E  +M+ + HPN++ L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL----LG 74
Query: 76  TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY-TYQIFRGLAYIHTVPRV 134
             ++   F  ++ E++  +   +L +    N++     V LY   QI   + Y+      
Sbjct: 75  VCTREPPFY-IITEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNF 130
Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATEY 191
            HRDL  +N LV    H VK+ DFG ++ L+ G+   ++  ++F   + APE +    ++
Sbjct: 131 IHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL-AYNKF 187
Query: 192 TTSIDIWSAGCVLAEL-LLGQPLFPG 216
           +   D+W+ G +L E+   G   +PG
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 84
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 85  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 144
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 145 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 202
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 203 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLI 262
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 263 RWCLALRPSDRPTFEEIQNHPW 284

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 76
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 77  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 136
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 137 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 194
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 195 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLI 254
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPW 276

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 77
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 138 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 195
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLI 255
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPW 277

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 108/262 (41%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 57
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 118 QVLEAVRHCHNXG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 175
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLI 235
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+    +D   F +I+ HPW
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPW 257

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/262 (23%), Positives = 107/262 (40%), Gaps = 26/262 (9%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNV--ISLK 70
           Y    ++G+G FG V+    +     VAIK V +DR     EL        PN   + ++
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--------PNGTRVPME 77
Query: 71  HCFFSTTSKNELFLNLVMEYV--PESMYRVLKHYSSANQRMPLI---------YVKLYTY 119
                  S     +  ++++   P+S   +L+           I           + + +
Sbjct: 78  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y
Sbjct: 138 QVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVY 195
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     +  S  +WS G +L +++ G  P    E  +   V   + +    +  I
Sbjct: 196 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLI 255
Query: 239 R-CMNPNYTDF-RFPQIKAHPW 258
           R C+     D   F +I+ HPW
Sbjct: 256 RWCLALRPXDRPTFEEIQNHPW 277

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 90/179 (50%), Gaps = 18/179 (10%)
Query: 56  QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYV 114
           Q +  + HP+++ + +    T    +    +VMEYV  +S+ R      S  Q++P+   
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR------SKGQKLPVAEA 184
Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 174
             Y  +I   L+Y+H++  V + DLKP+N+++     Q+K+ D G+  ++     +  Y+
Sbjct: 185 IAYLLEILPALSYLHSIGLV-YNDLKPENIML--TEEQLKLIDLGAVSRI----NSFGYL 237
Query: 175 -CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 232
             +  ++APE++   T  T + DI++ G  LA L L  P   G   VD L E   VL T
Sbjct: 238 YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 16  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 67
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ ++  HPN+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVKL- 116
           +L         ++  +L L +EY P           RVL+    ++ AN     +  +  
Sbjct: 90  NL-----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 117 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 173
             +   + RG+ Y+ +  +  HRDL  +N+LV    +  KI DFG S  Q +  +  +  
Sbjct: 145 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 203 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 16  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 67
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ ++  HPN+I
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVKL- 116
           +L         ++  +L L +EY P           RVL+    ++ AN     +  +  
Sbjct: 80  NL-----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 117 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 173
             +   + RG+ Y+ +  +  HRDL  +N+LV    +  KI DFG S  Q +  +  +  
Sbjct: 135 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 192
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 193 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           ++  + ++G G FG V++ + L  G  VA+K++ ++R          E++++ +  H N+
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQI--FR 123
           + L+    + T +      LV  Y+   S+   L+    +    PL + K     +   R
Sbjct: 90  LRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPESQP--PLDWPKRQRIALGSAR 142
Query: 124 GLAYIHT--VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--Y 179
           GLAY+H    P++ HRD+K  N+L+D     V + DFG AK +   + ++         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 214
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 17  RVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNV 66
           + +G G FG V +A         G T    K+L++       R    E  +++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 116
           I L    +   S++   L L++EY   + Y  L+ +   ++++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEY---AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 117 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 162
                         + +QI +G+ Y+  + ++ HRDL  +N+LV     ++KI DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSR 198
Query: 163 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            +   ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           ++  + ++G G FG V++ + L  G  VA+K++ ++R          E++++ +  H N+
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNL 97
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQI--FR 123
           + L+    + T +      LV  Y+   S+   L+    +    PL + K     +   R
Sbjct: 98  LRLRGFCMTPTERL-----LVYPYMANGSVASCLRERPESQP--PLDWPKRQRIALGSAR 150
Query: 124 GLAYIHT--VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFY 179
           GLAY+H    P++ HRD+K  N+L+D     V + DFG AK +   + ++      +  +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF 214
            APE +    + +   D++  G +L EL+ GQ  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/256 (25%), Positives = 122/256 (47%), Gaps = 27/256 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 73
           + +G+G FG+V   K  +    VA+K + +    ++   +E Q M  + HP ++     F
Sbjct: 14  KELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVK----F 68
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           +   SK E  + +V EY+      +L +  S  + +    +    Y +  G+A++ +  +
Sbjct: 69  YGVCSK-EYPIYIVTEYISNGC--LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES-HQ 124
Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFGATE 190
             HRDL  +N LVD     VK+ DFG  + ++  +  +S + ++F   + APE +F   +
Sbjct: 125 FIHRDLAARNCLVDR-DLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPE-VFHYFK 181
Query: 191 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
           Y++  D+W+ G ++ E+  LG+   P +   +  V ++KV      +  R   P+     
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGK--MPYDLYTNSEV-VLKV-----SQGHRLYRPHLASDT 233
Query: 250 FPQIKAHPWHKVFHKR 265
             QI    WH++  KR
Sbjct: 234 IYQIMYSCWHELPEKR 249

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 17  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L        ++N ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPE 183
            +  R  HRD+  +N+LV   T  VK+ DFG ++ +   E +  Y  S+      + APE
Sbjct: 128 ES-KRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLL 209
            I     +T++ D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRVMDHPNVISLK 70
           +G G FG+V++     T  TVA+KK+         + ++  ++E+++M    H N++ L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY-VKLYTYQ-IFRGLAYI 128
              FS+   +   L LV  Y+P     +L   S  +   PL + ++    Q    G+ ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYIC-SRFYRAPELI 185
           H    + HRD+K  N+L+D      KI DFG A+  +  A     S I  +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQP 212
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 1   MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR---- 53
           M ++  I +       +V+G+G FG V +   +  GE++ I    KV++D+  +      
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV 62
Query: 54  --ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 111
              +  +  +DH +++ L      ++      L LV +Y+P  +  +L H       +  
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPGSS------LQLVTQYLP--LGSLLDHVRQHRGALGP 114
Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA-------KQL 164
             +  +  QI +G+ Y+     V HR+L  +N+L+   + QV++ DFG A       KQL
Sbjct: 115 QLLLNWGVQIAKGMYYLEEHGMV-HRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQL 172
Query: 165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           +  EA       ++     + FG  +YT   D+WS G  + EL+
Sbjct: 173 LYSEAKTPI---KWMALESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 27/206 (13%)
Query: 17  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L        ++N ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 456 L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPE 183
            +  R  HRD+  +N+LV   T  VK+ DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ES-KRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLL 209
            I     +T++ D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK---KVLQDRRYKNR------ELQLMRVMDHPNVI 67
           +V+G+G FG V +   +  GE++ I    KV++D+  +         +  +  +DH +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L      ++      L LV +Y+P  +  +L H       +    +  +  QI +G+ Y
Sbjct: 97  RLLGLCPGSS------LQLVTQYLP--LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA-------KQLIAGEANISYICSRFYR 180
           +     V HR+L  +N+L+   + QV++ DFG A       KQL+  EA       ++  
Sbjct: 149 LEEHGMV-HRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMA 203
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELL 208
              + FG  +YT   D+WS G  + EL+
Sbjct: 204 LESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 49/238 (20%)
Query: 17  RVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNV 66
           + +G G FG V +A         G T    K+L++       R    E  +++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 116
           I L    +   S++   L L++EY   + Y  L+ +   ++++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEY---AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 117 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 162
                         + +QI +G+ Y+  + ++ HRDL  +N+LV     ++KI DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSR 198
Query: 163 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            +   ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRVMDHPNVISLK 70
           +G G FG+V++     T  TVA+KK+         + ++  ++E+++M    H N++ L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY-VKLYTYQ-IFRGLAYI 128
              FS+   +   L LV  Y+P     +L   S  +   PL + ++    Q    G+ ++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 149
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG---SAKQLIAGEANISYICSRFYRAPELI 185
           H    + HRD+K  N+L+D      KI DFG   ++++          + +  Y APE +
Sbjct: 150 HENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQP 212
            G  E T   DI+S G VL E++ G P
Sbjct: 208 RG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRVMDHPNVISLK 70
           +G G FG+V++     T  TVA+KK+         + ++  ++E+++M    H N++ L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY-VKLYTYQ-IFRGLAYI 128
              FS+   +   L LV  Y+P     +L   S  +   PL + ++    Q    G+ ++
Sbjct: 90  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFL 143
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFG---SAKQLIAGEANISYICSRFYRAPELI 185
           H    + HRD+K  N+L+D      KI DFG   ++++          + +  Y APE +
Sbjct: 144 HENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQP 212
            G  E T   DI+S G VL E++ G P
Sbjct: 202 RG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 17  RVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNV 66
           + +G G FG V +A         G T    K+L++       R    E  +++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL---------- 116
           I L    +   S++   L L++EY   + Y  L+ +   ++++   Y+            
Sbjct: 89  IKL----YGACSQDGPLL-LIVEY---AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 117 --------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK 162
                         + +QI +G+ Y+  +  V HRDL  +N+LV     ++KI DFG ++
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMSLV-HRDLAARNILVAE-GRKMKISDFGLSR 198
Query: 163 QLIAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            +   ++ +     R    + A E +F    YTT  D+WS G +L E++ LG   +PG
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRV---LKHYSSANQRMPLIYVKLYTYQIFRGL 125
           L        ++N ++  ++ME       R    ++ YS     + L  + LY YQ+   L
Sbjct: 73  L----IGVITENPVW--IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTAL 121
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           AY+ +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + 
Sbjct: 122 AYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWM 176
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLL 209
           APE I     +T++ D+W  G  + E+L+
Sbjct: 177 APESI-NFRRFTSASDVWMFGVCMWEILM 204

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 38/293 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           ++++V+G G  G V +     TG+  A+K +    + +       +    P+++ +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YIH 129
            +        L ++ME +        + +S   +R    + +    +I R +     ++H
Sbjct: 92  ENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +   + HRD+KP+NLL         +K+ DFG AK+    +  +   C + +Y APE + 
Sbjct: 146 S-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVAPE-VL 201
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F             + +    +  IR       
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----G 248
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
            + FP  +   W +V       +A  L   LL+  P+ R T  +   HP+ ++
Sbjct: 249 QYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRV---LKHYSSANQRMPLIYVKLYTYQIFRGL 125
           L        ++N ++  ++ME       R    ++ YS     + L  + LY YQ+   L
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTAL 124
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           AY+ +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + 
Sbjct: 125 AYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWM 179
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLL 209
           APE I     +T++ D+W  G  + E+L+
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 97  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 181
           ++ +  +  HRDL  +N ++D     VK+ DFG A+ ++  E +  +  +       + A
Sbjct: 149 FLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
            E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        +  R 
Sbjct: 207 LESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QGRRL 257
Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
           + P Y      ++    WH      M P   +L SR+
Sbjct: 258 LQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRV---LKHYSSANQRMPLIYVKLYTYQIFRGL 125
           L        ++N ++  ++ME       R    ++ YS     + L  + LY YQ+   L
Sbjct: 78  L----IGVITENPVW--IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTAL 126
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           AY+ +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + 
Sbjct: 127 AYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWM 181
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLL 209
           APE I     +T++ D+W  G  + E+L+
Sbjct: 182 APESI-NFRRFTSASDVWMFGVCMWEILM 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRV---LKHYSSANQRMPLIYVKLYTYQIFRGL 125
           L        ++N ++  ++ME       R    ++ YS     + L  + LY YQ+   L
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTAL 124
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           AY+ +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + 
Sbjct: 125 AYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWM 179
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLL 209
           APE I     +T++ D+W  G  + E+L+
Sbjct: 180 APESI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRV---LKHYSSANQRMPLIYVKLYTYQIFRGL 125
           L        ++N ++  ++ME       R    ++ YS     + L  + LY YQ+   L
Sbjct: 79  L----IGVITENPVW--IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTAL 127
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           AY+ +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + 
Sbjct: 128 AYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWM 182
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLL 209
           APE I     +T++ D+W  G  + E+L+
Sbjct: 183 APESI-NFRRFTSASDVWMFGVCMWEILM 210

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 123/293 (41%), Gaps = 38/293 (12%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCF 73
           ++++V+G G  G V +     TG+  A+K +    + +       +    P+++ +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YIH 129
            +        L ++ME +        + +S   +R    + +    +I R +     ++H
Sbjct: 73  ENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +   + HRD+KP+NLL         +K+ DFG AK+    +  +   C + +Y APE + 
Sbjct: 127 S-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVAPE-VL 182
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  +Y  S D+WS G ++  LL G P F             + +    +  IR       
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRRIRL-----G 229
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
            + FP  +   W +V       +A  L   LL+  P+ R T  +   HP+ ++
Sbjct: 230 QYGFPNPE---WSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 274

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRV---LKHYSSANQRMPLIYVKLYTYQIFRGL 125
           L        ++N ++  ++ME       R    ++ YS     + L  + LY YQ+   L
Sbjct: 104 L----IGVITENPVW--IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTAL 152
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           AY+ +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + 
Sbjct: 153 AYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWM 207
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLL 209
           APE I     +T++ D+W  G  + E+L+
Sbjct: 208 APESI-NFRRFTSASDVWMFGVCMWEILM 235

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 17  RVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRV---LKHYSSANQRMPLIYVKLYTYQIFRGL 125
           L        ++N ++  ++ME       R    ++ YS     + L  + LY YQ+   L
Sbjct: 81  L----IGVITENPVW--IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTAL 129
Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           AY+ +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + 
Sbjct: 130 AYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWM 184
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLL 209
           APE I     +T++ D+W  G  + E+L+
Sbjct: 185 APESI-NFRRFTSASDVWMFGVCMWEILM 212

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 16  ERVVGTGSFGIVFQAKCLETG--ETVAIKKVLQ-----DRRYKNRELQLM-RVMDHPNVI 67
           + V+G G+FG V +A+  + G     AIK++ +     D R    EL+++ ++  HPN+I
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPES-------MYRVLK---HYSSANQRMPLIYVKL- 116
           +L         ++  +L L +EY P           RVL+    ++ AN     +  +  
Sbjct: 87  NL-----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 117 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISY 173
             +   + RG+ Y+ +  +  HR+L  +N+LV    +  KI DFG S  Q +  +  +  
Sbjct: 142 LHFAADVARGMDYL-SQKQFIHRNLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 199
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           +  R+     L +    YTT+ D+WS G +L E++
Sbjct: 200 LPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 95  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 146
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 181
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    +  +       + A
Sbjct: 147 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
            E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        +  R 
Sbjct: 205 LESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QGRRL 255
Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
           + P Y      ++    WH      M P   +L SR+
Sbjct: 256 LQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 88  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 139
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 140 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 193
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 245
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 246 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 283

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 115 LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 166
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 167 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 220
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 221 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 272
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 273 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 310

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 11  ISYMA-ERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVM 61
           +SY+  E V+G G FG V + +    G+    VAIK +      + RR    E  +M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           +HPN+I L+     T S   + L   ME      +  L      + +  +I +      I
Sbjct: 73  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLN-----DGQFTVIQLVGMLRGI 125
Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 178
             G+ Y+  +  V HRDL  +N+LV+      K+ DFG ++ L    ++ +Y  S     
Sbjct: 126 ASGMRYLAEMSYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + APE I    ++T++ D WS G V+ E++
Sbjct: 184 PIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 96  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 148 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 201
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 253
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 254 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 93  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 145 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 198
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 250
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 288

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 114 LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 165
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 166 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 219
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 220 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 271
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 272 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 309

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 94  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 146 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 199
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 251
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 252 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 40/229 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLM---RVMD----HPN 65
           + +G G+FG V +A     G+  A+ KV    L+   + + +  LM   ++M     H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 66  VISL--------------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 111
           +++L              ++C +          + V+E  P         ++ AN  +  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--------FAIANSTLST 163
Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 171
             +  ++ Q+ +G+A++ +     HRD+  +N+L+    H  KI DFG A+ ++     I
Sbjct: 164 RDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYI 221
Query: 172 SYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+V+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L+     T  K  + +   ME    S+   L+     + R  +I +      I  G+ Y
Sbjct: 94  HLEGVV--TKCKPVMIITEYMEN--GSLDAFLRK---NDGRFTVIQLVGMLRGIGSGMKY 146
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF---YRAPE 183
           +  +  V HRDL  +N+LV+      K+ DFG ++ L    EA  +    +    + APE
Sbjct: 147 LSDMSAV-HRDLAARNILVNS-NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 204
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            I    ++T++ D+WS G V+ E++
Sbjct: 205 AI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 103/239 (43%), Gaps = 37/239 (15%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET-----VAIKKV----LQDRRYKNRELQLMRVMDHPNV 66
           +R +G G+FG VF A+C     T     VA+K +    L  R+   RE +L+  + H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLIY 113
           +     F+      +  + +V EY+             P++M  V      A   + L  
Sbjct: 80  VK----FYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---AN 170
           +     QI  G+ Y+ +     HRDL  +N LV      VKI DFG ++ + + +     
Sbjct: 135 MLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGA-NLLVKIGDFGMSRDVYSTDYYRVG 192
Query: 171 ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEII 227
              +    +  PE I    ++TT  D+WS G +L E+     QP F   N   +++E I
Sbjct: 193 GHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIECI 248

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 69/145 (47%), Gaps = 5/145 (3%)
Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS 176
           + +Q+   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +
Sbjct: 162 FFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGT 219
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTR 235
           R Y  PE I     +  S  +WS G +L +++ G  P    E  +   V   + + +  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 279
Query: 236 EEIR-CMNPNYTDF-RFPQIKAHPW 258
             IR C+    +D   F +I+ HPW
Sbjct: 280 HLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 96  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 148 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 201
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 253
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 254 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 51/284 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------ELQLMRVMDHP 64
            V+G G FG V+    L+       KK+    +  NR            E  +M+   HP
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 65  NVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIF 122
           NV+SL   C  S  S         +  +P   +  L+++       P +   + +  Q+ 
Sbjct: 91  NVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 142
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
           +G+ Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         
Sbjct: 143 KGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGA 196
Query: 183 EL--------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP 233
           +L             ++TT  D+WS G +L EL+  G P +P  N  D  V ++      
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------ 250
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
             +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 251 --QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 290

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 17  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L        ++N ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 456 L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 507
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPE 183
            +  R  HRD+  +N+LV      VK+ DFG ++ +   E +  Y  S+      + APE
Sbjct: 508 ES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPE 562
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLL 209
            I     +T++ D+W  G  + E+L+
Sbjct: 563 SI-NFRRFTSASDVWMFGVCMWEILM 587

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 91  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL-- 184
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    Y         +L  
Sbjct: 143 YLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPV 196
Query: 185 ------IFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE 237
                      ++TT  D+WS G +L EL+  G P +P  N  D  V ++        + 
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QG 248
Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
            R + P Y      ++    WH      M P   +L SR+
Sbjct: 249 RRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 286

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 45/281 (16%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------ELQLMRVMDHP 64
            V+G G FG V+    L+       KK+    +  NR            E  +M+   HP
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 65  NVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIF 122
           NV+SL   C  S  S         +  +P   +  L+++       P +   + +  Q+ 
Sbjct: 151 NVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 202
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
           +G+ ++ +  +  HRDL  +N ++D     VK+ DFG A+ +   E +  +  +      
Sbjct: 203 KGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 236
            + A E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        +
Sbjct: 261 KWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------Q 311
Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
             R + P Y      ++    WH      M P   +L SR+
Sbjct: 312 GRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 350

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 121/277 (43%), Gaps = 37/277 (13%)
Query: 17  RVVGTGSFGIVFQAKCLET-GETV--AIKKV--LQDRRYKNRELQ---LMRVMDHPNVIS 68
            V+G G FG V+    L+  G+ +  A+K +  + D    ++ L    +M+   HPNV+S
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 69  LKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           L   C  S  S         +  +P   +  L+++       P +   + +  Q+ +G+ 
Sbjct: 96  LLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 181
           ++ +  +  HRDL  +N ++D     VK+ DFG A+ +   E +  +  +       + A
Sbjct: 148 FLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
            E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        +  R 
Sbjct: 206 LESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------QGRRL 256
Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
           + P Y      ++    WH      M P   +L SR+
Sbjct: 257 LQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           ERV+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L+     T SK  + +   ME    S+   LK     + +  +I +      I  G+ Y
Sbjct: 87  HLEGVV--TKSKPVMIVTEYME--NGSLDTFLK---KNDGQFTVIQLVGMLRGISAGMKY 139
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF---YRAPE 183
           +  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    +    + APE
Sbjct: 140 LSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 197
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            I    ++T++ D+WS G V+ E++
Sbjct: 198 AI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 101/229 (44%), Gaps = 38/229 (16%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLM---RVMD----HPN 65
           + +G G+FG V +A     G+  A+ KV    L+   + + +  LM   ++M     H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 66  VISL--------------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 111
           +++L              ++C +         LN +    P  +        +  +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGD------LLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 171
             +  ++ Q+ +G+A++ +     HRD+  +N+L+    H  KI DFG A+ ++     I
Sbjct: 166 RDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYI 223
Query: 172 SYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 45/282 (15%)
Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------ELQLMRVMDH 63
             V+G G FG V+    L+       KK+    +  NR            E  +M+   H
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 64  PNVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQI 121
           PNV+SL   C  S  S         +  +P   +  L+++       P +   + +  Q+
Sbjct: 96  PNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 147
Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 178
            +G+ ++ +  +  HRDL  +N ++D     VK+ DFG A+ +   E +  +  +     
Sbjct: 148 AKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 205
Query: 179 --YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR 235
             + A E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        
Sbjct: 206 VKWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------- 256
Query: 236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
           +  R + P Y      ++    WH      M P   +L SR+
Sbjct: 257 QGRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 296

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 45/281 (16%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------ELQLMRVMDHP 64
            V+G G FG V+    L+       KK+    +  NR            E  +M+   HP
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 65  NVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIF 122
           NV+SL   C  S  S         +  +P   +  L+++       P +   + +  Q+ 
Sbjct: 92  NVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 143
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
           +G+ ++ +  +  HRDL  +N ++D     VK+ DFG A+ +   E +  +  +      
Sbjct: 144 KGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 236
            + A E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        +
Sbjct: 202 KWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------Q 252
Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
             R + P Y      ++    WH      M P   +L SR+
Sbjct: 253 GRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 45/281 (16%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------ELQLMRVMDHP 64
            V+G G FG V+    L+       KK+    +  NR            E  +M+   HP
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 65  NVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIF 122
           NV+SL   C  S  S         +  +P   +  L+++       P +   + +  Q+ 
Sbjct: 90  NVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 141
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
           +G+ ++ +  +  HRDL  +N ++D     VK+ DFG A+ +   E +  +  +      
Sbjct: 142 KGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 236
            + A E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        +
Sbjct: 200 KWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------Q 250
Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
             R + P Y      ++    WH      M P   +L SR+
Sbjct: 251 GRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 289

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+V+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L+     T  K  + +   ME    S+   L+     + R  +I +      I  G+ Y
Sbjct: 73  HLEGVV--TKCKPVMIITEYME--NGSLDAFLRK---NDGRFTVIQLVGMLRGIGSGMKY 125
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF---YRAPE 183
           +  +  V HRDL  +N+LV+      K+ DFG ++ L    EA  +    +    + APE
Sbjct: 126 LSDMSYV-HRDLAARNILVNS-NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 183
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            I    ++T++ D+WS G V+ E++
Sbjct: 184 AI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 116/281 (41%), Gaps = 45/281 (16%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR------------ELQLMRVMDHP 64
            V+G G FG V+    L+       KK+    +  NR            E  +M+   HP
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 65  NVISLKH-CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIF 122
           NV+SL   C  S  S         +  +P   +  L+++       P +   + +  Q+ 
Sbjct: 93  NVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 144
Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
           +G+ ++ +  +  HRDL  +N ++D     VK+ DFG A+ +   E +  +  +      
Sbjct: 145 KGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 179 -YRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 236
            + A E +    ++TT  D+WS G +L EL+  G P +P  N  D  V ++        +
Sbjct: 203 KWMALESL-QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL--------Q 253
Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
             R + P Y      ++    WH      M P   +L SR+
Sbjct: 254 GRRLLQPEYCPDPLYEVMLKCWHP--KAEMRPSFSELVSRI 292

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+V+G G FG V   +    G+    VAIK +      K R     E  +M   DHPN+I
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L+     T  K  + +   ME    S+   L+     + R  +I +      I  G+ Y
Sbjct: 79  HLEGVV--TKCKPVMIITEYME--NGSLDAFLRK---NDGRFTVIQLVGMLRGIGSGMKY 131
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF---YRAPE 183
           +  +  V HRDL  +N+LV+      K+ DFG ++ L    EA  +    +    + APE
Sbjct: 132 LSDMSYV-HRDLAARNILVNS-NLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPE 189
Query: 184 LIFGATEYTTSIDIWSAGCVLAELL 208
            I    ++T++ D+WS G V+ E++
Sbjct: 190 AI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRV--MDHPNVISLKHCF 73
            V   G FG V++A+ L   E VA+K   +QD++    E ++  +  M H N++      
Sbjct: 30  EVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--- 130
              TS +     +   +   S+   LK    +   +  I        + RGLAY+H    
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI-----AETMARGLAYLHEDIP 142
Query: 131 ------VPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYR 180
                  P + HRD+K +N LL + LT    I DFG A +  AG++       + +R Y 
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 181 APELIFGATEYTTS----IDIWSAGCVLAEL 207
           APE++ GA  +       ID+++ G VL EL
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLM---RVMDH----PN 65
           + +G G+FG V +A     G+  A+ KV    L+   + + +  LM   ++M H     N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSAN----QRMPLIYVKL--YT 118
           +++L     + T    + +  + EY     +   L+  + A+       PL    L  ++
Sbjct: 104 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            Q+ +G+A++ +     HRD+  +N+L+    H  KI DFG A+ ++     I    +R 
Sbjct: 159 SQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYIVKGNARL 216
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 217 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 23/213 (10%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----------LMRVM 61
           Y    ++G G FG VF    L     VAIK + ++R      L            L +V 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 62  ---DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 118
               HP VI L   F       E F+ ++   +P    + L  Y +    +     + + 
Sbjct: 93  AGGGHPGVIRLLDWF----ETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFF 145
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            Q+   + + H+   V HRD+K +N+L+D      K+ DFGS   L+  E    +  +R 
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGA-LLHDEPYTDFDGTRV 203
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ 211
           Y  PE I     +     +WS G +L +++ G 
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLM---RVMDH----PN 65
           + +G G+FG V +A     G+  A+ KV    L+   + + +  LM   ++M H     N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYV-PESMYRVLKHYSSAN----QRMPLIYVKL--YT 118
           +++L     + T    + +  + EY     +   L+  + A+       PL    L  ++
Sbjct: 112 IVNL---LGACTHGGPVLV--ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
            Q+ +G+A++ +     HRD+  +N+L+    H  KI DFG A+ ++     I    +R 
Sbjct: 167 SQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYIVKGNARL 224
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 225 PVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 26/208 (12%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+V+G G FG V        G+    VAIK +      K R     E  +M   DHPNVI
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L+     +T      + ++ E++   S+   L+     + +  +I +      I  G+ 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMK 149
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------YR 180
           Y+  +  V HRDL  +N+LV+      K+ DFG ++ L    ++ +Y  +        + 
Sbjct: 150 YLADMNYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELL 208
           APE I    ++T++ D+WS G V+ E++
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLM---RVMDH----PN 65
           + +G G+FG V +A     G+  A+ KV    L+   + + +  LM   ++M H     N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 66  VISL--------------KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL 111
           +++L              ++C +          + V+E  P         ++ AN     
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--------FAIANSTAST 163
Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI 171
             +  ++ Q+ +G+A++ +     HRD+  +N+L+    H  KI DFG A+ ++     I
Sbjct: 164 RDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDIMNDSNYI 221
Query: 172 SYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
               +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+++G+G  G V   +    G+    VAIK +      + R     E  +M   DHPN+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L+       ++  L + +V EY+   S+   L+ +      M L+ +      +  G+ 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRA 181
           Y+  +  V HRDL  +N+LVD      K+ DFG ++ ++  + + +Y  +       + A
Sbjct: 166 YLSDLGYV-HRDLAARNVLVDS-NLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTA 222
Query: 182 PELIFGATEYTTSIDIWSAGCVLAELL 208
           PE I   T ++++ D+WS G V+ E+L
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN--- 52
           L C I +    + E++ G GSFG+V + +    +G+TV++        VL      +   
Sbjct: 11  LTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           RE+  M  +DH N+I L     +   K      +V E  P  +  +L           L 
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAP--LGSLLDRLRKHQGHFLLG 121
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +  Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +  
Sbjct: 122 TLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH-- 177
Query: 173 YICSRFYR------APELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 225
           Y+     +      APE +   T ++ + D W  G  L E+   GQ  + G N    L +
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 236
Query: 226 IIK 228
           I K
Sbjct: 237 IDK 239

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 20  GTGSFGIVFQAKCLETGETVAIKKVL--------QDRRYKNRELQLMRVMDHPNVISLKH 71
           G G FG+V++     T  TVA+KK+         + ++  ++E+++     H N++ L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY-VKLYTYQ-IFRGLAYIH 129
             FS+   +   L LV  Y P     +L   S  +   PL +  +    Q    G+ ++H
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG--SLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK--QLIAGEANISYIC-SRFYRAPELIF 186
               + HRD+K  N+L+D      KI DFG A+  +  A     S I  +  Y APE + 
Sbjct: 142 ENHHI-HRDIKSANILLDE-AFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR 199
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQP 212
           G  E T   DI+S G VL E++ G P
Sbjct: 200 G--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG A+ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLARVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 27/241 (11%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN--- 52
           L C I +    + E++ G GSFG+V + +    +G+TV++        VL      +   
Sbjct: 11  LTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           RE+  M  +DH N+I L     +   K      +V E  P  +  +L           L 
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAP--LGSLLDRLRKHQGHFLLG 121
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +  Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +  
Sbjct: 122 TLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXV 179
Query: 173 YICSR----FYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 227
               R     + APE +   T ++ + D W  G  L E+   GQ  + G N    L +I 
Sbjct: 180 MQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
Query: 228 K 228
           K
Sbjct: 239 K 239

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 102/241 (42%), Gaps = 27/241 (11%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN--- 52
           L C I +    + E++ G GSFG+V + +    +G+TV++        VL      +   
Sbjct: 1   LTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 59
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           RE+  M  +DH N+I L     +   K      +V E  P  +  +L           L 
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAP--LGSLLDRLRKHQGHFLLG 111
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +  Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +  
Sbjct: 112 TLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHXV 169
Query: 173 YICSR----FYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII 227
               R     + APE +   T ++ + D W  G  L E+   GQ  + G N    L +I 
Sbjct: 170 MQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228
Query: 228 K 228
           K
Sbjct: 229 K 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 17  RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYK-----NRELQLMRVMDHPNV 66
           R +G G+FG VFQA+       E    VA+K + ++          RE  LM   D+PN+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKH------YSSANQRM--------PLI 112
           + L            LF  +    + E +  +  H      +S  + R         PL 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 113 YVK--LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-- 168
             +      Q+  G+AY+ +  +  HRDL  +N LV      VKI DFG ++ + + +  
Sbjct: 173 CAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYY 230
Query: 169 -ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
            A+ +      +  PE IF    YTT  D+W+ G VL E+ 
Sbjct: 231 KADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIF 270

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGAV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN--- 52
           L C I +    + E++ G GSFG+V + +    +G+TV++        VL      +   
Sbjct: 1   LTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 59
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           RE+  M  +DH N+I L     +   K      +V E  P  +  +L           L 
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAP--LGSLLDRLRKHQGHFLLG 111
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +  Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +  
Sbjct: 112 TLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH-- 167
Query: 173 YICSRFYR------APELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 225
           Y+     +      APE +   T ++ + D W  G  L E+   GQ  + G N    L +
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
Query: 226 IIK 228
           I K
Sbjct: 227 IDK 229

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN--- 52
           L C I +    + E++ G GSFG+V + +    +G+TV++        VL      +   
Sbjct: 5   LTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 63
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           RE+  M  +DH N+I L     +   K      +V E  P  +  +L           L 
Sbjct: 64  REVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAP--LGSLLDRLRKHQGHFLLG 115
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +  Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +  
Sbjct: 116 TLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH-- 171
Query: 173 YICSRFYR------APELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 225
           Y+     +      APE +   T ++ + D W  G  L E+   GQ  + G N    L +
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 230
Query: 226 IIK 228
           I K
Sbjct: 231 IDK 233

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN--- 52
           L C I +    + E++ G GSFG+V + +    +G+TV++        VL      +   
Sbjct: 5   LTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 63
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           RE+  M  +DH N+I L     +   K      +V E  P  +  +L           L 
Sbjct: 64  REVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAP--LGSLLDRLRKHQGHFLLG 115
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +  Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +  
Sbjct: 116 TLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH-- 171
Query: 173 YICSRFYR------APELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 225
           Y+     +      APE +   T ++ + D W  G  L E+   GQ  + G N    L +
Sbjct: 172 YVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 230
Query: 226 IIK 228
           I K
Sbjct: 231 IDK 233

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 31/243 (12%)
Query: 3   LVCCILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIK------KVLQDRRYKN--- 52
           L C I +    + E++ G GSFG+V + +    +G+TV++        VL      +   
Sbjct: 1   LTCLIGEKDLRLLEKL-GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 59
Query: 53  RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLI 112
           RE+  M  +DH N+I L     +   K      +V E  P  +  +L           L 
Sbjct: 60  REVNAMHSLDHRNLIRLYGVVLTPPMK------MVTELAP--LGSLLDRLRKHQGHFLLG 111
Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
            +  Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +  
Sbjct: 112 TLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDH-- 167
Query: 173 YICSRFYR------APELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE 225
           Y+     +      APE +   T ++ + D W  G  L E+   GQ  + G N    L +
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226
Query: 226 IIK 228
           I K
Sbjct: 227 IDK 229

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 17  RVVGTGSFGIVFQAKCLET---GETVAIK--KVLQDRRYKNRELQ---LMRVMDHPNVIS 68
           R +G G FG V Q   +        VAIK  K       + + LQ    MR  DHP+++ 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L        ++N ++  ++ME       R        +  + L  + LY YQ+   LAY+
Sbjct: 76  L----IGVITENPVW--IIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYL 127
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAPE 183
            +  R  HRD+  +N+LV      VK+ DFG ++ +   E +     S+      + APE
Sbjct: 128 ES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYM---EDSTXXKASKGKLPIKWMAPE 182
Query: 184 LIFGATEYTTSIDIWSAGCVLAELLL 209
            I     +T++ D+W  G  + E+L+
Sbjct: 183 SI-NFRRFTSASDVWMFGVCMWEILM 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           ERV+G G FG V   +    G+    VAIK +      K R     E  +M   DHPNV+
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L+     T  K  + +   ME      + + KH    + +  +I +      I  G+ Y
Sbjct: 108 HLEGVV--TRGKPVMIVIEFMENGALDAF-LRKH----DGQFTVIQLVGMLRGIAAGMRY 160
Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 182
           +  +  V HRDL  +N+LV+      K+ DFG ++ +I  +    Y  +       + AP
Sbjct: 161 LADMGYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL 208
           E I    ++T++ D+WS G V+ E++
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 14  MAERVVGTGSFGIVFQA--KCLETGETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNV 66
           +A+  +G G+FG V Q   +  +    VAIK + Q     D     RE Q+M  +D+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     +        L LVME        + K      + +P+  V    +Q+  G+ 
Sbjct: 73  VRLIGVCQAEA------LMLVMEMAGGG--PLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-------Y 179
           Y+       HRDL  +N+L+    H  KI DFG +K L A +   SY  +R        +
Sbjct: 125 YLEE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLKW 179
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE I    ++++  D+WS G  + E L
Sbjct: 180 YAPECI-NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG  + L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKN-RELQLMRVMDHPNVISLKHCF 73
           +G G+FG VF  +       VA+K   +    D + K  +E ++++   HPN++ L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
              T K  ++  +VME V    +        A  R+  +   +       G+ Y+ +  +
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA--GMEYLES--K 232
Query: 134 VC-HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE-- 190
            C HRDL  +N LV    + +KI DFG +++    EA+  Y  S   R   + + A E  
Sbjct: 233 CCIHRDLAARNCLVTE-KNVLKISDFGMSRE----EADGVYAASGGLRQVPVKWTAPEAL 287
Query: 191 ----YTTSIDIWSAGCVLAELL-LGQPLFP 215
               Y++  D+WS G +L E   LG   +P
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYP 317

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+++G+G  G V   +    G+    VAIK +      + R     E  +M   DHPN+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L+       ++  L + +V EY+   S+   L+ +      M L+ +      +  G+ 
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM---LRGVGAGMR 165
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF---YRAP 182
           Y+  +  V HRDL  +N+LVD      K+ DFG ++ L    +A  +    +    + AP
Sbjct: 166 YLSDLGYV-HRDLAARNVLVDS-NLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAP 223
Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL 208
           E I   T ++++ D+WS G V+ E+L
Sbjct: 224 EAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 73  QFDHPNIIRLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGMLR 125
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 126 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 184 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 17  RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR------ELQLMRVMDHPNVI 67
           +++G G FG V +    +   T   VA+K +  D   +        E   M+   HPNVI
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 68  SLKHCFFSTTSKN---ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            L       +S+     + +   M+Y     Y +     +  + +PL  +  +   I  G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 125 LAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           + Y+       HRDL  +N +L D +T  V + DFG +K++ +G+    Y   R  + P 
Sbjct: 160 MEYLSN-RNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIYSGDY---YRQGRIAKMP- 212
Query: 184 LIFGATE------YTTSIDIWSAGCVLAELLL-GQPLFPG 216
           + + A E      YT+  D+W+ G  + E+   G   +PG
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 101
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 102 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 154
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 155 GIASGMKYLSDMGFV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 212
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 213 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 40  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 99
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ + +   +  +I +     
Sbjct: 100 QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKHDA---QFTVIQLVGMLR 152
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 153 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 210
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 211 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 30  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 89
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 90  QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 142
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 143 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 200
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 201 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 11  ISYMA-ERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVM 61
           +SY+  E V+G G FG V + +    G+    VAIK +      + RR    E  +M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           +HPN+I L+     T S   + L   ME      +  L      + +  +I +      I
Sbjct: 75  EHPNIIRLEGVV--TNSMPVMILTEFMENGALDSFLRLN-----DGQFTVIQLVGMLRGI 127
Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 178
             G+ Y+  +  V HRDL  +N+LV+      K+ DFG ++ L    ++ +   S     
Sbjct: 128 ASGMRYLAEMSYV-HRDLAARNILVNS-NLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + APE I    ++T++ D WS G V+ E++
Sbjct: 186 PIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 104/236 (44%), Gaps = 45/236 (19%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLM---RVMDH----PN 65
           + +G G+FG V +A     G+  A+ KV    L+   + + +  LM   ++M H     N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 66  VISL--------------KHC-------FFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 104
           +++L              ++C       F    ++  L  +L     PE + +       
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDK------E 150
Query: 105 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 164
             + + L  +  ++ Q+ +G+A++ +     HRD+  +N+L+    H  KI DFG A+ +
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLTN-GHVAKIGDFGLARDI 208
Query: 165 IAGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           +     I    +R    + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 80/190 (42%), Gaps = 25/190 (13%)
Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQL-IAGEAN------- 170
           +   L ++H    + HRDLKP+N+L +       VKICDFG    + + G+ +       
Sbjct: 120 VASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPEL 178
Query: 171 ISYICSRFYRAPELIFGATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
           ++   S  Y APE++   +E    Y    D+WS G +L  LL G P F G    D   + 
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD- 237
Query: 227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 286
            +    P  + +   +     + FP      W       +   A DL S+LL      R 
Sbjct: 238 -RGEACPACQNMLFESIQEGKYEFPD---KDW-----AHISCAAKDLISKLLVRDAKQRL 288
Query: 287 TALEACAHPF 296
           +A +   HP+
Sbjct: 289 SAAQVLQHPW 298

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 8   LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMR 59
           L   +   ++VVG G FG V   +     +   +VAIK +      K R     E  +M 
Sbjct: 13  LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMG 72
Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
             DHPN+I L+     T SK  + +   ME    S+   L+ +   + +  +I +     
Sbjct: 73  QFDHPNIIRLEGVV--TKSKPVMIVTEYME--NGSLDSFLRKH---DAQFTVIQLVGMLR 125
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-EANISYICSRF 178
            I  G+ Y+  +  V HRDL  +N+L++      K+ DFG ++ L    EA  +    + 
Sbjct: 126 GIASGMKYLSDMGYV-HRDLAARNILINS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 183
Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              + +PE I    ++T++ D+WS G VL E++
Sbjct: 184 PIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 117/291 (40%), Gaps = 58/291 (19%)
Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQL-MRVMDHPNVISLKHC 72
           +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +   
Sbjct: 21  VTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA----YI 128
           + +  +  +  L +VME +        + +S    R    + +    +I + +     Y+
Sbjct: 80  YENLYAGRKCLL-IVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           H++  + HRD+KP+NLL         +K+ DFG AK+   GE                  
Sbjct: 134 HSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE------------------ 173
Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +Y  S D+WS G ++  LL G P F   + +         +    +  IR       
Sbjct: 174 ---KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------AISPGMKTRIR-----MG 217
Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            + FP  +   W +V       E   L   LL+  P+ R T  E   HP+ 
Sbjct: 218 QYEFPNPE---WSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 79/190 (41%), Gaps = 25/190 (13%)
Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDF--GSAKQLIAGEANISY--- 173
           +   L ++H    + HRDLKP+N+L +       VKICDF  GS  +L    + IS    
Sbjct: 120 VASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 174 ---ICSRFYRAPELIFGATE----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
                S  Y APE++   +E    Y    D+WS G +L  LL G P F G    D   + 
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD- 237
Query: 227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 286
            +    P  + +   +     + FP      W       +   A DL S+LL      R 
Sbjct: 238 -RGEACPACQNMLFESIQEGKYEFPD---KDW-----AHISCAAKDLISKLLVRDAKQRL 288
Query: 287 TALEACAHPF 296
           +A +   HP+
Sbjct: 289 SAAQVLQHPW 298

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 14  MAERVVGTGSFGIVFQA--KCLETGETVAIKKVLQ-----DRRYKNRELQLMRVMDHPNV 66
           +A+  +G G+FG V Q   +  +    VAIK + Q     D     RE Q+M  +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     +        L LVME        + K      + +P+  V    +Q+  G+ 
Sbjct: 399 VRLIGVCQAEA------LMLVMEMAGGG--PLHKFLVGKREEIPVSNVAELLHQVSMGMK 450
Query: 127 YIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------- 178
           Y+     V HR+L  +N LLV+   H  KI DFG +K L    A+ SY  +R        
Sbjct: 451 YLEEKNFV-HRNLAARNVLLVN--RHYAKISDFGLSKAL---GADDSYYTARSAGKWPLK 504
Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           + APE I    ++++  D+WS G  + E L
Sbjct: 505 WYAPECI-NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKN-RELQLMRVMDHPNVISLKHCF 73
           +G G+FG VF  +       VA+K   +    D + K  +E ++++   HPN++ L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
              T K  ++  +VME V    +        A  R+  +   +       G+ Y+ +  +
Sbjct: 179 GVCTQKQPIY--IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA--GMEYLES--K 232
Query: 134 VC-HRDLKPQNLLVDPLTHQVKICDFGSAKQ----LIAGEANISYICSRFYRAPELIFGA 188
            C HRDL  +N LV    + +KI DFG +++    + A    +  +  ++     L +G 
Sbjct: 233 CCIHRDLAARNCLVTE-KNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG- 290
Query: 189 TEYTTSIDIWSAGCVLAELL-LGQPLFP 215
             Y++  D+WS G +L E   LG   +P
Sbjct: 291 -RYSSESDVWSFGILLWETFSLGASPYP 317

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 82/312 (26%), Positives = 129/312 (41%), Gaps = 65/312 (20%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 83  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICS 176
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +        +  
Sbjct: 138 EIADGMAYLNA-KKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTPT 234
             + APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++ +       
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV------- 245
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 293
                 M+  Y D         P         P    DL     Q++P++R T LE    
Sbjct: 246 ------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNL 285
Query: 294 -----HPFFDEL 300
                HP F E+
Sbjct: 286 LKDDLHPSFPEV 297

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 83  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICS 176
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +        +  
Sbjct: 138 EIADGMAYLNA-KKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
             + APE +     +TTS D+WS G VL E+
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 79
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 80  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 134
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICS 176
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +        +  
Sbjct: 135 EIADGMAYLNA-KKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 192
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
             + APE +     +TTS D+WS G VL E+
Sbjct: 193 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+V+G G FG V        G+    VAIK +      K R     E  +M   DHPNVI
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L+     +T      + ++ E++   S+   L+     + +  +I +      I  G+ 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMK 123
Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------YR 180
           Y+  +  V HR L  +N+LV+      K+ DFG ++ L    ++ +Y  +        + 
Sbjct: 124 YLADMNYV-HRALAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 181 APELIFGATEYTTSIDIWSAGCVLAELL 208
           APE I    ++T++ D+WS G V+ E++
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 83  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICS 176
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +        +  
Sbjct: 138 EIADGMAYLNA-KKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
             + APE +     +TTS D+WS G VL E+
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 76/353 (21%), Positives = 138/353 (39%), Gaps = 64/353 (18%)
Query: 18  VVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISL 69
           V+G G      V  A+   TGE V ++++  +        +   EL + ++ +HPN++  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           +  F    + NEL++         +   +  H+      + + Y+      + + L YIH
Sbjct: 76  RATFI---ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---------YR 180
            +  V HR +K  ++L+  +  +V +    S   +I+       +   F         + 
Sbjct: 130 HMGYV-HRSVKASHILIS-VDGKVYLSGLRSNLSMIS-HGQRQRVVHDFPKYSVKVLPWL 186
Query: 181 APELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT------- 232
           +PE++    + Y    DI+S G    EL  G   F    A   L+E  K+ GT       
Sbjct: 187 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPCLLDT 244
Query: 233 -----------PTR--------EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 273
                      P+R        + +    P  ++   P   +HP+H+ F     P     
Sbjct: 245 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHF 297
Query: 274 ASRLLQYSPSLRCTALEACAHPFFDEL-REPNARLPN-GRPLPPLFNFKQELS 324
             + LQ +P  R +A     H FF ++ R  +  LP   RP+ P+ NF+   S
Sbjct: 298 VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQS 350

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 82  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 136
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICS 176
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +        +  
Sbjct: 137 EIADGMAYLNA-KKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL 207
             + APE +     +TTS D+WS G VL E+
Sbjct: 195 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEI 224

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 76/353 (21%), Positives = 138/353 (39%), Gaps = 64/353 (18%)
Query: 18  VVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISL 69
           V+G G      V  A+   TGE V ++++  +        +   EL + ++ +HPN++  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           +  F    + NEL++         +   +  H+      + + Y+      + + L YIH
Sbjct: 92  RATFI---ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---------YR 180
            +  V HR +K  ++L+  +  +V +    S   +I+       +   F         + 
Sbjct: 146 HMGYV-HRSVKASHILIS-VDGKVYLSGLRSNLSMIS-HGQRQRVVHDFPKYSVKVLPWL 202
Query: 181 APELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT------- 232
           +PE++    + Y    DI+S G    EL  G   F    A   L+E  K+ GT       
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLNGTVPCLLDT 260
Query: 233 -----------PTR--------EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDL 273
                      P+R        + +    P  ++   P   +HP+H+ F     P     
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHF 313
Query: 274 ASRLLQYSPSLRCTALEACAHPFFDEL-REPNARLPN-GRPLPPLFNFKQELS 324
             + LQ +P  R +A     H FF ++ R  +  LP   RP+ P+ NF+   S
Sbjct: 314 VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQS 366

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 129/313 (41%), Gaps = 67/313 (21%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 83  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG----EANISYIC 175
           +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +       +     + 
Sbjct: 138 EIADGMAYLNA-KKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETAYYRKGGKGLLP 195
Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTP 233
            R + APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++ +      
Sbjct: 196 VR-WMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV------ 245
Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
                  M+  Y D         P         P    DL     Q++P +R T LE   
Sbjct: 246 -------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMRPTFLEIVN 284
Query: 294 ------HPFFDEL 300
                 HP F E+
Sbjct: 285 LLKDDLHPSFPEV 297

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 34/236 (14%)
Query: 16  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNV 66
           +R +G G+FG VF A+C     E  + +   K L+D     R+  +RE +L+  + H ++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHY-------SSANQRMPLIYVKLY- 117
           +     F+    + +  + +V EY+    + + L+ +       +  N    L   ++  
Sbjct: 78  VK----FYGVCVEGDPLI-MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH 132
Query: 118 -TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISY 173
              QI  G+ Y+ +     HRDL  +N LV      VKI DFG ++ + + +        
Sbjct: 133 IAQQIAAGMVYLAS-QHFVHRDLATRNCLVGE-NLLVKIGDFGMSRDVYSTDYYRVGGHT 190
Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL--GQPLFPGENAVDQLVEII 227
           +    +  PE I    ++TT  D+WS G VL E+     QP +   N  ++++E I
Sbjct: 191 MLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECI 243

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 19  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 69
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ ++ H +++  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 107
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRM---------PLIYVKLYTY 119
              FF   ++    L +V EY+    + R L+ +    + +         PL   +L   
Sbjct: 108 ---FFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 120 --QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             Q+  G+ Y+  +  V HRDL  +N LV      VKI DFG ++ + +   +   +  R
Sbjct: 164 ASQVAAGMVYLAGLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYS--TDYYRVGGR 219
Query: 178 F-----YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
                 +  PE I    ++TT  D+WS G VL E+ 
Sbjct: 220 TMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 254

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 129/312 (41%), Gaps = 65/312 (20%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 83
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 84  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 138
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICS 176
           +I  G+AY++   +  HR+L  +N +V      VKI DFG  + +   +        +  
Sbjct: 139 EIADGMAYLNA-KKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTPT 234
             + APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++ +       
Sbjct: 197 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV------- 246
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 293
                 M+  Y D         P         P    DL     Q++P++R T LE    
Sbjct: 247 ------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNL 286
Query: 294 -----HPFFDEL 300
                HP F E+
Sbjct: 287 LKDDLHPSFPEV 298

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 81/312 (25%), Positives = 129/312 (41%), Gaps = 65/312 (20%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  A+ +  GE    VA+K V +    + R     E  +M+     +V
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 82
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----ESMYRVLKHYSSANQRMP---LIYVKLYTY 119
           + L        SK +  L +VME +     +S  R L+  +  N   P   L  +     
Sbjct: 83  VRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 137
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICS 176
           +I  G+AY++   +  HR+L  +N +V      VKI DFG  + +   +        +  
Sbjct: 138 EIADGMAYLNA-KKFVHRNLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 195
Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAEL--LLGQPLFPGENAVDQLVEIIKVLGTPT 234
             + APE +     +TTS D+WS G VL E+  L  QP     N  +Q+++ +       
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVLKFV------- 245
Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA- 293
                 M+  Y D         P         P    DL     Q++P++R T LE    
Sbjct: 246 ------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNL 285
Query: 294 -----HPFFDEL 300
                HP F E+
Sbjct: 286 LKDDLHPSFPEV 297

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 113/262 (43%), Gaps = 31/262 (11%)
Query: 17  RVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKN------RELQLMRVMDHPNVI 67
           R++G G FG V +A+  +   +   VA+K +  D    +      RE   M+  DHP+V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 68  SLKHCFFSTTSKNELFLNLV----MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
            L      + +K  L + +V    M++     + +          +PL  +  +   I  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 124 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---Y 179
           G+ Y+ +     HRDL  +N +L + +T  V + DFG ++++ +G+       S+    +
Sbjct: 149 GMEYLSS-RNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG-ENAVDQLVEIIKVL--GTPTR 235
            A E +     YT   D+W+ G  + E++  GQ  + G ENA     EI   L  G   +
Sbjct: 206 LALESL-ADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----EIYNYLIGGNRLK 259
Query: 236 EEIRCMNPNYTDFRFPQIKAHP 257
           +   CM   Y D  +    A P
Sbjct: 260 QPPECMEEVY-DLMYQCWSADP 280

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 19  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 69
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ ++ H +++  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 78
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRM---------PLIYVKLYTY 119
              FF   ++    L +V EY+    + R L+ +    + +         PL   +L   
Sbjct: 79  ---FFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 120 --QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             Q+  G+ Y+  +  V HRDL  +N LV      VKI DFG ++ + +   +   +  R
Sbjct: 135 ASQVAAGMVYLAGLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYS--TDYYRVGGR 190
Query: 178 F-----YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
                 +  PE I    ++TT  D+WS G VL E+ 
Sbjct: 191 TMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 225

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 36/216 (16%)
Query: 19  VGTGSFGIVFQAKCL----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISL 69
           +G G+FG VF A+C     E  + +   K L++     R+   RE +L+ ++ H +++  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR- 84
Query: 70  KHCFFSTTSKNELFLNLVMEYVPES-MYRVLKHYSSANQRM---------PLIYVKLYTY 119
              FF   ++    L +V EY+    + R L+ +    + +         PL   +L   
Sbjct: 85  ---FFGVCTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 120 --QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             Q+  G+ Y+  +  V HRDL  +N LV      VKI DFG ++ + +   +   +  R
Sbjct: 141 ASQVAAGMVYLAGLHFV-HRDLATRNCLVGQ-GLVVKIGDFGMSRDIYS--TDYYRVGGR 196
Query: 178 F-----YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
                 +  PE I    ++TT  D+WS G VL E+ 
Sbjct: 197 TMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIF 231

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL----QLMRVMDHPNVISLKHC 72
           R +G+GSFG ++    ++T E VAIK  L++ + K+ +L    ++ R++     I     
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           F      N L ++L+   + E ++         ++++ L  V +   Q+   + ++H+  
Sbjct: 71  FGVEGDYNVLVMDLLGPSL-EDLFNF------CSRKLSLKTVLMLADQMINRVEFVHS-K 122
Query: 133 RVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQ 163
              HRD+KP N L+      +QV I DFG AK+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVIS-LKHCF 73
           VG G +G V++      GE VA+K +   R  K+  RE +L    ++ H N++  +    
Sbjct: 45  VGKGRYGEVWRGSW--QGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 101
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--- 130
            S  S  +L+L +   +   S+Y  L+  +     +  +        I  GLA++H    
Sbjct: 102 TSRHSSTQLWL-ITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 155
Query: 131 ----VPRVCHRDLKPQNLLVDPLTHQVKICDFG-------SAKQLIAGEANISYICSRFY 179
                P + HRDLK +N+LV     Q  I D G       S  QL  G  N   + ++ Y
Sbjct: 156 GTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVG--NNPRVGTKRY 212
Query: 180 RAPELIFGATEYT-----TSIDIWSAGCVLAEL 207
            APE++    +         +DIW+ G VL E+
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVIS-LKHCF 73
           VG G +G V++      GE VA+K +   R  K+  RE +L    ++ H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--- 130
            S  S  +L+L +   +   S+Y  L+  +     +  +        I  GLA++H    
Sbjct: 73  TSRHSSTQLWL-ITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 131 ----VPRVCHRDLKPQNLLVDPLTHQVKICDFG-------SAKQLIAGEANISYICSRFY 179
                P + HRDLK +N+LV     Q  I D G       S  QL  G  N   + ++ Y
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVG--NNPRVGTKRY 183
Query: 180 RAPELIFGATEYT-----TSIDIWSAGCVLAEL 207
            APE++    +         +DIW+ G VL E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVIS-LKHCF 73
           VG G +G V++      GE VA+K +   R  K+  RE +L    ++ H N++  +    
Sbjct: 16  VGKGRYGEVWRGSW--QGENVAVK-IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--- 130
            S  S  +L+L +   +   S+Y  L+  +     +  +        I  GLA++H    
Sbjct: 73  TSRHSSTQLWL-ITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 131 ----VPRVCHRDLKPQNLLVDPLTHQVKICDFG-------SAKQLIAGEANISYICSRFY 179
                P + HRDLK +N+LV     Q  I D G       S  QL  G  N   + ++ Y
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVG--NNPRVGTKRY 183
Query: 180 RAPELIFGATEYT-----TSIDIWSAGCVLAEL 207
            APE++    +         +DIW+ G VL E+
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 129/331 (38%), Gaps = 68/331 (20%)
Query: 5   CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL 57
           C  ++   Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L
Sbjct: 6   CISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
            ++  H + I   + +  T    + ++ +VME     +   LK   S +      Y K  
Sbjct: 65  NKLQQHSDKIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-- 118
Query: 118 TYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 172
                  L  +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+     ++   S
Sbjct: 119 -----NMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 171
Query: 173 YICSRFYRAPELIFGATEYTTS----------IDIWSAGCVLAELLLGQPLFPGENAVDQ 222
            + +  Y  PE I   +    +           D+WS GC+L  +  G+   P +  ++Q
Sbjct: 172 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQ 229
Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQ 279
           + ++  ++           +PN+ +  FP I              PE  DL   L   L+
Sbjct: 230 ISKLHAII-----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLK 262
Query: 280 YSPSLRCTALEACAHPFFDELREPNARLPNG 310
             P  R +  E  AHP+      P  ++  G
Sbjct: 263 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 129/331 (38%), Gaps = 68/331 (20%)
Query: 5   CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL 57
           C  ++   Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L
Sbjct: 3   CISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
            ++  H + I   + +  T    + ++ +VME     +   LK   S +      Y K  
Sbjct: 62  NKLQQHSDKIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-- 115
Query: 118 TYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 172
                  L  +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+     ++   S
Sbjct: 116 -----NMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 173 YICSRFYRAPELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
            + +  Y  PE I   +            +   D+WS GC+L  +  G+   P +  ++Q
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQ 226
Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQ 279
           + ++  ++           +PN+ +  FP I              PE  DL   L   L+
Sbjct: 227 ISKLHAII-----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLK 259
Query: 280 YSPSLRCTALEACAHPFFDELREPNARLPNG 310
             P  R +  E  AHP+      P  ++  G
Sbjct: 260 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 16  ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKNR-----ELQLMRVMDHPN 65
           ++V+G G FG V++   L+T        VAIK +      K R     E  +M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           +I L+       SK +  + ++ EY+   ++ + L+        + L+ +      I  G
Sbjct: 108 IIRLEGVI----SKYKPMM-IITEYMENGALDKFLREKDGEFSVLQLVGM---LRGIAAG 159
Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----Y 179
           + Y+  +  V HRDL  +N+LV+      K+ DFG ++ ++  +   +Y  S       +
Sbjct: 160 MKYLANMNYV-HRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRW 216
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE I    ++T++ D+WS G V+ E++
Sbjct: 217 TAPEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 129/331 (38%), Gaps = 68/331 (20%)
Query: 5   CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL 57
           C  ++   Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L
Sbjct: 2   CISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
            ++  H + I   + +  T    + ++ +VME     +   LK   S +      Y K  
Sbjct: 61  NKLQQHSDKIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-- 114
Query: 118 TYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 172
                  L  +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+     ++   S
Sbjct: 115 -----NMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 167
Query: 173 YICSRFYRAPELIFGATEYTTS----------IDIWSAGCVLAELLLGQPLFPGENAVDQ 222
            + +  Y  PE I   +    +           D+WS GC+L  +  G+   P +  ++Q
Sbjct: 168 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQ 225
Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQ 279
           + ++  ++           +PN+ +  FP I              PE  DL   L   L+
Sbjct: 226 ISKLHAII-----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLK 258
Query: 280 YSPSLRCTALEACAHPFFDELREPNARLPNG 310
             P  R +  E  AHP+      P  ++  G
Sbjct: 259 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 84/204 (41%), Gaps = 49/204 (24%)
Query: 125 LAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFY 179
           L  +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+     ++   S + +  Y
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194
Query: 180 RAPELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 229
             PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  +
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAI 252
Query: 230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRC 286
           +           +PN+ +  FP I              PE  DL   L   L+  P  R 
Sbjct: 253 I-----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRI 285
Query: 287 TALEACAHPFFDELREPNARLPNG 310
           +  E  AHP+      P  ++  G
Sbjct: 286 SIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 38/212 (17%)
Query: 22  GSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRV--MDHPNVISLKHCFFSTTS 78
           G FG V++A+ +   + VA+K   LQD++    E ++     M H N++     F +   
Sbjct: 26  GRFGCVWKAQLMN--DFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQ----FIAAEK 79
Query: 79  KN---ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT--- 130
           +    E+ L L+  +  +     L  Y   N    + + +L      + RGL+Y+H    
Sbjct: 80  RGSNLEVELWLITAFHDKGS---LTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVP 133
Query: 131 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYR 180
                   P + HRD K +N+L+      V + DFG A +   G+        + +R Y 
Sbjct: 134 WCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 181 APELIFGATEYTTS----IDIWSAGCVLAELL 208
           APE++ GA  +       ID+++ G VL EL+
Sbjct: 193 APEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 129/331 (38%), Gaps = 68/331 (20%)
Query: 5   CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL 57
           C  ++   Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L
Sbjct: 50  CISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
            ++  H + I   + +  T    + ++ +VME     +   LK   S +      Y K  
Sbjct: 109 NKLQQHSDKIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-- 162
Query: 118 TYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 172
                  L  +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+     ++   S
Sbjct: 163 -----NMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 173 YICSRFYRAPELIFGATEYTTS----------IDIWSAGCVLAELLLGQPLFPGENAVDQ 222
            + +  Y  PE I   +    +           D+WS GC+L  +  G+   P +  ++Q
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQ 273
Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQ 279
           + ++  ++           +PN+ +  FP I              PE  DL   L   L+
Sbjct: 274 ISKLHAII-----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLK 306
Query: 280 YSPSLRCTALEACAHPFFDELREPNARLPNG 310
             P  R +  E  AHP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 129/331 (38%), Gaps = 68/331 (20%)
Query: 5   CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL 57
           C  ++   Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L
Sbjct: 50  CISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
            ++  H + I   + +  T    + ++ +VME     +   LK   S +      Y K  
Sbjct: 109 NKLQQHSDKIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-- 162
Query: 118 TYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 172
                  L  +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+     ++   S
Sbjct: 163 -----NMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 173 YICSRFYRAPELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
            + +  Y  PE I   +            +   D+WS GC+L  +  G+  F  +  ++Q
Sbjct: 216 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQ 273
Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQ 279
           + ++  ++           +PN+ +  FP I              PE  DL   L   L+
Sbjct: 274 ISKLHAII-----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLK 306
Query: 280 YSPSLRCTALEACAHPFFDELREPNARLPNG 310
             P  R +  E  AHP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 129/331 (38%), Gaps = 68/331 (20%)
Query: 5   CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQL 57
           C  ++   Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L
Sbjct: 50  CISVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
            ++  H + I   + +  T    + ++ +VME     +   LK   S +      Y K  
Sbjct: 109 NKLQQHSDKIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-- 162
Query: 118 TYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 172
                  L  +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+     ++   S
Sbjct: 163 -----NMLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 173 YICSRFYRAPELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ 222
            + +  Y  PE I   +            +   D+WS GC+L  +  G+  F  +  ++Q
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQ 273
Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQ 279
           + ++  ++           +PN+ +  FP I              PE  DL   L   L+
Sbjct: 274 ISKLHAII-----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLK 306
Query: 280 YSPSLRCTALEACAHPFFDELREPNARLPNG 310
             P  R +  E  AHP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 74/323 (22%), Positives = 125/323 (38%), Gaps = 68/323 (21%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPN 65
           Y   + +G+G    VFQ    E  +  AIK V  +         Y+N    L ++  H +
Sbjct: 30  YSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            I   + +  T    + ++ +VME     +   LK   S +      Y K         L
Sbjct: 89  KIIRLYDYEIT----DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWK-------NML 137
Query: 126 AYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYR 180
             +HT+ +  + H DLKP N L+  +   +K+ DFG A Q+      +   S + +  Y 
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 181 APELIFGATE----------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 230
            PE I   +            +   D+WS GC+L  +  G+   P +  ++Q+ ++  ++
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII 253
Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL---LQYSPSLRCT 287
                      +PN+ +  FP I              PE  DL   L   L+  P  R +
Sbjct: 254 -----------DPNH-EIEFPDI--------------PEK-DLQDVLKCCLKRDPKQRIS 286
Query: 288 ALEACAHPFFDELREPNARLPNG 310
             E  AHP+      P  ++  G
Sbjct: 287 IPELLAHPYVQIQTHPVNQMAKG 309

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVIS-LKHCFF 74
           +G G +G V+  K    GE VA+K          ++  E+    +M H N++  +     
Sbjct: 45  IGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--- 130
            T S  +L+L  + +Y    S+Y  LK  +   + M    +KL  Y    GL ++HT   
Sbjct: 103 GTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSM----LKL-AYSSVSGLCHLHTEIF 155
Query: 131 ----VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--GEANI---SYICSRFYRA 181
                P + HRDLK +N+LV        I D G A + I+   E +I   + + ++ Y  
Sbjct: 156 STQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 182 PELI---FGATEYTTSI--DIWSAGCVLAEL 207
           PE++        + + I  D++S G +L E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 48/102 (47%), Gaps = 16/102 (15%)
Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----------- 168
           QI   + ++H+   + HRDLKP N+    +   VK+ DFG    +   E           
Sbjct: 172 QIAEAVEFLHS-KGLMHRDLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 229
Query: 169 --ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL 208
              +   + ++ Y +PE I G   Y+  +DI+S G +L ELL
Sbjct: 230 YATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL----QLMRVMDHP-NVI 67
           Y   R +G+GSFG ++    + +GE VAIK  L+  + K+ +L    +  ++M     + 
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIK--LECVKTKHPQLHIESKFYKMMQGGVGIP 68
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           S+K C          +  +VME +  S+  +   ++  +++  L  V L   Q+   + Y
Sbjct: 69  SIKWC-----GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 128 IHTVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQ 163
           IH+     HRD+KP N L+      + V I DFG AK+
Sbjct: 121 IHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 38/214 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRR----YKNRELQLMRVMDHPNVIS-LKHCF 73
           VG G +G V++   L  GE+VA+K +   R     ++  E+    ++ H N++  +    
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM 72
Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT--- 130
            S  S  +L+L +   +   S+Y  L+  +      P + ++L       GLA++H    
Sbjct: 73  TSRNSSTQLWL-ITHYHEHGSLYDFLQRQTLE----PHLALRLAVSAAC-GLAHLHVEIF 126
Query: 131 ----VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-----ANISYICSRFYRA 181
                P + HRD K +N+LV     Q  I D G A     G       N   + ++ Y A
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKS-NLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 182 PELI--------FGATEYTTSIDIWSAGCVLAEL 207
           PE++        F + ++T   DIW+ G VL E+
Sbjct: 186 PEVLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 23/202 (11%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISL-KHC 72
           ++G G FG V++   L  G  VA+K+      Q       E++ +    HP+++SL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQI--FRGLAYIH 129
                 +NE+ L  + +Y+     +  +H Y S    M + + +     I   RGL Y+H
Sbjct: 105 ----DERNEMIL--IYKYMENGNLK--RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC--SRFYRAPELIF 186
           T   + HRD+K  N+L+D      KI DFG S K    G+ ++  +   +  Y  PE  F
Sbjct: 157 TRA-IIHRDVKSINILLDE-NFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEY-F 213
Query: 187 GATEYTTSIDIWSAGCVLAELL 208
                T   D++S G VL E+L
Sbjct: 214 IKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVISLKHCFF 74
           +G G FG V++ K    GE VA+K +   R  ++  RE ++ +  ++ H N++     F 
Sbjct: 50  IGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILG----FI 102
Query: 75  STTSKNE---LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           +  +K+      L LV +Y    S++  L  Y+   + M  I + L T     GLA++H 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS---GLAHLHM 157
Query: 131 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-----ICSRF 178
                   P + HRDLK +N+LV        I D G A +  +    I       + ++ 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 179 YRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 207
           Y APE++  +      E     DI++ G V  E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVISLKHCFF 74
           +G G FG V++ K    GE VA+K +   R  ++  RE ++ +  ++ H N++     F 
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILG----FI 63
Query: 75  STTSKNE---LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           +  +K+      L LV +Y    S++  L  Y+   + M  I + L T     GLA++H 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS---GLAHLHM 118
Query: 131 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-----ICSRF 178
                   P + HRDLK +N+LV        I D G A +  +    I       + ++ 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 179 YRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 207
           Y APE++  +      E     DI++ G V  E+
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVISLKHCFF 74
           +G G FG V++ K    GE VA+K +   R  ++  RE ++ +  ++ H N++     F 
Sbjct: 14  IGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILG----FI 66
Query: 75  STTSKNE---LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           +  +K+      L LV +Y    S++  L  Y+   + M  I + L T     GLA++H 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS---GLAHLHM 121
Query: 131 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-----ICSRF 178
                   P + HRDLK +N+LV        I D G A +  +    I       + ++ 
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 180
Query: 179 YRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 207
           Y APE++  +      E     DI++ G V  E+
Sbjct: 181 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVISLKHCFF 74
           +G G FG V++ K    GE VA+K +   R  ++  RE ++ +  ++ H N++     F 
Sbjct: 17  IGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILG----FI 69
Query: 75  STTSKNE---LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH- 129
           +  +K+      L LV +Y    S++  L  Y+   + M  I + L T     GLA++H 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS---GLAHLHM 124
Query: 130 ------TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-----ICSRF 178
                   P + HRDLK +N+LV        I D G A +  +    I       + ++ 
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 183
Query: 179 YRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 207
           Y APE++  +      E     DI++ G V  E+
Sbjct: 184 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVISLKHCFF 74
           +G G FG V++ K    GE VA+K +   R  ++  RE ++ +  ++ H N++     F 
Sbjct: 12  IGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILG----FI 64
Query: 75  STTSKNE---LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           +  +K+      L LV +Y    S++  L  Y+   + M  I + L T     GLA++H 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS---GLAHLHM 119
Query: 131 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-----ICSRF 178
                   P + HRDLK +N+LV        I D G A +  +    I       + ++ 
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 178
Query: 179 YRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 207
           Y APE++  +      E     DI++ G V  E+
Sbjct: 179 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMR--VMDHPNVISLKHCFF 74
           +G G FG V++ K    GE VA+K +   R  ++  RE ++ +  ++ H N++     F 
Sbjct: 37  IGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILG----FI 89
Query: 75  STTSKNE---LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           +  +K+      L LV +Y    S++  L  Y+   + M  I + L T     GLA++H 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM--IKLALSTAS---GLAHLHM 144
Query: 131 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY-----ICSRF 178
                   P + HRDLK +N+LV        I D G A +  +    I       + ++ 
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 203
Query: 179 YRAPELIFGAT-----EYTTSIDIWSAGCVLAEL 207
           Y APE++  +      E     DI++ G V  E+
Sbjct: 204 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL----QLMRVMDHP-NVI 67
           Y   R +G+GSFG ++    +  GE VAIK  L+  + K+ +L    ++ ++M     + 
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           +++ C          +  +VME +  S+  +   ++  +++  L  V L   Q+   + Y
Sbjct: 69  TIRWC-----GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 128 IHTVPRVCHRDLKPQNLL--VDPLTHQVKICDFGSAKQ 163
           IH+     HRD+KP N L  +    + V I DFG AK+
Sbjct: 121 IHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNREL----QLMRVMDHP-NVI 67
           Y   R +G+GSFG ++    +  GE VAIK  L+  + K+ +L    ++ ++M     + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           +++ C          +  +VME +  S+  +   ++  +++  L  V L   Q+   + Y
Sbjct: 67  TIRWC-----GAEGDYNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 128 IHTVPRVCHRDLKPQNLL--VDPLTHQVKICDFGSAKQ 163
           IH+     HRD+KP N L  +    + V I DFG AK+
Sbjct: 119 IHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  AK +   E    VAIK V +    + R     E  +M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP---LIYVKLYTYQIFR 123
           + L     S      + + L+     +S  R L+   + N  +    L  +     +I  
Sbjct: 91  VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFY 179
           G+AY++   +  HRDL  +N +V      VKI DFG  + +   +         +  R+ 
Sbjct: 150 GMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAEL 207
               L  G   +TT  D+WS G VL E+
Sbjct: 208 SPESLKDGV--FTTYSDVWSFGVVLWEI 233

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 8/88 (9%)
Query: 135 CHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANI--SYICSRFYRAPELIFGATE 190
            HRD+KP+N+LV  D   +   + DFG A      +     + + + +Y APE  F  + 
Sbjct: 156 THRDVKPENILVSADDFAY---LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESH 211
Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGEN 218
            T   DI++  CVL E L G P + G+ 
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGDQ 239

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  AK +   E    VAIK V +    + R     E  +M+  +  +V
Sbjct: 16  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 75
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP---LIYVKLYTYQIFR 123
           + L     S      + + L+     +S  R L+     N  +    L  +     +I  
Sbjct: 76  VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFY 179
           G+AY++   +  HRDL  +N +V      VKI DFG  + +   +         +  R+ 
Sbjct: 135 GMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 192
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAEL 207
               L  G   +TT  D+WS G VL E+
Sbjct: 193 SPESLKDGV--FTTYSDVWSFGVVLWEI 218

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 106/259 (40%), Gaps = 49/259 (18%)
Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV----------LQDRRYKNRELQLMRVM 61
           ++   + +G G+FG +   K L T E VAIK            L+ R YK    QL    
Sbjct: 5   NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYK----QLSATE 60
Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
             P V      +F    K   +  +V+E +  S+  +   +   ++   L  V +   Q+
Sbjct: 61  GVPQVY-----YFGPXGK---YNAMVLELLGPSLEDL---FDLCDRTFTLKTVLMIAIQL 109
Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVD-PLT---HQVKICDFGSAKQLIAGEANISYICSR 177
              + Y+HT   + +RD+KP+N LV  P T   H + I DFG AK+ I  E    +I   
Sbjct: 110 ITRMEYVHT-KSLIYRDVKPENFLVGRPGTKRQHAIHIIDFGLAKEYIDPETK-KHIP-- 165
Query: 178 FYRAPELIFGATEYTT-----------SIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
            YR  + + G   Y +             D+ + G +    L G   + G  A D L E 
Sbjct: 166 -YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-DTLKER 223
Query: 227 IKVLGTPTRE---EIRCMN 242
            + +G   R    E+ C N
Sbjct: 224 YQKIGDTKRATPIEVLCEN 242

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  AK +   E    VAIK V +    + R     E  +M+  +  +V
Sbjct: 25  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 84
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP---LIYVKLYTYQIFR 123
           + L     S      + + L+     +S  R L+     N  +    L  +     +I  
Sbjct: 85  VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFY 179
           G+AY++   +  HRDL  +N +V      VKI DFG  + +   +         +  R+ 
Sbjct: 144 GMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 201
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAEL 207
               L  G   +TT  D+WS G VL E+
Sbjct: 202 SPESLKDGV--FTTYSDVWSFGVVLWEI 227

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  AK +   E    VAIK V +    + R     E  +M+  +  +V
Sbjct: 21  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 80
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP---LIYVKLYTYQIFR 123
           + L     S      + + L+     +S  R L+   + N  +    L  +     +I  
Sbjct: 81  VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFY 179
           G+AY++   +  HRDL  +N +V      VKI DFG  + +   +         +  R+ 
Sbjct: 140 GMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 197
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAEL 207
               L  G   +TT  D+WS G VL E+
Sbjct: 198 SPESLKDGV--FTTYSDVWSFGVVLWEI 223

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVISL-KHC 72
           ++G G FG V++   L  G  VA+K+      Q       E++ +    HP+++SL   C
Sbjct: 46  LIGHGVFGKVYKG-VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC 104
Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQI--FRGLAYIH 129
                 +NE+ L  + +Y+     +  +H Y S    M + + +     I   RGL Y+H
Sbjct: 105 ----DERNEMIL--IYKYMENGNLK--RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI-----CSRFYRAPEL 184
           T   + HRD+K  N+L+D      KI DFG +K+    E + +++      +  Y  PE 
Sbjct: 157 TRA-IIHRDVKSINILLDE-NFVPKITDFGISKK--GTELDQTHLXXVVKGTLGYIDPEY 212
Query: 185 IFGATEYTTSIDIWSAGCVLAELL 208
            F     T   D++S G VL E+L
Sbjct: 213 -FIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 22/208 (10%)
Query: 17  RVVGTGSFGIVFQ--AKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           R +G GSFG+V++  AK +   E    VAIK V +    + R     E  +M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRM---PLIYVKLYTYQIFR 123
           + L     S      + + L+     +S  R L+     N  +    L  +     +I  
Sbjct: 91  VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFY 179
           G+AY++   +  HRDL  +N +V      VKI DFG  + +   +         +  R+ 
Sbjct: 150 GMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAEL 207
               L  G   +TT  D+WS G VL E+
Sbjct: 208 SPESLKDGV--FTTYSDVWSFGVVLWEI 233

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	353
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-100
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-98
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-97
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-93
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-93
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-92
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-92
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-91
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-91
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-91
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-89
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-89
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-89
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-88
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-88
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-88
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-88
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-87
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-86
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-86
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-85
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-81
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-65
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-65
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-64
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-62
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-62
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-61
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-58
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-58
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-58
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-56
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-54
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-54
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-54
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-54
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-54
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-52
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-52
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-52
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-52
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-51
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-51
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-51
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-51
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-50
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-50
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-50
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-50
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-50
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-50
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-49
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-49
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-48
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-48
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-48
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-48
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-48
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-47
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-47
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-47
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-47
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-47
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-46
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-46
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-46
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-45
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-45
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-45
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-45
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-45
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-45
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-45
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-45
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-45
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-45
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-45
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-45
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-44
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-44
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-44
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-44
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-44
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-43
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-43
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-43
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-43
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-42
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-42
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-42
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-41
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-41
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-41
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-41
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-41
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-41
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-41
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-41
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-41
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-40
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-40
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-40
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-39
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-39
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-38
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-38
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-38
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-38
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-38
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-37
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-37
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-37
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-37
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-37
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-36
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-36
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-36
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-36
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-35
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-35
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-35
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-35
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-35
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-35
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-34
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-34
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-34
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-34
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-34
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-33
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-32
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-32
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-32
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-30
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-26
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-19
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	9e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-18
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-18
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	9e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-17
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-16
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-16
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-16
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-15
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  610 bits (1576), Expect = 0.0
 Identities = 224/346 (64%), Positives = 280/346 (80%), Gaps = 2/346 (0%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 111

Query: 69  LKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+  K +E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 172 IHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350

Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHPAGT 353
           PNGR  P LFNF  +   ++P L   LIP H + Q   +    A  
Sbjct: 351 PNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATA 396

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  602 bits (1555), Expect = 0.0
 Identities = 211/339 (62%), Positives = 272/339 (80%), Gaps = 3/339 (0%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           + I+Y   +V+G GSFG+VFQAK +E+ E VAIKKVLQD+R+KNRELQ+MR++ HPNV+ 
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVD 96

Query: 69  LKHCFFSTTSK-NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           LK  F+S   K +E+FLNLV+EYVPE++YR  +HY+   Q MP++ +KLY YQ+ R LAY
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH++  +CHRD+KPQNLL+DP +  +K+ DFGSAK LIAGE N+SYICSR+YRAPELIFG
Sbjct: 157 IHSI-GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG 215

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT YTT+IDIWS GCV+AEL+ GQPLFPGE+ +DQLVEIIKVLGTP+RE+I+ MNPNY +
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYME 275

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
            +FPQI+ HP+ KVF  R PP+AIDL SRLL+Y+PS R TA+EA  HPFFDELR   AR+
Sbjct: 276 HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARM 335

Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLN 346
           PNGR LPPLFN+ +E     P+L+++L+P H + +L   
Sbjct: 336 PNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSR 374

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  575 bits (1485), Expect = 0.0
 Identities = 150/339 (44%), Positives = 216/339 (63%), Gaps = 11/339 (3%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM---DHPN 65
           +   +  ER+ G G+FG V   K   TG +VAIKKV+QD R++NRELQ+M+ +    HPN
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPN 80

Query: 66  VISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           ++ L+  F++   +   +++LN+VMEYVP++++R  ++Y       P I +K++ +Q+ R
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 124 GLAYIHTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
            +  +H     VCHRD+KP N+LV+     +K+CDFGSAK+L   E N++YICSR+YRAP
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP 200

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           ELIFG   YTT++DIWS GC+ AE++LG+P+F G+N+  QL EI++VLG P+RE +R +N
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260

Query: 243 PNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
           P++TD      K  PW  VF     +   EA DL S LLQY P  R    EA  HP+FDE
Sbjct: 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320

Query: 300 LREPNARLPNGRPLPP-LFNF-KQELSGASPELVNKLIP 336
           L +P  +LPN + LP  LF F   E+   S     KL+ 
Sbjct: 321 LHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVR 359

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  559 bits (1442), Expect = 0.0
 Identities = 165/377 (43%), Positives = 240/377 (63%), Gaps = 44/377 (11%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
            +  Y   + +GTGSFGIV +   +E+G+  A+KKVLQD RYKNREL +M+V+DH N+I 
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIK 64

Query: 69  LKHCFFSTTSK---------------------------------NELFLNLVMEYVPESM 95
           L   F++T  +                                    +LN++MEYVP+++
Sbjct: 65  LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124

Query: 96  YRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI 155
           ++VLK +  + + +P+  + +Y YQ+FR + +IH++  +CHRD+KPQNLLV+   + +K+
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKL 183

Query: 156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 215
           CDFGSAK+LI  E +++YICSRFYRAPEL+ GATEYT SID+WS GCV  EL+LG+PLF 
Sbjct: 184 CDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243

Query: 216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS 275
           GE ++DQLV II+++GTPT+E++  MNP+YT+ RFP +KA  W K+  +  P  AIDL  
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE 303

Query: 276 RLLQYSPSLRCTALEACAHPFFDELREP-------NARLPNG--RPLPPLFNF-KQELSG 325
           ++L+Y P LR    EA AHPFFD LR         N+  P+G  + +P LFNF   ELS 
Sbjct: 304 QILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSI 363

Query: 326 ASPELVNKLIPDHVKRQ 342
               ++N+++P +    
Sbjct: 364 IPGNVLNRILPKNFSPN 380

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  297 bits (763), Expect = e-100
 Identities = 98/313 (31%), Positives = 157/313 (50%), Gaps = 22/313 (7%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G GS+G+VF+ +  +TG+ VAIKK L+            RE+++++ + HPN+++L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
           F     K  L L  V EY   ++   L  Y    + +P   VK  T+Q  + + + H   
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
              HRD+KP+N+L+      +K+CDFG A+ L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 249
              +D+W+ GCV AELL G PL+PG++ VDQL  I K LG       ++   N  ++  +
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 250 FPQIK-AHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
            P  +   P    F   +   A+ L    L   P+ R T  +   HP+F+ +RE    L 
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298

Query: 309 NGRPLPPLFNFKQ 321
                P    + Q
Sbjct: 299 KEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  292 bits (750), Expect = 7e-98
 Identities = 96/295 (32%), Positives = 155/295 (52%), Gaps = 21/295 (7%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           VG GS+G+V + +  +TG  VAIKK L+    K       RE++L++ + H N+++L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                 K   +L  V E+V  ++   L+ +      +    V+ Y +QI  G+ + H+  
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELIFGATEY 191
            + HRD+KP+N+LV   +  VK+CDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--EIRCMNPNYTDFR 249
             ++D+W+ GC++ E+ +G+PLFPG++ +DQL  I+  LG       E+   NP +   R
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 250 FPQIKAH-PWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
            P+IK   P  + +  ++    IDLA + L   P  R    E   H FF      
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  289 bits (743), Expect = 6e-97
 Identities = 99/326 (30%), Positives = 169/326 (51%), Gaps = 33/326 (10%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMD 62
           +Y+    +G G++  V++ K   T   VA+K++    R ++         RE+ L++ + 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           H N+++L     +  S     L LV EY+ + + + L         + +  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLL 110

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFY 179
           RGLAY H   +V HRDLKPQNLL++    ++K+ DFG A+         +Y   + + +Y
Sbjct: 111 RGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAK--SIPTKTYDNEVVTLWY 166

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 236
           R P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG    +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            I      +  + +P+ +A         R+  +  DL ++LLQ+    R +A +A  HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

Query: 297 FDELREPNARLPNGRPLPPLFNFKQE 322
           F  L E   +LP+   +  L   + +
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQ 310

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  288 bits (738), Expect = 2e-96
 Identities = 88/313 (28%), Positives = 154/313 (49%), Gaps = 30/313 (9%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQD-----RRYKNRELQLMRVMDHPNV 66
           YM  + +G G  G+VF A   +  + VAIKK+ L D          RE++++R +DH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 67  ISLKHCFFSTTSKNELFLN---------LVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           + +      + S+    +          +V EY+   +  VL+        +   + +L+
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLLEEHARLF 125

Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----Y 173
            YQ+ RGL YIH+   V HRDLKP NL ++     +KI DFG A+ +    ++       
Sbjct: 126 MYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           + +++YR+P L+     YT +ID+W+AGC+ AE+L G+ LF G + ++Q+  I++ +   
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244

Query: 234 TREEIRCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
             E+ + +      +          P  ++    +  EA+D   ++L +SP  R TA EA
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 292 CAHPFFDELREPN 304
            +HP+      P 
Sbjct: 304 LSHPYMSIYSFPM 316

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  286 bits (734), Expect = 3e-95
 Identities = 105/346 (30%), Positives = 181/346 (52%), Gaps = 34/346 (9%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 65
           +  + ++G G++G+V  A    TGE VAIKK+          R    RE+++++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +I++ +     + +N   + ++ E +   ++RV+       Q +   +++ + YQ  R +
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAV 125

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-----------YI 174
             +H    V HRDLKP NLL++     +K+CDFG A+ +    A+ S           ++
Sbjct: 126 KVLHGS-NVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +R+YRAPE++  + +Y+ ++D+WS GC+LAEL L +P+FPG +   QL+ I  ++GTP 
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243

Query: 235 REEI--RCMNPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
            +       +P   ++    P   A P  K+F + + P+ IDL  R+L + P+ R TA E
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKE 302

Query: 291 ACAHPFFDELREPNARLPNGRPLPPL-FNFKQELSGASPELVNKLI 335
           A  HP+     +PN   P G P+PP  F F       + + + KLI
Sbjct: 303 ALEHPYLQTYHDPN-DEPEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  284 bits (728), Expect = 2e-94
 Identities = 103/312 (33%), Positives = 157/312 (50%), Gaps = 33/312 (10%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 69
           +G G F  V++A+   T + VAIKK+    R +          RE++L++ + HPN+I L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
              F   ++     ++LV +++   +  ++K     +  +   ++K Y     +GL Y+H
Sbjct: 78  LDAFGHKSN-----ISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIF 186
               + HRDLKP NLL+D     +K+ DFG AK    G  N +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLDE-NGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLF 185

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI---RCMNP 243
           GA  Y   +D+W+ GC+LAELLL  P  PG++ +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
           +Y    F      P H +F      + +DL   L  ++P  R TA +A    +F     P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299

Query: 304 NARLPNGRPLPP 315
                   P P 
Sbjct: 300 GPTPGCQLPRPN 311

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  281 bits (722), Expect = 8e-94
 Identities = 87/303 (28%), Positives = 151/303 (49%), Gaps = 23/303 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLMRVM-DHPNVISLK 70
           Y   R +G G +  VF+A  +   E V +K +   ++ K  RE++++  +   PN+I+L 
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 97

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                  S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H+
Sbjct: 98  DIVKDPVSRTPA---LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 148

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
           +  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+     
Sbjct: 149 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 207

Query: 191 YTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRC-----MNPN 244
           Y  S+D+WS GC+LA ++   +P F G +  DQLV I KVLGT    +        ++P 
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267

Query: 245 YTDFRFPQIKAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
           + D    +     W +  H      + PEA+D   +LL+Y    R TA EA  HP+F  +
Sbjct: 268 FND-ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326

Query: 301 REP 303
            + 
Sbjct: 327 VKD 329

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  282 bits (724), Expect = 1e-93
 Identities = 97/332 (29%), Positives = 159/332 (47%), Gaps = 33/332 (9%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------------RELQL 57
           Y  +R + +GS+G V        G  VAIK+V                       RE++L
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPL--IYVK 115
           +    HPN++ L+  F          L LV E +   + +V+       QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD-----QRIVISPQHIQ 137

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
            + Y I  GL  +H    V HRDL P N+L+    + + ICDF  A++  A      Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILLAD-NNDITICDFNLAREDTADANKTHYVT 195

Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 235
            R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G    +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255

Query: 236 EEIRCM-NP---NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
           E++    +P   +Y       + A  W  V      P A+DL +++L+++P  R +  +A
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 292 CAHPFFDELREPNARLPNGRPLPPLFNFKQEL 323
             HP+F+ L +P   L  G      F+F + +
Sbjct: 315 LRHPYFESLFDPL-DLTEGLSER--FHFDESV 343

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  280 bits (718), Expect = 3e-93
 Identities = 97/313 (30%), Positives = 154/313 (49%), Gaps = 41/313 (13%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G V++A    T ETVAIK++  +   +       RE+ L++ + H N+I LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                  + L L  + EY        LK Y   N  + +  +K + YQ+  G+ + H+  
Sbjct: 102 I---HHNHRLHL--IFEY----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-R 151

Query: 133 RVCHRDLKPQNLLVDPLTH----QVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 185
           R  HRDLKPQNLL+          +KI DFG A+    G     +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMN 242
            G+  Y+TS+DIWS  C+ AE+L+  PLFPG++ +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
           P++    FP+ +     +V    +  E +DL + +L+  P  R +A  A  HP+F     
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325

Query: 303 PNARLPNGRPLPP 315
                       P
Sbjct: 326 ---------DFDP 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  276 bits (709), Expect = 6e-92
 Identities = 102/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           VG G++G+V++AK    G  VA+K++  D   +       RE+ L++ + HPN++SL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             S        L LV E++ + + +VL         +    +K+Y YQ+ RG+A+ H   
Sbjct: 88  IHSERC-----LTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 189
           R+ HRDLKPQNLL++     +K+ DFG A+    G    SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINS-DGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 246
           +Y+TS+DIWS GC+ AE++ G+PLFPG    DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
              F   +  PW  +       E IDL S +L + P+ R +A +A  HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  278 bits (713), Expect = 7e-92
 Identities = 109/341 (31%), Positives = 177/341 (51%), Gaps = 36/341 (10%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 65
           Y     +G G++G+V  A        VAIKK+          R    RE++++    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +I +     + T +    + +V + +   +Y++LK      Q +   ++  + YQI RGL
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGL 141

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----YICSRFYRA 181
            YIH+   V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRA
Sbjct: 142 KYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE++  +  YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259

Query: 242 -NPNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
            N    ++    P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ +
Sbjct: 260 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 318

Query: 299 ELR----EPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 335
           +      EP A           F F  EL     E + +LI
Sbjct: 319 QYYDPSDEPIA--------EAPFKFDMELDDLPKEKLKELI 351

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  274 bits (703), Expect = 2e-91
 Identities = 97/294 (32%), Positives = 160/294 (54%), Gaps = 28/294 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N++ L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             +        L LV E++ + + ++L         +  +  K +  Q+  G+AY H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 189
           RV HRDLKPQNLL++    ++KI DFG A+    G     Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLINR-EGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNYT 246
           +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKYD 235

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
              F   +  PW     K +    IDL S++L+  P+ R TA +A  H +F E 
Sbjct: 236 PN-FTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  275 bits (705), Expect = 6e-91
 Identities = 105/304 (34%), Positives = 162/304 (53%), Gaps = 25/304 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 64
           Y++   VG+G++G V  A    +GE VAIKK+           R Y  REL L++ M H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI L   F   +S    +   LVM ++   + +++        +     ++   YQ+ +
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           GL YIH+   V HRDLKP NL V+    ++KI DFG A+   A      Y+ +R+YRAPE
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNE-DCELKILDFGLARH--ADAEMTGYVVTRWYRAPE 193

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 242
           +I     Y  ++DIWS GC++AE+L G+ LF G++ +DQL +I+KV G P  E ++ + +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253

Query: 243 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                +    PQ     + ++F  R  P+A DL  ++L+     R TA +A  HPFF+  
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312

Query: 301 REPN 304
           R+P 
Sbjct: 313 RDPE 316

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  275 bits (706), Expect = 7e-91
 Identities = 104/335 (31%), Positives = 173/335 (51%), Gaps = 29/335 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 64
           Y   + VG+G++G V  A    TG  VAIKK+           R Y  REL+L++ M H 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY--RELRLLKHMRHE 84

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI L   F    + ++     LVM ++   + +++K     ++++    ++   YQ+ +
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           GL YIH    + HRDLKP NL V+    ++KI DFG A+Q  A      Y+ +R+YRAPE
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNE-DCELKILDFGLARQ--ADSEMTGYVVTRWYRAPE 195

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 242
           +I     YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP  E ++ + +
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255

Query: 243 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
               ++    P+++   +  +      P A++L  ++L      R TA EA AHP+F+ L
Sbjct: 256 DEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314

Query: 301 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 335
            +         P    ++   +    + +   ++ 
Sbjct: 315 HDTED-----EPQVQKYDDSFDDVDRTLDEWKRVT 344

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  269 bits (691), Expect = 1e-89
 Identities = 102/298 (34%), Positives = 157/298 (52%), Gaps = 28/298 (9%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKHC 72
           +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N++ L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
             S        L LV E+  + + +      S N  +    VK + +Q+ +GL + H+  
Sbjct: 70  LHSDKK-----LTLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELIFGAT 189
            V HRDLKPQNLL++    ++K+ +FG A+    G     Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLINR-NGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 190 EYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE---EIRCMNPNY 245
            Y+TSID+WSAGC+ AEL   G+PLFPG +  DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
             +            V   ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  270 bits (693), Expect = 2e-89
 Identities = 96/320 (30%), Positives = 159/320 (49%), Gaps = 41/320 (12%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVISL 69
           +G G++  V++     TG  VA+K+V    +  +         RE+ LM+ + H N++ L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN--QRMPLIYVKLYTYQIFRGLAY 127
                +        L LV E++   + + +   +  N  + + L  VK + +Q+ +GLA+
Sbjct: 69  YDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 184
            H   ++ HRDLKPQNLL++    Q+K+ DFG A+    G    ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLINK-RGQLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDV 179

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           + G+  Y+TSIDIWS GC+LAE++ G+PLFPG N  +QL  I  ++GTP  E +    P+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN-ESLW---PS 235

Query: 245 YTDF-----RFPQIKAHPWHKVFHK----RMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
            T          Q       +V        +    +D    LLQ +P +R +A +A  HP
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295

Query: 296 FFDELREPNARLPNGRPLPP 315
           +F E     A +   R    
Sbjct: 296 WFAEYYHH-ASMGGSRSHHH 314

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  270 bits (693), Expect = 8e-89
 Identities = 107/335 (31%), Positives = 170/335 (50%), Gaps = 29/335 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 64
           Y     VG+G++G V  A   +TG  VA+KK+ +         R Y  REL+L++ M H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 65  NVISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           NVI L   F    S  E   + LV   +   +  ++K      Q++   +V+   YQI R
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILR 143

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           GL YIH+   + HRDLKP NL V+    ++KI DFG A+     +    Y+ +R+YRAPE
Sbjct: 144 GLKYIHSA-DIIHRDLKPSNLAVNE-DCELKILDFGLARH--TADEMTGYVATRWYRAPE 199

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-N 242
           ++     Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ + +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 243 PNYTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
            +  ++     Q+    +  VF     P A+DL  ++L      R TA +A AH +F + 
Sbjct: 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

Query: 301 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 335
            +P+       P+   ++   E      +    L 
Sbjct: 319 HDPDD-----EPVADPYDQSLESRDLLIDEWKSLT 348

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  270 bits (691), Expect = 1e-88
 Identities = 97/335 (28%), Positives = 162/335 (48%), Gaps = 35/335 (10%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+           R Y  REL LM+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+I L + F    S  E   + +VME +  ++ +V++        +    +    YQ+  
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 138

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 139 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++ G  LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 197 VILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255

Query: 244 NYTDF--RFPQIKAHPWHKVFHKRMP-----------PEAIDLASRLLQYSPSLRCTALE 290
               +    P+   + + K+F   +             +A DL S++L    S R +  E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315

Query: 291 ACAHPFFDELREPNARLPNGRPLPPLFNF-KQELS 324
           A  HP+ +   +P+       P  P     ++E +
Sbjct: 316 ALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREHT 349

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  272 bits (697), Expect = 2e-88
 Identities = 101/382 (26%), Positives = 159/382 (41%), Gaps = 79/382 (20%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHP 64
           Y    ++GTGS+G V +A        VAIKK+L+         R    RE+ ++  ++H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           +V+ +         +    L +V+E       ++ +        +  +++K   Y +  G
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVG 168

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS------------ 172
           + Y+H+   + HRDLKP N LV+     VK+CDFG A+ +   E   S            
Sbjct: 169 VKYVHSA-GILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 173 ----------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL------- 209
                           ++ +R+YRAPELI     YT +ID+WS GC+ AELL        
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286

Query: 210 ----GQPLFPGENAV--------------------DQLVEIIKVLGTPTREEIRCM-NPN 244
                 PLFPG +                      DQL  I  +LGTP+ E+I  +   +
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKED 346

Query: 245 YTDF--RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
              +   FP+ +     + F      +AI L  R+L ++P+ R T  E  AHPFF E+R 
Sbjct: 347 AKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405

Query: 303 PNARLPNGRPLPPLFNFKQELS 324
                     +   FN    + 
Sbjct: 406 AEVETNATEKVRLPFNDWMNMD 427

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  267 bits (684), Expect = 3e-88
 Identities = 84/300 (28%), Positives = 139/300 (46%), Gaps = 31/300 (10%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RE---LQLMRVMDHPNV 66
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L     ++ +  E+ + LV E+V + +   L    +    +P   +K    Q  RGL 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLD 134

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPE 183
           ++H    + HRDLKP+N+LV      VK+ DFG A+        ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVTS-GGTVKLADFGLAR---IYSYQMALTPVVVTLWYRAPE 189

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++  +T Y T +D+WS GC+ AE+   +PLF G +  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 244 NYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                    FP     P   V    M      L   +L ++P  R +A  A  H +  + 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  267 bits (685), Expect = 3e-88
 Identities = 99/325 (30%), Positives = 157/325 (48%), Gaps = 34/325 (10%)

Query: 19  VGTGSFGIVFQAK-CLETGETVAIKKVLQDRRYKN-------RE---LQLMRVMDHPNVI 67
           +G G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L      + +  E  L LV E+V + +   L         +P   +K   +Q+ RGL +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 135

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPEL 184
           +H+  RV HRDLKPQN+LV   + Q+K+ DFG A+        ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAPEV 190

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +  ++ Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P  E+     P 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245

Query: 245 YT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 301
                   F    A P  K     +     DL  + L ++P+ R +A  A +HP+F +L 
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304

Query: 302 EPNARLPNGRPLPPLFNFKQELSGA 326
                L       P      EL+ A
Sbjct: 305 RCKENLD---SHLPPSQNTSELNTA 326

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  270 bits (692), Expect = 1e-87
 Identities = 96/332 (28%), Positives = 166/332 (50%), Gaps = 36/332 (10%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--------DRRYKNRELQLMRVMDHP 64
           Y   + +G+G+ GIV  A        VAIKK+ +         R Y  REL LM+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 65  NVISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N+ISL + F    +  E   + LVME +  ++ +V++        +    +    YQ+  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLC 175

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           G+ ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE
Sbjct: 176 GIKHLHSA-GIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P
Sbjct: 234 VILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292

Query: 244 NYTDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALE 290
              ++    P+     + K+F           +K    +A DL S++L   P+ R +  +
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352

Query: 291 ACAHPFFDELREPNARLPNGRPLPPLFNFKQE 322
           A  HP+ +   +P        P P +++ + +
Sbjct: 353 ALQHPYINVWYDPAEVEA---PPPQIYDKQLD 381

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  263 bits (674), Expect = 3e-86
 Identities = 84/320 (26%), Positives = 141/320 (44%), Gaps = 36/320 (11%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMDHPNVIS 68
           +G G+FG VF+A+  +TG+ VA+KKV      +N          RE+++++++ H NV++
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 80

Query: 69  LK---HCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRG 124
           L        S  ++ +  + LV ++        L    S+   +  L  +K     +  G
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDF----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ--LIAGEANISY---ICSRFY 179
           L YIH   ++ HRD+K  N+L+      +K+ DFG A+   L        Y   + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE--- 236
           R PEL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E   
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVF-HKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
            +      Y      + +              P A+DL  +LL   P+ R  + +A  H 
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313

Query: 296 FFDELREPNARLPNGRPLPP 315
           FF    +P      G     
Sbjct: 314 FFWS--DPMPSDLKGMLSTH 331

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  263 bits (674), Expect = 7e-86
 Identities = 91/361 (25%), Positives = 171/361 (47%), Gaps = 61/361 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---QD-----RRYKNRELQLMRVM-DH 63
           Y   + +G G++GIV+++    TGE VA+KK+    Q+     R +  RE+ ++  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
            N+++L +   +  +  +++L  V +Y+   ++ V++        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRAD-NDRDVYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS----------- 172
            + Y+H+   + HRD+KP N+L++     VK+ DFG ++  +      +           
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 173 -----------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD 221
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG + ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 222 QLVEIIKVLGTPTREEIRCM-NPNYTDF--RFPQIKAHPWHKVFHKRMP----------- 267
           QL  II V+  P+ E++  + +P          +                          
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 268 ----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQEL 323
                EA+DL  +LLQ++P+ R +A +A  HPF      PN        +    N   + 
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358

Query: 324 S 324
           S
Sbjct: 359 S 359

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  262 bits (671), Expect = 7e-85
 Identities = 98/376 (26%), Positives = 164/376 (43%), Gaps = 75/376 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQD--RRYKNRELQLMRVMDHP 64
           Y+ + ++G GS+G V+ A    T + VAIKKV      L D  R    RE+ ++  +   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 65  NVISLKHCFFSTTSK--NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
            +I L            +EL++  V+E     + ++ K        +   ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFK----TPIFLTEEHIKTILYNLL 139

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS---------- 172
            G  +IH    + HRDLKP N L++     VK+CDFG A+ + + +              
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQ-DCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 173 -------------YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-------- 211
                        ++ +R+YRAPELI     YT SIDIWS GC+ AELL           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 212 ---PLFPG-----------------ENAVDQLVEIIKVLGTPTREEIRCM-NPNYTDF-- 248
              PLFPG                 ++  DQL  I  ++GTPT ++++ +  P    +  
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP 308
            FP  K     + +   +  + I+L   +L+++P+ R T  +A  HP+  ++R+      
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENF 376

Query: 309 NGRPLPPLFNFKQELS 324
           + + +   F+    LS
Sbjct: 377 STKKIILPFDDWMVLS 392

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  252 bits (646), Expect = 2e-81
 Identities = 94/345 (27%), Positives = 157/345 (45%), Gaps = 40/345 (11%)

Query: 19  VGTGSFGIVFQAKCLE--TGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 74
           VG G++G V++AK  +    +  A+K++       +  RE+ L+R + HPNVISL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 75  STTSKNELFLNLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIH 129
           S   +    + L+ +Y    ++ ++K + ++       ++P   VK   YQI  G+ Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 130 TVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQLIAGEANISYICSR----FYRAP 182
               V HRDLKP N+LV        +VKI D G A+   +    ++ +       +YRAP
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---------DQLVEIIKVLGTP 233
           EL+ GA  YT +IDIW+ GC+ AELL  +P+F               DQL  I  V+G P
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264

Query: 234 TRE---------EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 284
             +         E   +  ++    +       + +    +   +A  L  +LL   P  
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324

Query: 285 RCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPE 329
           R T+ +A   P+F E  +P             +  ++ L+   P+
Sbjct: 325 RITSEQAMQDPYFLE--DPLPTSDVFAGCQIPYPKREFLTEEEPD 367

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  212 bits (541), Expect = 2e-65
 Identities = 97/339 (28%), Positives = 160/339 (47%), Gaps = 54/339 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 63
           Y   +V+G GSFG V +A   +  + VA+K V  ++R+      E++++  +      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
            NVI +   F   T +N + +    E +  ++Y ++K   +  Q   L  V+ + + I +
Sbjct: 159 MNVIHMLENF---TFRNHICM--TFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQ 211

Query: 124 GLAYIHTVPRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
            L  +H   R+ H DLKP+N LL       +K+ DFGS+      +   +YI SRFYRAP
Sbjct: 212 CLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC--YEHQRVYTYIQSRFYRAP 268

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR--- 239
           E+I GA  Y   ID+WS GC+LAELL G PL PGE+  DQL  +I++LG P+++ +    
Sbjct: 269 EVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327

Query: 240 --------CMNPNYTDF---------------RFPQIKAHPWHKVFHKRMPPEA----ID 272
                      P Y                  R  +++  P  + +   +        +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387

Query: 273 LASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGR 311
              + L++ P++R T  +A  HP+    R    + P G 
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL---RRRLPKPPTGE 423

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  209 bits (534), Expect = 6e-65
 Identities = 87/339 (25%), Positives = 146/339 (43%), Gaps = 42/339 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 64
           Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 65  NVISLKHC-----FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
           + +   H       F+    N + + +V E + E++  ++K Y   ++ +PLIYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYI 174
           Q+  GL Y+H    + H D+KP+N+L++ +        +KI D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW--YDEHYTNSI 196

Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 228
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  +         D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 229 VLGTPTREEIR-------CMNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLAS 275
           +LG      +R         N         ++K  P   V  ++         E  D  S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 276 RLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP 314
            +LQ  P  R  A     HP+  +           R L 
Sbjct: 316 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  208 bits (530), Expect = 2e-64
 Identities = 96/333 (28%), Positives = 150/333 (45%), Gaps = 56/333 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM------DH 63
           Y  + ++G GSFG V +A      E VAIK +   + + N    E++L+ +M        
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
             ++ LK  F     +N L L  V E +  ++Y +L++ +   + + L   + +  Q+  
Sbjct: 116 YYIVHLKRHF---MFRNHLCL--VFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCT 168

Query: 124 GLAYIHTV-PRVCHRDLKPQN-LLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRA 181
            L ++ T    + H DLKP+N LL +P    +KI DFGS+ Q   G+    YI SRFYR+
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSRFYRS 226

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR-- 239
           PE++ G   Y  +ID+WS GC+L E+  G+PLF G N VDQ+ +I++VLG P    +   
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285

Query: 240 ---------CMNPNYTDFRFPQIKAH---PWHKVFH-----KRMPPEA------------ 270
                      +  +   +    K     P  +  H     +   P              
Sbjct: 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345

Query: 271 ----IDLASRLLQYSPSLRCTALEACAHPFFDE 299
                DL  R+L Y P  R     A  H FF +
Sbjct: 346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  202 bits (515), Expect = 1e-62
 Identities = 81/334 (24%), Positives = 137/334 (41%), Gaps = 54/334 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 62
           Y     +G G+FG V +    + G   VA+K V    RY      E+Q++  +       
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
               + +   F        + +  V E +  S Y  +K          L +++   YQI 
Sbjct: 76  TFRCVQMLEWF---EHHGHICI--VFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQIC 128

Query: 123 RGLAYIHTVPRVCHRDLKPQN-LLVD-----------------PLTHQVKICDFGSAKQL 164
           + + ++H+  ++ H DLKP+N L V                   +   +K+ DFGSA   
Sbjct: 129 KSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--T 185

Query: 165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 224
              E + + + +R YRAPE+I     ++   D+WS GC+L E  LG  +FP  ++ + L 
Sbjct: 186 YDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244

Query: 225 EIIKVLGTPTREEIR-CMNPNY-TDFRFPQIKAHPWHKVFHKRMPP-------------E 269
            + ++LG   +  I+      Y    R    +     +   +   P              
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304

Query: 270 AIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
             DL  ++L+Y P+ R T  EA  HPFFD L++ 
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  201 bits (513), Expect = 5e-62
 Identities = 75/335 (22%), Positives = 135/335 (40%), Gaps = 60/335 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVM-----DHP 64
           ++  R +G G+FG V   + ++  +  A+K V   ++Y      E  +++ +     ++ 
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           N++     F      + + L  + E +  S+Y ++   +       +  +KLY  +I + 
Sbjct: 97  NIVKYHGKF---MYYDHMCL--IFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKA 149

Query: 125 LAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------------QVKICDFGS 160
           L Y+  +  + H DLKP+N LL DP                           +K+ DFG 
Sbjct: 150 LNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
           A      + + S I +R YRAPE+I     +  S D+WS GCVLAEL  G  LF     +
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265

Query: 221 DQLVEIIKVLGTPTREEIR---------CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA- 270
           + L  +  ++    +  +           +N +     +P+  +        K+  P   
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325

Query: 271 -------IDLASRLLQYSPSLRCTALEACAHPFFD 298
                   D    +LQ  P+LR +  E   H F +
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  199 bits (508), Expect = 2e-61
 Identities = 77/343 (22%), Positives = 130/343 (37%), Gaps = 54/343 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDRRYKN---RELQLMRVM------D 62
           Y     +G G+FG V +      G   VA+K +    +Y+     E+ +++ +      +
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
               + +   F        + +    E + ++ +  LK  +   Q  PL +V+   YQ+ 
Sbjct: 81  KFLCVLMSDWF---NFHGHMCI--AFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLC 133

Query: 123 RGLAYIHTVPRVCHRDLKPQN-LLVDPLTH-----------------QVKICDFGSAKQL 164
             L ++H   ++ H DLKP+N L V+                      +++ DFGSA   
Sbjct: 134 HALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--T 190

Query: 165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 224
              E + + + +R YR PE+I     +    D+WS GC+L E   G  LF      + LV
Sbjct: 191 FDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249

Query: 225 EIIKVLGTPTREEIRCM---------NPNYTDFRFPQIKAHPWHKVFHKRMPPEA----- 270
            + K+LG      I               + +            K     M  ++     
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309

Query: 271 -IDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRP 312
             DL  R+L++ P+ R T  EA  HPFF  L          R 
Sbjct: 310 LFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  193 bits (492), Expect = 1e-58
 Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 65
           Y   + +G+G    VFQ    E  +  AIK V  +            E+  +  +   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 66  -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +I L           + ++ +VME     +   LK      + +     K Y   +   
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 181
           +  IH    + H DLKP N L+      +K+ DFG A Q+     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 182 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 230
           PE I             ++ +   D+WS GC+L  +  G+  F    N + +L  II   
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 281

Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
                      +PN+    FP I               +  D+    L+  P  R +  E
Sbjct: 282 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 317

Query: 291 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 350
             AHP+      P  ++  G      +   Q +   SP  + K      +   G    + 
Sbjct: 318 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 377

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  189 bits (483), Expect = 4e-58
 Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 62/320 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRVMDHPN- 65
           Y   + +G+G    VFQ    E  +  AIK V      ++   +   E+  +  +   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 66  -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +I L           + ++ +VME     +   LK      + +     K Y   +   
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 181
           +  IH    + H DLKP N L+      +K+ DFG A Q+     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 182 PELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 230
           PE I             ++ +   D+WS GC+L  +  G+  F    N + +L  II   
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 253

Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
                      +PN+    FP I               +  D+    L+  P  R +  E
Sbjct: 254 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 289

Query: 291 ACAHPFFDELREPNARLPNG 310
             AHP+      P  ++  G
Sbjct: 290 LLAHPYVQIQTHPVNQMAKG 309

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  190 bits (484), Expect = 6e-58
 Identities = 73/360 (20%), Positives = 124/360 (34%), Gaps = 62/360 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPN- 65
           Y   + +G+G    VFQ    E  +  AIK V  +            E+  +  +   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 66  -VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +I L           + ++ +VME     +   LK      + +     K Y   +   
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRA 181
           +  IH    + H DLKP N L+      +K+ DFG A Q+     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 182 PELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPG-ENAVDQLVEIIKVL 230
           PE I             ++ +   D+WS GC+L  +  G+  F    N + +L  II   
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 234

Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
                      +PN+    FP I               +  D+    L+  P  R +  E
Sbjct: 235 -----------DPNHE-IEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPE 270

Query: 291 ACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLHP 350
             AHP+      P  ++  G      +   Q +   SP  + K      +   G    + 
Sbjct: 271 LLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNS 330

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  185 bits (473), Expect = 1e-56
 Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 52/299 (17%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQ-LMRVMDHP 64
           S+     +G GS+G VF+ +  E G   A+K+ +      +DR  K  E+    +V  HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
             + L+  +          L L  E    S+ +  + +      +P   V  Y       
Sbjct: 118 CCVRLEQAWEEGGI-----LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLA 169

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           LA++H+   + H D+KP N+ + P   + K+ DFG   +L    A         Y APEL
Sbjct: 170 LAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     Y T+ D++S G  + E+     L  G     QL +                   
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---------------- 269

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
                            F   +  E   +   +L+  P LR TA    A P     R+P
Sbjct: 270 --------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL---RQP 311

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  185 bits (471), Expect = 3e-56
 Identities = 66/310 (21%), Positives = 109/310 (35%), Gaps = 48/310 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 68
           Y+  + +G G F  V   + L  G   A+K++L    QDR    RE  + R+ +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 69  LKHCFF-STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L         +K+E +  L++ +    +++  ++        +    +      I RGL 
Sbjct: 91  LVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK----------QLIAGEANISYICS 176
            IH      HRDLKP N+L+     Q  + D GS            Q +  +   +  C+
Sbjct: 149 AIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 177 RFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
             YRAPEL             D+WS GCVL  ++ G+  +         V +  V     
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-VQN--- 262

Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                           PQ            R       L + ++   P  R       + 
Sbjct: 263 ------------QLSIPQ----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300

Query: 295 PFFDELREPN 304
               +   P 
Sbjct: 301 LEALQPPAPG 310

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  179 bits (456), Expect = 1e-54
 Identities = 69/299 (23%), Positives = 115/299 (38%), Gaps = 45/299 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y     +GTGS+G   + +    G+ +  K++        +++    E+ L+R + HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +         T+     L +VMEY     +  V+   +   Q +   +V     Q+   L
Sbjct: 68  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 126 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYR 180
              H        V HRDLKP N+ +D     VK+ DFG A+ L    +       + +Y 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           +PE +     Y    DIWS GC+L EL    P F   +   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                 + +F +I           R   E  ++ +R+L      R +  E   +P   E
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  183 bits (467), Expect = 2e-54
 Identities = 71/301 (23%), Positives = 125/301 (41%), Gaps = 51/301 (16%)

Query: 11  ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVIS 68
           IS+  + V+G G+ G +   + +     VA+K++L +   + +RE+QL+R  D HPNVI 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMY-RVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
                     K+  F  + +E    ++   V +   +     P+  ++    Q   GLA+
Sbjct: 83  YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 128 IHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSAKQLIAGEANISY---IC-SRFY 179
           +H++  + HRDLKP N+L+         +  I DFG  K+L  G  + S    +  +  +
Sbjct: 134 LHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 180 RAPELIFGATE--YTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTRE 236
            APE++    +   T ++DI+SAGCV   ++  G   F                    + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL----------------QR 236

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
           +   +               P      K     A +L  +++   P  R +A     HPF
Sbjct: 237 QANILLGAC-SLDCLH----PE-----KHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286

Query: 297 F 297
           F
Sbjct: 287 F 287

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  181 bits (461), Expect = 2e-54
 Identities = 44/333 (13%), Positives = 90/333 (27%), Gaps = 57/333 (17%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-------NRELQLMRVMDHP 64
                  +  G   +VF  + +E  E  A+K                +        +   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 65  NVISLKHCFFSTTSKNELFLN---------------------LVMEYVP---ESMYRVLK 100
           +    +         + + +                      L+M       E ++  L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 101 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 160
                     ++ + + T Q+ R  A + +   + H    P NL + P   ++ + D  +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMP-DGRLMLGDVSA 240

Query: 161 AKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 219
             +   G    +      Y   E +      +T +++ W  G  +  +      F     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQ 279
             +       L  P  +                             +P     L  R L 
Sbjct: 299 GIKGSWKRPSLRVPGTD--------------------SLAFGSCTPLPDFVKTLIGRFLN 338

Query: 280 YSPSLRCTALEACAHPFFDELR-EPNARLPNGR 311
           +    R   LEA   P F +L+ E ++ L  G+
Sbjct: 339 FDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  179 bits (456), Expect = 4e-54
 Identities = 57/301 (18%), Positives = 119/301 (39%), Gaps = 21/301 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L      TT+++     L+ME+ P  S+Y VL+  S+A   +P     +    +  G+ 
Sbjct: 71  KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAY-GLPESEFLIVLRDVVGGMN 126

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           ++     + HR++KP N++           K+ DFG+A++L   E  +S   +  Y  P+
Sbjct: 127 HLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 184 LIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
           +   A        +Y  ++D+WS G        G   F       +  E++  + T    
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                     +         P      + +      + + +L+          +  A   
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305

Query: 297 F 297
            
Sbjct: 306 D 306

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  178 bits (453), Expect = 8e-54
 Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 59/312 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 69
           +    V+G G+FG V +A+        AIKK+       +    E+ L+  ++H  V+  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 70  KHCF--------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 120
              +          T  K +  L + MEY    ++Y ++   +   QR           Q
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD---EYWRLFRQ 124

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR--- 177
           I   L+YIH+   + HRDLKP N+ +D  +  VKI DFG AK +      +         
Sbjct: 125 ILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 178 ------------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 225
                        Y A E++ G   Y   ID++S G +  E++   P   G       V 
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RVN 236

Query: 226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 285
           I+K L +                 FP     P    F          +   L+ + P+ R
Sbjct: 237 ILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNKR 275

Query: 286 CTALEACAHPFF 297
             A       + 
Sbjct: 276 PGARTLLNSGWL 287

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  175 bits (446), Expect = 1e-52
 Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 44/294 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 65
           +  E+ +G G F  V++A CL  G  VA+KKV        + R    +E+ L++ ++HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           VI     F          LN+V+E      + R++KH+    + +P   V  Y  Q+   
Sbjct: 94  VIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPE 183
           L ++H+  RV HRD+KP N+ +   T  VK+ D G  +   +      S + + +Y +PE
Sbjct: 149 LEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMN 242
            I     Y    DIWS GC+L E+   Q  F G+   +  L + I           +C  
Sbjct: 207 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------EQC-- 253

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                  +P + +             E   L +  +   P  R           
Sbjct: 254 ------DYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  174 bits (442), Expect = 2e-52
 Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 50/297 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHC 72
           +    ++G+G FG VF+AK    G+T  IK+V  +     RE++ +  +DH N++    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 73  F-----------FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ 120
           +            +++      L + ME+  + ++ + ++      +++  +       Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQ 130

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 180
           I +G+ YIH+  ++ +RDLKP N+ +   T QVKI DFG    L           +  Y 
Sbjct: 131 ITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           +PE I    +Y   +D+++ G +LAELL                ++              
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD------------ 233

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                               +       +   L  +LL   P  R    E       
Sbjct: 234 -------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  177 bits (451), Expect = 4e-52
 Identities = 81/314 (25%), Positives = 135/314 (42%), Gaps = 60/314 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMR-VMDHPNVISLK 70
            ++E+++G GS G V   +    G  VA+K++L D       E++L+    DHPNVI   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY- 74

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMY-RVLKH--YSSANQRMPLIYVKLYTYQIFRGLAY 127
           +C  +T    + FL + +E    ++   V          +            QI  G+A+
Sbjct: 75  YCSETT----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 128 IHTVPRVCHRDLKPQNLLVD------------PLTHQVKICDFGSAKQLIAGEANISYIC 175
           +H++ ++ HRDLKPQN+LV                 ++ I DFG  K+L +G+++     
Sbjct: 131 LHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 176 SRF-----YRAPELIFGATE------YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQL 223
           +       +RAPEL+  +         T SIDI+S GCV   +L  G+  F  +    + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 224 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 283
             II+                   F   ++K      +       EA DL S+++ + P 
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285

Query: 284 LRCTALEACAHPFF 297
            R TA++   HP F
Sbjct: 286 KRPTAMKVLRHPLF 299

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  172 bits (439), Expect = 8e-52
 Identities = 78/304 (25%), Positives = 129/304 (42%), Gaps = 50/304 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKN---RELQLMRVMDHPNVISLKHC 72
            V+G G++GIV+  + L     +AIK++  +D RY      E+ L + + H N++     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           +  + S+N  F+ + ME VP  S+  +L+  +         I    YT QI  GL Y+H 
Sbjct: 84  YLGSFSENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELIFGAT 189
             ++ HRD+K  N+L++  +  +KI DFG++K+L        ++  +  Y APE+I    
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 190 E-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y  + DIWS GC + E+  G+P F       +L E    +                 F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236

Query: 249 RFPQIKAHPWHKVFHKRMP----PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
           +    K HP        +P     EA     +  +  P  R  A +     F     +  
Sbjct: 237 KVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

Query: 305 ARLP 308
              P
Sbjct: 290 KTQP 293

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  171 bits (437), Expect = 2e-51
 Identities = 76/318 (23%), Positives = 124/318 (38%), Gaps = 50/318 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLMRVMDHPN 65
           Y+  R +G G F   F+    +T E  A K     +L     +     E+ + R + H +
Sbjct: 17  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           V+     F      + +F  +V+E     S+  + K      + +     + Y  QI  G
Sbjct: 77  VVGFHGFF---EDNDFVF--VVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLG 127

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
             Y+H   RV HRDLK  NL ++    +VKI DFG A ++         +C +  Y APE
Sbjct: 128 CQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++     ++  +D+WS GC++  LL+G+P F      +  + I K               
Sbjct: 186 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------------- 230

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
              ++  P              + P A  L  ++LQ  P+ R T  E     FF     P
Sbjct: 231 ---EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275

Query: 304 NARLPNGRPLPPLFNFKQ 321
                    +PP F+   
Sbjct: 276 ARLPITCLTIPPRFSIAP 293

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  173 bits (440), Expect = 2e-51
 Identities = 65/292 (22%), Positives = 106/292 (36%), Gaps = 47/292 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRVMDHPNVISLKH 71
              +  VG GSFG V + K  +TG   A+KKV L+   ++  EL     +  P ++ L  
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGLSSPRIVPLYG 117

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                       +N+ ME +   S+ +++K        +P      Y  Q   GL Y+HT
Sbjct: 118 AVREGPW-----VNIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT 168

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------FYRAPEL 184
             R+ H D+K  N+L+     +  +CDFG A  L       S +          + APE+
Sbjct: 169 R-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           + G       +DIWS+ C++  +L G   +         ++I      P           
Sbjct: 228 VMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPI---------- 275

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                  +I              P         L+  P  R +A+E      
Sbjct: 276 ------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  171 bits (435), Expect = 8e-51
 Identities = 76/319 (23%), Positives = 124/319 (38%), Gaps = 50/319 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLMRVMDHPN 65
           Y+  R +G G F   F+    +T E  A K     +L     +     E+ + R + H +
Sbjct: 43  YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           V+     F      + +F+  V+E     S+  + K      + +     + Y  QI  G
Sbjct: 103 VVGFHGFF---EDNDFVFV--VLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLG 153

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
             Y+H   RV HRDLK  NL ++    +VKI DFG A ++         +C +  Y APE
Sbjct: 154 CQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++     ++  +D+WS GC++  LL+G+P F      +  + I K               
Sbjct: 212 VLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------------- 256

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
              ++  P              + P A  L  ++LQ  P+ R T  E     FF     P
Sbjct: 257 ---EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301

Query: 304 NARLPNGRPLPPLFNFKQE 322
                    +PP F+    
Sbjct: 302 ARLPITCLTIPPRFSIAPS 320

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  171 bits (436), Expect = 9e-51
 Identities = 65/298 (21%), Positives = 114/298 (38%), Gaps = 46/298 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y+  + +G GSFG     K  E G    IK++       ++R    RE+ ++  M HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +  +  F    S     L +VM+Y     +++ +              +  +  QI   L
Sbjct: 86  VQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLAL 138

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            ++H   ++ HRD+K QN+ +      V++ DFG A+ L +          + +Y +PE+
Sbjct: 139 KHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEI 196

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
                 Y    DIW+ GCVL EL   +  F   + +  LV  I             ++ +
Sbjct: 197 CEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------SGSFPPVSLH 248

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
           Y                       +   L S+L + +P  R +        F  +  E
Sbjct: 249 Y---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  173 bits (441), Expect = 4e-50
 Identities = 74/322 (22%), Positives = 129/322 (40%), Gaps = 53/322 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 66
           Y   + +G+G++G V   +   T    AIK +               E+ +++++DHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 122
           + L   F     +++    LVME     E    ++    ++            +   Q+ 
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVL 146

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 180
            G+ Y+H    + HRDLKP+NLL++       +KI DFG +      +     + + +Y 
Sbjct: 147 SGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++    +Y    D+WS G +L  LL G P F G+   DQ  EI+         ++  
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
               +            W  V        A DL  ++LQ+    R +A +A  HP+  E+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

Query: 301 REPNARLPNGRPLPPLF-NFKQ 321
                       L     N ++
Sbjct: 299 CSKKESGIELPSLANAIENMRK 320

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  173 bits (440), Expect = 4e-50
 Identities = 87/322 (27%), Positives = 138/322 (42%), Gaps = 53/322 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 65
           Y  +RV+G GSFG V   K   TG+  A+K +         D+    RE+QL++ +DHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQI 121
           ++ L   F     +++ +  LV E     E    ++    +S                Q+
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFY 179
             G+ Y+H   ++ HRDLKP+NLL++  +    ++I DFG +    A +     I + +Y
Sbjct: 136 LSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APE++ G   Y    D+WS G +L  LL G P F G N  D L ++ K           
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----------- 241

Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                   + F       W KV        A DL  ++L Y PS+R +A +A  H +   
Sbjct: 242 ------GKYTFE---LPQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287

Query: 300 LREPNARLPNGRPLPPLFNFKQ 321
             +    +        + N +Q
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQ 309

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  173 bits (440), Expect = 4e-50
 Identities = 82/322 (25%), Positives = 132/322 (40%), Gaps = 53/322 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 66
           Y    ++G GSFG V + K   T +  A+K +       +D     RE++L++ +DHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 122
           + L         ++     +V E     E    ++K   +S                Q+F
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 180
            G+ Y+H    + HRDLKP+N+L++       +KI DFG +            I + +Y 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++ G   Y    D+WSAG +L  LL G P F G+N  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                  + F       W  +       +A DL  ++L + PSLR TA +   HP+  + 
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283

Query: 301 REPNARLPNGRPLPPLF-NFKQ 321
                 + +   L     N +Q
Sbjct: 284 SSETPTISDLPSLESAMTNIRQ 305

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  168 bits (427), Expect = 4e-50
 Identities = 62/290 (21%), Positives = 116/290 (40%), Gaps = 42/290 (14%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISLKH 71
            +G GSF  V++    ET   VA  ++   +  K+       E ++++ + HPN++    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
            + ST    +  + LV E +   ++   LK +    + M +  ++ +  QI +GL ++HT
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147

Query: 131 -VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
             P + HRDLK  N+ +   T  VKI D G A    A  A  + I +  + APE+     
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMY--EE 204

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
           +Y  S+D+++ G  + E+   +  +       Q+   +      T               
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV------TSGVKPASFDKVAI-- 256

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                             PE  ++    ++ +   R +  +   H FF E
Sbjct: 257 ------------------PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  168 bits (427), Expect = 6e-50
 Identities = 64/318 (20%), Positives = 120/318 (37%), Gaps = 60/318 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVI 67
           +   + +G G FG+VF+AK        AIK++        R    RE++ +  ++HP ++
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 68  SLKHCFF-------STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTY 119
              + +           S  +++L + M+    E++   +    +  +R           
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER-ERSVCLHIFL 125

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 177
           QI   + ++H+   + HRDLKP N+        VK+ DFG    +   E   + +     
Sbjct: 126 QIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 178 -----------FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
                       Y +PE I G   Y+  +DI+S G +L ELL   P F  +    + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 286
           ++                  + +FP +           +  P    +   +L  SP  R 
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272

Query: 287 TALEACAHPFFDELREPN 304
            A+    +  F++L  P 
Sbjct: 273 EAINIIENAVFEDLDFPG 290

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  170 bits (433), Expect = 7e-50
 Identities = 50/293 (17%), Positives = 112/293 (38%), Gaps = 23/293 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           ++   ++G G+   VF+ +  +TG+  AIK       L+    + RE ++++ ++H N++
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L      TT+++     L+ME+ P       + +  ++    +P     +    +  G+
Sbjct: 71  KLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLT---HQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
            ++     + HR++KP N++           K+ DFG+A++L   E  +S   +  Y  P
Sbjct: 126 NHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 183 ELIFGAT-------EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR 235
           ++   A        +Y  ++D+WS G        G   F       +  E++  + T   
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 288
                      +         P      + +      + + +L+         
Sbjct: 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  167 bits (424), Expect = 8e-50
 Identities = 76/302 (25%), Positives = 130/302 (43%), Gaps = 52/302 (17%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  ++   +A+K     ++ +        RE+++   + HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F        ++  L++EY P  ++YR L+       +        Y  ++   L+Y 
Sbjct: 75  YGYFH---DATRVY--LILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 125

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
           H+  RV HRD+KP+NLL+     ++KI DFG +    +       +C +  Y  PE+I G
Sbjct: 126 HS-KRVIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTD--LCGTLDYLPPEMIEG 181

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+WS G +  E L+G+P F      +    I +V                 +
Sbjct: 182 -RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------E 223

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F FP      +       +   A DL SRLL+++PS R    E   HP+        +  
Sbjct: 224 FTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

Query: 308 PN 309
            N
Sbjct: 272 QN 273

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  166 bits (423), Expect = 1e-49
 Identities = 74/294 (25%), Positives = 127/294 (43%), Gaps = 49/294 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN---RELQLMRVMDHPN 65
           +    ++G GSF  V++A+ + TG  VAIK    K +           E+++   + HP+
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++ L + F      N ++  LV+E      M R LK   +  +       + + +QI  G
Sbjct: 73  ILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITG 124

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           + Y+H+   + HRDL   NLL+      +KI DFG A QL         +C +  Y +PE
Sbjct: 125 MLYLHSH-GILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +    + +    D+WS GC+   LL+G+P F  +   + L +++                
Sbjct: 183 IATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-------------- 227

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
              D+  P      +       +  EA DL  +LL+ +P+ R +      HPF 
Sbjct: 228 ---DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  168 bits (428), Expect = 1e-49
 Identities = 62/328 (18%), Positives = 127/328 (38%), Gaps = 52/328 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN----------------REL 55
           R +  G F  +   +  +  +  A+K      + + R +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 56  QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP-----ESMYRVLKHYSSANQRMP 110
           Q++  + +   ++ +      T+ +E+++  + EY+      +          +    +P
Sbjct: 95  QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 111 LIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN 170
           +  +K     +    +YIH    +CHRD+KP N+L+D    +VK+ DFG ++ ++  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK-NGRVKLSDFGESEYMVDKKIK 208

Query: 171 ISYIC-SRFYRAPELIFGATEY-TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
            S    +  +  PE     + Y    +DIWS G  L  +      F  + ++ +L   I+
Sbjct: 209 GS--RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 288
                  + I    P   +  F     +      +  +  E ID     L+ +P+ R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

Query: 289 LEACAHPFF-----DELREPNARLPNGR 311
            +A  H +      ++LRE +  L   R
Sbjct: 318 EDALKHEWLADTNIEDLREFSKELYKKR 345

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  169 bits (430), Expect = 1e-48
 Identities = 74/332 (22%), Positives = 129/332 (38%), Gaps = 63/332 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------------KVLQDRRYKNREL 55
           Y   R +G+G++G V   K        AIK                  + +       E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 56  QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPL 111
            L++ +DHPN+I L   F     +++ +  LV E+    E   +++    +         
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146

Query: 112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA 169
                   QI  G+ Y+H    + HRD+KP+N+L++       +KI DFG +        
Sbjct: 147 -DAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 170 NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 229
               + + +Y APE++    +Y    D+WS G ++  LL G P F G+N  DQ  +II  
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256

Query: 230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 289
                 +++      +          + W  +       EA +L   +L Y  + RCTA 
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297

Query: 290 EACAHPFFDELREPNARLPNGRPLPPLFNFKQ 321
           EA    +  +      +         L N ++
Sbjct: 298 EALNSRWIKKYANNINKSDQKTLCGALSNMRK 329

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  163 bits (415), Expect = 2e-48
 Identities = 80/298 (26%), Positives = 126/298 (42%), Gaps = 52/298 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 68
           Y  E  +G GS+G V  A    T    A K      ++D     +E+++M+ +DHPN+I 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRG 124
           L   F     ++   + LVME     E   RV+    +  +               +   
Sbjct: 71  LYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DAARIMKDVLSA 118

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRA 181
           +AY H +  V HRDLKP+N L    +    +K+ DFG A +   G+  +     + +Y +
Sbjct: 119 VAYCHKL-NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVS 176

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           P+++ G   Y    D WSAG ++  LL G P F      + +++I +             
Sbjct: 177 PQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG------------ 222

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                 F FP      W  V      P+A  L  RLL  SP  R T+L+A  H +F++
Sbjct: 223 -----TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  164 bits (417), Expect = 4e-48
 Identities = 78/348 (22%), Positives = 132/348 (37%), Gaps = 84/348 (24%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL---------QDRRYKNRELQLMRVMDH 63
           Y  +  +G GS+G+V  A   +T    AIK +          +D      E++LM+ + H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKL----- 116
           PN+  L   +     ++E ++ LVME       + ++      +  +  +  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 117 ------------------------------YTYQIFRGLAYIHTVPRVCHRDLKPQNLLV 146
                                            QIF  L Y+H    +CHRD+KP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLF 201

Query: 147 D-PLTHQVKICDFGSAKQLIAGEANISYIC-----SRFYRAPELIFGATE-YTTSIDIWS 199
               + ++K+ DFG +K+         Y       + ++ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 200 AGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWH 259
           AG +L  LL+G   FPG N  D + +++                      F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 260 KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
            +      P A DL S LL  +   R  A+ A  HP+  +  +   ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  162 bits (412), Expect = 8e-48
 Identities = 52/323 (16%), Positives = 93/323 (28%), Gaps = 80/323 (24%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVM-DHPN 65
           +     +G+G FG VF+      G   AIK+         D +   RE+    V+  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           V+     +          + +  EY    S+   +              +K    Q+ RG
Sbjct: 73  VVRYFSAWAEDDH-----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDP------------------LTHQVKICDFGSAKQLIA 166
           L YIH+   + H D+KP N+ +                         KI D G   ++  
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-- 184

Query: 167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
             +         + A E++     +    DI++    +      +PL             
Sbjct: 185 -SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN---------- 233

Query: 227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPP-------EAIDLASRLLQ 279
                                          WH++   R+P        E  +L   ++ 
Sbjct: 234 ----------------------------GDQWHEIRQGRLPRIPQVLSQEFTELLKVMIH 265

Query: 280 YSPSLRCTALEACAHPFFDELRE 302
             P  R +A+    H        
Sbjct: 266 PDPERRPSAMALVKHSVLLSASR 288

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  163 bits (415), Expect = 8e-48
 Identities = 76/342 (22%), Positives = 120/342 (35%), Gaps = 64/342 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVM-DHPNVI 67
               RV+  G F  V++A+ + +G   A+K++L    +  R   +E+  M+ +  HPN++
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 68  SLKHCFF-----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
                       S T + E    L+ E     +   LK    +   +    V    YQ  
Sbjct: 90  QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146

Query: 123 RGLAYIHT-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG-------------E 168
           R + ++H   P + HRDLK +NLL+      +K+CDFGSA  +                E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 169 ANISYICSRFYRAPELI--FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEI 226
             I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F     +      
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259

Query: 227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 286
                       R +N  Y     P           H         L   +LQ +P  R 
Sbjct: 260 ------------RIVNGKY---SIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294

Query: 287 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASP 328
           +  E        E+       P   P+  L         A+ 
Sbjct: 295 SIAEVVHQLQ--EIAAARNVNPK-SPITELLEQNGGYGSATL 333

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  162 bits (411), Expect = 9e-48
 Identities = 71/302 (23%), Positives = 121/302 (40%), Gaps = 56/302 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           ++ +R +G+G+FG V   +   +G    IK     +          E+++++ +DHPN+I
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--------ESMYRVLKHYSSANQRMPLIYVKLYTY 119
            +   F     ++   + +VME            S     K  S         YV     
Sbjct: 84  KIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG-------YVAELMK 131

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSR 177
           Q+   LAY H+   V H+DLKP+N+L    +    +KI DFG A+   + E + +   + 
Sbjct: 132 QMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APE+     + T   DIWSAG V+  LL G   F G +  +   +            
Sbjct: 191 LYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-------- 240

Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                    +  +               + P+A+DL  ++L   P  R +A +   H +F
Sbjct: 241 ---------EPNYAV---ECRP------LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

Query: 298 DE 299
            +
Sbjct: 283 KQ 284

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  169 bits (429), Expect = 2e-47
 Identities = 77/303 (25%), Positives = 127/303 (41%), Gaps = 17/303 (5%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           +  +  +GTG FG V +    +TGE VAIK+  Q+   KN      E+Q+M+ ++HPNV+
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75

Query: 68  SLKHCFFSTTSKNELFLN-LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           S +             L  L MEY     + + L  + +    +    ++     I   L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISSAL 134

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPE 183
            Y+H   R+ HRDLKP+N+++ P   +   KI D G AK+L  GE    ++ +  Y APE
Sbjct: 135 RYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           L+    +YT ++D WS G +  E + G   F       Q    ++     + E I   + 
Sbjct: 194 LLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHIVVYDD 249

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
                +F  +   P H      +  +       +L +    R T  +      F  L   
Sbjct: 250 LTGAVKFSSVLPTPNH--LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307

Query: 304 NAR 306
            + 
Sbjct: 308 LSL 310

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  164 bits (416), Expect = 2e-47
 Identities = 77/339 (22%), Positives = 126/339 (37%), Gaps = 46/339 (13%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 68
           Y     +G+G+FG+V +     TG     K        D+     E+ +M  + HP +I+
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L   F     K E+   L++E++   E   R+       ++      V  Y  Q   GL 
Sbjct: 113 LHDAF---EDKYEMV--LILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163

Query: 127 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
           ++H    + H D+KP+N++        VKI DFG A +L   E       +  + APE I
Sbjct: 164 HMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                     D+W+ G +   LL G   F GE+ ++ L  + +                 
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
            D+ F       +  V      PEA D    LLQ  P  R T  +A  HP+   L+  ++
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPW---LKGDHS 313

Query: 306 RLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKRQLG 344
            L +  P       +Q++     +               
Sbjct: 314 NLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFS 352

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  161 bits (409), Expect = 2e-47
 Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 52/296 (17%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK--NRELQLMRVMDHPNVISL 69
           R +G G FG V+ A+  +    +A+K     ++ ++       RE+++   + HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
            + +F    +    + L++E+ P   +Y+ L+     + R        +  ++   L Y 
Sbjct: 80  -YNYFHDRKR----IYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYC 130

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
           H   +V HRD+KP+NLL+     ++KI DFG +    +        C +  Y  PE+I G
Sbjct: 131 HE-RKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM--CGTLDYLPPEMIEG 186

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              +   +D+W AG +  E L+G P F   +  +    I+ V                 D
Sbjct: 187 -KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------D 228

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
            +FP     P+       +   + DL S+LL+Y P  R        HP+       
Sbjct: 229 LKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  164 bits (417), Expect = 3e-47
 Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 56/306 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 60
           Y+  + +G+G+ G V  A   +T + VAI+    +       +          E+++++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT 118
           ++HP +I +K+ F +          +V+E +   E   +V+ +     +R+     KLY 
Sbjct: 197 LNHPCIIKIKNFFDAED------YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYF 245

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC- 175
           YQ+   + Y+H    + HRDLKP+N+L+        +KI DFG +K L      +  +C 
Sbjct: 246 YQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 176 SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           +  Y APE++       Y  ++D WS G +L   L G P F        L + I   G  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360

Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
                         + F       W +V       +A+DL  +LL   P  R T  EA  
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALR 399

Query: 294 HPFFDE 299
           HP+  +
Sbjct: 400 HPWLQD 405

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  162 bits (412), Expect = 5e-47
 Identities = 62/339 (18%), Positives = 106/339 (31%), Gaps = 81/339 (23%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----------KVLQDRRYKNR-------- 53
            +   V+G        +A   ETGE+  +             + Q +    R        
Sbjct: 75  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134

Query: 54  -------------ELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLK 100
                           L++      +I ++         +  FL   M+   ++   VL 
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194

Query: 101 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 160
            +SS ++ +        T Q+ R LA +H    + H  L+P ++++D     V +  F  
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEH 252

Query: 161 AKQLIAGEANISYICSRFYRAPELI----------FGATEYTTSIDIWSAGCVLAELLLG 210
             +     A +    SR +  PEL              T  T S D W+ G V+  +   
Sbjct: 253 LVRD---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 211 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEA 270
                 + A+               E I         FR              K +P   
Sbjct: 310 DLPITKDAALG------------GSEWI---------FRSC------------KNIPQPV 336

Query: 271 IDLASRLLQYSPSLRCTALEACAHPFFDELREP-NARLP 308
             L    L+Y    R   L+A   P +++LR   +A LP
Sbjct: 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  160 bits (406), Expect = 1e-46
 Identities = 79/333 (23%), Positives = 130/333 (39%), Gaps = 60/333 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--------RELQLMRV 60
           Y+  + +G+G+ G V  A   +T + VAIK    +       +          E+++++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKL 116
           ++HP +I +K+ FF           +V+E +   E   +V+       A  +       L
Sbjct: 72  LNHPCIIKIKN-FFDAED-----YYIVLELMEGGELFDKVVGNKRLKEATCK-------L 118

Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYI 174
           Y YQ+   + Y+H    + HRDLKP+N+L+        +KI DFG +K L      +  +
Sbjct: 119 YFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176

Query: 175 C-SRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG 231
           C +  Y APE++       Y  ++D WS G +L   L G P F        L + I   G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235

Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA 291
                           + F       W +V       +A+DL  +LL   P  R T  EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272

Query: 292 CAHPFFDELREPNARLPNGRPLPPLFNFKQELS 324
             HP+  +                     Q L+
Sbjct: 273 LRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  158 bits (402), Expect = 2e-46
 Identities = 78/299 (26%), Positives = 126/299 (42%), Gaps = 52/299 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 66
           Y    ++G GSFG V + K   T +  A+K       +++      RE++L++ +DHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 122
           + L         ++     +V E     E    ++K   +S                Q+F
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYR 180
            G+ Y+H    + HRDLKP+N+L++       +KI DFG +            I + +Y 
Sbjct: 132 SGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           APE++ G   Y    D+WSAG +L  LL G P F G+N  D L  +              
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                  + F       W  +       +A DL  ++L + PSLR TA +   HP+  +
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  157 bits (400), Expect = 7e-46
 Identities = 78/323 (24%), Positives = 130/323 (40%), Gaps = 51/323 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN---RELQLMRVMDHP 64
           Y+   ++G GS+G V +    ET    A+K     K+ +    +    +E+QL+R + H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           NVI L    ++   K ++++  VMEY    M  +L       +R P+     Y  Q+  G
Sbjct: 67  NVIQLVDVLYNEE-KQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGYFCQLIDG 121

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC--SRFYRA 181
           L Y+H+   + H+D+KP NLL+      +KI   G +         +       S  ++ 
Sbjct: 122 LEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 182 PELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           PE+  G   ++   +DIWSAG  L  +  G   F G+N + +L E I             
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIG------------ 226

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                  +  P                P   DL   +L+Y P+ R +  +   H +F + 
Sbjct: 227 ----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

Query: 301 REPNARLPNGRPLPPLFNFKQEL 323
             P        P+PP  + K   
Sbjct: 271 HPPAEAPV---PIPPSPDTKDRW 290

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  157 bits (399), Expect = 8e-46
 Identities = 73/306 (23%), Positives = 124/306 (40%), Gaps = 52/306 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVIS 68
           ++   V+G+G+F  VF  K   TG+  A+K               E+ +++ + H N+++
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRG 124
           L+  +    S    +  LVM+ V   E   R+L+   Y+  +         L   Q+   
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDAS-------LVIQQVLSA 118

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRA 181
           + Y+H    + HRDLKP+NLL        ++ I DFG +K  +     +S  C +  Y A
Sbjct: 119 VKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVA 175

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE +     Y+ ++D WS G +   LL G P F  E       +I +             
Sbjct: 176 PE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 301
                 + F    +  W  +        A D    LL+  P+ R T  +A +HP+ D   
Sbjct: 223 -----YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269

Query: 302 EPNARL 307
             +  +
Sbjct: 270 ALHRDI 275

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  163 bits (414), Expect = 1e-45
 Identities = 76/345 (22%), Positives = 132/345 (38%), Gaps = 47/345 (13%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 68
           Y     +GTG+FG+V +     TG   A K V      D+    +E+Q M V+ HP +++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L   F          + ++ E++   E   +V   ++  ++   + Y++    Q+ +GL 
Sbjct: 219 LHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLC 269

Query: 127 YIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
           ++H      H DLKP+N++     ++++K+ DFG    L   ++      +  + APE+ 
Sbjct: 270 HMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 328

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G        D+WS G +   LL G   F GEN  +            T   ++  + N 
Sbjct: 329 EG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVKSCDWNM 375

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
            D  F  I               +  D   +LL   P+ R T  +A  HP+   L   NA
Sbjct: 376 DDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHPW---LTPGNA 419

Query: 306 RLPNGR-PLPPLFNFKQELSGASPELVNKLIPDHVKRQLGLNFLH 349
              + + P       +  +          L P            H
Sbjct: 420 PGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 464

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  156 bits (397), Expect = 1e-45
 Identities = 75/312 (24%), Positives = 122/312 (39%), Gaps = 58/312 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 62
           Y     +G+G F IV + +   TG+  A K          +    R    RE+ ++R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 118
           HPN+I+L   F    +K ++ L  ++E V   E    + +    +             + 
Sbjct: 67  HPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEKESLTEDE-------ATQFL 114

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 175
            QI  G+ Y+H+  R+ H DLKP+N+++   +    ++K+ DFG A ++ AG      I 
Sbjct: 115 KQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172

Query: 176 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  + APE I          D+WS G +   LL G   F GE   + L  I  V     
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226

Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                       ++ F       +           A D   RLL   P  R T  ++  H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266

Query: 295 PFFDELREPNAR 306
            +   +R  N R
Sbjct: 267 SWIKAIRRRNVR 278

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  157 bits (400), Expect = 1e-45
 Identities = 72/295 (24%), Positives = 119/295 (40%), Gaps = 47/295 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 71
           Y  +  +G GS+ +  +     T    A+K + + +R    E++++ R   HPN+I+LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 72  CFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLAY 127
            +      +  ++ +V E +   E + ++L+   +S               + I + + Y
Sbjct: 84  VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASA-------VLFTITKTVEY 131

Query: 128 IHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           +H    V HRDLKP N+L          ++ICDFG AKQL A    +   C +  + APE
Sbjct: 132 LHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL-GTPTREEIRCMN 242
            +     Y  + DIWS G +L  +L G   F           + ++  G           
Sbjct: 191 -VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG----------- 238

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                F         W+ V        A DL S++L   P  R TA     HP+ 
Sbjct: 239 ----KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  157 bits (398), Expect = 2e-45
 Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 50/301 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVA---IKKVLQDRRYKNRELQLMRVMDHPNVISL 69
           YM    +G G FGIV +     + +T     +K    D+    +E+ ++ +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK---HYSSANQRMPLIYVKLYTYQIFRG 124
              F    S  EL   ++ E++   +   R+       +          +  Y +Q+   
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE-------IVSYVHQVCEA 114

Query: 125 LAYIHTVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAP 182
           L ++H+   + H D++P+N++     +  +KI +FG A+QL  G+ N   +  +  Y AP
Sbjct: 115 LQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRLLFTAPEYYAP 172

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E +      +T+ D+WS G ++  LL G   F  E   +Q  +II        E I    
Sbjct: 173 E-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAE 219

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
             + +  F +I               EA+D   RLL      R TA EA  HP+  +  E
Sbjct: 220 YTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

Query: 303 P 303
            
Sbjct: 267 R 267

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  159 bits (405), Expect = 2e-45
 Identities = 76/320 (23%), Positives = 124/320 (38%), Gaps = 52/320 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G+F +V +   +  G+  A   +   +          RE ++ R++ HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 122
           + L           E    L+ + V   E    ++   +YS A              QI 
Sbjct: 73  VRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-------DASHCIQQIL 120

Query: 123 RGLAYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFY 179
             + + H +  V HR+LKP+NLL    L    VK+ DFG A ++   +        +  Y
Sbjct: 121 EAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            +PE +     Y   +D+W+ G +L  LL+G P F  E+      +I             
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA----------- 227

Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                   + FP   +  W  V      PEA DL +++L  +PS R TA EA  HP+   
Sbjct: 228 ------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273

Query: 300 LREPNARLPNGRPLPPLFNF 319
                + +     +  L  F
Sbjct: 274 RSTVASCMHRQETVDCLKKF 293

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  157 bits (399), Expect = 3e-45
 Identities = 81/319 (25%), Positives = 128/319 (40%), Gaps = 51/319 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 66
           Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R + HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 122
           + L         + E F  LV + V   E    ++    YS A+             QI 
Sbjct: 91  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 138

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANISYICSRFYR 180
             +AY H+   + HR+LKP+NLL+        VK+ DFG A ++   EA   +  +  Y 
Sbjct: 139 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 197

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I              
Sbjct: 198 SPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 245

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                  + +P   +  W  V      PEA  L   +L  +P  R TA +A   P+    
Sbjct: 246 ------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291

Query: 301 REPNARLPNGRPLPPLFNF 319
               + +     +  L  F
Sbjct: 292 ERVASAIHRQDTVDCLKKF 310

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  156 bits (397), Expect = 3e-45
 Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 45/319 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 74
           ++V+G G  G V +     TG+  A+K +L D     +E+    +    P+++ +    +
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91

Query: 75  STTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
                 +  L ++ME +           R  + ++                 I   + ++
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER-------EAAEIMRDIGTAIQFL 144

Query: 129 HTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           H+   + HRD+KP+NLL         +K+ DFG AK+       +   C + +Y APE +
Sbjct: 145 HSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-V 200

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G  +Y  S D+WS G ++  LL G P F           + +          R     Y
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----------RIRLGQY 250

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPN 304
             F  P      W +V       +A  L   LL+  P+ R T  +   HP+    +  P 
Sbjct: 251 -GFPNP-----EWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299

Query: 305 ARLPNGRPLPPLFNFKQEL 323
             L   R L    +   E+
Sbjct: 300 TPLHTARVLQEDKDHWDEV 318

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  155 bits (395), Expect = 3e-45
 Identities = 78/311 (25%), Positives = 124/311 (39%), Gaps = 64/311 (20%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-------------KVLQDRRYKNRELQ-LM 58
           Y  + ++G G   +V +     T +  A+K             +V + R    +E+  L 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 59  RVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYV 114
           +V  HPN+I LK  +     +   F  LV + +   E    + +    S    R      
Sbjct: 79  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR------ 127

Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 174
                 +   +  +H +  + HRDLKP+N+L+D     +K+ DFG + QL  GE  +  +
Sbjct: 128 -KIMRALLEVICALHKL-NIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEK-LREV 183

Query: 175 C-SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK 228
           C +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+ 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

Query: 229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA 288
                             +++F    +  W             DL SR L   P  R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278

Query: 289 LEACAHPFFDE 299
            EA AHPFF +
Sbjct: 279 EEALAHPFFQQ 289

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  155 bits (394), Expect = 3e-45
 Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 53/298 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKN--RELQLMRVMDHPNV 66
           Y  +  +G G+F +V +     TG   A K    K L  R ++   RE ++ R + HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIF 122
           + L         + E F  LV + V   E    ++    YS A+             QI 
Sbjct: 68  VRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQIL 115

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 179
             +AY H+   + HR+LKP+NLL+        VK+ DFG A ++   EA       +  Y
Sbjct: 116 ESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGY 173

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            +PE +     Y+  +DIW+ G +L  LL+G P F  E+      +I             
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG---------- 222

Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                   + +P   +  W  V      PEA  L   +L  +P  R TA +A   P+ 
Sbjct: 223 -------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  156 bits (396), Expect = 4e-45
 Identities = 73/327 (22%), Positives = 121/327 (37%), Gaps = 59/327 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 62
           Y     +G+G F IV + +   TG   A K          +    R    RE+ ++R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 118
           H NVI+L   +    ++ ++ L  ++E V   E    + +    S             + 
Sbjct: 74  HHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 175
            QI  G+ Y+HT  ++ H DLKP+N+++   +     +K+ DFG A ++  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 176 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  + APE I          D+WS G +   LL G   F G+   + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233

Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                        + F       +           A D   +LL      R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 295 PFFDELREPNARLPNGRPLPPLFNFKQ 321
           P+     +    +     +  L NF++
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFRK 299

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  156 bits (397), Expect = 5e-45
 Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 60/335 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK---------KVLQDRRYKNRELQLMRVMDH 63
           Y    V+G G F +V +    ETG+  A+K                   RE  +  ++ H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIY----VKLY 117
           P+++ L   +      ++  L +V E++   +  + ++K   +        Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135

Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYI 174
             QI   L Y H    + HRD+KP  +L+   +  +  VK+  FG A QL          
Sbjct: 136 MRQILEALRYCHDN-NIIHRDVKPHCVLLASKEN-SAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 175 C-SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
             +  + APE +     Y   +D+W  G +L  LL G   F G    ++L E I      
Sbjct: 194 VGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII----- 245

Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
                         ++        W  +        A DL  R+L   P+ R T  EA  
Sbjct: 246 -----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALN 286

Query: 294 HPFFDELREPNARLPNGRPLPPL--FNFKQELSGA 326
           HP+  E      ++     +  L  FN +++L GA
Sbjct: 287 HPWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  156 bits (396), Expect = 8e-45
 Identities = 74/327 (22%), Positives = 123/327 (37%), Gaps = 59/327 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 62
           Y     +G+G F IV + +   TG   A K          +    R    RE+ ++R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 118
           HPN+I+L   +    ++ ++ L  ++E V   E    + +    S             + 
Sbjct: 74  HPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 175
            QI  G+ Y+HT  ++ H DLKP+N+++   +     +K+ DFG A ++  G      I 
Sbjct: 122 KQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179

Query: 176 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  + APE I          D+WS G +   LL G   F G+   + L  I  V     
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233

Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                        + F       + +         A D   +LL      R T  EA  H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 295 PFFDELREPNARLPNGRPLPPLFNFKQ 321
           P+     +    +     +  L NFK+
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFKK 299

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  155 bits (393), Expect = 1e-44
 Identities = 73/327 (22%), Positives = 126/327 (38%), Gaps = 59/327 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK----------KVLQDRRYKNRELQLMRVMD 62
           Y     +G+G F +V + +   TG   A K          +    R    RE+ +++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYT 118
           HPNVI+L   +    +K ++ L  ++E V   E    + +    +             + 
Sbjct: 73  HPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEKESLTEEE-------ATEFL 120

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYIC 175
            QI  G+ Y+H++ ++ H DLKP+N+++   +    ++KI DFG A ++  G      I 
Sbjct: 121 KQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178

Query: 176 -SRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
            +  + APE I          D+WS G +   LL G   F G+   + L  +  V     
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232

Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                    NY +F         +           A D   RLL   P  R T  ++  H
Sbjct: 233 ---------NY-EFEDE-----YFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272

Query: 295 PFFDELREPNARLPNGRPLPPLFNFKQ 321
           P+    ++    L        +  FK+
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFKK 298

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  155 bits (394), Expect = 1e-44
 Identities = 72/311 (23%), Positives = 128/311 (41%), Gaps = 33/311 (10%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYKNRELQLMRVMDHPNVISLKHC 72
            +G G+ G+VF+     +G  +A K +        R    RELQ++   + P ++     
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99

Query: 73  FFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
           F+S        +++ ME++   S+ +VLK       R+P   +   +  + +GL Y+   
Sbjct: 100 FYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 191
            ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G   Y
Sbjct: 151 HKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTH-Y 207

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
           +   DIWS G  L E+ +G+   P  +A +  +     +     E               
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 252 QIKAHPWHKVF---------------HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
            + + P   +F                     E  D  ++ L  +P+ R    +   H F
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327

Query: 297 FDELREPNARL 307
                      
Sbjct: 328 IKRSDAEEVDF 338

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  156 bits (396), Expect = 2e-44
 Identities = 73/293 (24%), Positives = 117/293 (39%), Gaps = 43/293 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 71
            +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 72  CFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
             +         L +VME +           R  + ++                 I   +
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------EASEIMKSIGEAI 174

Query: 126 AYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
            Y+H++  + HRD+KP+NLL     P    +K+ DFG AK+  +  +  +   + +Y AP
Sbjct: 175 QYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E + G  +Y  S D+WS G ++  LL G P F   + +     +            R   
Sbjct: 233 E-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------RIRM 281

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
             Y +F  P      W +V       E   L   LL+  P+ R T  E   HP
Sbjct: 282 GQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 323

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  154 bits (390), Expect = 6e-44
 Identities = 77/308 (25%), Positives = 129/308 (41%), Gaps = 63/308 (20%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK------------KVLQDRRYKNRELQLMR- 59
           Y  + V+G G   +V +     TG   A+K            ++ + R    RE  ++R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVK 115
           V  HP++I+L   + S++     F+ LV + +   E    + +    S    R       
Sbjct: 156 VAGHPHIITLIDSYESSS-----FMFLVFDLMRKGELFDYLTEKVALSEKETR------- 203

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
                +   ++++H    + HRDLKP+N+L+D    Q+++ DFG +  L  GE  +  +C
Sbjct: 204 SIMRSLLEAVSFLHAN-NIVHRDLKPENILLDD-NMQIRLSDFGFSCHLEPGEK-LRELC 260

Query: 176 -SRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 229
            +  Y APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I++ 
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320

Query: 230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 289
                             ++F    +  W             DL SRLLQ  P  R TA 
Sbjct: 321 -----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTAE 355

Query: 290 EACAHPFF 297
           +A  HPFF
Sbjct: 356 QALQHPFF 363

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  151 bits (384), Expect = 9e-44
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 41/289 (14%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 71
            +G G++G+V + + + +G+ +A+K++      Q+++    +L   MR +D P  ++   
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
             F         + + ME +  S+ +  K      Q +P   +      I + L ++H+ 
Sbjct: 74  ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG---A 188
             V HRD+KP N+L++    QVK+CDFG +  L+   A       + Y APE I      
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
             Y+   DIWS G  + EL + +  +       Q ++ + V                   
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             PQ+ A  +          E +D  S+ L+ +   R T  E   HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  152 bits (385), Expect = 1e-43
 Identities = 76/312 (24%), Positives = 128/312 (41%), Gaps = 44/312 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLM-RVMDHPNVISL 69
            + ++ +G GSF I  +    ++ +  A+ K++  R   N  +E+  +     HPN++ L
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQKEITALKLCEGHPNIVKL 71

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGL 125
              F      ++L   LVME +   E   R+ K  H+S                ++   +
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAV 119

Query: 126 AYIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFYRAP 182
           +++H V  V HRDLKP+NLL  D   + ++KI DFG A+        +   C +  Y AP
Sbjct: 120 SHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E +     Y  S D+WS G +L  +L GQ  F   +        ++++     ++I+   
Sbjct: 179 E-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG- 231

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
               DF F       W  V       EA DL   LL   P+ R        + +  +  +
Sbjct: 232 ----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279

Query: 303 -PNARLPNGRPL 313
             +  L     L
Sbjct: 280 LSSNPLMTPDIL 291

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  153 bits (388), Expect = 1e-43
 Identities = 73/294 (24%), Positives = 119/294 (40%), Gaps = 46/294 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           Y   + +G+G+FG+    +   T E VA+K       + +     RE+   R + HPN++
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
             K       +   L   ++MEY    E     L        R      + +  Q+  G+
Sbjct: 80  RFKEVI---LTPTHLA--IIMEYASGGE-----LYERICNAGRFSEDEARFFFQQLLSGV 129

Query: 126 AYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
           +Y H++ ++CHRDLK +N L+D     ++KICDFG +K  +      S + +  Y APE+
Sbjct: 130 SYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 185 IFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +    EY     D+WS G  L  +L+G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
               +  P             R+ PE   L SR+    P+ R +  E   H +F
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  153 bits (388), Expect = 2e-43
 Identities = 78/302 (25%), Positives = 132/302 (43%), Gaps = 45/302 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLMRVMDHPNVISLKH 71
             ++G G FG V + +   TG  +A K    + ++D+     E+ +M  +DH N+I L  
Sbjct: 94  TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153

Query: 72  CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            F    SKN++   LVMEYV   E   R++    +  +   ++++K    QI  G+ ++H
Sbjct: 154 AF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILFMK----QICEGIRHMH 204

Query: 130 TVPRVCHRDLKPQNLL-VDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
            +  + H DLKP+N+L V+    Q+KI DFG A++    E  +     +  + APE +  
Sbjct: 205 QM-YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNFGTPEFLAPE-VVN 261

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
               +   D+WS G +   LL G   F G+N  + L  I+                 + D
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--------------RW-D 306

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
                     +  +       EA +  S+LL    S R +A EA  HP+  + +  +   
Sbjct: 307 LEDE-----EFQDI-----SEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLS 356

Query: 308 PN 309
             
Sbjct: 357 AQ 358

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  151 bits (383), Expect = 6e-43
 Identities = 79/292 (27%), Positives = 122/292 (41%), Gaps = 48/292 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 70
           +  E  +G G+  IV++ K   T +  A+K + +    K    E+ ++  + HPN+I LK
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLA 126
             F    +  E+ L  V+E V   E   R+++  +YS  +             QI   +A
Sbjct: 115 EIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAA-------DAVKQILEAVA 162

Query: 127 YIHTVPRVCHRDLKPQNLL-VDPLTH-QVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           Y+H    + HRDLKP+NLL   P     +KI DFG +K +      +  +C +  Y APE
Sbjct: 163 YLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPE 220

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            I     Y   +D+WS G +   LL G   F  E     +   I            C   
Sbjct: 221 -ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL----------NC--- 266

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
              ++ F    +  W +V        A DL  +L+   P  R T  +A  HP
Sbjct: 267 ---EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQALQHP 307

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  152 bits (384), Expect = 1e-42
 Identities = 55/343 (16%), Positives = 101/343 (29%), Gaps = 84/343 (24%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR----------------- 59
            V+G        +A   ETGE+  +       R  +  ++ M+                 
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 60  ---------------VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSS 104
                                +I ++         +  FL   M+   ++   VL  +SS
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 105 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 164
            ++ +        T Q+ R LA +H    + H  L+P ++++D     V +  F      
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQ-RGGVFLTGFEHLV-- 259

Query: 165 IAGEANISYICSRFYRAPELI---------FGATEYTTSIDIWSAGCVLAELLLGQPLFP 215
             G + +S    R +  PE              T  T + D W+ G  +  +        
Sbjct: 260 RDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFH--KRMPPEAIDL 273
            + A+                                        +F   K +P     L
Sbjct: 319 DDAALGGS-----------------------------------EWIFRSCKNIPQPVRAL 343

Query: 274 ASRLLQYSPSLRCTALEACAHPFFDELRE-PNARLPNGRPLPP 315
               L+Y    R   L+A   P +++LR   +A LP  +    
Sbjct: 344 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGE 386

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  146 bits (371), Expect = 6e-42
 Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 52/297 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           +   + +G G++G V  A    T E VA+K     + +       +E+ + ++++H NV+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
                       N  +L   +EY    E     L      +  MP    + + +Q+  G+
Sbjct: 69  KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 182
            Y+H +  + HRD+KP+NLL+D     +KI DFG A           ++ +C +  Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 183 ELIFGATEYT-TSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           EL+    E+    +D+WS G VL  +L G+ P     ++  +  +  +            
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE------------ 223

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                           PW K     +    + L  ++L  +PS R T  +     ++
Sbjct: 224 -----KKTYLN-----PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  147 bits (373), Expect = 9e-42
 Identities = 82/316 (25%), Positives = 134/316 (42%), Gaps = 53/316 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYK-NRELQLMRVMDHPNV 66
           Y   + +G G+F  V  A+ + TG  VAIK     ++      K  RE+++M++++HPN+
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           + L        ++  L+L  +MEY    E     +  Y  A+ RM     +    QI   
Sbjct: 77  VKLFEVI---ETEKTLYL--IMEYASGGE-----VFDYLVAHGRMKEKEARSKFRQIVSA 126

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           + Y H   R+ HRDLK +NLL+D     +KI DFG + +   G   +   C +  Y APE
Sbjct: 127 VQYCHQK-RIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAAPE 183

Query: 184 LIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           L  G  +Y    +D+WS G +L  L+ G   F G+N + +L E +               
Sbjct: 184 LFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL-------------- 227

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                +R P      +       M  +  +L  R L  +P  R T  +     + +   E
Sbjct: 228 --RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273

Query: 303 PNARLPNGRPLPPLFN 318
            +   P   P   + +
Sbjct: 274 EDELKPFVEPELDISD 289

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  147 bits (372), Expect = 1e-41
 Identities = 70/311 (22%), Positives = 122/311 (39%), Gaps = 56/311 (18%)

Query: 14  MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDH-PNV 66
           +  + +G G F +V Q     TG+  A K + + RR ++       E+ ++ +    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP------ESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
           I+L   +    + +E+ L  ++EY          +  + +  S  +       V     Q
Sbjct: 92  INLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSEND-------VIRLIKQ 139

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAKQLIAGEANISYIC-SR 177
           I  G+ Y+H    + H DLKPQN+L+  +     +KI DFG ++++      +  I  + 
Sbjct: 140 ILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTP 197

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 237
            Y APE I      TT+ D+W+ G +   LL     F GE+  +  + I +V        
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248

Query: 238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                    +  +       +  V        A D    LL  +P  R TA    +H + 
Sbjct: 249 ---------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291

Query: 298 DELREPNARLP 308
            +    N   P
Sbjct: 292 QQWDFENLFHP 302

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  146 bits (371), Expect = 2e-41
 Identities = 69/313 (22%), Positives = 127/313 (40%), Gaps = 50/313 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKNRELQLMRVMDHPNVI 67
           +   + +G G++G V  A    T E VA+K     + +       +E+ + ++++H NV+
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
                       N  +L   +EY    E     L      +  MP    + + +Q+  G+
Sbjct: 69  KFYGHR---REGNIQYL--FLEYCSGGE-----LFDRIEPDIGMPEPDAQRFFHQLMAGV 118

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN--ISYIC-SRFYRAP 182
            Y+H +  + HRD+KP+NLL+D     +KI DFG A           ++ +C +  Y AP
Sbjct: 119 VYLHGI-GITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 183 ELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           EL+    E+    +D+WS G VL  +L G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 301
                          PW K     +    + L  ++L  +PS R T  +     ++++  
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269

Query: 302 EPNARLPNGRPLP 314
           +  A+ P      
Sbjct: 270 KKGAKRPRVTSGG 282

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  146 bits (370), Expect = 2e-41
 Identities = 73/311 (23%), Positives = 112/311 (36%), Gaps = 58/311 (18%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIK----KVLQDRRYKNRELQLM-RVMDHPNVISLK 70
           E V+G G+   V     L T +  A+K    +    R    RE++++ +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 71  HCFFSTTSKNELFLNLVMEYVP--ESMYRVLK--HYSSANQRMPLIYVKLYTYQIFRGLA 126
             F     + E    LV E +     +  + K  H++     +           +   L 
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-------VVQDVASALD 125

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICSR---- 177
           ++H    + HRDLKP+N+L     H      VKICDF     +                 
Sbjct: 126 FLHN-KGIAHRDLKPENIL---CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181

Query: 178 ----FYRAPELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV 229
                Y APE++      A+ Y    D+WS G +L  LL G P F G    D   +  + 
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241

Query: 230 LGTPTR---EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 286
                    E I+        + FP      W  +        A DL S+LL      R 
Sbjct: 242 CPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRL 288

Query: 287 TALEACAHPFF 297
           +A +   HP+ 
Sbjct: 289 SAAQVLQHPWV 299

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  145 bits (367), Expect = 2e-41
 Identities = 82/296 (27%), Positives = 117/296 (39%), Gaps = 54/296 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPN 65
           Y+    +G G+FG V   +   TG  VA+K     K+          RE+Q +++  HP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           +I L       ++  + F  +VMEYV   E     L  Y   + R+  +  +    QI  
Sbjct: 73  IIKLYQVI---STPTDFF--MVMEYVSGGE-----LFDYICKHGRVEEMEARRLFQQILS 122

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC-SRFYRA 181
            + Y H    V HRDLKP+N+L+D      KI DFG S           S  C S  Y A
Sbjct: 123 AVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 178

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE+I G       +DIWS G +L  LL G   F  E+ V  L + I+             
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIR------------- 224

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                 F  P      +       +      L   +LQ  P  R T  +   H +F
Sbjct: 225 ---GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  150 bits (380), Expect = 4e-41
 Identities = 78/329 (23%), Positives = 129/329 (39%), Gaps = 53/329 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 69
           RV+G G FG VF  +   TG+  A KK+ + R  K +  Q   V       +    ++SL
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            + F  T +     L LVM  +   +  Y  + +    N          YT QI  GL +
Sbjct: 251 AYAF-ETKTD----LCLVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +H    + +RDLKP+N+L+D   + V+I D G A +L AG+        +  + APEL+ 
Sbjct: 305 LHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           G  EY  S+D ++ G  L E++  +  F                     +E+        
Sbjct: 363 G-EEYDFSVDYFALGVTLYEMIAARGPFRARGE------------KVENKEL-------- 401

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELR 301
                ++        +  +  P + D    LLQ  P  R      +      HP F ++ 
Sbjct: 402 ---KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI- 455

Query: 302 EPN-ARLPNGRPLPPLFNFKQELSGASPE 329
             +  +L  G   PP     + +   + +
Sbjct: 456 --SWRQLEAGMLTPPFVPDSRTVYAKNIQ 482

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  145 bits (368), Expect = 5e-41
 Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 39/300 (13%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 71
            +G G++G V +     +G+ +A+K++      ++++    +L  +MR  D P ++    
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKH-YSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
             F           + ME +  S  +  K+ YS  +  +P   +   T    + L ++  
Sbjct: 89  ALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
             ++ HRD+KP N+L+D  +  +K+CDFG + QL+   A       R Y APE I  +  
Sbjct: 144 NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSAS 202

Query: 191 ---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              Y    D+WS G  L EL  G+  +P  N+V   +  + V G P              
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP-------------- 247

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
              PQ+      + F     P  I+  +  L    S R    E   HPF     E    +
Sbjct: 248 ---PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  144 bits (366), Expect = 5e-41
 Identities = 71/299 (23%), Positives = 109/299 (36%), Gaps = 76/299 (25%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKH 71
            +  +V+G G  G V Q     T E  A+K +LQD     RE++L  R    P+++ +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 72  CFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYT--------YQI 121
             +         L +VME +   E   R+      A           +T          I
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-----------FTEREASEIMKSI 126

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDFGSAKQLIAGEANISYICS 176
              + Y+H++  + HRD+KP+NLL    T +     +K+ DFG AK+    +        
Sbjct: 127 GEAIQYLHSI-NIAHRDVKPENLL---YTSKRPNAILKLTDFGFAKETTGEK-------- 174

Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
                         Y  S D+WS G ++  LL G P F   + +     +          
Sbjct: 175 --------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------- 212

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
             R     Y +F  P      W +V       E   L   LL+  P+ R T  E   HP
Sbjct: 213 --RIRMGQY-EFPNP-----EWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  144 bits (366), Expect = 5e-41
 Identities = 67/320 (20%), Positives = 120/320 (37%), Gaps = 73/320 (22%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--------------- 52
           Y  +  +G GS+G+V  A         A+K     K+++   +                 
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 53  ----------RELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLK 100
                     +E+ +++ +DHPNV+ L        +++ L++  V E V     M     
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGPVMEVP-- 129

Query: 101 HYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS 160
                 + +     + Y   + +G+ Y+H   ++ HRD+KP NLLV      +KI DFG 
Sbjct: 130 ----TLKPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGE-DGHIKIADFGV 183

Query: 161 AKQLIAGEANISYIC-SRFYRAPELIFGAT-EYT-TSIDIWSAGCVLAELLLGQPLFPGE 217
           + +    +A +S    +  + APE +      ++  ++D+W+ G  L   + GQ  F  E
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

Query: 218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRL 277
             +  L   IK                     FP              +  +  DL +R+
Sbjct: 244 R-IMCLHSKIK----------------SQALEFPD----------QPDIAEDLKDLITRM 276

Query: 278 LQYSPSLRCTALEACAHPFF 297
           L  +P  R    E   HP+ 
Sbjct: 277 LDKNPESRIVVPEIKLHPWV 296

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  145 bits (367), Expect = 9e-41
 Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 51/294 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPN 65
           Y+    +G GSFG V  A   +T + VA+K      + +   +    RE+  ++++ HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +I L       T+  ++ +  V+EY    ++     Y    +RM     + +  QI   +
Sbjct: 71  IIKLYDVI---TTPTDIVM--VIEYAGGELF----DYIVEKKRMTEDEGRRFFQQIICAI 121

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC-SRFYRAPE 183
            Y H   ++ HRDLKP+NLL+D     VKI DFG S           S  C S  Y APE
Sbjct: 122 EYCHRH-KIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           +I G       +D+WS G VL  +L+G+  F  E  +  L + +                
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
               +  P      +       + P A  L  R++   P  R T  E    P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  148 bits (376), Expect = 2e-40
 Identities = 88/341 (25%), Positives = 138/341 (40%), Gaps = 66/341 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRV-------MDHPNVISL 69
           RV+G G FG V   +   TG+  A KK+ + R  K +   +          ++   V+SL
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            + +  T       L LV+  +   +  + +   Y       P      Y  +I  GL  
Sbjct: 250 AYAY-ETKDA----LCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAEICCGLED 301

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           +H   R+ +RDLKP+N+L+D   H ++I D G A  +  G+     + +  Y APE++  
Sbjct: 302 LHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              YT S D W+ GC+L E++ GQ  F                    REE+         
Sbjct: 360 -ERYTFSPDWWALGCLLYEMIAGQSPFQQRKK------------KIKREEV--------- 397

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELRE 302
                +K  P  + + +R  P+A  L S+LL   P+ R      +A E   HP F +L  
Sbjct: 398 --ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL-- 451

Query: 303 PN-ARLPNGRPLPP------------LFNFKQELSGASPEL 330
            N  RL  G   PP            + + +Q  +    EL
Sbjct: 452 -NFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVEL 491

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  143 bits (363), Expect = 3e-40
 Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 61/318 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 62
           Y    ++G+G FG V+    +     VAIK     ++       N      E+ L++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 63  H--PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
                VI L   F      +   L  ++E         L  + +    +     + + +Q
Sbjct: 105 SGFSGVIRLLDWF---ERPDSFVL--ILERPEPVQD--LFDFITERGALQEELARSFFWQ 157

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 179
           +   + + H    V HRD+K +N+L+D    ++K+ DFGS   L       +    +R Y
Sbjct: 158 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVY 214

Query: 180 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
             PE I     Y   S  +WS G +L +++ G   F  +       EII+          
Sbjct: 215 SPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 257

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
                      F             +R+  E   L    L   PS R T  E   HP+  
Sbjct: 258 -------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

Query: 299 ELREPNARLP-NGRPLPP 315
           ++  P      +   L P
Sbjct: 299 DVLLPQETAEIHLHSLSP 316

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  142 bits (361), Expect = 4e-40
 Identities = 77/304 (25%), Positives = 123/304 (40%), Gaps = 64/304 (21%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 69
           +++G GSF  V  A+ L T    AIK      ++++    Y  RE  +M  +DHP  + L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
              F     +++  L   + Y    E     L  Y            + YT +I   L Y
Sbjct: 96  YFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTRFYTAEIVSALEY 145

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 182
           +H    + HRDLKP+N+L++   H ++I DFG+AK L           + F     Y +P
Sbjct: 146 LHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQAR--ANSFVGTAQYVSP 201

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           EL+        S D+W+ GC++ +L+ G P F   N    + + I               
Sbjct: 202 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII-------------- 245

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT------ALEACAHPF 296
               ++ FP            ++  P+A DL  +LL    + R             AHPF
Sbjct: 246 --KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

Query: 297 FDEL 300
           F+ +
Sbjct: 292 FESV 295

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  140 bits (355), Expect = 3e-39
 Identities = 61/301 (20%), Positives = 110/301 (36%), Gaps = 46/301 (15%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKKV-----LQDRRYKNRELQ-LMRVMDHPNVISLKH 71
            +G+G+ G V++ +  +TG  +A+K++      ++ +    +L  +++  D P ++    
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 72  CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            F + T      + + ME +        K        +P   +   T  I + L Y+   
Sbjct: 92  TFITNTD-----VFIAMELMGTC---AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI----FG 187
             V HRD+KP N+L+D    Q+K+CDFG + +L+  +A         Y APE I      
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIRCMNPNYT 246
             +Y    D+WS G  L EL  GQ  +       + L ++++    P             
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR 306
               P +         H     +        L      R    +   H F          
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296

Query: 307 L 307
           +
Sbjct: 297 V 297

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  146 bits (369), Expect = 4e-39
 Identities = 73/302 (24%), Positives = 120/302 (39%), Gaps = 58/302 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRE-----------LQLMRVMDHPN 65
           R++G G FG V+  +  +TG+  A+K  L  +R K ++           L L+   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           ++ + + F    + ++L    +++ +   +  Y + +H            ++ Y  +I  
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           GL ++H    V +RDLKP N+L+D   H V+I D G A      + + + + +  Y APE
Sbjct: 304 GLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++     Y +S D +S GC+L +LL G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CT---ALEACAHPFFD 298
                                   PE   L   LLQ   + R  C    A E    PFF 
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

Query: 299 EL 300
            L
Sbjct: 455 SL 456

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  142 bits (359), Expect = 1e-38
 Identities = 86/296 (29%), Positives = 121/296 (40%), Gaps = 54/296 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN--RELQLMRVMDHPN 65
           Y+    +G G+FG V   K   TG  VA+K     K+          RE+Q +++  HP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           +I L       ++ +++F+  VMEYV   E     L  Y   N R+     +    QI  
Sbjct: 78  IIKLYQVI---STPSDIFM--VMEYVSGGE-----LFDYICKNGRLDEKESRRLFQQILS 127

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG-SAKQLIAGEANISYIC-SRFYRA 181
           G+ Y H    V HRDLKP+N+L+D      KI DFG S           S  C S  Y A
Sbjct: 128 GVDYCHRH-MVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 183

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE+I G       +DIWS+G +L  LL G   F  ++ V  L + I              
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC------------- 229

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                 F  P      +       + P  I L   +LQ  P  R T  +   H +F
Sbjct: 230 ---DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  141 bits (357), Expect = 2e-38
 Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 58/297 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 68
           +++G G+FG V   K   TG   A+K +L+      +        E ++++   HP + +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           LK+ F  T  +    L  VMEY    E  + +     S  +       + Y  +I   L 
Sbjct: 213 LKYSF-QTHDR----LCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALD 262

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           Y+H+   V +RDLK +NL++D   H +KI DFG  K+ I   A +   C +  Y APE++
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVL 321

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
               +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I                  
Sbjct: 322 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------M 363

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
            + RFP            + + PEA  L S LL+  P  R       A E   H FF
Sbjct: 364 EEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  137 bits (347), Expect = 4e-38
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 18/215 (8%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 73
           E VVG G+FG+V +AK     + VAIK++  +   K    EL+ +  ++HPN++      
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVK----L 66

Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--T 130
           +         + LVMEY    S+Y VL H +         +   +  Q  +G+AY+H   
Sbjct: 67  YGACLNP---VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
              + HRDLKP NLL+      +KICDFG+A  +       +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI--QTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE 225
           Y+   D++S G +L E++  +  F         + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  138 bits (349), Expect = 5e-38
 Identities = 34/316 (10%), Positives = 92/316 (29%), Gaps = 66/316 (20%)

Query: 12  SYMAERVVGTGSFGIVFQAKC-----LETGETVAIK----KVLQDRRYKNRELQLMRVMD 62
                 ++G G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
               +           +N   L  V E       +  +  + ++  + MP   V  +  +
Sbjct: 126 QHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ----------VKICDFGSAKQLIAGEAN 170
           +   +  +H    + H D+KP N ++     +          + + D G +  +      
Sbjct: 181 MLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 171 ---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF-PGENAVDQLVEI 226
               +   +  ++  E++     +   ID +     +  +L G  +    E    +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 227 IKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 286
            +                    R P +    W++ FH             +L        
Sbjct: 299 FR--------------------RLPHL--DMWNEFFHV------------MLNIPDCHHL 324

Query: 287 TALEACAHPFFDELRE 302
            +L+          ++
Sbjct: 325 PSLDLLRQKLKKVFQQ 340

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  139 bits (351), Expect = 5e-38
 Identities = 81/364 (22%), Positives = 136/364 (37%), Gaps = 84/364 (23%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK---NRELQLMRVM-----DHP 64
           Y   R +G G F  V+ +  ++  + VA+K V     Y      E++L++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 65  N---VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
           N   V+ L   F   +  N   + +V E +   + + +   +   Q +PL  VK    Q+
Sbjct: 99  NREMVVQLLDDF-KISGVNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLV----------------------------------- 146
            +GL Y+HT  R+ H D+KP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 147 -------------DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 193
                        +    +VKI D G+A      +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 194 SIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIKVLGTPTREEIR-------C 240
             DIWS  C+  EL  G  LF   +        D +  II++LG   R+ I         
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMP------PEAIDLASRLLQYSPSLRCTALEACAH 294
                      ++K     +V  ++            D    +L+  P  R TA E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 295 PFFD 298
           P+ +
Sbjct: 393 PWLN 396

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  137 bits (346), Expect = 9e-38
 Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 60/299 (20%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-------RELQLMRV 60
           Y     +G+G+FG V+ A   E  + V +K     KVL+D   ++        E+ ++  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 61  MDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
           ++H N+I +   F     +N+ F  LVME     +   L  +   + R+          Q
Sbjct: 86  VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLD--LFAFIDRHPRLDEPLASYIFRQ 138

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFY 179
           +   + Y+     + HRD+K +N+++      +K+ DFGSA  L  G+      C +  Y
Sbjct: 139 LVSAVGYLRLK-DIIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGK-LFYTFCGTIEY 195

Query: 180 RAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
            APE++ G   Y    +++WS G  L  L+  +  F       +L E ++          
Sbjct: 196 CAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---------- 238

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                       P              +  E + L S LLQ  P  R T  +    P+ 
Sbjct: 239 -------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  136 bits (345), Expect = 1e-37
 Identities = 76/297 (25%), Positives = 130/297 (43%), Gaps = 59/297 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR--------ELQLMRVMDHPNVIS 68
           +++G G+FG V   +   TG   A+K +L+      +        E ++++   HP + +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           LK+ F  T  +    L  VMEY    E  + + +      +       + Y  +I   L 
Sbjct: 70  LKYAF-QTHDR----LCFVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALE 119

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           Y+H+   V +RD+K +NL++D   H +KI DFG  K+ I+  A +   C +  Y APE++
Sbjct: 120 YLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
               +Y  ++D W  G V+ E++ G+  F  ++  ++L E+I                  
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------M 219

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
            + RFP            + + PEA  L + LL+  P  R       A E   H FF
Sbjct: 220 EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  135 bits (343), Expect = 1e-37
 Identities = 73/320 (22%), Positives = 113/320 (35%), Gaps = 62/320 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDRRYKN-----RELQLMRVMD 62
           Y    ++G G FG VF    L     VAIK     +VL      +      E+ L+  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 63  ----HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 118
               HP VI L   +F T         LV+E    +    L  Y +    +     + + 
Sbjct: 93  AGGGHPGVIRL-LDWFETQEG----FMLVLERPLPAQD--LFDYITEKGPLGEGPSRCFF 145

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SR 177
            Q+   + + H+   V HRD+K +N+L+D      K+ DFGS   L       +    +R
Sbjct: 146 GQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTR 202

Query: 178 FYRAPELIFGATEYT-TSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
            Y  PE I    +Y      +WS G +L +++ G   F  +       EI++        
Sbjct: 203 VYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA------- 248

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                     +  FP              + P+   L  R L   PS R +  E    P+
Sbjct: 249 ----------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286

Query: 297 FDELREPNARLPNGRPLPPL 316
                E     P+     PL
Sbjct: 287 MQTPAEDVPLNPSKGGPAPL 306

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  137 bits (347), Expect = 2e-37
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 54/298 (18%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 69
           R +G GSFG V   +  +T +  A+K     K ++    R   +ELQ+M+ ++HP +++L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            +  F       +F  +V++ +   +  Y + +     N       VKL+  ++   L Y
Sbjct: 81  WYS-FQDEED--MF--MVVDLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDY 130

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF- 186
           +    R+ HRD+KP N+L+D   H V I DF  A  L       +   ++ Y APE+   
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 187 -GATEYTTSIDIWSAGCVLAELLLGQPLFPGENA--VDQLVEIIKVLGTPTREEIRCMNP 243
                Y+ ++D WS G    ELL G+  +   ++    ++V   +               
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFFDEL 300
             T   +P                 E + L  +LL+ +P  R + L      P+ +++
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  134 bits (340), Expect = 3e-37
 Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 30/219 (13%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----------RELQLMRVMDHP 64
           E+ +G G FG+V + + ++    VAIK ++                  RE+ +M  ++HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           N++      +           +VME+VP   +Y  L         +           I  
Sbjct: 84  NIVK----LYGLMHNP---PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIAL 133

Query: 124 GLAYIHTV-PRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANISYICSRF 178
           G+ Y+    P + HRDL+  N+ +           K+ DFG ++   +  +    + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 179 YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPG 216
           + APE I    E YT   D +S   +L  +L G+  F  
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  135 bits (341), Expect = 3e-37
 Identities = 64/359 (17%), Positives = 125/359 (34%), Gaps = 105/359 (29%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           +   + +G G FG+VF+AK        AIK++    R        RE++ +  ++HP ++
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 68  SLKH----------------------------------------------------CFFS 75
              +                                                        
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 76  TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV 134
             S  +++L + M+    E++   +    S   R   + + ++  QI   + ++H+   +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI-QIAEAVEFLHS-KGL 185

Query: 135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLI-------------AGEANISYICSRFYRA 181
            HRDLKP N+        VK+ DFG    +              A   +   + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE I G   Y+  +DI+S G +L ELL                E ++++      ++R  
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELL--YSFSTQM-------ERVRII-----TDVR-- 287

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                + +FP +    +         P+   +   +L  SP+ R  A +   +  F+ L
Sbjct: 288 -----NLKFPLLFTQKY---------PQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  135 bits (342), Expect = 5e-37
 Identities = 79/294 (26%), Positives = 125/294 (42%), Gaps = 56/294 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHPNVI 67
           +++G GSFG VF A+  +T +  AIK  L+       +           L    +HP + 
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIK-ALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            +   F  T       L  VMEY+   + MY +         +  L     Y  +I  GL
Sbjct: 82  HMFCTF-QTKEN----LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 131

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            ++H+   + +RDLK  N+L+D   H +KI DFG  K+ + G+A  +  C +  Y APE+
Sbjct: 132 QFLHSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 189

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           + G  +Y  S+D WS G +L E+L+GQ  F G++  ++L   I+                
Sbjct: 190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------------- 231

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-CAHPFF 297
             +  +P            + +  EA DL  +L    P  R         HP F
Sbjct: 232 MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  134 bits (340), Expect = 1e-36
 Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 59/298 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 68
           RV+G GSFG V  A+  ETG+  A+K + +D   ++ +++        L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  CF    + + LF   VME+V   + M+ + K      +R      + Y  +I   L 
Sbjct: 89  LFCCF---QTPDRLFF--VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALM 138

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           ++H    + +RDLK  N+L+D   H  K+ DFG  K+ I      +  C +  Y APE++
Sbjct: 139 FLHDK-GIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                Y  ++D W+ G +L E+L G   F  EN  D L E I                  
Sbjct: 197 QE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL----------------N 238

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 297
            +  +P              +  +A  +    +  +P++R              HPFF
Sbjct: 239 DEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  135 bits (341), Expect = 1e-36
 Identities = 75/297 (25%), Positives = 120/297 (40%), Gaps = 59/297 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQ-DRRYKNRELQ--------LMRVMDHPNVI 67
           +V+G GSFG V  A+        A+K VLQ     K +E +        L++ + HP ++
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVK-VLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L   F  T  K    L  V++Y+   E  Y + +      +       + Y  +I   L
Sbjct: 103 GLHFSF-QTADK----LYFVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            Y+H++  + +RDLKP+N+L+D   H + + DFG  K+ I   +  S  C +  Y APE+
Sbjct: 153 GYLHSL-NIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     Y  ++D W  G VL E+L G P F   N   ++ + I                 
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR----CTALEACAHPFF 297
               +                +   A  L   LLQ   + R       +E  +H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  135 bits (342), Expect = 2e-36
 Identities = 76/314 (24%), Positives = 120/314 (38%), Gaps = 67/314 (21%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM----RVM---DHPNVISL 69
           +V+G G+F  V   K  +TG+  A+K + +    K  E+        V+   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
              F     +N L+  LVMEY    + +       S   +R+P    + Y  +I   +  
Sbjct: 127 HFAF---QDENYLY--LVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 182
           +H +    HRD+KP N+L+D   H +++ DFGS  +L A     S +         Y +P
Sbjct: 178 VHRL-GYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLV---AVGTPDYLSP 232

Query: 183 ELI------FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
           E++       G   Y    D W+ G    E+  GQ  F  ++   +    I         
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI--------- 282

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACA 293
               ++        P            + +P EA D   RLL   P  R     A +   
Sbjct: 283 ----VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327

Query: 294 HPFF-----DELRE 302
           HPFF     D LR+
Sbjct: 328 HPFFFGLDWDGLRD 341

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  134 bits (339), Expect = 2e-36
 Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 68
            V+G GSFG V  ++   T E  A+K + +D   ++ +++        L      P +  
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  CF  T  +    L  VMEYV   + MY + +       R    +   Y  +I  GL 
Sbjct: 86  LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 135

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           ++ +   + +RDLK  N+++D   H +KI DFG  K+ I         C +  Y APE+I
Sbjct: 136 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 193

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                Y  S+D W+ G +L E+L GQ  F GE+  D+L + I          +       
Sbjct: 194 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 238

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
               +P            K M  EA+ +   L+   P  R         +   H FF
Sbjct: 239 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  135 bits (341), Expect = 3e-36
 Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 65/312 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQ--DRRYKNRELQLMRVMDHPNVISL 69
           +V+G G+FG V   K     +  A+K     ++L+  +      E  ++   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            + F     +++  L LVM+Y    + +       S    R+P    + Y  ++   +  
Sbjct: 140 HYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 182
           +H +    HRD+KP N+L+D   H +++ DFGS  +L+      S +         Y +P
Sbjct: 191 VHQL-HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSV---AVGTPDYISP 245

Query: 183 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           E++     G   Y    D WS G  + E+L G+  F  E+ + +    I           
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI----------- 293

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHP 295
             MN     F+FP              +   A DL  RL+  S   R       +   HP
Sbjct: 294 --MNHK-ERFQFPT---------QVTDVSENAKDLIRRLIC-SREHRLGQNGIEDFKKHP 340

Query: 296 FF-----DELRE 302
           FF     D +R 
Sbjct: 341 FFSGIDWDNIRN 352

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  130 bits (329), Expect = 1e-35
 Identities = 76/305 (24%), Positives = 122/305 (40%), Gaps = 50/305 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--------LQDRRYKNRELQLMRVMDHP 64
           Y  + V+G+G+  +V  A C    E VAIK++        + +     +E+Q M    HP
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQAMSQCHHP 73

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI----YVKLYTY 119
           N++S    F     K+EL+  LVM+ +   S+  ++KH  +  +    +     +     
Sbjct: 74  NIVSYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-- 177
           ++  GL Y+H      HRD+K  N+L+      V+I DFG +  L A   +I+    R  
Sbjct: 129 EVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFL-ATGGDITRNKVRKT 185

Query: 178 -----FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT 232
                 + APE++     Y    DIWS G    EL  G   +     +  L+  ++    
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---- 241

Query: 233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 292
                    N        P ++     K   K+       + S  LQ  P  R TA E  
Sbjct: 242 ---------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

Query: 293 AHPFF 297
            H FF
Sbjct: 287 RHKFF 291

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  130 bits (330), Expect = 2e-35
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 69/304 (22%)

Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIK-----KVLQDRRYKNR---ELQLMRVMDHPN 65
           RV+G G +G VFQ + +    TG+  A+K      ++++ +       E  ++  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           ++ L + F  T  K    L L++EY+   E   ++ +                Y  +I  
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISM 132

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF----- 178
            L ++H    + +RDLKP+N++++   H VK+ DFG  K+ I            F     
Sbjct: 133 ALGHLHQK-GIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTV----THTFCGTIE 186

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           Y APE++   + +  ++D WS G ++ ++L G P F GEN   + ++ I       + ++
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKL 238

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 293
                       P              +  EA DL  +LL+ + + R       A E  A
Sbjct: 239 ----------NLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276

Query: 294 HPFF 297
           HPFF
Sbjct: 277 HPFF 280

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  130 bits (329), Expect = 4e-35
 Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 68
           RV+G GS+  V   +  +T    A+K V ++    + ++           +  +HP ++ 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  C F T S+    L  V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 75  LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 124

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           Y+H    + +RDLK  N+L+D   H +K+ D+G  K+ +      S  C +  Y APE++
Sbjct: 125 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G  +Y  S+D W+ G ++ E++ G+  F    + D   +        T + +       
Sbjct: 183 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 227

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR------CTALEACAHPFF 297
               F  I          + +  +A  +    L   P  R          +   HPFF
Sbjct: 228 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  128 bits (324), Expect = 4e-35
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--------RELQLMRVMDHPNVI 67
           E ++G G FG V++A  +  G+ VA+K    D             +E +L  ++ HPN+I
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           +L+         N   L LVME+     + RVL       +R+P   +  +  QI RG+ 
Sbjct: 70  ALRGV--CLKEPN---LCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119

Query: 127 YIH--TVPRVCHRDLKPQNLLVD-------PLTHQVKICDFGSAKQLIAGEANISYICSR 177
           Y+H   +  + HRDLK  N+L+             +KI DFG A+        +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAY 178

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 216
            + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 179 AWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  129 bits (327), Expect = 4e-35
 Identities = 74/298 (24%), Positives = 127/298 (42%), Gaps = 59/298 (19%)

Query: 17  RVVGTGSFGIVFQAK---CLETGETVAIK-----KVLQDRRYKNR-ELQLMRVMDHPNVI 67
           +V+G GSFG VF  K     +  +  A+K      +    R + + E  ++  ++HP ++
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            L + F  T  K    L L+++++   +   R+ K             VK Y  ++   L
Sbjct: 90  KLHYAF-QTEGK----LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPEL 184
            ++H++  + +RDLKP+N+L+D   H +K+ DFG +K+ I  E      C +  Y APE+
Sbjct: 140 DHLHSL-GIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     +T S D WS G ++ E+L G   F G++   + + +I                 
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
                 PQ             + PEA  L   L + +P+ R         E   H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  131 bits (331), Expect = 5e-35
 Identities = 71/304 (23%), Positives = 122/304 (40%), Gaps = 62/304 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 69
           +V+G G+FG V   +   T +  A+K     ++++     +   E  +M   + P V+ L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            + F     +++ +L +VMEY+P  + +  ++      N  +P  + + YT ++   L  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGD-LVNLMS-----NYDVPEKWARFYTAEVVLALDA 183

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YRAP 182
           IH++    HRD+KP N+L+D   H +K+ DFG+  ++                   Y +P
Sbjct: 184 IHSM-GFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDT---AVGTPDYISP 238

Query: 183 ELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
           E++    G   Y    D WS G  L E+L+G   F  ++ V             T  +I 
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------------TYSKI- 285

Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT---ALEACAHPF 296
            MN       FP              +  EA +L    L     +R       E   H F
Sbjct: 286 -MNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLF 332

Query: 297 FDEL 300
           F   
Sbjct: 333 FKND 336

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  129 bits (326), Expect = 5e-35
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 69
           +  +G GSFG V +A+    G  VA+K +++   +        RE+ +M+ + HPN++  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
                + T    L +  V EY+   S+YR+L H S A +++         Y + +G+ Y+
Sbjct: 100 MG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 129 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIF 186
           H   P + HR+LK  NLLVD   + VK+CDFG ++   +   +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPG 216
                    D++S G +L EL   Q  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  133 bits (335), Expect = 2e-34
 Identities = 78/297 (26%), Positives = 121/297 (40%), Gaps = 58/297 (19%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 68
            V+G GSFG V  ++   T E  A+K + +D   ++ +++        L      P +  
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  CF  T  +    L  VMEYV   + MY + +       R    +   Y  +I  GL 
Sbjct: 407 LHSCF-QTMDR----LYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLF 456

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           ++ +   + +RDLK  N+++D   H +KI DFG  K+ I         C +  Y APE+I
Sbjct: 457 FLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                Y  S+D W+ G +L E+L GQ  F GE+  D+L + I          +       
Sbjct: 515 AY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNV------- 559

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFF 297
               +P            K M  EA+ +   L+   P  R         +   H FF
Sbjct: 560 ---AYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  129 bits (325), Expect = 2e-34
 Identities = 56/338 (16%), Positives = 111/338 (32%), Gaps = 47/338 (13%)

Query: 20  GTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKN--RELQLMRVMDHPNVISLKHCF 73
           G      V  A+   TGE V ++++      +        EL + ++ +HPN++  +  F
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 74  FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
            +        L +V  ++   S   ++  +      M  + +      + + L YIH + 
Sbjct: 96  IADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM- 147

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--------GEANISYICSRFYRAPEL 184
              HR +K  ++L+  +  +V +    S   +I+         +     +    + +PE+
Sbjct: 148 GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206

Query: 185 IF-GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK--------------- 228
           +      Y    DI+S G    EL  G   F    A   L+E +                
Sbjct: 207 LQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAE 266

Query: 229 --VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC 286
              +          ++ + T               +H+   P       + LQ +P  R 
Sbjct: 267 ELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP 326

Query: 287 TALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELS 324
           +A     H FF        +      LP L      ++
Sbjct: 327 SASTLLNHSFFK-----QIKRRASEALPELLRPVTPIT 359

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  129 bits (325), Expect = 3e-34
 Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 50/298 (16%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHPNVIS 68
           RV+G GS+  V   +  +T    A++ V ++    + ++           +  +HP ++ 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           L  C F T S+    L  V+EYV   + M+ + +      +++P  + + Y+ +I   L 
Sbjct: 118 LHSC-FQTESR----LFFVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALN 167

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELI 185
           Y+H    + +RDLK  N+L+D   H +K+ D+G  K+ +      S  C +  Y APE++
Sbjct: 168 YLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 225

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G  +Y  S+D W+ G ++ E++ G+  F    + D   +        T + +       
Sbjct: 226 RG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL------- 270

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR--CTALEAC----AHPFF 297
               F  I          + +  +A  +    L   P  R  C           HPFF
Sbjct: 271 ----FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  127 bits (322), Expect = 4e-34
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 53/296 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 65
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            I  + C+     ++  +  LVMEY   S   +L+ +    + +  + +   T+   +GL
Sbjct: 116 TIQYRGCYL---REHTAW--LVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGL 167

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPE 183
           AY+H+   + HRD+K  N+L   L+    VK+ DFGSA  +    AN S++ + ++ APE
Sbjct: 168 AYLHSH-NMIHRDVKAGNIL---LSEPGLVKLGDFGSASIM--APAN-SFVGTPYWMAPE 220

Query: 184 LIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           +I    E  Y   +D+WS G    EL   +P     NA+  L  I +             
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------N 268

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                    P +++  W + F         +     LQ  P  R T+     H F 
Sbjct: 269 ES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  127 bits (322), Expect = 4e-34
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 60/299 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K     KV++ +   +   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           +  F     K+   L +VMEYV   E     +  +     R    + + Y  QI     Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHARFYAAQIVLTFEY 156

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +H++  + +RDLKP+NLL+D   + +++ DFG AK++   +     +C +    APE+I 
Sbjct: 157 LHSL-DLIYRDLKPENLLIDQQGY-IQVTDFGFAKRV---KGRTWTLCGTPEALAPEIIL 211

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y  ++D W+ G ++ E+  G P F  +    Q+ E I                   
Sbjct: 212 S-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV----------------SG 253

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAHPFFDEL 300
             RFP                 +  DL   LLQ   + R   L     +   H +F   
Sbjct: 254 KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  127 bits (321), Expect = 5e-34
 Identities = 74/306 (24%), Positives = 130/306 (42%), Gaps = 65/306 (21%)

Query: 17  RVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDRRYKNRELQ---------LMRVMDHP 64
           +V+GTG++G VF  + +   +TG+  A+K + +    +  +           L  +   P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
            +++L + F  T +K    L+L+++Y+   E    + +      +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF-QTETK----LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---- 178
             L ++H +  + +RD+K +N+L+D   H V + DFG +K+ +A E         F    
Sbjct: 170 LALEHLHKL-GIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETER---AYDFCGTI 224

Query: 179 -YRAPELIFGATE-YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
            Y AP+++ G    +  ++D WS G ++ ELL G   F  +   +   EI          
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------R 276

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEA 291
            I       ++  +PQ             M   A DL  RLL   P  R       A E 
Sbjct: 277 RIL-----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 319

Query: 292 CAHPFF 297
             H FF
Sbjct: 320 KEHLFF 325

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  126 bits (319), Expect = 6e-34
 Identities = 79/306 (25%), Positives = 125/306 (40%), Gaps = 74/306 (24%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIK-----KVLQDR--RYKNRELQLMRVMDHPNVISL 69
           R +GTGSFG V   +    G   A+K      V++ +   + N E  ++ ++ HP +I +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 70  KHCFFSTTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
              F     ++   + ++M+Y+   E    + K     +QR P    K Y  ++   L Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--------EANISYICSRFY 179
           +H+   + +RDLKP+N+L+D   H +KI DFG AK +           +          Y
Sbjct: 122 LHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD----------Y 169

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APE++     Y  SID WS G ++ E+L G   F   N   +  E I            
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL----------- 216

Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-----EACAH 294
                  + RFP                 +  DL SRL+    S R   L     +   H
Sbjct: 217 -----NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259

Query: 295 PFFDEL 300
           P+F E+
Sbjct: 260 PWFKEV 265

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  125 bits (316), Expect = 9e-34
 Identities = 68/291 (23%), Positives = 124/291 (42%), Gaps = 45/291 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 68
           Y     +G G+ G V+ A  + TG+ VAI+++       +     E+ +MR   +PN+++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
               +      +EL+  +VMEY+   S+  V+         M    +     +  + L +
Sbjct: 82  YLDSYL---VGDELW--VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEF 131

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIF 186
           +H+  +V HRD+K  N+L+  +   VK+ DFG   Q+   ++   + + + ++ APE++ 
Sbjct: 132 LHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y   +DIWS G +  E++ G+P +  EN +  L  I    GTP  +          
Sbjct: 190 R-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN--------- 238

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                         +F         D  +R L+     R +A E   H F 
Sbjct: 239 --------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  125 bits (315), Expect = 1e-33
 Identities = 75/303 (24%), Positives = 119/303 (39%), Gaps = 50/303 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           +     +G GSFG VF+     T + VAIK +  +          +E+ ++   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
                +   T      L ++MEY+   S   +L+        +    +     +I +GL 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLD 133

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA--GEANISYICSRFYRAPEL 184
           Y+H+  +  HRD+K  N+L+     +VK+ DFG A QL     + N +++ + F+ APE+
Sbjct: 134 YLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRN-TFVGTPFWMAPEV 190

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           I  +  Y +  DIWS G    EL  G+P     + +  L  I K    PT E        
Sbjct: 191 IKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG------- 241

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                        + K           +     L   PS R TA E   H F     +  
Sbjct: 242 ------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281

Query: 305 ARL 307
           + L
Sbjct: 282 SYL 284

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  124 bits (313), Expect = 4e-33
 Identities = 73/310 (23%), Positives = 128/310 (41%), Gaps = 48/310 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMR-VMDHPNVIS 68
           +    +VG G++G V++ + ++TG+  AIK +     +     +E+ +++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 69  LKHCFFSTTSKNELF-LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
               F           L LVME+    S+  ++K  ++    +   ++     +I RGL+
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLS 143

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAP 182
           ++H   +V HRD+K QN+L   LT   +VK+ DFG + QL    G  N ++I + ++ AP
Sbjct: 144 HLHQ-HKVIHRDIKGQNVL---LTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAP 198

Query: 183 ELI----FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           E+I         Y    D+WS G    E+  G P     + +  L  I +          
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD 298
              NP       P++K+  W K F               L  + S R    +   HPF  
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291

Query: 299 ELREPNARLP 308
           +         
Sbjct: 292 DQPNERQVRI 301

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  124 bits (312), Expect = 6e-33
 Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 71
            + +G G +G V+  K    GE VA+K     +     RE  +    +M H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 129
               T S  +L+L  + +Y    S+Y  LK  +  A   + L Y          GL ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY------SSVSGLCHLH 151

Query: 130 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 177
           T        P + HRDLK +N+LV        I D G A + I+    +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 178 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 208
            Y  PE++  +      +     D++S G +L E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  123 bits (311), Expect = 7e-33
 Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 47/292 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 70
           +     +G GS+G V++A   ETG+ VAIK+V  +   +   +E+ +M+  D P+V+   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 71  HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
             +F      +L+  +VMEY    S+  +++     N+ +    +        +GL Y+H
Sbjct: 91  GSYF---KNTDLW--IVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 130 TVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYRAPELI 185
            + R  HRD+K  N+L   L      K+ DFG A QL     + N + I + F+ APE+I
Sbjct: 143 FM-RKIHRDIKAGNIL---LNTEGHAKLADFGVAGQLTDTMAKRN-TVIGTPFWMAPEVI 197

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                Y    DIWS G    E+  G+P +   + +  +  I      PT  +        
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK-------- 247

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                       W   F         D   + L  SP  R TA +   HPF 
Sbjct: 248 ---------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  123 bits (310), Expect = 1e-32
 Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 45/291 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 68
             +   +G GS GIV  A+   +G  VA+K +     Q R     E+ +MR   H NV+ 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           +   +       EL+  ++ME++   ++  ++        R+    +      + + LAY
Sbjct: 107 MYKSYL---VGEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAY 156

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN-ISYICSRFYRAPELIF 186
           +H    V HRD+K  ++L+  L  +VK+ DFG   Q+        S + + ++ APE+I 
Sbjct: 157 LHA-QGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
             + Y T +DIWS G ++ E++ G+P +  ++ V  +  +      P  +          
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN--------- 263

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                   +H    V          D   R+L   P  R TA E   HPF 
Sbjct: 264 --------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  121 bits (306), Expect = 1e-32
 Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 22/211 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISL 69
              +     G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
                   S       L+  ++P  S+Y VL  +   N  +       +   + RG+A++
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 129 HTV-PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           HT+ P +    L  +++++D      +I          +     +      + APE +  
Sbjct: 128 HTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA----WVAPEALQK 182

Query: 188 --ATEYTTSIDIWSAGCVLAELLLGQPLFPG 216
                   S D+WS   +L EL+  +  F  
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  122 bits (307), Expect = 2e-32
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 34/216 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 71
              VG G +G V++      GE VA+K    +D +   RE  L    ++ H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 129
              S  S  +L+L  +  Y    S+Y  L+  +      + ++        I  GLA++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRIVL------SIASGLAHLH 122

Query: 130 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 177
                    P + HRDLK +N+LV     Q  I D G A         +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 178 FYRAPELI-----FGATEYTTSIDIWSAGCVLAELL 208
            Y APE++         +    +DIW+ G VL E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  120 bits (304), Expect = 6e-32
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 35/231 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMDHPNVISLKH 71
             V+G G FG   +    ETGE + +K++++     +R   +E+++MR ++HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK--- 71

Query: 72  CFF--STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
            F       K    LN + EY+   ++  ++K   S + + P      +   I  G+AY+
Sbjct: 72  -FIGVLYKDKR---LNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYL 124

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-------- 180
           H++  + HRDL   N LV      V + DFG A+ ++  +     + S            
Sbjct: 125 HSM-NIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182

Query: 181 -------APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV 224
                  APE+I G   Y   +D++S G VL E++      P         
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  121 bits (306), Expect = 6e-32
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 34/216 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNVIS-LKH 71
           +  +G G FG V++ K    GE VA+K    ++ R   RE  +    ++ H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 72  CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFRGLAYIH 129
                 +  +L+L  V +Y    S++  L  Y+ +    + L            GLA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL------STASGLAHLH 156

Query: 130 TV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS-----R 177
                    P + HRDLK +N+LV        I D G A +  +    I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 178 FYRAPELIFGAT-----EYTTSIDIWSAGCVLAELL 208
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  120 bits (304), Expect = 6e-32
 Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 39/303 (12%)

Query: 10  TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-QDRRYKNRE--LQLMRVMDHPNV 66
           ++      V   G FG V++A+     E VA+K    QD++    E  +  +  M H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 67  IS-LKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYS-SANQRMPLIYVKLYTYQIFR 123
           +  +      T+   +L+L  +  +  + S+   LK    S N+   +         + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET------MAR 132

Query: 124 GLAYIHT---------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG--EANIS 172
           GLAY+H           P + HRD+K +N+L+        I DFG A +  AG    +  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTH 191

Query: 173 YIC-SRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
               +R Y APE++ GA     +    ID+++ G VL EL        G      L    
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251

Query: 228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT 287
           ++   P+ E+++         + P ++ + W K     M     +       +    R +
Sbjct: 252 EIGQHPSLEDMQ--EVVVHKKKRPVLRDY-WQKHAGMAM---LCETIEECWDHDAEARLS 305

Query: 288 ALE 290
           A  
Sbjct: 306 AGC 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  120 bits (303), Expect = 6e-32
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 26/224 (11%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 69
            + +G+GSFG V++ K       VA+K +               E+ ++R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F   ++  +L +  V ++    S+Y  L    ++  +  +  +     Q  RG+ Y+
Sbjct: 85  ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELI 185
           H    + HRDLK  N+ +    + VKI DFG A +      +  +        + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 186 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEII 227
                  Y+   D+++ G VL EL+ GQ  +   N  DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  119 bits (301), Expect = 1e-31
 Identities = 68/301 (22%), Positives = 128/301 (42%), Gaps = 58/301 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 65
           +     +G G+FG V++AK  ETG   A K +       L+D      E++++   DHP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCDHPY 77

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           ++ L   ++      +L+  +++E+ P  ++  ++      ++ +    +++   Q+   
Sbjct: 78  IVKLLGAYY---HDGKLW--IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEA 129

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIA--GEANISYICSRFYR 180
           L ++H+  R+ HRDLK  N+L   +T    +++ DFG + + +    + + S+I + ++ 
Sbjct: 130 LNFLHSK-RIIHRDLKAGNVL---MTLEGDIRLADFGVSAKNLKTLQKRD-SFIGTPYWM 184

Query: 181 APELIFGAT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE 236
           APE++   T     Y    DIWS G  L E+   +P     N +  L++I K    PT  
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLL 243

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                                W   F         D     L  +P  R +A +   HPF
Sbjct: 244 T-----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPF 278

Query: 297 F 297
            
Sbjct: 279 V 279

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  117 bits (295), Expect = 1e-30
 Identities = 52/245 (21%), Positives = 96/245 (39%), Gaps = 41/245 (16%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 69
             ++G G FG V+  +       VAI+ +  +R  ++      RE+   R   H NV+  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 70  K-HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
              C     S   L +  +       ++Y V++    A   + +   +    +I +G+ Y
Sbjct: 95  MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF------YRA 181
           +H    + H+DLK +N+  D    +V I DFG        +A       R       + A
Sbjct: 146 LHAKGIL-HKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLA 202

Query: 182 PELIFGATE--------YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           PE+I   +         ++   D+++ G +  EL   +  F  + A      II  +GT 
Sbjct: 203 PEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTG 258

Query: 234 TREEI 238
            +  +
Sbjct: 259 MKPNL 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  113 bits (285), Expect = 5e-29
 Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 48/306 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRELQLMRV--MDHPNVISLKHC 72
             ++G G +G V++         VA+K     +R+    E  + RV  M+H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT- 130
               T+   +   LVMEY P  S+ + L  ++S       +      + + RGLAY+HT 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130

Query: 131 -------VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---------ANISYI 174
                   P + HRDL  +N+LV        I DFG + +L             A IS +
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 175 CSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVD-QLVEI 226
            +  Y APE++ GA            +D+++ G +  E+ +    LFPGE+  + Q+   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 227 IKVLGTPTREEIR---CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPS 283
            +V   PT E+++            R P+     W +  +        +           
Sbjct: 250 TEVGNHPTFEDMQVLVSRE----KQR-PKFPEA-WKE--NSLAVRSLKETIEDCWDQDAE 301

Query: 284 LRCTAL 289
            R TA 
Sbjct: 302 ARLTAQ 307

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (280), Expect = 1e-28
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 28/221 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDH 63
           Y     +G G    V+ A+       VAIK  +           +R++ RE+     + H
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFE-REVHNSSQLSH 70

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
            N++S+         +++ +  LVMEY+       L  Y  ++  + +     +T QI  
Sbjct: 71  QNIVSM----IDVDEEDDCYY-LVMEYIEG---PTLSEYIESHGPLSVDTAINFTNQILD 122

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICSRFY 179
           G+ + H + R+ HRD+KPQN+L+D     +KI DFG AK     E +++     + +  Y
Sbjct: 123 GIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQY 178

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
            +PE   G      + DI+S G VL E+L+G+P F GE AV
Sbjct: 179 FSPEQAKGEATDECT-DIYSIGIVLYEMLVGEPPFNGETAV 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (277), Expect = 4e-28
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 28/224 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDH 63
           Y    ++G G    V  A+ L     VA+K VL+           R++ RE Q    ++H
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFR-REAQNAAALNH 71

Query: 64  PNVISLKHCFFSTTSKNELFLN---LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
           P ++++    + T            +VMEYV       L+        M           
Sbjct: 72  PAIVAV----YDTGEAETPAGPLPYIVMEYVDG---VTLRDIVHTEGPMTPKRAIEVIAD 124

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY----ICS 176
             + L + H    + HRD+KP N+++   T+ VK+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182

Query: 177 RFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV 220
             Y +PE   G +    S D++S GCVL E+L G+P F G++ V
Sbjct: 183 AQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  111 bits (278), Expect = 5e-27
 Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 42/257 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQD-------RRYKNRELQLMRVMDHP 64
           Y  +  +  G  G ++ A      G  V +K  L               E Q +  + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAM-AERQFLAEVVHP 139

Query: 65  NVISLKHCFFSTTSKNELFLN-LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           +++ +   F   T ++   +  +VMEYV  +S+ R         Q++P+     Y  +I 
Sbjct: 140 SIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEIL 192

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-----IAGEANISYICSR 177
             L+Y+H++  V + DLKP+N+++     Q+K+ D G+  ++     + G          
Sbjct: 193 PALSYLHSIGLV-YNDLKPENIMLTE--EQLKLIDLGAVSRINSFGYLYGTPG------- 242

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR-E 236
            ++APE++      T + DI++ G  LA L L  P   G   VD L E   VL T     
Sbjct: 243 -FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGR-YVDGLPEDDPVLKTYDSYG 298

Query: 237 EI--RCMNPNYTDFRFP 251
            +  R ++P+    RF 
Sbjct: 299 RLLRRAIDPDPRQ-RFT 314

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (263), Expect = 4e-26
 Identities = 50/219 (22%), Positives = 83/219 (37%), Gaps = 26/219 (11%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-----QDRRYK---NRELQLMRVMDHP 64
           Y   R+VG G  G V++A+       VA+K ++      D  ++    RE +    +  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           +V+ +          +   L + M  +       L         +          QI   
Sbjct: 95  HVVPI----HDFGEIDGQ-LYVDMRLING---VDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYR 180
           L   H      HRD+KP+N+LV        + DFG A      +  +    + + + +Y 
Sbjct: 147 LDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYM 202

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA 219
           APE    +   T   DI++  CVL E L G P + G+  
Sbjct: 203 APERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQL 240

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 94.7 bits (236), Expect = 2e-22
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 30/210 (14%)

Query: 16  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
            + +G G+FG V   +       TGE VA+KK LQ    ++     RE+++++ + H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 125
           +  K      ++       L+MEY+P   Y  L+ Y   ++ R+  I +  YT QI +G+
Sbjct: 74  VKYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 178
            Y+ T  R  HRDL  +N+LV+   ++VKI DFG  K L     +  +   +       F
Sbjct: 128 EYLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEFFKVKEPGESPIF 182

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           + APE +   ++++ + D+WS G VL EL 
Sbjct: 183 WYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 68/228 (29%), Positives = 98/228 (42%), Gaps = 30/228 (13%)

Query: 16  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
            R +G G FG V           TGE VA+K +  D   ++     +E+ ++R + H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           I  K C           L LVMEYVP      L+ Y   +  + L  + L+  QI  G+A
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLPRH-SIGLAQLLLFAQQICEGMA 148

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 179
           Y+H      HRDL  +N+L+D     VKI DFG AK +        Y   R       F+
Sbjct: 149 YLHAQ-HYIHRDLAARNVLLDN-DRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFW 203

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEI 226
            APE +     +  + D+WS G  L ELL              +L+ I
Sbjct: 204 YAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 94.0 bits (234), Expect = 5e-22
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)

Query: 16  ERVVGTGSFGIVFQAKCL----ETGETVAIKK----VLQDRRYKNRELQLMRVMDHPNVI 67
            + +G G+FG V   +       TGE VA+KK      +  R   RE+++++ + H N++
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 126
             K      ++       L+MEY+P   Y  L+ Y   ++ R+  I +  YT QI +G+ 
Sbjct: 106 KYKGV--CYSAGRRNLK-LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------FY 179
           Y+ T  R  HRDL  +N+LV+   ++VKI DFG  K L     +  Y   +       F+
Sbjct: 160 YLGTK-RYIHRDLATRNILVEN-ENRVKIGDFGLTKVL---PQDKEYYKVKEPGESPIFW 214

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELL 208
            APE +   ++++ + D+WS G VL EL 
Sbjct: 215 YAPESLT-ESKFSVASDVWSFGVVLYELF 242

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 93.1 bits (232), Expect = 7e-22
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 29/210 (13%)

Query: 16  ERVVGTGSFGIVFQAKCL----ETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
            R +G G FG V   +       TGE VA+K +  +    +     +E++++R + H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSAN-QRMPLIYVKLYTYQIFRGL 125
           +  K     T         L+ME++P      LK Y   N  ++ L     Y  QI +G+
Sbjct: 86  VKYKGI--CTEDGGNGIK-LIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 178
            Y+ +  +  HRDL  +N+LV+   HQVKI DFG  K +   E +  Y   +       F
Sbjct: 140 DYLGSR-QYVHRDLAARNVLVES-EHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVF 194

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           + APE +  +  +  + D+WS G  L ELL
Sbjct: 195 WYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 93.2 bits (232), Expect = 1e-21
 Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 40/228 (17%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
            R++G G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 67  ISLKH-CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIF 122
             L      S          +++ ++    ++  L           L    L  +   I 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR-- 180
            G+ Y+ +     HRDL  +N ++      V + DFG ++++ +G+         +YR  
Sbjct: 148 CGMEYLSSR-NFIHRDLAARNCMLAE-DMTVCVADFGLSRKIYSGD---------YYRQG 196

Query: 181 ----------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
                     A E L      YT   D+W+ G  + E++  GQ  + G
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 30/210 (14%)

Query: 16  ERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
              +G G+FG V   +       TG  VA+K  LQ           RE+Q+++ +    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 125
           +  +   +    ++   L LVMEY+P      L+ +   ++ R+    + LY+ QI +G+
Sbjct: 87  VKYRGVSYGPGRQS---LRLVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-------F 178
            Y+ +  R  HRDL  +N+LV+     VKI DFG AK L     +  Y   R       F
Sbjct: 141 EYLGSR-RCVHRDLAARNILVES-EAHVKIADFGLAKLL---PLDKDYYVVREPGQSPIF 195

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELL 208
           + APE +     ++   D+WS G VL EL 
Sbjct: 196 WYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 92.0 bits (229), Expect = 2e-21
 Identities = 47/227 (20%), Positives = 87/227 (38%), Gaps = 39/227 (17%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
            +++G G FG V +    +       VA+K +       ++      E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKL--YTYQIFR 123
           I L       +S+      +++ ++    ++  L +         +    L  +   I  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 180
           G+ Y+       HRDL  +N ++      V + DFG +K++ +G+         +YR   
Sbjct: 159 GMEYLSNR-NFLHRDLAARNCMLRD-DMTVCVADFGLSKKIYSGD---------YYRQGR 207

Query: 181 ---------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
                    A E L      YT+  D+W+ G  + E+   G   +PG
Sbjct: 208 IAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 30/237 (12%)

Query: 6   CILQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQ 56
            IL+   +   +V+G+G+FG V++   +  GE     VAIK++ +    K       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69

Query: 57  LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVK 115
           +M  +D+P+V  L          + +   L+ + +P   +  L  Y   ++  +   Y+ 
Sbjct: 70  VMASVDNPHVCRL----LGICLTSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLL 120

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
            +  QI +G+ Y+    R+ HRDL  +N+LV      VKI DFG AK L A E       
Sbjct: 121 NWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 176 SRF---YRAPE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 225
            +    + A E ++     YT   D+WS G  + EL+  G   + G  A +   ++E
Sbjct: 179 GKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 38/243 (15%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 64
            + +G G+FG V +A        +   TVA+K +     L +R     EL+++  + +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPL 111
           N+++L        +     L ++ EY                 +          +  + L
Sbjct: 88  NIVNLLGA----CTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 112 IYVKLYT--YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 169
               L +  YQ+ +G+A++ +     HRDL  +N+L+       KICDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200

Query: 170 NISYICSRF-YR--APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 225
            +    +R   +  APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 226 IIK 228
           +IK
Sbjct: 260 MIK 262

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 86.1 bits (214), Expect = 2e-19
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 73
            + +G G FG V        G  VA+K +  D   +    E  +M  + H N++ L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 79

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 131
                + +  L +V EY+       L  Y  +  R  L    L  ++  +   + Y+   
Sbjct: 80  LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 187
               HRDL  +N+LV    +  K+ DFG  K+  + +        +   +  APE L   
Sbjct: 137 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 189

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             +++T  D+WS G +L E+   G+  +P 
Sbjct: 190 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 21/210 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           +  +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 281

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 130
                ++   F  ++ E++    Y  L  Y     R  +  V L     QI   + Y+  
Sbjct: 282 -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 187
                HR+L  +N LV    H VK+ DFG + +L+ G+   ++  ++F   + APE +  
Sbjct: 337 K-NFIHRNLAARNCLVGE-NHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAY 393

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              ++   D+W+ G +L E+   G   +PG
Sbjct: 394 NK-FSIKSDVWAFGVLLWEIATYGMSPYPG 422

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 28/226 (12%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE----TVAIK--KVLQDRRYKN---RELQLMRVMDHPNV 66
            +V+G+G FG V +   +  GE     V IK  +    R+        +  +  +DH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGL 125
           + L          + L   LV +Y+P      L  +   ++  +    +  +  QI +G+
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAP 182
            Y+     + HR+L  +N+L+     QV++ DFG A  L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 225
           E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 187 ESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.0 bits (211), Expect = 5e-19
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 41/224 (18%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIK--KVLQDRRYKN---RELQLMRVMDHPNVI 67
           +RV+G G FG+V+  + ++  +     AIK    + + +      RE  LMR ++HPNV+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 123
           +L           E   ++++ Y+    +  L  +  + QR P    LI    +  Q+ R
Sbjct: 86  AL----IGIMLPPEGLPHVLLPYMC---HGDLLQFIRSPQRNPTVKDLIS---FGLQVAR 135

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 180
           G+ Y+    +  HRDL  +N ++D  +  VK+ DFG A+ ++  E    Y   + +R   
Sbjct: 136 GMEYLAEQ-KFVHRDLAARNCMLDE-SFTVKVADFGLARDILDRE----YYSVQQHRHAR 189

Query: 181 ------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
                 A E L      +TT  D+WS G +L ELL  G P +  
Sbjct: 190 LPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 85.1 bits (211), Expect = 6e-19
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 28/236 (11%)

Query: 6   CILQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQ 56
            IL+   +   +V+G+G+FG V++   +  GE     VAIK++ +    K       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69

Query: 57  LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVK 115
           +M  +D+P+V  L       TS     + L+ + +P   +  L  Y   ++  +   Y+ 
Sbjct: 70  VMASVDNPHVCRLLGI--CLTST----VQLITQLMP---FGCLLDYVREHKDNIGSQYLL 120

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC 175
            +  QI +G+ Y+    R+ HRDL  +N+LV      VKI DFG AK L A E       
Sbjct: 121 NWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEG 178

Query: 176 SRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD--QLVE 225
            +    + A E I     YT   D+WS G  + EL+  G   + G  A +   ++E
Sbjct: 179 GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 85.9 bits (213), Expect = 9e-19
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 27/210 (12%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCF 73
            + +G G FG V        G  VA+K +  D   +    E  +M  + H N++ L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL---- 251

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHTV 131
                + +  L +V EY+       L  Y  +  R  L    L  ++  +   + Y+   
Sbjct: 252 LGVIVEEKGGLYIVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 187
               HRDL  +N+LV    +  K+ DFG  K+  + +        +   +  APE L   
Sbjct: 309 -NFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREK 361

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             +++T  D+WS G +L E+   G+  +P 
Sbjct: 362 --KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           E  +G G FG V+      T   VAIK +           +E Q+M+ + H  ++ L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 130
            ++  S+  ++  +V EY+       L  +        L   +L     QI  G+AY+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 187
           +    HRDL+  N+LV       K+ DFG A+ LI      +   ++F   + APE    
Sbjct: 299 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 355

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              +T   D+WS G +L EL   G+  +PG
Sbjct: 356 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 84.2 bits (209), Expect = 9e-19
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           +  +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL--- 74

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 130
                ++   F  ++ E++    Y  L  Y     R  +  V L     QI   + Y+  
Sbjct: 75  -LGVCTREPPFY-IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 186
                HRDL  +N LV    H VK+ DFG ++ L+ G+   ++  ++F   + APE L +
Sbjct: 130 K-NFIHRDLAARNCLVGE-NHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAY 186

Query: 187 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              +++   D+W+ G +L E+   G   +PG
Sbjct: 187 N--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           E  +G G FG V+      T   VAIK +           +E Q+M+ + H  ++ L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 130
            ++  S+  ++  +V EY+       L  +        L   +L     QI  G+AY+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPELIFG 187
           +    HRDL+  N+LV       K+ DFG A+ LI      +   ++F   + APE    
Sbjct: 382 M-NYVHRDLRAANILVGE-NLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALY 438

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              +T   D+WS G +L EL   G+  +PG
Sbjct: 439 GR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 33/220 (15%)

Query: 14  MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKN------RELQLMRVMDHPN 65
           + ++ +G+G+FG V +           VA+K +  +            E  +M+ +D+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           ++ +                LVME         L  Y   N+ +    +    +Q+  G+
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 180
            Y+       HRDL  +N+L+    H  KI DFG +K L A E   +Y  ++ +      
Sbjct: 131 KYLEES-NFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADE---NYYKAQTHGKWPVK 185

Query: 181 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             APE + +   ++++  D+WS G ++ E    GQ  + G
Sbjct: 186 WYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRG 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 45/226 (19%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 67
             V+G G FG V+    L+        A+K +     + +      E  +M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL-YTYQIFRGLA 126
           SL        S+      +V+ Y+    +  L+++       P +   + +  Q+ +G+ 
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 180
           Y+ +  +  HRDL  +N ++D     VK+ DFG A+ +   E         +Y       
Sbjct: 143 YLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE---------YYSVHNKTG 191

Query: 181 --------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
                   A E L     ++TT  D+WS G +L EL+  G P +P 
Sbjct: 192 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 70
              +G G+FG VF  +       VA+K   +      +     E ++++   HPN++ L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 71  HCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                  ++ +    +VME V        L+   +   R+ +  +         G+ Y+ 
Sbjct: 178 ---IGVCTQKQPIY-IVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLE 230

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LI 185
           +   + HRDL  +N LV    + +KI DFG +++   G    S    +   +  APE L 
Sbjct: 231 SKCCI-HRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 186 FGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           +G   Y++  D+WS G +L E   LG   +P 
Sbjct: 289 YG--RYSSESDVWSFGILLWETFSLGASPYPN 318

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 25/211 (11%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           E+ +G G FG V+ A   +    VA+K +            E  +M+ + H  ++ L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--- 248

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 130
             +  +K  ++  ++ E++       L  +  +++       KL  ++ QI  G+A+I  
Sbjct: 249 -HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIF 186
                HRDL+  N+LV   +   KI DFG A ++I      +   ++F   + APE + F
Sbjct: 303 R-NYIHRDLRAANILVSA-SLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINF 359

Query: 187 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           G   +T   D+WS G +L E++  G+  +PG
Sbjct: 360 G--SFTIKSDVWSFGILLMEIVTYGRIPYPG 388

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 82.0 bits (203), Expect = 9e-18
 Identities = 59/243 (24%), Positives = 103/243 (42%), Gaps = 50/243 (20%)

Query: 17  RVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 66
           R +G GSFG+V++       +      VAIK V     +++R     E  +M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK----HYSSANQRMPLIYVKL--YTY 119
           + L        S+ +  L ++ME +    +   L+      ++     P    K+     
Sbjct: 91  VRLLGV----VSQGQPTL-VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
           +I  G+AY++    V HRDL  +N +V      VKI DFG  + +   +         +Y
Sbjct: 146 EIADGMAYLNANKFV-HRDLAARNCMVAE-DFTVKIGDFGMTRDIYETD---------YY 194

Query: 180 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 225
           R            +PE L  G   +TT  D+WS G VL E+  L +  + G +  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 226 IIK 228
            + 
Sbjct: 252 FVM 254

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 59/249 (23%), Positives = 103/249 (41%), Gaps = 53/249 (21%)

Query: 17  RVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMD-HPN 65
           + +G G+FG V +A         T  TVA+K +       + R    EL+++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 112
           V++L      T     L   +++E+               E +   +         + L 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 113 YVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
           ++  Y++Q+ +G+ ++ +  +  HRDL  +N+L+    + VKICDFG A+ +        
Sbjct: 149 HLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIY----KDP 202

Query: 173 YICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENA 219
                 Y             APE IF    YT   D+WS G +L E+  LG   +PG   
Sbjct: 203 D-----YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 220 VDQLVEIIK 228
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 81.5 bits (200), Expect = 1e-17
 Identities = 51/336 (15%), Positives = 91/336 (27%), Gaps = 86/336 (25%)

Query: 19  VGTGSFGIVFQAKCLETGETVAIKKV-LQDRRYKNRE--------------------LQL 57
           +G G FG VFQ         VAIK + ++     N                      L  
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 58  MRVMDHPNVISLKHCFF---------------------------STTSKNELFLNLVMEY 90
                    I L                                     ++LF+ L  E+
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 91  VPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT 150
               + ++    SS          K   +Q+   LA      R  HRDL   N+L+   T
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK-T 198

Query: 151 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG 210
              K+    + K                     L     +YT S        V  ++ + 
Sbjct: 199 SLKKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245

Query: 211 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP-------NYTDFRFPQIKAHPW--HKV 261
           + LF G+   D   +I +++           +P       +Y   +  +        +  
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303

Query: 262 FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
             K++  +  +    +L +S     +A +       
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 41/224 (18%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 67
             V+G G FG V+    L+        A+K +     + +      E  +M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMP----LIYVKLYTYQIFR 123
           SL        S+      +V+ Y+    +  L+++       P    LI    +  Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR--- 180
           G+ ++ +  +  HRDL  +N ++D     VK+ DFG A+ +   E    +          
Sbjct: 204 GMKFLASK-KFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKE----FDSVHNKTGAK 257

Query: 181 ------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
                 A E L     ++TT  D+WS G +L EL+  G P +P 
Sbjct: 258 LPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 54/249 (21%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLM-RVMDHP 64
            + +G G+FG V +A     G+      VA+K +       ++     EL++M  +  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVP---------ESMYRVLKHYSSANQRMPLIYVK 115
           N+++L        +     L ++ EY                +    + A          
Sbjct: 111 NIVNLLGA----CTHGGPVL-VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 116 L--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
           L  ++ Q+ +G+A++ +     HRD+  +N+L+    H  KI DFG A+ ++    N S 
Sbjct: 166 LLHFSSQVAQGMAFLASK-NCIHRDVAARNVLLTN-GHVAKIGDFGLARDIM----NDSN 219

Query: 174 ICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 219
                Y             APE IF    YT   D+WS G +L E+  LG  P +PG   
Sbjct: 220 -----YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP-YPGILV 272

Query: 220 VDQLVEIIK 228
             +  +++K
Sbjct: 273 NSKFYKLVK 281

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.9 bits (198), Expect = 2e-17
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 25/211 (11%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
              +G G FG V+          VA+K + Q     +    E  LM+ + H  ++ L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL--YTYQIFRGLAYIHT 130
            ++  ++  ++  ++ EY+       L  +      + L   KL     QI  G+A+I  
Sbjct: 74  -YAVVTQEPIY--IITEYMENG---SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIF 186
                HRDL+  N+LV   T   KI DFG A +LI      +   ++F  +  APE + +
Sbjct: 128 R-NYIHRDLRAANILVSD-TLSCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 187 GATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           G   +T   D+WS G +L E++  G+  +PG
Sbjct: 185 G--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 80.8 bits (200), Expect = 2e-17
 Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 63/258 (24%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 64
            +V+G+G+FG V  A             VA+K +       +R     EL++M ++  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVP------------------ESMYRVLKHYSSAN 106
           N+++L       T    ++  L+ EY                    E  Y   K      
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 107 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 164
               L +  L  + YQ+ +G+ ++       HRDL  +N+LV      VKICDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTH-GKVVKICDFGLARDI 222

Query: 165 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAEL--LLG 210
           ++            Y             APE +F    YT   D+WS G +L E+  L  
Sbjct: 223 MSDSN---------YVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 211 QPLFPGENAVDQLVEIIK 228
            P +PG        ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.2 bits (198), Expect = 2e-17
 Identities = 37/313 (11%), Positives = 68/313 (21%), Gaps = 76/313 (24%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNR---ELQLMRVMDHPN 65
           Y      G       +QA        VA+  V                    +  +D P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           V  +              L +V E++   S+  V             +        +   
Sbjct: 93  VARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAA 141

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPEL 184
               H    V      P  + V      V +                             
Sbjct: 142 ADAAHRAG-VALSIDHPSRVRVSI-DGDVVLAYPA-------------------TMPDA- 179

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
                      DI   G  L  LL+ +   P       L    +        E   ++ +
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPADIDRD 231

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                                +P +   +A+R +Q    +R  +         + +++  
Sbjct: 232 ---------------------IPFQISAVAARSVQGDGGIRSASTLL------NLMQQAT 264

Query: 305 ARLPNGRPLPPLF 317
           A       L P+ 
Sbjct: 265 AVADRTEVLGPID 277

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.8 bits (199), Expect = 7e-17
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 33/220 (15%)

Query: 14  MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q+M  +D+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           + L            L   LVME      +++ L       + +P+  V    +Q+  G+
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGM 449

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 180
            Y+       HR+L  +N+L+    H  KI DFG +K L A +   SY  +R        
Sbjct: 450 KYLEEK-NFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 504

Query: 181 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             APE + F   ++++  D+WS G  + E L  GQ  +  
Sbjct: 505 WYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 542

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 29/217 (13%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           E+++G+G  G V   +    G+    VAIK +      + R     E  +M   DHPN+I
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L        ++  L + +V EY+   S+   L+ +      M L+        +  G+ 
Sbjct: 114 RL----EGVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVG---MLRGVGAGMR 165

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR--A 181
           Y+  +    HRDL  +N+LVD      K+ DFG ++ ++  + + +Y  +  +   R  A
Sbjct: 166 YLSDL-GYVHRDLAARNVLVDS-NLVCKVSDFGLSR-VLEDDPDAAYTTTGGKIPIRWTA 222

Query: 182 PE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           PE + F    ++++ D+WS G V+ E+L  G+  +  
Sbjct: 223 PEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWN 257

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 64/258 (24%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
            + +G G FG V +A            TVA+K +       + R    E  +++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP-------------------ESMYRVLKHYSSAN 106
           VI L       +    L   L++EY                      S            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 107 QRMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 164
               L    L  + +QI +G+ Y+  + ++ HRDL  +N+LV     ++KI DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM-KLVHRDLAARNILVAE-GRKMKISDFGLSRDV 200

Query: 165 IAGEANISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LG- 210
                         Y             A E +F    YTT  D+WS G +L E++ LG 
Sbjct: 201 Y----EEDS-----YVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 211 QPLFPGENAVDQLVEIIK 228
            P +PG    ++L  ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)

Query: 14  MAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDRRYKNR-----ELQLMRVMDHPNV 66
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q+M  +D+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHY-SSANQRMPLIYVKLYTYQIFRGL 125
           + L            L   LVME         L  +     + +P+  V    +Q+  G+
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR----- 180
            Y+       HRDL  +N+L+    H  KI DFG +K L A +   SY  +R        
Sbjct: 124 KYLEEK-NFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADD---SYYTARSAGKWPLK 178

Query: 181 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             APE + F   ++++  D+WS G  + E L  GQ  +  
Sbjct: 179 WYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKK 216

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 31/218 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
           ++VVG G FG V   +     +   +VAIK +      K R     E  +M   DHPN+I
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
            L        +K++  + +V EY+   S+   L+ + +    + L+        I  G+ 
Sbjct: 110 RL----EGVVTKSKPVM-IVTEYMENGSLDSFLRKHDAQFTVIQLVG---MLRGIASGMK 161

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 180
           Y+  +    HRDL  +N+L++      K+ DFG  + L   +   +   +R  +      
Sbjct: 162 YLSDM-GYVHRDLAARNILINS-NLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWT 217

Query: 181 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           +PE + +   ++T++ D+WS G VL E++  G+  +  
Sbjct: 218 SPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWE 253

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 51/222 (22%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ-----LMRVMDHPNVISL- 69
           + ++G G FG V++   L  G  VA+K+   +      E +     L     HP+++SL 
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLI 101

Query: 70  KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL-------IYVKLYTYQI 121
             C      +NE+ L  + +Y+   ++ R L  Y S    M +       I +       
Sbjct: 102 GFC----DERNEMIL--IYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICI-----GA 148

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF--- 178
            RGL Y+HT   + HRD+K  N+L+D      KI DFG +K     E + +++ +     
Sbjct: 149 ARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISK--KGTELDQTHLSTVVKGT 204

Query: 179 --YRAPELIFGATEY------TTSIDIWSAGCVLAELLLGQP 212
             Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 205 LGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 57/250 (22%), Positives = 101/250 (40%), Gaps = 57/250 (22%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRVMDHPNV 66
           +R +G G+FG VF A+C           VA+K +    L  R+   RE +L+  + H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYVK 115
           +             +  + +V EY+                 +L        +  L   +
Sbjct: 80  VKFYGV----CGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 116 LY--TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY 173
           +     QI  G+ Y+ +     HRDL  +N LV      VKI DFG ++ + + +     
Sbjct: 135 MLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA-NLLVKIGDFGMSRDVYSTD----- 187

Query: 174 ICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGEN 218
               +YR             PE +++   ++TT  D+WS G +L E+   G QP +   +
Sbjct: 188 ----YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP-WFQLS 240

Query: 219 AVDQLVEIIK 228
              +++E I 
Sbjct: 241 -NTEVIECIT 249

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 23/210 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
            + +G+G FG+V     L   + VAIK + +    +     E ++M  + HP ++ L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL--- 68

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            +    +      LV E++    +   L+          L+        +  G+AY+   
Sbjct: 69  -YGVCLEQAPIC-LVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCLDVCEGMAYLEEA 123

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF---YRAPE-LIFG 187
             V HRDL  +N LV      +K+ DFG  +  +  +   S   ++F   + +PE   F 
Sbjct: 124 -CVIHRDLAARNCLVGE-NQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 180

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              Y++  D+WS G ++ E+   G+  +  
Sbjct: 181 --RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 56/249 (22%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV----LQDRRYKNRELQLMRVMDHPNV 66
           +  +G G+FG VF A+C           VA+K +       R+   RE +L+ ++ H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP----------ESMYRVLKHYSSANQRMPLIYVKL 116
           +          ++    L +V EY+                 L          PL   +L
Sbjct: 106 VRFFGV----CTEGRPLL-MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 117 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 174
                Q+  G+ Y+  +    HRDL  +N LV      VKI DFG ++ + + +      
Sbjct: 161 LAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTD------ 212

Query: 175 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPGENA 219
              +YR             PE +++   ++TT  D+WS G VL E+   G QP +   + 
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265

Query: 220 VDQLVEIIK 228
             + ++ I 
Sbjct: 266 NTEAIDCIT 274

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.1 bits (188), Expect = 6e-16
 Identities = 49/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
            + +G+G FG+V   K       VA+K + +    ++   +E Q M  + HP ++     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF--- 68

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            +   SK      +V EY+    +   L+ +    +   L+      Y +  G+A++ + 
Sbjct: 69  -YGVCSKEYPIY-IVTEYISNGCLLNYLRSHGKGLEPSQLLE---MCYDVCEGMAFLESH 123

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------APE-L 184
            +  HRDL  +N LVD     VK+ DFG  + ++  +    Y+ S   +      APE  
Sbjct: 124 -QFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVF 177

Query: 185 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
            +   +Y++  D+W+ G ++ E+  LG+  +  
Sbjct: 178 HYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.0 bits (192), Expect = 6e-16
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 34/218 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
            R +G G FG V Q   +        VAIK          R     E   MR  DHP+++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 126
            L        ++N ++  ++ME         L+ +    +  + L  + LY YQ+   LA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 180
           Y+ +   V HRD+  +N+LV      VK+ DFG ++ +     + +Y  +   +      
Sbjct: 506 YLESKRFV-HRDIAARNVLVSS-NDCVKLGDFGLSRYM----EDSTYYKASKGKLPIKWM 559

Query: 181 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           APE + F    +T++ D+W  G  + E+L  G   F G
Sbjct: 560 APESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQG 595

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 76.1 bits (188), Expect = 7e-16
 Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 34/220 (15%)

Query: 16  ERVVGTGSFGIVFQAKC-LETGET--VAIKKVLQDRRYKN-------RELQLMRVMDHPN 65
              +G GSFG+V + +    +G+T  VA+K +  D   +        RE+  M  +DH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRG 124
           +I L    +       +   +V E  P      L      +Q    L  +  Y  Q+  G
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR---- 180
           + Y+ +  R  HRDL  +NLL+      VKI DFG  + L   +    Y+     +    
Sbjct: 134 MGYLESK-RFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFA 189

Query: 181 --APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             APE L      ++ + D W  G  L E+   GQ  + G
Sbjct: 190 WCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIG 227

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 75.8 bits (187), Expect = 7e-16
 Identities = 35/227 (15%), Positives = 77/227 (33%), Gaps = 44/227 (19%)

Query: 16  ERVVGTGSFGIVFQAKCLETGET-------VAIKKVLQDRRYKN----RELQLMRVMDHP 64
              +G G+F  +F+    E G+        V +K + +  R  +        +M  + H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           +++      +      +  + LV E+V   S+   LK   +    +  +       Q+  
Sbjct: 73  HLVLN----YGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKLE---VAKQLAA 124

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-------VKICDFGSAKQLIAGEANISYICS 176
            + ++     + H ++  +N+L+     +       +K+ D G +  ++  +        
Sbjct: 125 AMHFLEEN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-------- 175

Query: 177 RFYR------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
              +       PE I        + D WS G  L E+   G      
Sbjct: 176 -ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 77.0 bits (190), Expect = 7e-16
 Identities = 48/231 (20%), Positives = 85/231 (36%), Gaps = 47/231 (20%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
            R +G G+FG V++ +        +   VA+K +      QD      E  ++   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 121
           ++         + ++     +++E +    +   L +     +Q   L  + L      I
Sbjct: 136 IVRCIGV----SLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 179
             G  Y+       HRD+  +N L+         KI DFG A+ +             +Y
Sbjct: 191 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YY 240

Query: 180 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           R             PE  + G   +T+  D WS G +L E+  LG   +P 
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 75.9 bits (187), Expect = 8e-16
 Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 43/223 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 69
           Y   R +G GSFG++F+   L   + VAIK   +         E +  +++     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            +       +  L   LV++ +  S+  +L       ++  +  V +   Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH 123

Query: 130 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
               + +RD+KP N L+        + + + DFG  K          Y          YR
Sbjct: 124 EK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF---------YRDPVTKQHIPYR 173

Query: 181 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 211
             + + G   Y  SI            D+ + G V    L G 
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 76.2 bits (188), Expect = 8e-16
 Identities = 49/231 (21%), Positives = 85/231 (36%), Gaps = 47/231 (20%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
            R +G G+FG V++ +        +   VA+K +      QD      E  ++   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVL-KHYSSANQRMPLIYVKL--YTYQI 121
           ++         + ++     ++ME +    +   L +     +Q   L  + L      I
Sbjct: 95  IVRCIGV----SLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFY 179
             G  Y+       HRD+  +N L+         KI DFG A+ +             +Y
Sbjct: 150 ACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YY 199

Query: 180 R------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           R             PE  + G   +T+  D WS G +L E+  LG   +P 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 57/252 (22%)

Query: 16  ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 62
            + +G G+FG V  A+ +            VA+K +      +D      E+++M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPL 111
           H N+I+L        +++     +++EY                     +  S N    L
Sbjct: 134 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 112 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 169
               L    YQ+ RG+ Y+ +  +  HRDL  +N+LV    + +KI DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHID- 245

Query: 170 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
                   +Y+            APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 217 ENAVDQLVEIIK 228
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGET---VAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
            R++G G FG V++            VA+K   +D    N+     E  +M+ +DHP+++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 126
            L         +   +  ++ME  P   Y  L HY   N+  + ++ + LY+ QI + +A
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 180
           Y+ ++    HRD+  +N+LV      VK+ DFG ++ +   +    Y  +   R      
Sbjct: 128 YLESI-NCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDED----YYKASVTRLPIKWM 181

Query: 181 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           +PE + F    +TT+ D+W     + E+L  G+  F  
Sbjct: 182 SPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFW 217

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 30/218 (13%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE----TVAIKKV-----LQDRRYKNRELQLMRVMDHPNV 66
           ++V+G G FG V++     +       VAIK +      + R     E  +M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           I L        SK +  + ++ EY+   ++ + L+        + L+        I  G+
Sbjct: 109 IRL----EGVISKYKPMM-IITEYMENGALDKFLREKDGEFSVLQLVG---MLRGIAAGM 160

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICS--RF-YR-- 180
            Y+  +    HRDL  +N+LV+      K+ DFG ++ ++  +   +Y  S  +   R  
Sbjct: 161 KYLANM-NYVHRDLAARNILVNS-NLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWT 217

Query: 181 APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           APE + +    +T++ D+WS G V+ E++  G+  +  
Sbjct: 218 APEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWE 253

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 75.0 bits (185), Expect = 1e-15
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 44/223 (19%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVI 67
            R +G G FG V Q   +        VAIK          R     E   MR  DHP+++
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ-RMPLIYVKLYTYQIFRGLA 126
            L        ++N ++  ++ME         L+ +    +  + L  + LY YQ+   LA
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR------ 180
           Y+ +  R  HRD+  +N+LV      VK+ DFG ++ +             +Y+      
Sbjct: 131 YLESK-RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDST---------YYKASKGKL 179

Query: 181 -----APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
                APE + F    +T++ D+W  G  + E+L  G   F G
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQG 220

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 44/229 (19%), Positives = 78/229 (34%), Gaps = 40/229 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 69
           ++  + +G+G FG+++ A      E  A   V  + +       EL+  + +   + I  
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 70  K--------------HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 115
                          +    T  K   +  +VME +       L+  S  N       V 
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID----LQKISGQNGTFKKSTVL 154

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGEANISYI 174
               ++   L YIH    V H D+K  NLL+      QV + D+G + +      +  Y 
Sbjct: 155 QLGIRMLDVLEYIHENEYV-HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213

Query: 175 CSRFYRAPELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 211
                   +   G  E+ TS+            D+   G  +   L G+
Sbjct: 214 ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 54/239 (22%), Positives = 86/239 (35%), Gaps = 57/239 (23%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE-----TVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
              +G   FG V++              VAIK +        R     E  L   + HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYV 114
           V+ L        +K++    ++  Y                  V         +  L   
Sbjct: 74  VVCLLGV----VTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 115 KL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS 172
                  QI  G+ Y+ +   V H+DL  +N+LV      VKI D G  +++ A +    
Sbjct: 129 DFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAAD---- 182

Query: 173 YICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG-QPLFPG 216
                +Y+            APE +++G  +++   DIWS G VL E+   G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCG 233

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 43/223 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIK--KVLQDRRYKNRELQLMRVMDH-PNVISL 69
           +   + +G G+FG +   K L T E VAIK   +       + E +  + +     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            +           +  +V+E +  S+  +       ++   L  V +   Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLEDLFD---LCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 130 TVPRVCHRDLKPQNLLV----DPLTHQVKICDFGSAKQLIAGEANISYICSRF-----YR 180
           +   + +RD+KP+N L+    +     + I DF  AK+         YI         YR
Sbjct: 123 SK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172

Query: 181 APELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 211
             + + G   Y  SI            D+ + G +    L G 
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 60/259 (23%), Positives = 102/259 (39%), Gaps = 66/259 (25%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
            R +G G+FG VFQA+       E    VA+K +        +    RE  LM   D+PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYV-------------PESMYRVLKHYSSANQRMPLI 112
           ++ L        +  +    L+ EY+             P ++  +     S   R+   
Sbjct: 112 IVKLLGV----CAVGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 113 YVKLYT--------YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 164
                +         Q+  G+AY+    +  HRDL  +N LV      VKI DFG ++ +
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRDLATRNCLVGE-NMVVKIADFGLSRNI 224

Query: 165 IAGEANISYICSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LG 210
            + +         +Y+             PE + +    YTT  D+W+ G VL E+   G
Sbjct: 225 YSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYG 273

Query: 211 -QPLFPGENAVDQLVEIIK 228
            QP + G    ++++  ++
Sbjct: 274 LQP-YYGMA-HEEVIYYVR 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 61/252 (24%), Positives = 109/252 (43%), Gaps = 57/252 (22%)

Query: 16  ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 62
            + +G G FG V  A+ +       +   TVA+K +      +D      E+++M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 111
           H N+I+L        +++     +++EY  +                  +  +      +
Sbjct: 146 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 112 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 169
            +  L   TYQ+ RG+ Y+ +  +  HRDL  +N+LV    + +KI DFG A+ +     
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDIN---- 254

Query: 170 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           NI Y     Y+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 255 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 217 ENAVDQLVEIIK 228
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 73.7 bits (182), Expect = 4e-15
 Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 70/296 (23%)

Query: 18  VVGTGSFGIVFQAKCLETGETVAIKK--------VLQ-DRRYKNRELQLMRVMDHPNVIS 68
            +G G FG+V++   +    TVA+KK          +  +++   E+++M    H N++ 
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQ-EIKVMAKCQHENLVE 94

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQ 120
           L     S+   +     LV  Y+P  S   +L   S  +   PL       I        
Sbjct: 95  LLGF--SSDGDDLC---LVYVYMPNGS---LLDRLSCLDGTPPLSWHMRCKIAQG----- 141

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 178
              G+ ++H    + HRD+K  N+L+D      KI DFG A+   + +   + + SR   
Sbjct: 142 AANGINFLHENHHI-HRDIKSANILLDE-AFTAKISDFGLAR--ASEKFAQTVMTSRIVG 197

Query: 179 ---YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ------LVEIIKV 229
              Y APE + G  E T   DI+S G VL E++ G P      AVD+      L++I + 
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP------AVDEHREPQLLLDIKEE 249

Query: 230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 285
           +    +     ++    D     ++                  +AS+ L    + R
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVE--------------AMYSVASQCLHEKKNKR 291

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.9 bits (182), Expect = 5e-15
 Identities = 58/240 (24%), Positives = 102/240 (42%), Gaps = 56/240 (23%)

Query: 16  ERVVGTGSFGIVFQAKCL-------ETGETVAIKKV-----LQDRRYKNRELQLM-RVMD 62
            + +G G+FG V  A+ +       +   TVA+K +      +D      E+++M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPE-----------SMYRVLKHYSSANQRMPL 111
           H N+I+L        +++     +++EY  +                  +  +      +
Sbjct: 100 HKNIINLLGA----CTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 112 IYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 169
            +  L   TYQ+ RG+ Y+ +  +  HRDL  +N+LV    + +KI DFG A+ +     
Sbjct: 155 TFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARNVLVTE-NNVMKIADFGLARDI----N 208

Query: 170 NISYICSRFYR------------APELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
           NI Y     Y+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 209 NIDY-----YKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 73.0 bits (180), Expect = 7e-15
 Identities = 48/210 (22%), Positives = 94/210 (44%), Gaps = 23/210 (10%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
            + +GTG FG+V   K       VAIK + +    ++    E ++M  + H  ++ L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL--- 84

Query: 73  FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV 131
            +   +K      ++ EY+    +   L+      Q   L+        +   + Y+ + 
Sbjct: 85  -YGVCTKQRPIF-IITEYMANGCLLNYLREMRHRFQTQQLLE---MCKDVCEAMEYLESK 139

Query: 132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-YR--APE-LIFG 187
            +  HRDL  +N LV+     VK+ DFG ++  +  +   S + S+F  R   PE L++ 
Sbjct: 140 -QFLHRDLAARNCLVND-QGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYS 196

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
             ++++  DIW+ G ++ E+  LG+  +  
Sbjct: 197 --KFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 40/217 (18%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNR-----ELQLMRVMDHPNVISLK 70
           + ++G G FG V++ + L  G  VA+K++ ++R          E++++ +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 71  HCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPL-------IYVKLYTYQIF 122
                 T    L   LV  Y+   S+   L        + PL       I +        
Sbjct: 94  GF--CMTPTERL---LVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALG-----SA 141

Query: 123 RGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 178
           RGLAY+H    P++ HRD+K  N+L+D    +  + DFG AK +   +   +++ +    
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLM---DYKDTHVTTAVRG 197

Query: 179 ---YRAPE-LIFGATEYTTSIDIWSAGCVLAELLLGQ 211
              + APE L  G +  +   D++  G +L EL+ GQ
Sbjct: 198 TIGHIAPEYLSTGKS--SEKTDVFGYGVMLLELITGQ 232

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDH-PNVISL 69
           Y   R +G+GSFG ++    +  GE VAIK      ++     E ++ ++M     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           + C          +  +VME +  S+  +       +++  L  V L   Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 130 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           +     HRD+KP N L+      + V I DFG AK+      +  +I    YR  + + G
Sbjct: 123 SK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH-QHIP---YRENKNLTG 177

Query: 188 ATEYTTSI------------DIWSAGCVLAELLLGQ 211
              Y  SI            D+ S G VL    LG 
Sbjct: 178 TARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 31/216 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVM-DHPNVISL 69
           +   R +G+GSFG ++    ++T E VAIK      ++     E ++ R++     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           +            +  LVM+ +  S+  +       ++++ L  V +   Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 130 TVPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           +     HRD+KP N L+      +QV I DFG AK+      +  +I    YR  + + G
Sbjct: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH-QHIP---YRENKNLTG 175

Query: 188 ATEYTTSI------------DIWSAGCVLAELLLGQ 211
              Y  S+            D+ S G VL   L G 
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 70.8 bits (174), Expect = 5e-14
 Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 56/236 (23%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 67
           + V+G G+FG V +A+  + G     AIK++       D R    EL+++ ++  HPN+I
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP-----------ESMYRVLKHYSSANQRMPLIYVKL 116
           +L         +  L+  L +EY P             +        + +    L   +L
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 117 --YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 174
             +   + RG+ Y+    +  HRDL  +N+LV    +  KI DFG ++            
Sbjct: 145 LHFAADVARGMDYLSQK-QFIHRDLAARNILVGE-NYVAKIADFGLSR-------GQEV- 194

Query: 175 CSRFYR------------APE-LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPG 216
               Y             A E L +    YTT+ D+WS G +L E++ LG   + G
Sbjct: 195 ----YVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 38/228 (16%), Positives = 74/228 (32%), Gaps = 41/228 (17%)

Query: 16  ERVVGTGSFGIVFQAKCLETG--------ETVAIKKVLQDRRYKNRELQLMRVMDHPNVI 67
           +      + GI+++A    T         +  ++K   +D R  N +    R      V 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106

Query: 68  SLK-----------HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKL 116
             K            C      +++    LV+  +  S+   L         +    V  
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLGRSLQSALDVSP--KHVLSERSVLQ 163

Query: 117 YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGEANISYIC 175
              ++   L ++H    V H ++  +N+ VDP    QV +  +G A +      +++Y  
Sbjct: 164 VACRLLDALEFLHENEYV-HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY-- 220

Query: 176 SRFYRAPELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 211
                      G  E+  S+            D+ S G  + + L G 
Sbjct: 221 -VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 43/231 (18%), Positives = 75/231 (32%), Gaps = 41/231 (17%)

Query: 13  YMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVI 67
           +     +G G FG ++ A     + + +     +K    D      EL+  +    P  I
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 68  SLK--------------HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIY 113
                                      + +  ++M+     +    K Y +  +R     
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ---KIYEANAKRFSRKT 153

Query: 114 VKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT-HQVKICDFGSAKQLIAGEANIS 172
           V   + +I   L YIH    V H D+K  NLL++     QV + D+G A +      + +
Sbjct: 154 VLQLSLRILDILEYIHEHEYV-HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 173 YICSRFYRAPELIFGATEYTTSI------------DIWSAGCVLAELLLGQ 211
           Y             G  E+ TSI            D+   G  + + L G 
Sbjct: 213 YA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 12/187 (6%)

Query: 50  YKNRELQLMRVMDHPNVI--SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQ 107
           YK +  +  +  D+   I   LK    S TS      +  +E    S     +       
Sbjct: 128 YKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED-LY 186

Query: 108 RMPLIYVKL--YTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
           +  L    L  Y++Q+ +G+ ++ +   + HRDL  +N+L+    + VKICDFG A+ + 
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLSE-KNVVKICDFGLARDIY 244

Query: 166 AGEANISYICSRF---YRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
                +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG    +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303

Query: 222 QLVEIIK 228
           +    +K
Sbjct: 304 EFCRRLK 310

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 1e-07
 Identities = 67/380 (17%), Positives = 114/380 (30%), Gaps = 123/380 (32%)

Query: 42  KKVLQDRRYKNRELQLMRVMDHPNVIS-LKHCFFSTTSKNELFLNLVMEYVPESM---YR 97
           K +L      +       ++   + +S     F++  SK E    +V ++V E +   Y+
Sbjct: 43  KSILSKEEIDH-------IIMSKDAVSGTLRLFWTLLSKQE---EMVQKFVEEVLRINYK 92

Query: 98  VLKHYSSANQRMPLIYVKLYTYQ---IFRGLAYI--HTVPRV--------CHRDLKP-QN 143
            L       QR P +  ++Y  Q   ++        + V R+           +L+P +N
Sbjct: 93  FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152

Query: 144 LLVDPLTHQVKICDFGSAKQLIAGEA------------NISYICSRFYRAPELIF----- 186
           +L+      V     GS K  +A +              I ++  +   +PE +      
Sbjct: 153 VLI----DGVL----GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK 204

Query: 187 ------------GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-----VEII-- 227
                               + I S    L  LL  +P    EN +  L      +    
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY---ENCLLVLLNVQNAKAWNA 261

Query: 228 -----KVLGTPTREEIRCMNPNYTDFRFPQIKAHP----WHKVFHKRMPPEAIDLASRLL 278
                K+L T TR          TDF       H              P E   L  + L
Sbjct: 262 FNLSCKILLT-TR------FKQVTDFLSAATTTHISLDHHSMTLT---PDEVKSLLLKYL 311

Query: 279 QYSPS-LRCTALEACA-HPFF-----DELREPNARLPNGRPLPPLFNFKQELSGASPELV 331
              P  L     E    +P       + +R+  A            N+K        + +
Sbjct: 312 DCRPQDLP---REVLTTNPRRLSIIAESIRDGLATWD---------NWKHVNC----DKL 355

Query: 332 NKLIPDHVKRQLGLNFLHPA 351
             +I      +  LN L PA
Sbjct: 356 TTII------ESSLNVLEPA 369

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	353
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.07
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.59
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.42
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.39
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.24
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.17
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.15
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.14
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.72
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.62
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.59
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.53
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.41
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.34
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.3
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.18
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.15
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.02
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.74
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.38
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.13
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.05

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5e-67  Score=454.95  Aligned_cols=249  Identities=29%  Similarity=0.443  Sum_probs=203.6

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++|||||+++++|     .+...
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence            68999999999999999999999999999999986432       2356899999999999999999998     44455


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +|+|||||+|+|.+.+..    .+++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus        88 ~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~  161 (275)
T 3hyh_A           88 IIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDE-HLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TCCEEECCSSCC--
T ss_pred             EEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECC-CCCEEEeecCCCee
Confidence            899999999998887764    5789999999999999999999999 89999999999999996 78899999999987


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ........+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.......+.+.              
T Consensus       162 ~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--------------  227 (275)
T 3hyh_A          162 MTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--------------  227 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------------
T ss_pred             cCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--------------
Confidence            766666667899999999999987665678999999999999999999999988877766665542              


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                         .+            .++..+|+++++||++||++||++|||++|+++||||+.
T Consensus       228 ---~~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          228 ---VY------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             ---CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             ---CC------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence               01            123458999999999999999999999999999999974

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-66  Score=472.74  Aligned_cols=320  Identities=33%  Similarity=0.615  Sum_probs=254.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~   82 (353)
                      +++|++++.||+|+||+||+|+++.+|+.||||++.+..      ....+|+.+|+.++|||||++++++..... ....
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            578999999999999999999999999999999996432      234579999999999999999998754322 2335


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|+|||||+|+|.+.+.    ..+++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus       133 ~~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNE-NCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCB
T ss_pred             EEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCC-CCCEEEeecceee
Confidence            689999999999877765    45789999999999999999999999 79999999999999996 8899999999998


Q ss_pred             ccccC-----CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          163 QLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       163 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      .....     ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||.+.+..+++..|.+..+.|+...
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV  286 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence            65432     2234678999999999998877789999999999999999999999999999999999999999988765


Q ss_pred             HhhcCcCCCC---CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCC
Q 018619          238 IRCMNPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP  314 (353)
Q Consensus       238 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~  314 (353)
                      +.........   ..++.....+|...++ .+|++++|||.+||++||.+|+|++|+|+||||++...+....    ...
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p----~~~  361 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEP----DCA  361 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSC----CCS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCcccc----CCC
Confidence            4322111000   0223334445555443 5899999999999999999999999999999999887654332    123


Q ss_pred             CCCCchhhhccCCHHHHhhccHHHHH
Q 018619          315 PLFNFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      +.+++..+....+.+.+++++.+++.
T Consensus       362 ~~~~~~~~~~~~~~~~~k~~i~~ei~  387 (398)
T 4b99_A          362 PPFDFAFDREALTRERIKEAIVAEIE  387 (398)
T ss_dssp             SCCCCHHHHSCCCHHHHHHHHHHHHH
T ss_pred             CCCCCccchhhcCHHHHHHHHHHHHH
Confidence            33444545555666767766655543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.1e-67  Score=460.96  Aligned_cols=256  Identities=30%  Similarity=0.522  Sum_probs=222.1

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++|||||+++++|     ++.
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~  104 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD  104 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            457899999999999999999999999999999999643       23456899999999999999999999     445


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+|||||+| +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~-~g~vKl~DFGl  178 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGT  178 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcC-CCCEEEEEcCC
Confidence            569999999984 77777753    4689999999999999999999999 89999999999999996 78899999999


Q ss_pred             ccccccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          161 AKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       161 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+......   ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+...++.+.        
T Consensus       179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------  249 (311)
T 4aw0_A          179 AKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--------  249 (311)
T ss_dssp             CEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred             ceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence            99765432   23467899999999999765 4899999999999999999999999999888888777652        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHH------HhcCcccccccCCCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPNA  305 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~------~l~hp~f~~~~~~~~  305 (353)
                               .+.            ++..+|+++++||++||++||++|+|++|      +++||||+++.+...
T Consensus       250 ---------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          250 ---------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             ---------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             ---------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence                     111            23468999999999999999999999987      589999999887653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-65  Score=456.84  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=216.3

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|.+     ...+|+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            5699999999999999999999999999999999543    3456799999999999999999999944     345999


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      |||||+| +|.+.+..     +++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECC-CCCEEEecCcCceecC
Confidence            9999995 67666643     579999999999999999999999 79999999999999996 8899999999998765


Q ss_pred             cCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ... ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+.+..+........          
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------  290 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------  290 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence            543 34567899999999999654 599999999999999999999999999988887776655211000          


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                      .....+|+++++||.+||++||++|||++|+|+||||++..
T Consensus       291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                            01235899999999999999999999999999999998743

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.4e-65  Score=457.51  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=211.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.+..      ..+.+|+.+|+.++|||||+++++|.     +...
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~   97 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGS   97 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCE
Confidence            379999999999999999999999999999999996542      34568999999999999999999984     3445


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||+ |+|.+.+..  .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus        98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~DFGla~  173 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTK-DGTVQLGDFGIAR  173 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECT-TCCEEECSTTEES
T ss_pred             EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECC-CCCEEEcccccce
Confidence            899999998 588887764  234568999999999999999999999 79999999999999996 7899999999998


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ....... ..+.+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+.++.+..-.         
T Consensus       174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---------  243 (350)
T 4b9d_A          174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---------  243 (350)
T ss_dssp             CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------
T ss_pred             eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------
Confidence            7654322 3456799999999999764 5999999999999999999999999999988888777662110         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                         .++..+|+++++||.+||++||++|||++|+|+||||++
T Consensus       244 -------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          244 -------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             -------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence                               022458999999999999999999999999999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.3e-64  Score=458.32  Aligned_cols=251  Identities=28%  Similarity=0.421  Sum_probs=216.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      +.|++.+.||+|+||.||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|..     ...+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            5699999999999999999999999999999999643    3456799999999999999999999954     335999


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      |||||+| +|.+.+..     +++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECT-TCCEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEecCccceECC
Confidence            9999995 67666643     569999999999999999999999 79999999999999996 8899999999998765


Q ss_pred             cC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .. ....+.+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+.......           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------  366 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------  366 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence            44 334567999999999999654 59999999999999999999999999998888777665521100           


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                     ......+|+++++||.+||++||.+|+|++|+|+||||++.
T Consensus       367 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          367 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             ---------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence                           00123589999999999999999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.7e-64  Score=439.43  Aligned_cols=252  Identities=24%  Similarity=0.362  Sum_probs=209.2

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      |++.+.||+|+||+||+|.++.+++.||+|++.+..      ..+.+|+.+++.++|||||+++++|.... .+...+|+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            478889999999999999999999999999986432      33568999999999999999999885432 33456899


Q ss_pred             Eecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           87 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        87 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||+ +|  |+||||||+|||++..++.+||+|||+|+.
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~  181 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence            999998 577777653    4679999999999999999999999 78  999999999999985578999999999985


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .. .....+.+||+.|+|||++.+  .|+.++|||||||++|+|+||+.||.+.+....+...+.....|          
T Consensus       182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~----------  248 (290)
T 3fpq_A          182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------  248 (290)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred             CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC----------
Confidence            43 334456789999999999854  49999999999999999999999998766655544433211111          


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                      ..++...++++++||.+||++||++|||++|+|+||||++
T Consensus       249 ----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          249 ----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence                            1123457899999999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.6e-65  Score=447.09  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=211.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ...++|++.+.||+|+||+||+|++.   .+++.||||++.+.      .....+|+.+++.++|||||+++++|.    
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----   96 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ----   96 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE----
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE----
Confidence            34578999999999999999999984   46889999998643      234568999999999999999999984    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       +...+|+|||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus        97 -~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~-~g~vKl~D  169 (304)
T 3ubd_A           97 -TEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDE-EGHIKLTD  169 (304)
T ss_dssp             -ETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TSCEEEES
T ss_pred             -ECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcC-CCCEEecc
Confidence             3445899999999 577776653    4689999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          158 FGSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       158 fg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ||+|+..... ....+.+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+..      
T Consensus       170 FGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~------  242 (304)
T 3ubd_A          170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK------  242 (304)
T ss_dssp             SEEEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------
T ss_pred             cccceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC------
Confidence            9999865443 334567899999999999765 59999999999999999999999999999888887776520      


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                                 .            .++..+|+++++||++||++||++|||     ++|+++||||+.+++.
T Consensus       243 -----------~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~  291 (304)
T 3ubd_A          243 -----------L------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN  291 (304)
T ss_dssp             -----------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -----------C------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence                       1            123468999999999999999999998     5799999999987653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=9.2e-64  Score=445.35  Aligned_cols=257  Identities=26%  Similarity=0.358  Sum_probs=213.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      .+.|++.+.||+|+||.||+|+++.+|+.||||++..+... .+|+.+++.++|||||+++++|.     +...+|+|||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-VEELVACAGLSSPRIVPLYGAVR-----EGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-THHHHTTTTCCCTTBCCEEEEEE-----ETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-HHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEEEEe
Confidence            45789999999999999999999999999999999765433 47999999999999999999984     3445899999


Q ss_pred             ccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC
Q 018619           90 YVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE  168 (353)
Q Consensus        90 ~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~  168 (353)
                      ||+ |+|.+.+..    .+++++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999 577777754    4679999999999999999999999 7999999999999999733469999999998765432


Q ss_pred             Cc------ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          169 AN------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       169 ~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..      ...+||+.|||||++.+. .|+.++||||+||++|+|++|++||.+.+..+...++...  .++        
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~--------  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP--------  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG--------
T ss_pred             cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC--------
Confidence            21      234799999999999765 5999999999999999999999999887776666665541  111        


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH-------------hcCcccccccCCC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA-------------CAHPFFDELREPN  304 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~-------------l~hp~f~~~~~~~  304 (353)
                                      ...++..+|+++.+||.+||++||.+|||+.|+             |+|||+...+.+.
T Consensus       275 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          275 ----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             ----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             ----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence                            011345689999999999999999999999997             6899998876553

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-62  Score=450.33  Aligned_cols=334  Identities=63%  Similarity=1.130  Sum_probs=301.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCC-CCceeEEE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFLNL   86 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~l   86 (353)
                      ....+|++.+.||+|+||.||+|++..+++ ||+|++.++.....+|+.+++.++||||++++++|..... .+..++++
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            345789999999999999999999877765 9999998777777799999999999999999999876554 55667889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      ||||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++..++.+||+|||+|+....
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            99999999888887777777899999999999999999999999 79999999999999995588999999999998766


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT  246 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
                      ........+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+++..+.|....+...++++.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666788999999999998776799999999999999999999999999999999999999999999999999999998


Q ss_pred             CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCchhhhccC
Q 018619          247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGA  326 (353)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (353)
                      ...++.....+|...++..+++++.+||.+||++||.+|||+.|+++||||+.+++.....+..+.+++++++..+....
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSV  354 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhc
Confidence            88899888899999999899999999999999999999999999999999999998888888888899999998877777


Q ss_pred             CHHHHhhccHHHHHhhc
Q 018619          327 SPELVNKLIPDHVKRQL  343 (353)
Q Consensus       327 ~~~~~~~~~~~~~~~~~  343 (353)
                      .++.+.+++|.....++
T Consensus       355 ~~~~~~~~~~~~~~~~~  371 (394)
T 4e7w_A          355 RPDLISRLVPQHAEAEL  371 (394)
T ss_dssp             CGGGHHHHSCGGGCSSS
T ss_pred             CHHHHHhhccHhhhhhh
Confidence            88888888887774333

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-62  Score=449.78  Aligned_cols=333  Identities=50%  Similarity=0.956  Sum_probs=285.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCC---------
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS---------   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---------   78 (353)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++..+.....+|+.+++.++||||++++++|.....         
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            34679999999999999999999999999999999998887777799999999999999999999865443         


Q ss_pred             ------------------------CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCe
Q 018619           79 ------------------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRV  134 (353)
Q Consensus        79 ------------------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i  134 (353)
                                              ....++++||||++++|.+.+..+...+..+++..++.++.||+.||+|||+ +||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CcC
Confidence                                    3445688999999999999998887888899999999999999999999999 799


Q ss_pred             eeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCC
Q 018619          135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLF  214 (353)
Q Consensus       135 ~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  214 (353)
                      +||||||+|||++..++.+||+|||+|+............+|+.|+|||++.+...++.++||||+||++|+|++|+.||
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            99999999999986578999999999998777666677889999999999987767999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          215 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+.+..+.+..+++..+.|..+.+..+++.+.+..++......|...++..+++++.+||.+||++||.+|||+.|+++|
T Consensus       243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccC-------CCCCCCCC--CCCCCCCCchh-hhccCCHHHHhhccHHHHHh
Q 018619          295 PFFDELRE-------PNARLPNG--RPLPPLFNFKQ-ELSGASPELVNKLIPDHVKR  341 (353)
Q Consensus       295 p~f~~~~~-------~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  341 (353)
                      |||+.++.       .....+..  +.++.++++.. +++...++...+++|+....
T Consensus       323 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  379 (383)
T 3eb0_A          323 PFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSP  379 (383)
T ss_dssp             GGGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC----
T ss_pred             HHHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhcc
Confidence            99998765       22333433  56777777774 44455888888888876653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-61  Score=449.37  Aligned_cols=326  Identities=67%  Similarity=1.186  Sum_probs=289.2

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCC-CCceeEEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFLNLV   87 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv   87 (353)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+.+++.++||||++++++|+.... .+..++++|
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            4558999999999999999999999999999999998877777789999999999999999998865433 445678899


Q ss_pred             eccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           88 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      |||+++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+++.....
T Consensus       132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            9999999888888777778899999999999999999999999 799999999999999975678999999999977666


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      .......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+.++++.++.|..+.+..+++.+.+
T Consensus       211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~  290 (420)
T 1j1b_A          211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  290 (420)
T ss_dssp             CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred             CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence            66667789999999999977667999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCchhhhccCC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGAS  327 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (353)
                      +.++.....+|...+...+++++++||++||++||.+|||+.|+++||||+.++++....+.....+..+++........
T Consensus       291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (420)
T 1j1b_A          291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN  370 (420)
T ss_dssp             CCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTC
T ss_pred             hccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhccC
Confidence            99999999999999999999999999999999999999999999999999999888777777777777777765444444


Q ss_pred             HHHHhhcc
Q 018619          328 PELVNKLI  335 (353)
Q Consensus       328 ~~~~~~~~  335 (353)
                      +.....+.
T Consensus       371 ~~~~~~~~  378 (420)
T 1j1b_A          371 PPLATILI  378 (420)
T ss_dssp             GGGHHHHS
T ss_pred             hhHHHhhC
Confidence            44444333

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1e-61  Score=439.87  Aligned_cols=278  Identities=28%  Similarity=0.461  Sum_probs=216.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc--cchHHHHHHHHHc-CCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++.+.||+|+||+||+|+++   .+++.||||++.+..  ....+|+.+|+.+ +||||++++++|.     ....
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----ECCE
Confidence            578999999999999999999875   467899999886543  3456899999988 6999999999984     3445


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||+ |+|.+.+       +.+++.+++.++.||+.||+|||+ +||+||||||+|||++.+.+.+||+|||+|+
T Consensus        95 ~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            899999998 5666655       358999999999999999999999 7999999999999999755899999999997


Q ss_pred             ccccCC-----------------------------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCC
Q 018619          163 QLIAGE-----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL  213 (353)
Q Consensus       163 ~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p  213 (353)
                      ......                             ...+.+||+.|+|||++.+...|+.++||||+||++|+|++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            543321                             122457999999999998877799999999999999999999999


Q ss_pred             C-CCCChHHHHHHHHHHhCCCCHHHHhhcCcC-------C--------------CCCcCCCC----CCCccccccCCCCC
Q 018619          214 F-PGENAVDQLVEIIKVLGTPTREEIRCMNPN-------Y--------------TDFRFPQI----KAHPWHKVFHKRMP  267 (353)
Q Consensus       214 f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~--------------~~~~~~~~----~~~~~~~~~~~~~~  267 (353)
                      | .+.+..+++..+.+..|.+...........       .              .+...+..    ............+|
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            8 556778888899888886554332211000       0              00000000    00111111234689


Q ss_pred             hhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          268 PEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       268 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ++++|||++||++||.+|+|++|+|+||||+++
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999876

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6e-61  Score=423.75  Aligned_cols=260  Identities=23%  Similarity=0.387  Sum_probs=193.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC-------
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS-------   78 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------   78 (353)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....     ....+|+.+|+.++|||||+++++|.....       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46999999999999999999999999999999986432     334589999999999999999999865442       


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      ....++|+|||||. |+|.+.+.... .....++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~-~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECC-CCcEEEcc
Confidence            23456899999998 47777665421 12234567789999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCCC-------------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018619          158 FGSAKQLIAGEA-------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV  224 (353)
Q Consensus       158 fg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  224 (353)
                      ||+|+.......             ..+.+||+.|||||++.+. .|+.++|||||||++|||++   ||.+..  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999987654322             2345799999999999764 59999999999999999996   775432  2222


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      .+...........                         ....++.+.+||++||+.||.+|||+.|+++||||+++.++.
T Consensus       236 ~~~~~~~~~~p~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          236 TLTDVRNLKFPPL-------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HHHHHHTTCCCHH-------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HHHHHhcCCCCCC-------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            2222111111000                         112467889999999999999999999999999999876654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8e-60  Score=449.90  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=210.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHH---HHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNR---ELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +.-++|++.++||+|+||+||+|+++.+|+.||||++.+..       ....+   ++.+++.++|||||+++++|    
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f----  261 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF----  261 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE----
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE----
Confidence            34578999999999999999999999999999999996532       11223   35566677999999999999    


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       .+...+|+|||||+| +|...+..    .+.+++..++.|+.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus       262 -~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~-~G~vKL~  334 (689)
T 3v5w_A          262 -HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRIS  334 (689)
T ss_dssp             -ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TSCEEEC
T ss_pred             -EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeC-CCCEEec
Confidence             445569999999994 77766653    4789999999999999999999999 79999999999999996 8899999


Q ss_pred             eeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 018619          157 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGTP  233 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~  233 (353)
                      |||+|+...... ..+.+||+.|+|||++.+...|+.++|||||||++|+|++|.+||.+.+..   .....+...    
T Consensus       335 DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~----  409 (689)
T 3v5w_A          335 DLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----  409 (689)
T ss_dssp             CCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----
T ss_pred             ccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----
Confidence            999998765433 446789999999999965556999999999999999999999999764322   222222220    


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                                               ...++..+|+++++||.+||++||.+|++     ++|+++||||+.+.|.
T Consensus       410 -------------------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          410 -------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             -------------------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             -------------------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence                                     01134568999999999999999999998     7999999999998764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.8e-59  Score=445.81  Aligned_cols=258  Identities=25%  Similarity=0.403  Sum_probs=222.2

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++....    ....+|+.+|+.++|||||+++++|     .+...+|+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEEE
Confidence            68999999999999999999999999999999986543    3456899999999999999999999     44556999


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC-CCcEEEeeecccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQL  164 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~-~~~vkl~Dfg~a~~~  164 (353)
                      |||||+| +|.+.+..   ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+.+||+|||+|+..
T Consensus       232 v~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          232 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            9999985 77666542   45689999999999999999999999 799999999999999852 478999999999988


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .........+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+.+..+.+....++          
T Consensus       308 ~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~----------  376 (573)
T 3uto_A          308 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD----------  376 (573)
T ss_dssp             CTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC----------
T ss_pred             cCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC----------
Confidence            777666778899999999999765 589999999999999999999999999998888777665321111          


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                     ......+|+++++||++||++||.+|||++|+|+||||+...++
T Consensus       377 ---------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          377 ---------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             ---------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             ---------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence                           11124589999999999999999999999999999999976554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-58  Score=407.87  Aligned_cols=258  Identities=23%  Similarity=0.344  Sum_probs=212.1

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeec
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFST   76 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (353)
                      .-+..++|.+.+.||+|+||+||+|++.     .++..||||++....    +.+.+|+.+|+.++|||||++++++.+ 
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-   86 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-   86 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-
Confidence            4467889999999999999999999875     357889999996432    345689999999999999999999843 


Q ss_pred             CCCCceeEEEEecccc-chHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           77 TSKNELFLNLVMEYVP-ESMYRVLKHYS---------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                          ...+|+|||||+ |+|.+.+....         .....+++..+..++.|++.||+|||+ ++|+||||||+|||+
T Consensus        87 ----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl  161 (299)
T 4asz_A           87 ----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLV  161 (299)
T ss_dssp             ----SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEE
T ss_pred             ----CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEE
Confidence                334889999998 68888886532         234579999999999999999999999 799999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  222 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  222 (353)
                      ++ ++.+||+|||+|+.......   .....||+.|+|||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus       162 ~~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~  239 (299)
T 4asz_A          162 GE-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV  239 (299)
T ss_dssp             CG-GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred             CC-CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            96 78999999999986544332   2235689999999999765 49999999999999999998 8999999988877


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      +..+.+....                            ..+..+|+++.+|+.+||+.||++|||+.++  |+|++++.
T Consensus       240 ~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~  288 (299)
T 4asz_A          240 IECITQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA  288 (299)
T ss_dssp             HHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred             HHHHHcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence            7666552110                            1234689999999999999999999999999  67887764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.1e-57  Score=403.35  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=201.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +..+++.+.+.||+|+||+||+|++.     .+++.||||++....    ..+.+|+.+|+.++|||||++++++..   
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~---  114 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE---  114 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE---
Confidence            56678999999999999999999865     368899999996432    345689999999999999999999843   


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSS-----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~-----------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                        ...+|+|||||+ |+|.+.+.....           ...++++.++..++.|++.||+|||+ ++|+||||||+|||+
T Consensus       115 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          115 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLV  191 (329)
T ss_dssp             --SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEE
T ss_pred             --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEE
Confidence              334889999999 688887765321           23579999999999999999999999 799999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQ  222 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~  222 (353)
                      +. ++.+||+|||+|+.......   .....||+.|+|||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.
T Consensus       192 ~~-~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~  269 (329)
T 4aoj_A          192 GQ-GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA  269 (329)
T ss_dssp             ET-TTEEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred             CC-CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence            96 88999999999986544332   2345789999999999664 59999999999999999998 8999999888877


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +..+.+....                            .++..+++++.+|+.+||+.||++|||++|++++
T Consensus       270 ~~~i~~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          270 IDCITQGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHcCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            7666542110                            1234689999999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-57  Score=399.08  Aligned_cols=252  Identities=22%  Similarity=0.296  Sum_probs=200.1

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      |-+..+++.+.+.||+|+||+||+|+..   ..||||++...      ...+.+|+.+++.++|||||++++++..    
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----  103 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----  103 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----
Confidence            4567789999999999999999999853   35999988532      2345689999999999999999997621    


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      +  .+|+|||||+ |+|.+.+..   ...++++..+..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+||
T Consensus       104 ~--~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~-~~~~Ki~DF  176 (307)
T 3omv_A          104 D--NLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHE-GLTVKIGDF  176 (307)
T ss_dssp             S--SCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEET-TEEEEECCC
T ss_pred             C--eEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECC-CCcEEEeec
Confidence            1  2689999999 577777653   35679999999999999999999999 79999999999999996 889999999


Q ss_pred             ccccccccCC---CcceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+|+......   ......||+.|||||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+..++.....+
T Consensus       177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~  256 (307)
T 3omv_A          177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS  256 (307)
T ss_dssp             SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred             cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence            9998654322   23456899999999999653  358999999999999999999999999887766665555421111


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +                 .      ...++..+|+++.+||.+||+.||++|||+.|++++
T Consensus       257 p-----------------~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          257 P-----------------D------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             C-----------------C------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             C-----------------C------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            0                 0      011234689999999999999999999999987543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-56  Score=420.28  Aligned_cols=286  Identities=31%  Similarity=0.560  Sum_probs=228.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++.+.      .....+|+.+++.++||||+++++++..... ...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            457899999999999999999999999999999999653      2334589999999999999999999854432 233


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||+++++...+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus       140 ~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~-~~~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCCC
T ss_pred             CeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeC-CCCEEEEEEEee
Confidence            4588999999998776663      348999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +............||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+++..+++.+|.|....+...
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             eecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            877666556678899999999999775 5999999999999999999999999999999999999999999988776544


Q ss_pred             CcCCCCC--cCCCCCCCccccccCCC-----------CChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          242 NPNYTDF--RFPQIKAHPWHKVFHKR-----------MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       242 ~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      .+....+  ..+......+...++..           .++++++||.+||++||.+|||++|+|+||||+.+..+
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~  365 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  365 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence            3211111  01111111222222221           25689999999999999999999999999999976554

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.1e-56  Score=416.26  Aligned_cols=322  Identities=30%  Similarity=0.520  Sum_probs=237.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..++|++.+.||+|+||+||+|.++.+++.||||++.+.      .....+|+.+++.++||||+++++++.........
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            357899999999999999999999999999999998653      23345899999999999999999998665545556


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|+||||++++|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus       131 ~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~-~~~~kl~DFGla~  204 (458)
T 3rp9_A          131 ELYVVLEIADSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQ-DCSVKVCDFGLAR  204 (458)
T ss_dssp             CEEEEECCCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TCCEEECCCTTCB
T ss_pred             eEEEEEeccccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECC-CCCEeecccccch
Confidence            689999999998887775    35679999999999999999999999 79999999999999996 7899999999998


Q ss_pred             ccccCC----------------------------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-----
Q 018619          163 QLIAGE----------------------------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-----  209 (353)
Q Consensus       163 ~~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-----  209 (353)
                      ......                            .....+||++|+|||++.....++.++|||||||++|+|++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            654321                            12345789999999988666679999999999999999998     


Q ss_pred             ------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCcCCCC---CcCCCCCCCcccc
Q 018619          210 ------GQPLFPGEN--------------------AVDQLVEIIKVLGTPTREEIRCMNPNYTD---FRFPQIKAHPWHK  260 (353)
Q Consensus       210 ------g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  260 (353)
                            |.++|.+.+                    ..+.+..+.+.+|.|....+.........   ..++......+..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  778887654                    35778889999999998776543211000   0122222233333


Q ss_pred             ccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhccHHHHH
Q 018619          261 VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       261 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      .+ ..+++++.+||++||++||.+|||++|+|+||||+.+++..........+.  ..+. +....+.+.++..+.+++.
T Consensus       365 ~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~e~~  440 (458)
T 3rp9_A          365 RF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVR--LPFN-DWMNMDEPQLRYAFVKEIQ  440 (458)
T ss_dssp             GS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCC--CSSC-TTSCCCHHHHHHHHHHHHT
T ss_pred             HC-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCC--CCcc-ccccCCHHHHHHHHHHHHH
Confidence            33 347999999999999999999999999999999999877654322221111  1121 2234566777777777765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-56  Score=397.77  Aligned_cols=251  Identities=24%  Similarity=0.289  Sum_probs=205.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +...++++.+.||+|+||+||+|...     .+++.||||++...     ...+.+|+.+++.++|||||++++++..  
T Consensus        23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--  100 (308)
T 4gt4_A           23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--  100 (308)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--
Confidence            45568899999999999999999853     46789999998543     2346689999999999999999999843  


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcE
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNL  144 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Ni  144 (353)
                         ...+++|||||+ |+|.+.+.....            ....+++..+..++.|++.||+|||+ ++|+||||||+||
T Consensus       101 ---~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NI  176 (308)
T 4gt4_A          101 ---DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNV  176 (308)
T ss_dssp             ---SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             ---CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccce
Confidence               334889999998 688888864321            13568999999999999999999999 7999999999999


Q ss_pred             EEeCCCCcEEEeeeccccccccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChH
Q 018619          145 LVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAV  220 (353)
Q Consensus       145 ll~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~  220 (353)
                      |++. ++++||+|||+|+......   ......||+.|+|||++.+. .|+.++|||||||++|||+| |..||.+.+..
T Consensus       177 Ll~~-~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~  254 (308)
T 4gt4_A          177 LVYD-KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ  254 (308)
T ss_dssp             EECG-GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred             EECC-CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9996 8899999999998654432   22346789999999999765 49999999999999999998 89999998887


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          221 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +.+..+.+....                            ..+..+|+++.+|+.+||+.||++|||+.|++++
T Consensus       255 ~~~~~i~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          255 DVVEMIRNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            776655432110                            1234689999999999999999999999999754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.5e-55  Score=401.76  Aligned_cols=305  Identities=46%  Similarity=0.866  Sum_probs=251.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHcCCCceeecceeeeecCC--CCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTS--KNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~   83 (353)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++..+..   ...+++..+..++||||+++++++.....  ....+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            34689999999999999999999999999999999866543   23456677788899999999999866543  34556


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--cCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH--~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      +++||||+++++...+..+......+++..++.++.|++.||.|||  + +||+||||||+|||++..++.+||+|||++
T Consensus       101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            8899999999988888777777888999999999999999999999  9 799999999999999965789999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .............||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+....+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            97776666666788999999999977666899999999999999999999999999999999999999999999988888


Q ss_pred             CcCCCCCcCCCCCCCccccccCC---CCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHK---RMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLP  314 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~  314 (353)
                      .+......+......+|...+..   ..++++.+||.+||+.||.+|||+.|+|+||||+++..+....+....++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~  335 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLP  335 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCC
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCC
Confidence            77766666555555566655543   36789999999999999999999999999999999987766655544444

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-55  Score=405.14  Aligned_cols=318  Identities=29%  Similarity=0.572  Sum_probs=235.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcC-CCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.+.      .....+|+.+++.+. ||||+++++++...   +..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence            47899999999999999999999999999999988543      223457999999997 99999999988542   223


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|+|||||+++|...+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNA-ECHVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred             EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcC-CCCEEecCCcccc
Confidence            4889999999998877754     579999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccC----------------------CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH
Q 018619          163 QLIAG----------------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  220 (353)
Q Consensus       163 ~~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  220 (353)
                      .....                      ......+||++|+|||++.+...++.++||||+||++|+|++|++||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                      11234678999999999987667999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCcCCCCCcC------CCCCCCcccccc------------CCCCChhHHHHHHHhcCcCC
Q 018619          221 DQLVEIIKVLGTPTREEIRCMNPNYTDFRF------PQIKAHPWHKVF------------HKRMPPEAIDLASRLLQYSP  282 (353)
Q Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~------------~~~~~~~~~~li~~~L~~dp  282 (353)
                      +.+..+...++.|....+......+.....      .......+...+            ...+++++.+||.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            999999999999998776543322110000      000001111111            12578999999999999999


Q ss_pred             CCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhccHHHHH
Q 018619          283 SLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       283 ~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      .+|||++|+|+||||+.+..++........+...  +. +....+.+..++++.+++.
T Consensus       318 ~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~  372 (388)
T 3oz6_A          318 NKRISANDALKHPFVSIFHNPNEEPNCDHIITIP--IN-DNVKHSIDDYRNLVYSEIS  372 (388)
T ss_dssp             GGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC---------CCHHHHHHHHHHHHH
T ss_pred             ccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCC--cc-ccccCCHHHHHHHHHHHHH
Confidence            9999999999999999887665433222222221  11 1223455666666655554

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.6e-55  Score=409.38  Aligned_cols=324  Identities=29%  Similarity=0.487  Sum_probs=247.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      -..++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++........
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            34789999999999999999999999999999999996432      344589999999999999999998865443333


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||++++|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus       103 ~~~~lv~e~~~~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~-~~~~kL~DFGla  176 (432)
T 3n9x_A          103 DELYIVLEIADSDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQ-DCSVKVCDFGLA  176 (432)
T ss_dssp             CCEEEEEECCSEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred             CeEEEEEecCCcCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECC-CCCEEEccCCCc
Confidence            5689999999999887775    35679999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCC-----------------------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh---------
Q 018619          162 KQLIAGEA-----------------------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL---------  209 (353)
Q Consensus       162 ~~~~~~~~-----------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~---------  209 (353)
                      +.......                       ....+||++|+|||++.....++.++||||+||++|+|++         
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~  256 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP  256 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence            87644321                       2457889999999998666679999999999999999998         


Q ss_pred             --CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCcCCCC---CcCCCCCCCccccccCCCCC
Q 018619          210 --GQPLFPGEN-----------------AVDQLVEIIKVLGTPTREEIRCMNPNYTD---FRFPQIKAHPWHKVFHKRMP  267 (353)
Q Consensus       210 --g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  267 (353)
                        |.++|.+.+                 ..+++..+.+.+|.|+.+.+.........   ..++......+...+ ..++
T Consensus       257 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s  335 (432)
T 3n9x_A          257 TNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSIS  335 (432)
T ss_dssp             GGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSC
T ss_pred             ccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCC
Confidence              555565544                 46788899999999998776543211000   011222222333333 3589


Q ss_pred             hhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCchhhhccCCHHHHhhccHHHHHh
Q 018619          268 PEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR  341 (353)
Q Consensus       268 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (353)
                      +++.+||++||++||.+|||++|+|+||||+.+++..........+.  ..+. +....+.+.++.++.+++..
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~e~~~  406 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKII--LPFD-DWMVLSETQLRYIFLKEVQS  406 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCC--CSSC-TTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCC--CChh-hcccCCHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999987654322222111  1122 22346677777777777653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.5e-56  Score=401.04  Aligned_cols=255  Identities=25%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCC-----CcEEEEEEeeccc-----cchHHHHHHHHHcCC-Cceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDR-----RYKNRELQLMRVMDH-PNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h-~~iv~~~~~~~   74 (353)
                      |-+..++|++.+.||+|+||+||+|.+..+     ++.||||.+....     +.+.+|+.+|..++| ||||++++++.
T Consensus        59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            446678999999999999999999997654     3679999986532     345689999999976 89999999874


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCC
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP  141 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp  141 (353)
                      ..    ...+|+|||||+ |+|.+.+.....            ....+++..+..++.|++.||+|||+ ++|+||||||
T Consensus       139 ~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~  213 (353)
T 4ase_A          139 KP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA  213 (353)
T ss_dssp             CT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred             ec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCc
Confidence            32    223789999999 688888865332            13458999999999999999999999 7999999999


Q ss_pred             CcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 018619          142 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE  217 (353)
Q Consensus       142 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~  217 (353)
                      +|||++. ++.+||+|||+|+.......   .....||+.|||||++.+. .|+.++|||||||++|||+| |..||.+.
T Consensus       214 ~NILl~~-~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          214 RNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             GGEEECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             cceeeCC-CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            9999996 78999999999987654432   2345789999999999765 59999999999999999998 99999887


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +..+.+...+..-..+                           .++..+++++.+|+.+||+.||++|||+.|+++|
T Consensus       292 ~~~~~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          292 KIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             CCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            6555554444421111                           1234579999999999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.5e-55  Score=388.11  Aligned_cols=280  Identities=34%  Similarity=0.579  Sum_probs=228.5

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..     ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            58999999999999999999999999999999986432      334589999999999999999999843     3458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++||||+++++...+..   ..+.+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEeecccceec
Confidence            89999999987777654   45789999999999999999999999 79999999999999996 788999999999866


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .... ......+|+.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+.+..+.+..+.+....+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            4332 234467899999999997766689999999999999999987766 67788888888899888888766543322


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ........+..........+...+++++++||++||+.||.+|||++|+++||||+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence            1111111122112222222334689999999999999999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4e-55  Score=391.15  Aligned_cols=281  Identities=36%  Similarity=0.671  Sum_probs=229.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..++|++.+.||+|+||+||+|++. +|+.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence            3579999999999999999999985 58999999986432      2345899999999999999999998     3444


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++||||+++++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus        93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~  167 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINS-DGALKLADFGLAR  167 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECC-CCCEEEccCcCce
Confidence            5889999999988877764   44669999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.+....+...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            765332 2334578999999999977667899999999999999999999999999999999999998888876544322


Q ss_pred             Cc--CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          242 NP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       242 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ..  .+....+......+|... ...+++++.+||.+||++||.+|||++|+++||||+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSI-IPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHH-STTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hccchhhhcccccccCCcHHHh-CcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            11  011112222233344433 345899999999999999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.1e-55  Score=391.78  Aligned_cols=256  Identities=29%  Similarity=0.452  Sum_probs=219.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++.+..      ....+|+.+++.++||||+++++++     ...
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence            34678999999999999999999999999999999986542      2345899999999999999999998     334


Q ss_pred             eeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+||||++ ++|.+.+..    .+++++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~  160 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDA-DMNIKIADFGF  160 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcC-CCCEEEeeccC
Confidence            45899999997 577766653    3679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+...           
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------  229 (328)
T 3fe3_A          161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG-----------  229 (328)
T ss_dssp             CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred             ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------
Confidence            987766666667789999999999987765568999999999999999999999998877776666541           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                            .+.            ++..+++++.+||++||+.||.+|||++|+++||||+.....
T Consensus       230 ------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          230 ------KYR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             ------CCC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             ------CCC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence                  011            223579999999999999999999999999999999876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-54  Score=394.35  Aligned_cols=317  Identities=32%  Similarity=0.556  Sum_probs=240.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            3678999999999999999999999999999999985432      234589999999999999999999854322 122


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||++++|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus       103 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a  175 (367)
T 1cm8_A          103 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA  175 (367)
T ss_dssp             CCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred             ceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcC-CCCEEEEeeecc
Confidence            34689999998888877754     579999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +....  ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.++.+.+...
T Consensus       176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          176 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             ccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            86543  2345678999999999987667999999999999999999999999999999999999999999988766543


Q ss_pred             CcCCCC---CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCC
Q 018619          242 NPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN  318 (353)
Q Consensus       242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~  318 (353)
                      ......   ..++......|...+ ..+++++.+||.+||+.||.+|||++++|+||||+.+........ ..    ..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~-~~----~~~  327 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ-VQ----KYD  327 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------C-CC----CCC
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCC-CC----CCC
Confidence            211000   012333334444433 468999999999999999999999999999999999876543211 11    122


Q ss_pred             chhhhccCCHHHHhhccHHHHH
Q 018619          319 FKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      +..+....+.+.+.+++..++.
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~  349 (367)
T 1cm8_A          328 DSFDDVDRTLDEWKRVTYKEVL  349 (367)
T ss_dssp             CC-----CCHHHHHHHHHHHHH
T ss_pred             CChhhhcCCHHHHHHHHHHHHH
Confidence            2222234556666666666654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.6e-54  Score=393.29  Aligned_cols=319  Identities=33%  Similarity=0.617  Sum_probs=251.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +++|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++..........+
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            579999999999999999999999999999999986432     334589999999999999999999865544444568


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+||||++++|.+.+..     ..+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus       106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEEC
T ss_pred             EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECC-CCCEEEEeCcceEec
Confidence            89999999998887754     569999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          165 IAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       165 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .....    .....||+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+.+....+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            44322    23457899999999987766689999999999999999999999999999999999999999998876654


Q ss_pred             cCcCCC---CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCC
Q 018619          241 MNPNYT---DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLF  317 (353)
Q Consensus       241 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~  317 (353)
                      ......   ....+.....+|...+ ..+++++.+||.+||+.||.+|||+.|+|+||||++...+....    .....+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~----~~~~~~  333 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAPF  333 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSCC
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCccccc----CCCCcC
Confidence            221000   0011222223343332 45899999999999999999999999999999999875443221    112233


Q ss_pred             CchhhhccCCHHHHhhccHHHHH
Q 018619          318 NFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      .+..+......+.+.+++.++.+
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~e~~  356 (364)
T 3qyz_A          334 KFDMELDDLPKEKLKELIFEETA  356 (364)
T ss_dssp             CCC-----CCHHHHHHHHHHHTG
T ss_pred             CcccccccCCHHHHHHHHHHHHH
Confidence            44445556667777777766654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-55  Score=391.42  Aligned_cols=292  Identities=33%  Similarity=0.633  Sum_probs=230.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-----chHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+|+.+++.++||||+++++++..     ...++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            689999999999999999999999999999998864321     23479999999999999999998843     34488


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +||||++++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINE-RGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECT-TCCEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECC-CCCEEEccCccccccc
Confidence            9999999998887764   35679999999999999999999999 79999999999999996 7889999999998654


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+....+......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            3322 334578999999999977667899999999999999999999999999999999999999988876544322111


Q ss_pred             --CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCC
Q 018619          245 --YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPL  313 (353)
Q Consensus       245 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~  313 (353)
                        +..+.++......+.. ....+++++.+||.+||+.||.+|||++|+|+||||.++.......+....+
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~  301 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSI  301 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCG
T ss_pred             hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcH
Confidence              1111122222222211 2245899999999999999999999999999999999987765555444333

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-54  Score=382.40  Aligned_cols=278  Identities=35%  Similarity=0.642  Sum_probs=223.4

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|+||.||+|++ .+|+.||+|++....      ....+|+.+++.++||||+++++++..     ...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            6899999999999999999998 689999999985432      334589999999999999999999843     3348


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      ++||||++++|.+.+..   ..+.+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEeECcccccc
Confidence            89999999998877764   34679999999999999999999999 79999999999999996 788999999999865


Q ss_pred             ccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            4332 233457899999999997766689999999999999999999999999999999999998888776544332111


Q ss_pred             CC-CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NY-TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .. .+..++.....+|.. +...+++++.+||++||+.||++|||++|+++||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            00 000112222233333 335689999999999999999999999999999999863

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-54  Score=384.82  Aligned_cols=287  Identities=30%  Similarity=0.523  Sum_probs=230.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcC---CCceeecceeee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMD---HPNVISLKHCFF   74 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~---h~~iv~~~~~~~   74 (353)
                      .+..++|++.+.||+|+||+||+|++..+++.||+|++....         ....+|+.+++.++   ||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            345789999999999999999999999999999999986322         23457888777664   999999999997


Q ss_pred             ecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           75 STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                      .........+++||||++++|.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~-~~~~k  160 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTS-GGTVK  160 (308)
T ss_dssp             ECCSSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECT-TSCEE
T ss_pred             ccCCCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCEE
Confidence            7666666678999999999988887642  23449999999999999999999999 79999999999999996 78899


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      |+|||++.............+|+.|+|||++.+.. ++.++||||+||++|+|++|..||.+.+..+.+.++.+..+.++
T Consensus       161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          161 LADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EeeCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999998776665566678899999999997654 89999999999999999999999999999999999999888877


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ...+..... .....++.....++. .+...+++++.+||.+||++||.+|||+.|+|+||||++.
T Consensus       240 ~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          240 EDDWPRDVS-LPRGAFPPRGPRPVQ-SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TTTSCSSCS-SCGGGSCCCCCCCHH-HHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhhccchhh-ccccccCCCCCCcHH-HhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            654322110 011111211112222 2334689999999999999999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.9e-54  Score=385.82  Aligned_cols=290  Identities=32%  Similarity=0.567  Sum_probs=217.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++     .....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   77 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK   77 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence            4578999999999999999999999999999999986432     3456899999999999999999998     34445


Q ss_pred             EEEEeccccchHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~--~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      +|+||||++++|.+.+.....  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus        78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~  155 (317)
T 2pmi_A           78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINK-RGQLKLGDFGLA  155 (317)
T ss_dssp             EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCSSC
T ss_pred             EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcC-CCCEEECcCccc
Confidence            889999999999888865432  22468999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+....+..
T Consensus       156 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          156 RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             EETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGG
T ss_pred             eecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhh
Confidence            8664332 234567899999999997766689999999999999999999999999999999999999888876544332


Q ss_pred             cCc--CCCCCcCCCCCCCc----cccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCC
Q 018619          241 MNP--NYTDFRFPQIKAHP----WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNAR  306 (353)
Q Consensus       241 ~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~  306 (353)
                      ...  .+. ...+......    +.......+++++.+||.+||+.||.+|||++|+++||||++.......
T Consensus       236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          236 VTKLPKYN-PNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             GGGCTTCC-TTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred             hhhhhhcc-cccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence            111  000 0011101111    1122234688999999999999999999999999999999998765443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.2e-54  Score=389.75  Aligned_cols=257  Identities=26%  Similarity=0.398  Sum_probs=218.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ..++|.+.+.||+|+||.||+|.++.+|+.||+|.+.+..          ....+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            4678999999999999999999999999999999986532          2356899999999999999999998     


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC---cEE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVK  154 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~---~vk  154 (353)
                      .....+|+|||||. ++|.+.+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++..+.   .+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEE
Confidence            34445899999997 57766654    35679999999999999999999999 79999999999999986332   799


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      |+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+.......+
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            9999999877666555667899999999999654 589999999999999999999999999888877766654322111


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      .                         .+...+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus       239 ~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          239 E-------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             H-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             c-------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            1                         12245899999999999999999999999999999998643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-54  Score=393.74  Aligned_cols=318  Identities=33%  Similarity=0.544  Sum_probs=236.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            4589999999999999999999999999999999986432      334589999999999999999998854321 122


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+|||+++++|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       107 ~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECC----
T ss_pred             CeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECC-CCCEEEeecccc
Confidence            34789999999887766643     579999999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +....  ......+|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.|....+...
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          180 RHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            86443  2345688999999999977667899999999999999999999999999999999999999999987766543


Q ss_pred             CcCCC-C--CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCC
Q 018619          242 NPNYT-D--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN  318 (353)
Q Consensus       242 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~  318 (353)
                      ..... .  ..++......|...+ ..+++++.+||++||+.||.+|||+.|+|+||||+.+..+....     ..+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~-----~~~~~~  331 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYD  331 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC-----CCCCCC
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC-----CCCCCC
Confidence            21100 0  012222233343333 35799999999999999999999999999999999887654321     112233


Q ss_pred             chhhhccCCHHHHhhccHHHHHh
Q 018619          319 FKQELSGASPELVNKLIPDHVKR  341 (353)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~  341 (353)
                      +..+......+.+.+++.+++..
T Consensus       332 ~~~~~~~~~~~~~~~~~~~e~~~  354 (367)
T 2fst_X          332 QSLESRDLLIDEWKSLTYDEVIS  354 (367)
T ss_dssp             GGGSSCCCCHHHHHHHHHHHHHH
T ss_pred             cchhhccCCHHHHHHHHHHHHHH
Confidence            33333456677788887777764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.6e-54  Score=386.75  Aligned_cols=284  Identities=33%  Similarity=0.589  Sum_probs=228.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            45679999999999999999999999999999999985432      234589999999999999999999843     3


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC----CCCcEEEee
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICD  157 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~----~~~~vkl~D  157 (353)
                      ..+|+||||++++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++.    ..+.+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            45889999999988877764    4679999999999999999999999 79999999999999953    245699999


Q ss_pred             eccccccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          158 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       158 fg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ||++....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+...
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            99998654332 23445779999999999776668999999999999999999999999999999999999988888765


Q ss_pred             HHhhcCc--CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          237 EIRCMNP--NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       237 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      .+.....  .+. ..++......+...+...+++++.+||.+||+.||.+|||++|+|+||||++..+
T Consensus       261 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          261 TWPGVTALPDWK-QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             TSTTGGGSTTCC-TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhh-hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            4432211  111 1223333344444455568999999999999999999999999999999998654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-53  Score=384.59  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=215.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++|++.+.||+|+||+||+|+++.+|+.||+|++.+..       ....+|+.+++.++||||+++++++     ...
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~   77 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeC
Confidence            4579999999999999999999999999999999996532       2345799999999999999999988     344


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+||||++| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DFG~  151 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGL  151 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECC-CCCEEEeeccc
Confidence            458999999985 66665543    4679999999999999999999999 79999999999999996 78899999999


Q ss_pred             cccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          161 AKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       161 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      |+.... ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.......+...          
T Consensus       152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------  220 (337)
T 1o6l_A          152 CKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------  220 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             hhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence            986433 3344567899999999998654 5899999999999999999999999988877766665541          


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                             ..            .++..+++++.+||.+||+.||.+||     +++++++||||+.+.+.
T Consensus       221 -------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~  270 (337)
T 1o6l_A          221 -------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ  270 (337)
T ss_dssp             -------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             -------CC------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence                   01            12345899999999999999999999     89999999999987653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-54  Score=391.53  Aligned_cols=255  Identities=28%  Similarity=0.479  Sum_probs=211.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|..+++.+ +||||+++++++     .
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~   94 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q   94 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence            55679999999999999999999999999999999997532       2345789999988 799999999998     4


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+|||||.| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~-~g~ikL~DF  168 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDH-EGHCKLADF  168 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECC-CCCEEEccc
Confidence            44458999999985 66666653    4679999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          159 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       159 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+|+..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+...        
T Consensus       169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------  239 (353)
T 3txo_A          169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--------  239 (353)
T ss_dssp             TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred             cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence            999854332 334456899999999999764 4899999999999999999999999999988887777652        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH------HHHhcCcccccccCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELREP  303 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~~~l~hp~f~~~~~~  303 (353)
                               ..            .++..+++++.+||++||++||.+|+++      +++++||||+.+.+.
T Consensus       240 ---------~~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          240 ---------EV------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             ---------CC------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence                     11            1234579999999999999999999998      899999999987653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.6e-54  Score=392.46  Aligned_cols=321  Identities=31%  Similarity=0.508  Sum_probs=234.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....      ....+|+.+++.++||||+++++++..... ...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4579999999999999999999999999999999986532      234589999999999999999998854332 223


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||+++++.+.+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       103 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a  174 (371)
T 2xrw_A          103 QDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  174 (371)
T ss_dssp             CEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCCCC-
T ss_pred             cceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcC-CCCEEEEEeecc
Confidence            3688999999998877764      358999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+++..+.+....+..+
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            876555445567889999999999764 5899999999999999999999999999999999999998888877655433


Q ss_pred             CcCCCCC--cCCCCCCCccccccC-----------CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCC
Q 018619          242 NPNYTDF--RFPQIKAHPWHKVFH-----------KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP  308 (353)
Q Consensus       242 ~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~  308 (353)
                      .+....+  ..+......+...++           ...++++++||++||+.||.+|||++|+|+||||+.+..+.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~  333 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA  333 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC
Confidence            2211000  001111111111111           112578999999999999999999999999999987654322211


Q ss_pred             CCCCCCCCCCchhhhccCCHHHHhhccHHHHHh
Q 018619          309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVKR  341 (353)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (353)
                         +.+.......+....+.+..++++.+++.+
T Consensus       334 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (371)
T 2xrw_A          334 ---PPPKIPDKQLDEREHTIEEWKELIYKEVMD  363 (371)
T ss_dssp             ---CCCCCCTTTTCCCCCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCChhhccccCcHHHHHHHHHHHHHH
Confidence               112222222233456777788887777763

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-53  Score=383.71  Aligned_cols=284  Identities=34%  Similarity=0.597  Sum_probs=227.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....         ....+|+.+++.++||||+++++++.     
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   82 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----   82 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----
Confidence            3578999999999999999999999999999999886421         23458999999999999999999983     


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      .....++||||+++++...+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        83 ~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg  157 (346)
T 1ua2_A           83 HKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFG  157 (346)
T ss_dssp             CTTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCG
T ss_pred             eCCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcC-CCCEEEEecc
Confidence            3344889999999988777653   34578999999999999999999999 79999999999999996 7899999999


Q ss_pred             cccccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          160 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       160 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ++....... ......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+.+..+.+....+
T Consensus       158 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          158 LAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             GGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            998764433 2345678999999999977666899999999999999999999999999999999999998888876554


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      ...........+......++.. +...+++++++||++||+.||.+|||++|+++||||++...+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             hhhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            3322211111222222222222 224688999999999999999999999999999999876443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.8e-52  Score=381.93  Aligned_cols=320  Identities=30%  Similarity=0.549  Sum_probs=241.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------------cchHHHHHHHHHcCCCceeecceee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------RYKNRELQLMRVMDHPNVISLKHCF   73 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~~iv~~~~~~   73 (353)
                      ..++|++.+.||+|+||.||+|.+. +|+.||||++....               ....+|+.+++.++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            3579999999999999999999975 49999999885421               3346899999999999999999999


Q ss_pred             eecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           74 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                      ..........+|+||||+++++.+.+..   ....+++..++.++.||+.||.|||+ +||+||||||+||+++. ++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~  173 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLAD-NNDI  173 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCE
T ss_pred             EeccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcC-CCCE
Confidence            7766666667899999999998887763   45579999999999999999999999 79999999999999996 7889


Q ss_pred             EEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          154 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      ||+|||++.............+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            99999999866655555667889999999999775668999999999999999999999999999999999999999998


Q ss_pred             CHHHHhhcCcC----CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCC
Q 018619          234 TREEIRCMNPN----YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPN  309 (353)
Q Consensus       234 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~  309 (353)
                      ...........    +............|.. .....++.+.+||.+||+.||.+|||+.|+++||||+.+..+....  
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~--  330 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLT--  330 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGT--
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCccccc--
Confidence            87654322110    0001111222233333 2345789999999999999999999999999999999875543221  


Q ss_pred             CCCCCCCCCchhhhccCCHHHHhhccHHHHH
Q 018619          310 GRPLPPLFNFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                       ..+.....+.  ..........+.+..++.
T Consensus       331 -~~~~~~~~~~--~~~~~~~~~~~~~~~e~~  358 (362)
T 3pg1_A          331 -EGLSERFHFD--ESVTDVYDMHKIFTAEVE  358 (362)
T ss_dssp             -TTCCCCCCCC--TTCCCHHHHHHHHHHHHH
T ss_pred             -cccccccChh--hhhhhHHHHHHHHHHHHH
Confidence             1122222222  234455555666655554

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.8e-53  Score=388.54  Aligned_cols=255  Identities=25%  Similarity=0.463  Sum_probs=210.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||+||+|+++.+++.||+|++.+..       ....+|..++..+ +||||++++++|     .
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence            45679999999999999999999999999999999997542       2345788888876 899999999998     3


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+|||||+| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DF  197 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDY  197 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECC-CCCEEEeec
Confidence            44458999999985 66665543    4679999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccc-cCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH--------H-HHHHHHH
Q 018619          159 GSAKQLI-AGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV--------D-QLVEIIK  228 (353)
Q Consensus       159 g~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~-~~~~~~~  228 (353)
                      |+|+... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||......        + ....+..
T Consensus       198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            9998633 33445567899999999999764 5899999999999999999999999643221        1 1222221


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH------HHHhcCcccccccC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE  302 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~~~l~hp~f~~~~~  302 (353)
                      .                             ...++..+++++++||++||+.||.+|+++      +|+++||||+.+.+
T Consensus       277 ~-----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w  327 (396)
T 4dc2_A          277 K-----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  327 (396)
T ss_dssp             C-----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred             c-----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence            0                             011335689999999999999999999985      79999999998865


Q ss_pred             C
Q 018619          303 P  303 (353)
Q Consensus       303 ~  303 (353)
                      .
T Consensus       328 ~  328 (396)
T 4dc2_A          328 D  328 (396)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-52  Score=380.43  Aligned_cols=323  Identities=31%  Similarity=0.586  Sum_probs=247.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      -..++|.+.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++.........
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            34689999999999999999999999999999999985432     2335899999999999999999887544333445


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ..|+||||+.++|.+.+..     ..+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        88 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           88 EVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINS-NCDLKVCDFGLAR  160 (353)
T ss_dssp             CEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred             eEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcC-CCcEEEEeccccc
Confidence            6889999999998877754     579999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCC-----------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 018619          163 QLIAGEA-----------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       163 ~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      .......           .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            6543221           12346799999999987766789999999999999999999999999999888888888888


Q ss_pred             CCCHHHHhhcCcC--CCC--CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCC
Q 018619          232 TPTREEIRCMNPN--YTD--FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL  307 (353)
Q Consensus       232 ~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~  307 (353)
                      .+...........  ..+  ...+......+.. ....+++++.+||.+||+.||.+|||+.++++||||+....+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~  319 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEP  319 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSC
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccccc
Confidence            7763211000000  000  0011111112222 2246899999999999999999999999999999999987765443


Q ss_pred             CCCCCCC-CCCCchhhhccCCHHHHhhccHHHH
Q 018619          308 PNGRPLP-PLFNFKQELSGASPELVNKLIPDHV  339 (353)
Q Consensus       308 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  339 (353)
                      . ..+++ ..+.+.........+.+++++..++
T Consensus       320 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
T 2b9h_A          320 E-GEPIPPSFFEFDHYKEALTTKDLKKLIWNEI  351 (353)
T ss_dssp             C-CCCCCGGGGGGGCCSSCCCHHHHHHHHHHHH
T ss_pred             c-cCCCCcceeeecchhhcCCHHHHHHHHHHHh
Confidence            3 23333 3344444445567777777766655

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-52  Score=373.54  Aligned_cols=283  Identities=33%  Similarity=0.614  Sum_probs=221.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     ...
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRR   76 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCe
Confidence            368999999999999999999999999999999885543      234579999999999999999999843     344


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .++||||++++++..+.   .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus        77 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           77 LHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITK-HSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcC-CCCEEEeeCCCchh
Confidence            88999999976544443   245679999999999999999999999 79999999999999996 78999999999987


Q ss_pred             cccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-
Q 018619          164 LIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-  241 (353)
Q Consensus       164 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (353)
                      ...... .....+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....+.+..+.......... 
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence            653332 345678999999999987677899999999999999999999999999999999888888877665433221 


Q ss_pred             -CcCCCCCcCCCCCC-CccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          242 -NPNYTDFRFPQIKA-HPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       242 -~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                       ...+.....+.... .++.. ....+++++.+||.+||+.||.+|||++|+++||||+++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          232 TNQYFSGVKIPDPEDMEPLEL-KFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             TCGGGTTCCCCCCSSCCCHHH-HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cccccccCcCCCccccchhhh-hcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence             11111122221111 11111 123589999999999999999999999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.5e-53  Score=392.29  Aligned_cols=264  Identities=25%  Similarity=0.404  Sum_probs=221.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|..++..++||||++++++|     ..
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~  145 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QD  145 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----EC
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ee
Confidence            4568999999999999999999999999999999998642       23356899999999999999999988     44


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|||||. |+|.+.+..   ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~-~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDM-NGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcC-CCCEEEcchh
Confidence            455899999997 577777653   35679999999999999999999999 79999999999999996 7899999999


Q ss_pred             cccccccCCCc--ceeeeeceeeChhhhh----CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          160 SAKQLIAGEAN--ISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       160 ~a~~~~~~~~~--~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      +|+........  ...+||+.|+|||++.    +...++.++||||+||++|+|++|..||.+.+..+...+++..... 
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-  299 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-  299 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc-
Confidence            99866544332  3357999999999986    2445899999999999999999999999999988888777642110 


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCcccccccCCCC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREPNA  305 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~~~~~  305 (353)
                                    +.+|.         ....+|+++++||++||+.+|.+  |++++|+++||||+.+.+...
T Consensus       300 --------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          300 --------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             --------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             --------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence                          01111         11348999999999999999998  999999999999999887654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-53  Score=379.45  Aligned_cols=256  Identities=26%  Similarity=0.399  Sum_probs=218.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....   ....+|+.+++.++||||+++++++..     ...+++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence            578999999999999999999999999999999886432   335689999999999999999999843     335889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC-CCcEEEeeecccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQL  164 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~-~~~vkl~Dfg~a~~~  164 (353)
                      |||||+| +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++.. ++.+||+|||++...
T Consensus        79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            9999985 77666643   34579999999999999999999999 799999999999999853 578999999999887


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ..........+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+......+....       
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T 1tki_A          155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             CCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-------
Confidence            666655667899999999999654 479999999999999999999999999988887777766433222221       


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                        ...+|+++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             ------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence                              13579999999999999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.4e-53  Score=389.48  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=218.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|.+.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|+.+++.++||||++++++|     .+
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~  140 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QD  140 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EE
Confidence            4567999999999999999999999999999999998642       23456899999999999999999998     44


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|||||+ |+|.+.+..     ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~-~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDK-SGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECC-CCCEEEeccc
Confidence            456899999997 577776643     469999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCC--cceeeeeceeeChhhhhCCCC---CCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          160 SAKQLIAGEA--NISYICSRFYRAPELIFGATE---YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      +|+.......  ..+.+||+.|+|||++.+...   ++.++|||||||++|+|++|..||.+.+..+...++.+..... 
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-  292 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL-  292 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc-
Confidence            9987654432  235679999999999976432   7789999999999999999999999999888877776531100 


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCC--CCCHHHHhcCcccccccCC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL--RCTALEACAHPFFDELREP  303 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~~~l~hp~f~~~~~~  303 (353)
                                    .++.          ...+|+++++||++||+.+|.+  |++++|+++||||+.+.+.
T Consensus       293 --------------~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~  339 (410)
T 3v8s_A          293 --------------TFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA  339 (410)
T ss_dssp             --------------CCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred             --------------cCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence                          0110          1248999999999999999999  9999999999999998664

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.4e-53  Score=393.62  Aligned_cols=264  Identities=26%  Similarity=0.393  Sum_probs=215.9

Q ss_pred             CceeeeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeee
Q 018619            1 MYLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFF   74 (353)
Q Consensus         1 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (353)
                      |-.+.+.-..++|++.+.||+|+||.||+|.++.+|+.||+|++....      ....+|+.+++.++||||+++++++ 
T Consensus         1 M~~~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-   79 (444)
T 3soa_A            1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-   79 (444)
T ss_dssp             ------CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-
T ss_pred             CCccccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-
Confidence            334455566789999999999999999999999999999999986543      3346899999999999999999988 


Q ss_pred             ecCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCC
Q 018619           75 STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTH  151 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~  151 (353)
                          ......|+|||||.| +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++.  .++
T Consensus        80 ----~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~  150 (444)
T 3soa_A           80 ----SEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGA  150 (444)
T ss_dssp             ----ECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTC
T ss_pred             ----EECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCC
Confidence                444558899999985 66666653    5679999999999999999999999 79999999999999984  256


Q ss_pred             cEEEeeeccccccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 018619          152 QVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL  230 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  230 (353)
                      .+||+|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+....
T Consensus       151 ~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~  229 (444)
T 3soa_A          151 AVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA  229 (444)
T ss_dssp             CEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred             cEEEccCceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Confidence            899999999986654433 3456899999999999654 58999999999999999999999999988887777766532


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ...+.                    ..     ...+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       230 ~~~~~--------------------~~-----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          230 YDFPS--------------------PE-----WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             CCCCT--------------------TT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             CCCCc--------------------cc-----cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            11110                    11     13579999999999999999999999999999999764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-52  Score=375.96  Aligned_cols=252  Identities=29%  Similarity=0.478  Sum_probs=216.1

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++.+.       .....+|..+++.++||||+++++++     ...
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~   78 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDA   78 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECS
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeC
Confidence            457899999999999999999999999999999998653       23345799999999999999999988     344


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+||||+.| +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~Dfg~  152 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGF  152 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSS
T ss_pred             CEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcC-CCCEEEeecCc
Confidence            458999999985 77766653    5679999999999999999999999 79999999999999996 78999999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ++....  ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+.+..          
T Consensus       153 a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------  219 (318)
T 1fot_A          153 AKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------  219 (318)
T ss_dssp             CEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC----------
T ss_pred             ceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            986543  23456789999999999654 58999999999999999999999999988877777666520          


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                             .            .++..+++++.+||++||+.||.+|+     +++++++||||+.+.+.
T Consensus       220 -------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~  268 (318)
T 1fot_A          220 -------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  268 (318)
T ss_dssp             -------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             -------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence                   1            12345799999999999999999999     89999999999987653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.8e-53  Score=383.49  Aligned_cols=255  Identities=29%  Similarity=0.502  Sum_probs=214.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|.+.+.||+|+||.||+|+++.+|+.||||++.+..       .....|..++..+ +||||+++++++     .
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~   88 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----Q   88 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----E
Confidence            45689999999999999999999999999999999996532       2345788888876 999999999988     3


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+|||||+| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~vkL~DF  162 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADF  162 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECC-CCCEEEeEC
Confidence            44458999999974 77666653    3679999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          159 GSAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       159 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+|+..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+...  .     
T Consensus       163 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~-----  234 (345)
T 1xjd_A          163 GMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--N-----  234 (345)
T ss_dssp             TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--C-----
T ss_pred             hhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--C-----
Confidence            999864332 334567899999999999664 5899999999999999999999999998887777666541  0     


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH-HHhcCcccccccCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELREP  303 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-~~l~hp~f~~~~~~  303 (353)
                                            ..++..+++++++||.+||+.||.+||++. ++++||||+.+.+.
T Consensus       235 ----------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          235 ----------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             ----------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             ----------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence                                  012345899999999999999999999998 99999999988653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-54  Score=388.31  Aligned_cols=252  Identities=29%  Similarity=0.446  Sum_probs=212.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.+.       .....+|+.+++.++||||+++++++.     .
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----T   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----e
Confidence            3457899999999999999999999999999999998643       234568999999999999999999984     3


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...+++||||++|+|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~DFG~  154 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDD-NLNVKIADFGL  154 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECT-TCCEEECCSSC
T ss_pred             CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcC-CCCEEEEEecc
Confidence            345889999999998887754    3679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............||+.|+|||++.+....+.++||||+||++|+|++|..||.+........                
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------  218 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------  218 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------
Confidence            9877666666677899999999999776545789999999999999999999997644221100                


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                 ...  .-...++..+++++.+||++||+.||.+|||++|+++||||+.
T Consensus       219 -----------~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          219 -----------KVN--SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             -----------CCC--SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             -----------HHH--cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence                       000  0011234568999999999999999999999999999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=375.97  Aligned_cols=255  Identities=26%  Similarity=0.411  Sum_probs=216.1

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++....          ....+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            3578999999999999999999999999999999986432          33568999999999999999999883    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC----cE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QV  153 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~----~v  153 (353)
                       ....+++||||+. ++|.+.+.    ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++    .+
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~-~~~~~~~~  157 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLD-RNVPKPRI  157 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESC-SSSSSCCE
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEec-CCCCCCCE
Confidence             3445889999997 57766664    35679999999999999999999999 79999999999999985 44    79


Q ss_pred             EEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          154 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      ||+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+.......
T Consensus       158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  236 (326)
T 2y0a_A          158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF  236 (326)
T ss_dssp             EECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             EEEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence            99999999877655555567899999999998654 58999999999999999999999999988877776665532222


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ...                         ....+++.+.+||++||+.||.+|||+.++|+||||+..
T Consensus       237 ~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          237 EDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CHH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             Ccc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            111                         123578999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-52  Score=386.58  Aligned_cols=264  Identities=27%  Similarity=0.426  Sum_probs=219.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|+++.+|+.||||++.+.       .....+|..++..++||||++++++|     .+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~  132 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QD  132 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----EC
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ee
Confidence            4578999999999999999999999999999999999642       23456899999999999999999988     44


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|||||. |+|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~-~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDR-CGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecC-CCCEEEeech
Confidence            456899999996 577777754   24579999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCc--ceeeeeceeeChhhhhC------CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 018619          160 SAKQLIAGEAN--ISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       160 ~a~~~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      +|+........  ...+||+.|+|||++.+      ...++.++|||||||++|+|++|+.||.+.+..+...++.+...
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~  287 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE  287 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence            99876544332  34579999999999863      34589999999999999999999999999988887777664210


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCC---CCHHHHhcCcccccccCCCCC
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR---CTALEACAHPFFDELREPNAR  306 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~~~l~hp~f~~~~~~~~~  306 (353)
                      ..               .++.         +...+|+++++||++||+ ||.+|   ++++|+++||||+.+.+....
T Consensus       288 ~~---------------~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          288 HL---------------SLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             HC---------------CCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred             Cc---------------CCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence            00               0010         123589999999999999 99998   589999999999998876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.3e-52  Score=370.78  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=213.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++...     ..+|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            468999999999999999999999999999999985432    3356899999999999999999988543     3488


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +|||||. ++|.+.+..     ..+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECC-CCCEEEeeCCCceec
Confidence            9999997 577766653     469999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+........         
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------  236 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---------  236 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC---------
T ss_pred             CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            54433 3456789999999999765 489999999999999999999999998887777665554211100         


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                       ..+..+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus       237 -----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          237 -----------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             -----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -----------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence                             0123579999999999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.3e-52  Score=388.87  Aligned_cols=281  Identities=32%  Similarity=0.564  Sum_probs=229.4

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHc------CCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVM------DHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~   78 (353)
                      ....+|++.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.+      +|+||+++++++..   
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~---  170 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF---  170 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE---
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc---
Confidence            34668999999999999999999999999999999997653   3345788888877      57799999998843   


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCc--EEEe
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ--VKIC  156 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~--vkl~  156 (353)
                        ...+|+||||++++|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.  +||+
T Consensus       171 --~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~-~~~~~vkL~  244 (429)
T 3kvw_A          171 --RNHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQ-QGRSGIKVI  244 (429)
T ss_dssp             --TTEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESS-TTSCCEEEC
T ss_pred             --CCeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcc-CCCcceEEe
Confidence              3458899999999988888752  23459999999999999999999999 79999999999999996 555  9999


Q ss_pred             eeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          157 DFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      |||+|.....  ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+++..+.++..
T Consensus       245 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~  321 (429)
T 3kvw_A          245 DFGSSCYEHQ--RVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK  321 (429)
T ss_dssp             CCTTCEETTC--CCCSSCSCGGGCCHHHHHTB-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecccceecCC--cccccCCCCCccChHHHhCC-CCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            9999975432  33456889999999999775 48999999999999999999999999999999999999999999887


Q ss_pred             HHhhcCcC--------CCCC----------------------cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC
Q 018619          237 EIRCMNPN--------YTDF----------------------RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC  286 (353)
Q Consensus       237 ~~~~~~~~--------~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  286 (353)
                      .+......        +..+                      .........|...+....++++.+||++||++||.+||
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp  401 (429)
T 3kvw_A          322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM  401 (429)
T ss_dssp             HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence            65432110        0000                      00011233455556666789999999999999999999


Q ss_pred             CHHHHhcCcccccc
Q 018619          287 TALEACAHPFFDEL  300 (353)
Q Consensus       287 t~~~~l~hp~f~~~  300 (353)
                      |++|+|+||||++.
T Consensus       402 ta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          402 TPGQALRHPWLRRR  415 (429)
T ss_dssp             CHHHHHTSTTTC--
T ss_pred             CHHHHhCChhhccC
Confidence            99999999999874

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.9e-52  Score=380.73  Aligned_cols=317  Identities=34%  Similarity=0.581  Sum_probs=241.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCC-Cc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~   81 (353)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ..
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3579999999999999999999999999999999986532      3345899999999999999999998544331 11


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+||||+.++|.+.+      ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       120 ~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECSTTCC
T ss_pred             eeEEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECC-CCCEEEEecCcc
Confidence            234899999999876655      2459999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ......  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+........
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          192 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            854332  334577999999999977567899999999999999999999999999999999999999999887765443


Q ss_pred             CcCCCCC---cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCC
Q 018619          242 NPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN  318 (353)
Q Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~  318 (353)
                      .......   ..+......+.. +...+++++.+||.+||+.||.+|||+.|+|+||||+.++.+........++..   
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~---  345 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD---  345 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC---
T ss_pred             hhhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc---
Confidence            2110000   011111122222 224579999999999999999999999999999999988765443322222222   


Q ss_pred             chhhhccCCHHHHhhccHHHHH
Q 018619          319 FKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                       ..+....+.+.+++.+.+++.
T Consensus       346 -~~~~~~~~~~~~~~~~~~~~~  366 (371)
T 4exu_A          346 -SLEHEKLTVDEWKQHIYKEIV  366 (371)
T ss_dssp             -TTSSCCCCHHHHHHHHHHHHH
T ss_pred             -chhhcccchHHHHHHHHHHHH
Confidence             112234555566666655543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.3e-52  Score=378.31  Aligned_cols=261  Identities=27%  Similarity=0.389  Sum_probs=213.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc---------ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ...++|++.+.||+|+||.||+|.++.+|+.||||++...         .....+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---   97 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS---   97 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe---
Confidence            4467899999999999999999999999999999998532         2345689999999999999999998843   


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKI  155 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl  155 (353)
                        ...+|+|||||. ++|.+.+.........+++..++.++.||+.||+|||+ +||+||||||+|||++.+  ...+||
T Consensus        98 --~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           98 --DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             --TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             --CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEE
Confidence              345899999998 57777776655556679999999999999999999999 799999999999999752  234999


Q ss_pred             eeeccccccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          156 CDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      +|||++........ .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+ .+....+.+......
T Consensus       175 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~  252 (351)
T 3c0i_A          175 GGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMN  252 (351)
T ss_dssp             CCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCC
T ss_pred             ecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCC
Confidence            99999987655433 3456789999999999654 48999999999999999999999998753 334444433211111


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ..                         ....+++++++||.+||+.||.+|||+.++++||||+...
T Consensus       253 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          253 PR-------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            11                         1134799999999999999999999999999999998643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.1e-52  Score=378.77  Aligned_cols=287  Identities=28%  Similarity=0.491  Sum_probs=225.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC---C
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---K   79 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~   79 (353)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4579999999999999999999999999999999885432      234589999999999999999998855432   1


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....+|+||||+++++...+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcC-CCCEEEccch
Confidence            1345889999999988777754   34679999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccC-----CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          160 SAKQLIAG-----EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       160 ~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      +|......     .......||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+....+.+..+.++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99865422     2223457899999999997766689999999999999999999999999999999999988888776


Q ss_pred             HHHHhhcCcC--CCCCcCCCCCCCccccccC-CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          235 REEIRCMNPN--YTDFRFPQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       235 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ...+......  +................+. ...++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  318 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence            5443322110  0001111000000000000 0137789999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-52  Score=377.18  Aligned_cols=255  Identities=25%  Similarity=0.449  Sum_probs=209.4

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||.||+|+++.+++.||+|++.+..       ....+|..+++.+ +||||+++++++     .
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence            45689999999999999999999999999999999997542       2245789999887 899999999998     3


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+||||+.| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~DF  154 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDS-EGHIKLTDY  154 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEEec
Confidence            44458999999985 77666653    3679999999999999999999999 79999999999999996 788999999


Q ss_pred             cccccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHH
Q 018619          159 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQLVEIIK  228 (353)
Q Consensus       159 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------~~~~~~~~~  228 (353)
                      |+|+.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.....         ......+..
T Consensus       155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             cccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence            99986432 3334556899999999999664 589999999999999999999999975321         112222221


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH------HHHhcCcccccccC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------LEACAHPFFDELRE  302 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~~~l~hp~f~~~~~  302 (353)
                      .                 .            ..++..+++++++||.+||+.||.+||++      +++++||||+.+.+
T Consensus       234 ~-----------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          234 K-----------------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             C-----------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             C-----------------C------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            0                 0            01334689999999999999999999995      89999999998765


Q ss_pred             C
Q 018619          303 P  303 (353)
Q Consensus       303 ~  303 (353)
                      .
T Consensus       285 ~  285 (345)
T 3a8x_A          285 D  285 (345)
T ss_dssp             H
T ss_pred             H
Confidence            3

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=382.48  Aligned_cols=257  Identities=25%  Similarity=0.390  Sum_probs=214.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ..+..++|.+.+.||+|+||.||+|.+..+++.||+|++.+..       ....+|+.+++.++||||++++++|     
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----   84 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----   84 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence            4466789999999999999999999999999999999986532       3445899999999999999999988     


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .....+|+||||+.| +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~D  158 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDE-HGHVHITD  158 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECC-CCCEEEec
Confidence            344458999999975 6655554    45679999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLGT  232 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~  232 (353)
                      ||+|.............||+.|+|||++.+.  ..++.++|||||||++|+|++|..||...+..   .....+...   
T Consensus       159 FG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~---  235 (384)
T 4fr4_A          159 FNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT---  235 (384)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC---
T ss_pred             cceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc---
Confidence            9999987666666778899999999998642  34889999999999999999999999754322   222222110   


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-HHHHhcCcccccccC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-ALEACAHPFFDELRE  302 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~~~l~hp~f~~~~~  302 (353)
                                                ...++..+++++.+||.+||+.||.+||+ ++++++||||+.+.+
T Consensus       236 --------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          236 --------------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             --------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             --------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence                                      00123457999999999999999999998 899999999998765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-53  Score=379.02  Aligned_cols=254  Identities=21%  Similarity=0.269  Sum_probs=187.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc-h--HHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||++...... .  +.|+..+..++|||||++++++..... ....+|+
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~l   78 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEE
Confidence            46799999999999999999987  6899999999654322 2  345666677899999999998865432 2345789


Q ss_pred             Eecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CeeeccCCCCcEEEeCCCCcEEEee
Q 018619           87 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        87 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~--------~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      |||||+ |+|.+.+..     .++++..+..++.|++.||+|||+ +        +|+||||||+|||++. ++++||+|
T Consensus        79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~D  151 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIAD  151 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEECC
T ss_pred             EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECC-CCCEEEEe
Confidence            999998 688777754     568999999999999999999998 6        8999999999999996 88999999


Q ss_pred             eccccccccCCCc-----ceeeeeceeeChhhhhCCC-----CCCccccchhHHHHHHHHHhCCCCCCCCChH-------
Q 018619          158 FGSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------  220 (353)
Q Consensus       158 fg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------  220 (353)
                      ||+|+........     ...+||+.|+|||++.+..     .++.++|||||||++|||+||.+||......       
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~  231 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  231 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence            9999876544322     2457999999999996542     2567999999999999999998877533211       


Q ss_pred             -------HHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          221 -------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       221 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                             +.+...+..-+         ..+     .+|.    .+   .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~---------~rp-----~~p~----~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          232 VPSDPSVEEMRKVVCEQK---------LRP-----NIPN----RW---QSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SCSSCCHHHHHHHHTTSC---------CCC-----CCCG----GG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccccchHHHHHHHHhccc---------CCC-----CCCc----cc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence                   11111110000         000     0000    00   00113457889999999999999999999975


Q ss_pred             C
Q 018619          294 H  294 (353)
Q Consensus       294 h  294 (353)
                      .
T Consensus       291 ~  291 (303)
T 3hmm_A          291 T  291 (303)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-52  Score=381.11  Aligned_cols=255  Identities=28%  Similarity=0.436  Sum_probs=215.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|.+.+.||+|+||.||+|.++.+|+.||+|++....      ....+|+.+++.++||||+++++++     .....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            568999999999999999999999999999999996542      3345899999999999999999988     34445


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEeeecc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS  160 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~Dfg~  160 (353)
                      .|+|||||.| +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++..  ++.+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            8899999985 6666554    35679999999999999999999999 799999999999999752  34699999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+.......+      
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------  250 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------  250 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred             ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            9877665555567899999999999654 589999999999999999999999999888777766655211111      


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                    ...|     ..+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus       251 --------------~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          251 --------------SPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             --------------TTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             --------------cccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence                          0111     3479999999999999999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.3e-52  Score=378.61  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=216.4

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...++|++.+.||+|+||.||+|+++.+|+.||+|++.+..       ....+|+.+++.++||||+++++++     ..
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~  112 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KD  112 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----Ec
Confidence            45689999999999999999999999999999999986432       2345799999999999999999988     34


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||+. ++|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       113 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~g~~kL~DFg  186 (350)
T 1rdq_E          113 NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTDFG  186 (350)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECC-CCCEEEcccc
Confidence            445899999997 577776654    3579999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      +++.....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....         
T Consensus       187 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------  254 (350)
T 1rdq_E          187 FAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------  254 (350)
T ss_dssp             TCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred             cceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence            99865433  3456899999999999664 58999999999999999999999999988877776665520         


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE  302 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~  302 (353)
                              .            .++..+++++.+||.+||+.||.+||+     ++++++||||+.+.+
T Consensus       255 --------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          255 --------V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             --------C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             --------C------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence                    0            123458999999999999999999998     999999999998765

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-52  Score=381.01  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=214.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||.||+|+++.+++.||||++.+..       ....+|..++..+ +||||+++++++     .
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~   91 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q   91 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----E
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----E
Confidence            45678999999999999999999999999999999996532       2345788888877 799999999988     4


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+||||++| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~vkL~DF  165 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADF  165 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCC
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcC-CCcEEEEeC
Confidence            44468999999985 77766653    3679999999999999999999999 79999999999999996 788999999


Q ss_pred             cccccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          159 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       159 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+|+.... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...        
T Consensus       166 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------  236 (353)
T 2i0e_A          166 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------  236 (353)
T ss_dssp             TTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred             CcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--------
Confidence            99986433 3334567899999999999654 5899999999999999999999999998888777776652        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELREP  303 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~~  303 (353)
                               ..            .++..+++++.+||++||+.||.+||+     ++++++||||+.+.+.
T Consensus       237 ---------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~  286 (353)
T 2i0e_A          237 ---------NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  286 (353)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred             ---------CC------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence                     01            123468999999999999999999994     6999999999987653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.8e-52  Score=377.04  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=211.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      ..++|.+.+.||+|+||.||+|.++.+|+.||+|++.+......+|+.++..+ +||||+++++++     .+...+|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence            36789999999999999999999999999999999988777778899999888 799999999998     444568999


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC---cEEEeeeccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDFGSAKQ  163 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~---~vkl~Dfg~a~~  163 (353)
                      ||||.| +|.+.+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||+...++   .+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999985 7766664    35679999999999999999999999 79999999999999854333   599999999987


Q ss_pred             cccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE---NAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ..... ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.   +..+....+...          
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~----------  238 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG----------  238 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC----------
T ss_pred             CcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC----------
Confidence            65433 33456789999999999654 4889999999999999999999999763   333333333321          


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                             .+.++        ...+..+++++++||++||+.||.+|||+.++++||||.++.
T Consensus       239 -------~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~  285 (342)
T 2qr7_A          239 -------KFSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD  285 (342)
T ss_dssp             -------CCCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred             -------CcccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence                   01010        112245899999999999999999999999999999997754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-51  Score=364.47  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=209.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++     ......
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   95 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM   95 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence            478999999999999999999999999999999986543     3456899999999999999999988     334458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeeeccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSA  161 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Dfg~a  161 (353)
                      ++||||+++ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++.  .++.+||+|||++
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            899999985 8888887666667889999999999999999999999 79999999999999953  2467999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .............+|+.|+|||++.+  .++.++||||+||++|+|++|..||.+.+..+....+........       
T Consensus       175 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------  245 (285)
T 3is5_A          175 ELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-------  245 (285)
T ss_dssp             CC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------
T ss_pred             eecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-------
Confidence            87666555566778999999999843  589999999999999999999999998876665544433110000       


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                         .....+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus       246 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          246 -------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             -------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             -------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence                               001237899999999999999999999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.1e-52  Score=372.34  Aligned_cols=256  Identities=25%  Similarity=0.350  Sum_probs=208.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...     .....+|+.+++.++||||+++++++     ......
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCeE
Confidence            57899999999999999999999999999999998543     24457899999999999999999988     344458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+|||||++ +|.+.    ......+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~----l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~-~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           81 YLFLEYCSGGELFDR----IEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATV  154 (323)
T ss_dssp             EEEEECCTTEEGGGG----SBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHH----HhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeC-CCCEEEEEeeccce
Confidence            899999985 54433    3456679999999999999999999999 79999999999999996 78899999999986


Q ss_pred             cccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ......   .....||+.|+|||++.+...++.++||||+||++|+|++|..||...+...............       
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-------  227 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  227 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-------
T ss_pred             eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-------
Confidence            543322   2356789999999999876655889999999999999999999998766543322222210000       


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                    ..+     ...+++++.+||.+||+.||.+|||+.|+++||||++...
T Consensus       228 --------------~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          228 --------------LNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             --------------STT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             --------------CCc-----cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence                          001     1347999999999999999999999999999999987543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.8e-52  Score=385.27  Aligned_cols=291  Identities=32%  Similarity=0.521  Sum_probs=213.1

Q ss_pred             cceeeE-eeeeecCCCeEEEEEEEC--CCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMA-ERVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+.|++ .++||+|+||.||+|+++  .+++.||||++....  ....+|+.+++.++||||+++++++....   ...+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~   95 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKV   95 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeE
Confidence            456777 458999999999999966  578999999996543  34568999999999999999999986532   3358


Q ss_pred             EEEeccccchHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe---CCCCcEEEe
Q 018619           85 NLVMEYVPESMYRVLKHYSSA-----NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKIC  156 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~-----~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~---~~~~~vkl~  156 (353)
                      |+||||+.++|.+.+......     ...+++..++.++.||+.||+|||+ +||+||||||+|||+.   ..++.+||+
T Consensus        96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            899999999988887654322     2359999999999999999999999 7999999999999993   236789999


Q ss_pred             eeccccccccCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---------HHHH
Q 018619          157 DFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---------VDQL  223 (353)
Q Consensus       157 Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---------~~~~  223 (353)
                      |||+|.......    ......||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+.         .+.+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            999998664332    223467899999999998766689999999999999999999999987654         4788


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCC---------CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          224 VEIIKVLGTPTREEIRCMNPNY---------TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ..+.+.++.|....+.......         ....+.......+........++++.+||++||++||.+|||++|+|+|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            8899998888765443221100         0000000000011111222347899999999999999999999999999


Q ss_pred             cccccccCCC
Q 018619          295 PFFDELREPN  304 (353)
Q Consensus       295 p~f~~~~~~~  304 (353)
                      |||+....+.
T Consensus       335 p~f~~~~~~~  344 (405)
T 3rgf_A          335 PYFLEDPLPT  344 (405)
T ss_dssp             GGGTSSSCCC
T ss_pred             hhhccCCCCc
Confidence            9998765443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.4e-52  Score=372.58  Aligned_cols=283  Identities=33%  Similarity=0.595  Sum_probs=227.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++....      ....+|+.+++.++||||+++++++.     ..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   96 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK   96 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence            45689999999999999999999999999999999885432      22357999999999999999999984     33


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ...++||||++++++..+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~  171 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQ-SGVVKLCDFGFA  171 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred             CEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcC-CCcEEEEeCCCc
Confidence            45889999999875555432   45679999999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh-
Q 018619          162 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR-  239 (353)
Q Consensus       162 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  239 (353)
                      ....... ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+....+........ 
T Consensus       172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence            8654432 23445789999999999776568999999999999999999999999999999999998888877654332 


Q ss_pred             -hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          240 -CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                       ...+.+.....+..............+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence             2223333344444433333333334689999999999999999999999999999999863

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5e-52  Score=389.64  Aligned_cols=254  Identities=30%  Similarity=0.453  Sum_probs=217.3

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .+..++|.+.+.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++.     
T Consensus        12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----   86 (476)
T 2y94_A           12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----   86 (476)
T ss_dssp             CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            356789999999999999999999999999999999996432       34568999999999999999999883     


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+|||||+ ++|.+.+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        87 ~~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~-~~~vkL~DF  160 (476)
T 2y94_A           87 TPSDIFMVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIADF  160 (476)
T ss_dssp             CSSEEEEEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECT-TCCEEECCC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEec-CCCeEEEec
Confidence            3345889999997 56665553    45789999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |++.............||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....        
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------  232 (476)
T 2y94_A          161 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--------  232 (476)
T ss_dssp             SSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--------
T ss_pred             cchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------
Confidence            999877666555667899999999999776555789999999999999999999999888776665554311        


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                               +.            .+..+++++.+||++||+.||.+|||+.++++||||+..
T Consensus       233 ---------~~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 ---------FY------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ---------CC------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ---------cC------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence                     00            123578999999999999999999999999999999863

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-51  Score=377.95  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=215.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|.+...    .....+|+.+++.++||||+++++++.     ....++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            46899999999999999999999999999999998653    234568999999999999999999983     344588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC-CCCcEEEeeeccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQ  163 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~-~~~~vkl~Dfg~a~~  163 (353)
                      +|||||.+ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+|||++..
T Consensus       125 lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999985 66655542   34579999999999999999999999 79999999999999974 246799999999997


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+......           
T Consensus       201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~-----------  268 (387)
T 1kob_A          201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----------  268 (387)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred             cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            7666555567899999999999654 5899999999999999999999999998887776665542110           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                            ++        ......+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       269 ------~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          269 ------FD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             ------CC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ------CC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence                  00        11123579999999999999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.6e-52  Score=380.64  Aligned_cols=289  Identities=20%  Similarity=0.298  Sum_probs=211.2

Q ss_pred             eeecceeeEeeeeecC--CCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            7 ILQTISYMAERVVGTG--SFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ....++|++.+.||+|  +||.||+|++..+|+.||||++....      ....+|+.+++.++||||+++++++..   
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---   97 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---   97 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence            3568899999999999  99999999999999999999996543      334579999999999999999999844   


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                        ...+|+|||||. ++|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~d  171 (389)
T 3gni_B           98 --DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISV-DGKVYLSG  171 (389)
T ss_dssp             --TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECC
T ss_pred             --CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcC-CCCEEEcc
Confidence              334899999998 5777766542  23569999999999999999999999 79999999999999996 78999999


Q ss_pred             eccccccccCC--------CcceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 018619          158 FGSAKQLIAGE--------ANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       158 fg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  228 (353)
                      ||.+.......        ......||+.|+|||++.+. ..++.++||||+||++|+|++|..||.+.+..+.+..+..
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            99986543221        11224678999999999763 4589999999999999999999999988776655544433


Q ss_pred             HhCCCCHHHH----hhcC---------cCCCCCcC---C-CCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          229 VLGTPTREEI----RCMN---------PNYTDFRF---P-QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       229 ~~~~~~~~~~----~~~~---------~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                      ..........    ....         ....+...   + ..........++..+++++.+||++||+.||++|||++|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            2110000000    0000         00000000   0 0000111122445689999999999999999999999999


Q ss_pred             hcCcccccccCCC
Q 018619          292 CAHPFFDELREPN  304 (353)
Q Consensus       292 l~hp~f~~~~~~~  304 (353)
                      |+||||+++....
T Consensus       332 l~hp~f~~~~~~~  344 (389)
T 3gni_B          332 LNHSFFKQIKRRA  344 (389)
T ss_dssp             TTSGGGGGC---C
T ss_pred             hcCHHHHHHhhcc
Confidence            9999999887543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-52  Score=381.62  Aligned_cols=259  Identities=27%  Similarity=0.453  Sum_probs=198.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++....   ....+|+.+++.++||||+++++++.     ....+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~   91 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHL   91 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEE
Confidence            45689999999999999999999999999999999997543   34568999999999999999999984     33458


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC--cEEEeeeccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSA  161 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~--~vkl~Dfg~a  161 (353)
                      |+|||||. ++|.+.+..    .+++++..++.++.|++.||+|||+ +||+||||||+|||++. ++  .+||+|||++
T Consensus        92 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           92 AIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDG-SPAPRLKICDFGYS  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECS-SSSCCEEECCCCCC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcC-CCCceEEEeecCcc
Confidence            89999997 577666643    4579999999999999999999999 79999999999999985 44  4999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +............||+.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......++......        
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~--------  237 (361)
T 3uc3_A          166 KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV--------  237 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT--------
T ss_pred             ccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC--------
Confidence            865555555567899999999999776644555999999999999999999998755433333322211100        


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                           .+.++          ....+++++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus       238 -----~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          238 -----KYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             -----CCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             -----CCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence                 00111          012478999999999999999999999999999999764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.2e-51  Score=362.10  Aligned_cols=263  Identities=26%  Similarity=0.392  Sum_probs=218.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence            3689999999999999999999999999999999986543      3345799999999999999999988     3444


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEeeec
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFG  159 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~Dfg  159 (353)
                      ..++||||+.+ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++.+  ++.+||+|||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            58899999985 66666543    3679999999999999999999999 799999999999999752  2349999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ++.............+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+.......+.    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  228 (284)
T 3kk8_A          154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----  228 (284)
T ss_dssp             TCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT----
T ss_pred             eeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc----
Confidence            99877666555567889999999999664 4899999999999999999999999998887776666552211110    


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL  307 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~  307 (353)
                                           .....+++++.+||.+||+.||.+|||++|+++||||++.+......
T Consensus       229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~  275 (284)
T 3kk8_A          229 ---------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI  275 (284)
T ss_dssp             ---------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSC
T ss_pred             ---------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHh
Confidence                                 01135789999999999999999999999999999998865544433

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-51  Score=369.73  Aligned_cols=285  Identities=28%  Similarity=0.501  Sum_probs=222.1

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHcC-CCceeecceeeeecCCCCceeE
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++ ||||+++++++...   .....
T Consensus        32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~  108 (330)
T 3nsz_A           32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTP  108 (330)
T ss_dssp             CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCE
T ss_pred             ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCce
Confidence            34578999999999999999999999999999999998643 345678999999997 99999999988542   23447


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++||||+.+ +|...+       ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++..+||+|||++..
T Consensus       109 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEEEECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            899999995 444333       248999999999999999999999 79999999999999997455899999999987


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhh-c
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP-GENAVDQLVEIIKVLGTPTREEIRC-M  241 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~-~  241 (353)
                      ...........+|+.|+|||++.+...++.++|||||||++|+|++|..||. +.+..+.+..+.+..+.+....... .
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          181 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             cCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            7666655667889999999999776679999999999999999999999984 5556666666666665443322111 1


Q ss_pred             CcCCCCC---cCCCCCCCcccccc----CCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          242 NPNYTDF---RFPQIKAHPWHKVF----HKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      .......   .........|...+    ...+++++.+||.+||+.||.+|||++|+|+||||+.+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence            1000000   00111112222221    2347999999999999999999999999999999998754

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.3e-52  Score=379.52  Aligned_cols=255  Identities=25%  Similarity=0.432  Sum_probs=210.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-------chHHHHHH-HHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-------YKNRELQL-MRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||.||+|+++.+++.||||++.+...       ...+|..+ ++.++||||++++++|     .
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence            456789999999999999999999999999999999965432       22345554 4667999999999988     3


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+||||+.| +|...+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~g~ikL~DF  183 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDS-QGHIVLTDF  183 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECC-CCCEEEeeC
Confidence            44468999999985 66666653    4679999999999999999999999 79999999999999996 788999999


Q ss_pred             cccccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          159 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       159 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+|+.... ........||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+...        
T Consensus       184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------  254 (373)
T 2r5t_A          184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--------  254 (373)
T ss_dssp             CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--------
T ss_pred             ccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------
Confidence            99986433 3344567899999999999664 5899999999999999999999999998888777766652        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH----HHHhcCcccccccCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA----LEACAHPFFDELREP  303 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~~~l~hp~f~~~~~~  303 (353)
                               ..            .++..+++++++||++||+.||.+|+++    .++++||||+.+.+.
T Consensus       255 ---------~~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~  303 (373)
T 2r5t_A          255 ---------PL------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD  303 (373)
T ss_dssp             ---------CC------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred             ---------cc------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence                     00            1234589999999999999999999986    699999999987654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-51  Score=372.55  Aligned_cols=316  Identities=34%  Similarity=0.591  Sum_probs=239.2

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCC-Cce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK-NEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~   82 (353)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++...... ...
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            578999999999999999999999999999999986432      2345799999999999999999988543321 112


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|+||||+.++|.+.+      ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNE-DCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECT-TCCEEECSTTCTT
T ss_pred             eEEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECC-CCcEEEeeccccc
Confidence            35899999998765443      2459999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .....  .....+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..+.+..+.+.........
T Consensus       175 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          175 HADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            64332  3346789999999999775678999999999999999999999999999999999999999988876654432


Q ss_pred             cCCCC---CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCc
Q 018619          243 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF  319 (353)
Q Consensus       243 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  319 (353)
                      .....   ...+......+.. ....+++++.+||.+||+.||++|||++++++||||+....+........+    ++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~----~~~  327 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP----FDD  327 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC----CCC
T ss_pred             hHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCC----Ccc
Confidence            11000   0011111112222 224579999999999999999999999999999999987665433222211    122


Q ss_pred             hhhhccCCHHHHhhccHHHHH
Q 018619          320 KQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      ..+....+.+...+.+..++.
T Consensus       328 ~~~~~~~~~~~~~~~~~~~~~  348 (353)
T 3coi_A          328 SLEHEKLTVDEWKQHIYKEIV  348 (353)
T ss_dssp             TTTTCCCCHHHHHHHHHHHHH
T ss_pred             chhhccCCHHHHHHHHHHHHH
Confidence            222334555666665555544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.9e-51  Score=367.86  Aligned_cols=257  Identities=26%  Similarity=0.385  Sum_probs=217.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      -..++|++.+.||+|+||.||+|.+..+|+.||+|.+....          ....+|+.+++.++||||+++++++.   
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---   85 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE---   85 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe---
Confidence            34678999999999999999999999999999999986532          23568999999999999999999883   


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC----c
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----Q  152 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~----~  152 (353)
                        ....+++||||+. ++|.+.+.    ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++    .
T Consensus        86 --~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~-~~~~~~~  157 (321)
T 2a2a_A           86 --NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLD-KNIPIPH  157 (321)
T ss_dssp             --CSSEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESC-TTSSSCC
T ss_pred             --cCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEec-CCCCcCC
Confidence              3445889999997 57776665    35679999999999999999999999 79999999999999986 44    7


Q ss_pred             EEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          153 VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       153 vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      +||+|||++.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+......
T Consensus       158 ~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  236 (321)
T 2a2a_A          158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD  236 (321)
T ss_dssp             EEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC
T ss_pred             EEEccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc
Confidence            999999999877665555567789999999999654 5899999999999999999999999988877776655442211


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ..                         ..+...+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus       237 ~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          237 FD-------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             CC-------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             cC-------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            11                         112245789999999999999999999999999999998654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.4e-50  Score=363.90  Aligned_cols=289  Identities=34%  Similarity=0.573  Sum_probs=233.2

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEEC-CCCcEEEEEEeeccc------cchHHHHHHHHHc---CCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCL-ETGETVAIKKVLQDR------RYKNRELQLMRVM---DHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~   78 (353)
                      ..++|++.+.||+|+||.||+|.+. .+|+.||+|++....      ....+|+.+++.+   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3588999999999999999999995 678999999885432      2445788877776   89999999998864444


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      .....+++||||++++|.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~-~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECSC
T ss_pred             CCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcC-CCCEEEecC
Confidence            456678999999999988887652  23459999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+
T Consensus       165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          165 GLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             cccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            999876554444556789999999999664 4899999999999999999999999999999999999998888776544


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      ...... ....+......+ ...+...+++++.+||.+||+.||.+|||+.++++||||+.+....
T Consensus       244 ~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          244 PRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             CTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             cccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            321110 000111111111 2234456899999999999999999999999999999999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2e-51  Score=374.65  Aligned_cols=282  Identities=25%  Similarity=0.434  Sum_probs=224.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcC-----CCceeecceeeeecC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----HPNVISLKHCFFSTT   77 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~   77 (353)
                      +.+..++|.+.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.++     ||||+++++++... 
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-  108 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-  108 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-
Confidence            3456789999999999999999999999999999999986432   33457999999986     99999999988443 


Q ss_pred             CCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC---------
Q 018619           78 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---------  148 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~---------  148 (353)
                          ..+|+||||++++|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.         
T Consensus       109 ----~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~  181 (360)
T 3llt_A          109 ----DHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLIT  181 (360)
T ss_dssp             ----TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred             ----CeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccc
Confidence                348899999988988888652  23469999999999999999999999 79999999999999973         


Q ss_pred             ---------------CCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCC
Q 018619          149 ---------------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL  213 (353)
Q Consensus       149 ---------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p  213 (353)
                                     .++.+||+|||+|.....  ......||+.|+|||++.+. .++.++||||+||++|+|++|+.|
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p  258 (360)
T 3llt_A          182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLL  258 (360)
T ss_dssp             EECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             hhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCC
Confidence                           267899999999986433  23356789999999999765 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC-CcCCCCCCCcccc----------------ccCCCCChhHHHHHHH
Q 018619          214 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD-FRFPQIKAHPWHK----------------VFHKRMPPEAIDLASR  276 (353)
Q Consensus       214 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------------~~~~~~~~~~~~li~~  276 (353)
                      |.+.+..+.+..+....+.++...+......... +.........|..                .+....++.+.+||.+
T Consensus       259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  338 (360)
T 3llt_A          259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS  338 (360)
T ss_dssp             CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence            9999999999999888888776655432211100 0000000000100                0111235788899999


Q ss_pred             hcCcCCCCCCCHHHHhcCcccc
Q 018619          277 LLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       277 ~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                      ||+.||.+|||++|+|+||||+
T Consensus       339 ~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          339 ILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HhcCChhhCCCHHHHhcCcccC
Confidence            9999999999999999999995

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.2e-52  Score=367.88  Aligned_cols=256  Identities=26%  Similarity=0.442  Sum_probs=206.5

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------------------------cchHHHHH
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------------------------RYKNRELQ   56 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~   56 (353)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++....                              ....+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            355689999999999999999999999999999999986432                              33568999


Q ss_pred             HHHHcCCCceeecceeeeecCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCee
Q 018619           57 LMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC  135 (353)
Q Consensus        57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~  135 (353)
                      +++.++||||+++++++...   ....+|+||||+++ +|.+.     .....+++..++.++.|++.||+|||+ +||+
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iv  159 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQDLIKGIEYLHY-QKII  159 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS-----SCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             HHHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH-----hhcCCCCHHHHHHHHHHHHHHHHHHHH-CCee
Confidence            99999999999999988542   23458899999985 43221     234679999999999999999999999 7999


Q ss_pred             eccCCCCcEEEeCCCCcEEEeeeccccccccCCC-cceeeeeceeeChhhhhCCCC--CCccccchhHHHHHHHHHhCCC
Q 018619          136 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA-NISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQP  212 (353)
Q Consensus       136 H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~l~~g~~  212 (353)
                      ||||||+||+++. ++.+||+|||++........ .....||+.|+|||++.+...  ++.++|||||||++|+|++|..
T Consensus       160 H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          160 HRDIKPSNLLVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCCGGGEEECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCCCHHHEEECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            9999999999996 78899999999987654332 234678999999999865432  3778999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          213 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       213 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      ||...+.......+....                 ..++          ....+++++.+||.+||+.||.+|||+.|++
T Consensus       239 pf~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l  291 (298)
T 2zv2_A          239 PFMDERIMCLHSKIKSQA-----------------LEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIK  291 (298)
T ss_dssp             SSCCSSHHHHHHHHHHCC-----------------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCCccHHHHHHHHhccc-----------------CCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence            998887665554443310                 0011          0135789999999999999999999999999


Q ss_pred             cCccccc
Q 018619          293 AHPFFDE  299 (353)
Q Consensus       293 ~hp~f~~  299 (353)
                      +||||++
T Consensus       292 ~hp~~~~  298 (298)
T 2zv2_A          292 LHPWVTR  298 (298)
T ss_dssp             TCHHHHC
T ss_pred             cCccccC
Confidence            9999963

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.2e-51  Score=371.23  Aligned_cols=257  Identities=27%  Similarity=0.438  Sum_probs=208.8

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeeccc--------cchHHHHHHHHHcCCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (353)
                      ..+..++|++.+.||+|+||.||+|++.   .+++.||+|++.+..        ....+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3466789999999999999999999985   689999999986532        23457999999999999999999884


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                      .     ...+|+|||||. ++|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+
T Consensus        92 ~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~-~~~~  160 (327)
T 3a62_A           92 T-----GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNH-QGHV  160 (327)
T ss_dssp             C-----SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECT-TSCE
T ss_pred             c-----CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECC-CCcE
Confidence            3     344889999998 577666653    4678999999999999999999999 79999999999999996 7889


Q ss_pred             EEeeeccccccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          154 KICDFGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      ||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+... 
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-  238 (327)
T 3a62_A          161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-  238 (327)
T ss_dssp             EECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-
T ss_pred             EEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-
Confidence            999999997543322 23345789999999999654 589999999999999999999999999888777766655210 


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                                                  .++..+++++.+||.+||+.||.+||     ++.++++||||+.+.+.
T Consensus       239 ----------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~  286 (327)
T 3a62_A          239 ----------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE  286 (327)
T ss_dssp             ----------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred             ----------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence                                        12245799999999999999999999     89999999999987643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-51  Score=364.73  Aligned_cols=260  Identities=25%  Similarity=0.386  Sum_probs=201.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      +..++|++.+.||+|+||.||+|.+..+|+.||+|++.....      ...++...++.++||||+++++++..     .
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~   78 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----E   78 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----S
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----c
Confidence            567899999999999999999999999999999999864421      12234445777899999999998853     3


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++||||+++++.+.+.........+++..++.++.|++.||+|||+ + ||+||||||+||+++. ++.+||+|||+
T Consensus        79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~  156 (290)
T 3fme_A           79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDFGI  156 (290)
T ss_dssp             SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECT-TCCEEBCCC--
T ss_pred             CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECC-CCCEEEeecCC
Confidence            3488999999999988888777778899999999999999999999999 8 9999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhh---hCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHH
Q 018619          161 AKQLIAGEANISYICSRFYRAPELI---FGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~  236 (353)
                      +.............+|+.|+|||++   .....++.++||||+||++|+|++|..||.... ....+...... ..+.  
T Consensus       157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~--  233 (290)
T 3fme_A          157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQ--  233 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCCC--
T ss_pred             cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCCC--
Confidence            9876665555556789999999997   234558899999999999999999999998643 33333333331 0000  


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                              .....+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       234 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          234 ------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             ------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             ------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence                                    01135789999999999999999999999999999998743

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-51  Score=365.76  Aligned_cols=248  Identities=27%  Similarity=0.350  Sum_probs=198.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHH-HcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMR-VMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....      ....|+..+. ..+||||+++++++.     ...
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~  130 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGG  130 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCC
Confidence            3789999999999999999999999999999998854322      1223444444 448999999999884     344


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+|+||||++++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++.
T Consensus       131 ~~~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~  205 (311)
T 3p1a_A          131 ILYLQTELCGPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGP-RGRCKLGDFGLLV  205 (311)
T ss_dssp             EEEEEEECCCCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECG-GGCEEECCCTTCE
T ss_pred             EEEEEEeccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECC-CCCEEEccceeee
Confidence            5889999999998887765   35679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ............||+.|+|||++.+  .++.++||||+||++|+|++|..||.+......   +..  +..         
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~---------  269 (311)
T 3p1a_A          206 ELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYL---------  269 (311)
T ss_dssp             ECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCC---------
T ss_pred             ecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCC---------
Confidence            7765555556678999999999865  589999999999999999999777655332221   111  000         


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                      ...++..+++++.+||.+||+.||.+|||++|+++||||++
T Consensus       270 ----------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          270 ----------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             ----------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             ----------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence                            11123458999999999999999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.5e-51  Score=388.18  Aligned_cols=257  Identities=27%  Similarity=0.462  Sum_probs=216.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----------------cchHHHHHHHHHcCCCceeecce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------------RYKNRELQLMRVMDHPNVISLKH   71 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~~iv~~~~   71 (353)
                      ..++|++.+.||+|+||+||+|.++.+++.||+|++.+..                 ....+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999999999999999986432                 23457999999999999999999


Q ss_pred             eeeecCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC
Q 018619           72 CFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT  150 (353)
Q Consensus        72 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~  150 (353)
                      ++     .....+|+|||||.| +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++..+
T Consensus       114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTT
T ss_pred             EE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCC
Confidence            98     444568999999985 77666653    3679999999999999999999999 7999999999999998633


Q ss_pred             --CcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 018619          151 --HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       151 --~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  228 (353)
                        ..+||+|||+|.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+.+
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~  261 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK  261 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence              2699999999987766666667789999999999853  489999999999999999999999999988887777765


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      .........                         ...+|+++++||++||++||.+|||++|+|+||||++...
T Consensus       262 ~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          262 GKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            322222111                         1358999999999999999999999999999999987643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.7e-51  Score=388.15  Aligned_cols=256  Identities=29%  Similarity=0.499  Sum_probs=214.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++.+.||+|+||+||+|++..+++.||||++.+.      .....+|+.+++.++||||+++++++     .....
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCE
Confidence            57899999999999999999999999999999998532      23456899999999999999999998     34445


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeeecc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGS  160 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Dfg~  160 (353)
                      +|+|||||.+ +|.+.+..    ...+++..++.++.||+.||.|||+ +||+||||||+|||++.  .++.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            8999999985 77666653    3679999999999999999999999 79999999999999963  245799999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+........      
T Consensus       171 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------  242 (486)
T 3mwu_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------  242 (486)
T ss_dssp             TTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC------
T ss_pred             CeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------
Confidence            987766655566789999999999965  489999999999999999999999999988887777655311111      


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                    ...|     ..+|+++++||.+||+.||.+|||+.++|+||||++...
T Consensus       243 --------------~~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          243 --------------LPQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             --------------SGGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             --------------Cccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence                          0111     347999999999999999999999999999999998643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.3e-52  Score=387.17  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=208.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|++..+|+.||||++.+..       ....+|+.+++.++||||+++++++..     
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----  219 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----  219 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----
Confidence            34578999999999999999999999999999999986431       233478889999999999999998843     


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|||||++ +|...+..    ...+++..++.++.||+.||+|||+.+||+||||||+|||++. ++.+||+|||
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG  294 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFG  294 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCC
Confidence            3348899999985 66665543    4679999999999999999999996249999999999999996 7899999999


Q ss_pred             cccccccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          160 SAKQLIAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       160 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +|+..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+...         
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~---------  364 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------  364 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC---------
Confidence            99864332 333456789999999999764 5899999999999999999999999998887776666541         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                              ..            .++..+++++.+||.+||+.||.+||     |++|+++||||+.+.+.
T Consensus       365 --------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~  414 (446)
T 4ejn_A          365 --------EI------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ  414 (446)
T ss_dssp             --------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred             --------CC------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence                    01            12345899999999999999999999     99999999999987654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=6.5e-51  Score=357.88  Aligned_cols=254  Identities=30%  Similarity=0.457  Sum_probs=216.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++     ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence            56899999999999999999999999999999998653    23456899999999999999999988     3444588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE---eCCCCcEEEeeeccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSA  161 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill---~~~~~~vkl~Dfg~a  161 (353)
                      +||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||++   +. ++.+||+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~-~~~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSP-DSPLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSST-TCCEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCC-CCcEEEEecccc
Confidence            99999985 76666543    4679999999999999999999999 799999999999999   53 778999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .............+|+.|+|||++.+  .++.++||||+||++|+|++|..||...+..+....+.+.....+....   
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---  231 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred             eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence            87766666666789999999999854  3899999999999999999999999998888777776653322222211   


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                            ..+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence                                  24789999999999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-51  Score=390.52  Aligned_cols=259  Identities=32%  Similarity=0.554  Sum_probs=219.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++.+.       .....+|+.+++.++||||+++++++     ..
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   97 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED   97 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            4567999999999999999999999999999999998543       23356899999999999999999998     44


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEee
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICD  157 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~D  157 (353)
                      ...+|+|||||.+ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.  .++.+||+|
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            4568999999984 6666554    35679999999999999999999999 79999999999999952  367899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||++.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+.+......   
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~---  247 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE---  247 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            999987766666666789999999999976  489999999999999999999999999988887777665211111   


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                       ...|     ..+|+++++||++||+.||.+|||+.|+|+||||+.....
T Consensus       248 -----------------~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          248 -----------------LPQW-----KKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             -----------------SGGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             -----------------Cccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence                             0111     3479999999999999999999999999999999986543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=365.87  Aligned_cols=290  Identities=30%  Similarity=0.509  Sum_probs=222.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCC---
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTS---   78 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   78 (353)
                      +....++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++.....   
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            3455789999999999999999999999999999999886442    334589999999999999999988743211   


Q ss_pred             ------CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCc
Q 018619           79 ------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ  152 (353)
Q Consensus        79 ------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~  152 (353)
                            ......|+||||++++|.+.+.     .+++++..++.++.|++.||+|||+ +||+||||||+||+++..++.
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             C----CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCe
Confidence                  2335688999999998877764     3679999999999999999999999 799999999999999865779


Q ss_pred             EEEeeeccccccccCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 018619          153 VKICDFGSAKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       153 vkl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  228 (353)
                      +||+|||++.......    ......+|+.|+|||.+.+...++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  239 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE  239 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998654321    123345688999999987766789999999999999999999999999999888888888


Q ss_pred             HhCCCCHHHHhhcCcCCCCC---cCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          229 VLGTPTREEIRCMNPNYTDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      ...................+   ... ....++ ..+...+++++.+||.+||+.||.+|||++++++||||+....+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMT-EPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTT-SCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             hcCCCchhhhhhhhhcCccccccccc-CCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            77666554433221110000   000 000111 11234689999999999999999999999999999999976544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.8e-51  Score=386.76  Aligned_cols=258  Identities=27%  Similarity=0.417  Sum_probs=214.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|.+.+.||+|+||.||+|+++.+|+.||+|++.+..       ....+|+.+++.++||||++++++|     ..
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  256 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET  256 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence            45689999999999999999999999999999999996432       2345799999999999999999988     34


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||++ |+|...+.........+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~-~g~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDD-DGNVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeC-CCCEEEeecc
Confidence            445899999998 57777776544445679999999999999999999999 79999999999999996 7899999999


Q ss_pred             cccccccCCCc-ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Q 018619          160 SAKQLIAGEAN-ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLVEIIKVLGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~  234 (353)
                      ++......... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.    .+....+...     
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----  408 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----  408 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence            99876554433 345899999999999764 589999999999999999999999987542    3333333221     


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE  302 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~  302 (353)
                                              ...++..+++++.+||++||+.||.+||+     ++++++||||+.+.+
T Consensus       409 ------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          409 ------------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             ------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             ------------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence                                    00123468999999999999999999995     589999999998764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-51  Score=392.48  Aligned_cols=258  Identities=29%  Similarity=0.464  Sum_probs=214.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|.++.+|+.||+|++.+..       ....+|+.+++.++||||+++++++     ..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence            56788999999999999999999999999999999986432       2345799999999999999999988     34


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||++ |+|...+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~-~g~vKL~DFG  331 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDD-HGHIRISDLG  331 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeC-CCCeEEEecc
Confidence            445899999997 5776666532  23459999999999999999999999 79999999999999996 7899999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  236 (353)
                      +|.............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.   ...+...+...      
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------  404 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------  404 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred             cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence            99877665555567899999999999664 489999999999999999999999987642   22222222110      


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                                            ...++..+|+++++||++||+.||.+||     +++|+++||||+.+.+.
T Consensus       405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~  454 (576)
T 2acx_A          405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK  454 (576)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred             ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence                                  0112346899999999999999999999     79999999999987653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.6e-51  Score=368.32  Aligned_cols=255  Identities=27%  Similarity=0.392  Sum_probs=195.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .++|++.+.||+|+||.||+|++..+++.||||++...  .....+|+.+++.++||||+++++++.     .....++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEEE
Confidence            56799999999999999999999999999999998654  344568999999999999999999983     33458899


Q ss_pred             ecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeeecccccc
Q 018619           88 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQL  164 (353)
Q Consensus        88 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Dfg~a~~~  164 (353)
                      |||+. ++|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++.  .++.+||+|||++...
T Consensus       127 ~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          127 LELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             ECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99998 47666654    35679999999999999999999999 79999999999999973  3678999999999876


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL-VEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ..+.+...            
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~------------  268 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY------------  268 (349)
T ss_dssp             -----------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC------------
T ss_pred             CcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC------------
Confidence            555445567789999999999664 4899999999999999999999999877655433 33322100            


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                           .+        .......++.++.+||++||+.||++|||+.|+++||||...
T Consensus       269 -----~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          269 -----YF--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             -----CC--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             -----cc--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence                 00        001123579999999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.4e-51  Score=369.60  Aligned_cols=262  Identities=28%  Similarity=0.470  Sum_probs=211.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+..         ....+|+.+++.++||||+++++++     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence            578999999999999999999999999999999986432         3456799999999999999999998     33


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhc------------------------------------CCCCCHHHHHHHHHHHHH
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSA------------------------------------NQRMPLIYVKLYTYQIFR  123 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qll~  123 (353)
                      ....++|||||+ ++|.+.+..+...                                    ...+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            445889999997 5776665421111                                    223578889999999999


Q ss_pred             HHHHhHcCCCeeeccCCCCcEEEeCCCC--cEEEeeeccccccccCCC-----cceeeeeceeeChhhhhCC-CCCCccc
Q 018619          124 GLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFGA-TEYTTSI  195 (353)
Q Consensus       124 al~~LH~~~~i~H~Dlkp~Nill~~~~~--~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~-~~~~~~~  195 (353)
                      ||+|||+ +||+||||||+||+++. ++  .+||+|||++........     .....||+.|+|||++.+. ..++.++
T Consensus       180 ~l~~LH~-~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          180 ALHYLHN-QGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHH-TTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHH-CCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999 79999999999999985 44  899999999986543221     2356789999999998653 4689999


Q ss_pred             cchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHH
Q 018619          196 DIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLAS  275 (353)
Q Consensus       196 DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  275 (353)
                      |||||||++|+|++|..||.+.+..+....+..........                         ....+++++.+||.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~  312 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLS  312 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHH
Confidence            99999999999999999999998888877766532111110                         11247899999999


Q ss_pred             HhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          276 RLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       276 ~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      +||+.||.+|||+.++++||||+++.+.
T Consensus       313 ~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          313 NLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHcCCChhHCCCHHHHhcChhhccChHh
Confidence            9999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-50  Score=366.36  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=211.5

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|.+.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++...     ..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence            56999999999999999999999999999999986432       2345899999999999999999988543     34


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      .++||||+.|++.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECC-CCCEEEeeccCcee
Confidence            889999999998877754   34679999999999999999999999 79999999999999996 88999999999976


Q ss_pred             cccCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          164 LIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|..||...+..+.+..+.......        
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------  272 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA--------  272 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------
Confidence            543   234678999999999863  3458899999999999999999999999888777666554421100        


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                         .....+++.+.+||.+||+.||.+|||++++++||||...
T Consensus       273 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          273 -------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence                               0113478999999999999999999999999999999763

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.6e-51  Score=374.10  Aligned_cols=253  Identities=28%  Similarity=0.393  Sum_probs=207.2

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEEec
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLVME   89 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e   89 (353)
                      ...+.||+|+||.||+|.+..+|+.||+|++...    ...+.+|+.+++.++||||+++++++.     ....+++|||
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E  166 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVME  166 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEE
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEe
Confidence            3367899999999999999999999999998653    344568999999999999999999883     3345889999


Q ss_pred             cccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe-CCCCcEEEeeeccccccccC
Q 018619           90 YVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        90 ~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~-~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      |+++ +|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++ ..++.+||+|||++......
T Consensus       167 ~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~  242 (373)
T 2x4f_A          167 YVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR  242 (373)
T ss_dssp             CCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred             CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence            9984 66666643   33568999999999999999999999 7999999999999994 23678999999999977666


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........            
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------------  309 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED------------  309 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS------------
T ss_pred             cccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh------------
Confidence            555566799999999998654 5899999999999999999999999999888887777663211110            


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                   .....+++++++||.+||+.||.+|||+.|+++||||+..+
T Consensus       310 -------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          310 -------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             -------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             -------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence                         01135799999999999999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.3e-51  Score=386.23  Aligned_cols=255  Identities=27%  Similarity=0.460  Sum_probs=212.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++.+.||+|+||+||+|+++.+++.||+|++.+.      .....+|+.+++.++||||+++++++     .....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            45899999999999999999999999999999998643      23456899999999999999999998     34445


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEeeecc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS  160 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~Dfg~  160 (353)
                      +|+|||||.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++..  ++.+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            8899999985 66666643    3679999999999999999999999 799999999999999752  34599999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |.............||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.+..+.........     
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-----  258 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS-----  258 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence            988776666667789999999999853  5899999999999999999999999999888877776653221111     


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                     ..     ...+|+++++||++||+.||.+|||+.++|+||||+...
T Consensus       259 ---------------~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  299 (494)
T 3lij_A          259 ---------------PE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC  299 (494)
T ss_dssp             ---------------GG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred             ---------------hh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence                           11     135899999999999999999999999999999998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.9e-50  Score=367.40  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=213.5

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHc-CCCceeecceeeeecC
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVM-DHPNVISLKHCFFSTT   77 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~   77 (353)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++    
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~----  169 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY----  169 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence            57999999999999999999999999999999886432            2345799999998 799999999988    


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       ......|+||||+.| +|.+.+..    ...+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.+||+
T Consensus       170 -~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~-~~~ikl~  242 (365)
T 2y7j_A          170 -ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDD-NMQIRLS  242 (365)
T ss_dssp             -EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred             -eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECC-CCCEEEE
Confidence             334458899999985 77666653    4679999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCCcceeeeeceeeChhhhhCC-----CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 018619          157 DFGSAKQLIAGEANISYICSRFYRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      |||++.............||+.|+|||++.+.     ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999877666656667899999999998632     3478899999999999999999999998887777666655322


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      .+....                         ...+++++.+||.+||+.||.+|||+.++++||||++
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            222111                         1347899999999999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-50  Score=357.48  Aligned_cols=259  Identities=27%  Similarity=0.432  Sum_probs=212.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----------ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+...          .....+|+.+++.++||||+++++++.    
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   78 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE----   78 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec----
Confidence            467899999999999999999999999999999988643          234568999999999999999999884    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC----cE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH----QV  153 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~----~v  153 (353)
                       .....++||||+. ++|.+.+..    ...+++..++.++.|++.||.|||+ +|++||||||+||+++. ++    .+
T Consensus        79 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~~~~  151 (283)
T 3bhy_A           79 -NKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLD-KNVPNPRI  151 (283)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESC-SSSSSCCE
T ss_pred             -CCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEec-CCCCCCce
Confidence             3345889999997 577776653    4679999999999999999999999 79999999999999985 44    79


Q ss_pred             EEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          154 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      ||+|||++.............+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+.......
T Consensus       152 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  230 (283)
T 3bhy_A          152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF  230 (283)
T ss_dssp             EECCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC
T ss_pred             EEEecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC
Confidence            99999999876655555566789999999998654 58999999999999999999999999888776665554321111


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN  304 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~  304 (353)
                      ..                         .....+++.+.+||.+||+.||++|||+.++++||||+.++...
T Consensus       231 ~~-------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          231 DE-------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             CH-------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             cc-------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            11                         11235789999999999999999999999999999999886554

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-50  Score=396.37  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=215.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|.+.+.||+|+||.||+|+++.+++.||||++.+..       .....|..++..+ +||+|++++.+|     .
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~  412 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q  412 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----B
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----E
Confidence            34578999999999999999999999999999999986532       2345788888877 799999999988     4


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+||||++| +|...+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~-~g~ikL~DF  486 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDS-EGHIKIADF  486 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECS-SSCEEECCC
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcC-CCcEEEeec
Confidence            45568999999985 77666653    3679999999999999999999999 79999999999999996 789999999


Q ss_pred             cccccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          159 GSAKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       159 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      |+|+.... ........||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+..+....+.+.        
T Consensus       487 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--------  557 (674)
T 3pfq_A          487 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------  557 (674)
T ss_dssp             TTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--------
T ss_pred             ceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--------
Confidence            99986433 3334567899999999999654 5899999999999999999999999999888877776541        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCH-----HHHhcCcccccccCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA-----LEACAHPFFDELREP  303 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~~~l~hp~f~~~~~~  303 (353)
                               ..            .++..+++++++||++||+.||.+|+++     +|+++||||+.+.+.
T Consensus       558 ---------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          558 ---------NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             ---------CC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence                     11            1334689999999999999999999997     999999999988754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-50  Score=376.58  Aligned_cols=256  Identities=28%  Similarity=0.447  Sum_probs=198.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++.+..            ....+|+.+++.++||||+++++++    
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~----  209 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF----  209 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE----
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            578999999999999999999999999999999986532            2356899999999999999999986    


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEE
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVK  154 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vk  154 (353)
                       .... .|+||||+.+ +|.+    +......+++..++.++.|++.||+|||+ +||+||||||+|||++..  +..+|
T Consensus       210 -~~~~-~~lv~e~~~~g~L~~----~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          210 -DAED-YYIVLELMEGGELFD----KVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             -ESSE-EEEEEECCTTCBGGG----GTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             -ecCc-eEEEEEcCCCCcHHH----HHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEE
Confidence             2222 6799999985 5433    33456789999999999999999999999 799999999999999742  34699


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |+|||+|+............||+.|+|||++.+  ...++.++||||+||++|+|++|..||........+...+.....
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999987766555566789999999999853  345788999999999999999999999875543333332221111


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ..                        .......+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus       363 ~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          363 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            00                        011123579999999999999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4e-50  Score=370.57  Aligned_cols=285  Identities=29%  Similarity=0.431  Sum_probs=222.4

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcC--------CCceeecceeeeec
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD--------HPNVISLKHCFFST   76 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~~iv~~~~~~~~~   76 (353)
                      ...++|++.+.||+|+||+||+|++..+++.||||++....   ....+|+.+++.++        |+||+++++++...
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            34689999999999999999999999999999999997543   34458999999885        78899999988432


Q ss_pred             CCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeeccCCCCcEEEeCCC-----
Q 018619           77 TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLT-----  150 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~i~H~Dlkp~Nill~~~~-----  150 (353)
                      . .....+|+||||+++++.+.+...  ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.++     
T Consensus       114 ~-~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          114 G-VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             E-TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             C-CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhh
Confidence            2 245568999999999888777642  33679999999999999999999999 8 999999999999998522     


Q ss_pred             -------------------------------------------CcEEEeeeccccccccCCCcceeeeeceeeChhhhhC
Q 018619          151 -------------------------------------------HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG  187 (353)
Q Consensus       151 -------------------------------------------~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~  187 (353)
                                                                 ..+||+|||++......  .....||+.|+|||++.+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC
Confidence                                                       27999999999865433  344578999999999977


Q ss_pred             CCCCCccccchhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCc----CCCC-CCC
Q 018619          188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVDQLVEIIKVLGTPTREEIRCMNPNYTDFR----FPQI-KAH  256 (353)
Q Consensus       188 ~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~  256 (353)
                      .. ++.++|||||||++|+|++|..||...+      ..+.+..+.+..+.++...+.........+.    .... ...
T Consensus       268 ~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          268 SG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             SC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            54 8999999999999999999999998655      5677788888888887765432211100000    0000 001


Q ss_pred             ccc--------cccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          257 PWH--------KVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       257 ~~~--------~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      +|.        ..++...++++.+||.+||+.||.+|||++|+|+||||++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            110        0112234567899999999999999999999999999974

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-50  Score=363.22  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=187.4

Q ss_pred             ceeeEe---eeeecCCCeEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHcC-CCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAE---RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ++|.+.   +.||+|+||.||+|.+..+++.||+|++.+.. ....+|+.+++.+. ||||+++++++     .+....|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence            567775   78999999999999999999999999997653 44568999999997 99999999998     3445588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC--CcEEEeeecccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVKICDFGSAK  162 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~--~~vkl~Dfg~a~  162 (353)
                      +|||||.+ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++  ..+||+|||++.
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 77766653    5679999999999999999999999 7999999999999998522  279999999998


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCC
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------DQLVEIIKVLGTPT  234 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~  234 (353)
                      ....... .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..       +....+...     
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~-----  231 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG-----  231 (325)
T ss_dssp             ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT-----
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC-----
Confidence            6544332 3456789999999998654 5899999999999999999999999875432       222222110     


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                  .+.+        .......+++++++||.+||+.||.+|||++++++||||+..
T Consensus       232 ------------~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          232 ------------DFSF--------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             ------------CCCC--------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             ------------CCCC--------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence                        0000        011113579999999999999999999999999999999874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-50  Score=365.74  Aligned_cols=245  Identities=24%  Similarity=0.402  Sum_probs=207.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            468999999999999999999999999999999986542            2345799999999999999999988    


Q ss_pred             CCCceeEEEEecccc-c-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           78 SKNELFLNLVMEYVP-E-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                       .....+++||||+. | +|...+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL  171 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAE-DFTIKL  171 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEE
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcC-CCcEEE
Confidence             44445889999986 4 6666554    45679999999999999999999999 79999999999999996 788999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||......      ..       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh-------
Confidence            99999988776666667789999999999977664588999999999999999999999652210      00       


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                .            ....+..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus       239 ----------~------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          239 ----------A------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             ----------T------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             ----------h------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                      0            001123479999999999999999999999999999999763

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.8e-50  Score=354.24  Aligned_cols=253  Identities=28%  Similarity=0.465  Sum_probs=210.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     ..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HD   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ec
Confidence            5568999999999999999999999999999999998543       23355799999999999999999988     33


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....++||||++ ++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~-~~~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECT-TSCEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcC-CCCEEEEecc
Confidence            445889999998 577666654    3679999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ++...... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||...+..+....+.....        
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------  224 (279)
T 3fdn_A          155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------  224 (279)
T ss_dssp             EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------
T ss_pred             ccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC--------
Confidence            98654332 23456789999999998654 589999999999999999999999998887776665544211        


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                           .++..+++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus       225 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          225 ---------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence                                 122457899999999999999999999999999999988543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=8.7e-50  Score=366.62  Aligned_cols=283  Identities=32%  Similarity=0.522  Sum_probs=218.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcC-CC-----ceeecceeeeecCCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-HP-----NVISLKHCFFSTTSK   79 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~   79 (353)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++....   ....+|+.+++.++ |+     +|+++++++..    
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~----  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF----  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE----
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc----
Confidence            3578999999999999999999999999999999997543   23346888888875 44     48888888743    


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHc-CCCeeeccCCCCcEEEeC-CCCcEEEee
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT-VPRVCHRDLKPQNLLVDP-LTHQVKICD  157 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~-~~~i~H~Dlkp~Nill~~-~~~~vkl~D  157 (353)
                       ...+|+||||++++|.+.+...  ....+++..++.++.|++.||.|||+ ..||+||||||+|||++. .++.+||+|
T Consensus       128 -~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 -RNHLCLVFEMLSYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             -CCceEEEEecCCCCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence             3358899999999998888752  23569999999999999999999994 159999999999999953 367899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||+|.....  ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.++...
T Consensus       205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999986543  23456789999999999765 489999999999999999999999999999999999999999888765


Q ss_pred             HhhcCcC------C--CCCcC----------CCCCCCccccccCC-----------------CCChhHHHHHHHhcCcCC
Q 018619          238 IRCMNPN------Y--TDFRF----------PQIKAHPWHKVFHK-----------------RMPPEAIDLASRLLQYSP  282 (353)
Q Consensus       238 ~~~~~~~------~--~~~~~----------~~~~~~~~~~~~~~-----------------~~~~~~~~li~~~L~~dp  282 (353)
                      +......      .  ..+..          .......+...+..                 ..++++++||++||++||
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  361 (382)
T 2vx3_A          282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP  361 (382)
T ss_dssp             HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred             HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence            4321100      0  00000          00000000000000                 001478999999999999


Q ss_pred             CCCCCHHHHhcCccccccc
Q 018619          283 SLRCTALEACAHPFFDELR  301 (353)
Q Consensus       283 ~~R~t~~~~l~hp~f~~~~  301 (353)
                      ++|||++|+|+||||++..
T Consensus       362 ~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          362 KTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             TTSCCHHHHTTSGGGCC--
T ss_pred             hhCCCHHHHhcCcccccCC
Confidence            9999999999999998753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.6e-50  Score=360.31  Aligned_cols=262  Identities=25%  Similarity=0.351  Sum_probs=210.9

Q ss_pred             cceeeEe-eeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcC-CCceeecceeeeecCCCCc
Q 018619           10 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        10 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (353)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.+. ||||+++++++     ...
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~  101 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENT  101 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeC
Confidence            5678887 89999999999999999999999999986532      34458999999985 69999999998     344


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeee
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDF  158 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Df  158 (353)
                      ..+++||||+.+ +|.+.+..  .....+++..++.++.||+.||+|||+ +||+||||||+||+++.  .++.+||+||
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             CeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence            458899999986 55444322  234679999999999999999999999 79999999999999984  2578999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.........   
T Consensus       179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---  254 (327)
T 3lm5_A          179 GMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE---  254 (327)
T ss_dssp             GGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT---
T ss_pred             ccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc---
Confidence            999877665555567899999999999654 5899999999999999999999999998887777666553222111   


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA  305 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~  305 (353)
                                            .....+++.+.+||.+||+.||.+|||++++|+||||+++.+...
T Consensus       255 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~  299 (327)
T 3lm5_A          255 ----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL  299 (327)
T ss_dssp             ----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred             ----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence                                  112357899999999999999999999999999999998876543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-50  Score=372.57  Aligned_cols=260  Identities=25%  Similarity=0.377  Sum_probs=199.2

Q ss_pred             cceeeEe-eeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           10 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        10 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .++|.+. +.||+|+||+||+|.++.+|+.||||++... ....+|+.++ +..+||||++++++|.... .+...+|+|
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~lv  137 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV  137 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEEE
Confidence            4567776 7999999999999999999999999998643 4456788877 4568999999999874322 235568999


Q ss_pred             ecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEeeecccccc
Q 018619           88 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQL  164 (353)
Q Consensus        88 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~Dfg~a~~~  164 (353)
                      ||||. |+|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++..  ++.+||+|||+++..
T Consensus       138 ~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          138 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            99998 4777777542  23469999999999999999999999 799999999999999853  578999999999876


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhh
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD----QLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~  240 (353)
                      ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+...    ....+...           
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~-----------  282 (400)
T 1nxk_A          215 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-----------  282 (400)
T ss_dssp             C-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT-----------
T ss_pred             CCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC-----------
Confidence            65555566788999999999855 458999999999999999999999997765321    11112110           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                            .+.++.   .     ....+++++.+||++||+.||.+|||+.++++||||.+.
T Consensus       283 ------~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          283 ------QYEFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             ------CCCCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             ------cccCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence                  111110   0     113579999999999999999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-49  Score=356.62  Aligned_cols=250  Identities=26%  Similarity=0.428  Sum_probs=208.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .|...+.||+|+||.||+|++..+|+.||||++....    ....+|+.+++.++||||+++++++...     ...++|
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  120 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVL  120 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEE
Confidence            4888899999999999999999999999999986432    3355899999999999999999988543     348899


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |||+.+ +|.+.+.     ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.....
T Consensus       121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~  193 (321)
T 2c30_A          121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISK  193 (321)
T ss_dssp             ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECC-CCcEEEeeeeeeeeccc
Confidence            999985 6655543     3579999999999999999999999 79999999999999996 78899999999986654


Q ss_pred             CC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      .. ......||+.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+..... +.           
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~-----------  260 (321)
T 2c30_A          194 DVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PK-----------  260 (321)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC-----------
T ss_pred             CccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CC-----------
Confidence            33 23456789999999999654 589999999999999999999999998887766655443210 00           


Q ss_pred             CCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                             .       .....+++++.+||.+||+.||++|||+.++++||||.+.
T Consensus       261 -------~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          261 -------L-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             -------C-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             -------c-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence                   0       0112478999999999999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.2e-50  Score=354.29  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=213.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      .....++|.+.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++.    
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----   85 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE----   85 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec----
Confidence            3455789999999999999999999999999999999986542       23457999999999999999999883    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       .....++||||++ ++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~d  158 (294)
T 2rku_A           86 -DNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGD  158 (294)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECC
T ss_pred             -cCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcC-CCCEEEEe
Confidence             3445889999998 466665543    4679999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          158 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       158 fg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ||++....... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||...+..+....+...       
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------  230 (294)
T 2rku_A          159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-------  230 (294)
T ss_dssp             CTTCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------
T ss_pred             ccCceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-------
Confidence            99998654332 23445789999999998654 5899999999999999999999999988776655444321       


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                ..            .++..+++.+.++|.+||+.||++|||++++++||||+....+
T Consensus       231 ----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          231 ----------EY------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             ----------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ----------cC------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence                      00            1224578999999999999999999999999999999875444

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.4e-50  Score=360.82  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC------
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS------   78 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------   78 (353)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++....     ....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            468999999999999999999999999999999986432     345689999999999999999998865432      


Q ss_pred             ----------------------------------------------CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCH
Q 018619           79 ----------------------------------------------KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPL  111 (353)
Q Consensus        79 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~  111 (353)
                                                                    ....++++|||||.+ +|.+.+... ......++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhh
Confidence                                                          123358899999985 676666542 22344566


Q ss_pred             HHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCC-------------Ccceeeeece
Q 018619          112 IYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE-------------ANISYICSRF  178 (353)
Q Consensus       112 ~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~~t~~  178 (353)
                      ..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            7789999999999999999 79999999999999996 7899999999998765542             1233568999


Q ss_pred             eeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCcc
Q 018619          179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPW  258 (353)
Q Consensus       179 y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (353)
                      |+|||++.+. .++.++||||+||++|+|++|..|+..     ...............                      
T Consensus       242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc----------------------
Confidence            9999999765 489999999999999999998766421     111111110100000                      


Q ss_pred             ccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          259 HKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       259 ~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                         .....++++.+||.+||+.||.+|||++|+++||||+++
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence               012357788999999999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-49  Score=354.82  Aligned_cols=258  Identities=28%  Similarity=0.431  Sum_probs=213.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...        .....+|+.+++.++||||+++++++...   ..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence            47899999999999999999999999999999998643        23456899999999999999999987532   23


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ...|+||||+.+++.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~-~~~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTT-GGTLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred             CeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcC-CCcEEeeccccc
Confidence            348899999998877777653  35679999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCC---CcceeeeeceeeChhhhhCCC-CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          162 KQLIAGE---ANISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       162 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      .......   ......+|+.|+|||++.+.. .++.++||||+||++|+|++|..||.+.+..+....+.+.        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------  228 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--------  228 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--------
Confidence            8654322   223456899999999986533 2477999999999999999999999988776665554431        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                               ..            .++..+++++.+||.+||+.||.+|||++++++||||++....
T Consensus       229 ---------~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          229 ---------SY------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             ---------CC------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             ---------CC------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence                     00            1224578999999999999999999999999999999986544

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.4e-49  Score=352.99  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=215.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHHcC-CCceeecceeeee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCFFS   75 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~   75 (353)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....             ....+|+.+++.+. ||||+++++++  
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--   93 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   93 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee--
Confidence            578999999999999999999999999999999986432             23457999999995 99999999988  


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                         ......++||||++ ++|.+.+..    ...+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+|
T Consensus        94 ---~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~k  164 (298)
T 1phk_A           94 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIK  164 (298)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEE
T ss_pred             ---ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcC-CCcEE
Confidence               34455889999998 577777653    3679999999999999999999999 79999999999999996 78899


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhh-----CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIF-----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV  229 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  229 (353)
                      |+|||++.............+|+.|+|||++.     ....++.++|||||||++|+|++|..||...+.......+...
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          165 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            99999998776655556677899999999985     2345789999999999999999999999988877766655542


Q ss_pred             hCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ......                    .     ....++.++.+||.+||+.||.+|||+.++++||||++...
T Consensus       245 ~~~~~~--------------------~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          245 NYQFGS--------------------P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             CCCCCT--------------------T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             CcccCc--------------------c-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            111110                    0     11347899999999999999999999999999999987643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-49  Score=351.03  Aligned_cols=254  Identities=26%  Similarity=0.457  Sum_probs=213.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ..+..++|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   84 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH----   84 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE----
Confidence            345678999999999999999999999999999999998543       234568999999999999999999883    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       .....++||||+. ++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~D  157 (284)
T 2vgo_A           85 -DRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGY-KGELKIAD  157 (284)
T ss_dssp             -CSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECT-TCCEEECC
T ss_pred             -cCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcC-CCCEEEec
Confidence             3445889999997 477777654    3579999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||++...... ......+++.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+...        
T Consensus       158 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------  227 (284)
T 2vgo_A          158 FGWSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV--------  227 (284)
T ss_dssp             CTTCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--------
T ss_pred             ccccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc--------
Confidence            9998755432 23346789999999999664 4899999999999999999999999988776665544431        


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                               ..            .++..++.++.+||.+||+.||.+|||++++++||||+...
T Consensus       228 ---------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          228 ---------DL------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             ---------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             ---------cc------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence                     00            12245799999999999999999999999999999998754

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-49  Score=359.09  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=214.1

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...++|.+.+.||+|+||.||++.+..+++.||+|++.+..       ....+|+.+++.++||||+++++++.     .
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  112 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----D  112 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            45679999999999999999999999999999999986542       33457999999999999999999883     3


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||+. ++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg  186 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNE-DLEVKIGDFG  186 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCT
T ss_pred             CCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcC-CCCEEEeecc
Confidence            445889999998 466665543    4679999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          160 SAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       160 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ++....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+...         
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------  256 (335)
T 2owb_A          187 LATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------  256 (335)
T ss_dssp             TCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT---------
T ss_pred             CceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC---------
Confidence            998664332 23446789999999999764 4899999999999999999999999988776665554431         


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                              ..            .++..+++++.+||.+||+.||++|||++|+++||||+....+
T Consensus       257 --------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          257 --------EY------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             --------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             --------CC------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence                    00            1224578999999999999999999999999999999875443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.8e-49  Score=349.81  Aligned_cols=258  Identities=24%  Similarity=0.333  Sum_probs=210.9

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...+..|++.+.||+|+||.||+|.+..++..||+|.+....      ....+|+.+++.++||||+++++++.... .+
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~  100 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG  100 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SS
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CC
Confidence            345667999999999999999999999999999999986432      23457999999999999999999875443 34


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEee
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      ...+++||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +|  |+||||||+||+++..++.+||+|
T Consensus       101 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          101 KKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             CEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             CceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEee
Confidence            5668899999975 77776653    3679999999999999999999999 78  999999999999985578999999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||++..... .......||+.|+|||++.+  .++.++||||+||++|+|++|..||..................     
T Consensus       176 fg~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  247 (290)
T 1t4h_A          176 LGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----  247 (290)
T ss_dssp             TTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----
T ss_pred             CCCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-----
Confidence            999975433 23345678999999998854  4899999999999999999999999886665554433321110     


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                           ...++...++++.+||.+||+.||.+|||++++++||||++
T Consensus       248 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          248 ---------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             ---------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             ---------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence                                 11123456889999999999999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-49  Score=358.40  Aligned_cols=286  Identities=26%  Similarity=0.468  Sum_probs=222.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEE-CCCCcEEEEEEeeccc---cchHHHHHHHHHcCCC------ceeecceeeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKC-LETGETVAIKKVLQDR---RYKNRELQLMRVMDHP------NVISLKHCFFS   75 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------~iv~~~~~~~~   75 (353)
                      +-...++|++.+.||+|+||.||+|.+ ..+++.||+|++....   ....+|+.+++.++|+      +++++++++. 
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-   87 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-   87 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-
Confidence            345678999999999999999999998 5688999999986543   3456799999888665      4888888873 


Q ss_pred             cCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC------
Q 018619           76 TTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL------  149 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~------  149 (353)
                          ....+|+||||++++|.+.+...  ...++++..++.++.||+.||+|||+ +||+||||||+|||++..      
T Consensus        88 ----~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~  160 (339)
T 1z57_A           88 ----HHGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAY  160 (339)
T ss_dssp             ----ETTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEE
T ss_pred             ----cCCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEecccccccc
Confidence                33458899999998988887652  23468999999999999999999999 799999999999999752      


Q ss_pred             ------------CCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC
Q 018619          150 ------------THQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE  217 (353)
Q Consensus       150 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~  217 (353)
                                  ++.+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus       161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          161 NPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             C----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                        45799999999986433  23356789999999999664 5899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCC----CCcCCCCC---------CCcccc--ccCCCCChhHHHHHHHhcCcCC
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYT----DFRFPQIK---------AHPWHK--VFHKRMPPEAIDLASRLLQYSP  282 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~L~~dp  282 (353)
                      +..+....+.+..+..+...+........    ........         ..++..  ......++++.+||.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            99888888888888777665543221100    00000000         000000  0011235788999999999999


Q ss_pred             CCCCCHHHHhcCcccccccC
Q 018619          283 SLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       283 ~~R~t~~~~l~hp~f~~~~~  302 (353)
                      .+|||+.|+++||||+.++.
T Consensus       318 ~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          318 AKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             TTSCCHHHHTTSGGGGGGGC
T ss_pred             ccccCHHHHhcCHHHHHHhc
Confidence            99999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.3e-50  Score=350.18  Aligned_cols=255  Identities=25%  Similarity=0.355  Sum_probs=206.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence            478999999999999999999999999999999986432     345689999999999999999998843     3458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+||||+++ +|.+.+    .....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEcc-CCCEEEeeCCCccc
Confidence            899999985 554433    345679999999999999999999999 79999999999999996 78899999999986


Q ss_pred             cccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .....   ......+|+.|+|||++.+...++.++||||+||++|+|++|..||...+..............        
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------  226 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--------  226 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--------
Confidence            54332   2234578999999999976554578999999999999999999999876543222221111000        


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                   ....     ...+++++.+||.+||+.||++|||++|+++||||++..
T Consensus       227 -------------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          227 -------------YLNP-----WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             -------------TSTT-----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             -------------ccCc-----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence                         0000     134799999999999999999999999999999998753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=359.43  Aligned_cols=254  Identities=24%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCC--CceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDH--PNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~   79 (353)
                      +.+++|++.+.||+|+||.||++.+ .+++.||||++....      ....+|+.+++.++|  |||+++++++.     
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----   79 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----   79 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----
Confidence            5678999999999999999999987 568999999986432      234579999999986  99999999883     


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....+|+|||+.+++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++  ++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~--~~~~kl~DFG  152 (343)
T 3dbq_A           80 TDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFG  152 (343)
T ss_dssp             CSSEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEEEECCCS
T ss_pred             eCCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE--CCcEEEeecc
Confidence            3446899999888888887764    5679999999999999999999999 7999999999999997  5779999999


Q ss_pred             cccccccCCC---cceeeeeceeeChhhhhC----------CCCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHH
Q 018619          160 SAKQLIAGEA---NISYICSRFYRAPELIFG----------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVE  225 (353)
Q Consensus       160 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~  225 (353)
                      ++........   .....||+.|+|||++.+          ...++.++|||||||++|+|++|..||...... ..+..
T Consensus       153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  232 (343)
T 3dbq_A          153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  232 (343)
T ss_dssp             SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence            9986654332   234578999999999864          245889999999999999999999999765433 22222


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      +..   ..                        ....++...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       233 ~~~---~~------------------------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          233 IID---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             HHC---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             Hhc---CC------------------------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            211   00                        01112344678999999999999999999999999999998643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=361.77  Aligned_cols=275  Identities=20%  Similarity=0.297  Sum_probs=211.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      .....++|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++....   
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   80 (319)
T 4euu_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---   80 (319)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred             ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---
Confidence            4456889999999999999999999999999999999986432     33458999999999999999999875432   


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE----eCCCCcEEE
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKI  155 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill----~~~~~~vkl  155 (353)
                      ....++||||+. ++|.+.+... .....+++..++.++.|++.||+|||+ +||+||||||+|||+    +. ++.+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL  157 (319)
T 4euu_A           81 TRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKL  157 (319)
T ss_dssp             TCCEEEEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTS-CEEEEE
T ss_pred             CceEEEEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCC-CceEEE
Confidence            234789999997 5777777643 233449999999999999999999999 799999999999998    53 667999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhC-------CCCCCccccchhHHHHHHHHHhCCCCCCCCCh----HHHHH
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFG-------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA----VDQLV  224 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~----~~~~~  224 (353)
                      +|||++.............||+.|+|||++..       ...++.++||||+||++|+|++|..||.....    .+...
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  237 (319)
T 4euu_A          158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (319)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred             ccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence            99999988766666666789999999999852       34589999999999999999999999975332    33344


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccc------cCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV------FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                      .+...........+...          ......|...      +...+++.+.+||++||+.||++|||++|+|+||-
T Consensus       238 ~~~~~~p~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          238 KIITGKPSGAISGVQKA----------ENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHHHCCTTCCEEEECS----------TTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             HHhcCCCcccchhhhcc----------cCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            44332111111111000          0011112221      22345678899999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.7e-49  Score=363.86  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=201.4

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcC--CCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~   79 (353)
                      +...+|++.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+++.++  ||||+++++++..    
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----  127 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----  127 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----
Confidence            445679999999999999999999764 8999999986442      33468999999996  5999999998743    


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                       ...+|+|||+.+++|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++  ++.+||+|||
T Consensus       128 -~~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~--~~~~kl~DFG  199 (390)
T 2zmd_A          128 -DQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGMLKLIDFG  199 (390)
T ss_dssp             -SSEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEES--SSCEEECCCS
T ss_pred             -CCEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEEE--CCeEEEEecC
Confidence             334899999877888877764    4578999999999999999999999 7999999999999996  5789999999


Q ss_pred             cccccccCCC---cceeeeeceeeChhhhhCC----------CCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHH
Q 018619          160 SAKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVE  225 (353)
Q Consensus       160 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~  225 (353)
                      ++........   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|..||...... ..+..
T Consensus       200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~  279 (390)
T 2zmd_A          200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA  279 (390)
T ss_dssp             SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred             ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH
Confidence            9986644332   2345789999999998652          35889999999999999999999999875432 22322


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      +..   ..            .            ...++...+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       280 ~~~---~~------------~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          280 IID---PN------------H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             HHC---TT------------S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HhC---cc------------c------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            221   00            0            0012234578999999999999999999999999999998643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.5e-50  Score=352.15  Aligned_cols=251  Identities=28%  Similarity=0.471  Sum_probs=186.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .++|.+.+.||+|+||.||+|++..+|+.||+|.+....       ....+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   84 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN   84 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence            468999999999999999999999999999999986432       3456899999999999999999988     3344


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..++||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~  159 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTR-NMNIKIADFGLA  159 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECT-TCCEEECCCTTC
T ss_pred             eEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcC-CCCEEEEeecce
Confidence            5889999997 477666653   34679999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ....... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||...+..+....+..            
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------  226 (278)
T 3cok_A          160 TQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL------------  226 (278)
T ss_dssp             EECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS------------
T ss_pred             eeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh------------
Confidence            8654332 23346789999999998654 488999999999999999999999987654332211100            


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                           .+            ..++..++.++.+||.+||+.||++|||++++++||||.+.
T Consensus       227 -----~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          227 -----AD------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             -----SC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             -----cc------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence                 00            01234578999999999999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.3e-50  Score=350.94  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=204.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +.+..++|++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++||||+++++++.    
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   81 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS----   81 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe----
Confidence            3456789999999999999999999999999999999986432       24468999999999999999999883    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       .....++||||+. ++|.+.+..    ...+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+||+|
T Consensus        82 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~~l~d  154 (276)
T 2h6d_A           82 -TPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDA-HMNAKIAD  154 (276)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECT-TSCEEECC
T ss_pred             -cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECC-CCCEEEee
Confidence             3345889999997 477777654    3579999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||++.............+|+.|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.....      
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------  228 (276)
T 2h6d_A          155 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF------  228 (276)
T ss_dssp             CCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------
T ss_pred             cccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------
Confidence            99998766555455667899999999997655457899999999999999999999988776665554433100      


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                             .++..++.++.++|.+||+.||.+|||+.++++||||++
T Consensus       229 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          229 -----------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -----------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence                                   022357899999999999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3e-50  Score=368.29  Aligned_cols=266  Identities=14%  Similarity=0.130  Sum_probs=189.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHc--CCCceeecceeee------
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVM--DHPNVISLKHCFF------   74 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l--~h~~iv~~~~~~~------   74 (353)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.+  +||||++++..+.      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999997643       2234675444444  6999888654332      


Q ss_pred             -ecCC------------CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHH------HHHHHHHHHHHHHhHcCCCee
Q 018619           75 -STTS------------KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYV------KLYTYQIFRGLAYIHTVPRVC  135 (353)
Q Consensus        75 -~~~~------------~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~------~~i~~qll~al~~LH~~~~i~  135 (353)
                       ....            .....+|+|||||+++|.+.+....   ..+++...      ..++.||+.||+|||+ +||+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQS-KGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCc
Confidence             1111            0114588999999999998887642   23344444      5677999999999999 7999


Q ss_pred             eccCCCCcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCC
Q 018619          136 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLF  214 (353)
Q Consensus       136 H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf  214 (353)
                      ||||||+|||++. ++.+||+|||+|+.....  .....+|+.|+|||++.+. ..++.++||||+||++|+|++|..||
T Consensus       217 HrDikp~NIll~~-~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          217 HGHFTPDNLFIMP-DGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             ETTCSGGGEEECT-TSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCcCCHHHEEECC-CCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999996 788999999999865322  2245667999999999641 35899999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          215 PGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+......                    ..+............+.......+++++.+||.+||+.||++|||+.++++|
T Consensus       294 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          294 GLVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TBCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            77642200                    0001000111111111111224689999999999999999999999999999


Q ss_pred             cccccccC
Q 018619          295 PFFDELRE  302 (353)
Q Consensus       295 p~f~~~~~  302 (353)
                      |||+++.+
T Consensus       354 p~f~~~~~  361 (371)
T 3q60_A          354 PEFLQLQN  361 (371)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.4e-50  Score=358.19  Aligned_cols=256  Identities=26%  Similarity=0.364  Sum_probs=197.5

Q ss_pred             cceeeEe-eeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHc-CCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++. +.||+|+||.||+|.+..+++.||||++....    ....+|+.++..+ +||||+++++++..     ...
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~~   85 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----EDR   85 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CCE
Confidence            5689985 78999999999999999999999999986542    3456899999884 79999999999843     335


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC---cEEEeeec
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH---QVKICDFG  159 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~---~vkl~Dfg  159 (353)
                      +|+||||+. ++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++   .+||+|||
T Consensus        86 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           86 FYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH-PNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESC-SSSSCSEEECCTT
T ss_pred             EEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEcc-CCCcCceEEEEcc
Confidence            889999998 577777654    3579999999999999999999999 79999999999999985 44   39999999


Q ss_pred             cccccccCC--------CcceeeeeceeeChhhhhCC----CCCCccccchhHHHHHHHHHhCCCCCCCCChH-------
Q 018619          160 SAKQLIAGE--------ANISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-------  220 (353)
Q Consensus       160 ~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------  220 (353)
                      ++.......        ......||+.|+|||++.+.    ..++.++||||+||++|+|++|..||.+....       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            987553221        12234589999999998641    24788999999999999999999999875421       


Q ss_pred             --------HHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          221 --------DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       221 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                              .....+......                 ++        ......+++++++||++||+.||.+|||++|++
T Consensus       240 ~~~~~~~~~~~~~i~~~~~~-----------------~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKYE-----------------FP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCCC-----------------CC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ccchhHHHHHHHHHhccCcc-----------------cC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                    122222221000                 00        001134789999999999999999999999999


Q ss_pred             cCccccccc
Q 018619          293 AHPFFDELR  301 (353)
Q Consensus       293 ~hp~f~~~~  301 (353)
                      +||||++..
T Consensus       295 ~hp~~~~~~  303 (316)
T 2ac3_A          295 QHPWVQGCA  303 (316)
T ss_dssp             HSTTCC---
T ss_pred             cChhhcCCC
Confidence            999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.1e-49  Score=357.58  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=205.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            578999999999999999999999999999999885432            235689999999999999999988732  


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC--CcEE
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT--HQVK  154 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~--~~vk  154 (353)
                         .. .|+||||+.+ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+||+++..+  ..+|
T Consensus        87 ---~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 ---ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEE
Confidence               12 7899999975 6666554    45789999999999999999999999 7999999999999998522  2599


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhh--CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+...+.....
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998765544344567899999999974  3455889999999999999999999999765543222222221110


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ..                        .......+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       238 ~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          238 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             cc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            00                        011123579999999999999999999999999999999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-49  Score=349.97  Aligned_cols=251  Identities=20%  Similarity=0.245  Sum_probs=204.5

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHc-CCCceeecceeeeecCCCCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+..+..+ +||||+++++++..     ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----~~   84 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----DD   84 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----TT
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CC
Confidence            578999999999999999999999999999999986532      2344788888888 99999999998843     33


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC-------------
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-------------  148 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~-------------  148 (353)
                      ..++||||+++ +|.+.+.........+++..++.++.||+.||+|||+ +||+||||||+||+++.             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC--------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCccccccccc
Confidence            58899999975 8888887765556789999999999999999999999 79999999999999973             


Q ss_pred             -----CCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHH
Q 018619          149 -----LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQL  223 (353)
Q Consensus       149 -----~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~  223 (353)
                           ....+||+|||.+.......   ...+|+.|+|||++.+...++.++|||||||++|+|++|.+|+...+...  
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--  238 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH--  238 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH--
T ss_pred             ccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH--
Confidence                 23479999999998665432   34589999999999776567789999999999999999998875543221  


Q ss_pred             HHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          224 VEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                       .+.+.                   .         ...++..+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       239 -~~~~~-------------------~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          239 -EIRQG-------------------R---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             -HHHTT-------------------C---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             -HHHcC-------------------C---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence             11110                   0         011234689999999999999999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-49  Score=353.31  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=211.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ..++|.+.+.||+|+||.||+|++..+|+.||+|.+....    ....+|+.+++.++||||+++++++.     ....+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   81 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHY   81 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEE
Confidence            3678999999999999999999999999999999986542    34568999999999999999999883     34458


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE---eCCCCcEEEeeecc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGS  160 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill---~~~~~~vkl~Dfg~  160 (353)
                      |+||||++ ++|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+||++   + .++.+||+|||+
T Consensus        82 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~  155 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPE-ENSKIMITDFGL  155 (304)
T ss_dssp             EEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSS-TTCCEEBCSCST
T ss_pred             EEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCC-CCCCEEEccCCc
Confidence            89999997 477766653    3579999999999999999999999 799999999999999   4 377899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +..... .......+|+.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+.+.....       
T Consensus       156 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------  226 (304)
T 2jam_A          156 SKMEQN-GIMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF-------  226 (304)
T ss_dssp             TCCCCC-BTTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC-------
T ss_pred             ceecCC-CccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            875432 223345689999999998654 58999999999999999999999999888777666655421110       


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                        ...+...+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus       227 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          227 ------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             ------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence                              111224579999999999999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5.8e-49  Score=359.95  Aligned_cols=290  Identities=29%  Similarity=0.472  Sum_probs=223.1

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcC-----------CCceeecce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLKH   71 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~   71 (353)
                      ..+..++|++.+.||+|+||.||+|++..+++.||||++..+.   ....+|+.+++.++           ||||+++++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            3456789999999999999999999999999999999997543   34457899888876           899999999


Q ss_pred             eeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeeccCCCCcEEEeC--
Q 018619           72 CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDP--  148 (353)
Q Consensus        72 ~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~i~H~Dlkp~Nill~~--  148 (353)
                      ++.... .+...+++|||+++++|.+.+...  ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.  
T Consensus        94 ~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKG-PNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEE-TTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEE
T ss_pred             HhhccC-CCCceEEEEEecCCCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccC
Confidence            885433 234468899999988988888753  24569999999999999999999999 8 9999999999999953  


Q ss_pred             ---CCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC------h
Q 018619          149 ---LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------A  219 (353)
Q Consensus       149 ---~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~  219 (353)
                         ..+.+||+|||++......  .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+      .
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               2347999999999865432  33457899999999997754 8999999999999999999999998654      5


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCC------CCC-cCCCCCCCcc------ccccCCCCChhHHHHHHHhcCcCCCCCC
Q 018619          220 VDQLVEIIKVLGTPTREEIRCMNPNY------TDF-RFPQIKAHPW------HKVFHKRMPPEAIDLASRLLQYSPSLRC  286 (353)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~-~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dp~~R~  286 (353)
                      .+.+.++.+..+.++...+.......      ... ........+.      ...++...++++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            56777888888887765443211000      000 0000000000      0012234567899999999999999999


Q ss_pred             CHHHHhcCcccccccC
Q 018619          287 TALEACAHPFFDELRE  302 (353)
Q Consensus       287 t~~~~l~hp~f~~~~~  302 (353)
                      |++|+|+||||++...
T Consensus       327 t~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             CHHHHHTCGGGTTCTT
T ss_pred             CHHHHhhChhhhcccC
Confidence            9999999999998643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.3e-51  Score=375.43  Aligned_cols=254  Identities=20%  Similarity=0.217  Sum_probs=194.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHH---HHHHcCCCceeecceeee-----
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQ---LMRVMDHPNVISLKHCFF-----   74 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~---~l~~l~h~~iv~~~~~~~-----   74 (353)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.   +++.++||||+++++.+.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            57899999999999999999999999999999998632       133458884   455558999999984332     


Q ss_pred             --ecC---------CCCc---eeEEEEeccccchHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec
Q 018619           75 --STT---------SKNE---LFLNLVMEYVPESMYRVLKHYSSA---NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR  137 (353)
Q Consensus        75 --~~~---------~~~~---~~~~lv~e~~~~~l~~~l~~~~~~---~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~  137 (353)
                        ...         ..+.   ...|+||||++|+|.+.+......   ...+++..++.++.||+.||+|||+ +||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecC
Confidence              111         1111   137899999999999888753221   1234458888899999999999999 799999


Q ss_pred             cCCCCcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCC----------CCCCccccchhHHHHHHHH
Q 018619          138 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAEL  207 (353)
Q Consensus       138 Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~l  207 (353)
                      ||||+|||++. ++.+||+|||+|+....  ......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~-~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQ-RGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECT-TCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcC-CCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            99999999996 78999999999985322  3334566 999999999765          2589999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC
Q 018619          208 LLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT  287 (353)
Q Consensus       208 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  287 (353)
                      ++|..||.+.+.......+                                 ......+++++.+||.+||+.||.+|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            9999999665432111000                                 0011357999999999999999999999


Q ss_pred             HHHHhcCccccccc
Q 018619          288 ALEACAHPFFDELR  301 (353)
Q Consensus       288 ~~~~l~hp~f~~~~  301 (353)
                      +.++++||||+.++
T Consensus       354 ~~e~l~hp~f~~~~  367 (377)
T 3byv_A          354 PLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHTSHHHHHHH
T ss_pred             HHHHhhChHHHHHH
Confidence            99999999998864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.5e-49  Score=358.80  Aligned_cols=285  Identities=25%  Similarity=0.428  Sum_probs=221.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCC-cEEEEEEeeccc---cchHHHHHHHHHcCCCc------eeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETG-ETVAIKKVLQDR---RYKNRELQLMRVMDHPN------VISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~   77 (353)
                      +..++|++.+.||+|+||.||+|.+..++ +.||+|++....   ....+|+.+++.++|++      ++.+.+++.   
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---   92 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---   92 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE---
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee---
Confidence            55789999999999999999999998877 689999986532   34457999999987655      777777763   


Q ss_pred             CCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC---------
Q 018619           78 SKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP---------  148 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~---------  148 (353)
                        ....+|+||||+++++.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++.         
T Consensus        93 --~~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           93 --FHGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             --ETTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             --eCCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccc
Confidence              33358899999999888877642  23579999999999999999999999 79999999999999931         


Q ss_pred             ---------CCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh
Q 018619          149 ---------LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA  219 (353)
Q Consensus       149 ---------~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~  219 (353)
                               .++.+||+|||++.....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                     367899999999986433  23446789999999999664 589999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCC----CCcCCCCC---------CCccccc--cCCCCChhHHHHHHHhcCcCCCC
Q 018619          220 VDQLVEIIKVLGTPTREEIRCMNPNYT----DFRFPQIK---------AHPWHKV--FHKRMPPEAIDLASRLLQYSPSL  284 (353)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~  284 (353)
                      .+.+..+.+..+..+...+........    ....+...         ..++...  .....+.++.+||++||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            988888888888877665543211100    00000000         0000000  00123458899999999999999


Q ss_pred             CCCHHHHhcCcccccccCC
Q 018619          285 RCTALEACAHPFFDELREP  303 (353)
Q Consensus       285 R~t~~~~l~hp~f~~~~~~  303 (353)
                      |||+.|+++||||+.+...
T Consensus       325 Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCHH
T ss_pred             CcCHHHHhcChhhcCCChh
Confidence            9999999999999987543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.7e-49  Score=349.43  Aligned_cols=256  Identities=29%  Similarity=0.467  Sum_probs=212.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++.     ....
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            468999999999999999999999999999999986432      34568999999999999999999883     3345


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEeeecc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGS  160 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~Dfg~  160 (353)
                      .++||||+. ++|.+.+..    ...+++..++.++.|++.||+|||+ +|++|+||||+||+++..  +..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            889999997 476666643    3579999999999999999999999 799999999999999753  34799999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............+|+.|+|||.+.+  .++.++||||+||++|+|++|..||.+.+..+....+.........     
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----  243 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL-----  243 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred             ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc-----
Confidence            987665555555678999999999865  3899999999999999999999999998877666555442111000     


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                          .....+++++.+||++||+.||.+|||+.++++||||++...
T Consensus       244 --------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          244 --------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             --------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             --------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence                                011357999999999999999999999999999999998643

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-49  Score=356.13  Aligned_cols=263  Identities=23%  Similarity=0.332  Sum_probs=210.7

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++..... 
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-   86 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-   86 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-
Confidence            455789999999999999999999999999999999996542       234578899999999999999998754432 


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      .....|+||||++ ++|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+||
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Df  160 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDF  160 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEET-TSCEEECCC
T ss_pred             CCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcC-CCCEEEeec
Confidence            2345689999997 577776653    3679999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          159 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       159 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      |++........    .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+...........+.
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP  239 (311)
T ss_dssp             SCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred             cCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence            99986544322    2235689999999999765 489999999999999999999999999888777666555322221


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ..                         ....+++++.+||.+||+.||.+||++.+++.|+|++....
T Consensus       240 ~~-------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          240 SA-------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HH-------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             cc-------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            11                         12358999999999999999999999999999999987543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.5e-48  Score=347.06  Aligned_cols=258  Identities=24%  Similarity=0.407  Sum_probs=207.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      -..++|++.+.||+|+||.||+|.+..+++.||+|++....    ....+|+.+++.++||||+++++++..     ...
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   90 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGK   90 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-C
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCe
Confidence            45678999999999999999999999999999999885432    344579999999999999999998843     334


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +++||||+++ +|...+..   ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||++.
T Consensus        91 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTL-EGDIRLADFGVSA  165 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TSCEEECCCHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECC-CCCEEEEECCCCc
Confidence            8899999985 56555543   35679999999999999999999999 79999999999999996 7889999999876


Q ss_pred             ccccC-CCcceeeeeceeeChhhhh----CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          163 QLIAG-EANISYICSRFYRAPELIF----GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       163 ~~~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ..... .......+|+.|+|||++.    ....++.++|||||||++|+|++|..||...+..+....+.......    
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----  241 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----  241 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC----
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc----
Confidence            43221 1223457899999999984    34458899999999999999999999999888776665554421100    


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                            ...+..++.++.+||.+||+.||.+|||+.++++||||+.+.
T Consensus       242 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          242 ----------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             ----------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             ----------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence                                  001235789999999999999999999999999999998754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=346.71  Aligned_cols=256  Identities=29%  Similarity=0.427  Sum_probs=207.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|.+....  ....+|+.+++.++||||+++++++..     ...+|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEE
Confidence            4678999999999999999999999999999999987543  445689999999999999999998854     334889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ||||+++ +|.+.+..   ....+++..++.++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++....
T Consensus       102 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          102 VMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNT-EGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECB
T ss_pred             EeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECC-CCCEEEeecccchhhh
Confidence            9999985 77766653   35679999999999999999999999 79999999999999996 7889999999998655


Q ss_pred             cCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .... .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||...+.......+..... +.          
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----------  244 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PT----------  244 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC----------
T ss_pred             hhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-cc----------
Confidence            4322 3345789999999998654 589999999999999999999999988876655544332100 00          


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                     ...+..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       245 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          245 ---------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             ---------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             ---------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence                           001234689999999999999999999999999999998743

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-49  Score=354.20  Aligned_cols=272  Identities=26%  Similarity=0.362  Sum_probs=194.2

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .+.+..++|++.+.||+|+||.||+|.+..+++.||||.+...     .....+|+.+++.++||||+++++++...   
T Consensus         9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---   85 (303)
T 2vwi_A            9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK---   85 (303)
T ss_dssp             ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS---
T ss_pred             ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec---
Confidence            4567789999999999999999999999999999999988543     23345789999999999999999988443   


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSS----ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                        ...++||||+. ++|.+.+.....    ....+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+|
T Consensus        86 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~k  161 (303)
T 2vwi_A           86 --DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGE-DGSVQ  161 (303)
T ss_dssp             --SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEE
T ss_pred             --CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcC-CCCEE
Confidence              34889999997 577777764332    24569999999999999999999999 79999999999999996 78899


Q ss_pred             EeeeccccccccCC------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 018619          155 ICDFGSAKQLIAGE------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       155 l~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  228 (353)
                      |+|||++.......      ......+|+.|+|||++.+...++.++|||||||++|+|++|..||...+..+.......
T Consensus       162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  241 (303)
T 2vwi_A          162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ  241 (303)
T ss_dssp             ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred             EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence            99999987654322      123456899999999986544589999999999999999999999988776655433322


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ......                   ............+++++.+||.+||+.||.+|||+.++++||||++.+.
T Consensus       242 ~~~~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          242 NDPPSL-------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             SSCCCT-------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             cCCCcc-------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            110000                   0000011123468899999999999999999999999999999998654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-48  Score=342.95  Aligned_cols=258  Identities=25%  Similarity=0.366  Sum_probs=213.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++++...   ...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   80 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT   80 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence            3579999999999999999999999999999999986432      3345899999999999999999987543   233


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----eeeccCCCCcEEEeCCCCcEEEe
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-----i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                      .+++||||++ ++|.+.+.........+++..++.++.|++.||+|||+ +|     |+||||||+||+++. ++.+||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~-~~~~kl~  158 (279)
T 2w5a_A           81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLG  158 (279)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECS-SSCEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcC-CCCEEEe
Confidence            5889999998 48888887765556779999999999999999999999 78     999999999999996 7889999


Q ss_pred             eeccccccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          157 DFGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       157 Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      |||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.....    
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----  233 (279)
T 2w5a_A          159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----  233 (279)
T ss_dssp             CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred             cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc----
Confidence            9999986544322 2235679999999999765 489999999999999999999999998887666555544110    


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                              ..++..+++++.++|.+||+.||.+|||+.++++|+|+..-
T Consensus       234 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 ------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                                    01224578999999999999999999999999999999874

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-49  Score=361.91  Aligned_cols=258  Identities=27%  Similarity=0.448  Sum_probs=204.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeecc--------ccchHHHHHHHHHc-CCCceeecceeeeec
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRVM-DHPNVISLKHCFFST   76 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~   76 (353)
                      ..++|++.+.||+|+||.||+|++.   .+++.||||++.+.        .....+|+.+++.+ +||||+++++++.. 
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  130 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-  130 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence            3479999999999999999999984   58999999988542        23345799999999 69999999998843 


Q ss_pred             CCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           77 TSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                          ...+++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||
T Consensus       131 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl  200 (355)
T 1vzo_A          131 ----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVL  200 (355)
T ss_dssp             ----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEE
T ss_pred             ----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCcEEE
Confidence                3348899999985 77776654    3579999999999999999999999 79999999999999996 789999


Q ss_pred             eeeccccccccCCC--cceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          156 CDFGSAKQLIAGEA--NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      +|||+++.......  .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+..... 
T Consensus       201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-  279 (355)
T 1vzo_A          201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-  279 (355)
T ss_dssp             SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-
T ss_pred             eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-
Confidence            99999986543322  2345789999999999753 3478999999999999999999999975432221222211100 


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                             ..                 ...++..+++.+.+||.+||+.||.+||     |++++++||||+.+.+
T Consensus       280 -------~~-----------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~  330 (355)
T 1vzo_A          280 -------KS-----------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  330 (355)
T ss_dssp             -------HC-----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -------cc-----------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence                   00                 0012345789999999999999999999     9999999999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-49  Score=362.64  Aligned_cols=284  Identities=26%  Similarity=0.409  Sum_probs=210.8

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     .
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  103 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----D  103 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----T
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----C
Confidence            456789999999999999999999999999999999986542     334589999999999999999998844     3


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ..+|+||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ + ||+||||||+||+++. ++.+||+|||
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~-~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg  177 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNS-RGEIKLCDFG  177 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-HHCCCCSCCSGGGEEECT-TCCEEECCCC
T ss_pred             CEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHH-hCCEEcCCccHHHEEECC-CCCEEEEECC
Confidence            348899999985 77777654    3579999999999999999999998 5 8999999999999996 7889999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH-
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-  238 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-  238 (353)
                      ++...... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||...+..+....+............ 
T Consensus       178 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3eqc_A          178 VSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP  255 (360)
T ss_dssp             CCHHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred             CCcccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence            98754332 23346789999999999664 5899999999999999999999999887766543332111110000000 


Q ss_pred             hhc--CcCCCCCcCCC------------CCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          239 RCM--NPNYTDFRFPQ------------IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       239 ~~~--~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      ...  ......+....            .............++.++.+||++||+.||.+|||++|+++||||+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  334 (360)
T 3eqc_A          256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  334 (360)
T ss_dssp             ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence            000  00000000000            000000111123478899999999999999999999999999999986543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-48  Score=344.13  Aligned_cols=251  Identities=27%  Similarity=0.401  Sum_probs=210.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ...
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   94 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTK   94 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCe
Confidence            3567999999999999999999999999999999986432     345689999999999999999998844     334


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +++||||+++ +|.+.+.     .+.+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.+||+|||++.
T Consensus        95 ~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~  167 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSE-HGEVKLADFGVAG  167 (303)
T ss_dssp             EEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECC-CCCEEEeecccce
Confidence            8899999985 6666553     3679999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      ....... .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+....           
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------  235 (303)
T 3a7i_A          168 QLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-----------  235 (303)
T ss_dssp             ECBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----------
T ss_pred             ecCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC-----------
Confidence            6654432 2345789999999999654 58899999999999999999999998887766554443310           


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                       ...+...++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       236 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          236 -----------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             -----------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             -----------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence                             001234579999999999999999999999999999999764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-48  Score=347.35  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=206.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHc-CCCceeecceeeeecCCC-Ccee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK-NELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~-~~~~   83 (353)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+|+.+++.+ +||||+++++++...... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            467999999999999999999999999999999998643   34456899999998 799999999998654321 1346


Q ss_pred             EEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +++||||+++ +|.+.+...  ....+++..++.++.||+.||+|||+ +||+|+||||+||+++. ++.+||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTE-NAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECT-TCCEEECCCTTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcC-CCCEEEeeCcCce
Confidence            8899999985 887777653  23578999999999999999999999 79999999999999996 7889999999988


Q ss_pred             ccccCC-CcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          163 QLIAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       163 ~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ...... ......+|+.|+|||++.+    ...++.++|||||||++|+|++|..||...+.......+..... +    
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----  252 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P----  252 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C----
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c----
Confidence            654332 2334578999999999852    34578999999999999999999999988877666554433100 0    


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                            ......+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus       253 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          253 ----------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             ----------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             ----------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence                                  00123578999999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-48  Score=345.50  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=206.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++||||+++++++     ..
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~   82 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EE   82 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----EC
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----ee
Confidence            45789999999999999999999999999999999885322       2345799999999999999999988     44


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||++| +|.+.+..    .+++++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg  156 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFG  156 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECC-CCCEEEEeCC
Confidence            4558899999985 77776653    3679999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          160 SAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       160 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ++........  .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+..+...+...... +.   
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~---  231 (294)
T 4eqm_A          157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PN---  231 (294)
T ss_dssp             SSTTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CC---
T ss_pred             CccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CC---
Confidence            9986544322  2345689999999999765 489999999999999999999999998887666544433111 11   


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                          ....+...+++.+.++|.+||+.||.+||+..+.+.+.|.+-+.
T Consensus       232 --------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          232 --------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             --------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             --------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence                                11112346899999999999999999999777777777765543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7e-48  Score=342.50  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=200.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCC--------
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTS--------   78 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--------   78 (353)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            578999999999999999999999999999999986543   334579999999999999999998765321        


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .....+|+||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~-~~~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDE-SRNVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcC-CCCEEEee
Confidence            235678999999974 88877764   34568889999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccC---------------CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHH
Q 018619          158 FGSAKQLIAG---------------EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ  222 (353)
Q Consensus       158 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  222 (353)
                      ||++......               .......+|+.|+|||++.+...++.++||||+||++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9999865422               122345689999999999766568999999999999999998   5543322222


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      ....+...                ...        +...+....++.+.+||++||+.||.+|||+.++++||||+.
T Consensus       237 ~~~~~~~~----------------~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          237 ILKKLRSV----------------SIE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHHST----------------TCC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHhcccc----------------ccc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            22111110                000        111133457888999999999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.7e-48  Score=351.93  Aligned_cols=267  Identities=22%  Similarity=0.356  Sum_probs=186.7

Q ss_pred             eeecceeeEee-eeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            7 ILQTISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         7 ~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ....++|.+.+ .||+|+||.||+|.++.+|+.||||++........+....++.++||||+++++++.... .+...++
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~  102 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLL  102 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEE
Confidence            34578899955 699999999999999999999999999776555544555677889999999999885432 3355688


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEeeecccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAK  162 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~Dfg~a~  162 (353)
                      +|||||.+ +|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+||+++..  ++.+||+|||++.
T Consensus       103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            99999985 887777642  23579999999999999999999999 799999999999999742  4469999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..... ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||..................          
T Consensus       180 ~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------  247 (336)
T 3fhr_A          180 ETTQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL----------  247 (336)
T ss_dssp             EC-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred             ecccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc----------
Confidence            65432 23456779999999998554 4889999999999999999999999776544332211111000          


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                         ....++        ......+++++.+||.+||+.||.+|||++|+++||||++.
T Consensus       248 ---~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          248 ---GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             ------CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             ---cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence               000000        01113579999999999999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-48  Score=348.93  Aligned_cols=267  Identities=25%  Similarity=0.345  Sum_probs=189.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-----chHHHHH-HHHHcCCCceeecceeeeecCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-----YKNRELQ-LMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +-+..++|.+.+.||+|+||.||+|.+..+|+.||||++.....     ...+|+. +++.++||||+++++++..    
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----   92 (327)
T 3aln_A           17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR----   92 (327)
T ss_dssp             ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----
T ss_pred             cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----
Confidence            45677899999999999999999999999999999999865421     2224444 6677899999999998843    


Q ss_pred             CceeEEEEeccccchHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeeccCCCCcEEEeCCCCcEEEee
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~-~~~~l~~~~~~~i~~qll~al~~LH~~~-~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       ....++||||+.++|.+.+..... ....+++..++.++.|++.||.|||+ + ||+||||||+||+++. ++.+||+|
T Consensus        93 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~-~~~~kl~D  169 (327)
T 3aln_A           93 -EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDR-SGNIKLCD  169 (327)
T ss_dssp             -SSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEET-TTEEEECC
T ss_pred             -CCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcC-CCCEEEcc
Confidence             335889999999988877764322 35789999999999999999999999 8 9999999999999996 88999999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhh---CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIF---GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      ||++.............||+.|+|||++.   ....++.++|||||||++|+|++|..||...+.....  +...     
T Consensus       170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~-----  242 (327)
T 3aln_A          170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--LTQV-----  242 (327)
T ss_dssp             CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC-----
T ss_pred             CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--HHHH-----
Confidence            99998765554445557899999999983   2345889999999999999999999999765432110  0000     


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                 ...     ....+.......+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus       243 -----------~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~  294 (327)
T 3aln_A          243 -----------VKG-----DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE  294 (327)
T ss_dssp             -----------CCS-----CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             -----------hcC-----CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence                       000     0001111122457999999999999999999999999999999987543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=342.01  Aligned_cols=259  Identities=26%  Similarity=0.437  Sum_probs=202.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ++|.....||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++++..     ....++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   96 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKI   96 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEE
Confidence            34444559999999999999999999999999986542    335689999999999999999998843     335889


Q ss_pred             Eecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      ||||++ ++|.+.+... .....+++..++.++.|++.||+|||+ +||+|+||||+||+++..++.+||+|||++....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EEECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEEeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            999997 5777766542 223457799999999999999999999 7999999999999999657889999999998654


Q ss_pred             cCCC-cceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          166 AGEA-NISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       166 ~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      .... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+..............           
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  243 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV-----------  243 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-----------
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-----------
Confidence            4322 3345789999999998653 23789999999999999999999999765443322111111110           


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                     ...++..+++++.+||.+||+.||.+|||++++++||||+....
T Consensus       244 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          244 ---------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             ---------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             ---------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence                           11123458999999999999999999999999999999987543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.7e-48  Score=348.32  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=206.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcC--CCceeecceeeee
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFS   75 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~   75 (353)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++....          ....+|+.+++.++  ||||+++++++. 
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~-  118 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-  118 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-
Confidence            45778999999999999999999999999999999986542          33457999999996  599999999883 


Q ss_pred             cCCCCceeEEEEecccc--chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           76 TTSKNELFLNLVMEYVP--ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                          .....++|||++.  ++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+|||++.+++.+
T Consensus       119 ----~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          119 ----RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             ----CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEE
T ss_pred             ----cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCE
Confidence                3345889999997  677777654    4679999999999999999999999 7999999999999999557899


Q ss_pred             EEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          154 KICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      ||+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|..||...+.      +...    
T Consensus       190 kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~----  258 (320)
T 3a99_A          190 KLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG----  258 (320)
T ss_dssp             EECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC----
T ss_pred             EEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc----
Confidence            99999999865433 233467899999999997666557899999999999999999999965321      1110    


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                                               ...++..+++++.+||.+||+.||.+|||++++++||||++..
T Consensus       259 -------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          259 -------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             -------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -------------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence                                     0012245899999999999999999999999999999998753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=343.73  Aligned_cols=260  Identities=23%  Similarity=0.342  Sum_probs=191.5

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc------chHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR------YKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++.....      ...++..+++.++||||+++++++..     
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----   95 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----   95 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----
Confidence            3456799999999999999999999999999999999865421      12234456788899999999998843     


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC-CeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP-RVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~-~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+++||||+++.+......   ....+++..++.++.|++.||.|||+ + ||+|+||||+||+++. ++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~-~~~~kl~dfg  170 (318)
T 2dyl_A           96 NTDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDE-RGQIKLCDFG  170 (318)
T ss_dssp             SSEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECT-TSCEEECCCT
T ss_pred             CCcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECC-CCCEEEEECC
Confidence            345889999997655444432   35679999999999999999999998 6 9999999999999996 7889999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCC
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-AVDQLVEIIKVLGTPT  234 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~  234 (353)
                      ++.............+|+.|+|||++.+    ...++.++||||+||++|+|++|..||.... ..+....+.... .+.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~  249 (318)
T 2dyl_A          171 ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE-PPL  249 (318)
T ss_dssp             TC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC-CCC
T ss_pred             CchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC-CCC
Confidence            9987665555556678999999999852    3457899999999999999999999998744 334444333310 000


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                     ++          ....+++++.+||.+||+.||.+|||++++++||||++...
T Consensus       250 ---------------~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (318)
T 2dyl_A          250 ---------------LP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET  292 (318)
T ss_dssp             ---------------CC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred             ---------------CC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence                           00          01247899999999999999999999999999999987643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-47  Score=342.54  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=197.5

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      .+..++|++.+.||+|+||.||+|++  +|+.||+|++....      ....+|+.+++.++||||+++++++.     .
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~  105 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----Q  105 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----E
Confidence            35678999999999999999999986  68899999986543      23457999999999999999999883     3


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEee
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      ...+++||||+.+ +|.+.+.... ....+++..++.++.|++.||+|||+ +|  |+||||||+||+++. ++.+||+|
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~-~~~~kL~D  182 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDK-KYTVKVCD  182 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECT-TCCEEECC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeC-CCcEEECC
Confidence            3348899999985 7777765421 12248999999999999999999999 79  999999999999996 78999999


Q ss_pred             eccccccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          158 FGSAKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       158 fg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+......    
T Consensus       183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~----  257 (309)
T 3p86_A          183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR----  257 (309)
T ss_dssp             CC-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----
T ss_pred             CCCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----
Confidence            99997544332 23356789999999999664 4899999999999999999999999988877665544331111    


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc--Cccccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE  299 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~--hp~f~~  299 (353)
                                             ..++..+++++.+||.+||+.||.+|||++++++  +++++.
T Consensus       258 -----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          258 -----------------------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             -----------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                   1133468999999999999999999999999986  444443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.2e-47  Score=340.32  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=202.4

Q ss_pred             ceeeeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcC--CCceeecceee
Q 018619            2 YLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMD--HPNVISLKHCF   73 (353)
Q Consensus         2 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~~iv~~~~~~   73 (353)
                      |.....+..++|++.+.||+|+||.||++.+. +++.||+|++....      ....+|+.+++.++  ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            34445677889999999999999999999975 58899999986432      33457999999997  59999999988


Q ss_pred             eecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           74 FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                      .     ....+++|||+.+++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++  ++.+
T Consensus        98 ~-----~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~--~~~~  165 (313)
T 3cek_A           98 I-----TDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV--DGML  165 (313)
T ss_dssp             E-----CSSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE--TTEE
T ss_pred             e-----cCCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE--CCeE
Confidence            3     3345889999888888887764    4678999999999999999999999 7999999999999997  4789


Q ss_pred             EEeeeccccccccCCC---cceeeeeceeeChhhhhCC----------CCCCccccchhHHHHHHHHHhCCCCCCCCChH
Q 018619          154 KICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----------TEYTTSIDIWSAGCVLAELLLGQPLFPGENAV  220 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~  220 (353)
                      ||+|||++........   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|..||......
T Consensus       166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence            9999999986544332   2345689999999998652          35788999999999999999999999775433


Q ss_pred             H-HHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          221 D-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       221 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      . ....+..   ..                        ....++...++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       246 ~~~~~~~~~---~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          246 ISKLHAIID---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HHHHHHHHC---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             HHHHHHHHh---cc------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            2 2222111   00                        001122346889999999999999999999999999999986


Q ss_pred             c
Q 018619          300 L  300 (353)
Q Consensus       300 ~  300 (353)
                      .
T Consensus       299 ~  299 (313)
T 3cek_A          299 Q  299 (313)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6e-48  Score=350.01  Aligned_cols=274  Identities=20%  Similarity=0.310  Sum_probs=207.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------------------cchHHHHHHHHHcCCCce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------------------RYKNRELQLMRVMDHPNV   66 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~~i   66 (353)
                      ...++|++.+.||+|+||.||+|.+  +++.||+|.+....                     ....+|+.+++.++||||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            4467999999999999999999998  99999999986431                     456789999999999999


Q ss_pred             eecceeeeecCCCCceeEEEEeccccc-hHHHHHHhh--hhc--CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCC
Q 018619           67 ISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY--SSA--NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP  141 (353)
Q Consensus        67 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~--~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp  141 (353)
                      +++++++..     ...+|+||||+++ +|.+.+...  ...  ...+++..++.++.|++.||+|||+.+||+||||||
T Consensus       106 ~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p  180 (348)
T 2pml_X          106 LTCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP  180 (348)
T ss_dssp             CCCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred             ceEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence            999999843     3458899999986 554431100  222  578999999999999999999999723999999999


Q ss_pred             CcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCc-cccchhHHHHHHHHHhCCCCCCCCCh-
Q 018619          142 QNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT-SIDIWSAGCVLAELLLGQPLFPGENA-  219 (353)
Q Consensus       142 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwSlG~il~~l~~g~~pf~~~~~-  219 (353)
                      +||+++. ++.+||+|||++...... ......+|+.|+|||++.+...++. ++||||+||++|+|++|..||...+. 
T Consensus       181 ~Nil~~~-~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          181 SNILMDK-NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             GGEEECT-TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             HhEEEcC-CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            9999996 788999999999865443 3345678999999999976544655 99999999999999999999988776 


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      .+....+.......+.        ....+ ...... .-.......+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus       259 ~~~~~~i~~~~~~~~~--------~~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~  328 (348)
T 2pml_X          259 VELFNNIRTKNIEYPL--------DRNHF-LYPLTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD  328 (348)
T ss_dssp             HHHHHHHTSCCCCCCC--------SSSSS-TTTTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHhccCcCCcc--------chhhh-hccccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence            4444333221000000        00000 000000 0001122458999999999999999999999999999999987


Q ss_pred             c
Q 018619          300 L  300 (353)
Q Consensus       300 ~  300 (353)
                      .
T Consensus       329 ~  329 (348)
T 2pml_X          329 T  329 (348)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-47  Score=345.59  Aligned_cols=253  Identities=19%  Similarity=0.222  Sum_probs=203.6

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHc-CCCceeecceeeeecCCCCc
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   81 (353)
                      +.++.+++|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+.+++.+ +||||+++++++..     .
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~   77 (330)
T 2izr_A            3 GVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----G   77 (330)
T ss_dssp             -CCEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----T
T ss_pred             ceEEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----C
Confidence            3456789999999999999999999999999999999988643  34567999999999 99999999998743     3


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCc-----EEEe
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKIC  156 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~-----vkl~  156 (353)
                      ...++||||++++|.+.+...   ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.     +||+
T Consensus        78 ~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~-~~~~~~~~~kl~  152 (330)
T 2izr_A           78 KYNAMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGR-PGNKTQQVIHII  152 (330)
T ss_dssp             TEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECC-GGGTCTTSEEEC
T ss_pred             CccEEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecc-CCCCCCceEEEE
Confidence            458899999988888887652   5689999999999999999999999 79999999999999985 555     9999


Q ss_pred             eeccccccccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---HHHHHH
Q 018619          157 DFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVE  225 (353)
Q Consensus       157 Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~  225 (353)
                      |||++........        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.   .+.+..
T Consensus       153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EcccceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            9999987544332        2356789999999999764 489999999999999999999999987443   233333


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +.......+...                        .....+ ++.++|.+||+.||.+||+++++++
T Consensus       232 i~~~~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          232 IGDTKRATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhhhccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            322211111111                        112244 9999999999999999999988764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=341.55  Aligned_cols=258  Identities=24%  Similarity=0.437  Sum_probs=205.6

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..+..++|++.+.||+|+||+||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~   79 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----D   79 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----C
Confidence            457789999999999999999999999999999999988543    2345689999999999999999999854     3


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~  154 (310)
T 3s95_A           80 KRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRE-NKNVVVADFGL  154 (310)
T ss_dssp             TEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECT-TSCEEECCCTT
T ss_pred             CeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECC-CCCEEEeeccc
Confidence            348899999985 77777654   35679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCc---------------ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 018619          161 AKQLIAGEAN---------------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE  225 (353)
Q Consensus       161 a~~~~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  225 (353)
                      +.........               ....||+.|+|||++.+. .++.++||||+||++|+|++|..||.........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~--  231 (310)
T 3s95_A          155 ARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD--  231 (310)
T ss_dssp             CEECC--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT--
T ss_pred             ceecccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH--
Confidence            9865433221               145689999999999664 5899999999999999999999998653321000  


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                              .............+..+++++.++|.+||+.||++|||+.++++  +++.++.
T Consensus       232 ------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~  282 (310)
T 3s95_A          232 ------------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM  282 (310)
T ss_dssp             ------------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred             ------------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence                                    00000000111123468899999999999999999999999985  7776643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.5e-47  Score=335.73  Aligned_cols=252  Identities=18%  Similarity=0.221  Sum_probs=205.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHc-CCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+|+.+++.+ +|+|++++++++     .....
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   80 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGLH   80 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETTE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCce
Confidence            45688999999999999999999999999999999988643  34567899999999 799999998887     33445


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCc-----EEEeee
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-----VKICDF  158 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~-----vkl~Df  158 (353)
                      .++||||++++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.     +||+||
T Consensus        81 ~~lv~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Df  155 (298)
T 1csn_A           81 NVLVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGR-PNSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECC-SSSTTTTCEEECCC
T ss_pred             eEEEEEecCCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecc-CCCCCCCeEEEEEC
Confidence            889999998888888764   34569999999999999999999999 79999999999999985 443     999999


Q ss_pred             ccccccccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC---hHHHHHHHH
Q 018619          159 GSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN---AVDQLVEII  227 (353)
Q Consensus       159 g~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~~~  227 (353)
                      |++........        .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+   .......+.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            99986654322        2345689999999998664 48999999999999999999999998743   334444433


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .....+....                        +...+++++.+||.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          235 EKKQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hhccCccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            3222222111                        12357999999999999999999999999863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-47  Score=334.34  Aligned_cols=249  Identities=18%  Similarity=0.312  Sum_probs=206.1

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +.+..++|++.+.||+|+||.||++.+. +++.||+|++....   ....+|+.+++.++||||+++++++.     ...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~   78 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA   78 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSS
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCC
Confidence            5678899999999999999999999986 57789999997543   34568999999999999999999883     334


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..++||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~  153 (269)
T 4hcu_A           79 PICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMT  153 (269)
T ss_dssp             SEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECG-GGCEEECCTTGG
T ss_pred             ceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcC-CCCEEecccccc
Confidence            48899999985 67766653   34569999999999999999999999 79999999999999986 788999999999


Q ss_pred             cccccCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      .......  ......+|+.|+|||.+.+. .++.++||||+||++|+|++ |..||...+..+....+.....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------  225 (269)
T 4hcu_A          154 RFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------  225 (269)
T ss_dssp             GGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------
T ss_pred             ccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-------
Confidence            8654322  12234567889999999654 48999999999999999999 9999998887776655543211       


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                           ...+...++++.+++.+||+.||.+|||+.++++|
T Consensus       226 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          226 ---------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                                 01123478999999999999999999999999865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=343.46  Aligned_cols=249  Identities=23%  Similarity=0.310  Sum_probs=202.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      .-+..++|++.+.||+|+||.||+|.+..+++   .||||++...     ...+.+|+.+++.++||||+++++++    
T Consensus        44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----  119 (325)
T 3kul_A           44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV----  119 (325)
T ss_dssp             CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence            34667899999999999999999999986655   4999998653     23355799999999999999999988    


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       ......|+||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus       120 -~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~  193 (325)
T 3kul_A          120 -TRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDS-NLVCKVS  193 (325)
T ss_dssp             -CGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEEC
T ss_pred             -EeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECC-CCCEEEC
Confidence             344458899999975 77777653   34679999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 018619          157 DFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       157 Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      |||++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus       194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  272 (325)
T 3kul_A          194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR  272 (325)
T ss_dssp             CCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             CCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC
Confidence            99999876543321    223457789999999765 48999999999999999999 9999998888777665544211


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .+                            .+..+++++.+||.+||+.||.+|||+.++++
T Consensus       273 ~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          273 LP----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11                            22357999999999999999999999999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=361.06  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=196.4

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHc-CCCceeecceeeeecCCCCceeE
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+...+|.+.+.||+|+||+|+. ....+|+.||||++... .....+|+.+++.+ +||||+++++++     .....+
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~~   93 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTE-----KDRQFQ   93 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEE-----EETTEE
T ss_pred             EEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCEE
Confidence            35567899999999999999763 45678999999998654 34567999999999 799999999887     344458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC----CCcEEEeeecc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL----THQVKICDFGS  160 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~----~~~vkl~Dfg~  160 (353)
                      |+|||||+++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++..    ...+||+|||+
T Consensus        94 ~lv~E~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           94 YIAIELCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEEECCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEEECCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99999999998888764   23445556678899999999999999 799999999999999531    23688999999


Q ss_pred             ccccccCC----CcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          161 AKQLIAGE----ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       161 a~~~~~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+......    ......||+.|+|||++.+  ...++.++||||+||++|+|++ |..||.......... +   .+..
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~  245 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGAC  245 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCC
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccC
Confidence            98765432    2234678999999999864  2446789999999999999999 999996654432211 1   1111


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ..               ....       .....+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus       246 ~~---------------~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          246 SL---------------DCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             CC---------------TTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             Cc---------------cccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            00               0000       0112456789999999999999999999999999997643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-48  Score=351.06  Aligned_cols=257  Identities=18%  Similarity=0.220  Sum_probs=206.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEE-----ECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +..++|++.+.||+|+||.||+|.     +..+++.||||++...     .....+|+.+++.++||||+++++++.   
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~---  144 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL---  144 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe---
Confidence            446789999999999999999999     4567889999998543     223457999999999999999999883   


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CC
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--TH  151 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~  151 (353)
                        .....++|||||. ++|.+.+.....   ....+++..++.++.|++.||+|||+ +||+||||||+|||++..  +.
T Consensus       145 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          145 --QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred             --cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCc
Confidence              3334789999997 588888775432   23569999999999999999999999 799999999999999841  33


Q ss_pred             cEEEeeeccccccccC---CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018619          152 QVKICDFGSAKQLIAG---EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  227 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  227 (353)
                      .+||+|||+|+.....   .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            6999999999754322   222345678999999999765 48999999999999999998 999999988777665554


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      .....                            ..+..+++++.+||.+||+.||.+|||+.++++|.++-.
T Consensus       301 ~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            32110                            012457899999999999999999999999999988754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.4e-47  Score=346.90  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=203.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      +..++|.+.+.||+|+||.||+|++.       .++..||+|++....     ....+|+.+++.+ +||||+++++++.
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            45689999999999999999999975       345679999986542     2345899999999 8999999999883


Q ss_pred             ecCCCCceeEEEEeccccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCC
Q 018619           75 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP  141 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp  141 (353)
                           ....+|+||||+.+ +|.+.+.....            ....+++..++.++.||+.||+|||+ +||+||||||
T Consensus       158 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp  231 (370)
T 2psq_A          158 -----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAA  231 (370)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCG
T ss_pred             -----cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccch
Confidence                 33448899999985 88887765321            23468999999999999999999999 7999999999


Q ss_pred             CcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 018619          142 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE  217 (353)
Q Consensus       142 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~  217 (353)
                      +|||++. ++.+||+|||+++.......   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus       232 ~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~  309 (370)
T 2psq_A          232 RNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGI  309 (370)
T ss_dssp             GGEEECT-TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hhEEECC-CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999996 78999999999986544322   2234567899999999765 48999999999999999999 99999887


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +..+....+....                            ....+..+++++.+||.+||+.||.+|||+.|++++
T Consensus       310 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          310 PVEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             CGGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7665554333210                            001224578999999999999999999999999853

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3e-47  Score=346.85  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=205.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEE-----ECCCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      +.+..++|++.+.||+|+||.||+|+     +..+++.||||++....     ....+|+.++..+ +||||+++++++.
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            44678999999999999999999998     55677999999996532     2356899999999 7899999999874


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhc------------------------------------------------
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------------------------------------------------  105 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~------------------------------------------------  105 (353)
                      ..    ...+++|||||. |+|.+.+......                                                
T Consensus        97 ~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           97 KP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             ST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             cC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            32    233789999998 4888777653221                                                


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCC--
Q 018619          106 --------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA--  169 (353)
Q Consensus       106 --------------~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~--  169 (353)
                                    ...+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++........  
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~  250 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYV  250 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCE
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccch
Confidence                          1228999999999999999999999 79999999999999996 78899999999986544332  


Q ss_pred             -cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          170 -NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       170 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                       .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.....+.....+.             
T Consensus       251 ~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  316 (359)
T 3vhe_A          251 RKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------------  316 (359)
T ss_dssp             EC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-------------
T ss_pred             hccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-------------
Confidence             2345678899999999764 48999999999999999998 9999988776555544444211111             


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                    .+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       317 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          317 --------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                          223578999999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6.7e-47  Score=333.26  Aligned_cols=252  Identities=24%  Similarity=0.368  Sum_probs=210.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecC-----------C
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTT-----------S   78 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----------~   78 (353)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+........+|+.+++.++||||+++++++....           .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            57899999999999999999999999999999999887778889999999999999999998874311           1


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      .....+++||||+++ +|.+.+...  ....+++..++.++.|++.||.|||+ +||+|+||||+||+++. ++.+||+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~D  165 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVD-TKQVKIGD  165 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECC
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcC-CCCEEECc
Confidence            224568899999995 888877643  24679999999999999999999999 79999999999999996 78999999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      ||++.............+|+.|+|||++.+. .++.++|||||||++|+|++|..||....  .....+..         
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~---------  233 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD---------  233 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred             chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence            9999877665555566789999999999764 48999999999999999999998874211  11111100         


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                            ..++..++.++.+||.+||+.||.+|||+.++++|.+.-.
T Consensus       234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                                  0012347899999999999999999999999999988654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=343.20  Aligned_cols=249  Identities=26%  Similarity=0.384  Sum_probs=198.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHc----CCCceeecceee
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVM----DHPNVISLKHCF   73 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~~iv~~~~~~   73 (353)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....          ....+|+.+++.+    +||||+++++++
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~  107 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF  107 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence            34678999999999999999999999999999999985432          2334799999998    899999999988


Q ss_pred             eecCCCCceeEEEEecc-cc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC
Q 018619           74 FSTTSKNELFLNLVMEY-VP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH  151 (353)
Q Consensus        74 ~~~~~~~~~~~~lv~e~-~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~  151 (353)
                      .     .....++|||+ +. ++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++..++
T Consensus       108 ~-----~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          108 E-----TQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             ----------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTT
T ss_pred             e-----cCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCC
Confidence            3     33447899998 54 677777654    3579999999999999999999999 79999999999999995478


Q ss_pred             cEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 018619          152 QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      .+||+|||++...... ......+|+.|+|||++.+....+.++||||+||++|+|++|+.||.....      +...  
T Consensus       178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~--  248 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA--  248 (312)
T ss_dssp             EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT--
T ss_pred             eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh--
Confidence            9999999999866543 334567899999999987655446689999999999999999999965321      1110  


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                     .            ..++..++.++.+||.+||+.||++|||++++++||||+....
T Consensus       249 ---------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          249 ---------------E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             ---------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             ---------------c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence                           0            0123457999999999999999999999999999999987544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.5e-47  Score=355.68  Aligned_cols=260  Identities=30%  Similarity=0.412  Sum_probs=193.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHc-CCCceeecceeeeecCCCCceeEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..+.|.+.+.||+|+||+||.+ ...+|+.||||++..+. ....+|+.+++.+ +||||+++++++     .....+|+
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~l   86 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYI   86 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEE
Confidence            4567888999999999999875 45789999999986543 3446899999876 899999999887     44456899


Q ss_pred             EeccccchHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC------------CC
Q 018619           87 VMEYVPESMYRVLKHYSSANQR---MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL------------TH  151 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~---l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~------------~~  151 (353)
                      |||||+|+|.+.+.........   .++..++.++.||+.||+|||+ +||+||||||+|||++..            +.
T Consensus        87 v~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           87 ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             EECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             EEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCce
Confidence            9999999998888653222111   1334567899999999999999 799999999999999742            34


Q ss_pred             cEEEeeeccccccccCCC-----cceeeeeceeeChhhhhC------CCCCCccccchhHHHHHHHHHh-CCCCCCCCCh
Q 018619          152 QVKICDFGSAKQLIAGEA-----NISYICSRFYRAPELIFG------ATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA  219 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~  219 (353)
                      .+||+|||+|........     .....||+.|+|||++.+      ...++.++||||+||++|+|++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            899999999987654432     124578999999999965      2458999999999999999999 9999976654


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      ..  ..+.....                 ..+...     ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       246 ~~--~~i~~~~~-----------------~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          246 RE--SNIIRGIF-----------------SLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HH--HHHHHTCC-----------------CCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hH--HHHhcCCC-----------------Cccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            33  22222100                 011000     0001235688999999999999999999999999999964

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.1e-47  Score=341.83  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=191.2

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      .+..++|++.+.||+|+||.||+|.+..+++   .||+|++...      .....+|+.+++.++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            4567899999999999999999999887765   8999988643      234568999999999999999999886543


Q ss_pred             CCCc-eeEEEEeccccc-hHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           78 SKNE-LFLNLVMEYVPE-SMYRVLKHYSS--ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        78 ~~~~-~~~~lv~e~~~~-~l~~~l~~~~~--~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                      ..+. ...++||||+.+ +|.+.+.....  ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~-~~~~  176 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAE-DMTV  176 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcC-CCCE
Confidence            3221 234899999985 77777754332  22369999999999999999999999 79999999999999996 7899


Q ss_pred             EEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 018619          154 KICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKV  229 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~  229 (353)
                      ||+|||++.........   ....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            99999999865443322   234557889999999765 48999999999999999999 99999988877666554431


Q ss_pred             hCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-------HHHHhcCcccccc
Q 018619          230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-------ALEACAHPFFDEL  300 (353)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-------~~~~l~hp~f~~~  300 (353)
                      ...                            ..+..+++++.+||.+||+.||.+|||       ++++++|||+...
T Consensus       256 ~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          256 NRL----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCC----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            100                            112357899999999999999999999       7888999999874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.3e-47  Score=329.78  Aligned_cols=248  Identities=19%  Similarity=0.286  Sum_probs=203.9

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      -+..++|++.+.||+|+||.||++.+. ++..||+|++....   ....+|+.+++.++||||+++++++     .....
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   77 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYP   77 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCc
Confidence            356789999999999999999999875 67789999986543   3456899999999999999999988     34444


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus        78 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~  152 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDR-DLCVKVSDFGMTR  152 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECT-TCCEEECCTTCEE
T ss_pred             eEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECC-CCCEEEccCccce
Confidence            889999997 567777754   23469999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ........  ....+|+.|+|||++.+.. ++.++||||+||++|+|++ |..||...+..+....+......       
T Consensus       153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------  224 (268)
T 3sxs_A          153 YVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------  224 (268)
T ss_dssp             ECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------
T ss_pred             ecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-------
Confidence            65444322  2334567899999996644 8999999999999999999 99999988877666554431100       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                           ..+...++++.++|.+||+.||.+|||+.++++|
T Consensus       225 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          225 ---------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                 0123468899999999999999999999999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-47  Score=342.28  Aligned_cols=272  Identities=24%  Similarity=0.277  Sum_probs=200.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..+..++|++.+.||+|+||.||+|++.  ++.||||++.....   ...+|+.+++.++||||+++++++..... ...
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~   95 (322)
T 3soc_A           19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDV   95 (322)
T ss_dssp             EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSE
T ss_pred             cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCc
Confidence            4577889999999999999999999874  89999999865432   23468888999999999999999865442 234


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC----------CeeeccCCCCcEEEeCCCC
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP----------RVCHRDLKPQNLLVDPLTH  151 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~----------~i~H~Dlkp~Nill~~~~~  151 (353)
                      .+++|||||.+ +|.+.+..     ..+++..++.++.|++.||+|||+ .          ||+||||||+|||++. ++
T Consensus        96 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~  168 (322)
T 3soc_A           96 DLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKN-NL  168 (322)
T ss_dssp             EEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECT-TC
T ss_pred             eEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECC-CC
Confidence            57899999985 88777754     459999999999999999999999 8          9999999999999996 78


Q ss_pred             cEEEeeeccccccccCCC---cceeeeeceeeChhhhhCC----CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018619          152 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGA----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV  224 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  224 (353)
                      .+||+|||+++.......   .....||+.|+|||++.+.    ..++.++||||+||++|+|++|..||.+........
T Consensus       169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  248 (322)
T 3soc_A          169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP  248 (322)
T ss_dssp             CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred             eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence            999999999986554332   2335789999999999763    235568899999999999999999997654322211


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ........+....+........  ..+.. ...|.   ....++++.+||.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          249 FEEEIGQHPSLEDMQEVVVHKK--KRPVL-RDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSC--CCCCC-CGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhccCCchhhhhhhhhccc--CCCCc-ccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1111222222222211100000  00000 00010   0123456999999999999999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.8e-47  Score=348.29  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=203.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      |.+..++|.+.+.||+|+||.||+|.+..+++.||||.+....     ..+.+|+.+++.++||||+++++++.     .
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~  183 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----Q  183 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----c
Confidence            4567789999999999999999999999999999999886432     34558999999999999999999883     3


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+||||++ ++|.+.+..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~-~~~~kl~DfG  258 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTE-KNVLKISDFG  258 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECCGG
T ss_pred             CCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcC-CCcEEECcCC
Confidence            334889999997 577777754   34568999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          160 SAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       160 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +++........   ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....    
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~----  333 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR----  333 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC----
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence            99864332211   123457789999999654 48999999999999999998 9999998877655443332100    


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                              ...+..+++++.+||.+||+.||++|||+.++++
T Consensus       334 ------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          334 ------------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence                                    0122457899999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=343.55  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=205.5

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCC-------CcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCF   73 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~   73 (353)
                      .+..++|.+.+.||+|+||.||+|++..+       +..||+|++....     ....+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            45678999999999999999999997543       3579999986542     3345899999999 999999999988


Q ss_pred             eecCCCCceeEEEEeccccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCC
Q 018619           74 FSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLK  140 (353)
Q Consensus        74 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlk  140 (353)
                      .     ....+++||||+.+ +|.+.+.....            ....+++..++.++.||+.||+|||+ +||+|||||
T Consensus       145 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlk  218 (382)
T 3tt0_A          145 T-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLA  218 (382)
T ss_dssp             C-----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCC
T ss_pred             c-----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCC
Confidence            3     33348899999985 88888765331            12469999999999999999999999 799999999


Q ss_pred             CCcEEEeCCCCcEEEeeeccccccccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCC
Q 018619          141 PQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPG  216 (353)
Q Consensus       141 p~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~  216 (353)
                      |+|||++. ++.+||+|||+|.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+
T Consensus       219 p~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          219 ARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             GGGEEECT-TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cceEEEcC-CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999996 7889999999998664432   22334568899999999764 48999999999999999999 9999998


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          217 ENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+..+....+.....                            ...+..+++++.+||.+||+.||++|||+.+++++
T Consensus       297 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          297 VPVEELFKLLKEGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CCHHHHHHHHHTTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHcCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            887665544433110                            01224579999999999999999999999999875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.4e-46  Score=341.57  Aligned_cols=260  Identities=15%  Similarity=0.143  Sum_probs=197.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCC-----CcEEEEEEeeccccchHHHHH---------------HHHHcCCCceee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLET-----GETVAIKKVLQDRRYKNRELQ---------------LMRVMDHPNVIS   68 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~E~~---------------~l~~l~h~~iv~   68 (353)
                      ..++|++.+.||+|+||.||+|.+..+     ++.||||++........+|+.               .++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            356999999999999999999998764     588999998766544444443               445567999999


Q ss_pred             cceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe-
Q 018619           69 LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD-  147 (353)
Q Consensus        69 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~-  147 (353)
                      +++++.... .+..+.|+|||||+++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++ 
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEES
T ss_pred             EEeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEec
Confidence            999886533 33466889999998888887764   34679999999999999999999999 7999999999999998 


Q ss_pred             -CCCCcEEEeeeccccccccCCCc--------ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC
Q 018619          148 -PLTHQVKICDFGSAKQLIAGEAN--------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN  218 (353)
Q Consensus       148 -~~~~~vkl~Dfg~a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  218 (353)
                       . ++.+||+|||+|+........        ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus       188 ~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          188 KN-PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             SC-TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CC-CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence             4 678999999999765433221        234589999999999665 48999999999999999999999998643


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          219 AVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..............+....+..               .+|   ....+++++.+++.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~---------------~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          266 KDPKYVRDSKIRYRENIASLMD---------------KCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             TCHHHHHHHHHHHHHCHHHHHH---------------HHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cCHHHHHHHHHHhhhhHHHHHH---------------Hhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            3322222222111111111100               000   01357999999999999999999999998864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=339.67  Aligned_cols=256  Identities=25%  Similarity=0.367  Sum_probs=189.2

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcC-CCceeecceeeeecCC---
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMD-HPNVISLKHCFFSTTS---   78 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~---   78 (353)
                      .+...+|++.+.||+|+||.||+|++..+++.||+|++....    ....+|+.+++.+. ||||+++++++.....   
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            355779999999999999999999999999999999885432    33457999999996 9999999998854322   


Q ss_pred             CCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEe
Q 018619           79 KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                      .....++++|||+.|+|.+.+... ...+.+++..++.++.||+.||+|||+ +|  |+||||||+|||++. ++.+||+
T Consensus       104 ~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~-~~~~kl~  180 (337)
T 3ll6_A          104 TGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSN-QGTIKLC  180 (337)
T ss_dssp             TSSEEEEEEEECCSEEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECT-TSCEEBC
T ss_pred             cCCceEEEEEEecCCCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECC-CCCEEEe
Confidence            445568899999999998887653 345679999999999999999999999 79  999999999999996 7889999


Q ss_pred             eeccccccccCCCc-------------ceeeeeceeeChhhhh--CCCCCCccccchhHHHHHHHHHhCCCCCCCCChHH
Q 018619          157 DFGSAKQLIAGEAN-------------ISYICSRFYRAPELIF--GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD  221 (353)
Q Consensus       157 Dfg~a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~  221 (353)
                      |||++.........             ....+|+.|+|||++.  ....++.++|||||||++|+|++|..||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999866543221             1345899999999983  23457889999999999999999999997654332


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                      .....                     .          ........+..+.+||++||+.||.+|||+.++++|-+
T Consensus       261 ~~~~~---------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          261 IVNGK---------------------Y----------SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------------------------C----------CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hhcCc---------------------c----------cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            21100                     0          00011346788999999999999999999999998744

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.7e-47  Score=339.26  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             ceeeeeeecceeeEeeeeecCCCeEEEEEEECCCCcE----EEEEEeecc-----ccchHHHHHHHHHcCCCceeeccee
Q 018619            2 YLVCCILQTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHC   72 (353)
Q Consensus         2 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~   72 (353)
                      -.+...+..++|++.+.||+|+||.||+|.+..+++.    ||+|.+...     .....+|+.+++.++||||++++++
T Consensus         4 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (325)
T 3kex_A            4 KVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL   83 (325)
T ss_dssp             CCCCCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred             HHHHhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            3455678889999999999999999999999888876    677766432     2344589999999999999999997


Q ss_pred             eeecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC
Q 018619           73 FFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH  151 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~  151 (353)
                      +.     + ...++||||+. ++|.+.+..   ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++
T Consensus        84 ~~-----~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~  152 (325)
T 3kex_A           84 CP-----G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKS-PS  152 (325)
T ss_dssp             EC-----B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESS-SS
T ss_pred             Ec-----C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECC-CC
Confidence            72     1 22779999998 577766653   23578999999999999999999999 79999999999999986 78


Q ss_pred             cEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018619          152 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  227 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  227 (353)
                      .+||+|||+++.......   .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+....+.
T Consensus       153 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~  231 (325)
T 3kex_A          153 QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE  231 (325)
T ss_dssp             CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH
T ss_pred             eEEECCCCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH
Confidence            899999999987654432   2344567889999999765 48999999999999999999 999998877665544433


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ....                            ...+..++.++.++|.+||+.||.+|||+.++++|
T Consensus       232 ~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          232 KGER----------------------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTCB----------------------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cCCC----------------------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2100                            01123467889999999999999999999999876

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-46  Score=330.48  Aligned_cols=253  Identities=23%  Similarity=0.245  Sum_probs=201.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++...  .....+|+.+++.++|++++..+..+..    .....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~   81 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV   81 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence            3578999999999999999999999999999999988643  3456789999999999887776655533    223578


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe--CCCCcEEEeeeccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQ  163 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~--~~~~~vkl~Dfg~a~~  163 (353)
                      +||||++++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++  ..++.+||+|||++..
T Consensus        82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            9999998888887764   34679999999999999999999999 7999999999999994  2377899999999987


Q ss_pred             cccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 018619          164 LIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT  232 (353)
Q Consensus       164 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~  232 (353)
                      ......        .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.   ......+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            654432        2345789999999999764 489999999999999999999999986432   2223332221111


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .+...                        +...+++++.+||.+||+.||.+|||++++++
T Consensus       237 ~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          237 TPIEV------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             SCHHH------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CchHH------------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            11111                        12357899999999999999999999999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-46  Score=336.13  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=203.8

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeec
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFST   76 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (353)
                      .+..++|.+.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++.++||||+++++++.  
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--   96 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--   96 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe--
Confidence            456789999999999999999999973     456899999986532     33457999999999999999999883  


Q ss_pred             CCCCceeEEEEecccc-chHHHHHHhhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCee
Q 018619           77 TSKNELFLNLVMEYVP-ESMYRVLKHYSS--------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVC  135 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~  135 (353)
                         ....+++||||+. ++|.+.+.....                    ....+++..++.++.||+.||+|||+ +||+
T Consensus        97 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iv  172 (314)
T 2ivs_A           97 ---QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLV  172 (314)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             ---cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCc
Confidence               3334889999998 688887765332                    12458999999999999999999999 7999


Q ss_pred             eccCCCCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CC
Q 018619          136 HRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQ  211 (353)
Q Consensus       136 H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~  211 (353)
                      ||||||+||+++. ++.+||+|||++.........   ....+|+.|+|||.+.+. .++.++||||+||++|+|++ |.
T Consensus       173 H~dikp~NIli~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          173 HRDLAARNILVAE-GRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             CCCCSGGGEEEET-TTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccccchheEEEcC-CCCEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999996 789999999999866443321   234567889999999764 48999999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          212 PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       212 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                      .||.+.+.......+....                            ....+..+++++.++|.+||+.||.+|||+.++
T Consensus       251 ~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l  302 (314)
T 2ivs_A          251 NPYPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI  302 (314)
T ss_dssp             CSSTTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9998877655544332210                            001224589999999999999999999999999


Q ss_pred             hcC
Q 018619          292 CAH  294 (353)
Q Consensus       292 l~h  294 (353)
                      +++
T Consensus       303 ~~~  305 (314)
T 2ivs_A          303 SKD  305 (314)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5e-46  Score=329.65  Aligned_cols=252  Identities=24%  Similarity=0.258  Sum_probs=198.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+|+.+++.++|++++..+..+...    ....+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~   81 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNV   81 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceE
Confidence            3468999999999999999999999999999999986543  34567899999999998887776665432    23478


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE---eCCCCcEEEeeecccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV---DPLTHQVKICDFGSAK  162 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill---~~~~~~vkl~Dfg~a~  162 (353)
                      +||||++++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||+   +. ++.+||+|||++.
T Consensus        82 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~-~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           82 MVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGG-TTCEEECCCTTCE
T ss_pred             EEEEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCC-CCeEEEecCccce
Confidence            9999998888887764   34679999999999999999999999 799999999999999   54 7889999999998


Q ss_pred             ccccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhC
Q 018619          163 QLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVLG  231 (353)
Q Consensus       163 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~  231 (353)
                      .......        .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..   .....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            7654332        2345789999999999765 4899999999999999999999999764432   22222222111


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..+..                        .+...+++++.+||.+||+.||.+|||++++++
T Consensus       236 ~~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          236 STPIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HSCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cchhh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            11111                        112357899999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=9e-48  Score=354.76  Aligned_cols=272  Identities=22%  Similarity=0.335  Sum_probs=205.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      .....++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++....   
T Consensus         4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---   80 (396)
T 4eut_A            4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---   80 (396)
T ss_dssp             EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---
T ss_pred             CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---
Confidence            3456789999999999999999999999999999999986432     33458999999999999999999875432   


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE----eCCCCcEEE
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV----DPLTHQVKI  155 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill----~~~~~~vkl  155 (353)
                      ....++|||||. ++|.+.+... .....+++..++.++.|++.||+|||+ +||+||||||+|||+    +. ++.+||
T Consensus        81 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~-~~~~kL  157 (396)
T 4eut_A           81 TRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDG-QSVYKL  157 (396)
T ss_dssp             TCCEEEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTS-CEEEEE
T ss_pred             CCeeEEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCC-ceeEEE
Confidence            234789999997 5777666542 223449999999999999999999999 799999999999998    53 667999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhCC-------CCCCccccchhHHHHHHHHHhCCCCCCCC----ChHHHHH
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGA-------TEYTTSIDIWSAGCVLAELLLGQPLFPGE----NAVDQLV  224 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~~l~~g~~pf~~~----~~~~~~~  224 (353)
                      +|||+++............||+.|+|||++.+.       ..++.++||||+||++|+|++|..||...    ...+.+.
T Consensus       158 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  237 (396)
T 4eut_A          158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (396)
T ss_dssp             CCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred             ecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence            999999877665555567789999999998541       34678999999999999999999999643    2334444


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccc------cCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKV------FHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .+..  +.|. ..+....       ........|...      +...+++.+.++|++||+.||++|+|++++++
T Consensus       238 ~~~~--~~p~-~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          238 KIIT--GKPS-GAISGVQ-------KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHH--SCCT-TCCEEEE-------CSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             HHhc--CCCc-ccchhhe-------eccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            4433  2221 1110000       000001112222      22335568899999999999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=338.66  Aligned_cols=255  Identities=22%  Similarity=0.323  Sum_probs=204.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeecc-----ccchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      +.+..++|.+.+.||+|+||.||+|.+.     .+++.||+|.+...     .....+|+.+++.+ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4566789999999999999999999973     45678999998643     23456899999999 8999999999884


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCe
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSA-------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRV  134 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~-------------------~~~l~~~~~~~i~~qll~al~~LH~~~~i  134 (353)
                      .     ...+++||||++ ++|.+.+......                   ...+++..++.++.||+.||+|||+ +||
T Consensus       120 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i  193 (344)
T 1rjb_A          120 L-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSC  193 (344)
T ss_dssp             S-----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             e-----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCc
Confidence            3     334889999997 5888877653211                   1348999999999999999999999 799


Q ss_pred             eeccCCCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-C
Q 018619          135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-G  210 (353)
Q Consensus       135 ~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g  210 (353)
                      +||||||+||+++. ++.+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |
T Consensus       194 vH~Dikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          194 VHRDLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             EETTCSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTS
T ss_pred             ccCCCChhhEEEcC-CCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCC
Confidence            99999999999996 88999999999986654432   2235668899999998664 48999999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHH
Q 018619          211 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE  290 (353)
Q Consensus       211 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~  290 (353)
                      ..||.+.+........+.....                           ...+..+++++.+||.+||+.||.+|||+.+
T Consensus       272 ~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  324 (344)
T 1rjb_A          272 VNPYPGIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN  324 (344)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCcccCCcHHHHHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            9999887765555444432100                           0122357899999999999999999999999


Q ss_pred             HhcCc
Q 018619          291 ACAHP  295 (353)
Q Consensus       291 ~l~hp  295 (353)
                      +++|-
T Consensus       325 l~~~l  329 (344)
T 1rjb_A          325 LTSFL  329 (344)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.6e-46  Score=333.28  Aligned_cols=254  Identities=24%  Similarity=0.345  Sum_probs=205.8

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      +.+..++|++.+.||+|+||.||+|.+     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            446678999999999999999999985     4577899999986442     3456899999999 9999999999883


Q ss_pred             ecCCCCceeEEEEeccccc-hHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           75 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS--------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      .     ....++||||+.+ +|.+.+.....              ....+++..++.++.|++.||+|||+ +||+||||
T Consensus        98 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl  171 (313)
T 1t46_A           98 I-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDL  171 (313)
T ss_dssp             S-----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCC
T ss_pred             c-----CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCC
Confidence            3     3347899999974 88887765321              12358999999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+||+++. ++.+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.
T Consensus       172 kp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          172 AARNILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             SGGGEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccceEEEcC-CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999996 88999999999987654433   2234568889999998764 48999999999999999998 999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +................+                           ..+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          250 GMPVDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             TCCSSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            877655555444421110                           1123578999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-46  Score=331.93  Aligned_cols=249  Identities=18%  Similarity=0.260  Sum_probs=202.6

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +.+..++|++.+.||+|+||.||++.+. ++..||+|++....   ....+|+.+++.++||||+++++++     ....
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   92 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR   92 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCC
Confidence            4567889999999999999999999875 67789999997543   3456899999999999999999988     3344


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~~  167 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLS  167 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TSCEEECSTTGG
T ss_pred             CeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcC-CCCEEEcccccc
Confidence            4889999997 577777654   24569999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ........  .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||...+..+....+......      
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------  240 (283)
T 3gen_A          168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------  240 (283)
T ss_dssp             GGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC------
T ss_pred             ccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC------
Confidence            86543221  2233457889999999765 48999999999999999998 99999998877766655442111      


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                            ..+...++.+.++|.+||+.||.+|||+.++++|
T Consensus       241 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          241 ----------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ----------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence                                  0123468999999999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=340.64  Aligned_cols=250  Identities=26%  Similarity=0.320  Sum_probs=203.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +..++|++.+.||+|+||.||+|++.     .+++.||+|.+....     ....+|+.+++.++||||+++++++.   
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---  120 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA---  120 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc---
Confidence            45789999999999999999999987     355899999986542     33568999999999999999999883   


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeee
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSA--------------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCH  136 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------------------~~~l~~~~~~~i~~qll~al~~LH~~~~i~H  136 (353)
                        ....+|+||||+.+ +|.+.+......                    ...+++..++.++.||+.||+|||+ +||+|
T Consensus       121 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH  197 (343)
T 1luf_A          121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVH  197 (343)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCC
T ss_pred             --cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeec
Confidence              33448899999985 888887653211                    2679999999999999999999999 79999


Q ss_pred             ccCCCCcEEEeCCCCcEEEeeeccccccccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCC
Q 018619          137 RDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQP  212 (353)
Q Consensus       137 ~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~  212 (353)
                      |||||+||+++. ++.+||+|||++.......   ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..
T Consensus       198 ~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          198 RDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             SCCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCCcceEEECC-CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccHHHHHHHHHHHhcCCC
Confidence            999999999996 7889999999998654332   12345678899999998765 48999999999999999999 999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          213 LFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       213 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      ||.+.+..+....+.....                            ..++..+++++.+||.+||+.||.+|||+.+++
T Consensus       276 p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~  327 (343)
T 1luf_A          276 PYYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIH  327 (343)
T ss_dssp             TTTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cCCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            9998887766554433100                            012245789999999999999999999999997


Q ss_pred             c
Q 018619          293 A  293 (353)
Q Consensus       293 ~  293 (353)
                      +
T Consensus       328 ~  328 (343)
T 1luf_A          328 R  328 (343)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.6e-46  Score=327.44  Aligned_cols=245  Identities=28%  Similarity=0.432  Sum_probs=191.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||.||+|.+  +++.||+|++....        ....+|+.+++.++||||+++++++.     
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   76 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----   76 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             cchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----
Confidence            3568999999999999999999997  48899999885431        33457999999999999999999883     


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC---eeeccCCCCcEEEeC-------
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR---VCHRDLKPQNLLVDP-------  148 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~---i~H~Dlkp~Nill~~-------  148 (353)
                      .....++||||+++ +|.+.+.     ...+++..++.++.|++.||+|||+ +|   |+||||||+||+++.       
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~  150 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDL  150 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCC
T ss_pred             cCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccc
Confidence            34458899999974 5555542     4679999999999999999999999 78   999999999999985       


Q ss_pred             CCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 018619          149 LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  228 (353)
                      .++.+||+|||++....... .....||+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+..
T Consensus       151 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  228 (271)
T 3dtc_A          151 SNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM  228 (271)
T ss_dssp             SSCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT
T ss_pred             cCcceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc
Confidence            25679999999998654433 2345789999999999765 489999999999999999999999998877665544332


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ...                           ...++..+++++.++|.+||+.||.+|||+.|+++|
T Consensus       229 ~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          229 NKL---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             SCC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCC---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            100                           111234678999999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.2e-46  Score=329.73  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=208.1

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .+.+..++|++.+.||+|+||.||+|.+..+++.||+|.+..+.   ....+|+.+++.++||||+++++++     ...
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~   81 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TRE   81 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSS
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccC
Confidence            35578899999999999999999999999999999999997554   3455899999999999999999988     334


Q ss_pred             eeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+++||||+. ++|.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~~l~Dfg~  157 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGL  157 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECG-GGCEEECCCCG
T ss_pred             CCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcC-CCCEEEccCcc
Confidence            44889999998 6887777542  34569999999999999999999999 79999999999999986 78899999999


Q ss_pred             ccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 018619          161 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREE  237 (353)
Q Consensus       161 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  237 (353)
                      +........  .....+|+.|+|||.+.+. .++.++||||+||++|+|++ |..||...+.......+....       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~-------  229 (288)
T 3kfa_A          158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------  229 (288)
T ss_dssp             GGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------
T ss_pred             ceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC-------
Confidence            986654432  2234568889999999765 48999999999999999999 999998877665544333210       


Q ss_pred             HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          238 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                           ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       230 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          230 ---------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence                                 01122457899999999999999999999999964

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4e-46  Score=329.03  Aligned_cols=246  Identities=23%  Similarity=0.363  Sum_probs=198.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHHcCCCceeecceeeee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDHPNVISLKHCFFS   75 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (353)
                      .+..++|++.+.||+|+||.||+|.+..+++.||+|++....           ....+|+.+++.++||||+++++++  
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--   92 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--   92 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee--
Confidence            356789999999999999999999999999999999885321           3456899999999999999999987  


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCc
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQ  152 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~  152 (353)
                         ....  ++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +|  |+||||||+||+++. ++.
T Consensus        93 ---~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~-~~~  162 (287)
T 4f0f_A           93 ---HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQS-LDE  162 (287)
T ss_dssp             ---TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESC-CCT
T ss_pred             ---cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEec-cCC
Confidence               2222  58999998 677666653   45679999999999999999999999 79  999999999999985 444


Q ss_pred             -----EEEeeeccccccccCCCcceeeeeceeeChhhhhC-CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHH--HH
Q 018619          153 -----VKICDFGSAKQLIAGEANISYICSRFYRAPELIFG-ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ--LV  224 (353)
Q Consensus       153 -----vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~--~~  224 (353)
                           +||+|||++.....  ......+|+.|+|||++.+ ...++.++||||+||++|+|++|..||...+....  ..
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  240 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN  240 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH
T ss_pred             CCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH
Confidence                 99999999974433  3345678999999999843 23468899999999999999999999987654333  22


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .+... +                          +...++..+++++.+||.+||+.||.+|||++++++
T Consensus       241 ~~~~~-~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          241 MIREE-G--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHS-C--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhcc-C--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            22210 0                          111133468999999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=337.89  Aligned_cols=258  Identities=14%  Similarity=0.148  Sum_probs=193.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC---CCcEEEEEEeeccccc---------------hHHHHHHHHHcCCCceeec
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDRRY---------------KNRELQLMRVMDHPNVISL   69 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~~iv~~   69 (353)
                      +..++|++.+.||+|+||.||+|.+..   ++..||+|+.......               ..+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            346799999999999999999999987   7889999998754322               2356777788899999999


Q ss_pred             ceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC
Q 018619           70 KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL  149 (353)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~  149 (353)
                      ++++.... .+....|+||||++++|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. 
T Consensus       114 ~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-  186 (345)
T 2v62_A          114 YGSGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGY-  186 (345)
T ss_dssp             EEEEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEES-
T ss_pred             eccccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEcc-
Confidence            99886533 33556899999997787776643    3489999999999999999999999 79999999999999986 


Q ss_pred             CC--cEEEeeeccccccccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC--
Q 018619          150 TH--QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE--  217 (353)
Q Consensus       150 ~~--~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~--  217 (353)
                      ++  .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.  
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            45  899999999986543221        1345789999999999765 4899999999999999999999999652  


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +...............+.. +....+                   ...+++++.++|.+||+.||++|||++++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~-~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          266 DPVAVQTAKTNLLDELPQS-VLKWAP-------------------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             CHHHHHHHHHHHHHTTTHH-HHHHSC-------------------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccHHHHHHHHhhcccccHH-HHhhcc-------------------ccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            2222222222211111111 110000                   0257999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.1e-46  Score=332.20  Aligned_cols=261  Identities=27%  Similarity=0.399  Sum_probs=196.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ..+..++|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            34678999999999999999999998    56789999999986543    34568999999999999999999874322


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                         ...+++||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus        85 ---~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~-~~~~kl~  156 (295)
T 3ugc_A           85 ---RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIG  156 (295)
T ss_dssp             ---HTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEEC
T ss_pred             ---CCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcC-CCeEEEc
Confidence               223789999997 588777764   23459999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||++........    .....++..|+|||.+.+. .++.++||||+||++|+|++|..||......  .   ....+.
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~  230 (295)
T 3ugc_A          157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGN  230 (295)
T ss_dssp             CCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCT
T ss_pred             cCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcC
Confidence            9999986644322    1223457789999999765 4899999999999999999999998654321  1   111111


Q ss_pred             CCHHH------HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREE------IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .....      ......             ......+..+++++.+||.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          231 DKQGQMIVFHLIELLKN-------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TCCTHHHHHHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccchhHHHHHHHHhc-------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11000      000000             0011123468999999999999999999999999874

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-46  Score=338.39  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=203.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEE--EEEEeecc-----ccchHHHHHHHHHc-CCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETV--AIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||.||+|++..++..+  |+|.+...     .....+|+.+++.+ +||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----   97 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----   97 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----
Confidence            55689999999999999999999999888865  99988642     23456899999999 89999999998843    


Q ss_pred             CceeEEEEecccc-chHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEE
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLV  146 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill  146 (353)
                       ...+|+||||++ ++|.+.+....            .....+++..++.++.||+.||+|||+ +||+||||||+||++
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~  175 (327)
T 1fvr_A           98 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILV  175 (327)
T ss_dssp             -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEE
T ss_pred             -CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEE
Confidence             345889999997 48888776532            234579999999999999999999999 799999999999999


Q ss_pred             eCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 018619          147 DPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVE  225 (353)
Q Consensus       147 ~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~  225 (353)
                      +. ++.+||+|||++.............+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus       176 ~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~  253 (327)
T 1fvr_A          176 GE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  253 (327)
T ss_dssp             CG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             cC-CCeEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence            96 778999999999754433333445668889999999664 48999999999999999998 9999998877655443


Q ss_pred             HHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +....                            ....+..+++++.+||.+||+.||.+|||++++++|
T Consensus       254 ~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          254 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            32210                            001223578999999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.1e-46  Score=331.93  Aligned_cols=257  Identities=20%  Similarity=0.269  Sum_probs=196.4

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECC---CCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      .+..++|.+.+.||+|+||.||+|.+..   +++.||+|.+....      ....+|+.+++.++||||+++++++....
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            4667899999999999999999998765   55689999986432      23457999999999999999999986655


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYS--SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                      ..+....++||||+.+ +|.+.+....  .....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+|
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~k  187 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRD-DMTVC  187 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECT-TSCEE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEE
Confidence            4444457899999984 7777764322  234679999999999999999999999 79999999999999996 78899


Q ss_pred             EeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 018619          155 ICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL  230 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  230 (353)
                      |+|||++........   .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            999999986544321   2234567889999999764 58999999999999999999 899998887766555443311


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .                            ..++..+++++.++|.+||+.||.+|||+.+++++
T Consensus       267 ~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          267 R----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             C----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             C----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            0                            01224578999999999999999999999999854

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.5e-46  Score=328.46  Aligned_cols=249  Identities=27%  Similarity=0.353  Sum_probs=192.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCC---CcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +.+..++|++.+.||+|+||.||+|.+..+   +..||+|.+...     .....+|+.+++.++||||+++++++.   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc---
Confidence            346788999999999999999999998654   456999988543     233558999999999999999998862   


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                        . ...|+||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus        87 --~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~  158 (281)
T 1mp8_A           87 --E-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLG  158 (281)
T ss_dssp             --S-SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEEC
T ss_pred             --c-CccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECC-CCCEEEC
Confidence              1 126799999985 77777654   34579999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          157 DFGSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       157 Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |||++.........  ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+....+.....  
T Consensus       159 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~--  235 (281)
T 1mp8_A          159 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--  235 (281)
T ss_dssp             C-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred             ccccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC--
Confidence            99999866443322  233457889999999654 48999999999999999996 9999998877666554433100  


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                                ..++..+++++.++|.+||+.||.+|||+.+++++
T Consensus       236 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          236 --------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                      01234589999999999999999999999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.4e-46  Score=334.84  Aligned_cols=262  Identities=24%  Similarity=0.286  Sum_probs=211.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFS   75 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (353)
                      +.+..++|++.+.||+|+||.||+|.+.     .+++.||+|.+....     ....+|+.+++.++||||+++++++. 
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   98 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-   98 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc-
Confidence            4466789999999999999999999876     357889999986432     23457999999999999999999883 


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~------~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                          .....++||||+. ++|.+.+......      ...+++..++.++.|++.||+|||+ +||+||||||+||+++.
T Consensus        99 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           99 ----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             ----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT
T ss_pred             ----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcC
Confidence                3334789999998 4888877653321      2567999999999999999999999 79999999999999996


Q ss_pred             CCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 018619          149 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLV  224 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~  224 (353)
                       ++.+||+|||++........   .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+...
T Consensus       174 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          174 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             -TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             -CCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence             78899999999986543322   2234668899999998764 48999999999999999999 899999887766655


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC------cccc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH------PFFD  298 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h------p~f~  298 (353)
                      .+.....                            ...+..+++++.+||.+||+.||.+|||+.++++|      |+|+
T Consensus       252 ~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~  303 (322)
T 1p4o_A          252 FVMEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  303 (322)
T ss_dssp             HHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence            4433100                            00123578999999999999999999999999876      7777


Q ss_pred             cccCC
Q 018619          299 ELREP  303 (353)
Q Consensus       299 ~~~~~  303 (353)
                      .+...
T Consensus       304 ~~~~~  308 (322)
T 1p4o_A          304 EVSFY  308 (322)
T ss_dssp             HHCST
T ss_pred             ccccc
Confidence            66544

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.3e-46  Score=338.13  Aligned_cols=268  Identities=22%  Similarity=0.298  Sum_probs=203.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ...++|.+.+.||+|+||.||+|.+ .+++.||+|++....     ....+|+.+++.++||||+++++++..     ..
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~  100 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PT  100 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SS
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CC
Confidence            4567999999999999999999984 478999999986432     245789999999999999999998843     33


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC---CeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---RVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~---~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ..++||||+.+ +|.+.+.........+++..++.++.|++.||+|||+ +   ||+||||||+|||++. ++.+||+||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Df  178 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDE-EFEAVVGDF  178 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECT-TCCEEECCC
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECC-CCCEEeccC
Confidence            47899999985 8888887655556679999999999999999999999 8   9999999999999996 788999999


Q ss_pred             ccccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCC
Q 018619          159 GSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN----AVDQLVEIIKVLGT  232 (353)
Q Consensus       159 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~~~~~~~~~~~~~~  232 (353)
                      |++........  .....||+.|+|||++.+.. ++.++||||+||++|+|++|..||....    ..........    
T Consensus       179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----  253 (326)
T 3uim_A          179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK----  253 (326)
T ss_dssp             SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT----
T ss_pred             ccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH----
Confidence            99986644333  23345899999999996654 8999999999999999999999995211    0000000000    


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                                ...................+....+.++.+++.+||+.||.+|||+.++++|-.-.
T Consensus       254 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 ----------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             ----------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             ----------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                      00001111111111112222233457899999999999999999999999876543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.3e-46  Score=330.86  Aligned_cols=246  Identities=16%  Similarity=0.213  Sum_probs=197.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCC-------cEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (353)
                      .-+..++|.+.+.||+|+||.||+|.+..++       ..||+|.+....    ....+|+.+++.++||||+++++++.
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            3467889999999999999999999998877       469999986443    33458999999999999999999884


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCc-
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQ-  152 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~-  152 (353)
                      .     ....++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++. 
T Consensus        83 ~-----~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~-~~~~  152 (289)
T 4fvq_A           83 C-----GDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIR-EEDR  152 (289)
T ss_dssp             C-----TTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEE-CCBG
T ss_pred             e-----CCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEec-CCcc
Confidence            3     334789999998 588777764   23448999999999999999999999 79999999999999986 554 


Q ss_pred             -------EEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCC-CCCCCCChHHHHH
Q 018619          153 -------VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLV  224 (353)
Q Consensus       153 -------vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~  224 (353)
                             +||+|||++.....   .....+|+.|+|||++.+...++.++||||+||++|+|++|. +||...+..... 
T Consensus       153 ~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-  228 (289)
T 4fvq_A          153 KTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-  228 (289)
T ss_dssp             GGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-
T ss_pred             cccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-
Confidence                   99999999875432   223457889999999977556899999999999999999954 555555444332 


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ......                             ..++...++++.+||.+||+.||.+|||+.++++|
T Consensus       229 ~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          229 QFYEDR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHTT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHhhcc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            222210                             01123467889999999999999999999999854

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.6e-46  Score=324.07  Aligned_cols=249  Identities=18%  Similarity=0.307  Sum_probs=204.8

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +.+..++|++.+.||+|+||.||++.+. +++.||+|++....   ....+|+.+++.++||||+++++++..     ..
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   76 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QA   76 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SS
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CC
Confidence            5677899999999999999999999986 67889999997543   345689999999999999999998833     33


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..++||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~-~~~~kl~dfg~~  151 (267)
T 3t9t_A           77 PICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMT  151 (267)
T ss_dssp             SCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECG-GGCEEECCTTGG
T ss_pred             CeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECC-CCCEEEcccccc
Confidence            4889999998 577777654   34578999999999999999999999 79999999999999986 788999999999


Q ss_pred             cccccCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      .......  ......+++.|+|||++.+. .++.++||||+||++|+|++ |..||...+..+....+.....       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-------  223 (267)
T 3t9t_A          152 RFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------  223 (267)
T ss_dssp             GGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------
T ss_pred             cccccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-------
Confidence            8653321  12234567889999999654 48999999999999999999 8999998887766655433110       


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                           ...+...++++.+++.+||+.||.+|||+.+++++
T Consensus       224 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          224 ---------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                 01123478999999999999999999999999854

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9e-46  Score=333.71  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=204.6

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCc-----EEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      +.+..++|.+.+.||+|+||.||+|.+..+++     .||+|.+....     ....+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34567899999999999999999999987664     79999886542     3456899999999 8999999999883


Q ss_pred             ecCCCCceeEEEEeccccc-hHHHHHHhhhh----------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCc
Q 018619           75 STTSKNELFLNLVMEYVPE-SMYRVLKHYSS----------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQN  143 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~----------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~N  143 (353)
                           ....+++||||+++ +|.+.+.....          ....+++..++.++.|++.||+|||+ +||+||||||+|
T Consensus       121 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~N  194 (333)
T 2i1m_A          121 -----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARN  194 (333)
T ss_dssp             -----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred             -----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccce
Confidence                 33348899999984 88888765332          14568999999999999999999999 799999999999


Q ss_pred             EEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCCh
Q 018619          144 LLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENA  219 (353)
Q Consensus       144 ill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~  219 (353)
                      |+++. ++.+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+...
T Consensus       195 Il~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          195 VLLTN-GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             CEEEG-GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             EEECC-CCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            99996 78999999999986544332   1234568889999998764 48999999999999999998 9999988766


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          220 VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ......+......+                           ..+...++++.++|.+||+.||.+|||+.++++
T Consensus       273 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          273 NSKFYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             SHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            55555544421111                           012346889999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=335.93  Aligned_cols=258  Identities=23%  Similarity=0.374  Sum_probs=201.8

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++...    .....+|+.+++.++||||+++++++.... ....
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~  103 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH  103 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence            46678999999999999999999999999999999988543    234568999999999999999999885432 2345


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..++||||+.+ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~  181 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGD-EGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCSSC
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcC-CCCEEEEecCcc
Confidence            68899999985 8888887766667889999999999999999999999 79999999999999986 788999999998


Q ss_pred             cccccCCCc----------ceeeeeceeeChhhhhCCC--CCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 018619          162 KQLIAGEAN----------ISYICSRFYRAPELIFGAT--EYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIK  228 (353)
Q Consensus       162 ~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~~~~  228 (353)
                      .........          ....||+.|+|||++.+..  .++.++|||||||++|+|++|..||...... +.......
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  261 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ  261 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence            754321111          1235689999999986533  2688999999999999999999999431100 00111111


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .                 ....+          ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       262 ~-----------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 N-----------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C-----------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c-----------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            0                 00000          113578999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.1e-46  Score=329.96  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=194.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHH--cCCCceeecceeeeecCCCCceeE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ...++|++.+.||+|+||.||++++  +++.||||++.... ....+|.+++..  ++||||+++++++.... .....+
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~   81 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL   81 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence            4578999999999999999999987  78999999986543 233467777776  79999999998875433 334568


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH--------~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                      ++||||+++ +|.+.+.     ...+++..++.++.|++.||+|||        + +||+||||||+|||++. ++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~-~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKK-NGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECT-TSCEEE
T ss_pred             EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcC-CCCEEE
Confidence            899999985 7777763     357999999999999999999999        8 79999999999999996 788999


Q ss_pred             eeeccccccccCCCc-----ceeeeeceeeChhhhhCCC-----CCCccccchhHHHHHHHHHhC----------CCCCC
Q 018619          156 CDFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLG----------QPLFP  215 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g----------~~pf~  215 (353)
                      +|||+|.........     ....||+.|+|||++.+..     .++.++||||+||++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999999765443332     2347899999999996643     234689999999999999999          88886


Q ss_pred             CCCh----HHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          216 GENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       216 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                      ....    ...........+.                 .+...    ...+....++++.+||.+||+.||.+|||+.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQ-----------------RPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCC-----------------CCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCC-----------------CCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            5322    2222222111000                 00000    011122356789999999999999999999998


Q ss_pred             hc
Q 018619          292 CA  293 (353)
Q Consensus       292 l~  293 (353)
                      ++
T Consensus       294 ~~  295 (301)
T 3q4u_A          294 KK  295 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-45  Score=330.76  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=203.9

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEE-----CCCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      +.+..++|++.+.||+|+||.||+|.+     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++.
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            346678999999999999999999985     4577899999986542     2345899999999 7899999999874


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCC
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSA------------NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP  141 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~------------~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp  141 (353)
                      ..    ...+++||||+. ++|.+.+......            ...+++..++.++.|++.||.|||+ +||+||||||
T Consensus       102 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp  176 (316)
T 2xir_A          102 KP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA  176 (316)
T ss_dssp             CT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSG
T ss_pred             cC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCcc
Confidence            32    234789999998 5888777653221            1238999999999999999999999 7999999999


Q ss_pred             CcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCC
Q 018619          142 QNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGE  217 (353)
Q Consensus       142 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~  217 (353)
                      +||+++. ++.+||+|||++.........   ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.
T Consensus       177 ~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          177 RNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             GGEEECG-GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEECC-CCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999996 788999999999866443322   235678899999999764 48999999999999999998 99999887


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +..+.....+.....+                           ..+..+++++.++|.+||+.||.+|||+.++++|
T Consensus       255 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          255 KIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6554444433321110                           0223478999999999999999999999999876

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-45  Score=332.00  Aligned_cols=253  Identities=24%  Similarity=0.351  Sum_probs=203.1

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-------CCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeeccee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-------ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHC   72 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~   72 (353)
                      +.+..++|++.+.||+|+||.||+|++.       .+++.||+|++....     ....+|+.+++.+ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3466789999999999999999999976       456789999986542     2345899999999 89999999998


Q ss_pred             eeecCCCCceeEEEEeccccc-hHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           73 FFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      +.     ....+|+||||+.+ +|.+.+.....            ....+++..++.++.||+.||+|||+ +||+||||
T Consensus       110 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dl  183 (334)
T 2pvf_A          110 CT-----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDL  183 (334)
T ss_dssp             EC-----SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCC
T ss_pred             Ec-----cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCC
Confidence            83     33458899999985 88887765322            12358999999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+||+++. ++.+||+|||++........   .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.
T Consensus       184 kp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          184 AARNVLVTE-NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             SGGGEEECT-TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccceEEEcC-CCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            999999996 78899999999986654332   2234567889999998764 48999999999999999999 999999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +.+..+....+.....                            ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          262 GIPVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             TCCHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8877666554443210                            01224578999999999999999999999999854

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.6e-46  Score=334.77  Aligned_cols=250  Identities=25%  Similarity=0.344  Sum_probs=196.8

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEE----EEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeee
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFS   75 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (353)
                      ...+..++|++.+.||+|+||+||+|++..+++.+    |+|.+...     ...+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            35677899999999999999999999998887754    77766432     2345689999999999999999998843


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                      .     . .++|+||+. |+|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+|
T Consensus        89 ~-----~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~-~~~~k  157 (327)
T 3poz_A           89 S-----T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVK  157 (327)
T ss_dssp             S-----S-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEE
T ss_pred             C-----C-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECC-CCCEE
Confidence            1     1 567888887 577776654   35679999999999999999999999 79999999999999996 78999


Q ss_pred             EeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 018619          155 ICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL  230 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  230 (353)
                      |+|||+|+........   ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus       158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  236 (327)
T 3poz_A          158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  236 (327)
T ss_dssp             ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EccCcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC
Confidence            9999999876544332   233457889999999765 48999999999999999999 999998877655443332211


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ..                            ..+...+.++.+++.+||+.||.+|||+.+++++
T Consensus       237 ~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          237 RL----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CC----------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CC----------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            00                            0123478899999999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.7e-46  Score=333.36  Aligned_cols=267  Identities=25%  Similarity=0.318  Sum_probs=203.5

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeec
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFST   76 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (353)
                      ..++..++|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++.. 
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   95 (327)
T 3lxl_A           17 PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG-   95 (327)
T ss_dssp             CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec-
Confidence            356788999999999999999999999    56789999999986543    335689999999999999999988754 


Q ss_pred             CCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           77 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                        .+...+++||||++ ++|.+.+...   ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||
T Consensus        96 --~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~-~~~~kl  168 (327)
T 3lxl_A           96 --PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVES-EAHVKI  168 (327)
T ss_dssp             --SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEE
T ss_pred             --CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECC-CCCEEE
Confidence              23445889999996 5777777642   3469999999999999999999999 79999999999999996 889999


Q ss_pred             eeeccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 018619          156 CDFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      +|||++........    .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||........... .....
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~  246 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERD  246 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccc
Confidence            99999987654332    2234578889999999765 489999999999999999999999965433211100 00000


Q ss_pred             CCCHHHHh-hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          232 TPTREEIR-CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+....+. .....             .....+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       247 ~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          247 VPALSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CCHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00000000 00000             0111234689999999999999999999999999643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=338.43  Aligned_cols=258  Identities=13%  Similarity=0.144  Sum_probs=197.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCC--------CcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeee-------
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLET--------GETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFF-------   74 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-------   74 (353)
                      .++|++.+.||+|+||.||+|++..+        ++.||+|.+... ....+|+.+++.++||||+++++.+.       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i  119 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAI  119 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCc
Confidence            58999999999999999999999874        889999998755 45679999999999999998433211       


Q ss_pred             ----ecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC
Q 018619           75 ----STTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT  150 (353)
Q Consensus        75 ----~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~  150 (353)
                          ..........|+||||++++|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. +
T Consensus       120 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~~~-~  195 (352)
T 2jii_A          120 PTCMGFGVHQDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDP-E  195 (352)
T ss_dssp             CCCCEEEEETTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEEET-T
T ss_pred             cchhhccccCCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEEcC-C
Confidence                0001123458899999988988888752  23679999999999999999999999 79999999999999996 6


Q ss_pred             C--cEEEeeeccccccccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC-h
Q 018619          151 H--QVKICDFGSAKQLIAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN-A  219 (353)
Q Consensus       151 ~--~vkl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-~  219 (353)
                      +  .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            5  899999999986543321        1234789999999999664 58999999999999999999999998764 3


Q ss_pred             HHHHHHHHHHh-CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          220 VDQLVEIIKVL-GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       220 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      .+.+....... ..+.            .+..   ...     ....+++++.+||.+||+.||.+|||++++++
T Consensus       275 ~~~~~~~~~~~~~~~~------------~~~~---~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          275 TEDIMKQKQKFVDKPG------------PFVG---PCG-----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHHSCC------------CEEC---TTS-----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhccCChh------------hhhh---hcc-----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            33333322211 1110            0000   000     01247899999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-45  Score=323.94  Aligned_cols=251  Identities=26%  Similarity=0.302  Sum_probs=203.1

Q ss_pred             eeeecceeeEee-eeecCCCeEEEEEEEC--CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            6 CILQTISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         6 ~~~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      ..+..++|.+.+ .||+|+||.||+|.+.  .+++.||+|++....     ....+|+.+++.++||||+++++++ ...
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            346678888887 9999999999999864  467889999986532     3345899999999999999999987 211


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                           ..++||||+.+ +|.+.+..   ....+++..++.++.|++.||.|||+ +||+||||||+||+++. ++.+||+
T Consensus        83 -----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~  152 (287)
T 1u59_A           83 -----ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKIS  152 (287)
T ss_dssp             -----SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEEC
T ss_pred             -----CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcC-CCCEEEC
Confidence                 27899999985 77666643   34679999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 018619          157 DFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       157 Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      |||++.........    ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||...+..+....+.....
T Consensus       153 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~  231 (287)
T 1u59_A          153 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR  231 (287)
T ss_dssp             CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC
T ss_pred             cccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc
Confidence            99999876443322    223457889999999654 48999999999999999998 9999998877665544433100


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                                                  ..++..+++++.++|.+||+.||.+|||+.++++|.+
T Consensus       232 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          232 ----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             ----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ----------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                                        0123468999999999999999999999999997754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.4e-45  Score=327.66  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=193.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++..     .
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence            456899999999999999999999999999999998642       1234589999999999999999998854     3


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++||||+.+ +|.+.+.........+++..++.++.|++.||.|||+ +|++||||||+||+++. ++.+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~-~~~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITA-TGVVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcC-CCCEEEEeccc
Confidence            348899999985 8888887766667889999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Q 018619          161 AKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       161 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  238 (353)
                      +........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.... ......+.....      
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------  255 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY------  255 (310)
T ss_dssp             ----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCS------
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccC------
Confidence            986544322 2345789999999998654 5899999999999999999999999764321 112111111000      


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                  +.        .....+++++.+||.+||+.||.+|||+.++++  .++++
T Consensus       256 ------------~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~--~l~~l  295 (310)
T 2wqm_A          256 ------------PP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD--VAKRM  295 (310)
T ss_dssp             ------------CC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             ------------CC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH--HHHHH
Confidence                        00        011357899999999999999999999999984  34444

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-45  Score=324.08  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECC---CCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLE---TGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      -+..++|.+.+.||+|+||.||+|.+..   ++..||+|.+...     .....+|+.+++.++||||+++++++.    
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC----
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc----
Confidence            4567899999999999999999998654   3456999998654     234567999999999999999999862    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       .. ..++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus        84 -~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~kl~D  156 (281)
T 3cc6_A           84 -EE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVAS-PECVKLGD  156 (281)
T ss_dssp             -SS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEE-TTEEEECC
T ss_pred             -CC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECC-CCcEEeCc
Confidence             11 2579999998 577777754   34569999999999999999999999 79999999999999996 78999999


Q ss_pred             eccccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          158 FGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       158 fg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      ||++........  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......+ 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~-  234 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP-  234 (281)
T ss_dssp             CCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-
T ss_pred             cCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-
Confidence            999986544332  2234567889999999654 48999999999999999998 999998777666554443321100 


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                                 .+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       235 ---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          235 ---------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence                                       123578999999999999999999999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-45  Score=328.96  Aligned_cols=246  Identities=23%  Similarity=0.282  Sum_probs=189.7

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .-++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence            3478999999999999999999999999999999986542       334579999999999999999998843     3


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+||||+++ +|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~  180 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSA-DDFAYLVDFGI  180 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcC-CCCEEEecCcc
Confidence            358899999985 77777654    3579999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          161 AKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       161 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +........  .....+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. .....+.... +     
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~-~-----  252 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI-P-----  252 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC-C-----
T ss_pred             CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC-C-----
Confidence            976544322  2345789999999998654 5899999999999999999999999876654 2222222100 0     


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-CHHHHh
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-TALEAC  292 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-t~~~~l  292 (353)
                                         ....+...+++++.++|.+||+.||.+|| |+++++
T Consensus       253 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~  288 (309)
T 2h34_A          253 -------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLS  288 (309)
T ss_dssp             -------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             -------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHH
Confidence                               01112346899999999999999999999 777765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.2e-47  Score=338.84  Aligned_cols=266  Identities=22%  Similarity=0.233  Sum_probs=199.1

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ..++|.+.+.||+|+||.||+|.+ .+++.||+|++....    ....+|+.+++.++||||+++++++.     .....
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~  110 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-----ERNEM  110 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-----CTTCC
T ss_pred             HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeE
Confidence            457999999999999999999996 478999999886443    34568999999999999999999883     33347


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++||||+.+ +|.+.+.........+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++..
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDE-NFVPKITDFGISKK  188 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECT-TCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECC-CCCEEEeecccccc
Confidence            899999985 6655554332233469999999999999999999999 79999999999999996 88999999999986


Q ss_pred             cccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .....   ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+........     ....  
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~--  260 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESH--  260 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHH--
T ss_pred             cccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcc--
Confidence            44322   22345689999999998765 4899999999999999999999999765432211100000     0000  


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  295 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp  295 (353)
                      ...     .+...........+....+..+.+++.+||+.||++|||+.++++|-
T Consensus       261 ~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          261 NNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             TTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            000     01111111111122234567899999999999999999999998764

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=332.09  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=194.9

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEE----EEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeee
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETV----AIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFS   75 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (353)
                      ...+..++|++.+.||+|+||.||+|.+..+++.+    |+|.+...     .....+|+.+++.++||||+++++++..
T Consensus         9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A            9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            35677899999999999999999999998888765    56655322     2345689999999999999999998843


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                      .     . .+++++++. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+|
T Consensus        89 ~-----~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~k  157 (327)
T 3lzb_A           89 S-----T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVK  157 (327)
T ss_dssp             S-----S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEE
T ss_pred             C-----C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcC-CCCEE
Confidence            2     1 567888887 577776654   35679999999999999999999999 79999999999999996 78999


Q ss_pred             EeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 018619          155 ICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL  230 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  230 (353)
                      |+|||++.........   ....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus       158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  236 (327)
T 3lzb_A          158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  236 (327)
T ss_dssp             ECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999866443322   234457789999999765 48999999999999999999 999998877665544433211


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..                            ..+..++.++.+||++||+.||.+|||+.++++
T Consensus       237 ~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          237 RL----------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            00                            012347889999999999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.5e-45  Score=325.27  Aligned_cols=264  Identities=25%  Similarity=0.369  Sum_probs=198.2

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      .+...+|++.+.||+|+||.||+|+    +..+++.||+|++....     ....+|+.+++.++||||+++++++... 
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-   95 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED-   95 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC-
Confidence            3556789999999999999999999    57789999999986432     3456899999999999999999988543 


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                        +...+++||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus        96 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~  168 (302)
T 4e5w_A           96 --GGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVES-EHQVKIG  168 (302)
T ss_dssp             ----CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEEC
T ss_pred             --CCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcC-CCCEEEC
Confidence              22347899999975 87777754   34679999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 018619          157 DFGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       157 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      |||++........    .....+|..|+|||++.+.. ++.++||||+||++|+|++|..|+.....     ......+.
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~  242 (302)
T 4e5w_A          169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGP  242 (302)
T ss_dssp             CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCS
T ss_pred             cccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCC
Confidence            9999987655432    22345688899999997654 88999999999999999999988643211     11111111


Q ss_pred             CCHHH-HhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREE-IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..... ........         ........+..+++++.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          243 THGQMTVTRLVNTL---------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             CCGGGHHHHHHHHH---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cccccCHHHHHHHH---------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            11000 00000000         000011123468999999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.3e-45  Score=341.47  Aligned_cols=247  Identities=22%  Similarity=0.309  Sum_probs=201.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      +.+..++|.+.+.||+|+||.||++.+  +|+.||||++..+.  ..+.+|+.+++.++||||+++++++....    ..
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  261 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GG  261 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SC
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cc
Confidence            456778999999999999999999987  47899999997543  34568999999999999999999875432    24


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||. |+|.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~  337 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLTK  337 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TSCEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECC-CCCEEEeeCCCcc
Confidence            889999998 5888877642  23347999999999999999999999 79999999999999996 7889999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .....  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...          
T Consensus       338 ~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  404 (450)
T 1k9a_A          338 EASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK----------  404 (450)
T ss_dssp             ECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC----------
T ss_pred             ccccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            54332  2233567889999999764 58999999999999999998 9999988776655544432100          


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                        ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus       405 ------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          405 ------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                              0123468999999999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.3e-46  Score=339.48  Aligned_cols=248  Identities=24%  Similarity=0.315  Sum_probs=191.0

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      .+..++|.+.+.||+|+||.||+|++.   .++..||||++...     ...+.+|+.+++.++||||+++++++.    
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----  116 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----  116 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC----
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence            456779999999999999999999876   46778999998643     234568999999999999999999883    


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       ....+++||||++ ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus       117 -~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~-~~~~kl~D  190 (373)
T 2qol_A          117 -KSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINS-NLVCKVSD  190 (373)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECC
T ss_pred             -eCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcC-CCCEEECc
Confidence             3344889999997 587777753   34579999999999999999999999 79999999999999996 78999999


Q ss_pred             eccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          158 FGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       158 fg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      ||+++........    ....+++.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus       191 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~  269 (373)
T 2qol_A          191 FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL  269 (373)
T ss_dssp             C----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC
T ss_pred             CccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999866443221    122346789999999764 48999999999999999998 99999988877665544332111


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +                            .+..++.++.++|.+||+.||.+|||+.++++
T Consensus       270 ~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 P----------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             C----------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C----------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            0                            12347889999999999999999999998874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-45  Score=349.11  Aligned_cols=250  Identities=21%  Similarity=0.334  Sum_probs=205.6

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +.+..++|.+.+.||+|+||.||++.++.++..||||.+..+.   ..+.+|+.+++.++||||+++++++.     ...
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~  289 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REP  289 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence            4456788999999999999999999999999999999997543   34568999999999999999999883     333


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+|||||. |+|.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a  365 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGE-NHLVKVADFGLS  365 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECG-GGCEEECCTTCE
T ss_pred             cEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECC-CCcEEEeecccc
Confidence            4889999998 6888777642  23568999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +.......  .....+++.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....        
T Consensus       366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------  436 (495)
T 1opk_A          366 RLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------  436 (495)
T ss_dssp             ECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------
T ss_pred             eeccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence            86543321  1223457789999999664 48999999999999999999 999999887665544332210        


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                          ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       437 --------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          437 --------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence                                01123458999999999999999999999999963

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.1e-45  Score=323.95  Aligned_cols=244  Identities=25%  Similarity=0.354  Sum_probs=187.8

Q ss_pred             cceeeEe-eeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-HHcCCCceeecceeeeecCCCCceeEEEE
Q 018619           10 TISYMAE-RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        10 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +..+||||+++++++.... .+...+++|
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~lv   93 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   93 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEEEE
Confidence            4567776 8899999999999999999999999998644 4456788887 6679999999999884422 235568899


Q ss_pred             eccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC--CCcEEEeeecccccc
Q 018619           88 MEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL--THQVKICDFGSAKQL  164 (353)
Q Consensus        88 ~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~--~~~vkl~Dfg~a~~~  164 (353)
                      |||+.+ +|.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++..  ++.+||+|||++...
T Consensus        94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  170 (299)
T 3m2w_A           94 MECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  170 (299)
T ss_dssp             ECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEecccccccc
Confidence            999985 888777652  23579999999999999999999999 799999999999999853  568999999998643


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      .                      ...++.++||||+||++|+|++|..||.+.+..........                
T Consensus       171 ~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~----------------  212 (299)
T 3m2w_A          171 T----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----------------  212 (299)
T ss_dssp             T----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC----------------
T ss_pred             c----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH----------------
Confidence            2                      12478899999999999999999999977654322100000                


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                        .....   ...+.......+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       213 --~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          213 --RIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             --SSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             --HHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence              00000   00011111145899999999999999999999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.1e-45  Score=323.23  Aligned_cols=247  Identities=24%  Similarity=0.288  Sum_probs=199.2

Q ss_pred             eeeecceeeEee-eeecCCCeEEEEEE--ECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeec
Q 018619            6 CILQTISYMAER-VVGTGSFGIVFQAK--CLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFST   76 (353)
Q Consensus         6 ~~~~~~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (353)
                      ..+...+|.+.+ .||+|+||.||+|.  +..+++.||+|++...      .....+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            346678999999 99999999999994  4567889999998654      23456899999999999999999987 21


Q ss_pred             CCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           77 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                           ...++||||+. ++|.+.+..    ...+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||
T Consensus        90 -----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~-~~~~kl  158 (291)
T 1xbb_A           90 -----ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKI  158 (291)
T ss_dssp             -----SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEE
T ss_pred             -----CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeC-CCcEEE
Confidence                 12779999998 577766653    4679999999999999999999999 79999999999999996 789999


Q ss_pred             eeeccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHh
Q 018619          156 CDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVL  230 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~  230 (353)
                      +|||++.........    ....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+... 
T Consensus       159 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-  236 (291)
T 1xbb_A          159 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-  236 (291)
T ss_dssp             CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-
T ss_pred             ccCCcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence            999999866544332    1234568899999996644 8899999999999999999 99999988776655443321 


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..                           ..++..+++++.++|.+||+.||.+|||+.++++
T Consensus       237 ~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          237 ER---------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CC---------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            00                           0122457999999999999999999999999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-45  Score=329.26  Aligned_cols=249  Identities=21%  Similarity=0.293  Sum_probs=195.9

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      -+...+|.+.+.||+|+||.||+|.+..++    ..||+|.+....     ....+|+.+++.++||||+++++++    
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----  115 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI----  115 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence            466789999999999999999999987553    459999986432     2345799999999999999999988    


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                       .....+++||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+
T Consensus       116 -~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~-~~~~kl~  189 (333)
T 1mqb_A          116 -SKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVS  189 (333)
T ss_dssp             -CSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEEC
T ss_pred             -ecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECC-CCcEEEC
Confidence             334458899999985 77777653   34679999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 018619          157 DFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       157 Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      |||++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~  268 (333)
T 1mqb_A          190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR  268 (333)
T ss_dssp             CCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             CCCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence            99999865443221    123457789999999664 48999999999999999998 9999988887666554433111


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+                            .+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       269 ~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 LP----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CC----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CC----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            00                            123578999999999999999999999998754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-46  Score=348.45  Aligned_cols=253  Identities=20%  Similarity=0.200  Sum_probs=192.7

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCC-Cceeecc---------ee-
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDH-PNVISLK---------HC-   72 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-~~iv~~~---------~~-   72 (353)
                      ..|...+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.++| +|...+.         +. 
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4588999999999999999999999999999988632       2334589999998876 3221111         11 


Q ss_pred             -----------eeecCCCCceeEEEEeccccchHHHHHHhh---hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeecc
Q 018619           73 -----------FFSTTSKNELFLNLVMEYVPESMYRVLKHY---SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRD  138 (353)
Q Consensus        73 -----------~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~D  138 (353)
                                 +..........++++|+++.++|.+.+...   ......+++..+..++.|++.||+|||+ +||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence                       101000112236789999999888877543   2234568888999999999999999999 7999999


Q ss_pred             CCCCcEEEeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhh---------CCCCCCccccchhHHHHHHHHHh
Q 018619          139 LKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF---------GATEYTTSIDIWSAGCVLAELLL  209 (353)
Q Consensus       139 lkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwSlG~il~~l~~  209 (353)
                      |||+|||++. ++.+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       237 iKp~NILl~~-~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQ-RGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECT-TCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEec-CCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            9999999996 778999999998864433  334566 9999999983         33447889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH
Q 018619          210 GQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL  289 (353)
Q Consensus       210 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  289 (353)
                      |+.||...+..+....+                       ++          -...+|+++.+||.+||+.||.+|||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999765432111000                       00          0125789999999999999999999999


Q ss_pred             HHhcCccccccc
Q 018619          290 EACAHPFFDELR  301 (353)
Q Consensus       290 ~~l~hp~f~~~~  301 (353)
                      ++++||||+.+.
T Consensus       360 ~~l~~~~~~~~~  371 (413)
T 3dzo_A          360 QAMETPEYEQLR  371 (413)
T ss_dssp             HHTTSHHHHHHH
T ss_pred             HHHhCHHHHHHH
Confidence            999999998764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-45  Score=332.52  Aligned_cols=257  Identities=18%  Similarity=0.218  Sum_probs=202.2

Q ss_pred             eecceeeEeeeeecCCCeEEEEEE-----ECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAK-----CLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      +..++|++.+.||+|+||.||+|+     +..+++.||+|.+...     .....+|+.+++.++||||+++++++..  
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence            567899999999999999999999     5567889999998543     2334579999999999999999998843  


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCC
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSS---ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTH  151 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~  151 (353)
                         ....|+||||+. ++|.+.+.....   ....+++..++.++.|++.||.|||+ +||+||||||+||+++.  .+.
T Consensus       105 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          105 ---SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             ---SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTC
T ss_pred             ---CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcc
Confidence               334789999996 688888765322   12458999999999999999999999 79999999999999983  244


Q ss_pred             cEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 018619          152 QVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEII  227 (353)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~  227 (353)
                      .+||+|||++........   .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||...+..+....+.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            699999999975433221   2234568899999998664 48999999999999999998 999998887766554443


Q ss_pred             HHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          228 KVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      ....                            ...+..+++.+.++|.+||+.||.+|||+.++++|.|+-.
T Consensus       260 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          260 SGGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             TTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            3100                            0012457899999999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.2e-45  Score=320.25  Aligned_cols=247  Identities=18%  Similarity=0.251  Sum_probs=200.6

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      -+..++|.+.+.||+|+||.||+|++  +++.||+|++....      ....+|+.+++.++||||+++++++....   
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   80 (271)
T 3kmu_A            6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---   80 (271)
T ss_dssp             CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---
T ss_pred             CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---
Confidence            45678999999999999999999998  48899999986432      23557999999999999999999884331   


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEee
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      ....++||||++ ++|.+.+..  .....+++..++.++.|++.||+|||+ +|  |+||||||+||+++. ++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~-~~~~~l~~  156 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDE-DMTARISM  156 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECT-TSCEEEEG
T ss_pred             CCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcC-CcceeEEe
Confidence            234789999998 488877764  122358999999999999999999999 79  999999999999996 78899999


Q ss_pred             eccccccccCCCcceeeeeceeeChhhhhCCCC--CCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          158 FGSAKQLIAGEANISYICSRFYRAPELIFGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       158 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      ||++.....    ....+|+.|+|||++.+...  ++.++||||+||++|+|++|..||.+.+..+....+......+  
T Consensus       157 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--  230 (271)
T 3kmu_A          157 ADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--  230 (271)
T ss_dssp             GGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--
T ss_pred             ccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--
Confidence            988754322    23567999999999976432  2337999999999999999999999888777665554421111  


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                               .++..+++++.++|.+||+.||.+|||++++++
T Consensus       231 -------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          231 -------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     123468999999999999999999999999974

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-46  Score=361.43  Aligned_cols=285  Identities=26%  Similarity=0.344  Sum_probs=207.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCC-CCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~   83 (353)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+.+++.++||||+++++++..... .....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999999999999988643     2334579999999999999999887633211 12445


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC--cEEEeeecc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGS  160 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~--~vkl~Dfg~  160 (353)
                      .|+|||||+ ++|.+.+... .....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.  .+||+|||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            789999996 5777776542 223468999999999999999999999 79999999999999985322  499999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.............||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+..........   ...........
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCS
T ss_pred             ccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhh
Confidence            998766665666789999999999865 45899999999999999999999999876543221110   00000000000


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      .........+..  ..+....+...+++.+.+||.+||++||.+|||+.++++||||+.+..
T Consensus       247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~  306 (676)
T 3qa8_A          247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS  306 (676)
T ss_dssp             CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred             hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence            000001111111  111222233457789999999999999999999999999999987653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.1e-45  Score=323.78  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=189.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +-+..++|++.+.||+|+||.||++++.   ..||+|++....      ....+|+.+++.++||||++++++. .    
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~----   90 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T----   90 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C----
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c----
Confidence            3466889999999999999999999853   359999885432      3346899999999999999998854 1    


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                       ....++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+||
T Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~-~~~~kl~Df  164 (289)
T 3og7_A           91 -APQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHE-DNTVKIGDF  164 (289)
T ss_dssp             -SSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TTEEEECCC
T ss_pred             -CCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECC-CCCEEEccc
Confidence             122679999998 566666543   35679999999999999999999999 79999999999999996 789999999


Q ss_pred             ccccccccCC---CcceeeeeceeeChhhhhC--CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGE---ANISYICSRFYRAPELIFG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |++.......   ......||+.|+|||++..  ...++.++||||+||++|+|++|..||...+..+.+.........+
T Consensus       165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (289)
T 3og7_A          165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS  244 (289)
T ss_dssp             C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred             eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence            9997554322   2234568999999999852  3457889999999999999999999998877766665555432111


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..                       ...+...+++++.+||.+||+.||.+|||+.++++
T Consensus       245 ~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          245 PD-----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CC-----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc-----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            10                       01122457899999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.6e-45  Score=342.36  Aligned_cols=247  Identities=25%  Similarity=0.351  Sum_probs=202.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +.+..++|.+.+.||+|+||.||+|.+. ++..||||++....   ..+.+|+.+++.++||||+++++++.      ..
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~  255 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KE  255 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SS
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CC
Confidence            4466789999999999999999999975 56789999997543   34568999999999999999998873      12


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+|||||. |+|.+.+...  ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DFG~a  331 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSA-SLVCKIADFGLA  331 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECT-TCCEEECSTTGG
T ss_pred             ccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECC-CCcEEEeeCCCc
Confidence            3789999998 5888877642  22358889999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +.......  .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......+     
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-----  405 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-----  405 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC-----
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-----
Confidence            86543211  1223457789999999654 48999999999999999999 999999988877766655421111     


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                                             .+..+++++.+||.+||+.||.+|||+++++
T Consensus       406 -----------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~  436 (454)
T 1qcf_A          406 -----------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQ  436 (454)
T ss_dssp             -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             -----------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence                                   1235789999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.4e-44  Score=338.14  Aligned_cols=252  Identities=22%  Similarity=0.250  Sum_probs=199.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .....+|+.+++.++|++.+..+..+..    .....+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~   79 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV   79 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence            4578999999999999999999999999999999987543  3456789999999988655554444432    233478


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEe--CCCCcEEEeeeccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVD--PLTHQVKICDFGSAKQ  163 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~--~~~~~vkl~Dfg~a~~  163 (353)
                      +||||+.++|.+.+..   ....+++..++.++.||+.||+|||+ +||+||||||+|||++  ..++.+||+|||+++.
T Consensus        80 lvme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           80 LVMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            9999998898888764   34679999999999999999999999 7999999999999993  2378899999999987


Q ss_pred             cccCCCc--------ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Q 018619          164 LIAGEAN--------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA---VDQLVEIIKVLGT  232 (353)
Q Consensus       164 ~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~  232 (353)
                      .......        ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...   ...+..+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA  234 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence            6544321        256789999999999765 489999999999999999999999987543   2333333322111


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      .....                        +...+++++.+||.+||+.||.+||++.+++
T Consensus       235 ~~~~~------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~  270 (483)
T 3sv0_A          235 TSIEA------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLK  270 (483)
T ss_dssp             SCHHH------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             ccHHH------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            11111                        1235789999999999999999999998765

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.8e-45  Score=320.68  Aligned_cols=248  Identities=21%  Similarity=0.320  Sum_probs=195.4

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      .+.+..++|++.+.||+|+||.||++.+  +|+.||+|.+....  ....+|+.+++.++||||+++++++...    ..
T Consensus        15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~   88 (278)
T 1byg_A           15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG   88 (278)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred             cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CC
Confidence            3567789999999999999999999987  58899999986543  3456899999999999999999986432    22


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+++||||+++ +|.+.+....  ...+++..++.++.|++.||+|||+ +|++||||||+||+++. ++.+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~  164 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLT  164 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC-
T ss_pred             ceEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeC-CCcEEEeecccc
Confidence            47899999985 8888776421  2347899999999999999999999 79999999999999996 788999999998


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .......  ....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||...+..+....+.+.           
T Consensus       165 ~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-----------  230 (278)
T 1byg_A          165 KEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----------  230 (278)
T ss_dssp             -------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred             ccccccc--cCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------
Confidence            7544322  234568889999999664 48999999999999999998 99999887765544333221           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                       +....+..+++++.++|.+||+.||.+|||+.++++
T Consensus       231 -----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          231 -----------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence                             001123457999999999999999999999999874

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-44  Score=318.13  Aligned_cols=248  Identities=25%  Similarity=0.308  Sum_probs=201.4

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |.+..++|++.+.||+|+||.||+|.+. +++.||+|.+....   ....+|+.+++.++||||+++++++.     .. 
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~-   80 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----QE-   80 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS-
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----CC-
Confidence            5567899999999999999999999974 56789999986543   34568999999999999999998763     11 


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..++||||+. ++|.+.+...  ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~  156 (279)
T 1qpc_A           81 PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLA  156 (279)
T ss_dssp             SCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTC
T ss_pred             CcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcC-CCCEEECCCccc
Confidence            2679999997 5777666432  12368999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      ........  .....+++.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+....+.+...       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------  228 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------  228 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred             ccccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-------
Confidence            86654322  1234567789999999654 48999999999999999999 9999998887666554433100       


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                           ...+..+++++.++|.+||+.||++|||++++++
T Consensus       229 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          229 ---------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                                 0122457899999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-44  Score=320.64  Aligned_cols=246  Identities=23%  Similarity=0.355  Sum_probs=194.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..+|++.+.||+|+||.||+|.+..++   ..||+|.+....     ....+|+.+++.++||||+++++++...    .
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence            468999999999999999999975443   458999886432     3345899999999999999999986432    2


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~-~~~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECC-CCCEEECcccc
Confidence            347799999986 77777653   35678999999999999999999999 79999999999999996 78999999999


Q ss_pred             ccccccCC-----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          161 AKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       161 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      +.......     ......+|+.|+|||.+.+. .++.++||||+||++|+|++ |.+||...+..+....+.....   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---  250 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  250 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence            98654332     12334567889999999665 48999999999999999999 6778877766555544433111   


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                               ...+..+++++.++|.+||+.||.+|||+.++++
T Consensus       251 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          251 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                                     0112357899999999999999999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=8e-45  Score=340.44  Aligned_cols=248  Identities=25%  Similarity=0.306  Sum_probs=198.5

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +.+..++|++.+.||+|+||.||++.+.. +..||||++....   ..+.+|+.+++.++||||+++++++..      .
T Consensus       179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~  251 (452)
T 1fmk_A          179 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E  251 (452)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred             cccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------C
Confidence            34667899999999999999999999864 4679999987543   345689999999999999999988732      2


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+||||+. |+|.+.+...  ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~-~~~~kl~DfG~a  327 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLA  327 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTT
T ss_pred             ceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECC-CCCEEECCCccc
Confidence            3789999998 5888777542  23568999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +.......  .....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......      
T Consensus       328 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------  400 (452)
T 1fmk_A          328 RLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------  400 (452)
T ss_dssp             C--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             eecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            86543321  1234457889999998764 48999999999999999999 99999988877766554431110      


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                            ..+..+++.+.+||.+||+.||++|||++++++
T Consensus       401 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          401 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                  122457899999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=7.3e-45  Score=321.44  Aligned_cols=255  Identities=26%  Similarity=0.360  Sum_probs=197.0

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECC-CCc--EEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeee
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLE-TGE--TVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFF   74 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (353)
                      .+.+..++|++.+.||+|+||.||+|.+.. +++  .||+|++...       .....+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (291)
T 1u46_A           12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   91 (291)
T ss_dssp             CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            467788999999999999999999998643 333  6899988543       133458999999999999999999874


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                      ..     . .++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +|++|+||||+||+++. ++.+
T Consensus        92 ~~-----~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~-~~~~  160 (291)
T 1u46_A           92 TP-----P-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLV  160 (291)
T ss_dssp             SS-----S-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEE
T ss_pred             cC-----C-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcC-CCCE
Confidence            31     1 679999998 577777764   23568999999999999999999999 79999999999999996 7899


Q ss_pred             EEeeeccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 018619          154 KICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  228 (353)
                      ||+|||++.........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~  239 (291)
T 1u46_A          161 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK  239 (291)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             EEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence            99999999876544322    234567789999999664 47899999999999999999 9999998887766655443


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      ....+                           ..+..+++++.++|.+||+.||.+|||+.++++  ++.+.
T Consensus       240 ~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~  282 (291)
T 1u46_A          240 EGERL---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEA  282 (291)
T ss_dssp             SCCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred             cCCCC---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHh
Confidence            11000                           012357999999999999999999999999986  45543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=326.91  Aligned_cols=279  Identities=23%  Similarity=0.310  Sum_probs=194.8

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-chHHHHHH--HHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQL--MRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~--l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ..+..++|++.+.||+|+||.||+|++  +++.||||++..... ....|..+  +..++||||+++++.+......+..
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            446778999999999999999999976  789999999865432 22334444  4458999999998876655556666


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC---------CeeeccCCCCcEEEeCCCCc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP---------RVCHRDLKPQNLLVDPLTHQ  152 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~---------~i~H~Dlkp~Nill~~~~~~  152 (353)
                      .+++|||||+ ++|.+.+..     ...++..++.++.||+.||+|||+ +         ||+||||||+|||++. ++.
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~-~~~  158 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKN-DGT  158 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECT-TSC
T ss_pred             eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcC-CCc
Confidence            7889999997 588777754     445889999999999999999999 8         9999999999999996 789


Q ss_pred             EEEeeeccccccccCC---------CcceeeeeceeeChhhhhCC------CCCCccccchhHHHHHHHHHhCCCCCCCC
Q 018619          153 VKICDFGSAKQLIAGE---------ANISYICSRFYRAPELIFGA------TEYTTSIDIWSAGCVLAELLLGQPLFPGE  217 (353)
Q Consensus       153 vkl~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwSlG~il~~l~~g~~pf~~~  217 (353)
                      +||+|||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            9999999998654322         12234689999999999653      23567899999999999999997665332


Q ss_pred             Ch-HHHHHHHHH-HhCCCCHHHHhhcC-cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh--
Q 018619          218 NA-VDQLVEIIK-VLGTPTREEIRCMN-PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC--  292 (353)
Q Consensus       218 ~~-~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l--  292 (353)
                      .. .+....... ....+....+.... .......++.    .|..  ....++++.+||.+||+.||++|||+.|++  
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKE--NSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCC--CSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----cccc--ccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            21 110000011 11111111111100 0000000110    0000  012455899999999999999999999994  


Q ss_pred             ----cCccccc
Q 018619          293 ----AHPFFDE  299 (353)
Q Consensus       293 ----~hp~f~~  299 (353)
                          .++|-++
T Consensus       313 L~~ll~~~~~~  323 (336)
T 3g2f_A          313 MAELMMIWERN  323 (336)
T ss_dssp             HHHHHHCCCC-
T ss_pred             HHHHHHHHHhc
Confidence                4555554

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=321.40  Aligned_cols=246  Identities=30%  Similarity=0.435  Sum_probs=188.4

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+..++|++.+.||+|+||.||++++  +++.||+|++....  ....+|+.+++.++||||+++++++.     +.  .
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~   74 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--V   74 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--T
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--c
Confidence            35678999999999999999999987  47899999986543  34568999999999999999988763     22  6


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC--CCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV--PRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~--~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ++||||+.+ +|.+.+... .....+++..+..++.|++.||+|||+.  +||+||||||+||+++.++..+||+|||++
T Consensus        75 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             EEEEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            799999974 777776532 1123478899999999999999999983  389999999999999964445899999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVD--QLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  239 (353)
                      ......  .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......  ....+..  +.       
T Consensus       154 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~-------  221 (307)
T 2eva_A          154 CDIQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT-------  221 (307)
T ss_dssp             -------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC-------
T ss_pred             cccccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC-------
Confidence            754332  2345689999999999654 58999999999999999999999997643322  1111111  00       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                         ...+...+++.+.++|.+||+.||.+|||++++++
T Consensus       222 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          222 -------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             -------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                               00122457999999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-44  Score=317.02  Aligned_cols=246  Identities=23%  Similarity=0.370  Sum_probs=193.9

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...|.+.+.||+|+||.||+|.+..+++   .||+|.+....     ....+|+.+++.++||||+++++++....    
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            3467888999999999999999765554   79999886432     33458999999999999999999884322    


Q ss_pred             eeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~-~~~~kl~Dfg~  170 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDE-SFTVKVADFGL  170 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECCTTS
T ss_pred             CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcC-CCcEEeCcCCC
Confidence            22479999996 677776653   35678999999999999999999999 79999999999999996 78999999999


Q ss_pred             ccccccCC-----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCC
Q 018619          161 AKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       161 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      +.......     ......+|+.|+|||.+.+. .++.++||||+||++|+|++| .+||...+..+....+......  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--  247 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL--  247 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--
Confidence            97553322     22334568899999999654 489999999999999999995 5556665555444333321100  


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                                ..+..+++++.+||.+||+.||.+|||+.++++
T Consensus       248 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          248 --------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --------------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                      112357899999999999999999999999874

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=330.39  Aligned_cols=250  Identities=13%  Similarity=0.172  Sum_probs=194.0

Q ss_pred             eeecceeeEeeeeecCCCeEEEEE-----EECCCCcEEEEEEeeccc-cchHHHHHHHHHcC---CCceeecceeeeecC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQA-----KCLETGETVAIKKVLQDR-RYKNRELQLMRVMD---HPNVISLKHCFFSTT   77 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~   77 (353)
                      .+..++|.+.+.||+|+||.||+|     .+..+++.||+|++.... ....+|+.+++.++   |+||+++++++... 
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-  139 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-  139 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-
Confidence            356789999999999999999999     467789999999986543 34567888888887   89999999988443 


Q ss_pred             CCCceeEEEEecccc-chHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC------
Q 018619           78 SKNELFLNLVMEYVP-ESMYRVLKHYSS-ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL------  149 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~-~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~------  149 (353)
                          ...|+|||||+ |+|.+.+..... ....+++..++.++.||+.||+|||+ +||+||||||+|||++..      
T Consensus       140 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          140 ----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             ----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGTCC--
T ss_pred             ----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEecccccCccc
Confidence                33789999998 688888865443 35679999999999999999999999 799999999999999741      


Q ss_pred             ----CCcEEEeeecccccccc---CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHH
Q 018619          150 ----THQVKICDFGSAKQLIA---GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQ  222 (353)
Q Consensus       150 ----~~~vkl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~  222 (353)
                          ++.+||+|||+|+....   ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... 
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                57899999999975432   22334567899999999997654 8999999999999999999999996543210 


Q ss_pred             HHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcc
Q 018619          223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF  296 (353)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~  296 (353)
                                               +........       ...++.+.+++.+||+.+|.+|++..+.+.+.+
T Consensus       293 -------------------------~~~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          293 -------------------------CKPEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             -------------------------EEECSCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             -------------------------eeechhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence                                     000000000       013668899999999999999977655555444

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=325.11  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=188.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHc--CCCceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR-YKNRELQLMRVM--DHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..++|++.+.||+|+||.||+|++  +++.||+|++..... ...+|.+++..+  +||||+++++++..... ....+|
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~~  111 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG-SWTQLY  111 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG-GGCEEE
T ss_pred             cccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC-CCCceE
Confidence            357999999999999999999987  489999999865433 233555555544  89999999998855432 224588


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC--------CeeeccCCCCcEEEeCCCCcEEEe
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP--------RVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~--------~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                      +||||+.+ +|.+.+..     ..+++..++.++.|++.||+|||+ +        ||+||||||+|||++. ++.+||+
T Consensus       112 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl~  184 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKK-NGTCCIA  184 (337)
T ss_dssp             EEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECT-TSCEEEC
T ss_pred             EEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECC-CCCEEEE
Confidence            99999985 88877753     469999999999999999999999 8        9999999999999996 7889999


Q ss_pred             eeccccccccCCCc-----ceeeeeceeeChhhhhCCCCCCc------cccchhHHHHHHHHHhC----------CCCCC
Q 018619          157 DFGSAKQLIAGEAN-----ISYICSRFYRAPELIFGATEYTT------SIDIWSAGCVLAELLLG----------QPLFP  215 (353)
Q Consensus       157 Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DiwSlG~il~~l~~g----------~~pf~  215 (353)
                      |||++.........     ....||+.|+|||++.+.. +..      ++|||||||++|+|++|          ..||.
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            99999765443322     2457899999999996644 344      39999999999999999          66775


Q ss_pred             CCCh----HHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH
Q 018619          216 GENA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA  291 (353)
Q Consensus       216 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~  291 (353)
                      ....    .............         .+     .++       .......+++++.+||.+||+.||.+|||+.++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~---------~~-----~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKL---------RP-----SFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCC---------CC-----CCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhcc---------Cc-----ccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence            4321    1122111110000         00     000       000112356789999999999999999999999


Q ss_pred             hcC
Q 018619          292 CAH  294 (353)
Q Consensus       292 l~h  294 (353)
                      ++|
T Consensus       323 l~~  325 (337)
T 3mdy_A          323 KKT  325 (337)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            865

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.5e-45  Score=323.30  Aligned_cols=257  Identities=23%  Similarity=0.305  Sum_probs=194.7

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .|...+.||+|+||.||+|.+  +++.||+|++...        .....+|+.+++.++||||+++++++..     ...
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCc
Confidence            345568999999999999985  6889999988542        2345689999999999999999998833     334


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .++||||+. ++|.+.+... .....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||++.
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~  181 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDE-AFTAKISDFGLAR  181 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcC-CCcEEEeeccccc
Confidence            889999997 5777777542 345679999999999999999999999 79999999999999996 7899999999998


Q ss_pred             ccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          163 QLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       163 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .......   .....||+.|+|||.+.+  .++.++|||||||++|+|++|..||...+.......+.+...........
T Consensus       182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (307)
T 2nru_A          182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED  259 (307)
T ss_dssp             ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred             ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence            6544322   223568999999999854  37899999999999999999999998765443333332221111100000


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      ......              .......++.+.+++.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~~--------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          260 YIDKKM--------------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HSCSSC--------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hccccc--------------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            000000              00112346789999999999999999999999853

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=331.12  Aligned_cols=247  Identities=22%  Similarity=0.348  Sum_probs=187.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCC---cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...|.+.+.||+|+||.||+|.+..++   ..||+|.+....     ..+.+|+.+++.++||||+++++++...    .
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~  163 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E  163 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence            346899999999999999999875443   468999885432     3345799999999999999999986432    2


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...++||||+.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~-~~~~kL~DFG~  238 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGL  238 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC--
T ss_pred             CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECC-CCCEEEeeccc
Confidence            247799999985 77777653   34568999999999999999999999 79999999999999996 78999999999


Q ss_pred             ccccccCCC-----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          161 AKQLIAGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       161 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      ++.......     .....+|+.|+|||++.+. .++.++|||||||++|+|++ |.+||...+..+....+.+...   
T Consensus       239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~---  314 (373)
T 3c1x_A          239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  314 (373)
T ss_dssp             -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC---
T ss_pred             cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC---
Confidence            986543321     1234567889999999764 48999999999999999999 7888887665554443332100   


Q ss_pred             HHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                               ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       315 -------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          315 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                                     00123578999999999999999999999999754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.4e-44  Score=321.38  Aligned_cols=257  Identities=28%  Similarity=0.356  Sum_probs=193.4

Q ss_pred             eecceeeEeeeeecCCCeEEEEEE----ECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +....|++.+.||+|+||.||++.    +..+++.||+|++....     ....+|+.+++.++||||+++++++...  
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA--  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC--
Confidence            333445999999999999998775    34578999999997542     3356899999999999999999988543  


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                       +...+++||||+++ +|.+.+..     ..+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|
T Consensus       106 -~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~-~~~~kl~D  177 (318)
T 3lxp_A          106 -GAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDN-DRLVKIGD  177 (318)
T ss_dssp             -TTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEEECC
T ss_pred             -CCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcC-CCCEEECC
Confidence             23458899999985 77666643     459999999999999999999999 79999999999999996 78899999


Q ss_pred             eccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          158 FGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       158 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      ||++........    .....+|+.|+|||++.+.. ++.++||||+||++|+|++|..||........     ...+..
T Consensus       178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~  251 (318)
T 3lxp_A          178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIA  251 (318)
T ss_dssp             GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSC
T ss_pred             ccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhccc
Confidence            999987655432    22345688899999997654 78999999999999999999999975432110     000000


Q ss_pred             CHH----HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          234 TRE----EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       234 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      ...    .+......            ......+..+++++.+||.+||+.||.+|||+.+++
T Consensus       252 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  302 (318)
T 3lxp_A          252 QGQMTVLRLTELLER------------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLI  302 (318)
T ss_dssp             CHHHHHHHHHHHHHT------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccchhHHHHHHHHhc------------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            000    00000000            000112346899999999999999999999999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=320.06  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=197.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEE----ECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAK----CLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||.||+|+    +..+++.||+|++....    ....+|+.+++.++||||+++++++....  
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence            456789999999999999999998    46789999999986542    34568999999999999999998874322  


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                       ...+++||||+++ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+||
T Consensus       116 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~-~~~~kL~Df  189 (326)
T 2w1i_A          116 -RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVEN-ENRVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEEEECCC
T ss_pred             -CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcC-CCcEEEecC
Confidence             2347899999984 88777764   34569999999999999999999999 79999999999999996 789999999


Q ss_pred             ccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 018619          159 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT  234 (353)
Q Consensus       159 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  234 (353)
                      |++.........    ....++..|+|||.+.+.. ++.++|||||||++|+|++|..||......     ..+..+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~-----~~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-----HHHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHH-----HHHhhcccc
Confidence            999876544321    2234577899999997654 889999999999999999999998643211     111111111


Q ss_pred             HHH-----H-hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          235 REE-----I-RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       235 ~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ...     + ...... .            ....+..+++++.+||++||+.||.+|||+.++++
T Consensus       264 ~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          264 QGQMIVFHLIELLKNN-G------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CTHHHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             chhhhHHHHHHHhhcC-C------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            100     0 000000 0            00123458999999999999999999999999874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.1e-44  Score=342.92  Aligned_cols=248  Identities=26%  Similarity=0.312  Sum_probs=202.4

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |.+..++|++.+.||+|+||.||++.+.. +..||||++....   ..+.+|+.+++.++||||+++++++..      .
T Consensus       262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~  334 (535)
T 2h8h_A          262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E  334 (535)
T ss_dssp             SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred             eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------c
Confidence            44667899999999999999999999864 4679999997543   345689999999999999999988732      2


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+|||||. ++|.+.+...  ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~-~~~~kl~DFG~a  410 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLA  410 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCTTST
T ss_pred             cceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcC-CCcEEEcccccc
Confidence            3789999998 5888777542  23568999999999999999999999 79999999999999996 788999999999


Q ss_pred             cccccCC--CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGE--ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +......  ......++..|+|||++.+. .++.++|||||||++|+|++ |..||.+....+.+..+......      
T Consensus       411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------  483 (535)
T 2h8h_A          411 RLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------  483 (535)
T ss_dssp             TTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             eecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------
Confidence            8654321  11223457789999998764 48999999999999999999 99999988877766554431110      


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                            ..+..+++++.+||.+||+.||++|||++++++
T Consensus       484 ----------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          484 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                  122457899999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1e-43  Score=344.94  Aligned_cols=244  Identities=24%  Similarity=0.289  Sum_probs=193.8

Q ss_pred             ecceeeEe-eeeecCCCeEEEEEEE--CCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            9 QTISYMAE-RVVGTGSFGIVFQAKC--LETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         9 ~~~~y~~~-~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      ....+.+. +.||+|+||.||+|.+  ..+++.||||++....      ..+.+|+.+++.++||||+++++++.     
T Consensus       366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----  440 (635)
T 4fl3_A          366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----  440 (635)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----
Confidence            33445554 4899999999999954  4567899999986532      34568999999999999999999872     


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      .. ..++|||||. ++|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       441 ~~-~~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~-~~~~kL~DF  513 (635)
T 4fl3_A          441 AE-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDF  513 (635)
T ss_dssp             SS-SEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCT
T ss_pred             cC-CEEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeC-CCCEEEEEc
Confidence            11 2679999998 56776664    35679999999999999999999999 79999999999999996 789999999


Q ss_pred             ccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+|+.......    .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+...... 
T Consensus       514 Gla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-  591 (635)
T 4fl3_A          514 GLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-  591 (635)
T ss_dssp             THHHHTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-
T ss_pred             CCccccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99987654332    2233457889999999664 48999999999999999998 99999998887666555432110 


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                                 ..+..+++++.+||.+||+.||.+|||++++++
T Consensus       592 ---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          592 ---------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence                                       123458999999999999999999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.6e-46  Score=336.78  Aligned_cols=249  Identities=20%  Similarity=0.202  Sum_probs=184.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHcC---------CCce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMD---------HPNV   66 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~~i   66 (353)
                      +..++|++.+.||+|+||+||+|++  +|+.||||++....            ....+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            3457899999999999999999998  78999999997542            34568999999886         5555


Q ss_pred             eecce-----------------eeeecC--------CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHH
Q 018619           67 ISLKH-----------------CFFSTT--------SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQ  120 (353)
Q Consensus        67 v~~~~-----------------~~~~~~--------~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~q  120 (353)
                      +++.+                 +|....        ..+...+|+|||||.+ ++++.+.     ...+++..++.++.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQ  169 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHH
Confidence            55544                 442210        0114458899999975 3444432     256899999999999


Q ss_pred             HHHHHHHhH-cCCCeeeccCCCCcEEEeCCCC--------------------cEEEeeeccccccccCCCcceeeeecee
Q 018619          121 IFRGLAYIH-TVPRVCHRDLKPQNLLVDPLTH--------------------QVKICDFGSAKQLIAGEANISYICSRFY  179 (353)
Q Consensus       121 ll~al~~LH-~~~~i~H~Dlkp~Nill~~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~t~~y  179 (353)
                      |+.||+||| + +||+||||||+|||++. ++                    .+||+|||+|+.....    ...||+.|
T Consensus       170 i~~aL~~lH~~-~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y  243 (336)
T 2vuw_A          170 LTASLAVAEAS-LRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHHHH-HCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCT
T ss_pred             HHHHHHHHHHh-CCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecc
Confidence            999999999 9 79999999999999996 44                    8999999999865432    45899999


Q ss_pred             eChhhhhCCCCCCccccchhHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCc
Q 018619          180 RAPELIFGATEYTTSIDIWSAGCV-LAELLLGQPLFPGENAVD-QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHP  257 (353)
Q Consensus       180 ~aPE~~~~~~~~~~~~DiwSlG~i-l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (353)
                      +|||++.+..  +.++||||+|++ .+++++|..||....... ....+........                      .
T Consensus       244 ~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------------------~  299 (336)
T 2vuw_A          244 MDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT----------------------K  299 (336)
T ss_dssp             TCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS----------------------C
T ss_pred             cChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc----------------------c
Confidence            9999997643  889999998777 777889999984321111 1112221100000                      0


Q ss_pred             cccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh-cCcccc
Q 018619          258 WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFD  298 (353)
Q Consensus       258 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l-~hp~f~  298 (353)
                      ........+++++++||++||++|     |++|+| +||||+
T Consensus       300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            000112347889999999999987     999999 999995

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-43  Score=342.20  Aligned_cols=251  Identities=26%  Similarity=0.310  Sum_probs=197.5

Q ss_pred             eecceeeEee-eeecCCCeEEEEEEEC--CCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAER-VVGTGSFGIVFQAKCL--ETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..+++.+.+ .||+|+||.||+|.++  .++..||||++...     ...+.+|+.+++.++||||+++++++..    
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----  407 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----  407 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES----
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc----
Confidence            4456666666 8999999999999875  35667999998653     2345689999999999999999998732    


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                        ..+++|||||.+ +|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       408 --~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~-~~~vkL~DF  480 (613)
T 2ozo_A          408 --EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVN-RHYAKISDF  480 (613)
T ss_dssp             --SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCC
T ss_pred             --CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcC-CCcEEEeec
Confidence              127899999985 67666643   35679999999999999999999999 79999999999999996 789999999


Q ss_pred             ccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+++........    ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.+...  
T Consensus       481 Gla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~--  557 (613)
T 2ozo_A          481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--  557 (613)
T ss_dssp             STTTTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--
T ss_pred             cCcccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999866443221    122346789999999654 58999999999999999998 9999999887776655443110  


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH---hcCcccc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFD  298 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~---l~hp~f~  298 (353)
                                                ..++..+++++.+||.+||+.||.+|||+.++   |++.|++
T Consensus       558 --------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          558 --------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                                      01234589999999999999999999999987   4454443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=318.84  Aligned_cols=254  Identities=20%  Similarity=0.249  Sum_probs=197.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +.+..++|++.+.||+|+||.||++.+..   .||+|++...      .....+|+.+++.++||||+++++++...   
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---  101 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP---  101 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS---
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC---
Confidence            45667899999999999999999998753   4999988542      23445899999999999999999988433   


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                        ..+++||||+. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++  ++.+||+||
T Consensus       102 --~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~--~~~~~l~Df  173 (319)
T 2y4i_B          102 --PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD--NGKVVITDF  173 (319)
T ss_dssp             --SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC----CCEECCC
T ss_pred             --CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe--CCCEEEeec
Confidence              34889999998 576666543   34579999999999999999999999 7999999999999998  468999999


Q ss_pred             ccccccccC------CCcceeeeeceeeChhhhhC--------CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHH
Q 018619          159 GSAKQLIAG------EANISYICSRFYRAPELIFG--------ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLV  224 (353)
Q Consensus       159 g~a~~~~~~------~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~  224 (353)
                      |++......      .......||+.|+|||++.+        ...++.++|||||||++|+|++|..||...+......
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  253 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW  253 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            998754321      12233457899999999864        2347889999999999999999999999888766655


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      .+.......                           .....++.++.++|.+||+.||.+|||+.++++  .++.+..
T Consensus       254 ~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~  302 (319)
T 2y4i_B          254 QMGTGMKPN---------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPK  302 (319)
T ss_dssp             HHHTTCCCC---------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--
T ss_pred             HhccCCCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHH
Confidence            443311000                           011247889999999999999999999999984  4454433

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.4e-43  Score=317.89  Aligned_cols=254  Identities=22%  Similarity=0.298  Sum_probs=194.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHH--cCCCceeecceeeeecCCCCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRV--MDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      .++|.+.+.||+|+||.||++++  +|+.||||++.... ....+|..++..  ++||||+++++++.... .....+++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~l  117 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL  117 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEE
Confidence            57899999999999999999987  68999999986543 334578888887  78999999999875433 12235889


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH--------cCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH--------TVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH--------~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      ||||+.+ +|.+.+..     ..+++..++.++.|++.||+|||        + +||+||||||+||+++. ++.+||+|
T Consensus       118 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~-~~~~kL~D  190 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKK-NGTCCIAD  190 (342)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECT-TSCEEECC
T ss_pred             EEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECC-CCCEEEEE
Confidence            9999985 88877754     46999999999999999999999        8 79999999999999996 78999999


Q ss_pred             eccccccccCCC-----cceeeeeceeeChhhhhCCCC-----CCccccchhHHHHHHHHHhC----------CCCCCCC
Q 018619          158 FGSAKQLIAGEA-----NISYICSRFYRAPELIFGATE-----YTTSIDIWSAGCVLAELLLG----------QPLFPGE  217 (353)
Q Consensus       158 fg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~~l~~g----------~~pf~~~  217 (353)
                      ||++........     .....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            999986654432     234578999999999966432     23689999999999999999          7888664


Q ss_pred             Ch----HHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          218 NA----VDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       218 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ..    .+...........         .+     .++    ..|   .....+..+.+||.+||+.||++|||+.++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~---------~~-----~~~----~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~  329 (342)
T 1b6c_B          271 VPSDPSVEEMRKVVCEQKL---------RP-----NIP----NRW---QSCEALRVMAKIMRECWYANGAARLTALRIKK  329 (342)
T ss_dssp             SCSSCCHHHHHHHHTTSCC---------CC-----CCC----GGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcCcccHHHHHHHHHHHHh---------CC-----CCc----ccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            32    1222211110000         00     000    000   01124568899999999999999999999986


Q ss_pred             C
Q 018619          294 H  294 (353)
Q Consensus       294 h  294 (353)
                      |
T Consensus       330 ~  330 (342)
T 1b6c_B          330 T  330 (342)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.8e-43  Score=340.37  Aligned_cols=246  Identities=27%  Similarity=0.357  Sum_probs=199.3

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCC---CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|.+.+.||+|+||.||+|.+..+   +..||+|.+....     ....+|+.+++.++||||+++++++.     
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----  461 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----  461 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence            5578899999999999999999998654   4579999886432     34558999999999999999999872     


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      . ..+|+||||+. |+|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~-~~~vkL~DF  535 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDF  535 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEECCC
T ss_pred             c-CceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeC-CCCEEEEec
Confidence            1 12679999998 577777653   34568999999999999999999999 79999999999999996 789999999


Q ss_pred             ccccccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          159 GSAKQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       159 g~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      |++.........  ....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..+....+......   
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---  611 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---  611 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            999866443322  234457889999999664 58999999999999999997 99999998887776665542111   


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                               .++..+++++.+||.+||+.||.+|||+.++++
T Consensus       612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                                     122457899999999999999999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-43  Score=345.64  Aligned_cols=244  Identities=24%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECC-CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLE-TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      +..++|++.+.||+|+||.||++.+.. +|+.||||++....     ....+|+.+++.++||||+++++++......+.
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            446899999999999999999999976 78999999885432     234579999999999999999999876655455


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...|+||||++| +|.+.+.      ..+++..++.++.||+.||.|||+ +||+||||||+|||++.  +.+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~--~~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTE--EQLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS--SCEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeC--CcEEEEeccc
Confidence            557899999985 5443322      379999999999999999999999 79999999999999985  3799999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      ++.....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|.+||.+....          +         
T Consensus       228 a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~---------  283 (681)
T 2pzi_A          228 VSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------G---------  283 (681)
T ss_dssp             CEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------S---------
T ss_pred             chhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------c---------
Confidence            9865443   345789999999998653  588999999999999999999988642110          0         


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                               .+.  ..+     ....++.+.+||.+||+.||.+||+..+.+.|+|+.-+
T Consensus       284 ---------~~~--~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 ---------LPE--DDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ---------CCT--TCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ---------ccc--ccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                     000  000     01246789999999999999999999999999998654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.1e-41  Score=298.42  Aligned_cols=228  Identities=14%  Similarity=0.057  Sum_probs=177.8

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      +..++|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.++..++||||+++++++..     
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----  102 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----  102 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----
Confidence            55688999999999999999999999999999999996542       345689999999999999999998843     


Q ss_pred             ceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....|+||||++ ++|.+.+..     + .....+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+++|
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~-~g~~kl~~~~  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSI-DGDVVLAYPA  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEET-TSCEEECSCC
T ss_pred             CCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcC-CCCEEEEecc
Confidence            344889999998 477666532     2 3556788899999999999999 79999999999999996 7889998544


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .                   ++        .++.++|||||||++|+|++|+.||.+.+..+.+..              
T Consensus       175 ~-------------------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------  213 (286)
T 3uqc_A          175 T-------------------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------  213 (286)
T ss_dssp             C-------------------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------
T ss_pred             c-------------------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------
Confidence            2                   22        378999999999999999999999987653211100              


Q ss_pred             hcCcCCCCCcCCCC-CCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          240 CMNPNYTDFRFPQI-KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                               ..... ........+...+++++.+||.+||+.||.+| |+.++++  .+.++.
T Consensus       214 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~~  264 (286)
T 3uqc_A          214 ---------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQAT  264 (286)
T ss_dssp             ---------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHHH
T ss_pred             ---------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHHh
Confidence                     00000 00011112334689999999999999999999 9999985  344443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.5e-35  Score=279.36  Aligned_cols=180  Identities=19%  Similarity=0.088  Sum_probs=124.7

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeeccc--------------cchHHHHHHHHHc-CCCceeecceeeeecCCCCc
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--------------RYKNRELQLMRVM-DHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...+.|+.|.+..++....|+.||+|.+.++.              +.+.+|+++|+++ .|+||+++++++     +++
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~  314 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENA  314 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECS
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EEC
Confidence            35667888888888878899999999996542              2345799999999 699999999998     555


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|||||||+| +|.+.+.    ..+++++.   .|+.||+.||+|||+ +||+||||||+|||++. ++++||+|||+
T Consensus       315 ~~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~-dg~vKL~DFGl  385 (569)
T 4azs_A          315 QSGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDA-RQHARLIDFGS  385 (569)
T ss_dssp             SEEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECT-TSCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECC-CCCEEEeeccc
Confidence            669999999996 6666665    45677765   478999999999999 79999999999999996 88999999999


Q ss_pred             ccccccCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCC
Q 018619          161 AKQLIAGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQP  212 (353)
Q Consensus       161 a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~  212 (353)
                      |+...... ...+.+||+.|+|||++.+  .+..++|+||+|+++++|.++..
T Consensus       386 Ar~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          386 IVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             EESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             CeeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccc
Confidence            98665433 3445789999999999865  36778999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.8e-28  Score=233.55  Aligned_cols=179  Identities=17%  Similarity=0.209  Sum_probs=133.5

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ...+.||+|+||.||++.  ..++.+++|+.....            ....+|+.+++.++||||+++..+......   
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~---  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN---  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence            446699999999999994  467889999764321            224689999999999999955444432222   


Q ss_pred             eeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                        .|+|||||+ ++|.+.+..            +..++.|++.||+|||+ +||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC---eEEEEECcc
Confidence              579999998 677666542            56789999999999999 79999999999999994   899999999


Q ss_pred             ccccccCCCc--------ceeeeeceeeChhhhhCC-CCCCccccchhHHHHHHHHHhCCCCCC
Q 018619          161 AKQLIAGEAN--------ISYICSRFYRAPELIFGA-TEYTTSIDIWSAGCVLAELLLGQPLFP  215 (353)
Q Consensus       161 a~~~~~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~  215 (353)
                      |+........        ....||+.|+|||++.+. ..|+..+|+||..+-..+.+.++.+|.
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9876543221        256789999999998541 247888999999998888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=2.9e-25  Score=194.50  Aligned_cols=139  Identities=17%  Similarity=0.191  Sum_probs=109.3

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHHcCCCceeec
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISL   69 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~   69 (353)
                      .|.+.+.||+|+||.||+|.+ .+|+.||+|.+....                      ....+|+.+++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            345559999999999999999 889999999985321                      23468999999999  5 677


Q ss_pred             ceeeeecCCCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           70 KHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        70 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                      .+++..      ...|+||||++| +|.+ +          .......++.|++.||.|||+ +||+||||||+|||++ 
T Consensus       167 ~~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          167 PKVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             CCEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-
T ss_pred             CeEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-
Confidence            665521      236899999986 5443 2          112355799999999999999 7999999999999999 


Q ss_pred             CCCcEEEeeeccccccccCCCcceeeeeceeeChhhhh
Q 018619          149 LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF  186 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~  186 (353)
                       ++.+||+|||+|..            +..+.|||.+.
T Consensus       228 -~~~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence             67899999999963            33467888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=2.8e-22  Score=173.39  Aligned_cols=135  Identities=19%  Similarity=0.235  Sum_probs=103.5

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcE--EEEEEeeccc----------------------------cchHHHHHHHHHc
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQDR----------------------------RYKNRELQLMRVM   61 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l   61 (353)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478999999999999999998788999  9999864321                            1356799999999


Q ss_pred             CCCceeecceeeeecCCCCceeEEEEeccccc------hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhH-cCCCe
Q 018619           62 DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE------SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH-TVPRV  134 (353)
Q Consensus        62 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH-~~~~i  134 (353)
                      .|+++... ..+. .     ...++||||+++      .|.+....       .++..+..++.|++.||.||| + +||
T Consensus       128 ~~~~i~~p-~~~~-~-----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~-~gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYT-Y-----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE-AEL  192 (258)
T ss_dssp             HHTTCCCC-CEEE-E-----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT-SCE
T ss_pred             HhCCCCCC-eEEE-c-----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH-CCE
Confidence            88764221 1121 1     125799999953      44433211       235567889999999999999 9 799


Q ss_pred             eeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619          135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus       135 ~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999984   7999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=7e-19  Score=158.28  Aligned_cols=135  Identities=13%  Similarity=0.129  Sum_probs=91.5

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc--------------------------hHHHHHHHHHcCCCc
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY--------------------------KNRELQLMRVMDHPN   65 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~E~~~l~~l~h~~   65 (353)
                      -|++.+.||+|++|.||+|.+ .+|+.||||++......                          ..+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            389999999999999999997 57999999987432100                          013444444443322


Q ss_pred             eeecceeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEE
Q 018619           66 VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL  145 (353)
Q Consensus        66 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nil  145 (353)
                      +. ....+ ..     ...++||||++|..   +...      ........++.|++.+|.+||+ +|||||||||.|||
T Consensus       175 v~-vp~p~-~~-----~~~~LVME~i~G~~---L~~l------~~~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FP-VPEPI-AQ-----SRHTIVMSLVDALP---MRQV------SSVPDPASLYADLIALILRLAK-HGLIHGDFNEFNIL  237 (397)
T ss_dssp             CS-CCCEE-EE-----ETTEEEEECCSCEE---GGGC------CCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEE
T ss_pred             CC-CCeee-ec-----cCceEEEEecCCcc---Hhhh------cccHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEE
Confidence            21 11111 00     11359999999742   2211      1122356788999999999999 79999999999999


Q ss_pred             EeCCCC----------cEEEeeeccccccc
Q 018619          146 VDPLTH----------QVKICDFGSAKQLI  165 (353)
Q Consensus       146 l~~~~~----------~vkl~Dfg~a~~~~  165 (353)
                      ++. ++          .+.|+||+-+....
T Consensus       238 l~~-dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          238 IRE-EKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEE-EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EeC-CCCcccccccccceEEEEeCCcccCC
Confidence            985 33          38999999876543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.35  E-value=4.1e-12  Score=109.69  Aligned_cols=135  Identities=16%  Similarity=0.088  Sum_probs=99.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeec----cccchHHHHHHHHHcC-CCceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQ----DRRYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +.|++...++.|+.+.||++..  .++.+++|....    ......+|+.+++.+. +..+.++++...     .....|
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~   86 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSN   86 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEE
T ss_pred             ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCCceE
Confidence            4689999999999999999974  468999998863    3345779999999885 556666666552     223478


Q ss_pred             EEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------
Q 018619           86 LVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------  131 (353)
Q Consensus        86 lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~---------------------------------  131 (353)
                      +|||+++|. +.+.+         .+......++.++..+|..||+.                                 
T Consensus        87 lv~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            999999984 32221         01122346778899999999981                                 


Q ss_pred             -------------------------CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 -------------------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 -------------------------~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                                               ..++|+|++|.||+++. +..+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence                                     24899999999999984 5556799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=5.5e-11  Score=102.25  Aligned_cols=133  Identities=14%  Similarity=0.060  Sum_probs=90.2

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-ccchHHHHHHHHHcCCCc--eeecceeeeecCCCCceeEEEEe
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-RRYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVM   88 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~   88 (353)
                      .|.+..+.+.|..+.||++. ..+|+.+++|..... .....+|+.+++.+.+.+  +.+++.....     ....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence            45665555567779999996 456788999987543 244678999999886544  3445554421     22377999


Q ss_pred             ccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCC------------------------------------
Q 018619           89 EYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP------------------------------------  132 (353)
Q Consensus        89 e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~------------------------------------  132 (353)
                      |+++|.... .       ....   ...++.++...|..||+..                                    
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999974222 1       0111   1245667777777777621                                    


Q ss_pred             ---------------------CeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          133 ---------------------RVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       133 ---------------------~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                                           +++|+|++|.||+++. +..+.|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence                                 1999999999999985 5556799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.07  E-value=4.6e-10  Score=101.41  Aligned_cols=141  Identities=17%  Similarity=0.179  Sum_probs=98.7

Q ss_pred             eEeeeeecCCCeEEEEEEECCCCcEEEEEEee--cc-----ccchHHHHHHHHHcCC--CceeecceeeeecCCCCceeE
Q 018619           14 MAERVVGTGSFGIVFQAKCLETGETVAIKKVL--QD-----RRYKNRELQLMRVMDH--PNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .-.+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.+..  ..+.+++..+.+.  ......
T Consensus        41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~  116 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRA  116 (359)
T ss_dssp             CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSC
T ss_pred             ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCe
Confidence            3467889999999999875  34688999776  22     3456789999999974  3455665544221  111236


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC---------------------------------
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV---------------------------------  131 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~---------------------------------  131 (353)
                      |+|||+++|..   +..  .....++......++.++..+|..||+.                                 
T Consensus       117 ~~vme~v~G~~---l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          117 FYIMEFVSGRV---LWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEEEECCCCBC---CCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEEEecCCee---cCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            69999999842   110  1123467888888999999999999972                                 


Q ss_pred             ------------------------CCeeeccCCCCcEEEeCCCC-cEEEeeeccccc
Q 018619          132 ------------------------PRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQ  163 (353)
Q Consensus       132 ------------------------~~i~H~Dlkp~Nill~~~~~-~vkl~Dfg~a~~  163 (353)
                                              ..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    36899999999999986332 369999999863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.04  E-value=1e-10  Score=103.14  Aligned_cols=185  Identities=16%  Similarity=0.195  Sum_probs=111.5

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCceeecceeeeecC-CCCceeEEEEecccc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTT-SKNELFLNLVMEYVP   92 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv~e~~~   92 (353)
                      .+.++.|....||++.     ..+++|.....  .....+|..+++.+....-+.+-.++.... .......|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999763     56899976543  244568999998884322122222222211 122223568999999


Q ss_pred             ch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------------
Q 018619           93 ES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------------  131 (353)
Q Consensus        93 ~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~----------------------------------------  131 (353)
                      |. +.....      ..++..+...++.|+...|..||+.                                        
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            73 221111      2356666667777777777777751                                        


Q ss_pred             -----------------CCeeeccCCCCcEEEeCC-CCcEEEeeeccccccccCCCccee------ee---------ece
Q 018619          132 -----------------PRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQLIAGEANISY------IC---------SRF  178 (353)
Q Consensus       132 -----------------~~i~H~Dlkp~Nill~~~-~~~vkl~Dfg~a~~~~~~~~~~~~------~~---------t~~  178 (353)
                                       ..++|+|++|.||+++.+ +..+.|+||+.+............      .+         ...
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                             247999999999999953 346789999998643221100000      00         001


Q ss_pred             eeC-hhhhhCCCCCCccccchhHHHHHHHHHhCCCCC
Q 018619          179 YRA-PELIFGATEYTTSIDIWSAGCVLAELLLGQPLF  214 (353)
Q Consensus       179 y~a-PE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  214 (353)
                      ... |+....   ...-.+.|++|.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r---~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEK---YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHH---HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHH---HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111 222211   122368999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.59  E-value=3.8e-07  Score=80.22  Aligned_cols=69  Identities=10%  Similarity=-0.056  Sum_probs=45.0

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCc---eeecceeeeecCCCCceeEEEEecc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPN---VISLKHCFFSTTSKNELFLNLVMEY   90 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~   90 (353)
                      .+.++.|....||++     |..+++|+....  .....+|..+|+.+.+..   +.+.+....  .  .....++|||+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEec
Confidence            456788998999987     577899975432  234568999999997532   222222221  1  12235699999


Q ss_pred             ccc
Q 018619           91 VPE   93 (353)
Q Consensus        91 ~~~   93 (353)
                      ++|
T Consensus        95 i~G   97 (306)
T 3tdw_A           95 VQG   97 (306)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            997

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.42  E-value=2.4e-06  Score=73.49  Aligned_cols=130  Identities=15%  Similarity=0.140  Sum_probs=83.2

Q ss_pred             eecCCCe-EEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHcCC-CceeecceeeeecCCCCceeEEEEeccccch-
Q 018619           19 VGTGSFG-IVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLNLVMEYVPES-   94 (353)
Q Consensus        19 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-   94 (353)
                      +..|..| .||+......+..+++|.-.... ....+|...|+.+.. -.+.+++.+..+     ....++|||+++|. 
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence            3445444 69998877777889999875442 345689999988852 123344443322     22367999999973 


Q ss_pred             HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------------------------------------------
Q 018619           95 MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------------------------------------------  131 (353)
Q Consensus        95 l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-------------------------------------------  131 (353)
                      +.+....        .......+..++...|.-||+.                                           
T Consensus       107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            3322211        1112234555666666666652                                           


Q ss_pred             --------------CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 --------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 --------------~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                                    ..++|+|++|.||+++. ++.+-|+||+.+.
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~  222 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence                          01799999999999995 5666799999885

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.24  E-value=4.8e-06  Score=74.16  Aligned_cols=30  Identities=27%  Similarity=0.589  Sum_probs=26.5

Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      ..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence            58999999999999975 5679999999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.15  E-value=1.2e-05  Score=72.06  Aligned_cols=78  Identities=12%  Similarity=0.081  Sum_probs=48.8

Q ss_pred             eEeeee-ecCCCeEEEEEEEC--C----CCcEEEEEEeeccc-------cchHHHHHHHHHcCC---Cceeecceeeeec
Q 018619           14 MAERVV-GTGSFGIVFQAKCL--E----TGETVAIKKVLQDR-------RYKNRELQLMRVMDH---PNVISLKHCFFST   76 (353)
Q Consensus        14 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~~iv~~~~~~~~~   76 (353)
                      ...+.| +.|....+|++...  .    +++.+++|......       ....+|+.+++.+..   -.+.+++......
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345677 88889999988753  0    26789999775432       346789999888742   2344444433111


Q ss_pred             CCCCceeEEEEeccccc
Q 018619           77 TSKNELFLNLVMEYVPE   93 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~~   93 (353)
                        ......++|||+++|
T Consensus       103 --~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          103 --DVLGTPFFLMDYVEG  117 (357)
T ss_dssp             --TTTSSCEEEEECCCC
T ss_pred             --CccCCceEEEEecCC
Confidence              111234689999986

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.14  E-value=1.5e-05  Score=72.59  Aligned_cols=72  Identities=19%  Similarity=0.184  Sum_probs=44.5

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----------cchHHHHHHHHHcCC--Cc-eeecceeeeecCCCC
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----------RYKNRELQLMRVMDH--PN-VISLKHCFFSTTSKN   80 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h--~~-iv~~~~~~~~~~~~~   80 (353)
                      -.+.+|.|..+.||++....+++.|++|......           .....|..+++.+..  |. +.+++..  +..   
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~---  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE---  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT---
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC---
Confidence            4568999999999999765567899999764221           223578888887742  33 2233321  211   


Q ss_pred             ceeEEEEeccccc
Q 018619           81 ELFLNLVMEYVPE   93 (353)
Q Consensus        81 ~~~~~lv~e~~~~   93 (353)
                      .  .++|||++++
T Consensus       109 ~--~~lvmE~l~g  119 (397)
T 2olc_A          109 M--AVTVMEDLSH  119 (397)
T ss_dssp             T--TEEEECCCTT
T ss_pred             c--cEEEEEeCCC
Confidence            1  4589999975

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.72  E-value=0.00019  Score=62.68  Aligned_cols=65  Identities=15%  Similarity=0.098  Sum_probs=40.4

Q ss_pred             eeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCce-eecceeeeecCCCCceeEEEEeccc
Q 018619           16 ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEYV   91 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~~   91 (353)
                      .+.|+.|....+|++      +.+++|+.....   ....+|..+++.+....+ .+++...     ...  -++++||+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            678899999999998      568999875432   223578888877743222 2332221     111  23789999


Q ss_pred             -cc
Q 018619           92 -PE   93 (353)
Q Consensus        92 -~~   93 (353)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             54

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.62  E-value=0.00052  Score=55.98  Aligned_cols=98  Identities=17%  Similarity=0.060  Sum_probs=63.1

Q ss_pred             hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCccee
Q 018619           94 SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY  173 (353)
Q Consensus        94 ~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (353)
                      +|.++|..   .+.+++++++|.++.|.+.+|.-+-..+.-..+=+.|..|++.. +|.|.+.+ +.+.           
T Consensus        34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~-dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWR-DGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEET-TSCEEECC-C--------------
T ss_pred             cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEec-CCceeccc-cccc-----------
Confidence            67778876   47899999999999999999887621011113334578899986 77776653 1110           


Q ss_pred             eeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh
Q 018619          174 ICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL  209 (353)
Q Consensus       174 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~  209 (353)
                      .....+.|||...  ...+.+.=|+|||+++|.-+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1122466888752  235678899999999999884

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.59  E-value=0.0013  Score=56.86  Aligned_cols=76  Identities=13%  Similarity=0.045  Sum_probs=50.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +....-++.+|.|..+.||++.. .+|+.|++|+.....    ..+.+|+..|+.+....-+.+-.++...  .    -+
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~   86 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RT   86 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ce
Confidence            34456678899999999999984 578999999875432    2357899999988532112221222111  1    24


Q ss_pred             EEecccc
Q 018619           86 LVMEYVP   92 (353)
Q Consensus        86 lv~e~~~   92 (353)
                      +|||++.
T Consensus        87 lv~e~l~   93 (288)
T 3f7w_A           87 LAMEWVD   93 (288)
T ss_dssp             EEEECCC
T ss_pred             EEEEeec
Confidence            7899886

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.53  E-value=0.0006  Score=62.48  Aligned_cols=79  Identities=13%  Similarity=-0.041  Sum_probs=45.7

Q ss_pred             HcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccCCCcceeee--eceeeChhhhhCCCC--CCccccchhHHHHH
Q 018619          129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATE--YTTSIDIWSAGCVL  204 (353)
Q Consensus       129 H~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~--~~~~~DiwSlG~il  204 (353)
                      +. ..++|+|++|.||+++. ++ ++++||+.+..-...........  ...|.+|+.......  -....++.++...+
T Consensus       230 ~~-~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          230 RA-QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             BC-CEEECSCCSGGGEEECS-SC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CC-CeEEecCCCCCcEEEeC-CC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            45 68999999999999985 44 99999999874321111101111  133555554421110  11224445777777


Q ss_pred             HHHHhC
Q 018619          205 AELLLG  210 (353)
Q Consensus       205 ~~l~~g  210 (353)
                      +..+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.41  E-value=0.00054  Score=60.21  Aligned_cols=144  Identities=11%  Similarity=0.024  Sum_probs=73.5

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeec--cccchHHHHHHHHHcCCCc--eeecceeeeecCC--CCceeEEEEe
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQ--DRRYKNRELQLMRVMDHPN--VISLKHCFFSTTS--KNELFLNLVM   88 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~   88 (353)
                      -.+.|+.|....+|++...  +..+++|....  .......|..+++.+....  +.+++... ....  ......++++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCSCEEETTEEEEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCEEEEECCEEEEEE
Confidence            3456778888999998752  34788998865  3445567888887774222  22222110 0000  0012356899


Q ss_pred             ccccchH------------HHH---HHhhhhc-CCC----CC---HHHHH--------H----HHHHHHHHHHHhHc---
Q 018619           89 EYVPESM------------YRV---LKHYSSA-NQR----MP---LIYVK--------L----YTYQIFRGLAYIHT---  130 (353)
Q Consensus        89 e~~~~~l------------~~~---l~~~~~~-~~~----l~---~~~~~--------~----i~~qll~al~~LH~---  130 (353)
                      ++++|..            ...   +...... ..+    ..   +....        .    +...+...++.+..   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9997621            111   1111000 000    01   11000        0    00112333444442   


Q ss_pred             ---CCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          131 ---VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       131 ---~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                         ..+++|+|+++.||+++. +..+.|+||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence               137999999999999985 5545799999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.34  E-value=0.0036  Score=57.83  Aligned_cols=70  Identities=14%  Similarity=0.230  Sum_probs=44.5

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeecccc---chHHHHHHHHHcCCCce-eecceeeeecCCCCceeEEEEecc
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFLNLVMEY   90 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~   90 (353)
                      -.+.|+.|....+|++.....+..|++|+......   ...+|..+++.+...++ .+++..+     .+    ..||||
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            34578888889999998654457899998754322   22589999999865444 3444433     21    148888


Q ss_pred             ccc
Q 018619           91 VPE   93 (353)
Q Consensus        91 ~~~   93 (353)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.30  E-value=0.0019  Score=59.25  Aligned_cols=70  Identities=14%  Similarity=0.238  Sum_probs=45.4

Q ss_pred             EeeeeecCCCeEEEEEEECC-------CCcEEEEEEeec-cc-cchHHHHHHHHHcCCCce-eecceeeeecCCCCceeE
Q 018619           15 AERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQ-DR-RYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~   84 (353)
                      -.+.|+.|....||++....       .++.|++|+... .. ....+|..+++.+...++ .++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            35678888889999998642       257899998844 22 344478888888753333 3444433     21    


Q ss_pred             EEEeccccc
Q 018619           85 NLVMEYVPE   93 (353)
Q Consensus        85 ~lv~e~~~~   93 (353)
                      .+|+||++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            178888875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.29  E-value=0.0018  Score=56.75  Aligned_cols=72  Identities=13%  Similarity=0.032  Sum_probs=49.7

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHcCC---CceeecceeeeecCCCCceeEEEEecc
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDH---PNVISLKHCFFSTTSKNELFLNLVMEY   90 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~~~lv~e~   90 (353)
                      -.+.|+.|....+|++..  .+..+++|...... ....+|...|+.+..   ..+.+++....     .....++|||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEe
Confidence            356789999999999874  56789999876543 345689888888742   34555544331     12347799999


Q ss_pred             ccc
Q 018619           91 VPE   93 (353)
Q Consensus        91 ~~~   93 (353)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            985

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0022  Score=56.61  Aligned_cols=32  Identities=41%  Similarity=0.476  Sum_probs=26.9

Q ss_pred             CCeeeccCCCCcEEEeCC---CCcEEEeeeccccc
Q 018619          132 PRVCHRDLKPQNLLVDPL---THQVKICDFGSAKQ  163 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~---~~~vkl~Dfg~a~~  163 (353)
                      ..++|+|+.+.||+++.+   .+.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            579999999999999852   15799999998863

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.18  E-value=0.002  Score=58.02  Aligned_cols=138  Identities=14%  Similarity=0.198  Sum_probs=75.5

Q ss_pred             eeeeecCCCeEEEEEEECC-------CCcEEEEEEeecc---ccchHHHHHHHHHcCCCce-eecceeeeecCCCCceeE
Q 018619           16 ERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQD---RRYKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~   84 (353)
                      .+.|..|....+|++....       .++.|++|+....   .....+|..+++.+..-.+ .+++..+     .+    
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            4567778888999988532       3578999986432   2234579888887742222 3343333     22    


Q ss_pred             EEEeccccchH---------------HHHHHhhhhc----CCCC--CHHHHHHHHHHHHH-------------------H
Q 018619           85 NLVMEYVPESM---------------YRVLKHYSSA----NQRM--PLIYVKLYTYQIFR-------------------G  124 (353)
Q Consensus        85 ~lv~e~~~~~l---------------~~~l~~~~~~----~~~l--~~~~~~~i~~qll~-------------------a  124 (353)
                      .+||||++|..               .+.|...-..    ....  .+.++..+..++-.                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            17899997511               1111111111    1111  23556656554422                   1


Q ss_pred             HHHh----Hc---CCCeeeccCCCCcEEEeCC---CCcEEEeeecccc
Q 018619          125 LAYI----HT---VPRVCHRDLKPQNLLVDPL---THQVKICDFGSAK  162 (353)
Q Consensus       125 l~~L----H~---~~~i~H~Dlkp~Nill~~~---~~~vkl~Dfg~a~  162 (353)
                      +..|    ..   ...++|+|+.+.||+++.+   .+.+.++||..|.
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2222    21   1258999999999999863   2679999999885

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.15  E-value=0.003  Score=55.55  Aligned_cols=73  Identities=14%  Similarity=0.031  Sum_probs=43.0

Q ss_pred             eeeecCCCeEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHcCCCc--eeecceeeeecCC--CCceeEEEEec
Q 018619           17 RVVGTGSFGIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMDHPN--VISLKHCFFSTTS--KNELFLNLVME   89 (353)
Q Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~lv~e   89 (353)
                      +.++ |....||++.. .+|+.+++|.....   ......|..+++.+....  +.+++..  ....  ......+++|+
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEE
Confidence            3566 77889998763 45678999988632   334557888887774222  2333221  1100  01224568999


Q ss_pred             cccc
Q 018619           90 YVPE   93 (353)
Q Consensus        90 ~~~~   93 (353)
                      +++|
T Consensus       108 ~i~G  111 (328)
T 1zyl_A          108 SVGG  111 (328)
T ss_dssp             CCCC
T ss_pred             ecCC
Confidence            9986

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.02  E-value=0.0018  Score=58.15  Aligned_cols=69  Identities=13%  Similarity=0.136  Sum_probs=40.1

Q ss_pred             eeeeecCCCeEEEEEEECC--------CCcEEEEEEeecccc---chHHHHHHHHHcCCCce-eecceeeeecCCCCcee
Q 018619           16 ERVVGTGSFGIVFQAKCLE--------TGETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELF   83 (353)
Q Consensus        16 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~   83 (353)
                      .+.++.|....+|++....        .++.+++|+......   ....|..+++.+...++ .+++..+     .    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            4567788888999998643        136889998754332   23578888888753333 2443322     1    


Q ss_pred             EEEEeccccc
Q 018619           84 LNLVMEYVPE   93 (353)
Q Consensus        84 ~~lv~e~~~~   93 (353)
                      -++||||++|
T Consensus       109 ~~~v~e~i~G  118 (369)
T 3c5i_A          109 GGRIEEWLYG  118 (369)
T ss_dssp             TEEEEECCCS
T ss_pred             CcEEEEEecC
Confidence            1378888875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.74  E-value=0.0053  Score=54.38  Aligned_cols=31  Identities=26%  Similarity=0.473  Sum_probs=26.5

Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~-~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGN-EESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECG-GGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeC-CCeEEEEECCCCee
Confidence            47999999999999985 56799999988763

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.13  E-value=0.054  Score=49.40  Aligned_cols=70  Identities=11%  Similarity=0.154  Sum_probs=44.1

Q ss_pred             EeeeeecCCCeEEEEEEECCC-------CcEEEEEEeecccc---chHHHHHHHHHcCCCce-eecceeeeecCCCCcee
Q 018619           15 AERVVGTGSFGIVFQAKCLET-------GETVAIKKVLQDRR---YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKNELF   83 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~   83 (353)
                      -++.+..|....+|++.....       ++.|++|+......   ...+|..+++.+...++ .++++.+     .    
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            345677788899999986421       57899998754322   23589998888753222 2333322     1    


Q ss_pred             EEEEeccccc
Q 018619           84 LNLVMEYVPE   93 (353)
Q Consensus        84 ~~lv~e~~~~   93 (353)
                      -+.||||++|
T Consensus       145 ~~~I~efI~G  154 (424)
T 3mes_A          145 EGRIEEFIDG  154 (424)
T ss_dssp             TEEEEECCCS
T ss_pred             CCEEEEEeCC
Confidence            1478899876

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.05  E-value=0.4  Score=43.26  Aligned_cols=29  Identities=24%  Similarity=0.486  Sum_probs=24.4

Q ss_pred             eeeccCCCCcEEEe-----CCCCcEEEeeecccc
Q 018619          134 VCHRDLKPQNLLVD-----PLTHQVKICDFGSAK  162 (353)
Q Consensus       134 i~H~Dlkp~Nill~-----~~~~~vkl~Dfg~a~  162 (353)
                      ++|+|+.+.||++.     +++..+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            67999999999993     235679999999886

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	353
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-122
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-70
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-69
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-66
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-65
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-65
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-65
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-65
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-64
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-63
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-62
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-61
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-61
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-60
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-59
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-58
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-58
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-58
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-57
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-56
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-56
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-55
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-53
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-52
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-50
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-50
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-47
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-47
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-43
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-41
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-41
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-39
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-39
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-39
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-38
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-37
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-35
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-35
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-33
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-32
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  353 bits (906), Expect = e-122
 Identities = 222/333 (66%), Positives = 277/333 (83%), Gaps = 2/333 (0%)

Query: 9   QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVIS 68
           Q +SY   +V+G GSFG+V+QAK  ++GE VAIKKVLQD+R+KNRELQ+MR +DH N++ 
Sbjct: 18  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 77

Query: 69  LKHCFFST-TSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           L++ F+S+   K+E++LNLV++YVPE++YRV +HYS A Q +P+IYVKLY YQ+FR LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           IH+   +CHRD+KPQNLL+DP T  +K+CDFGSAKQL+ GE N+SYICSR+YRAPELIFG
Sbjct: 138 IHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
           AT+YT+SID+WSAGCVLAELLLGQP+FPG++ VDQLVEIIKVLGTPTRE+IR MNPNYT+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
           F+FPQIKAHPW KVF  R PPEAI L SRLL+Y+P+ R T LEACAH FFDELR+PN +L
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

Query: 308 PNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           PNGR  P LFNF  +   ++P L   LIP H +
Sbjct: 317 PNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (586), Expect = 9e-74
 Identities = 108/341 (31%), Positives = 177/341 (51%), Gaps = 24/341 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV--LQDRRYKN---RELQLMRVMDHPNVI 67
           Y     +G G++G+V  A        VAIKK+   + + Y     RE++++    H N+I
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            +     + T +    + LV   +   +Y++LK      Q +   ++  + YQI RGL Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRAPE 183
           IH+   V HRDLKP NLL++  T  +KICDFG A+       +      Y+ +R+YRAPE
Sbjct: 125 IHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM-- 241
           ++  +  YT SIDIWS GC+LAE+L  +P+FPG++ +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 242 -NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                     P     PW+++F      +A+DL  ++L ++P  R    +A AHP+ ++ 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 301 REPNARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVKR 341
            +P+            F F  EL     E + +LI +   R
Sbjct: 302 YDPSDE----PIAEAPFKFDMELDDLPKEKLKELIFEETAR 338

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (562), Expect = 2e-70
 Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 31/305 (10%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           +     +G G+ G+VF+     +G  +A K +  + +        RELQ++   + P ++
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
                F+S        +++ ME++       L        R+P   +   +  + +GL Y
Sbjct: 68  GFYGAFYSDGE-----ISICMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           +    ++ HRD+KP N+LV+    ++K+CDFG + QLI   AN S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENA-VDQLVEIIKVLGTPTREEIRCMNPNYT 246
            T Y+   DIWS G  L E+ +G+   P  +A   +L+   +V G       R   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 247 DFRF--------------PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC 292
              +                I   P  K+       E  D  ++ L  +P+ R    +  
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296

Query: 293 AHPFF 297
            H F 
Sbjct: 297 VHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 5e-69
 Identities = 96/304 (31%), Positives = 150/304 (49%), Gaps = 23/304 (7%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---------RELQLMRVMDHPNVI 67
             +G G F  V++A+   T + VAIKK+    R +          RE++L++ + HPN+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            L   F   ++     ++LV +++   +          +  +   ++K Y     +GL Y
Sbjct: 64  GLLDAFGHKSN-----ISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIF 186
           +H    + HRDLKP NLL+D     +K+ DFG AK   +     ++   +R+YRAPEL+F
Sbjct: 116 LHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
           GA  Y   +D+W+ GC+LAELLL  P  PG++ +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR--EPN 304
              F      P H +F      + +DL   L  ++P  R TA +A    +F       P 
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

Query: 305 ARLP 308
            +LP
Sbjct: 293 CQLP 296

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-66
 Identities = 104/337 (30%), Positives = 164/337 (48%), Gaps = 23/337 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNV 66
           Y     VG+G++G V  A   +TG  VA+KK+      +   +   REL+L++ M H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           I L   F    S  E     ++ ++  +    +       Q++   +V+   YQI RGL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIF 186
           YIH+   + HRDLKP NL V+      KI DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 187 GATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
               Y  ++DIWS GC++AELL G+ LFPG + +DQL  I++++GTP  E ++ ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 247 DF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
                   Q+    +  VF     P A+DL  ++L      R TA +A AH +F +  +P
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 304 NARLPNGRPLPPLFNFKQELSGASPELVNKLIPDHVK 340
           +       P+   ++   E      +    L  D V 
Sbjct: 311 DD-----EPVADPYDQSFESRDLLIDEWKSLTYDEVI 342

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 2e-65
 Identities = 103/316 (32%), Positives = 167/316 (52%), Gaps = 21/316 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y   + VG+G++G V  A    TG  VAIKK+ +  + +       REL+L++ M H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 67  ISLKHCFFSTTSKNELF-LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           I L   F    + ++     LVM ++   + +++KH     +++    ++   YQ+ +GL
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            YIH    + HRDLKP NL V+    ++KI DFG A+Q         Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                YT ++DIWS GC++AE++ G+ LF G + +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 246 TDF---RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                   P+++   +  +      P A++L  ++L      R TA EA AHP+F+ L +
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

Query: 303 PNARLPNGRPLPPLFN 318
                P  +     F+
Sbjct: 310 TE-DEPQVQKYDDSFD 324

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  207 bits (527), Expect = 3e-65
 Identities = 89/300 (29%), Positives = 148/300 (49%), Gaps = 21/300 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYK-NRELQLM-RVMDHPNVISLK 70
           Y   R +G G +  VF+A  +   E V +K +   ++ K  RE++++  +   PN+I+L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
                  S+      LV E+V  + ++ L       Q +    ++ Y Y+I + L Y H+
Sbjct: 97  DIVKDPVSRT---PALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS 147

Query: 131 VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATE 190
           +  + HRD+KP N+++D    ++++ D+G A+    G+     + SR+++ PEL+     
Sbjct: 148 M-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 191 YTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
           Y  S+D+WS GC+LA ++  + P F G +  DQLV I KVLGT    +         D R
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 250 FPQI----KAHPWHKVFHKR----MPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 301
           F  I        W +  H      + PEA+D   +LL+Y    R TA EA  HP+F  + 
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 6e-65
 Identities = 101/307 (32%), Positives = 167/307 (54%), Gaps = 21/307 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           +     +G G++G+V++A+   TGE VA+KK+  D   +       RE+ L++ ++HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L           E  L LV E++ + + + +    SA   +PL  +K Y +Q+ +GLA
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA-GEANISYICSRFYRAPELI 185
           + H+  RV HRDLKPQNLL++     +K+ DFG A+            + + +YRAPE++
Sbjct: 117 FCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 244
            G   Y+T++DIWS GC+ AE++  + LFPG++ +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                FP+     + KV    +  +   L S++L Y P+ R +A  A AHPFF ++ +P 
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292

Query: 305 ARLPNGR 311
             +P+ R
Sbjct: 293 --VPHLR 297

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 9e-65
 Identities = 81/309 (26%), Positives = 146/309 (47%), Gaps = 22/309 (7%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G+FG VF+A+  +TG+ VA+KKVL +   +       RE+++++++ H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 67  ISLKHCFFSTTS---KNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           ++L     +  S   + +  + LV ++    +       S+   +  L  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDL---AGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-----SYICSRF 178
           GL YIH   ++ HRD+K  N+L+      +K+ DFG A+     + +      + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G     QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 239 RCMNPNYTDFRFPQIKAHP---WHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP 295
             ++      +   +K        ++      P A+DL  +LL   P+ R  + +A  H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 296 FFDELREPN 304
           FF     P+
Sbjct: 307 FFWSDPMPS 315

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  205 bits (523), Expect = 3e-64
 Identities = 71/325 (21%), Positives = 127/325 (39%), Gaps = 41/325 (12%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL----QDRRYKNRELQLMRVMDHPNVIS 68
           Y     +GTG+FG+V +     TG   A K V+     D+    +E+Q M V+ HP +++
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   F      NE+ +  + E++      + +  +  + +M       Y  Q+ +GL ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSGGE--LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 129 HTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           H      H DLKP+N++     ++++K+ DFG    L   ++      +  + APE+  G
Sbjct: 141 HE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
                   D+WS G +   LL G   F GEN  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP--NA 305
                             +  +  D   +LL   P+ R T  +A  HP+      P  ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293

Query: 306 RLPNGRPLPPLFNFKQELSGASPEL 330
           ++P+ R      + K +       L
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPEPL 318

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 2e-63
 Identities = 97/299 (32%), Positives = 155/299 (51%), Gaps = 17/299 (5%)

Query: 13  YMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQDRRYKN------RELQLMRVM---D 62
           Y     +G G++G VF+A+ L+  G  VA+K+V      +       RE+ ++R +   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           HPNV+ L      + +  E  L LV E+V + +   L         +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLL 126

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
           RGL ++H+  RV HRDLKPQN+LV   + Q+K+ DFG A+      A  S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E++   + Y T +D+WS GC+ AE+   +PLF G + VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW-PRD 242

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR 301
                  F    A P  K     +     DL  + L ++P+ R +A  A +HP+F +L 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (505), Expect = 2e-62
 Identities = 101/299 (33%), Positives = 156/299 (52%), Gaps = 18/299 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G++G VF+AK  ET E VA+K+V  D   +       RE+ L++ + H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L          ++  L LV E+       + K++ S N  +    VK + +Q+ +GL 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS-YICSRFYRAPELI 185
           + H+   V HRDLKPQNLL++    ++K+ +FG A+         S  + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 186 FGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           FGA  Y+TSID+WSAGC+ AEL    +PLFPG +  DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
                +P   A         ++     DL   LL+ +P  R +A EA  HP+F +   P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-61
 Identities = 72/328 (21%), Positives = 133/328 (40%), Gaps = 32/328 (9%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLM-RVMDHPNVISLKHCFF 74
            +V+G G  G V Q     T E  A+ K+LQD     RE++L  R    P+++ +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 75  STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
           +  +  +  L +VME +    ++  ++     +Q             I   + Y+H++  
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-N 131

Query: 134 VCHRDLKPQNLLVDPLTHQ--VKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEY 191
           + HRD+KP+NLL         +K+ DFG AK+  +  +  +   + +Y APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
             S D+WS G ++  LL G P F   + +     +        +  IR     + +  + 
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRMGQYEFPNPEWS 242

Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF-DELREPNARLPNG 310
           ++               E   L   LL+  P+ R T  E   HP+     + P   L   
Sbjct: 243 EV-------------SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289

Query: 311 RPLPPLFNFKQELSGASPELVNKLIPDH 338
           R L       +++       +  +  D+
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDY 317

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  195 bits (497), Expect = 4e-61
 Identities = 96/295 (32%), Positives = 157/295 (53%), Gaps = 20/295 (6%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y     +G G++G+V++A+    GET A+KK+  ++  +       RE+ +++ + H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLA 126
           + L           +  L LV E++ + + ++L         +  +  K +  Q+  G+A
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIA 114

Query: 127 YIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL-IAGEANISYICSRFYRAPELI 185
           Y H   RV HRDLKPQNLL++    ++KI DFG A+   I        I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI-RCMNPN 244
            G+ +Y+T+IDIWS GC+ AE++ G PLFPG +  DQL+ I ++LGTP  +         
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
             D  F   +  PW     K +    IDL S++L+  P+ R TA +A  H +F E
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 3e-60
 Identities = 66/301 (21%), Positives = 114/301 (37%), Gaps = 44/301 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           +   + +G G++G V  A    T E VA+K V   R         +E+ + ++++H NV+
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
                             L +EY               +  MP    + + +Q+  G+ Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAPEL 184
           +H    + HRD+KP+NLL+D     +KI DFG A                 +  Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 185 IFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN 244
           +     +   +D+WS G VL  +L G+  +   +   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226

Query: 245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                      +PW K+         + L  ++L  +PS R T  +     ++++  +  
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKG 270

Query: 305 A 305
           A
Sbjct: 271 A 271

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 6e-60
 Identities = 64/289 (22%), Positives = 118/289 (40%), Gaps = 40/289 (13%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVISL 69
           +  +G GSF  V++    ET   VA  ++   +  K+       E ++++ + HPN++  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
            +  + +T K +  + LV E +       LK Y    + M +  ++ +  QI +GL ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMTSGT---LKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 130 T-VPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGA 188
           T  P + HRDLK  N+ +   T  VKI D G A    A  A  + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIGTPEFMAPEMYEE- 187

Query: 189 TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDF 248
            +Y  S+D+++ G  + E+   +  +       Q+   +     P               
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS------------- 233

Query: 249 RFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                        F K   PE  ++    ++ +   R +  +   H FF
Sbjct: 234 -------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  194 bits (494), Expect = 8e-60
 Identities = 71/322 (22%), Positives = 126/322 (39%), Gaps = 42/322 (13%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 68
           Y     +G+G+FG+V +     TG     K +      D+     E+ +M  + HP +I+
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   F     K E+ L  ++E++      +    ++ + +M    V  Y  Q   GL ++
Sbjct: 91  LHDAF---EDKYEMVL--ILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 129 HTVPRVCHRDLKPQNLLVD-PLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           H    + H D+KP+N++ +      VKI DFG A +L   E       +  + APE++  
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
                   D+W+ G +   LL G   F GE+ ++ L  + +       +           
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
                             + PEA D    LLQ  P  R T  +A  HP+    +  ++ L
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL---KGDHSNL 293

Query: 308 PNGRPLPPLFNFKQELSGASPE 329
            +  P       +Q++     +
Sbjct: 294 TSRIPSSRYNKIRQKIKEKYAD 315

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-59
 Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 45/296 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL------QDRRYKNRELQLMRVMDHPNV 66
           Y     +GTGS+G   + +    G+ +  K++        +++    E+ L+R + HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +         T+     L +VMEY     +  V+   +   Q +   +V     Q+   L
Sbjct: 66  VRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 126 AYIH----TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYR 180
              H        V HRDLKP N+ +D     VK+ DFG A+ L    +   +++ + +Y 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           +PE +     Y    DIWS GC+L EL    P F   +  +   +I +            
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG----------- 229

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                   +F +I               E  ++ +R+L      R +  E   +P 
Sbjct: 230 --------KFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 2e-59
 Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 44/294 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 68
           +     +G G+FG V++A+  ET    A K +     ++      E+ ++   DHPN++ 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L   F+   +     L +++E+                + +    +++   Q    L Y+
Sbjct: 74  LLDAFYYENN-----LWILIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI-SYICSRFYRAPELIFG 187
           H   ++ HRDLK  N+L       +K+ DFG + +         S+I + ++ APE++  
Sbjct: 127 HD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 188 AT----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
            T     Y    D+WS G  L E+   +P     N +  L++I                 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
                     K+ P       R      D   + L+ +   R T  +   HPF 
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-59
 Identities = 97/343 (28%), Positives = 171/343 (49%), Gaps = 32/343 (9%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNV 66
           Y   + +G+G+ GIV  A        VAIKK+ +  + +       REL LM+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 67  ISLKHCFFSTTSKNEL-FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           ISL + F    +  E   + LVME +  ++ +V++      +      +    YQ+  G+
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSYLLYQMLCGI 132

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            ++H+   + HRDLKP N++V      +KI DFG A+          Y+ +R+YRAPE+I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G   Y  ++DIWS GC++ E++  + LFPG + +DQ  ++I+ LGTP  E ++ + P  
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 246 TDF--RFPQIKAHPWHKVF-----------HKRMPPEAIDLASRLLQYSPSLRCTALEAC 292
            ++    P+     + K+F           +K    +A DL S++L   P+ R +  +A 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 293 AHPFFDELREPNARLPNGRPLPPLFNFKQELSGASPELVNKLI 335
            HP+ +   +P        P P +++ + +    + E   +LI
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQLDEREHTIEEWKELI 349

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 7e-59
 Identities = 74/305 (24%), Positives = 119/305 (39%), Gaps = 49/305 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 65
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ + HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            I  + C+       E    LVMEY   S            + +  + +   T+   +GL
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSA---SDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
           AY+H+   + HRD+K  N+L+      VK+ DFGSA  +       S++ + ++ APE+I
Sbjct: 129 AYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 186 FGATE--YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
               E  Y   +D+WS G    EL   +P     NA+  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
                       +    +          +     LQ  P  R T+     H F    R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276

Query: 304 NARLP 308
              + 
Sbjct: 277 TVIMD 281

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 3e-58
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 48/292 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 65
           +   R +G G FG V+ A+  ++   +A+K +               RE+++   + HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           ++ L   F   T      + L++EY P      +        +        Y  ++   L
Sbjct: 68  ILRLYGYFHDATR-----VYLILEYAPLGT---VYRELQKLSKFDEQRTATYITELANAL 119

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
           +Y H+  RV HRD+KP+NLL+     ++KI DFG +    +     +   +  Y  PE+I
Sbjct: 120 SYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRT-TLCGTLDYLPPEMI 176

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
            G   +   +D+WS G +  E L+G+P F      +    I +V                
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 297
            +F FP              +   A DL SRLL+++PS R    E   HP+ 
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  190 bits (482), Expect = 4e-58
 Identities = 95/349 (27%), Positives = 156/349 (44%), Gaps = 49/349 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 69
           Y+  R +G G F  V+ AK +     VA+K V  D+ Y      E++L++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 70  KH----------CFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTY 119
                         F+    N + + +V E + E++  ++K Y   ++ +PLIYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 120 QIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-----QVKICDFGSAKQLIAGEANISYI 174
           Q+  GL Y+H    + H D+KP+N+L++ +       Q+KI D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENA------VDQLVEIIK 228
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  +         D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 229 VLGTPTREEIRCMNPNYTDF-------RFPQIKAHPWHKV------FHKRMPPEAIDLAS 275
           +LG      +R      T F          ++K  P   V      F K    E  D  S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 276 RLLQYSPSLRCTALEACAHPFF------DELREPNARL-PNGRPLPPLF 317
            +LQ  P  R  A     HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 6e-58
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 40/296 (13%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVISL 69
           YM    +G G FGIV +     + +T   K V     D+    +E+ ++ +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
              F S        L ++ E++    ++  +    ++   +    +  Y +Q+   L ++
Sbjct: 67  HESFESMEE-----LVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFL 118

Query: 129 HTVPRVCHRDLKPQNLLVDPLTH-QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFG 187
           H+   + H D++P+N++        +KI +FG A+QL  G+       +  Y APE+   
Sbjct: 119 HS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH 177

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
               +T+ D+WS G ++  LL G   F  E     +  I+    T   E           
Sbjct: 178 -DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF--------- 227

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP 303
                           K +  EA+D   RLL      R TA EA  HP+  +  E 
Sbjct: 228 ----------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 7e-57
 Identities = 71/317 (22%), Positives = 128/317 (40%), Gaps = 50/317 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV----LQDRRYKNRELQLMRVMDHPNVIS 68
           Y     +G G+ G V+ A  + TG+ VAI+++       +     E+ +MR   +PN+++
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
               +      +EL++  VMEY    +             M    +     +  + L ++
Sbjct: 82  YLDSY---LVGDELWV--VMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPELIFG 187
           H+  +V HRD+K  N+L+      VK+ DFG   Q+   ++  S +  + ++ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 188 ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD 247
              Y   +DIWS G +  E++ G+P +  EN +  L  I    GTP             +
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------E 235

Query: 248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARL 307
            + P            +++     D  +R L      R +A E   H F    +      
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL---- 279

Query: 308 PNGRPLPPLFNFKQELS 324
                L PL    +E +
Sbjct: 280 ---SSLTPLIAAAKEAT 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 70/303 (23%), Positives = 114/303 (37%), Gaps = 42/303 (13%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNVI 67
           Y    V+GTG+F  V  A+   T + VAIK + +            E+ ++  + HPN++
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           +L   +    S   L+L  +M+ V       L                   +Q+   + Y
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVS---GGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTH--QVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
           +H    + HRDLKP+NLL   L    ++ I DFG +K    G    +   +  Y APE++
Sbjct: 123 LHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                Y+ ++D WS G +   LL G P F  EN      +I+K                 
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNA 305
                           +   +   A D    L++  P  R T  +A  HP+       + 
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275

Query: 306 RLP 308
            + 
Sbjct: 276 NIH 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  182 bits (463), Expect = 4e-56
 Identities = 74/306 (24%), Positives = 117/306 (38%), Gaps = 54/306 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------------LQDRRYKNRELQLMR 59
           Y  + ++G G   +V +     T +  A+K +              + R    +E+ ++R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 60  -VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYT 118
            V  HPN+I LK  +     +   F  LV + + +     L  Y +    +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGE---LFDYLTEKVTLSEKETRKIM 116

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF 178
             +   +  +H    + HRDLKP+N+L+D   + +K+ DFG + QL  GE       +  
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 179 YRAPELIFGATE-----YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP 233
           Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+      
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234

Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
              E                                  DL SR L   P  R TA EA A
Sbjct: 235 GSPE-------------------------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

Query: 294 HPFFDE 299
           HPFF +
Sbjct: 270 HPFFQQ 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 2e-55
 Identities = 82/320 (25%), Positives = 127/320 (39%), Gaps = 59/320 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVL-------QDRRYKNRELQLMRVMDHPN 65
           +   +++G GSF  V  A+ L T    AIK +            Y  RE  +M  +DHP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
            + L   F       +L+    + Y        L  Y            + YT +I   L
Sbjct: 70  FVKLYFTF---QDDEKLYF--GLSYAKNGE---LLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---SYICSRFYRAP 182
            Y+H    + HRDLKP+N+L++     ++I DFG+AK L          S++ +  Y +P
Sbjct: 122 EYLHG-KGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           EL+        S D+W+ GC++ +L+ G P F   N      +IIK+             
Sbjct: 180 ELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------------- 225

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC------AHPF 296
               ++ FP+            +  P+A DL  +LL    + R    E        AHPF
Sbjct: 226 ----EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269

Query: 297 FDELREPNARLPNGRPLPPL 316
           F+ +      L    P P L
Sbjct: 270 FESVT--WENLHQQTP-PKL 286

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 4e-53
 Identities = 69/317 (21%), Positives = 122/317 (38%), Gaps = 49/317 (15%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD 62
           Y     +G+G F +V + +   TG   A K + + R   +          RE+ +++ + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           HPNVI+L   +     +N+  + L++E V       L  + +  + +       +  QI 
Sbjct: 72  HPNVITLHEVY-----ENKTDVILILELVAGGE---LFDFLAEKESLTEEEATEFLKQIL 123

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVD---PLTHQVKICDFGSAKQLIAGEANISYICSRFY 179
            G+ Y+H+  ++ H DLKP+N+++        ++KI DFG A ++  G    +   +  +
Sbjct: 124 NGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 180 RAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR 239
            APE++          D+WS G +   LL G   F G+   + L  +  V      E   
Sbjct: 183 VAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE--- 238

Query: 240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE 299
                                 +       A D   RLL   P  R T  ++  HP+   
Sbjct: 239 ----------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

Query: 300 LREPNARLPNGRPLPPL 316
                A L +    P  
Sbjct: 277 KDTQQA-LSSAWSHPQF 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-52
 Identities = 88/338 (26%), Positives = 140/338 (41%), Gaps = 62/338 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQ--------LMRVMDHP 64
           ++  +++G GSFG VF A+  +T +  AIK + +D    + +++        L    +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
            +  +   F     + +  L  VMEY+       L ++  +  +  L     Y  +I  G
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC-SRFYRAPE 183
           L ++H+   + +RDLK  N+L+D   H  KI DFG  K+ + G+A  +  C +  Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 184 LIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           ++ G  +Y  S+D WS G +L E+L+GQ  F G++  +                IR  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC-AHPFFDELRE 302
            Y  +                 +  EA DL  +L    P  R         HP F E+  
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263

Query: 303 PNARLPNGRPLPP----------LFNFKQELSGASPEL 330
               L      PP            NF +E     P L
Sbjct: 264 --EELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 299

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-50
 Identities = 64/303 (21%), Positives = 109/303 (35%), Gaps = 56/303 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN----------RELQLMRVMD 62
           Y    ++G+G FG V+    +     VAIK V +DR               E+ L++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 63  --HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQ 120
                VI L   F    S       L++E         L  + +    +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFERPDS-----FVLILERPEPVQD--LFDFITERGALQEELARSFFWQ 118

Query: 121 IFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYR 180
           +   + + H    V HRD+K +N+L+D    ++K+ DFGS   L+       +  +R Y 
Sbjct: 119 VLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
            PE I     +  S  +WS G +L +++ G   F  +  + +                  
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR------------------ 218

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL 300
                                F +R+  E   L    L   PS R T  E   HP+  ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261

Query: 301 REP 303
             P
Sbjct: 262 LLP 264

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  170 bits (432), Expect = 1e-50
 Identities = 72/320 (22%), Positives = 121/320 (37%), Gaps = 55/320 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD 62
           +   R++G G FG V+  +  +TG+  A+K + + R            +   L L+   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
            P ++ + + F +        L+ +++ +       L ++ S +       ++ Y  +I 
Sbjct: 66  CPFIVCMSYAFHTPDK-----LSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAEII 117

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAP 182
            GL ++H    V +RDLKP N+L+D   H V+I D G A      + + S   +  Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
           E++     Y +S D +S GC+L +LL G   F      D+       L            
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFF 297
                                    PE   L   LLQ   + R       A E    PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

Query: 298 DELREPNARLPNGRPLPPLF 317
             L   + ++   +  PP  
Sbjct: 269 RSL---DWQMVFLQKYPPPL 285

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  168 bits (426), Expect = 3e-50
 Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPN 65
           +   R +GTGSFG V   +    G   A+K +       L+   + N E  ++ ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           +I +   F     ++   + ++M+Y+       L      +QR P    K Y  ++   L
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLAL 117

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELI 185
            Y+H+   + +RDLKP+N+L+D   H +KI DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 186 FGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNY 245
                Y  SID WS G ++ E+L G   F   N +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 246 TDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDEL 300
            + RFP                 +  DL SRL+    S R         +   HP+F E+
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (407), Expect = 8e-48
 Identities = 61/291 (20%), Positives = 106/291 (36%), Gaps = 49/291 (16%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKV------LQDRRYKNRELQLMRVMDHPNVISL 69
            + +G+GSFG V++ K       VA+K +       Q  +    E+ ++R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 70  KHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
                         L +V ++    S+Y  L        +  +I +     Q  +G+ Y+
Sbjct: 70  MGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISY---ICSRFYRAPELI 185
           H    + HRDLK  N+ +      VKI DFG A        +  +     S  + APE+I
Sbjct: 121 HA-KSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 186 FG--ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
                  Y+   D+++ G VL EL+ GQ  +   N  DQ++ ++                
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------------- 223

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
               +  P +             P     L +  L+     R    +  A 
Sbjct: 224 --RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (405), Expect = 2e-47
 Identities = 62/295 (21%), Positives = 107/295 (36%), Gaps = 43/295 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPN 65
           Y    ++G G    V  A+ L     VA+K +  D            RE Q    ++HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGL 125
           ++++     + T    L   +VMEYV       L+        M             + L
Sbjct: 69  IVAVYDTGEAETPAGPLPY-IVMEYVDGVT---LRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 126 AYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI----SYICSRFYRA 181
            + H    + HRD+KP N+++   T+ VK+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 182 PELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           PE   G        D++S GCVL E+L G+P F G++ V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                                H+ +  +   +  + L  +P  R           
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 2e-47
 Identities = 71/311 (22%), Positives = 122/311 (39%), Gaps = 53/311 (17%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN-------RELQLMRVMDHPNVISL 69
           +++G G+FG V   +   TG   A+K + ++             E ++++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           K+ F +        L  VMEY        L  + S  +       + Y  +I   L Y+H
Sbjct: 71  KYAFQT-----HDRLCFVMEYANGGE---LFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           +   V +RD+K +NL++D     +KI DFG  K+ I+  A +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
           +Y  ++D W  G V+ E++ G+  F  ++       I+                   + R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACAHPFFDELREPN 304
           FP            + + PEA  L + LL+  P  R       A E   H FF  +    
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269

Query: 305 ARLPNGRPLPP 315
             +   + LPP
Sbjct: 270 QDVVQKKLLPP 280

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-44
 Identities = 53/282 (18%), Positives = 100/282 (35%), Gaps = 45/282 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLKHCFF 74
           + +G G FG V        G  VA+K +  D   +    E  +M  + H N++ L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 75  STTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                    L +V EY+ + S+   L+  S     +    +  ++  +   + Y+     
Sbjct: 71  EEKGG----LYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEG-NN 123

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTT 193
             HRDL  +N+LV    +  K+ DFG  K+        +      + APE +    +++T
Sbjct: 124 FVHRDLAARNVLVSE-DNVAKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFST 179

Query: 194 SIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQ 252
             D+WS G +L E+   G+  +P     D +  + K                   ++   
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD- 220

Query: 253 IKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                         PP   ++         ++R + L+    
Sbjct: 221 ---------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 9e-44
 Identities = 58/302 (19%), Positives = 103/302 (34%), Gaps = 45/302 (14%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 70
           Y   R +G+GSFG ++    +  GE VAIK      ++     E ++ ++M     I   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
               +       +  +VME +  S+      ++  +++  L  V L   Q+   + YIH+
Sbjct: 69  RWCGAEGD----YNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121

Query: 131 VPRVCHRDLKPQNLLV--DPLTHQVKICDFGSAKQLIAGEANI--------SYICSRFYR 180
                HRD+KP N L+      + V I DFG AK+      +         +   +  Y 
Sbjct: 122 -KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 181 APELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC 240
           +     G  E +   D+ S G VL    LG   + G  A  +  +  ++        I  
Sbjct: 181 SINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA---LEACAHPFF 297
           +   Y                     P E     +         +       +   + F 
Sbjct: 240 LCKGY---------------------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

Query: 298 DE 299
            +
Sbjct: 279 RQ 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (376), Expect = 4e-43
 Identities = 48/267 (17%), Positives = 94/267 (35%), Gaps = 24/267 (8%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN--RELQLMRVMDHPNVISLK 70
           Y   R +G GSFG++F+   L   + VAIK   +         E +  +++     I   
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 71  HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHT 130
           + F        L   LV++ +  S+  +L       ++  +  V +   Q+   +  IH 
Sbjct: 67  YYFGQE----GLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 131 VPRVCHRDLKPQNLLVD----PLTHQVKICDFGSAKQLIAGEANI--------SYICSRF 178
              + +RD+KP N L+        + + + DFG  K                 +   +  
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           Y +     G  E +   D+ + G V    L G   + G  A     +  ++        +
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKR 265
           R +   + +  F +   +  +  F   
Sbjct: 238 RELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  145 bits (367), Expect = 3e-41
 Identities = 61/313 (19%), Positives = 115/313 (36%), Gaps = 57/313 (18%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKV-------LQDRRYKNRELQLMRVMDHPNVISL 69
           + +GTGSFG V   K  E+G   A+K +       L+   +   E ++++ ++ P ++ L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
           +  F           + +   +       +  +     R    + + Y  QI     Y+H
Sbjct: 107 EFSFKDN--------SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGAT 189
           ++  + +RDLKP+NLL+D     +++ DFG AK++       +   +    APE+I    
Sbjct: 159 SL-DLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVK--GRTWTLCGTPEALAPEIILS-K 213

Query: 190 EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
            Y  ++D W+ G ++ E+  G P F  +  +    +I                       
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP-----SLRCTALEACAHPFFDELREPN 304
                       F      +  DL   LLQ        +L+    +   H +F      +
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTD 301

Query: 305 ARLPNGRPLPPLF 317
                 R +   F
Sbjct: 302 WIAIYQRKVEAPF 314

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 7e-41
 Identities = 61/300 (20%), Positives = 112/300 (37%), Gaps = 37/300 (12%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGETVAIKKV---LQDRRYKNRELQLMRVMDHPNVIS 68
           + + +  +G G FG V++ K    GE VA+K      +   ++  E+    ++ H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 69  LKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
                 +  +     L LV +Y    S++  L  Y      + +  +         GLA+
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAH 115

Query: 128 IHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSRF-- 178
           +H         P + HRDLK +N+LV        I D G A +  +    I    +    
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 179 ---YRAPELIFGA-----TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVL 230
              Y APE++  +      E     DI++ G V  E+     +  G +   QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233

Query: 231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
             P+ EE+R +          +++ +  ++            +       + + R TAL 
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 7e-41
 Identities = 73/332 (21%), Positives = 131/332 (39%), Gaps = 58/332 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCL---ETGETVAIKKV--------LQDRRYKNRELQLMRVM 61
           +   +V+GTG++G VF  + +   +TG+  A+K +         +   +   E Q++  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQI 121
                +   H  F T +K    L+L+++Y+       L  + S  +R     V++Y  +I
Sbjct: 86  RQSPFLVTLHYAFQTETK----LHLILDYI---NGGELFTHLSQRERFTEHEVQIYVGEI 138

Query: 122 FRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC---SRF 178
              L ++H    + +RD+K +N+L+D     V + DFG +K+ +A E   +Y       +
Sbjct: 139 VLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
                +  G + +  ++D WS G ++ ELL G   F  +   +   EI +          
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 246

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR-----CTALEACA 293
                       P          + + M   A DL  RLL   P  R       A E   
Sbjct: 247 -----RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291

Query: 294 HPFFDELREPNARLPNGRPLPPLFNFKQELSG 325
           H FF ++      L   +   P   FK  +  
Sbjct: 292 HLFFQKINW--DDLAAKKVPAP---FKPVIRD 318

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-39
 Identities = 65/296 (21%), Positives = 103/296 (34%), Gaps = 47/296 (15%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           E  +G G FG V+      T   VAIK +           +E Q+M+ + H  ++ L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                S+  +++  V EY+ +             + + L  +     QI  G+AY+    
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 190
              HRDL+  N+LV       K+ DFG A+ +   E  A         + APE       
Sbjct: 133 NYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 191 YTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFR 249
           +T   D+WS G +L EL   G+  +PG    + L ++ +    P   E            
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239

Query: 250 FPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDELREP 303
                            P    DL  +  +  P  R T     A    +F      
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 48/291 (16%), Positives = 98/291 (33%), Gaps = 45/291 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 73
           + +G+G FG+V         + VAIK + +    +     E ++M  + HP ++ L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
                     + LV E++      +  +  +         +      +  G+AY+     
Sbjct: 70  LEQA-----PICLVFEFMEHGC--LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-AC 121

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFGATEY 191
           V HRDL  +N LV      +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 192 TTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFP 251
           ++  D+WS G ++ E+     +     +  ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 252 QIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE 302
                 +     +        + +   +  P  R             E+ E
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ--LAEIAE 261

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 62/299 (20%), Positives = 105/299 (35%), Gaps = 51/299 (17%)

Query: 6   CILQTISYMAERVVGTGSFGIVFQAKCLET---GETVAIKKVLQDRRYKN-------REL 55
           C++          +G GSFG+V + +         +VA+K +  D   +        RE+
Sbjct: 3   CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62

Query: 56  QLMRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVK 115
             M  +DH N+I L     +        + +V E  P  +  +L           L  + 
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLS 114

Query: 116 LYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANI---S 172
            Y  Q+  G+ Y+ +  R  HRDL  +NLL+      VKI DFG  + L   + +     
Sbjct: 115 RYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQE 172

Query: 173 YICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLG 231
           +    F            ++ + D W  G  L E+   GQ  + G N    L +I K   
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--- 229

Query: 232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
                            R P+           +  P +  ++  +   + P  R T + 
Sbjct: 230 --------------EGERLPRP----------EDCPQDIYNVMVQCWAHKPEDRPTFVA 264

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-39
 Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 47/293 (16%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISL 69
                 +G G FG V+          VA+K + Q     +    E  LM+ + H  ++ L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 70  KHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIH 129
                   ++  +++  + EY+            S   ++ +  +     QI  G+A+I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 130 TVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAPELIFG 187
                 HRDL+  N+LV       KI DFG A+ +   E            + APE I  
Sbjct: 127 E-RNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 188 ATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYT 246
              +T   D+WS G +L E++  G+  +PG    + +  + +                  
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225

Query: 247 DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFF 297
                      +  V     P E   L     +  P  R T     +    FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-39
 Identities = 62/303 (20%), Positives = 109/303 (35%), Gaps = 56/303 (18%)

Query: 16  ERVVGTGSFGIVFQAKC--LETGETVAIKKVLQDRRYKN------RELQLMRVMDHPNVI 67
           ++ +G+G+FG V +      +  +TVA+K +  +            E  +M+ +D+P ++
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
            +     + +        LVME         L  Y   N+ +    +    +Q+  G+ Y
Sbjct: 72  RMIGICEAES------WMLVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE----ANISYICSRFYRAPE 183
           +       HRDL  +N+L+    H  KI DFG +K L A E    A         + APE
Sbjct: 123 LEE-SNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 184 LIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN 242
            I    ++++  D+WS G ++ E    GQ  + G    +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225

Query: 243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDE 299
                 R                 P E  DL +    Y    R           + ++D 
Sbjct: 226 ----GERMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

Query: 300 LRE 302
           + E
Sbjct: 272 VNE 274

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 5e-39
 Identities = 55/294 (18%), Positives = 111/294 (37%), Gaps = 43/294 (14%)

Query: 16  ERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHC 72
           +  +G G +G V++    +   TVA+K + +D        +E  +M+ + HPN++ L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 73  FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVP 132
                        ++ E++            +  Q +  + +     QI   + Y+    
Sbjct: 82  CTREPP-----FYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK-K 134

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE--ANISYICSRFYRAPELIFGATE 190
              HRDL  +N LV    H VK+ DFG ++ +      A+        + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 191 YTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++   D+W+ G +L E+            + Q+ E+++                  D+R 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235

Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPN 304
                        +  P +  +L     Q++PS R +  E   H  F+ + + +
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE--IHQAFETMFQES 277

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-39
 Identities = 73/314 (23%), Positives = 120/314 (38%), Gaps = 53/314 (16%)

Query: 7   ILQTISYMAERVVGTGSFGIVFQAKCLETGET----VAIKKVLQDRRYKN-----RELQL 57
           IL+   +   +V+G+G+FG V++   +  GE     VAIK++ +    K       E  +
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64

Query: 58  MRVMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLY 117
           M  +D+P+V  L     ++T      + L+ + +P     +L +       +   Y+  +
Sbjct: 65  MASVDNPHVCRLLGICLTST------VQLITQLMPFGC--LLDYVREHKDNIGSQYLLNW 116

Query: 118 TYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR 177
             QI +G+ Y+    R+ HRDL  +N+LV    H VKI DFG AK L A E        +
Sbjct: 117 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 178 ---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTP 233
               + A E I     YT   D+WS G  + EL+  G   + G  A  ++  I++     
Sbjct: 175 VPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILE----- 227

Query: 234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA 293
                          R P                 +   +  +        R    E   
Sbjct: 228 ------------KGERLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELII 265

Query: 294 HPFFDELREPNARL 307
             F    R+P   L
Sbjct: 266 E-FSKMARDPQRYL 278

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 66/309 (21%), Positives = 114/309 (36%), Gaps = 54/309 (17%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDH 63
               E+V+G G FG V        G+    VAIK +      + RR    E  +M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 64  PNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFR 123
           PNVI L+     +T      + ++ E++           +  + +  +I +      I  
Sbjct: 87  PNVIHLEGVVTKST-----PVMIITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139

Query: 124 GLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR------ 177
           G+ Y+       HRDL  +N+LV+      K+ DFG ++ L    ++ +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 178 FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTRE 236
            + APE I    ++T++ D+WS G V+ E++  G+  +      D +  I +        
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------- 248

Query: 237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPF 296
                     D+R P               P     L     Q   + R    +      
Sbjct: 249 ----------DYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287

Query: 297 FDELREPNA 305
              +R PN+
Sbjct: 288 DKMIRNPNS 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 4e-38
 Identities = 61/314 (19%), Positives = 111/314 (35%), Gaps = 70/314 (22%)

Query: 16  ERVVGTGSFGIVFQAKCLETGET-----VAIKKVLQDRRYKN-----RELQLM-RVMDHP 64
            +V+G+G+FG V  A      +T     VA+K + +            EL++M ++  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLK-------------------HYSS 104
           N+++L       T    ++  L+ EY     +   L+                       
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 105 ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL 164
               +    +  + YQ+ +G+ ++       HRDL  +N+LV      VKICDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRDLAARNVLVTH-GKVVKICDFGLARDI 214

Query: 165 IAGEANISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAV 220
           ++    +    +R    + APE +F    YT   D+WS G +L E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 221 DQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQY 280
               ++I+                   F+                   E   +      +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306

Query: 281 SPSLRCTALEACAH 294
               R +     + 
Sbjct: 307 DSRKRPSFPNLTSF 320

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-37
 Identities = 50/284 (17%), Positives = 103/284 (36%), Gaps = 45/284 (15%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKN---RELQLMRVMDHPNVISLKHCF 73
           + +GTG FG+V   K       VAIK + +    ++    E ++M  + H  ++ L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 74  FSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR 133
              T +  +F  ++ EY+      +L +      R     +      +   + Y+ +  +
Sbjct: 69  ---TKQRPIF--IITEYMANGC--LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQ 120

Query: 134 VCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANIS--YICSRFYRAPELIFGATEY 191
             HRDL  +N LV+     VK+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 192 TTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRF 250
           ++  DIW+ G ++ E+  LG+  +      +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------R 222

Query: 251 PQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
           P +               +   +           R T     ++
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 4e-37
 Identities = 59/293 (20%), Positives = 111/293 (37%), Gaps = 51/293 (17%)

Query: 16  ERVVGTGSFGIVFQAKCLE---TGETVAIKKV-----LQDRRYKNRELQLMRVMDHPNVI 67
             V+G G FG V+    L+        A+K +     + +      E  +M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAY 127
           SL         ++E    +V+ Y+     R             +  +  +  Q+ +G+ +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKF 145

Query: 128 IHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR-----FYRAP 182
           + +  +  HRDL  +N ++D     VK+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           E +    ++TT  D+WS G +L EL+  G P +P  N  D  V +++          R +
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------GRRLL 254

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
            P Y                     P    ++  +       +R +  E  + 
Sbjct: 255 QPEY--------------------CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 5e-37
 Identities = 66/303 (21%), Positives = 108/303 (35%), Gaps = 54/303 (17%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE--TVAIKKVLQDRRYKN-----RELQLMRVMDHPNVIS 68
           +  +G G+FG V Q       +   VAIK + Q     +     RE Q+M  +D+P ++ 
Sbjct: 14  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 69  LKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYI 128
           L     +        L LVME        + K      + +P+  V    +Q+  G+ Y+
Sbjct: 74  LIGVCQAEA------LMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125

Query: 129 HTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYICSR----FYRAPEL 184
                  HRDL  +N+L+    H  KI DFG +K L A ++  +   +      + APE 
Sbjct: 126 EE-KNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 185 IFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP 243
           I    ++++  D+WS G  + E L  GQ  +      + +  I +        E      
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237

Query: 244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA---HPFFDEL 300
                                  PPE   L S    Y    R   L         ++   
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274

Query: 301 REP 303
            + 
Sbjct: 275 SKV 277

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 5e-36
 Identities = 61/300 (20%), Positives = 110/300 (36%), Gaps = 56/300 (18%)

Query: 16  ERVVGTGSFGIVFQAKCLETGE--TVAIKKV-----LQDRRYKNRELQLM-RVMDHPNVI 67
           + V+G G+FG V +A+  + G     AIK++       D R    EL+++ ++  HPN+I
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 68  SLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLK------------HYSSANQRMPLIYV 114
           +L          +  +L L +EY P  ++   L+              +S    +    +
Sbjct: 75  NLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 115 KLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYI 174
             +   + RG+ Y+    +  HRDL  +N+LV    +  KI DFG ++            
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 175 CSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPT 234
               + A E +   + YTT+ D+WS G +L E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                        +R                   E  DL  +  +  P  R +  +    
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-35
 Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 65/305 (21%)

Query: 16  ERVVGTGSFGIVFQAKCL-----ETGETVAIKKV-----LQDRRYKNRELQLM-RVMDHP 64
            + +G G+FG V +A        +   TVA+K +     L +R     EL+++  + +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVP-ESMYRVLKHY--------------SSANQRM 109
           N+++L       T      +  + EY     +   L+                      +
Sbjct: 88  NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 110 PLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA 169
            L  +  ++YQ+ +G+A++ +     HRDL  +N+L+       KICDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSN 200

Query: 170 NISYICSR---FYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVE 225
            +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 226 IIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLR 285
           +IK                             +  +  +  P E  D+        P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 286 CTALE 290
            T  +
Sbjct: 293 PTFKQ 297

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-35
 Identities = 55/292 (18%), Positives = 95/292 (32%), Gaps = 50/292 (17%)

Query: 12  SYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQDRRYKN-----RELQLMRVMD 62
               ++V+G G FG V++     +       VAIK +      K       E  +M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 63  HPNVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIF 122
           H N+I L+             + ++ EY+        K     +    ++ +      I 
Sbjct: 68  HHNIIRLEGVISKYKP-----MMIITEYMENGAL--DKFLREKDGEFSVLQLVGMLRGIA 120

Query: 123 RGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC----SRF 178
            G+ Y+       HRDL  +N+LV+      K+ DFG ++ L                  
Sbjct: 121 AGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 179 YRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI 238
           + APE I      + S D+WS G V+ E++        E +  ++++ I           
Sbjct: 179 WTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE 290
                    FR P               P     L  +  Q   + R    +
Sbjct: 228 -------DGFRLP----------TPMDCPSAIYQLMMQCWQQERARRPKFAD 262

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-35
 Identities = 68/293 (23%), Positives = 101/293 (34%), Gaps = 50/293 (17%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGET---VAIKKVL-----QDRRYKNRELQLMRVMDHP 64
               R +G G FG V Q   +        VAIK          R    +E   MR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 65  NVISLKHCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRG 124
           +++ L           E  + ++ME       R           + L  + LY YQ+   
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 125 LAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--SRFYRAP 182
           LAY+ +  R  HRD+  +N+LV      VK+ DFG ++ +       +        + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 183 ELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM 241
           E I     +T++ D+W  G  + E+L+ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234

Query: 242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH 294
                                    PP    L ++   Y PS R    E  A 
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 1e-34
 Identities = 68/321 (21%), Positives = 115/321 (35%), Gaps = 64/321 (19%)

Query: 13  YMAERVVGTGSFGIVFQAKC-----LETGETVAIKKVLQD------RRYKNRELQLMRVM 61
               + +G G+FG V +A         T  TVA+K + +       R   +    L+ + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 62  DHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSANQR 108
            H NV++L              L +++E+    ++   L+                    
Sbjct: 75  HHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 109 MPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGE 168
           + L ++  Y++Q+ +G+ ++ +  +  HRDL  +N+L+    + VKICDFG A+ +    
Sbjct: 131 LTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDP 188

Query: 169 ANI---SYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV 224
             +          + APE IF    YT   D+WS G +L E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSL 284
             +K                 T  R P                PE            PS 
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280

Query: 285 RCTALEACAHPFFDELREPNA 305
           R T  E   H     L + NA
Sbjct: 281 RPTFSELVEH--LGNLLQANA 299

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 4e-33
 Identities = 67/321 (20%), Positives = 108/321 (33%), Gaps = 73/321 (22%)

Query: 17  RVVGTGSFGIVFQAKC-----LETGETVAIKKVLQDRRYKN-----RELQLMRVMDHPNV 66
           R +G G+FG VFQA+       E    VA+K + ++          RE  LM   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 67  ISLKHCFFSTTSKNELFLNLVMEYVP---------------------ESMYRVLKHYSSA 105
           +              + L  + EY+                        +    +  S  
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 106 NQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI 165
              +          Q+  G+AY+    +  HRDL  +N LV      VKI DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIY 191

Query: 166 AGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVD 221
           + +   A+ +      +  PE IF    YTT  D+W+ G VL E+   G   + G    +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 222 QLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYS 281
            +  +                          I A P      +  P E  +L        
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282

Query: 282 PSLRCTALEACAHPFFDELRE 302
           P+ R +      H     + E
Sbjct: 283 PADRPSFCS--IHRILQRMCE 301

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 4e-32
 Identities = 61/309 (19%), Positives = 114/309 (36%), Gaps = 66/309 (21%)

Query: 13  YMAERVVGTGSFGIVFQAKCLETGE-------TVAIKKVLQD------RRYKNRELQLMR 59
            +  + +G G+FG V  A+ +   +        VA+K +  D          +    +  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 60  VMDHPNVISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHY------------SSAN 106
           +  H N+I+L           +  L +++EY  + ++   L+               +  
Sbjct: 75  IGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 107 QRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA 166
           +++    +    YQ+ RG+ Y+ +  +  HRDL  +N+LV    + +KI DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHH 187

Query: 167 GEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQ 222
            +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245

Query: 223 LVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSP 282
           L +++K                    R                   E   +        P
Sbjct: 246 LFKLLK-----------------EGHRMD----------KPSNCTNELYMMMRDCWHAVP 278

Query: 283 SLRCTALEA 291
           S R T  + 
Sbjct: 279 SQRPTFKQL 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 62/312 (19%), Positives = 111/312 (35%), Gaps = 63/312 (20%)

Query: 16  ERVVGTGSFGIVFQAKC-----LETGETVAIKKV-----LQDRRYKNRELQLMRVMDHPN 65
            R +G GSFG+V++         E    VAIK V     +++R     E  +M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 66  VISLKHCFFSTTSKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLI------YVKLYT 118
           V+ L                ++ME +    +   L+    A    P++       +    
Sbjct: 85  VVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 119 YQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEANISYIC--- 175
            +I  G+AY++   +  HRDL  +N +V      VKI DFG  + +   +          
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 176 SRFYRAPELIFGATEYTTSIDIWSAGCVLAELL-LGQPLFPGENAVDQLVEIIKVLGTPT 234
              + +PE +     +TT  D+WS G VL E+  L +  + G +    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 235 REEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTA------ 288
                                           P    +L     QY+P +R +       
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

Query: 289 LEACAHPFFDEL 300
           ++    P F E+
Sbjct: 289 IKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.8 bits (201), Expect = 4e-19
 Identities = 31/200 (15%), Positives = 62/200 (31%), Gaps = 24/200 (12%)

Query: 17  RVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFST 76
           +++G G    VF     E      +K   +      ++++  R     +   L       
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVK-FHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 77  TSKNELFL---NLVMEYVPESMYRVLKHYSSANQR-MPLIYVKLYTYQIFRGLAYIHTVP 132
             +    L    +   Y  E    +++   +     + +         I   +A  +   
Sbjct: 64  EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH-R 122

Query: 133 RVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA------NISYICSRFYRAPELIF 186
            + H DL   N+LV      + I DF  + ++           ++  I + F R      
Sbjct: 123 GIVHGDLSQYNVLVSE--EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR------ 174

Query: 187 GATEYTTSIDIWSAGCVLAE 206
               Y T  DI SA   + +
Sbjct: 175 ---TYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	353
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.42
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.93
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.14
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.95
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.72

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-67  Score=473.27  Aligned_cols=327  Identities=68%  Similarity=1.190  Sum_probs=288.2

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHcCCCceeecceeeeecCC-CCceeEEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNELFLNLV   87 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv   87 (353)
                      +.-+|...++||+|+||+||+|+++.+|+.||||++.++.....+|+.+|+.++||||++++++|+.... .+..++|+|
T Consensus        18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             ccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            3458999999999999999999999999999999998887777899999999999999999999866543 455678999


Q ss_pred             eccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccccC
Q 018619           88 MEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAG  167 (353)
Q Consensus        88 ~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~  167 (353)
                      ||||++++...+..+......+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+||+|||+|......
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence            9999998888887777778899999999999999999999999 899999999999999975568999999999987776


Q ss_pred             CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCC
Q 018619          168 EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTD  247 (353)
Q Consensus       168 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
                      ....+..||+.|+|||.+.+...++.++||||+||++|+|++|+.||...+..+.+..+.+..|.+....+....+.+..
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence            66777889999999999987777999999999999999999999999999999999999999999999999998888888


Q ss_pred             CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCchhhhccCC
Q 018619          248 FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNFKQELSGAS  327 (353)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (353)
                      ..++.....+|.......+++++.+||.+||++||.+|||+.|+|+||||++++.++..++..+..+.+.++..+.....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~  336 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN  336 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTC
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCC
Confidence            88888888888888888899999999999999999999999999999999999988887787777777777776555555


Q ss_pred             HHHHhhccH
Q 018619          328 PELVNKLIP  336 (353)
Q Consensus       328 ~~~~~~~~~  336 (353)
                      ++....++|
T Consensus       337 ~~~~~~~~p  345 (350)
T d1q5ka_         337 PPLATILIP  345 (350)
T ss_dssp             GGGHHHHSC
T ss_pred             ccccccCCC
Confidence            555444444

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-64  Score=435.49  Aligned_cols=253  Identities=25%  Similarity=0.340  Sum_probs=209.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+.+++.++||||+++++++.+     ...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            47899999999999999999999999999999998643     2345689999999999999999999844     3458


Q ss_pred             EEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      |+|||||+| +|.+.+    ...+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDE-RDNLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECC-CCCEEEccchhhee
Confidence            999999985 554443    456789999999999999999999999 79999999999999996 78899999999987


Q ss_pred             cccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .....   .....+||+.|+|||++.+...++.++||||+||++|+|++|++||...+...............       
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------  225 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  225 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            65433   23456899999999999876656788999999999999999999998765543333332211100       


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                    ..     ....+|+++++||++||+.||++|||++|+|+||||++
T Consensus       226 --------------~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         226 --------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             --------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             --------------CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence                          00     11357999999999999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-63  Score=430.40  Aligned_cols=249  Identities=29%  Similarity=0.501  Sum_probs=214.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .-++|++.+.||+|+||+||+|+++.+++.||+|++.+.       .....+|+.+++.++||||+++++++.     +.
T Consensus         4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~   78 (263)
T d2j4za1           4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DA   78 (263)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----EC
Confidence            357899999999999999999999999999999998643       233468999999999999999999984     44


Q ss_pred             eeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+|||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~~kl~DFG~  152 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGS-AGELKIADFGW  152 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEECCCCS
T ss_pred             CEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecC-CCCEeecccce
Confidence            45899999998 477666653    4679999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |...... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+.+.           
T Consensus       153 a~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-----------  219 (263)
T d2j4za1         153 SVHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------  219 (263)
T ss_dssp             CSCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred             eeecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence            9865443 33456799999999999764 5899999999999999999999999988877776655431           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                            ..            .++..+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       220 ------~~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         220 ------EF------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             ------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             ------CC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence                  11            123458999999999999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-63  Score=433.94  Aligned_cols=256  Identities=30%  Similarity=0.520  Sum_probs=216.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKN   80 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (353)
                      ...++|++.+.||+|+||+||+|+++.+|+.||||++.+..       ....+|+.+++.++||||++++++|     .+
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~   79 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QD   79 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----EC
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EE
Confidence            35678999999999999999999999999999999986431       3356899999999999999999998     44


Q ss_pred             ceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           81 ELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        81 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ...+|+|||||+| +|.+.+.    ..+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus        80 ~~~~~ivmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~-~~~vkl~DFG  153 (288)
T d1uu3a_          80 DEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNE-DMHIQITDFG  153 (288)
T ss_dssp             SSEEEEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCT
T ss_pred             CCEEEEEEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCC-CceEEecccc
Confidence            4558999999985 6666554    34789999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCC---CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          160 SAKQLIAGE---ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       160 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +|+......   ...+..||+.|+|||++.+. .|+.++||||+||++|+|++|..||.+.+..+...++.+.       
T Consensus       154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-------  225 (288)
T d1uu3a_         154 TAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------  225 (288)
T ss_dssp             TCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-------
T ss_pred             cceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-------
Confidence            998765432   23356799999999999765 4899999999999999999999999998888777666541       


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHH------HhcCcccccccCCC
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE------ACAHPFFDELREPN  304 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~------~l~hp~f~~~~~~~  304 (353)
                                .+            .++..+|+++++||++||+.||++|||++|      +++||||+.+.+..
T Consensus       226 ----------~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         226 ----------EY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN  277 (288)
T ss_dssp             ----------CC------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred             ----------CC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence                      11            133468999999999999999999999987      58999999987654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-62  Score=431.13  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=213.3

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++....    ....+|+.+++.++|||||+++++|..     ...+|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            47999999999999999999999999999999986432    345689999999999999999999844     334899


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      |||||+| +|.+.+..     +.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus        95 vmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECC-CCcEeeccchhheeec
Confidence            9999985 66554432     579999999999999999999999 79999999999999996 7889999999998765


Q ss_pred             cCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ... ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+..... +.          
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~----------  235 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE----------  235 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC----------
T ss_pred             cccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC----------
Confidence            443 34556799999999999764 589999999999999999999999999888877776655311 10          


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                     ...+..+|+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       236 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             ---------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             ---------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence                           0122458999999999999999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-62  Score=432.24  Aligned_cols=275  Identities=35%  Similarity=0.614  Sum_probs=226.6

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .+++||+|+||+||+|+++.+|+.||||++....         ....+|+.+++.++|||||++++++.     ....+|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence            4689999999999999999999999999985432         23568999999999999999999984     334488


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      +|||||.+++...+.   .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecC-CCccccccCccccccC
Confidence            999999987655443   356789999999999999999999999 79999999999999996 8899999999998665


Q ss_pred             cCC-CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          166 AGE-ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       166 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ... .....+||+.|+|||++.+...|+.++||||+||++|+|++|.+||.+.+..+.+.++.+..+.+....+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            443 3345678999999999977777899999999999999999999999999999999999999998887654332222


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                      .....+......++...+ ..+++++++||.+||++||++|||++|+|+||||++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             chhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence            222222222333333322 3589999999999999999999999999999999864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-62  Score=425.75  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=206.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|.+....      ..+.+|+.+++.++|||||++++++.+..   ...
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCE
Confidence            589999999999999999999999999999999986432      23458999999999999999999885422   234


Q ss_pred             EEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC-----eeeccCCCCcEEEeCCCCcEEEee
Q 018619           84 LNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR-----VCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        84 ~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~-----i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                      +|+|||||+ |+|.+.+.........+++..++.++.||+.||+|||+ +|     |+||||||+|||++. ++.+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~-~~~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG-KQNVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECT-TSCEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCC-CCcEEEee
Confidence            889999998 58888887776778899999999999999999999998 56     999999999999996 78999999


Q ss_pred             eccccccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          158 FGSAKQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       158 fg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      ||+|+....... .....||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.+..+....+.+..-     
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-----  231 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----  231 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            999987655433 3457889999999999654 589999999999999999999999999888777666554200     


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF  297 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f  297 (353)
                                             ..++..+|+++.+||++||+.||.+|||++|+++|||+
T Consensus       232 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         232 -----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence                                   01234689999999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.3e-62  Score=436.81  Aligned_cols=258  Identities=25%  Similarity=0.393  Sum_probs=221.3

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.+..    ..+.+|+.+++.++|||||+++++|.+     ...+|+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            58999999999999999999999999999999986543    334689999999999999999999843     345899


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC-CCCcEEEeeecccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQL  164 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~-~~~~vkl~Dfg~a~~~  164 (353)
                      |||||+| +|.+.+..   ..+++++..++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+|||+|+..
T Consensus       101 vmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            9999984 76666542   45679999999999999999999999 79999999999999964 2578999999999988


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ..........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+......+..         
T Consensus       177 ~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------  246 (350)
T d1koaa2         177 DPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD---------  246 (350)
T ss_dssp             CTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC---------
T ss_pred             ccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---------
Confidence            777777778899999999999775 4899999999999999999999999999888888777663222111         


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                                      .....+|+++++||++||++||++|||++|+|+||||+....+
T Consensus       247 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         247 ----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             ----------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             ----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence                            1123589999999999999999999999999999999876543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-62  Score=431.98  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=202.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .+.|++.+.||+|+||+||+|+++.+|+.||||++.+..     ....+|+.+++.++|||||++++++     .+...+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            567999999999999999999999999999999986532     3345899999999999999999998     444558


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeeeccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSA  161 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Dfg~a  161 (353)
                      |+|||||+ |+|.+.+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||+..  .++.+||+|||+|
T Consensus        83 ~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             EEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             EEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEecccee
Confidence            99999998 57777765    35789999999999999999999999 79999999999999953  3678999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +.........+.+||+.|+|||++.+. .|+.++||||+||++|+|++|.+||.+.+..+....+.+....++       
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------  229 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD-------  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-------
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-------
Confidence            877666666678899999999999664 589999999999999999999999999888777766655211111       


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                        ......+|+++++||.+||++||++|||++|+++||||++
T Consensus       230 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         230 ------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             ------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                              1122468999999999999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-61  Score=420.75  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=210.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..+.-|++.+.||+|+||+||+|.+..+++.||+|++....      ..+.+|+++++.++|||||+++++|.... .+.
T Consensus         6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~   84 (270)
T d1t4ha_           6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGK   84 (270)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSC
T ss_pred             CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccC
Confidence            33444578889999999999999999999999999986432      23468999999999999999999885543 334


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCC--eeeccCCCCcEEEeCCCCcEEEeee
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPR--VCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~--i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ..+|+|||||++ +|.+.+..    ...+++..++.++.||+.||+|||+ ++  |+||||||+|||++.+++.+||+||
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            568899999985 77666653    4679999999999999999999999 78  9999999999999755788999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |+|+.... ....+..||+.|+|||++.+  .++.++||||+||++|+|++|+.||.+......+.+.+.....      
T Consensus       160 Gla~~~~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~------  230 (270)
T d1t4ha_         160 GLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------  230 (270)
T ss_dssp             TGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC------
T ss_pred             CcceeccC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC------
Confidence            99985433 33446789999999999854  4899999999999999999999999876665554443321100      


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                                          ...++...++++.+||.+||+.||++|||++|+|+||||+
T Consensus       231 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         231 --------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             --------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             --------------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence                                0112345789999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-62  Score=426.09  Aligned_cols=254  Identities=24%  Similarity=0.363  Sum_probs=213.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .+.|++.+.||+|+||+||+|+++.+|+.||+|++.+.    .....+|+.+++.++|||||++++++..     ...+|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~   85 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLW   85 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEE
Confidence            35799999999999999999999999999999998643    2455689999999999999999999844     33488


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +|||||++ +|...+..   ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++++||+|||+|...
T Consensus        86 lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~  160 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTL-DGDIKLADFGVSAKN  160 (288)
T ss_dssp             EEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECC-CCCEEEEechhhhcc
Confidence            99999985 66655543   35679999999999999999999999 79999999999999996 788999999999765


Q ss_pred             ccCC-CcceeeeeceeeChhhhhC----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          165 IAGE-ANISYICSRFYRAPELIFG----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       165 ~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      .... ...+..||+.|+|||++.+    ...|+.++||||+||++|+|++|+.||.+.+..+.+.++.+.....      
T Consensus       161 ~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------  234 (288)
T d2jfla1         161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------  234 (288)
T ss_dssp             HHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------
T ss_pred             CCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence            4332 2335678999999999843    3457899999999999999999999999988887777666521100      


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                          ...+..+|+++++||++||+.||.+|||++|+++||||+.
T Consensus       235 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         235 --------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             --------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             --------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                0112458999999999999999999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-61  Score=426.41  Aligned_cols=283  Identities=35%  Similarity=0.658  Sum_probs=231.9

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++++.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++|||||+++++|.+     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            6899999999999999999999999999999998543      2345689999999999999999999944     3448


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+|||||.+++...+..  .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINT-EGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecc-cCcceeccCCcceec
Confidence            99999999887766643  245679999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccC-CCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAG-EANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ... .......||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.+..+.+..+.+..........
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            543 3344568999999999987777678999999999999999999999999999999999999888877554332211


Q ss_pred             C-CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCC
Q 018619          244 N-YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREP  303 (353)
Q Consensus       244 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~  303 (353)
                      . .....++......+... ...+|+++++||++||+.||++|||++|+|+||||+++.++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKV-VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHH-STTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccccccchhhh-ccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            1 00111222222222222 23588999999999999999999999999999999987544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=432.83  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=217.6

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .-++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+|+.++||||++++++|     .+.
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~   77 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH   77 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccc
Confidence            347899999999999999999999999999999999653       23345899999999999999999999     455


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+|||||+| +|...+.    ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus        78 ~~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~-~g~vkl~DFG~  151 (337)
T d1o6la_          78 DRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDK-DGHIKITDFGL  151 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTT
T ss_pred             cccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecC-CCCEEEeeccc
Confidence            569999999995 5555544    45789999999999999999999999 79999999999999996 78999999999


Q ss_pred             cccccc-CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          161 AKQLIA-GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       161 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      |+.... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+....+...          
T Consensus       152 a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----------  220 (337)
T d1o6la_         152 CKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------  220 (337)
T ss_dssp             CBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred             ccccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC----------
Confidence            987544 3344567899999999999665 5899999999999999999999999999887777666542          


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE  302 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~  302 (353)
                             ..            .++..+|+++++||++||++||.+|++     ++|+++||||+++.+
T Consensus       221 -------~~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         221 -------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             -------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             -------CC------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence                   11            133568999999999999999999994     899999999998754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=423.40  Aligned_cols=286  Identities=34%  Similarity=0.579  Sum_probs=235.0

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCC-CcEEEEEEeecc------ccchHHHHHHHHHc---CCCceeecceeeeecCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLET-GETVAIKKVLQD------RRYKNRELQLMRVM---DHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~~   79 (353)
                      .++|++++.||+|+||+||+|++..+ ++.||||++..+      .....+|+.+++.+   +||||++++++|......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47999999999999999999999766 667999998543      22345788887766   799999999998766656


Q ss_pred             CceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeec
Q 018619           80 NELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFG  159 (353)
Q Consensus        80 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg  159 (353)
                      ....++++||||.+++......  .....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~-~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTS-SGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcC-CCCeeecchh
Confidence            6778999999999876554433  345779999999999999999999999 79999999999999996 7889999999


Q ss_pred             cccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          160 SAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       160 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      +++............||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            99876666666678899999999999765 59999999999999999999999999999999999999999988766543


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ...... ...+......+ ...+...+++++++||++||++||++|||++|+|+||||++++.
T Consensus       241 ~~~~~~-~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         241 RDVALP-RQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TTCSSC-GGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccch-hhhhccccccc-hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            221111 11111111122 22344578999999999999999999999999999999998754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-61  Score=424.48  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=218.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..          ..+.+|+.+|+.++|||||+++++|     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            578999999999999999999999999999999986431          2356899999999999999999998     4


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC---CcEEE
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT---HQVKI  155 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~---~~vkl  155 (353)
                      +...+|+|||||+ |+|.+.+..    .+.+++..++.++.|++.||+|||+ +||+||||||+|||++..+   ..+||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEe
Confidence            4456899999998 477776654    4679999999999999999999999 7999999999999998532   25999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +|||+|.............+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+.+.......
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            999999987766666677899999999999654 5899999999999999999999999999888877766553222111


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                                               .++.++|+++++||++||+.||++|||++|+++||||+...+
T Consensus       238 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         238 -------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             -------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             -------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence                                     122458999999999999999999999999999999987543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-61  Score=432.40  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=219.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .++|++++.||+|+||+||+|.++.+|+.||||++.+..    ....+|+.+|+.++|||||+++++|     .....+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            367999999999999999999999999999999986543    3446899999999999999999998     4445589


Q ss_pred             EEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC-CCCcEEEeeeccccc
Q 018619           86 LVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP-LTHQVKICDFGSAKQ  163 (353)
Q Consensus        86 lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~-~~~~vkl~Dfg~a~~  163 (353)
                      +|||||+| +|.+.+.   ....++++.+++.++.||+.||+|||+ +||+||||||+|||++. .++.+||+|||+|..
T Consensus       103 ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         103 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeeccccee
Confidence            99999995 6554433   245679999999999999999999999 79999999999999973 367899999999998


Q ss_pred             cccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          164 LIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       164 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ...........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..+.+....++         
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------  248 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------  248 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             cCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            8777767778899999999999664 599999999999999999999999999998888877766322111         


Q ss_pred             CCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          244 NYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                      ......+|+++++||++||++||.+|||++|+|+||||+..
T Consensus       249 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 ----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             ----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence                            11224589999999999999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-61  Score=425.41  Aligned_cols=248  Identities=29%  Similarity=0.428  Sum_probs=211.0

Q ss_pred             eeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           12 SYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      .|++.+.||+|+||+||+|+++.+|+.||||++....       ..+.+|+.+++.++|||||++++++.+     ...+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence            5999999999999999999999999999999986542       234589999999999999999999844     3348


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      |+|||||.+++...+.   ...+++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|...
T Consensus        91 ~iv~E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSE-PGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEET-TTEEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECC-CCCEEEeeccccccc
Confidence            9999999976554433   245789999999999999999999999 79999999999999996 889999999999865


Q ss_pred             ccCCCcceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..   .....||+.|+|||++.+.  ..|+.++||||+||++|+|++|..||.+.+..+.+..+......+.        
T Consensus       166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------  234 (309)
T d1u5ra_         166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--------  234 (309)
T ss_dssp             SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------
T ss_pred             CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence            43   3456899999999998653  3589999999999999999999999999888877776665211100        


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                         .+..+|+++++||.+||+.||.+|||++|+|+||||.+
T Consensus       235 -------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         235 -------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             -------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             -------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence                               12357999999999999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-62  Score=434.48  Aligned_cols=283  Identities=26%  Similarity=0.432  Sum_probs=209.5

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +..++|++.+.||+|+||+||+|+++.+|+.||+|++..+.     ....+|+.+|+.++|||||+++++|.     ...
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~   77 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDG   77 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSS
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECC
Confidence            34789999999999999999999999999999999986432     23468999999999999999999994     344


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+|||||.| +|.+.+..    .+.+++..++.++.||+.||+|||+.+||+||||||+|||++. ++++||+|||+|
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla  152 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS  152 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCc
Confidence            58999999995 77766653    4679999999999999999999996138999999999999996 789999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCCHHHHhh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVE-IIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~  240 (353)
                      +..... ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+.... .....+.+.......
T Consensus       153 ~~~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         153 GQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             HHHHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             cccCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence            865432 23467899999999999875 499999999999999999999999987665433221 111111111110000


Q ss_pred             cCcCC--CCC---cCCCC---------CCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          241 MNPNY--TDF---RFPQI---------KAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~--~~~---~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      .....  ...   ..+..         ............+|.+++|||.+||++||.+|||++|+|+||||++..+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence            00000  000   00000         0000111111246889999999999999999999999999999987543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-60  Score=423.18  Aligned_cols=250  Identities=29%  Similarity=0.474  Sum_probs=215.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++||||+++++++     .....
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            6799999999999999999999999999999998643       23456899999999999999999998     44456


Q ss_pred             EEEEeccccch-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           84 LNLVMEYVPES-MYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        84 ~~lv~e~~~~~-l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      +|+|||||.|+ +...+    .....+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|+
T Consensus        79 ~~ivmE~~~gg~l~~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~-~g~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLL----RKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDK-NGHIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHH----HHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECT-TSCEEECCCSSCE
T ss_pred             eeeEeeecCCccccccc----cccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcC-CCCEEEecCccce
Confidence            89999999964 43333    356788999999999999999999999 79999999999999996 8899999999998


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      .....  ..+..||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+...++.+..            
T Consensus       153 ~~~~~--~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------  217 (316)
T d1fota_         153 YVPDV--TYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------  217 (316)
T ss_dssp             ECSSC--BCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred             Eeccc--cccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------------
Confidence            75433  3457899999999999664 58999999999999999999999999998888877766521            


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccCC
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELREP  303 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~~  303 (353)
                           .            .++..+|++++++|++||++||.+|+     |++++++||||+++.+.
T Consensus       218 -----~------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         218 -----L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             -----C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred             -----C------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence                 1            12345899999999999999999996     89999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.3e-60  Score=414.01  Aligned_cols=254  Identities=28%  Similarity=0.410  Sum_probs=218.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------------cchHHHHHHHHHcC-CCceeecceeeee
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------------RYKNRELQLMRVMD-HPNVISLKHCFFS   75 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~~iv~~~~~~~~   75 (353)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..             ....+|+.+++.++ ||||+++++++  
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--   79 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--   79 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE--
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec--
Confidence            478999999999999999999999999999999986532             13457999999997 99999999999  


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEE
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVK  154 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vk  154 (353)
                         .+...+|+|||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|
T Consensus        80 ---~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~-~~~~k  150 (277)
T d1phka_          80 ---ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDD-DMNIK  150 (277)
T ss_dssp             ---ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TCCEE
T ss_pred             ---ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcC-CCCeE
Confidence               44456899999998 588777753    4679999999999999999999999 79999999999999996 88899


Q ss_pred             EeeeccccccccCCCcceeeeeceeeChhhhhC-----CCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 018619          155 ICDFGSAKQLIAGEANISYICSRFYRAPELIFG-----ATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKV  229 (353)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~  229 (353)
                      |+|||+|+............||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+.+.
T Consensus       151 l~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~  230 (277)
T d1phka_         151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  230 (277)
T ss_dssp             ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             EccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence            999999998777666667889999999999853     334788999999999999999999999999988877776653


Q ss_pred             hCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          230 LGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      ...+.                         .....++|+++++||.+||+.||++|||++|+|+||||++
T Consensus       231 ~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         231 NYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CCCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            11111                         1112358999999999999999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.9e-60  Score=415.11  Aligned_cols=277  Identities=35%  Similarity=0.639  Sum_probs=226.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...      ...+.+|+.+|+.++||||++++++|..     ....
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence            68999999999999999999985 8899999998543      2345689999999999999999999844     3348


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++||++.+++...+..   ..+.+++..++.++.||+.||+|||+ .||+||||||+|||++. ++.+||+|||.|...
T Consensus        76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINR-EGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TSCEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcC-CCCEEecccccceec
Confidence            89999999886666543   56789999999999999999999999 79999999999999996 788999999999876


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNP  243 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
                      ..... .....+++.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            54333 34457899999999998777789999999999999999999999999999999999999988887655433221


Q ss_pred             CCC-CCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          244 NYT-DFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       244 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      ... ...+......++. .+...++++++|||++||++||++|||++|+|+||||++
T Consensus       231 ~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             STTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            111 1112222223333 344568999999999999999999999999999999974

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=423.52  Aligned_cols=317  Identities=32%  Similarity=0.565  Sum_probs=240.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      ..++|++++.||+|+||+||+|.++.+|+.||||++.+..      ....+|+.+|+.++|||||+++++|..... ...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3789999999999999999999999999999999986432      234589999999999999999999865432 233


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+|||||++++......     .++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus        96 ~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a  168 (346)
T d1cm8a_          96 TDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNE-DCELKILDFGLA  168 (346)
T ss_dssp             CCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred             ceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhccc-ccccccccccce
Confidence            45789999998877666543     679999999999999999999999 79999999999999996 888999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +....  ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+.+..+....+.++...+...
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         169 RQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             EECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             eccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            86543  3345788999999999988777899999999999999999999999999999999999999999887765533


Q ss_pred             CcCCCC---CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCC
Q 018619          242 NPNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFN  318 (353)
Q Consensus       242 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~  318 (353)
                      ......   ..++......|... ...++++++|||++||++||++|||++|+|+||||+.+.+.... +..+.    .+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~-~~~~~----~~  320 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE-PQVQK----YD  320 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-------CCCC----CC
T ss_pred             cchhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccc-ccCCC----CC
Confidence            221000   01223333344433 34689999999999999999999999999999999988654332 11111    11


Q ss_pred             chhhhccCCHHHHhhccHHHHH
Q 018619          319 FKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      ...+....+.+...+++..++.
T Consensus       321 ~~~~~~~~~~~e~k~~~~~e~~  342 (346)
T d1cm8a_         321 DSFDDVDRTLDEWKRVTYKEVL  342 (346)
T ss_dssp             CC-----CCHHHHHHHHHHHHH
T ss_pred             CchhhhhcCHHHHHHHHHHHhh
Confidence            1112223455666666655554

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-60  Score=422.13  Aligned_cols=255  Identities=25%  Similarity=0.401  Sum_probs=219.6

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      -++|++.+.||+|+||+||+|.++.+|+.||||++....   ....+|+.+|+.++|||||+++++|.     +...+|+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~l   78 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            478999999999999999999999999999999997543   33568999999999999999999984     3445899


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCC-CCcEEEeeecccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPL-THQVKICDFGSAKQL  164 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~-~~~vkl~Dfg~a~~~  164 (353)
                      |||||+| +|.+.+..   ....+++.+++.++.||+.||+|||+ +||+||||||+|||++.+ ..++||+|||++...
T Consensus        79 vmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            9999995 77666643   34579999999999999999999999 799999999999999752 458999999999987


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ..........+|+.|+|||.+.+. .|+.++||||+||++|+|++|..||.+.+..+.+..+.+....++...       
T Consensus       155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------  226 (321)
T d1tkia_         155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA-------  226 (321)
T ss_dssp             CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred             ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-------
Confidence            666666677889999999998654 589999999999999999999999999999888888876433222221       


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                                        ...+|+++++||.+||++||.+|||++|+++||||++
T Consensus       227 ------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             ------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence                              2358999999999999999999999999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.6e-60  Score=425.35  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=215.7

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      .-++|++++.||+|+||.||+|+++.+|+.||||++.+..       ....+|+.+|+.++||||+++++++     ...
T Consensus        39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~  113 (350)
T d1rdqe_          39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccc
Confidence            3478999999999999999999999999999999986432       2345899999999999999999998     444


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+++||||+.+ ++...+..    .+.+++..++.++.||+.||.|||+ +||+||||||+|||++. ++.+||+|||+
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~-~g~ikL~DFG~  187 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQ-QGYIQVTDFGF  187 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TSCEEECCCTT
T ss_pred             cccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCC-CCCEEeeecee
Confidence            458899999995 55555543    4679999999999999999999999 79999999999999996 78999999999


Q ss_pred             ccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          161 AKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       161 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      |+.....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.....         
T Consensus       188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------  255 (350)
T d1rdqe_         188 AKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------  255 (350)
T ss_dssp             CEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             eeecccc--cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC---------
Confidence            9876543  3457899999999999764 589999999999999999999999999888877777665211         


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                                          .++..+|+++.+||++||++||.+|+     |++++++||||+.+.+
T Consensus       256 --------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~  302 (350)
T d1rdqe_         256 --------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             --------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             --------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence                                12345899999999999999999995     9999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.6e-60  Score=427.01  Aligned_cols=255  Identities=27%  Similarity=0.391  Sum_probs=208.3

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHH---HHHHHHHcCCCceeecceeeeecCCC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNR---ELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      -++|++.+.||+|+||.||+|+++.+|+.||||++.+..       ....+   |+.+++.++|||||+++++|     .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence            468999999999999999999999999999999986432       11223   45666677899999999998     3


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      ....+|+|||||. |+|.+.+..    ...+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~-~g~iKl~DF  151 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDE-HGHVRISDL  151 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECS-SSCEEECCC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcC-CCcEEEeee
Confidence            4445899999999 577666653    4678999999999999999999999 79999999999999996 788999999


Q ss_pred             ccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          159 GSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       159 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      |+|+..... ......||+.|+|||++.+...|+.++||||+||++|+|++|+.||.+.+..+... +.+.....     
T Consensus       152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~-----  224 (364)
T d1omwa3         152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTM-----  224 (364)
T ss_dssp             TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSC-----
T ss_pred             ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccC-----
Confidence            999866543 33456899999999999766668999999999999999999999998765433322 22111100     


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCC-----HHHHhcCcccccccC
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCT-----ALEACAHPFFDELRE  302 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~~~l~hp~f~~~~~  302 (353)
                                          ...++..+|+++++||.+||++||.+|||     ++|+++||||+++.+
T Consensus       225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~  273 (364)
T d1omwa3         225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  273 (364)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence                                01133568999999999999999999999     799999999998754

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-59  Score=418.55  Aligned_cols=320  Identities=33%  Similarity=0.611  Sum_probs=244.5

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCCCCcee
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELF   83 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (353)
                      .+.+|++++.||+|+||+||+|.++.+|+.||||++.+..     ....+|+.+|+.++||||+++++++..........
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3578999999999999999999999999999999986432     23458999999999999999999986655445556


Q ss_pred             EEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           84 LNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        84 ~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      +|+++++++++|.+.+..     .++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+|..
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNT-TCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECC-CCCEEEcccCceee
Confidence            788888888899888754     479999999999999999999999 79999999999999996 78999999999986


Q ss_pred             cccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          164 LIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       164 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      ......    .....||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+...........+......
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            544322    3446789999999998666678999999999999999999999999999999998888888888765432


Q ss_pred             hcCcC---CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCC
Q 018619          240 CMNPN---YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPL  316 (353)
Q Consensus       240 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~  316 (353)
                      .....   ......+.....+|...+ ..+|+++++||.+||++||.+|||++|+|+||||+....+....    ..+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~----~~~~~  313 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEP----IAEAP  313 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSC----CCSSC
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCc----cccCc
Confidence            21100   000112333334444433 35899999999999999999999999999999999765543221    11223


Q ss_pred             CCchhhhccCCHHHHhhccHHHHH
Q 018619          317 FNFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      .++..+......+.+++++.++..
T Consensus       314 ~~~~~~~~~~~~~~l~~l~~~e~~  337 (345)
T d1pmea_         314 FKFDMELDDLPKEKLKELIFEETA  337 (345)
T ss_dssp             C--------CCHHHHHHHHHHHSG
T ss_pred             cCCChhhhhCCHHHHHHHHHHHHH
Confidence            444555566677777776665544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-60  Score=411.61  Aligned_cols=245  Identities=26%  Similarity=0.407  Sum_probs=205.7

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------cchHHHHHHHHHcC--CCceeecceeeeecC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------RYKNRELQLMRVMD--HPNVISLKHCFFSTT   77 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~   77 (353)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.++.          ....+|+.+++.++  ||||++++++|    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            568999999999999999999999999999999986432          23458999999986  89999999998    


Q ss_pred             CCCceeEEEEeccccc--hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           78 SKNELFLNLVMEYVPE--SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~--~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                       .....+|+||||+.+  ++.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEE
Confidence             334458899999974  5555544    34679999999999999999999999 799999999999999975679999


Q ss_pred             eeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          156 CDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      +|||+|+.... ....+..||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+      .+.+.      
T Consensus       153 ~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------  219 (273)
T d1xwsa_         153 IDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------  219 (273)
T ss_dssp             CCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred             Cccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence            99999986433 334467899999999999776656788999999999999999999997532      12210      


Q ss_pred             HHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          236 EEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                 .            ..++..+|+++++||++||+.||++|||++|+++||||+++
T Consensus       220 -----------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         220 -----------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             -----------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             -----------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence                       0            11335689999999999999999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=417.01  Aligned_cols=251  Identities=29%  Similarity=0.519  Sum_probs=212.0

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHH-HHcCCCceeecceeeeecCCCCce
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLM-RVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.++.       ....+|..++ +.++||||+++++++     ....
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            68999999999999999999999999999999996432       1234566655 478999999999998     4444


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+|||||++ +|.+.+.    ....+++..++.++.||+.||+|||+ +||+||||||+|||+++ ++.+||+|||+|
T Consensus        77 ~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~-~~~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDK-DGHIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECT-TSCEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecC-CCceeccccchh
Confidence            59999999985 6666654    35679999999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +....... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            86554333 3456899999999999765 5899999999999999999999999998887777666541  11       


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH-HHhcCcccccccC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL-EACAHPFFDELRE  302 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-~~l~hp~f~~~~~  302 (353)
                                          .+++.+|+++++||++||++||.+|||+. ++++||||+++++
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~  263 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW  263 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence                                12346899999999999999999999995 8999999998754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-58  Score=414.20  Aligned_cols=284  Identities=29%  Similarity=0.489  Sum_probs=225.3

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHcC-CCceeecceeeeecCCCCceeEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMD-HPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|+.++ ||||++++++|...   ....+++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeE
Confidence            5688999999999999999999999999999999987543 45678999999995 99999999988543   2334889


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLIA  166 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~  166 (353)
                      |||||.++.+   ..   ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+++.+||+|||+|+....
T Consensus       110 v~e~~~~~~L---~~---~~~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         110 VFEHVNNTDF---KQ---LYQTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             EEECCCSCBG---GG---TTTSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             EEeecCCCcH---HH---HhcCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999996532   21   23579999999999999999999999 79999999999999997566799999999998777


Q ss_pred             CCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcCcCC
Q 018619          167 GEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGE-NAVDQLVEIIKVLGTPTREEIRCMNPNY  245 (353)
Q Consensus       167 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
                      ........+|+.|+|||.+.+...++.++||||+||++|+|++|..||... +..+....+.+.++.+............
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence            666677889999999999988777899999999999999999999999654 4555666666666655443332211111


Q ss_pred             CCC----cCCCCCCCccccc----cCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccC
Q 018619          246 TDF----RFPQIKAHPWHKV----FHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELRE  302 (353)
Q Consensus       246 ~~~----~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~  302 (353)
                      ...    .........|...    ....++++++|||++||++||.+|||++|+|+||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            110    0111111222221    22347899999999999999999999999999999998754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-58  Score=416.71  Aligned_cols=320  Identities=30%  Similarity=0.509  Sum_probs=233.9

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~   81 (353)
                      .-++|++++.||+|+||+||+|.++.+|+.||||++.+..      ....+|+.+++.++||||++++++|..... +..
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            3478999999999999999999999999999999996432      234589999999999999999999854432 344


Q ss_pred             eeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           82 LFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        82 ~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      ..+|+|||||.+++...+.      ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||++
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~-~~~~kl~df~~~  166 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKS-DCTLKILDFGLA  166 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCCCC-
T ss_pred             ceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCcccccccc-ccceeeechhhh
Confidence            6789999999998776553      568999999999999999999999 79999999999999996 778999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      +............+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+......++....+.+....+...
T Consensus       167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         167 RTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             --------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             hccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            877776666777899999999999775 5899999999999999999999999999999999999999998887766543


Q ss_pred             CcCCCCC--cCCCCCCCcccc-----------ccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCC
Q 018619          242 NPNYTDF--RFPQIKAHPWHK-----------VFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLP  308 (353)
Q Consensus       242 ~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~  308 (353)
                      ......+  ..+......+..           ......|++++|||++||++||++||||+|+|+||||+...++.... 
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~-  324 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-  324 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT-
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc-
Confidence            3221100  000001111111           11123567899999999999999999999999999999764432221 


Q ss_pred             CCCCCCCCCCchhhhccCCHHHHhhccHHHHH
Q 018619          309 NGRPLPPLFNFKQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (353)
                        ...+...+...+....+.+.+.+++..+++
T Consensus       325 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T d2b1pa1         325 --APPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_dssp             --CCCC-------CCCCCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence              112233333333345666667776666654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-59  Score=418.61  Aligned_cols=263  Identities=24%  Similarity=0.363  Sum_probs=209.8

Q ss_pred             cceeeEee-eeecCCCeEEEEEEECCCCcEEEEEEeeccccchHHHHHHHH-HcCCCceeecceeeeecCCCCceeEEEE
Q 018619           10 TISYMAER-VVGTGSFGIVFQAKCLETGETVAIKKVLQDRRYKNRELQLMR-VMDHPNVISLKHCFFSTTSKNELFLNLV   87 (353)
Q Consensus        10 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~~lv   87 (353)
                      .++|.+.+ .||+|+||+||+|+++.+++.||||++.+. ....+|+.++. ..+|||||+++++|.+.. .....+|+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~iv   87 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLIV   87 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEEE
Confidence            46898875 699999999999999999999999998643 45668998865 558999999999884432 234568999


Q ss_pred             ecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeeecccccc
Q 018619           88 MEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQL  164 (353)
Q Consensus        88 ~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Dfg~a~~~  164 (353)
                      ||||+ |+|.+.+..  .....+++.+++.++.||+.||+|||+ +||+||||||+|||++.  ..+.+||+|||+|+..
T Consensus        88 mEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~  164 (335)
T d2ozaa1          88 MECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  164 (335)
T ss_dssp             EECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceeeec
Confidence            99998 588887764  234579999999999999999999999 79999999999999974  2457999999999987


Q ss_pred             ccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 018619          165 IAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPN  244 (353)
Q Consensus       165 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
                      ..........||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+.......+......            
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~------------  231 (335)
T d2ozaa1         165 TSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------  231 (335)
T ss_dssp             CCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS------------
T ss_pred             cCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc------------
Confidence            776666778899999999998654 5899999999999999999999999877654444333221110            


Q ss_pred             CCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          245 YTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                       ..+.++.        .....+|+++++||++||++||++|||+.|+++||||.+
T Consensus       232 -~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         232 -GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             -CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             -CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence             1111111        111247999999999999999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=400.63  Aligned_cols=281  Identities=34%  Similarity=0.575  Sum_probs=227.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      ++|++++.||+|+||+||+|++..+|+.||||++..+.      ....+|+.+++.++||||+++++++.     .....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            58999999999999999999999999999999986432      33468999999999999999999983     44458


Q ss_pred             EEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           85 NLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        85 ~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +++++++.++.+..+.   ...+.+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||.|+..
T Consensus        77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINR-NGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECT-TCCEEECCCTTCEEC
T ss_pred             eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCccccccc-CCceeeeecchhhcc
Confidence            8999999986544443   356789999999999999999999999 79999999999999996 778999999999876


Q ss_pred             ccCCC-cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          165 IAGEA-NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPL-FPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       165 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ..... .....+++.|+|||++.+...++.++||||+||++|+|++|..| |.+.+..+...++....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            54433 33456788999999997777689999999999999999999987 56677777788888888877765443332


Q ss_pred             cCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccccc
Q 018619          243 PNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELR  301 (353)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~  301 (353)
                      ........+..............+++++++||++||++||.+|||++|+|+||||+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence            22122222222222333334456899999999999999999999999999999998754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=411.19  Aligned_cols=316  Identities=34%  Similarity=0.555  Sum_probs=243.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC-CCce
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS-KNEL   82 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~   82 (353)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..      ....+|+.+|+.++|||||++++++..... ++..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            689999999999999999999999999999999986542      234589999999999999999998854433 2333


Q ss_pred             eEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619           83 FLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus        83 ~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .+++++++++|+|.+.+.     .+++++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+|++|||+|.
T Consensus        97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~-~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNE-DCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccc-cccccccccchhc
Confidence            455666666678877664     3579999999999999999999999 79999999999999996 7899999999997


Q ss_pred             ccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 018619          163 QLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIRCMN  242 (353)
Q Consensus       163 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
                      ...  ....+..||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+.+..+.+.........
T Consensus       170 ~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         170 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             ccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            543  233456789999999998777778999999999999999999999999999999999999998888776543221


Q ss_pred             cCCCC---CcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccccCCCCCCCCCCCCCCCCCc
Q 018619          243 PNYTD---FRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPLPPLFNF  319 (353)
Q Consensus       243 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~~~~~~~~~~~~~~~~~~~~  319 (353)
                      .....   ...+......+...+ ..++++++|||++||+.||.+|||++|+|+||||+++..+...     +..+..+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~-----~~~~~~~~  321 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-----PVADPYDQ  321 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC-----CCCCCCCC
T ss_pred             chhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC-----CCCCCCCC
Confidence            11000   011222222333322 3589999999999999999999999999999999987654332     23333344


Q ss_pred             hhhhccCCHHHHhhccHHHHH
Q 018619          320 KQELSGASPELVNKLIPDHVK  340 (353)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~  340 (353)
                      ..+......+.+.+++.+++.
T Consensus       322 ~~~~~~~~~~~~k~~~~~e~~  342 (348)
T d2gfsa1         322 SFESRDLLIDEWKSLTYDEVI  342 (348)
T ss_dssp             GGGGCCCCHHHHHHHHHHHHH
T ss_pred             cccchhcCHHHHHHHHHHHhh
Confidence            444556666666766656554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-57  Score=406.17  Aligned_cols=285  Identities=28%  Similarity=0.476  Sum_probs=222.1

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCC---CC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTS---KN   80 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~   80 (353)
                      .++|.+++.||+|+||+||+|+++.+|+.||||++....      ....+|+.+|+.++||||+++++++.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            589999999999999999999999999999999885432      234589999999999999999998854322   22


Q ss_pred             ceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           81 ELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        81 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ...+|+|||||.+++.....   .....+++..++.++.|++.||+|||+ +||+||||||+|||+++ ++.+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~-~~~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITR-DGVLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECT-TSCEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecC-CCcEEeeecce
Confidence            34588999999987655443   356789999999999999999999999 79999999999999996 78999999999


Q ss_pred             ccccccCC-----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 018619          161 AKQLIAGE-----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTR  235 (353)
Q Consensus       161 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  235 (353)
                      |.......     ...+..||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....+.+..+.+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            97654322     2234578999999999987777999999999999999999999999999999999999998888776


Q ss_pred             HHHhhcCcCCCCCcC--CCCCCCccccccC-CCCChhHHHHHHHhcCcCCCCCCCHHHHhcCccccc
Q 018619          236 EEIRCMNPNYTDFRF--PQIKAHPWHKVFH-KRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDE  299 (353)
Q Consensus       236 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~  299 (353)
                      ...............  ...........+. ...+++++|||.+||++||++|||++|+|+||||+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            543322211111001  1101111111110 124778999999999999999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-56  Score=391.53  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=204.8

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc-------cchHHHHHHHHHcCCCceeecceeeeecCCCCc
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR-------RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNE   81 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (353)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++.+..       ..+.+|+.+++.++||||+++++++.... ...
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~   83 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   83 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence            4688999999999999999999999999999999986432       23468999999999999999999886544 334


Q ss_pred             eeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecc
Q 018619           82 LFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGS  160 (353)
Q Consensus        82 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~  160 (353)
                      ..+|+|||||+| +|...+.    ..+++++.+++.++.||+.||+|||+ +||+||||||+|||++. ++.++|+|||.
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~-~~~~~l~d~~~  157 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGI  157 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEET-TSCEEECCCTT
T ss_pred             ceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCc-cccceeehhhh
Confidence            458899999995 5554443    45789999999999999999999999 79999999999999996 78899999999


Q ss_pred             ccccccCC----CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 018619          161 AKQLIAGE----ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTRE  236 (353)
Q Consensus       161 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  236 (353)
                      +.......    ......||+.|+|||++.+. .++.++||||+||++|+|+||++||.+.+..+...++......++  
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--  234 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--  234 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC--
Confidence            87554332    23456799999999999664 589999999999999999999999999988887777665322111  


Q ss_pred             HHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccc
Q 018619          237 EIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFD  298 (353)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~  298 (353)
                                             ......+|+++.+||++||++||.+||+..+.+.|+|.+
T Consensus       235 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 -----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             -----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                                   112246899999999999999999999554555677764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-56  Score=390.16  Aligned_cols=256  Identities=21%  Similarity=0.302  Sum_probs=208.3

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |-+..++|++.+.||+|+||+||+|.++.+|+.||||++..+.   +.+.+|+.+++.++|||||++++++..     ..
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~   86 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EP   86 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEee-----CC
Confidence            4567789999999999999999999999999999999986553   345689999999999999999999843     33


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+|||||+ |++...+..  .....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a  162 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGE-NHLVKVADFGLS  162 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCCT
T ss_pred             eeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECC-CCcEEEccccce
Confidence            4789999999 577776654  245679999999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 018619          162 KQLIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       162 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  239 (353)
                      +........  ....||+.|+|||++.+. .|+.++||||+||++|+|++|..||........+.+++....        
T Consensus       163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~--------  233 (287)
T d1opja_         163 RLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------  233 (287)
T ss_dssp             TTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--------
T ss_pred             eecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC--------
Confidence            876544332  335678999999998765 489999999999999999997666554444444444433110        


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCcccccc
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFFDEL  300 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp~f~~~  300 (353)
                                         ...++..+|+++.+||.+||+.||.+|||++|+++  +|+.+
T Consensus       234 -------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         234 -------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             -------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence                               11133568999999999999999999999999964  56554

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=393.75  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=206.6

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCc-----EEEEEEeecc-----ccchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGE-----TVAIKKVLQD-----RRYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      |.+..++|++.+.||+|+||+||+|++..+++     .||+|.+...     ...+.+|+.++..+ +|||||++++++.
T Consensus        32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            44667899999999999999999999876654     6999988543     23355899999988 8999999999984


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCe
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS-------------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRV  134 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-------------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i  134 (353)
                           ....+|+|||||+ |+|.+.+.....                   ....+++..++.++.|++.||+|||+ ++|
T Consensus       112 -----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~I  185 (325)
T d1rjba_         112 -----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSC  185 (325)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTE
T ss_pred             -----eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCe
Confidence                 3344889999998 588887764321                   12468999999999999999999999 799


Q ss_pred             eeccCCCCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-C
Q 018619          135 CHRDLKPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-G  210 (353)
Q Consensus       135 ~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g  210 (353)
                      +||||||+|||++. ++.+||+|||+|+........   .+..||+.|+|||++.+. .++.++|||||||++|||+| |
T Consensus       186 iHRDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         186 VHRDLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             EETTCSGGGEEEET-TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTS
T ss_pred             eeccCchhcccccc-CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCC
Confidence            99999999999996 889999999999876554432   345679999999999765 48999999999999999997 8


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHH
Q 018619          211 QPLFPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALE  290 (353)
Q Consensus       211 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~  290 (353)
                      .+||.+.+....+.++++....+                           ..+..+|+++++||.+||+.||++|||++|
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~e  316 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPN  316 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            99999877766666665521111                           123468999999999999999999999999


Q ss_pred             HhcC
Q 018619          291 ACAH  294 (353)
Q Consensus       291 ~l~h  294 (353)
                      +++|
T Consensus       317 i~~~  320 (325)
T d1rjba_         317 LTSF  320 (325)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=383.77  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=201.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc------ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD------RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      |.+..++|++.+.||+|+||+||+|+.   +..||||++...      ...+.+|+.+++.++|||||++++++..    
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~----   75 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----   75 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----
Confidence            456788999999999999999999974   346999998533      1345589999999999999999886521    


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                        ..+++|||||+ |+|.+.+..   ....+++..+..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+||
T Consensus        76 --~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~-~~~~Kl~DF  148 (276)
T d1uwha_          76 --PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHE-DLTVKIGDF  148 (276)
T ss_dssp             --SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET-TSSEEECCC
T ss_pred             --cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcC-CCCEEEccc
Confidence              12689999998 577777653   45679999999999999999999999 79999999999999996 889999999


Q ss_pred             ccccccccCC---CcceeeeeceeeChhhhhCC--CCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGE---ANISYICSRFYRAPELIFGA--TEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+|+......   ...+..||+.|+|||++.+.  ..|+.++|||||||++|||+||+.||.+.+....+...+.....+
T Consensus       149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  228 (276)
T d1uwha_         149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS  228 (276)
T ss_dssp             CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred             cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence            9998654332   22345789999999998643  347899999999999999999999999887776666555432111


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +.                       ...++..+|+++.+||.+||+.||++|||++|+++|
T Consensus       229 p~-----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         229 PD-----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CC-----------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Cc-----------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            10                       111234689999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=380.24  Aligned_cols=247  Identities=19%  Similarity=0.303  Sum_probs=195.0

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeE
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFL   84 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (353)
                      +..++|++.+.||+|+||+||+|.+. +++.||||++.++.   ..+.+|+.+++.++|||||++++++...     ..+
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~   75 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----API   75 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-----Cce
Confidence            56789999999999999999999975 67789999996543   3456899999999999999999998433     338


Q ss_pred             EEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccc
Q 018619           85 NLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQ  163 (353)
Q Consensus        85 ~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~  163 (353)
                      ++|||||+ |+|.+.+..   ....+++..+..++.|++.||+|||+ ++|+||||||+|||++. ++++||+|||+|+.
T Consensus        76 ~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~  150 (263)
T d1sm2a_          76 CLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGE-NQVIKVSDFGMTRF  150 (263)
T ss_dssp             EEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECG-GGCEEECSCC----
T ss_pred             EEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecC-CCCeEecccchhee
Confidence            89999998 567666543   44678999999999999999999999 79999999999999996 78999999999986


Q ss_pred             cccCCCc--ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          164 LIAGEAN--ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       164 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      .......  ....||+.|+|||++.+. .++.++||||+||++|||+| |.+||...+..+.+..+......        
T Consensus       151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------  221 (263)
T d1sm2a_         151 VLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------  221 (263)
T ss_dssp             --------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC--------
T ss_pred             ccCCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC--------
Confidence            6544332  345689999999999665 59999999999999999999 56777777766666555442110        


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                          ..+...++++.+||.+||+.||++|||++|+++|
T Consensus       222 --------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         222 --------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                                1224578999999999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-55  Score=385.82  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=192.7

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCCc---EEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETGE---TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      +..++|++.+.||+|+||+||+|+++.+++   .||||.+...     .+.+.+|+.+|+.++|||||++++++..    
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----   98 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----   98 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee----
Confidence            556889999999999999999999987765   5889987543     2345689999999999999999999843    


Q ss_pred             CceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                       ...+|+|||||++ +|.+.+..   ..+.+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++++||+||
T Consensus        99 -~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~-~~~~Kl~DF  172 (299)
T d1jpaa_          99 -STPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNS-NLVCKVSDF  172 (299)
T ss_dssp             -SSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECCC
T ss_pred             -CCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECC-CCcEEECCc
Confidence             3348899999995 56555543   35679999999999999999999999 79999999999999996 889999999


Q ss_pred             ccccccccCCCc------ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 018619          159 GSAKQLIAGEAN------ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       159 g~a~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      |+|+........      ....+|+.|+|||.+.+. .++.++|||||||++|||+| |..||.+.+..+....+.+...
T Consensus       173 Gla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~  251 (299)
T d1jpaa_         173 GLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR  251 (299)
T ss_dssp             -----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred             ccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999866543322      224568899999999764 58999999999999999998 8999999888776665543211


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+                            .+..+++++.+||.+||+.||++|||+.|++++
T Consensus       252 ~~----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         252 LP----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CC----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CC----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            11                            123579999999999999999999999998754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-55  Score=381.52  Aligned_cols=254  Identities=26%  Similarity=0.316  Sum_probs=206.3

Q ss_pred             eeecceeeEeee-eecCCCeEEEEEEECCC--CcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            7 ILQTISYMAERV-VGTGSFGIVFQAKCLET--GETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         7 ~~~~~~y~~~~~-lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      ++..++|.+.+. ||+|+||+||+|.++.+  +..||||++....     ..+.+|+.+++.++|||||++++++..   
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---   80 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---   80 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---
Confidence            567789999995 99999999999987644  4579999986432     335689999999999999999998732   


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                        + .+|+|||||++ +|.+.+..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|
T Consensus        81 --~-~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~-~~~~Kl~D  152 (285)
T d1u59a_          81 --E-ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVN-RHYAKISD  152 (285)
T ss_dssp             --S-SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEE-TTEEEECC
T ss_pred             --C-eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeecc-CCceeecc
Confidence              1 27899999995 66665532   45679999999999999999999999 89999999999999996 88999999


Q ss_pred             eccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 018619          158 FGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       158 fg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      ||+|+........    ....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+... 
T Consensus       153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-  230 (285)
T d1u59a_         153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-  230 (285)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-
T ss_pred             chhhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence            9999876544322    234678999999999765 48999999999999999998 9999998887766655433100 


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH---hcCcccccc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDEL  300 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~---l~hp~f~~~  300 (353)
                                                 ..++..+|+++.+||.+||+.||++|||+.++   |+|+|++-.
T Consensus       231 ---------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         231 ---------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ---------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence                                       01234689999999999999999999999877   788988643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=381.61  Aligned_cols=254  Identities=24%  Similarity=0.312  Sum_probs=205.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |-+..++|++.+.||+|+||.||+|.++ +++.||||++..+.   ..+.+|+.+++.++|||||++++++..     . 
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~-   80 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-   80 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----C-
Confidence            4567789999999999999999999975 67889999996543   345689999999999999999997621     1 


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+|||||+ |+|.+.+..  .....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~-~~~~Kl~DFGla  156 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSD-TLSCKIADFGLA  156 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECT-TSCEEECCCTTC
T ss_pred             CeEEEEEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeec-ccceeeccccce
Confidence            2679999998 466555433  223468999999999999999999999 79999999999999996 889999999999


Q ss_pred             cccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +.......  .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||...+..+....+.+...       
T Consensus       157 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-------  228 (272)
T d1qpca_         157 RLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------  228 (272)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred             EEccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-------
Confidence            87654432  2345688999999999764 489999999999999999995 566666666555544432110       


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc--Cccccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDE  299 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~--hp~f~~  299 (353)
                                           ...+..+++++.+||.+||+.||++|||++++++  |+||+.
T Consensus       229 ---------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         229 ---------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             ---------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                                 0123468999999999999999999999999988  889874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-55  Score=375.70  Aligned_cols=246  Identities=18%  Similarity=0.261  Sum_probs=205.7

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      ..++|++.+.||+|+||+||+|+++ +++.||||++.++.   ..+.+|+.+++.++||||+++++++..     ...++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-----~~~~~   75 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-----QRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECC-----SSSEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEee-----CCceE
Confidence            5678999999999999999999974 78899999997643   445689999999999999999998843     33488


Q ss_pred             EEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeecccccc
Q 018619           86 LVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQL  164 (353)
Q Consensus        86 lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~  164 (353)
                      +||||+. |++...+..   ....+++..++.++.|++.||+|||+ +||+||||||+||+++. ++.+||+|||+|+..
T Consensus        76 iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~  150 (258)
T d1k2pa_          76 IITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVND-QGVVKVSDFGLSRYV  150 (258)
T ss_dssp             EEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECT-TCCEEECCCSSCCBC
T ss_pred             EEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcC-CCcEEECcchhheec
Confidence            9999998 565555443   45678999999999999999999999 79999999999999996 789999999999865


Q ss_pred             ccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 018619          165 IAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRCM  241 (353)
Q Consensus       165 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
                      .....  .....+|+.|+|||++.+. .++.++||||+||++|||+| |+.||.+.+..+....+.+....         
T Consensus       151 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---------  220 (258)
T d1k2pa_         151 LDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---------  220 (258)
T ss_dssp             SSSSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC---------
T ss_pred             cCCCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            54333  2345689999999999765 48999999999999999998 89999999887776655442111         


Q ss_pred             CcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          242 NPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                         ..+...++++.+||++||+.||++|||++++++|
T Consensus       221 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         221 -------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence                               1234578999999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=392.25  Aligned_cols=257  Identities=27%  Similarity=0.454  Sum_probs=208.4

Q ss_pred             cceeeEeeeeecCCCeEEEEEEEC---CCCcEEEEEEeecc--------ccchHHHHHHHHHcCC-CceeecceeeeecC
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCL---ETGETVAIKKVLQD--------RRYKNRELQLMRVMDH-PNVISLKHCFFSTT   77 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~   77 (353)
                      -++|++.+.||+|+||+||+|++.   .+|+.||||++.+.        .....+|+.++++++| |||+++++++.   
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~---   99 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ---   99 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE---
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec---
Confidence            478999999999999999999974   46899999988532        2334589999999977 79999999883   


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                        ....++++|||+.+ +|.+.+..    .+.+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+
T Consensus       100 --~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~-~~~vkL~  171 (322)
T d1vzoa_         100 --TETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDS-NGHVVLT  171 (322)
T ss_dssp             --ETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECT-TSCEEES
T ss_pred             --cCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecC-CCCEEEe
Confidence              34458899999994 66666553    4678899999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCC--cceeeeeceeeChhhhhCCC-CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 018619          157 DFGSAKQLIAGEA--NISYICSRFYRAPELIFGAT-EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       157 Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |||+|+.......  .....|++.|+|||.+.+.. .++.++||||+||+||+|++|..||.+.+..+....+.+....+
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            9999986544332  34567899999999997643 46889999999999999999999998876555544444421100


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCC-----CHHHHhcCcccccccC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRC-----TALEACAHPFFDELRE  302 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~~~l~hp~f~~~~~  302 (353)
                                               ...++..+|+++++||.+||++||.+|+     |++|+++||||+.+++
T Consensus       252 -------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~  300 (322)
T d1vzoa_         252 -------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW  300 (322)
T ss_dssp             -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred             -------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence                                     0112346899999999999999999999     5899999999998764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=378.33  Aligned_cols=250  Identities=24%  Similarity=0.298  Sum_probs=198.5

Q ss_pred             ecceeeEe-eeeecCCCeEEEEEEEC--CCCcEEEEEEeeccc------cchHHHHHHHHHcCCCceeecceeeeecCCC
Q 018619            9 QTISYMAE-RVVGTGSFGIVFQAKCL--ETGETVAIKKVLQDR------RYKNRELQLMRVMDHPNVISLKHCFFSTTSK   79 (353)
Q Consensus         9 ~~~~y~~~-~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (353)
                      ....+.+. +.||+|+||+||+|.+.  .+++.||||++....      ..+.+|+.+++.++|||||++++++..    
T Consensus         4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~----   79 (277)
T d1xbba_           4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA----   79 (277)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred             chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc----
Confidence            34444554 47999999999999754  456789999985432      235689999999999999999998721    


Q ss_pred             CceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           80 NELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        80 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                       + ..++|||||+ |+|.+.+.    ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+||
T Consensus        80 -~-~~~lvmE~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~-~~~~kl~DF  151 (277)
T d1xbba_          80 -E-SWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVT-QHYAKISDF  151 (277)
T ss_dssp             -S-SEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEE-TTEEEECCC
T ss_pred             -C-CEEEEEEcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccc-cCcccccch
Confidence             1 1679999998 46666554    45779999999999999999999999 79999999999999996 889999999


Q ss_pred             ccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          159 GSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       159 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |+|+........    ....||+.|+|||++.+. .++.++|||||||++|||++ |+.||.+.+..+....+.+...  
T Consensus       152 Gla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~--  228 (277)
T d1xbba_         152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--  228 (277)
T ss_dssp             TTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--
T ss_pred             hhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence            999876544332    234678999999999765 48999999999999999997 8999998887766554433100  


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHH---hcCccccc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEA---CAHPFFDE  299 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~---l~hp~f~~  299 (353)
                                                ..++..+|+++.+||.+||+.||++|||++++   |+|+|+.-
T Consensus       229 --------------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         229 --------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --------------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence                                      01234689999999999999999999999988   56777653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-54  Score=373.24  Aligned_cols=249  Identities=27%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCC---cEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecC
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTT   77 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   77 (353)
                      |-+..++|++.+.||+|+||.||+|.+..++   ..||||.+...     ...+.+|+.+++.++||||+++++++..  
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--   79 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--   79 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence            3466789999999999999999999987554   46889988532     2335589999999999999999998721  


Q ss_pred             CCCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEe
Q 018619           78 SKNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKIC  156 (353)
Q Consensus        78 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~  156 (353)
                          ..+|+|||||++ ++...+..   ....+++..++.++.||+.||+|||+ ++|+||||||+||++++ ++.+||+
T Consensus        80 ----~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~-~~~~Kl~  150 (273)
T d1mp8a_          80 ----NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSS-NDCVKLG  150 (273)
T ss_dssp             ----SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEE-TTEEEEC
T ss_pred             ----CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecC-CCcEEEc
Confidence                237899999994 55554432   45679999999999999999999999 79999999999999996 7899999


Q ss_pred             eeccccccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 018619          157 DFGSAKQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTP  233 (353)
Q Consensus       157 Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  233 (353)
                      |||+|+.......  .....||+.|+|||++.+. .++.++|||||||++|||++ |.+||.+.+..+....+.+...  
T Consensus       151 DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~--  227 (273)
T d1mp8a_         151 DFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--  227 (273)
T ss_dssp             C-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--
T ss_pred             cchhheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--
Confidence            9999986544332  2345678999999999764 58999999999999999998 8999998888777665543110  


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                                ..++.++|+++.+||.+||+.||.+|||++|+++|
T Consensus       228 --------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         228 --------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                      01235689999999999999999999999999876

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=372.39  Aligned_cols=255  Identities=25%  Similarity=0.318  Sum_probs=200.7

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      |-+..++|++.+.||+|+||+||+|+++.+ +.||||++..+.   ..+.+|+.+++.++|||||++++++..     . 
T Consensus        12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~-   84 (285)
T d1fmka3          12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----E-   84 (285)
T ss_dssp             SBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-
T ss_pred             eEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-----C-
Confidence            456779999999999999999999998655 579999986543   345689999999999999999998721     1 


Q ss_pred             eEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+++|||||.+ ++...+..  .....+++.++..++.||+.||+|||+ +||+||||||+|||++. ++++||+|||+|
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~-~~~~kl~DfGla  160 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGE-NLVCKVADFGLA  160 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECG-GGCEEECCCCTT
T ss_pred             CeEEEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECC-CCcEEEcccchh
Confidence            16799999995 55555543  234569999999999999999999999 79999999999999996 789999999999


Q ss_pred             cccccCCC--cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHHHH
Q 018619          162 KQLIAGEA--NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGTPTREEI  238 (353)
Q Consensus       162 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  238 (353)
                      +.......  .....||+.|+|||.+.+. .++.++||||+||++|||++|. +||......+.+..+.+....      
T Consensus       161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~------  233 (285)
T d1fmka3         161 RLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------  233 (285)
T ss_dssp             C--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC------
T ss_pred             hhccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC------
Confidence            86644332  2345689999999999764 4899999999999999999965 555666655555544331111      


Q ss_pred             hhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc--Ccccccc
Q 018619          239 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA--HPFFDEL  300 (353)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~--hp~f~~~  300 (353)
                                            .++..+++++++||.+||+.||++|||++++++  |+||+..
T Consensus       234 ----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         234 ----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                                  123458999999999999999999999999987  8888764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-53  Score=368.03  Aligned_cols=247  Identities=20%  Similarity=0.266  Sum_probs=189.6

Q ss_pred             eecceeeEeeeeecCCCeEEEEEEECCCC----cEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            8 LQTISYMAERVVGTGSFGIVFQAKCLETG----ETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      +....|++.++||+|+||.||+|.++.++    ..||||++....     ..+.+|+.+++.++|||||++++++..   
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~---   80 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK---   80 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec---
Confidence            45678999999999999999999987655    469999985432     234689999999999999999998843   


Q ss_pred             CCceeEEEEeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEee
Q 018619           79 KNELFLNLVMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICD  157 (353)
Q Consensus        79 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~D  157 (353)
                        ....++|||||.+ ++...+.   .....+++..+..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus        81 --~~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~-~~~~Kl~D  153 (283)
T d1mqba_          81 --YKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNS-NLVCKVSD  153 (283)
T ss_dssp             --SSSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECT-TCCEEECC
T ss_pred             --CCceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECC-CCeEEEcc
Confidence              3348899999996 4444433   345779999999999999999999999 79999999999999996 88999999


Q ss_pred             eccccccccCCC----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCC
Q 018619          158 FGSAKQLIAGEA----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLVEIIKVLGT  232 (353)
Q Consensus       158 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~  232 (353)
                      ||+|+.......    .....||+.|+|||++.+. .++.++|||||||++|||++|. +||...+..+....+..... 
T Consensus       154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-  231 (283)
T d1mqba_         154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-  231 (283)
T ss_dssp             CCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-
T ss_pred             cchhhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-
Confidence            999987644322    2234678999999999765 5999999999999999999965 55555555444433322110 


Q ss_pred             CCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          233 PTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                                                 ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus       232 ---------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         232 ---------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             ---------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence                                       1123457899999999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=376.44  Aligned_cols=250  Identities=25%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCCc----EEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeec
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETGE----TVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFST   76 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (353)
                      .++..++|++.+.||+|+||+||+|.+..+|+    .||+|++...     .+.+.+|+.+++.++|||||++++++...
T Consensus         4 ~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             EECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             ccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            45666789999999999999999999988876    5888877532     23456899999999999999999988432


Q ss_pred             CCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEE
Q 018619           77 TSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKI  155 (353)
Q Consensus        77 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl  155 (353)
                           . .++++|++. ++|.+.+..   ....+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||
T Consensus        84 -----~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~-~~~~kl  152 (317)
T d1xkka_          84 -----T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKT-PQHVKI  152 (317)
T ss_dssp             -----S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEE-TTEEEE
T ss_pred             -----C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCC-CCCeEe
Confidence                 2 446666666 677666543   46789999999999999999999999 79999999999999996 889999


Q ss_pred             eeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 018619          156 CDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLG  231 (353)
Q Consensus       156 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~  231 (353)
                      +|||+|+........   ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.+...
T Consensus       153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~  231 (317)
T d1xkka_         153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER  231 (317)
T ss_dssp             CCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC
T ss_pred             eccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999999876544332   234679999999999765 48999999999999999998 7999988776665544433111


Q ss_pred             CCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcCc
Q 018619          232 TPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHP  295 (353)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~hp  295 (353)
                       +                           ..+..+++++.+||.+||+.||.+|||+.|+++|.
T Consensus       232 -~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         232 -L---------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             -C---------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -C---------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence             1                           02245789999999999999999999999999883

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=371.80  Aligned_cols=255  Identities=25%  Similarity=0.352  Sum_probs=193.8

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      |.+..++|++.+.||+|+||.||+|.+..     +++.||||++....     +...+|..++.++ +|+||+.+++++.
T Consensus         8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1           8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            34667899999999999999999999754     45789999986432     2234566666665 6889999888764


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCC
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSS------------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKP  141 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp  141 (353)
                      ..    ...+++|||||+ |+|.+.+.....            ....+++..+..++.|++.||+|||+ +||+||||||
T Consensus        88 ~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp  162 (299)
T d1ywna1          88 KP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAA  162 (299)
T ss_dssp             ST----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCG
T ss_pred             cC----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCc
Confidence            32    234789999998 678877765332            13458999999999999999999999 7999999999


Q ss_pred             CcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhC-CCCCCCC
Q 018619          142 QNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGE  217 (353)
Q Consensus       142 ~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~  217 (353)
                      +|||++. ++.+||+|||+|+.......   .....||+.|+|||++.+. .++.++||||+||++|||++| .+||.+.
T Consensus       163 ~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         163 RNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             GGEEECG-GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cceeECC-CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            9999996 78999999999986544332   2345789999999999764 589999999999999999986 5788877


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          218 NAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      +..+.+...+.....+                           .++..+++++.+||.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         241 KIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             CCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6655555554421111                           1234579999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=367.31  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=196.4

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCC-C--cEEEEEEeecc-------ccchHHHHHHHHHcCCCceeecceeee
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLET-G--ETVAIKKVLQD-------RRYKNRELQLMRVMDHPNVISLKHCFF   74 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (353)
                      ++++..++|++.+.||+|+||.||+|+...+ +  ..||||++.++       .+.+.+|+.+++.++||||+++++++.
T Consensus         2 t~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           2 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ceEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            5678889999999999999999999986533 3  36899988543       134568999999999999999999883


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcE
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQV  153 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~v  153 (353)
                      +     . .+++|||||+ |++.+.+..   ....+++..+..++.|++.||+|||+ +||+||||||+||+++. ++.+
T Consensus        82 ~-----~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~-~~~v  150 (273)
T d1u46a_          82 T-----P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLAT-RDLV  150 (273)
T ss_dssp             S-----S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEE-TTEE
T ss_pred             e-----c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhcccc-ccce
Confidence            2     1 2679999998 566655543   34679999999999999999999999 89999999999999997 7899


Q ss_pred             EEeeeccccccccCCCc----ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 018619          154 KICDFGSAKQLIAGEAN----ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       154 kl~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~  228 (353)
                      ||+|||+++........    ....++..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+....+.+
T Consensus       151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~  229 (273)
T d1u46a_         151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK  229 (273)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred             eeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh
Confidence            99999999976544332    234567889999999765 48999999999999999998 8999999988887766654


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      ....+                           ..+..+|+++.+||.+||+.||++|||+++++
T Consensus       230 ~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         230 EGERL---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             SCCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            21111                           12346899999999999999999999999985

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=364.51  Aligned_cols=249  Identities=21%  Similarity=0.316  Sum_probs=199.8

Q ss_pred             eeeeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc--cchHHHHHHHHHcCCCceeecceeeeecCCCCce
Q 018619            5 CCILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR--RYKNRELQLMRVMDHPNVISLKHCFFSTTSKNEL   82 (353)
Q Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (353)
                      +|.+.-++|++.+.||+|+||.||+|.+  +|+.||||++.++.  +.+.+|+++++.++||||+++++++...    ..
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~   74 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KG   74 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CC
Confidence            4778889999999999999999999997  57899999996653  4466899999999999999999987432    22


Q ss_pred             eEEEEecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccc
Q 018619           83 FLNLVMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSA  161 (353)
Q Consensus        83 ~~~lv~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a  161 (353)
                      .+|+||||++ |+|.+.+...  ....+++..++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s  150 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSE-DNVAKVSDFGLT  150 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TSCEEECCCCC-
T ss_pred             cEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecC-CCCEeecccccc
Confidence            3789999998 5777777542  22358999999999999999999999 79999999999999996 888999999999


Q ss_pred             cccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 018619          162 KQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFPGENAVDQLVEIIKVLGTPTREEIRC  240 (353)
Q Consensus       162 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
                      +.....  .....+|+.|+|||++.+. .++.++|||||||++|||+| |++||...+..+....+.+.           
T Consensus       151 ~~~~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~-----------  216 (262)
T d1byga_         151 KEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----------  216 (262)
T ss_dssp             -------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-----------
T ss_pred             eecCCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-----------
Confidence            865432  2345678899999999765 48999999999999999998 78999887776665554321           


Q ss_pred             cCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          241 MNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                       ....++..+++++.+||++||+.||.+|||+.+++++
T Consensus       217 -----------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         217 -----------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             -----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                             0112345689999999999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.4e-52  Score=366.49  Aligned_cols=258  Identities=23%  Similarity=0.266  Sum_probs=201.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      .+++|++.+.||+|+||.||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+..    .....++
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i   80 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM   80 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence            367899999999999999999999999999999987643  3456789999999988876665544432    2234789


Q ss_pred             EeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC--CCCcEEEeeecccccc
Q 018619           87 VMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP--LTHQVKICDFGSAKQL  164 (353)
Q Consensus        87 v~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~--~~~~vkl~Dfg~a~~~  164 (353)
                      |||||++++...+..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++.  .+..+||+|||+|+..
T Consensus        81 vme~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          81 VMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            999999987766543   45789999999999999999999999 79999999999999863  2457999999999876


Q ss_pred             ccCCC--------cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC---CC
Q 018619          165 IAGEA--------NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLG---TP  233 (353)
Q Consensus       165 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~  233 (353)
                      .....        .....||+.|+|||.+.+. .++.++|||||||++|+|++|..||......+....+.+...   .+
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            54322        2345789999999999764 489999999999999999999999988766554443322111   01


Q ss_pred             CHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHH---HHhcCccccc
Q 018619          234 TREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL---EACAHPFFDE  299 (353)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~---~~l~hp~f~~  299 (353)
                      +.                        ..+..++|+++.+||.+||+.||++||+++   ++|+|+|.+.
T Consensus       236 ~~------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         236 PI------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             CH------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             Ch------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            11                        112246899999999999999999999986   5578877654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=369.51  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=205.2

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcE--EEEEEeec-----cccchHHHHHHHHHc-CCCceeecceeeeecCC
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGET--VAIKKVLQ-----DRRYKNRELQLMRVM-DHPNVISLKHCFFSTTS   78 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~-----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~   78 (353)
                      .+.-++|++.++||+|+||+||+|.++.+|..  ||||++..     ....+.+|+.+|..+ +|||||++++++...  
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--
Confidence            35678999999999999999999999888864  67787643     233467899999998 799999999998543  


Q ss_pred             CCceeEEEEecccc-chHHHHHHhh------------hhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEE
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHY------------SSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLL  145 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~------------~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nil  145 (353)
                         ..+++|||||+ |+|.+.+...            ......+++..+..++.||+.||.|||+ ++|+||||||+|||
T Consensus        84 ---~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL  159 (309)
T d1fvra_          84 ---GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNIL  159 (309)
T ss_dssp             ---TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEE
T ss_pred             ---CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEE
Confidence               34889999999 6888777542            1235779999999999999999999999 79999999999999


Q ss_pred             EeCCCCcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCC-CCCCCCChHHHHH
Q 018619          146 VDPLTHQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PLFPGENAVDQLV  224 (353)
Q Consensus       146 l~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~  224 (353)
                      ++. ++.+||+|||+|+............||+.|+|||.+.+. .++.++|||||||++|||++|. +||.+.+..+...
T Consensus       160 ~~~-~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~  237 (309)
T d1fvra_         160 VGE-NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  237 (309)
T ss_dssp             ECG-GGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EcC-CCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            996 788999999999876555555566789999999999765 4899999999999999999965 6788877766655


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                      .+.+..                            ...++..+++++.+||.+||+.||++|||+.++++|
T Consensus       238 ~i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         238 KLPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HGGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            443210                            011234689999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=363.91  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=198.2

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECCCC-------cEEEEEEeecccc-----chHHHHHHHHHc-CCCceeeccee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLETG-------ETVAIKKVLQDRR-----YKNRELQLMRVM-DHPNVISLKHC   72 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~   72 (353)
                      |.+..++|++.+.||+|+||.||+|++..++       ..||||++.++..     ...+|...+..+ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            4467899999999999999999999987654       3699999865432     234677777777 89999999999


Q ss_pred             eeecCCCCceeEEEEecccc-chHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           73 FFSTTSKNELFLNLVMEYVP-ESMYRVLKHYS------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                      +..     ...+++|||||. |++.+.+....            .....+++..+..++.||+.||+|||+ ++|+||||
T Consensus        88 ~~~-----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDi  161 (299)
T d1fgka_          88 CTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDL  161 (299)
T ss_dssp             ECS-----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCC
T ss_pred             ccc-----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeee
Confidence            843     344889999998 57777775432            123569999999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+|||++. ++.+||+|||+++.......   .....+|+.|+|||.+.+. .|+.++|||||||++|+|++ |.+||.
T Consensus       162 Kp~NiLl~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~  239 (299)
T d1fgka_         162 AARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYP  239 (299)
T ss_dssp             SGGGEEECT-TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cccceeecC-CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCC
Confidence            999999996 78899999999987655433   2346789999999999764 59999999999999999998 789998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +.+.......+.+. ..+                           .++..+++++.+||.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         240 GVPVEELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             TCCHHHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            87776554433221 111                           123468999999999999999999999999975

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-51  Score=363.76  Aligned_cols=253  Identities=25%  Similarity=0.308  Sum_probs=203.4

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeeecCC
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFSTTS   78 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   78 (353)
                      -.++|++.+.||+|+||+||+|+.+     .+++.||||++....     ..+.+|+.+++.++||||+++++++..   
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~---   87 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---   87 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc---
Confidence            3678999999999999999999975     356789999986432     345689999999999999999998843   


Q ss_pred             CCceeEEEEecccc-chHHHHHHhhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeec
Q 018619           79 KNELFLNLVMEYVP-ESMYRVLKHYS--------------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHR  137 (353)
Q Consensus        79 ~~~~~~~lv~e~~~-~~l~~~l~~~~--------------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~  137 (353)
                        ....+++|||+. |+|.+.+....                    .....+++..+..++.|++.||+|||+ ++|+||
T Consensus        88 --~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHr  164 (301)
T d1lufa_          88 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHR  164 (301)
T ss_dssp             --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCS
T ss_pred             --CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEee
Confidence              334789999998 67777775321                    123458999999999999999999999 799999


Q ss_pred             cCCCCcEEEeCCCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCC-CC
Q 018619          138 DLKPQNLLVDPLTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQ-PL  213 (353)
Q Consensus       138 Dlkp~Nill~~~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~-~p  213 (353)
                      ||||+|||++. ++.+||+|||+|+...+...   ..+..+|+.|+|||.+.+. .++.++|||||||++|||++|. +|
T Consensus       165 DlKp~NILld~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p  242 (301)
T d1lufa_         165 DLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP  242 (301)
T ss_dssp             CCSGGGEEECG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             EEcccceEECC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCC
Confidence            99999999996 78899999999986544322   2345678999999999765 4999999999999999999985 78


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          214 FPGENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       214 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      |.+.+..+....+.+...                            ..++..+++++.+||.+||+.||++|||+.|++ 
T Consensus       243 ~~~~~~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~-  293 (301)
T d1lufa_         243 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIH-  293 (301)
T ss_dssp             TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH-
T ss_pred             CCCCCHHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH-
Confidence            888888777665543110                            012346899999999999999999999999995 


Q ss_pred             Cccccc
Q 018619          294 HPFFDE  299 (353)
Q Consensus       294 hp~f~~  299 (353)
                       .++++
T Consensus       294 -~~L~~  298 (301)
T d1lufa_         294 -RILQR  298 (301)
T ss_dssp             -HHHHH
T ss_pred             -HHHHH
Confidence             34444

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=362.93  Aligned_cols=259  Identities=23%  Similarity=0.284  Sum_probs=210.1

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEECC-----CCcEEEEEEeeccc-----cchHHHHHHHHHcCCCceeecceeeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCLE-----TGETVAIKKVLQDR-----RYKNRELQLMRVMDHPNVISLKHCFFS   75 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~   75 (353)
                      |.+..++|.+.+.||+|+||.||+|.++.     ++..||||++.+..     ..+.+|+.+++.++||||+++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            45678999999999999999999998753     35789999996432     234589999999999999999998833


Q ss_pred             cCCCCceeEEEEecccc-chHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC
Q 018619           76 TTSKNELFLNLVMEYVP-ESMYRVLKHYSS------ANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP  148 (353)
Q Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~------~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~  148 (353)
                           ....++|||||. |+|.+.+.....      ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus        95 -----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          95 -----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAE  168 (308)
T ss_dssp             -----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECT
T ss_pred             -----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecC
Confidence                 334889999998 577776654221      12457899999999999999999999 79999999999999996


Q ss_pred             CCCcEEEeeeccccccccCCC---cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhC-CCCCCCCChHHHHH
Q 018619          149 LTHQVKICDFGSAKQLIAGEA---NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLG-QPLFPGENAVDQLV  224 (353)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g-~~pf~~~~~~~~~~  224 (353)
                       ++++||+|||+|+.......   .....+|+.|+|||.+.+. .++.++||||+||++|||+|| .+||.+.+..+.+.
T Consensus       169 -~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         169 -DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             -TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             -CceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence             88999999999986544332   2345789999999999765 489999999999999999998 58898888777776


Q ss_pred             HHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc------Ccccc
Q 018619          225 EIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA------HPFFD  298 (353)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~------hp~f~  298 (353)
                      .+.+...                            ...+..+++.+.+||.+||+.||++|||+.++++      +|+|+
T Consensus       247 ~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         247 FVMEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             HHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HHHhCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence            5544110                            0123458899999999999999999999999987      77776


Q ss_pred             cc
Q 018619          299 EL  300 (353)
Q Consensus       299 ~~  300 (353)
                      ++
T Consensus       299 ~~  300 (308)
T d1p4oa_         299 EV  300 (308)
T ss_dssp             HH
T ss_pred             CC
Confidence            54

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=358.72  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=205.3

Q ss_pred             eeeecceeeEeeeeecCCCeEEEEEEEC-----CCCcEEEEEEeeccc-----cchHHHHHHHHHc-CCCceeecceeee
Q 018619            6 CILQTISYMAERVVGTGSFGIVFQAKCL-----ETGETVAIKKVLQDR-----RYKNRELQLMRVM-DHPNVISLKHCFF   74 (353)
Q Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~~iv~~~~~~~   74 (353)
                      |.+..++|++.+.||+|+||.||+|+..     .+++.||||++....     ..+.+|+.+++.+ +|||||++++++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            5567899999999999999999999863     466789999996543     2345799999998 6999999999983


Q ss_pred             ecCCCCceeEEEEecccc-chHHHHHHhhh--------------hcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccC
Q 018619           75 STTSKNELFLNLVMEYVP-ESMYRVLKHYS--------------SANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDL  139 (353)
Q Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--------------~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dl  139 (353)
                           ....+++|||||+ |++...+....              .....+++..+..++.||+.||+|||+ ++++||||
T Consensus        98 -----~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDL  171 (311)
T d1t46a_          98 -----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDL  171 (311)
T ss_dssp             -----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCC
T ss_pred             -----eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccc
Confidence                 3334889999998 57777765432              123468999999999999999999999 79999999


Q ss_pred             CCCcEEEeCCCCcEEEeeeccccccccCCCc---ceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHh-CCCCCC
Q 018619          140 KPQNLLVDPLTHQVKICDFGSAKQLIAGEAN---ISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLL-GQPLFP  215 (353)
Q Consensus       140 kp~Nill~~~~~~vkl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~-g~~pf~  215 (353)
                      ||+||+++. ++.+|++|||+++........   ....||+.|+|||++.+. .++.++|||||||++|+|+| |.+||.
T Consensus       172 Kp~NIl~~~-~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         172 AARNILLTH-GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             SGGGEEEET-TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccccccc-cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCC
Confidence            999999996 889999999999876544332   335789999999999754 58999999999999999998 677787


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          216 GENAVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      +.+..+.+.++++.-..+.                           .+..+++++.+||.+||+.||.+|||++++++
T Consensus       250 ~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         250 GMPVDSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             TCCSSHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            7777666666665311111                           22457899999999999999999999999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.7e-49  Score=348.75  Aligned_cols=250  Identities=19%  Similarity=0.218  Sum_probs=201.0

Q ss_pred             ecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeecc--ccchHHHHHHHHHcCC-CceeecceeeeecCCCCceeEE
Q 018619            9 QTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQD--RRYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      .+++|++.+.||+|+||+||+|++..+|+.||||++...  .....+|++.++.++| +|++.+++++.     .....+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccE
Confidence            478999999999999999999999999999999988543  3456789999999976 89999888773     334578


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeC----CCCcEEEeeeccc
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDP----LTHQVKICDFGSA  161 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~----~~~~vkl~Dfg~a  161 (353)
                      +|||||+++|...+..   ....+++..+..++.|++.||+|||+ +||+||||||+|||++.    .++.+||+|||+|
T Consensus        78 ~vme~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          78 LVIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EEEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEEEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEccccee
Confidence            9999999998877654   45679999999999999999999999 79999999999999963    2467999999999


Q ss_pred             cccccCC--------CcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Q 018619          162 KQLIAGE--------ANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV---DQLVEIIKVL  230 (353)
Q Consensus       162 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~  230 (353)
                      +......        ......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+....   .....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            8754322        12345799999999999764 5999999999999999999999999765432   2233332221


Q ss_pred             CCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHh
Q 018619          231 GTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEAC  292 (353)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l  292 (353)
                      ..++...                        +..++|+++.+++..|++.+|++||+.+.+.
T Consensus       233 ~~~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         233 QSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             CCCChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence            1111111                        2245899999999999999999999987664

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-50  Score=365.09  Aligned_cols=289  Identities=29%  Similarity=0.471  Sum_probs=210.8

Q ss_pred             eeecceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc---cchHHHHHHHHHcC-----------CCceeeccee
Q 018619            7 ILQTISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR---RYKNRELQLMRVMD-----------HPNVISLKHC   72 (353)
Q Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~~iv~~~~~   72 (353)
                      .+..++|++++.||+|+||+||+|+++.+|+.||||++.++.   ....+|+.+++.++           |+||++++++
T Consensus         9 ~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_           9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            344467999999999999999999999999999999997654   33457888888775           5788888887


Q ss_pred             eeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCC-
Q 018619           73 FFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTH-  151 (353)
Q Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~-  151 (353)
                      +.... ......++.++++.++......  ......+++..++.++.|++.||+|||+..||+||||||+|||++..+. 
T Consensus        89 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          89 FNHKG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEEEE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             eeecc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence            74322 2222333344444444333332  3456789999999999999999999997358999999999999975222 


Q ss_pred             ----cEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCC------hHH
Q 018619          152 ----QVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGEN------AVD  221 (353)
Q Consensus       152 ----~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~------~~~  221 (353)
                          .++++|||.|.....  ......||+.|+|||++.+. .++.++|+||+||++++|++|+.||...+      ..+
T Consensus       166 ~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence                499999999985433  33456789999999999765 48999999999999999999999997543      345


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCcCCCC-------CcCCCCCCCcccc------ccCCCCChhHHHHHHHhcCcCCCCCCCH
Q 018619          222 QLVEIIKVLGTPTREEIRCMNPNYTD-------FRFPQIKAHPWHK------VFHKRMPPEAIDLASRLLQYSPSLRCTA  288 (353)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~t~  288 (353)
                      .+...+..+|.++.............       .........++..      .+....+++++|||.+||++||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            67777888888877655332111000       0111111111111      1223356789999999999999999999


Q ss_pred             HHHhcCccccccc
Q 018619          289 LEACAHPFFDELR  301 (353)
Q Consensus       289 ~~~l~hp~f~~~~  301 (353)
                      +|+|+||||++..
T Consensus       323 ~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         323 GGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHTCGGGTTCT
T ss_pred             HHHhcCcccCCCC
Confidence            9999999999654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=352.31  Aligned_cols=242  Identities=21%  Similarity=0.296  Sum_probs=188.5

Q ss_pred             EeeeeecCCCeEEEEEEECCCC---cEEEEEEeecc-----ccchHHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           15 AERVVGTGSFGIVFQAKCLETG---ETVAIKKVLQD-----RRYKNRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..++||+|+||+||+|.+..++   ..||||++.+.     ...+.+|++++++++||||+++++++....    ...++
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~l  106 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLV  106 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEE
Confidence            3678999999999999986654   36899998532     234568999999999999999999875432    24789


Q ss_pred             Eeccccc-hHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCCCcEEEeeeccccccc
Q 018619           87 VMEYVPE-SMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLI  165 (353)
Q Consensus        87 v~e~~~~-~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~~~~  165 (353)
                      |||||++ ++.+.+..   ....+++..+..++.|++.||.|||+ ++|+||||||+|||+++ ++.+||+|||+++...
T Consensus       107 v~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDE-KFTVKVADFGLARDMY  181 (311)
T ss_dssp             EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECT-TCCEEECSSGGGCCTT
T ss_pred             EEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECC-CCCEEEecccchhhcc
Confidence            9999995 55555442   45567888999999999999999999 79999999999999996 8899999999998654


Q ss_pred             cCCC-----cceeeeeceeeChhhhhCCCCCCccccchhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHh
Q 018619          166 AGEA-----NISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAV-DQLVEIIKVLGTPTREEIR  239 (353)
Q Consensus       166 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  239 (353)
                      ....     .....||+.|+|||.+.+. .++.++|||||||++|||++|..||...... +....+.+. ..       
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~-------  252 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RR-------  252 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CC-------
T ss_pred             ccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CC-------
Confidence            4322     2235679999999998765 4899999999999999999988777654333 222222211 00       


Q ss_pred             hcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhcC
Q 018619          240 CMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAH  294 (353)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~h  294 (353)
                                          ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       253 --------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         253 --------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence                                01234578999999999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=347.60  Aligned_cols=268  Identities=22%  Similarity=0.230  Sum_probs=188.8

Q ss_pred             cceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccccc-h--HHHHHHHHHcCCCceeecceeeeecCCCCceeEEE
Q 018619           10 TISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDRRY-K--NRELQLMRVMDHPNVISLKHCFFSTTSKNELFLNL   86 (353)
Q Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l   86 (353)
                      ..+|.+.+.||+|+||+||+|+.  +|+.||||++..+... .  +.|+..+..++||||+++++++.... .....+|+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEE
Confidence            56899999999999999999986  7899999998654322 2  23455556789999999999986654 33446889


Q ss_pred             Eecccc-chHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC-------CCeeeccCCCCcEEEeCCCCcEEEeee
Q 018619           87 VMEYVP-ESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV-------PRVCHRDLKPQNLLVDPLTHQVKICDF  158 (353)
Q Consensus        87 v~e~~~-~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~-------~~i~H~Dlkp~Nill~~~~~~vkl~Df  158 (353)
                      |||||+ |+|...+..     ..+++.....++.|++.||+|||+.       +||+||||||+||||+. ++.+||+||
T Consensus        79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DF  152 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADL  152 (303)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCC
T ss_pred             EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEec
Confidence            999998 588777764     4689999999999999999999962       59999999999999996 889999999


Q ss_pred             ccccccccCCC-----cceeeeeceeeChhhhhCCC-----CCCccccchhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 018619          159 GSAKQLIAGEA-----NISYICSRFYRAPELIFGAT-----EYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIK  228 (353)
Q Consensus       159 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~~~~  228 (353)
                      |+++.......     .....||+.|+|||++.+..     .++.++|||||||++|||+||..||............. 
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-  231 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-  231 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-
Confidence            99987655432     23457899999999986532     14678999999999999999998875432110000000 


Q ss_pred             HhCCCCHHHHhhcCcCCCCCcCCCCCCCccccccCCCCChhHHHHHHHhcCcCCCCCCCHHHHhc
Q 018619          229 VLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACA  293 (353)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~~~l~  293 (353)
                      ....+....+......  ...-|...    ...........+.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~--~~~~p~~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         232 VPSDPSVEEMRKVVCE--QKLRPNIP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             SCSSCCHHHHHHHHTT--SCCCCCCC----GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccccchHHHHHHHHhc--cccCCCCC----cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            0000000000000000  00000000    00001123356899999999999999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=1.3e-26  Score=189.58  Aligned_cols=165  Identities=18%  Similarity=0.127  Sum_probs=116.7

Q ss_pred             eeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----------------------cchHHHHHHHHHcCCCceeecc
Q 018619           13 YMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----------------------RYKNRELQLMRVMDHPNVISLK   70 (353)
Q Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~~iv~~~   70 (353)
                      |.+.+.||+|+||+||+|.+ .+|+.||||++....                      ....+|...+..+.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            57899999999999999997 478999999764210                      1112578888899999988765


Q ss_pred             eeeeecCCCCceeEEEEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcCCCeeeccCCCCcEEEeCCC
Q 018619           71 HCFFSTTSKNELFLNLVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTVPRVCHRDLKPQNLLVDPLT  150 (353)
Q Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~~~i~H~Dlkp~Nill~~~~  150 (353)
                      +..     .    .+++|||+++..   .       ..++...+..++.|++.||+|||+ +||+||||||+|||++. +
T Consensus        81 ~~~-----~----~~lvme~~~~~~---~-------~~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~-~  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKE---L-------YRVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSE-E  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEE---G-------GGCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEET-T
T ss_pred             Eec-----C----CEEEEEeecccc---c-------cchhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeC-C
Confidence            442     1    358999999741   1       224555677899999999999999 79999999999999994 4


Q ss_pred             CcEEEeeeccccccccCCCcceeeeeceeeChhhhhCCCCCCccccchhHHHH
Q 018619          151 HQVKICDFGSAKQLIAGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCV  203 (353)
Q Consensus       151 ~~vkl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i  203 (353)
                       .++|+|||.|.....+.... ......-.-.+.+ . ..|+.++|+||+.--
T Consensus       140 -~~~liDFG~a~~~~~~~~~~-~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~  188 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWRE-ILERDVRNIITYF-S-RTYRTEKDINSAIDR  188 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHH-HHHHHHHHHHHHH-H-HHHCCCCCHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHH-HHHHHHHHHHHHH-c-CCCCCcccHHHHHHH
Confidence             49999999997654332211 1000000001222 1 347899999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.42  E-value=8.3e-07  Score=73.98  Aligned_cols=136  Identities=15%  Similarity=0.099  Sum_probs=83.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECCCCcEEEEEEeeccc----cchHHHHHHHHHcCC-CceeecceeeeecCCCCceeEE
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLETGETVAIKKVLQDR----RYKNRELQLMRVMDH-PNVISLKHCFFSTTSKNELFLN   85 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~   85 (353)
                      +.|++++..+.++.+.||++.  ..++.+++|+.....    ....+|...++.+.- -.+.+++...     ......+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~   86 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN   86 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceE
Confidence            467787776666678999886  366778889875432    345689988887742 1233333333     1223467


Q ss_pred             EEeccccchHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHhHcC----------------------------------
Q 018619           86 LVMEYVPESMYRVLKHYSSANQRMPLIYVKLYTYQIFRGLAYIHTV----------------------------------  131 (353)
Q Consensus        86 lv~e~~~~~l~~~l~~~~~~~~~l~~~~~~~i~~qll~al~~LH~~----------------------------------  131 (353)
                      +||++++|.......   .     +......++.++...+..||+.                                  
T Consensus        87 lv~~~l~G~~~~~~~---~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEY---E-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHT---T-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccc---c-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            999999874221110   0     0011222344455555555542                                  


Q ss_pred             ------------------------CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 ------------------------PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 ------------------------~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                                              ..++|+|+.|.||+++. ++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecC-CceEEEeechhcc
Confidence                                    12789999999999995 5555699999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=2.2e-05  Score=64.65  Aligned_cols=68  Identities=13%  Similarity=0.077  Sum_probs=42.7

Q ss_pred             ecCC-CeEEEEEEECCCCcEEEEEEeeccc-cchHHHHHHHHHcCCCc--eeecceeeeecCCCCceeEEEEeccccc
Q 018619           20 GTGS-FGIVFQAKCLETGETVAIKKVLQDR-RYKNRELQLMRVMDHPN--VISLKHCFFSTTSKNELFLNLVMEYVPE   93 (353)
Q Consensus        20 g~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~~   93 (353)
                      ..|. .+.||++.. ..+..+++|...... ....+|...++.+....  +.+++.+..     +....++||++++|
T Consensus        19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            3444 468998874 567778889775443 34568999888774333  333443331     22246799999976

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.93  E-value=5e-05  Score=66.84  Aligned_cols=72  Identities=21%  Similarity=0.171  Sum_probs=43.1

Q ss_pred             EeeeeecCCCeEEEEEEECCCCcEEEEEEeecc-----------ccchHHHHHHHHHcC-C-C-ceeecceeeeecCCCC
Q 018619           15 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQD-----------RRYKNRELQLMRVMD-H-P-NVISLKHCFFSTTSKN   80 (353)
Q Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~-h-~-~iv~~~~~~~~~~~~~   80 (353)
                      ..+.||.|....||++.+..+++.|++|.-...           ..+...|...|+.+. + | .+.+++.  ++...  
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~--  105 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM--  105 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT--
T ss_pred             eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC--
Confidence            355789999999999998777889999965321           112346888887763 2 2 2333332  22221  


Q ss_pred             ceeEEEEeccccc
Q 018619           81 ELFLNLVMEYVPE   93 (353)
Q Consensus        81 ~~~~~lv~e~~~~   93 (353)
                         .++|||++++
T Consensus       106 ---~~lvmE~L~~  115 (392)
T d2pula1         106 ---AVTVMEDLSH  115 (392)
T ss_dssp             ---TEEEECCCTT
T ss_pred             ---CEEEEeccCC
Confidence               3489999974

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.14  E-value=0.0014  Score=55.71  Aligned_cols=37  Identities=16%  Similarity=0.047  Sum_probs=27.3

Q ss_pred             eEEEEEEECCCCcEEEEEEeecc---ccchHHHHHHHHHcC
Q 018619           25 GIVFQAKCLETGETVAIKKVLQD---RRYKNRELQLMRVMD   62 (353)
Q Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~   62 (353)
                      -.||++.. .+|+.|++|+....   ...+..|...+..|.
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence            57999874 68889999987543   234567888888774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.95  E-value=0.003  Score=55.14  Aligned_cols=73  Identities=14%  Similarity=0.198  Sum_probs=45.8

Q ss_pred             ceeeEeeeeecCCCeEEEEEEECC-------CCcEEEEEEeecccc--chHHHHHHHHHcCCCce-eecceeeeecCCCC
Q 018619           11 ISYMAERVVGTGSFGIVFQAKCLE-------TGETVAIKKVLQDRR--YKNRELQLMRVMDHPNV-ISLKHCFFSTTSKN   80 (353)
Q Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~   80 (353)
                      +..+ ++.|+.|..-.+|++....       .++.|.+++......  ...+|..+++.+.-.++ .+++..+     .+
T Consensus        43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~  116 (395)
T d1nw1a_          43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG  116 (395)
T ss_dssp             GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred             cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC
Confidence            3344 4678889999999998642       345688887653222  23478888888753333 3454444     22


Q ss_pred             ceeEEEEeccccc
Q 018619           81 ELFLNLVMEYVPE   93 (353)
Q Consensus        81 ~~~~~lv~e~~~~   93 (353)
                          ..|+||++|
T Consensus       117 ----g~I~efi~g  125 (395)
T d1nw1a_         117 ----GRLEEYIPS  125 (395)
T ss_dssp             ----EEEECCCCE
T ss_pred             ----ceEEEEecc
Confidence                378888875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.72  E-value=0.0089  Score=50.09  Aligned_cols=30  Identities=27%  Similarity=0.203  Sum_probs=26.0

Q ss_pred             CCeeeccCCCCcEEEeCCCCcEEEeeecccc
Q 018619          132 PRVCHRDLKPQNLLVDPLTHQVKICDFGSAK  162 (353)
Q Consensus       132 ~~i~H~Dlkp~Nill~~~~~~vkl~Dfg~a~  162 (353)
                      .|+||+|+.++|++++. +...-++||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLG-DELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhccc-ccceeEecccccc
Confidence            47999999999999995 6666899999875